PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ayuda-Duran, B; Gonzalez-Manzano, S; Miranda-Vizuete, A; Duenas, M; Santos-Buelga, C; Gonzalez-Paramas, AM				Ayuda-Duran, Begona; Gonzalez-Manzano, Susana; Miranda-Vizuete, Antonio; Duenas, Montserrat; Santos-Buelga, Celestino; Gonzalez-Paramas, Ana M.			Epicatechin modulates stress-resistance in C. elegans via insulin/IGF-1 signaling pathway	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; OXIDATIVE-STRESS; TRANSCRIPTION FACTOR; METHYLATED METABOLITES; FACTOR SKN-1; DAF-16; LONGEVITY; QUERCETIN; MITOHORMESIS	The nematode Caenorhabditis elegans has been used to examine the influence of epicatechin (EC), an abundant flavonoid in the human diet, in some stress biomarkers (ROS production, lipid peroxidation and protein carbonylation). Furthermore, the ability of EC to modulate the expression of some key genes in the insulin/IGF-1 signaling pathway (IIS), involved in longevity and oxidative or heat shock stress response, has also been explored. The final aim was to contribute to the elucidation of the mechanisms involved in the biological effects of flavonoids. The results showed that EC-treated wild-type C. elegans exhibited increased survival and reduced oxidative damage of biomolecules when submitted to thermal stress. EC treatment led to a moderate elevation in ROS levels, which might activate endogenous mechanisms of defense protecting against oxidative insult. The enhanced stress resistance induced by EC was found to be mediated through the IIS pathway, since assays in daf-2, age-1, akt-1, akt-2, sgk-1, daf-16, skn-1 and hsf-1 loss of function mutant strains failed to show any heat-resistant phenotype against thermal stress when treated with EC. Consistently, EC treatment upregulated the expression of some stress resistance associated genes, such as gst-4, hsp-16.2 and hsp-70, which are downstream regulated by the IIS pathway.	[Ayuda-Duran, Begona; Gonzalez-Manzano, Susana; Duenas, Montserrat; Santos-Buelga, Celestino; Gonzalez-Paramas, Ana M.] Univ Salamanca, Grp Invest Polifenoles, Campus Miguel de Unamuno, Salamanca, Spain; [Miranda-Vizuete, Antonio] Univ Seville, Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla, Seville, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Santos-Buelga, C (corresponding author), Univ Salamanca, Grp Invest Polifenoles, Campus Miguel de Unamuno, Salamanca, Spain.	csb@usal.es	González-Paramás, Ana M/D-2229-2011; Santos-Buelga, Celestino/A-1071-2008; Ayuda-Durán, Begoña/AAH-6908-2019; Santos-Buelga, Celestino/U-1358-2019; González-Paramás, Ana María/O-3771-2019; Miranda-Vizuete, Antonio/D-6927-2012	González-Paramás, Ana M/0000-0001-5477-0703; Santos-Buelga, Celestino/0000-0001-6592-5299; Ayuda-Durán, Begoña/0000-0001-9001-7399; González-Paramás, Ana María/0000-0001-5477-0703; Gonzalez Manzano, Susana/0000-0002-5739-515X; Miranda-Vizuete, Antonio/0000-0002-6856-5396	MINECO [AGL2015-64522-C2, BFU2015-64408-P]; FEDER-Interreg Espana-Portugal Programme [0377_IBERPHENOL_6_E]; Junta de Castilla y Leon [Orden EDU/310/2015]	MINECO(Spanish Government); FEDER-Interreg Espana-Portugal Programme(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was funded by MINECO (Spanish National Projects AGL2015-64522-C2 to CS-B and BFU2015-64408-P to AM-V) and FEDER-Interreg Espana-Portugal Programme (Ref. 0377_IBERPHENOL_6_E). Author BA-D is recipient of a PhD fellowship from the Junta de Castilla y Leon (Orden EDU/310/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by MINECO (Spanish National Project AGL2015-64522-C2) (BFU2015-64408-P) and FEDER-Interreg Espana-Portugal Programme (Project ref. 0377_IBERPHENOL_6_E). B.A-D is recipient of PhD fellowships from the Junta de Castilla y Leon (Orden EDU/310/2015). The authors are thankful to Marta Rodriguez-Romero and Jose Antonio Mora-Lorca for providing the necessary help with the assays of RT-qPCR and fluorescence microscopy, respectively.	Abbas S, 2010, PHYTOMEDICINE, V17, P902, DOI 10.1016/j.phymed.2010.03.008; Altintas O, 2016, BMB REP, V49, P81, DOI 10.5483/BMBRep.2016.49.2.261; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andreoli R, 2003, RAPID COMMUN MASS SP, V17, P637, DOI 10.1002/rcm.960; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Asthana J, 2016, FREE RADICAL RES, V50, P861, DOI 10.1080/10715762.2016.1187268; Bahia PK, 2008, J NEUROCHEM, V106, P2194, DOI 10.1111/j.1471-4159.2008.05542.x; Granado-Serrano AB, 2010, BRIT J NUTR, V103, P168, DOI 10.1017/S0007114509991747; Bonomo LDF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089933; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchter C, 2013, INT J MOL SCI, V14, P11895, DOI 10.3390/ijms140611895; Cai WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028835; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Desjardins D, 2017, AGING CELL, V16, P104, DOI 10.1111/acel.12528; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gladyshev VN, 2014, ANTIOXID REDOX SIGN, V20, P727, DOI 10.1089/ars.2013.5228; Gonzalez-Manzano S, 2012, J AGR FOOD CHEM, V60, P8911, DOI 10.1021/jf3004256; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Heidler T, 2010, BIOGERONTOLOGY, V11, P183, DOI 10.1007/s10522-009-9239-x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Koch K, 2014, SCI WORLD J, DOI 10.1155/2014/920398; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansuri ML, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0400-z; Martorell P, 2011, J AGR FOOD CHEM, V59, P2077, DOI 10.1021/jf104217g; Meng J, 2017, REDOX BIOL, V11, P365, DOI 10.1016/j.redox.2016.12.026; Miranda-Vizuete A, 2017, REDOX BIOL, V11, P708, DOI 10.1016/j.redox.2016.12.020; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pietsch K, 2009, BIOGERONTOLOGY, V10, P565, DOI 10.1007/s10522-008-9199-6; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sanz A, 2016, BBA-BIOENERGETICS, V1857, P1116, DOI 10.1016/j.bbabio.2016.03.018; Saul N, 2008, MECH AGEING DEV, V129, P611, DOI 10.1016/j.mad.2008.07.001; Saul N, 2009, MECH AGEING DEV, V130, P477, DOI 10.1016/j.mad.2009.05.005; Schuster E, 2010, MOL SYST BIOL, V10, P6; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Surco-Laos F, 2012, FOOD RES INT, V46, P514, DOI 10.1016/j.foodres.2011.10.014; Surco-Laos F, 2011, FOOD FUNCT, V2, P445, DOI 10.1039/c1fo10049a; Tissenbaum HA, 2015, INVERTEBR REPROD DEV, V59, P59, DOI 10.1080/07924259.2014.940470; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tullet JMA, 2017, AGING CELL, V16, P1191, DOI 10.1111/acel.12627; Upadhyay A, 2013, BIOSCI BIOTECH BIOCH, V77, P217, DOI 10.1271/bbb.120351; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xiong LG, 2018, REDOX BIOL, V14, P305, DOI 10.1016/j.redox.2017.09.019; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105	58	31	31	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0199483	10.1371/journal.pone.0199483	http://dx.doi.org/10.1371/journal.pone.0199483			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689636	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800001
J	Layton, C; Shelamoff, V; Cameron, MJ; Tatsumi, M; Wright, JT; Johnson, CR				Layton, Cayne; Shelamoff, Victor; Cameron, Matthew J.; Tatsumi, Masayuki; Wright, Jeffrey T.; Johnson, Craig R.			Resilience and stability of kelp forests: The importance of patch dynamics and environment-engineer feedbacks	PLOS ONE			English	Article							HABITAT-FORMING KELP; ECKLONIA-RADIATA; PHYSICAL DISTURBANCE; MACROCYSTIS-PYRIFERA; POPULATION BIOLOGY; LIGHT PENETRATION; SEDIMENT MOVEMENT; SUBTIDAL HABITAT; CANOPY; RECRUITMENT	Habitat forming 'ecosystem engineers' such as kelp species create complex habitats that support biodiverse and productive communities. Studies of the resilience and stability of ecosystem engineers have typically focussed on the role of external factors such as disturbance. However, their population dynamics are also likely to be influenced by internal processes, such that the environmental modifications caused by engineer species feedback to affect their own demography (e.g. recruitment, survivorship). In numerous regions globally, kelp forests are declining and experiencing reductions in patch size and kelp density. To explore how resilience and stability of kelp habitats is influenced by this habitat degradation, we created an array of patch reefs of various sizes and supporting adult Ecklonia radiata kelp transplanted at different densities. This enabled testing of how sub-canopy abiotic conditions change with reductions in patch size and adult kelp density, and how this influenced demographic processes of microscopic and macroscopic juvenile kelp. We found that ecosystem engineering by adult E. radiata modified the environment to reduce sub-canopy water flow, sedimentation, and irradiance. However, the capacity of adult kelp canopy to engineer abiotic change was dependent on patch size, and to a lesser extent, kelp density. Reductions in patch size and kelp density also impaired the recruitment, growth and survivorship of microscopic and macroscopic juvenile E. radiata, and even after the provisioning of established juveniles, demographic processes were impaired in the absence of sufficient adult kelp. These results are consistent with the hypothesis that ecosystem engineering by adult E. radiata facilitates development of juvenile conspecifics. Habitat degradation seems to impair the ability of E. radiata to engineer abiotic change, causing breakdown of positive intraspecific feedback and collapse of demographic functions, and overall, leading to reductions in ecosystem stability and resilience well before local extirpation.	[Layton, Cayne; Shelamoff, Victor; Cameron, Matthew J.; Tatsumi, Masayuki; Wright, Jeffrey T.; Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Tasmania	Layton, C (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	cayne.layton@utas.edu.au	Layton, Cayne/J-8443-2013; Wright, Jeffrey/J-7536-2014	Layton, Cayne/0000-0002-3390-6437; Wright, Jeffrey/0000-0002-1085-4582	Australian Research Council [DP130101113]; Holsworth Wildlife Research Endowment; Australian Government Postgraduate Award	Australian Research Council(Australian Research Council); Holsworth Wildlife Research Endowment; Australian Government Postgraduate Award(Australian Government)	This study was funded by an Australian Research Council Discovery Grant (DP130101113; www.arc.gov.au) awarded to JTW and CRJ, and a Holsworth Wildlife Research Endowment (www.ecolsoc.org.au/awards-and-prizes/holsworth-wildlife-research-endowment) awarded to CL. CL was also supported by an Australian Government Postgraduate Award (www.education.gov.au) administered through the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Altamirano M, 2004, AQUAT BOT, V79, P125, DOI 10.1016/j.aquabot.2004.01.011; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Bennett S, 2015, ECOL LETT, V18, P677, DOI 10.1111/ele.12446; Bennett S, 2014, J ECOL, V102, P1462, DOI 10.1111/1365-2745.12302; Bulleri F, 2009, J ECOL, V97, P1121, DOI 10.1111/j.1365-2745.2009.01567.x; CHAPMAN ARO, 1984, J EXP MAR BIOL ECOL, V78, P99, DOI 10.1016/0022-0981(84)90072-8; Cie DK, 2008, J PHYCOL, V44, P495, DOI 10.1111/j.1529-8817.2008.00464.x; Coleman MA, 2009, MAR FRESHWATER RES, V60, P802, DOI 10.1071/MF08268; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2003, MAR BIOL, V142, P1065, DOI 10.1007/s00227-003-1021-z; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Crain CM, 2006, BIOSCIENCE, V56, P211; Crotty SM, 2015, ECOLOGY, V96, P2575, DOI 10.1890/15-0240.1; Cuddington K, 2009, AM NAT, V173, P488, DOI 10.1086/597216; DAYTON PK, 1984, ECOL MONOGR, V54, P253, DOI 10.2307/1942498; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; Denny M, 1998, LIMNOL OCEANOGR, V43, P955, DOI 10.4319/lo.1998.43.5.0955; DEVINNY JS, 1978, MAR BIOL, V48, P343, DOI 10.1007/BF00391638; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V129, P173, DOI 10.1016/0022-0981(89)90055-5; Fairhead VA, 2004, MAR BIOL, V145, P41, DOI 10.1007/s00227-004-1308-8; Filbee-Dexter K, 2018, BIOSCIENCE, V68, P64, DOI 10.1093/biosci/bix147; FLETCHER WJ, 1983, J EXP MAR BIOL ECOL, V71, P205, DOI 10.1016/0022-0981(83)90115-6; Flukes EB, 2014, MAR ECOL PROG SER, V514, P57, DOI 10.3354/meps10964; Flukes EB, 2012, MAR ECOL PROG SER, V464, P179, DOI 10.3354/meps09881; FONSECA MS, 1986, MAR ECOL PROG SER, V29, P15, DOI 10.3354/meps029015; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Graham MH, 2003, ECOLOGY, V84, P1250, DOI 10.1890/0012-9658(2003)084[1250:CPOTSA]2.0.CO;2; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hurd CL, 2000, J PHYCOL, V36, P453, DOI 10.1046/j.1529-8817.2000.99139.x; Irving AD, 2002, MAR ECOL PROG SER, V245, P83, DOI 10.3354/meps245083; Irving AD, 2006, MAR ECOL PROG SER, V324, P127, DOI 10.3354/meps324127; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones CG, 2010, OIKOS, V119, P1862, DOI 10.1111/j.1600-0706.2010.18782.x; JONES GP, 1990, AUST J ECOL, V15, P505, DOI 10.1111/j.1442-9993.1990.tb01474.x; Jurg B, 1996, AQUAT SCI, V58, P283, DOI 10.1007/BF00877472; KENDRICK GA, 1991, J EXP MAR BIOL ECOL, V147, P47, DOI 10.1016/0022-0981(91)90036-V; KENNELLY SJ, 1987, J EXP MAR BIOL ECOL, V112, P49, DOI 10.1016/S0022-0981(87)80014-X; KENNELLY SJ, 1993, J EXP MAR BIOL ECOL, V168, P35, DOI 10.1016/0022-0981(93)90115-5; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P145, DOI 10.3354/meps040145; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Kinlan BP, 2003, J PHYCOL, V39, P47, DOI 10.1046/j.1529-8817.2003.02087.x; KIRKMAN H, 1981, J EXP MAR BIOL ECOL, V55, P243, DOI 10.1016/0022-0981(81)90115-5; Kitching JA, 1941, BIOL BULL-US, V80, P324, DOI 10.2307/1537719; KOMAR PD, 1973, J SEDIMENT PETROL, V43, P1101; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; LUNING K, 1979, HELGOLAND WISS MEER, V32, P403, DOI 10.1007/BF02277985; Mabin CJT, 2013, MAR ECOL PROG SER, V483, P117, DOI 10.3354/meps10261; Mohring MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065310; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Porter ET, 2000, LIMNOL OCEANOGR, V45, P145, DOI 10.4319/lo.2000.45.1.0145; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; REED DC, 1990, ECOLOGY, V71, P776, DOI 10.2307/1940329; Romero GQ, 2015, BIOL REV, V90, P877, DOI 10.1111/brv.12138; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Smale DA, 2011, MAR BIOL, V158, P1757, DOI 10.1007/s00227-011-1689-4; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Strain EMA, 2014, GLOBAL CHANGE BIOL, V20, P3300, DOI 10.1111/gcb.12619; Tatsumi M, 2016, MAR ECOL PROG SER, V552, P131, DOI 10.3354/meps11743; Teagle H, 2017, J EXP MAR BIOL ECOL, V492, P81, DOI 10.1016/j.jembe.2017.01.017; THOMPSON TL, 1994, LIMNOL OCEANOGR, V39, P1768, DOI 10.4319/lo.1994.39.7.1768; Toohey B, 2004, MAR BIOL, V144, P1019, DOI 10.1007/s00227-003-1267-5; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Toohey BD, 2007, J EXP MAR BIOL ECOL, V349, P170, DOI 10.1016/j.jembe.2007.05.008; Valentine JP, 2005, BOT MAR, V48, P106, DOI 10.1515/BOT.2005.025; van der Zee EM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2326; Vega JMA, 2005, REV CHIL HIST NAT, V78, P33; VELIMIROV B, 1979, BOT MAR, V22, P169, DOI 10.1515/botm.1979.22.3.169; Verges A, 2016, P NATL ACAD SCI USA, V113, P13791, DOI 10.1073/pnas.1610725113; Watanabe H, 2016, SCI REP-UK, V6, DOI 10.1038/srep18677; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2018, OCEANOGRAPHY MARINE, V57; WOOD WF, 1987, MAR BIOL, V96, P143, DOI 10.1007/BF00394848; Wright JP, 2004, OIKOS, V105, P336, DOI 10.1111/j.0030-1299.2004.12654.x	88	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210220	10.1371/journal.pone.0210220	http://dx.doi.org/10.1371/journal.pone.0210220			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682047	Green Published, gold, Green Accepted			2022-12-27	WOS:000457037500028
J	Souverein, D; Euser, SM; Herpers, BL; Kluytmans, J; Rossen, JWA; Den Boer, JW				Souverein, Dennis; Euser, Sjoerd M.; Herpers, Bjorn L.; Kluytmans, Jan; Rossen, John W. A.; Den Boer, Jeroen W.			Association between rectal colonization with Highly Resistant Gram-negative Rods (HR-GNRs) and subsequent infection with HR-GNRs in clinical patients: A one year historical cohort study	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; INTENSIVE-CARE; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; HOSPITAL ADMISSION; PREVALENCE; BACTEREMIA; CARRIAGE; DECOLONIZATION; EPIDEMIOLOGY	Objective Rectal colonization with Highly Resistant Gram-negative Rods (HR-GNRs) probably precedes infection. We aimed to assess the association between rectal HR-GNR colonization and subsequent HR-GNR infection in clinical patients during a follow-up period of one year in a historical cohort study design. Methods Rectal HR-GNR colonization was assessed by culturing. Subsequent development of infection was determined by assessing all clinical microbiological culture results extracted from the laboratory information system including clinical data regarding HR-GNR infections. A multivariable logistic regression model was constructed with HR-GNR rectal colonization as independent variable and HR-GNR infection as dependent variable. Gender, age, antibiotic use, historic clinical admission and previous (HR-GNR) infections were included as possible confounders. Results 1133 patients were included of whom 68 patients (6.1%) were colonized with a HR-GNR. In total 22 patients with HR-GNR infections were detected. Urinary tract infections were most common (n = 14, 63.6%), followed by bloodstream infections (n = 5, 22.7%) and other infections (n = 8, 36.4%). Eight out of 68 HR-GNR colonized patients (11.8%) developed a subsequent HR-GNR infection compared to 14 out of 1065 HR-GNR negative patients (1.3%), resulting in an odds ratio (95% CI) of 7.1 (2.8-18.1) in the multivariable logistic regression analyses. Conclusions Rectal colonization with a HR-GNR was a significant risk factor for a subsequent HR-GNR infection. This implies that historical colonization culture results should be considered in the choice of empirical antibiotic therapy to include coverage of the cultured HR-GNR, at least in critically ill patients.	[Souverein, Dennis; Euser, Sjoerd M.; Herpers, Bjorn L.; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands; [Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan] Univ Med Ctr, Utrecht, Netherlands; [Rossen, John W. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	Amphia Hospital; Utrecht University; Utrecht University Medical Center; University of Groningen	Souverein, D (corresponding author), Reg Publ Hlth Lab Kennemerland, Dept Epidemiol & Infect Prevent, Haarlem, Netherlands.	d.souverein@streeklabhaarlem.nl	Rossen, John W/G-7564-2011	Rossen, John W/0000-0002-7167-8623				Abernethy J, 2017, J HOSP INFECT, V95, P365, DOI 10.1016/j.jhin.2016.12.008; Bar-Yoseph H, 2016, J ANTIMICROB CHEMOTH, V71, P2729, DOI 10.1093/jac/dkw221; Blakiston M, 2014, INFECT DRUG RESIST, V7, P301, DOI 10.2147/IDR.S66036; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Donker Tjibbe, 2015, Ned Tijdschr Geneeskd, V159, pA8468; European Association of Urology, GUIDELINES UROLOGICA; Ferdous M, 2015, J CLIN MICROBIOL, V53, P3530, DOI 10.1128/JCM.01899-15; Fouda R, 2016, J INFECT DEV COUNTR, V10, P329, DOI 10.3855/jidc.6798; Goodman KE, 2016, CLIN INFECT DIS, V63, P896, DOI 10.1093/cid/ciw425; Gorrie CL, 2017, CLIN INFECT DIS, V65, P208, DOI 10.1093/cid/cix270; Grigoryan L, 2014, JAMA-J AM MED ASSOC, V312, P1677, DOI 10.1001/jama.2014.12842; Harris AD, 2016, INFECT CONT HOSP EP, V37, P544, DOI 10.1017/ice.2015.346; Kirby A, 2015, J HOSP INFECT, V89, P259, DOI 10.1016/j.jhin.2014.11.016; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Manges AR, 2016, INFECT DIS-NOR, V48, P587, DOI 10.1080/23744235.2016.1177199; Martin RM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00261-16; Nicolle L E, 2005, Can J Infect Dis Med Microbiol, V16, P349; NIVEL/IQ, INC PREV; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pires J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01069; Platteel TN, 2015, CLIN MICROBIOL INFEC, V21, P141, DOI 10.1016/j.cmi.2014.09.014; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Rottier WC, 2015, CLIN INFECT DIS, V60, P1622, DOI 10.1093/cid/civ121; Rottier WC, 2012, J ANTIMICROB CHEMOTH, V67, P1311, DOI 10.1093/jac/dks065; Ruppe E, 2012, EUR J CLIN MICROBIOL, V31, P319, DOI 10.1007/s10096-011-1313-z; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Schwaber MJ, 2005, ANTIMICROB AGENTS CH, V49, P2137, DOI 10.1128/AAC.49.5.2137-2139.2005; SELDEN R, 1971, ANN INTERN MED, V74, P657, DOI 10.7326/0003-4819-74-5-657; Souverein D, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0107-6; Twisk JWR., 2011, INLEIDING TOEGEPASTE; Valenza G, 2017, INFECT DIS-NOR, V49, P405, DOI 10.1080/23744235.2016.1274420; Willemsen I, 2011, INFECT CONT HOSP EP, V32, P333, DOI 10.1086/658941; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou K, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.009	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211016	10.1371/journal.pone.0211016	http://dx.doi.org/10.1371/journal.pone.0211016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682095	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500091
J	Tombak, EM; Mannik, A; Burk, RD; Le Grand, R; Ustav, E; Ustav, M				Tombak, Eva-Maria; Mannik, Andres; Burk, Robert D.; Le Grand, Roger; Ustav, Ene; Ustav, Mart			The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing	PLOS ONE			English	Article							DNA-REPLICATION; EPIDERMODYSPLASIA-VERRUCIFORMIS; TRANSCRIPTION MAP; CERVICAL-CANCER; MESSENGER-RNAS; PHYSICAL STATE; GENE-PRODUCT; TYPE-16 DNA; E2 PROTEINS; CELL-LINES	Due to the extreme tissue and species restriction of the papillomaviruses (PVs), there is a great need for animal models that accurately mimic PV infection in humans for testing therapeutic strategies against human papillomaviruses (HPVs). In this study, we present data that demonstrate that in terms of gene expression during initial viral DNA amplification, Macaca fascicularis PV (MfPV) types 5 and 8 appear to be similar to mucosal oncogenic HPVs, while MfPV1 (isolated from skin) resembles most high-risk cutaneous beta HPVs (HPV5). Similarities were also observed in replication properties during the initial amplification phase of the MfPV genomes. We demonstrate that high-risk mucosal HPV-specific inhibitors target the transient replication of the MfPV8 genomes, which indicates that similar pathways are used by the high-risk HPVs and MfPVs during their genome replication. Taking all into account, we propose that Macaca fascicularis may serve as a highly relevant model for preclinical tests designed to evaluate therapeutic strategies against HPV-associated lesions.	[Tombak, Eva-Maria; Mannik, Andres; Ustav, Ene; Ustav, Mart] Univ Tartu, Inst Technol, Tartu, Estonia; [Tombak, Eva-Maria; Mannik, Andres; Ustav, Mart] Icosagen Cell Factory Ltd, Eerika Tee 1, Kambja, Tartumaa, Estonia; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat Genet, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Le Grand, Roger] Univ Paris Sud, INSERM, U1184,IDMIT Dept,IBFJ, Immunol Viral Infect & Autoimmune Dis IMVA,CEA, Fontenay Aux Roses, France; [Ustav, Mart] Estonian Acad Sci, Tallinn, Estonia	University of Tartu; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Tartu, Estonia.; Ustav, M (corresponding author), Icosagen Cell Factory Ltd, Eerika Tee 1, Kambja, Tartumaa, Estonia.; Ustav, M (corresponding author), Estonian Acad Sci, Tallinn, Estonia.	mart.ustav@icosagen.ee			Estonian Research Council [PRG198, IUT 20-27]; Center of Excellence in Molecular Cell Engineering through the European Regional Development Fund [2014-2020.4.01.15-0013]	Estonian Research Council; Center of Excellence in Molecular Cell Engineering through the European Regional Development Fund	This study was funded by the Estonian Research Council, http://www.etag.ee/en/, funding numbers PRG198 (recipient Prof. Mart Ustav) and IUT 20-27 (recipient Prof. Andres Merits); and by the Center of Excellence in Molecular Cell Engineering (2014-2020.4.01.15-0013) through the European Regional Development Fund (recipient Prof. Tanel Tenson), http://ec.europa.eu/regional_policy/en/funding/erdf/.The funder provided support in the form of salaries for authors [MU, EMT, AM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi A, 1996, J CLIN MICROBIOL, V34, P369, DOI 10.1128/JCM.34.2.369-375.1996; Alazawi W, 2002, CANCER RES, V62, P6959; Ammermann I, 2008, J VIROL, V82, P5127, DOI 10.1128/JVI.02647-07; Antony S, 2007, NUCLEIC ACIDS RES, V35, P4474, DOI 10.1093/nar/gkm463; ATANASIU P, 1948, ANN I PASTEUR PARIS, V74, P246; Benoit RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153158; Bergin IL, 2013, VET PATHOL, V50, P200, DOI 10.1177/0300985812439725; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chan SY, 1997, J VIROL, V71, P4938, DOI 10.1128/JVI.71.7.4938-4943.1997; Chen ZG, 2009, VIROLOGY, V393, P304, DOI 10.1016/j.virol.2009.07.012; CHESTERS PM, 1985, J GEN VIROL, V66, P615, DOI 10.1099/0022-1317-66-3-615; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHIANG CM, 1992, J VIROL, V66, P5224, DOI 10.1128/JVI.66.9.5224-5231.1992; CHOO KB, 1987, J MED VIROL, V21, P101, DOI 10.1002/jmv.1890210202; CHOW LT, 1987, J VIROL, V61, P2581, DOI 10.1128/JVI.61.8.2581-2588.1987; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; Dexheimer TS, 2009, J MED CHEM, V52, P7122, DOI 10.1021/jm901061s; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; DURST M, 1985, J GEN VIROL, V66, P1515, DOI 10.1099/0022-1317-66-7-1515; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Flores ER, 1997, J VIROL, V71, P7167, DOI 10.1128/JVI.71.10.7167-7179.1997; FRATTINI MG, 1994, VIROLOGY, V204, P799, DOI 10.1006/viro.1994.1596; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Gao G, 2016, CYTOGENET GENOME RES, V150, P185, DOI 10.1159/000458166; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Grassmann K, 1996, J VIROL, V70, P2339, DOI 10.1128/JVI.70.4.2339-2349.1996; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Henno Liisi, 2017, Curr Protoc Microbiol, V45, DOI 10.1002/cpmc.28; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hong SY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003295; Isok-Paas H, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0292-6; Jeckel S, 2003, J VIROL, V77, P8736, DOI 10.1128/JVI.77.16.8736-8744.2003; Joh J, 2009, J GEN VIROL, V90, P987, DOI 10.1099/vir.0.006544-0; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; KRISTIANSEN E, 1994, J CLIN PATHOL, V47, P253, DOI 10.1136/jcp.47.3.253; Kumar Sushil, 2015, Med J Armed Forces India, V71, P171, DOI 10.1016/j.mjafi.2015.02.006; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; Lace MJ, 2008, J VIROL, V82, P10841, DOI 10.1128/JVI.01481-08; Lacey CJN, 2013, J EUR ACAD DERMATOL, V27, pe263, DOI 10.1111/j.1468-3083.2012.04493.x; LAMBERT PF, 1990, J VIROL, V64, P950, DOI 10.1128/JVI.64.2.950-956.1990; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; Nicol AF, 2015, ANN DIAGN PATHOL, V19, P418, DOI 10.1016/j.anndiagpath.2015.07.008; Orav M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15952; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; OSTROW RS, 1990, P NATL ACAD SCI USA, V87, P8170, DOI 10.1073/pnas.87.20.8170; Peh WL, 2002, J VIROL, V76, P10401, DOI 10.1128/JVI.76.20.10401-10416.2002; Pfister H, 2003, ARCH DERMATOL RES, V295, P273, DOI 10.1007/s00403-003-0435-2; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; Pim D, 2012, FEBS J, V279, P3530, DOI 10.1111/j.1742-4658.2012.08709.x; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Rosales R, 2014, WORLD J CLIN ONCOL, V5, P1002, DOI 10.5306/wjco.v5.i5.1002; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHVARTZMAN JB, 1990, MOL CELL BIOL, V10, P3078, DOI 10.1128/MCB.10.6.3078; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; SEDMAN SA, 1991, J VIROL, V65, P4860, DOI 10.1128/JVI.65.9.4860-4866.1991; Sedman T, 1997, J VIROL, V71, P2887, DOI 10.1128/JVI.71.4.2887-2896.1997; SMOTKIN D, 1989, J VIROL, V63, P1441, DOI 10.1128/JVI.63.3.1441-1447.1989; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Stubenrauch F, 2000, J VIROL, V74, P1178, DOI 10.1128/JVI.74.3.1178-1186.2000; SVERDRUP F, 1994, J VIROL, V68, P505, DOI 10.1128/JVI.68.1.505-509.1994; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; THIERRY F, 1987, J VIROL, V61, P134, DOI 10.1128/JVI.61.1.134-142.1987; Toots M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006168; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; Van Doorslaer K, 2013, VIROLOGY, V445, P11, DOI 10.1016/j.virol.2013.05.012; VANRANST M, 1991, J ORAL PATHOL MED, V20, P325; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wood CE, 2011, VET PATHOL, V48, P731, DOI 10.1177/0300985810383875; Wood CE, 2004, VET PATHOL, V41, P108, DOI 10.1354/vp.41-2-108; Wood CE, 2007, J VIROL, V81, P6339, DOI 10.1128/JVI.00233-07; Zobel T, 2003, MOL CELL BIOL, V23, P8352, DOI 10.1128/MCB.23.22.8352-8362.2003	83	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211235	10.1371/journal.pone.0211235	http://dx.doi.org/10.1371/journal.pone.0211235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682126	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500130
J	Varkey, R; Du, Q; Karnell, JL; Xiao, XD; Casey, KA; Woods, R; Rosenthai, K; Wilson, S; Dall'Acqua, WF; Wu, H; Herbst, R; Ettinger, R; Damschroder, M				Varkey, Reena; Du, Qun; Karnell, Jodi L.; Xiao, Xiaodong; Casey, Kerry A.; Woods, Rob; Rosenthai, Kim; Wilson, Susan; Dall'Acqua, William F.; Wu, Herren; Herbst, Ronald; Ettinger, Rachel; Damschroder, Melissa			Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy	PLOS ONE			English	Article							COMMON GAMMA-CHAIN; MONOCLONAL-ANTIBODIES; VARIABLE REGION; MOUSE MODEL; RECEPTOR; INTERLEUKIN-21; GENERATION; GLYCOSYLATION; CARBOHYDRATE; PROTEINS	Interleukin-21 (IL-21), a member of the common cytokine receptor gamma chain (gamma(c)) family, is secreted by CD4(+)T cells and natural killer T cells and induces effector function through interactions with the IL-21 receptor (IL-21R)/gamma(c) complex expressed on both immune and non-immune cells. Numerous studies suggest that IL-21 plays a significant role in autoimmune disorders. Therapeutic intervention to disrupt the IL-21/IL-21R/gamma(c) interaction and inhibit subsequent downstream signal transduction could offer a treatment paradigm for these diseases. Potent neutralizing antibodies reported in the literature were generated after extensive immunizations with human IL-21 alone and in combination with various adjuvants. To circumvent the laborious method of antibody generation while targeting a conserved functional epitope, we designed a novel alternating-antigen immunization strategy utilizing both human and cynomolgus monkey (cyno) IL-21. Despite the high degree of homology between human and cyno IL-21, our alternating-immunization strategy elicited higher antibody titers and more potent neutralizing hybridomas in mice than did the immunization with human IL-21 antigen alone. The lead hybridoma clone was humanized by grafting the murine complementarity-determining regions onto human germline framework templates, using a unique rational design. The final humanized and engineered antibody, MEDI7169, encodes only one murine residue at the variable heavy/light-chain interface, retains the sub-picomolar affinity for IL-21, specifically inhibits IL-21/IL-21R-mediated signaling events and is currently under clinical development as a potential therapeutic agent for autoimmune diseases. This study provides experimental evidence of the immune system's potential to recognize and respond to shared epitopes of antigens from distinct species, and presents a generally applicable, novel method for the rapid generation of exceptional therapeutic antibodies using the hybridoma platform.	[Varkey, Reena; Du, Qun; Xiao, Xiaodong; Woods, Rob; Rosenthai, Kim; Wilson, Susan; Dall'Acqua, William F.; Wu, Herren; Damschroder, Melissa] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Karnell, Jodi L.; Casey, Kerry A.; Herbst, Ronald; Ettinger, Rachel] MedImmune LLC, Dept Resp Inflammat & Autoimmun, Gaithersburg, MD USA; [Karnell, Jodi L.; Ettinger, Rachel] Viela Bio, Gaithersburg, MD USA; [Xiao, Xiaodong] Jecho Labs, Frederick, MD USA; [Woods, Rob] Novavax, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Damschroder, M (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	DamschroderM@medimmune.com	Casey, Kerry A/B-5274-2011; Casey, Kerry A/N-1456-2019	Casey, Kerry A/0000-0001-7194-8585; 	MedImmune, the global R&D biologics arm of AstraZeneca	MedImmune, the global R&D biologics arm of AstraZeneca	This work was funded by MedImmune, the global R&D biologics arm of AstraZeneca.	Abdiche YN, 2009, ANAL BIOCHEM, V386, P172, DOI 10.1016/j.ab.2008.11.038; ABEL CA, 1968, BIOCHEMISTRY-US, V7, P1271, DOI 10.1021/bi00844a004; Adair JR, 1999, US patent, Patent No. [5,859,205, 5859205]; Ahmadzadeh Vahideh, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P67, DOI 10.1089/mab.2013.0080; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Bazan J, 2012, HUM VACC IMMUNOTHER, V8, P1817, DOI 10.4161/hv.21703; Brewer JM, 1999, J IMMUNOL, V163, P6448; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Coloma MJ, 1999, J IMMUNOL, V162, P2162; Costanzo A, 2010, J DERMATOL SCI, V60, P61, DOI 10.1016/j.jdermsci.2010.08.016; Dall'Acqua WF, 2005, METHODS, V36, P43, DOI 10.1016/j.ymeth.2005.01.005; Damschroder MM, 2007, MOL IMMUNOL, V44, P3049, DOI 10.1016/j.molimm.2006.12.019; Dolff S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3474; Dong S, 2017, ANAL BIOCHEM, V531, P60, DOI 10.1016/j.ab.2017.05.016; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Ettinger CK, US, Patent No. [10, 022, 443, B2, 10022443]; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Hamming OJ, 2012, J BIOL CHEM, V287, P9454, DOI 10.1074/jbc.M111.311084; Herber D, 2007, J IMMUNOL, V178, P3822, DOI 10.4049/jimmunol.178.6.3822; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Kabat EA, 1991, SEQUENCES PROTEINS I; Kang KY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3504; KHAZAELI MB, 1994, J IMMUNOTHER, V15, P42, DOI 10.1097/00002371-199401000-00006; Kohler G, 2005, J IMMUNOL, V174, P2453; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Li QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068145; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Liu LM, 2015, J PHARM SCI-US, V104, P1866, DOI 10.1002/jps.24444; Liu R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4100; Lo Benny K C, 2004, Methods Mol Biol, V248, P135; Maurer MF, 2012, MABS-AUSTIN, V4, P69, DOI 10.4161/mabs.4.1.18713; McGuire HM, 2011, IMMUNITY, V34, P602, DOI 10.1016/j.immuni.2011.01.021; Michels DA, 2012, ANAL CHEM, V84, P5380, DOI 10.1021/ac3008847; Nakou M, 2013, CLIN EXP RHEUMATOL, V31, P172; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Reichert JM, 2016, THERAPEUTIC MONOCLON; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Rossant CJ, 2015, J BIOMOL SCREEN, V20, P508, DOI 10.1177/1087057114557464; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Terrier B, 2012, ARTHRITIS RHEUM-US, V64, P2001, DOI 10.1002/art.34327; Vugmeyster Y, 2010, MABS-AUSTIN, V2, P335, DOI 10.4161/mabs.2.3.11850; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; Wu PW., 2008, RAT RABBIT CYNOMOLGU; Yagami H, 2013, PHARM PAT ANAL, V2, P249, DOI [10.4155/PPA.13.2, 10.4155/ppa.13.2]; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zhang JL, 2003, BIOCHEM BIOPH RES CO, V300, P291, DOI 10.1016/S0006-291X(02)02836-X; Zhu M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-65	58	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211236	10.1371/journal.pone.0211236	http://dx.doi.org/10.1371/journal.pone.0211236			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682117	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500131
J	Drysch, M; Wallner, C; Schmidt, SV; Reinkemeier, F; Wagner, JM; Lehnhardt, M; Behr, B				Dryschi, Marius; Wallner, Christoph; Schmidt, Sonja Verena; Reinkemeier, Felix; Wagner, Johannes Maximilian; Lehnhardt, Marcus; Behr, Bjoern			An optimized low-pressure tourniquet murine hind limb ischemia reperfusion model: Inducing acute ischemia reperfusion injury in C57BL/6 wild type mice	PLOS ONE			English	Article							P38 MAPK; SKELETAL-MUSCLE; MOUSE MODEL; ACTIVATION; CELLS; ISCHEMIA/REPERFUSION; PERFUSION; MARKER; KINASE	Acute ischemia reperfusion injury in skeletal muscle remains an important issue in several fields of regenerative medicine. Thus, a valid model is essential to gain deeper insights into pathophysiological relations and evaluate possible treatment options. While the vascular anatomy of mice regularly prevents sufficient vessel occlusion by invasive methods, there is a multitude of existing models to induce ischemia reperfusion injury without surgical procedures. Since there is no consensus on which model to prefer, this study aims to develop and evaluate a novel, optimized low-pressure tourniquet model. C57BL/6 mice underwent an ischemic procedure by either tourniquet or invasive artery clamping. A sham group served as control. With exception of the sham group, mice underwent 2 hours of ischemia followed by 4 hours of reperfusion. Groups were compared using microcirculatory and spectroscopic measurements, distinctions in tissue edema, histological and immunohistochemical analyses. Both procedures led to a significant decrease in tissue blood flow (-97% vs. -86%) and oxygenation (-87% vs. -75%) with a superiority of the low-pressure tourniquet. Tissue edema in the tourniquet cohort was significantly increased (+59%), while the increase in the clamping cohort was non-significant (+7%). Haematoxylin Eosin staining showed significantly more impaired muscle fibers in the tourniquet group (+77 p.p. vs. +11 p.p.) and increased neutrophil infiltration/ROI (+51 vs. +8). Immunofluorescence demonstrated an equal increase of p38 in both groups (7-fold vs. 8-fold), while the increase in apoptotic markers (Caspase-3, 3-Nitrotyrosine, 4-Hydroxynonenal) was significantly higher in the tourniquet group. The low-pressure tourniquet has been proven to produce reproducible and thus reliable ischemia reperfusion injury. In addition, significantly less force was needed than previously stated. It is therefore an important instrument for studying the pathophysiology of ischemia reperfusion injury and for the development of prophylactic as well as therapeutic interventions.	[Dryschi, Marius; Wallner, Christoph; Schmidt, Sonja Verena; Reinkemeier, Felix; Wagner, Johannes Maximilian; Lehnhardt, Marcus; Behr, Bjoern] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Burkle Camp Pl 1, Bochum, Germany	Ruhr University Bochum	Wallner, C (corresponding author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Burkle Camp Pl 1, Bochum, Germany.	christoph.wallner@bergmannsheil.de	Behr, Björn/AAS-1877-2021; Drysch, Marius/AAY-2816-2020	, Marius/0000-0001-8447-2694				Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Bonheur JA, 2004, J SURG RES, V116, P55, DOI 10.1016/S0022-4804(03)00232-4; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Claytor RB, 2007, J RECONSTR MICROSURG, V23, P93, DOI 10.1055/s-2007-970189; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Gomez-Rodriguez V, 2015, FASEB J, V29, P960, DOI 10.1096/fj.14-259689; Griffin G, 2014, REV SCI TECH OIE, V33, P265, DOI 10.20506/rst.33.1.2283; Hammers DW, 2011, EXP GERONTOL, V46, P265, DOI 10.1016/j.exger.2010.11.002; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Herce-Pagliai C, 1998, NITRIC OXIDE-BIOL CH, V2, P324, DOI 10.1006/niox.1998.0192; Ikebe K, 2001, J SURG RES, V99, P1, DOI 10.1006/jsre.2001.6134; Kim SH, 2019, MINERVA ANESTESIOL, V85, P279, DOI 10.23736/S0375-9393.18.13015-X; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koca K, 2011, J TRAUMA, V70, P717, DOI 10.1097/TA.0b013e3181f30fb0; Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047; Koul Ashok Raj, 2013, Indian J Plast Surg, V46, P247, DOI 10.4103/0970-0358.118600; Kumphune S, 2015, PHARM BIOL, V53, P1831, DOI 10.3109/13880209.2015.1014569; Liu W, 2000, J CELL SCI, V113, P635; Marais E, 2001, J MOL CELL CARDIOL, V33, P769, DOI 10.1006/jmcc.2001.1347; Mars M, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1125; Martins L, 2014, METHODS MOL BIOL, V1213, P147, DOI 10.1007/978-1-4939-1453-1_13; McFalls EO, 2004, AM J PHYSIOL-HEART C, V287, pH1328, DOI 10.1152/ajpheart.01188.2003; Muyskens JB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12671; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; Padgett ME, 2016, JOVE-J VIS EXP, DOI 10.3791/54166; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rasmussen LE, 2018, KNEE, V25, P306, DOI 10.1016/j.knee.2018.01.002; Soenmez TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066498; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Syslova K, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/562860; Thomas D, 2016, TISSUE ENG PART C-ME, V22, P370, DOI [10.1089/ten.tec.2015.0441, 10.1089/ten.TEC.2015.0441]; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; Yassin MMI, 2002, WORLD J SURG, V26, P115, DOI 10.1007/s00268-001-0169-2; Zarkovic N., MOL ASPECTS MED, V24, P281	40	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210961	10.1371/journal.pone.0210961	http://dx.doi.org/10.1371/journal.pone.0210961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677066	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400037
J	Meybosch, S; De Monie, A; Anne, C; Bruyndonckx, L; Jurgens, A; De Winter, BY; Trouet, D; Ledeganck, KJ				Meybosch, Sarang; De Monie, Amandine; Anne, Charlotte; Bruyndonckx, Luc; Juergens, Angelika; De Winter, Benedicte Y.; Trouet, Dominique; Ledeganck, Kristien J.			Epidermal growth factor and its influencing variables in healthy children and adults	PLOS ONE			English	Article							EGF; EXCRETION; URINE; RAT; EXPRESSION; RECOVERY; ROLES; TRPM6; AGE	Background & objective Epidermal growth factor (EGF) stimulates cell proliferation and differentiation after binding to its receptor. Next to its role in magnesium homeostasis, EGF disturbances have been described in oncology, diabetes and autism spectrum disorders. The aim of this study was to determine EGF serum and urine values for both healthy children and adults. Next, we investigated the relation between several variables and urinary and serum EGF concentrations. Methods Both healthy adults (n = 50) and children (n = 78) were included. Serum and urinary EGF concentrations were measured with ELISA technology. Results Serum EGF was inversely correlated with age (r = -0.873; p<0.001) and positively correlated with serum magnesium (r = 0.597; p<0.001). The urinary EGF was also inversely correlated with age (r = -0.855; p<0.001). In adults and children older than 13 years of age, the urinary EGF significantly differed between sexes (p = 0.001). Urinary EGF was positively correlated with serum magnesium (r = 0.583; p<0.001) and creatinine clearance (r = 0.524; p<0.001) and negatively correlated with the fractional excretion of magnesium (r = 0.248; p = 0.014). In a multivariate model, age and serum magnesium remained independently related to serum EGF while age, serum EGF and serum magnesium remained independently related to urinary EGF. Conclusions This study provides valuable insights in urinary and serum EGF patterns in healthy subjects. By systematically correcting EGF for body surface, significant correlations with age, gender and magnesium were observed.	[Meybosch, Sarang; De Monie, Amandine; Anne, Charlotte; Bruyndonckx, Luc; Juergens, Angelika; De Winter, Benedicte Y.; Trouet, Dominique; Ledeganck, Kristien J.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium; [Bruyndonckx, Luc; Trouet, Dominique] Antwerp Univ Hosp, Dept Pediat Nephrol, Antwerp, Belgium	University of Antwerp; University of Antwerp	Ledeganck, KJ (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.	kristien.ledeganck@uantwerpen.be	Ledeganck, Kristien/AAY-1428-2020; trouet, dominique/AAW-8587-2021; De Winter, Benedicte Y/G-2616-2011; Bruyndonckx, Luc/F-4777-2013	Ledeganck, Kristien/0000-0003-4377-7648; De Winter, Benedicte Y/0000-0003-0327-6304; Bruyndonckx, Luc/0000-0002-2315-9925				Chou JS, 1997, ANN CLIN LAB SCI, V27, P116; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; Ellison DH, 2008, NEPHROL DIAL TRANSPL, V23, P1497, DOI 10.1093/ndt/gfm952; Grandaliano G, 2000, KIDNEY INT, V58, P182, DOI 10.1046/j.1523-1755.2000.00153.x; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Hassan M, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003592; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; JOH T, 1986, CLIN CHIM ACTA, V158, P81, DOI 10.1016/0009-8981(86)90118-X; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; KATORI R, 1979, TOHOKU J EXP MED, V128, P377, DOI 10.1620/tjem.128.377; Ledeganck KJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060677; Ledeganck KJ, 2014, NEPHROL DIAL TRANSPL, V29, P1097, DOI 10.1093/ndt/gft498; Ledeganck KJ, 2011, AM J PHYSIOL-RENAL, V301, pF486, DOI 10.1152/ajprenal.00116.2011; LEVRAN A, 1990, CLIN CHIM ACTA, V192, P201, DOI 10.1016/0009-8981(90)90222-E; Li ZZ, 2012, PEDIATR NEPHROL, V27, P2251, DOI 10.1007/s00467-012-2243-4; MATTILA AL, 1986, LIFE SCI, V39, P1879, DOI 10.1016/0024-3205(86)90298-5; MATTILA AL, 1985, J CLIN ENDOCR METAB, V61, P997, DOI 10.1210/jcem-61-5-997; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; NIELSEN S, 1989, AM J PHYSIOL, V256, pE55, DOI 10.1152/ajpendo.1989.256.1.E55; NORMAN J, 1990, CLIN SCI, V78, P445, DOI 10.1042/cs0780445; OLSEN PS, 1984, REGUL PEPTIDES, V10, P37, DOI 10.1016/0167-0115(84)90051-X; Onore Charity, 2012, Autism Res Treat, V2012, P205362, DOI 10.1155/2012/205362; Saika T, 2000, UROL RES, V28, P230; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Tsau YK, 1996, PEDIATR RES, V39, P20, DOI 10.1203/00006450-199601000-00003; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Xian CJ, 2004, FRONT BIOSCI-LANDMRK, V9, P85, DOI 10.2741/1210; Zeng F, 2014, SEMIN CELL DEV BIOL, V28, P2, DOI 10.1016/j.semcdb.2014.01.011	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211212	10.1371/journal.pone.0211212	http://dx.doi.org/10.1371/journal.pone.0211212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677083	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400062
J	Neves, HHR; Vargas, G; Brito, LF; Schenkel, FS; Albuquerque, LG; Carvalheiro, R				Neves, Haroldo H. R.; Vargas, Giovana; Brito, Luiz F.; Schenkel, Flavio S.; Albuquerque, Lucia G.; Carvalheiro, Roberto			Genetic and genomic analyses of testicular hypoplasia in Nellore cattle	PLOS ONE			English	Article							SPERM MOTILITY; PROTEIN; PHOSPHORYLATION; ASSOCIATION; NETWORKS; DATABASE; PATHWAY; GROWTH; KEGG; TOOL	Reproductive performance is a key indicator of the long-term sustainability of any livestock production system. Testicular hypoplasia (TH) is a morphological and functional reproductive disorder that affects bulls around the world and consequently causes major economic losses due to reduced fertility rates. Despite the improvements in management practices to enhance performance of affected animals, the use of hypoplastic animals for reproduction might contribute to expand the prevalence of this disorder. The aim of this study was to identify genomic regions that are associated with TH in Nellore cattle by performing a genome-wide association study (GWAS) and functional analyses. Phenotypic and pedigree data from 47,563 animals and genotypes (500,689 Single Nucleotide Polymorphism, SNPs) from 265 sires were used in this study. TH was evaluated as a binary trait measured at 18 months of age. The estimated breeding values (EBVs) were calculated by fitting a single-trait threshold animal model using a Bayesian approach. The SNP effects were estimated using the Bayes C method and de-regressed EBVs for TH as the response variable (pseudo-phenotype). The top-15 ranking windows (5-adjacent SNPs) that explained the highest proportion of variance were identified for further functional and biological network analyses. The posterior mean (95% highest posterior density) of the heritability for TH was 0.16 (0.08; 0.23). The most important genomic windows were located on BTA1, BTA3, BTA4, BTA5, BTA9, BTA22, BTA23, and BTA25. These windows explained together 22.69% of the total additive genetic variance for TH. Strong candidate genes associated with metabolism and synthesis of steroids, cell survival, spermatogenesis process and sperm motility were identified, which might play an important role in the expression of TH. Our findings contribute to a better biological understanding of TH and future characterization of causal variants might enable improved genomic prediction of this trait in beef cattle.	[Neves, Haroldo H. R.; Carvalheiro, Roberto] GenSys Associated Consultants, Porto Alegre, RS, Brazil; [Vargas, Giovana; Albuquerque, Lucia G.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Anim Sci, Jaboticabal, SP, Brazil; [Brito, Luiz F.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Schenkel, Flavio S.] Univ Guelph, Dept Anim Biosci, CGIL, Guelph, ON, Canada; [Albuquerque, Lucia G.; Carvalheiro, Roberto] Cnpq, Natl Council Sci & Technol Dev, Brasilia, DF, Brazil	Universidade Estadual Paulista; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Guelph	Vargas, G (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Anim Sci, Jaboticabal, SP, Brazil.	gi.vargas@hotmail.com	Schenkel, Flavio/ABG-1842-2021; Albuquerque, Lucia/A-7402-2013; Carvalheiro, Roberto/AAG-2222-2020	Albuquerque, Lucia/0000-0002-2030-7590; Carvalheiro, Roberto/0000-0002-4506-0555; Schenkel, Flavio/0000-0001-8700-0633; Neves, Haroldo/0000-0002-8317-9434	Sao Paulo Research Foundation (FAPESP) [2017/10630-2]; CNPq [308636/2014-7]; GenSys Associated Consultants	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); GenSys Associated Consultants	This work was supported by Grant #2017/10630-2 Sao Paulo Research Foundation (FAPESP); grant #308636/2014-7 (CNPq). GenSys Associated Consultants provided support in the form of salaries for authors HHRN and RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Aparicio IM, 2007, REPRODUCTION, V134, P435, DOI 10.1530/REP-06-0388; Bicudo S., 2007, BIOL GICO, V69, P43; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CALO LL, 1973, J ANIM SCI, V37, P676, DOI 10.2527/jas1973.373676x; Carreau Serge, 2003, Reprod Biol Endocrinol, V1, P35, DOI 10.1186/1477-7827-1-35; COULTER GH, 1976, J DAIRY SCI, V59, P730, DOI 10.3168/jds.S0022-0302(76)84265-8; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Galloway DB, 1979, FATORES QUE AFETAM F, P209; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Geweke J, 1992, BAYESIAN STAT, V4, P169; Gianola D, 1993, GENET SEL EVOL, V15, P201; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hiendleder S, 2003, J HERED, V94, P496, DOI 10.1093/jhered/esg090; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; KAY GW, 1992, J REPROD FERTIL, V96, P537; Legarra A., 2014, GS3 USER MANUAL; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; McClure MC, 2010, ANIM GENET, V41, P597, DOI 10.1111/j.1365-2052.2010.02063.x; McEntee K., 1990, SCROTUM SPERMATIC CO, P279; Miller WL., 1995, ENDOCRINOL METAB, P555; Nascimento EF, 2003, PATOLOGIA REPROD ANI, P133; Pelz L, 2017, J BIOL CHEM, V292, P21490, DOI 10.1074/jbc.RA117.000113; Perumal P, 2014, Int Sch Res Notices, V2014, P249537, DOI 10.1155/2014/249537; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Roso V.M., 2006, P WORLD CONG GEN APP, V8, P13; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Schulke JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011717; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sorensen D., 2002, STAT BIOL HEALTH; Steffen D, 1997, VET CLIN N AM-FOOD A, V13, P243, DOI 10.1016/S0749-0720(15)30338-8; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van den Berg I, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-19; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Venhoranta H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075659; Vijayaraghavan S, 2000, BIOL REPROD, V62, P1647, DOI 10.1095/biolreprod62.6.1647; Zhang ZG, 2016, MOL BIOL CELL, V27, P3705, DOI 10.1091/mbc.E16-05-0318; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	48	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211159	10.1371/journal.pone.0211159	http://dx.doi.org/10.1371/journal.pone.0211159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677076	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400055
J	Upton, EC; Maciunas, LJ; Loll, PJ				Upton, Elizabeth C.; Maciunas, Lina J.; Loll, Patrick J.			Vancomycin does not affect the enzymatic activities of purified VanS(A)	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; GLYCOPEPTIDE RESISTANCE GENES; ENTEROCOCCUS-FAECIUM BM4147; MEMBRANE-PROTEINS; HISTIDINE KINASE; IN-VIVO; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; INDUCTION; BINDING	VanS is a membrane-bound sensor histidine kinase responsible for sensing vancomycin and activating transcription of vancomycin-resistance genes. In the presence of vancomycin, VanS phosphorylates the transcription factor VanR, converting it to its transcriptionally active form. In the absence of vancomycin, VanS dephosphorylates VanR, thereby maintaining it in a transcriptionally inactive state. To date, the mechanistic details of how vancomycin modulates VanS activity have remained elusive. We have therefore studied these details in an in vitro system, using the full-length VanS and VanR proteins responsible for type-A vancomycin resistance in enterococci. Both detergent-and amphipol-solubilized VanS(A) display all the enzymatic activities expected for a sensor histidine kinase, with amphipol reconstitution providing a marked boost in overall activity relative to detergent solubilization. A putative constitutively activated VanS(A) mutant (T168K) was constructed and purified, and was found to exhibit the expected reduction in phosphatase activity, providing confidence that detergent-solubilized VanS(A) behaves in a physiologically relevant manner. In both detergent and amphipol solutions, VanS(A)'s enzymatic activities were found to be insensitive to vancomycin, even at levels many times higher than the antibiotic's minimum inhibitory concentration. This result argues against direct activation of VanS(A) via formation of a binary antibiotic-kinase complex, suggesting instead that either additional factors are required to form a functional signaling complex, or that activation does not require direct interaction with the antibiotic.	[Upton, Elizabeth C.; Maciunas, Lina J.; Loll, Patrick J.] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Loll, PJ (corresponding author), Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA.	pjl28@drexel.edu		Loll, Patrick/0000-0001-5416-4500	National Institutes of Health [R01 GM079508, F31 AI136385]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI136385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by National Institutes of Health R01 GM079508; F31 AI136385 (LJM) Departmental Funding, Dept. of Biochemistry & Molecular Biology, Drexel University College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN NE, 1995, FEMS MICROBIOL LETT, V132, P107, DOI 10.1016/0378-1097(95)00296-H; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arthur M, 1997, J BACTERIOL, V179, P97, DOI 10.1128/jb.179.1.97-106.1997; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; Arthur M, 1999, MICROBIOL-UK, V145, P1849, DOI 10.1099/13500872-145-8-1849; Baptista M, 1996, ANTIMICROB AGENTS CH, V40, P2291, DOI 10.1128/AAC.40.10.2291; Baptista M, 1997, MOL MICROBIOL, V25, P93, DOI 10.1046/j.1365-2958.1997.4401812.x; Baptista M, 1999, MOL MICROBIOL, V32, P17, DOI 10.1046/j.1365-2958.1999.01308.x; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Carlson HK, 2010, ANAL BIOCHEM, V397, P139, DOI 10.1016/j.ab.2009.10.009; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Depardieu F, 2009, ANTIMICROB AGENTS CH, V53, P1952, DOI 10.1128/AAC.01348-08; Eriks LR, 2003, ANAL BIOCHEM, V323, P234, DOI 10.1016/j.ab.2003.09.002; Gao R, 2018, METHOD ENZYMOL, V607, P301, DOI 10.1016/bs.mie.2018.04.004; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; GrissomArnold J, 1997, MICROB DRUG RESIST, V3, P53, DOI 10.1089/mdr.1997.3.53; Haldimann A, 1997, J BACTERIOL, V179, P5903, DOI 10.1128/jb.179.18.5903-5913.1997; HANDWERGER S, 1990, FEMS MICROBIOL LETT, V70, P167, DOI 10.1016/S0378-1097(05)80033-3; Hornschemeyer P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149187; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hughes CS, 2017, DATA BRIEF, V14, P41, DOI 10.1016/j.dib.2017.07.012; Hughes CS, 2017, BBA-GEN SUBJECTS, V1861, P1951, DOI 10.1016/j.bbagen.2017.05.011; Hussain R, 2016, BIOCHEM SOC T, V44, P810, DOI 10.1042/BST20160023; Jacob-Dubuisson F, 2018, NAT REV MICROBIOL, V16, P585, DOI 10.1038/s41579-018-0055-7; King ST, 2007, METHOD ENZYMOL, V422, P352, DOI 10.1016/S0076-6879(06)22017-2; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwun MJ, 2013, ANTIMICROB AGENTS CH, V57, P4470, DOI 10.1128/AAC.00523-13; Loll PJ, 2014, ACTA CRYSTALLOGR F, V70, P1576, DOI 10.1107/S2053230X14025035; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; McComas CC, 2003, J AM CHEM SOC, V125, P9314, DOI 10.1021/ja035901x; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Ortet P, 2015, NUCLEIC ACIDS RES, V43, pD536, DOI 10.1093/nar/gku968; Phillips-Jones Mary K, 2018, Biophys Rev, V10, P347, DOI 10.1007/s12551-018-0404-9; Phillips-Jones MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46180; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Reyes K, 2016, INFECT DIS CLIN N AM, V30, P953, DOI 10.1016/j.idc.2016.07.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva JC, 1998, P NATL ACAD SCI USA, V95, P11951, DOI 10.1073/pnas.95.20.11951; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Srivastava SK, 2014, J BACTERIOL, V196, P2876, DOI 10.1128/JB.01530-14; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Vergis JM, 2010, ANAL BIOCHEM, V407, P1, DOI 10.1016/j.ab.2010.07.019; Walsh CT, 1996, CHEM BIOL, V3, P21, DOI 10.1016/S1074-5521(96)90079-4; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Willett JW, 2013, MBIO, V4, DOI 10.1128/mBio.00420-13; Willett JW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003084; WRIGHT GD, 1993, BIOCHEMISTRY-US, V32, P5057, DOI 10.1021/bi00070a013; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zoonens M., 2014, MEMBRANE PROTEINS PR, P173; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	63	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210627	10.1371/journal.pone.0210627	http://dx.doi.org/10.1371/journal.pone.0210627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677074	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400020
J	Espunyes, J; Bartolome, J; Garel, M; Galvez-Ceron, A; Aguilar, XF; Colom-Cadena, A; Calleja, JA; Gasso, D; Jarque, L; Lavin, S; Marco, I; Serrano, E				Espunyes, Johan; Bartolome, Jordi; Garel, Mathieu; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Antonio Calleja, Juan; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel			Seasonal diet composition of Pyrenean chamois is mainly shaped by primary production waves	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RUPICAPRA-PYRENAICA; FECAL ANALYSIS; RED DEER; CHEMICAL-COMPOSITION; AUTUMN NUTRITION; SUMMER DIET; LAND-USE; ALPINE; VEGETATION	In alpine habitats, the seasonally marked climatic conditions generate seasonal and spatial differences in forage availability for herbivores. Vegetation availability and quality during the growing season are known to drive life history traits of mountain ungulates. However, little effort has been made to understand the association between plant phenology and changes in the foraging strategies of these mountain dwellers. Furthermore, this link can be affected by the seasonal presence of livestock in the same meadows. The objective of this work was to study the seasonal changes in diet composition of Pyrenean chamois (Rupicapra p. pyrenaica) and its relationship to primary production trends in a Mediterranean alpine environment. Moreover, diet composition in two populations with contrasting livestock pressure was compared in order to study the effect of sheep flocks on the feeding behaviour of chamois. From 2009 to 2012, monthly diet composition was estimated by cuticle microhistological analysis of chamois faeces collected in the eastern Pyrenees. The primary production cycle was assessed by remote sensing, using the Normalized Difference Vegetation Index. Additionally, the diet of sheep sharing seasonally the subalpine and alpine meadows with chamois was analysed. Diet selection of chamois and sheep and their overlap was also assessed. Our results show an intra-annual variation in the diet composition of Pyrenean chamois and demonstrate a strong relationship between plant consumption dynamics and phenology in alpine areas. In addition, Calluna vulgaris, Cytisusspp. and Festucaspp., as well as forbs in the summer, are found to be key forage species for Pyrenean chamois. Furthermore, this study couldn't detect differences between both chamois populations despite the presence of sheep flocks in only one area. However, the detection of a shift in the diet of chamois in both areas after the arrival of high densities of multi-specific livestock suggest a general livestock effect. In conclusion, Pyrenean chamois are well adapted to the variations in the seasonal availability of plants in alpine habitats but could be disturbed by the seasonal presence of livestock. Due to the key plants in their diet, we suggest that population management programmes should focus on the preservation of mixed grasslands composed of patches of shrubs and herbs. The effects of climate change and shrub expansion should be studied as they may potentially affect chamois population dynamics through changes in habitat composition and temporal shifts in forage availability.	[Espunyes, Johan; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel] Univ Autonoma Barcelona, Wildlife Ecol & Hlth Grp WE&H, Barcelona, Spain; [Espunyes, Johan; Galvez-Ceron, Arturo; Fernandez Aguilar, Xavier; Colom-Cadena, Andreu; Gasso, Diana; Jarque, Laia; Lavin, Santiago; Marco, Ignasi; Serrano, Emmanuel] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Fac Vet, Barcelona, Spain; [Bartolome, Jordi; Jarque, Laia] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Ruminant Res Grp, Fac Vet, Barcelona, Spain; [Garel, Mathieu] Unite Ongules Sauvages, Off Natl Chasse & Faune Sauvage, Gieres, France; [Galvez-Ceron, Arturo] Univ Narino, Fac Ciencias Pecuarias, Pasto, Colombia; [Fernandez Aguilar, Xavier] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Antonio Calleja, Juan] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Bot, Bellaterra, Spain; [Antonio Calleja, Juan] CREAF, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Calgary; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Espunyes, J; Serrano, E (corresponding author), Univ Autonoma Barcelona, Wildlife Ecol & Hlth Grp WE&H, Barcelona, Spain.; Espunyes, J; Serrano, E (corresponding author), Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Fac Vet, Barcelona, Spain.	johan.espunyes@gmail.com; emmanuel.serrano@uab.cat	Fernandez Aguilar, Xavier/P-9919-2017; Espunyes, Johan/AAV-9517-2020; Marco, Ignasi/E-8633-2015; Alarcón, Juan Antonio Calleja/T-2297-2019; SERRANO-FERRON, Emmanuel/J-4489-2013; /P-4243-2017; Lavín, Santiago/L-5975-2014; Bartolomé, Jordi/AAB-4362-2020	Fernandez Aguilar, Xavier/0000-0002-4939-6048; Espunyes, Johan/0000-0002-8692-1593; Marco, Ignasi/0000-0001-7479-3419; Alarcón, Juan Antonio Calleja/0000-0002-6586-0939; SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; /0000-0003-4553-8528; Lavín, Santiago/0000-0001-5655-588X; Bartolomé, Jordi/0000-0002-3784-5248	Government of Andorra [ATC015]; Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal [RYC2016-21120]	Government of Andorra; Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal	JE acknowledges a predoctoral grant from the Government of Andorra, ATC015 - AND-2015/2016, 2016/2017 and 2017/2018. ES was funded by the Spanish Ministerio de Economia y Competitividad (MINECO) through a Ramon y Cajal agreement (RYC2016-21120). The same RYC-2016-21120 project has partially covered the publication fees of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldezabal A, 2002, ECOSISTEMAS, V11; ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; Ammar H, 2004, ANIM FEED SCI TECH, V115, P327, DOI 10.1016/j.anifeedsci.2004.03.003; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MB, 2018, J ENVIRON POL PLAN, V20, P198, DOI 10.1080/1523908X.2017.1348286; Andreoli E, 2016, WILDLIFE BIOL, V22, P78, DOI 10.2981/wlb.00153; ANTHONY RG, 1974, J WILDLIFE MANAGE, V38, P535, DOI 10.2307/3800886; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; ARMSTRONG DG, 1953, J AGR SCI, V43, P223, DOI 10.1017/S0021859600045019; BARTOLOME J, 1995, J RANGE MANAGE, V48, P267, DOI 10.2307/4002432; Bartolome J, 1998, ACTAS DE LA XXXVIII, P367; Bartolome J, 2011, RANGELAND ECOL MANAG, V64, P319, DOI 10.2111/REM-D-09-00160.1; Berducou C., 1986, P390; Bergman EJ, 2014, J WILDLIFE MANAGE, V78, P448, DOI 10.1002/jwmg.683; Bertolino S, 2009, J ZOOL, V277, P63, DOI 10.1111/j.1469-7998.2008.00512.x; Bocci A, 2010, J ZOOL, V280, P379, DOI 10.1111/j.1469-7998.2009.00672.x; Bovolenta S, 2008, ANIM FEED SCI TECH, V146, P178, DOI 10.1016/j.anifeedsci.2008.06.003; BRAND MR, 1978, AM MIDL NAT, V100, P228, DOI 10.2307/2424794; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Celaya R, 2011, ANIMAL, V5, P1467, DOI 10.1017/S1751731111000449; Chapuis JL, 2001, J RANGE MANAGE, V54, P239, DOI 10.2307/4003240; Chirichella R., 2014, BEHAV MANAGEMENT EUR, P110; Chirichella R, 2013, MAMM BIOL, V78, P344, DOI 10.1016/j.mambio.2013.04.005; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Christianson D, 2009, ECOL APPL, V19, P1323, DOI 10.1890/08-0987.1; Cook JG, 2004, WILDLIFE MONOGR, P1; Corlatti L, 2013, J ZOOL, V291, P111, DOI 10.1111/jzo.12049; Corlatti L, 2011, MAMMAL REV, V41, P163, DOI 10.1111/j.1365-2907.2011.00187.x; Crampe JP, 2007, CAN J ZOOL, V85, P16, DOI 10.1139/Z06-185; CROKER BARBARA H., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P72; DAGET P, 1971, ANN AGRON, V22, P5; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; Didan K, 2015, MOD13Q1 MODIS TERRA, DOI [10.5067/MODIS/MOD13Q1.006, DOI 10.5067/MODIS/MOD13Q1.006]; Ernakovich JG, 2014, GLOBAL CHANGE BIOL, V20, P3256, DOI 10.1111/gcb.12568; Evju M, 2006, ECOSCIENCE, V13, P459, DOI 10.2980/1195-6860(2006)13[459:SHSATA]2.0.CO;2; Fankhauser R, 2008, EUR J WILDLIFE RES, V54, P88, DOI 10.1007/s10344-007-0115-1; FERRARI C, 1988, Z SAUGETIERKD, V53, P170; Ferretti F, 2015, BEHAV ECOL, V26, P550, DOI 10.1093/beheco/aru226; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Forkel M, 2015, GLOBAL CHANGE BIOL, V21, P3414, DOI 10.1111/gcb.12950; Forkel M, 2013, REMOTE SENS-BASEL, V5, P2113, DOI 10.3390/rs5052113; Galvez-Ceron A, 2013, EUR J WILDLIFE RES, V59, P115, DOI 10.1007/s10344-012-0672-9; Garcia-Gonzalez R., 1984, ACTA BIOL MONTANA, V4, P333; Garcia-gonzalez R, 1984, DOC ECOL PYRENEENNE, V3-4, P307; Garcia-Gonzalez R, 1986, 26 REUN CIENT SEEP, P119; GarciaGonzalez R, 1996, FOREST ECOL MANAG, V88, P15, DOI 10.1016/S0378-1127(96)03805-4; GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; HAVSTAD KM, 1978, J RANGE MANAGE, V31, P469, DOI 10.2307/3897210; Hibert F, 2011, EUR J WILDLIFE RES, V57, P495, DOI 10.1007/s10344-010-0458-x; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hofmann RR, 1984, FEEDING HABITS MOUFL, P341; Homolka M, 2001, FOLIA ZOOL, V50, P89; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; JALAL MAF, 1982, PHYTOCHEMISTRY, V21, P1397, DOI 10.1016/0031-9422(82)80150-7; JOHNSON MK, 1981, J RANGE MANAGE, V34, P232, DOI 10.2307/3898049; Jonas T, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000680; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; K?rner C., 2011, ALPINE PLANT LIFE FU; La Morgia V, 2009, ECOL RES, V24, P1043, DOI 10.1007/s11284-008-0581-2; Loison A., 2003, Ecological Studies, V167, P351; Lovari S, 2014, ANIM CONSERV, V17, P359, DOI 10.1111/acv.12103; Mack G, 2013, ENVIRON SCI POLICY, V32, P48, DOI 10.1016/j.envsci.2013.01.019; Manly BFJ, 1993, RESOURCE SELECTION B; Marinas A, 2003, ANIM SCI, V76, P461, DOI 10.1017/S1357729800058689; Marinas A, 2006, PIRINEOS, V161, P85, DOI DOI 10.3989/pirineos.2006.v161.4; Mason THE, 2017, BEHAV ECOL, V28, P908, DOI 10.1093/beheco/arx057; Mason THE, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0069-6; MCINNIS ML, 1983, J RANGE MANAGE, V36, P302, DOI 10.2307/3898474; Montalvo AE, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00320; Montserrat P., 1990, ECOSYSTEMS WORLD, V17, P37; Morano S, 2013, J MAMMAL, V94, P162, DOI 10.1644/12-MAMM-A-074.1; MOSS R, 1969, J ANIM ECOL, V38, P103, DOI 10.2307/2741; Mottet A, 2006, AGR ECOSYST ENVIRON, V114, P296, DOI 10.1016/j.agee.2005.11.017; Nagy L, 2009, THE BIOLOGY OF ALPIN; Neuner G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00654; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PerezBarberia FJ, 1997, ACTA THERIOL, V42, P37, DOI 10.4098/AT.arch.97-5; Pettorelli N, 2013, THE NORMALIZED DIFFE; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Poyatos R, 2003, MT RES DEV, V23, P362, DOI 10.1659/0276-4741(2003)023[0362:LUALCC]2.0.CO;2; Prevosto B, 2006, ACTA OECOL, V30, P258, DOI 10.1016/j.actao.2006.05.001; Prevosto B, 2011, FOLIA GEOBOT, V46, P303, DOI 10.1007/s12224-010-9096-z; R Core Team, 2018, R A LANGUAGE AND ENV; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Rebollo S., 1993, Pirineos, V141-142, P47; Redjadj C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084756; Rieger G, 2008, J AGR FOOD CHEM, V56, P9080, DOI 10.1021/jf801104e; ROMINGER EM, 1988, J WILDLIFE MANAGE, V52, P47, DOI 10.2307/3801056; Ruttimann S, 2008, EUR J WILDLIFE RES, V54, P110, DOI 10.1007/s10344-007-0118-y; Rughetti M, 2011, ACTA THERIOL, V56, P329, DOI 10.1007/s13364-011-0040-2; Schoenecker KA, 2016, WILD EQUIDS ECOLOGY; Scornavacca D, 2016, ETHOLOGY, V122, P807, DOI 10.1111/eth.12530; SMITH EP, 1982, ECOLOGY, V63, P1248, DOI 10.2307/1938851; STAINES BW, 1982, J APPL ECOL, V19, P65, DOI 10.2307/2402991; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; Suter W, 2004, WILDLIFE BIOL, V10, P43, DOI 10.2981/wlb.2004.008; Takahashi H, 2001, ECOL RES, V16, P257, DOI 10.1046/j.1440-1703.2001.00391.x; Thuiller W, 2018, DIVERS DISTRIB, V24, P352, DOI 10.1111/ddi.12684; Tolera A, 1997, ANIM FEED SCI TECH, V67, P181, DOI 10.1016/S0377-8401(96)01119-4; Tollefson TN, 2010, J WILDLIFE MANAGE, V74, P974, DOI 10.2193/2008-529; Treanor JJ, 2015, ECOL EVOL, V5, P3783, DOI 10.1002/ece3.1633; Vigo J, 2008, LALTA MUNTANYA CATAL; Vigop J, 1984, FLORA DELS PAISOSCAT, V1; Villamuelas M, 2016, ECOL INDIC, V61, P658, DOI 10.1016/j.ecolind.2015.10.017; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yockney IJ, 2000, NEW ZEAL J ECOL, V24, P31	108	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210819	10.1371/journal.pone.0210819	http://dx.doi.org/10.1371/journal.pone.0210819			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673757	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800054
J	Rose-Clarke, K; Bentley, A; Marston, C; Prost, A				Rose-Clarke, Kelly; Bentley, Abigail; Marston, Cicely; Prost, Audrey			Peer-facilitated community-based interventions for adolescent health in low- and middle-income countries: A systematic review	PLOS ONE			English	Review							YOUNG METHAMPHETAMINE USERS; REDUCING PHYSICAL VIOLENCE; PRIMARY-SCHOOL STUDENTS; EDUCATION INTERVENTIONS; NETWORK INTERVENTION; REPRODUCTIVE HEALTH; HIV PREVENTION; TOBACCO USE; PEOPLE; TRIAL	Background Adolescents aged 10-19 represent one sixth of the world's population and have a high burden of morbidity, particularly in low-resource settings. We know little about the potential of community-based peer facilitators to improve adolescent health in such contexts. Methods We did a systematic review of peer-facilitated community-based interventions for adolescent health in low- and middle-income countries (LM I Cs). We searched databases for randomised controlled trials of interventions featuring peer education, counselling, activism, and/or outreach facilitated by young people aged 10-24. We included trials with outcomes across key areas of adolescent health: infectious and vaccine preventable diseases, under nutrition, HIV/AIDS, sexual and reproductive health, unintentional injuries, violence, physical disorders, mental disorders and substance use. We summarised evidence from these trials narratively. PROSPERO registration: CRD42016039190. Results We found 20 studies (61,014 adolescents). Fourteen studies tested interventions linked to schools or colleges, and 12 had non-peer-facilitated components, e.g. health worker training. Four studies had HIV-related outcomes, but none reported reductions in HIV prevalence or incidence. Nine studies had clinical sexual and reproductive health outcomes, but only one reported a positive effect: a reduction in Herpes Simplex Virus-2 incidence. Three studies had violence-related outcomes, two of which reported reductions in physical violence by school staff and perpetration of physical violence by adolescents. Seven studies had mental health outcomes, four of which reported reductions in depressive symptoms. Finally, we found eight studies on substance use, four of which reported reductions in alcohol consumption and smoking or tobacco use. There were no studies on infectious and vaccine preventable diseases, undernutrition, or injuries. Conclusions There are few trials on the effects of peer-facilitated community-based interventions for adolescent health in LMICs. Existing trials have mixed results, with the most promising evidence supporting work with peer facilitators to improve adolescent mental health and reduce substance use and violence.	[Rose-Clarke, Kelly] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Bentley, Abigail] UCL, Inst Global Hlth, London, England; [Marston, Cicely; Prost, Audrey] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of London; King's College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Rose-Clarke, K (corresponding author), Kings Coll London, Dept Global Hlth & Social Med, London, England.	kelly.rose-clarke@kcl.ac.uk	Marston, Cicely/ABB-9376-2020; Marston, Cicely A/T-3551-2017	Marston, Cicely A/0000-0002-5529-4646	Children's Investment Fund Foundation - Children's Investment Fund Foundation	Children's Investment Fund Foundation - Children's Investment Fund Foundation	The study was funded by the Children's Investment Fund Foundation (www.ciff.org) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Children's Investment Fund Foundation. We thank Hassan Haghparast-Bidgoli and Ni Yanyan for their help translating non-English articles, and Heather Chesters for her advice on search strategies for the electronic database search.	Al-sheyab N, 2012, PEDIATRICS, V129, pE106, DOI 10.1542/peds.2011-0346; [Anonymous], 2016, DEATHS CAUS AG SEX C; Askew I, 2004, MULTISECTORAL APPROA; Australian Injecting & Illicit Drug Users League (AIVL), 2006, FRAM PEER ED DRUG US; Ayaz S, 2015, J PEDIATR NURS, V30, pE3, DOI 10.1016/j.pedn.2014.11.009; Balaji M, 2011, J ADOLESCENT HEALTH, V48, P453, DOI 10.1016/j.jadohealth.2010.07.029; Bonell C, 2012, SOC SCI MED, V75, P2299, DOI 10.1016/j.socscimed.2012.08.032; Brieger WR, 2001, J ADOLESCENT HEALTH, V29, P436, DOI 10.1016/S1054-139X(01)00264-6; Carlson M, 2012, SOC SCI MED, V75, P1078, DOI 10.1016/j.socscimed.2012.04.035; Carson KV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001291.pub2; Chen L, 2014, ADDICT BEHAV, V39, P189, DOI 10.1016/j.addbeh.2013.09.026; Church Dawson, 2012, Depress Res Treat, V2012, P257172, DOI 10.1155/2012/257172; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS49, DOI 10.1016/j.jadohealth.2016.06.020; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS61, DOI 10.1016/j.jadohealth.2016.06.021; De Koker P, 2014, J ADOLESCENT HEALTH, V54, P3, DOI 10.1016/j.jadohealth.2013.08.008; Decat P, 2015, ADDRESSING UNMET CON; Devries K, 2018, J ADOLESCENT HEALTH, V62, P303, DOI 10.1016/j.jadohealth.2017.09.004; Devries KM, 2015, LANCET GLOB HEALTH, V3, pE378, DOI 10.1016/S2214-109X(15)00060-1; Federal Democratic Republic of Ethiopia Ministry of Health, 2007, NAT AD YOUTH REPR HL; German D, 2012, J COMMUNITY PSYCHOL, V40, P799, DOI 10.1002/jcop.21488; Government of India, 2014, RASHTR KISH SWASTH K; Harden A., 1999, REV EFFECTIVENESS AP; Harrell MB, 2016, HEALTH EDUC RES, V31, P624, DOI 10.1093/her/cyw039; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kim CR, 2008, INT FAM PLAN PERSPEC, V34, P89, DOI 10.1363/ifpp.34.0089.08; Lotrean LM, 2010, HEALTH EDUC RES, V25, P803, DOI 10.1093/her/cyq034; Maticka-Tyndale E, 2009, EVAL PROGRAM PLANN, V33, P98, DOI [10.1016/j.evalprogplan.2009.07, DOI 10.1016/J.EVALPROGPLAN.2009.07]; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mmbaga EJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4245-4; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Nepal Ministry of Health, 2000, NAT AD HLTH DEV STRA; Okonofua Friday E., 2003, International Journal of Infectious Diseases, V7, P61, DOI 10.1016/S1201-9712(03)90044-0; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Perry CL, 2009, AM J PUBLIC HEALTH, V99, P899, DOI 10.2105/AJPH.2008.145433; Plan UK, 2014, REACH OUT LEARN GUID; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS11, DOI 10.1016/j.jadohealth.2016.05.022; Shackleton N, 2016, J ADOLESCENT HEALTH, V58, P382, DOI 10.1016/j.jadohealth.2015.12.017; Sherman SG, 2009, SOC SCI MED, V68, P69, DOI 10.1016/j.socscimed.2008.09.061; Singhal N, 2010, EUR J CLIN NUTR, V64, P364, DOI 10.1038/ejcn.2009.150; Ssewamala FM, 2009, SOC SCI MED, V69, P191, DOI 10.1016/j.socscimed.2009.05.019; Thurman TR, 2016, AIDS CARE, V28, P8, DOI 10.1080/09540121.2016.1146213; Tolli MV, 2012, HEALTH EDUC RES, V27, P904, DOI 10.1093/her/cys055; TOWNSEND JW, 1987, STUD FAMILY PLANN, V18, P103, DOI 10.2307/1966701; Turner G, 1999, HEALTH EDUC RES, V14, P235, DOI 10.1093/her/14.2.235; Uganda Ministry of Health, 2011, NAT AD HLHT STRAT 20; UNAIDS, 1999, PEER ED HIV AIDS CON; UNICEF, 2012, REPORT NO CONTRACT N; Veritas Health Innovation, COV SYST REV SOFTW M; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Visser Maretha J, 2007, SAHARA J, V4, P678; Wiehe SE, 2005, J ADOLESCENT HEALTH, V36, P162, DOI 10.1016/j.jadohealth.2004.12.003; World Bank, WORLD DEV IND; World Health Organization, HLTH TOP HLTH ED 201	58	18	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210468	10.1371/journal.pone.0210468	http://dx.doi.org/10.1371/journal.pone.0210468			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673732	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000456442800043
J	Chung, CM; Hung, CC; Lee, CH; Lee, CP; Lee, KW; Chen, MK; Yeh, KT; Ko, YC				Chung, Chia-Min; Hung, Chung-Chieh; Lee, Chien-Hung; Lee, Chi-Pin; Lee, Ka-Wo; Chen, Mu-Kuan; Yeh, Kun-Tu; Ko, Ying-Chin			Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; SUBMUCOUS FIBROSIS; CANCER; SUSCEPTIBILITY; ASSOCIATION; BIOMARKERS; LESIONS; HEAD; MUTATIONS	A number of genetic variants were suggested to be associated with oral malignancy, few variants can be replicated. The aim of this study was to identify significant variants that enhanced personal risk prediction for oral malignancy. A total of 360 patients diagnosed with oral squamous cell carcinoma, 486 controls and 17 newly diagnosed patients with OPMD including leukoplakia or oral submucous fibrosis were recruited. Fifteen tagSNPs which were derived from somatic mutations were genotyped and examined in associations with the occurrence of oral malignancy. Environmental variables along with the SNPs data were used to developed risk predictive models for oral malignancy occurrence. The step-wise model analysis was conducted to fit the best model in an economically efficient way. Two tagSNPs, rs28647489 in FAT1 gene and rs550675 in COL9A1 gene, were significantly associated with the risk of oral malignancy. The sensitivity and specificity were 85.7% and 85.5%, respectively (area under the receiver operating characteristic curve (AUC) was 0.91) for predicting oral squamous cell carcinoma occurrence with the combined genetic variants, betel-quid, alcohol and age. The AUC for OPMD was only 0.69. The predictive probability of squamous cell carcinoma occurrence for genetic risk score without substance use increased from 10% up to 43%; with substance use increased from 73% up to 92%. Genetic variants with or without substance use may enhance risk prediction for oral malignancy occurrence in male population. The prediction model may be useful as a clinical index for oral malignancy occurrence and its risk assessments.	[Chung, Chia-Min; Lee, Chi-Pin; Ko, Ying-Chin] China Med Univ Hosp, Environm Om Dis Res Ctr, Taichung, Taiwan; [Chung, Chia-Min; Hung, Chung-Chieh] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Hung, Chung-Chieh] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Lee, Ka-Wo] Kaohsiung Med Univ Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Oral Canc Ctr, Changhua, Taiwan; [Yeh, Kun-Tu] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Changhua Christian Hospital; Changhua Christian Hospital	Ko, YC (corresponding author), China Med Univ Hosp, Environm Om Dis Res Ctr, Taichung, Taiwan.	ycko0406@gmail.com	Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X	Ministry of Science and Technology [MOST106-2314-B-039-016-MY3]; China Medical University Hospital [DMR-107-090]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Medical University Hospital	This work is supported by Ministry of Science and Technology, MOST106-2314-B-039-016-MY3, and China Medical University Hospital, DMR-107-090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatnagar R, 2012, ORAL ONCOL, V48, P831, DOI 10.1016/j.oraloncology.2012.03.007; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Chang PY, 2017, J AGR FOOD CHEM, V65, P10197, DOI 10.1021/acs.jafc.7b03999; Chang YS, 2016, APPL IMMUNOHISTO M M, V24, P97, DOI 10.1097/PAI.0000000000000158; Chen F, 2017, ONCOTARGET, V8, P55525, DOI 10.18632/oncotarget.14821; Chuang SL, 2017, CANCER-AM CANCER SOC, V123, P1597, DOI 10.1002/cncr.30517; Chung CM, 2017, CANCER PREV RES, V10, P355, DOI 10.1158/1940-6207.CAPR-16-0259; Normando AGC, 2017, SUPPORT CARE CANCER, V25, P2969, DOI 10.1007/s00520-017-3783-8; Dionne KR, 2015, INT J CANCER, V136, P503, DOI 10.1002/ijc.28754; Er TK, 2015, ORAL DIS, V21, P872, DOI 10.1111/odi.12357; Guha N, 2014, INT J CANCER, V135, P1433, DOI 10.1002/ijc.28643; Johansson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036888; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee CH, 2003, BRIT J CANCER, V88, P366, DOI 10.1038/sj.bjc.6600727; Lee CH, 2018, JAMA PSYCHIAT, V75, P261, DOI 10.1001/jamapsychiatry.2017.4307; Lee CH, 2014, ADDICTION, V109, P1194, DOI 10.1111/add.12530; Li N, 2011, MED HYPOTHESES, V77, P834, DOI 10.1016/j.mehy.2011.07.049; Lian IB, 2013, ORAL ONCOL, V49, P427, DOI 10.1016/j.oraloncology.2012.12.004; Liao G, 2014, ORAL DIS, V20, P644, DOI 10.1111/odi.12184; Lingen MW, 2011, ORAL DIS, V17, P7, DOI 10.1111/j.1601-0825.2011.01789.x; Liu Y, 2017, ONCOTARGET, V8, P46057, DOI 10.18632/oncotarget.17550; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126760; Liu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24014; Luo L, 2011, GENOME RES, V21, P1099, DOI 10.1101/gr.115998.110; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Radoi L, 2013, COMMUNITY DENT ORAL, V41, DOI 10.1111/j.1600-0528.2012.00710.x; Rao SK, 2016, COMMUNITY DENT ORAL, V44, P76, DOI 10.1111/cdoe.12192; RYAN DAJ, 1992, BIOMETRICS, V48, P155, DOI 10.2307/2532746; Sharan RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042759; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanuma JI, 2010, ONCOL REP, V23, P739, DOI 10.3892/or_00000692; Vairaktaris E, 2009, ORAL ONCOL, V45, P247, DOI 10.1016/j.oraloncology.2008.05.003; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yan LJ, 2017, EUR ARCH OTO-RHINO-L, V274, P1945, DOI 10.1007/s00405-016-4427-1; Zeng XT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-469	40	4	4	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210901	10.1371/journal.pone.0210901	http://dx.doi.org/10.1371/journal.pone.0210901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657779	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000021
J	Adem, KS; Janakiraman, B; Gebremeskel, BF; Chala, MB; Gelaw, AY; Alemu, K				Adem, Kedir Sany; Janakiraman, Balamurugan; Gebremeskel, Berihu Fisseha; Chala, Mulugeta Bayisa; Gelaw, Asmare Yitayeh; Alemu, Kassahun			Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SENSORY NEUROPATHY; SCREENING TOOL; RISK; ART; TOLERABILITY; AFRICA	Background Antiretroviral therapy has surely increased the life expectancy of people living with HIV. However, long term complications like HIV associated sensory neuropathy has a negative impact on quality of life among people living with HIV (PLHIV). In Ethiopia, lack of data on magnitude of the burden and predictors of HIV associated sensory neuropathy in many resource limited setting has led to under diagnosis and eventually under management of HIV-SN. Hence, this study was set out to establish the burden of HIV-associated sensory neuropathy and, its association with demographic, health and clinical characteristics among people living with HIV in Ethiopia. Methods Cross-sectional study was conducted to assess the prevalence of HIV-associated sensory neuropathy and the associated factors among adult HIV patients at University of Gondar Teaching Hospital, Gondar, Ethiopia. Brief Peripheral Neuropathy Screening tool validated by AIDs Clinical trial group was used for screening HIV-associated sensory neuropathy. Data were analyzed descriptively and through uni-and multivariate logistic regression. Results In total 359 adult PLHIV with a mean age of 36.5 +/- 9.07 years participated, their median duration of HIV infection was 60 months (IQR 36-84) and their median CD4 count 143cells/mu L (IQR 69.5-201.5). Age above 40 years, anti-tuberculosis regimen, tallness, and exposure to didanosine contained antiretroviral therapy were found to be associated with HIVassociated sensory neuropathy (AOR 1.82, 1.84, 1.98 and 4.33 respectively). Conclusions More than half of the HIV patients who attended HIV care clinic at University of Gondar hospital during the study period were found to present with peripheral sensory neuropathy. Higher age, tallness, TB medication, and didanosine in ART were significantly associated with HIV-SN as screened by effective diagnostic (BPNS) tool.	[Adem, Kedir Sany; Janakiraman, Balamurugan; Chala, Mulugeta Bayisa; Gelaw, Asmare Yitayeh] Univ Gondar, Dept Physiotherapy, Coll Med & Hlth Sci, Gondar, Ethiopia; [Gebremeskel, Berihu Fisseha] Mekelle Univ, Dept Physiotherapy, Sch Med, Coll Hlth Sci, Mekelle, North Ethiopia, Ethiopia; [Gebremeskel, Berihu Fisseha] Mekelle Univ, Ayder Comprehens Specialized Hosp, Mekelle, North Ethiopia, Ethiopia; [Gelaw, Asmare Yitayeh] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Alemu, Kassahun] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; Mekelle University; Mekelle University; Monash University; University of Gondar	Janakiraman, B (corresponding author), Univ Gondar, Dept Physiotherapy, Coll Med & Hlth Sci, Gondar, Ethiopia.	bala77physio@gmail.com	Janakiraman, Balamurugan/AAG-9563-2020; Chala, Mulugeta/R-7878-2019; Gelaw, Asmare Yitayeh/N-6610-2017	Janakiraman, Balamurugan/0000-0003-3866-9351; Gelaw, Asmare Yitayeh/0000-0002-7050-7961; Chala, Mulugeta Bayisa/0000-0002-4851-5025	University of Gondar	University of Gondar	The total budget and other necessary equipment were totally funded by the University of Gondar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Firstly, we would like to express our deepest gratitude to the University of Gondar for ethical approval and funding. Our gratitude and appreciation go to data collectors, adults living with HIV attending HIV care clinic who participated in this study. We are also grateful to all hospital authorities and HIV care clinic staffs for their cooperation.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Arenas-Pinto A, 2016, J NEUROVIROL, V22, P104, DOI 10.1007/s13365-015-0374-7; Balamurugan J, 2013, INT J MED RES HEALTH, V2, P479, DOI 10.5958/j.2319-5886.2.3.083; Biraguma J, 2012, SAHARA J-J SOC ASP H, V9, P88, DOI 10.1080/17290376.2012.683582; Chai NC, 2016, CHRONIC PAIN HIV PRA, P51; Chen HC, 2013, J NEUROVIROL, V19, P557, DOI 10.1007/s13365-013-0216-4; Cherry CL, 2009, NEUROLOGY, V73, P315, DOI 10.1212/WNL.0b013e3181af7a22; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cochran W.G., 2007, SAMPLING TECHNIQUES; Colvin M, 2008, ANAL HIV PREVENTION; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Evans S, 2005, STAT MED, V24, P1245, DOI 10.1002/sim.2023; Evans SR, 2012, J NEUROVIROL, V18, P428, DOI 10.1007/s13365-012-0119-9; Evans SR, 2011, AIDS, V25, P919, DOI 10.1097/QAD.0b013e328345889d; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Hoffmann CJ, 2008, AIDS, V22, P67, DOI 10.1097/QAD.0b013e3282f2306e; Jember G, 2017, J DIABETES METAB DIS, V16, DOI 10.1186/s40200-017-0295-5; Kamerman PR, 2012, CURR PAIN HEADACHE R, V16, P226, DOI 10.1007/s11916-012-0257-z; Lichtenstein KA, 2005, CLIN INFECT DIS, V40, P148, DOI 10.1086/426076; Lifson AR, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-016-0069-2; Luma HN, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-35; Mehta SA, 2010, AM J TROP MED HYG, V83, P565, DOI 10.4269/ajtmh.2010.09-0629; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Modayil RR, 2010, PHARMACOEPIDEM DR S, V19, P247, DOI 10.1002/pds.1907; Mullin S, 2011, TROP MED INT HEALTH, V16, P1291, DOI 10.1111/j.1365-3156.2011.02825.x; Oshinaike O, 2012, AIDS RES TREAT, V2012, P2012, DOI DOI 10.HTTP://DX.D0I.0RG/10.1155/2012/961510; Pettersen JA, 2006, ANN NEUROL, V59, P816, DOI 10.1002/ana.20816; Saylor D, 2017, NEUROLOGY, V89, P485, DOI 10.1212/WNL.0000000000004136; Shurie Jaffer Shiffa, 2010, Ethiop Med J, V48, P85; Simpson DM, 2008, NEUROLOGY, V70, P2305, DOI 10.1212/01.wnl.0000314647.35825.9c; Skopelitis EE, 2006, INT J STD AIDS, V17, P467, DOI 10.1258/095646206777689062; Theroux N, 2013, J NEUROSCI NURS, V45, P5, DOI 10.1097/JNN.0b013e318275b1b2; Venkataramana Anita B, 2005, AIDS Read, V15, P341; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; Wang X, 2011, J NEUROIMMUNE PHARM, V6, P477, DOI 10.1007/s11481-011-9296-1; World Health Organization, 2007, WHO CASE DEFINITIONS	38	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211354	10.1371/journal.pone.0211354	http://dx.doi.org/10.1371/journal.pone.0211354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695060	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400028
J	Duncan, DT; Park, SH; Goedel, WC; Sheehan, DM; Regan, SD; Chaix, B				Duncan, Dustin T.; Park, Su Hyun; Goedel, William C.; Sheehan, Diana M.; Regan, Seann D.; Chaix, Basile			Acceptability of smartphone applications for global positioning system (GPS) and ecological momentary assessment (EMA) research among sexual minority men	PLOS ONE			English	Article							PREVALENCE ODDS RATIO; POOR SLEEP HEALTH; ASSOCIATION; BEHAVIOR; TRACKING; RISK; GAY	Background Emerging research is using global positioning system (GPS) and ecological momentary assessment (EMA) methods among sexual minority men (SMM), a population that experiences multiple health disparities. However, we are not aware of any research that has combined these approaches among SMM, highlighting the need for acceptability and feasibility research. The purpose of this study was to examine the acceptability of implementing GPS and EMA research protocols using smartphone applications among SMM as well as related socio-demographic correlates. Methods Data come from a sample of SMM on a popular geosocial-networking app in Paris, France (n = 580). We assessed the acceptability of implementing GPS and EMA research protocols on smartphone apps as well as socio-demographic characteristics (i.e., age, sexual orientation, country of origin, employment status, and relationship status). We examined the anticipated acceptability of GPS and EMA data collection methods as well as socio-demographic correlates of acceptability of GPS and EMA methods. Results We found that over half (54.1%) of the sample was willing to download a smartphone app for GPS-based research and we found that almost 60% of the participants were willing to download a smartphone app for EMA-based research. In total, 44.0% reported that they were willing to download both GPS and EMA apps. In addition, we found that older participants were less willing to download a smartphone app for EMA research than younger participants aged 18-24 (40-49 years: aPR = 0.40; 95% CI = 0.20, 0.78) and students were more willing to download smartphone apps for both GPS and EMA research (aPR = 1.41; 95% CI = 1.02, 1.95). Conclusion Results from this study suggest that using smartphone apps to implement GPS and EMA methods among some SMM are acceptable. However, care should be taken as segments of SMM are less likely to be willing to engage in this type of research.	[Duncan, Dustin T.; Park, Su Hyun; Goedel, William C.; Regan, Seann D.] NYU, Sch Med, Dept Populat Hlth, Spatial Epidemiol Lab, New York, NY 10003 USA; [Sheehan, Diana M.] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA; [Chaix, Basile] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR S 1136,Pierre Louis Inst Epidemiol & Publ Hlt, Paris, France	New York University; State University System of Florida; Florida International University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Duncan, DT (corresponding author), NYU, Sch Med, Dept Populat Hlth, Spatial Epidemiol Lab, New York, NY 10003 USA.	Dustin.Duncan@nyulangone.org	Chaix, Basile/B-8625-2014; Regan, Seann/AAL-3863-2021	Regan, Seann/0000-0002-1034-0282; Park, Su Hyun/0000-0002-5527-7520	National Institutes of Health [R01MH112406, R21MH110190, R03DA039748]; Centers for Disease Control and Prevention [U01PS005122]; New York University School of Medicine Start-Up Research Fund; National Institute On Minority Health And Health Disparities [K01MD013770]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U01PS005122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112406, R25MH083620, R21MH110190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA039748] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [K01MD013770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); New York University School of Medicine Start-Up Research Fund; National Institute On Minority Health And Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded in part by National Institutes of Health grants R01MH112406, R21MH110190, and R03DA039748 and the Centers for Disease Control and Prevention grant U01PS005122. This work was supported by Dr. Dustin Duncan's New York University School of Medicine Start-Up Research Fund. Diana Sheehan was supported in part by a grant from the National Institute On Minority Health And Health Disparities (Award K01MD013770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauermeister JA, 2017, J SEX RES, V54, P446, DOI 10.1080/00224499.2016.1271862; Behrens T, 2004, METHOD INFORM MED, V43, P505; Cerda M, 2017, SOCIAL PSYCHIAT PSYC, P1; Chaix B, 2009, SOC SCI MED, V69, P1306, DOI 10.1016/j.socscimed.2009.07.018; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Duncan D.I., 2018, ATMOS CHEM PHYS, V18, P1, DOI [10.5194/acp-2018-275, DOI 10.5194/ACP-2018-275]; Duncan D. T., 2018, NEIGHBORHOODS HLTH; Duncan DT, 2016, SLEEP HEALTH, V2, P316, DOI 10.1016/j.sleh.2016.07.003; Duncan DT, 2017, J URBAN HEALTH, V94, P399, DOI 10.1007/s11524-017-0148-z; Duncan DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147520; Epstein DH, 2014, DRUG ALCOHOL DEPEN, V134, P22, DOI [10.1016/j.drugalcdep.2013.09.007, 10.1016/j.d]; Harkness J., 2003, CROSS CULTURAL SURVE, P35; Hektner J.M., 2002, HDB ENV PSYCHOL PP, P233; Kirchner TR, 2016, SOC PSYCH PSYCH EPID, V51, P1211, DOI 10.1007/s00127-016-1277-5; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; M-P Kwan, 2012, ANN GIS, V18, P245, DOI DOI 10.1080/19475683.2012.727867; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mitchell JT, 2014, J DUAL DIAGN, V10, P19, DOI 10.1080/15504263.2013.866841; Rendina HJ, 2018, J AFFECT DISORDERS, V227, P289, DOI 10.1016/j.jad.2017.11.005; Rowe C, 2016, JMIR MHEALTH UHEALTH, V4, P5, DOI 10.2196/mhealth.5368; Runyan JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071325; Schwartz JE, 1998, HEALTH PSYCHOL, V17, P6, DOI 10.1037/0278-6133.17.1.6; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Stone A. A., 1994, ANN BEHAV MED; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Toch E, 2013, P 2013 ACM INT JOINT; Torous J, 2016, JMIR MENTAL HLTH, V3; Wray TB, 2016, AIDS BEHAV, V20, P2231, DOI 10.1007/s10461-015-1272-y; Wu XC, 2013, PERVASIVE MOB COMPUT, V9, P881, DOI 10.1016/j.pmcj.2013.07.003; Yang C, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4344	30	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210240	10.1371/journal.pone.0210240	http://dx.doi.org/10.1371/journal.pone.0210240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689651	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800005
J	O'Brien, KT; Golla, K; Kranjc, T; O'Donovan, D; Allen, S; Maguire, P; Simpson, JC; O'Connell, D; Moran, N; Shields, DC				O'Brien, Kevin T.; Golla, Kalyan; Kranjc, Tilen; O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; Simpson, Jeremy C.; O'Connell, David; Moran, Niamh; Shields, Denis C.			Computational and experimental analysis of bioactive peptide linear motifs in the integrin adhesome	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CYTOPLASMIC DOMAIN; STRUCTURE PREDICTION; BINDING; CELL; ADHESION; ACTIVATION; ACTIN; TAIL; RECEPTORS	Therapeutic modulation of protein interactions is challenging, but short linear motifs (SLiMs) represent potential targets. Focal adhesions play a central role in adhesion by linking cells to the extracellular matrix. Integrins are central to this process, and many other intracellular proteins are components of the integrin adhesome. We applied a peptide network targeting approach to explore the intracellular modulation of integrin function in platelets. Firstly, we computed a platelet-relevant integrin adhesome, inferred via homology of known platelet proteins to adhesome components. We then computationally selected peptides from the set of platelet integrin adhesome cytoplasmic and membrane adjacent protein-protein interfaces. Motifs of interest in the intracellular component of the platelet integrin adhesome were identified using a predictor of SLiMs based on analysis of protein primary amino acid sequences (SLiMPred), a predictor of strongly conserved motifs within disordered protein regions (SLiMPrints), and information from the literature regarding protein interactions in the complex. We then synthesized peptides incorporating these motifs combined with cell penetrating factors (tat peptide and palmitylation for cytoplasmic and membrane proteins respectively). We tested for the platelet activating effects of the peptides, as well as their abilities to inhibit activation. Bioactivity testing revealed a number of peptides that modulated platelet function, including those derived from a-actinin (ACTN1) and syndecan (SDC4), binding to vinculin and syntenin respectively. Both chimeric peptide experiments and peptide combination experiments failed to identify strong effects, perhaps characterizing the adhesome as relatively robust against within-adhesome synergistic perturbation. We investigated in more detail peptides targeting vinculin. Combined experimental and computational evidence suggested a model in which the positively charged tat-derived cell penetrating part of the peptide contributes to bioactivity via stabilizing charge interactions with a region of the ACTN1 negatively charged surface. We conclude that some interactions in the integrin adhesome appear to be capable of modulation by short peptides, and may aid in the identification and characterization of target sites within the complex that may be useful for therapeutic modulation.	[O'Brien, Kevin T.; Shields, Denis C.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [O'Brien, Kevin T.; Kranjc, Tilen; O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; Simpson, Jeremy C.; O'Connell, David; Shields, Denis C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland; [Golla, Kalyan; Moran, Niamh] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Kranjc, Tilen; Simpson, Jeremy C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland; [O'Donovan, Darragh; Allen, Seamus; Maguire, Patricia; O'Connell, David] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland	University College Dublin; University College Dublin; Royal College of Surgeons - Ireland; University College Dublin; University College Dublin	Shields, DC (corresponding author), Univ Coll Dublin, Sch Med, Dublin, Ireland.; Shields, DC (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland.	Denis.shields@ucd.ie		O'Connell, David/0000-0002-6461-7750; Maguire, Patricia/0000-0002-0362-3778; Shields, Denis/0000-0003-4015-2474; Simpson, Jeremy/0000-0002-7956-7805	Irish Research Council; Science Foundation Ireland [08/IN1/B1864]	Irish Research Council(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Irish Research Council (www.research.ie) grant for the Bioinformatics and Systems Biology PhD Programme GREP 2007-2015 to DCS; and by Science Foundation Ireland (www.sfi.ie) Principal Investigator (08/IN1/B1864) Award to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Aylward K, 2006, J THROMB HAEMOST, V4, P1804, DOI 10.1111/j.1538-7836.2006.02041.x; Baciu PC, 2000, J CELL SCI, V113, P315; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bois PRJ, 2005, MOL CELL BIOL, V25, P6112, DOI 10.1128/MCB.25.14.6112-6122.2005; Boyanova Desislava, 2012, Blood, V119, pe22, DOI 10.1182/blood-2011-10-387308; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; COLLER BS, 1995, CIRCULATION, V92, P2373, DOI 10.1161/01.CIR.92.9.2373; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Davey NE, 2012, NUCLEIC ACIDS RES, V40, P10628, DOI 10.1093/nar/gks854; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dimitriou AA, 2009, PLATELETS; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Haslam NJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003372; Horton ER, 2016, J CELL SCI, V129, P4159, DOI 10.1242/jcs.192054; Inomata M, 1996, ARCH BIOCHEM BIOPHYS, V328, P129, DOI 10.1006/abbi.1996.0152; Jiang Q, 2017, J MOL GRAPH MODEL, V76, P379, DOI 10.1016/j.jmgm.2017.07.015; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; Koloka V, 2008, PLATELETS, V19, P502, DOI 10.1080/09537100802266875; Landesberg R, 2005, J ORAL MAXIL SURG, V63, P529, DOI 10.1016/j.joms.2004.12.007; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Liu SC, 2000, J CELL SCI, V113, P3563; Lombardi F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004119; Mirabello C, 2013, BIOINFORMATICS, V29, P2056, DOI 10.1093/bioinformatics/btt344; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nanda SY, 2014, J CELL BIOCHEM, V115, P1206, DOI 10.1002/jcb.24772; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nelson ES, 2011, MOL CANCER RES, V9, P712, DOI 10.1158/1541-7786.MCR-10-0599; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; OTEY CA, 1993, J BIOL CHEM, V268, P21193; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Raab M, 2010, PROTEOMICS, V10, P2790, DOI 10.1002/pmic.200900621; Schwab N, 2015, INT IMMUNOL, V27, P47, DOI 10.1093/intimm/dxu096; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Sheibani N, 2008, J CELL PHYSIOL, V214, P655, DOI 10.1002/jcp.21256; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tompa P, 2002, J BIOL CHEM, V277, P9022, DOI 10.1074/jbc.C100700200; Van Roey K, 2012, CURR OPIN STRUC BIOL, V22, P378, DOI 10.1016/j.sbi.2012.03.004; Wagner CL, 1996, BLOOD, V88, P907; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Wu HY, 2003, NEUROSCI RES, V47, P131, DOI 10.1016/S0168-0102(03)00195-0; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210337	10.1371/journal.pone.0210337	http://dx.doi.org/10.1371/journal.pone.0210337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689642	Green Submitted, Green Published, gold			2022-12-27	WOS:000457041800006
J	Ohashi, T; Nakade, Y; Ibusuki, M; Kitano, R; Yamauchi, T; Kimoto, S; Inoue, T; Kobayashi, Y; Sumida, Y; Ito, K; Nakao, H; Umezawa, K; Yoneda, M				Ohashi, Tomohiko; Nakade, Yukiomi; Ibusuki, Mayu; Kitano, Rena; Yamauchi, Taeko; Kimoto, Satoshi; Inoue, Tadahisa; Kobayashi, Yuji; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Umezawa, Kazuo; Yoneda, Masashi			Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENE-EXPRESSION; STELLATE CELLS; PPAR AGONISTS; STEATOHEPATITIS; FIBROSIS; MODEL; OBESE; EPIDEMIOLOGY; INDUCTION	Conophylline (CnP), a vinca alkaloid extracted from the leaves of the tropical plant Tabernaemontana divaricate, attenuates hepatic fibrosis in mice. We have previously shown that CnP inhibits non-alcoholic steatohepatitis (NASH) using a methionine-choline-deficient (MCD) diet-fed mouse model. However, little is known about the CnP mediated inhibition of hepatic steatosis in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) mouse models. CnP (0.5 and 1 mu g/g/body weight) was co-administered along with a high-fat diet to male BALB/c mice. After nine weeks of administering the high-fat diet, hepatic steatosis, triglyceride, and hepatic fat metabolism-related markers were examined. Administration of a high-fat diet for 9 weeks was found to induce hepatic steatosis. CnP dose-dependently attenuated the high-fat diet-induced hepatic steatosis. The diet also attenuated hepatic peroxisome proliferator-activated receptor alpha (PPARA) mRNA levels. PPARA is known to be involved in beta-oxidation. CnP upregulated the mRNA levels of hepatic PPARA and its target genes, such as carnitine palmitoyl transferase 1 (CPT1) and CPT2, in a dose-dependent manner in the liver. Furthermore, levels of hepatic beta-hydroxybutyrate, which is a type of ketone body, were increased by CnP in a dose-dependent manner. Finally, CnP increased the expression of the autophagosomal marker LC3-II and decreased the expression of p62, which are known to be selectively degraded during autophagy. These results indicate that CnP inhibits hepatic steatosis through the stimulation of beta-oxidation and autophagy in the liver. Therefore, CnP might prove to be a suitable therapeutic target for NAFLD.	[Ohashi, Tomohiko; Nakade, Yukiomi; Ibusuki, Mayu; Kitano, Rena; Yamauchi, Taeko; Kimoto, Satoshi; Inoue, Tadahisa; Kobayashi, Yuji; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan; [Umezawa, Kazuo] Aichi Med Univ, Dept Mol Target Med, Nagakute, Aichi, Japan	Aichi Medical University; Aichi Medical University	Nakade, Y (corresponding author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan.	ynakade@aichi-med-u.ac.jp	Inoue, Tadahisa/AFK-7576-2022; Sumida, Yoshio/AAL-6723-2020	Inoue, Tadahisa/0000-0003-0718-9099; 	Program for the Strategic Research Foundation at Private Universities [S1101027]; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	Program for the Strategic Research Foundation at Private Universities; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for the Strategic Research Foundation at Private Universities 2011-2015 (S1101027 to M.Y.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeda-Valdes P, 2009, ANN HEPATOL, V8, pS18, DOI 10.1016/S1665-2681(19)31822-8; Atsumi S, 2003, CELL MOL LIFE SCI, V60, P2516, DOI 10.1007/s00018-003-3299-x; Barbosa-da-Silva S, 2015, LIFE SCI, V127, P73, DOI 10.1016/j.lfs.2015.02.003; BRANDES R, 1990, BIOCHIM BIOPHYS ACTA, V1034, P53, DOI 10.1016/0304-4165(90)90152-M; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Christel CM, 2007, J COMP PHYSIOL B, V177, P129, DOI 10.1007/s00360-006-0115-6; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kam TS, 2003, ORG BIOMOL CHEM, V1, P1292, DOI 10.1039/b301167d; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Kawaguchi K, 2004, BIOCHEM BIOPH RES CO, V315, P187, DOI 10.1016/J.BBRC.2004.01.038; Kawakami M, 2010, BIOMED PHARMACOTHER, V64, P226, DOI 10.1016/j.biopha.2009.09.025; Kubo N, 2014, LIVER INT, V34, P1057, DOI 10.1111/liv.12328; Kudo H, 2009, LIVER INT, V29, P988, DOI 10.1111/j.1478-3231.2009.02006.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Mukai K, 2016, J IMMUNOL, V196, P395, DOI 10.4049/jimmunol.1402709; Nakade Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178436; Nakano S, 2015, J CLIN EXP HEPATOL, V5, P190, DOI 10.1016/j.jceh.2015.02.005; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Okada Y, 2013, LIVER INT, V33, P301, DOI 10.1111/liv.12033; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Saito R, 2012, ENDOCRINOLOGY, V153, P621, DOI 10.1210/en.2011-1767; Sasazawa Y, 2015, J BIOL CHEM, V290, P6168, DOI 10.1074/jbc.M114.606293; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	44	17	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210068	10.1371/journal.pone.0210068	http://dx.doi.org/10.1371/journal.pone.0210068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689650	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800004
J	Denaro, M; Navari, E; Ugolini, C; Seccia, V; Donati, V; Casani, AP; Basolo, F				Denaro, Maria; Navari, Elena; Ugolini, Clara; Seccia, Veronica; Donati, Valentina; Casani, Augusto Pietro; Basolo, Fulvio			A microRNA signature for the differential diagnosis of salivary gland tumors	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; DOWN-REGULATION; EXPRESSION; CANCER; INVASION; BETA; METASTASIS; BIOMARKERS; TARGETS; MATRIX	Salivary gland tumors (SGTs) are rare tumors of the head and neck with different clinical behavior. Preoperative diagnosis, based on instrumental and cytologic examinations, is crucial for their correct management. The identification of molecular markers might improve the accuracy of pre-surgical diagnosis helping to plan the proper treatment especially when a definitive diagnosis based only on cytomorphology cannot be achieved. miRNAs appear to be new promising biomarkers in the diagnosis and prognosis of cancer. Studies concerning the useful of miRNA expression in clinical decision-making regarding SGTs remain limited and controversial. The expression of a panel of 798 miRNAs was investigated using Nano-string technology in 14 patients with malignant SGTs (6 mucoepidermoid carcinomas, 4 adenoid cystic carcinomas, 1 acinic cell carcinoma, 1 ductal carcinoma, 1 cystadenocarcinoma and 1 adenocarcinoma) and in 10 patients with benign SGTs (pleomorphic adenomas). The DNA Intelligent Analysis (DIANA)-miRPath v3.0 software was used to determinate the miRNA regulatory roles and to identify the controlled significant Kyoto Encyclopedia of Genes and Genomes (KEGG) molecular pathways. Forty six miRNAs were differentially expressed (False Discovery Rate-FDR<0.05) between malignant and benign SGTs. DIANA miRPath software revealed enriched pathways involved in cancer processes as well as tumorigenesis, cell proliferation, cell growth and survival, tumor suppressor expression, angiogenesis and tumor progression. Interestingly, clustering analysis showed that this signature of 46 miRNAs is able to differentiate the two analyzed groups. We found a correlation between histological diagnosis (benign or malignant) and miRNA expression profile. The molecular signature identified in this study might become an important preoperative diagnostic tool.	[Denaro, Maria; Basolo, Fulvio] Univ Pisa, Dept Surg Pathol Med Mol & Crit Area, Pisa, Italy; [Navari, Elena; Seccia, Veronica; Casani, Augusto Pietro] Azienda Osped Univ Pisana, Dept Surg Pathol Med Mol & Crit Area, Otorhinolaryngol Unit, Pisa, Italy; [Ugolini, Clara] Azienda Osped Univ Pisana, Dept Lab Med, Sect Pathol, Pisa, Italy; [Donati, Valentina] Azienda Osped Univ Pisana, Unit Anat Pathol 2, Pisa, Italy	University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Azienda Ospedaliero Universitaria Pisana	Basolo, F (corresponding author), Univ Pisa, Dept Surg Pathol Med Mol & Crit Area, Pisa, Italy.	fulvio.basolo@med.unipi.it	Seccia, Veronica/AAN-9738-2020; Basolo, Fulvio/AAC-2727-2019; UGOLINI, CLARA/AAI-6489-2021; UGOLINI, Clara/AAG-1760-2019	Basolo, Fulvio/0000-0003-1657-5020; UGOLINI, Clara/0000-0002-3489-8280				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baroni S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.224; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binmadi NO, 2018, ORAL DIS, V24, P537, DOI 10.1111/odi.12800; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Santos PRB, 2017, PATHOL RES PRACT, V213, P1470, DOI 10.1016/j.prp.2017.10.012; Brennan PA, 2010, BRIT J ORAL MAX SURG, V48, P26, DOI 10.1016/j.bjoms.2008.12.014; Brinkmann O, 2011, ADV CLIN CHEM, V55, P21, DOI 10.1016/B978-0-12-387042-1.00002-2; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Cardo LF, 2013, J NEUROL, V260, P1420, DOI 10.1007/s00415-013-6900-8; Chen W, 2014, ONCOL LETT, V7, P2029, DOI 10.3892/ol.2014.1975; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Cinpolat O, 2017, BRAZ J OTORHINOLAR, V83, P276, DOI 10.1016/j.bjorl.2016.03.013; Colella G, 2010, J ORAL MAXIL SURG, V68, P2146, DOI 10.1016/j.joms.2009.09.064; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Farhan M, 2017, INT J BIOL SCI, V13, P815, DOI 10.7150/ijbs.20052; Gallo Alessia, 2013, Methods Mol Biol, V1024, P183, DOI 10.1007/978-1-62703-453-1_14; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gurha P, 2016, CURR OPIN CARDIOL, V31, P249, DOI 10.1097/HCO.0000000000000280; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Li BH, 2011, EUR J CANCER, V47, P2166, DOI 10.1016/j.ejca.2011.04.037; Liu L, 2013, J ORAL PATHOL MED, V42, P140, DOI 10.1111/j.1600-0714.2012.01189.x; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mairembam P, 2016, CYTOPATHOLOGY, V27, P91, DOI 10.1111/cyt.12232; Matse JH, 2013, CLIN CANCER RES, V19, P3032, DOI 10.1158/1078-0432.CCR-12-3505; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066778; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Pfeiffer J, 2012, INT J ORAL MAX SURG, V41, P437, DOI 10.1016/j.ijom.2011.12.005; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Pusztaszeri MP, 2015, SEMIN DIAGN PATHOL, V32, P264, DOI 10.1053/j.semdp.2014.12.008; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schena FP, 2014, NEPHROL DIAL TRANSPL, V29, P755, DOI 10.1093/ndt/gft223; Shang C, 2012, MED SCI MONITOR, V18, pBR149, DOI 10.12659/MSM.882617; Stewart CJR, 2000, DIAGN CYTOPATHOL, V22, P139; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vasioukhin Valeri, 2012, Subcell Biochem, V60, P379, DOI 10.1007/978-94-007-4186-7_16; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang M, 2015, INT J CLIN EXP PATHO, V8, P14110; Wasylishen AR, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026211; Xu K, 2014, BBA-REV CANCER, V1846, P638, DOI 10.1016/j.bbcan.2014.10.007; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang XY, 2009, INT J CANCER, V124, P2855, DOI 10.1002/ijc.24298; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	64	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210968	10.1371/journal.pone.0210968	http://dx.doi.org/10.1371/journal.pone.0210968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682201	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500082
J	Di Tella, M; Ghiggia, A; Testa, S; Castelli, L; Adenzato, M				Di Tella, Marialaura; Ghiggia, Ada; Testa, Silvia; Castelli, Lorys; Adenzato, Mauro			The Fear of Pain Questionnaire: Factor structure, validity and reliability of the Italian translation	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; AVOIDANCE MODEL; INVENTORY-II; FIT INDEXES; SHORT-FORM; BACK-PAIN; SENSITIVITY; PREDICTION; PERCEPTION; ANXIETY	Background The Fear of Pain Questionnaire-III (FPQ-III) is a self-report instrument developed to assess fear of different stimuli usually causing pain. The present study aimed to construct an Italian version of the FPQ-III and examine its psychometric properties in a heterogeneous sample of Italian healthy individuals. Methods The questionnaire was translated following the forward-backward method and completed by 511 Italian adults who met the inclusion criteria. Within 2 months of the first assessment, a subgroup of participants (n = 164) was re-tested. The factorial structure of the FPQ-III was assessed by confirmatory factor analysis (CFA). To better comprehend the FPQ-III's factorial structure, a CFA was also performed for each of the two reduced versions of the FPQ-III, namely the FPQ-Short Form and the FPQ-9. Divergent validity, test-retest reliability, and gender/age measurement invariance were also evaluated. Results The results of the CFA revealed that the original three-factor model poorly fitted the data, but it became satisfactory after allowing correlated error terms. Concerning divergent validity, correlations between FPQ-III scores and pain intensity, depression, and anxiety were found to be positive but weak in magnitude (<.20). FPQ-III subscales and total scores showed good internal consistency and time reliability. Finally, scalar invariance was only partially obtained, whereas all the other types of invariance were fully respected both for gender and age. Conclusions The current findings indicate that the Italian version of the FPQ-III provides valid and reliable scores for the assessment of fear of pain in the Italian population.	[Di Tella, Marialaura; Ghiggia, Ada; Testa, Silvia; Castelli, Lorys; Adenzato, Mauro] Univ Turin, Dept Psychol, Via Verdi, Turin, Italy	University of Turin	Testa, S (corresponding author), Univ Turin, Dept Psychol, Via Verdi, Turin, Italy.	silvia.testa@unito.it	Castelli, Lorys/G-9973-2012; Adenzato, Mauro/I-5127-2012; Adenzato, Mauro/AFQ-8675-2022; Testa, Silvia/AAH-2129-2021; Di Tella, Marialaura/V-4975-2017	Castelli, Lorys/0000-0001-5009-2271; Adenzato, Mauro/0000-0002-6997-9283; Adenzato, Mauro/0000-0002-6997-9283; Testa, Silvia/0000-0002-8732-4790; DI TELLA, MARIALAURA/0000-0003-3616-2434	University of Turin (Ricerca scientifica finanziata dall'Universita)	University of Turin (Ricerca scientifica finanziata dall'Universita)	Mauro Adenzato was supported by the University of Turin (Ricerca scientifica finanziata dall'Universita). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaret MC, 2004, EUR J PAIN, V8, P273, DOI 10.1016/j.ejpain.2003.09.005; Alodaibi FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193566; Asmundson GJG, 2008, PAIN, V134, P51, DOI 10.1016/j.pain.2007.03.033; Bandalos D.L., 2001, NEW DEV TECHNIQUES S, DOI DOI 10.4324/9781410601858; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; Cardoso S, 2016, REV BRAS REUMATOL, V56, P377, DOI [10.1016/j.rbre.2016.02.012, 10.1016/j.rbr.2015.10.006]; Carleton RN, 2016, J ANXIETY DISORD, V41, P5, DOI 10.1016/j.janxdis.2016.03.011; Carleton RN, 2009, J PAIN, V10, P29, DOI 10.1016/j.jpain.2008.06.007; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Gatzounis R, 2017, SCAND J PAIN, V17, P132, DOI 10.1016/j.sjpain.2017.07.020; Ghisi M., 2006, BDI 2 BECK DEPRESSIO, DOI [10.1007/s12144-019-0132-8, DOI 10.1007/s12144-019-0132-8]; Haukenes I, 2015, EUR J PAIN, V19, P826, DOI 10.1002/ejp.609; Hirsh AT, 2008, J PAIN, V9, P806, DOI 10.1016/j.jpain.2008.03.012; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Linton SJ, 2018, PHYS THER, V98, P315, DOI 10.1093/ptj/pzy027; McNeil DW, 2018, EUR J PAIN, V22, P39, DOI 10.1002/ejp.1074; McNeil DW, 2001, PAIN, V89, P245, DOI 10.1016/S0304-3959(00)00368-7; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Meier ML, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000601; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Nees F, 2018, NEUROSCIENCE, V387, P72, DOI 10.1016/j.neuroscience.2017.08.051; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Osman A, 2002, J BEHAV MED, V25, P155, DOI 10.1023/A:1014884704974; Pedrabissi L, 1989, INVENTARIO ANSIA STA; Peters ML, 2002, BEHAV RES THER, V40, P85, DOI 10.1016/S0005-7967(01)00005-5; Poiraudeau S, 2006, PAIN, V124, P305, DOI 10.1016/j.pain.2006.04.019; Poole H, 2006, CLIN J PAIN, V22, P790, DOI 10.1097/01.ajp.0000210930.20322.93; Roelofs J, 2005, PAIN, V116, P339, DOI 10.1016/j.pain.2005.05.003; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI [10.13287/j.1001-9332.202201.010, DOI 10.1002/0470010940]; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SLADE PD, 1983, BEHAV RES THER, V21, P409, DOI 10.1016/0005-7967(83)90010-4; Sole E, 2019, J HEALTH PSYCHOL, V24, P1134, DOI 10.1177/1359105316686669; Spielberger C.D., 1970, STATE TRAIT ANXIETY, DOI DOI 10.1037/T06496-000; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; van Wijk AJ, 2006, EUR J PAIN, V10, P479, DOI 10.1016/j.ejpain.2005.06.008; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Volders S, 2015, BEHAV RES THER, V64, P31, DOI 10.1016/j.brat.2014.11.003; Widaman KF., 1997, SCI PREVENTION METHO, P281, DOI [10.1037/10222-009, DOI 10.1037/10222-009]; Zaman J, 2015, NEUROSCI BIOBEHAV R, V51, P118, DOI 10.1016/j.neubiorev.2015.01.009; Zvolensky MJ, 2001, BEHAV RES THER, V39, P683, DOI 10.1016/S0005-7967(00)00049-8	49	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210757	10.1371/journal.pone.0210757	http://dx.doi.org/10.1371/journal.pone.0210757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682182	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500060
J	Humiston, GB; Wamsley, EJ				Humiston, Graelyn B.; Wamsley, Erin J.			Unlearning implicit social biases during sleep: A failure to replicate	PLOS ONE			English	Article							MEMORY; PREJUDICE; REACTIVATION; HIPPOCAMPUS; REDUCTION; REPLAY	A 2015 article in Science (Hu et al.) proposed a new way to reduce implicit racial and gender biases during sleep. The method built on an existing counter-stereotype training procedure, using targeted memory reactivation to strengthen counter-stereotype memory by playing cues associated with the training during a 90min nap. If effective, this procedure would have potential real-world usefulness in reducing implicit biases and their myriad effects. We replicated this procedure on a sample of n = 31 college students. Contrary to the results reported by Hu et al., we found no effect of cueing on implicit bias, either immediately following the nap or one week later. In fact, bias was non-significantly greater for cued than for uncued stimuli. Our failure to detect an effect of cueing on implicit bias could indicate either that the original report was a false positive, or that the current study is a false negative. However, several factors argue against Type II error in the current study. Critically, this replication was powered at 0.9 for detecting the originally reported cueing effect. Additionally, the 95% confidence interval for the cueing effect in the present study did not overlap with that of the originally reported effect; therefore, our observations are not easily explained as a noisy estimate of the same underlying effect. Ultimately, the outcome of this replication study reduces our confidence that cueing during sleep can reduce implicit bias.	[Humiston, Graelyn B.; Wamsley, Erin J.] Furman Univ, Dept Psychol, Greenville, SC 29613 USA; [Humiston, Graelyn B.; Wamsley, Erin J.] Furman Univ, Program Neurosci, Greenville, SC 29613 USA		Wamsley, EJ (corresponding author), Furman Univ, Dept Psychol, Greenville, SC 29613 USA.	erin.wamsley@furman.edu		Humiston, Graelyn/0000-0002-1875-5546	South Carolina IDeA Networks of Biomedical Research Excellence [P20GM103499]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	South Carolina IDeA Networks of Biomedical Research Excellence; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.B.H. was supported by a summer fellowship from South Carolina IDeA Networks of Biomedical Research Excellence (https://sites.google.com/view/scinbre/home), funded by grant P20GM103499 from the National Institute of General Medical Sciences (https://www.nigms.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Bendor D, 2012, NAT NEUROSCI, V15, P1439, DOI 10.1038/nn.3203; Burns MD, 2017, J EXP SOC PSYCHOL, V73, P97, DOI 10.1016/j.jesp.2017.06.003; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Diekelmann S, 2011, NAT NEUROSCI, V14, P381, DOI 10.1038/nn.2744; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Feld GB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00622; Forscher PS, 2016, PSYARXIV, DOI [10.17605/OSF.IO/DV8TU, DOI 10.17605/OSF.IO/DV8TU]; Gawronski B, 2008, J EXP SOC PSYCHOL, V44, P370, DOI 10.1016/j.jesp.2006.12.004; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Harrison MS, 2009, J APPL SOC PSYCHOL, V39, P134, DOI 10.1111/j.1559-1816.2008.00433.x; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hu XQ, 2015, SCIENCE, V348, P1013, DOI 10.1126/science.aaa3841; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lai CK, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000179; Lai CK, 2014, J EXP PSYCHOL GEN, V143, P1765, DOI 10.1037/a0036260; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; Penner LA, 2010, J EXP SOC PSYCHOL, V46, P436, DOI 10.1016/j.jesp.2009.11.004; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Sara SJ, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00185; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211416	10.1371/journal.pone.0211416	http://dx.doi.org/10.1371/journal.pone.0211416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682167	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500167
J	Katsukawa, C; Kenri, T; Shibayama, K; Takahashi, K				Katsukawa, Chihiro; Kenri, Tsuyoshi; Shibayama, Keigo; Takahashi, Kazuo			Genetic characterization of Mycoplasma pneumoniae isolated in Osaka between 2011 and 2017: Decreased detection rate of macrolide-resistance and increase of p1 gene type 2 lineage strains	PLOS ONE			English	Article							HOMOLOGOUS DNA RECOMBINATION; TANDEM-REPEAT ANALYSIS; INFECTIONS; JAPAN; IDENTIFICATION; SEQUENCE; PROTEIN; EPIDEMIOLOGY; EMERGENCE	We characterized 419 Mycoplasma pneumoniae isolates collected between 2011 and 2017 in Osaka prefecture of Japan. This analysis revealed high prevalence of macrolide-resistant M. pneumoniae (MRMP) in Osaka during 2011 and 2014 with annual detection rates of MRMP strains between 71.4% and 81.8%. However, in 2015 and after, the detection rate of MRMP decreased significantly and did not exceed 50%. Genotyping of the p1 gene of these isolates showed that most of MRMP strains harbored type 1 p1 gene. In contrast, strains expressing p1 gene type 2 or its variant were largely macrolide-susceptible M. pneumoniae (MSMP) strains. There was a strong correlation between p1 gene genotype and the presence of mutations conferring macrolide resistance in M. pneumoniae isolated in Osaka. These results indicate that lower incidence of MRMP strains in Osaka from 2015 was associated with the relative increase of p1 gene type 2 lineage strains. During these experiments, we also isolated three M. pneumoniae strains that showed irregular typing pattern in the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis of the p1 gene. Two of these strains harbored new variants of type 2 p1 gene and were designated as type 2f and 2g. The remaining strain with an irregular typing pattern had a large deletion in the p1 operon.	[Katsukawa, Chihiro] Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan; [Katsukawa, Chihiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Vet Sci, Osaka, Japan; [Kenri, Tsuyoshi; Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan; [Takahashi, Kazuo] Int Univ Hlth & Welf, Otawara, Tochigi, Japan	Osaka Prefectural Institute of Public Health; Osaka Metropolitan University; National Institute of Infectious Diseases (NIID); International University of Health & Welfare	Kenri, T (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kenri@niid.go.jp			Japan Society for the Promotion of Science [25460834]; Japan Agency for Medical Research and Development [18jk0210004j0101, 17jk0210004j0001, 16jk0210004j0001, 15jk0210004h0027]; Ministry of Health, Labour and Welfare [H26-Kokui-Shitei-001]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Japan Society for the Promotion of Science 25460834, Dr. Chihiro Katsukawa; Japan Agency for Medical Research and Development 18jk0210004j0101, Dr. Tsuyoshi Kenri; Japan Agency for Medical Research and Development 17jk0210004j0001, Dr. Keigo Shibayama; Japan Agency for Medical Research and Development 16jk0210004j0001, Dr. Keigo Shibayama; Japan Agency for Medical Research and Development 15jk0210004h0027, Dr. Keigo Shibayama; Ministry of Health, Labour and Welfare H26-Kokui-Shitei-001, Dr. Keigo Shibayama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balish MF, 2003, MOL MICROBIOL, V47, P49, DOI 10.1046/j.1365-2958.2003.03282.x; Brown RJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00157; Charron A, 1994, 10 INT C INT ORG MYC; Cousin-Allery A, 2000, EPIDEMIOL INFECT, V124, P103, DOI 10.1017/S0950268899003313; CRAVEN RB, 1976, J CLIN MICROBIOL, V4, P225; Diaz MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174701; Diaz MH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv106; Diaz MH, 2015, J CLIN MICROBIOL, V53, P124, DOI 10.1128/JCM.02597-14; Dumke R, 2010, CLIN MICROBIOL INFEC, V16, P613, DOI 10.1111/j.1469-0691.2009.02968.x; Dumke R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00039; Eshaghi A, 2013, EMERGING INFECT DIS, V19; Eun BW, 2008, J INFECTION, V56, P326, DOI 10.1016/j.jinf.2008.02.018; Fan LP, 2017, EXP THER MED, V14, P1892, DOI 10.3892/etm.2017.4721; FOY HM, 1979, J INFECT DIS, V139, P681, DOI 10.1093/infdis/139.6.681; Ho PL, 2015, J CLIN MICROBIOL, V53, P3560, DOI 10.1128/JCM.01983-15; Ishiguro N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173635; Izumikawa K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00800; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P2252, DOI 10.1128/AAC.00048-13; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Kenri T, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00513-17; Kenri T, 2012, J MED MICROBIOL, V61, P1633, DOI 10.1099/jmm.0.046441-0; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Krishnakumar R, 2010, APPL ENVIRON MICROB, V76, P5297, DOI 10.1128/AEM.00024-10; Kubota H, 2015, JPN J INFECT DIS, V68, P76, DOI 10.7883/yoken.JJID.2014.336; Lee JK, 2018, EMERG INFECT DIS, V24, P1465, DOI 10.3201/eid2408.180081; Lenglet A, 2012, EURO SURVEILLANCE B, V17; Li SL, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00087-16; LIND K, 1988, EPIDEMIOL INFECT, V101, P377, DOI 10.1017/S0950268800054327; Matsuoka M, 2004, ANTIMICROB AGENTS CH, V48, P4624, DOI 10.1128/AAC.48.12.4624-4630.2004; Morozumi M, 2005, ANTIMICROB AGENTS CH, V49, P2302, DOI 10.1128/AAC.49.6.2302-2306.2005; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Okazaki N, 2001, MICROBIOL IMMUNOL, V45, P617, DOI 10.1111/j.1348-0421.2001.tb01293.x; Parrott GL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00513; Pereyre S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00974; Rastawicki W, 1998, Euro Surveill, V3, P99; Sasaki T, 1996, J CLIN MICROBIOL, V34, P447, DOI 10.1128/JCM.34.2.447-449.1996; Sauteur PMM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00329; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Sluijter M, 2010, MOL MICROBIOL, V77, P1261, DOI 10.1111/j.1365-2958.2010.07288.x; Spuesens EBM, 2011, MICROBIOL-SGM, V157, P473, DOI 10.1099/mic.0.045591-0; Spuesens EBM, 2009, MICROBIOL-SGM, V155, P2182, DOI 10.1099/mic.0.028506-0; Sun HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170253; Suzuki Y, 2017, JPN J INFECT DIS, V70, P642, DOI 10.7883/yoken.JJID.2017.276; Suzuki Yu, 2015, Kansenshogaku Zasshi, V89, P16; Tanaka T, 2017, EMERG INFECT DIS, V23, P1703, DOI 10.3201/eid2310.170106; TJHIE JHT, 1994, J CLIN MICROBIOL, V32, P11, DOI 10.1128/JCM.32.1.11-16.1994; Waites KB, 2017, CLIN MICROBIOL REV, V30, P747, DOI 10.1128/CMR.00114-16; Xiao JH, 2014, DIAGN MICR INFEC DIS, V78, P24, DOI 10.1016/j.diagmicrobio.2013.08.008; Yamazaki T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00693; Zhao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141702	51	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209938	10.1371/journal.pone.0209938	http://dx.doi.org/10.1371/journal.pone.0209938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682029	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500018
J	Shirakawa, K; Yano, W; Inoue, K; Katsumata, Y; Endo, J; Sano, M				Shirakawa, Kohsuke; Yano, Wataru; Inoue, Keisuke; Katsumata, Yoshinori; Endo, Jin; Sano, Motoaki			Influence of long term administration of tofogliflozin on chronic inflammation of visceral adipose tissue in mice with obesity induced by a high-fat diet	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITOR; T-CELLS; CARDIOVASCULAR-DISEASE; DIABETIC-NEPHROPATHY; SKELETAL-MUSCLE; OSTEOPONTIN; SENESCENCE; MORTALITY	We previously found that senescence of cluster of differentiation 4 (CD4) T cells is accelerated in the visceral adipose tissue (VAT) of mice with diet-induced obesity (DIO) due to a high-fat diet (HFD), and that these senescent-associated T cells cause chronic inflammation of visceral adipose tissue through secretion of osteopontin, provoking systemic insulin resistance. In this study, we examined whether the development of chronic inflammation and senescence-associated T cells in VAT of DIO mice was improved by long-term weight loss after switching to normal chow (NC) or by administration of a sodium glucose cotransporter 2 inhibitor (tofogliflozin). Wild-type mice were fed an HFD for 26 weeks from 4 weeks old. At 30 weeks of age, half of these DIO mice were switched to NC with or without 0.005% tofogliflozin for 38 weeks. The other mice remained on the HFD with or without 0.005% tofogliflozin for 38 weeks. When DIO mice were switched to NC, their weight decreased to that of mice kept on NC since weaning. After 38 weeks (68 weeks of age), chronic inflammation of the VAT subsided with disappearance of senescence-associated T cells. In the HFD groups, the carbohydrate intake per mouse was half or less of that in the NC group, and urinary glucose excretion by the effect of tofogliflozin was lower in the HFD mice than in the NC mice. Mice that remained on the HFD showed no improvement in chronic inflammation in VAT, possibly because urinary glucose excretion was not sufficiently promoted by tofogliflozin due to the low carbohydrate intake. Thus, no improvement in glucose metabolism or weight loss was observed in these mice.	[Shirakawa, Kohsuke; Katsumata, Yoshinori; Endo, Jin; Sano, Motoaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Yano, Wataru; Inoue, Keisuke] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan	Keio University; Kowa Company, Ltd.	Sano, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	msano@a8.keio.jp	Katsumata, Yoshinori/AAC-4159-2021; Sano, Motoaki/L-3405-2013	Katsumata, Yoshinori/0000-0001-5576-5789; Sano, Motoaki/0000-0003-1771-8310; Yano, Wataru/0000-0002-6866-8520	Kowa Company, Ltd.;  [18K15197]	Kowa Company, Ltd.; 	A joint research agreement was concluded between Keio University and Kowa Company, Ltd. Tofogliflozin was provided by Kowa Company, Ltd. and this joint research project was funded by Kowa Company, Ltd. The funder provided support in the form of salaries for the authors W.Y. and K.I., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by Grant-in-Aid for Scientific Research Grant Number 18K15197. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalrhim AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156965; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Benetti E, 2016, J PHARMACOL EXP THER, V359, P45, DOI 10.1124/jpet.116.235069; Bosello O, 2000, Obes Rev, V1, P47, DOI 10.1046/j.1467-789x.2000.00008.x; Chiba Y, 2007, HYPERTENS RES, V30, P229, DOI 10.1291/hypres.30.229; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Gordin D, 2014, DIABETES CARE, V37, P2593, DOI 10.2337/dc14-0065; Itoh H, 2006, DRUGS TODAY, V42, P9; Ji WJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179960; Jia YL, 2018, CELL PHYSIOL BIOCHEM, V45, P1747, DOI 10.1159/000487783; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mattoo H, 2009, INT IMMUNOL, V21, P1277, DOI 10.1093/intimm/dxp094; Naznin F, 2017, EUR J PHARMACOL, V794, P37, DOI 10.1016/j.ejphar.2016.11.028; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shirakawa K, 2018, CIRCULATION, V138, P2021, DOI 10.1161/CIRCULATIONAHA.118.035047; Shirakawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186303; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Stromnes IM, 2007, NAT IMMUNOL, V8, P19, DOI 10.1038/ni0107-19; Suzuki M, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.20; Suzuki M, 2012, J PHARMACOL EXP THER, V341, P692, DOI 10.1124/jpet.112.191593; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; Takagi S, 2018, J DIABETES INVEST, V9, P1025, DOI 10.1111/jdi.12802; Vallon V, 2014, AM J PHYSIOL-RENAL, V306, pF194, DOI 10.1152/ajprenal.00520.2013; Wang XXX, 2017, J BIOL CHEM, V292, P5335, DOI 10.1074/jbc.M117.779520; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yokono M, 2014, EUR J PHARMACOL, V727, P66, DOI 10.1016/j.ejphar.2014.01.040	32	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211387	10.1371/journal.pone.0211387	http://dx.doi.org/10.1371/journal.pone.0211387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682139	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500163
J	Slepchenko, SM; Gusev, AV; Svyatova, EO; Hong, JH; Oh, CS; Lim, DS; Shin, DH				Slepchenko, Sergey Mikhailovich; Gusev, Alexander Vasilyevich; Svyatova, Evgenia Olegovna; Hong, Jong Ha; Oh, Chang Seok; Lim, Do Seon; Shin, Dong Hoon			Medieval mummies of Zeleny Yar burial ground in the Arctic Zone of Western Siberia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA	Notwithstanding the pioneering achievements of studies on arctic mummies in Siberia, there are insufficient data for any comprehensive understanding of the bio-cultural details of medieval people living in the region. In the Western Siberian arctic, permafrost mummies have been found in 12th to 13th century graves located in the Zeleny Yar (Z-Y) burial ground (66 degrees 19'4.54 ''; 67 degrees 21'13.54 ''). In 2013-2016, we were fortunate to be able to excavate that cemetery, locating a total of 47 burials, including cases of mummification. Some of these mummies had been wrapped in a multi-layered birch-bark cocoon. After removal of the cocoon, we conducted interdisciplinary studies using various scientific techniques. Gross anatomical examination and CT radiography showed that the internal organs were still well preserved inside the body cavities. Under light and electron microscopy, the histological findings were very similar to those for naturally mummified specimens discovered in other countries. Ancient DNA analysis showed that the Z-Y mummies' mtDNA haplotypes belong to five different haplogroups, namely U5a (#34), H3ao (#53), D (#67-1), U4b1b1 (#67-2), and D4j8 (#68), which distinguish them for their unique combination of Western- and Eastern Siberia-specific mtDNA haplogroups. Our interdisciplinary study obtained fundamental information that will form the foundation of successful future investigations on medieval mummies found in the Western Siberian arctic.	[Slepchenko, Sergey Mikhailovich] Russian Acad Sci, Tyumen Sci Ctr, Siberian Branch, Tyumen, Russia; [Gusev, Alexander Vasilyevich] Arctic Res Ctr, Archeol Dept, Archeol & Ethnol Sect, Salekhard, Russia; [Svyatova, Evgenia Olegovna] Sci & Prod Ctr, Inst Culture Sverdlovsk Reg, Ctr Protect & Use Monuments Hist & Culture Sverdl, Ekaterinburg, Russia; [Hong, Jong Ha; Oh, Chang Seok; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Lab Bioanthropol Paleopathol & Hist Dis, Dept Anat,Inst Forens Sci, Seoul, South Korea; [Lim, Do Seon] Eulji Univ, Coll Hlth Sci, Dept Dent Hyg, Seongnam, South Korea	Russian Academy of Sciences; Seoul National University (SNU); Eulji University	Slepchenko, SM (corresponding author), Russian Acad Sci, Tyumen Sci Ctr, Siberian Branch, Tyumen, Russia.; Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Lab Bioanthropol Paleopathol & Hist Dis, Dept Anat,Inst Forens Sci, Seoul, South Korea.	s_slepchenko@list.ru; cuteminjae@gmail.com	Slepchenko, Sergey M/H-3454-2017; Slepchenko, Sergey/AAN-5737-2020	Slepchenko, Sergey M/0000-0002-9365-3849; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03030127]; Basic Research Program RAS 2018-2020 of Tyumen Scientific Center, SB RAS [XII.186.2, 0372-2016-0002]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Basic Research Program RAS 2018-2020 of Tyumen Scientific Center, SB RAS	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03030127). DHS received the funding. This study was also funded by Basic Research Program RAS 2018-2020 (program XII.186.2), project 0372-2016-0002 of Tyumen Scientific Center, SB RAS. SMS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Bagashev AN, 2017, ARCHAEOL ETHNOL ANTH, V45, P135, DOI 10.17746/1563-0102.2017.45.1.135-145; Bozzola J.J., 1992, ELECT MICROSCOPY PRI, P14; COCKBURN A, 1998, MUMMIES DIS ANCIENT, P336; Cockburn T.A., 1998, MUMMIES DIS ANCIENT; Dabernat H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089877; Dedouit F, 2010, FORENSIC SCI INT, V200, DOI 10.1016/j.forsciint.2010.03.028; Derbeneva OA, 2002, RUSS J GENET+, V38, P1316, DOI 10.1023/A:1021111530654; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Hansen JPH, 1996, MAN IN ICE, V3, P107; Hayat M.A., 1970, PRINCIPLES TECHNIQUE, V1, P109; Hess MW, 1998, AM J PHYS ANTHROPOL, V106, P521; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Iwamura Edna Sadayo Miazato, 2004, Rev. Hosp. Clin., V59, P383, DOI 10.1590/S0041-87812004000600012; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Keyser C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0385; Kim YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099779; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; Lynnerup N, 2015, ANAT REC, V298, P1001, DOI 10.1002/ar.23131; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Marota I, 2002, CELL MOL LIFE SCI, V59, P97, DOI 10.1007/s00018-002-8408-8; Naumova OY, 2009, RUSS J GENET+, V45, P756, DOI 10.1134/S1022795409060167; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Polosmak N.V., 1994, NATL GEOGR, V186, P80; Ricaut FX, 2006, AM J HUM BIOL, V18, P654, DOI 10.1002/ajhb.20535; Ruffer MA., 1921, STUDIES PALAEOPATHOL; Sato T, 2011, J HUM GENET, V56, P602, DOI 10.1038/jhg.2011.68; Sheehan D.C., 1980, THEORY PRACTICE HIST; Shin DH, 2003, FORENSIC SCI INT, V137, P172, DOI 10.1016/S0379-0738(03)00335-9; Slepchenko SM, 2015, MEM I OSWALDO CRUZ, V110, P974, DOI 10.1590/0074-02760150156; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Zimmerman M. R., 1998, MUMMIES DIS ANCIENT, P138	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210718	10.1371/journal.pone.0210718	http://dx.doi.org/10.1371/journal.pone.0210718			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682121	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500054
J	Zhang, R; He, GZ; Wang, YK; Wang, J; Chen, W; Xu, YC				Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun			The effect of different treatments of lymph after intestinal ischemia-reperfusion in rats on macrophages in vitro	PLOS ONE			English	Article								Background To observe the effects of different treatments of lymph after intestinal I/R in rats on macrophages in vitro. Methods Forty-eight healthy SPF SD rats weighing 300 +/- 20 g, were randomly divided into two groups: group A, and group B. The rats in group A were drained of lymph fluid for 180 min; the rats in group B were subjected to 60 min ischemia by clamping the SMA, followed by 120 min reperfusion and 180 min of lymph drainage. The lymph fluid collected was divided into 4 sub-groups: 1. no treatment (A1, Ly, and B1, I/R Ly); 2. protein degradation (A2, Ly PD, and B2 I/R PD); 3. endotoxin removal (A3, Ly ER, and B3, I/R ER); 4. protein degradation plus endotoxin removal (A4, Ly PD+ER, and B4, I/R PD+ER), then used to stimulate a monocyte-macrophage cell line. Results Compared with group A1, the levels of the inflammatory cytokines, chemokines, HMGB1 concentration, protein and mRNA expression of TLR4, HMGB1 and NF-kappa Bp65 were significantly increased in group B1. There was a significant reduction in proinflammatory cytokines and of the expression of TLR4, NF-kappa Bp65, and chemokines in groups A2, B2, A4, and B4. However, there were no significant decrease of these factors in groups A3 and B3. Conclusions The lymph fluid drained after intestinal I/R can cause inflammation in vivo and in vitro. Deproteinization of lymph fluid with proteinase K significantly reduced the concentration of proinflammatory cytokines, chemokines, TLR4 and NF-kappa Bp65 in cell culture supernatant, exerting a protective effect on inflammatory reaction caused by the intestinal I/R. Passage of lymph fluid through an endotoxin removal column did not reduce the levels of active proinflammatory factors produced by macrophages in vitro.	[Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China; [Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun] Peking Union Med Coll, CAMS, Beijing, Peoples R China; [Zhang, Rui; He, Guizhen; Wang, Yukang; Wang, Jie; Chen, Wei; Xu, Yingchun] PUMC, Beijing, Peoples R China; [Zhang, Rui; Xu, Yingchun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	He, GZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Parenteral & Enteral Nutr, Beijing, Peoples R China.; He, GZ (corresponding author), Peking Union Med Coll, CAMS, Beijing, Peoples R China.; He, GZ (corresponding author), PUMC, Beijing, Peoples R China.	hegzhpumch@163.com			National Natural Sciences Foundation of China [30940069]; National Natural Sciences Foundation of Beijing [7102127]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Sciences Foundation of Beijing	This study was supported by the National Natural Sciences Foundation of China (30940069) and by the National Natural Sciences Foundation of Beijing (7102127). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2001, SURGERY, V129, P351, DOI 10.1067/msy.2001.111698; Ben DF, 2012, J SURG RES, V174, P326, DOI 10.1016/j.jss.2010.12.005; Damle SS, 2007, J SURG RES, V143, P136, DOI 10.1016/j.jss.2007.04.016; Fanous MYZ, 2007, J PANCREAS, V8, P374; Feinman R, 2010, AM J PHYSIOL-GASTR L, V1, P833; Guzel A, 2013, TOXICOL IND HEALTH, V29, P633, DOI 10.1177/0748233711430984; Jordan JR, 2008, J APPL PHYSIOL, V104, P1161, DOI 10.1152/japplphysiol.00022.2007; Kougias P, 2007, J VASC SURG, V46, P467, DOI 10.1016/j.jvs.2007.04.045; Lin ZL, 2014, WORLD J GASTROENTERO, V20, P17905, DOI 10.3748/wjg.v20.i47.17905; Liu Mu-Lin, 2008, Zhonghua Yi Xue Za Zhi, V88, P225; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; van der Heijden KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108453; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015; Watkins AC, 2008, J TRAUMA, V64, P126, DOI 10.1097/TA.0b013e3181574a8a; Wohlauer MV, 2011, J SURG RES, V170, P314, DOI 10.1016/j.jss.2011.03.045; Wu H, 2014, WORLD J GASTROENTERO, V20, P15327, DOI 10.3748/wjg.v20.i41.15327; Yang H, 2013, NEUROPEPTIDES, V47, P237, DOI 10.1016/j.npep.2013.04.003; Zhao Z, 2008, CHINESE J PATHOPHYSI, V10, P2051	20	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211195	10.1371/journal.pone.0211195	http://dx.doi.org/10.1371/journal.pone.0211195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682177	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500121
J	Gonzalez-Garcia, S; Alvarez-Perez, JM; de Miera, LES; Cobos, R; Ibanez, A; Diez-Galan, A; Garzon-Jimeno, E; Coque, JJR				Gonzalez-Garcia, Sandra; Manuel Alvarez-Perez, Jose; Saenz de Miera, Luis E.; Cobos, Rebeca; Ibanez, Ana; Diez-Galan, Alba; Garzon-Jimeno, Enrique; Coque, Juan Jose R.			Developing tools for evaluating inoculation methods of biocontrol Streptomyces sp. strains into grapevine plants	PLOS ONE			English	Article							BLACK FOOT; DISEASE; SOIL; RAPD	The endophytic Streptomyces sp. VV/E1, and rhizosphere Streptomyces sp. VV/R4 strains, isolated from grapevine plants were shown in a previous work to reduce the infection rate of fungal pathogens involved in young grapevine decline. In this study we cloned fragments from randomly amplified polymorphic DNA (RAPD), and developed two stably diagnostic sequence-characterized amplified region (SCAR) markers of 182 and 160 bp for the VV/E1 and VV/R4 strains, respectively. The SCAR markers were not found in another 50 actino-bacterial strains isolated from grapevine plants. Quantitative real-time PCR protocols based on the amplification of these SCAR markers were used for the detection and quantification of both strains in plant material. These strains were applied on young potted plants using two methods: perforation of the rootstock followed by injection of the microorganisms or soaking the root system in a bacterial suspension. Both methods were combined with a booster treatment by direct addition of a bacterial suspension to the soil near the root system. Analysis of uprooted plants showed that those inoculated by injection exhibited the highest rate of colonization. In contrast, direct addition of either strain to the soil did not lead to reliable colonization. This study has developed molecular tools for analyzing different methods for inoculating grapevine plants with selected Streptomyces sp. strains which protect them from fungal infections that enter through their root system. These tools are of great applied interest since they could easily be established in nurseries to produce grafted grapevine plants that are protected against fungal pathogens. Finally, this methodology might also be applied to other vascular plants for their colonization with beneficial biological control agents.	[Gonzalez-Garcia, Sandra; Manuel Alvarez-Perez, Jose; Ibanez, Ana; Garzon-Jimeno, Enrique; Coque, Juan Jose R.] Univ Leon, Inst Invest Vina & Vino, Leon, Spain; [Saenz de Miera, Luis E.] Univ Leon, Dept Biol Mol, Area Genet, Leon, Spain; [Cobos, Rebeca; Diez-Galan, Alba] RGA Bioinvest SL, Leon, Spain	Universidad de Leon; Universidad de Leon	Coque, JJR (corresponding author), Univ Leon, Inst Invest Vina & Vino, Leon, Spain.	jjrubc@unileon.es	Sáenz de Miera, Luis/ABA-4573-2021; de Miera, Luis E Sáenz/D-6864-2018; Alvarez-Perez, Jose Manuel/AAG-7167-2019; Cobos, Rebeca/F-2322-2016; Coque, Juan Jose Rubio/AAV-2049-2021	Sáenz de Miera, Luis/0000-0003-1871-7379; de Miera, Luis E Sáenz/0000-0003-1871-7379; Cobos, Rebeca/0000-0002-6487-1556; Coque, Juan Jose Rubio/0000-0001-8221-7817; Diez-Galan, Alba/0000-0002-2721-0388; Ibanez Sanchez, Ana Maria/0000-0002-8867-0732	Viveros Villanueva Vides S.L. (Larraga, Spain) - Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain) [FPU15/03475]; Programa Torres Quevedo from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain) [PTQ-14-06849]; University of Leon (Spain)	Viveros Villanueva Vides S.L. (Larraga, Spain) - Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain); Programa Torres Quevedo from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain); University of Leon (Spain)	This work was supported by Viveros Villanueva Vides S.L. (Larraga, Spain) which was financed by the Centro para el Desarrollo Tecnologico Industrial-CDTI-(Madrid, Spain) through the GLOBALVITI project (CIEN Program) (http://viverosvillanueva.es/, https://www.cdti.es/).SGG was supported by an FPU fellowship (Grant number FPU15/03475) from the Ministerio de Educacion, Cultura y Deporte (Madrid, Spain) (http://www.mecd.gob.es/).RC was supported by the Programa Torres Quevedo (Grant number PTQ-14-06849) from the Ministerio de Ciencia, Innovacion y Universidades (Madrid, Spain), (http://www.ciencia.gob.es/).RGA Bio-Investigacion S.L. is a spin-off of the University of Leon (Spain) that provided support in the form of salaries for authors RC and ADG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Auffret M, 2011, WATER RES, V45, P6753, DOI 10.1016/j.watres.2011.10.020; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Bhagyawant S. S., 2016, J BIOSCI MED, V4, P1, DOI DOI 10.4236/JBM.2016.41001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlucci A, 2017, PHYTOPATHOL MEDITERR, V56, P10, DOI 10.14601/Phytopathol_Mediterr-18769; Corte L, 2005, J APPL MICROBIOL, V99, P609, DOI 10.1111/j.1365-2672.2005.02631.x; De Mendiburu F, 2009, THESIS; Di Marco S, 2007, PHYTOPATHOL MEDITERR, V46, P73; Doumbou CL, 2001, PHYTOPROTECTION, V82, P85, DOI 10.7202/706219ar; Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001; Fourie PR, 2004, PLANT DIS, V88, P1241, DOI 10.1094/PDIS.2004.88.11.1241; Gharaibeh R, 2003, J BASIC MICROB, V43, P18, DOI 10.1002/jobm.200390000; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Halleen F, 2006, PHYTOPATHOL MEDITERR, V45, pS55; Hiltunen LH, 2009, J APPL MICROBIOL, V106, P199, DOI 10.1111/j.1365-2672.2008.03992.x; Hopwood D.A., 1985, GENETIC MANIPULATION; Kinkel LL, 2012, RES MICROBIOL, V163, P490, DOI 10.1016/j.resmic.2012.07.005; Kiran U, 2010, FITOTERAPIA, V81, P969, DOI 10.1016/j.fitote.2010.08.002; Law JWF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00003; Leisso RS, 2009, CAN J PLANT PATHOL, V31, P38, DOI 10.1080/07060660909507570; Li J, 2012, ANTON LEEUW INT J G, V101, P515, DOI 10.1007/s10482-011-9661-3; Alvarez-Perez JM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01564-17; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Pertot I, 2016, BIOCONTROL, V61, P257, DOI 10.1007/s10526-016-9723-6; Schlatter DC, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0470-6; Schrey SD, 2008, ANTON LEEUW INT J G, V94, P11, DOI 10.1007/s10482-008-9241-3; Schrey SD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-164; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Toumatia O, 2016, S AFR J BOT, V105, P234, DOI 10.1016/j.sajb.2016.03.020; Van der Meij A, 2017, FEMS MICROBIOL REV, V41, P392, DOI 10.1093/femsre/fux005; Vurukonda SSKP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040952; Yang LQ, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-501	32	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211225	10.1371/journal.pone.0211225	http://dx.doi.org/10.1371/journal.pone.0211225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677098	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400063
J	Prado-Gutierrez, P; Martinez-Montes, E; Weinstein, A; Zanartu, M				Prado-Gutierrez, Pavel; Martinez-Montes, Eduardo; Weinstein, Alejandro; Zanartu, Matias			Estimation of auditory steady-state responses based on the averaging of independent EEG epochs	PLOS ONE			English	Article							AMPLITUDE-MODULATED TONES; VENTRAL COCHLEAR NUCLEUS; EVOKED-POTENTIALS; 40 HZ; P2 COMPONENTS; TIME-COURSE; STIMULATION; RAT; ADAPTATION; HEARING	The amplitude of auditory steady-state responses (ASSRs) generated in the brainstem of rats exponentially decreases over the sequential averaging of EEG epochs. This behavior is partially due to the adaptation of the ASSR induced by the continuous and monotonous stimulation. In this study, we analyzed the potential clinical relevance of the ASSR adaptation. ASSR were elicited in eight anesthetized adult rats by 8-kHz tones, modulated in amplitude at 115 Hz. We called independent epochs to those EEG epochs acquired with sufficiently long interstimulus interval, so the ASSR contained in any given epoch is not affected by the previous stimulation. We tested whether the detection of ASSRs is improved when the response is computed by averaging independent EEG epochs, containing only unadapted auditory responses. The improvements in the ASSR detection obtained with standard, weighted and sorted averaging were compared. In the absence of artifacts, when the ASSR was elicited by continuous acoustic stimulation, the computation of the ASSR amplitude relied upon the averaging method. While the adaptive behavior of the ASSR was still evident after the weighting of epochs, the sorted averaging resulted in under-estimations of the ASSR amplitude. In the absence of artifacts, the ASSR amplitudes computed by averaging independent epochs did not depend on the averaging procedure. Averaging independent epochs resulted in higher ASSR amplitudes and halved the number of EEG epochs needed to be acquired to achieve the maximum detection rate of the ASSR. Acquisition protocols based on averaging independent EEG epochs, in combination with appropriate averaging methods for artifact reduction might contribute to develop more accurate hearing assessments based on ASSRs.	[Prado-Gutierrez, Pavel; Weinstein, Alejandro; Zanartu, Matias] Univ Tecn Federico Santa Maria, Adv Ctr Elect & Elect Engn, Valparaiso, Chile; [Martinez-Montes, Eduardo] Cuban Neurosci Ctr, Neuroinformat Dept, Havana, Cuba; [Weinstein, Alejandro] Univ Valparaiso, Biomed Engn Sch, Valparaiso, Chile; [Zanartu, Matias] Univ Tecn Federico Santa Maria, Dept Elect Engn, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad de Valparaiso; Universidad Tecnica Federico Santa Maria	Prado-Gutierrez, P (corresponding author), Univ Tecn Federico Santa Maria, Adv Ctr Elect & Elect Engn, Valparaiso, Chile.	pavel.prado@usm.cl	Weinstein, Alejandro/O-1919-2019; Prado, Pavel/O-2711-2019; Zañartu, Matías/N-1338-2019; Martínez-Montes, Eduardo/AAA-9485-2020	Weinstein, Alejandro/0000-0003-1486-7003; Prado, Pavel/0000-0002-1324-6400; Zañartu, Matías/0000-0001-5581-4392; Martínez-Montes, Eduardo/0000-0002-5852-964X	CONICYT [BASAL FB0008, MEC 80170124, FONDECYT 3150442]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC015446] Funding Source: NIH RePORTER	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by CONICYT grants BASAL FB0008, MEC 80170124, and FONDECYT 3150442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts J, 2010, AUDIOL NEURO-OTOL, V15, P116, DOI 10.1159/000231637; Andrade GN, 2015, EUR J NEUROSCI, V41, P923, DOI 10.1111/ejn.12849; [Anonymous], 2007, CLIN NEUROPHYSIOL; BOURBON WT, 1987, ELECTROEN CLIN NEURO, V66, P160, DOI 10.1016/0013-4694(87)90185-4; Boutros NN, 1997, BIOL PSYCHIAT, V42, P1051, DOI 10.1016/S0006-3223(97)00161-3; Budd TW, 2013, BRAIN RES, V1498, P59, DOI 10.1016/j.brainres.2012.12.033; Choi JM, 2011, EAR HEARING, V32, P593, DOI 10.1097/AUD.0b013e318212085e; COHEN LT, 1991, J ACOUST SOC AM, V90, P2467, DOI 10.1121/1.402050; Custead R, 2015, BRAIN RES, V1622, P81, DOI 10.1016/j.brainres.2015.06.025; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; de Bruin NMWJ, 2001, BIOL PSYCHOL, V55, P195, DOI 10.1016/S0301-0511(00)00084-3; Duque D, 2018, HEARING RES, V370, P294, DOI 10.1016/j.heares.2018.08.011; ELBERLING C, 1985, SCAND AUDIOL, V14, P89, DOI 10.3109/01050398509045928; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Glaser EM, 1976, PRINCIPLES NEUROBIOL, DOI [10.1016/j.ijpsycho.2014.09.012, DOI 10.1016/J.IJPSYCHO.2014.09.012]; Griskova-Bulanova I, 2014, ACTA NEUROBIOL EXP, V74, P91; HEFFNER H, 1980, J ACOUST SOC AM, V68, P1584, DOI 10.1121/1.385213; HOKE M, 1984, ELECTROEN CLIN NEURO, V57, P484, DOI 10.1016/0013-4694(84)90078-6; John M Sasha, 2002, J Am Acad Audiol, V13, P246; John MS, 2004, EAR HEARING, V25, P539, DOI 10.1097/01.AUD.0000148050.80749.AC; John MS, 2002, EAR HEARING, V23, P106, DOI 10.1097/00003446-200204000-00004; John MS, 2000, COMPUT METH PROG BIO, V61, P125, DOI 10.1016/S0169-2607(99)00035-8; John MS, 2001, AUDIOL NEURO-OTOL, V6, P12, DOI 10.1159/000046805; John MS, 2001, CLIN NEUROPHYSIOL, V112, P555, DOI 10.1016/S1388-2457(01)00456-4; John MS., 2008, AUDITORY STEADY STAT, P11; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; KNIGHT RT, 1985, ELECTROEN CLIN NEURO, V61, P430, DOI 10.1016/0013-4694(85)91035-1; Lins OG, 1996, EAR HEARING, V17, P81, DOI 10.1097/00003446-199604000-00001; Loquet G, 2004, AUDIOL NEURO-OTOL, V9, P144, DOI 10.1159/000077266; LUTKENHONER B, 1985, BIOL CYBERN, V52, P409, DOI 10.1007/BF00449599; Luts H, 2004, INT J PEDIATR OTORHI, V68, P915, DOI 10.1016/j.ijporl.2004.02.007; Luts H, 2008, EAR HEARING, V29, P638, DOI 10.1097/AUD.0b013e318174f051; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; McFadden KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085748; Meyer K, 2007, HEARING RES, V228, P144, DOI 10.1016/j.heares.2007.02.002; Muhler R, 1999, SCAND AUDIOL, V28, P145, DOI 10.1080/010503999424716; OHMAN A, 1972, PHYSIOL BEHAV, V8, P79, DOI 10.1016/0031-9384(72)90132-1; Ozdamar O, 2006, J ACOUST SOC AM, V119, P429, DOI 10.1121/1.2133682; Ozdamar O, 2007, CLIN NEUROPHYSIOL, V118, P1261, DOI 10.1016/j.clinph.2007.02.016; Paiva TO, 2016, CLIN NEUROPHYSIOL, V127, P499, DOI 10.1016/j.clinph.2015.06.016; Pereira DR, 2014, INT J PSYCHOPHYSIOL, V94, P311, DOI 10.1016/j.ijpsycho.2014.09.012; Perez-Abalo MC, 2001, EAR HEARING, V22, P200, DOI 10.1097/00003446-200106000-00004; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Picton TW, 2001, CLIN NEUROPHYSIOL, V112, P1698, DOI 10.1016/S1388-2457(01)00608-3; Prado-Gutierrez P, 2015, AUDIOL RES, V5, P21, DOI 10.4081/audiores.2015.113; Prado-Gutierrez P, 2012, INT J AUDIOL, V51, P309, DOI 10.3109/14992027.2011.639812; Presacco A, 2010, CLIN NEUROPHYSIOL, V121, P1540, DOI 10.1016/j.clinph.2010.03.020; Perez-Alcazar M, 2008, EXP NEUROL, V210, P144, DOI 10.1016/j.expneurol.2007.10.017; Rahne I., J NEUROSCI METHODS; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Resende LM, 2015, J NEUROENG REHABIL, V12, P1; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; Rosburg T, 2016, CLIN NEUROPHYSIOL, V127, P397, DOI 10.1016/j.clinph.2015.04.071; Rosburg T, 2010, EXP BRAIN RES, V205, P559, DOI 10.1007/s00221-010-2391-3; Sambeth A, 2004, INT J PSYCHOPHYSIOL, V53, P197, DOI 10.1016/j.ijpsycho.2004.04.004; Santos TS, 2016, HEARING RES, V339, P125, DOI 10.1016/j.heares.2016.05.017; Savio G, 2001, AUDIOL NEURO-OTOL, V6, P279, DOI 10.1159/000046133; SHAW NA, 1988, PROG NEUROBIOL, V31, P19, DOI 10.1016/0301-0082(88)90021-4; Tan XD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00697; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Fortuny AT, 2011, ACTA OTORRINOLAR ESP, V62, P173, DOI 10.1016/j.otorri.2010.10.008; Valdes JL, 1997, EAR HEARING, V18, P420, DOI 10.1097/00003446-199710000-00007; Van Eeckhoutte M, 2018, EAR HEARING, V39, P260, DOI 10.1097/AUD.0000000000000483; Van Eeckhoutte M, 2016, HEARING RES, V342, P58, DOI 10.1016/j.heares.2016.09.009; Van Maanen A, 2005, INT J AUDIOL, V44, P613, DOI 10.1080/14992020500258628; Venkataraman Y, 2014, DEV NEUROBIOL, V74, P541, DOI 10.1002/dneu.22148; Vercammen C, 2017, INT J AUDIOL, V56, P464, DOI 10.1080/14992027.2017.1288304; Voicikas A, 2016, NEUROSCI LETT, V629, P215, DOI 10.1016/j.neulet.2016.07.019; Wilding TS, 2012, EAR HEARING, V33, P279, DOI 10.1097/AUD.0b013e318230bba0; Wilson US, 2016, INT J AUDIOL, V55, P239, DOI 10.3109/14992027.2015.1122238; Zacharias N, 2012, PSYCHOPHYSIOLOGY, V49, P909, DOI 10.1111/j.1469-8986.2012.01370.x; Zhang F, 2009, J AM ACAD AUDIOL, V20, P239, DOI 10.3766/jaaa.20.4.4; ZUREK PM, 1992, EAR HEARING, V13, P307, DOI 10.1097/00003446-199210000-00008	73	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0206018	10.1371/journal.pone.0206018	http://dx.doi.org/10.1371/journal.pone.0206018			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677031	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400003
J	Howe, PDL; Vargas-Saenz, A; Hulbert, CA; Boldero, JM				Howe, Piers D. L.; Vargas-Saenz, Adriana; Hulbert, Carol A.; Boldero, Jennifer M.			Predictors of gambling and problem gambling in Victoria, Australia	PLOS ONE			English	Article							GENDER-DIFFERENCES; PROTECTIVE FACTORS; INJUNCTIVE NORMS; IMPACT; RISK; PERSONALITY; BEHAVIOR; EXPOSURE; ADVERTISEMENTS; DISPOSITIONS	In 2016, the gambling habits of a sample of 3361 adults in the state of Victoria, Australia, were surveyed. It was found that a number of factors that were highly correlated with self reported gambling frequency and gambling problems were not significant predictors of gambling frequency and problem gambling. The major predictors of gambling frequency were the degree to which family members and peers were perceived to gamble, self-reported approval of gambling, the frequency of discussing gambling offline, and the participant's Canadian Problem Gambling Severity Index (PGSI) score. Age was a significant predictor of gambling frequency for certain types of gambling (e.g. buying lottery tickets). Approximately 91% of the explainable variance in the participant's PGSI score could be explained by just five predictors: Positive Urgency. Frequency of playing poker machines at pubs, hotels or sporting clubs; Participation in online discussions of betting on gaming tables at casinos; Frequency of gambling on the internet, and Overestimating the chances of winning. Based on these findings, suggestions are made as to how gambling-related harm can be reduced.	[Howe, Piers D. L.; Vargas-Saenz, Adriana; Hulbert, Carol A.; Boldero, Jennifer M.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Howe, PDL (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	pdhowe@unimelb.edu.au		Vargas Saenz, Adriana/0000-0002-0578-0953; Howe, Piers/0000-0001-6171-1381	Victorian Foundation for Responsible Gambling	Victorian Foundation for Responsible Gambling	PH, JB and CH received funding from Victorian Foundation for Responsible Gambling (round 7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://responsiblegambling.vic.gov.au/.	Aasved M, 2003, SOCIOLOGY GAMBLING; Abbott M, 2016, J GAMBL STUD, V32, P47, DOI 10.1007/s10899-015-9542-1; Bastiani L, 2013, J GAMBL STUD, V29, P1, DOI 10.1007/s10899-011-9283-8; Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x; Boldero J.M., 2010, INT GAMBL STUD, V10, P151, DOI DOI 10.1080/14459795.2010.501808; Boldero JM, 2012, INT GAMBL STUD, V12, P145, DOI 10.1080/14459795.2011.643907; Breen RB, 1999, PERS INDIV DIFFER, V27, P1097, DOI 10.1016/S0191-8869(99)00052-5; Buth S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02188; Calado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073; Chiu J, 2010, J GAMBL STUD, V26, P205, DOI 10.1007/s10899-009-9160-x; CLARK C, 2009, INT GAMBL STUD, V0009; Clemens F, 2017, J GAMBL STUD, V33, P1, DOI 10.1007/s10899-016-9606-x; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Cyders MA, 2008, PERS INDIV DIFFER, V45, P503, DOI 10.1016/j.paid.2008.06.002; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Deans EG, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0131-8; Delfabbro P, 2003, J ADOLESCENCE, V26, P313, DOI 10.1016/S0140-1971(03)00013-7; Delfabbro P., 2005, INT GAMBL STUD, V5, P209, DOI [10.1080/14459790500303469, DOI 10.1080/14459790500303469]; Delfabbro PH., 2009, INT GAMBL STUD, V9, P151, DOI [10.1080/14459790902755001, DOI 10.1080/14459790902755001]; Derevensky J, 2010, INT J MENT HEALTH AD, V8, P21, DOI 10.1007/s11469-009-9211-7; Desai RA, 2008, SOC PSYCH PSYCH EPID, V43, P173, DOI 10.1007/s00127-007-0283-z; Dickson L., 2008, INT GAMBL STUD, V8, P25, DOI [10.1080/14459790701870118, DOI 10.1080/14459790701870118]; Dowling NA, 2017, CLIN PSYCHOL REV, V51, P109, DOI 10.1016/j.cpr.2016.10.008; Dussault F, 2011, J CHILD PSYCHOL PSYC, V52, P130, DOI 10.1111/j.1469-7610.2010.02313.x; Felsher JR., 2004, INT GAMBL STUD, V4, P109, DOI [DOI 10.1080/14459790412331296956, 10.1080/14459790412331296956]; Ferris J., 2001, CANADIAN PROBLEM GAM, DOI DOI 10.1007/S10899-010-9224-Y; Fortune EE, 2013, J GAMBL STUD, V29, P329, DOI 10.1007/s10899-012-9303-3; Fried BG, 2010, ADDICT RES THEORY, V18, P586, DOI 10.3109/16066350903428945; Gainsbury SM, 2014, PSYCHOL ADDICT BEHAV, V28, P769, DOI 10.1037/a0036207; Goldstein AL, 2009, PSYCHOL ADDICT BEHAV, V23, P113, DOI 10.1037/a0013912; Griffiths M, 1995, J Gambl Stud, V11, P123, DOI 10.1007/BF02107111; Hare S, 2015, STUDY GAMBLING HLTH; Hing N, 2014, RES REPORT; Hing N, 2016, J GAMBL STUD, V32, P511, DOI 10.1007/s10899-015-9548-8; Holdsworth L, 2013, ASIAN J GAMBL ISS PU, V3, P1, DOI DOI 10.1186/2195-3007-3-11; Huang JH, 2007, CAN J PSYCHIAT, V52, P657, DOI 10.1177/070674370705201006; IBM Corp, 2017, IBM SPSS STAT WINDOW; Jackson A.C., 2008, INT J MENT HEALTH AD, V6, P325, DOI [https://doi.org/10.1007/s11469-008-9149-1, DOI 10.1007/S11469-008-9149-1]; Jansbol K., 2009, INT GAMBL STUD, V9, P67, DOI DOI 10.1080/14459790802656903; King SM, 2010, J GAMBL STUD, V26, P347, DOI 10.1007/s10899-009-9163-7; Larimer ME, 2003, PSYCHOL ADDICT BEHAV, V17, P235, DOI 10.1037/0893-164X.17.3.235; Lee GP, 2011, J ADOLESCENT HEALTH, V48, P164, DOI 10.1016/j.jadohealth.2010.06.002; Lee HS, 2008, J GAMBL STUD, V24, P25, DOI 10.1007/s10899-007-9078-0; Lindsay S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-719; Lorenz V. C., 1988, J GAMBLING BEHAV, V4, P13, DOI [10.1007/BF01043525, DOI 10.1007/BF01043525]; LORENZ VC, 1983, J COMMUNITY PSYCHOL, V11, P67, DOI 10.1002/1520-6629(198301)11:1<67::AID-JCOP2290110107>3.0.CO;2-O; Marchica L, 2016, J BEHAV ADDICT, V5, P1, DOI 10.1556/2006.5.2016.006; Martins SS, 2008, AM J ADDICTION, V17, P126, DOI 10.1080/10550490701861227; McDaniel SR, 2003, PERS INDIV DIFFER, V35, P1385, DOI 10.1016/S0191-8869(02)00357-4; Molde H, 2009, SCAND J PSYCHOL, V50, P55, DOI 10.1111/j.1467-9450.2008.00667.x; Monaghan SM., 2008, INT J MENT HEALTH AD, V6, P537, DOI [DOI 10.1007/S11469-008-9155-3, 10.1007/s11469-008-9155-3]; Moodie C, 2008, J GAMBL ISSUES, P30, DOI 10.4309/jgi.2008.21.5; Moore SM, 1999, SOC BEHAV PERSONAL, V27, P455, DOI 10.2224/sbp.1999.27.5.455; Neighbors C, 2007, J GAMBL STUD, V23, P259, DOI 10.1007/s10899-007-9059-3; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Parker JDA, 2008, PERS INDIV DIFFER, V45, P174, DOI 10.1016/j.paid.2008.03.018; Pitt H, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0136-3; Pitt H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3610-z; Potenza MN, 2011, J AM ACAD CHILD PSY, V50, P150, DOI 10.1016/j.jaac.2010.11.006; Queensland Government Statistician's Office Queensland Treasury, 2017, AUSTR GAMBL STAT, V33; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rockloff MJ, 2006, J GAMBL STUD, V22, P101, DOI 10.1007/s10899-005-9005-1; Scholes-Balog KE, 2014, J ADOLESCENCE, V37, P215, DOI 10.1016/j.adolescence.2013.12.006; Shaw MC, 2007, CNS SPECTRUMS, V12, P615, DOI 10.1017/S1092852900021416; Steenbergh TA, 2002, PSYCHOL ADDICT BEHAV, V16, P143, DOI 10.1037//0893-164X.16.2.143; Szolnoki G., 2013, WINE EC POLICY, V2, P57, DOI DOI 10.1016/J.WEP.2013.10.001; Thomas S, 2012, AUST NZ J PUBL HEAL, V36, P145, DOI 10.1111/j.1753-6405.2012.00856.x; Thomas SL, 2015, HEALTH EXPECT, V18, P124, DOI 10.1111/hex.12018; Turner N.E., 2008, INT J MENT HEALTH AD, V6, P223, DOI DOI 10.1007/S11469-007-9117-1; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Welte JW, 2011, J GAMBL STUD, V27, P49, DOI 10.1007/s10899-010-9195-z; Williams RJ, 2012, PROBLEM GAMBLING MET	73	18	18	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209277	10.1371/journal.pone.0209277	http://dx.doi.org/10.1371/journal.pone.0209277			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673709	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800016
J	Primo, ME; Thompson, CS; Valentini, BS; Sarli, M; Novoa, MB; Mangold, AJ; de Echaide, ST				Primo, Maria E.; Thompson, Carolina S.; Valentini, Beatriz S.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.; de Echaide, Susana T.			Development of a novel fusion protein with Anaplasma marginale and A. centrale MSP5 improved performance of Anaplasma antibody detection by cELISA in infected and vaccinated cattle	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CROSS-REACTIVITY; DIAGNOSIS; ELISA; TICK	Detection of antibodies to Anaplasma spp. using commercial competitive enzyme-linked immunosorbent assay (ccELISA) is based on the recombinant major surface protein 5 fused to maltose binding protein (MBP-MSP5) or glutathione S-transferase (GST-MSP5). To avoid false positive reactions due to the presence of antibodies against E. coli M BP in cattle, previous sera absorption is required. This study evaluated the replacement of MBP-MSP5 or GST-MSP5 antigens by the truncate MSP5 (residues 28-210) of A. marginale (tMSP5m), A. centrale (tMSP5c) and fusion protein MSP5 (tMSP5cm), expressed without N-terminus transmembrane helix in the ccELISA test. Immunoreactivity was evaluated by western blot using monoclonal antibodies against the tMSP5 and by in-house cELISA (hcELISA) with purified tMSP5m, tMSP5c or tMSP5cm using sera from cattle infected with A. marginale (n = 226) or vaccinated with A. centrale (n = 173) and uninfected cattle (n = 216). Results of hcELISA were compared with those of ccELISA. Recombinant protein was expressed highly soluble (> 95%) in E. coli without a molecular chaperone. Specificity of the hcELISA-tMSP5m,-MSP5c or-tMSP5cm was identical to (99.5%) and greater than that in ccELISA (96.3%). Sensitivity of hcELISA-tMSP5m and ccELISA was identical (95.5%), but lower than that of hcELISA-tMSP5cm (96.2%) and-tMSP5c (97.2%). The analysis of vaccinated cattle by hcELISA-tMSP5c showed sensitivity of 99.4%. In summary, the generation of fusion MSP5 A. marginale-A. centrale protein without transmembrane helix was a very effective method to express the recombinant protein highly soluble in the bacterial cytoplasm and contributed to an increased test performance for detecting antibodies in cattle naturally infected with A. marginale or vaccinated with A. centrale.	[Primo, Maria E.; Thompson, Carolina S.; Valentini, Beatriz S.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.; de Echaide, Susana T.] Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Rafaela, Santa Fe, Argentina; [Primo, Maria E.; Sarli, Macarena; Novoa, Maria B.; Mangold, Atilio J.] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Primo, ME (corresponding author), Inst Nacl Tecnol Agr, Estn Expt Agr Rafaela, Rafaela, Santa Fe, Argentina.; Primo, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina.	primo.maria@inta.gob.ar		Sarli, Macarena/0000-0001-8592-6635; Novoa, Maria Belen/0000-0001-6726-5239; Primo, Maria Evangelina/0000-0002-6873-8867	ANPCyT [PICT 2013-0369]; TCP INTA EEA Rafaela Asoc . Coop. [426100]	ANPCyT(ANPCyT); TCP INTA EEA Rafaela Asoc . Coop.	This work was supported by ANPCyT (PICT 2013-0369) and TCP INTA EEA Rafaela Asoc. Coop. 426100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala A A, 1990, Rev Elev Med Vet Pays Trop, V43, P155; Al-Adhami B, 2011, J VET DIAGN INVEST, V23, P1181, DOI 10.1177/1040638711425593; Anziani O, 1979, MEMORIA REUNION ANUA; ANZIANI OS, 1987, TROP ANIM HEALTH PRO, V19, P83, DOI 10.1007/BF02297324; Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x; Bono F, 2004, ANAPLASMOSIS BOVINA; Chung C, 2014, J VET DIAGN INVEST, V26, P61, DOI 10.1177/1040638713511813; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; de Echaide ST, 2005, VET MICROBIOL, V106, P287, DOI 10.1016/j.vetmic.2004.12.026; Diaz AA, 2010, BIOTECHNOL BIOENG, V105, P374, DOI 10.1002/bit.22537; Dreher UM, 2005, CLIN DIAGN LAB IMMUN, V12, P1177, DOI 10.1128/CDLI.12.10.1177-1183.2005; DUZGUN A, 1988, VET PARASITOL, V29, P1, DOI 10.1016/0304-4017(88)90002-7; ERIKS IS, 1993, J CLIN MICROBIOL, V31, P2091, DOI 10.1128/JCM.31.8.2091-2096.1993; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; GONZALEZ EF, 1978, AM J VET RES, V39, P1538; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Mastropaolo M., 2009, FAVE, V8, P29, DOI 10.14409/favecv.v8i1.1477; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Molad T, 2006, VET MICROBIOL, V113, P55, DOI 10.1016/j.vetmic.2005.10.026; Molloy JB, 1999, AUST VET J, V77, P245, DOI 10.1111/j.1751-0813.1999.tb11712.x; Molloy JB, 2001, INT J PARASITOL, V31, P179, DOI 10.1016/S0020-7519(00)00145-4; MONTENEGROJAMES S, 1990, AM J VET RES, V51, P1518; OIE, 2015, BOV AN; Palacios C, 2014, RES VET SCI, V97, P514, DOI 10.1016/j.rvsc.2014.10.005; POTGIETER FT, 1979, J S AFR VET ASSOC, V50, P367; POTGIETER FT, 1983, ONDERSTEPOORT J VET, V50, P29; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Strik NI, 2007, CLIN VACCINE IMMUNOL, V14, P262, DOI 10.1128/CVI.00320-06; Theiler A., 1910, REP GOV VET BACTERIO, P7; VISSER ES, 1992, INFECT IMMUN, V60, P5139, DOI 10.1128/IAI.60.12.5139-5144.1992; Yang Z, 2014, KOREAN J PARASITOL, V52, P367, DOI [10.3347/kjp.2014.52.4.367, 10.3347/kjp.2014.52.4.367.]	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211149	10.1371/journal.pone.0211149	http://dx.doi.org/10.1371/journal.pone.0211149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673770	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800077
J	Huynh, TV; Bekrater-Bodmann, R; Frohner, J; Vogt, J; Beckerle, P				The Vu Huynh; Bekrater-Bodmann, Robin; Froehner, Jakob; Vogt, Joachim; Beckerle, Philipp			Robotic hand illusion with tactile feedback: Unravelling the relative contribution of visuotactile and visuomotor input to the representation of body parts in space	PLOS ONE			English	Article							RUBBER HAND; OWNERSHIP; LIMB; EMBODIMENT; AGENCY; BRAIN; TOUCH; EXPERIENCE; ARM	The rubber hand illusion describes a phenomenon in which participants experience a rubber hand as being part of their body by the synchronous application of visuotactile stimulation to the real and the artificial limb. In the recently introduced robotic hand illusion (RobHl), a robotic hand is incorporated into one's body representation due to the integration of synchronous visuomotor information. However, there are no setups so far that combine visuotactile and visuomotor feedback, which is expected to unravel mechanisms that cannot be detected in experimental designs applying this information in isolation. We developed a robotic hand, controlled by a sensor glove and equipped with pressure sensors, and varied systematically and separately the synchrony for motor feedback (MF) and tactile feedback (TF). In Experiment 1, we implemented a ball-grasping task and assessed the perceived proprioceptive drift of one's own hand as a behavioral measure of the spatial calibration of body coordinates as well as explicit embodiment experiences by a questionnaire. Results revealed significant main effects of both MF and TF for proprioceptive drift data, but we only observed main effects for MF on perceived embodiment. Furthermore, for the proprioceptive drift we found that synchronous feedback in one factor compensates for asynchronous feedback in the other. In Experiment 2, including a new sample of naive participants, we further explored this finding by adding unimodal conditions, in which we manipulated the presence or absence of MF and/or TF. These findings replicated the results from Experiment 1 and we further found evidence for a supper-additive multisensory effect on spatial body representation caused by the presence of both factors. Results on conscious body perception were less consistent across both experiments. The findings indicate that sensory and motor input equally contribute to the representation of spatial body coordinates which for their part are subject to multisensory enhancing effects. The results outline the potential of human-in-the-loop approaches and might have important implications for clinical applications such as for the future design of robotic prostheses.	[The Vu Huynh; Vogt, Joachim] Tech Univ Darmstadt, Work & Engn Psychol Res Grp, Darmstadt, Germany; [Bekrater-Bodmann, Robin] Heidelberg Univ, Dept Cognit & Clin Neurosci, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Froehner, Jakob] Tech Univ Munich, Dept Elect & Comp Engn, Chair Informat Oriented Control, Munich, Germany; [Beckerle, Philipp] Tech Univ Dortmund, Elast Lightweight Robot Grp, Robot Res Inst, Dept Elect Engn & Informat Technol, Dortmund, Germany; [Beckerle, Philipp] Tech Univ Darmstadt, Inst Mechatron Syst Mech Engn, Darmstadt, Germany	Technical University of Darmstadt; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Technical University of Munich; Dortmund University of Technology; Technical University of Darmstadt	Huynh, TV (corresponding author), Tech Univ Darmstadt, Work & Engn Psychol Res Grp, Darmstadt, Germany.	huynh@psychologie.tu-darmstadt.de	Beckerle, Philipp/H-5731-2015	Beckerle, Philipp/0000-0001-5703-6029				Abrams AMH, 2018, ACMIEEE INT CONF HUM, P289, DOI 10.1145/3173386.3176915; [Anonymous], 2017, JASP VERS 0 8 4; Apps MAJ, 2014, NEUROSCI BIOBEHAV R, V41, P85, DOI 10.1016/j.neubiorev.2013.01.029; Arata J, 2014, IEEE T HAPTICS, V7, P526, DOI 10.1109/TOH.2014.2304722; Beckerle P, WILEY INTERDISCIPLIN; Beckerle P, 2016, 2016 25 IEEE INT S R; Beckerle P, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00024; Bekrater-Bodmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087013; Bekrater-Bodmann R, 2013, J NEUROSCI, V33, P2729, DOI 10.1523/JNEUROSCI.5547-12.2013; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Canzoneri E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044306; Caspar EA, 2015, BEHAV RES METHODS, V47, P744, DOI 10.3758/s13428-014-0498-3; Christ O., 2012, Biomedical Engineering-Biomedizinische Technik, V57, DOI 10.1515/bmt-2012-4297; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; De Beir A, 2014, 23 IEEE INT S ROB HU; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Erro R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20551-6; Filippetti ML, 2017, COGNITION, V159, P1, DOI 10.1016/j.cognition.2016.11.002; Flogel M, 2016, PSYCHOL RES-PSYCH FO, V80, P298, DOI 10.1007/s00426-015-0650-4; Fuchs X, 2016, SCI REP-UK, V6, DOI 10.1038/srep24362; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Hara M, 2016, IEEE T HUM-MACH SYST, V46, P78, DOI 10.1109/THMS.2015.2487499; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Imaizumi S, 2016, CONSCIOUS COGN, V45, P75, DOI 10.1016/j.concog.2016.08.019; Ismail MAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159619; Jenkinson PM, 2013, NEUROPSYCHOLOGIA, V51, P1453, DOI 10.1016/j.neuropsychologia.2013.03.029; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kalveram K.T., 1998, WIE INDIVIDUUM SEINE; Keetels M., 2012, NEURAL BASEMULTISE; Kern U, 2009, SCHMERZ, V23, P479, DOI 10.1007/s00482-009-0786-5; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Olive I, 2015, HUM BRAIN MAPP, V36, P717, DOI 10.1002/hbm.22659; Padilla-Castaneda MA, 2014, PRESENCE-TELEOP VIRT, V23, P209, DOI 10.1162/PRES_a_00181; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Romano D, 2015, NEUROPSYCHOLOGIA, V70, P414, DOI 10.1016/j.neuropsychologia.2014.10.033; Rosen B, 2009, SCAND J PLAST RECONS, V43, P260, DOI 10.3109/02844310903113107; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SANCHEZVIVES MV, 2010, PLOS ONE, V5; Serino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18603; Shimada S, 2005, NEUROIMAGE, V24, P1225, DOI 10.1016/j.neuroimage.2004.10.039; Shimada S., 2009, PLOS ONE, V4; Synofzik M, 2008, CONSCIOUS COGN, V17, P411, DOI 10.1016/j.concog.2008.03.008; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034	61	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210058	10.1371/journal.pone.0210058	http://dx.doi.org/10.1371/journal.pone.0210058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673739	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800029
J	Graser, JV; Bastiaenen, CHG; van Hedel, HJA				Graser, Judith V.; Bastiaenen, Caroline H. G.; van Hedel, Hubertus J. A.			The role of the practice order: A systematic review about contextual interference in children	PLOS ONE			English	Review							MOTOR; ACQUISITION; RETENTION; SKILL; EXPERIENCE; TASK; INDIVIDUALS; VARIABILITY; MECHANISMS	Aim We aimed to identify and evaluate the quality and evidence of the motor learning literature about intervention studies regarding the contextual interference (CI) effect (blocked vs. random practice order) in children with brain lesions and typically developing (TD) children. Method Eight databases (Cinahl, Cochrane, Embase, PubMed, Pedro, PsycINFO, Scopus and Web of Knowledge) were searched systematically with predefined search terms. Controlled studies examining the CI effect in children (with brain lesions or TD) were included. Evidence level, conduct quality, and risk of bias were evaluated by two authors independently. A best evidence synthesis was performed. Results Twenty-five papers evaluating TD children were included. One of these studies also assessed children with cerebral palsy. Evidence levels were I, II, or III. Conduct quality was low and the risk of bias high, due to methodological issues in the study designs or poor description thereof. Best evidence synthesis showed mainly no or conflicting evidence. Single tasks showed limited to moderate evidence supporting the CI effect in TD children. Conclusion There is a severe limitation of good-quality evidence about the CI effect in children who practice different tasks in one session, especially in children with brain lesions.	[Graser, Judith V.; van Hedel, Hubertus J. A.] Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Paediat Rehab Res Grp, Affoltern Am Albis, Switzerland; [Graser, Judith V.; van Hedel, Hubertus J. A.] Univ Childrens Hosp Zurich, Childrens Res Ctr CRC, Zurich, Switzerland; [Graser, Judith V.; Bastiaenen, Caroline H. G.] Maastricht Univ, Dept Epidemiol, Res Line Functioning & Rehabil CAPHRI, Maastricht, Netherlands	University Children's Hospital Zurich; University Children's Hospital Zurich; Maastricht University	Graser, JV (corresponding author), Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Paediat Rehab Res Grp, Affoltern Am Albis, Switzerland.; Graser, JV (corresponding author), Univ Childrens Hosp Zurich, Childrens Res Ctr CRC, Zurich, Switzerland.; Graser, JV (corresponding author), Maastricht Univ, Dept Epidemiol, Res Line Functioning & Rehabil CAPHRI, Maastricht, Netherlands.	judith.graser@kispi.uzh.ch	van Hedel, Hubertus/AAL-3818-2021; graser, judith/ABD-6346-2021; Bastiaenen, Caroline/R-8701-2019	graser, judith/0000-0002-9921-8581; van Hedel, Hubertus/0000-0002-9577-5049	Clinical Research Priority Programme (CRPP) Neuro-Rehabilitation of the University of Zurich; Maxi Foundation	Clinical Research Priority Programme (CRPP) Neuro-Rehabilitation of the University of Zurich; Maxi Foundation	This study has been funded by the Clinical Research Priority Programme (CRPP) Neuro-Rehabilitation of the University of Zurich and the Maxi Foundation.	ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Barreiros J, 2007, EUR PHYS EDUC REV, V13, P195, DOI 10.1177/1356336X07076876; Bartlett DJ, 2002, PHYS THER, V82, P237, DOI 10.1093/ptj/82.3.237; Battig W., 1972, TOPICS LEARNING PERF, P131; Bejjanki VR, 2014, P NATL ACAD SCI USA, V111, P16961, DOI 10.1073/pnas.1417056111; Bertollo M, 2010, PERCEPT MOTOR SKILL, V110, P77, DOI 10.2466/PMS.110.1.77-84; BORTOLI L, 1992, PERCEPT MOTOR SKILL, V75, P555, DOI 10.2466/PMS.75.5.555-562; Brady F, 1998, QUEST, V50, P266, DOI 10.1080/00336297.1998.10484285; Brady F, 2008, PERCEPT MOTOR SKILL, V106, P461, DOI 10.2466/PMS.106.2.461-472; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Broadbent DP, 2015, MED SCI SPORT EXER, V47, P1243, DOI 10.1249/MSS.0000000000000530; BROWN AL, 1988, COGNITIVE PSYCHOL, V20, P493, DOI 10.1016/0010-0285(88)90014-X; Cauraugh JH, 2003, J NEUROL NEUROSUR PS, V74, P1562, DOI 10.1136/jnnp.74.11.1562; Darrah J, 2008, AACPDM METHODOLOGY D; DELREY P, 1983, PERCEPT MOTOR SKILL, V57, P241, DOI 10.2466/pms.1983.57.1.241; DELREY P, 1983, PERCEPT MOTOR SKILL, V56, P581, DOI 10.2466/pms.1983.56.2.581; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Duff SV, 2003, DEV MED CHILD NEUROL, V45, P746, DOI 10.1017/S00121622030012397; Edwards JM., 1986, ADAPTED PHYSICAL ACT, V3, P250, DOI 10.1123/apaq.3.3.250; Fialho JVAP, 2006, J HUM MOVEMENT STUD, V50, P65; FRENCH KE, 1990, PERCEPT MOTOR SKILL, V71, P179, DOI 10.2466/pms.1990.71.1.179; Giboin L-S, 2018, J SCI MED SPORT; Gophna S, 2007, ISR J OCCUP THER, V16, P89; Green DP, 1995, PERCEPT MOTOR SKILL, V81, P1275, DOI 10.2466/pms.1995.81.3f.1275; Gregory E, 2016, COGN NEUROPSYCHOL, V33, P220, DOI 10.1080/02643294.2016.1172478; Hanlon RE, 1996, ARCH PHYS MED REHAB, V77; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hodges NJ, 2014, J MOTOR BEHAV, V46, P455, DOI 10.1080/00222895.2014.947911; Jarus T, 2001, Can J Occup Ther, V68, P280; Jarus T, 1999, PERCEPT MOTOR SKILL, V88, P437, DOI 10.2466/PMS.88.2.437-447; Jones LL, 2007, PERCEPT MOTOR SKILL, V105, P883, DOI 10.2466/PMS.105.3.883-890; Kattner F, 2017, CURR BIOL, V27, P840, DOI 10.1016/j.cub.2017.01.046; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LEE TD, 1992, Q J EXP PSYCHOL-A, V44, P627, DOI 10.1080/14640749208401303; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; McNamee D, 2015, J NEUROSCI, V35, P3764, DOI 10.1523/JNEUROSCI.4677-14.2015; Meira CM, 2003, J HUM MOVEMENT STUD, V45, P449; Merbah S, 2011, PSYCHOL BELG, V51, P15, DOI 10.5334/pb-51-1-15; PAINTER MA, 1994, ADAPT PHYS ACT Q, V11, P383, DOI 10.1123/apaq.11.4.383; Perez CR, 2005, PERCEPT MOTOR SKILL, V100, P58; PIGOTT RE, 1984, RES Q EXERCISE SPORT, V55, P41, DOI 10.1080/02701367.1984.10605353; Pollock BJ, 1997, PERCEPT MOTOR SKILL, V84, P851, DOI 10.2466/pms.1997.84.3.851; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Saemi E, 2012, KINESIOLOGY, V44, P191; Schweighofer N, 2011, J NEUROPHYSIOL, V106, P2632, DOI 10.1152/jn.00399.2011; Seidler RD, 2013, ADV EXP MED BIOL, V782, P39, DOI 10.1007/978-1-4614-5465-6_3; Seidler RD, 2004, J COGNITIVE NEUROSCI, V16, P65, DOI 10.1162/089892904322755566; Stambaugh LA, 2011, J RES MUSIC EDUC, V58, P368, DOI 10.1177/0022429410385945; Ste-Marie DM, 2004, J MOTOR BEHAV, V36, P115, DOI 10.3200/JMBR.36.1.115-126; Steinemann NA, 2016, NEUROIMAGE, V137, P152, DOI 10.1016/j.neuroimage.2016.05.001; Tsutsui S, 1998, J MOTOR BEHAV, V30, P151, DOI 10.1080/00222899809601332; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vera JG, 2003, PERCEPT MOTOR SKILL, V96, P1015, DOI 10.2466/PMS.96.3.1015-1024; Wegman E, 1999, PERCEPT MOTOR SKILL, V88, P182, DOI 10.2466/PMS.88.1.182-187; Winstein CJ, 1999, NEUROPSYCHOLOGIA, V37, P975, DOI 10.1016/S0028-3932(98)00145-6; World Health Organization, 2007, INT CLASS FUNCT DIS; WRISBERG CA, 1983, RES Q EXERCISE SPORT, V54, P67, DOI 10.1080/02701367.1983.10605274; Zetou E, 2007, PERCEPT MOTOR SKILL, V104, P995, DOI 10.2466/PMS.104.3.995-1004	60	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0209979	10.1371/journal.pone.0209979	http://dx.doi.org/10.1371/journal.pone.0209979			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668587	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400002
J	Akazawa, N; Harada, K; Okawa, N; Tamura, K; Moriyama, H				Akazawa, Naoki; Harada, Kazuhiro; Okawa, Naomi; Tamura, Kimiyuki; Moriyama, Hideki			Low body mass index negatively affects muscle mass and intramuscular fat of chronic stroke survivors	PLOS ONE			English	Article							OLDER-ADULTS; PHYSICAL-ACTIVITY; ULTRASOUND; OVERWEIGHT; ATROPHY; OBESITY; INDEPENDENCE; PERFORMANCE; SONOGRAPHY; SARCOPENIA	Objective Relationship between secondary changes in skeletal muscle and body weight in chronic stroke survivors has not yet been carefully examined. The objective of this study was to clarify the relationships between muscle mass, intramuscular fat, and body weight in chronic stroke survivors. Methods Seventy-two chronic stroke survivors participated in this study. Transverse ultrasound images were acquired using B-mode ultrasound imaging. Quadriceps muscle mass and intramuscular fat were assessed based on muscle thickness and echo intensity, respectively. We used a stepwise multiple regression analysis to identify the factors that were independently associated with the body mass index. We entered quadriceps thickness and echo intensity of the paretic and non-paretic sides into another stepwise multiple regression model to avoid multicollinearity. Age, sex, type of stroke, time since stroke, thigh length, number of medications, and an updated Charlson comorbidity index were included as the independent variables. Results The quadriceps thickness and echo intensity of the paretic and non-paretic sides were significantly independently associated with the body mass index: quadriceps thickness of the paretic side, beta = 0.52; quadriceps thickness of the non-paretic side, beta = 0.55; quadriceps echo intensity of the paretic side, beta = -0.35; quadriceps echo intensity of the non-paretic side, beta = -0.27). Conclusions Our results suggest that low body mass index is associated with loss of muscle mass and increased intramuscular fat on both the paretic and non-paretic sides of chronic stroke survivors. Further studies examining whether appropriate weight management, along with targeted rehabilitation programs aimed at increasing muscle mass and decreasing intramuscular fat, achieves good outcomes in chronic stroke survivors are warranted.	[Akazawa, Naoki] Tokushima Bunri Univ, Fac Hlth & Welf, Dept Phys Therapy, Tokushima, Tokushima, Japan; [Harada, Kazuhiro] Kibi Int Univ, Fac Hlth Med Care & Welf, Dept Phys Therapy, Takahashi, Okayama, Japan; [Okawa, Naomi; Tamura, Kimiyuki] Kasei Tamura Hosp, Dept Rehabil, Wakayama, Wakayama, Japan; [Moriyama, Hideki] Kobe Univ, Life & Med Sci Area, Hlth Sci Discipline, Kobe, Hyogo, Japan	Tokushima Bunri University; Kobe University	Akazawa, N (corresponding author), Tokushima Bunri Univ, Fac Hlth & Welf, Dept Phys Therapy, Tokushima, Tokushima, Japan.	akazawa@tks.bunri-u.ac.jp						Abe T, 2011, J SPORT SCI MED, V10, P145; Akazawa N, 2018, PHYSIOTHERAPY, V104, P438, DOI 10.1016/j.physio.2017.08.009; Akazawa N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201789; Akazawa N, 2017, GERIATR GERONTOL INT, V17, P1683, DOI 10.1111/ggi.12869; Akima H, 2016, MAGN RESON IMAGING, V34, P397, DOI 10.1016/j.mri.2015.12.038; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Burke DT, 2014, ARCH PHYS MED REHAB, V95, P1055, DOI 10.1016/j.apmr.2014.01.019; Cadore EL, 2012, EXP GERONTOL, V47, P473, DOI 10.1016/j.exger.2012.04.002; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Doehner W, 2013, EUR HEART J, V34, P268, DOI 10.1093/eurheartj/ehs340; Dupont AC, 2001, J CLIN ULTRASOUND, V29, P230, DOI 10.1002/jcu.1025; Englund DA, 2018, J GERONTOL A-BIOL, V73, P95, DOI 10.1093/gerona/glx141; Fukumoto Y, 2015, ULTRASOUND MED BIOL, V41, P3013, DOI 10.1016/j.ultrasmedbio.2015.06.017; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Hunnicutt JL, 2017, TOP STROKE REHABIL, V24, P463, DOI 10.1080/10749357.2017.1292720; Ikezoe T, 2011, EUR J APPL PHYSIOL, V111, P989, DOI 10.1007/s00421-010-1728-8; Jonsson AC, 2008, STROKE, V39, P918, DOI 10.1161/STROKEAHA.107.497602; Kim BJ, 2011, NEUROLOGY, V76, P567, DOI 10.1212/WNL.0b013e31820b7667; Miyatani M, 2004, EUR J APPL PHYSIOL, V91, P264, DOI 10.1007/s00421-003-0974-4; Nijholt W, 2017, J CACHEXIA SARCOPENI, V8, P702, DOI 10.1002/jcsm.12210; Oesch L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171334; Olsen TS, 2008, NEUROEPIDEMIOLOGY, V30, P93, DOI 10.1159/000118945; Parry SM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.05.024; Pillen S, 2006, ULTRASOUND MED BIOL, V32, P1315, DOI 10.1016/j.ultrasmedbio.2006.05.028; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Prado-Medeiros CL, 2012, PHYS THER, V92, P429, DOI 10.2522/ptj.20090127; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Ramsay JW, 2011, J BIOMECH, V44, P2741, DOI 10.1016/j.jbiomech.2011.09.001; Rech A, 2014, AGE, V36, DOI 10.1007/s11357-014-9708-2; REIMERS K, 1993, J ULTRAS MED, V12, P73; Ryan A S, 2000, J Stroke Cerebrovasc Dis, V9, P185, DOI 10.1053/jscd.2000.7237; Ryan AS, 2011, NEUROREHAB NEURAL RE, V25, P865, DOI 10.1177/1545968311408920; Ryan AS, 2011, STROKE, V42, P416, DOI 10.1161/STROKEAHA.110.602441; Ryan ED, 2016, APPL PHYSIOL NUTR ME, V27, P1; Scherbakov N, 2013, INT J CARDIOL, V170, P89, DOI 10.1016/j.ijcard.2013.10.031; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Sun WP, 2016, J NEUROL SCI, V370, P140, DOI 10.1016/j.jns.2016.09.029; Ticinesi A, 2017, J AM MED DIR ASSOC, V18, P290, DOI 10.1016/j.jamda.2016.11.013; Tillquist M, 2014, JPEN-PARENTER ENTER, V38, P886, DOI 10.1177/0148607113501327; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilhelm EN, 2014, AGE, V36, P1113, DOI 10.1007/s11357-014-9625-4; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Young HJ, 2015, MUSCLE NERVE, V52, P963, DOI 10.1002/mus.24656; Zhao L, 2014, J STROKE CEREBROVASC, V23, pE201, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.002	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211145	10.1371/journal.pone.0211145	http://dx.doi.org/10.1371/journal.pone.0211145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657790	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000032
J	Izuegbuna, O; Otunola, G; Bradley, G				Izuegbuna, Ogochukwu; Otunola, Gloria; Bradley, Graeme			Chemical composition, antioxidant, anti-inflammatory, and cytotoxic activities of Opuntia stricta cladodes	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; ESSENTIAL OILS; FICUS-INDICA; VITAMIN-C; ANTINOCICEPTIVE ACTIVITY; ALPHA-PINENE; BETA-IONONE; CELL-DEATH; CANCER	Background The Opuntia spp. have been used in traditional medicine for many centuries. It is used in the management of diseases that involves oxidative stress, especially diabetes, obesity and cancer. Opuntia stricta (Haw) is one of the relatively unknown species in South Africa where it is regarded more as a weed. Because of this, not much is known about its chemical composition. Aim To determine the chemical composition, antioxidant, anti-inflammatory, and cytotoxic activities of Opuntia stricta cladodes. Methods The phytochemical composition of acetone, aqueous and ethanol extract of cladodes of Opuntia stricta (Haw), as well as the vitamins A, C and E of its dried weight cladodes and the antioxidant activities, were evaluated using standard in vitro methods. The anti-inflammatory and cytotoxic activities were evaluated using cell-based assays. The phytochemical composition and vitamins were determined spectrophotometrically, while the antioxidant activities were determined by DPPH, nitric oxide, hydrogen peroxide scavenging activity and phosphomolybdenum (total) antioxidant activity. Anti-inflammatory activity was determined using RAW 264.7 cells, while cytotoxicity was determined using U937 cells. Results The phytochemical composition showed a significant difference in the various extracts. The total phenolics were higher than other phytochemicals in all the extracts used. All the extracts displayed antioxidant activity, while most of the extracts showed anti-inflammatory activity. Only one extract showed cytotoxicity, and it was mild. Conclusion The results show that the Opuntia stricta is rich in polyphenolic compounds and has good antioxidant activity as well as anti-inflammatory activities.	[Izuegbuna, Ogochukwu; Bradley, Graeme] Univ Ft Hare, Fac Sci & Agr, Dept Biochem, Alice, South Africa; [Otunola, Gloria] Univ Ft Hare, Med Plants & Econ Dev MPED Res Ctr, Dept Bot, Fac Sci & Agr, Alice, South Africa	University of Fort Hare; University of Fort Hare	Bradley, G (corresponding author), Univ Ft Hare, Fac Sci & Agr, Dept Biochem, Alice, South Africa.	gbradley@ufh.ac.za	Otunola, Gloria A/AAG-5334-2020; Bradley, Graeme/B-8604-2009; izuegbuna, ogochukwu/AGH-0578-2022	Otunola, Gloria A/0000-0003-2613-2741; Bradley, Graeme/0000-0002-9036-9869; izuegbuna, ogochukwu/0000-0001-8395-8967	University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant [C168]	University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant	This work was supported by University of Fort Hare, Govan Mbeki Research and Development Centre Seed Grant - C168; Recipient GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Ahmed D, 2015, ANTIOXIDANTS-BASEL, V4, P394, DOI 10.3390/antiox4020394; Albano SM, 2012, REC NAT PROD, V6, P35; Alves F. A. L., 2016, Journal of Medicinal Plants Research, V10, P732; Ansari M, 2016, EUR J MED CHEM, V123, P141, DOI 10.1016/j.ejmech.2016.07.037; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Asokkumar S, 2012, MOL CELL BIOCHEM, V363, P335, DOI 10.1007/s11010-011-1186-6; Aydin E, 2013, ARH HIG RADA TOKSIKO, V64, P415, DOI 10.2478/10004-1254-64-2013-2365; Aydin E, 2013, BIOLOGIA, V68, P1004, DOI 10.2478/s11756-013-0230-2; Barbieri SS, 2003, CARDIOVASC RES, V60, P187, DOI 10.1016/S0008-6363(03)00365-1; Basholli-Salihu M, 2017, PHARM BIOL, V55, P1553, DOI 10.1080/13880209.2017.1309555; Beg Sarwar, 2011, Pharmacogn Rev, V5, P120, DOI 10.4103/0973-7847.91102; Bendaoud H, 2010, J FOOD SCI, V75, pC466, DOI 10.1111/j.1750-3841.2010.01711.x; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Boddu SHS, 2015, INT J PHARMACEUT, V479, P207, DOI 10.1016/j.ijpharm.2014.12.051; Boligon AA, 2013, NAT PROD RES, V27, P68, DOI 10.1080/14786419.2011.653971; Boora F., 2014, J FOOD PROCESS PRES, V2014, DOI DOI 10.1155/2014/918018; Caceres-Mella A, 2013, INT J FOOD SCI TECH, V48, P2588, DOI 10.1111/ijfs.12253; Chen MF, 2016, BMC CANCER, V16; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Correa Mariana Goncalves, 2016, Asian Pac J Cancer Prev, V17, P4199; Csanyi G, 2014, INT J MOL SCI, V15, P6002, DOI 10.3390/ijms15046002; Dagdemir A, 2004, SUPPORT CARE CANCER, V12, P263, DOI 10.1007/s00520-004-0591-8; DIB H, 2013, INT J MED PHARM SCI, V3, P147; El-Mostafa K, 2014, MOLECULES, V19, P14879, DOI 10.3390/molecules190914879; Fuchs-Tarlovsky V, 2013, NUTRITION, V29, P15, DOI 10.1016/j.nut.2012.02.014; Gandia-Herrero F, 2016, CRIT REV FOOD SCI, V56, P937, DOI 10.1080/10408398.2012.740103; Garoby-Salom S, 2016, J PHYSIOL BIOCHEM, V72, P59, DOI 10.1007/s13105-015-0461-5; Gebre-Mariam T., 2012, J BIOMATERIALS NANOB, V3, P79, DOI [10.4236/jbnb.2012.31010, DOI 10.4236/JBNB.2012.31010]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gupta RK, 2014, ASIAN PAC J CANCER P, V15, P4405, DOI 10.7314/APJCP.2014.15.11.4405; Hahm SW, 2010, PLANT FOOD HUM NUTR, V65, P247, DOI 10.1007/s11130-010-0188-y; Hansen JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120083; Harrabi B, 2017, ARCH PHYSIOL BIOCHEM, V123, P225, DOI 10.1080/13813455.2017.1307413; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Iachininoto MG, 2013, MOLECULES, V18, P10132, DOI 10.3390/molecules180910132; Igwe O. U., 2013, International Research Journal of Pharmaceutical and Applied Sciences, V3, P51; Iwasaki K, 2016, WORLD J GASTROENTERO, V22, P9765, DOI 10.3748/wjg.v22.i44.9765; Jana D, 2014, INDIA J SURG ONCOL, V5, P59, DOI 10.1007/s13193-014-0290-y; Kang CH, 2013, TOXICOL IN VITRO, V27, P782, DOI 10.1016/j.tiv.2012.12.012; Kazemi M, 2015, NAT PROD RES, V29, P551, DOI 10.1080/14786419.2014.951934; Khan M, 2016, J CELL MOL MED, V20, P389, DOI 10.1111/jcmm.12749; Khor SC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/914853; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kim DS, 2015, AM J CHINESE MED, V43, P731, DOI 10.1142/S0192415X15500457; Kim J, 2015, J SCI FOOD AGR, V95, P2601, DOI 10.1002/jsfa.6968; Kim MJ, 2014, NAT PROD COMMUN, V9, P727; Kim YS, 2009, CANCER PREV RES, V2, P200, DOI 10.1158/1940-6207.CAPR-08-0141; Koki Alane T, 2002, Cancer Control, V9, P28; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Macedo EMA, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165103, 10.1590/1414-431x20165103]; Miller PG, 2017, NATURE, V549, P462, DOI 10.1038/nature23548; Mishra A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/915436; Montecinos V, 2007, J BIOL CHEM, V282, P15506, DOI 10.1074/jbc.M608361200; Noori S, 2012, J CLIN CELL IMMUNOL, V01, P1, DOI DOI 10.4172/SCIENTIFICREPORTS.413; Nowacki L, 2015, PHYTOTHER RES, V29, P1964, DOI 10.1002/ptr.5491; Olajuyigbe OO, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-130; Omoruyi BE, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-215; Onodera Y, 2015, FEBS OPEN BIO, V5, P492, DOI 10.1016/j.fob.2015.06.001; Onyesife C. O., 2014, Annals of Biological Research, V5, P20; Osorio-Esquivel O, 2012, PLANT FOOD HUM NUTR, V67, P365, DOI 10.1007/s11130-012-0320-2; Osuna-Martinez U., 2014, NAT PROD CHEM RES, V2, P2, DOI [10.4172/2329-6836.1000153, DOI 10.4172/2329-6836.1000153]; Oyedemi SO, 2010, AFR J PHARM PHARMACO, V4, P70; Peana AT, 2006, LIFE SCI, V78, P719, DOI 10.1016/j.lfs.2005.05.065; Pinheiro BG, 2011, J ETHNOPHARMACOL, V138, P479, DOI 10.1016/j.jep.2011.09.037; Prabhakaran D, 2017, J PHARM RES, V11, P793; Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Salleh WMNHW, 2016, NAT PROD COMMUN, V11, P853; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Diaz MDS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8634249; Saravanakumar A, 2015, FRONT LIFE SCI, V8, P182, DOI 10.1080/21553769.2015.1028655; Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; Schuurman AG, 2002, CANCER CAUSE CONTROL, V13, P573, DOI 10.1023/A:1016332208339; Siddiqui F, 2016, J ETHNOPHARMACOL, V182, P221, DOI 10.1016/j.jep.2016.02.016; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Sobolewski Cyril, 2010, Int J Cell Biol, V2010, P215158, DOI 10.1155/2010/215158; Sreekanth D, 2007, PHYTOMEDICINE, V14, P739, DOI 10.1016/j.phymed.2007.03.017; Tambe V.D., 2014, RRJPP, V2, P41; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Turkez H, 2014, BIOLOGIA, V69, P936, DOI 10.2478/s11756-014-0393-5; Turkez H, 2014, CYTOTECHNOLOGY, V66, P597, DOI 10.1007/s10616-013-9611-1; Unuofin JO, 2017, ASIAN PAC J TROP BIO, V7, P901, DOI 10.1016/j.apjtb.2017.09.008; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Varela-Lopez A, 2015, ANTIOXIDANTS-BASEL, V4, P447, DOI 10.3390/antiox4030447; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wintola OA, 2011, PHARMACOGN MAG, V7, P325, DOI 10.4103/0973-1296.90414; Xiang LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36291; Yasueda A, 2016, INTEGR CANCER THER, V15, P17, DOI 10.1177/1534735415610427; Zhang YB, 2014, J OLEO SCI, V63, P1251, DOI 10.5650/jos.ess14061	93	18	18	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0209682	10.1371/journal.pone.0209682	http://dx.doi.org/10.1371/journal.pone.0209682			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695064	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400007
J	Rodriguez-Hernandez, MG; Wadsworth, DW				Rodriguez-Hernandez, Mynor G.; Wadsworth, Danielle W.			The effect of 2 walking programs on aerobic fitness, body composition, and physical activity in sedentary office employees	PLOS ONE			English	Article							ACCELEROMETER WEAR TIME; CARDIOVASCULAR-DISEASE; INTERMITTENT EXERCISE; BRISK WALKING; UNITED-STATES; SHORT BOUTS; ADULTS; HEALTH; INTERVENTIONS; WEIGHT	Purpose The present study examined changes in body composition, maximum oxygen uptake, and physical activity in sedentary office employees prescribed with two different walking programs during a 10-week intervention. Methods 68 sedentary employees were randomly assigned to one of three groups: multiple bouts of walking (n = 24 (5 male, 19 female) Age = 46 +/- 9, BMI = 30.5 +/- 5.78 kg/m(2)), continuous walking (n = 22 (6 male, 16 female) Age = 48 +/- 9, BMI = 30.6 +/- 6.2 kg/m(2)) and the control group (n = 22 (5 male, 17 female) Age = 42 +/- 10, BMI = 27.5 +/- 5.23 kg/m(2)). Dual-energy X-ray absorptiometry (iDXA) assessed body composition and a Bruce protocol treadmill test assessed aerobic fitness at baseline and week 11. At baseline, week 6 and week 11 a waist worn accelerometer measured physical activity and sedentary behavior. Physical activity was measured throughout the program with a wrist worn accelerometer. Results The results from the mixed-design ANOVA show that fat mass (p < .000) and fat percentage (p < .000) decreased for all three groups as a main effect of time. Sedentary behavior did not change (p>0.05) for all three groups. Moderate intensity physical activity increased significantly from pre-test to week 6 (p<0.05), then decreased from week 6 to post-test (p<0.05), with no significant changes observed from pre-test to post-test (p>0.05) for all groups. No changes in VO2 were observed (p>0.05) for all groups. Conclusions Continuous or intermittent walking activity produce similar benefits on body weight, fat mass and body fat percentage in sedentary employees. Meanwhile, intermittent walking allowed these sedentary employees to increase lean mass and fat free mass. Intermittent walking could provide at least similar benefits on body composition compared to a continuous walking program.	[Rodriguez-Hernandez, Mynor G.] Univ Costa Rica, Educ Dept, San Ramon, Alajuela, Costa Rica; [Rodriguez-Hernandez, Mynor G.; Wadsworth, Danielle W.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA	Universidad Costa Rica; Auburn University System; Auburn University	Rodriguez-Hernandez, MG (corresponding author), Univ Costa Rica, Educ Dept, San Ramon, Alajuela, Costa Rica.; Rodriguez-Hernandez, MG (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.	mynor.rodriguez@ucr.ac.cr; mynorgrh@gmail.com		Rodriguez-Hernandez, Mynor/0000-0002-7394-0146				ACSM, 2010, ACSMS HLTH REL PHYS; American College of Sports Medicine (ACSM), 2014, ACSMS GUIDELINES EXE; Amiri H, 2013, EUROPEAN J EXPT BIOL, V3, P282; [Anonymous], 2012, ACCELEROMETER DATA C; Barkley JE, 2014, VALIDITY COMMERCIALL; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Centers for disease control and prevention, 2015, BEH RISK FACT SURV S; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dempsey PC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0522-0; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Gaba A, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0343-1; Hanson S, 2015, BRIT J SPORT MED, V49, P710, DOI 10.1136/bjsports-2014-094157; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Herrmann SD, 2013, J PHYS ACT HEALTH, V10, P742, DOI 10.1123/jpah.10.5.742; Holmstrup M, 2014, METABOLISM, V63, P510, DOI 10.1016/j.metabol.2013.12.006; Hornbuckle LM, 2005, MED SCI SPORT EXER, V37, P1069, DOI 10.1249/01.mss.0000166575.35311.07; Jakicic JM, 1999, JAMA-J AM MED ASSOC, V282, P1554, DOI 10.1001/jama.282.16.1554; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Kephart WC, 2016, AMINO ACIDS, V48, P779, DOI 10.1007/s00726-015-2125-8; Lin YP, 2018, J OCCUP ENVIRON MED, V60, pE290, DOI 10.1097/JOM.0000000000001299; Linke SE, 2011, ANN BEHAV MED, V42, P197, DOI 10.1007/s12160-011-9279-8; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Macfarlane DJ, 2006, PREV MED, V43, P332, DOI 10.1016/j.ypmed.2006.06.002; Martin A, 2015, BRIT J SPORT MED, V49, P1056, DOI 10.1136/bjsports-2014-094524; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; McGrath R, 2017, J PHYS ACT HEALTH, V14, P919, DOI 10.1123/jpah.2016-0584; Merrill RM, 2005, AM J HEALTH BEHAV, V29, P371, DOI 10.5993/AJHB.29.4.9; Murphy MH, 2006, BMC PUBLIC HEALTH, V6, P1, DOI 10.1186/1471-2458-6-136; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Neuhaus M, 2014, OBES REV, V15, P822, DOI 10.1111/obr.12201; Norton LH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/929782; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Osei-Tutu KB, 2005, PREV MED, V40, P92, DOI 10.1016/j.ypmed.2004.05.005; Owen N, 2012, RES DIGEST, V13; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Pelssers J, 2013, J AGING PHYS ACTIV, V21, P167, DOI 10.1123/japa.21.2.167; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Rooney Brenda, 2003, WMJ, V102, P31; Saidj M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070213; Serwe KM, 2011, J WOMENS HEALTH, V20, P247, DOI 10.1089/jwh.2010.2019; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; SMUTOK MA, 1980, ARCH PHYS MED REHAB, V61, P569; Steeves JA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-95; Taylor AH, 2004, J SPORT SCI, V22, P703, DOI 10.1080/02640410410001712421; Taylor WC, 2011, CURR CARDIOVASC RISK, V5, P350, DOI 10.1007/s12170-011-0174-4; Taylor WC, 2010, WORK, V37, P433, DOI 10.3233/WOR-2010-1097; Thompson DL, 2004, MED SCI SPORT EXER, V36, P911, DOI 10.1249/01.MSS.0000126787.14165.B3; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Williams DM, 2008, MED SCI SPORT EXER, V40, pS567, DOI 10.1249/MSS.0b013e31817c7006; Williamson ML, 2014, 61 M AM COLL SPORTS; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Woolf-May K, 1999, HEALTH EDUC RES, V14, P803, DOI 10.1093/her/14.6.803; Yuenyongchaiwat K, 2015, THAMMASAT INT J SCI, V20, P38	65	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210447	10.1371/journal.pone.0210447	http://dx.doi.org/10.1371/journal.pone.0210447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695080	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400009
J	Kulan, H; Dag, T				Kulan, Handan; Dag, Tamer			In silico identification of critical proteins associated with learning process and immune system for Down syndrome	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TS65DN MOUSE; MEMORY; MODEL; MEMANTINE; ACTIVATION; MECHANISMS; EXPRESSION; DEFICITS; STRESS	Understanding expression levels of proteins and their interactions is a key factor to diagnose and explain the Down syndrome which can be considered as the most prevalent reason of intellectual disability in human beings. In the previous studies, the expression levels of 77 proteins obtained from normal genotype control mice and from trisomic Ts65Dn mice have been analyzed after training in contextual fear conditioning with and without injection of the memantine drug using statistical methods and machine learning techniques. Recent studies have also pointed out that there may be a linkage between the Down syndrome and the immune system. Thus, the research presented in this paper aim at in silico identification of proteins which are significant to the learning process and the immune system and to derive the most accurate model for classification of mice. In this paper, the features are selected by implementing forward feature selection method after preprocessing step of the dataset. Later, deep neural network, gradient boosting tree, support vector machine and random forest classification methods are implemented to identify the accuracy. It is observed that the selected feature subsets not only yield higher accuracy classification results but also are composed of protein responses which are important for the learning and memory process and the immune system.	[Kulan, Handan; Dag, Tamer] Kadir Has Univ, Comp Engn Dept, Istanbul, Turkey	Kadir Has University	Kulan, H (corresponding author), Kadir Has Univ, Comp Engn Dept, Istanbul, Turkey.	20161102001@stu.khas.edu.tr	Dag, Tamer/K-7830-2014; Dag, Tamer/T-4593-2019	Dag, Tamer/0000-0001-7020-3741; Kulan, Handan/0000-0001-8166-1967	Tubitak 2211 A National Scholarship Programme for PhD Students	Tubitak 2211 A National Scholarship Programme for PhD Students(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	HK holds a PhD Scholarship from Tubitak 2211 A National Scholarship Programme for PhD Students. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2010, ENCY RES DESIGN, P935; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119491; Ahmed MM, 2014, MOL CELL PROTEOMICS, V13, P919, DOI 10.1074/mcp.M113.035568; [Anonymous], 2005, TECHNICAL REPORT; Berthold MR, 2007, STUDIES CLASSIFICATI; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Block A, 2018, NEUROSCIENCE, V372, P192, DOI 10.1016/j.neuroscience.2017.12.038; Braudeau J, 2011, J PSYCHOPHARMACOL, V25, P1030, DOI 10.1177/0269881111405366; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Busciglio J, 2013, CYTOGENET GENOME RES, V141, P260, DOI 10.1159/000354306; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Chang Q, 2008, NEUROBIOL LEARN MEM, V89, P167, DOI 10.1016/j.nlm.2007.05.007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen HSV, 2005, J PHARMACOL EXP THER, V314, P961, DOI 10.1124/jpet.105.085142; Chen JN, 2009, EXPERT SYST APPL, V36, P5432, DOI 10.1016/j.eswa.2008.06.054; Corrales A, 2013, J PINEAL RES, V54, P346, DOI 10.1111/jpi.12037; Cortes C., 1995, MACH LEARN, V20, P1, DOI DOI 10.1007/BF00994018; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Das I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005983; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eicher T, 2016, THESIS; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Feng Bing, 2018, INT C INT INT SYST A, P302, DOI [10.1007/978-3-319-69096-4_42, DOI 10.1007/978-3-319-69096-4_42]; Gardiner KJ, 2014, DRUG DES DEV THER, V9, P103, DOI 10.2147/DDDT.S51476; Gardiner KJ, 2010, TRENDS PHARMACOL SCI, V31, P66, DOI 10.1016/j.tips.2009.10.010; Head E, 2016, CURR ALZHEIMER RES, V13, P18, DOI 10.2174/1567205012666151020114607; Higuera C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129126; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075; Kidambi Srivatsan, 2010, BMC Res Notes, V3, P201, DOI 10.1186/1756-0500-3-201; Kulan H, 2018, 2 INT C BIOINF COMP; Kumar V., 2014, SMART COMPUTING REV, V4, P211, DOI [DOI 10.6029/SMARTCR.2014.03.007, 10.6029/smartcr.2014.03.007]; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Lipton SA, 2007, CURR DRUG TARGETS, V8, P621, DOI 10.2174/138945007780618472; Lott IT, 2012, PROG BRAIN RES, V197, P101, DOI 10.1016/B978-0-444-54299-1.00006-6; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; McCombe PA, 2011, CURR MOL MED, V11, P246; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Nguyen CD, 2011, J NEUROGENET, V25, P40, DOI 10.3109/01677063.2011.558606; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G; Olivares D, 2012, CURR ALZHEIMER RES, V9, P746; Ortega-Martinez S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00046; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pollonini G, 2008, NEUROSCIENCE, V156, P99, DOI 10.1016/j.neuroscience.2008.07.025; RAHMANI Z, 1990, AM J MED GENET, P98; Reese LC, 2011, CURR NEUROPHARMACOL, V9, P685, DOI 10.2174/157015911798376316; Rueda N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/584071; Shao CY, 2011, ACTA NEUROPATHOL, V122, P285, DOI 10.1007/s00401-011-0843-x; Shen CP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-36; Shupp A, 2017, ONCOTARGET, V8, P17373, DOI 10.18632/oncotarget.14538; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; Sujashvili R, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4190390; Sullivan KD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13858-3; Tano T, 2013, NEOPLASIA, V15, P305, DOI 10.1593/neo.121528; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; Yu X, 2016, NEUROPSYCH DIS TREAT, V12, P685, DOI 10.2147/NDT.S98387; Zhang GR, 2009, HIPPOCAMPUS, V19, P413, DOI 10.1002/hipo.20506	70	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210954	10.1371/journal.pone.0210954	http://dx.doi.org/10.1371/journal.pone.0210954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689644	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800015
J	Strauch, MA; Tomaz, MA; Monteiro-Machado, M; Cons, BL; Patrao-Neto, FC; Teixeira-Cruz, JD; Tavares-Henriques, MD; Nogueira-Souza, PD; Gomes, SLS; Costa, PRR; Schaeffer, E; da Silva, AJM; Melo, PA				Strauch, Marcelo A.; Tomaz, Marcelo Amorim; Monteiro-Machado, Marcos; Cons, Bruno Lemos; Patrao-Neto, Fernando Chagas; Teixeira-Cruz, Jhonatha da Mota; Tavares-Henriques, Matheus da Silva; Nogueira-Souza, Pamella Dourila; Gomes, Sara L. S.; Costa, Paulo R. R.; Schaeffer, Edgar; da Silva, Alcides J. M.; Melo, Paulo A.			Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms	PLOS ONE			English	Article							PRELIMINARY PHARMACOLOGICAL EVALUATION; HEMORRHAGIC ACTIVITIES; PHOSPHOLIPASE A(2); JARARACUSSU VENOM; AQUEOUS EXTRACT; NEUTRALIZATION; INHIBITION; METALLOPROTEINASES; PURIFICATION; JARARHAGIN	Background It is known that local tissue injuries incurred by snakebites are quickly instilled causing extensive, irreversible, tissue destruction that may include loss of limb function or even amputation. Such injuries are not completely neutralized by the available antivenins, which in general are focused on halting systemic effects. Therefore it is prudent to investigate the potential antiophidic effects of natural and synthetic compounds, perhaps combining them with serum therapy, to potentially attenuate or eliminate the adverse local and systemic effects of snake venom. This study assessed a group of quinones that are widely distributed in nature and constitute an important class of natural products that exhibit a range of biological activities. Of these quinones, lapachol is one of the most important compounds, having been first isolated in 1882 from the bark of Tabebuia avellanedae. Methodology/Principal findings It was investigated the ability of lapachol and some new potential active analogues based on the 2-hydroxi-naphthoquinone scaffold to antagonize important activities of Bothrops venoms (Bothrops atrox and Bothrops jararaca) under different experimental protocols in vitro and in vivo. The bioassays used to test the compounds were: procoagulant, phospholipase A(2), collagenase and proteolytic activities in vitro, venom-induced hemorrhage, edematogenic, and myotoxic effects in mice. Proteolytic and collagenase activities of Bothrops atrox venom were shown to be inhibited by lapachol and its analogues 3a, 3b, 3c, 3e. The inhibition of these enzymatic activities might help to explain the effects of the analogue 3a in vivo, which decreased skin hemorrhage induced by Bothrops venom. Lapachol and the synthetic analogues 3a and 3b did not inhibit the myotoxic activity induced by Bothrops atrox venom. The negative protective effect of these compounds against the myotoxicity can be partially explained by their lack of ability to effectively inhibit phospholipase A(2) venom activity. Bothrops atrox venom also induced edema, which was significantly reduced by the analogue 3a. Conclusions This research using a natural quinone and some related synthetic quinone compounds has shown that they exhibit antivenom activity; especially the compound 3a. The data from 3a showed a decrease in inflammatory venom effects, presumably those that are metalloproteinase- derived. Its ability to counteract such snake venom activities contributes to the search for improving the management of venomous snakebites.	[Strauch, Marcelo A.; Tomaz, Marcelo Amorim; Monteiro-Machado, Marcos; Cons, Bruno Lemos; Patrao-Neto, Fernando Chagas; Teixeira-Cruz, Jhonatha da Mota; Tavares-Henriques, Matheus da Silva; Nogueira-Souza, Pamella Dourila; Melo, Paulo A.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Toxinas, Rio De Janeiro, RJ, Brazil; [Strauch, Marcelo A.] Inst Vital Brazil, Niteroi, RJ, Brazil; [Gomes, Sara L. S.; Schaeffer, Edgar; da Silva, Alcides J. M.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat Walter Mors, Lab Quim Bioorgan, Rio De Janeiro, RJ, Brazil; [Gomes, Sara L. S.; Costa, Paulo R. R.] Univ Fed Rio de Janeiro, Inst Pesquisas Prod Nat Walter Mors, Lab Catalise Organ, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Strauch, MA; Tomaz, MA; Melo, PA (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Toxinas, Rio De Janeiro, RJ, Brazil.; Strauch, MA (corresponding author), Inst Vital Brazil, Niteroi, RJ, Brazil.	strauchmarcelo@yahoo.com.br; marcelotomaz.fisio@gmail.com; melo.pa@gmail.com	Monteiro-Machado, Marcos/J-4931-2016; da Silva, Alcides José/AAV-6031-2020; Patrão-Neto, Fernando C/L-3516-2017; Costa, Paulo Roberto Ribeiro/F-1153-2013; da Mota Teixeira Cruz, Jhonatha/AAT-8226-2020; Costa, Paulo Roberto Ribeiro/AAH-4777-2021; Strauch, Marcelo A/J-2443-2016	Monteiro-Machado, Marcos/0000-0002-1657-1356; da Silva, Alcides José/0000-0002-3200-0318; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; da Mota Teixeira Cruz, Jhonatha/0000-0002-3167-0723; Costa, Paulo Roberto Ribeiro/0000-0001-9541-1707; Patrao-Neto, Fernando/0000-0002-4583-0476; Melo, Paulo A/0000-0003-1250-6933	Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ E_02/2017 - CNE]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306969/2015-7]; FAPERJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	PAM received awards from Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ E_02/2017 - CNE - 2014/2017 http://www.faperj.br/) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process 306969/2015-7 http://www.cnpq.br/). MAS received PhD fellowship from FAPERJ. MAT received PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MI, 2003, J ETHNOPHARMACOL, V86, P75, DOI 10.1016/S0378-8741(03)00049-7; Anz AW, 2010, J AM ACAD ORTHOP SUR, V18, P749, DOI 10.5435/00124635-201012000-00005; Baldo C, 2015, TOXICON, V108, P240, DOI 10.1016/j.toxicon.2015.10.016; Barbosa-Filho Jose Maria, 2004, Phyton (Buenos Aires), V2004, P221; Borges MH, 2005, J ETHNOPHARMACOL, V98, P21, DOI 10.1016/j.jep.2004.12.014; Buarque CD, 2011, BIOORGAN MED CHEM, V19, P6885, DOI 10.1016/j.bmc.2011.09.025; Castellanos JRG, 2009, J ETHNOPHARMACOL, V121, P1, DOI 10.1016/j.jep.2008.10.004; Cavalcante WLG, 2007, J ETHNOPHARMACOL, V112, P490, DOI 10.1016/j.jep.2007.04.002; Chandra JNNS, 2007, CURR TOP MED CHEM, V7, P787, DOI 10.2174/156802607780487678; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Chippaux JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005662; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; da Silva AJM, 2002, BIOORGAN MED CHEM, V10, P2731, DOI 10.1016/S0968-0896(02)00100-1; da Silva AJM, 2001, BIOORG MED CHEM LETT, V11, P283, DOI 10.1016/S0960-894X(00)00621-1; da Silva NMV, 2007, TOXICON, V50, P196, DOI 10.1016/j.toxicon.2007.03.010; DEALMEIDA ER, 1990, J ETHNOPHARMACOL, V29, P239, DOI 10.1016/0378-8741(90)90061-W; DRISCOLL JS, 1974, CANCER CHEMOTH REP 2, V4, P1; Epifano F, 2014, PHYTOCHEM REV, V13, P37, DOI 10.1007/s11101-013-9289-1; Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013; Fernandes FFA, 2014, J ETHNOPHARMACOL, V155, P552, DOI 10.1016/j.jep.2014.05.056; GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0; Gomes SLS, 2017, J BRAZIL CHEM SOC, V28, P1573, DOI 10.21577/0103-5053.20160326; GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.63, 10.1038/nrdp.2017.79]; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8040093; HOMMA M, 1971, BRIT J EXP PATHOL, V52, P538; Hussain H, 2007, ARKIVOC, P145, DOI 10.3998/ark.5550190.0008.204; KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; Kohlhoff M, 2012, J PROTEOMICS, V75, P2181, DOI 10.1016/j.jprot.2012.01.020; Lee RI, 1913, AM J MED SCI, V145, P495, DOI 10.1097/00000441-191304000-00004; LEGAT FJ, 1994, BRIT J PHARMACOL, V112, P453, DOI 10.1111/j.1476-5381.1994.tb13094.x; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8100304; MARINETT.GV, 1965, BIOCHIM BIOPHYS ACTA, V98, P554, DOI 10.1016/0005-2760(65)90152-9; MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7; MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545; MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0; MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A; Melo PA, 2010, TOXICON, V55, P488, DOI 10.1016/j.toxicon.2009.09.021; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Monteiro-Machado M, 2015, TOXICON, V98, P20, DOI 10.1016/j.toxicon.2015.02.010; MORS WB, 1989, TOXICON, V27, P1003, DOI 10.1016/0041-0101(89)90151-7; Murakami MT, 2005, J MOL BIOL, V350, P416, DOI 10.1016/j.jmb.2005.04.072; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Newman DJ, 2017, J BRAZIL CHEM SOC, V28, P402, DOI 10.21577/0103-5053.20160225; NISHIOKA SD, 1992, AM J TROP MED HYG, V47, P805, DOI 10.4269/ajtmh.1992.47.805; Oliveira CZ, 2005, J ETHNOPHARMACOL, V98, P213, DOI 10.1016/j.jep.2004.12.028; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; PAINE MJI, 1992, J BIOL CHEM, V267, P22869; Patrao-Neto FC, 2013, TOXICON, V69, P55, DOI 10.1016/j.toxicon.2013.01.023; PEREIRA NA, 1994, PLANTA MED, V60, P99, DOI 10.1055/s-2006-959425; Regalado AI, 2015, J PHARM PHARMACOGN R, V3, P109; Reis FP, 2014, J ETHNOPHARMACOL, V158, P352, DOI 10.1016/j.jep.2014.10.045; Rios-Luci C, 2012, EUR J MED CHEM, V53, P264, DOI 10.1016/j.ejmech.2012.04.008; RIZZINI CT, 1988, REV BRAS FARM, V69, P82; Rojas E, 2005, ACTA TROP, V93, P85, DOI 10.1016/j.actatropica.2004.09.008; Rosenfeld G., 1971, VENOMOUS ANIMALS THE, P687, DOI DOI 10.1016/B978-0-12-138902-4.50021-0; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Souto AL, 2011, MOLECULES, V16, P8515, DOI 10.3390/molecules16108515; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Strauch MA, 2013, J ETHNOPHARMACOL, V145, P50, DOI 10.1016/j.jep.2012.10.033; Tan NH, 2009, J ETHNOPHARMACOL, V123, P356, DOI 10.1016/j.jep.2009.03.025; Toschi E, 2001, MOL BIOL CELL, V12, P2934, DOI 10.1091/mbc.12.10.2934; WARRELL DA, 2004, VENOMOUS REPTILES W; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, WORK OV GLOB IMP NEG; [No title captured]	71	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211229	10.1371/journal.pone.0211229	http://dx.doi.org/10.1371/journal.pone.0211229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689661	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800023
J	Ahn, YJ; Park, SH; Shin, SY				Ahn, Ye Jin; Park, Shin Hae; Shin, Sun Young			Changes in axial length in accommodative esotropia patients with minimal hyperopic correction	PLOS ONE			English	Article							COMPONENT GROWTH-CURVES; REFRACTIVE ERROR; CHILDREN; EMMETROPIZATION; INFANTS	Purpose To compare the changes of spherical equivalent refractive error (SER) and axial length (AL) for three years in hyperopic children with minimal undercorrection according to the presence of accommodative esotropia (AE). Methods A total of 67 hyperopic children were enrolled. The patients were divided into 3 groups and matched by initial age upon examination; esotropic eyes with AE (AE group), fellow eyes with AE (FE group), and right eyes without esotropia (HE group). Changes of SER and AL were serially measured every six months for three years and collected data were compared among the groups. Results All three groups underwent significant myopic shift and AL elongation during the follow-up period. However, the least amount of change was found in the AE group. The AE group (-0.96 +/- 1.38D) exhibited significantly less change in SER compared to the HE group (-1.76 +/- 1.11D) and the FE group (-1.57 +/- 1.33D) (both p<0.001). Meanwhile, smaller changes of AL were noticeable in the AE group (0.62 +/- 0.88mm) compared to the other two groups (HE 0.99 +/- 0.29mm; p<0.001, FE 0.73 +/- 0.65mm; p = 0.04). The SER and AL changes were not significantly different between the HE group and FE group. Conclusions Esotropic eyes with AE patients with minimal undercorrection exhibited little negative shift of SER and AL elongation compared to not only hyperopic eyes without AE but also fellow eyes with AE.	[Ahn, Ye Jin; Park, Shin Hae; Shin, Sun Young] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	eyeshin@catholic.ac.kr			Catholic Medical Center Research Foundation [5-2018-B0001-00006]	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2018 (no. 5-2018-B0001-00006).	ABRAHAMSSON M, 1992, BRIT J OPHTHALMOL, V76, P723, DOI 10.1136/bjo.76.12.723; Atkinson J, 2000, INVEST OPHTH VIS SCI, V41, P3726; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Brown NP, 1999, EYE, V13, P83, DOI 10.1038/eye.1999.16; INGRAM RM, 1991, BRIT J OPHTHALMOL, V75, P414, DOI 10.1136/bjo.75.7.414; Ingram RM, 2000, BRIT J OPHTHALMOL, V84, P324, DOI 10.1136/bjo.84.3.324; Jones LA, 2005, INVEST OPHTH VIS SCI, V46, P2317, DOI 10.1167/iovs.04-0945; Khan Arif O, 2009, Binocul Vis Strabismus Q, V24, P151; Koretz J F, 1995, Trans Am Ophthalmol Soc, V93, P105; Koretz JF, 1995, T AM OPHTHAL SOC, V93, P118; Kulp MT, 2012, AM J OPHTHALMOL, V154, P297, DOI 10.1016/j.ajo.2012.02.035; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; LEPARD CW, 1975, AM J OPHTHALMOL, V80, P485, DOI 10.1016/0002-9394(75)90212-3; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Mutti DO, 2007, OPTOMETRY VISION SCI, V84, P97, DOI 10.1097/OPX.0b013e318031b079; NASTRI G, 1984, DOC OPHTHALMOL, V56, P265, DOI 10.1007/BF00159077; 김나혜, 2015, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V56, P580, DOI 10.3341/jkos.2015.56.4.580; Park KA, 2010, OPHTHALMOLOGY, V117, P2196, DOI 10.1016/j.ophtha.2010.02.019; Shih YF, 2009, INVEST OPHTH VIS SCI, V50, P2637, DOI 10.1167/iovs.08-3090; Smith EL, 1999, OPHTHAL PHYSL OPT, V19, P90, DOI 10.1046/j.1475-1313.1999.00429.x; Uretmen O, 2003, ACTA OPHTHALMOL SCAN, V81, P260, DOI 10.1034/j.1600-0420.2003.00062.x; Wildsoet CF, 1997, OPHTHAL PHYSL OPT, V17, P279, DOI 10.1111/j.1475-1313.1997.tb00059.x; Wong HB, 2010, INVEST OPHTH VIS SCI, V51, P1341, DOI 10.1167/iovs.09-3431; Yang HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110663	24	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0203584	10.1371/journal.pone.0203584	http://dx.doi.org/10.1371/journal.pone.0203584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682011	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500005
J	Alotaibi, B; Yassin, Y; Mushi, A; Maashi, F; Thomas, A; Mohamed, G; Hassan, A; Yezli, S				Alotaibi, Badriah; Yassin, Yara; Mushi, Abdulaziz; Maashi, Fuad; Thomas, Abin; Mohamed, Gamal; Hassan, Amir; Yezli, Saber			Tuberculosis knowledge, attitude and practice among healthcare workers during the 2016 Hajj	PLOS ONE			English	Article							INFECTION-CONTROL KNOWLEDGE; PULMONARY TUBERCULOSIS; ADDIS-ABABA; DISTRICT; FACILITIES; PILGRIMS; STIGMA; IRAN	Background Given the inherent characteristics of the Hajj pilgrimage, the event is a risk for tuberculosis (TB) infection. Early diagnosis and appropriate management of TB cases by knowledgeable and skilled healthcare workers (HCWs) are key in improving patients' outcome and preventing transmission during the Hajj mass gathering and globally. Method We conducted a cross-sectional study to assess knowledge, attitude and practice (KAP) of HCWs deployed during the 2016 Hajj regarding TB and its management using an anonymous self-administered questionnaire. Results Data was collected from 540 HCWs from 13 hospitals. HCWs originated from 17 countries and included physicians, nurses and other non-administrative HCWs. Nearly half of HCWs declared having experience dealing with TB patients. In general, HCWs had average knowledge (mean knowledge score of 52%), above average attitude (mean attitude score of 73%) and good practice (mean practice score of 85%) regarding TB, based on our scoring system and cut-off points. Knowledge gaps were identified in relation to the definition of MDR-/XDR-TB and LTBI, smear microscopy results, length of standard TB treatment for drug-sensitive TB, 2nd line anti-TB drugs, BCG vaccination, and appropriate PPE to be used with active PTB patients. Poor attitudes were found in relation to willingness to work in TB clinic/ward and to the management and treatment of TB patients. Poor practices were reported for commencing anti-TB treatment on suspected TB cases before laboratory confirmation and not increasing natural ventilation in TB patients' rooms. Age, gender, nationality, occupation, length of work experience and experience dealing with TB patients were associated with knowledge scores. Age and occupation were associated with attitude scores while length of work experience and occupation were associated with practice scores. There was a weak but statistically significant positive correlation between score for knowledge and attitude (r(s) = 0.11, p = 0.009) and attitude and practice (r(s) = 0.13, p = 0.002). Conclusions While the results of the study are encouraging, important knowledge gaps and some poor attitudes and practices regarding TB were identified among HCWs during Hajj. This calls for multifaceted interventions to improve HCWs KAP regarding TB including tailored, periodic TB education and training aimed at boosting knowledge and improving behaviour.	[Alotaibi, Badriah; Yassin, Yara; Mushi, Abdulaziz; Maashi, Fuad; Yezli, Saber] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia; [Thomas, Abin] Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Mohamed, Gamal; Hassan, Amir] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	Ministry of Health - Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Liverpool School of Tropical Medicine	Alotaibi, B (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh, Saudi Arabia.	bmalotaibi@moh.gov.sa		Thomas, Abin/0000-0002-8283-6762; Yassin, Yara/0000-0002-8762-5403; Yezli, Saber/0000-0002-3380-7092				Abd Wahab F, 2016, MALAYS J MED SCI, V23, P25, DOI 10.21315/mjms2016.23.6.3; Al-Orainey IO, 2013, SAUDI MED J, V34, P676; Awofeso N, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-20; Bhebhe LT, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.597; Buregyeya E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1740-7; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Dielman M, 2006, IMPROVING HLTH WORKE; Dodor EA, 2008, INT J TUBERC LUNG D, V12, P1048; Dodor EA, 2010, HEALTH POLICY, V98, P195, DOI 10.1016/j.healthpol.2010.06.017; Engelbrecht M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1984-2; Ferreira Júnior Sérgio, 2013, Rev. bras. epidemiol., V16, P100, DOI 10.1590/S1415-790X2013000100010; Ghabrah TM, 2007, SCAND J INFECT DIS, V39, P1018, DOI 10.1080/00365540701466173; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; Hashim D S, 2003, East Mediterr Health J, V9, P718; Hoa NP, 2005, HEALTH POLICY, V72, P1, DOI 10.1016/j.healthpol.2004.02.013; Hoffman SJ, 2016, AM J TROP MED HYG, V94, P959, DOI 10.4269/ajtmh.15-0538; HONG YP, 1995, TUBERCLE LUNG DIS, V76, P431, DOI 10.1016/0962-8479(95)90010-1; Irani AD, 2015, AM J INFECT CONTROL, V43, pE7, DOI 10.1016/j.ajic.2015.01.020; Isara AR, 2015, NIGER J CLIN PRACT, V18, P664, DOI 10.4103/1119-3077.154212; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lai KK, 1996, INFECT CONT HOSP EP, V17, P168; Langendam MW, 2012, EUR RESPIR J, V39, P1012, DOI 10.1183/09031936.00125511; Lateef Fatimah, 2010, J Emerg Trauma Shock, V3, P348, DOI 10.4103/0974-2700.70743; Lertkanokkun S, 2013, JITMM2012 P, V2, P1; Malangu N, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.774; Minnery M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075698; Naidoo S, 2002, SADJ, V57, P476; Naidoo S, 2011, Educ Health (Abingdon), V24, P514; Noe A, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0344-8; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Schmidt BM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5518-2; Shrestha A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2828-4; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; Temesgen C, 2014, BMC HEALTH SERV RES, V14, P593; Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979; van der Werf MJ, 2012, EUR RESPIR J, V39, P1248, DOI 10.1183/09031936.00125611; WHO, 2017, GLOB TUB REP 2017; Woith W, 2012, INT J TUBERC LUNG D, V16, P1092, DOI 10.5588/ijtld.10.0779; Woith WM, 2010, INT J TUBERC LUNG D, V14, P1489; World Health Organization, 2008, ADVOCACY COMMUNICATI; World Health Organization, 2014, GLOB TUB REP; Yezli S, 2018, TRAVEL MED INFECT DI, P30281; Yezli S, 2017, AM J TROP MED HYG, V97, P1304, DOI 10.4269/ajtmh.17-0271; Yezli S, 2017, SAUDI MED J, V38, P868, DOI 10.15537/smj.2017.8.20124	45	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210913	10.1371/journal.pone.0210913	http://dx.doi.org/10.1371/journal.pone.0210913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682065	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500074
J	Perkins, ZB; Captur, G; Bird, R; Gleeson, L; Singer, B; O'Brien, B				Perkins, Zane B.; Captur, Gabriella; Bird, Ruth; Gleeson, Liam; Singer, Ben; O'Brien, Benjamin			Trauma induced acute kidney injury	PLOS ONE			English	Article							RENAL-REPLACEMENT THERAPY; RISK-FACTORS; INITIATION; FAILURE; TRANSFUSION	Background Injured patients are at risk of developing acute kidney injury (AKI), which is associated with increased morbidity and mortality. The aim of this study is to describe the incidence, timing, and severity of AKI in a large trauma population, identify risk factors for AKI, and report mortality outcomes. Methods A prospective observational study of injured adults, who met local criteria for trauma team activation, and were admitted to a UK Major Trauma Centre. AKI was defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Multivariable logistic regression and Cox proportional hazard modelling was used to analyse parameters associated with AKI and mortality. Results Of the 1410 patients enrolled in the study, 178 (12.6%) developed AKI. Age; injury severity score (ISS); admission systolic blood pressure, lactate and serum creatinine; units of Packed Red Blood Cells transfused in first 24 hours and administration of nephrotoxic therapy were identified as independent risk factors for the development of AKI. Patients that developed AKI had significantly higher mortality than those with normal renal function (47/178 [26.4%] versus 128/ 1232 [10.4%]; OR 3.09 [2.12 to 4.53]; p< 0.0001). After adjusting for other clinical prognostic factors, AKI was an independent risk factor for mortality. Conclusions AKI is a frequent complication following trauma and is associated with prolonged hospital length of stay and increased mortality. Future research is needed to improve our ability to rapidly identify those at risk of AKI, and develop resuscitation strategies that preserve renal function in trauma patients.	[Perkins, Zane B.] Queen Mary Univ London, Ctr Trauma Sci, London, England; [Captur, Gabriella; Bird, Ruth; Gleeson, Liam; Singer, Ben; O'Brien, Benjamin] Barts Hlth NHS Trust, St Bartholomews Hosp & Barts Heart Ctr, London, England; [Captur, Gabriella] UCL, Inst Cardiovasc Sci, Gower St, London, England; [Singer, Ben; O'Brien, Benjamin] QMUL, William Harvey Res Inst, London, England; [O'Brien, Benjamin] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA	University of London; Queen Mary University London; Barts Health NHS Trust; University of London; University College London; University of London; Queen Mary University London; Cleveland Clinic Foundation	Perkins, ZB (corresponding author), Queen Mary Univ London, Ctr Trauma Sci, London, England.	z.perkins@qmul.ac.uk	Perkins, Zane/AAC-6949-2019	Perkins, Zane/0000-0003-4807-8803; O'Brien, Benjamin/0000-0001-7024-2337	National Institute for Health Research: Programme Grant for Applied Research [RP-PG-0407-10036]; NIHR Rare Diseases Translational Research Collaboration	National Institute for Health Research: Programme Grant for Applied Research; NIHR Rare Diseases Translational Research Collaboration	This study was supported by grants from the National Institute for Health Research: Programme Grant for Applied Research (RP-PG-0407-10036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; G.C. is supported by the NIHR Rare Diseases Translational Research Collaboration. The authors would like to thank the research fellows, past and present, at the Centre for Trauma Sciences for collecting the data presented in this study.	Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2013, J TRAUMA ACUTE CARE, V74, P1005, DOI 10.1097/TA.0b013e31828586ec; Bihorac A, 2010, ANN SURG, V252, P158, DOI 10.1097/SLA.0b013e3181deb6bc; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Gennarelli TA, 2008, ABBREVIATED INJURY S; Godin M, 2015, CLIN APPROACH PATIEN, P12; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Haines RW, 2019, J TRAUMA ACUTE CARE, V86, P141, DOI 10.1097/TA.0000000000002085; Haines RW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21929-2; Harrois A, 2017, CURR OPIN CRIT CARE, V23, P447, DOI 10.1097/MCC.0000000000000463; Heegard KD, 2015, J TRAUMA ACUTE CARE, V78, P988, DOI 10.1097/TA.0000000000000607; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karkouti K, 2012, BRIT J ANAESTH, V109, pI29, DOI 10.1093/bja/aes422; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Lai WH, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0330-4; Matejovic M, 2011, CONTRIB NEPHROL, V174, P78, DOI 10.1159/000329239; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nevin DG, 2017, ANAESTHESIA, V72, P1443, DOI 10.1111/anae.14034; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Shashaty MGS, 2012, J CRIT CARE, V27, P496, DOI 10.1016/j.jcrc.2012.02.002; Skinner DL, 2014, INJURY, V45, P259, DOI 10.1016/j.injury.2013.07.013; Sutherland SM, 2015, CLIN J AM SOC NEPHRO, V10, P554, DOI 10.2215/CJN.01900214; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wierstra BT, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1291-8	30	32	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211001	10.1371/journal.pone.0211001	http://dx.doi.org/10.1371/journal.pone.0211001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682106	Green Published, gold			2022-12-27	WOS:000457037500088
J	Rabovsky, M; Conrad, M; Alvarez, CJ; Paschke-Goldt, J; Sommer, W				Rabovsky, Milena; Conrad, Markus; Alvarez, Carlos J.; Paschke-Goldt, Joerg; Sommer, Werner			Attentional modulation of orthographic neighborhood effects during reading: Evidence from event-related brain potentials in a psychological refractory period paradigm	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; DUAL-TASK INTERFERENCE; CHRONOMETRIC EVIDENCE; GREATER AUTOMATICITY; OVERLAPPING TASKS; LEXICAL DECISION; FREQUENCY; MODEL; N400; INFORMATION	It is often assumed that word reading proceeds automatically. Here, we tested this assumption by recording event-related potentials during a psychological refractory period (PRP) paradigm, requiring lexical decisions about written words. Specifically, we selected words differing in their orthographic neighborhood size-the number of words that can be obtained from a target by exchanging a single letter-and investigated how influences of this variable depend on the availability of central attention. As expected, when attentional resources for lexical decisions were unconstrained, words with many orthographic neighbors elicited larger N400 amplitudes than those with few neighbors. However, under conditions of high temporal overlap with a high priority primary task, the N400 effect was not statistically different from zero. This finding indicates strong attentional influences on processes sensitive to orthographic neighbors during word reading, providing novel evidence against the full automaticity of processes involved in word reading. Furthermore, in conjunction with the observation of an underadditive interaction between stimulus onset asynchrony (SOA) and orthographic neighborhood size in lexical decision performance, commonly taken to indicate automaticity, our results raise issues concerning the standard logic of cognitive slack in the PRP paradigm.	[Rabovsky, Milena] Free Univ Berlin, Dept Psychol, Berlin, Germany; [Conrad, Markus; Alvarez, Carlos J.] Univ La Laguna, Dept Psychol, Tenerife, Spain; [Paschke-Goldt, Joerg; Sommer, Werner] Humboldt Univ, Dept Psychol, Berlin, Germany	Free University of Berlin; Universidad de la Laguna; Humboldt University of Berlin	Rabovsky, M (corresponding author), Free Univ Berlin, Dept Psychol, Berlin, Germany.	milena.rabovsky@gmail.com	Álvarez, Carlos J/R-6785-2018; Sommer, Werner/H-4672-2011; Sommer, Werner/N-1945-2019; Conrad, Markus/N-3184-2014	Álvarez, Carlos J/0000-0003-2737-956X; Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Conrad, Markus/0000-0003-1335-437X; Rabovsky, Milena/0000-0001-7729-1027	European Union [658999]; Spanish Ministry of Economy, Industry, and Competitiveness [PSI2013-47959-P]	European Union(European Commission); Spanish Ministry of Economy, Industry, and Competitiveness	This project has received funding from the European Union's Horizon 2020 research and innovation programme (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowska-curie-actions) under the Marie Sklodowska-Curie grant agreement No 658999 to MR and by grant PSI2013-47959-P from the Spanish Ministry of Economy, Industry, and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/) to CJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2002, PSYCHOL AGING, V17, P505, DOI 10.1037//0882-7974.17.3.505; ANDREWS S, 1989, J EXP PSYCHOL LEARN, V15, P802, DOI 10.1037/0278-7393.15.5.802; Andrews S, 1997, PSYCHON B REV, V4, P439, DOI 10.3758/BF03214334; Arnell KM, 2004, PSYCHON B REV, V11, P77, DOI 10.3758/BF03206464; Augustinova M, 2014, CURR DIR PSYCHOL SCI, V23, P343, DOI 10.1177/0963721414540169; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; Besner D, 2016, CURR DIR PSYCHOL SCI, V25, P162, DOI 10.1177/0963721416639351; Besner D, 2009, Q J EXP PSYCHOL, V62, P2222, DOI 10.1080/17470210902747187; Braun M, 2006, BRAIN RES, V1073, P431, DOI 10.1016/j.brainres.2005.12.078; Brisson B, 2007, PSYCHOPHYSIOLOGY, V44, P323, DOI 10.1111/j.1469-8986.2007.00503.x; BROADBEN.DE, 1967, PSYCHOL REV, V74, P1, DOI 10.1037/h0024206; Brouwer H., 2014, ELECTROPHYSIOLOGY LA; Carrasco-Ortiz H, 2017, J NEUROLINGUIST, V41, P1, DOI 10.1016/j.jneuroling.2016.06.007; Carreiras M, 1997, J EXP PSYCHOL LEARN, V23, P857, DOI 10.1037/0278-7393.23.4.857; Cleland AA, 2006, J EXP PSYCHOL HUMAN, V32, P104, DOI 10.1037/0096-1523.32.1.104; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Coltheart M., 1977, ATTENTION PERFORM, P535, DOI DOI 10.1006/BRLN.2001.2475; Conrad M, 2007, MEM COGNITION, V35, P974, DOI 10.3758/BF03193470; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Debruille JB, 2007, BRAIN RES REV, V56, P472, DOI 10.1016/j.brainresrev.2007.10.001; Debruille JB, 1998, BRAIN LANG, V62, P202, DOI 10.1006/brln.1997.1904; DEJONG R, 1995, Q J EXP PSYCHOL-A, V48, P2, DOI 10.1080/14640749508401372; Dell'Acqua R, 2005, EXP BRAIN RES, V165, P54, DOI 10.1007/s00221-005-2281-2; Forster K. I., 1976, NEW APPROACHES LANGU, P257; FORSTER KI, 1973, J VERB LEARN VERB BE, V12, P627, DOI 10.1016/S0022-5371(73)80042-8; Forster KI, 1996, J EXP PSYCHOL LEARN, V22, P696, DOI 10.1037/0278-7393.22.3.696; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Grainger J, 2005, Q J EXP PSYCHOL-A, V58, P981, DOI 10.1080/02724980443000386; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Hohfeld A, 2004, J EXP PSYCHOL LEARN, V30, P1012, DOI 10.1037/0278-7393.30.5.1012; Hohlfeld A, 2004, BRAIN LANG, V89, P569, DOI 10.1016/j.bandl.2004.02.002; Holcomb PJ, 2002, J COGNITIVE NEUROSCI, V14, P938, DOI 10.1162/089892902760191153; HOWES DH, 1951, J EXP PSYCHOL, V41, P401, DOI 10.1037/h0056020; Hutzler F, 2004, NEUROSCI LETT, V372, P179, DOI 10.1016/j.neulet.2004.07.050; Johnston JC, 1995, PSYCHOL SCI, V6, P365, DOI 10.1111/j.1467-9280.1995.tb00527.x; Kahnemann D., 1973, ATTENTION EFFORT; Keele S.W., 1973, ATTENTION HUMAN PERF; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Laszlo S, 2014, BRAIN LANG, V132, P22, DOI 10.1016/j.bandl.2014.03.002; Laszlo S, 2012, BRAIN LANG, V120, P271, DOI 10.1016/j.bandl.2011.09.001; Laszlo S, 2011, PSYCHOPHYSIOLOGY, V48, P176, DOI 10.1111/j.1469-8986.2010.01058.x; Lien MC, 2008, J EXP PSYCHOL HUMAN, V34, P751, DOI 10.1037/0096-1523.34.3.751; Lien MC, 2006, PSYCHOL AGING, V21, P431, DOI 10.1037/0882-7974.21.3.431; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; McCann RS, 2000, J EXP PSYCHOL HUMAN, V26, P1352, DOI 10.1037//0096-1523.26.4.1352; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; MCLEOD P, 1977, ACTA PSYCHOL, V41, P381, DOI 10.1016/0001-6918(77)90016-6; Molinaro N, 2010, COGN NEUROSCI, V1, P1, DOI 10.1080/17588920903373952; MONSELL S, 1989, J EXP PSYCHOL GEN, V118, P43, DOI 10.1037/0096-3445.118.1.43; Monsell S., 1991, NATURE LOCUS WORD FR, DOI [10.1037/0096-1523.32.1.104, DOI 10.1037/0096-1523.32.1.104]; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Mulatti C, 2006, J EXP PSYCHOL HUMAN, V32, P799, DOI 10.1037/0096-1523.32.4.799; Muller O, 2010, PSYCHOPHYSIOLOGY, V47, P455, DOI 10.1111/j.1469-8986.2009.00960.x; Nunez P. L., 2006, NEUROPHYSICS EEG, DOI [10.1093/acprof:oso/ 9780195050387.001.0001, DOI 10.1093/ACPROF:OSO/9780195050387.001.0001]; O'Malley S, 2008, J EXP PSYCHOL LEARN, V34, P422, DOI 10.1037/0278-7393.34.2.422; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1017/S0048577200000305; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Rabovsky M, 2008, BRAIN RES, V1222, P156, DOI 10.1016/j.brainres.2008.05.066; Rabovsky M, 2018, NAT HUM BEHAV, V2, P693, DOI 10.1038/s41562-018-0406-4; Rabovsky M, 2014, COGNITION, V132, P68, DOI 10.1016/j.cognition.2014.03.010; Reynolds M, 2006, J EXP PSYCHOL HUMAN, V32, P1303, DOI 10.1037/0096-1523.32.6.1303; RUBENSTEIN H, 1970, J VERB LEARN VERB BE, V9, P487, DOI 10.1016/S0022-5371(70)80091-3; Ruthruff E, 2008, PSYCHON B REV, V15, P337, DOI 10.3758/PBR.15.2.337; SCHWEICKERT R, 1978, J MATH PSYCHOL, V18, P105, DOI 10.1016/0022-2496(78)90059-7; SEARS CR, 1995, J EXP PSYCHOL HUMAN, V21, P876, DOI 10.1037/0096-1523.21.4.876; Sebastian-Galles N., 2000, LEXESP BASE DATOS IN; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Sommer W, 2008, LIT STUD, V1, P125, DOI 10.1007/978-0-387-74980-8_5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Telford CW, 1931, J EXP PSYCHOL, V14, P1, DOI 10.1037/h0073262; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Vachon F, 2012, J COGNITIVE NEUROSCI, V24, P611, DOI 10.1162/jocn_a_00149; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; ZIEGLER JC, 1995, J MEM LANG, V34, P567, DOI 10.1006/jmla.1995.1026; Ziegler JC, 2000, PSYCHOL SCI, V11, P234, DOI 10.1111/1467-9280.00247	82	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0199084	10.1371/journal.pone.0199084	http://dx.doi.org/10.1371/journal.pone.0199084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682023	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500001
J	Ren, XW; Xia, JL				Ren, Xiaowei; Xia, Jielai			An algorithm for computing profile likelihood based pointwise confidence intervals for nonlinear dose-response models	PLOS ONE			English	Article								This study was inspired by the need to estimate pointwise confidence intervals (CIs) for a nonlinear dose-response model from a dose-finding clinical trial. Profile likelihood based CI for a nonlinear dose response model is often recommended. However, it is still not commonly used in dose-finding studies because it cannot generally be calculated explicitly. Most previous research has mainly focused on the performance of the profile likelihood based CI method compared with other common approaches. However, there are still no reports on computing profile likelihood based pointwise CIs for an entire dose-response curve. Based on a previous dose-finding trial with binary-response data, this present study proposed to calculate profile likelihood based pointwise CIs by using the bisection method with proper calculation order for doses in the curve plus crude search when the expected response is close to a boundary. The convergence could be improved by applying appropriate starting values for the optimization procedure with straightforward programming techniques. The algorithm worked well in most cases based on the simulation study and it can be applied more generally to other dose-response models, and other type of data like normally distributed response. It would indeed be great to be able to use profile likelihood approaches more routinely when constructing pointwise CIs for nonlinear dose-response models.	[Ren, Xiaowei; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China; [Ren, Xiaowei] Bayer Healthcare Co Ltd, Stat & Data Insights, Beijing, Peoples R China	Air Force Military Medical University; Bayer AG	Xia, JL (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian, Shaanxi, Peoples R China.	jielaixia@yahoo.com						Baayen C, 2015, STAT MED, V34, P3546, DOI 10.1002/sim.6566; Belz RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033432; Brain P, 2014, PHARM STAT, V13, P364, DOI 10.1002/pst.1636; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; Bretz F, 2008, BIOMETRICAL J, V50, P480, DOI 10.1002/bimj.200810438; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Dinse GE, 2011, J AGR BIOL ENVIR ST, V16, P221, DOI 10.1007/s13253-010-0045-3; Efron B., 1994, MONOGRAPHS STAT APPL; Millar RB, 2011, STAT PRACT, P1, DOI 10.1002/9780470094846; Moerbeek M, 2004, RISK ANAL, V24, P31, DOI 10.1111/j.0272-4332.2004.00409.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Peddada Shyamal D., 2005, Dose-Response, V3, P342, DOI 10.2203/dose-response.003.03.005; SAS, 2015, SAS STAT 14 1 US GUI; Ting N., 2006, DOSE FINDING DRUG DE; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; Wicklin R., 2013, SIMULATING DATA SAS	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210953	10.1371/journal.pone.0210953	http://dx.doi.org/10.1371/journal.pone.0210953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682081	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500078
J	Roth, N; Biedermann, L; Fournier, N; Butter, M; Vavricka, SR; Navarini, AA; Rogler, G; Scharl, M				Roth, Nina; Biedermann, Luc; Fournier, Nicolas; Butter, Matthias; Vavricka, Stephan R.; Navarini, Alexander A.; Rogler, Gerhard; Scharl, Michael		Swiss IBD Cohort Study Grp	Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study	PLOS ONE			English	Article							EXTRAINTESTINAL MANIFESTATIONS; CROHNS-DISEASE; PYODERMA-GANGRENOSUM; ERYTHEMA-NODOSUM; ULCERATIVE-COLITIS; SMOKING-CESSATION; CLINICAL-COURSE; COMPLICATIONS; DIAGNOSIS	Background/Aims Extraintestinal cutaneous manifestations of IBD represent a severe disease complication and an early and accurate treatment might positively influence the disease course. Using the patient collective of the Swiss IBD Cohort Study (SIBDCS), we analysed epidemiological as well as clinical factors being associated with the onset of pyoderma gangrenosum, erythema nodosum and aphthous ulcers in IBD patients. Methods We included 3266 SIBDCs patients, 1840 with Crohn's disease (CD) and 1426 with ulcerative colitis (UC) or IBD unclassified (IBDU) and analysed the association of cutaneous manifestations with age, age at diagnosis time, type of disease, gender, family history, HLA-allotype, smoking, intestinal disease activity, therapy and other extraintestinal manifestations (EIM). Results 354 CD patients and 136 UC/IBDU patients presented with skin manifestations at any time during their disease course. In both, CD and UC, female gender and younger age at IBD diagnosis were significantly associated with extraintestinal skin manifestations. For CD, we also detected a positive family history as associated factor. As an indicator of more intensive intestinal disease activity, patients with cutaneous manifestations of IBD needed more frequently therapy with antibiotics, steroids, immunomodulators and anti-TNF. Multivariate analysis revealed female gender, younger age at diagnosis and presence of other extraintestinal manifestations as factors being associated with skin EIM in IBD patients and anti-TNF as well as immunomodulatory treatment in CD patients. Conclusion Our results suggest that young females with a positive family history of IBD might be at increased risk for the onset of skin manifestations and require a careful screening for such complications.	[Roth, Nina; Biedermann, Luc; Butter, Matthias; Vavricka, Stephan R.; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Roth, Nina] Buergerspital Solothurn, Dept Internal Med, Solothurn, Switzerland; [Fournier, Nicolas] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Navarini, Alexander A.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland; [Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland.; Scharl, M (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.	michael.scharl@usz.ch	; Navarini, Alexander/C-5504-2014	Scharl, Michael/0000-0002-6729-1469; Navarini, Alexander/0000-0001-7059-632X	Stiftung Experimentelle Biomedizin; Promedica Foundation; Swiss National Science Foundation [314730_166381, 3347CO-108792]; Promedica & Bruno Bloch Foundation; HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland	Stiftung Experimentelle Biomedizin; Promedica Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Promedica & Bruno Bloch Foundation; HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland	This work was supported by research grants from the Stiftung Experimentelle Biomedizin to MS, the Promedica Foundation to MS, the Swiss National Science Foundation to MS [Grant No. 314730_166381] and to GR for the Swiss IBD Cohort [Grant No. 3347CO-108792], the Promedica & Bruno Bloch Foundation and by the HSM-2 grant "Immunvermittelte Erkrankungen" from the Kanton of Zurich, Switzerland to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampuero J, 2014, J GASTROEN HEPATOL, V29, P291, DOI 10.1111/jgh.12352; Ardizzone S, 2008, DIGEST LIVER DIS, V40, pS253, DOI 10.1016/S1590-8658(08)60534-4; Bastida G, 2011, WORLD J GASTROENTERO, V17, P2740, DOI [10.3748/wjg.v17.i22.2740, 10.3748/wjg.v17.i22.2734]; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; BHAGAT S, 1994, GASTROENTEROLOGY, V107, P103, DOI 10.1016/0016-5085(94)90066-3; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Ciccacci C, 2013, J CROHNS COLITIS, V7, P44, DOI 10.1016/j.crohns.2012.02.020; Cosnes J, 1999, ALIMENT PHARM THERAP, V13, P1403; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Danese S, 2005, WORLD J GASTROENTERO, V11, P7227, DOI 10.3748/wjg.v11.i46.7227; Das KM, 1999, DIGEST DIS SCI, V44, P1, DOI 10.1023/A:1026629528233; Farhi D, 2008, MEDICINE, V87, P281, DOI 10.1097/MD.0b013e318187cc9c; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Gravina AG, 2016, UNITED EUR GASTROENT, V4, P165, DOI 10.1177/2050640615597835; GREENSTEIN AJ, 1976, MEDICINE, V55, P401, DOI 10.1097/00005792-197609000-00004; Greuter T, 2017, CLIN REV ALLERG IMMU, V53, P413, DOI 10.1007/s12016-017-8617-4; Kethu SR, 2006, J CLIN GASTROENTEROL, V40, P467, DOI 10.1097/00004836-200607000-00003; Menachem Y, 2004, ISRAEL MED ASSOC J, V6, P88; Mendoza JL, 2005, MED CLIN-BARCELONA, V125, P297; MONSEN U, 1990, AM J GASTROENTEROL, V85, P711; Nunes T, 2016, AM J GASTROENTEROL, V111, P411, DOI 10.1038/ajg.2015.401; Nunes T, 2013, INFLAMM BOWEL DIS, V19, P23, DOI 10.1002/ibd.22959; Orchard TR, 2002, GASTROENTEROLOGY, V123, P714, DOI 10.1053/gast.2002.35396; Orchard TR, 2000, GASTROENTEROLOGY, V118, P274, DOI 10.1016/S0016-5085(00)70209-5; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; RANKIN GB, 1979, GASTROENTEROLOGY, V77, P914; Ricart E, 2004, INFLAMM BOWEL DIS, V10, P207, DOI 10.1097/00054725-200405000-00005; Rothfuss KS, 2006, WORLD J GASTROENTERO, V12, P4819; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; Su CYG, 2002, GASTROENTEROL CLIN N, V31, P307, DOI 10.1016/S0889-8553(01)00019-X; Trikudanathan G, 2012, DRUGS, V72, P2333, DOI 10.2165/11638120-000000000-00000; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1794, DOI 10.1097/MIB.0000000000000429; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Veloso FT, 2004, ALIMENT PHARM THER, V20, P50, DOI 10.1111/j.1365-2036.2004.02055.x; Veloso FT, 1996, J CLIN GASTROENTEROL, V23, P29, DOI 10.1097/00004836-199607000-00009; Yuksel I, 2009, INFLAMM BOWEL DIS, V15, P546, DOI 10.1002/ibd.20807; Zelinkova Z, 2012, J CROHNS COLITIS, V6, P771, DOI 10.1016/j.crohns.2012.01.002	40	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210436	10.1371/journal.pone.0210436	http://dx.doi.org/10.1371/journal.pone.0210436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682031	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000457037500037
J	Teh, LCL; Caddell, R; Allison, EH; Finkbeiner, EM; Kittinger, JN; Nakamura, K; Ota, Y				Teh, Lydia C. L.; Caddell, Richard; Allison, Edward H.; Finkbeiner, Elena M.; Kittinger, John N.; Nakamura, Katrina; Ota, Yoshitaka			The role of human rights in implementing socially responsible seafood	PLOS ONE			English	Article							STEWARDSHIP COUNCIL CERTIFICATION; MARINE; TRADE; FISH; LAW; CHALLENGES; MANAGEMENT; BUSINESS; LABOR	Sustainability standards for seafood mainly address environmental performance criteria and are less concerned with the welfare of fisheries workers who produce the seafood. Yet human rights violations such as slavery and human trafficking are widespread in fisheries around the world, and underscore the need for certification bodies and other seafood supply chain actors to improve social performance, in addition to addressing environmental challenges. Calls for socially responsible seafood have referenced human rights law and policy frameworks to shape the guiding principles of socially responsible seafood and to provide the legal machinery to implement these aspirations, but practical guidance on how to achieve this is lacking. To provide clarity on this challenge, we reviewed the literature concerning human rights in the seafood supply chain, and prepared an analysis of opportunities and challenges to implement socially responsible seafood through relevant human rights, legal and policy instruments. We observe that human rights laws are generally framed in favour of addressing violations of civil and political rights, but there remains considerable scope for applying economic, social and cultural (ESC) rights in this context. Other challenges include weakly defined ESC rights infringements, a lack of straightforward mechanisms to enforce human rights entitlements, and practical difficulties such as resources to support and secure rights. On the positive side, governments can draw on international instruments to inspire national policies and legislation to eliminate illegalities from the seafood supply chain. However, for socially responsible seafood principles to translate into tangible actions, these objectives must be rooted in clear legal obligations and be supported by sufficient national capacity and political will.	[Teh, Lydia C. L.; Finkbeiner, Elena M.; Ota, Yoshitaka] Nippon Fdn Nereus Program, Vancouver, BC, Canada; [Teh, Lydia C. L.] Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Caddell, Richard] Cardiff Univ, Sch Law & Polit, Cardiff, S Glam, Wales; [Allison, Edward H.; Ota, Yoshitaka] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA; [Allison, Edward H.] WorldFish, CGIAR Res Program Fish, George Town, Malaysia; [Finkbeiner, Elena M.] Stanford Univ, Ctr Ocean Solut, Monterey, CA USA; [Kittinger, John N.] Conservat Int Ctr Oceans, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Ctr Biodivers Outcomes, Julie Ann Wrigley Global Inst Sustainabil, Life Sci Ctr, Tempe, AZ USA; [Kittinger, John N.] Betty & Gordon Moore Ctr Sci, Conservat Int, Arlington, VA USA; [Nakamura, Katrina] Sustainability Incubator, Honolulu, HI USA	University of British Columbia; Cardiff University; University of Washington; University of Washington Seattle; CGIAR; Worldfish; Stanford University; Arizona State University; Arizona State University-Tempe; Conservation International	Teh, LCL (corresponding author), Nippon Fdn Nereus Program, Vancouver, BC, Canada.; Teh, LCL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Vancouver, BC, Canada.	lydia.teh@oceans.ubc.ca	Allison, Edward Hugh/B-8615-2009		Nippon Foundation Nereus Program; Nippon Foundation; WorldFish	Nippon Foundation Nereus Program; Nippon Foundation(Nippon Foundation); WorldFish(CGIAR)	This study is a product of the Nippon Foundation Nereus Program, a collaborative initiative by the Nippon Foundation and partners including The University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto JA, 2017, AQUAT CONSERV, V27, P353, DOI 10.1002/aqc.2665; Acciaioli G, 2017, J IMMIGR REFUG STUD, V15, P232, DOI 10.1080/15562948.2017.1319526; Allain J, 2010, HUM RIGHTS LAW REV, V10, P546, DOI 10.1093/hrlr/ngq025; Allison EH, 2012, FISH FISH, V13, P14, DOI 10.1111/j.1467-2979.2011.00405.x; Amnesty International, 2014, HUM RIGHTS HUM DIGN; Anderson, 2005, SEAFARERS RIGHTS; [Anonymous], 2018, ILO NEWS        0717; [Anonymous], 2015, ODU MAGAZINE    1119; [Anonymous], 2018, AL JAZEERA NEWS 0328; [Anonymous], BUSINESS COMMITMENTS; Banks S., 2014, REV MARINE STEWARDSH; Bennett NJ, 2015, MAR POLICY, V57, P61, DOI 10.1016/j.marpol.2015.03.026; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Blackstock S, 2014, ECOLOGICAL BENEFITS; Boserup Ester., 2013, WOMANS ROLE EC DEV; Burton J., 2011, GUARDIAN; Caddell R, 2015, NETH YEARB INT LAW S, V45, P359, DOI 10.1007/978-94-6265-060-2_14; Capture Fisheries Standard, FAIR TRAD CERT; Carrell Severin, 2018, GUARDIAN; CEA, 2017, PROGR SUST SEAF NUMB; Charles A, 2013, LAND TENURE J; Choo P, 2006, GLOB S GEND FISH PEN, P174; Choudhury B, 2018, INT COMP LAW Q, V67, P961, DOI 10.1017/S0020589318000155; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Conklin WE, 2012, EUR J INT LAW, V23, P837, DOI 10.1093/ejil/chs048; Conservation Alliance for Seafood Solutions, COMM VIS SUST SEAF; Couper A, 2015, FISHERS PLUNDERERS; Crona BI, 2016, MAR POLICY, V65, P1, DOI 10.1016/j.marpol.2015.11.016; Delaney A., 2017, SMALL SCALE FISHERIE, P313, DOI [10.1007/978-3-319-55074-9_15, DOI 10.1007/978-3-319-55074-9_15, 10.1007/978-3-319-55074-9_12]; Delgado-Gustavson V, 2011, FISHING COMMUNITIES; Engelhardt M. von, 2009, Verfassung und Recht in Ubersee, V42, P502; Fabinyi M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00181; Fabinyi M, 2017, HUM ECOL, V45, P177, DOI 10.1007/s10745-016-9874-1; FAO, 2015, VOL GUID SEC SUST SM; FAO-ILO, 2011, GOOD PRACT GUID ADDR; *FRAM SOC RESP SEA, 2018, FRAM SOC RESP SEAF S; Frey J, 2014, INT J COMMONS, V8, DOI [10.1835/IJC.408, DOI 10.1835/IJC.408]; Frocklin S, 2013, AMBIO, V42, P951, DOI 10.1007/s13280-013-0451-1; Froese R, 2012, MAR POLICY, V36, P1284, DOI 10.1016/j.marpol.2012.03.017; Gaymer CF, 2014, AQUAT CONSERV, V24, P128, DOI 10.1002/aqc.2508; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gjana E, 2016, CIVIL POLITICAL RIGH; Graham T, 1998, OCEAN COAST MANAGE, V40, P143, DOI 10.1016/S0964-5691(98)00045-3; Grobler J, 2011, SPAINS HAKE APPETITE; Guilfoyle D, 2009, CAMB STUD INT COMP, P1, DOI 10.1017/CBO9780511596636; Gutierrez AT, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00072; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Harre T., 2013, THESIS; Harrison J., 2017, SAVING OCEANS LAW IN; Human Rights Watch, 2010, TURN CRIT CRIM HUM R, P16; ILAB, 2017, TOOL KIT RESP BUS; ILO, 2013, CAUGHT SEA FORC LAB, P85; IOM, 2011, TRAFF FISH THAIL; IOM, 2015, SUPP TRAFF CHILDR GH; Isaacs M., 2011, MARIT STUD, V10, P63; ITF, 2006, OUT SIGHT OUT MIND S; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Jentoft S, 2014, MARIT STUD, V13, DOI 10.1186/s40152-014-0016-3; Johnston B, 2006, EC MARKETING LIVE RE; Khadaroo ST, 2016, CHRISTIAN SCI MONITO; Khaliq U, 2015, JURISDICTION SHIPS P; Khaliq U., 2015, JURISDICTION SHIPS H; Kittinger JN, 2017, SCIENCE, V356, P912, DOI 10.1126/science.aam9969; Leach M, ENV ENTITLEMENTS FRA; Lewis SG, 2017, CONSERVATION FOR THE ANTHROPOCENE OCEAN: INTERDISCIPLINARY SCIENCE IN SUPPORT OF NATURE AND PEOPLE, P379, DOI 10.1016/B978-0-12-805375-1.00018-0; Macfarlane D, 2017, ASIAN J INT LAW, V7, P94, DOI 10.1017/S2044251315000235; Marschke M, 2016, MAR POLICY, V68, P39, DOI 10.1016/j.marpol.2016.02.009; Marschke M, 2014, MAR POLICY, V50, P197, DOI 10.1016/j.marpol.2014.06.010; Martin SM, 2012, REV FISH SCI, V20, P61, DOI 10.1080/10641262.2011.654287; McSweeney E, 2017, GUARDIAN; Nakamura K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701833; Opal C, 2017, IMPROVING SOCIAL PER; Orakhelashvili A, 2006, PEREMPTORY NORMS INT; Osterblom H, 2017, P NATL ACAD SCI USA, V114, P9038, DOI 10.1073/pnas.1704453114; Papanicolopulu Irini, 2018, INT LAW PROTECTION P; Pearson E., 2006, MEKONG CHALLENGE UND; Petursdottir G., 2001, SAFETY SEA INTEGRAL; Pocock NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168500; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Potts J., 2016, STATE SUSTAINABILITY; Purcell SW, 2018, ICES J MAR SCI, V75, P1758, DOI 10.1093/icesjms/fsy036; Rajagopalan R., 2013, LAND TENURE J; Ratner BD, 2014, GLOBAL ENVIRON CHANG, V27, P120, DOI 10.1016/j.gloenvcha.2014.05.006; Ratner BD, 2012, J ENVIRON MANAGE, V107, P131, DOI 10.1016/j.jenvman.2012.04.014; Ribot JC, 2003, RURAL SOCIOL, V68, P153, DOI 10.1111/j.1549-0831.2003.tb00133.x; Sampson GS, 2015, SCIENCE, V348, P504, DOI 10.1126/science.aaa4639; Sarriegi J. M., 2012, WORLD DEV, V1, P31; SEAFDEC, 2018, DEV REG APPR SEC SUS; Sharma C, 2011, SECURING EC SOCIAL C, P21; Simmons G, 2014, MAR POLICY, V50, P74, DOI 10.1016/j.marpol.2014.05.013; Stratoudakis Y, 2016, FISH RES, V182, P39, DOI 10.1016/j.fishres.2015.08.021; Stringer C, 2014, FISHERIES CRIME LINK; Suarez SM, 2013, J PEASANT STUD, V40, P239, DOI 10.1080/03066150.2011.652950; Sutton T, SEAFOOD SLAVERY; Taylor PL, 2005, WORLD DEV, V33, P129, DOI 10.1016/j.worlddev.2004.07.007; Teh LSL, 2015, OCEAN COAST MANAGE, V116, P449, DOI 10.1016/j.ocecoaman.2015.08.019; Teh LCL, 2012, HUM ECOL, V40, P213, DOI 10.1007/s10745-012-9464-9; Tickler D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07118-9; United Nations, SUST DEV GOALS; UNODC, 2011, TRANSN ORG CRIM FISH, P140; UNSC United Nations Security Council., 2019, GUIDING PRINCIPLES S; Urbina I., 2015, NY TIMES	104	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210241	10.1371/journal.pone.0210241	http://dx.doi.org/10.1371/journal.pone.0210241			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682056	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000457037500030
J	Weinberg, EO; Ferran, B; Tsukahara, Y; Hatch, MMS; Han, JY; Murdoch, CE; Matsui, R				Weinberg, Ellen O.; Ferran, Beatriz; Tsukahara, Yuko; Hatch, Michaela M. S.; Han, Jingyan; Murdoch, Colin E.; Matsui, Reiko			IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages	PLOS ONE			English	Article							NF-KAPPA-B; S-GLUTATHIONYLATION; LUNG INFLAMMATION; CYTOKINE IL-33; INTERLEUKIN-33; RECEPTOR; GENE; EXPRESSION; POLARIZATION; ACTIVATION	Interleukin (IL)-33 is an interleukin-1 like cytokine that enhances Th2 responses and mediates mucosal immunity and allergic inflammation but the mechanism regulating endogenous IL-33 production are still under investigation. In macrophages, lipopolysaccharide (LPS) administration resulted in marked induction of IL-33 mRNA that was blunted in macrophages from glutaredoxin-1 (Glrx) knockout mice and in RAW264.7 macrophages with Glrx knockdown by siRNA. Glutaredoxin-1 is a small cytosolic thioltransferase that controls a reversible protein thiol modification, S-glutationylation (protein-GSH adducts), thereby regulating redox signaling. In this study, we examined the mechanism of Glrx regulation of endogenous IL-33 induction in macrophages. Glrx knockdown resulted in impaired de-glutathionylation of TRAF6, which is required for TRAF6 activation, and inhibited downstream IKK beta and NF-kappa B activation. Inhibitors of NF-kappa B suppressed IL-33 induction and chromatin IP sequencing data analysis confirmed that IL-33 is an NF-kappa B-responsive gene. Since TRAF6-NF-kappa B activation is also essential for IL-33 signaling through its receptor, ST2L, we next tested the involvement of Glrx in exogenous IL-33 responses in RAW264.7 cells. Recombinant IL-33 (rIL-33) administration induced IL-33 mRNA expression in RAW264.7 macrophages, and this was inhibited by Glrx knockdown. Interestingly, rIL-33-induced IL-33 protein was identified as the 20 kDa cleaved form whereas LPS-induced IL-33 protein was identified as full-length IL-33, which may be less active than the cleaved form. In a clinically-relevant mouse model of asthma, intra-tracheal cockroach antigen treatment induced Glrx protein in wild type mouse lungs but Glrx induction was attenuated in IL-33 knockout mouse lungs, suggesting that IL-33 may regulate Glrx induction in vivo in response to allergen challenge. In summary, our data reveal a novel mechanism by which Glrx controls both LPS-and IL-33-mediated NF-kappa B activation leading to IL-33 production, and paracrine IL-33 can induce Glrx to further regulate inflammatory reactions.	[Weinberg, Ellen O.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Ferran, Beatriz; Tsukahara, Yuko; Hatch, Michaela M. S.; Han, Jingyan; Murdoch, Colin E.; Matsui, Reiko] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA; [Weinberg, Ellen O.] Tufts Univ, Sch Med, Dept Immunol, Boston, MA 02111 USA; [Hatch, Michaela M. S.] Univ Calif Irvine, Mol Biol & Biochem, Irvine, CA USA; [Murdoch, Colin E.] Univ Dundee, Sch Med, Med Syst, Dundee, Scotland	Boston University; Boston University; Tufts University; University of California System; University of California Irvine; University of Dundee	Matsui, R (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA.	rmatsui@bu.edu	; Murdoch, Colin/J-9798-2016	Weinberg, Ellen/0000-0002-6937-0371; Murdoch, Colin/0000-0002-0274-819X	NIH [R03 AI 090404, R01 HL133013];  [R03 AG051857]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL133013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS108724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG051857] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by NIH R03 AI 090404 (EOW), NIH R01 HL133013 (RM) and R03 AG051857 (RM).	Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Aesif SW, 2011, AM J RESP CELL MOL, V44, P491, DOI 10.1165/rcmb.2009-0136OC; Aizawa H, 2018, RESP RES, V19, P1, DOI [10.1186/s12931-017-0698-3, DOI 10.1186/S12931-017-0698-3, 10.1186/s12931-018-0752-9, DOI 10.1186/S12931-018-0752-9]; Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Carter RW, 2001, EUR J IMMUNOL, V31, P2979, DOI 10.1002/1521-4141(2001010)31:10<2979::AID-IMMU2979>3.0.CO;2-B; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chantzoura E, 2010, BIOCHEM BIOPH RES CO, V403, P335, DOI 10.1016/j.bbrc.2010.11.029; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cohen ES, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9327; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gautier V, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Hazlett LD, 2010, INVEST OPHTH VIS SCI, V51, P1524, DOI 10.1167/iovs.09-3983; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; Hiraide S, 2018, EUR J PHARMACOL, V818, P235, DOI 10.1016/j.ejphar.2017.10.057; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Hoffman SM, 2016, AM J RESP CELL MOL, V55, P377, DOI 10.1165/rcmb.2015-0401OC; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Kuipers I, 2011, AM J RESP CELL MOL, V45, P931, DOI 10.1165/rcmb.2010-0249OC; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Murdoch CE, 2014, BIOCHEM SOC T, V42, P1665, DOI 10.1042/BST20140213; Murdoch CE, 2014, J BIOL CHEM, V289, P8633, DOI 10.1074/jbc.M113.517219; Nile CJ, 2010, IMMUNOLOGY, V130, P172, DOI 10.1111/j.1365-2567.2009.03221.x; Oboki K, 2011, ALLERGY ASTHMA IMMUN, V3, P81, DOI 10.4168/aair.2011.3.2.81; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Park JB, 1997, GENE, V197, P189, DOI 10.1016/S0378-1119(97)00262-X; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shelton MD, 2008, MOL CELLS, V25, P332; Sjoberg LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03674-0; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tashiro H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157571; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210827	10.1371/journal.pone.0210827	http://dx.doi.org/10.1371/journal.pone.0210827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682073	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500066
J	Yu, JT; Liu, Y; Dong, P; Cheng, RE; Ke, SX; Chen, KQ; Wang, JJ; Shen, ZS; Tang, QY; Zhang, Z				Yu, Jia-Tian; Liu, Ye; Dong, Ping; Cheng, Run-En; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe			Up-regulation of antioxidative proteins TRX1, TXNL1 and TXNRD1 in the cortex of PTZ kindling seizure model mice	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; THIOL REDOX STATE; OXIDATIVE STRESS; THIOREDOXIN; EPILEPSY; PENTYLENETETRAZOL; INVOLVEMENT; GLUTATHIONE	Oxidative stress has been considered as one of pathogenesis of brain damage led by epilepsy. Reducing oxidative stress can ameliorate brain damage during seizures. However, expression levels of important antioxidative enzymes such as thioredoxin-1 (TRX1), thioredoxin-like 1 protein (TXNL1) and thioredoxin reductase 1 (TXNRD1) during seizures have not been investigated. In this study, we examined protein and mRNA expression levels of TRX1, TXNL1 and TXNRD1 in different brain regions in PTZ induced seizure model mice. We found that protein expression levels of TRX1, TXNL1 and TXNRD1 are simultaneously up-regulated by 2- or 3-fold in the cortex of both acute and chronic seizure model mice. But there is no unified expression pattern change of these enzymes in the hippocampus, cerebellum and diencephalon in the seizure model mice. Less extent up-regulation of mRNA expression of these enzymes were also observed in the cortex of seizure mice. These data suggest that antioxidative enzymes may provide a protective effect against oxidative stress in the cortex during seizures.	[Liu, Ye; Dong, Ping; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Liu, Ye; Dong, Ping; Ke, Shao-Xi; Chen, Kai-Qin; Wang, Jing-Jing; Shen, Zhong-Shan; Tang, Qiong-Yao; Zhang, Zhe] Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China; [Yu, Jia-Tian] Xuzhou Med Univ, Coll Biomed Sci, Dept Anat, Xuzhou, Jiangsu, Peoples R China; [Cheng, Run-En] Xuzhou Med Univ, Sch Clin Med, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Tang, QY; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; Tang, QY; Zhang, Z (corresponding author), Xuzhou Med Univ, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou, Jiangsu, Peoples R China.	Qiongyaotang@hotmail.com; Zhangzhe70@xzhmu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022; wang, jing/GRS-7509-2022; Zhang, Zhe/C-5068-2011	Zhang, Zhe/0000-0001-7295-6894	Natural Science Foundation of China (NSFC) [81471314, 81671090]; Natural Science Foundation of Jiangsu Province [BK20151170]; Xuzhou Science and Technology Program [KC16H0230, 16631635]; NSFC [31671212]; General Project of Natural Science in College and University in Jiangsu Province [14KJB180023]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Xuzhou Science and Technology Program; NSFC(National Natural Science Foundation of China (NSFC)); General Project of Natural Science in College and University in Jiangsu Province	This work was supported by Natural Science Foundation of China (NSFC) grant to Z.Z. (81471314, 81671090), Natural Science Foundation of Jiangsu Province to Z.Z (BK20151170). Xuzhou Science and Technology Program (16631635) to Z.Z. NSFC grant to Q.-Y.T. (31671212), Xuzhou Science and Technology Program to Q.-Y.T (KC16H0230). The General Project of Natural Science in College and University in Jiangsu Province to J.T Yu (14KJB180023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Booze ML, 2016, FREE RADICAL BIO MED, V99, P533, DOI 10.1016/j.freeradbiomed.2016.09.013; Brown JD, 2013, CELL REP, V5, P1425, DOI 10.1016/j.celrep.2013.10.036; Emoto MC, 2017, BIOCHEM BIOPH RES CO, V485, P802, DOI 10.1016/j.bbrc.2017.02.134; Emoto MC, 2015, NEUROSCI LETT, V608, P40, DOI 10.1016/j.neulet.2015.10.008; Ercegovac M, 2010, SEIZURE-EUR J EPILEP, V19, P205, DOI 10.1016/j.seizure.2010.02.002; Gataullina S, 2015, DEV MED CHILD NEUROL, V57, P194, DOI 10.1111/dmcn.12574; Ishii T, 2013, J BIOL CHEM, V288, P7263, DOI 10.1074/jbc.M112.418004; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Kaas GA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0221-16.2016; Lin YT, 2010, CELL MOL NEUROBIOL, V30, P947, DOI 10.1007/s10571-010-9524-x; Liu ZH, 2013, NEURAL REGEN RES, V8, P3275, DOI 10.3969/j.issn.1673-5374.2013.35.002; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Mendez-Armenta M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/293689; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Patsoukis N, 2005, EPILEPSIA, V46, P1205, DOI 10.1111/j.1528-1167.2005.63704.x; Patsoukis N, 2004, EPILEPSY RES, V62, P65, DOI 10.1016/j.eplepsyres.2004.08.005; Rauca C, 2004, BRAIN RES, V1009, P203, DOI 10.1016/j.brainres.2004.01.082; Ren XY, 2017, ANTIOXID REDOX SIGN, V27, P989, DOI 10.1089/ars.2016.6925; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Shin EJ, 2008, NEUROCHEM INT, V52, P1134, DOI 10.1016/j.neuint.2007.12.003; Shin EJ, 2015, FREE RADICAL BIO MED, V84, P355, DOI 10.1016/j.freeradbiomed.2015.03.031; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Tang QY, 2016, CELL REP, V14, P129, DOI 10.1016/j.celrep.2015.12.019; Tinkov AA, 2018, CELL MOL LIFE SCI, V75, P1567, DOI 10.1007/s00018-018-2745-8; Ueda Y, 2007, EXP BRAIN RES, V181, P571, DOI 10.1007/s00221-007-0954-8; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Zhu XJ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00377; Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9	29	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210670	10.1371/journal.pone.0210670	http://dx.doi.org/10.1371/journal.pone.0210670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677045	Green Submitted, gold, Green Published			2022-12-27	WOS:000456700400024
J	Cantu-Iris, M; Pastor-Palacios, G; Mauricio-Castillo, JA; Banuelos-Hernandez, B; Avalos-Calleros, JA; Juarez-Reyes, A; Rivera-Bustamante, R; Arguello-Astorga, GR				Cantu-Iris, Mariana; Pastor-Palacios, Guillermo; Armando Mauricio-Castillo, Jorge; Banuelos-Hernandez, Bernardo; Aaron Avalos-Calleros, Jesus; Juarez-Reyes, Alejandro; Rivera-Bustamante, Rafael; Arguello-Astorga, Gerardo R.			Analysis of a new begomovirus unveils a composite element conserved in the CP gene promoters of several Geminiviridae genera: Clues to comprehend the complex regulation of late genes	PLOS ONE			English	Article							COAT PROTEIN PROMOTER; CURLY TOP VIRUS; SINGLE-STRANDED-DNA; 1ST REPORT; TOMATO; SEQUENCE; IDENTIFICATION; ACTIVATION; EXPRESSION; AC2	A novel bipartite begomovirus, Blechum interveinal chlorosis virus (BIeICV), was characterized at the genome level. Comparative analyses revealed that BIeICV coat protein (CP) gene promoter is highly divergent from the equivalent region of other begomoviruses (BGVs), with the single exception of Tomato chino La Paz virus (ToChLPV) with which it shares a 23-bp phylogenetic footprint exhibiting dyad symmetry. Systematic examination of the homologous CP promoter segment of 132 New World BGVs revealed the existence of a quasi-palindromic DNA segment displaying a strongly conserved ACTT-(N7)-AAGT core. The spacer sequence between the palindromic motifs is constant in length, but its sequence is highly variable among viral species, presenting a relaxed consensus (TT)GGKCCCY, which is similar to the Conserved Late Element or CLE (GTGGTCCC), a putative TrAP-responsive element. The homologous CP promoter region of Old World BGVs exhibited a distinct organization, with the putative TATA-box overlapping the left half of the ACTT-N7 composite element. Similar CP promoter sequences, dubbed "TATA-associated composite element" or TACE, were found in viruses belonging to different Geminiviridae genera, hence hinting unsuspected evolutionary relationships among those lineages. To get cues about the TACE function, the regulatory function of the CLE was explored in distinct experimental systems. Transgenic tobacco plants harboring a GUS reporter gene driven by a promoter composed by CLE multimers expressed high beta-glucuronidase activity in absence of viral factors, and that expression was increased by begomovirus infection. On the other hand, the TrAP-responsiveness of a truncated CP promoter of Tomato golden mosaic virus (TGMV) was abolished by site-directed mutation of the only CLE present in it, whereas the artificial addition of one CLE to the -125 truncated promoter strongly enhanced the transactivation level in tobacco protoplasts. These results indicate that the CLE is a TrAP-responsive element, hence providing valuable clues to interpret the recurrent association of the CLE with the TACE. On the basis of the aforesaid direct evidences and the insights afforded by the extensive comparative analysis of BIeICV CP promoter, we propose that the TACE might be involved in the TrAP-mediated derepression of CP gene in vascular tissues.	[Cantu-Iris, Mariana; Aaron Avalos-Calleros, Jesus; Juarez-Reyes, Alejandro; Arguello-Astorga, Gerardo R.] Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, San Luis Potosi, SLP, Mexico; [Pastor-Palacios, Guillermo] CONACYT CIIDZA Inst Potosino Invest Cient & Tecno, San Luis Potosi, SLP, Mexico; [Armando Mauricio-Castillo, Jorge] Univ Autonoma Zacatecas, Unidad Acad Agron, Cieneguillas, Zacatecas, Mexico; [Banuelos-Hernandez, Bernardo] Univ La Salle Bajio, Fac Agron & Vet, Ave Univ 602, Lomas Del Campestre, Leon Guanajuato, Mexico; [Rivera-Bustamante, Rafael] IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Irapuato, Gto, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma de Zacatecas; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Arguello-Astorga, GR (corresponding author), Inst Potosino Invest Cient & Tecnol AC, Div Biol Mol, San Luis Potosi, SLP, Mexico.	grarguel@ipicyt.edu.mx	Rivera-Bustamante, Rafael F./AAL-8009-2020; Rivera-Bustamante, Rafael Francisco/CBN-8680-2022; Bañuelos-Hernández, Bernardo/P-8851-2019	Rivera-Bustamante, Rafael F./0000-0002-5114-2370; Rivera-Bustamante, Rafael Francisco/0000-0002-5114-2370; Bañuelos-Hernández, Bernardo/0000-0003-4399-0887; JUAREZ REYES, ALEJANDRO/0000-0002-9732-3345; Arguello-Astorga, Gerardo R./0000-0003-1901-7761; Pastor-Palacios, Guillermo/0000-0003-4273-2851	Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico [SEP-CB-2015-257136]; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)	Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Mexico (URL-https://www.conacyt.gob.mx/). Grant SEP-CB-2015-257136 to GRAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank to Dr. Roberto Ruiz-Medrano, Dr. Jose Trinidad Ascencio-Ibanez and MSc. Nadia Martinez-Marrero, for critical reading of the manuscript and thoughtful comments and suggestions. MCI and AAC were supported by a fellowship from the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico).	Al Rwahnih M, 2017, PHYTOPATHOLOGY, V107, P240, DOI 10.1094/PHYTO-07-16-0282-R; ARGUELLOASTORGA G, 1994, PLANT MOL BIOL, V26, P553, DOI 10.1007/BF00013742; ArguelloAstorga GR, 1996, PLANT PHYSIOL, V112, P1151, DOI 10.1104/pp.112.3.1151; ARGUELLOASTORGA GR, 1994, VIROLOGY, V203, P90, DOI 10.1006/viro.1994.1458; Babu KSD, 2018, BIOINFORMATION, V14, P294, DOI 10.6026/97320630014294; Borah BK, 2016, VIROLOGY, V495, P101, DOI 10.1016/j.virol.2016.04.033; Briddon RW, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-97; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Briddon RW, 1996, VIROLOGY, V219, P387, DOI 10.1006/viro.1996.0264; BROUGH CL, 1992, VIROLOGY, V187, P1, DOI 10.1016/0042-6822(92)90289-2; Brown JK, 2015, ARCH VIROL, V160, P1593, DOI 10.1007/s00705-015-2398-y; Cazzonelli CI, 2005, PLANT MOL BIOL, V58, P465, DOI 10.1007/s11103-005-6589-x; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fondong VN, 2013, MOL PLANT PATHOL, V14, P635, DOI 10.1111/mpp.12032; Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006; Gregorio-Jorge J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-275; GUMUCIO DL, 1992, MOL CELL BIOL, V12, P4919, DOI 10.1128/MCB.12.11.4919; HALEY A, 1992, VIROLOGY, V188, P905, DOI 10.1016/0042-6822(92)90551-Y; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Hartitz MD, 1999, VIROLOGY, V263, P1, DOI 10.1006/viro.1999.9925; Hernandez C, 2010, PLANT DIS, V94, P917, DOI 10.1094/PDIS-94-7-0917B; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jeske H., TT VIRUSES 2009, P185; Klute KA, 1996, J GEN VIROL, V77, P1369, DOI 10.1099/0022-1317-77-7-1369; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lacatus G, 2008, VIROLOGY, V376, P79, DOI 10.1016/j.virol.2008.03.012; Lacatus G, 2009, VIROLOGY, V392, P196, DOI 10.1016/j.virol.2009.07.004; Lefeuvre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019193; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liang PB, 2015, J GEN VIROL, V96, P2411, DOI 10.1099/vir.0.000173; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; Liu L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0302-7; Loconsole G, 2012, VIROLOGY, V432, P162, DOI 10.1016/j.virol.2012.06.005; Ma YX, 2015, J GEN VIROL, V96, P2421, DOI 10.1099/vir.0.000175; Macedo MA, 2018, ARCH VIROL, V163, P737, DOI 10.1007/s00705-017-3662-0; Martinez-Hernandez A, 2002, PLANT PHYSIOL, V128, P1223, DOI 10.1104/pp.010678; Mauricio-Castillo JA, 2007, PLANT DIS, V91, P1513, DOI 10.1094/PDIS-91-11-1513B; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Rojas MR, 2005, ANNU REV PHYTOPATHOL, V43, P361, DOI 10.1146/annurev.phyto.43.040204.135939; Ruiz-Medrano R, 1999, VIROLOGY, V253, P162, DOI 10.1006/viro.1998.9484; SAUNDERS K, 1995, J GEN VIROL, V76, P2287, DOI 10.1099/0022-1317-76-9-2287; Shimada-Beltran H, 2007, J GEN VIROL, V88, P3145, DOI 10.1099/vir.0.83003-0; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Soitamo AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-204; Sung YK, 1996, FEBS LETT, V383, P51, DOI 10.1016/0014-5793(96)00217-7; SUNTER G, 1994, VIROLOGY, V203, P203, DOI 10.1006/viro.1994.1477; Sunter G, 1997, VIROLOGY, V232, P269, DOI 10.1006/viro.1997.8549; Sunter G, 2003, VIROLOGY, V305, P452, DOI 10.1006/viro.2002.1757; SUNTER G, 1992, PLANT CELL, V4, P1321, DOI 10.1105/tpc.4.10.1321; Medina CGV, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02665; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Varsani A, 2017, ARCH VIROL, V162, P1819, DOI 10.1007/s00705-017-3268-6; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Zerbini FM, 2017, J GEN VIROL, V98, P131, DOI 10.1099/jgv.0.000738	60	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210485	10.1371/journal.pone.0210485	http://dx.doi.org/10.1371/journal.pone.0210485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673741	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800044
J	Wood, N; McMunn, A; Webb, E; Stafford, M				Wood, Natasha; McMunn, Anne; Webb, Elizabeth; Stafford, Mai			Marriage and physical capability at mid to later life in England and the USA	PLOS ONE			English	Article							MARITAL-STATUS; SOCIAL-RELATIONS; GRIP STRENGTH; DISABILITY ONSET; OLDER EUROPEANS; COHORT PROFILE; UNITED-STATES; HEALTH; MEN; RISK	Background Married people have lower rates of mortality and report better physical and mental health at older ages, compared to their unmarried counterparts. However, there is limited evidence on the association between marriage and physical capability, the ability to carry out the tasks of daily living, which is predictive of future mortality and social care use. We investigate the association between marital status and physical capability at mid to later life in England and the United States. Methods We examine the association between marriage and physical capability at mid to later life in England and the USA using two performance-based measures of physical capability: grip strength and walking speed. Multiple linear regression was carried out on Wave 4 (2008) of the English Longitudinal Study of Ageing (ELSA) and Waves 8 and 9 (2006 and 2008) of the US Health and Retirement Study (HRS). Results In age adjusted models married men and women had better physical capability than their unmarried counterparts. Much of the marriage advantage was explained by the greater wealth of married people. However, remarried men were found to have stronger grip strength and widowed and never married men had a slower walking speed than men in their first marriage, which was not explained by wealth, demographic and socioeconomic characteristics, health behaviours, chronic disease or depressive symptoms. There were no differences in the association between England and the USA. Conclusions Marriage may be an important factor in maintaining physical capability in both England and the USA, particularly because of the greater wealth which married people have accrued by the time they reach older ages. The grip strength advantage for remarried men may be due to unobserved selective factors into remarriage.	[Wood, Natasha] UCL Inst Educ, CLOSER, London, England; [McMunn, Anne; Webb, Elizabeth] UCL, Dept Epidemiol & Publ Hlth, London, England; [Stafford, Mai] Hlth Fdn, London, England	University of London; University College London; UCL Institute of Education; University of London; University College London	Wood, N (corresponding author), UCL Inst Educ, CLOSER, London, England.	natasha.wood.12@ucl.ac.uk		McMunn, Anne/0000-0003-3237-9345	Economic and Social Research Council [ES/J500185/1]; ESRC [ES/R008930/1] Funding Source: UKRI; MRC [MC_UU_12019/5] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Economic and Social Research Council, grant number ES/J500185/1 (https://esrc.ukri.org/) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Avlund K, 2004, ARCH GERONTOL GERIAT, V38, P85, DOI 10.1016/j.archger.2003.08.003; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Banks J, 2012, J EPIDEMIOL COMMUN H, V66, P259, DOI 10.1136/jech.2010.108415; Blekesaune M, 2005, EUR SOCIOL REV, V21, P259, DOI 10.1093/esr/jci016; Brewer M., 2014, PARTNERSHIP DISSOLUT; Brunner E, 2009, J GERONTOL A-BIOL, V64, P1082, DOI 10.1093/gerona/glp078; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Cawthon PM, 2009, J AM GERIATR SOC, V57, P1411, DOI 10.1111/j.1532-5415.2009.02366.x; Cherlin AJ, 2005, FUTURE CHILD, V15, P33, DOI 10.1353/foc.2005.0015; Clarke P, 2011, J GERONTOL B-PSYCHOL, V66, P457, DOI 10.1093/geronb/gbr054; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Clouston SAP, 2014, CAN J AGING, V33, P413, DOI 10.1017/S0714980814000282; COOPER R, 2010, BRIT MED J, V341; Cooper R., 2013, LIFE COURSE APPROACH; Cooper R., 2011, PLOS ONE, V6; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Fuhrer R, 2002, SOC SCI MED, V54, P811, DOI 10.1016/S0277-9536(01)00111-3; Gjonca E, 2009, J EPIDEMIOL COMMUN H, V63, P928, DOI 10.1136/jech.2008.082776; GOLDMAN N, 1995, SOC SCI MED, V40, P1717, DOI 10.1016/0277-9536(94)00281-W; Guralnik JM, 2009, AGING CLIN EXP RES, V21, P174; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307; Hurst L, 2013, AM J PUBLIC HEALTH, V103, P1641, DOI 10.2105/AJPH.2013.301240; Jarvis S, 1999, POP STUD-J DEMOG, V53, P237, DOI 10.1080/00324720308077; KIERNAN KE, 1988, J BIOSOC SCI, V20, P253, DOI 10.1017/S0021932000006593; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2007, J GERONTOL A-BIOL, V62, P717, DOI 10.1093/gerona/62.7.717; Lin IF, 2012, GERONTOLOGIST, V52, P153, DOI 10.1093/geront/gnr141; Litwin H, 2013, EUR J AGEING, V10, P159, DOI 10.1007/s10433-013-0269-5; Lund R, 2010, AGE AGEING, V39, P319, DOI 10.1093/ageing/afq020; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Monden CWS, 2013, EUR J POPUL, V29, P103, DOI 10.1007/s10680-012-9269-y; ONS. Office for National Statistic, 2014, MARR DIV STAT 2012; Pienta AM, 2000, J FAM ISSUES, V21, P559, DOI 10.1177/019251300021005003; Ploubidis GB, 2015, AM J PUBLIC HEALTH, pe1; Raley R. Kelly, 2009, RACE SOC PROBL, V1, P132, DOI DOI 10.1007/S12552-009-9013-3; Rapp I, 2012, KOLNER Z SOZIOL SOZ, V64, P783, DOI 10.1007/s11577-012-0184-3; Rastegar A., 2011, RAND HRS DATA DOCUME; Schane RE, 2008, J GEN INTERN MED, V23, P1757, DOI 10.1007/s11606-008-0749-z; Schneider D, 2011, AM J SOCIOL, V117, P627, DOI 10.1086/661594; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Stansfeld, 2006, SOCIAL DETERMINANTS; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Syddall H, 2009, J AGING HEALTH, V21, P913, DOI 10.1177/0898264309340793; van den Brink CL, 2004, J AM GERIATR SOC, V52, P353, DOI 10.1111/j.1532-5415.2004.52105.x; Vespa J, 2011, DEMOGRAPHY, V48, P983, DOI 10.1007/s13524-011-0043-2; Wahrendorf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071893; Waite LJ., 2001, CASE MARRIAGE WHY MA; Williams K, 2004, J HEALTH SOC BEHAV, V45, P81, DOI 10.1177/002214650404500106; Wilmoth J, 2002, J MARRIAGE FAM, V64, P254, DOI 10.1111/j.1741-3737.2002.00254.x; Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402	57	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209388	10.1371/journal.pone.0209388	http://dx.doi.org/10.1371/journal.pone.0209388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673714	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800017
J	Escobar-Flores, JG; Sandoval, S; Valdez, R; Shahriary, E; Torres, J; Alvarez-Cardenas, S; Gallina-Tessaro, P				Gabriel Escobar-Flores, Jonathan; Sandoval, Sarahi; Valdez, Raul; Shahriary, Eahsan; Torres, Jorge; Alvarez-Cardenas, Sergio; Gallina-Tessaro, Patricia			Waterhole detection using a vegetation index in desert bighorn sheep (Ovis canadensis cremnobates) habitat	PLOS ONE			English	Article							BAJA-CALIFORNIA; WILDLIFE; ENVIRONMENTS; POPULATION; CLIMATE; NDVI; NDWI	In arid ecosystems, desert bighorn sheep are dependent on natural waterholes, particularly in summer when forage is scarce and environmental temperatures are high. To detect waterholes in Sierra Santa Isabel, which is the largest area of desert bighorn sheep habitat in the state of Baja California, Mexico, we used the normalized difference vegetation index (NDVI) and normalized difference water index (NDWI) from Sentinel-2 satellite images. Waterhole detection was based on the premise that sites with greater water availability, where NDVI was higher, can be identified by their density of vegetation greenness. For the detected waterholes, we estimated the escape terrain (presence of cliffs or steep, rocky slopes) around each by the vector ruggedness measure to determine their potential use by desert bighorn sheep based on the animals' presence as documented by camera traps. We detected 14 waterholes with the NDVI of which 11 were known by land owners and 3 were unrecorded. Desert bighorn were not detected in waterholes with high values of escape terrain, i.e., flat areas. Waterhole detection by NDVI is a simple method, and with the assistance and knowledge of the inhabitants of the Sierra, it was possible to confirm the presence each waterhole in the field.	[Gabriel Escobar-Flores, Jonathan] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, Durango, Mexico; [Sandoval, Sarahi] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, CONACYT, Durango, Mexico; [Valdez, Raul] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Shahriary, Eahsan] Univ Texas El Paso, Environm Sci & Engn Program, El Paso, TX 79968 USA; [Torres, Jorge] Ctr Invest Cient & Educ Super Ensenada, Dept Comp Sci, Ensenada, Baja California, Mexico; [Alvarez-Cardenas, Sergio; Gallina-Tessaro, Patricia] Ctr Invest Biol Noroeste, La Paz, Baja California, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; New Mexico State University; University of Texas System; University of Texas El Paso; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Sandoval, S (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Durango, CONACYT, Durango, Mexico.	sarahisandovale@gmail.com		Sandoval, Sarahi/0000-0001-7221-5498	Comision Nacional de Ciencia y Tecnologia [205965];  [98109-1916]	Comision Nacional de Ciencia y Tecnologia; 	All the funding or sources of support received during this specific study. JiJi Foundation (grant number 98109-1916) URL: http://jiji.org/. Comision Nacional de Ciencia y Tecnologia (grant number 205965) URL:www.conacyt.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira V., 2001, SEMERGEN, V27, P247, DOI [DOI 10.1016/S1138-3593(01)73955-X, 10.1016/S1138-3593(01)73955-X]; Aguilar C, 2012, ECOL INDIC, V23, P290, DOI 10.1016/j.ecolind.2012.04.008; Alvarez-Cardenas S, 2009, TROP CONSERV SCI, V2, P189, DOI 10.1177/194008290900200206; [Anonymous], [No title captured]; BERGER J, 1991, ANIM BEHAV, V41, P61, DOI 10.1016/S0003-3472(05)80503-2; Bleich VC, 2006, WILDLIFE SOC B, V34, P627, DOI 10.2193/0091-7648(2006)34[627:QOWATW]2.0.CO;2; Borras J, 2017, REV TELEDETEC, P55, DOI 10.4995/raet.2017.7133; Cain JW, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2007-209; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; DeForge J., 1993, DESERT BIGHORN COUNC, V37, P24; Dowdy S., 2004, STAT RES, V3rd; Du Y, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040354; Escobar-Flores JG, 2016, THESIS; Escobar-Flores Jonathan G., 2015, Therya, V6, P519, DOI 10.12933/therya-15-284; Gilad O, 2013, APPL GEOGR, V41, P96, DOI 10.1016/j.apgeog.2013.03.012; GIONFRIDDO JP, 1986, J WILDLIFE MANAGE, V50, P331, DOI 10.2307/3801923; Gonzalez-Abraham CE, 2010, B SOC BOT MEX, V87, P69; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hatcher L., 2003, STEP BY STEP BASIC S; Hoglander C, 2015, J WILDLIFE MANAGE, V79, P77, DOI 10.1002/jwmg.818; Isaacson S, 2017, REMOTE SENS ENVIRON, V198, P95, DOI 10.1016/j.rse.2017.05.035; Jones H.G., 2010, REMOTE SENSING VEGET; Krausman PR, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P139; Lee R, 2012, CALIF FISH GAME, V98, P51; Lioubimtseva E, 2004, PROG PHYS GEOG, V28, P502, DOI 10.1191/0309133304pp422oa; Littell RC, 2002, SAS LINEAR MODELS; Martinez GR, 2011, MUESTREO TERRESTRE A; Martinez-Gallardo R, 2008, ADV STUDY MAMMALS ME, VII, P661; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Miranda E., 2018, P 2018 INT C INFORM, P69, DOI 10.1109/ICIMTech.2018.8528122; Owen HJF, 2015, REMOTE SENS ECOL CON, V1, P61, DOI 10.1002/rse2.5; Parkes David, 2003, Ecological Management & Restoration, V4, pS29, DOI 10.1046/j.1442-8903.4.s.4.x; Perry TW, 2010, SOUTHWEST NAT, V55, P517, DOI 10.1894/SGM-07.1; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Rebman J.P., 2012, BAJA CALIFORNIA PLAN; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; Rokni K, 2014, REMOTE SENS-BASEL, V6, P4173, DOI 10.3390/rs6054173; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Rouse JW, 1974, P 3 EARTH RES TECHN, P301; Sandoval AV, 2014, ECOLOGIA MANEJO FAUN, P475; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sisay A., 2016, AM J GEOGRAPHIC INFO, V5, P33, DOI [10.5923/j.ajgis.20160502.01, DOI 10.5923/J.AJGIS.20160502.01]; Villepique J.T., 2015, ADV ECOL, V2015, P1, DOI [10.1155/2015/357080, DOI 10.1155/2015/357080]; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179	46	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211202	10.1371/journal.pone.0211202	http://dx.doi.org/10.1371/journal.pone.0211202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668602	gold, Green Published, Green Submitted			2022-12-27	WOS:000456306400034
J	Lee, SR; Cho, AR; Lee, SY; Cho, YH; Park, EJ; Kim, YJ; Lee, JG				Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju; Kim, Yun Jin; Lee, Jeong Gyu			Secondhand smoke knowledge, sources of information, and associated factors among hospital staff	PLOS ONE			English	Article							EXPOSURE; ATTITUDES; BEHAVIORS	Purpose To evaluate knowledge of secondhand smoke (SHS) risks, sources of information, and associated factors and behaviors among hospital staff. Methods We conducted a cross-sectional survey using a 40-item self-administered questionnaire among 328 employees at a university hospital. The questions on representative diseases related to SHS were used to measure the degree of knowledge of SHS. Multiple regression analysis was used to determine the correlation between SHS knowledge scores and variables. Results Females had better SHS knowledge scores than males, regardless of smoking status (p<0.05). SHS knowledge was positively correlated with cessation education in males, nonsmokers, and the total sample (beta = 3.950, 2.356, and 2.684, respectively, p<0.05). It was correlated with the experience of any SHS exposure-related symptoms in males, non-smokers, and the total sample (beta = 3.950, 2.356, and 2.684, respectively, p<0.05) and discomfort when exposed to SHS in non-smokers and the total sample (beta = 0.670 and 0.821, respectively, p<0.05). Conclusion SHS knowledge is high among females, when hospital staff are educated about SHS risks, and when they have experienced any SHS exposure-related symptoms or felt uncomfortable when exposed to SHS. SHS risk education is an effective tool to increase SHS knowledge in hospital staff.	[Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju] Pusan Natl Univ, Yangsan Hosp, Family Med Clin, Yangsan, South Korea; [Lee, Sae Rom; Cho, A-ra; Lee, Sang Yeoup; Cho, Young Hye; Park, Eun Ju] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Lee, Sang Yeoup] Pusan Natl Univ, Sch Med, Dept Med Educ, Yangsan, South Korea; [Kim, Yun Jin; Lee, Jeong Gyu] Pusan Natl Univ, Sch Med, Dept Family Med, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, SY (corresponding author), Pusan Natl Univ, Yangsan Hosp, Family Med Clin, Yangsan, South Korea.; Lee, SY (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.; Lee, SY (corresponding author), Pusan Natl Univ, Sch Med, Dept Med Educ, Yangsan, South Korea.	saylee@pnu.edu	Lee, Sang Yeoup/AAV-2125-2020; Park, Eunju/AAC-5266-2021	Lee, Sang Yeoup/0000-0002-3585-9910				Aronson E., 1969, ADV EXP SOC PSYCHOL, P1, DOI [10.1016/s0065-2601(08)60075-1, DOI 10.1016/S0065-2601(08)60075-1]; Eisner MD, 2001, ENVIRON HEALTH PERSP, V109, P809, DOI 10.2307/3454823; Evans KA, 2012, J PUBLIC HEALTH-UK, V34, P183, DOI 10.1093/pubmed/fdr104; Gharaibeh H, 2011, INT J ENV RES PUB HE, V8, P4207, DOI 10.3390/ijerph8114207; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Jones LL, 2011, NICOTINE TOB RES, V13, P479, DOI 10.1093/ntr/ntr030; Ma GX, 2005, ADDICT BEHAV, V30, P725, DOI 10.1016/j.addbeh.2004.08.018; Nakkash R, 2009, TOB CONTROL, V18, P310, DOI 10.1136/tc.2008.029405; Ponsonby AL, 1996, J EPIDEMIOL COMMUN H, V50, P40, DOI 10.1136/jech.50.1.40; Robinson J, 2007, SOC SCI MED, V65, P641, DOI 10.1016/j.socscimed.2007.03.048; Sim HS, 2000, KOREAN J PREV MED, V33, P91; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; Tshitenge S, 2015, S AFR FAM PRACT, V57, P177, DOI 10.1080/20786190.2014.976963; World Health Organization, 2003, FRAM CONV TOB CONTR, DOI DOI 10.1136/TC.12.3.241	14	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210981	10.1371/journal.pone.0210981	http://dx.doi.org/10.1371/journal.pone.0210981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668578	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400024
J	Griffin, LP; Griffin, CR; Finn, JT; Prescott, RL; Faherty, M; Still, BM; Danylchuk, AJ				Griffin, Lucas P.; Griffin, Curtice R.; Finn, John T.; Prescott, Robert L.; Faherty, Mark; Still, Brett M.; Danylchuk, Andy J.			Warming seas increase cold-stunning events for Kemp's ridley sea turtles in the northwest Atlantic	PLOS ONE			English	Article							GULF-OF-MEXICO; OIL-SPILL; PATTERNS; STRANDINGS; MORTALITY; HABITAT; MODELS; WATERS; LAGOON; LOST	Since the 1970s, the magnitude of turtle cold-stun strandings have increased dramatically within the northwestern Atlantic. Here, we examine oceanic, atmospheric, and biological factors that may affect the increasing trend of cold-stunned Kemp's ridleys in Cape Cod Bay, Massachusetts, United States of America. Using machine learning and Bayesian inference modeling techniques, we demonstrate higher cold-stunning years occur when the Gulf of Maine has warmer sea surface temperatures in late October through early November. Surprisingly, hatchling numbers in Mexico, a proxy for population abundance, was not identified as an important factor. Further, using our Bayesian count model and forecasted sea surface temperature projections, we predict more than 2,300 Kemp's ridley turtles may coldstun annually by 2031 as sea surface temperatures continue to increase within the Gulf of Maine. We suggest warmer sea surface temperatures may have modified the northerly distribution of Kemp's ridleys and act as an ecological bridge between the Gulf Stream and nearshore waters. While cold-stunning may currently account for a minor proportion of juvenile mortality, we recommend continuing efforts to rehabilitate cold-stunned individuals to maintain population resiliency for this critically endangered species in the face of a changing climate and continuing anthropogenic threats.	[Griffin, Lucas P.; Griffin, Curtice R.; Finn, John T.; Danylchuk, Andy J.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Prescott, Robert L.; Faherty, Mark] Massachusetts Audubon Soc, Wellfleet Bay Wildlife Sanctuary, South Wellfleet, MA USA; [Still, Brett M.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Rhode Island	Griffin, LP (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	lucaspgriffin@gmail.com		Griffin, Lucas/0000-0002-8560-0683				Avens L, 2012, P 31 ANN S SEA TURTL; Bailey LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167980; Bevan E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1244; BLEAKNEY J. SHERMAN, 1965, CAN FIELD NATUR, V79, P120; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briscoe DK, 2017, DEEP-SEA RES PT II, V140, P182, DOI 10.1016/j.dsr2.2016.11.004; BURKE VJ, 1991, COPEIA, P1136; Butt N, 2016, BIOL CONSERV, V204, P189, DOI 10.1016/j.biocon.2016.10.012; Caillouet Charles W. Jr, 2011, Marine Turtle Newsletter, V130, P1; Caillouet Charles W. Jr., 2014, Marine Turtle Newsletter, P1; Caillouet Charles W. Jr, 2010, Marine Turtle Newsletter, V128, P1; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; Clayton D., 1992, STAT MODELS LONGITUD, P301; Coles WC, 2000, COPEIA, P551, DOI 10.1643/0045-8511(2000)000[0551:SSSTAA]2.0.CO;2; Crowder L, 2011, SOLUTIONS, V2, P67; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; EPPERLY SP, 1995, CONSERV BIOL, V9, P384, DOI 10.1046/j.1523-1739.1995.9020384.x; Gallaway Benny J., 2016, Gulf of Mexico Science, V33, P138; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Heppell SS, 2002, BIOL SEA TURTLES, VII, P275; Hunt KE, 2016, CONSERV PHYSIOL, V4; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; Bellido JJ, 2010, CHELONIAN CONSERV BI, V9, P276, DOI 10.2744/CCB-0802.1; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Kocmoud AR, 2019, ECOL MODEL, V392, P159, DOI 10.1016/j.ecolmodel.2018.11.014; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; LAZELL JD, 1980, COPEIA, P290, DOI 10.2307/1444006; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Martino S., 2009, IMPLEMENTING APPROXI; Martins TG, 2013, COMPUT STAT DATA AN, V67, P68, DOI 10.1016/j.csda.2013.04.014; Mazaris AD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600730; MEYLAN AB, 1986, NAT HIST, V95, P90; Monzon-Arguello C, 2012, J R SOC INTERFACE, V9, P1725, DOI 10.1098/rsif.2011.0788; Morreale SJ, 2005, CHELONIAN CONSERV BI, V4, P872; MORREALE SJ, 1992, J HERPETOL, V26, P301, DOI 10.2307/1564885; Muff S, 2015, J R STAT SOC C-APPL, V64, P231, DOI 10.1111/rssc.12069; Musick John A., 1997, P137; Musick John A., 1994, NOAA Technical Memorandum NMFS-SEFSC, V341, P121; National Marine Fisheries Service (NMFS) and US Fish and Wildlife Service (US FWS), 2015, KEMPS RIDL SEA TURTL; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pirhalla DE, 2015, ESTUAR COAST, V38, P2310, DOI 10.1007/s12237-014-9918-y; Provancha JA, 2012, P 31 ANN S SEA TURTL; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Putman NF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0345; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Roberts K, 2014, PHYS GEOGR, V35, P134, DOI 10.1080/02723646.2014.898573; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Shoop C.R., 1992, Herpetological Monographs, P43; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spotila James R., 1997, P297; Still BM, 2005, CHELONIAN CONSERV BI, V4; Taylor AH, 1998, TELLUS A, V50, P134, DOI 10.1034/j.1600-0870.1998.00010.x; Team RS, 2015, RSTUDIO INT DEV ENV; Turner BE, 2000, IAU SYMP, P31; Turtle Expert Working Group, 2000, NMFSSEFSC444 NOAA TU, V444, P115; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; Visbeck M., 2003, GEOPHYS MONOGR SER, V134, P113, DOI DOI 10.1029/134GM06; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; WITHERINGTON BE, 1989, COPEIA, P696; Zuur A.F., 2017, BEGINNERS GUIDE SPAT	67	21	23	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211503	10.1371/journal.pone.0211503	http://dx.doi.org/10.1371/journal.pone.0211503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695074	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400040
J	Jiao, Y; Fu, Z; Li, YQ; Zhang, W; Liu, YH				Jiao, Yan; Fu, Zhuo; Li, Yanqing; Zhang, Wei; Liu, Yahui			Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer	PLOS ONE			English	Article							INTERACTOR CATS; PROTEIN; GENES; CALM	FAM64A, a marker of cell proliferation, has been investigated as a potential biomarker in several cancers. In the present study, we examined the value of FAM64A expression in the diagnosis and prognosis of pancreatic cancer through bioinformatics analysis of data obtained from The Cancer Genome Atlas (TCGA) database. The diagnostic value of FAM64A expression in pancreatic cancer tissue was deteremined through receiver operating characteristic (ROC) curve analysis, and based on the obtained cut-off value, patients were divided into two groups (high FAM64A expression and low FAM64A expression). Chi-square and Fisher exact tests were applied to identify associations between FAM64A expression and clinical features. Moreover, the effect of FAM64A expression in the survival of pancreatic cancer patients was observed by Kaplan-Meier and Cox analyses. Gene set enrichment analysis (GSEA) was performed using the TCGA dataset. Our results showed that high FAM64A expression in pancreatic cancer was associated with survival status, overall survival (OS), and recurrence. The area under the ROC curve was 0.736, which indicated modest diagnostic value. Patients with higher FAM64A expression had significantly shorter OS and recurrence-free survival (RFS) times. Multivariate survival analysis demonstrated that high FAM64A expression was an independent risk factor for OS and RFS. GSEA identified mitotic spindles, myc targets, MTORC1 signaling, G2M checkpoint, E2F targets, DNA repair, glycolysis and unfolded protein response as differentially enriched with the high FAM64A expression phenotype. In conclusion, high FAM64A mRNA expression is an independent risk factor for poor prognosis in pancreatic cancer.	[Jiao, Yan; Zhang, Wei; Liu, Yahui] Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China; [Fu, Zhuo] Jilin Univ, Hosp 1, Dept Hand & Foot Surg, Changchun, Jilin, Peoples R China; [Li, Yanqing] Jilin Univ, Coll Basic Med Sci, Dept Pathophysiol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Liu, YH (corresponding author), Jilin Univ, Hosp 1, Dept Hepatobiliary & Pancreat Surg, Changchun, Jilin, Peoples R China.	liuyahui2008@yeah.net	jiao, yan/Q-1481-2019; , 付卓/AAV-3208-2020	jiao, yan/0000-0001-6914-7949; Fu, Zhuo/0000-0001-6462-7695				Archangelo LF, 2006, ONCOGENE, V25, P4099, DOI 10.1038/sj.onc.1209438; Archangelo LF, 2013, BBA-MOL CELL RES, V1833, P1269, DOI 10.1016/j.bbamcr.2013.02.004; Archangelo LF, 2008, MOL ONCOL, V2, P356, DOI 10.1016/j.molonc.2008.08.001; Barbutti I, 2016, ONCOTARGET, V7, P68385, DOI 10.18632/oncotarget.11630; Hashimoto K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04823-1; Hu SF, 2017, ONCOTARGET, V8, P41334, DOI 10.18632/oncotarget.17295; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kimes PK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku521; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Stelzer G, 2016, GENECARDS SUITE GENE; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Team RDC, 2012, COMPUTING, V1, P12; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Therneau TM, 2000, TECHNOMETRICS, V97, P353; Tony G, 2012, HALLMARKS CANC, V9, P703, DOI [10.4161/rna.20481, DOI 10.4161/RNA.20481]; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yamada Y, 2018, CANCER SCI, V109, P2919, DOI 10.1111/cas.13722; Zhang C, 2014, INT J ONCOL, V44, P2025, DOI 10.3892/ijo.2014.2352; Zhang LL, 2018, WORLD J GASTROENTERO, V24, P2047, DOI 10.3748/wjg.v24.i19.2047	20	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211291	10.1371/journal.pone.0211291	http://dx.doi.org/10.1371/journal.pone.0211291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695070	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400023
J	Kanmiki, EW; Awoonor-Williams, JK; Phillips, JF; Kachur, SP; Achana, SF; Akazili, J; Bawah, AA				Kanmiki, Edmund Wedam; Awoonor-Williams, John Koku; Phillips, James F.; Kachur, Stephen Patrick; Achana, Sabastian F.; Akazili, James; Bawah, Ayaga A.			Socio-economic and demographic disparities in ownership and use of insecticide- treated bed nets for preventing malaria among rural reproductive-aged women in northern Ghana	PLOS ONE			English	Article								Background Malaria continues to be a leading cause of morbidity and mortality in most countries in SubSaharan Africa. Insecticide-treated bed nets (ITNs) is one of the cost-effective interventions for preventing malaria in endemic settings. Ghana has made tremendous efforts to ensure widespread ownership and use of ITNs. However, national coverage statistics can mask important inequities that demand targeted attention. This study assesses the disparities in ownership and utilization of ITNs among reproductive-aged women in a rural impoverished setting of Ghana. Methods Population-based cross-sectional data of 3,993 women between the age of 15 and 49 years were collected in seven districts of the Upper East region of Ghana using a two-stage cluster sampling approach. Bivariate and multivariate regression models were used to assess the social, economic and demographic disparities in ownership and utilization of ITN and to compare utilization rates among women in households owning at least one ITN. Results As high as 79% of respondents were found to own ITN while 62% of ITN owners used them the night preceding the survey. We identified disparities in both ownership and utilization of ITNs in wealth index, occupational status, religion, and district of residence. Respondents in the relative richest wealth quintile were 74% more likely to own ITNs compared to those in the poorest quintile (p-value< 0.001, CI = 1.29-2.34) however, they were 33% less likely to use ITNs compared to the poorest (p-value = 0.01, CI = 0.50-0.91). Conclusion Interventions aimed at preventing and controlling malaria through the use of bed nets in rural Ghana and other similar settings should give more attention to disadvantage populations such as the poor and unemployed. Tailored massages and educational campaigns are required to ensure consistent use of treated bed nets.	[Kanmiki, Edmund Wedam; Bawah, Ayaga A.] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana; [Awoonor-Williams, John Koku] Ghana Hlth Serv, Policy Planning Monitoring & Evaluat Div, Accra, Ghana; [Phillips, James F.; Kachur, Stephen Patrick] Columbia Univ, Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY USA; [Achana, Sabastian F.; Akazili, James] Ghana Hlth Serv, Navrongo Hlth Res Ctr, Upper East Region, Navrongo, Ghana	University of Ghana; Ghana Health Service; Columbia University; Ghana Health Service; Navrongo Health Research Center	Kanmiki, EW (corresponding author), Univ Ghana, Reg Inst Populat Studies, Accra, Ghana.	eddykan100@gmail.com	Kachur, Patrick/ABE-7220-2021; Kanmiki, Edmund Wedam/AAF-7415-2020; Phillips, James F./AAE-5123-2019	Kanmiki, Edmund Wedam/0000-0001-7175-5222; Phillips, James F./0000-0002-6720-7204	Doris Duke Charitable Foundation's (DDCF) African Health Initiative [200905813]	Doris Duke Charitable Foundation's (DDCF) African Health Initiative(Doris Duke Charitable Foundation (DDCF))	The Ghana Essential Health Intervention Program (GEHIP) was supported by grants from the Doris Duke Charitable Foundation's (DDCF) African Health Initiative. Grant number 200905813. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahorlu CK, 2006, TROP MED INT HEALTH, V11, P1022, DOI 10.1111/j.1365-3156.2006.01660.x; Akazili J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0637-7; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; Ankomah A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-105; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; [Anonymous], 1998, COCHRANE DB SYST REV; Awintuen I, 2018, SOCIODEMOGRAPHIC DE, P1; Awoonor-Williams JK, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S3; Batisso E, 2012, MALARIA J, V11, P1; Baume CA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-265; Centers for Disease Control and Prevention, MAL WORLDW IMP MAL; Ernst KC, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1660-4; Eteng M, 2014, MALARIA J, V13, P1; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Ghana Health Service, 2015, GHAN HLTH SERV 2014; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV R; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV R; Ghana Statistical Service (GSS) GHSG and ICF, 2017, GHAN MAL IND SURV 20; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Graves PM., 2011, MALARIA J, V10, P1; GSS, 2016, POP STAT; Kanmiki EW, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-24; Manu Grace, 2017, Malar Res Treat, V2017, P7481210, DOI 10.1155/2017/7481210; Mueller DH, MALAR J, V7, P1; National Malaria Control Programme Ghana, 2015, 2015 ANN REP NAT MAL; Roll Back Malaria, 2005, GLOB ESTR PLAN ROLL; Roll Back Malaria, GLOB ESTR PLAN ROLL; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Singh M, 2013, MALARIA J, V12, P1; Willey BA, 2012, B WORLD HEALTH ORGAN, V90, P672, DOI 10.2471/BLT.11.094771; World Health Organization, 2017, DEPRESSION	31	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211365	10.1371/journal.pone.0211365	http://dx.doi.org/10.1371/journal.pone.0211365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695044	gold, Green Published, Green Submitted			2022-12-27	WOS:000457046400031
J	Nakada, H; Yoshida, S; Muto, K				Nakada, Haruka; Yoshida, Sachie; Muto, Kaori			"Tell me what you suggest, and let's do that, doctor": Patient deliberation time during informal decision-making in clinical trials	PLOS ONE			English	Article							PERSONAL EXPERIENCES; QUALITY; CONSENT; HEALTH	Informed consent is an essential part of an ethical clinical trial; to this end, researchers have developed several interventions to promote participants' full understanding of trials and thereby improve the consent process. However, few empirical studies have examined how patients make the decision of whether to give consent. The objective of this study, therefore, is to analyze patients' decision-making process when participating in clinical trials. We conduct an internet survey (n = 2,045) and interview data analysis (n = 40) with patients and categorize respondents into three types of participants: active, passive, and non-participation. Our results show that patients often make informal and quick decisions before medical staff provide them with relevant information during the informed consent process. For example, 55.9% of patients received initial information on clinical trials from an online article or web advertising, and 54.5% consulted no one about whether to participate in the clinical trial before making a decision. Only 20.7% of respondents subjectively spent time making the decision whether to participate; 43.0% of patients who said that they "spent time" coming to a decision took four or more days to reach a decision, while 8.3% of people who "did not spend time" making a decision took this among of time. Based on these results, we were able to break patients' decision-making process into four steps: first contact, informal decision making, relevant information, and formal decision making. Our results show that patients are most likely to make a decision based on the first information they receive on the clinical trial, whatever the source. To this end, having a list of questions for potential participants to ask researchers would be useful in helping better collecting information of clinical trials. In addition, research teams should give patients more than four days to decide between providing them with relevant information and obtaining written consent, even if the patient seems to make a quick decision.	[Nakada, Haruka; Yoshida, Sachie; Muto, Kaori] Univ Tokyo, Dept Publ Policy, Human Genome Ctr, Inst Med Sci, Tokyo, Japan; [Nakada, Haruka] Natl Canc Ctr, Ctr Publ Hlth Sci, Div Bioeth & Hlth Care Law, Tokyo, Japan; [Yoshida, Sachie] Gunma Paz Univ, Fac Hlth Sci, Div Liberal Arts & Sci, Gunma, Japan	University of Tokyo; National Cancer Center - Japan	Nakada, H (corresponding author), Univ Tokyo, Dept Publ Policy, Human Genome Ctr, Inst Med Sci, Tokyo, Japan.; Nakada, H (corresponding author), Natl Canc Ctr, Ctr Publ Hlth Sci, Div Bioeth & Hlth Care Law, Tokyo, Japan.	hnakada@ncc.go.jp		Nakada, Haruka/0000-0003-1856-4640	JSPS KAKENHI Grant [JP24300294, JP17K17665]; AMED Grant [18kk0205001]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED Grant	This work was supported by JSPS KAKENHI Grant Numbers JP24300294, JP17K17665, and AMED Grant Number 18kk0205001. https://www.dsps.gov/english/e-grants/index.html, https://www.amed.go.jp/en/index.html.	Anderson Emily E, 2017, AJOB Empir Bioeth, V8, P178, DOI 10.1080/23294515.2017.1362488; [Anonymous], 2017, WHAT QUEST SHOULD I; [Anonymous], 2007, QUEST ASK PART CLIN; Brehaut JC, 2015, J CLIN EPIDEMIOL, V68, P1472, DOI 10.1016/j.jclinepi.2015.03.002; Brehaut JC, 2012, J CLIN EPIDEMIOL, V65, P708, DOI 10.1016/j.jclinepi.2012.01.004; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Elwyn G, 2010, HEALTH EXPECT, V13, P139, DOI 10.1111/j.1369-7625.2009.00572.x; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Ferguson PR, 2002, J MED ETHICS, V28, P45, DOI 10.1136/jme.28.1.45; Gillies K, 2015, COCHRANE DB SYST REV, V11; Gillies K, 2012, J MED ETHICS, V38, P751, DOI 10.1136/medethics-2011-100059; Gillies K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-307; Kohara Izumi, 2010, Oncol Nurs Forum, V37, pE124, DOI 10.1188/10.ONF.E124-E132; Locock L, 2011, PATIENT EDUC COUNS, V84, P303, DOI 10.1016/j.pec.2011.06.002; Nakada H, 2017, JPN J CLIN PHARM THE, V48, P31, DOI [10.3999/jscpt.48.31, DOI 10.3999/JSCPT.48.31]; Purcaru D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110139; Rowbotham MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058603; Ryan RE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003717.pub2; Tan SSL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5729; Tian Y, 2008, PATIENT EDUC COUNS, V71, P340, DOI 10.1016/j.pec.2008.02.006; U.S. Department of Health and Human Services, FED POL PROT HUM SUB; World Medical Association, 2018, WMA DECL HELS ETH PR; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	23	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211338	10.1371/journal.pone.0211338	http://dx.doi.org/10.1371/journal.pone.0211338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695047	Green Submitted, gold, Green Published			2022-12-27	WOS:000457046400026
J	Fung, JST; Akech, S; Kissoon, N; Wiens, MO; English, M; Ansermino, JM				Fung, Jollee S. T.; Akech, Samuel; Kissoon, Niranjan; Wiens, Matthew O.; English, Mike; Ansermino, J. Mark			Determining predictors of sepsis at triage among children under 5 years of age in resource-limited settings: A modified Delphi process	PLOS ONE			English	Article							MORTALITY	Sepsis is a life-threatening dysfunction of the immune system leading to multiorgan failure that is precipitated by infectious diseases and is a leading cause of death in children under 5 years of age. It is necessary to be able to identify a sick child at risk of developing sepsis at the earliest point of presentation to a healthcare facility so that appropriate care can be provided as soon as possible. Our study objective was to generate a list of consensus-driven predictor variables for the derivation of a prediction model that will be incorporated into a mobile device and operated by low-skilled healthcare workers at triage. By conducting a systematic literature review and examination of global guideline documents, a list of 72 initial candidate predictor variables was generated. A two-round modified Delphi process involving 26 experts from both resource-rich and resource-limited settings, who were also encouraged to suggest new variables, yielded a final list of 45 predictor variables after evaluating each variable based on three domains: predictive potential, measurement reliability, and level of training and resources required. The final list of predictor variables will be used to collect data and contribute to the derivation of a prediction model.	[Fung, Jollee S. T.; Kissoon, Niranjan; Wiens, Matthew O.; Ansermino, J. Mark] BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada; [Fung, Jollee S. T.] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Akech, Samuel; English, Mike] KEMRI Wellcome Trust, CanadaHlth Serv Unit, Nairobi, Kenya; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat & Emergency Med, Vancouver, BC, Canada; [Wiens, Matthew O.; Ansermino, J. Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Ansermino, J. Mark] Univ British Columbia, CanadaSch Populat & Publ Hlth, Vancouver, BC, Canada	BC Childrens Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Ansermino, JM (corresponding author), BC Childrens Hosp, Ctr Int Child Hlth, Vancouver, BC, Canada.; Ansermino, JM (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; Ansermino, JM (corresponding author), Univ British Columbia, CanadaSch Populat & Publ Hlth, Vancouver, BC, Canada.	anserminos@yahoo.ca	Wiens, Matthew/J-9249-2019; Kissoon, Niranjan/AAC-6140-2021	English, Michael/0000-0002-7427-0826; Ansermino, J Mark/0000-0001-8427-2035; Akech, Samuel/0000-0001-5126-1225; Kissoon, Niranjan/0000-0001-8847-9973; Wiens, Matthew/0000-0002-3287-5181				[Anonymous], 2011, CAR SICK CHILD; Eubank BH, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0165-8; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Global Sepsis Alliance, 2017, WHA AD RES SEPS; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hsu CC, 2007, PARE, V12, P1; Kissoon N, 2017, PEDIATR CRIT CARE ME, V18, pE625, DOI 10.1097/PCC.0000000000001340; Kissoon N, 2016, JAMA PEDIATR, V170, P107, DOI 10.1001/jamapediatrics.2015.3241; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Pashankar D, 2001, Pediatr Rev, V22, P219, DOI 10.1542/pir.22-7-219; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Rudd KE, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2157-z; The Emergency Medicine Society of South Africa, 2012, S AFR TRIAG SCAL SAT S AFR TRIAG SCAL SAT; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; WHO, 2014, IMCI CHART BOOKL; Wiens MO, 2016, AFR HEALTH SCI, V16, P162, DOI 10.4314/ahs.v16i1.22; World Health Organization, 2005, EM TRIAG ASS TREATM; World Health Organization, 2017, CHILDREN REDUCING MO	18	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211274	10.1371/journal.pone.0211274	http://dx.doi.org/10.1371/journal.pone.0211274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689660	Green Submitted, Green Published, gold			2022-12-27	WOS:000457041800024
J	Davidson, B; Du Toit, T; Jones, ESW; Barday, Z; Manning, K; Mc Curdie, F; Thomson, D; Rayner, BL; Muller, E; Wearne, N				Davidson, Bianca; Du Toit, Tinus; Jones, Erika S. W.; Barday, Zunaid; Manning, Kathryn; Mc Curdie, Fiona; Thomson, Dave; Rayner, Brian L.; Muller, Elmi; Wearne, Nicola			Outcomes and challenges of a kidney transplant programme at Groote Schuur Hospital, Cape Town: A South African perspective	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; RATIONING DIALYSIS; RECIPIENTS; EXPERIENCE; MORTALITY; DISEASE; CARE	Introduction Access to dialysis and transplantation in the developing world remains limited. Therefore, optimising renal allograft survival is essential. This study aimed to evaluate clinical outcomes and identify poor prognostic factors in the renal transplant programme at Groote Schuur Hospital [GSH], Cape Town. Method Data were collected on all patients who underwent a kidney transplant at GSH from 1st July 2010 to the 30 June 2015. Analyses were performed to assess baseline characteristics, graft and patient survival, as well as predictors of poor outcome. Results 198 patients were transplanted. The mean age was 38 +/- 10.5 years, 127 (64.1%) were male, and 86 (43.4%) were of African ethnicity. Deceased donor organs were used for 130 (66.7%) patients and living donors for 65 (33.3%). There were > 5 HLA mismatches in 58.9% of transplants. Sepsis was the commonest cause of death and delayed graft function [DGF] occurred in 41 (21.4%) recipients. Patient survival was 90.4% at 1 year and 83.1% at 5 years. Graft survival was 89.4% at 1 year and 80.0% at 5 years. DGF (HR 2.83 (1.127.19), p value = 0.028) and recipient age > 40 years (HR 3.12 (1.26-7.77), p value = 0.014) were predictors of death. Conclusion Despite the high infectious burden, stratified immunosuppression and limited tissue typing this study reports encouraging results from a resource constrained transplant programme in South Africa. Renal transplantation is critical to improve access to treatment of end stage kidney disease where access to dialysis is limited.	[Davidson, Bianca; Jones, Erika S. W.; Barday, Zunaid; Mc Curdie, Fiona; Rayner, Brian L.; Wearne, Nicola] Univ Cape Town, Groote Schuur Hosp, Dept Hypertens & Nephrol, Western Cape, South Africa; [Davidson, Bianca; Jones, Erika S. W.; Barday, Zunaid; Rayner, Brian L.; Wearne, Nicola] Univ Cape Town, Kidney & Hypertens Res Unit, Western Cape, South Africa; [Du Toit, Tinus; Manning, Kathryn; Thomson, Dave; Muller, Elmi] Univ Cape Town, Dept Surg, Western Cape, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Davidson, B (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Hypertens & Nephrol, Western Cape, South Africa.; Davidson, B (corresponding author), Univ Cape Town, Kidney & Hypertens Res Unit, Western Cape, South Africa.	bianca.davidson@uct.ac.za	Muller, Elmi/I-3258-2014; Rayner, Brian/AAA-3174-2021; Thomson, David/AAQ-9471-2021	Muller, Elmi/0000-0003-4891-5296; du Toit, Tinus/0000-0002-8840-9032; Thomson, David/0000-0003-2433-3611				Abderrahim E, 2017, EXP CLIN TRANSPLANT, V15, P84, DOI 10.6002/ect.mesot2016.O66; Ackoundou-N'Guessan C, 2015, TRANSPL P, V47, P1580, DOI 10.1016/j.transproceed.2015.03.053; [Anonymous], 2011, 2011 CENSUS MUNICIPA; [Anonymous], 2017, USRDS ANN DAT REP, V2; ANZDATA, 2015, ANZDATA ANN REP 2015; Bello AK, 2017, JAMA-J AM MED ASSOC, V317, P1864, DOI 10.1001/jama.2017.4046; Andrade Luis Gustavo Modelli de, 2014, Braz. J. Nephrol., V36, P194, DOI 10.5935/0101-2800.20140030; de Sandes-Freitas TV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144188; DOH, 2010, H11 DOH; du Toit T, 2017, SAMJ S AFR MED J, V107, P480, DOI [10.7196/samj.2017.v107i6.12391, 10.7196/SAMJ.2017.v107i6.12391]; Ehtuish Ehtuish F, 2006, Exp Clin Transplant, V4, P425; Garcia GG, 2012, CURR OPIN NEPHROL HY, V21, P229, DOI 10.1097/MNH.0b013e328352586d; Gonzalez F, 2002, REV INVEST CLIN, V54, P492; Haddiya I, 2012, TRANSPL P, V44, P2976, DOI 10.1016/j.transproceed.2012.02.038; Haller MC, 2017, CLIN J AM SOC NEPHRO, V12, P122, DOI 10.2215/CJN.04120416; Hernandez D, 2009, TRANSPLANTATION, V88, P803, DOI 10.1097/TP.0b013e3181b4ac2f; Kahwaji J, 2011, TRANSPLANTATION, V91, P225, DOI 10.1097/TP.0b013e3181ff8754; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kilonzo KG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176041; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Luan FL, 2014, CLIN TRANSPLANT, V28, P487, DOI 10.1111/ctr.12347; Manning K, 2017, S AFR TRANSPL SOC C; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Monteon Francisco J, 2003, Clin Transpl, P165; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Moosa MR, 2018, PERITON DIALYSIS INT, V38, P84, DOI 10.3747/pdi.2017.00179; Muller E, 2015, NEW ENGL J MED, V372, P613, DOI 10.1056/NEJMoa1408896; Narayanan M, 2014, CLIN TRANSPLANT, V28, P184, DOI 10.1111/ctr.12294; Okafor UH, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.112.7930; Oniscu GC, 2005, J AM SOC NEPHROL, V16, P1859, DOI 10.1681/ASN.2004121092; OPTN, 2015, OPTN ORG DAT; Pippias M, 2017, CLIN KIDNEY J, V10, P154, DOI 10.1093/ckj/sfw135; Pondrom S, 2009, AM J TRANSPLANT, V9, P1, DOI 10.1111/j.1600-6143.2008.02525.x; Rizvi SAH, 2013, KIDNEY INT SUPPL, V3, P236, DOI 10.1038/kisup.2013.22; Sharif MU, 2016, CLIN KIDNEY J, V9, P11, DOI 10.1093/ckj/sfv111; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; U. S. Renal Data System, 2014, USRDS 2014 ANN DAT R; Wearne N, 2017, INT J NEPHROL RENOV, V10, P1, DOI 10.2147/IJNRD.S104208; Willicombe Michelle, 2017, World J Transplant, V7, P34, DOI 10.5500/wjt.v7.i1.34; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; ZENT R, 1994, PERITON DIALYSIS INT, V14, P48	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211189	10.1371/journal.pone.0211189	http://dx.doi.org/10.1371/journal.pone.0211189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682138	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500120
J	Endersid, C; Lang, GE; Dreyhaupt, J; Loidl, M; Lang, GK; Werner, JU				Enders, Christian; Lang, Gabriele E.; Dreyhaupt, Jens; Loidl, Max; Lang, Gerhard K.; Werner, Jens U.			Quantity and quality of image artifacts in optical coherence tomography angiography	PLOS ONE			English	Article								Objective To analyze quality and frequency of OCTA artifacts and to evaluate their impact on the interpretability of OCTA images. Design 75 patients with diabetic retinopathy (DR), retinal artery occlusion (RAO), retinal vein occlusion (RVO), or neovascular age-related macular degeneration (nAMD) and healthy controls were enrolled in this cross-sectional study in the outpatient department of a tertiary eye care center. Methods All participants underwent an OCTA examination (spectral domain OCT Cirrus 5000 equipped with the AngioPlex module). OCTA scans were analyzed independently by two experienced ophthalmologists. Frequency of various artifacts for the entire OCTA scan and for different segmentation layers and the grading of OCTA interpretability were investigated. Results The analysis of 75 eyes of 38 women and 37 men between 24 and 94 years were included. Six eyes had no retinal disease, 19 eyes had nAMD, 16 had DR, 19 eyes had RVO, and 15 eyes showed RAO. A macular edema (ME) was present in 40 of the diseased eyes. Projection artifacts occurred in all eyes in any structure below the superficial retinal vessel layer, segmentation and motion artifacts were found in 55% (41/75) and 49% (37/75) of eyes, respectively. Other artifacts occurred less frequently. Segmentation artifacts were significantly more frequent in diseased than in healthy eyes (p< 0.01). Qualitative assessment of OCTA images was graded as excellent in 65% and sufficient in 25% of cases, adding up to 91% images deemed acceptable for examination. Presence of ME was associated with a significantly poorer interpretability (p< 0.01). Conclusion and relevance Various artifacts appear at different frequencies in OCTA images. Nevertheless, a qualitative assessment of the OCTA images is almost always possible. Good knowledge of possible artifacts and critical analysis of the complete OCTA dataset are essential for correct clinical interpretation and determining a precise clinical diagnosis.	[Enders, Christian; Lang, Gabriele E.; Loidl, Max; Lang, Gerhard K.; Werner, Jens U.] Ulm Univ, Dept Ophthalmol, Ulm, Germany; [Dreyhaupt, Jens] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	Ulm University; Ulm University	Endersid, C (corresponding author), Ulm Univ, Dept Ophthalmol, Ulm, Germany.	christian.enders@uniklinik-ulm.de		Enders, Christian/0000-0003-3922-3765	Carl Zeiss Meditec AG, Jena, Germany	Carl Zeiss Meditec AG, Jena, Germany	The authors CE, GEL, ML, GKL and JUW received financial support from Carl Zeiss Meditec AG, Jena, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2018, GRAEF ARCH CLIN EXP, V256, P2283, DOI 10.1007/s00417-018-4138-y; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Falavarjani KG, 2016, RETINA-J RET VIT DIS, V36, pS168, DOI 10.1097/IAE.0000000000001259; Lang GE, 2016, KLIN MONATSBL AUGENH, V233, P613, DOI 10.1055/s-0042-105325; Lang GE, 2017, KLIN MONATSBL AUGENH, V234, P1109, DOI 10.1055/s-0043-112857; Patel RC, 2018, OPHTHALMOL RETINA, V2, P816, DOI 10.1016/j.oret.2017.11.010; Say EAT, 2017, RETINA-J RET VIT DIS, V37, P1660, DOI 10.1097/IAE.0000000000001414; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Yu SS, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0277-2; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901; Zhang QQ, 2017, OPHTHALMOL RETINA, V1, P124, DOI 10.1016/j.oret.2016.08.005	11	39	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210505	10.1371/journal.pone.0210505	http://dx.doi.org/10.1371/journal.pone.0210505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682050	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500041
J	Fauser, BCJM; Boivin, J; Barri, PN; Tarlatzis, BC; Schmidt, L; Levy-Toledano, R				Fauser, Bart C. J. M.; Boivin, Jacky; Barri, Pedro N.; Tarlatzis, Basil C.; Schmidt, Lone; Levy-Toledano, Rachel			Beliefs, attitudes and funding of assisted reproductive technology: Public perception of over 6,000 respondents from 6 European countries	PLOS ONE			English	Article							FERTILITY AWARENESS; INFERTILITY TREATMENT; KNOWLEDGE; FEMALE; INTENTIONS; PARENTHOOD; STUDENTS; IMPACT; WOMEN; SIDE	Background Fertility rates in Europe are among the lowest in the world, which may be attributed to both biological and lifestyle factors. Cost and reimbursement of fertility treatments vary across Europe, although its citizens enjoy wide access to fertility care. Since few regional studies evaluating public support for fertility treatment exist, we conducted the Listening IVF and Fertility in Europe (LIFE) survey to ascertain public perception of in vitro fertilization (IVF) and gamete donation as a treatment for infertility among European men and women. Methods and findings This survey was distributed via an online questionnaire to 8,682 individuals who were voluntary participants in an online research panel residing in France, Germany, Italy, Spain, Sweden, or the UK. The survey covered items to determine respondents' beliefs regarding IVF and its success, the need for public funding, the use of IVF among modern families with different lifestyles, and the support for gamete donation. Results were analyzed by age, country of origin, sex, and sexual orientation. A total of 6,110 (70% of total) men and women responded. Among all respondents, 10% had undergone IVF treatment and 48% had considered or would consider IVF in case of infertility. Respondents estimated IVF mean success rate to be 47% and over half of respondents believed that availability of IVF would encourage people to delay conception. Although 93% of respondents believed that IVF treatment should be publicly funded to some extent, a majority believed that secondary infertility or use of fertility treatments allowing to delay parenthood should be financed privately. Survey respondents believed that the mean number of stimulated IVF cycles funded publicly should be limited 2 to 3 (average 2.4). 79% of respondents were willing to pay for IVF if needed with a mean amount of 5,400 (SIC) for a child brought to life through IVF. According to respondents, mean minimum and maximum ages for IVF should be 29 and 42 years old, respectively. The current survey showed support for egg and sperm donation (78%), for IVF in single women (61%) and for same-sex female couples (64%). When analyzing the results per group (i.e., sex, age, sexual orientation, and countries), youngest age groups, homosexuals, bisexuals, German respondents, and men had similar overall positive attitudes and beliefs toward IVF and opinions on public funding. Perceived limits to availability were stronger in women. Conclusion Overall, the survey results demonstrate a positive attitude among respondents in an online panel toward IVF, gamete donation, and support for public funding for fertility treatment. These findings could potentially drive discussions between patients and prescribers to explore IVF treatment and among legislators and payers to support public funding for these procedures.	[Fauser, Bart C. J. M.] Univ Utrecht, Utrecht, Netherlands; [Fauser, Bart C. J. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Boivin, Jacky] Cardiff Univ, Coll Biomed & Life Sci, Cardiff Fertil Studies Res Grp Sch Psychol, Cardiff, S Glam, Wales; [Barri, Pedro N.] Hosp Univ Dexeus, Dept Obstet Gynecol & Reprod, Barcelona, Spain; [Tarlatzis, Basil C.] Aristotle Univ Thessaloniki, Sch Med, Thessaloniki, Greece; [Schmidt, Lone] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Levy-Toledano, Rachel] Theramex HQ UK Ltd, London, England	Utrecht University; Utrecht University; Utrecht University Medical Center; Cardiff University; Aristotle University of Thessaloniki; University of Copenhagen	Fauser, BCJM (corresponding author), Univ Utrecht, Utrecht, Netherlands.; Fauser, BCJM (corresponding author), Univ Med Ctr Utrecht, Utrecht, Netherlands.	b.c.fauser@umcutrecht.nl		Schmidt, Lone/0000-0002-9518-1734	Teva Pharmaceuticals Europe; Theramex HQ UK Limited	Teva Pharmaceuticals Europe(Teva Pharmaceutical Industries); Theramex HQ UK Limited	This study was sponsored and funded by Teva Pharmaceuticals Europe, Women's Health Division (now Theramex HQ UK Limited). The study was designed by academic investigators and by representatives of the sponsor, Teva Pharmaceuticals Europe. Statistical analysis was completed by Renee Wurth, PhD and all authors. All authors contributed to the interpretation of data and writing or critically reviewing and revising the manuscript. All authors had access to the data, take complete responsibility for the integrity of the data and accuracy of the data analysis and take final responsibility to submit for publication. Teva Pharmaceuticals Europe and Theramex HQ UK Limited provided support in the form of honoraria for author RLT, but did not have any additional role in the, data collection, decision to publish, or preparation of the manuscript. All academic authors did not receive any financial compensation for their efforts in relation to this publication. The specific roles of these authors are articulated in the ` author contributions' section.	Aarts JWM, 2012, HUM REPROD UPDATE, V18, P211, DOI 10.1093/humupd/dmr045; Aarts JWM, 2011, HUM REPROD, V26, P1119, DOI 10.1093/humrep/der054; Adamson GD, 2013, FERTIL STERIL, V100, pS42, DOI 10.1016/j.fertnstert.2013.07.1807; Adashi EY, 2000, HUM REPROD, V15, P330; Ali S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-760; Blazeviciene A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-26; Brigham KB, 2013, HUM REPROD, V28, P666, DOI 10.1093/humrep/des418; Bunting L, 2013, HUM REPROD, V28, P385, DOI 10.1093/humrep/des402; Chambers GM, 2014, FERTIL STERIL, V101, P191, DOI 10.1016/j.fertnstert.2013.09.005; Chan CHY, 2015, HUM REPROD, V30, P364, DOI 10.1093/humrep/deu324; Childress KJ, 2015, FERTIL STERIL, V104, P180, DOI 10.1016/j.fertnstert.2015.04.002; Daniluk JC, 2013, FERTIL STERIL, V99, P839, DOI 10.1016/j.fertnstert.2012.10.033; Domar A, 2012, HUM REPROD, V27, P1073, DOI 10.1093/humrep/des016; Dyer S, 2016, HUM REPROD, V31, P1588, DOI 10.1093/humrep/dew082; Eisenberg ML, 2010, FERTIL STERIL, V94, P921, DOI 10.1016/j.fertnstert.2009.04.049; ESHRE and Fertility Europe, POL AUD FERT AN 9 EU; European IVF-monitoring Consortium (EIM), 2017, Hum Reprod, V32, P1957, DOI 10.1093/humrep/dex264; GENUIS SJ, 1993, CAN MED ASSOC J, V149, P153; Gerhard R, 2014, ASIAN J ANDROL, V16, P858, DOI 10.4103/1008-682X.132782; Gezinski LB, 2016, HEALTH SOC WORK, V41, P75, DOI 10.1093/hsw/hlw005; ICC/ ESOMAR. ICC/ ESOMAR international code on market, ICC ESOMAR INT COD M; Kudesia R, 2017, FERTIL STERIL, V108, P711, DOI 10.1016/j.fertnstert.2017.07.1158; Lampic C, 2006, HUM REPROD, V21, P558, DOI 10.1093/humrep/dei367; Market Research Society, MRS COD COND 2014; Meissner C, 2016, J ASSIST REPROD GEN, V33, P719, DOI 10.1007/s10815-016-0717-1; Nouri K, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-94; Peterson BD, 2012, HUM REPROD, V27, P1375, DOI 10.1093/humrep/des011; Settumba SN, 2018, APPL HLTH EC HLTH PO; Wennberg AL, 2016, ACTA OBSTET GYN SCAN, V95, P38, DOI 10.1111/aogs.12781; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	30	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211150	10.1371/journal.pone.0211150	http://dx.doi.org/10.1371/journal.pone.0211150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682152	Green Published, gold, Green Accepted			2022-12-27	WOS:000457037500113
J	Koeppen, K; Barnaby, R; Jackson, AA; Gerber, SA; Hogan, DA; Stanton, BA				Koeppen, Katja; Barnaby, Roxanna; Jackson, Angelyca A.; Gerber, Scott A.; Hogan, Deborah A.; Stanton, Bruce A.			Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles	PLOS ONE			English	Article							CYSTIC-FIBROSIS; INHALED TOBRAMYCIN; ALKALINE PROTEASE; BIOFILM FORMATION; GENE-EXPRESSION; ACTIVATION; CFTR; AZTREONAM; TRANSPORT; PROTEINS	Tobramycin is commonly used to treat Pseudomonas aeruginosa lung infections in patients with Cystic Fibrosis (CF). Tobramycin treatment leads to increased lung function and fewer clinical exacerbations in CF patients, and modestly reduces the density of P. aeruginosa in the lungs. P. aeruginosa resides primarily in the mucus overlying lung epithelial cells and secretes outer membrane vesicles (OMVs) that diffuse through the mucus and fuse with airway epithelial cells, thus delivering virulence factors into the cytoplasm that modify the innate immune response. The goal of this study was to test the hypothesis that Tobramycin reduces the abundance of virulence factors in OMVs secreted by P. aeruginosa. Characterization of the proteome of OMVs isolated from control or Tobramycin-exposed P. aeruginosa strain PAO1 revealed that Tobramycin reduced several OMV-associated virulence determinants, including AprA, an alkaline protease that enhances P. aeruginosa survival in the lung, and is predicted to contribute to the inhibitory effect of P. aeruginosa on Phe508del-CFTR Cl(-)secretion by primary human bronchial epithelial cells. Deletion of the gene encoding AprA reduced the inhibitory effect of P. aeruginosa on Phe508del-CFTR Cl- secretion. Moreover, as predicted by our proteomic analysis, OMVs isolated from Tobramycin treated P. aeruginosa had a diminished inhibitory effect on Phe508del-CFTR Cl- secretion compared to OMVs isolated from control P. aeruginosa. Taken together, our proteomic analysis of OMVs and biological validation suggest that Tobramycin may improve lung function in CF patients infected with P. aeruginosa by reducing several key virulence factors in OMVs that reduce CFTR Cl- secretion, which is essential for bacterial clearance from the lungs.	[Koeppen, Katja; Barnaby, Roxanna; Jackson, Angelyca A.; Hogan, Deborah A.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Gerber, Scott A.] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA	Dartmouth College; Dartmouth College	Koeppen, K (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	Katja.UU.Koeppen@Dartmouth.edu		Gerber, Scott/0000-0002-2964-5051	Cystic Fibrosis Foundation [STANTO16G0, STANTO19R0]; National Institutes of Health [R01-HL-074175, P30-GM106394, R01-AI091702, R01-GM122846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394, R01GM122846] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Cystic Fibrosis Foundation (www.cff.org), STANTO16G0 and STANTO19R0 to BAS as well as the National Institutes of Health (www.nih.gov), R01-HL-074175 and P30-GM106394 to BAS, R01-AI091702 to DAH, and R01-GM122846 to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; Reales-Calderon JA, 2015, J PROTEOMICS, V127, P352, DOI 10.1016/j.jprot.2015.06.009; Ballok AE, 2014, J BACTERIOL, V196, P3633, DOI 10.1128/JB.01760-14; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Butterworth MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100313; Butterworth MB, 2012, J BIOL CHEM, V287, P32556, DOI 10.1074/jbc.M112.369520; Chen H P, 2016, APPL SCI, V179, P1, DOI DOI 10.1038/SREP28902; Choi DS, 2011, PROTEOMICS, V11, P3424, DOI 10.1002/pmic.201000212; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Firoved AM, 2003, J BACTERIOL, V185, P1071, DOI 10.1128/JB.185.3.1071-1081.2003; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Hampton CM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02177; Hodson M E, 2002, J Cyst Fibros, V1, P199, DOI 10.1016/S1569-1993(02)00004-8; Hodson ME, 2002, EUR RESPIR J, V20, P658, DOI 10.1183/09031936.02.00248102; Hvorecny KL, 2018, AM J PHYSIOL-LUNG C, V314, pL150, DOI 10.1152/ajplung.00383.2017; Jackson AA, 2014, MICROBIOL-SGM, V160, P2215, DOI 10.1099/mic.0.081158-0; JAFFARBANDJEE MC, 1995, J CLIN MICROBIOL, V33, P924, DOI 10.1128/JCM.33.4.924-929.1995; Klimentova J, 2015, MICROBIOL RES, V170, P1, DOI 10.1016/j.micres.2014.09.006; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Lee SA, 2018, DEV COMP IMMUNOL, V81, P116, DOI 10.1016/j.dci.2017.11.014; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Maille E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00470; McFarland KA, 2015, P NATL ACAD SCI USA, V112, P8433, DOI 10.1073/pnas.1506299112; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Moss RB, 2002, CHEST, V121, P55, DOI 10.1378/chest.121.1.55; Trinh NTN, 2015, EUR RESPIR J, V45, P1590, DOI 10.1183/09031936.00076214; Park AJ, 2015, J PROTEOME RES, V14, P4524, DOI 10.1021/acs.jproteome.5b00262; Perez-Cruz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116896; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; READ RC, 1992, J APPL PHYSIOL, V72, P2271, DOI 10.1152/jappl.1992.72.6.2271; Rubino R, 2014, PFLUG ARCH EUR J PHY, V466, P2269, DOI 10.1007/s00424-014-1474-6; Saint-Criq V, 2018, THORAX, V73, P49, DOI 10.1136/thoraxjnl-2017-210298; Saint-Criq V, 2017, CELL MOL LIFE SCI, V74, P93, DOI 10.1007/s00018-016-2391-y; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; Stanton BA, 2017, AM J PHYSIOL-CELL PH, V312, pC357, DOI 10.1152/ajpcell.00373.2016; Stanton BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127742; Talebian L, 2009, CELL PHYSIOL BIOCHEM, V23, P199, DOI 10.1159/000204108; Team R Core, 2017, R LANG ENV STAT COMP; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Valot B, 2011, PROTEOMICS, V11, P3572, DOI 10.1002/pmic.201100120; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Wu X, 2015, MOL CELL PROTEOMICS, V14, P2126, DOI 10.1074/mcp.M115.050161; Yu QR, 2012, J ANTIMICROB CHEMOTH, V67, P2673, DOI 10.1093/jac/dks296; Zhang AD, 2012, EUKARYOT CELL, V11, P874, DOI 10.1128/EC.00095-12	60	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211290	10.1371/journal.pone.0211290	http://dx.doi.org/10.1371/journal.pone.0211290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682135	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500144
J	Liu, SM; Li, SP; Li, YJ; Wang, HP; Zhao, JJ; Chen, G				Liu, Shimeng; Li, Shunping; Li, Yujia; Wang, Haipeng; Zhao, Jingjing; Chen, Gang			Job preferences for healthcare administration students in China: A discrete choice experiment	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; HUMAN-RESOURCES; MEDICAL-STUDENTS; RURAL-AREAS; RETENTION; SATISFACTION; RECRUITMENT; MODELS; SYSTEM; REFORM	Background There is a deficiency of healthcare administrators in China as compared with other countries; furthermore, the distribution is unequal. To inform an effective policy intervention, it is crucial to understand healthcare administration students' career decision-making. This study aims to investigate the undergraduate students' stated preferences when choosing a job. Methods A discrete choice experiment (DCE) was conducted among a population-based multistage sample of 668 final year undergraduate healthcare administration students during April to June 2017 in eight universities of China to elicit their job preferences. Attributes include location, monthly income, bianzhi (which refers to the established posts and can be loosely regarded as state administrative staffing), training and career development opportunity, working environment and workload. Conditional and mixed logit models were used to analyze the relative importance of job attributes. Results All six attributes were statistically significant with the expected sign and demonstrated the existence of preference heterogeneity. Monthly income, workload and working environment were of most concern to healthcare administration students when deciding their future. Among the presented attributes bianzhi was of the least concern. Sub-group analysis showed that students who have an urban background and/or with higher annual family incomes were willing to pay more for working in the city. In addition, students from western and middle universities valued bianzhi higher than students from eastern universities. Conclusions This is the first study focusing on the career decision-making of Chinese healthcare administration students at a critical career decision-making point. Both monetary and non-monetary interventions could be considered by policy-makers to attract students to work in health institutions, especially in rural and remote health institutions in China. There exists preference heterogeneity on healthcare administration students' job preferences, which should also be taken into account in developing more effective policy incentive packages.	[Liu, Shimeng; Li, Shunping; Li, Yujia; Wang, Haipeng] Shandong Univ, Sch Hlth Care Management, Jinan, Shandong, Peoples R China; [Liu, Shimeng; Li, Shunping; Li, Yujia; Wang, Haipeng; Zhao, Jingjing] Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan, Shandong, Peoples R China; [Zhao, Jingjing] Shandong Univ, Sch Publ Hlth, Jinan, Shandong, Peoples R China; [Chen, Gang] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia	Shandong University; Shandong University; Shandong University; Flinders University South Australia	Li, SP (corresponding author), Shandong Univ, Sch Hlth Care Management, Jinan, Shandong, Peoples R China.; Li, SP (corresponding author), Shandong Univ, NHC Key Lab Hlth Econ & Policy Res, Jinan, Shandong, Peoples R China.	lishunping@sdu.edu.cn		Chen, Gang/0000-0002-8385-5965	Cheeloo College of Medicine, Shandong University [QLYXJY-201875]	Cheeloo College of Medicine, Shandong University	This project was funded by Cheeloo College of Medicine, Shandong University (QLYXJY-201875). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Healthcare Executives (ACHE), 2013, COD OF ETH; Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; Araujoa Edson C., 2013, RECRUIT RETAIN HLTH, DOI [10.13140/RG.2.2.34680.55041, DOI 10.13140/RG.2.2.34680.55041]; Bennett J., 2001, CHOICE MODELLING APP; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Brodsgaard KE, 2002, CHINA QUART, P361; Brooks RG, 2002, ACAD MED, V77, P790, DOI 10.1097/00001888-200208000-00008; Charles Donnetta M, 2005, Aust J Rural Health, V13, P331, DOI 10.1111/j.1440-1584.2005.00731.x; Chen J, 1987, CHINESE J SOCIAL MED, V03, P40; Cheng J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-15; Cleland JA, 2017, MED EDUC, V51, P839, DOI 10.1111/medu.13257; de Bekker-Grob EW, 2015, PATIENT, V8, P373, DOI 10.1007/s40271-015-0118-z; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Vries E, 2003, SAMJ S AFR MED J, V93, P789; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; Efendi F, 2016, INT J HEALTH PLAN M, V31, P430, DOI 10.1002/hpm.2289; Grobler L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005314.pub3; Haddock CC, 2002, CAREERS HEALTHCARE M; Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004; Hensher DA, 2012, TRANSPORT RES A-POL, V46, P480, DOI 10.1016/j.tra.2011.11.007; Hole AR, 2007, HEALTH ECON, V16, P827, DOI 10.1002/hec.1197; Hole AR, 2012, EMPIR ECON, V42, P445, DOI 10.1007/s00181-011-0500-1; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Hou JL, 2015, INT J HEALTH POLICY, V4, P327, DOI 10.15171/ijhpm.2015.57; Huang R., 2009, J NANJING COLL POPUL, V25, P5; Huicho L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050315; Kolstad JR, 2011, HEALTH ECON, V20, P196, DOI 10.1002/hec.1581; Kruk ME, 2010, B WORLD HEALTH ORGAN, V88, P333, DOI 10.2471/BLT.09.072892; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Liang W.N., 2017, HLTH CARE ADM, V4th; Liang YQ, 2016, CHINA HLTH IND, V13, P94; Liu SM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012358; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Mangham LJ, 2008, TROP MED INT HEALTH, V13, P1433, DOI 10.1111/j.1365-3156.2008.02167.x; Marshall HS, 2016, VACCINE, V34, P671, DOI 10.1016/j.vaccine.2015.11.075; McFadden D, 2000, J APPL ECONOMET, V15, P447, DOI 10.1002/1099-1255(200009/10)15:5<447::AID-JAE570>3.0.CO;2-1; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Organisation for Economic Co-operation and Development, RIS HLTH COSTS PUT P; Park BH, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0156-1; Pearmain D, 1991, STATED PREFERENCE TE; Perkins D, 2007, AUST J RURAL HEALTH, V15, P94, DOI 10.1111/j.1440-1584.2007.00860.x; Rabinowitz HK, 2005, ACAD MED, V80, P728, DOI 10.1097/00001888-200508000-00004; Richards Helen M, 2005, Rural Remote Health, V5, P365; Rockers PC, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-22; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Salampessy BH, 2015, PATIENT, V8, P521, DOI 10.1007/s40271-015-0115-2; Shi LY, 2014, PRIM HEALTH CARE RES, V15, P46, DOI 10.1017/S1463423612000692; Simoens S, 2002, SCOT MED J, V47, DOI 10.1177/003693300204700403; Smith D, 2012, SCI WORLD J, DOI 10.1100/2012/805659; Smitz MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165940; Song KM, 2015, HEALTH POLICY PLANN, V30, P68, DOI 10.1093/heapol/czt098; Takemura T, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-015-0097-0; Vujicic M, 2011, SOC SCI MED, V73, P970, DOI 10.1016/j.socscimed.2011.06.010; Wang Q., 2010, CHINA HIGH MED ED, V7, P3; Wang SL, 2011, RISUS, V2, P28; Weil TP, 2013, HEALTH SERV MANAG RE, V26, P76, DOI 10.1177/0951484813512288; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Wu D., 2017, CHIN GEN PRACT, V20, P3759; Xia BJ, 2011, CHINESE HOSP, V15, P16; Xia X, 2011, MED SOC, V24; [闫镝 Yan Di], 2014, [中国卫生政策研究, Chinese Journal of Health Policy], V7, P44; Yang Q, 2014, INT J HEALTH POLICY, V3, P359, DOI 10.15171/ijhpm.2014.129; Zhao Y, 2010, RESEARCHES MED ED, V9, P1599; Zhou KY, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0089-0	67	6	6	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211345	10.1371/journal.pone.0211345	http://dx.doi.org/10.1371/journal.pone.0211345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682170	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500152
J	Ong, IL; Dino, MJS; Calimag, MMP; Hidalgo, FA				Ong, Irvin L.; Dino, Michael Joseph S.; Calimag, Maria Minerva P.; Hidalgo, Fe A.			Development and validation of interprofessional learning assessment tool for health professionals in continuing professional development (CPD)	PLOS ONE			English	Article							MEDICAL-EDUCATION; NURSING-EDUCATION; COLLABORATION; SIMULATION; ATTITUDES; STUDENTS; EXPERIENCE; COMMUNICATION; COMPETENCE; PATIENT	Introduction Interprofessional learning (IPL) is increasingly recognized as a promising strategy in addressing the burgeoning challenges in healthcare. Its assessment remains to be perplexing and requires accurate measurements. Thus, this study intended to develop a valid and reliable reflective tool in assessing IPL as a Continuing Professional Development (CPD) outcome. Methods A one-group post-posttest pre-experimental design with tool development was employed to establish the validity and reliability of the "Inventory of Reflective Vignette-Interprofessional Learning" (IRV-IPL). This tool was developed from an extensive literature review and designed with three segments to assess interprofessional competencies before, after, and what if scenarios using vignettes. After it was validated by education experts (n = 5) and written consent forms were signed by the participants, the IRV-IPL was pilot tested among healthcare professionals (n = 10) for analysis and improvement. During the actual implementation, it was administered to healthcare professionals (n = 45) who participated in a university-provided CPD event. Collected data underwent validity and reliability testing. Results IRV-IPL generated excellent internal consistency (alpha = 0.98), and across all segments of collaboration (alpha = 0.96), coordination (alpha = 0.96), cooperation (alpha = 0.96), communication (alpha = 0.97), and commendation (alpha = 0.98). Items exhibited significantly positive large correlations (r > 0.35, p < 0.05) in all segments showing beneficial measures for postdictive validity in recalling prior interprofessional competencies, and predictive validity in estimating interprofessional learning as an outcome of CPD and alternative interventions. Conclusion This study provided a piece of groundwork evidence on the use of IRV-IPL as a reflective assessment tool for interprofessional learning in CPD contexts. Further studies are essential to explore the educational utility of IRV framework in crafting relevant assessments and to establish construct validity of IRV-IPL using exploratory and confirmatory factor analyses.	[Ong, Irvin L.; Dino, Michael Joseph S.; Calimag, Maria Minerva P.; Hidalgo, Fe A.] Univ Santo Tomas, Grad Sch, Manila, Philippines; [Ong, Irvin L.; Dino, Michael Joseph S.] Our Lady Fatima Univ, Res Dev & Innovat Ctr, Valenzuela City, Philippines; [Ong, Irvin L.; Dino, Michael Joseph S.] Sigma Theta Tau Int Honor Soc Nursing, Phi Gamma Chapter, Indianapolis, IN 46202 USA	University of Santo Tomas; Our Lady of Fatima University	Ong, IL (corresponding author), Univ Santo Tomas, Grad Sch, Manila, Philippines.; Ong, IL (corresponding author), Our Lady Fatima Univ, Res Dev & Innovat Ctr, Valenzuela City, Philippines.; Ong, IL (corresponding author), Sigma Theta Tau Int Honor Soc Nursing, Phi Gamma Chapter, Indianapolis, IN 46202 USA.	mr.irvinong@yahoo.com	DIÑO, MICHAEL JOSEPH/ABE-8983-2020; Calimag, Maria Minerva P./ABA-9839-2020; Diño, Michael Joseph/G-3947-2018; ONG, IRVIN/V-3629-2019	DIÑO, MICHAEL JOSEPH/0000-0003-1493-2549; Diño, Michael Joseph/0000-0003-1493-2549; ONG, IRVIN/0000-0001-7417-700X				Aase I, 2013, J INTERPROF CARE, V27, P238, DOI 10.3109/13561820.2012.745489; Agoritsas T, 2011, J CLIN EPIDEMIOL, V64, P107, DOI 10.1016/j.jclinepi.2010.02.007; American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Arif SA, 2014, CURR PHARM TEACH LEA, V6, P639, DOI 10.1016/j.cptl.2014.05.010; Axley L, 2008, NURS FORUM, V43, P214, DOI 10.1111/j.1744-6198.2008.00115.x; Balmer JT, 2014, J CONTIN EDUC NURS, V45, P153, DOI 10.3928/00220124-20140327-11; Balmer JT, 2013, ADV MED EDUC PRACT, V4, P171, DOI 10.2147/AMEP.S35087; Barr H., 2013, INTRO INTERPROFESSIO; Becker KL, 2014, JNP-J NURSE PRACT, V10, P240, DOI 10.1016/j.nurpra.2014.02.004; Bedwell WL, 2012, HUM RESOUR MANAGE R, V22, P128, DOI 10.1016/j.hrmr.2011.11.007; Bolderston A., 2007, J RADIOTHER PRACT, V6, DOI [10.1017/S1460396907005031, DOI 10.1017/S1460396907005031]; Bottenberg MM, 2013, CURR PHARM TEACH LEA, V5, P167, DOI 10.1016/j.cptl.2012.12.004; Braun HJ, 2015, INT J SURG, V13, P175, DOI 10.1016/j.ijsu.2014.11.032; Brock D, 2013, POSTGRAD MED J, V89, P642, DOI [10.1136/postgradmedj-2012-000952rep, 10.1136/bmjqs-2012-000952]; Busen NH, 2014, J PROF NURS, V30, P357, DOI 10.1016/j.profnurs.2014.01.002; Carvajal A, 2011, AN SIST SANIT NAVAR, V34, P63, DOI 10.4321/s1137-66272011000100007; Chipchase LS, 2012, MANUAL THER, V17, P89, DOI 10.1016/j.math.2011.09.004; Coleman M. T., 2017, J INTERPROF CARE, V8, P28, DOI [DOI 10.1016/J.XJEP.2017.05.003, 10.1016/j.xjep.2017.05.003]; Colon-Emeric CS, 2018, J AM MED DIR ASSOC, V19, P405, DOI 10.1016/j.jamda.2017.10.018; Committee on Measuring the Impact of Interprofessional Education on Collaborative Practice and Patient Outcomes Board of Global Health Institute of Medicine, 2015, MEASURING IMPACT INT, DOI [10.17226/21726, DOI 10.17226/21726]; Cruz-Correia R, 2014, PROC TECH, V16, P1367, DOI 10.1016/j.protcy.2014.10.154; Curran V, 2011, J INTERPROF CARE, V25, P339, DOI 10.3109/13561820.2011.589542; Das J, 2005, J DEV ECON, V78, P348, DOI 10.1016/j.jdeveco.2004.11.004; Davis LI, 2015, CURR PHARM TEACH LEA, V7, P169, DOI 10.1016/j.cptl.2014.11.017; de Voest M, 2013, CURR PHARM TEACH LEA, V5, P450, DOI 10.1016/j.cptl.2013.06.004; DePoy E., 2015, INTRO RES UNDERSTAND, V5th; Derbyshire JA, 2015, NURS EDUC TODAY, V35, P50, DOI 10.1016/j.nedt.2014.05.001; Dowd JJ, 2003, SOCIAL IDENTITIES LI; Failla KR, 2014, CLIN SIMUL NURS, V10, P574, DOI 10.1016/j.ecns.2014.07.006; Garrido M, 2014, CLIN SIMUL NURS, V10, P461, DOI 10.1016/j.ecns.2014.06.001; Gilbert JHV, 2013, J INTERPROF CARE, V27, P283, DOI 10.3109/13561820.2012.755807; Granheim BM, 2018, NURS EDUC TODAY, V62, P118, DOI 10.1016/j.nedt.2017.12.021; Grol-Prokopczyk H, 2015, DEMOGRAPHY, V52, P1703, DOI 10.1007/s13524-015-0422-1; Hays R, 2013, CLIN TEACH, V10, P339, DOI 10.1111/tct.12115; Hayward Mark F, 2014, BMC Med Educ, V14, P1049, DOI 10.1186/s12909-014-0279-9; Heinemann GD, 1999, EVAL HEALTH PROF, V22, P123, DOI 10.1177/01632789922034202; Hood K, 2014, NURSE EDUC PRACT, V14, P117, DOI 10.1016/j.nepr.2013.07.013; Hylin U, 2011, MED TEACH, V33, pE204, DOI 10.3109/0142159X.2011.557410; Jogerst K, 2015, ANN GLOB HEALTH, V81, P239, DOI 10.1016/j.aogh.2015.03.006; Judge MP, 2015, Int J Nurs Sci, V2, P248, DOI 10.1016/j.ijnss.2015.07.007; Kelly-Irving M, 2017, ADV LIFE COURSE RES, V32, P35, DOI 10.1016/j.alcr.2016.09.001; Kenaszchuk C, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-83; Ketcherside M, 2017, J PROF NURS, V33, P370, DOI 10.1016/j.profnurs.2017.03.002; King PK, 2014, CURR PHARM TEACH LEA, V6, P558, DOI 10.1016/j.cptl.2014.03.004; Knott RJ, 2017, SOC SCI MED, V190, P247, DOI 10.1016/j.socscimed.2017.08.033; Kumar S, 2014, INTERNET HIGH EDUC, V21, P60, DOI 10.1016/j.iheduc.2013.11.001; Lagan C, 2013, J SURG EDUC, V70, P95, DOI 10.1016/j.jsurg.2012.06.018; Lapkin S, 2013, NURS EDUC TODAY, V33, P90, DOI 10.1016/j.nedt.2011.11.006; Lavrakas PJ, 2008, ENCY SURVEY RES METH, DOI DOI 10.1371/journal.pone.0073008; Lawson C, 2015, RADIOGRAPHY, V21, pE74, DOI 10.1016/j.radi.2014.11.006; MacDonald CJ, 2010, J RES INTERPROFESSIO, V1; MacDonald Colla J, 2009, Int J Electron Healthc, V5, P33, DOI 10.1504/IJEH.2009.026271; Mann JE, 2018, RES SOC ADMIN PHARM, V14, P595, DOI 10.1016/j.sapharm.2017.07.008; Mann K., 2009, LEARNING HLTH SOCIAL, V8, P154, DOI [https://doi.org/10.1111/j.1473-6861.2008.00207.x, DOI 10.1111/J.1473-6861.2008.00207.X]; Martin, 2004, METHODS TESTING EVAL, P149, DOI [10.1002/0471654728.CH8, DOI 10.1002/0471654728.CH8]; McAllister S, 2010, INT J LANG COMM DIS, V45, P1, DOI 10.3109/13682820902745461; McFadyen A K, 2005, J Interprof Care, V19, P595; McFadyen A K, 2007, J Interprof Care, V21, P433, DOI 10.1080/13561820701352531; Morison S.L., 2005, LEARNING HLTH SOCIAL, V4, P192, DOI [https://doi.org/10.1111/j.1473-6861.2005.00103.x, DOI 10.1111/J.1473-6861.2005.00103.X]; National Research Council (U.S.) Institute of Medicine (U.S.), 2004, HLTH PROFESSIONS ED; Nelson M, 1997, DESIGN CONCEPTS NUTR, P241, DOI DOI 10.1093/ACPROF:OSO/9780192627391.003.0008; Orchard CA, 2012, J CONTIN EDUC HEALTH, V32, P58, DOI 10.1002/chp.21123; Packard K., 2016, J INTERPROF CARE, V4, P69, DOI [10.1016/j.xjep.2016.06.005, DOI 10.1016/J.XJEP.2016.06.005]; Peeters MJ, 2017, CURR PHARM TEACH LEA, V9, P925, DOI 10.1016/j.cptl.2017.06.001; Pfaff MA, 2014, TEACH LEARN NURS, V9, P108, DOI 10.1016/j.teln.2014.02.001; Riley BA, 2017, INT J OSTEOPATH MED, V23, P36, DOI 10.1016/j.ijosm.2016.07.001; Ruzafa-Martinez M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-19; Shaidullin RN, 2014, PROCD SOC BEHV, V131, P105, DOI 10.1016/j.sbspro.2014.04.087; Shrader S, 2017, AM J PHARM EDUC, V81, DOI 10.5688/ajpe816119; Sierpina VS, 2014, EXPLORE-NY, V10, P265, DOI 10.1016/j.explore.2014.04.011; Simmons B, 2011, J INTERPROF CARE, V25, P73, DOI 10.3109/13561820.2010.483746; Simmons B, 2009, J CONTIN EDUC HEALTH, V29, P168, DOI 10.1002/chp.20031; Skuladottir H, 2016, NURSE EDUC PRACT, V20, P31, DOI 10.1016/j.nepr.2016.06.008; Spoelstra H, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-14; Steel A, 2014, ADV INTEGR MED, V1, P17, DOI 10.1016/j.aimed.2013.05.001; Stone J, 2010, MED EDUC, V44, P396, DOI 10.1111/j.1365-2923.2009.03607.x; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; Watts P, 2014, CLIN SIMUL NURS, V10, P521, DOI 10.1016/j.ecns.2014.05.004; Wilson L, 2014, J LAW MED ETHICS, V42, P26, DOI 10.1111/jlme.12184; Wong AKC, 2017, NURS EDUC TODAY, V53, P13, DOI 10.1016/j.nedt.2017.03.004; World Health Organization, 2013, WHO GUID 2013; Yorke M, 2003, HIGH EDUC, V45, P477, DOI 10.1023/A:1023967026413	82	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211405	10.1371/journal.pone.0211405	http://dx.doi.org/10.1371/journal.pone.0211405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682137	Green Published, gold			2022-12-27	WOS:000457037500166
J	Rodriguez, P; Ochoa-Ochoa, LM; Munguia, M; Sanchez-Cordero, V; Navarro-Siguenza, AG; Flores-Villela, OA; Nakamura, M				Rodriguez, Pilar; Ochoa-Ochoa, Leticia M.; Munguia, Mariana; Sanchez-Cordero, Victor; Navarro-Siguenza, Adolfo G.; Flores-Villela, Oscar A.; Nakamura, Miguel			Environmental heterogeneity explains coarse-scale beta-diversity of terrestrial vertebrates in Mexico	PLOS ONE			English	Article							GLOBAL PATTERNS; TURNOVER; CLIMATE; DISTRIBUTIONS; COMPONENTS; RICHNESS; RANGE	We explored the hypothesis that high beta-diversity of terrestrial vertebrates of Mexico is associated with a high environmental heterogeneity (HEH) and identify the drivers of beta-diversity at different spatial scales. We used distribution range maps of 2,513 species of amphibians, reptiles, mammals, and birds occurring in Mexico. We estimated beta-diversity for each taxon at four spatial scales (grid cells of 2 degrees, 1 degrees,0.5 degrees and 0.25 degrees) using the multiplicative formula of Whittaker beta(w). For each spatial scale, we derived 10 variables of environmental heterogeneity among cells based on raw data of temperature, precipitation, elevation, vegetation and soil. We applied conditional autoregressive models (CAR) to identify the drivers of beta-diversity for each taxon at each spatial scale. CARs increased in explanatory power from fine-to-coarse spatial scales in amphibians, reptiles and mammals. The heterogeneity in precipitation including both, coefficient of variation (CV) and range of values (ROV), resulted in the most important drivers of beta-diversity of amphibians; the heterogeneity in temperature (CV) and elevation (ROV) were the most important drivers of beta-diversity for reptiles; the heterogeneity in temperature (ROV) resulted in the most important driver in beta-diversity for mammals. For birds, CARs resulted significant at fine scales (grid cells of 0.5 degrees and 0.25 degrees), and the precipitation (ROV and CV), temperature (ROV), and vegetation (H) and soil (H) were heterogeneity variables retained in the model. We found support for the hypothesis of environmental heterogeneity (HEH) for terrestrial vertebrates at coarse scales (grid cell of 2 degrees). Different variables of heterogeneity, mainly abiotic, were significant for each taxon, reflecting physiological differences among terrestrial vertebrate groups. Our study revealed the importance of mountain areas in the geographic patterns of beta-diversity of terrestrial vertebrates in Mexico. At a coarse scale, specific variables of heterogeneity can be used as a proxy of beta-diversity for amphibians and reptiles.	[Rodriguez, Pilar; Munguia, Mariana] Comis Nacl Conocimiento & Uso Biodiversidad, Mexico City, DF, Mexico; [Ochoa-Ochoa, Leticia M.; Navarro-Siguenza, Adolfo G.; Flores-Villela, Oscar A.] Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool, Mexico City, DF, Mexico; [Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico; [Nakamura, Miguel] Asociac Ci, Ctr Invest Matemat, Guanajuato, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; CIMAT - Centro de Investigacion en Matematicas	Ochoa-Ochoa, LM (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Museo Zool, Mexico City, DF, Mexico.	leticia.ochoa@ciencias.unam.mx	Ochoa-Ochoa, Leticia/C-5849-2015	Ochoa-Ochoa, Leticia/0000-0002-9846-4596	DGAPA-UNAM Posdoctoral fellowship	DGAPA-UNAM Posdoctoral fellowship	DGAPA-UNAM Posdoctoral fellowship to LMO-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Arita H. T, 1993, CIENCIAS, V7, P13; Arita HT, 1997, BIODIVERS CONSERV, V6, P787, DOI 10.1023/B:BIOC.0000010402.08813.ab; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Arita HT, 1997, CONSERV BIOL, V11, P92, DOI 10.1046/j.1523-1739.1997.95274.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; Bivand R. S., 2013, APPL SPATIAL DATA AN, V10, P1, DOI DOI 10.1007/978-0-387-78171-6; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Calderon-Patron JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082905; Ceballos G., 2002, MAMMALS MEXICO COMPO, P28; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Flores-Villela O, 2014, REV MEX BIODIVERS, V85, pS467, DOI 10.7550/rmb.43236; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston KJ, 2007, SCALING BIODIVERSITY, DOI [10.1017/cbo9780511814938.012, DOI 10.1017/CBO9780511814938.012, 10.1017/CBO9780511814938.012]; Harrison S., 1993, BIOTIC INTERACTIONS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Koleff P., 2008, CAPITAL NATURAL ME X; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Lira-Noriega A, 2007, DIVERS DISTRIB, V13, P185, DOI 10.1111/j.1472-4642.2006.00304.x; Lopez-Gonzalez C, 2015, ECOGRAPHY, V38, P261, DOI 10.1111/ecog.00813; Martin B, 2015, ACTA OECOL, V68, P1, DOI 10.1016/j.actao.2015.06.006; Mazel F, 2017, GLOBAL ECOL BIOGEOGR, V26, P1211, DOI 10.1111/geb.12632; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Munguia M, 2008, J BIOGEOGR, V35, P1879, DOI 10.1111/j.1365-2699.2008.01921.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Navarro S. Adolfo G., 2003, Bulletin of the British Ornithologists' Club, V123A, P207; Ochoa-Ochoa LM, 2014, REV MEX BIODIVERS, V85, P918, DOI 10.7550/rmb.38737; Ochoa-Ochoa LM, 2014, BIOL J LINN SOC, V111, P305, DOI 10.1111/bij.12201; Ochoa-Ochoa LM., 2006, AREAS DIVERSIDAD END; Ortega J, 1998, J MAMMAL, V79, P772, DOI 10.2307/1383088; Parra-Olea G, 2014, REV MEX BIODIVERS, V85, pS460, DOI 10.7550/rmb.32027; Penone C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1028; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Stein A, 2015, BIOL REV, V90, P815, DOI 10.1111/brv.12135; Team RC., 2013, R LANG ENV STAT COMP; Vitt L.J., 2013, HERPETOLOGY INTRO BI, DOI [10.1016/C2010-0-67152-5, DOI 10.1016/C2010-0-67152-5]; Waller LA, 2004, WILEY SERIES PROBABI, DOI [10.1198/jasa.2005.s15, DOI 10.1198/JASA.2005.S15]; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563	44	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210890	10.1371/journal.pone.0210890	http://dx.doi.org/10.1371/journal.pone.0210890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682061	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500073
J	Zhang, X; Ma, L; Wang, ZY; Xing, H				Zhang Xin; Ma Liang; Wang Zhanyou; Xing Hua			Psychosocial factors influencing shared bicycle travel choices among Chinese: An application of theory planned behavior	PLOS ONE			English	Article							PSYCHOLOGICAL-FACTORS; MEDICATION ADHERENCE; GENDER-DIFFERENCES; EXTENDED THEORY; TECHNOLOGY; INTENTIONS; HABITS; MODEL; USERS; AGE	The worldwide rise of shared bicycle use has changed the way people travel. Here we analyze shared bicycle use from the perspective of the theory of planned behavior, and propose a model to investigate factors influencing shared bicycle usage in China. A total of 211 shared bicycle users selected from 28 provinces throughout China completed a self-reported survey. Structural equation modelling (SEM) was used to delineate the pathway from shared bicycle usage. The SEM model demonstrated that: (1) shared bicycle use intention was significantly associated with four variables, namely travel attitude(beta = 0.491, t = 24.569), social norms(beta = 0.149, t = 6.771), travel habits(beta = 0.146, t = 7.226) and perceived behavioral control (beta = 0.190, t = 11.110); (2) shared bicycle use behavior was significantly affected by shared bicycle use intention(beta = 0.406, t = 15.936), and also by travel habits(beta = 0.320, t = 11.921); (3) shared bicycle use behavior was also affected by demographic variables (gender, age) and situational factors (distance). The conclusions of this study provide useful data for operators of bicycle services and government policy makers.	[Zhang Xin; Ma Liang; Wang Zhanyou; Xing Hua] Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China; [Wang Zhanyou] Shandong Management Univ, Off Acad Res, Jinan, Shandong, Peoples R China; [Xing Hua] Shandong Technol & Business Univ, Comp Sci & Technol, Yantai, Peoples R China	Shandong University of Finance & Economics; Shandong Management University; Shandong Technology & Business University	Ma, L (corresponding author), Shandong Univ Finance & Econ, Sch Management Sci & Engn, Jinan, Shandong, Peoples R China.	maliang1010@126.com	Ma, Liang/HCH-4858-2022		National Social Science Foundation of China [16AJY003, 17BGL198, 18BGL263]	National Social Science Foundation of China	This work was supported by National Social Science Foundation of China under project number 16AJY003, 17BGL198, 18BGL263.	Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Azjen I, 1991, BRIT J SOC PSYCHOL, V40, P471; Baker Elizabeth White, 2007, Information Technology & People, V20, P352, DOI 10.1108/09593840710839798; Barnes R, 2016, J TRANSP HEALTH, V3, P513, DOI 10.1016/j.jth.2016.03.003; Chaney RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188053; Chen CF, 2011, TRANSPORT RES F-TRAF, V14, P128, DOI 10.1016/j.trf.2010.11.006; Chen IYL, 2010, J INF SCI, V33, P451; Chen SY, 2016, TRANSPORT RES A-POL, V88, P58, DOI 10.1016/j.tra.2016.03.008; Chen XG, 2013, INT J INFORM MANAGE, V33, P917, DOI 10.1016/j.ijinfomgt.2013.08.010; CNNIC, 2018, 42 STAT REP DEV CHIN; Courtois C, 2014, COMPUT HUM BEHAV, V35, P278, DOI 10.1016/j.chb.2014.03.017; Donald IJ, 2014, J ENVIRON PSYCHOL, V40, P39, DOI 10.1016/j.jenvp.2014.03.003; El-Assi W, 2017, TRANSPORTATION, V44, P589, DOI 10.1007/s11116-015-9669-z; Elias W, 2015, TRANSPORT POLICY, V44, P19, DOI 10.1016/j.tranpol.2015.07.001; Fishbein M., 1975, PHILOS RHETORIC, V41, P842, DOI [DOI 10.1037/H0076477, 10.1037/h0076477]; Fu XM, 2017, TRANSPORTATION, V44, P91, DOI 10.1007/s11116-015-9626-x; GORDON P, 1989, REG STUD, V23, P499, DOI 10.1080/00343408912331345672; Guo YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185100; Hackbarth G, 2003, INFORM MANAGE-AMSTER, V40, P221, DOI 10.1016/S0378-7206(02)00006-X; Hair J. F., 2009, MULTIVARIATE DATA AN; Han H, 2010, TOURISM MANAGE, V31, P325, DOI 10.1016/j.tourman.2009.03.013; Harland P, 1999, J APPL SOC PSYCHOL, V29, P2505, DOI 10.1111/j.1559-1816.1999.tb00123.x; Hart PS, 2011, SCI COMMUN, V33, P28, DOI 10.1177/1075547010366400; Hsiao CH, 2010, TRANSPORT RES F-TRAF, V13, P277, DOI 10.1016/j.trf.2010.04.011; Hsu MK, 2010, INT J RETAIL DISTRIB, V38, P115, DOI 10.1108/09590551011020129; Hunecke M, 2007, J ENVIRON PSYCHOL, V27, P277, DOI 10.1016/j.jenvp.2007.08.001; Hung K, 2012, TOURISM MANAGE, V33, P855, DOI 10.1016/j.tourman.2011.09.007; Irawan M. Z., 2011, J SUSTAINABLE DEV, V4, P45, DOI DOI 10.5539/jsd.v4n1p45; Jappinen S, 2013, APPL GEOGR, V43, P13, DOI 10.1016/j.apgeog.2013.05.010; Ji YJ, 2017, INT J SUSTAIN TRANSP, V11, P308, DOI 10.1080/15568318.2016.1253802; Jun J, 2016, INT J HOSP MANAG, V53, P106, DOI 10.1016/j.ijhm.2015.12.002; Kaplan S, 2015, TOURISM MANAGE, V47, P34, DOI 10.1016/j.tourman.2014.08.017; Keil M, 2000, MIS QUART, V24, P299, DOI 10.2307/3250940; Khalifa M, 2007, EUR J INFORM SYST, V16, P780, DOI 10.1057/palgrave.ejis.3000711; Klockner CA, 2011, TRANSPORT RES F-TRAF, V14, P261, DOI 10.1016/j.trf.2011.01.006; Klockner CA, 2010, J ENVIRON PSYCHOL, V30, P574, DOI 10.1016/j.jenvp.2010.03.001; Kuo NW, 2012, APPL THEORY PLANNED, P45; Li MM, 2012, J TRAVEL RES, V51, P473, DOI 10.1177/0047287511418366; Li Z, 2013, TRANSPORTATION, V40, P505, DOI 10.1007/s11116-012-9445-2; Lin CY, 2016, EPILEPSY BEHAV, V61, P231, DOI 10.1016/j.yebeh.2016.05.030; Line T, 2010, J TRANSP GEOGR, V18, P238, DOI 10.1016/j.jtrangeo.2009.05.001; Liu DY, 2017, TRANSPORT RES A-POL, V105, P42, DOI 10.1016/j.tra.2017.08.004; Ma L, 2018, TRANSPORT RES A-POL, V118, P14, DOI 10.1016/j.tra.2018.08.040; Ma L, 2017, INT J MARKET RES, V59, P767, DOI 10.2501/IJMR-2017-053; Ma LN, 2019, OCUL IMMUNOL INFLAMM, V27, P636, DOI 10.1080/09273948.2018.1433302; Mathieson K, 1991, INFORM SYST RES, V2, P173, DOI 10.1287/isre.2.3.173; Moan IS, 2013, TRANSPORT RES F-TRAF, V20, P193, DOI 10.1016/j.trf.2013.08.001; Morris MG, 2005, IEEE T ENG MANAGE, V52, P69, DOI 10.1109/TEM.2004.839967; Murphy E, 2015, INT J SUSTAIN TRANSP, V9, P116, DOI 10.1080/15568318.2012.748855; Neal DT, 2012, J EXP SOC PSYCHOL, V48, P492, DOI 10.1016/j.jesp.2011.10.011; Nicolau JL, 2006, TOURISM MANAGE, V27, P982, DOI 10.1016/j.tourman.2005.09.009; Pakpour AH, 2014, J PSYCHOSOM RES, V77, P287, DOI 10.1016/j.jpsychores.2014.07.001; Piatkowski DP, 2015, TRAVEL BEHAV SOC, V2, P32, DOI 10.1016/j.tbs.2014.07.004; Polites GL, 2013, MIS QUART, V37, P221; Schwanen T, 2012, J TRANSP GEOGR, V24, P522, DOI 10.1016/j.jtrangeo.2012.06.003; Simlcevic J, 2016, TRANSPORTATION PLANN, V39, P1; Strong C, 2018, J SLEEP RES, V27, P23, DOI 10.1111/jsr.12566; Sun YQ, 2012, INFORM SYST RES, V23, P1195, DOI 10.1287/isre.1120.0421; Tao MH, 2014, ATMOS ENVIRON, V98, P417, DOI 10.1016/j.atmosenv.2014.09.026; Towler G., 1991, Food Quality and Preference, V3, P37, DOI 10.1016/0950-3293(91)90021-6; Wolf A, 2014, TRANSPORT RES A-POL, V69, P196, DOI 10.1016/j.tra.2014.08.007; Xing Y, 2010, TRANSPORT RES D-TR E, V15, P73, DOI 10.1016/j.trd.2009.09.004; Yasuoka J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194103; Zhang LH, 2015, J CLEAN PROD, V97, P124, DOI 10.1016/j.jclepro.2014.04.006; Zhang X., 2017, TOTAL QUAL MANAGE, V28, P1, DOI [10.1080/14783363, DOI 10.1080/14783363]; Zhang X, 2017, INF DISCOV DELIV, V45, P202, DOI 10.1108/IDD-03-2017-0022; Zhao J, 2015, TRANSPORT RES C-EMER, V58, P251, DOI 10.1016/j.trc.2015.01.030; Zill-e-Huma, 2017, INTERNET RES, V27, P97, DOI 10.1108/IntR-12-2014-0317	68	17	17	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210964	10.1371/journal.pone.0210964	http://dx.doi.org/10.1371/journal.pone.0210964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682066	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500081
J	Aldoghachi, AF; Tor, YS; Redzun, SZ; Bin Lokman, KA; Razaq, NAA; Shahbudin, AF; Badamasi, IM; Cheah, PS; Stanslas, J; Veerakumarasivam, A; Rosli, R; Ibrahim, N; Lye, MS; Ling, KH				Aldoghachi, Asraa Faris; Tor, Yin Sim; Redzun, Siti Zubaidah; Bin Lokman, Khairul Aiman; Razaq, Nurul Asyikin Abdul; Shahbudin, Aishah Farhana; Badamasi, Ibrahim Mohamed; Cheah, Pike-See; Stanslas, Johnson; Veerakumarasivam, Abhi; Rosli, Rozita; Ibrahim, Normala; Lye, Munn Sann; Ling, King-Hwa			Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; VAL66MET POLYMORPHISM; FACTOR GENE; HIGH-FAT; SERUM; PLASTICITY; ASSOCIATION; INCREASES; VARIANTS; RELEASE	Background Brain-derived neurotrophic factor (BDNF) is a neurotrophin found in abundance in brain regions such as the hippocampus, cortex, cerebellum and basal forebrain. It has been associated with the risk of susceptibility to major depressive disorder (MDD). This study aimed to determine the association of three BDNF variants (rs6265, rs1048218 and rs1048220) with Malaysian MDD patients. Methods The correlation of these variants to the plasma BDNF level among Malaysian MDD patients was assessed. A total of 300 cases and 300 matched controls recruited from four public hospitals within the Klang Valley of Selangor State, Malaysia and matched for age, sex and ethnicity were screened for BDNF rs6265, rs1048218 and rs1048220 using high resolution melting (HRM). Findings BDNF rs1048218 and BDNF rs1048220 were monomorphic and were excluded from further analysis. The distribution of the alleles and genotypes for BDNF rs6265 was in Hardy-Weinberg equilibrium for the controls (p = 0.13) but was in Hardy Weinberg disequilibrium for the cases (p = 0.011). Findings from this study indicated that having BDNF rs6265 in the Malaysian population increase the odds of developing MDD by 2.05 folds (95% CI = 1.48-3.65). Plasma from 206 cases and 206 controls were randomly selected to measure the BDNF level using enzyme-linked immunosorbent assay (ELISA). A significant decrease in the plasma BDNF level of the cases as compared to controls (p<0.0001) was observed. However, there was no evidence of the effect of the rs6265 genotypes on the BDNF level indicating a possible role of other factors in modulating the BDNF level that warrants further investigation. Conclusion The study indicated that having the BDNF rs6265 allele (A) increase the risk of developing MDD in the Malaysian population suggesting a possible role of BDNF in the etiology of the disorder.	[Aldoghachi, Asraa Faris; Rosli, Rozita; Ling, King-Hwa] Univ Putra Malaysia, Dept Biomed Sci, Serdang, Selangor, Malaysia; [Tor, Yin Sim; Bin Lokman, Khairul Aiman; Shahbudin, Aishah Farhana; Lye, Munn Sann] Univ Putra Malaysia, Dept Community Hlth, Serdang, Selangor, Malaysia; [Redzun, Siti Zubaidah; Razaq, Nurul Asyikin Abdul; Ibrahim, Normala] Univ Putra Malaysia, Dept Psychiat, Serdang, Selangor, Malaysia; [Badamasi, Ibrahim Mohamed; Stanslas, Johnson] Univ Putra Malaysia, Dept Med, Serdang, Selangor, Malaysia; [Cheah, Pike-See] Univ Putra Malaysia, Dept Human Anat, Serdang, Selangor, Malaysia; [Veerakumarasivam, Abhi] Sunway Univ, Dept Biol Sci, Sch Sci & Technol, Subang Jaya, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Sunway University	Ling, KH (corresponding author), Univ Putra Malaysia, Dept Biomed Sci, Serdang, Selangor, Malaysia.	lkh@upm.edu.my	Badamasi, Ibrahim/AAQ-6025-2021; sim, tor yin/M-6258-2017; Ling, King-Hwa/M-2349-2018; Stanslas, Johnson/E-8266-2011; Cheah, Pike-See/F-4978-2014; Veerakumarasivam, Abhi/AAX-3876-2020	Badamasi, Ibrahim/0000-0002-6747-4468; sim, tor yin/0000-0002-4354-1486; Ling, King-Hwa/0000-0002-3968-7263; Stanslas, Johnson/0000-0002-6938-954X; Veerakumarasivam, Abhi/0000-0002-2676-1815; Cheah, Pike See/0000-0003-2181-2502; ibrahim, normala/0000-0003-2868-9834; Shahbudin, Aishah Farhana/0000-0002-8206-212X	Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary) [GP-IPB/2013/9415701]	Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary)	The study was supported by Universiti Putra Malaysia internal funding, Geran Putra IPB (Interdisciplinary) (GP-IPB/2013/9415701) awarded to KHL and NI. There was no additional external funding received for this study.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Banerjee R, 2013, CLIN MED INSIGHTS PA; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Cardoso TD, 2014, NEUROCHEM RES, V39, P1571, DOI 10.1007/s11064-014-1349-4; Chagnon YC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00230; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Cole J, 2011, GENES BRAIN BEHAV, V10, P756, DOI 10.1111/j.1601-183X.2011.00714.x; Colle R, 2017, NEUROPSYCHOBIOLOGY, V75, P39, DOI 10.1159/000478862; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dotta-Panichi RM, 2015, REV BRAS PSIQUIATR, V37, P113, DOI 10.1590/1516-4446-2014-1421; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Faris A, 2018, MALAYSIAN J MED HLTH, V14, P64; Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410; Goekint M, 2008, MED SCI SPORT EXER, V40, P1990, DOI 10.1249/MSS.0b013e31817eee85; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Henderson CE, 1996, CURR OPIN NEUROBIOL, V6, P64, DOI 10.1016/S0959-4388(96)80010-9; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Iga JI, 2007, AM J MED GENET B, V144B, P1003, DOI 10.1002/ajmg.b.30520; Institute for Public Health (IPH), 2015, NAT HLTH MORB SURV 2, VII, DOI DOI 10.1017/CBO9781107415324.004; Jin P, 2015, J ALLERGY CLIN IMMUN, V135, P1486, DOI 10.1016/j.jaci.2014.12.1870; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lopizzo N, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.0068, 10.3389/fpsyt.2015.00068]; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Oswald P, 2005, EUR NEUROPSYCHOPHARM, V15, P491, DOI 10.1016/j.euroneuro.2005.01.001; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Piccinni A, 2008, J AFFECT DISORDERS, V105, P279, DOI 10.1016/j.jad.2007.05.005; Polacchini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17989; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Watanabe K, 2010, PROG NEURO-PSYCHOPH, V34, P1450, DOI 10.1016/j.pnpbp.2010.07.036; World Health Organization, 2017, DEPRESSION OTHER COM; Yoshida T, 2012, OPEN CLIN CHEM J, V5, P70, DOI [10.1016/j.jpsychires.2009.08.015, DOI 10.1016/J.JPSYCHIRES.2009.08.015]; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	57	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211241	10.1371/journal.pone.0211241	http://dx.doi.org/10.1371/journal.pone.0211241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677092	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400065
J	Kojima, K; Nakamura, T; Ooizumi, Y; Igarashi, K; Tanaka, T; Yokoi, K; Ishii, S; Nishizawa, N; Katoh, H; Kosaka, Y; Sato, T; Watanabe, M; Yamashita, K				Kojima, Keita; Nakamura, Takatoshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Tanaka, Toshimichi; Yokoi, Keigo; Ishii, Satoru; Nishizawa, Nobuyuki; Katoh, Hiroshi; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi			Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; CYSTEINE DIOXYGENASE; UNITED-STATES; ADENOCARCINOMAS; HYPERMETHYLATION; EPIDEMIOLOGY; CARCINOMA; SURVIVAL; MUTATION; RISK	Although small bowel cancer (SBC) is extremely rare, its prognosis is poor, and molecular mechanism of the SBC development remains unclear. The aim of our study is to elucidate whether DNA methylation of the promoter region of the cancer-specific methylation gene, cysteine dioxygenase 1 (CDO1), contributes to the carcinogenic process in SBC. The study group comprised patients with 53 patients with SBC, 107 colorectal cancer (CRC), and other rare tumors of the small intestine such as 4 malignant lymphomas, 2 leiomyosarcomas, and 9 gastrointestinal stromal tumors. We analyzed the extent of methylation in each tissue using quantitative TaqMan methylation-specific PCR for CDO1. Significantly higher CDO1 methylation was observed in cancer tissues compared with non-cancerous mucosa of the small intestine (ROC = 0.96). Among the various clinicopathological factors, positive correlation of CDO1 methylation with tumor diameter was observed (R = 0.31, p = 0.03), and the CDO1 methylation level was a possible prognostic factor for relapse-free survival (p = 0.09). Compared with CRC, SBC had a significantly poorer prognosis (p = 0.007) and displayed a significantly higher CDO1 methylation level (p < 0.0001). Intriguingly, especially in pStage I/II, there were robust prognostic difference between SBC and CRC (p = 0.08 / p < 0.0001), which may reflect CDO1 methylation status (p = 0.02 /p = 0.001). Among small bowel tumors, CDO1 methylation in SBC was higher in order of malignant lymphoma, cancer, and leiomyosarcoma/GIST (p = 0.002) by ANOVA. The CDO1 gene shows extremely cancer-specific hypermethylation, and it can be a prognostic marker in SBC.	[Kojima, Keita; Nakamura, Takatoshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Tanaka, Toshimichi; Yokoi, Keigo; Ishii, Satoru; Nishizawa, Nobuyuki; Katoh, Hiroshi; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Ctr New Med Frontiers, Div Adv Surg Oncol, Dept Res & Dev, Sagamihara, Kanagawa, Japan	Kitasato University	Yamashita, K (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa, Japan.; Yamashita, K (corresponding author), Ctr New Med Frontiers, Div Adv Surg Oncol, Dept Res & Dev, Sagamihara, Kanagawa, Japan.	keishi23@med.kitasato-u.ac.jp			Parents' Association Grant of Kitasato University, School of Medicine	Parents' Association Grant of Kitasato University, School of Medicine	This work was supported by the Parents' Association Grant of Kitasato University, School of Medicine to KK.	Alvi MA, 2015, ONCOTARGET, V6, P20863, DOI 10.18632/oncotarget.4576; Arai M, 1997, INT J CANCER, V70, P390, DOI 10.1002/(SICI)1097-0215(19970207)70:4<390::AID-IJC3>3.0.CO;2-R; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI 10.1097/SLA.0b013e31818e4641; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Diosdado B, 2010, CLIN CANCER RES, V16, P1391, DOI 10.1158/1078-0432.CCR-09-1773; Friedman S, 2006, GASTROENTEROL CLIN N, V35, P621, DOI 10.1016/j.gtc.2006.07.008; FROST DB, 1994, ANN SURG ONCOL, V1, P290, DOI 10.1007/BF02303567; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Haselkorn T, 2005, CANCER CAUSE CONTROL, V16, P781, DOI 10.1007/s10552-005-3635-6; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joseph CA, 2007, CHEM COMMUN, P3338, DOI 10.1039/b702158e; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Kojima K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194785; KONISHI F, 1987, DIS COLON RECTUM, V30, P790, DOI 10.1007/BF02554629; Kwon J, 2015, TUMOR BIOL, V36, P7449, DOI 10.1007/s13277-015-3443-x; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Nishiyama KI, 2002, ONCOL REP, V9, P293; Overman Michael J, 2013, Am Soc Clin Oncol Educ Book, P189, DOI 10.1200/EdBook_AM.2013.33.189; PERZIN KH, 1981, CANCER, V48, P799, DOI 10.1002/1097-0142(19810801)48:3<799::AID-CNCR2820480324>3.0.CO;2-Q; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Ren PT, 2012, INTERNAL MED, V51, P877, DOI 10.2169/internalmedicine.51.6999; Schottenfeld D, 2009, ANN EPIDEMIOL, V19, P58, DOI 10.1016/j.annepidem.2008.10.004; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Warth A, 2011, MODERN PATHOL, V24, P564, DOI 10.1038/modpathol.2010.223; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546; Young JI, 2016, DIS COLON RECTUM, V59, P306, DOI 10.1097/DCR.0000000000000562	38	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211108	10.1371/journal.pone.0211108	http://dx.doi.org/10.1371/journal.pone.0211108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677088	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400049
J	Yamada, T; Tatsumi, N; Anraku, A; Suzuki, H; Kamejima, S; Uchiyama, T; Ohkido, I; Yokoo, T; Okabe, M				Yamada, Taku; Tatsumi, Norifumi; Anraku, Akane; Suzuki, Hideaki; Kamejima, Sahoko; Uchiyama, Taketo; Ohkido, Ichiro; Yokoo, Takashi; Okabe, Masataka			Gcm2 regulates the maintenance of parathyroid cells in adult mice	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; THYMUS ORGANOGENESIS; GENE-EXPRESSION; HORMONE GENE; HYPERPARATHYROIDISM; DIFFERENTIATION; MISSING-2; MAFB	Glial cells missing homolog 2 (GCM2), a zinc finger-type transcription factor, is essential for the development of parathyroid glands. It is considered to be a master regulator because the glands do not form when Gcm2 is deficient. Remarkably, Gcm2 expression is maintained throughout the fetal stage and after birth. Considering the Gcm2 function in embryonic stages, it is predicted that Gcm2 maintains parathyroid cell differentiation and survival in adults. However, there is a lack of research regarding the function of Gcm2 in adulthood. Therefore, we analyzed Gcm2 function in adult tamoxifen-inducible Gcm2 conditional knockout mice. One month after tamoxifen injection, Gcm2-knockout mice showed no significant difference in serum calcium, phosphate, and PTH levels and in the expressions of calcium-sensing receptor (Casr) and parathyroid hormone (Pth), whereas Ki-67 positive cells were decreased and terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) positive cell number did not change, as compared with those of controls. Seven months after tamoxifen injection, Gcm2-knockout mice showed shrinkage of the parathyroid glands and fewer parathyroid cells. A significant decrease was noted in Casr- and Pth-expressing cells and serum PTH and Ca levels, whereas serum phosphate levels increased, as compared with those of controls. All our results concluded that a reduction of Gcm2 expression leads to a reduction of parathyroid cell proliferation, an increase in cell death, and an attenuation of parathyroid function. Therefore, we indicate that Gcm2 plays a prominent role in adult parathyroid cell proliferation and maintenance.	[Yamada, Taku; Kamejima, Sahoko; Uchiyama, Taketo; Ohkido, Ichiro; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan; [Yamada, Taku; Tatsumi, Norifumi; Anraku, Akane; Suzuki, Hideaki; Kamejima, Sahoko; Okabe, Masataka] Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan	Jikei University; Jikei University	Okabe, M (corresponding author), Jikei Univ, Sch Med, Dept Anat, Tokyo, Japan.	maokabe@jikei.ac.jp		Tatsumi, Norifumi/0000-0001-6640-150X; Okabe, Masataka/0000-0002-8618-6859	Kidney Foundation, Japan [JKFB15-34]; Japan Society for the Promotion of Science (JSPS KAKENHI) [JP21370098]; JSPS KAKENHI [JP21370098]	Kidney Foundation, Japan(Kidney Foundation, Japan); Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Taku Yamada received an award from The Kidney Foundation, Japan (JKFB15-34 T.Y.), URL: http://www.jinzouzaidan.or.jp/, and Masataka Okabe received grant JP21370098 M.O. from the Japan Society for the Promotion of Science (JSPS KAKENHI). The sponsors played no role in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FLP mice were kindly gifted by Prof. Kenji Sakimura and Rie Natsume (Niigata University, Japan). We thank Takumi Kimura, Shizuka Ohki, and Miyoko Takazawa for providing technical support. We thank Prof. Tsutomu Miyake for advice on composition of English. This work was supported by The Kidney Foundation, Japan (JKFB15-34 T.Y.) and JSPS KAKENHI (JP21370098 M.O.).	Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2009, HUM MUTAT, V30, P85, DOI 10.1002/humu.20827; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chen H., 2013, OPEN ANATOMY J, V5, P1, DOI [10.2174/1877609401305010001, DOI 10.2174/1877609401305010001]; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Chojnowski JL, 2014, DEVELOPMENT, V141, P3697, DOI 10.1242/dev.110833; D'Agruma L, 2014, J CLIN ENDOCR METAB, V99, pE2794, DOI 10.1210/jc.2014-2857; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Guan B, 2016, AM J HUM GENET, V99, P1034, DOI 10.1016/j.ajhg.2016.08.018; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Han S, 2015, MOL CELL ENDOCRINOL, V411, P113, DOI 10.1016/j.mce.2015.04.018; Hendy GN, 2013, BEST PRACT RES CL EN, V27, P285, DOI 10.1016/j.beem.2013.02.009; Hitoshi S, 2011, NAT NEUROSCI, V14, P957, DOI 10.1038/nn.2875; Kamitani-Kawamoto A, 2011, J BONE MINER RES, V26, P2463, DOI 10.1002/jbmr.458; Kawahara M, 2010, BONE, V47, P534, DOI 10.1016/j.bone.2010.05.031; Kebebew E, 2004, SURGERY, V136, P1261, DOI 10.1016/j.surg.2004.06.056; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Manley NR, 2000, SEMIN IMMUNOL, V12, P421, DOI 10.1006/smim.2000.0263; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Mizobuchi M, 2009, J BONE MINER RES, V24, P1173, DOI [10.1359/JBMR.090211, 10.1359/jbmr.090211]; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Morito N, 2018, KIDNEY INT, V93, P54, DOI 10.1016/j.kint.2017.06.023; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; Ritter CS, 2012, J CLIN ENDOCR METAB, V97, pE1499, DOI 10.1210/jc.2011-3366; Stephen AE, 2004, SURGERY, V136, P1143, DOI 10.1016/j.surg.2004.06.042; Su DM, 2001, DEV BIOL, V236, P316, DOI 10.1006/dbio.2001.0342; Tatsumi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30580; Yuan ZQ, 2014, TRANSGENIC RES, V23, P631, DOI 10.1007/s11248-014-9799-7	29	16	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210662	10.1371/journal.pone.0210662	http://dx.doi.org/10.1371/journal.pone.0210662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677043	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400023
J	Broussou, DC; Toutain, PL; Woehrle, F; El Garch, F; Bousquet-Melou, A; Ferran, AA				Broussou, Diane C.; Toutain, Pierre-Louis; Woehrle, Frederique; El Garch, Farid; Bousquet-Melou, Alain; Ferran, Aude A.			Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus	PLOS ONE			English	Article							CELL-WALL; VANCOMYCIN; AMIKACIN; RESISTANCE; SYNERGY; PHARMACOKINETICS; ANTIBIOTICS; GENTAMICIN; DAPTOMYCIN; GUIDELINES	An easily implementable strategy to reduce treatment failures in severe bacterial infections is to combine already available antibiotics. However, most in vitro combination assays are performed by exposing standard bacterial inocula to constant concentrations of antibiotics over less than 24h, which can be poorly representative of clinical situations. The aim of this study was to assess the ability of static and dynamic in vitro Time-Kill Studies (TKS) to identify the potential benefits of an antibiotic combination (here, amikacin and vancomycin) on two different inoculum sizes of two S. aureus strains. In the static TKS (sTKS), performed by exposing both strains over 24h to constant antibiotic concentrations, the activity of the two drugs combined was not significantly different the better drug used alone. However, the dynamic TKS (dTKS) performed over 5 days by exposing one strain to fluctuating concentrations representative of those observed in patients showed that, with the large inoculum, the activities of the drugs, used alone or in combination, significantly differed over time. Vancomycin did not kill bacteria, amikacin led to bacterial regrowth whereas the combination progressively decreased the bacterial load. Thus, dTKS revealed an enhanced effect of the combination on a large inoculum not observed in sTKS. The discrepancy between the sTKS and dTKS results highlights that the assessment of the efficacy of a combination for severe infections associated with a high bacterial load could be demanding. These situations probably require the implementation of dynamic assays over the entire expected treatment duration rather than the sole static assays performed with steady drug concentrations over 24h.	[Broussou, Diane C.; Bousquet-Melou, Alain; Ferran, Aude A.] Univ Toulouse, UMR INTHERES 1436, INRA, ENVT, Toulouse, France; [Broussou, Diane C.; Woehrle, Frederique; El Garch, Farid] Vetoquinol SA, Lure, France; [Toutain, Pierre-Louis] Royal Vet Coll, Dept Vet Basics Sci, London, England	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; University of London; University of London Royal Veterinary College	Ferran, AA (corresponding author), Univ Toulouse, UMR INTHERES 1436, INRA, ENVT, Toulouse, France.	a.ferran@envt.fr	BOUSQUET-MELOU, Alain/AAS-5425-2020; Ferran, Aude/J-6344-2013	BOUSQUET-MELOU, Alain/0000-0002-7661-4311; Ferran, Aude/0000-0002-6629-1088; Broussou, Diane/0000-0002-0016-5820	Vetoquinol SA	Vetoquinol SA	The authors received no specific funding for this work. DCB, FEG and FW are employed by Vetoquinol SA. Vetoquinol SA provided support in the form of salaries for authors DCB, FEG and FW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section."	Abreu AC, 2014, DIAGN MICR INFEC DIS, V79, P125, DOI 10.1016/j.diagmicrobio.2014.03.002; Adamis G, 2004, INT J ANTIMICROB AG, V23, P144, DOI 10.1016/j.ijantimicag.2003.07.001; Broussou DC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00572; Butterfield JM, 2011, ANTIMICROB AGENTS CH, V55, P4277, DOI 10.1128/AAC.01674-10; Buyck JM, 2012, CLIN INFECT DIS, V55, P534, DOI 10.1093/cid/cis473; Cadwell JS., 2015, ADV ANTIBIOTICS ANTI, V1; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; CLSI, 2012, METH DIL ANT SUSC TE; Cokca Fugen, 1998, Clin Microbiol Infect, V4, P657, DOI 10.1111/j.1469-0691.1998.tb00349.x; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Dong CL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00553; Ekdahl C, 2005, EUR J CLIN MICROBIOL, V24, P596, DOI 10.1007/s10096-005-0011-0; ELIOPOULOS G M, 1988, Clinical Microbiology Reviews, V1, P139; Ferro BE, 2016, ANTIMICROB AGENTS CH, V60, P1242, DOI 10.1128/AAC.02282-15; Firsov AA, 2006, J ANTIMICROB CHEMOTH, V58, P1185, DOI 10.1093/jac/dkl387; Galvez R, 2011, INT J ANTIMICROB AG, V38, P146, DOI 10.1016/j.ijantimicag.2011.03.022; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Gumbo T, 2015, CLIN INFECT DIS, V61, pS18, DOI 10.1093/cid/civ426; Karlowsky JA, 1997, PHARMACOTHERAPY, V17, P549; Kato H, 2017, DRUGS R&D, V17, P177, DOI 10.1007/s40268-016-0165-5; Laishram S, 2017, INDIAN J MED MICROBI, V35, P445, DOI [10.4103/ijmm.ijmm_17_189, 10.4103/ijmm.IJMM_17_189]; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Liu P, 2002, INT J ANTIMICROB AG, V19, P285, DOI 10.1016/S0924-8579(02)00024-9; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MATZKE GR, 1986, CLIN PHARMACOKINET, V11, P257, DOI 10.2165/00003088-198611040-00001; MCGRATH BJ, 1994, ANTIMICROB AGENTS CH, V38, P2034, DOI 10.1128/AAC.38.9.2034; MOORE RD, 1987, J INFECT DIS, V155, P93, DOI 10.1093/infdis/155.1.93; Nicasio AM, 2012, ANTIMICROB AGENTS CH, V56, P682, DOI 10.1128/AAC.05664-11; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Patel N, 2011, CLIN INFECT DIS, V52, P969, DOI 10.1093/cid/cir078; Rose WE, 2009, ANTIMICROB AGENTS CH, V53, P805, DOI 10.1128/AAC.01009-08; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Yanagisawa C, 2009, ANTIMICROB AGENTS CH, V53, P63, DOI 10.1128/AAC.00762-08; Yuan WC, 2013, J ANTIMICROB CHEMOTH, V68, P1089, DOI 10.1093/jac/dks522	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211214	10.1371/journal.pone.0211214	http://dx.doi.org/10.1371/journal.pone.0211214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673774	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000456442800081
J	Olagaray, KE; Brouk, MJ; Mamedova, LK; Sivinski, SE; Liu, H; Robert, F; Dupuis, E; Zachut, M; Bradford, J				Olagaray, K. E.; Brouk, M. J.; Mamedova, L. K.; Sivinski, S. E.; Liu, H.; Robert, F.; Dupuis, E.; Zachut, M.; Bradford, J.			Dietary supplementation of Scutellaria baicalensis extract during early lactation decreases milk somatic cells and increases whole lactation milk yield in dairy cattle	PLOS ONE			English	Article							COWS; PERFORMANCE; INFLAMMATION; INDICATORS; QUERCETIN; BIOAVAILABILITY; BAICALIN; STRESS; GLUCOSE-6-PHOSPHATE; LIPOPOLYSACCHARIDE	Systemic inflammation is common in early lactation dairy cows and is associated with decreased milk production. The Scutellaria baicalensis plant contains flavonoids with anti-inflammatory and anti-oxidative properties, which may counteract the inflammatory state in early lactation dairy cows. The objective of this experiment was to determine whether Scutellaria baicalensis extract (SBE), a source of bioactive flavonoids, would alter the adaptation to lactation. Multiparous Holstein cows (n = 122) were used in a randomized block design to determine the effect of short-term and long-term postpartum administration of SBE on 305-d milk yield, 120-d milk component yield, and early lactation milk markers of inflammation and metabolic function. Treatments were 1) control, 2) short term (5-d) administration of the SBE (SBE5), and 3) long term (60-d) administration of the SBE (SBE60). Treatments were included in a treatment pellet that was identical to a control pellet in ingredient source and composition except for the extract (10 g/d SBE providing 3.3 g/d of the flavonoid baicalin), both provided via an automated milking system beginning on d 1 of lactation. Milk samples were collected on d 1, 3, and once during d 5-12 of lactation, followed by weekly sampling until 120 days in milk (DIM). Milk samples collected in the first 2 wk were used for biomarker analysis (haptoglobin, P-hydroxybutyrate [BHB], and glucose-6-phosphate [G6P]), and all samples were used for composition analysis. Cows were body condition scored every 2 wk prepartum and postpartum. Milk production, programmed pellet allocation, and actual provision of both pelleted feeds were recorded daily. Treatment effects were evaluated by contrasts between control and SBE5 and control and SBE60 for both the treatment (TP; wk 1-9) and carryover periods (CP; wk 10-37). Total pellet offered was greater for SBE60 in both the TP (P < 0.01) and CP (P = 0.02) but was not different for SBE5 during either period (P >= 0.13). No treatment effects were observed for body condition score (BCS), milk haptoglobin, BHB, or G6P. SBE5 did not alter milk yield or milk components. SBE60 increased whole-lactation milk yield by 1,419 kg (13%; P=0.03). SBE60 increased milk lactose and fat yields (P <= 0.04) and tended to increase milk protein yield (P=0.09) during TP, and each increased during CP (P <= 0.04). Somatic cell count decreased by 10% in SBE60 during TP (P=0.02) but not CP (P=0.13). Mastitis incidence tended to differ by treatment, being lesser for both SBE5 and SBE60 vs. control (14 and 15% vs. 33%). SBE supplementation did not impact time to pregnancy or hazard of leaving the herd. In conclusion, despite no detected treatment effects on BCS or milk biomarkers of inflammation and metabolic status, supplementation of postpartum dairy cows with Scutellaria baicalensis extract for 60 d was effective at increasing whole lactation milk yield.	[Olagaray, K. E.; Brouk, M. J.; Mamedova, L. K.; Sivinski, S. E.; Liu, H.; Bradford, J.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Robert, F.; Dupuis, E.] CCPA Grp, Janze, France; [Zachut, M.] Agr Res Org, Volcani Ctr, Rishon Leziyyon, Israel	Kansas State University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Bradford, J (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	bbradfor@ksu.edu	Bradford, Barry/B-7870-2010	Bradford, Barry/0000-0002-6775-4961; Mamedova, Laman/0000-0003-3612-0381	CCPA Group (Janze, France)	CCPA Group (Janze, France)	Contribution no. 18-364-J from the Kansas Agricultural Experiment Station. This work was funded in part by CCPA Group (Janze, France). The funder provided support in the form of salaries for authors FR and EDP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balcells J, 2012, J ANIM SCI, V90, P4975, DOI 10.2527/jas.2011-4955; Ballou MA, 2013, FLOR RUM NUTR S, P50; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; Berger LM, 2012, J DAIRY SCI, V95, P5047, DOI 10.3168/jds.2012-5439; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Besle JM, 2010, J DAIRY SCI, V93, P2846, DOI 10.3168/jds.2009-2939; Bjerre-Harpoth V, 2016, J DAIRY RES, V83, P156, DOI 10.1017/S0022029916000145; Bradford BJ, 2015, J DAIRY SCI, V98, P6631, DOI 10.3168/jds.2015-9683; Carpenter AJ, 2016, J DAIRY SCI, V99, P672, DOI 10.3168/jds.2015-10048; Cermak R, 2003, J NUTR, V133, P2802, DOI 10.1093/jn/133.9.2802; De Nardi R, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0653-4; Dematawewa CMB, 1997, J DAIRY SCI, V80, P754, DOI 10.3168/jds.S0022-0302(97)75995-2; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Enjalbert F, 2001, J DAIRY SCI, V84, P583, DOI 10.3168/jds.S0022-0302(01)74511-0; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; Ferruzzi MG, 2006, FOOD CHEM, V99, P484, DOI 10.1016/j.foodchem.2005.08.010; FOX LK, 1985, J DAIRY SCI, V68, P2100, DOI 10.3168/jds.S0022-0302(85)81074-2; Gao J, 2008, J PHARM PHARM SCI, V11, P77; Garavaglia L, 2015, NEW ZEAL VET J, V63, P313, DOI 10.1080/00480169.2015.1047911; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, P605, DOI 10.1111/jpn.12579; Gessner DK, 2015, J DAIRY SCI, V98, P8856, DOI 10.3168/jds.2015-9478; Gohlke A, 2013, J DAIRY SCI, V96, P2303, DOI 10.3168/jds.2012-6234; HARMON RJ, 1994, J DAIRY SCI, V77, P2103, DOI 10.3168/jds.S0022-0302(94)77153-8; He X, 2015, INT IMMUNOPHARMACOL, V28, P470, DOI DOI 10.1016/J.INTIMP.2015.07.012; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Hiss S, 2009, J DAIRY SCI, V92, P4439, DOI 10.3168/jds.2008-1632; Huzzey JM, 2015, PREV VET MED, V120, P291, DOI 10.1016/j.prevetmed.2015.04.011; Klein MS, 2010, J DAIRY SCI, V93, P1539, DOI 10.3168/jds.2009-2563; Lai MY, 2003, J PHARM PHARMACOL, V55, P205, DOI 10.1211/002235702522; Larsen T, 2015, ANIMAL, V9, P86, DOI 10.1017/S1751731114002043; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-19; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; McCarthy MM, 2016, J DAIRY SCI, V99, P680, DOI 10.3168/jds.2015-9694; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Robert F, 2014, 5 ANN M EAAP COP, P372; Robert F, 2016, United States patent, Patent No. [US 14/ 910,707, 14910707]; Shabtay A, 2012, ANIM FEED SCI TECH, V175, P24, DOI 10.1016/j.anifeedsci.2012.04.004; Silanikove N, 2014, J DAIRY RES, V81, P358, DOI 10.1017/S0022029914000260; Stoldt AK, 2015, J DAIRY SCI, V98, P4509, DOI 10.3168/jds.2014-9053; Tedesco D, 2004, J DAIRY SCI, V87, P2239, DOI 10.3168/jds.S0022-0302(04)70044-2; Thomas FC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0533-3; Wakabayashi I, 1999, PHARMACOL TOXICOL, V84, P288, DOI 10.1111/j.1600-0773.1999.tb01496.x; Wang Hong-zhi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1637; Wang QH, 2013, J ETHNOPHARMACOL, V146, P9, DOI 10.1016/j.jep.2012.12.013; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Winkler A, 2015, ARCH ANIM NUTR, V69, P425, DOI 10.1080/1745039X.2015.1093873; Ylioja CM, 2018, J DAIRY SCI, V101, P6066, DOI 10.3168/jds.2017-13991; Zachut M, 2016, RSC ADV, V6, P65412, DOI 10.1039/c6ra11924g	50	9	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210744	10.1371/journal.pone.0210744	http://dx.doi.org/10.1371/journal.pone.0210744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673736	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800052
J	Kim, JH; Park, EC				Kim, Jae-Hyun; Park, Eun-Cheol			Can diabetes patients seeking a second hospital get better care? Results from nested case-control study	PLOS ONE			English	Article							DOCTOR-SHOPPING BEHAVIOR; HEALTH-CARE; NATIONAL-HEALTH; COMMUNICATION; ASSOCIATION; COMPLICATIONS; CONTINUITY; OUTCOMES; SYSTEM; USERS	This study investigates the effects of the number of medical institutions visited on risk of death. This study conducted a nested case-control design using the National Health Insurance Service-Senior database from 2002 to 2013. Cases were defined as those with death among outpatients who had first diagnosis of diabetes mellitus (E10-E14) after entry into the base cohort and controls were selected by incidence density sampling and matched to cases based on age, and sex. Our main results were presented by conditional logistic regression for nested case-controls design. Of total 55,558 final study samples, there were 9,313 (16.8%) cases and 46,245 (83.2%) controls. With an increase by one point in the number of hospitals per medical utilization, risk of death significantly increased by 4.1% (odds ratio (OR): 1.041, 95% confidence interval [CI]: 1.039-1.043). In both medical utilization and number of hospitals, those with high medical utilization (OR: 1.065, 95% CI: 1.059-1.070) and number of hospitals (OR: 1.049, 95% CI: 1.041-1.058) for risk of death were significantly higher than those with low medical utilization (OR: 1.040, 95% CI: 1.037-1.043) and number of hospitals (OR: 1.029, 95% CI: 1.027-1.032), respectively. The number of medical institution visited was significantly associated with risk of death. Therefore, diabetics should be warned about the potential of risk of death incurred from excessive access to medical utilizations.	[Kim, Jae-Hyun] Dankook Univ, Dept Hlth Adm, Coll Hlth Sci, Cheonan, South Korea; [Kim, Jae-Hyun] Dankook Univ, Inst Hlth Promot & Policy, Cheonan, South Korea; [Park, Eun-Cheol] Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Dankook University; Dankook University; Yonsei University; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul, South Korea.; Park, EC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398				Asai A, 1998, BIOETHICS, V12, P162, DOI 10.1111/1467-8519.00102; Chu HY, 2012, MED CARE, V50, P1002, DOI 10.1097/MLR.0b013e31826c870f; DEMERS M, 1995, CAN MED ASSOC J, V153, P37; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; GREENE MG, 1994, SOC SCI MED, V38, P1279, DOI 10.1016/0277-9536(94)90191-0; Hagihara A, 2005, J EVAL CLIN PRACT, V11, P556, DOI 10.1111/j.1365-2753.2005.00581.x; Hariman KW, 2013, FEVER PREDICTOR DOCT, V1; Hsieh CI, 2013, PATIENT PREFER ADHER, V7, P693, DOI 10.2147/PPA.S43631; Hsu MH, 2011, INT J MED INFORM, V80, P181, DOI 10.1016/j.ijmedinf.2010.11.003; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Klienschmidt R, 1995, Aust Fam Physician, V24, P1037; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee HK, 2014, IRAN J PUBLIC HEALTH, V43, P6; Lee J, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0603-x; Lin CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-318; Lo A Y, 1994, Int J Qual Health Care, V6, P371; Mercer SW, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-46; National Statistical Office, 2014, ANN REP VIT STAT KOR; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Richardson DB, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2004.014472; SATO T, 1995, GEN HOSP PSYCHIAT, V17, P115, DOI 10.1016/0163-8343(94)00094-T; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Van Walraven C, 2006, CLIN CHEM, V52, P2219, DOI 10.1373/clinchem.2006.072934; Wang MJ, 2010, HEALTH POLICY, V94, P61, DOI 10.1016/j.healthpol.2009.08.009; Yang JH, 2015, INT J MED INFORM, V84, P912, DOI 10.1016/j.ijmedinf.2015.08.007	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210809	10.1371/journal.pone.0210809	http://dx.doi.org/10.1371/journal.pone.0210809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668580	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400015
J	Nishio, M; Kubo, T; Togashi, K				Nishio, Mizuho; Kubo, Takeshi; Togashi, Kaori			Estimation of lung cancer risk using homology-based emphysema quantification in patients with lung nodules	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CT; REGIONS	The purpose of this study was to assess whether homology-based emphysema quantification (HEQ) is significantly associated with lung cancer risk. This retrospective study was approved by our institutional review board. We included 576 patients with lung nodules (317 men and 259 women; age, 66.8 +/- 12.3 years), who were selected from a database previously generated for computer-aided diagnosis. Of these, 283 were diagnosed with lung cancer, whereas the remaining 293 showed benign lung nodules. HEQ was performed and percentage of low-attenuation lung area (LAA%) was calculated on the basis of computed tomography scans. Statistical models were constructed to estimate lung cancer risk using logistic regression; sex, age, smoking history (Brinkman index), LAA%, and HEQ were considered independent variables. The following three models were evaluated: the base model (sex, age, and smoking history); the LAA% model (the base model + LAA%); and the HEQ model (the base model + HEQ). Model performance was assessed using receiver operating characteristic analysis and the associated area under the curve (AUC). Differences in AUCs among the models were evaluated using Delong's test. AUCs of the base, LAA%, and HEQ models were 0.585, 0.593, and 0.622, respectively. HEQ coefficient was statistically significant in the HEQ model (P = 0.00487), but LAA% coefficient was not significant in the LAA% model (P = 0.199). Delong's test revealed significant difference in AUCs between the LAA% and HEQ models (P = 0.0455). In conclusion, after adjusting for age, sex, and smoking history (Brinkman index), HEQ was significantly associated with lung cancer risk.	[Nishio, Mizuho; Kubo, Takeshi; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Kyoto, Japan; [Nishio, Mizuho] Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Kyoto, Japan	Kyoto University; Kyoto University	Nishio, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Related Dis Res Ctr, Kyoto, Kyoto, Japan.	nmizuho@kuhp.kyoto-u.ac.jp	Nishio, Mizuho/ACC-0897-2022		Japan Society for the Promotion of Science KAKENHI [JP16K19883]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by Japan Society for the Promotion of Science KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adamek M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.04.03; AOYAMA G, 2016, MED IMAGING TECHNOL, V34, P267; Gierada DS, 2011, RADIOLOGY, V261, P950, DOI 10.1148/radiol.11110542; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Kawagishi M, 2017, INT J COMPUT ASS RAD, V12, P767, DOI 10.1007/s11548-017-1554-0; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakagomi K, 2013, MED IMAGE ANAL, V17, P62, DOI 10.1016/j.media.2012.08.002; Nakane K, 2013, DIAGN PATHOL, V8, P1; Nakane K, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0244-x; Nishio M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178217; Nishio M, 2016, INT J CHRONIC OBSTR, V11, P2125, DOI 10.2147/COPD.S110504; Nishio M, 2014, EUR J RADIOL, V83, P2268, DOI 10.1016/j.ejrad.2014.09.011; Sawano T, 2017, NEUROSCIENCE, V346, P43, DOI 10.1016/j.neuroscience.2016.12.052; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Tammemagi MC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001764; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; Wille MMW, 2016, EUR RADIOL, V26, P487, DOI 10.1007/s00330-015-3826-9; Wilson DO, 2011, J THORAC ONCOL, V6, P1200, DOI 10.1097/JTO.0b013e318219aa93; Zurawska JH, 2012, CHEST, V141, P1147, DOI 10.1378/chest.11-1863	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210720	10.1371/journal.pone.0210720	http://dx.doi.org/10.1371/journal.pone.0210720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668605	Green Submitted, Green Published, gold			2022-12-27	WOS:000456306400011
J	Abegaz, T; Gebremedhin, S				Abegaz, Teferi; Gebremedhin, Samson			Magnitude of road traffic accident related injuries and fatalities in Ethiopia	PLOS ONE			English	Article							GENDER	Background In many developing countries there is paucity of evidence regarding the epidemiology of road traffic accidents (RTAs). The study determines the rates of injuries and fatalities associated with RTAs in Ethiopia based on the data of a recent national survey. Methods The study is based on the secondary data of the Ethiopian Demographic and Health Survey conducted in 2016. The survey collected information about occurrence injuries and accidents including RTAs in the past 12 months among 75,271 members of 16,650 households. Households were selected from nine regions and two city administrations of Ethiopia using stratified cluster sampling procedure. Results Of the 75,271 household members enumerated, 123 encountered RTAs in the reference period and rate of RTA-related injury was 163 (95% confidence interval (CI): 136-195) per 100,000 population. Of the 123 causalities, 28 were fatal, making the fatality rate 37 (95% CI: 25-54) per 100,000 population. The RTA-related injuries and fatalities per 100,000 motor vehicles were estimated as 21,681 (95% CI: 18,090-25,938) and 4,922 (95% CI: 3325-7183), respectively. Next to accidental falls, RTAs were the second most common form of accidents and injuries accounting for 22.8% of all such incidents. RTAs contributed to 43.8% of all fatalities secondary to accidents and injuries. Among RTA causalities, 21.9% were drivers, 35.0% were passenger vehicle occupants and 36.0% were vulnerable road users including: motorcyclists (21.0%), pedestrians (12.1%) and cyclists (2.9%). Approximately half (47.1%) of the causalities were between 15-29 years of age and 15.3% were either minors younger than 15 years or seniors older than 64 years of age. Nearly two-thirds (65.0%) of the victims were males. Conclusion RTA-related causalities are extremely high in Ethiopia. Male young adults and vulnerable road users are at increased risk of RTAs. There is a urgent need for bringing road safety to the country's public health agenda.	[Abegaz, Teferi] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Gebremedhin, Samson] Hawassa Univ, Sch Publ Hlth, Hawassa, Ethiopia	Addis Ababa University; Hawassa University	Abegaz, T (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	teferiabegaz@gmail.com	Gebremedhin, Samson/O-2121-2019	Gebremedhin, Samson/0000-0002-7838-2470; Abegaz, Teferi/0000-0002-9830-1869				Abegaz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103001; Al-Balbissi Adli H, 2003, Traffic Inj Prev, V4, P64, DOI 10.1080/15389580309857; Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; [Anonymous], 2018, DAT; Baker D R, 2000, J Okla State Med Assoc, V93, P496; Bener A, 2008, INT J CRASHWORTHINES, V13, P331, DOI 10.1080/13588260801942684; Bishai D, 2006, HEALTH ECON, V15, P65, DOI 10.1002/hec.1020; Bodalal Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040454; Brown L H, 2000, Prehosp Emerg Care, V4, P7, DOI 10.1080/10903120090941551; Central Statistical Agency and ICF, 2017, ETH DEM HLTH SURV 20; Cordellieri P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01412; Dandona R, 2008, INJURY PREV, V14, P354, DOI 10.1136/ip.2008.019620; Elvik R, 2010, ACCIDENT ANAL PREV, V42, P245, DOI 10.1016/j.aap.2009.08.002; Ethiopian Federal Police Commission, 2017, ROAD TRAFF ACC REP; Glendon AI, 1996, RISK ANAL, V16, P755, DOI 10.1111/j.1539-6924.1996.tb00826.x; Martin JL, 2004, REV EPIDEMIOL SANTE, V52, P357, DOI 10.1016/S0398-7620(04)99065-7; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Nepal S, 2015, LANCET, V385, P7; Odero Wilson, 2003, Inj Control Saf Promot, V10, P53, DOI 10.1076/icsp.10.1.53.14103; Peden M., 2004, WORLD REPORT ROAD TR; Persson A., 2008, ADV T STUD, V15, P5; Population Census Comission [Ethiopia], 2008, SUMM STAT REP 2007 P; Qirjako G, 2008, CROAT MED J, V49, P734, DOI 10.3325/cmj.2008.49.734; Santamarina-Rubio E, 2014, ACCIDENT ANAL PREV, V65, P1, DOI 10.1016/j.aap.2013.11.015; Sehat M, 2012, INT J PREVENTIVE MED, V3, P181; Sleet DA, 2011, J SAFETY RES, V42, P147, DOI 10.1016/j.jsr.2011.02.001; United Nations Development Programme, 2018, SUST DEV GOALS; Watkins K., 2012, SAFE SUSTAINABLE ROA; World Health Organization, 2002, GENDER ROAD TRAFFIC; World Health Organization, 2021, GLOBAL STATUS REPORT; World Health Organization, 2018, ROAD TRAFF INJ KEY F; Zimmerman K, 2012, ACCIDENT ANAL PREV, V45, P204, DOI 10.1016/j.aap.2011.06.018; Zwerling C, 2005, INJURY PREV, V11, P24, DOI 10.1136/ip.2004.005959	34	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0202240	10.1371/journal.pone.0202240	http://dx.doi.org/10.1371/journal.pone.0202240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695028	Green Submitted, gold, Green Published			2022-12-27	WOS:000457046400002
J	Tanabu, R; Sato, K; Monai, N; Yamauchi, K; Gonome, T; Xie, YT; Takahashi, S; Ishiguro, S; Nakazawa, M				Tanabu, Reiko; Sato, Kota; Monai, Natsuki; Yamauchi, Kodai; Gonome, Takayuki; Xie, Yuting; Takahashi, Shizuka; Ishiguro, Sei-ichi; Nakazawa, Mitsuru			The findings of optical coherence tomography of retinal degeneration in relation to the morphological and electroretinographic features in RPE65(-/-) mice	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; GENE-THERAPY; MOUSE MODEL; SD-OCT; MUTATIONS; DYSTROPHY; THICKNESS; PHOTORECEPTORS; PROGRESSION	Purpose Mutations of the gene encoding RPE65 cause Leber congenital amaurosis (LCA) retinitis pigmentosa (RP). The optical coherence tomography (OCT) is increasingly utilized to noninvasively evaluate various types of retinal diseases, including RP. The present study was conducted to characterize the OCT findings of the RPE65(-/-) mice-an animal model of LCA and RP-in relation to the morphological features based on histological and electron microscopic findings as well as electroretinography (ERG) features. Materials and methods RPE65(-/-) mice were employed as a model of retinal degeneration. C57BL/6J mice were used as a wild-type control. OCT was performed on the RPE65(-/-) mice from postnatal day (P) 22 to 170. The longitudinal changes in the OCT images and fundus pictures were analyzed both qualitatively and quantitatively in comparison to those of C57BL/6J mice. The OCT images were also compared to the histological and electron microscopic findings. Full field combined rod and cone ERG was performed to analyze the relationship between morphology based on OCT and the amplitudes of the a- and b-waves. Results In the RPE65(-/-) mice, the photoreceptor rod and cone layer appeared as a diffuse hyperreflective zone contiguous with the inner segment ellipsoid zone (IS-EZ) on OCT, even on P22, whereas the IS-EZ and interdigitation zone were clearly identified in the age-matched C57BL/6J mice. The histological analyses revealed that the regular arrangement of the photoreceptor inner and outer segments was gradually lost in the RPE65(-/-) mice. On electron microscopy, most of the rod outer segments were degenerated from P21 to P35, whereas outer segments became variably shorter after P49 although ultrastructure appeared to normalize. The thickness of the outer nuclear layer of RPE65(-/-) mice was slowly and progressively reduced in comparison to C57BL/6J mice. Although the thickness of the inner and outer segment layer of RPE65(-/-) mice was significantly decreased in comparison to C57BL/6J mice, the change was not progressive, at least until P170. Even at P35, the amplitudes of both a- and b-waves on ERG were severely deteriorated in comparison to those of C57BL/6J mice. Mottled depigmented spots appeared throughout the fundus in RPE65(-/-) mice after P72, and were detected as hyperreflective deposits under the retinal pigment epithelium on OCT. Discussion The pathological changes in the inner and outer segments layer of RPE65(-/-) mice were identified as diffuse hyperreflective changes on OCT. The rod outer segments showed degeneration in the early postnatal periods but became morphologically normalized in the disc structure after P49, although the sizes of the length of the rod outer segments were variable. OCT could not qualitatively differentiate the early degeneration of rods from the late variability in size of rods. Although the morphology of the photoreceptor outer segments was relatively preserved in the RPE65(-/-) mice, the amplitudes of ERG were severely disturbed. These structural and functional deficits may be derived from the defective supply of 11-cisretinol to the photoreceptors.	[Tanabu, Reiko; Monai, Natsuki; Yamauchi, Kodai; Gonome, Takayuki; Xie, Yuting; Takahashi, Shizuka; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan; [Sato, Kota; Ishiguro, Sei-ichi] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan	Hirosaki University; Tohoku University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, Hirosaki, Aomori, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712; Takahashi, Shizuka/0000-0001-7225-979X	Japan Society of the Promotion of Science [C-16K11313, B-17K16954, B-17K16955]; Alcon; Santen; Novartis; Phizer; HOYA; K-Vision; Flower Medical; Eisai; Hirosaki University Eye Bank	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alcon(Novartis); Santen; Novartis(Novartis); Phizer; HOYA; K-Vision; Flower Medical; Eisai(Eisai Co Ltd); Hirosaki University Eye Bank	This work was supported by: Grant-in Aid for Scientific Research (C-16K11313), Japan Society of the Promotion of Science (http://www.jsps.go.jp/), MN; Grant-in Aid for Scientific Research for Young Investigators (B-17K16954), Japan Society of the Promotion of Science (http://www.jsps.go.jp), NM; Grant-in Aid for Scientific Research for Young Investigators (B-17K16955), Japan Society of the Promotion of Science (http://www.jsps.go.jp), ST; and research fundings from Alcon, Santen, Novartis, Phizer, HOYA, K-Vision, Flower Medical, Eisai, Hirosaki University Eye Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162835; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Caruso RC, 2010, INVEST OPHTH VIS SCI, V51, P5304, DOI 10.1167/iovs.10-5559; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Cottet S, 2006, FASEB J, V20, P2036, DOI 10.1096/fj.06-6211com; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; Grover S, 2006, AM J OPHTHALMOL, V141, P850, DOI 10.1016/j.ajo.2005.12.030; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Harris EW, 2001, INT OPHTHALMOL CLIN, V41, P73, DOI 10.1097/00004397-200101000-00008; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Levine ES, 2014, VISION RES, V102, P71, DOI 10.1016/j.visres.2014.07.011; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1998, EUR J HUM GENET, V6, P527, DOI 10.1038/sj.ejhg.5200205; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Monai N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193778; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Orhan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127319; Phelan JK, 2000, MOL VIS, V6, P116; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ryals RC, 2017, INVEST OPHTH VIS SCI, V58, P1378, DOI 10.1167/iovs.16-20363; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P4568, DOI 10.1167/iovs.08-1992; Sato K, 2010, EXP EYE RES, V91, P54, DOI 10.1016/j.exer.2010.03.020; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Xu F, 2012, MOL VIS, V18, P744; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210439	10.1371/journal.pone.0210439	http://dx.doi.org/10.1371/journal.pone.0210439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695025	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400008
J	Nerudova, D; Dobranschi, M				Nerudova, Danuse; Dobranschi, Marian			Alternative method to measure the VAT gap in the EU: Stochastic tax frontier model approach	PLOS ONE			English	Article							PANEL	In this paper, we pursue an alternative method to measure the Value Added Tax gap in the European Union using the stochastic tax frontier model. We use the Value Added Tax total tax liability as the input to estimate the optimal frontier of the Value Added Tax, as well as to predict technical inefficiency. Using the latest innovations of the stochastic frontier approach, we aim to obtain the accurate size of the Value Added Tax gap in the EU-26 countries and contrast them with extant estimates. The obtained estimates of the Value Added Tax gap using the stochastic tax frontier model are different from the estimates produced by the top-down method to calculate the Value Added Tax gap in the EU. Moreover, the stochastic tax frontier approach allows us to disentangle the Value Added Tax gap, which is time dependent, from the persistent Value Added Tax gap, which is country specific. The stochastic tax frontier model allows us to test the effect of exogenous factors on the technical inefficiency of the Value Added Tax and propose appropriate policy recommendations.	[Nerudova, Danuse; Dobranschi, Marian] Mendel Univ Brno, Fac Business & Econ, Dept Accounting & Taxat, Brno, Czech Republic	Mendel University in Brno	Dobranschi, M (corresponding author), Mendel Univ Brno, Fac Business & Econ, Dept Accounting & Taxat, Brno, Czech Republic.	marian.dobranschi@mendelu.cz	Nerudova, Danuse/J-3034-2012; Dobranschi, Marian/AAH-1569-2019; Dobranschi, Marian/V-6136-2018	Nerudova, Danuse/0000-0001-8150-6107; Dobranschi, Marian/0000-0002-5642-0341; Dobranschi, Marian/0000-0002-5642-0341				Aigner D., 1977, J EC, V6, P21; Alfirman L., 2003, WORKING PAPER, P03; Allingham M.G., 1972, J PUBLIC ECON, V1, P323, DOI 10.1016/0047-2727(72)90010-2; Alm J, 2014, PUBLIC BUDG FINANC, V34, P92, DOI 10.1111/pbaf.12043; Andreoni J, 1998, J EC LIT, V36; BARTHELEMY P, 1988, REV INCOME WEALTH, P183; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; BATTESE GE, 1988, J ECONOMETRICS, V38, P387, DOI 10.1016/0304-4076(88)90053-X; Belotti F, 2013, STATA J, V13, P719, DOI 10.1177/1536867X1301300404; CASE, 2015, STUD QUANT AN VAT GA; CASE, 2016, STUD QUANT AN VAT GA; [Central Planning Bureau (CPB) Center for Social and Economic Research (CASE)], 2013, STUD QUANT AN VAT GA; Cyan Musharraf, 2013, WORKING PAPER SERIES, V39; Diakite M., 2016, TAX POTENTIAL TAX EF; Ebrill L, 2001, MODERN VAT; ELFFERS H, 1987, J ECON PSYCHOL, V8, P311, DOI 10.1016/0167-4870(87)90026-2; EU policies and implementation-status in, 2016, THEMATIC REPORTS CON; European Commission, 2016, TAX POL EUR UN 2016; European Commission, 2009, STUD QUANT AN VAT GA, DOI 10.2778/018525; FEINSTEIN JS, 1991, RAND J ECON, V22, P14, DOI 10.2307/2601005; FELDSTEIN M, 1995, J POLIT ECON, V103, P551, DOI 10.1086/261994; Fenochietto R., 2013, INT MONETARY FUND, P13; Garg S, 2017, PUBLIC FINANC REV, V45, P232, DOI 10.1177/1091142115623855; Gemmell N, 2014, FISC STUD, V35, P275, DOI 10.1111/j.1475-5890.2014.12031.x; Gemmell Norman, 2012, ADV TAXATION, V20, P203, DOI 10.2139/ssrn.2199200; Giles D. E., 1999, EMPIR ECON, V24, P621, DOI DOI 10.1007/S001810050076; Greene W. H, 2008, MEASUREMENT PRODUCTI, P92, DOI DOI 10.1093/ACPROF:OSO/9780195183528.003.0002; Internal Revenue Service (IRS), 2016, USITC PUBL; IRS, 2012, TAX GAP ESTIMATES TA; JONDROW J, 1982, J ECONOMETRICS, V19, P233, DOI 10.1016/0304-4076(82)90004-5; Karahan M, 2017, EMPIR ECON, P1; Karakaplan MU, 2017, APPL ECON, V49, P5935, DOI 10.1080/00036846.2017.1363861; Keen M.M., 2013, ANATOMY VAT; Kirchler E., 2007, EC PSYCHOL TAX BEHAV; Kumbhakar S.C, 2015, STOCHASTIC FRONTIER; Kumbhakar SC, 2014, J PROD ANAL, V41, P321, DOI 10.1007/s11123-012-0303-1; Langford B, 2015, WORKING PAPER; Malik S, 2018, INT TAX PUBLIC FINAN, V25, P200, DOI 10.1007/s10797-017-9448-1; McManus J, 2006, EJOURNAL TAX RES, V4, P61; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; MUNDLAK Y, 1961, INT ECON REV, V2, P154, DOI 10.2307/2525442; Murphy R, 2014, TAX GAP TAX EVASION; Murphy R, 2017, WHY BOTHER TAX GAP I; Neslen A., 2017, GUARDIAN 0915; O'Doherty M, 2014, FISC STUD, V35, P297, DOI 10.1111/j.1475-5890.2014.12032.x; Pessino C, 2010, HACIENDA PUBLICA ESP, P65; Raczkowski K., 2015, J EC MANAGEMENT, V21, P58; RECKERS PMJ, 1994, NATL TAX J, V47, P825; SCHMIDT P, 1984, J ECONOMETRICS, V24, P349, DOI 10.1016/0304-4076(84)90058-7; Schneider F., 2015, J SELF GOVERNANCE MA, V3; Schneider F. G., 2012, SSRN ELECT J, DOI [10.2139/ssrn.2031951, DOI 10.2139/SSRN.2031951]; Skatteverket, 2014, DEV TAX GAP SWEDEN 2; The Organisation for Economic Co-operation and Development OECD, 2015, COMP INF OECD OTH AD; Wang HJ, 2002, J PROD ANAL, V18, P129, DOI 10.1023/A:1016565719882	54	11	11	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211317	10.1371/journal.pone.0211317	http://dx.doi.org/10.1371/journal.pone.0211317			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689663	gold, Green Published, Green Submitted			2022-12-27	WOS:000457041800029
J	Yeoh, YS; Koh, GCH; Tan, CS; Tu, TM; Singh, R; Chang, HM; De Silva, DA; Ng, YS; Ang, YH; Yap, P; Chew, E; Merchant, RA; Yeo, TT; Chou, N; Venketasubramanian, N; Lee, KE; Young, SH; Hoenig, H; Matchar, DB; Luo, N				Yeoh, Yen Shing; Koh, Gerald Choon-Huat; Tan, Chuen Seng; Tu, Tian Ming; Singh, Rajinder; Chang, Hui Meng; De Silva, Deidre A.; Ng, Yee Sien; Ang, Yan Hoon; Yap, Philip; Chew, Effie; Merchant, Reshma A.; Yeo, Tseng Tsai; Chou, Ning; Venketasubramanian, N.; Lee, Kim En; Young, Sherry H.; Hoenig, Helen; Matchar, David Bruce; Luo, Nan			Health-related quality of life loss associated with first-time stroke	PLOS ONE			English	Article							SELF-REPORT QUESTIONNAIRE; MINI-MENTAL-STATE; RHEUMATIC-DISEASES; POPULATION NORMS; EQ-5D; EUROQOL; VALIDATION; DISABILITY; RELIABILITY; PREVALENCE	Objectives This study aimed to quantify health-related quality of life (HRQoL) loss associated with first episode of stroke by comparing patient-reported HRQoL before and after stroke onset. The impact of stroke in local population was also evaluated by comparing the pre- and post-stroke HRQoL with that of the general population. Methods The HRQoL of stroke survivors was assessed with the EQ-5D-3L index score at recruitment, for recalled pre- stroke HRQoL, and at 3 and 12 month post-stroke. Change in HRQoL from pre- stroke to 3 and 12 month was self-reported by 285 and 238 patients, respectively. Mean EQ index score at each time point (baseline: 464 patients; 3 month post-stroke: 306 patients; 12 month post-stroke: 258 patients) was compared with published population norms for EQ-5D-3L. Results There was a significant decrease in HRQoL at 3 (0.25) and 12 month (0.09) post-stroke when compared to the retrospectively recalled patients' mean pre- stroke HRQoL level 0.87). The reduction at 3 month was associated with the reduction in all EQ-5D-3L health dimensions; reductions remaining at 12 month were limited to dimensions of mobility, self-care, usual activities, and anxiety/depression. Stroke patients had a lower mean EQ index than the general population by 0.07 points pre-stroke (0.87 vs. 0.94), 0.33 points at 3 month (0.61 vs. 0.94) and 0.18 points at 12 month (0.76 vs. 0.94) post-stroke. Conclusions Stroke has a substantial impact on HRQoL in Singapore, especially in the first three months post-stroke. Compared to the general population, stroke survivors have lower HRQoL even before stroke onset. This pre-stroke deficit in HRQoL should be taken into account when quantifying health burden of stroke or setting goals for stroke rehabilitation.	[Yeoh, Yen Shing; Koh, Gerald Choon-Huat; Tan, Chuen Seng; Luo, Nan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tu, Tian Ming; Singh, Rajinder] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [Chang, Hui Meng; De Silva, Deidre A.] Natl Neurosci Inst, Dept Neurol, Singapore Gen Hosp Campus, Singapore, Singapore; [Ng, Yee Sien] Singapore Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Ang, Yan Hoon; Yap, Philip] Khoo Teck Puat Hosp, Dept Geriatr Med, Singapore, Singapore; [Chew, Effie] Natl Univ Singapore Hosp, Dept Rehabil Med, Singapore, Singapore; [Merchant, Reshma A.] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore; [Yeo, Tseng Tsai; Chou, Ning] Natl Univ Singapore Hosp, Dept Neurosurg, Singapore, Singapore; [Venketasubramanian, N.] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore; [Lee, Kim En] Farrer Pk Hosp, Farrer Pk Med Ctr, Singapore, Singapore; [Young, Sherry H.] Changi Gen Hosp, Dept Rehabil Med, Singapore, Singapore; [Hoenig, Helen] Durham Vet Affairs Med Ctr, Phys Med & Rehabil Serv, Durham, NC USA; [Hoenig, Helen] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Matchar, David Bruce] Duke NUS Med Sch, Hlth Serv & Syst Res Programme, Singapore, Singapore; [Matchar, David Bruce] Duke Univ, Ctr Clin Hlth Policy Res, Med Ctr, Durham, NC USA	National University of Singapore; National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; National University of Singapore; Raffles Hospital; Changi General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; National University of Singapore; Duke University	Luo, N (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	ephln@nus.edu.sg	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Merchant, Reshma Aziz/I-3033-2019; Tu, Tian Ming/AAI-3949-2020; Tan, Chuen Seng/K-1078-2013; Yeo, Tseng Tsai/U-8864-2017; Merchant, Reshma/ABD-4044-2020; Chou, Ning/B-5314-2011	Merchant, Reshma Aziz/0000-0002-9032-0184; Tu, Tian Ming/0000-0002-7175-0357; Tan, Chuen Seng/0000-0002-6513-2309; Matchar, David/0000-0003-3020-2108; De Silva, Deidre Anne/0000-0002-7123-2381; Ng, Yee-Sien/0000-0003-1377-5852	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre [NMRC/CG/C026/2017_NUHS]; Health Services Research Competitive Research Grant [HSRG/0006/2010]	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre; Health Services Research Competitive Research Grant	This study was supported by the Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme - Singapore Population Health Improvement Centre (NMRC/CG/C026/2017_NUHS to GCHK) and Health Services Research Competitive Research Grant (HSRG/0006/2010 to GCHK). The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin E, 2015, QUAL LIFE RES, V24, P1545, DOI 10.1007/s11136-014-0859-5; Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898; Bour A, 2010, J NEUROL, V257, P630, DOI 10.1007/s00415-009-5387-9; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cameron CM, 2005, B WORLD HEALTH ORGAN, V83, P345; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS39, DOI 10.1097/PHM.0b013e31823d4df7; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Dorman PJ, 1997, STROKE, V28, P1883, DOI 10.1161/01.STR.28.10.1883; Fang J, 2016, SCI REPORTS, V6; Fayers P.M., 2013, QUALITY LIFE ASSESSM; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabbe BJ, 2007, J ORTHOP TRAUMA, V21, P223, DOI 10.1097/BOT.0b013e31803eb13c; Gokkaya NKO, 2005, INT J REHABIL RES, V28, P229, DOI 10.1097/00004356-200509000-00005; Golicki D, 2015, QUAL LIFE RES, V24, P1555, DOI 10.1007/s11136-014-0873-7; Hunger M, 2012, QUAL LIFE RES, V21, P1205, DOI 10.1007/s11136-011-0024-3; Luo N, 2003, ANN ACAD MED SINGAP, V32, P685; Luo N, 2003, QUAL LIFE RES, V12, P87, DOI 10.1023/A:1022063721237; Luo N, 2014, PHARMACOECONOMICS, V32, P495, DOI 10.1007/s40273-014-0142-1; Luo YH, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0246-0; Min KB, 2015, AGE AGEING, V44, P700, DOI 10.1093/ageing/afv060; Ministry of Health, 2011, NAT HLTH SURV 2010; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; Pinto EB, 2011, ARQ NEURO-PSIQUIAT, V69, P320, DOI 10.1590/S0004-282X2011000300010; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sneeuw KCA, 1997, STROKE, V28, P1541, DOI 10.1161/01.STR.28.8.1541; Staquet M, 1992, QUAL LIFE RES, V1; StataCorp, 2021, STATA STAT SOFTWARE; Subramaniam M, 2014, PSYCHIAT RES, V215, P46, DOI 10.1016/j.psychres.2013.10.002; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; Wee HL, 2007, ANN ACAD MED SINGAP, V36, P403; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; WITYK RJ, 1994, STROKE, V25, P362, DOI 10.1161/01.STR.25.2.362; Xie JP, 2006, STROKE, V37, P2567, DOI 10.1161/01.STR.0000240506.34616.10	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211493	10.1371/journal.pone.0211493	http://dx.doi.org/10.1371/journal.pone.0211493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689666	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800036
J	Berthold, F; Bartenhagen, C; Krempel, L				Berthold, Frank; Bartenhagen, Christoph; Krempel, Lothar			Are network growth and the contributions to congresses associated with publication success? A pediatric oncology model	PLOS ONE			English	Article							INDEX	Background The consistent focus of 'Advances in Neuroblastoma Research' congresses on the topic neuroblastoma sets it as a model for a circumscribed scientific community. Methods The contributions of authors, institutions and countries to congress abstracts and their collaborations were compared to the Hirsch index (h-index) calculated from the Web of Science publication output on the topic 'neuroblastoma'. Results From 1975 to 2016, 18 congresses were held. 8459 authors affiliated to 553 institutions of 53 countries presented 3,993 abstracts. The number of coauthors increased over the years from 2 to 7. A considerable proportion of authors, institutions and countries presented only once (53.7%/25.7%/13.2%). Authors with a high number of abstracts and with a large local network were often among those with a higher publication rate and success (R-2 = 0.508 for Pearson's correlation between weight and h-index, R-2 = 0.474 for degree centrality, R-2 = 0.364 for lobby-index). Closeness and betweenness centralities were less correlated (R-2 = 0.127/R-2 = 0.33, resp.). The institutions showed a similar impact of local interactions on publication success (degree centrality R-2 = 0.417, weight R-2 = 0.308), while countries demonstrated a higher correlation of betweenness centrality and h-Index (R-2 = 0.704) emphasizing their brokerage role. Of 553 institutions, 520 collaborated within 13 communities and belonged to the large scientific network. 33 satellite institutions had no connections to the central network. They attended 1-4 congresses over a period of 1-16 years. Conclusion A large scientific network has been developed during the recent 42 years. Growth and interaction at congresses were correlated to publication success. Weight is suggested as a useful and simple estimate.	[Berthold, Frank; Bartenhagen, Christoph] Univ Cologne, Dept Pediat Oncol & Hematol, Cologne, Germany; [Krempel, Lothar] Max Planck Inst Study Soci, Cologne, Germany	University of Cologne	Berthold, F (corresponding author), Univ Cologne, Dept Pediat Oncol & Hematol, Cologne, Germany.	frank.berthold@uk-koeln.de		Berthold, Frank/0000-0002-7613-1723				Abbasi A, 2013, SCIENTOMETRICS, V96, P633, DOI 10.1007/s11192-013-0959-y; Asnafi AR, 2017, COLLNET J SCIENTOMET, V11, P193, DOI 10.1080/09737766.2017.1284728; Ayaz S, 2018, SCIENTOMETRICS, V114, P993, DOI 10.1007/s11192-017-2618-1; Bertoli-Barsotti L, 2017, SCIENTOMETRICS, V113, P1209, DOI 10.1007/s11192-017-2508-6; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; EDS E. S., 2009, P 11 INT S ALG DAT S; Fortunato S, 2018, SCIENCE, V359, DOI 10.1126/science.aao0185; Gauffriau M, 2017, J INFORMETR, V11, P672, DOI 10.1016/j.joi.2017.05.009; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Korn A, 2009, PHYSICA A, V388, P2221, DOI 10.1016/j.physa.2009.02.013; Lu L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10168; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molinari A, 2008, SCIENTOMETRICS, V75, P339, DOI 10.1007/s11192-007-1872-z; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Osareh F, 2017, COLLNET J SCIENTOMET, V11, P223, DOI 10.1080/09737766.2017.1292666; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Ribeiro LC, 2018, SCIENTOMETRICS, V114, P159, DOI 10.1007/s11192-017-2573-x; Schubert A, 2009, SCIENTOMETRICS, V78, P375, DOI 10.1007/s11192-008-2218-1; Tal D, 2017, SCIENTOMETRICS, V112, P1391, DOI 10.1007/s11192-017-2425-8	20	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210994	10.1371/journal.pone.0210994	http://dx.doi.org/10.1371/journal.pone.0210994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682100	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500086
J	Galvao, EL; Pedras, MJ; Cota, GF; Rabello, A; Simoes, TC				Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Rabello, Ana; Simoes, Taynana Cesar			How cutaneous leishmaniasis and treatment impacts in the patients' lives: A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; DISEASE	Background Until now, few studies have evaluated the effect of cutaneous leishmaniasis (CL) on patients' quality of life, and none have used a specific instrument to measure this effect. The objective of this study was to identify factors that may be associated with the high impact of CL and to assess patients' satisfaction with treatment and health services by utilizing a disease-specific questionnaire. Methodology Between December 2015 and May 2017, 100 patients with localized cutaneous leishmaniasis were interviewed at a leishmaniasis referral center in Brazil. Data were collected by two questionnaires. One questionnaire compiled the sociodemographic, economic, and clinical information related to the disease. The second questionnaire was the Cutaneous Leishmaniasis Impact Questionnaire (CLIQ), which consisted of two subscales that measured 1) the general impact of CL and 2) patients' perceptions of treatment and health services. The median scores from each of these two subscales were used to dichotomize the dependent variables. Risk factors for the high impact of CL and for low patient satisfaction with treatment and health services were analyzed with a logistic regression analysis. Results The chance of higher impact of CL was increased in patients with the presence of comorbidities (OR: 3.9; CI 1.25-12.36), in those with absences from work (OR: 12.0; CI 3.78-42.55), in those who relied on public transportation by a municipal bus (OR: 5.8; CI 1.27-26.77), and in those who had illness-related expenses greater than U$137 (OR: 3.5; CI 1.17-10.24). The chance of patient dissatisfaction with treatment and health services increased with higher education (OR: 5.0; CI 1.19-21.03) and with illness-related expenses exceeding U$ 137 (OR: 4.64; CI 1.49-14.48). Once the sample was non-probabilistic, findings are not representative of CL patients in general. Conclusions CL and its treatment have a negative impact on patients' quality of life. Considering these effects during public health planning may help patients to confront the disease.	[Galvao, Endi Lanza; Pedras, Mariana Junqueira; Cota, Glaucia Fernandes; Rabello, Ana; Simoes, Taynana Cesar] Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infect Parasit, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Galvao, EL (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Pesquisa Clin & Polit Publ Doencas Infect Parasit, Belo Horizonte, MG, Brazil.	endilanza@yahoo.com.br	Junqueira Pedras, Mariana/ABF-1228-2021; Cota, Glaucia/ABC-5378-2020; Simões, Taynãna César/ABE-8964-2021	Junqueira Pedras, Mariana/0000-0003-2494-6178; Cota, Glaucia/0000-0003-0538-7403; Galvao, Endi Lanza/0000-0002-5648-3932	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]; FAPEMIG (Foundation for Research Support of the State of Minas Gerais) [12504]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Foundation for Research Support of the State of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	AR is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). ELG is Ph.D. student and is reciving a scholarship from FAPEMIG (Foundation for Research Support of the State of Minas Gerais) [12504]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kamel Mohamed A, 2016, Int J Womens Dermatol, V2, P93, DOI 10.1016/j.ijwd.2016.04.003; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x; Arana BA, 2000, ANN TROP MED PARASIT, V94, P779, DOI 10.1080/0003490020012416; Bennis I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5260-9; Bennis I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189906; Bennis I, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0267-5; Berger BA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005459; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Brito NC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184777; Chahed MK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005090; da Silva RD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4752-3; Martins AMEDL, 2009, CAD SAUDE PUBLICA, V25, P421, DOI 10.1590/S0102-311X2009000200021; Toledo Jr ACD, 2013, T ROY SOC TROP MED H, V107, P335, DOI 10.1093/trstmh/trt021; Duncan P, 2015, INT J HEALTH SERV, V45, P545, DOI 10.1177/0020731415584558; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gallegos-Carrillo K, 2006, REV SAUDE PUBL, V40, P792, DOI 10.1590/S0034-89102006000600008; Galvao EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203378; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Molarius A, 2002, J CLIN EPIDEMIOL, V55, P364, DOI 10.1016/S0895-4356(01)00491-7; PAHO, 2013, PAN AM HLTH ORG 2013; Passero LG, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00065015; Pavao ALB, 2013, SELF RATED HLTH ASS; Pereira RHM, 2016, REV SAUDE PUBL, P50, DOI [10.1590/S1518-8787, DOI 10.1590/S1518-8787]; Peres MA, 2010, REV SAUDE PUBL, V44, DOI 10.1590/S0034-89102010000500016; Petarli GB, 2015, CAD SAUDE PUBLICA, V31, P787, DOI 10.1590/0102-311X00083114; Ranawaka R R, 2014, Mymensingh Med J, V23, P345; Ribeiro MN, 2014, REV INST MED TROP SP, V56, P291, DOI 10.1590/S0036-46652014000400004; Ruo B, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.01.012; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Vares B, 2013, ARCH IRAN MED, V16, P474, DOI 013168/AIm.008; Yanik M, 2004, CLIN EXP DERMATOL, V29, P464, DOI 10.1111/j.1365-2230.2004.01605.x	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211374	10.1371/journal.pone.0211374	http://dx.doi.org/10.1371/journal.pone.0211374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682151	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500158
J	Helm, M; Ritzmann, R; Gollhofer, A; Freyler, K				Helm, Michael; Ritzmann, Ramona; Gollhofer, Albert; Freyler, Kathrin			Anticipation modulates neuromechanics of drop jumps in known or unknown ground stiffness	PLOS ONE			English	Article							NEUROMUSCULAR CONTROL; SURFACE INSTABILITY; LEG STIFFNESS; FORCE ENHANCEMENT; STRETCH REFLEXES; NEURAL-CONTROL; PERFORMANCE; MUSCLES; COCONTRACTION; HEIGHT	With an emphasis on ballistic movements, an accurately anticipated neural control is an essential prerequisite to deliver a motor response coincidentally with the event of ground contact. This study investigated how previous knowledge of the ground condition affects proactive and reactive motor control in drop jumps (DJ). Thereby, human anticipatory capacity of muscle activation was investigated regarding neuromuscular activation, joint kinematics and peak forces associated with DJ performance. In 18 subjects, the effect of knowledge of two different surface conditions during DJs was evaluated. Peak force, ground-contact-time (GCT), rate of force development (RFD) and jump height were assessed. Electromyographic (EMG) activities of the m. soleus (SOL) and gastrocnemius medialis (GM) were assessed for 150 ms before (PRE) and during ground contact (GC) for the short-, medium-, and long-latency responses. Ankle and knee joint kinematics were recorded in the sagittal plane. In the unknown conditions peak force, RFD and jump height declined, GCT was prolonged, proactive EMG activity (PRE) in SOL and GM was diminished (P<0.05). During GC, a decline in EMG activity in the unknown condition was manifested for SOL and GM for the SLR, MLR and LLR (P<0.05). Ankle and knee joint deflections during GC were increased in the unknown vs. known condition (P<0.05). Peak force, RFD and jump height were positively correlated to GM-EMG in PRE, SLR, MLR and LLR (P<0.05). Results revealed that proactive and reactive modulations in muscle activity prior and during GC are interrelated to the force-time characteristics and height of the jumps. The unknown condition revealed a comparable neuromuscular activity during pre-activation for both conditions, followed by an inhibition in the subsequent phase after touch down. These findings underline that anticipation is a determining factor influencing timing and adjustment of motor responses to accomplish ballistic movements regarding precision and performance.	[Helm, Michael; Ritzmann, Ramona; Gollhofer, Albert; Freyler, Kathrin] Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany	University of Freiburg	Helm, M (corresponding author), Univ Freiburg, Dept Sport & Sport Sci, Freiburg, Germany.	michael.helm@sport.uni-freiburg.de	Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019		German Aerospace Center [DLR 50WB1715]; Albert-Ludwigs-University Freiburg	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); Albert-Ludwigs-University Freiburg	This study was funded by the German Aerospace Center (DLR 50WB1715). The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arai A, 2013, EUR J SPORT SCI, V13, P490, DOI 10.1080/17461391.2013.764930; Arampatzis A, 2004, MED SCI SPORT EXER, V36, P451, DOI 10.1249/01.MSS.0000117166.87736.0A; Arampatzis A, 2001, MED SCI SPORT EXER, V33, P923, DOI 10.1097/00005768-200106000-00011; Avela J, 1996, EUR J APPL PHYSIOL, V72, P553, DOI 10.1007/BF00242290; Behm DG, 2010, APPL PHYSIOL NUTR ME, V35, P109, DOI 10.1139/H09-128; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P339; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P332; Chappell JD, 2007, AM J SPORT MED, V35, P235, DOI 10.1177/0363546506294077; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; da Fonseca ST, 2004, J ELECTROMYOGR KINES, V14, P239, DOI 10.1016/j.jelekin.2003.09.003; DE LUCA CJ, 1987, J NEUROPHYSIOL, V58, P525, DOI 10.1152/jn.1987.58.3.525; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Fagnani F, 2006, AM J PHYS MED REHAB, V85, P956, DOI 10.1097/01.phm.0000247652.94486.92; Farley CT, 1998, J APPL PHYSIOL, V85, P1044, DOI 10.1152/jappl.1998.85.3.1044; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferris DP, 1997, J APPL PHYSIOL, V82, P15, DOI 10.1152/jappl.1997.82.1.15; Finni T, 2001, ACTA PHYSIOL SCAND, V173, P369, DOI 10.1046/j.1365-201X.2001.00915.x; Fong SSM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001785; Freyler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167557; GOLLHOFER A, 1991, INT J SPORTS MED, V12, P34, DOI 10.1055/s-2007-1024652; GOLLHOFER A, 1992, EUR J APPL PHYSIOL, V64, P283, DOI 10.1007/BF00636213; GREENWOOD R, 1976, BRAIN, V99, P375, DOI 10.1093/brain/99.2.375; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Komi P.V., 2003, STRENGTH POWER SPORT, P184, DOI [10.1002/9780470757215.ch10, DOI 10.1002/9780470757215.CH10]; KOMI PV, 1984, MED SCI SPORT EXER, V16, P26; Komi PV, 1997, J APPL BIOMECH, V13, P451, DOI 10.1123/jab.13.4.451; Lee R G, 1975, Can J Neurol Sci, V2, P285; Leonhart R, 2004, LEHRBUCH STAT EINSTI; Lesinski M, 2017, SCAND J MED SCI SPOR, V27, P1090, DOI 10.1111/sms.12732; Lesinski M, 2018, INT J SPORTS MED, V39, P50, DOI 10.1055/s-0043-117610; Leukel C, 2012, HUM MOVEMENT SCI, V31, P152, DOI 10.1016/j.humov.2011.04.006; Makaruk H, 2011, BIOL SPORT, V28, P63, DOI 10.5604/935873; Marquez G, 2014, ACTA PHYSIOL, V212, P214, DOI 10.1111/apha.12356; Marquez G, 2010, EXP BRAIN RES, V204, P575, DOI 10.1007/s00221-010-2324-1; Marsden CD, 1978, PROGR CLIN NEUROPHYS, V4, P167; Mayer F, 2007, PRAVENTION VERLETZUN; McLean SG, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029278; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milner TE, 1995, EXP BRAIN RES, V107, P293; Moritz CT, 2005, J EXP BIOL, V208, P939, DOI 10.1242/jeb.01472; NIELSEN J, 1992, J PHYSIOL-LONDON, V456, P373, DOI 10.1113/jphysiol.1992.sp019341; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pollard CD, 2010, CLIN BIOMECH, V25, P142, DOI 10.1016/j.clinbiomech.2009.10.005; Prieske O, 2015, INT J SPORTS MED, V36, P75, DOI 10.1055/s-0034-1384549; Prieske O, 2013, EUR J APPL PHYSIOL, V113, P2943, DOI 10.1007/s00421-013-2724-6; Ritzmann R, 2016, J APPL PHYSIOL, V121, P1187, DOI 10.1152/japplphysiol.00692.2016; Roelants M, 2004, J AM GERIATR SOC, V52, P901, DOI 10.1111/j.1532-5415.2004.52256.x; Rosa M, 2015, J NOV PHYSIOTHER, V5, P1, DOI DOI 10.4172/2165-7025.1000248; SCHMIDT RA, 1968, PSYCHOL BULL, V70, P631, DOI 10.1037/h0026740; Sinkjaer T, 1999, CLIN NEUROPHYSIOL, V110, P951, DOI 10.1016/S1388-2457(99)00034-6; Taube W, 2012, SCAND J MED SCI SPOR, V22, P671, DOI 10.1111/j.1600-0838.2011.01293.x; Taube W, 2008, J NEUROPHYSIOL, V99, P1243, DOI 10.1152/jn.01118.2007; Taube W, 2012, EXERC SPORT SCI REV, V40, P106, DOI 10.1097/JES.0b013e31824138da; THOMPSON HW, 1995, NEUROREPORT, V6, P581, DOI 10.1097/00001756-199502000-00043; Walsh M, 2004, J STRENGTH COND RES, V18, P561; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; Wong AL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14624; Zuur AT, 2010, J PHYSIOL-LONDON, V588, P799, DOI 10.1113/jphysiol.2009.182709	61	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211276	10.1371/journal.pone.0211276	http://dx.doi.org/10.1371/journal.pone.0211276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682132	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500139
J	Hippner, P; Sumner, T; Houben, RMGJ; Cardenas, V; Vassall, A; Bozzani, F; Mudzengi, D; Mvusi, L; Churchyard, G; White, RG				Hippner, Piotr; Sumner, Tom; Houben, Rein M. G. J.; Cardenas, Vicky; Vassall, Anna; Bozzani, Fiammetta; Mudzengi, Don; Mvusi, Lindiwe; Churchyard, Gavin; White, Richard G.			Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa	PLOS ONE			English	Article							TRANSMISSION; IMPACT; INDIA; CHINA	South Africa has the highest tuberculosis (TB) disease incidence rate in the world, and TB is the leading infectious cause of death. Decisions on, and funding for, TB prevention and care policies are decentralised to the provincial governments and therefore, tools to inform policy need to operate at this level. We describe the use of a mathematical model planning tool at provincial level in a high HIV and TB burden country, to estimate the impact on TB burden of achieving the 90-(90)-90 targets of the Stop TB Partnership Global Plan to End TB. "TIME Impact" is a freely available, user-friendly TB modelling tool. In collaboration with provincial TB programme staff, and the South African National TB Programme, models for three (of nine) provinces were calibrated to TB notifications, incidence, and screening data. Reported levels of TB programme activities were used as baseline inputs into the models, which were used to estimate the impact of scale-up of interventions focusing on screening, linkage to care and treatment success. All baseline models predicted a trend of decreasing TB incidence and mortality, consistent with recent data from South Africa. The projected impacts of the interventions differed by province and were greatly influenced by assumed current coverage levels. The absence of provincial TB burden estimates and uncertainty in current activity coverage levels were key data gaps. A user-friendly modelling tool allows TB burden and intervention impact projection at the sub-national level. Key sub-national data gaps should be addressed to improve the quality of sub-national model predictions.	[Hippner, Piotr; Cardenas, Vicky; Mudzengi, Don; Churchyard, Gavin] Aurum Inst, Johannesburg, South Africa; [Sumner, Tom; Houben, Rein M. G. J.; White, Richard G.] London Sch Hyg & Trop Med, TB Modelling Grp, TB Ctr, London, England; [Sumner, Tom; Houben, Rein M. G. J.; White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Vassall, Anna; Bozzani, Fiammetta] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Mvusi, Lindiwe] Natl Dept Hlth, TB Control & Management, Pretoria, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin] South African Med Res Council, Adv Care & Treatment ACT TB HIV, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; South African Medical Research Council	Sumner, T (corresponding author), London Sch Hyg & Trop Med, TB Modelling Grp, TB Ctr, London, England.; Sumner, T (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	tom.sumner@lshtm.ac.uk	Mudzengi, Don/ABC-3042-2021; White, Richard G/D-5407-2009	Mudzengi, Don/0000-0003-2759-3320; White, Richard G/0000-0003-4410-6635; Churchyard, Gavin/0000-0002-4269-3699; Vassall, Anna/0000-0002-2911-1375	Bill and Melinda Gates Foundation (SA Modelling for Policy) [OPP110334]; MRC [MR/P002404/1] Funding Source: UKRI	Bill and Melinda Gates Foundation (SA Modelling for Policy); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Bill and Melinda Gates Foundation (SA Modelling for Policy #OPP110334). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], S AFR TUB DRUG RES S; Avenir Health, 2017, SPECTR GLAST; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Blaser N, 2016, EPIDEMICS-NETH, V14, P54, DOI 10.1016/j.epidem.2015.10.001; Churchyard GJ, 2015, XPERT MTB RIF VERSUS, DOI [10.1016/S2214-109X(15)00100-X, DOI 10.1016/S2214-109X(15)00100-X]; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2012, ANN REV PUBLIC H; Gilbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126267; Health Systems Trust, 2016, HLTH IND; Houben RMGJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0608-4; Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI [10.1016/s2214-109x(16)30199-1, 10.1016/S2214-109X(16)30199-1]; Knight GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122514; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Menzies NA, 2016, LANCET GLOB HEALTH, V4, pE816, DOI [10.1016/S2214-109X(16)30265-0, 10.1016/s2214-109x(16)30265-0]; Nanoo A, 2015, LANCET INFECT DIS, V15, P1066, DOI 10.1016/S1473-3099(15)00147-4; National Department of Health, 2014, NAT TUB MAN GUID 201; National Department of Health South African National AIDS Council, 12016 NAT DEP HLTH S; Pretorius C, 2014, POTENTIAL EFFECTS CH; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa, 2017, MORT CAUS DEATH S AF; Stop TB Partnership, 2016, PAR SHIFT 2016 2020; Treasury National, 2017, EST NAT EXP 2017; White RG, 2017, IJTLD; WHO, 2017, GLOB TUB REP	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209320	10.1371/journal.pone.0209320	http://dx.doi.org/10.1371/journal.pone.0209320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682028	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500015
J	Miyoshi, S; Kimura, S; Ootsuki, R; Higaki, T; Nakamasu, A				Miyoshi, Saori; Kimura, Seisuke; Ootsuki, Ryo; Higaki, Takumi; Nakamasu, Akiko			Developmental analyses of divarications in leaves of an aquatic fern Microsorum pteropus and its varieties	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LEAF DEVELOPMENT; GROWTH; ENDOPOLYPLOIDY; EVOLUTIONARY; PATTERNS; STRATEGY; PROGRAM; TISSUE; MODEL	Plant leaves occur in diverse shapes. Divarication patterns that develop during early growths are one of key factors that determine leaf shapes. We utilized leaves of Microsorum pteropus, a semi-aquatic fern, and closely related varieties to analyze a variation in the divarication patterns. The leaves exhibited three major types of divarication: no lobes, bifurcation, and trifurcation (i.e., monopodial branching). Our investigation of their developmental processes, using time-lapse imaging, revealed localized growths and dissections of blades near each leaf apex. Restricted cell divisions responsible for the apical growths were confirmed using a pulse-chase strategy for EdU labeling assays.	[Miyoshi, Saori; Kimura, Seisuke; Nakamasu, Akiko] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan; [Kimura, Seisuke] Kyoto Sangyo Univ, Ctr Ecol Evolutionary Dev Biol, Kyoto, Japan; [Ootsuki, Ryo] Komazawa Univ, Fac Arts & Sci, Dept Nat Sci, Tokyo, Japan; [Ootsuki, Ryo; Nakamasu, Akiko] Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan; [Higaki, Takumi] Kumamoto Univ, Int Res Org Adv Sci & Technol, Kumamoto, Japan; [Nakamasu, Akiko] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan	Kyoto Sangyo University; Kyoto Sangyo University; Japan Womens University; Kumamoto University; Meiji University	Nakamasu, A (corresponding author), Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Fac Life Sci, Kyoto, Japan.; Nakamasu, A (corresponding author), Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan.; Nakamasu, A (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan.	nakamasu@kumamoto-u.ac.jp			Japan Society for the Promotion of Science [12J10320, JP16H01472, JP16K07408, 26650146]; MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan [S1511023]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan	The Japan Society for the Promotion of Science provided grants to AK (12J10320), SK (JP16H01472 and JP16K07408), and RO (26650146). MEXT Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science & Technology of Japan provided support to SK (S1511023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Bainard JD, 2011, CHROMOSOME RES, V19, P763, DOI 10.1007/s10577-011-9228-1; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Blume KL, 1828, ENUMERATIO PLANTARUM, P125; Chitwood DH, 2016, CURR BIOL, V26, pR297, DOI 10.1016/j.cub.2016.02.033; Copeland EB, 1929, ORIENTAL GENERA POLY, P111; Das Gupta M, 2015, PLANT CELL, V27, P2785, DOI 10.1105/tpc.15.00196; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; GREEN PB, 1976, BOT GAZ, V137, P187, DOI 10.1086/336858; Guo YN, 2014, J PHYSIOL-LONDON, V592, P313, DOI 10.1113/jphysiol.2013.261099; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Ikeuchi M, 2013, AM J BOT, V100, P1116, DOI 10.3732/ajb.1200560; Kawamura E, 2010, PLANT J, V62, P429, DOI 10.1111/j.1365-313X.2010.04156.x; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Kreier HP, 2008, MOL PHYLOGENET EVOL, V48, P1155, DOI 10.1016/j.ympev.2008.05.001; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nakamasu A, 2017, DEV DYNAM, V246, P981, DOI [10.1002/DVDY.24587, 10.1002/dvdy.24587]; Nakamasu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111615; Nakayama H, 2015, BIO-PROTOCOL, V5, pe1600, DOI DOI 10.21769/BioProtoc.1600; Nakayama H, 2014, PLANT CELL, V26, P4733, DOI 10.1105/tpc.114.130229; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Runions A, 2017, NEW PHYTOL, V216, P401, DOI 10.1111/nph.14449; Steeves TA, 1990, PATTERNS PLANT DEV; Tsukaya H, 2014, CURR OPIN PLANT BIOL, V17, P103, DOI 10.1016/j.pbi.2013.11.012; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Xu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174946; Yin XF, 2016, NEW PHYTOL, V211, P1462, DOI 10.1111/nph.13980	30	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210141	10.1371/journal.pone.0210141	http://dx.doi.org/10.1371/journal.pone.0210141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682033	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500025
J	Yun, JW; Choi, MJ; Shin, GS; Lim, JO; Noh, JY; Kim, YK; Song, JY; Kim, WJ; Choi, SE; Cheong, HJ				Yun, Jae-Won; Choi, Min Joo; Shin, Gyeong-Seon; Lim, Jae-Ok; Noh, Ji Yun; Kim, Yun-Kyung; Song, Joon Young; Kim, Woo Joo; Choi, Sang-Eun; Cheong, Hee Jin			Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea	PLOS ONE			English	Article							HEALTH STATES; QUADRIVALENT; POPULATION; SAFETY; IMMUNOGENICITY; UTILITY; ADULTS	Objectives Despite a high vaccine uptake rate of over 80% in South Korea, the disease burden of influenza is still high among the elderly, which may be due to low effectiveness of vaccines. Therefore, the cost-effectiveness of use among the elderly was analyzed in order to compare the current trivalent influenza vaccine (TIV) with a quadrivalent influenza vaccine (QIV) or MF59-adjuvanted trivalent influenza vaccine (ATIV). Methods A static lifetime Markov model was used. It was assumed that the model would be repeated until individuals reached the age of 100. Cost-effectiveness was analyzed across three age groups (65-74 years, 75-84 years, and. 85 years), and the at-risk group was studied. Results Compared to the TIV, the QIV was expected to reduce the number of influenza infections by 342,873, complications by 17,011, hospitalizations by 8,568, and deaths by 2,031. The QIV was highly cost-effective when compared to the TIV, with a base case incremental cost-effectiveness ratio (ICER) estimated at USD 17,699/QALY (1USD = 1,151KRW), and the ICER decreased with age and was USD 3,431/QALY in the group aged 85 and above. Sensitivity analysis revealed that the ICER was sensitive to the QIV price, the proportion of influenza B, and vaccine mismatching. On the other hand, the ATIV was expected to reduce the number of influenza cases and complications by 1,812,395 and 89,747, respectively, annually, yielding cost-saving among all ages. ATIV price and vaccine efficacy were the most influential parameters for the ICER of ATIV. Conclusions The QIV and ATIV strategies were considered more cost-effective in comparison to the TIV for vaccination strategies implemented for the elderly. However, owing to a lack of data on the effectiveness of ATIV among the elderly, a large-scale effectiveness study is required.	[Yun, Jae-Won; Choi, Min Joo; Noh, Ji Yun; Song, Joon Young; Kim, Woo Joo; Cheong, Hee Jin] Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Shin, Gyeong-Seon; Lim, Jae-Ok; Choi, Sang-Eun] Korea Univ, Coll Pharm, Sejong, South Korea; [Kim, Yun-Kyung] Korea Univ, Coll Med, Ansan Hosp, Dept Pediat, Ansan, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Korea University Medicine (KU Medicine)	Cheong, HJ (corresponding author), Korea Univ, Coll Med, Guro Hosp, Div Infect Dis,Dept Internal Med, Seoul, South Korea.; Choi, SE (corresponding author), Korea Univ, Coll Pharm, Sejong, South Korea.	sechoi@korea.ac.kr; heejinmd@korea.ac.kr		Song, Joon Young/0000-0002-0148-7194; Cheong, Hee Jin/0000-0002-2532-1463	Korea Centers for Disease Control and Prevention [2016-E33009-00]	Korea Centers for Disease Control and Prevention	This research was supported by funding (code 2016-E33009-00) from the Korea Centers for Disease Control and Prevention.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Ara R, 2011, VALUE HEALTH, V14, P539, DOI 10.1016/j.jval.2010.10.029; Belongia EA, 2015, VACCINE, V33, P246, DOI 10.1016/j.vaccine.2014.06.052; Bertram MY, 2016, B WORLD HEALTH ORGAN, V94, P925, DOI 10.2471/BLT.15.164418; Choi WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172012; de Boer PT, 2017, EXPERT REV PHARM OUT, V17, P249, DOI 10.1080/14737167.2017.1343145; de Boer PT, 2016, VALUE HEALTH, V19, P964, DOI 10.1016/j.jval.2016.05.012; Edejer T, 2003, MAKING CHOICES HLTH; Eichner M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2399-4; ERICKSON P, 1995, YEARS HLTH LIFE; Fisman DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027420; Frey SE, 2014, VACCINE, V32, P5027, DOI 10.1016/j.vaccine.2014.07.013; Garcia A, 2016, HUM VACC IMMUNOTHER, V12, P2269, DOI 10.1080/21645515.2016.1182275; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gyu SN, 2015, REPORT KOREA HLTH PA; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jung YH, 2009, REPORT KOREA HLTH PA; KCDC, INFL WEEKL ANN REP; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Kim WJ, 2016, INFLUENZA TRANSGOVER; KISSLING E, 2013, EUROSURVEILLANCE, V18, P33; Korean Centre for Disease Control and Prevention (KCDC), 2015 2016 INFL MAN G; Korean Centre for Disease Control and Prevention (KCDC), 2016, 2016 2017 INFL MAN G; Korean Ministry of Health and Welfare, 2015, RES REPORT; Mannino S, 2012, AM J EPIDEMIOL, V176, P527, DOI 10.1093/aje/kws313; Mauskopf JA, 2000, PHARMACOECONOMICS, V17, P611, DOI 10.2165/00019053-200017060-00007; Moa AM, 2016, VACCINE, V34, P4092, DOI 10.1016/j.vaccine.2016.06.064; Noh JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178010; Park Minah, 2016, Am J Prev Med, V50, pe111, DOI 10.1016/j.amepre.2015.09.028; Prosser LA, 2004, PEDIATRICS, V113, P283, DOI 10.1542/peds.113.2.283; Raviotta JM, 2016, J AM GERIATR SOC, V64, P2126, DOI 10.1111/jgs.14323; Robinson LA, 2017, HEALTH POLICY PLANN, V32, P141, DOI 10.1093/heapol/czw096; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Suh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084121; Thommes EW, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1193-4; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; Villa M, 2013, AM J EPIDEMIOL, V178, P1139, DOI 10.1093/aje/kwt078; Yang MC, 2017, HUM VACC IMMUNOTHER, V13, P81, DOI 10.1080/21645515.2016.1225636	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209643	10.1371/journal.pone.0209643	http://dx.doi.org/10.1371/journal.pone.0209643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682030	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500016
J	Sabo, MC; Balkus, JE; Richardson, BA; Srinivasan, S; Kimani, J; Anzala, O; Schwebke, J; Feidler, TL; Fredricks, DN; McClelland, RS				Sabo, Michelle C.; Balkus, Jennifer E.; Richardson, Barbra A.; Srinivasan, Sujatha; Kimani, Joshua; Anzala, Omu; Schwebke, Jane; Feidler, Tina L.; Fredricks, David N.; McClelland, R. Scott			Association between vaginal washing and vaginal bacterial concentrations	PLOS ONE			English	Article							INTRAVAGINAL METRONIDAZOLE; HIV ACQUISITION; INCREASED RISK; AFRICAN WOMEN; VAGINOSIS; INTERVENTION	Vaginal washing is a common practice associated with adverse outcomes including bacterial vaginosis (BV) and HIV infection. Prior studies have not examined the associations between vaginal washing and individual vaginal bacteria, or whether these associations are independent of the effect of vaginal washing on BV. The purpose of this study was to characterize the association between vaginal washing and the presence and concentrations of vaginal bacteria associated with optimal and sub-optimal vaginal states. The analysis utilized data from participants in the placebo arm of the Preventing Vaginal Infections trial, which enrolled HIV-uninfected women from the United States and Kenya. Detection of bacterial taxa associated with BV was compared between visits with versus without reported vaginal washing. The effect of vaginal washing on a number of vaginal bacteria differed substantially (p< 0.05) between the US and Kenya, so results were stratified by country. In US women, vaginal washing was associated with a significantly higher likelihood of detection of BV associated bacterium 1 (BVAB1) (relative risk [RR] 1.55, 95% confidence interval [CI] 1.15-2.09, p = 0.004), BVAB2 (RR 1.99, 95% CI 1.46-2.71, p< 0.001), Mageeibacillus indolicus (RR 2.08, 95% CI 1.46-2.96, p< 0.001), Atopobium vaginae (RR 1.34, 95% CI 1.13-1.59, p = 0.001), Leptotrichia/Sneathia species (RR 1.66, 95% CI 1.33-2.09, p< 0.001), Megasphaera species (RR 1.78, 95% CI 1.34-2.37, p< 0.001) and Gardnerella vaginalis (RR 1.08, 95% CI 1.01-1.16, p = 0.02). No significant association between vaginal washing and bacterial detection was found in Kenyan women. Adjustment for bacterial vaginosis diagnosed by Gram stain did not alter these results. This study provides evidence that the association between vaginal washing and detection of individual bacterial taxa can vary regionally. For some vaginal bacteria, the association with vaginal washing may be independent of the effect on Gram stain detection of BV. Larger prospective studies in diverse geographic settings should explore whether eliminating vaginal washing impacts the presence and concentrations of key vaginal bacteria.	[Sabo, Michelle C.; McClelland, R. Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Balkus, Jennifer E.; Richardson, Barbra A.; Fredricks, David N.; McClelland, R. Scott] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Balkus, Jennifer E.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Balkus, Jennifer E.; Richardson, Barbra A.; Srinivasan, Sujatha; Feidler, Tina L.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kimani, Joshua; McClelland, R. Scott] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Anzala, Omu] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Schwebke, Jane] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Nairobi; University of Nairobi; University of Alabama System; University of Alabama Birmingham	Sabo, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	sabo@uw.edu		Fredricks, David/0000-0003-2735-6800; McClelland, Raymond Scott/0000-0003-2574-4201; Sabo, Michelle/0000-0002-5058-3166	National Institute of Allergy and Infectious Diseases [HHSN266200400073C, R01-AI099106]; University of Washington Center for AIDS Research [P30-AI27757, K24 HD88229]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD088229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007044, P30AI027757] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (contract HHSN266200400073C [through the Sexually Transmitted Infections Clinical Trials Group] and grant R01-AI099106, awarded to RSM). The Mombasa research site receives logistical and infrastructure support from the University of Washington Center for AIDS Research (grant P30-AI27757). RSM receives funding for mentoring through K24 HD88229. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2009, SEX TRANSM INFECT, V85, P348, DOI 10.1136/sti.2008.035451; Balkus JE, 2017, J INFECT DIS, V215, P723, DOI 10.1093/infdis/jiw622; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Hassan WM, 2007, SEX TRANSM DIS, V34, P384, DOI 10.1097/01.olq.0000243624.74573.63; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Hilbert DW, 2016, DIAGN MICR INFEC DIS, V86, P231, DOI 10.1016/j.diagmicrobio.2016.07.003; Jin L, 2007, J APPL MICROBIOL, V102, P1107, DOI 10.1111/j.1365-2672.2006.03147.x; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Masese L, 2013, SEX TRANSM INFECT, V89, P217, DOI 10.1136/sextrans-2012-050564; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; McClelland RS, 2015, J INFECT DIS, V211, P1875, DOI 10.1093/infdis/jiu818; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Nagot N, 2007, SEX TRANSM INFECT, V83, P365, DOI 10.1136/sti.2007.024794; Nelson DB, 2015, MATERN CHILD HLTH J, V19, P2682, DOI 10.1007/s10995-015-1790-2; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; Ness RB, 2003, SEX TRANSM DIS, V30, P71, DOI 10.1097/00007435-200301000-00014; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sivapalasingam S, 2014, AIDS RES HUM RETROV, V30, P1046, DOI 10.1089/aid.2013.0251; Srinivasan S, 2012, PLOS ONE, V7; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Verstraelen H, 2009, BMC MICROBIOL, V9	27	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210825	10.1371/journal.pone.0210825	http://dx.doi.org/10.1371/journal.pone.0210825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677048	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400027
J	Sun, SZ; Miao, ZQ; Ratcliffe, B; Campbell, P; Pasch, B; El-Kassaby, YA; Balasundaram, B; Chen, C				Sun, Shuzhen; Miao, Zhuqi; Ratcliffe, Blaise; Campbell, Polly; Pasch, Bret; El-Kassaby, Yousry A.; Balasundaram, Balabhaskar; Chen, Charles			SNP variable selection by generalized graph domination	PLOS ONE			English	Article							GENOME-WIDE; LINKAGE-DISEQUILIBRIUM; GRASSHOPPER MOUSE; RIDGE-REGRESSION; FULL PEDIGREE; CHALLENGES; POPULATIONS; PERFORMANCE; MARKERS; VALUES	Background High-throughput sequencing technology has revolutionized both medical and biological research by generating exceedingly large numbers of genetic variants. The resulting datasets share a number of common characteristics that might lead to poor generalization capacity. Concerns include noise accumulated due to the large number of predictors, sparse information regarding the p >> n problem, and overfitting and model mis-identification resulting from spurious collinearity. Additionally, complex correlation patterns are present among variables. As a consequence, reliable variable selection techniques play a pivotal role in predictive analysis, generalization capability, and robustness in clustering, as well as interpretability of the derived models. Methods and findings K-dominating set, a parameterized graph-theoretic generalization model, was used to model SNP (single nucleotide polymorphism) data as a similarity network and searched for representative SNP variables. In particular, each SNP was represented as a vertex in the graph, (dis)similarity measures such as correlation coefficients or pairwise linkage disequilibrium were estimated to describe the relationship between each pair of SNPs; a pair of vertices are adjacent, i.e. joined by an edge, if the pairwise similarity measure exceeds a user-specified threshold. A minimum k-dominating set in the SNP graph was then made as the smallest subset such that every SNP that is excluded from the subset has at least k neighbors in the selected ones. The strength of k-dominating set selection in identifying independent variables, and in culling representative variables that are highly correlated with others, was demonstrated by a simulated dataset. The advantages of k-dominating set variable selection were also illustrated in two applications: pedigree reconstruction using SNP profiles of 1,372 Douglas-fir trees, and species delineation for 226 grasshopper mouse samples. A C++ source code that implements SNP-SELECT and uses Gurobi optimization solver for the k-dominating set variable selection is available (https://github.com/transgenomicsosu/SNP-SELECT).	[Sun, Shuzhen; Chen, Charles] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Sun, Shuzhen; Ratcliffe, Blaise; El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [Miao, Zhuqi] Oklahoma State Univ, Ctr Hlth Syst Innovat, Stillwater, OK 74078 USA; [Campbell, Polly] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Campbell, Polly] Univ Calif Riverside, Dept Evolut Ecol & Organismal Biol, Riverside, CA 92521 USA; [Pasch, Bret] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ USA; [Balasundaram, Balabhaskar] Oklahoma State Univ, Sch Ind Engn & Management, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of British Columbia; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of California System; University of California Riverside; Northern Arizona University; Oklahoma State University System; Oklahoma State University - Stillwater	Chen, C (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	charles.chen@okstate.edu		Balasundaram, Balabhaskar/0000-0002-3490-4257; Chen, Charles/0000-0002-2203-0433	Oklahoma Wheat Research Foundation; NSF-MRI [1626257]; NSF-IOS [1558109]; NSF-CMMI [1404971]; Cornell Lab of Ornithology; USDA HATCH project [OKL03011]; Genome Canada; Genome Alberta through Alberta Economic Trade and Development; Genome British Columbia; University of Alberta; University of Calgary; High Performance Computing Center Facilities of Oklahoma State University; Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project; OCAST [PS15-011]	Oklahoma Wheat Research Foundation; NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-IOS(National Science Foundation (NSF)); NSF-CMMI(National Science Foundation (NSF)); Cornell Lab of Ornithology; USDA HATCH project; Genome Canada(Genome Canada); Genome Alberta through Alberta Economic Trade and Development; Genome British Columbia; University of Alberta(University of Alberta); University of Calgary; High Performance Computing Center Facilities of Oklahoma State University; Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project; OCAST	This research is funded by Oklahoma Wheat Research Foundation, OCAST (PS15-011) and NSF-MRI 1626257 (CC), NSF-IOS 1558109 (CC and PC), NSF-CMMI 1404971 (BB), and a fellowship from the Cornell Lab of Ornithology (BP). The work presented in this report also reflects the support from the USDA HATCH project OKL03011 (CC). SS, BR, YAE and CC acknowledge cash funding for this research from Genome Canada, Genome Alberta through Alberta Economic Trade and Development, Genome British Columbia, the University of Alberta and University of Calgary and others, including the Alberta forest industry in support of the Resilient Forests (RES-FOR): Climate, Pests & Policy-Genomic Applications project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Michael Stoebr from the Ministry of Forests, Lands and Natural Resource Operations, British Columbia, for the use of Douglas-fir data. We are also grateful to Ashlee Rowe, and to the following institutions for providing grasshopper mouse tissue samples: Museum of Southwestern Biology, Museum of Vertebrate Zoology, Oklahoma State University Collection of Vertebrates. The project was completed with support from the High Performance Computing Center Facilities of Oklahoma State University.	Ayers KL, 2010, GENET EPIDEMIOL, V34, P879, DOI 10.1002/gepi.20543; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; Balasundaram B, 2006, HDB OPTIMIZATION TEL, P865; Bartlett CW, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S8-S8; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bogdan M, 2015, ANN APPL STAT, V9, P1103, DOI 10.1214/15-AOAS842; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Butenko S, 2004, COOPERAT SYST, V3, P61; Chelo IM, 2014, HEREDITY, V112, P248, DOI 10.1038/hdy.2013.100; Chen C, 2013, TREE GENET GENOMES, V9, P1537, DOI 10.1007/s11295-013-0657-1; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046596; Cho S, 2010, ANN HUM GENET, V74, P416, DOI 10.1111/j.1469-1809.2010.00597.x; Christensen OF, 2012, ANIMAL, V6, P1565, DOI 10.1017/S1751731112000742; Degenhardt F, 2017, BRIEF BIOINFORM; Dehman A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0556-6; El-Kassaby YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025737; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; ELKASSABY YA, 1982, GENETICS, V101, P103; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; Fan JQ, 2012, J R STAT SOC B, V74, P37, DOI 10.1111/j.1467-9868.2011.01005.x; Fan JQ, 2010, STAT SINICA, V20, P101; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gonzalez-Martinez SC, 2009, ASS MAPPING PLANTS, pix; Guo F, 2009, J AM STAT ASSOC, V104, P142, DOI 10.1198/jasa.2009.0010; Gurobi Optimization, 2018, GUROBI OPTIMIZER REF; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Hainke K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1762-1; Hall E. R., 1981, MAMMALS N AM; Hall P, 2008, J R STAT SOC B, V70, P159, DOI 10.1111/j.1467-9868.2007.00631.x; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Haynes T. W., 1998, FUNDAMENTALS DOMINAT; He QC, 2011, BIOINFORMATICS, V27, P1, DOI 10.1093/bioinformatics/btq600; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; HENDERSON C. R., 1984, APPL LINEAR MODELS A, V11, P652; HINESLEY LL, 1979, J MAMMAL, V60, P117, DOI 10.2307/1379763; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Hong S, 2014, CANCER INFORM, V13, P55, DOI [10.4137/CIN.s16350, 10.4137/CIN.S16350]; Ishwaran H, 2014, CONTEMP MATH, V622, P81, DOI 10.1090/conm/622/12438; Jain AK., 1988, TECHNOMETRICS; JAMBU M., 1983, CLUSTER ANAL DATA AN; Jay JJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S7; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kirpich A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197910; Klapste J, 2014, TREE GENET GENOMES, V10, P241, DOI 10.1007/s11295-013-0673-1; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Li Yixue, 2014, Genomics Proteomics & Bioinformatics, V12, P187, DOI 10.1016/j.gpb.2014.10.001; Liu GM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-66; Liu L, 2010, J COMPUT BIOL, V17, P21, DOI 10.1089/cmb.2007.0228; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Long N, 2011, J ANIM BREED GENET, V128, P247, DOI 10.1111/j.1439-0388.2011.00917.x; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 2014, GENETICS, V198, P269, DOI 10.1534/genetics.114.166843; Maechler M., 2022, CLUSTER CLUSTER ANAL; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; May M, 2014, SCIENCE, V344, P1298, DOI 10.1126/science.opms.p1400086; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0369-3; Michael RG., 1979, COMPUTERS INTRACTABI, P90; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Muca M, 2015, EUROPEAN SCI J ESJ, V11; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Pes B, 2017, INFORM FUSION, V35, P132, DOI 10.1016/j.inffus.2016.10.001; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Ratcliffe B, 2017, GENETICS; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; ROBERTSON A, 1975, GENETICS, V81, P775; Santos JM, 2009, USE ADJUSTED RAND IN; Schulz-Streeck Torben, 2011, BMC Proc, V5 Suppl 3, pS12, DOI 10.1186/1753-6561-5-S3-S12; Shriver Mark D, 2004, Hum Genomics, V1, P274; Song JY, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0715-8; Spath H., 1980, CLUSTER ANAL ALGORIT; SULLIVAN RM, 1986, J MAMMAL, V67, P640, DOI 10.2307/1381126; Szymczak S, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0087-3; Team R. D. C, 2011, R LANG ENV STAT COMP; Thistlethwaite FR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4258-5; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135918; Wang H, 2012, GENET RES, V94, P73, DOI 10.1017/S0016672312000274; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wasserman L, 2009, ANN STAT, V37, P2178, DOI 10.1214/08-AOS646; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Weng LJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-99; West D.B., 1996, INTRO GRAPH THEORY; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078; Wolsey L.A., 1998, INTEGER PROGRAMMING; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yeung KY, 2001, BIOINFORMATICS; Zhang M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-251; Zhang X, 2009, COE A GENERAL APPROA	106	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0203242	10.1371/journal.pone.0203242	http://dx.doi.org/10.1371/journal.pone.0203242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677030	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400001
J	Doron, R; Sterkin, A; Fried, M; Yehezkel, O; Lev, M; Belkin, M; Rosner, M; Solomon, AS; Mandel, Y; Polat, U				Doron, Ravid; Sterkin, Anna; Fried, Moshe; Yehezkel, Oren; Lev, Maria; Belkin, Michael; Rosner, Mordechai; Solomon, Arieh S.; Mandel, Yossi; Polat, Uri			Spatial visual function in anomalous trichromats: Is less more?	PLOS ONE			English	Article							FOVEAL CONTRAST SENSITIVITY; COLOR-CAMOUFLAGED STIMULI; VISION DEFICIENCY; ADVANTAGE; DISCRIMINATION; DICHROMATS; BLINDNESS; ISHIHARA; ACUITY	Color deficiency is a common inherited disorder affecting 8% of Caucasian males with anomalous trichromacy (AT); it is the most common type of inherited color vision deficiency. Anomalous trichromacy is caused by alteration of one of the three cone-opsins' spectral sensitivity; it is usually considered to impose marked limitations for daily life as well as for choice of occupation. Nevertheless, we show here that anomalous trichromat subjects have superior basic visual functions such as visual acuity (VA), contrast sensitivity (CS), and stereo acuity, compared with participants with normal color vision. Both contrast sensitivity and stereo acuity performance were correlated with the severity of color deficiency. We further show that subjects with anomalous trichromacy exhibit a better ability to detect objects camouflaged in natural gray scale figures. The advantages of color-deficient subjects in spatial vision performance could explain the relatively high prevalence of color-vision polymorphism in humans.	[Doron, Ravid] Hadassah Acad Coll, Dept Optometry & Vis Sci, Jerusalem, Israel; [Sterkin, Anna; Fried, Moshe; Yehezkel, Oren; Belkin, Michael; Rosner, Mordechai; Solomon, Arieh S.] Tel Aviv Univ, Sackler Fac Med, Goldschleger Eye Res Inst, Tel Hashomer, Israel; [Lev, Maria; Mandel, Yossi; Polat, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sch Optometry & Vis Sci, Ramat Gan, Israel; [Mandel, Yossi] Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat BINA, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Bar Ilan University	Mandel, Y; Polat, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Sch Optometry & Vis Sci, Ramat Gan, Israel.; Mandel, Y (corresponding author), Bar Ilan Univ, Bar Ilan Inst Nanotechnol & Adv Mat BINA, Ramat Gan, Israel.	yossi.mandel@biu.ac.il; uri.polat@biu.ac.il	Solomon, Arieh/AAF-4361-2021		Israel Science Foundations (ISF) [ISF 188/10]; Israel Defense Force (IDF) IDF - 2010; Israel Science Foundation [ISF188/2010]	Israel Science Foundations (ISF); Israel Defense Force (IDF) IDF - 2010; Israel Science Foundation(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundations (ISF) ISF 188/10 and the Israel Defense Force (IDF) IDF - 2010. There was no additional external funding received for this study.; This study was supported by grants from the Israel Science Foundation (ISF188/2010).	Abramov I, 2000, INVEST OPHTH VIS SCI, V41, pS731; ADAM A, 1969, SOC BIOL, V16, P197, DOI 10.1080/19485565.1969.9987819; [Anonymous], 1940, NATURE, V146, P226; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Birch J., 1993, DIAGNOSIS DEFECTIVE; Birch J, 2010, OPHTHAL PHYSL OPT, V30, P667, DOI 10.1111/j.1475-1313.2010.00770.x; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Bosten JM, 2005, CURR BIOL, V15, pR950, DOI 10.1016/j.cub.2005.11.031; Clare G, 2010, BRIT J OPHTHALMOL, V94, P400, DOI 10.1136/bjo.2008.156323; Cockburn DM, 1999, OCCUP MED-OXFORD, V49, P247; Cole BL, 2007, CLIN EXP OPTOM, V90, P157, DOI 10.1111/j.1444-0938.2007.00135.x; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; Dain Stephen J, 2004, Clin Exp Optom, V87, P276; Davidoff C, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.5.2; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Gegenfurtner KR, 1998, VISION RES, V38, P1041, DOI 10.1016/S0042-6989(97)00200-9; Goldstein EB, 2016, SENSATION PERCEPTION; Gordon J, 2000, INVEST OPHTH VIS SCI, V41, pS807; Graham S. NV, 1989, VISUAL PATTERN ANAL; HALPERN DL, 1988, PERCEPTION, V17, P483, DOI 10.1068/p170483; Jagle H, 2006, GRAEF ARCH CLIN EXP, V244, P447, DOI 10.1007/s00417-005-0086-4; Janaky M, 2014, VISUAL NEUROSCI, V31, P99, DOI 10.1017/S0952523813000400; Judd DB, 1943, SCIENCE, V97, P544, DOI 10.1126/science.97.2529.544; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Katz G, 2010, GRAEF ARCH CLIN EXP, V248, P1699, DOI 10.1007/s00417-010-1413-y; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; Lahav K, 2011, ARCH OPHTHALMOL-CHIC, V129, P16, DOI 10.1001/archophthalmol.2010.332; LEGGE GE, 1989, VISION RES, V29, P989, DOI 10.1016/0042-6989(89)90114-4; MCKEE SP, 1987, J OPT SOC AM A, V4, P1104, DOI 10.1364/JOSAA.4.001104; Melamud Alex, 2004, Ophthalmic Genet, V25, P159, DOI 10.1080/13816810490498341; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Morgan M, 1992, BIOL SCI; Polat U, 2009, SPATIAL VISION, V22, P179, DOI 10.1163/156856809787465609; Remichen T, 1987, SOC BIOL, V34, P1; Saito A, 2006, PERCEPT MOTOR SKILL, V102, P3, DOI 10.2466/PMS.102.1.3-12; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Sharpe LT, 2006, J VISION, V6, P213, DOI 10.1167/6.3.3; Simunovic MP, 2001, INVEST OPHTH VIS SCI, V42, P3357; SNYDER CR, 1973, J SPEC EDUC, V7, P51, DOI 10.1177/002246697300700106; Spalding J Anthony B, 2004, Clin Exp Optom, V87, P344; Spalding JAB, 1999, OCCUP MED-OXFORD, V49, P247, DOI 10.1093/occmed/49.4.247; Sterkin A, 2017, VISION RES; STEWARD JM, 1989, OPTOMETRY VISION SCI, V66, P288, DOI 10.1097/00006324-198905000-00006; Tankus A, 2009, PHILOS T R SOC B, V364, P529, DOI 10.1098/rstb.2008.0211; THIBOS LN, 1992, APPL OPTICS, V31, P3594, DOI 10.1364/AO.31.003594; Troscianko J, 2017, BEHAV ECOL, V28, P556, DOI 10.1093/beheco/arw185; Verhulst S, 1998, VISION RES, V38, P3387, DOI 10.1016/S0042-6989(97)00339-8; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209662	10.1371/journal.pone.0209662	http://dx.doi.org/10.1371/journal.pone.0209662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673711	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800020
J	Zhang, JB				Zhang, Jiangbo			Opinion limits study for the multi-selection bounded confidence model	PLOS ONE			English	Article							DYNAMICS; CONSENSUS	In this work, we study the opinion limit states for a generalized bounded confidence agent based opinion model. Agents can select multiple opinions in the network, and the confidence bound is considered on the distance between the average of the selected opinions and agent opinion itself. The number of selection agents for a certain agent, which is also called the selection number, means the agent opinion interaction degree. It is known that when the confidence bound is large sufficiently, opinions reach consensus almost surely. We mainly study the opinion consensus and the opinion polarization when the confidence bound is small sufficiently. Firstly, we provide and prove the upper and lower bounds for the opinion consensus probability of this bound confidence model. It shows that the opinion consensus probability almost always decreases as the confidence bound decreases. Secondly, the opinion consensus probability is larger than the one for the opinion evolution of the Deffuant-Weisbuch model. Finally, we demonstrate the ultimate probability distribution of one agent opinion and compare it with the gossip form and the general bounded confidence form, and demonstrate how the opinion polarization probabilities evolve as the selection number changes. Specially, different from other studies, we find that the opinion polarization would happen more easily if the opinion interaction degree is strengthened. In a sum, the multiple selection mechanism will increase the opinion consensus probability and the opinion polarization probability, respectively, comparing to the single selection mechanism.	[Zhang, Jiangbo] Southwest Petr Univ, Sch Sci, Chengdu 610500, Sichuan, Peoples R China	Southwest Petroleum University	Zhang, JB (corresponding author), Southwest Petr Univ, Sch Sci, Chengdu 610500, Sichuan, Peoples R China.	eridalin@163.com			National Natural Science Foundation of China (NNSF) [11601450]; Department of Science and Technology of Sichuan Province (CN) [XQ15B10]	National Natural Science Foundation of China (NNSF)(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province (CN)	This work was supported by the National Natural Science Foundation of China (NNSF) under Grant 11601450 (website: https://isisn.nsfc.gov.cn/egrantweb/) and Department of Science and Technology of Sichuan Province (CN) under Grant XQ15B10 (website: http://xmgl.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronski JC, 2018, NONLINEARITY, V31, P2518, DOI 10.1088/1361-6544/aab0b5; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen H. F., 2002, STOCHASTIC APPROXIMA; Chen X, 2017, CHAOS, V27, DOI 10.1063/1.5008391; Chong D, 2010, AM POLIT SCI REV, V104, P663, DOI 10.1017/S0003055410000493; Chow Y. S., 1978, PROBABILITY THEORY I; Como G, 2011, ANN APPL PROBAB, V21, P1537, DOI 10.1214/10-AAP739; de Nooy W, 2013, ECOL SOC, V18, DOI 10.5751/ES-05648-180244; Durrett R, 2019, PROBABILITY THEORY E, V49; Fagnani F, 2008, IEEE J SEL AREA COMM, V26, P634, DOI 10.1109/JSAC.2008.080506; Fortunato S, 2005, INT J MOD PHYS C, V16, P1535, DOI 10.1142/S0129183105008126; Friedkin NE, 2016, SCIENCE, V354, P321, DOI 10.1126/science.aag2624; Gut Allan, 2009, TNTERNATIONAL COURSE; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Krueger T, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19070371; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Liang HL, 2013, PHYSICA A, V392, P2248, DOI 10.1016/j.physa.2013.01.008; Lorenz J, 2005, PHYSICA A, V355, P217, DOI 10.1016/j.physa.2005.02.086; Pan QH, 2017, INT J MOD PHYS C, V28, DOI 10.1142/S0129183117500036; Su W, 2017, AUTOMATICA, V85, P448, DOI 10.1016/j.automatica.2017.08.008; Torok J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.088701; Weisbuch G., 2002, Complexity, V7, P55, DOI 10.1002/cplx.10031; Yaniv I, 2007, ORGAN BEHAV HUM DEC, V103, P104, DOI 10.1016/j.obhdp.2006.05.006; Zhang JB, 2017, SIAM J CONTROL OPTIM, V55, P2543, DOI 10.1137/16M1083268; Zhang JB, 2015, J SYST SCI COMPLEX, V28, P773, DOI 10.1007/s11424-015-3240-z; Zhang JB, 2013, PHYSICA A, V392, P5289, DOI 10.1016/j.physa.2013.07.014; Zhang YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172982	27	2	2	9	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210745	10.1371/journal.pone.0210745	http://dx.doi.org/10.1371/journal.pone.0210745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673745	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800053
J	Welke, B; Jakubowitz, E; Seehaus, F; Daniilidis, K; Timpner, M; Tremer, N; Hurschler, C; Schwarze, M				Welke, Bastian; Jakubowitz, Eike; Seehaus, Frank; Daniilidis, Kiriakos; Timpner, Matthias; Tremer, Nils; Hurschler, Christof; Schwarze, Michael			The prevalence of osteoarthritis: Higher risk after transfemoral amputation?-A database analysis with 1,569 amputees and matched controls	PLOS ONE			English	Article							BACK-PAIN; LIMB; SECONDARY; KNEE	Background Several studies have shown that patients with a unilateral amputation have an increased risk of developing osteoarthritis (OA) in the knee of their sound leg. OBJECTIVE: The first objective was to investigate whether amputees are more frequently affected by gon-, cox- or polyarthritis as well as back pain or spinal disorders. We hypothesized that mobile and active transfemoral amputees more often experience OA and spinal disorders than non-amputees. The second objective was to compare the mean age of the patients with OA. Patients Patients with a unilateral transfemoral amputation (n = 1,569) and five abled-body control groups (each n = 1,569) matched in terms of age and gender resulting in total of 9,414 participants. Methods Groups were analyzed regarding the prevalence of six selected diagnoses regarding musculoskeletal disorders. Results A significantly decreased prevalence of OA and specific disorders of the spine in transfemoral amputees compared to a control group was found. The amputees with OA are significantly younger than patients with OA in the control group. Conclusion The results from the presented study contradict previously published literature. Apparently circumstances of life play an important role, like physical work and strenuous activities which are likely to be underrepresented in the amputee group. The results of the study need to be used cautiously due to the major limitation of the study which is the lack of detail in individual patients caused by the methodology.	[Welke, Bastian; Jakubowitz, Eike; Seehaus, Frank; Hurschler, Christof; Schwarze, Michael] Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Hannover, Germany; [Daniilidis, Kiriakos] Orthopadie Traumatol Ctr Regensburg, OTC, Regensburg, Germany; [Timpner, Matthias; Tremer, Nils] Techniker Krankenkasse, Hauptverwaltung Fachbereich GPH, Hamburg, Germany	Hannover Medical School	Welke, B (corresponding author), Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Hannover, Germany.	welke.bastian@mh-hannover.de	Schwarze, Michael/AEZ-2639-2022; Hurschler, Christof/AAF-8935-2019	Schwarze, Michael/0000-0001-5059-8029; Hurschler, Christof/0000-0001-8741-7463; Seehaus, Frank/0000-0002-1140-4196	Federal Ministry of Education and Research [BMBF FKZ 13EZ1112A-C]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by Federal Ministry of Education and Research (BMBF FKZ 13EZ1112A-C "meb-GO - Messtechnikbasierte Gangbildoptimierung bei transfemoral Amputierten"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner R, 2011, OPER ORTHOP TRAUMATO, V23, P289, DOI 10.1007/s00064-011-0041-y; Bieringer S., 2007, ORTHOP DIE UNF UP2DA, V2, P353, DOI [10.1055/s-2007-967065, DOI 10.1055/S-2007-967065]; BURKE MJ, 1978, ANN RHEUM DIS, V37, P252, DOI 10.1136/ard.37.3.252; Davies B, 2003, PROSTHET ORTHOT INT, V27, P186, DOI 10.1080/03093640308726681; Ehde DM, 2001, ARCH PHYS MED REHAB, V82, P731, DOI 10.1053/apmr.2001.21962; Ephraim PL, 2005, ARCH PHYS MED REHAB, V86, P1910, DOI 10.1016/j.apmr.2005.03.031; Friel K, 2005, J AM ACAD ORTHOP SUR, V13, P326, DOI 10.5435/00124635-200509000-00006; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Geertzen JHB, 2005, DISABIL REHABIL, V27, P101, DOI 10.1080/09638280400009345; Hammarlund CS, 2011, PROSTHET ORTHOT INT, V35, P97, DOI 10.1177/0309364610389357; Heller G, 2005, DEUT MED WOCHENSCHR, V130, P1689, DOI 10.1055/s-2005-871885; Holzer LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092943; Imhauser G, 1979, DER FUSS; Kulkarni J, 1998, CLIN REHABIL, V12, P348, DOI 10.1191/026921598672367610; LEMAIRE ED, 1994, ARCH PHYS MED REHAB, V75, P1094, DOI 10.1016/0003-9993(94)90084-1; Lloyd CH, 2010, GAIT POSTURE, V32, P296, DOI 10.1016/j.gaitpost.2010.05.003; Norvell DC, 2005, ARCH PHYS MED REHAB, V86, P487, DOI 10.1016/j.apmr.2004.04.034; Papazafiropoulou A, 2009, J DIABETES COMPLICAT, V23, P7, DOI 10.1016/j.jdiacomp.2007.11.008; Raspe H., 2012, GESUNDHEITSBERICHTER; Seidler A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2085-8; Struyf PA, 2009, ARCH PHYS MED REHAB, V90, P440, DOI 10.1016/j.apmr.2008.08.220; Sulsky SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031521; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization (WHO), 2016, INT STAT CLASS DIS I; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210868	10.1371/journal.pone.0210868	http://dx.doi.org/10.1371/journal.pone.0210868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668582	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400021
J	Grafe, K; Shanmugarajah, K; Zobel, T; Weidtkamp-Peters, S; Kleinschrodt, D; Smits, SHJ; Schmitt, L				Graefe, Katharina; Shanmugarajah, Kalpana; Zobel, Thomas; Weidtkamp-Peters, Stefanie; Kleinschrodt, Diana; Smits, Sander H. J.; Schmitt, Lutz			Cloning and expression of selected ABC transporters from the Arabidopsis thaliana ABCG family in Pichia pastoris	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; DRUG-RESISTANCE TRANSPORTER; HETEROLOGOUS PROTEIN EXPRESSION; ESCHERICHIA-COLI; NICOTIANA-TABACUM; RECOMBINANT EXPRESSION; TRANSLATION INITIATION; FUNCTIONAL EXPRESSION; MULTIDRUG TRANSPORTER; SECONDARY STRUCTURE	Phytohormones play a major role in plant growth and development. They are in most cases not synthesized in their target location and hence need to be transported to the site of action, by for instance ATP-binding cassette transporters. Within the ATP-binding cassette transporter family, Pleiotropic Drug Resistance transporters are known to be involved in phytohormone transport. Interestingly, PDRs are only present in plants and fungi. In contrast to fungi, there are few biochemical studies of plant PDRs and one major reason is that suitable overexpression systems have not been identified. In this study, we evaluate the expression system Pichia pastoris for heterologous overexpression of PDR genes of the model plant Arabidopsis thaliana. We successfully cloned and expressed the potential phytohormone transporters PDR2 and PDR8 in P. pastoris. Sucrose gradient centrifugation confirmed that the overexpressed proteins were correctly targeted to the plasma membrane of P. pastoris and initial functional studies demonstrated ATPase activity for WBC1. However, difficulties in cloning and heterologous overexpression might be particular obstacles of the PDR family, since cloning and overexpression of White Brown Complex 1, a half-size transporter of the same ABCG subfamily with comparable domain organization, was more easily achieved. We present strategies and highlight critical factors to successfully clone plant PDR genes and heterologously expressed in P. pastoris.	[Graefe, Katharina; Shanmugarajah, Kalpana; Kleinschrodt, Diana; Smits, Sander H. J.; Schmitt, Lutz] Heinrich Heine Univ, Inst Biochem, Dusseldorf, Germany; [Graefe, Katharina; Shanmugarajah, Kalpana; Schmitt, Lutz] Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany; [Zobel, Thomas; Weidtkamp-Peters, Stefanie] Heinrich Heine Univ, Ctr Adv Imaging, Dusseldorf, Germany; [Kleinschrodt, Diana] Heinrich Heine Univ, Prot Prod Facil, Dusseldorf, Germany; [Zobel, Thomas] Univ Munster, Cells Mot Interfac Ctr, Munster, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Munster	Schmitt, L (corresponding author), Heinrich Heine Univ, Inst Biochem, Dusseldorf, Germany.; Schmitt, L (corresponding author), Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany.	lutz.schmitt@hhu.de		Weidtkamp-Peters, Stefanie/0000-0001-7734-3771; Schmitt, Lutz/0000-0002-1167-9819	ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft	ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft	This work was supported by: LS, ECX 1028, CEPLAS, Deutsche Forschungsgemeinschaft, www.dfg.de, NO.	Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beaudet L, 1998, METHOD ENZYMOL, V292, P397; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Biala W, 2017, J EXP BOT, V68, P3231, DOI 10.1093/jxb/erx059; Bienert MD, 2012, PLANT J, V72, P745, DOI 10.1111/j.1365-313X.2012.05108.x; Borghi L, 2015, BIOCHEM SOC T, V43, P924, DOI 10.1042/BST20150106; Busso D, 2003, J BIOCHEM BIOPH METH, V55, P233, DOI 10.1016/S0165-022X(03)00049-6; Byme B, 2015, CURR OPIN STRUC BIOL, V32, P9, DOI 10.1016/j.sbi.2015.01.005; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Choi H, 2014, PLANT CELL, V26, P310, DOI 10.1105/tpc.113.118935; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; COLEMAN J, 1985, J MOL BIOL, V181, P139, DOI 10.1016/0022-2836(85)90332-8; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Demessie Z, 2017, PHYTOCHEMISTRY, V140, P118, DOI 10.1016/j.phytochem.2017.04.019; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Fu XQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00723; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gul N, 2014, J MOL BIOL, V426, P136, DOI 10.1016/j.jmb.2013.09.009; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hellsberg E, 2015, PLANTA MED, V81, P474, DOI 10.1055/s-0035-1545880; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Kang J, 2017, TRENDS PLANT SCI, V22, P455, DOI 10.1016/j.tplants.2017.03.003; Kang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9113; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Khare D, 2017, P NATL ACAD SCI USA, V114, pE5712, DOI 10.1073/pnas.1702259114; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim DY, 2010, PHYSIOL PLANTARUM, V139, P170, DOI 10.1111/j.1399-3054.2010.01353.x; Ko D, 2014, P NATL ACAD SCI USA, V111, P7150, DOI 10.1073/pnas.1321519111; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Kuromori T, 2014, PLANT PHYSIOL, V164, P1587, DOI 10.1104/pp.114.235556; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Lefevre F, 2015, BIOCHEM SOC T, V43, P931, DOI 10.1042/BST20150108; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Lu XL, 2015, PLANT PHYSIOL, V168, P814, DOI 10.1104/pp.15.00182; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Midgett CR, 2007, J STRUCT BIOL, V160, P265, DOI 10.1016/j.jsb.2007.07.001; Musielak TJ, 2015, PLANT REPROD, V28, P161, DOI 10.1007/s00497-015-0267-1; Nies AT, 2002, EUR J BIOCHEM, V269, P1866, DOI 10.1046/j.1432-1033.2002.02832.x; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; RAMESH V, 1994, PROTEIN ENG, V7, P1053, DOI 10.1093/protein/7.8.1053; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Sachdev D, 1998, BIOCHEM BIOPH RES CO, V244, P933, DOI 10.1006/bbrc.1998.8365; Sami M, 1997, J FERMENT BIOENG, V84, P1, DOI 10.1016/S0922-338X(97)82778-X; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sasse J, 2016, PLANT CELL ENVIRON, V39, P2725, DOI 10.1111/pce.12828; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt FR, 2004, APPL MICROBIOL BIOT, V65, P363, DOI 10.1007/s00253-004-1656-9; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shibata Y, 2016, PLANT CELL, V28, P1163, DOI 10.1105/tpc.15.00721; Shitan N, 2003, P NATL ACAD SCI USA, V100, P751, DOI 10.1073/pnas.0134257100; SIKORSKI RS, 1989, GENETICS, V122, P19; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Stindt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020562; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Svensson J, 2006, PROTEIN EXPRES PURIF, V48, P134, DOI 10.1016/j.pep.2006.01.005; Takeuchi M, 2018, J PLANT RES, V131, P297, DOI 10.1007/s10265-017-0979-4; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153; Toussaint F, 2017, BIOCHEM J, V474, P1689, DOI 10.1042/BCJ20170108; TSCHOPP JF, 1987, NUCLEIC ACIDS RES, V15, P3859, DOI 10.1093/nar/15.9.3859; Underwood W, 2013, P NATL ACAD SCI USA, V110, P12492, DOI 10.1073/pnas.1218701110; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Yazaki K, 2009, INT REV CEL MOL BIO, V276, P263, DOI 10.1016/S1937-6448(09)76006-X; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439; Zhang KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4274	98	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211156	10.1371/journal.pone.0211156	http://dx.doi.org/10.1371/journal.pone.0211156			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657786	Green Submitted, Green Published, gold			2022-12-27	WOS:000456017000033
J	Hoos, LA; Buckel, JA; Boyd, JB; Loeffler, MS; Lee, LM				Hoos, Liza A.; Buckel, Jeffrey A.; Boyd, Jacob B.; Loeffler, Michael S.; Lee, Laura M.			Fisheries management in the face of uncertainty: Designing time-area closures that are effective under multiple spatial patterns of fishing effort displacement in an estuarine gill net fishery	PLOS ONE			English	Article							MARINE RESERVES; SEA-TURTLES; BY-CATCH; BYCATCH; CONSERVATION; BEHAVIOR; POPULATIONS; LINE	A commonly cited reason for the failure of time-area closures to achieve fisheries management goals is the displacement of fishing effort from inside the closure into the surrounding area still open to fishing. Designing time-area closures that are predicted to achieve management goals under multiple spatial patterns of effort redistribution will increase chances of success. Using data from an estuarine gill net fishery, we tested if there are time-area closures predicted to reduce bycatch of two protected species groups while maintaining target catch under four simulated effort redistribution patterns. We found that the pattern of effort redistribution had a substantial impact on the amount of predicted bycatch in each closure scenario. Multiple closures were predicted to reduce bycatch of these species under all four simulations of effort redistribution. However, some combinations of closure and effort redistribution pattern resulted in estimated bycatch being higher than without a closure. We did not find any time-area closures that resulted in a predicted reduction in bycatch while maintaining target catch at original levels. We demonstrate a simple way for fisheries managers to account for the uncertainty in fishers' behavior by designing time-area closures that are predicted to reduce bycatch under multiple potential patterns of spatial redistribution of fishing effort.	[Hoos, Liza A.; Buckel, Jeffrey A.] North Carolina State Univ, Ctr Marine Sci & Technol, Dept Appl Ecol, Morehead City, NC 28557 USA; [Boyd, Jacob B.; Lee, Laura M.] North Carolina Dept Environm Qual, North Carolina Div Marine Fisheries, Morehead City, NC USA; [Loeffler, Michael S.] North Carolina Dept Environm Qual, North Carolina Div Marine Fisheries, Elizabeth City, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Hoos, LA (corresponding author), North Carolina State Univ, Ctr Marine Sci & Technol, Dept Appl Ecol, Morehead City, NC 28557 USA.	liza.hoos@gmail.com			North Carolina Coastal Recreational Fisheries License Fund award [6431]; NC Sea Grant award [E/GS-6]	North Carolina Coastal Recreational Fisheries License Fund award; NC Sea Grant award	This study was completed while LAH was a Marine Fisheries Management Fellow supported by North Carolina Coastal Recreational Fisheries License Fund award 6431 and NC Sea Grant award E/GS-6. JAB was also supported by NC Sea Grant award E/GS-6 (URL: https://ncseagrant.ncsu.edu/) and North Carolina Coastal Recreational Fisheries License Fund award 6431 (URL: http://portal.ncdenr.org/web/mf/crfl-grants-projects-applications-procedures). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2012, ECOL APPL, V22, P762, DOI 10.1890/11-1319.1; Adlerstein SA, 1998, J SEA RES, V39, P153, DOI 10.1016/S1385-1101(97)00055-5; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; [Anonymous], 2005, DISCARDS WORLDS MARI; Bastardie F, 2013, DISPLACE DYNAMIC IND, P366, DOI [10.1093/icesjms/tsu130, DOI 10.1093/ICESJMS/TSU130]; Bastardie F, 2015, ICES J MAR SCI, V72, P824, DOI 10.1093/icesjms/fsu215; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Branch TA, 2008, CAN J FISH AQUAT SCI, V65, P1435, DOI 10.1139/F08-065; Collins MR, 2000, B MAR SCI, V66, P917; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Diamond SL, 2010, CAN J FISH AQUAT SCI, V67, P1335, DOI 10.1139/F10-044; Dunn DC, 2016, P NATL ACAD SCI USA, V113, P668, DOI 10.1073/pnas.1513626113; Dunn DC, 2014, FISH FISH, V15, P359, DOI 10.1111/faf.12019; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Glaser SM, 2014, FISH FISH, V15, P616, DOI 10.1111/faf.12037; Greene K.E., 2009, ATLANTIC COAST DIADR; Greenstreet SPR, 2009, ICES J MAR SCI, V66, P90, DOI 10.1093/icesjms/fsn214; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Halpern BS, 2004, ECOL APPL, V14, P1248, DOI 10.1890/03-5136; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; Costa BHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065057; Kellner JB, 2007, ECOL APPL, V17, P1039, DOI 10.1890/05-1845; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Mason J, 2012, MAR POLICY, V36, P1054, DOI 10.1016/j.marpol.2012.03.002; McClellan CM, 2011, MAR POLICY, V35, P241, DOI 10.1016/j.marpol.2010.10.008; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Murray Kimberly T., 2000, Journal of Cetacean Research and Management, V2, P135; Murray Kimberly T., 2009, Endangered Species Research, V8, P211, DOI 10.3354/esr00211; National Marine Protected Areas Center, 2015, FRAM NAT SYST MAR PR; Needle CL, 2015, ICES J MAR SCI, V72, P151, DOI 10.1093/icesjms/fsu130; NMFS, 2006, FIN CONS ATL HIGHL M, P1600; North Carolina Division of Marine Fisheries, 2005, N CAR FISH MAN PLAN; O'Keefe CE, 2014, ICES J MAR SCI, V71, P1286, DOI 10.1093/icesjms/fst063; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Valcic B, 2009, MAR POLICY, V33, P215, DOI 10.1016/j.marpol.2008.06.001; van der Lee A, 2013, CAN J FISH AQUAT SCI, V70, P973, DOI 10.1139/cjfas-2012-0341; Watson JT, 2009, CONSERV BIOL, V23, P626, DOI 10.1111/j.1523-1739.2008.01121.x; Watson Reg A., 1993, North American Journal of Fisheries Management, V13, P326, DOI 10.1577/1548-8675(1993)013<0326:CSATPF>2.3.CO;2; Wilen JE, 2002, B MAR SCI, V70, P553; Ye YM, 2000, FISH RES, V45, P9, DOI 10.1016/S0165-7836(99)00105-8; Zollett Erika A., 2009, Endangered Species Research, V9, P49, DOI 10.3354/esr00221	44	15	15	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211103	10.1371/journal.pone.0211103	http://dx.doi.org/10.1371/journal.pone.0211103			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657789	gold, Green Published, Green Submitted			2022-12-27	WOS:000456017000031
J	Chen, JQ; Xing, YH; Yao, WJ; Xu, X; Zhang, CL; Zhang, ZH; Liu, Q				Chen, Jianqin; Xing, Yuhui; Yao, Wenjia; Xu, Xue; Zhang, Chenling; Zhang, Zhenhua; Liu, Qing			Phylomitogenomics reconfirm the phylogenetic position of the genus Metaplax inferred from the two grapsid crabs (Decapoda: Brachyura: Grapsoidea)	PLOS ONE			English	Article							MITOCHONDRIAL GENOMES; MOLECULAR PHYLOGENY; CRUSTACEA DECAPODA; ORDER; MORPHOLOGY; EVOLUTION; SELECTION	Two new complete mitogenomes of the grapsids, Metaplax longipes Stimpson, 1858 and Nanosesarma minutum (De Man, 1887) were sequenced using next-generation sequencing (NGS). By analyzing a combination of 75 Brachyura taxa, our phylomitogenomic inferences suggested that Metaplax crab seperated earlier from the sesarmid crabs and closely related to the varunids with respect to Nanosesarma crab. It reconfirmed that the Metaplax should be removed from the Sesarmidae and assinged to the Varunidae. Additional mitogenomic comparisons including gene rearrangement and genomic organization were conducted among the 33 taxa of Grapsoidea and Ocypodoidea, and a shared rearrangement pattern between Metaplax longipes and the varunids were recovered, which also strongly supported the inference for the phylogenetic position of the Metaplax.	[Chen, Jianqin; Zhang, Chenling; Zhang, Zhenhua; Liu, Qing] Jiangsu Second Normal Univ, Sch Life Sci Chem & Chem Engn, Inst Aquat Biol, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China; [Xing, Yuhui] Nanjing Normal Univ, Zhongbei Coll, Nanjing, Jiangsu, Peoples R China; [Yao, Wenjia; Xu, Xue] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Jiangsu Second Normal University; Nanjing Normal University; Nanjing Normal University	Chen, JQ (corresponding author), Jiangsu Second Normal Univ, Sch Life Sci Chem & Chem Engn, Inst Aquat Biol, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China.	jqchen1102@126.com	zhang, zh/GWV-4677-2022		Natural Science Fund of Colleges and Universities in Jiangsu Province [16KJA180005, 16KJB180006]	Natural Science Fund of Colleges and Universities in Jiangsu Province	This work was supported by the Natural Science Fund of Colleges and Universities in Jiangsu Province (16KJA180005, 16KJB180006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock A., 1900, J ASIATIC SOC BENGAL, V69, P279, DOI DOI 10.5962/BHL.TITLE.15344; BALSS H, 1957, KLASSEN ORDNUNGEN TI, V5, P1505; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Chen JQ, 2018, GENE, V675, P27, DOI 10.1016/j.gene.2018.06.088; Cuesta JA, 2001, CRUSTACEANA, V74, P895, DOI 10.1163/15685400152682656; Dai A., 1991, P1; DAVIE P. J. F., 2002, ZOOLOGICAL CATALOGUE, V19, P1; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Ding Hongyin, 2010, Transactions of Oceanology and Limnology, V2, P49; GUINOT D, 1978, Bulletin Biologique de la France et de la Belgique, V112, P211; Huang XX, 2017, J ZHEJIANG NORMAL U, V40, P446; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ji YK, 2014, J CRUSTACEAN BIOL, V34, P494, DOI 10.1163/1937240X-00002252; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kitaura J, 2002, J CRUSTACEAN BIOL, V22, P682, DOI 10.1651/0278-0372(2002)022[0682:MPOGAO]2.0.CO;2; Kitaura J, 2010, CRUSTACEANA, V83, P1315, DOI 10.1163/001121610X533548; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Tan MH, 2018, MOL PHYLOGENET EVOL, V127, P320, DOI 10.1016/j.ympev.2018.05.015; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Qian GH, 2011, ZOOL J LINN SOC-LOND, V162, P471, DOI 10.1111/j.1096-3642.2010.00686.x; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; Rathbun MJ, 1918, B US NATN MUS, V97, p[1, 1], DOI DOI 10.5479/SI.03629236.97.I; Sakai T., 1976, P1; Schubart CD, 2006, J ZOOL SYST EVOL RES, V44, P193, DOI 10.1111/j.1439-0469.2006.00354.x; Schubart CD, 2000, MOL PHYLOGENET EVOL, V15, P179, DOI 10.1006/mpev.1999.0754; Schubart CD, 2002, J CRUSTACEAN BIOL, V22, P28, DOI 10.1651/0278-0372(2002)022[0028:GANBFF]2.0.CO;2; Shen X, 2015, ACTA OCEANOL SIN, V34, P84, DOI 10.1007/s13131-015-0583-1; Sun HY, 2005, GENE, V349, P207, DOI 10.1016/j.gene.2004.12.036; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan MH, 2017, PEERJ, V5, DOI 10.7717/peerj.2982; Tan MH, 2015, MOL PHYLOGENET EVOL, V85, P180, DOI 10.1016/j.ympev.2015.02.009; Tsang LM, 2014, MOL BIOL EVOL, V31, P1173, DOI 10.1093/molbev/msu068; von Sternberg R., 1998, Journal of Comparative Biology, V3, P115; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xing YH, 2017, ZOOKEYS, P41, DOI 10.3897/zookeys.705.11852	43	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210763	10.1371/journal.pone.0210763	http://dx.doi.org/10.1371/journal.pone.0210763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682071	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500061
J	Chura-Chambi, RM; da Silva, CMR; Pereira, LR; Bartolini, P; Ferreira, LCD; Morganti, L				Chura-Chambi, Rosa Maria; Rosa da Silva, Cleide Mara; Pereira, Lennon Ramos; Bartolini, Paolo; de Souza Ferreira, Luis Carlos; Morganti, Ligia			Protein refolding based on high hydrostatic pressure and alkaline pH: Application on a recombinant dengue virus NS1 protein	PLOS ONE			English	Article							HUMAN GROWTH-HORMONE; INCLUSION-BODIES; ESCHERICHIA-COLI; SOLUBILIZATION; OPTIMIZATION; EXPRESSION; ENDOSTATIN; ARGININE	In this study we evaluated the association of high hydrostatic pressure (HHP) and alkaline pH as a minimally denaturing condition for the solubilization of inclusion bodies (IBs) generated by recombinant proteins expressed by Escherichia coli strains. The method was successfully applied to a recombinant form of the dengue virus (DENV) non-structural protein 1 (NS1). The minimal pH for IBs solubilization at 1 bar was 12 while a pH of 10 was sufficient for solubilization at HHP: 2.4 kbar for 90 min and 0.4 kbar for 14 h 30 min. An optimal refolding condition was achieved by compression of IBs at HHP and pH 10.5 in the presence of arginine, oxidized and reduced glutathiones, providing much higher yields (up to 8-fold) than association of HHP and GdnHCl via an established protocol. The refolded NS1, 109 +/- 9.5 mg/L bacterial culture was recovered mainly as monomer and dimer, corresponding up to 90% of the total protein and remaining immunologically active. The proposed conditions represent an alternative for the refolding of immunologically active recombinant proteins expressed as IBs.	[Chura-Chambi, Rosa Maria; Rosa da Silva, Cleide Mara; Bartolini, Paolo; Morganti, Ligia] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil; [Pereira, Lennon Ramos; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo	Morganti, L (corresponding author), IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Ctr Biotecnol, Sao Paulo, SP, Brazil.	lmorganti@ipen.br	; Morganti, Ligia/K-4352-2014	Ramos Pereira, Lennon/0000-0002-8070-7772; Morganti, Ligia/0000-0002-7870-1793	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/02574-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [130256/2015-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported from a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br), Process number 2015/02574-0 to LM and a Fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), Process number 130256/2015-3 to CMRdS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001; Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003; Athmaram TN, 2013, VIRUS GENES, V46, P219, DOI 10.1007/s11262-012-0851-5; Chura-Chambi RM, 2013, PROCESS BIOCHEM, V48, P250, DOI 10.1016/j.procbio.2012.12.017; Chura-Chambi RM, 2013, J BIOTECHNOL, V168, P511, DOI 10.1016/j.jbiotec.2013.09.017; Chura-Chambi RM, 2008, ANAL BIOCHEM, V379, P32, DOI 10.1016/j.ab.2008.04.024; Crisman RI, 2009, BIOTECHNOL BIOENG, V102, P483, DOI 10.1002/bit.22082; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemke LS, 2015, PROTEIN EXPRES PURIF, V106, P72, DOI 10.1016/j.pep.2014.10.013; Malavasi NV, 2011, PROCESS BIOCHEM, V46, P512, DOI 10.1016/j.procbio.2010.10.002; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Papaneophytou CP, 2014, PROTEIN EXPRES PURIF, V94, P22, DOI 10.1016/j.pep.2013.10.016; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Qoronfleh MW, 2007, PROTEIN EXPRES PURIF, V55, P209, DOI 10.1016/j.pep.2007.05.014; Rathore AS, 2013, J CHEM TECHNOL BIOT, V88, P1794, DOI 10.1002/jctb.4152; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Singh SM, 2008, J CHEM TECHNOL BIOT, V83, P1126, DOI 10.1002/jctb.1945; St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029; St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Vera A, 2007, BIOTECHNOL BIOENG, V96, P1101, DOI 10.1002/bit.21218; Xie Q, 2004, INT J BIOCHEM CELL B, V36, P296, DOI 10.1016/S1357-2725(03)00252-8; Yongsawatdigul J, 2004, J FOOD SCI, V69, pC499, DOI 10.1111/j.1365-2621.2004.tb13642.x	28	12	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211162	10.1371/journal.pone.0211162	http://dx.doi.org/10.1371/journal.pone.0211162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682103	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500115
J	Gomez-Marcos, MA; Gomez-Sanchez, L; Patino-Alonso, MC; Recio-Rodriguez, JI; Gomez-Sanchez, M; Rigo, F; Marti, R; Agudo-Conde, C; Maderuelo-Fernandez, JA; Ramos, R; Garcia-Ortiz, L; Rodriguez-Sanchez, E				Gomez-Marcos, Manuel A.; Gomez-Sanchez, Leticia; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Gomez-Sanchez, Marta; Rigo, Fernando; Marti, Ruth; Agudo-Conde, Cristina; Maderuelo-Fernandez, Jose A.; Ramos, Rafel; Garcia-Ortiz, Luis; Rodriguez-Sanchez, Emiliano			Capacity adiposity indices to identify metabolic syndrome in subjects with intermediate cardiovascular risk (MARK study)	PLOS ONE			English	Article							TO-HEIGHT RATIO; BODY-FAT; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; PHYSICAL-ACTIVITY; SCREENING TOOL; DISEASE; ASSOCIATION; WEIGHT; OLDER	Background Obesity increases mortality, and is linked to cardiovascular diseases and metabolic syndrome (MetS). Therefore, the purpose of this study was to analyze the ability of different adiposity indices to identify subjects with MetS among people with intermediate cariovascular risk. Materials and methods The cross-sectional study involved 2478 subjects, recruited by the MARK study. Adiposity measures: general adiposity by body mass index (BMI), central adiposity by waist-to-height ratio (WHtR), fat mass percent by the Clinica Universidad de Navarra-body adiposity estimator (CUN-BAE), percentage of body fat and of visceral adipose tissue by body roundness index (BRI) and visceral obesity and general adiposity with body shape index (ABSI). The diagnosis of MetS was made in accordance with the criteria established in the international consensus of the Joint Scientific Statement National Cholesterol Education Program III. Results The highest correlation coefficients were obtained by the glycemic components (HbA1c and FPG) of the MetS and ranged from 0.155 to 0.320. The exception was ABSI, which showed lower values in the global analysis and in the males. Values of the area under the ROC curve with the adiposity indices ranged from 0.773 with the BMI in males to 0.567 with ABSI in males. In the logistic regression analysis, all adiposity factors, except ABSI, showed similar OR values of MetS after adjusting for possible confounding factors. In the global analysis, the adiposity index that showed a highest OR of MetS was CUN-BAE (OR 5.50; 95% CI 4.27-7.09). In the analysis by gender, the highest ORs were BMI in males (OR 5.98; 95% CI 4.70-7.60) and both WHtR and BRI in females (OR 4.15; 95% CI 3.09-5.58). Conclusion All adiposity indices, except for ABSI, show an association with MetS and similar ability to detect subjects with MetS among people with intermediate cariovascular risk.	[Gomez-Marcos, Manuel A.; Gomez-Sanchez, Leticia; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Gomez-Sanchez, Marta; Agudo-Conde, Cristina; Maderuelo-Fernandez, Jose A.; Garcia-Ortiz, Luis; Rodriguez-Sanchez, Emiliano] Inst Biomed Res Salamanca IBSAL, Primary Hlth Care Res Unit, Alamedilla Hlth Ctr, Salamanca, Spain; [Gomez-Marcos, Manuel A.; Gomez-Sanchez, Leticia; Patino-Alonso, Maria C.; Recio-Rodriguez, Jose I.; Agudo-Conde, Cristina; Maderuelo-Fernandez, Jose A.; Rodriguez-Sanchez, Emiliano] Hlth Serv Castilla & Leon SACyL, Salamanca, Spain; [Gomez-Marcos, Manuel A.; Rodriguez-Sanchez, Emiliano] Univ Salamanca, Dept Med, Salamanca, Spain; [Patino-Alonso, Maria C.] Univ Salamanca, Dept Stat, Salamanca, Spain; [Recio-Rodriguez, Jose I.] Univ Salamanca, Dept Nursing & Phys Therapy, Salamanca, Spain; [Rigo, Fernando] Balearic Isl IBSALUD, San Agustin Hlth Care Ctr, Dept Hlth, Palma De Mallorca, Spain; [Marti, Ruth; Ramos, Rafel] Biomed Res Inst Girona Dr Josep Trueta IDBGI, Girona Res Unit, Primary Care Res Inst Jordi Gol IDIAP Jordi Gol, Girona, Spain; [Ramos, Rafel] Univ Girona, Dept Med Sci, Girona, Spain; [Garcia-Ortiz, Luis] Univ Salamanca, Dept Biomed Sci & Diag, Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; Atencio Primaria de Mallorca; Universitat de Girona; University of Salamanca	Gomez-Marcos, MA (corresponding author), Inst Biomed Res Salamanca IBSAL, Primary Hlth Care Res Unit, Alamedilla Hlth Ctr, Salamanca, Spain.; Gomez-Marcos, MA (corresponding author), Hlth Serv Castilla & Leon SACyL, Salamanca, Spain.; Gomez-Marcos, MA (corresponding author), Univ Salamanca, Dept Med, Salamanca, Spain.	magomez@usal.es	Maderuelo-Fernandez, Jose-Angel/R-8868-2018; Martí, Ruth/H-8198-2014; Rodríguez-Sánchez, Emiliano/N-5582-2014; Patino-Alonso, Carmen/I-4608-2014; Gomez-Sanchez, Leticia/AAR-8735-2021; Ramos, Rafel/D-9627-2016; Ramos, Rafel/P-2083-2019; Recio-Rodriguez, Jose I/AAA-8588-2020	Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684; Martí, Ruth/0000-0002-7320-9521; Rodríguez-Sánchez, Emiliano/0000-0003-3667-7155; Patino-Alonso, Carmen/0000-0001-8232-6685; Gomez-Sanchez, Leticia/0000-0001-8663-9339; Ramos, Rafel/0000-0001-7970-5537; Ramos, Rafel/0000-0001-7970-5537; Gomez-Marcos, Manuel A/0000-0003-0133-6123; Recio-Rodriguez, Jose I/0000-0002-3772-8746	Spanish Ministry of Science and Innovation (MICINN); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) [Red RedIAPP RD06/0018, RD16/0007/0003, RD16/0007/0004, RD16/0007/0008]; Health Research Fund [PI10/01088, PI10/02077, PI10/02043, PI13/01930]; Regional Health Management of Castile and Leon [GRS 635/A/11, GRS 906/B/14]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Health Research Fund(Instituto de Salud Carlos III); Regional Health Management of Castile and Leon	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN), the Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (Red RedIAPP RD06/0018, Research Groups: RD16/0007/0003, RD16/0007/0004, RD16/0007/0008), the Health Research Fund (PI10/01088, PI10/02077, PI10/02043; PI13/01930), and the Regional Health Management of Castile and Leon (GRS 635/A/11; GRS 906/B/14).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Behboudi-Gandevani S, 2016, EUR J OBSTET GYN R B, V205, P110, DOI 10.1016/j.ejogrb.2016.08.011; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Chang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2150-2; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Gomez-Sanchez L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175982; Gomez-Sanchez L, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0465-7; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; Kabat GC, 2014, ANN EPIDEMIOL, V24, P896, DOI 10.1016/j.annepidem.2014.10.007; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Li GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054233; Maessen MFH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107212; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marti R, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-61; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nevill AM, 2005, YEARB PHYS ANTHROPOL, V48, P141, DOI 10.1002/ajpa.20356; Nishida C, 2010, EUR J CLIN NUTR, V64, P2, DOI 10.1038/ejcn.2009.139; NY K, 2012, PLOS ONE, V7, P18; Oka R, 2010, OBESITY, V18, P153, DOI 10.1038/oby.2009.180; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Redondo A, 2011, REV ESP CARDIOL, V64, P997, DOI [10.1016/j.recesp.2011.06.020, 10.1016/j.rec.2011.06.020]; Romero-Corral A, 2008, NAT CLIN PRACT ENDOC, V4, P322, DOI 10.1038/ncpendmet0809; Salas-Salvado J, 2007, MED CLIN-BARCELONA, V128, P184, DOI 10.1016/S0025-7753(07)72531-9; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Slagter SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140599; Starr KNP, 2015, CLIN LIVER DIS, V19, P311, DOI 10.1016/j.cger.2015.04.001; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Thomas DM, 2013, OBESITY, V21, P2264, DOI 10.1002/oby.20408; Thomson CA, 2016, OBESITY, V24, P1061, DOI 10.1002/oby.21461; Tian SM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004642; Waters DL, 2013, EXP GERONTOL, V48, P1054, DOI 10.1016/j.exger.2013.02.005; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Zhao MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03226-6	44	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209992	10.1371/journal.pone.0209992	http://dx.doi.org/10.1371/journal.pone.0209992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682054	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500020
J	Ozeki, M; Jin, DN; Miyaoka, Y; Masubuchi, S; Hirokawa, F; Hayashi, M; Takai, S; Uchiyama, K				Ozeki, Maiko; Jin, Denan; Miyaoka, Yuta; Masubuchi, Shinsuke; Hirokawa, Fumitoshi; Hayashi, Michihiro; Takai, Shinji; Uchiyama, Kazuhisa			Comparison of a chymase inhibitor and hyaluronic acid/carboxymethylcellulose (Seprafilm) in a novel peritoneal adhesion model in rats	PLOS ONE			English	Article							DEPENDENT MATRIX-METALLOPROTEINASE-9 ACTIVATION; NONALCOHOLIC STEATOHEPATITIS; HIGH-FAT; SURGERY; DERIVATIVES; PREVENTS; CELLS; ACID	Adhesion formation that occurred after alkali-induced injury of the cecum was used as a novel adhesion model in rats, and it was compared with that of a common adhesion model after abrading the cecum. Using the novel adhesion model, inhibition of adhesion formation by a chymase inhibitor, Suc-Val-Pro-Phe(P) (OPh)(2), and by sodium hyaluronate/carboxymethylcellulose (Seprafilm) was evaluated, and their mechanisms were assessed. The degree of adhesion formation was more severe and more stable in the alkali-induced injury model than in the abrasion-induced injury model. Both the chymase inhibitor and Seprafilm showed significant attenuation of the degree of adhesion 14 days after alkali-induced injury. Chymase activity in the cecum was significantly increased after alkali-induced injury, but it was significantly attenuated by the chymase inhibitor and Seprafilm. Myeloperoxidase and trans-forming-growth factor (TGF)-beta levels were significantly increased after alkali-induced injury, but they were attenuated by both the chymase inhibitor and Seprafilm. At the level of the adhesions, the numbers of both chymase-positive cells and TGF-beta-positive cells were significantly increased, but their numbers were reduced by the chymase inhibitor and Seprafilm. In conclusion, a chymase inhibitor attenuated the degree of adhesions to the same degree as Seprafilm in a novel peritoneal adhesion model that was more severe and more stable than the common adhesion model, and not only the chymase inhibitor, but also Seprafilm reduced the chymase increase at the adhesions.	[Ozeki, Maiko; Miyaoka, Yuta; Masubuchi, Shinsuke; Hirokawa, Fumitoshi; Hayashi, Michihiro; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka, Japan; [Jin, Denan; Takai, Shinji] Osaka Med Coll, Grad Sch Med, Dept Innovat Med, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Takai, S (corresponding author), Osaka Med Coll, Grad Sch Med, Dept Innovat Med, Takatsuki, Osaka, Japan.	pha010@osaka-med.ac.jp		Takai, Shinji/0000-0003-3963-3983	Foundation for Promotion of Material Science and Technology of Japan [18K06709, 17K09443, 17K10679]	Foundation for Promotion of Material Science and Technology of Japan	This work was supported by the Foundation for Promotion of Material Science and Technology of Japan grant numbers 18K06709 (to ST), 17K09443 (to MH), and 17K10679 (to FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1999, SURG TODAY, V29, P51, DOI 10.1007/BF02482970; BURNS FR, 1990, INVEST OPHTH VIS SCI, V31, P107; Chegini N, 1999, J SOC GYNECOL INVEST, V6, P153, DOI 10.1016/S1071-5576(99)00007-6; Diamond MP, 2012, GYNECOL SURG, V9, P237, DOI 10.1007/s10397-012-0741-9; Diamond MP, 2012, GYNECOL SURG, V9, P247, DOI 10.1007/s10397-012-0742-8; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Espandar L, 2014, EYE CONTACT LENS, V40, P243, DOI 10.1097/ICL.0000000000000045; Ghellai AM, 2000, J GASTROINTEST SURG, V4, P316, DOI 10.1016/S1091-255X(00)80082-7; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Hosono S, 2006, WORLD J GASTROENTERO, V12, P7676, DOI 10.3748/wjg.v12.i47.7676; HULKA JF, 1978, FERTIL STERIL, V30, P661; Ishida K, 2008, J PHARMACOL EXP THER, V324, P422, DOI 10.1124/jpet.107.131946; Kakimoto K, 2010, J PHARMACOL EXP THER, V332, P684, DOI 10.1124/jpet.109.162933; Lee JH, 2009, SURG ENDOSC, V23, P1759, DOI 10.1007/s00464-008-0198-0; LIEBMAN SM, 1993, AM J SURG, V165, P127, DOI 10.1016/S0002-9610(05)80415-5; Lin LY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170555; Longley BJ, 1997, P NATL ACAD SCI USA, V94, P9017, DOI 10.1073/pnas.94.17.9017; Lucas PA, 1996, J SURG RES, V65, P135, DOI 10.1006/jsre.1996.0355; Miyaoka Y, 2018, EXP ANIM TOKYO, V67, P239, DOI 10.1538/expanim.17-0126; Miyaoka Y, 2017, J PHARMACOL SCI, V134, P139, DOI 10.1016/j.jphs.2017.04.005; Nishimoto M, 2001, CIRCULATION, V104, P1274, DOI 10.1161/hc3601.094304; Okamoto Y, 2002, FERTIL STERIL, V77, P1044, DOI 10.1016/S0015-0282(02)03083-2; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; OLEKSYSZYN J, 1991, BIOCHEMISTRY-US, V30, P485, DOI 10.1021/bi00216a026; Otake K, 2008, J SURG RES, V149, P243, DOI 10.1016/j.jss.2008.01.011; Poehnert D, 2015, INT J MED SCI, V12, P1, DOI 10.7150/ijms.8870; Ribatti D, 2018, INT ARCH ALLERGY IMM, V176, P55, DOI 10.1159/000487538; Schnuriger B, 2011, AM J SURG, V201, P111, DOI 10.1016/j.amjsurg.2010.02.008; Tajiri K, 2016, INT J OPHTHALMOL EYE, P6; Takai S, 2000, FEBS LETT, V467, P141, DOI 10.1016/S0014-5793(00)01125-X; Takai S, 2003, J PHARMACOL EXP THER, V305, P17, DOI 10.1124/jpet.102.045179; Takai S, 2017, J PHARMACOL SCI, V133, P65, DOI 10.1016/j.jphs.2016.10.009; Takai S, 2014, J HYPERTENS, V32, P1637, DOI 10.1097/HJH.0000000000000231; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; Uchida K, 2005, SURG TODAY, V35, P1054, DOI 10.1007/s00595-005-3085-5; Yao YL, 2000, J SURG RES, V92, P40, DOI 10.1006/jsre.2000.5837	37	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211391	10.1371/journal.pone.0211391	http://dx.doi.org/10.1371/journal.pone.0211391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682159	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500164
J	Phanthavong, S; Nonaka, D; Phonaphone, T; Kanda, K; Sombouaphan, P; Wake, N; Sayavong, S; Nakasone, T; Phongsavath, K; Arasaki, A				Phanthavong, Somphone; Nonaka, Daisuke; Phonaphone, Thongsavanh; Kanda, Kyoko; Sombouaphan, Phouphachanh; Wake, Norie; Sayavong, Sangvane; Nakasone, Toshiyuki; Phongsavath, Khampe; Arasaki, Akira			Oral health behavior of children and guardians' beliefs about children's dental caries in Vientiane, Lao People's Democratic Republic (Lao PDR)	PLOS ONE			English	Article							SELF-EFFICACY; ATTITUDES; INTENTION	Dental caries is considered a major health problem among schoolchildren in Lao People's Democratic Republic (Lao PDR). According to Health Belief Model (HBM)-based research, children's oral health behavior can be determined by their guardians' beliefs. This study aimed to describe children's oral health behavior and its association with childhood dental caries, as well as to assess associations between children's tooth-brushing behavior and guardians' beliefs in an urban area of Lao PDR, using HBM. Data were collected from ten primary schools in the Sisattanak district, the Vientiane capital, between 2013 and 2014. Ten dentists with the help of dental hygienists and schoolteachers conducted dental health check-ups at the schools that diagnosed dental caries based on visual inspection. They also conducted a questionnaire-based survey with the schoolchildren's guardians to collect data including socio-economic and demographic information, their children's oral health behavior, and guardians' beliefs derived from HBM, including perceived susceptibility to and perceived severity of child dental caries, perceived benefit of and perceived barrier to child's tooth brushing, and self-efficacy in making their children brush their teeth twice daily. A mixed-effects logistic regression model assessed the association between dental caries and children's oral health behavior and between children's tooth-brushing behavior and guardians' beliefs. Data from 1161 of 1304 (89.0%) children registered at the schools were used. The prevalence of dental caries was 82%. Children who brushed their teeth >= twice/day were significantly less likely to have dental caries than those brushing once or seldom (OR: 0.64, 95% CI: 0.45 to 0.91). The number of children who brushed twice daily also significantly increased with the increased level of guardians' self-efficacy (OR: 2.14, 95% CI: 1.91 to 2.41). In conclusion, childhood dental caries was associated with daily tooth brushing. Children's tooth-brushing behavior was associated with guardians' self-efficacy in making their children brush twice daily.	[Phanthavong, Somphone; Phonaphone, Thongsavanh; Sombouaphan, Phouphachanh; Sayavong, Sangvane; Phongsavath, Khampe] Setthathirath Hosp, Dent Div, Viangchan, Laos; [Phanthavong, Somphone] Univ Hlth Sci, Fac Dent, Viangchan, Laos; [Nonaka, Daisuke; Wake, Norie] Univ Ryukyus, Sch Hlth Sci, Fac Med, Nishihara, Okinawa, Japan; [Kanda, Kyoko] Univ Ryukyus, Int Collaborat Sect, Gen Strateg Planning Div, Nishihara, Okinawa, Japan; [Nakasone, Toshiyuki; Arasaki, Akira] Univ Ryukyus, Dept Oral & Maxillofacial Funct Rehabil, Grad Sch Med, Nishihara, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Nonaka, D (corresponding author), Univ Ryukyus, Sch Hlth Sci, Fac Med, Nishihara, Okinawa, Japan.	nonakad@med.u-ryukyu.ac.jp	Daisuke, Nonaka/AAB-8509-2020; Nonaka, Daisuke/AAP-7918-2021	Daisuke, Nonaka/0000-0001-6793-2062; 	Japan International Cooperation Agency; University of the Ryukyus	Japan International Cooperation Agency; University of the Ryukyus	This study used a part of data collected for the Cha-Ganjyu (long-life) School and Community based Oral Health Promotion Project that was funded by the Japan International Cooperation Agency. University of the Ryukyus received the fund for the project implementation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair PM, 2004, COMMUNITY DENT HLTH, V21, P102; Albino J, 2016, J DENT RES, V95, P35, DOI 10.1177/0022034515609034; Anagnostopoulos F, 2011, BEHAV MED, V37, P132, DOI 10.1080/08964289.2011.636770; Buglar ME, 2010, PATIENT EDUC COUNS, V78, P269, DOI 10.1016/j.pec.2009.06.014; Cooper AM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009378.pub2; de Silva-Sanigorski A, 2013, COMMUNITY DENT ORAL, V41, P345, DOI 10.1111/cdoe.12019; Duijster D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4203-1; Duijster D, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0145-0; Dumitrescu AL, 2014, ORAL HLTH PREV DENT, V12, P345, DOI 10.3290/j.ohpd.a31662; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Finlayson TL, 2007, COMMUNITY DENT ORAL, V35, P272, DOI 10.1111/j.1600-0528.2007.00313.x; Glanz K., 2008, HLTH BEHAV HLTH ED T; Hollister M Catherine, 2004, J Dent Hyg, V78, P6; Huebner CE, 2015, INT J DENT HYG, V13, P65, DOI 10.1111/idh.12100; Huebner CE, 2010, PEDIATR DENT, V32, P48; Jurgensen N, 2011, COMMUNITY DENT HLTH, V28, P280, DOI 10.1922/CDH_2600Jurgensen06; Jurgensen Nanna, 2009, BMC Oral Health, V9, P29, DOI 10.1186/1472-6831-9-29; Kasmaei P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-8; Kumar S, 2016, J DENT RES, V95, P1230, DOI 10.1177/0022034516655315; O'Malley L, 2017, HEALTH PSYCHOL, V36, P152, DOI 10.1037/hea0000428; Thornley S, 2017, J PAEDIATR CHILD H, V53, P494, DOI 10.1111/jpc.13449; Vanagas G, 2009, MEDICINA-LITHUANIA, V45, P718, DOI 10.3390/medicina45090094; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2003, DIET NUTR PREVENTION, V916; World Health Organization, 2003, WHO INF SER SCH HLTH; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th	26	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211257	10.1371/journal.pone.0211257	http://dx.doi.org/10.1371/journal.pone.0211257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682133	gold, Green Published			2022-12-27	WOS:000457037500135
J	Ward, A; Guillot, A; Nepomnyashchiy, LE; Graves, JC; Maloney, K; Omoniwa, OF; Emegbuonye, L; Opondo, C; Kerac, M; Omoluabi, E; Bhattacharya, A; Hariharan, KM; Wiwa, O; Cohen, JM; Le Menach, A				Ward, Abigail; Guillot, Andrea; Nepomnyashchiy, Lyudmila E.; Graves, Justin C.; Maloney, Kathleen; Omoniwa, Omowunmi F.; Emegbuonye, Leslie; Opondo, Charles; Kerac, Marko; Omoluabi, Elizabeth; Bhattacharya, Antoinette; Hariharan, Karen Milch; Wiwa, Owens; Cohen, Justin M.; Le Menach, Arnaud			Seasonal malaria chemoprevention packaged with malnutrition prevention in northern Nigeria: A pragmatic trial (SMAMP study) with nested case-control	PLOS ONE			English	Article							NUTRIENT SUPPLEMENTS LNS; NUTRITIONAL-STATUS; UNDERLYING CAUSE; CHILDREN; UNDERNUTRITION; ACCEPTABILITY; MORBIDITY; MORTALITY; INFECTION; DISEASES	Integrating seasonal malaria chemoprevention (SMC), recommended by the WHO since 2012 to prevent malaria infection, with nutrition interventions may improve health outcomes and operational efficiencies. This study assessed the effects of co-packaging interventions on distribution coverage, nutrition, and clinical malaria outcomes in northern Nigeria. From August to November 2014, community volunteers delivered sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) door-to-door each month to approximately 7,000 children aged 6-24 months in seven wards of Madobi, Kano State, Nigeria. In three of the wards children additionally received a lipid-based nutrient supplement (LNS-medium quantity), Plumpy Doz. Coverage, adherence, and anthropometric outcomes were assessed through baseline, midline, and endline household surveys. A facility-based case-control study was also conducted to estimate impact on clinical malaria outcomes. Coverage of SP-AQ was similar between arms at 89% (n = 2,409 child-months [88-90%]) in the SP-AQ only arm and 90% (n = 1,947 child-months [88-92%]) in the SP-AQ plus LNS arm (p = 0.52). Coverage of LNS was 83% (n = 2,409 child-months [81-84%]). Whilst there were marked changes in anthropometric status between baseline, midline and endline, these were largely accounted for by socioeconomic status and must be interpreted with care due to possible measurement issues, especially length-based indices. Overall nutritional status of our most robust measure, weight-for-age, does appear to have improved by endline, but was similar in the two study arms, suggesting no additional benefit of the LNS. While the odds of clinical malaria among those who received the intended intervention were lower in each study arm compared to children who did not receive interventions (SP-AQ only OR = 0.23 [0.09-0.6]; SP-AQ plus LNS OR = 0.22 [0.09-0.55]), LNS was not shown to have an additional impact. Coverage of SMC was high regardless of integrating LNS delivery into the SMC campaign. Supplementation with LNS did not appear to impact nutritional outcomes, but appeared to enhance the impact of SP-AQ on clinical odds of malaria. These results indicate that combining nutritional interventions with seasonal malaria chemoprevention in high-risk areas can be done successfully, warranting further exploration with other products or dosing.	[Ward, Abigail; Guillot, Andrea; Nepomnyashchiy, Lyudmila E.; Graves, Justin C.; Maloney, Kathleen; Omoniwa, Omowunmi F.; Emegbuonye, Leslie; Bhattacharya, Antoinette; Hariharan, Karen Milch; Wiwa, Owens; Cohen, Justin M.; Le Menach, Arnaud] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Opondo, Charles] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Kerac, Marko] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Omoluabi, Elizabeth] Akena, Abuja, Nigeria	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ward, A (corresponding author), Clinton Hlth Access Initiat, Boston, MA 02127 USA.	award@clintonhealthaccess.org	Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022	Kerac, Marko/0000-0002-3745-7317; Cohen, Justin/0000-0003-4481-6784; Opondo, Charles/0000-0001-8155-4117	Children's Investment Fund Foundation (CIFF); Dangote Foundation	Children's Investment Fund Foundation (CIFF); Dangote Foundation	This study was funded by the Children's Investment Fund Foundation (CIFF) and Dangote Foundation. Akena provided support in the form of salaries for author (EO), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ACCESS SMC, 2017, SEAS MAL CHEM TRANSF; Adu-Afarwuah S, 2011, MATERN CHILD NUTR, V7, P344, DOI 10.1111/j.1740-8709.2010.00286.x; [Anonymous], 2014, NIG DEM HLTH SURV DH; Arinaitwe E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-90; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Burki TK, 2013, LANCET, V382, P587, DOI 10.1016/S0140-6736(13)61732-8; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Chaparro CM, 2010, MATERN CHILD NUTR, V6, P1, DOI 10.1111/j.1740-8709.2009.00224.x; Christian P, 2015, INT J EPIDEMIOL, V44, P1862, DOI 10.1093/ije/dyv155; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Das D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1177-5; Deen JL, 2002, J TROP PEDIATRICS, V48, P78, DOI 10.1093/tropej/48.2.78; Denoeud-Ndam L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0963-3; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Hess SY, 2011, MATERN CHILD NUTR, V7, P357, DOI 10.1111/j.1740-8709.2010.00287.x; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Huybregts L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001313; Isanaka S, 2010, PEDIATRICS, V126, pE442, DOI 10.1542/peds.2009-2814; Kang H, 2013, INT J EPIDEMIOL, V42, P1390, DOI 10.1093/ije/dyt116; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kisinza W N, 2008, Tanzan J Health Res, V10, P232; Langendorf C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001714; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Man WDC, 1998, TROP MED INT HEALTH, V3, P678, DOI 10.1046/j.1365-3156.1998.00283.x; Matilsky DK, 2009, J NUTR, V139, P773, DOI 10.3945/jn.108.104018; Meremikwu MM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003756.pub4; Muller O, 2003, TROP MED INT HEALTH, V8, P507, DOI 10.1046/j.1365-3156.2003.01043.x; National Malaria Elimination Programme (NMEP); National Population Commission (NPopC); National Bureau of Statistics; ICF International, 2016, NIG MAL IND SURV 201; National Population Commission of Nigeria, 2006, NIG POP HOUS CENS 20; Nutriset, 2014, PLUMPYDOZ TECHN DAT; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Phuka J, 2011, MATERN CHILD NUTR, V7, P368, DOI 10.1111/j.1740-8709.2011.00297.x; Phuka JC, 2009, AM J CLIN NUTR, V89, P382, DOI 10.3945/ajcn.2008.26483; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Rutstein S. O., 2004, DHS WEALTH INDEX; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Snow RW, 1997, ACTA TROP, V65, P1, DOI 10.1016/S0001-706X(96)00601-8; Thakwalakwa CM, 2012, PUBLIC HEALTH NUTR, V15, P1755, DOI 10.1017/S1368980012003023; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WHO, 2015, WORLD MAL REP 2015; WHO Anthro:, 2011, WHO ANTHR SOFTW ASS; WHO policy recommendation, 2012, WHO POL REC SEAS MAL; World Health Organization, 2007, FOOD NUTR B S, V28; World Health Organization, 2013, ESS NUTR ACT IMPR MA	51	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210692	10.1371/journal.pone.0210692	http://dx.doi.org/10.1371/journal.pone.0210692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682069	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000457037500051
J	Fett, D; Trompeter, K; Platen, P				Fett, Daniela; Trompeter, Katharina; Platen, Petra			Prevalence of back pain in a group of elite athletes exposed to repetitive overhead activity	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; RISK-FACTORS; ADOLESCENT; SYMPTOMS; INJURIES; CHILDREN; PLAYERS; ROWERS; TRUNK	Background The prevalence of back pain in athletes has been investigated in several studies, but there are still under-or uninvestigated sports discipline like sports exposed to repetitive overhead activity. Elite athletes spend much time in training and competition and, because of the nature of their disciplines, subject their bodies to a great deal of mechanical strain, which puts a high level of stress on their musculoskeletal systems. From this it is hypothesized that elite athletes who engage in repetitive overhead motions experience a higher strain on their spine and thus possibly a higher prevalence of back pain compared with an active control group. Objectives To examine the prevalence of back pain and the exact location of pain in a cohort of elite athletes with repetitive overhead activity and in a control group of physically active sport students. Additionally, to examine different characteristics of pain, and to evaluate the influence of confounders on back pain. Methods A standardized and validated online back pain questionnaire was sent by the German Olympic Sports Confederation to German national and international elite athletes, and a control group of physically active but non-elite sports students. Results The final sample comprised 181 elite athletes of the sports disciplines badminton, beach volleyball, handball, tennis and volleyball and 166 physically active controls. In elite athletes, lifetime prevalence of back pain was 85%, 12-month prevalence was 75%, 3-month prevalence was 58% and point prevalence was 38%; for the physically active control group, these prevalences were 81%, 70%, 59% and 43%, respectively. There was no significant group difference in prevalence over all time periods. The lower back was the main location of back pain in elite athletes across all disciplines and in controls; additionally a distinct problem of upper back pain was found among volleyball players. Conclusion Despite the high mechanical load inherent in the sport disciplines included in this study, the elite athletes who engaged in repetitive overhead activities did not suffer more from back pain than the physically active controls. This suggests that other mechanisms may be influencing back pain prevalences in a positive way in these athletes. Furthermore, these disciplines may practice preventive factors for back pain that outweigh their detrimental factors. Therefore, we posit that extensive prevention work is already being implemented in these sports and that there are additional individual protection factors in play. More research is required to explore these suppositions, and should include investigations into which preventive training programs are being used. Nevertheless, in volleyball particularly, a focus on stabilization/preventive training should be applied to the upper back and neck.	[Fett, Daniela; Trompeter, Katharina; Platen, Petra] Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany	Ruhr University Bochum	Fett, D (corresponding author), Ruhr Univ Bochum, Dept Sports Med & Sports Nutr, Bochum, Germany.	daniela.fett@rub.de		Platen, Petra/0000-0002-3440-8245	German Federal Institute of Sport Science [ZMVI1-080102A/11-18]	German Federal Institute of Sport Science	The present study was funded by the German Federal Institute of Sport Science (http://www.bisp.de).The research was realized within the project RAN Rucken (ZMVI1-080102A/11-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyas F, 2007, BRIT J SPORT MED, V41, P836, DOI 10.1136/bjsm.2007.037747; Bahr R, 2004, SPINE, V29, P449, DOI 10.1097/01.BRS.0000096176.92881.37; Bahr R, 2009, BRIT J SPORT MED, V43, P966, DOI 10.1136/bjsm.2009.066936; Balague F, 1999, EUR SPINE J, V8, P429, DOI 10.1007/s005860050201; Bartolozzi C, 1991, Radiol Med, V82, P757; Bono CM, 2004, J BONE JOINT SURG AM, V86A, P382, DOI 10.2106/00004623-200402000-00027; Brynhildsen J, 1997, ACTA OBSTET GYN SCAN, V76, P873, DOI 10.3109/00016349709024368; Cali A, 2013, SCI SPORTS, V28, pe93, DOI [10.1016/j.scispo.2012.08.003, DOI 10.1016/J.SCISPO.2012.08.003]; Campbell A, 2016, J APPL BIOMECH, V32, P32, DOI 10.1123/jab.2015-0122; Campbell A, 2013, MED SCI SPORT EXER, V45, P1562, DOI 10.1249/MSS.0b013e31828bea5e; Close C, 2016, MIDWIFERY, V37, P1, DOI 10.1016/j.midw.2016.03.013; Correia JP, 2016, J SCI MED SPORT, V19, P311, DOI 10.1016/j.jsams.2015.04.002; Dalichau S, 2002, DEUT Z SPORTMED, V53, P12; Elders LAM, 2003, SPINE, V28, P1340, DOI 10.1097/00007632-200306150-00021; Eriksson K, 1996, SCAND J MED SCI SPOR, V6, P31; Fett D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180130; Fett J, 2017, INT J SPORTS SCI COA, V12, P119, DOI 10.1177/1747954116684393; Foster D, 1989, Br J Sports Med, V23, P150; Haus BM, 2012, CLIN SPORT MED, V31, P423, DOI 10.1016/j.csm.2012.03.011; Hendrick P, 2011, EUR SPINE J, V20, P464, DOI 10.1007/s00586-010-1616-2; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hoogendoorn WE, 2000, SPINE, V25, P3087, DOI 10.1097/00007632-200012010-00018; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Jonasson P, 2011, KNEE SURG SPORT TR A, V19, P1540, DOI 10.1007/s00167-011-1539-4; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Legault EP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0681-4; Ng L, 2014, J SCI MED SPORT, V17, P266, DOI 10.1016/j.jsams.2013.08.003; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; Maselli F, 2015, J BACK MUSCULOSKELET, V28, P365, DOI 10.3233/BMR-140529; Muller J, 2017, SCAND J MED SCI SPOR, V27, P448, DOI 10.1111/sms.12664; Narita T, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091875; Newlands C, 2015, BRIT J SPORT MED, V49, P951, DOI 10.1136/bjsports-2014-093889; Noll M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150542; Noormohammadpour P, 2016, EUR SPINE J, V25, P1196, DOI 10.1007/s00586-015-4034-7; Schulz SS, 2016, EUR SPINE J, V25, P1204, DOI 10.1007/s00586-015-4210-9; Shakeri H, 2013, J CHIROPR MED, V12, P160, DOI 10.1016/j.jcm.2013.08.005; Shan Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078109; Shehab DK, 2005, J ADOLESCENT HEALTH, V36, P32, DOI 10.1016/j.jadohealth.2003.12.011; SWARD L, 1990, SPINE, V15, P124; Trompeter K, 2017, SPORTS MED, V47, P1183, DOI 10.1007/s40279-016-0645-3; Tunas P, 2015, KNEE SURG SPORT TR A, V23, P2540, DOI 10.1007/s00167-014-3069-3; van Hilst J, 2015, J BACK MUSCULOSKELET, V28, P67, DOI 10.3233/BMR-140491; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4	44	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210429	10.1371/journal.pone.0210429	http://dx.doi.org/10.1371/journal.pone.0210429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677044	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400015
J	Ni, GQ				Ni, Guanqun			A pricing model for group buying based on network effects	PLOS ONE			English	Article							AUCTION	Group buying (GB) is a popular business model in e-commerce. With the rise of online social media, the positive network effect of buying with others is more important than price discount for consumers to choose GB. However, the negative network effect of GB is also significant for some consumers. In this paper, we classify consumers into two segments considering both positive and negative network effects, and three possible sales strategies as well as their optimal decisions on price are presented. We find that GB strategy dominates individual buying (IB) strategy when the positive network effect is sufficiently high or the proportion of consumers with low valuation is relatively large. We also find that MIX strategy offering both IB and GB is always better than IB, while the relationship between MIX and GB is depending on actual market situations. Some other managerial insights are also discussed.	[Ni, Guanqun] Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Ni, GQ (corresponding author), Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China.	guanqunni@163.com		Ni, Guanqun/0000-0002-4565-4484	National Natural Science Foundation of China [71501045]; Natural Science Foundation of Fujian Province [2016J01332]; Program for New Century Excellent Talents in Fujian Province University; Education Department of Fujian Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET)); Education Department of Fujian Province	This work is partially supported by National Natural Science Foundation of China [grant number 71501045]; Natural Science Foundation of Fujian Province [grant number 2016J01332]; and Program for New Century Excellent Talents in Fujian Province University. The support provided by Education Department of Fujian Province during a visit of Guanqun Ni to University of Alberta is also acknowledged.	Anand KS, 2003, MANAGE SCI, V49, P1546, DOI 10.1287/mnsc.49.11.1546.20582; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Borges A, 2010, J RETAIL CONSUM SERV, V17, P294, DOI 10.1016/j.jretconser.2010.02.007; Chen J, 2007, DECIS SUPPORT SYST, V43, P445, DOI 10.1016/j.dss.2006.11.002; Chen KY, 2008, M&SOM-MANUF SERV OP, V10, P654, DOI 10.1287/msom.1070.0177; Edelman B, 2016, MARKET LETT, V27, P39, DOI 10.1007/s11002-014-9289-y; Goodrich K, 2010, J BUS RES, V63, P1328, DOI 10.1016/j.jbusres.2009.12.004; Jing XQ, 2011, MANAGE SCI, V57, P1354, DOI 10.1287/mnsc.1110.1366; Kauffman RJ, 2010, ELECTRON COMMER R A, V9, P249, DOI 10.1016/j.elerap.2008.11.009; Kumar V, 2012, J ACAD MARKET SCI, V40, P120, DOI 10.1007/s11747-011-0283-0; Liang XY, 2014, EUR J OPER RES, V234, P331, DOI 10.1016/j.ejor.2013.10.031; Luo XM, 2005, J CONSUM PSYCHOL, V15, P288, DOI 10.1207/s15327663jcp1504_3; Luo XM, 2014, J MARKETING, V78, P20, DOI 10.1509/jm.12.0422; Mangleburg TF, 2004, J RETAILING, V80, P101, DOI 10.1016/j.jretai.2004.04.005; Ni GQ, 2015, INT J PROD RES, V53, P2995, DOI 10.1080/00207543.2014.965350; Ni GQ, 2015, ELECTRON COMMER R A, V14, P23, DOI 10.1016/j.elerap.2014.10.005; Tran T, 2017, EUR J OPER RES, V256, P68, DOI 10.1016/j.ejor.2016.05.054; Vaghefi MS, 2014, MARKET LETT, V25, P425, DOI 10.1007/s11002-013-9262-1; Wen FH, 2014, ECON COMPUT ECON CYB, V48, P235; Wen FH, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/158386; Yan RL, 2009, J RETAIL CONSUM SERV, V16, P306, DOI 10.1016/j.jretconser.2009.02.006; Zhang GQ, 2016, OMEGA-INT J MANAGE S, V63, P69, DOI 10.1016/j.omega.2015.10.003	22	0	1	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211109	10.1371/journal.pone.0211109	http://dx.doi.org/10.1371/journal.pone.0211109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677089	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400050
J	Siegfried, L; Schmidt, M; Mohrholz, V; Pogrzeba, H; Nardini, P; Bottinger, M; Scheuermann, G				Siegfried, Lydia; Schmidt, Martin; Mohrholz, Volker; Pogrzeba, Hans; Nardini, Pascal; Boettinger, Michael; Scheuermann, Gerik			The tropical-subtropical coupling in the Southeast Atlantic from the perspective of the northern Benguela upwelling system	PLOS ONE			English	Article							SEASONAL VARIABILITY; FRONTAL ZONE; INTERANNUAL VARIABILITY; EQUATORIAL UNDERCURRENT; INTEROCEAN EXCHANGE; EASTERN EQUATORIAL; OCEAN CIRCULATION; STRATIFIED OCEAN; FLOW-ANALYSIS; WATER MASSES	In the Benguela upwelling system, the environmental conditions are determined to a large extent by central water masses advected from remote areas onto the shelf. The origin, spreading pathways and fate of those water masses are investigated with a regional ocean model that is analysed using Eulerian passive tracers and on the basis of Lagrangian trajectories. Two major water masses influencing the Benguela upwelling system are identified: tropical South Atlantic Central Water (SACW) and subtropical Eastern South Atlantic Central Water (ESACW). The spreading of tropical waters into the subtropical Benguela upwelling system is mediated by equatorial currents and their continuation in the Southeast Atlantic. This tropical-subtropical connection has been attributed to signal propagation in the equatorial and coastal waveguides. However, there exists an additional spreading path for tropical central water in the open ocean. This mass transport fluctuates on a seasonal scale around an averaged meridional transport in Sverdrup balance. The inter-annual variability of the advection of tropical waters is related to Benguela Ninos, as evidenced by the 2010/2011 event. The northern Benguela upwelling system is a transition zone between SACW and ESACW since they encounter each other at about 20 degrees S. Both water masses have seasonal variable shares in the upwelled water there. To summarise the main pathways of central water mass transport, an enhanced scheme for the subsurface circulation in the Southeast Atlantic is presented.	[Siegfried, Lydia; Schmidt, Martin; Mohrholz, Volker] Leibniz Inst Balt Sea Res Warnemuende, Rostock, Germany; [Pogrzeba, Hans; Nardini, Pascal; Scheuermann, Gerik] Univ Leipzig, Inst Comp Sci, Leipzig, Germany; [Boettinger, Michael] Deutsch Klimarechenzentrum DKRZ, Hamburg, Germany	Leipzig University	Siegfried, L (corresponding author), Leibniz Inst Balt Sea Res Warnemuende, Rostock, Germany.	lydia.siegfried@io-warnemuende.de		Bottinger, Michael/0000-0001-9704-8235; Mohrholz, Volker/0000-0003-0778-9182	European Union [603521]; German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II [BMBF 03F0751B]; German Federal Ministry of Education and Research within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig [BMBF 01IS14014B]; Leibniz Association	European Union(European Commission); German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II; German Federal Ministry of Education and Research within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig; Leibniz Association	This work was partially funded by the German Federal Ministry of Education and Research within the project Southwest African Coastal Upwelling System and Benguela Ninos II (BMBF 03F0751B) and within the project Competence Center for Scalable Data Services and Solutions (ScaDS) Dresden/Leipzig (BMBF 01IS14014B). This work has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 603521. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENBAG JJ, 1988, S AFR J MARINE SCI, V6, P119, DOI 10.2989/025776188784480726; Agranovsky A, 2014, SYMP LARG DATA ANAL, P67, DOI 10.1109/LDAV.2014.7013206; ANDERSON DLT, 1975, DEEP-SEA RES, V22, P583, DOI 10.1016/0011-7471(75)90046-7; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; Bachelery ML, 2016, J GEOPHYS RES-OCEANS, V121, P284, DOI 10.1002/2015JC011168; BELJAARS ACM, 1995, Q J ROY METEOR SOC, V121, P255, DOI 10.1002/qj.49712152203; Bentamy A, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007479; Blanke B, 1997, J PHYS OCEANOGR, V27, P1038, DOI 10.1175/1520-0485(1997)027<1038:KOTPEU>2.0.CO;2; Bodin S, 1979, SE60176 SWED MET HYD; Boebel O, 2003, DEEP-SEA RES PT II, V50, P57, DOI 10.1016/S0967-0645(02)00379-X; Born S, 2013, IEEE PAC VIS SYMP, P129, DOI 10.1109/PacificVis.2013.6596137; Born S, 2012, IEEE PAC VIS SYMP, P105, DOI 10.1109/PacificVis.2012.6183580; Bourles B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015098; Brandt P, 2016, J PHYS OCEANOGR, V46, P3011, DOI 10.1175/JPO-D-15-0248.1; CARMACK EC, 1977, ESTUAR COAST MAR SCI, V5, P135, DOI 10.1016/0302-3524(77)90078-0; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; Colberg F, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002301; Danabasoglu G, 2006, J CLIMATE, V19, P2347, DOI 10.1175/JCLI3739.1; de Vries P, 2001, J ATMOS OCEAN TECH, V18, P1092; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doglioli AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026498; Doi T, 2007, J PHYS OCEANOGR, V37, P2698, DOI 10.1175/2007JPO3552.1; Donners J, 2005, J PHYS OCEANOGR, V35, P1841, DOI 10.1175/JPO2782.1; Donners J, 2004, J PHYS OCEANOGR, V34, P1019, DOI 10.1175/1520-0485(2004)034<1019:TLVOSA>2.0.CO;2; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Duncombe Rae C. M., 2005, AFRICAN J MARINE SCI, V27, P617, DOI DOI 10.2989/18142320509504122; Emeis K, 2017, J MARINE SYSTEMS; Fennel W, 1999, J PHYS OCEANOGR, V29, P177, DOI 10.1175/1520-0485(1999)029<0177:TOTBUS>2.0.CO;2; Fennel W., 1999, COMPUTERIZED MODELIN, P169; Fennel W, 2012, CONT SHELF RES, V45, P65, DOI 10.1016/j.csr.2012.06.004; Florenchie P, 2004, J CLIMATE, V17, P2318, DOI 10.1175/1520-0442(2004)017<2318:EOIWAC>2.0.CO;2; Gammelsrod T, 1998, J MARINE SCI, V19, P41, DOI [10.2989/025776198784126719, DOI 10.2989/025776198784126719]; GORDON AL, 1995, DEEP-SEA RES PT I, V42, P1, DOI 10.1016/0967-0637(94)00032-N; GORDON AL, 1991, DEEP-SEA RES, V38, pS323, DOI 10.1016/S0198-0149(12)80015-X; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Griffies SM, 2007, ELEMENTS OF MOM4P1; Hardman-Mountford NJ, 2003, PROG OCEANOGR, V59, P181, DOI 10.1016/j.pocean.2003.10.001; Hart TJ, 1960, DISCOVERY REPORTS, VXXXI; Herzfeld M, 2011, OCEAN MODEL, V37, P1, DOI 10.1016/j.ocemod.2010.12.008; Hormann V, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003931; HUNDSDORFER W, 1994, APPL NUMER MATH, V13, P469, DOI 10.1016/0168-9274(94)90009-4; Huthnance JM, 1995, PROG OCEANOGR, V35, P353, DOI 10.1016/0079-6611(95)00012-6; Jackett DR, 2006, J ATMOS OCEAN TECH, V23, P1709, DOI 10.1175/JTECH1946.1; John HC, 2001, J MARINE SYST, V28, P91, DOI 10.1016/S0924-7963(00)00085-3; Johns WE, 2014, CLIM DYNAM, V43, P3047, DOI 10.1007/s00382-014-2136-2; Johnson GC, 1997, J PHYS OCEANOGR, V27, P2448, DOI 10.1175/1520-0485(1997)027<2448:TPSCAA>2.0.CO;2; JONES PGW, 1971, DEEP-SEA RES, V18, P193, DOI 10.1016/0011-7471(71)90109-4; Junker T, 2017, J MARINE SYST, V165, P36, DOI 10.1016/j.jmarsys.2016.09.003; Junker T, 2015, J MARINE SYST, V143, P1, DOI 10.1016/j.jmarsys.2014.10.006; Kolodziejczyk N, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004976; Kolodziejczyk N, 2014, CLIM DYNAM, V43, P3025, DOI 10.1007/s00382-014-2107-7; Koseki S, 2017, CLIMATE DYNAMICS; Koseki S, 2018, OCEAN SCI DISCUSSION, V2018, P1, DOI [10.5194/os-2018-801520-0485(2003)33%3C753:ESADOT%3E2.0.CO;2, DOI 10.5194/OS-2018-801520-0485(2003)33%3C753:ESADOT%3E2.0.CO;2]; Kostianoy AG, 1999, J GEOPHYS RES-OCEANS, V104, P20963, DOI 10.1029/1999JC900017; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Lass HU, 2008, J MARINE SYST, V74, P1, DOI 10.1016/j.jmarsys.2007.09.008; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; Lett C, 2007, MARINE ECOLOGY PROGR; Louw DC, 2016, J MARINE SYST, V157, P124, DOI 10.1016/j.jmarsys.2016.01.009; Lubbecke JF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005964; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P51, DOI 10.2989/025776187784522621; Manizza M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL020778; Marchesiello P, 2003, J PHYS OCEANOGR, V33, P753, DOI 10.1175/1520-0485(2003)33<753:ESADOT>2.0.CO;2; Martin B, 2015, MAR ECOL-EVOL PERSP, V36, P637, DOI 10.1111/maec.12173; MAZEIKA PA, 1967, LIMNOL OCEANOGR, V12, P537, DOI 10.4319/lo.1967.12.3.0537; MCCREARY JP, 1981, PHILOS T R SOC A, V302, P385, DOI 10.1098/rsta.1981.0176; MEEUWIS JM, 1990, S AFR J MARINE SCI, V9, P261; Menemenlis D., 2008, MERCAT OCEAN Q NEWSL, V31(October), P13; Mercier H, 2003, DEEP-SEA RES PT I, V50, P863, DOI 10.1016/S0967-0637(03)00071-2; Mohrholz V, 2008, CONT SHELF RES, V28, P424, DOI 10.1016/j.csr.2007.10.001; Mohrholz V, 2001, S AFR J SCI, V97, P199; Mohrholz V, 2014, J MARINE SYST, V140, P92, DOI 10.1016/j.jmarsys.2014.04.019; MOORE D, 1978, GEOPHYS RES LETT, V5, P637, DOI 10.1029/GL005i008p00637; Moroshkin KV, 1970, OKEANOLOGIYA, V10, P38; Muller A, 2013, THESIS; Muller AA, 2014, J MARINE SYST, V140, P82, DOI 10.1016/j.jmarsys.2014.02.007; Nardini P, 2017, WORKSH VIS ENV SCI E, P1; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; PICAUT J, 1983, J PHYS OCEANOGR, V13, P18, DOI 10.1175/1520-0485(1983)013<0018:POTSUI>2.0.CO;2; Polo I, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004495; Poole R, 1999, DEEP-SEA RES PT I, V46, P1895, DOI 10.1016/S0967-0637(99)00025-4; Richter I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044461; Rouault M, 2007, J MARINE SYST, V68, P473, DOI 10.1016/j.jmarsys.2006.11.010; Rouault M, 2018, J MARINE SYST, V188, P39, DOI 10.1016/j.jmarsys.2017.07.007; Rouault M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052099; Rowe GD, 2000, J PHYS OCEANOGR, V30, P1172, DOI 10.1175/1520-0485(2000)030<1172:PESCVT>2.0.CO;2; SALAT J, 1992, CONT SHELF RES, V12, P355, DOI 10.1016/0278-4343(92)90036-J; Salzbrunn T, 2008, VISUAL COMPUT, V24, P1039, DOI 10.1007/s00371-007-0204-x; Salzbrunn T, 2006, IEEE T VIS COMPUT GR, V12, P1601, DOI 10.1109/TVCG.2006.104; Schmid C, 2014, DEEP-SEA RES PT I, V91, P50, DOI 10.1016/j.dsr.2014.04.015; Schmidt M, 2014, TEMPERATURE BIAS CIR; Schmidt M, 2016, PROG OCEANOGR, V149, P145, DOI 10.1016/j.pocean.2016.09.004; Schouten MW, 2005, DEEP-SEA RES PT I, V52, P477, DOI 10.1016/j.dsr.2004.10.007; Shannon LV, 1996, SOUTH ATLANTIC, P163; SHANNON LV, 1987, S AFR J MARINE SCI, V5, P11, DOI 10.2989/025776187784522261; SHANNON LV, 1986, J MAR RES, V44, P495, DOI 10.1357/002224086788403105; Shannon LV, 1966, INVESTL REP DIV FISH, V58, P1; Shannon LV, 1989, OCEANS LIFE SO AFRIC, P12; Small RJ, 2015, J CLIMATE, V28, P9409, DOI 10.1175/JCLI-D-15-0192.1; STACEY MW, 1995, J PHYS OCEANOGR, V25, P1037, DOI 10.1175/1520-0485(1995)025<1037:ANMOTC>2.0.CO;2; Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139; Stramma L., 2001, ENCY OCEAN SCI, V2 nd, P718; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; Tomczak M., 1994, REGIONAL OCEANOGRAPH; van Sebille E, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007684; Veitch JA, 2006, INT J REMOTE SENS, V27, P987, DOI 10.1080/01431160500127914; Veitch J, 2009, PROG OCEANOGR, V83, P296, DOI 10.1016/j.pocean.2009.07.008; Verstraete J. M., 1980, OCEANOGRAPHY SURFACE, V26, P343; VOITURIEZ B, 1981, OCEANOL ACTA, V4, P497; Voituriez B, 1982, RAPP PV C EXPLOR MER, V180, P107; von Bodungen B, 2008, J MARINE SYST, V74, P189, DOI 10.1016/j.jmarsys.2007.12.007; Wunsch C, 2011, J MAR RES, V69, P417, DOI 10.1357/002224011798765303; Xu Z, 2014, CLIM DYNAM, V43, P3123, DOI 10.1007/s00382-014-2247-9	116	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210083	10.1371/journal.pone.0210083	http://dx.doi.org/10.1371/journal.pone.0210083			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668590	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400005
J	Przekoracka-Krawczyk, A; Michalak, KP; Pyzalska, P				Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr; Pyzalska, Paulina			Deficient vergence prism adaptation in subjects with decompensated heterophoria	PLOS ONE			English	Article							FIXATION-DISPARITY CURVE; PHORIA ADAPTATION; EYE-MOVEMENTS; VISION; ACCOMMODATION; DISTANCE; LESIONS; VERMIS; REFLEX	Vergence prism adaptability was evaluated in subjects with high symptomatic and asymptomatic heterophoria and compared to individuals with a heterophoria within normal range ( the control group). A computer haploscope was used to measure phoria values and changes in the eye position after introducing 6 prism diopters base out in front of the right eye. Phoria values were measured with a nonius paradigm every minute for a period of 10 minutes during adaptation. The results showed that subjects with symptomatic heterophoria are characterized by a lower rate of prism adaptation and adapted to a smaller extent with respect to the control group. The group with high but asymptomatic heterophoria showed prolonged adaptation time but after several minutes of binocular viewing the subjects were able to adapt to the prism to a level similar to the control group. These findings suggest that an impairment in the slow vergence control system may be responsible for the inability to fully reduce vergence effort, which results in poor vergence ranges and asthenopic symptoms during prolonged viewing.	[Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr; Pyzalska, Paulina] Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland; [Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr] Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Przekoracka-Krawczyk, A (corresponding author), Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland.; Przekoracka-Krawczyk, A (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Vis & Neurosci Lab, Poznan, Poland.	ania_pk@amu.edu.pl	Michalak, Krzysztof Piotr/O-7865-2018	Michalak, Krzysztof Piotr/0000-0002-0267-5605; Pyzalska, Paulina/0000-0002-9664-4278; Przekoracka-Krawczyk, Anna/0000-0003-2401-4135				Alvarez TL, 2013, INVEST OPHTH VIS SCI, V54, P4122, DOI 10.1167/iovs.13-11797; Aprile I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00484; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P215, DOI 10.1111/j.1475-1313.2005.00276.x; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P211, DOI 10.1111/j.1475-1313.2005.00274.x; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P168, DOI 10.1111/j.1475-1313.2005.00275.x; Brautaset RL, 2006, INVEST OPHTH VIS SCI, V47, P2876, DOI 10.1167/iovs.04-1372; Brenk-Krakowska A, 2012, OPT APPL, V42, P805, DOI 10.5277/oa120412; Carter DB, 1963, OPTOMETRY VISION SCI, V40, P265; Cheng D, 2008, OPHTHAL PHYSL OPT, V28, P225, DOI 10.1111/j.1475-1313.2008.00560.x; DALZIEL CC, 1981, AM J OPTOM PHYS OPT, V58, P21; Deuschl G, 1996, J NEUROL NEUROSUR PS, V60, P515, DOI 10.1136/jnnp.60.5.515; Evans BJW, 2007, PICKWELLS BINOCULAR; Ezane MD, 2015, GRAEF ARCH CLIN EXP, V253, P1629, DOI 10.1007/s00417-015-3134-8; Furman JM, 1997, NEUROLOGY, V48, P5; Griffin J, 2002, BINOCULAR ANOMALIES, V4th; HAIN TC, 1990, INVEST OPHTH VIS SCI, V31, P1394; HENSON DB, 1980, AM J OPTOM PHYS OPT, V57, P129; Howard IP, 2008, SEEING IN DEPTH, V1; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 2008, VISION RES, V48, P253, DOI 10.1016/j.visres.2007.11.004; Jiang Bai-Chuan, 2007, Optometry, V78, P129, DOI 10.1016/j.optm.2006.08.017; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; Kojima Y, 2010, J NEUROSCI, V30, P13; Kono R, 2002, INVEST OPHTH VIS SCI, V43, P673; Krishnan VV, 1977, SYSTEMS MAN CYBERN A, V24, P6; Lang CE, 1999, J NEUROPHYSIOL, V82, P2108, DOI 10.1152/jn.1999.82.5.2108; Lang CE, 2002, J NEUROPHYSIOL, V87, P1336, DOI 10.1152/jn.00368.2001; Maples WC, 2009, OPTOMETRY, V80, P688, DOI 10.1016/j.optm.2009.06.003; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MILDER DG, 1983, ARCH NEUROL-CHICAGO, V40, P339, DOI 10.1001/archneur.1983.04050060039005; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Nawrot P, 2013, OPT APPL, V43, P551, DOI 10.5277/oa130314; Nilsson M, 2011, STRABISMUS, V19, P5, DOI 10.3109/09273972.2010.548845; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; North R, 1981, AM J OPTOMETRY PHYSL, V58, P12; Ogle KN, 1967, OCULOMOTOR IMBALANCE; Optican LM, 1980, J NEUROPHYSIOL, V44, P18; Pisella L, 2005, NEUROLOGY, V65, P150, DOI 10.1212/01.wnl.0000167945.34177.5e; Przekoracka-Krawczyk A, 2015, J VISION, V15, DOI 10.1167/15.11.6; Przekoracka-Krawczyk A, 2018, OPHTHATHERAPY, V3, P201, DOI [10.24292/01.OT.300918.9, DOI 10.24292/01.OT.300918.9]; Przekoracka-Krawczyk A, 2017, INVEST OPHTH VIS SCI, V58, P6470, DOI 10.1167/iovs.16-21305; Przekoracka-Krawczyk A, 2014, VISION RES, V98, P35, DOI 10.1016/j.visres.2014.03.008; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; Rosenfield M, 1994, OPHTHAL PHYSL OPT, V14, P13; Santos EM, 2018, VISION RES, V149, P59, DOI 10.1016/j.visres.2018.06.004; SCHOR CM, 1983, AM J OPTOM PHYS OPT, V60, P1; SCHOR CM, 1979, VISION RES, V19, P1359, DOI 10.1016/0042-6989(79)90208-6; SCHOR CM, 1979, VISION RES, V19, P757, DOI 10.1016/0042-6989(79)90151-2; Schor CM., 1983, VERGENCE EYE MOVEMEN; Sreenivasan V, 2015, VISION RES, V111, P105, DOI 10.1016/j.visres.2015.04.001; Sreenivasan V, 2014, VISION RES, V100, P99, DOI 10.1016/j.visres.2014.04.003; Takagi M, 2003, PROG BRAIN RES, V142, P19; Takagi M, 2001, VISION RES, V41, P3331, DOI 10.1016/S0042-6989(01)00016-5; Thiagarajan P., 2008, THESIS; Thiagarajan P, 2010, OPTOMETRY VISION SCI, V87, P487, DOI 10.1097/OPX.0b013e3181e19ec2; Wessel K, 1998, ARCH NEUROL-CHICAGO, V55, P949, DOI 10.1001/archneur.55.7.949	59	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211039	10.1371/journal.pone.0211039	http://dx.doi.org/10.1371/journal.pone.0211039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657792	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000027
J	Robson, JP; Remke, M; Kool, M; Julian, E; Korshunov, A; Pfister, SM; Osborne, GW; Taylor, MD; Wainwright, B; Reynolds, BA				Robson, Jonathan P.; Remke, Marc; Kool, Marcel; Julian, Elaine; Korshunov, Andrey; Pfister, Stefan M.; Osborne, Geoffrey W.; Taylor, Michael D.; Wainwright, Brandon; Reynolds, Brent A.			Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells	PLOS ONE			English	Article							CANCER STEM-CELLS; INDEPENDENT PROGNOSTIC MARKER; PEDIATRIC MEDULLOBLASTOMAS; HEDGEHOG PATHWAY; ADULT; BRAIN; EXPRESSION; DISTINCT; GROWTH; PURIFICATION	High morbidity and mortality are common traits of malignant tumours and identification of the cells responsible is a focus of on-going research. Many studies are now reporting the use of antibodies specific to Clusters of Differentiation (CD) cell surface antigens to identify tumour-initiating cell (TIC) populations in neural tumours. Medulloblastoma is one of the most common malignant brain tumours in children and despite a considerable amount of research investigating this tumour, the identity of the TICs, and the means by which such cells can be targeted remain largely unknown. Current prognostication and stratification of medulloblastoma using clinical factors, histology and genetic profiling have classified this tumour into four main subgroups: WNT, Sonic hedgehog (SHH), Group 3 and Group 4. Of these subgroups, SHH remains one of the most studied tumour groups due to the ability to model medulloblastoma formation through targeted deletion of the Shh pathway inhibitor Patched1 (Ptch1). Here we sought to utilise CD antibody expression to identify and isolate TIC populations in Ptch1 deleted medulloblastoma, and determine if these antibodies can help classify the identity of human medulloblastoma subgroups. Using a fluorescence-activated cell sorted (FACS) CD antibody panel, we identified CD24 as a marker of TICs in Ptch1 deleted medulloblastoma. CD24 expression was not correlated with markers of astro-cytes or oligodendrocytes, but co-labelled with markers of neural progenitor cells. In conjunction with CD15, proliferating CD24+/CD15+ granule cell precursors (GCPs) were identified as a TIC population in Ptch1 deleted medulloblastoma. On human medulloblastoma, CD24 was found to be highly expressed on Group 3, Group 4 and SHH subgroups compared with the WNT subgroup, which was predominantly positive for CD15, suggesting CD24 is an important marker of non-WNT medulloblastoma initiating cells and a potential therapeutic target in human medulloblastoma. This study reports the use of CD24 and CD15 to isolate a GCP-like TIC population in Ptch1 deleted medulloblastoma, and suggests CD24 expression as a marker to help stratify human WNT tumours from other medulloblastoma subgroups.	[Robson, Jonathan P.; Julian, Elaine; Wainwright, Brandon] Univ Queensland, Div Mol Genet & Dev, Inst Mol Biosci, Brisbane, Qld, Australia; [Remke, Marc] Univ Hosp Dusseldorf, Dept Pediat Neurooncogen, German Canc Res Ctr, Dusseldorf, Germany; [Remke, Marc] Univ Hosp Dusseldorf, German Canc Consortium, Dusseldorf, Germany; [Remke, Marc] Univ Hosp Dusseldorf, Med Fac, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Remke, Marc] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Neuropathol, Dusseldorf, Germany; [Kool, Marcel; Pfister, Stefan M.] Hopp Childrens Canc Ctr, Natl Ctr Tumor Dis, Heidelberg, Germany; [Kool, Marcel; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, German Canc Res Ctr, Div Clin Cooperat, Unit Neuropathol, Heidelberg, Germany; [Pfister, Stefan M.] Heidelberg Univ Hosp, Dept Pediat Hematol & Oncol, Heidelberg, Germany; [Osborne, Geoffrey W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Osborne, Geoffrey W.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON, Canada; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA	University of Queensland; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Queensland; University of Queensland; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University System of Florida; University of Florida	Robson, JP (corresponding author), Univ Queensland, Div Mol Genet & Dev, Inst Mol Biosci, Brisbane, Qld, Australia.	jonathanprobson@gmail.com	Pfister, Stefan M/F-6860-2013	Pfister, Stefan M/0000-0002-5447-5322; Wainwright, Brandon/0000-0003-0406-2092; Korshunov, Andrey/0000-0002-5257-3623; Taylor, Michael/0000-0001-7009-3466	National Health and Medical Research Council (NHMRC) [301198, 143072]; Cancer Council Queensland [456144]; John Trivett Foundation [3BWF18/UQ2002000886]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); John Trivett Foundation	For the work presented in this study, JPR, EJ, GWO, BW and BAR were funded in part through the National Health and Medical Research Council (NHMRC) grants 301198 (http://purl.org/au-research/grants/nhmrc/301198), and 143072 (http://purl.org/au-research/grants/nhmrc/143072); The Cancer Council Queensland grant 456144 (https://cancerqld.org.au/research/research-grants-program/); The John Trivett Foundation grant 3BWF18/UQ2002000886 (https://www.curebraincancer.org.au/page/114/the-john-trivett-foundation-). No specific funding was given for the analysis of CD24 on human tissue for this manuscript (re: MR, AK, MK, SMP and MDT). None of these funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Institute for Molecular Bioscience animal facility staff for all their support with animal maintenance and handling. We thank the University of Queensland ethics board for their assistance and support in carrying out the experiments. Special thanks to members of the Wainwright and Reynolds laboratories, past and present, for their technical support throughout the project. Thank you to the Queensland Brain Institute Flow Cytometry centre for all their assistance and support in carrying out the FACS experiments.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Ahlfeld J, 2013, CANCER RES, V73, P3796, DOI 10.1158/0008-5472.CAN-13-0238; Athar M, 2006, EXP DERMATOL, V15, P667, DOI 10.1111/j.1600-0625.2006.00473.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Della Corte CM, 2017, WORLD J GASTROENTERO, V23, P4330, DOI 10.3748/wjg.v23.i24.4330; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fogel M, 1999, CANCER LETT, V143, P87, DOI 10.1016/S0304-3835(99)00195-0; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Kim M, 2003, J NEUROSCI, V23, P10703; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2010, J CLIN ONCOL, V28, P3054, DOI 10.1200/JCO.2009.25.7121; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kristiansen G, 2003, BRIT J CANCER, V88, P231, DOI 10.1038/sj.bjc.6600702; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee RTH, 2016, DEVELOPMENT, V143, P367, DOI 10.1242/dev.120154; Mao XG, 2009, TRANSL ONCOL, V2, P247, DOI 10.1593/tlo.09136; Marino S, 2000, GENE DEV, V14, P994; Morrison LC, 2013, NEOPLASIA, V15, P384, DOI 10.1593/neo.13148; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Northcott PA, 2012, EXPERT REV NEUROTHER, V12, P871, DOI [10.1586/ERN.12.66, 10.1586/ern.12.66]; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; Remke M, 2011, J CLIN ONCOL, V29, P2717, DOI 10.1200/JCO.2011.34.9373; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rietze RL, 2006, METHOD ENZYMOL, V419, P3, DOI 10.1016/S0076-6879(06)19001-1; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2	71	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210665	10.1371/journal.pone.0210665	http://dx.doi.org/10.1371/journal.pone.0210665			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657775	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000016
J	Iga, N; Otsuka, A; Yamamoto, Y; Nakashima, C; Honda, T; Kitoh, A; Nakajima, S; Egawa, G; Nomura, T; Dainichi, T; Matsushita, S; Tanizaki, H; Yamamoto, Y; Funakoshi, T; Fujisawa, Y; Fujimura, T; Hata, H; Ishida, Y; Kabashima, K				Iga, Natsuko; Otsuka, Atsushi; Yamamoto, Yosuke; Nakashima, Chisa; Honda, Tetsuya; Kitoh, Akihiko; Nakajima, Saeko; Egawa, Gyohei; Nomura, Takashi; Dainichi, Teruki; Matsushita, Shigeto; Tanizaki, Hideaki; Yamamoto, Yuki; Funakoshi, Takeru; Fujisawa, Yasuhiro; Fujimura, Taku; Hata, Hiroo; Ishida, Yoshihiro; Kabashima, Kenji			Accumulation of exhausted CD8+T cells in extramammary Paget's disease	PLOS ONE			English	Article							CD8(+) T-LYMPHOCYTES; INDOLEAMINE 2,3-DIOXYGENASE; COLORECTAL-CANCER; IMMUNE CELLS; DYSFUNCTION; EXPRESSION; DOCETAXEL; PROGNOSIS; CARCINOMA; NIVOLUMAB	Cancer immunotherapy has highlighted the clinical relevance of enhancing anti-tumor response of CD8+ T cells in several cancer types. Little is known, however, about the involvement of the immune system in extramammary Paget's disease (EMPD). We examined the cytotoxicity and the effector functions of CD8+ T cells using paired samples of peripheral blood and tumors by flow cytometry. Expression levels of perforin, granzyme B, IFN-g, TNF-a, and IL-2 in CD8+ tumor-infiltrating lymphocytes (TILs) were significantly lower than those in CD8+ T cells of peripheral blood. Significantly higher expression of PD1 was found in CD8+ TILs than in CD8+ T cells of peripheral blood. A high number of CD8+ cells was significantly associated with poor overall survival (OS) adjusted with age, sex, and clinical stage (hazard ratio [HR] = 5.03, P = 0.045, 95% confidence interval [CI] 1.03-24.4). On the other hand, the number of PD-1+ cells was not associated with OS or disease-free survival (DFS). Moreover, we found that tumor cells produced immunosuppressive molecule indoleamine 2,3-dyoxygenae (IDO). In conclusion, CD8+ TILs displayed an exhausted phenotype in EMPD. IDO expression seemed more relevant in inducing CD8 exhaustion than PD-1 upregulation or PD-L1 expression by immune cells. Restoring the effector functions of CD8+ TILs could be an effective treatment strategy for advanced EMPD.	[Iga, Natsuko; Otsuka, Atsushi; Yamamoto, Yosuke; Nakashima, Chisa; Honda, Tetsuya; Kitoh, Akihiko; Nakajima, Saeko; Egawa, Gyohei; Nomura, Takashi; Dainichi, Teruki; Ishida, Yoshihiro; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Otsuka, Atsushi] Kyoto Univ, Grad Sch Med, Translat Res Dept Skin & Brain Dis, Kyoto, Japan; [Matsushita, Shigeto] Natl Hosp Org Kagoshima Med Ctr, Dept Dermatooncol Dermatol, Kagoshima, Japan; [Tanizaki, Hideaki] Osaka Med Coll, Dept Dermatol, Osaka, Japan; [Yamamoto, Yuki] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan; [Funakoshi, Takeru] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Fujisawa, Yasuhiro] Univ Tsukuba, Dept Dermatol, Tsukuba, Ibaraki, Japan; [Fujimura, Taku] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi, Japan; [Hata, Hiroo] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; [Kabashima, Kenji] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Kabashima, Kenji] ASTAR, Inst Med Biol, Singapore, Singapore	Kyoto University; Kyoto University; Osaka Medical College; Wakayama Medical University; Keio University; University of Tsukuba; Tohoku University; Hokkaido University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Otsuka, A; Kabashima, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.; Otsuka, A (corresponding author), Kyoto Univ, Grad Sch Med, Translat Res Dept Skin & Brain Dis, Kyoto, Japan.; Kabashima, K (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.; Kabashima, K (corresponding author), ASTAR, Inst Med Biol, Singapore, Singapore.	otsukamn@kuhp.kyoto-u.ac.jp; kaba@kuhp.kyoto-u.ac.jp	Dainichi, Teruki/AAL-5400-2020; Nakajima, Saeko/AAB-1577-2021; YAMAMOTO, Yosuke/HCH-0666-2022; Funakoshi, Takeru/A-7994-2015	Dainichi, Teruki/0000-0002-9497-0029; Funakoshi, Takeru/0000-0002-8893-4590; Nakajima, Saeko/0000-0003-0831-1447; Ishida, Yoshihiro/0000-0002-6210-5903; Fujisawa, Yasuhiro/0000-0003-3010-8496; Otsuka, Atsushi/0000-0001-7365-947X; Fujimura, Taku/0000-0001-6809-5833; Egawa, Gyohei/0000-0002-6101-4719				Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Godin-Ethier J, 2009, J IMMUNOL, V183, P7752, DOI 10.4049/jimmunol.0901004; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Herrel LA, 2015, ANN SURG ONCOL, V22, P1625, DOI 10.1245/s10434-014-4139-y; Liu HZ, 2009, J IMMUNOL, V183, P1022, DOI 10.4049/jimmunol.0900408; Moon YW, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0094-9; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Nakano O, 2001, CANCER RES, V61, P5132; Ohara K, 2016, J DERMATOL SCI, V83, P234, DOI 10.1016/j.jdermsci.2016.06.004; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Takeuchi Y, 2016, INT IMMUNOL, V28, P401, DOI 10.1093/intimm/dxw025; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu X, 2014, BRIT J CANCER, V111, P1391, DOI 10.1038/bjc.2014.416; Yoshino K, 2016, J DERMATOL, V43, P633, DOI 10.1111/1346-8138.13200; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211135	10.1371/journal.pone.0211135	http://dx.doi.org/10.1371/journal.pone.0211135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682105	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500108
J	Jia, J; Jiang, JP; Zhang, MH; Gao, KQ				Jia, Jia; Jiang, Jian-Ping; Zhang, Mei-Hua; Gao, Ke-Qin			Osteology of Batrachuperus yenyuanensis (Urodela, Hynobiidae), a high-altitude mountain stream salamander from western China	PLOS ONE			English	Article							AMBYSTOMA-TIGRINUM; COLUMELLA AURIS; AMPHIBIA; PHYLOGENY; APPARATUS; CAUDATA; MORPHOLOGY; EVOLUTION; PATTERNS	Batrachuperus yenyuanensis, commonly known as Yenyuan Stream Salamander, is a hynobiid species inhabiting high-altitude (2440-4025 m above sea level) mountain stream and pond environments along the eastern fringe of the Qinghai-Tibetan Plateau in western Sichuan Province, China. Although the species has been known for almost 70 years since its initial discovery in 1950, a thorough osteological description has never been provided. Our study provides a detailed account of the bony anatomy of this species, based on micro computed tomography scanning of multiple specimens collected from the type locality Shuangertang at Bailinshan, Yanyuan County, and several other localities in Sichuan Province. Our revised species diagnosis utilizes both bony and soft anatomical features. Comparative study of the specimens from the type locality in Yanyuan area with those from the nearby Xichang and Mianning areas confirms that they all pertain to Batrachuperus yenyuanensis, thereby removing doubt on the occurrence of the species in the latter areas. With this confirmation, the distribution of the species is extended from the type locality northwards some 180 km to the Mianning area, on both the west and east sides of the Yalong River, which is a major tributary of the upper Yangtze River. This distribution pattern indicates that the biogeographic origin and historical evolution of the species are closely associated with the orogeny of the Hengduan Mountains and formation of the Yalong River. Given the basalmost position of Batrachuperus yenyuanensis in relation to other congeneric species based on molecular studies, however, early expansion of the species distribution by dispersal is expected following the origin of the genus in early-middle Miocene in western Sichuan Province. Thus, the species may well have achieved its current distribution in western Sichuan before the drastic uplift of the Qinghai-Tibetan Plateau in Pliocene.	[Jia, Jia; Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing, Peoples R China; [Jia, Jia] Chinese Acad Sci, Nanjing Inst Geol & Paleontol, Key Lab Econ Stratig & Palaeogeog, Nanjing, Jiangsu, Peoples R China; [Jiang, Jian-Ping; Zhang, Mei-Hua] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	Peking University; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Gao, KQ (corresponding author), Peking Univ, Sch Earth & Space Sci, Beijing, Peoples R China.	kqgao@pku.edu.cn	JIA, JIA/AAL-9198-2020	Jia, Jia/0000-0002-8243-0156; Gao, Ke-Qin/0000-0002-5765-4596	National Natural Science Foundation of China [NSFC 41672003, NSFC 41702002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA19050201]; National Key R & D Program of China [2017YFC0505202]; Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology) [2017KF03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R & D Program of China; Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology)	The following grant information was disclosed by the authors: National Natural Science Foundation of China: NSFC 41672003, NSFC 41702002 to Ke-Qin Gao. Strategic Priority Research Program of the Chinese Academy of Sciences (XDA19050201) to Jianping Jiang. National Key R & D Program of China (2017YFC0505202) to Jianping Jiang. Key Laboratory of Economic Stratigraphy and Palaeogeography, Chinese Academy of Sciences (Nanjing Institute of Geology and Palaeontology) (No. 2017KF03) to Jia Jia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaWeb, INF AMPH BIOL CONS; AOYAMA FUMIO, 1930, ZEITSCHR GES ANAT ABT 1 ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V93, P107, DOI 10.1007/BF02117847; ASHLEYROSS MA, 1992, J MORPHOL, V211, P147, DOI 10.1002/jmor.1052110204; Boulenger G.A., 1878, B SOC ZOOLOGIQUE FRA, V3, P71; Chen MY, 2015, MOL PHYLOGENET EVOL, V83, P1, DOI 10.1016/j.ympev.2014.10.010; Cope E.D., 1859, P ACAD NAT SCI PHILA, V11, P122; David A., 1871, NOUVELLES ARCH MUSEU, V7, P75; den Uber N, 1911, ANAT ANZEIGER, V38, P401; Duellman W. E., 1986, BIOL AMPHIBIANS; DUMERIL AMC, 1806, ZOOLOGIE ANAL OU MET; Dunn ER, 1922, AM NAT, V56, P418, DOI 10.1086/279882; Dunn ER, 1923, P AM ACAD ARTS SCI, V58, P445, DOI 10.2307/20026019; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; EDWARDS JL, 1976, J MORPHOL, V148, P305, DOI 10.1002/jmor.1051480304; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fei L., 2010, COLORED ATLAS CHINES; Fei L., 2016, AMPHIBIANS CHINA, V1; Fei L., 2006, FAUNA SINICA AMPHIBI, V1; Francis ETB, 1934, ANATOMY SALAMANDER; Frost D. R., 2018, AMPHIBIAN SPECIES WO; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Fu J, 2008, MOL ECOL, V17, P1469, DOI 10.1111/j.1365-294X.2007.03681.x; Fu JZ, 2001, COPEIA, P1100, DOI 10.1643/0045-8511(2001)001[1100:GDOEBC]2.0.CO;2; Gao KQ, 2012, P NATL ACAD SCI USA, V109, P5767, DOI 10.1073/pnas.1009828109; Hanken J., 1981, Functional Photography, V16, P22; Jia J, 2016, PEERJ, V4, DOI 10.7717/peerj.2499; Jia J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153834; Jiang JP, 2018, PEERJ, V6, DOI 10.7717/peerj.4517; Kingsbury BF, 1909, J MORPHOL, V20, P549, DOI 10.1002/jmor.1050200403; Kingsbury BF, 1908, ANAT REC, V2, P81, DOI 10.1002/ar.1090020302; Lapage EO, 1928, J MORPHOL PHYSIOL, V45, P441, DOI 10.1002/jmor.1050450203; LAUDER GV, 1988, J MORPHOL, V197, P249, DOI 10.1002/jmor.1051970302; Litvinchuk SN, 2003, CONTRIB ZOOL, V72, P195, DOI 10.1163/18759866-07204001; LIU CH'ENG-CHAO, 1950, FIELDIANA ZOOL MEM, V2, P1; Liu L., 1973, ANIMAL PRESERVATION, V5, P37; Noble G.K., 1931, BIOL AMPHIBIA; OLSON EC, 1966, AM ZOOL, V6, P399; Peng R, 2010, MOL PHYLOGENET EVOL, V56, P252, DOI 10.1016/j.ympev.2009.12.011; Rose Christopher S., 2003, Amphibian Biology, V5, P1684; Schmalhausen I. I., 1958, Zoologicheskii Zhurnal, V37, P570; Sun BN, 2011, PALAEOGEOGR PALAEOCL, V304, P328, DOI 10.1016/j.palaeo.2010.09.023; Trueb Linda, 1993, P255; Vassilieva AB, 2015, VERTEBR ZOOL, V65, P117; WAKE DB, 1967, J MORPHOL, V122, P265, DOI 10.1002/jmor.1051220402; Xiong JL, 2013, ZOOLOGY, V116, P99, DOI 10.1016/j.zool.2012.10.004; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072	48	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211069	10.1371/journal.pone.0211069	http://dx.doi.org/10.1371/journal.pone.0211069			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682102	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500097
J	Lang, KC; Hackney, ME; Ting, LH; McKay, JL				Lang, Kimberly C.; Hackney, Madeleine E.; Ting, Lena H.; McKay, J. Lucas			Antagonist muscle activity during reactive balance responses is elevated in Parkinson's disease and in balance impairment	PLOS ONE			English	Article							POSTURAL CONTROL; COACTIVATION; ACTIVATION; STIFFNESS; SCALE; GAIT	d Background Abnormal antagonist leg muscle activity could indicate increased muscle co-contraction and clarify mechanisms of balance impairments in Parkinson's disease (PD). Prior studies in carefully selected patients showed PD patients demonstrate earlier, longer, and larger antagonist muscle activation during reactive balance responses to perturbations. Research question Here, we tested whether antagonist leg muscle activity was abnormal in a group of PD patients who were not selected for phenotype and most of whom had volunteered for exercise-based rehabilitation. Methods We compared antagonist activation during reactive balance responses to multidirectional support-surface translation perturbations in 31 patients with mild-moderate PD (age 68 +/- 9; H&Y 1-3; UPDRS-III 32 +/- 10) and 13 matched individuals (age 65 +/- 9). We quantified modulation of muscle activity (i.e., the ability to activate and inhibit muscles appropriately according to the perturbation direction) using modulation indices (MI) derived from minimum and maximum EMG activation levels observed across perturbation directions. Results Antagonist leg muscle activity was abnormal in unselected PD patients compared to controls. Linear mixed models identified significant associations between impaired modulation and PD (P<0.05) and PD severity (P<0.01); models assessing the entire sample without referencing PD status identified associations with balance ability (P<0.05), but not age (P=0.10). Significance Antagonist activity is increased during reactive balance responses in PD patients who are not selected on phenotype and are candidates for exercise-based rehabilitation. This activity may be a mechanism of balance impairment in PD and a potential rehabilitation target or outcome measure.	[Lang, Kimberly C.] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Hackney, Madeleine E.] Emory Univ, Sch Med, Dept Med, Div Gen Med & Geriatr, Atlanta, GA USA; [Hackney, Madeleine E.] Atlanta VA Med Ctr, Rehabil R&D Ctr, Atlanta, GA USA; [Ting, Lena H.] Emory Univ, Sch Med, Dept Rehabil Med, Div Phys Therapy, Atlanta, GA USA; [Ting, Lena H.; McKay, J. Lucas] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Ting, Lena H.; McKay, J. Lucas] Georgia Tech, Atlanta, GA 30332 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	McKay, JL (corresponding author), Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; McKay, JL (corresponding author), Georgia Tech, Atlanta, GA 30332 USA.	j.lucas.mckay@emory.edu			National Institutes of Health [KL2 TR000455, K25 HD086276, R01 HD46922, R21 HD075612, TL1TR000456, UL1 TR000454]; Department of Veterans Affairs [N0870W]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046922, K25HD086276] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000455, TL1TR000456, UL1TR000454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health (https://www.nih.gov/) KL2 TR000455 (JLM), K25 HD086276 (JLM), R01 HD46922 (LHT), R21 HD075612 (LHT), TL1TR000456 (KCL), and UL1 TR000454 (KCL) supported this work, in addition to Department of Veterans Affairs (https://www.va.gov/) N0870W (MEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Blumenstein, 1980, ELECTRODE PLACEMENT; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; Damiano Diane L., 1993, Physical and Occupational Therapy in Pediatrics, V12, P3, DOI 10.1080/J006v12n04_02; David FJ, 2016, J NEUROPHYSIOL, V116, P2298, DOI 10.1152/jn.01067.2015; Dimitrova D, 2004, J NEUROPHYSIOL, V91, P489, DOI 10.1152/jn.00094.2003; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Falconer K, 1985, Electromyogr Clin Neurophysiol, V25, P135; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Herman T, 2014, J NEUROL, V261, P2401, DOI 10.1007/s00415-014-7513-6; Ho CY, 2002, J GERONTOL A-BIOL, V57, pB344, DOI 10.1093/gerona/57.9.B344; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Kelly VE, 2005, MOVEMENT DISORD, V20, P694, DOI 10.1002/mds.20386; Klein PJ, 2011, PHYSIOTHER CAN, V63, P115, DOI 10.3138/ptc.2009-51; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; McKay JL, 2016, J NEUROL PHYS THER, V40, P257, DOI 10.1097/NPT.0000000000000150; McKay JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002465; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; Nagai K, 2013, ARCH GERONTOL GERIAT, V56, P129, DOI 10.1016/j.archger.2012.08.009; Nagai K, 2012, J GERONTOL A-BIOL, V67, P882, DOI 10.1093/gerona/glr252; Nagai K, 2011, ARCH GERONTOL GERIAT, V53, P338, DOI 10.1016/j.archger.2011.01.003; Nelson-Wong E, 2012, EUR J APPL PHYSIOL, V112, P1379, DOI 10.1007/s00421-011-2094-x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Schlenstedt C, 2015, ARCH PHYS MED REHAB, V96, P218, DOI 10.1016/j.apmr.2014.09.002; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; Warnica MJ, 2014, GAIT POSTURE, V39, P1115, DOI 10.1016/j.gaitpost.2014.01.019; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	32	22	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211137	10.1371/journal.pone.0211137	http://dx.doi.org/10.1371/journal.pone.0211137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682098	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500109
J	Uebayashi, K; Akasaka, K; Tamura, A; Otsudo, T; Sawada, Y; Okubo, Y; Hall, T				Uebayashi, Kazuma; Akasaka, Kiyokazu; Tamura, Akihiro; Otsudo, Takahiro; Sawada, Yutaka; Okubo, Yu; Hall, Toby			Characteristics of trunk and lower limb alignment at maximum reach during the Star Excursion Balance Test in subjects with increased knee valgus during jump landing	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURY; VIDEO ANALYSIS; BIOMECHANICAL MEASURES; POSTURAL STABILITY; TEAM HANDBALL; RISK-FACTORS; FEMALE; MECHANISMS; BASKETBALL; ASSOCIATION	Background The anterior cruciate ligament (ACL) is often injured during sport. The Star Excursion Balance Test (SEBT) has been used to evaluate ankle and knee stability of the supporting leg while reaching in eight different directions with the non-stance leg. We hypothesized that the SEBT might be useful in categorising ACL injury risk. The purpose of this study was to clarify the relationship between knee valgus alignment during single leg drop landing (SDL) and alignment of the trunk and lower limb during the SEBT. Methods A three-dimensional motion analysis system was used to measure the trunk, hip and knee angles during SDL and the SEBT. Groupings were allocated based on 5 degrees of knee valgus angle during SDL. Independent t-test's were used to identify differences in the trunk, hip and knee angles between the two groups. Results The knee valgus angles in the knee valgus group were greater than those in the control group in five directions of the SEBT (p < 0.05). In addition, the hip internal rotation angle in the knee valgus group was lower than that in the control group during two directions of the SEBT (p < 0.05). Furthermore, the knee flexion and trunk right rotation angles in the knee valgus group were lower than those in the control group in two directions of the SEBT (p < 0.05). Conclusion Decreases in hip internal rotation, knee flexion and trunk rotation to the supporting leg during the SEBT might be considered as risk factors for non-contact ACL injury.	[Uebayashi, Kazuma] Suzuki Clin Orthopaed River City, Dept Rehabil, Chuo Ku, Tokyo, Japan; [Akasaka, Kiyokazu; Otsudo, Takahiro; Okubo, Yu] Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan; [Akasaka, Kiyokazu; Otsudo, Takahiro; Sawada, Yutaka; Okubo, Yu] Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan; [Tamura, Akihiro] Int Univ Hlth & Welf, Dept Phys Therapy, Sch Hlth Sci Narita, Chiba, Japan; [Hall, Toby] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Saitama Medical University; Saitama Medical University; International University of Health & Welfare; Curtin University	Akasaka, K (corresponding author), Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan.; Akasaka, K (corresponding author), Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan.	akasaka-smc@umin.ac.jp	Tamura, Akihiro/ABF-1688-2021; Akasaka, Kiyokazu/ABI-0104-2022	Tamura, Akihiro/0000-0003-2972-5745; Akasaka, Kiyokazu/0000-0003-2110-205X; Uebayashi, Kazuma/0000-0002-9126-6239; Hall, Toby/0000-0003-4461-7259				Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Braun HJ, 2015, KNEE SURG SPORT TR A, V23, P1065, DOI 10.1007/s00167-014-2873-0; Delahunt E, 2013, J ATHL TRAINING, V48, P172, DOI 10.4085/1062-6050-48.2.05; Dempsey AR, 2007, MED SCI SPORT EXER, V39, P1765, DOI 10.1249/mss.0b013e31812f56d1; DiStefano LJ, 2009, AM J SPORT MED, V37, P495, DOI 10.1177/0363546508327542; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hegedus EJ, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094341; Herrington L, 2009, KNEE, V16, P149, DOI 10.1016/j.knee.2008.10.004; Hertel J, 2006, J ORTHOP SPORT PHYS, V36, P131, DOI 10.2519/jospt.2006.36.3.131; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kinzey SJ, 1998, J ORTHOP SPORT PHYS, V27, P356, DOI 10.2519/jospt.1998.27.5.356; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lin CF, 2009, J BIOMECH, V42, P418, DOI 10.1016/j.jbiomech.2008.12.005; McLean SG, 2005, CLIN BIOMECH, V20, P863, DOI 10.1016/j.clinbiomech.2005.05.007; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Russell KA, 2006, J ATHL TRAINING, V41, P166; Sigward SM, 2015, CLIN J SPORT MED, V25, P529, DOI 10.1097/JSM.0000000000000155	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211242	10.1371/journal.pone.0211242	http://dx.doi.org/10.1371/journal.pone.0211242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682114	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500134
J	Lee, KB; Hong, BY; Kim, JS; Sul, B; Yoon, SC; Ji, EK; Son, DB; Hwang, BY; Lim, SH				Lee, Kyoung Bo; Hong, Bo Young; Kim, Joon Sung; Sul, Bomi; Yoon, Sang Cheol; Ji, Eun-Kyu; Son, Dong Baek; Hwang, Byong Yong; Lim, Seong Hoon			Which brain lesions produce spasticity? An observational study on 45 stroke patients	PLOS ONE			English	Article							MODIFIED ASHWORTH SCALE; CORTICORETICULAR PATHWAY; BASAL GANGLIA; ORGANIZATION; RELIABILITY; ASSOCIATION; MOVEMENT; LOCATION	Spasticity is an important barrier that can hinder the restoration of function in stroke patients. Although several studies have attempted to elucidate the relationship between brain lesions and spasticity, the effects of specific brain lesions on the development of spasticity remain unclear. Thus, the present study investigated the effects of stroke lesions on spasticity in stroke patients. The present retrospective longitudinal observational study assessed 45 stroke patients using the modified Ashworth Scale to measure muscle spasticity. Each patient was assessed four times: initially (within 2 weeks of stroke) and at 1, 3, and 6 months after the onset of stroke. Brain lesions were analyzed using voxel-based lesion symptom mapping (VLSM) with magnetic resonance imaging images. Spasticity developed to a certain degree within 3 months in most stroke patients with spasticity. The VLSM method with non-parametric mapping revealed that lesions in the superior corona radiata, posterior limb of the internal capsule, posterior corona radiata, thalamus, putamen, premotor cortex, and insula were associated with the development of upper-limb spasticity. Additionally, lesions of the superior corona radiata, posterior limb of the internal capsule, caudate nucleus, posterior corona radiata, thalamus, putamen, and external capsule were associated with the development of lower-limb spasticity. The present study identified several brain lesions that contributed to post-stroke spasticity. Specifically, the involvement of white matter tracts and the striatum influenced the development of spasticity in the upper and lower limbs of stroke patients. These results may be useful for planning rehabilitation strategies and for understanding the pathophysiology of spasticity in stroke patients.	[Lee, Kyoung Bo; Hong, Bo Young; Kim, Joon Sung; Sul, Bomi; Yoon, Sang Cheol; Ji, Eun-Kyu; Son, Dong Baek; Lim, Seong Hoon] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Rehabil Med, Seoul, South Korea; [Hwang, Byong Yong] Yongin Univ, Coll Publ Hlth & Welf, Dept Phys Therapy, Gyeonggi Do, South Korea	Catholic University of Korea; Yongin University	Lim, SH (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Rehabil Med, Seoul, South Korea.	seonghoon@catholic.ac.kr		Lim, Seong Hoon/0000-0002-5475-4153	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2017R1E1A1A01074324]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT	SL: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (grant number: 2017R1E1A1A01074324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LD, 2009, STROKE, V40, P537, DOI 10.1161/STROKEAHA.108.527374; Barlow SJ, 2016, SOMATOSENS MOT RES, V33, P104, DOI 10.1080/08990220.2016.1197114; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Black KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088121; Blackburn M, 2002, PHYS THER, V82, P25, DOI 10.1093/ptj/82.1.25; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boudrias MH, 2010, CEREB CORTEX, V20, P169, DOI 10.1093/cercor/bhp084; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Castrop F, 2012, MOVEMENT DISORD, V27, P1432, DOI 10.1002/mds.24944; Cheung DK, 2016, NEUROREHAB NEURAL RE, V30, P63, DOI 10.1177/1545968315585357; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Galvan A, 2011, BASAL GANGLIA, V1, P179, DOI 10.1016/j.baga.2011.09.001; Gilat M, 2017, NEUROIMAGE, V152, P207, DOI 10.1016/j.neuroimage.2017.02.073; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Iglesias C, 2008, EUR J NEUROSCI, V28, P1351, DOI 10.1111/j.1460-9568.2008.06414.x; Jang SH, 2014, SOMATOSENS MOT RES, V31, P204, DOI 10.3109/08990220.2014.917292; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Jones PS, 2016, HUM BRAIN MAPP, V37, P689, DOI 10.1002/hbm.23059; LANCE JW, 1980, NEUROLOGY, V30, P1303, DOI 10.1212/WNL.30.12.1303; Lee K. B., 2015, BEHAV NEUROL, V2015, P6, DOI [DOI 10.4162/nrp.2015.9.6.586, DOI 10.4162/NRP.2015.9.6.586]; Lee K.B., 2017, BRAIN NEUROREHABIL, V10, P5, DOI [10.12786/bn.2017.10.e5, DOI 10.12786/BN.2017.10.E5]; Lee KB, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.868; Lee KB, 2017, J CLIN NEUROSCI, V37, P79, DOI 10.1016/j.jocn.2016.11.008; Li S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00120; Li S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00192; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Picelli A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/162754; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Smith Y, 2009, BRAIN RES BULL, V78, P60, DOI 10.1016/j.brainresbull.2008.08.015; Snijders AH, 2016, ANN NEUROL, V80, P644, DOI 10.1002/ana.24778; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; Wissel J, 2013, NEUROLOGY, V80, pS13, DOI 10.1212/WNL.0b013e3182762448; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1	35	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210038	10.1371/journal.pone.0210038	http://dx.doi.org/10.1371/journal.pone.0210038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677069	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400009
J	Rydahl, E; Declercq, E; Juhl, M; Maimburg, RD				Rydahl, Eva; Declercq, Eugene; Juhl, Mette; Maimburg, Rikke Damkjaer			Cesarean section on a rise-Does advanced maternal age explain the increase? A population register-based study	PLOS ONE			English	Article							6 YEAR EXPERIENCE; DELIVERY OUTCOMES; EPIDURAL ANALGESIA; LABOR; WOMEN; IMPACT; BIRTH; INDUCTION; MOTHERS; TERM	Background In Denmark, the cesarean section rate has increased by 49% between 1998 and 2015 and accounts for 21% of all births. Cesarean sections may cause short-as well as long-term consequences for both the mother and the child and impose further risks in future pregnancies. Delaying pregnancy until advanced maternal age at childbirth has been suggested as contributing to the increase. The proportion of women giving birth at 35 years or above increased from 15% (1998) to 21% (2015). Advanced maternal age at childbirth has been found to be related to increased pre-pregnancy morbidity and associated risk factors that may contribute to an increased risk of cesarean section. The aim of this study was to examine the association between advanced maternal age and cesarean section in a Danish population and the influence of demographic, anthropometric, health, and obstetric factors on this association. Methods This study draws on a national population-based cohort study of all Danish births between 1998 and 2015 (N = 1,122,964). Maternal age less than 30 years serves as reference with the following age categories: (30-34 years); (35-39 years), and (40 years and above). The primary outcome was a cesarean section. Multivariate regression models with adjustment for demographic, health, pregnancy, fetal, and obstetric characteristics were performed with the results further stratified by parity. Results In general, a positive association between advanced maternal age and cesarean section was found. Only minor changes in the risk estimate occurred after adjustment for relevant confounders. In comparison with the reference category, nulliparous women aged 35-39-years had twice the risk for cesarean section (adjusted odds ratio (AOR) 2.18, 95% confidence interval (CI) [2.11-2.26]) whereas for women of 40 years or above, the risk was more than tripled (AOR 3.64, 95% CI [3.41-3.90]). For multiparous women aged 35-39-years the risk was more moderate, but still with an AOR of 1.56, 95% CI [1.53-1.60], and for those 40 years and above, the AOR was 2.02, 95% CI [1.92-2.09]. Conclusions Overall, cesarean section increased with increasing maternal age. Adjustment for maternal and obstetric risk factors had only a minor influence on the association. The association was stronger in nulliparous women compared to multiparous women. Given the lack of impact of demographic and health risks on the relationship between maternal age and cesarean section, the authors suggest obstetric culture could be added to the list of risk factors for a cesarean. Future research on obstetric culture is recommended as are studies on a possible age-related decrease in the ability to maintain the progression of labor.	[Rydahl, Eva; Juhl, Mette] Univ Coll Copenhagen, Dept Midwifery, Copenhagen, Denmark; [Rydahl, Eva; Maimburg, Rikke Damkjaer] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Declercq, Eugene] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Maimburg, Rikke Damkjaer] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark	University College Copenhagen; Aarhus University; Boston University; Aarhus University	Rydahl, E (corresponding author), Univ Coll Copenhagen, Dept Midwifery, Copenhagen, Denmark.; Rydahl, E (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	evry@kp.dk		Rydahl, Eva/0000-0001-6272-0466; Juhl, Mette/0000-0003-3156-9518	Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science]; Danish Association of Midwifery; Herlev Hospital; Hanne Kjaergaard Memorial Fund; University College Copenhagen; Aarhus University	Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science]; Danish Association of Midwifery; Herlev Hospital; Hanne Kjaergaard Memorial Fund; University College Copenhagen; Aarhus University	This work was supported by Sundhedsvidenskabeligt Fakultet, Aarhus Universitet [Faculty of Health and Medical Science], https://healthsciences.ku.dk/; Danish Association of Midwifery, http://www.jordemoderforeningen.dk/; Herlev Hospital, https://www.herlevhospital.dk/; Hanne Kjaergaard Memorial Fund, http://www.jordemoderforeningen.dk/aktuelt/nyheder/nyhed/artikel/hanne-kjaergaardsmindelegat-2/; and University College Copenhagen, https://www.kp.dk/.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Boston University, School of Public Health, for the inspiration and goodwill to kick start the project and The Hanne Kjaergaard Memorial Fund for making a research stay in Boston possible. Furthermore, we thank Aarhus University, University College Copenhagen, Herlev Hospital and Danish Association of Midwifery for financial support.	[Anonymous], 2007, MED SOC; Bayrampour H, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-100; Bayrampour H, 2011, J OBSTET GYNAECOL CA, V33, P820, DOI 10.1016/S1701-2163(16)34985-4; BETRAN AP, 2016, PLOS ONE, V11; Bliddal M, 2018, EUR J EPIDEMIOL, V33, P27, DOI 10.1007/s10654-018-0356-1; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Cammu H, 2014, EUR J OBSTET GYN R B, V177, P106, DOI 10.1016/j.ejogrb.2014.04.008; Cheng ER, 2015, MATERN CHILD HLTH J, V19, P2578, DOI 10.1007/s10995-015-1776-0; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Cohen WR, 2014, BJOG-INT J OBSTET GY, V121, P252, DOI 10.1111/1471-0528.12563; Crankshaw DJ, 2015, REPROD SCI, V22, P1229, DOI 10.1177/1933719115572483; Declercq E, 2015, BIRTH-ISS PERINAT C, V42, P309, DOI 10.1111/birt.12201; DeVries R, 2001, BIRTH BY DESIGN; Eriksen LM, 2011, BIRTH-ISS PERINAT C, V38, P317, DOI 10.1111/j.1523-536X.2011.00486.x; Essex HN, 2013, BJOG-INT J OBSTET GY, V120, P732, DOI 10.1111/1471-0528.12177; Fox B, 1999, GENDER SOC, V13, P326, DOI 10.1177/089124399013003004; Gerli S, 2015, J OBSTET GYNAECOL, V35, P435, DOI 10.3109/01443615.2014.960825; Glantz JC, 2010, OBSTET GYNECOL, V115, P70, DOI 10.1097/AOG.0b013e3181c4ef96; Greenberg MB, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.058; Herstad L, 2015, BJOG-INT J OBSTET GY, V122, P1642, DOI 10.1111/1471-0528.12962; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Klemetti R, 2016, ACTA OBSTET GYN SCAN, V95, P1368, DOI 10.1111/aogs.13020; Kozhimannil KB, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001745; Langhoff-Roos J, 2003, VALIDERING LANDSPATI; Langhoff-Roos J, 2014, ACTA OBSTET GYN SCAN, V93, P132, DOI 10.1111/aogs.12302; Li YM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004026; Martinelli KG, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00206116, 10.1590/0102-311X00206116]; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Moore EK, 2014, J OBSTET GYNAECOL, V34, P238, DOI 10.3109/01443615.2013.838546; Moore LE, 2006, CLIN OBSTET GYNECOL, V49, P698, DOI 10.1097/00003081-200609000-00026; Oakley L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164462; Omih EE, 2016, J PERINAT MED, V44, P773, DOI 10.1515/jpm-2015-0128; Organisation for Economic Co-operation and Development O, 2015, HEALTH AT A GLANCE 2; Petropanagos A, 2015, AM J BIOETHICS, V15, P56, DOI 10.1080/15265161.2015.1088986; Poignant M, 2012, SEX REPROD HEALTHC, V3, P129, DOI 10.1016/j.srhc.2012.10.004; Richards MK, 2016, J PERINATOL, V36, P272, DOI 10.1038/jp.2015.204; Rossignol M, 2014, BIRTH-ISS PERINAT C, V41, P70, DOI 10.1111/birt.12088; Rydahl E, 2018, MED PREGNANCY CHILDB; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Smith GCS, 2008, PLOS MED, V5, P1123, DOI 10.1371/journal.pmed.0050144; Timofeev J, 2013, OBSTET GYNECOL, V122, P1184, DOI 10.1097/AOG.0000000000000017; VanGompel EW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1756-7; Vaughan DA, 2014, BJOG-INT J OBSTET GY, V121, P261, DOI 10.1111/1471-0528.12311; Waldenstrom U, 2017, ACTA OBSTET GYN SCAN, V96, P1063, DOI 10.1111/aogs.13167; WHO, 2015, GUID TREATM MAL; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Zaki MN, 2013, OBSTET GYNECOL, V122, P1018, DOI 10.1097/AOG.0b013e3182a9c92c	49	41	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210655	10.1371/journal.pone.0210655	http://dx.doi.org/10.1371/journal.pone.0210655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677047	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400022
J	Luplertlop, N; Muangkaew, W; Pumeesat, P; Suwanmanee, S; Singkum, P				Luplertlop, Natthanej; Muangkaew, Watcharamat; Pumeesat, Potjaman; Suwanmanee, San; Singkum, Pantira			Distribution of Scedosporium species in soil from areas with high human population density and tourist popularity in six geographic regions in Thailand	PLOS ONE			English	Article							PSEUDALLESCHERIA-BOYDII; APIOSPERMUM; TSUNAMI; SURVIVOR	Scedosporium is a genus comprising at least 10 species of airborne fungi (saprobes) that survive and grow on decaying organic matter. These fungi are found in high density in human-affected areas such as sewage-contaminated water, and five species, namely Scedosporium apiospermum, S. boydii, S. aurantiacum, S. dehoogii, and S. minutisporum, cause human infections. Thailand is a popular travel destination in the world, with many attractions present in densely populated areas; thus, large numbers of people may be exposed to pathogens present in these areas. We conducted a comprehensive survey of Scedosporium species in 350 soil samples obtained from 35 sites of high human population density and tourist popularity distributed over 23 provinces and six geographic regions of Thailand. Soil suspensions of each sample were inoculated on three plates of Scedo-Select III medium to isolate Scedosporium species. In total, 191 Scedosporium colonies were isolated from four provinces. The species were then identified using PCR and sequencing of the beta-tubulin (BT2) gene. Of the 191 isolates, 188 were S. apiospermum, one was S. dehoogii, and species of two could not be exactly identified. Genetic diversity analysis revealed high haplotype diversity of S. apiospermum. Soil is a major ecological niche for Scedosporium and may contain S. apiospermum populations with high genetic diversity. This study of Scedosporium distribution might encourage health care providers to consider Scedosporium infection in their patients.	[Luplertlop, Natthanej; Muangkaew, Watcharamat; Pumeesat, Potjaman; Suwanmanee, San; Singkum, Pantira] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Mahidol University	Luplertlop, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	natthanej.lup@mahidol.ac.th		luplertlop, natthanej/0000-0001-7964-5298	Mahidol University [80/2560]; Health System Research Institute [HRSI-61-002]	Mahidol University; Health System Research Institute	This research project is supported by Mahidol University (contract no. 80/2560) and Health System Research Institute agreement no. HRSI-61-002 to Natthanej Luplertlop.	Bernhardt A, 2013, J CYST FIBROS, V12, P592, DOI 10.1016/j.jcf.2013.05.007; Chen M, 2016, FUNGAL BIOL-UK, V120, P137, DOI 10.1016/j.funbio.2015.09.003; Chen TC, 2016, J FORMOS MED ASSOC, V115, P213, DOI 10.1016/j.jfma.2015.02.007; Crous PW, 2016, PERSOONIA, V37, P218, DOI 10.3767/003158516X694499; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Garzoni C, 2005, EMERG INFECT DIS, V11, P1591, DOI 10.3201/eid1110.050715; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leechawengwongs M, 2007, MYCOSES, V50, P512, DOI 10.1111/j.1439-0507.2007.01410.x; Lu QY, 2011, J CLIN MICROBIOL, V49, P960, DOI 10.1128/JCM.01813-10; Luplertlop N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159869; Nakamura Y, 2013, RESPIR INVESTIG, V51, P207, DOI 10.1016/j.resinv.2013.07.001; Rougeron A, 2018, MYCOPATHOLOGIA, V183, P185, DOI 10.1007/s11046-017-0200-2; Shimizu J, 2014, SPINE, V39, pE739, DOI 10.1097/BRS.0000000000000317; Tomasini N, 2013, INFECT GENET EVOL, V20, P188, DOI 10.1016/j.meegid.2013.08.029; Pham T, 2015, MED MYCOL, V53, P512, DOI 10.1093/mmy/myv015	18	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210942	10.1371/journal.pone.0210942	http://dx.doi.org/10.1371/journal.pone.0210942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673761	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800058
J	Shafii, T; Benson, SK; Morrison, DM; Hughes, JP; Golden, MR; Holmes, KK				Shafii, Taraneh; Benson, Samantha K.; Morrison, Diane M.; Hughes, James P.; Golden, Matthew R.; Holmes, King K.			Results from e-KISS: electronic-KIOSK Intervention for Safer Sex: A pilot randomized controlled trial of an interactive computer-based intervention for sexual health in adolescents and young adults	PLOS ONE			English	Article							RISK-REDUCTION INTERVENTION; HIV PREVENTION INTERVENTION; HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMITTED INFECTIONS; ASSISTED-INSTRUCTION; PRELIMINARY EFFICACY; PREGNANCY; STD; PREVALENCE; BEHAVIOR	Introduction Interactive computer-based interventions (ICBI) are potentially scalable tools for use in real-world settings to promote sexual health and prevent sexually transmitted infections (STIs) and unintended pregnancies. We developed and assessed the feasibility and acceptability of an ICBI for promoting adolescent and young adult sexual health, and the effectiveness of the intervention in reducing unprotected sex, STIs, and unintended pregnancy. Methods This pilot randomized controlled trial enrolled STI Clinic patients, in Seattle, Washington, who were 14-24 years old and reported unprotected vaginal sex during the last 2 months. Both the control and intervention group used a computerized survey to enter their sexual health and only the intervention group received the ICBI. The ICBI included personalized sexual health feedback from a physician avatar; instructive video modules advocating sexual health; and identification of one behavior to change. At 3-month follow-up, participants reported on interim sexual and pregnancy histories and underwent repeat STI testing. We assessed intervention impact on unprotected vaginal sex, number of sexual partners, incident STIs, and unintended pregnancy. Results Of 272 participants, 242 (89%) completed the study, of whom 65% were female. While these findings did not reach statistical significance, at 3-month follow-up, the intervention group reported a 33% lower rate of unprotected vaginal sex (no condom use) [IRR = 0.67, 95% CI: 0.44-1.02]; 29% fewer sex partners [IRR = 0.71, 95% CI: 0.50-1.03]; and 48% fewer STIs [IRR = 0.52, 95% CI: 0.25-1.08] when compared to the control group. Similarly, as compared to the control group, intervention females reported a lower rate of unprotected vaginal sex (no birth control) [IRR = 0.80, 95% CI: 0.47-1.35] and half as many unintended pregnancies (n = 5) versus control females (n = 10) [IRR = 0.51, 95% CI: 0.17-1.58]. In exploratory analyses, intervention females reported fewer partners [IRR = 0.71, 95% CI: 0.50-1.00] and a significantly lower rate of vaginal sex without condoms [IRR = 0.50, 95% Cl: 0.30-0.85]. Conclusion The intervention was acceptable to both males and females, and at 3-month follow-up, there were non-significant reductions in risk behavior for all outcomes. Among females, exploratory analysis showed a significant reduction in vaginal sex without condoms.	[Shafii, Taraneh] Univ Washington, Sch Med, Dept Pediat, Div Adolescent Med, Seattle, WA 98195 USA; [Benson, Samantha K.] Univ Washington, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA; [Morrison, Diane M.] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Golden, Matthew R.] Univ Washington, Sch Med, Dept Med, Publ Hlth Seattle & King Cty HIV STD Program, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [Holmes, King K.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Sch Publ Hlth, Dept Med, Seattle, WA 98195 USA; [Holmes, King K.] Ctr AIDS & STD, Seattle, WA USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shafii, T (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Adolescent Med, Seattle, WA 98195 USA.	Taraneh.shafii@seattlechildrens.org	Golden, Matthew/AAE-4314-2020	Benson, Samantha/0000-0001-7113-9462	Eunice Kennedy Shriver National Institute of Child and Human Development [5K23HD052621, A66661]	Eunice Kennedy Shriver National Institute of Child and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TS received funding from the Eunice Kennedy Shriver National Institute of Child and Human Development Grant No: 5K23HD052621, eGC1 Number: A66661, Project Title: Brief Clinician Intervention for High-Risk Behaviors in Adolescents, Grant PI: Taraneh Shafii, Project Period Dates: 7/1/07-5/31/13. Funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALEMI F, 1989, COMPUT BIOL MED, V19, P283, DOI 10.1016/0010-4825(89)90015-2; America PPFo, US COND BIRTH CONTR; Associates E, SEX MYTHS2010; Bailey JV, 2012, INT J STD AIDS, V23, P408, DOI 10.1258/ijsa.2011.011221; Bolu OO, 2004, SEX TRANSM DIS, V31, P469, DOI 10.1097/01.olq.0000135987.12346.f2; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; CDC, 2012, STIS IN ADOLESCENTS; CDC, SAF CITY2008; CDC, 2016, REPR HLTH TEEN PREGN; CDC, 2013, HIV SURV REP 2011; Cunningham RM, 2009, ACAD EMERG MED, V16, P1193, DOI 10.1111/j.1553-2712.2009.00513.x; Di Noia J, 2004, J ADOLESCENT HEALTH, V35, P62, DOI 10.1016/j.jadohealth.2003.09.006; DiClemente RJ, 2014, WOMEN HEALTH, V54, P726, DOI 10.1080/03630242.2014.932893; DiClemente RJ, 2014, JAMA PEDIATR, V168, P938, DOI 10.1001/jamapediatrics.2014.1436; DiClemente RJ, 2009, ARCH PEDIAT ADOL MED, V163, P1112, DOI 10.1001/archpediatrics.2009.205; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Downs JS, 2004, SOC SCI MED, V59, P1561, DOI 10.1016/j.socscimed.2004.01.032; Evans AE, 2000, J ADOLESCENT HEALTH, V26, P244, DOI 10.1016/S1054-139X(99)00093-2; Fisher JD, 2006, JAIDS-J ACQ IMM DEF, V41, P44, DOI 10.1097/01.qai.0000192000.15777.5c; Fisher JD, 2004, JAIDS-J ACQ IMM DEF, V37, pS78, DOI 10.1097/01.qai.0000140605.51640.5c; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; Forhan SE, 2009, PEDIATRICS, V124, P1505, DOI 10.1542/peds.2009-0674; Gilbert P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001988; Gold MA, 2016, J PEDIATR ADOL GYNEC, V29, P26, DOI 10.1016/j.jpag.2015.06.001; Heeren GA, 2013, AIDS BEHAV, V17, P1105, DOI 10.1007/s10461-011-0129-2; Jemmott JB, 2010, AM J PUBLIC HEALTH, V100, P720, DOI 10.2105/AJPH.2008.140657; Jenkins PR, 2000, CLIN INFECT DIS, V30, P730, DOI 10.1086/313743; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KANN LK, 1987, J SCHOOL HEALTH, V57, P282, DOI 10.1111/j.1746-1561.1987.tb03203.x; Kiene SM, 2006, J ADOLESCENT HEALTH, V39, P404, DOI 10.1016/j.jadohealth.2005.12.029; Klein CH, 2011, AIDS EDUC PREV, V23, P564, DOI 10.1521/aeap.2011.23.6.564; Kost K, 2014, US TEENAGE PREGNANCI; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Lightfoot M, 2007, AM J PUBLIC HEALTH, V97, P1027, DOI 10.2105/AJPH.2005.072652; Lopez LM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010915.pub2; Morrison-Beedy D, 2013, J ADOLESCENT HEALTH, V52, P314, DOI 10.1016/j.jadohealth.2012.07.005; Noar SA, 2009, AIDS, V23, P107, DOI 10.1097/QAD.0b013e32831c5500; Noar SM, 2011, AIDS CARE, V23, P525, DOI 10.1080/09540121.2010.516349; Oringanje C, 2010, INTERVENTIONS PREVEN; Peipert JF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.038; Peipert J, 2007, CONTEMP CLIN TRIALS, V28, P626, DOI 10.1016/j.cct.2007.01.012; Peskin MF, 2015, J ADOLESCENT HEALTH, V56, P515, DOI 10.1016/j.jadohealth.2015.01.001; Roberto AJ, 2007, HEALTH COMMUN, V21, P115, DOI 10.1080/10410230701306990; Roberto AJ, 2007, J HEALTH COMMUN, V12, P53, DOI 10.1080/10810730601096622; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; Spijkerman R, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1465; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wingood GM, 2011, PSYCHOL HEALTH, V26, P223, DOI 10.1080/08870446.2011.531576; Ybarra ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070083; Zule WA, 2013, AIDS BEHAV, V17, P3045, DOI 10.1007/s10461-013-0557-2	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209064	10.1371/journal.pone.0209064	http://dx.doi.org/10.1371/journal.pone.0209064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673710	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800012
J	Song, JU; Jang, Y; Lim, SY; Ryu, S; Song, WJ; Byrne, CD; Sung, KC				Song, Jae-Uk; Jang, Yoonjung; Lim, Si-Young; Ryu, Seungho; Song, Won Jun; Byrne, Christopher D.; Sung, Ki-Chul			Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study	PLOS ONE			English	Article							KOREA NATIONAL-HEALTH; INSULIN-RESISTANCE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; SMOKING; POPULATION; STEATOSIS; EPIDEMIOLOGY; FIBROSIS; WORKERS	Background Decreased lung function is associated with non-alcoholic fatty liver disease (NAFLD), based on linking mechanisms such as insulin resistance and systemic inflammation However, its association with the risk of developing NAFLD is unclear. Our aim was to investigate whether baseline lung function is associated with incident NAFLD in middle-aged healthy Koreans. Methods A cohort study of 96,104 subjects (mean age: 35.7 years) without NAFLD were followed up from 2002 to 2015. NAFLD was diagnosed by ultrasound after the exclusion of other possible causes of liver diseases. Baseline percent predicted forced expiratory volume in one second (FEV1%) and forced vital capacity (FVC%) were categorized in quartiles. Adjusted hazard ratios (aHR) and 95% confidence intervals (Cls) (using the highest quartile as reference) were calculated for incident NAFLD at follow-up, controlling for covariates and potential confounders. Results During 579,714.5 person-years of follow-up, 24,450 participants developed NAFLD (incidence rate, 42.2 per 1,000 person-years). The mean follow-up period was 5.9 +/- 3.4 years. Regardless of smoking history, the risk for incident NAFLD increased with decreasing quartiles of FEV1 (%) and FVC (%) in a dose-response manner (p for trend<0.001). In never smokers, the aHRs (95% Cls) for incident NAFLD were 1.15 (1.08-1.21), 1.11 (1.05-1.18), and 1.08 (1.02-1.14) in quartiles 1-3 for FEV1 (%) and 1.12 (1.06-1.18), 1.11 (1.05-1.18), and 1.09 (1.03-1.15) in quartiles 1-3 for FVC (%), compared with the highest quartile reference. Similar inverse association was present in smoke-exposed subjects (aHR for incident NAFLD were 1.14, 1.21, 1.13 and 1.17, 1.11, 1.09 across FEV1(%) and FVC(%) quartile in increasing order, respectively). Conclusions Reduced lung function was a risk factor for incident NAFLD in a large middle-aged Korean cohort with over half a million person-years of follow-up.	[Song, Jae-Uk; Jang, Yoonjung; Lim, Si-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Ctr Cohort Studies,Total Healthcare Ctr, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Ryu, Seungho] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Song, Won Jun] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Crit Care Med, Seoul, South Korea; [Byrne, Christopher D.] Univ Southampton, Southampton Gen Hosp, Nutr & Metab Grp, Southampton, Hants, England; [Byrne, Christopher D.] Univ Southampton, Southampton Gen Hosp, Southampton Natl Inst Hlth Res, Biomed Res Ctr, Southampton, Hants, England; [Sung, Ki-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; University of Southampton; University of Southampton; Sungkyunkwan University (SKKU); Samsung Medical Center	Sung, KC (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Cardiol,Dept Internal Med, Seoul, South Korea.	kcmd.sung@samsung.com		Byrne, Christopher D/0000-0001-6322-7753	Southampton National Institute for Health Research Biomedical Research Centre	Southampton National Institute for Health Research Biomedical Research Centre	We acknowledge the efforts of the health screening group at Kangbuk Samsung Hospital, Korea. CDB is supported in part by the Southampton National Institute for Health Research Biomedical Research Centre.	Adams LA, 2005, DIABETIC MED, V22, P1129, DOI 10.1111/j.1464-5491.2005.01748.x; ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Association American Association for the Study of Liver Diseases and American College of Gastroenterology, GASTROENTEROLOGY, V142, P1592, DOI [10.1053/j.gastro.2012.04.001, DOI 10.1053/J.GASTRO.2012.04.001]; Ballestri S, 2017, METABOLISM, V72, P57, DOI 10.1016/j.metabol.2017.04.003; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Barzilay JI, 2009, DIABETES CARE, V32, P736, DOI 10.2337/dc08-1781; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716; Jung DH, 2012, INTERN MED J, V42, P541, DOI 10.1111/j.1445-5994.2011.02644.x; Kato K, 2015, J DIABETES INVEST, V6, P158, DOI 10.1111/jdi.12271; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kwak MS, 2018, KOREAN J INTERN MED, V33, P64, DOI 10.3904/kjim.2017.343; Kwak MS, 2018, RESPIROLOGY, V23, P82, DOI 10.1111/resp.13127; Kwak MS, 2017, RESPIROLOGY; Kwon CH, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-38; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee CH, 2018, LIVER INT; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Lonardo A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00546-2017; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Mantovani A, 2018, METABOLISM, V79, P64, DOI 10.1016/j.metabol.2017.11.003; Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Miele CH, 2018, THORAX; Moon SW, 2018, INT J CHRONIC OBSTR, V13, P2603, DOI 10.2147/COPD.S166902; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Munsterman ID, 2017, SCAND J GASTROENTERO, V52, P881, DOI 10.1080/00365521.2017.1315169; Nigam P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049286; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; PENG TC, 2015, MEDICINE, V94; Piazzolla G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186708; Polyzos SA, 2011, METABOLISM, V60, P313, DOI 10.1016/j.metabol.2010.09.003; Qin L, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0168-4; Rezayat AA, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312117745223; RODE A, 1973, SCAND J RESPIR DIS, V54, P191; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Skogstad M, 2006, OCCUP ENVIRON MED, V63, P482, DOI 10.1136/oem.2005.024638; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Viglino D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01923-2016; Xu CF, 2010, HEPATOLOGY, V52, P803, DOI 10.1002/hep.23644	58	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208736	10.1371/journal.pone.0208736	http://dx.doi.org/10.1371/journal.pone.0208736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673698	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800009
J	Do, QN; Lewis, MA; Madhuranthakam, AJ; Xi, Y; Bailey, AA; Lenkinski, RE; Twickler, DM				Do, Quyen N.; Lewis, Matthew A.; Madhuranthakam, Ananth J.; Xi, Yin; Bailey, April A.; Lenkinski, Robert E.; Twickler, Diane M.			Texture analysis of magnetic resonance images of the human placenta throughout gestation: A feasibility study	PLOS ONE			English	Article							PROSTATE-CANCER; MRI; DIFFUSION; FEATURES	As fetal gestational age increases, other modalities such as ultrasound have demonstrated increased levels of heterogeneity in the normal placenta. In this study, we introduce and apply ROI-based texture analysis to a retrospective fetal MRI database to characterize the second-order statistics of placenta and to evaluate the relationship between heterogeneity and gestational age. Positive correlations were observed for several Haralick texture metrics derived from fetal-brain specific T2-weighted and gravid uterus T1-weighted and T2-weighted images, confirming a quantitative increase in placental heterogeneity with gestational age. Our study shows the importance of identifying baseline MR textural changes at certain gestational ages from which placental diseased states may be compared. Specifically, when evaluating for placental invasion or insufficiency, findings should be evaluated in the context of the normal placental aging process, which occurs throughout gestation.	[Do, Quyen N.; Lewis, Matthew A.; Madhuranthakam, Ananth J.; Xi, Yin; Bailey, April A.; Lenkinski, Robert E.; Twickler, Diane M.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Madhuranthakam, Ananth J.; Lenkinski, Robert E.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Xi, Yin] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bailey, April A.; Twickler, Diane M.] Univ Texas Southwestern Med Ctr Dallas, Obstet & Gynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Twickler, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA.; Twickler, DM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Obstet & Gynecol, Dallas, TX 75390 USA.	Diane.Twickler@UTSouthwestersn.edu	xi, yin/M-2268-2016; N., Quyen/D-1792-2017; Madhuranthakam, Ananth/AAG-2034-2021	xi, yin/0000-0001-9743-3010; N., Quyen/0000-0001-9511-7866; Twickler, Diane/0000-0001-5192-9782				Abele TA, 2013, J MAGN RESON IMAGING, V38, P786, DOI 10.1002/jmri.24032; Allen BC, 2013, RADIOL CLIN N AM, V51, P955, DOI 10.1016/j.rcl.2013.07.009; Barker DJP, 2013, PLACENTA, V34, P841, DOI 10.1016/j.placenta.2013.07.063; Bauckhage C, NUMPY SCIPY RECIPES; Blackledge MD, 2016, COMPUT BIOL MED, V69, P203, DOI 10.1016/j.compbiomed.2015.12.002; Capuani S, 2017, PLACENTA, V58, P33, DOI 10.1016/j.placenta.2017.08.003; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chen CY, 2011, ARCH GYNECOL OBSTET, V284, P13, DOI 10.1007/s00404-010-1555-5; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Dahdouh S, 2018, J MAGN RESON IMAGING, V47, P449, DOI 10.1002/jmri.25806; Do QN, 2017, P INT SOC MAG RESON, V25, P4822; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gnep K, 2017, J MAGN RESON IMAGING, V45, P103, DOI 10.1002/jmri.25335; GRANNUM PAT, 1979, AM J OBSTET GYNECOL, V133, P915, DOI 10.1016/0002-9378(79)90312-0; Guttmacher AE, 2014, PLACENTA, V35, P303, DOI 10.1016/j.placenta.2014.02.012; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; HOPPER KD, 1984, J ULTRAS MED, V3, P261, DOI 10.7863/jum.1984.3.6.261; Isakov KMM, 2018, AM J PERINAT, V35, P748, DOI 10.1055/s-0037-1615285; Johnson AP, 2004, J OPT SOC AM A, V21, P913, DOI 10.1364/JOSAA.21.000913; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kierans AS, 2014, AM J ROENTGENOL, V203, pW637, DOI 10.2214/AJR.14.12570; Lagana M, 2010, Comput Intell Neurosci, P254032, DOI 10.1155/2010/254032; Larroza A, 2016, ASSESSMENT CELLULAR, DOI DOI 10.5772/64641; Linduska N, 2009, PLACENTA, V30, P555, DOI 10.1016/j.placenta.2009.03.010; Loizou CP, 2009, 2009 9TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND APPLICATIONS IN BIOMEDICINE, P131; Manganaro L, 2010, PRENATAL DIAG, V30, P1178, DOI 10.1002/pd.2641; Nketiah G, 2017, EUR RADIOL, V27, P3050, DOI 10.1007/s00330-016-4663-1; Rac MWF, 2015, OBSTET GYNECOL, V125, P808, DOI 10.1097/AOG.0000000000000674; Rac MWF, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.022; Sanz-Cortes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069595; Sinding M, 2016, ULTRASOUND OBST GYN, V47, P748, DOI 10.1002/uog.14917; Twickler DM, 2002, AM J OBSTET GYNECOL, V187, P927, DOI 10.1067/mob.2002.127146; Victoria T, 2016, AM J ROENTGENOL, V206, P195, DOI 10.2214/AJR.14.14205; Victoria T, 2014, PEDIATR RADIOL, V44, P376, DOI 10.1007/s00247-013-2857-0; Welsh Robert C, 2011, Top Magn Reson Imaging, V22, P119, DOI 10.1097/RMR.0b013e318267f932; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Wright C, 2011, PLACENTA, V32, P1010, DOI 10.1016/j.placenta.2011.07.008; Zhou W, 2017, J MAGN RESON IMAGING, V45, P1476, DOI 10.1002/jmri.25454; Zwanenburg A, 2017, RADIOTHER ONCOL, V123, pS914, DOI 10.1016/S0167-8140(17)32209-0	40	19	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211060	10.1371/journal.pone.0211060	http://dx.doi.org/10.1371/journal.pone.0211060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668581	gold, Green Published, Green Submitted			2022-12-27	WOS:000456306400030
J	Hickey, J; Davidsen, J				Hickey, Joseph; Davidsen, Jorn			Self-organization and time-stability of social hierarchies	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DOMINANCE HIERARCHIES; ASSET EXCHANGE; HEALTH; MODEL; WEALTH; DISTRIBUTIONS; INSTABILITY; AGGRESSION; INEQUALITY	The formation and stability of social hierarchies is a question of general relevance. Here, we propose a simple generalized theoretical model for establishing social hierarchy via pairwise interactions between individuals and investigate its stability. In each interaction or fight, the probability of "winning" depends solely on the relative societal status of the participants, and the winner has a gain of status whereas there is an equal loss to the loser. The interactions are characterized by two parameters. The first parameter represents how much can be lost, and the second parameter represents the degree to which even a small difference of status can guarantee a win for the higher-status individual. Depending on the parameters, the resulting status distributions reach either a continuous unimodal form or lead to a totalitarian end state with one high-status individual and all other individuals having status approaching zero. However, we find that in the latter case long-lived intermediary distributions often exist, which can give the illusion of a stable society. As we show, our model allows us to make predictions consistent with animal interaction data and their evolution over a number of years. Moreover, by implementing a simple, but realistic rule that restricts interactions to sufficiently similar-status individuals, the stable or long-lived distributions acquire high-status structure corresponding to a distinct high-status class. Using household income as a proxy for societal status in human societies, we find agreement over their entire range from the low-to-middle-status parts to the characteristic high-status "tail". We discuss how the model provides a conceptual framework for understanding the origin of social hierarchy and the factors which lead to the preservation or deterioration of the societal structure.	[Hickey, Joseph; Davidsen, Jorn] Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB, Canada	University of Calgary	Hickey, J (corresponding author), Univ Calgary, Dept Phys & Astron, Complex Sci Grp, Calgary, AB, Canada.	joseph.hickey@ucalgary.ca		Hickey, Joseph/0000-0002-9373-1181	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	JH was financially supported by the Natural Sciences and Engineering Research Council of Canada through a Canada Graduate Scholarship. JD was financially supported by the Natural Sciences and Engineering Research Council of Canada through a Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; ANGELL CA, 1991, J NON-CRYST SOLIDS, V131, P13, DOI 10.1016/0022-3093(91)90266-9; Baro J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066121; Ben-Naim E, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/L11002; Ben-Naim E, 2006, EUR PHYS J B, V49, P531, DOI 10.1140/epjb/e2006-00095-y; Bischoff K, 2014, DIVERS DISPARITIES A; Boghosian B.M., 2016, 1 INT C COMPL INF SY; Boghosian BM, 2016, DESCRIBING REALISTIC, P1; Boghosian BM, 2017, PHYSICA A, V476, P15, DOI 10.1016/j.physa.2017.01.071; Boghosian BM, 2015, J STAT PHYS, V161, P1339, DOI 10.1007/s10955-015-1316-8; BONABEAU E, 1995, PHYSICA A, V217, P373, DOI 10.1016/0378-4371(95)00064-E; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Boyce WT, 2004, ANN NY ACAD SCI, V1036, P47, DOI 10.1196/annals.1330.003; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; Capasso M, 2009, ADV COMPLEX SYST, V12, P157, DOI 10.1142/S0219525909002131; Carr J., 2012, DEV STANDARDS COLLEC; Chakrabarti AS., 2010, ECONOMICS, V4, P1, DOI [10.5018/economics-ejournal.ja.2010-4, DOI 10.5018/ECONOMICS-EJOURNAL.JA.2010-4]; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Chase ID, 2002, P NATL ACAD SCI USA, V99, P5744, DOI 10.1073/pnas.082104199; Chase ID, 2011, ADV GENET, V75, P51, DOI 10.1016/B978-0-12-380858-5.00001-0; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; Cote S, 2017, J EXP PSYCHOL GEN, V146, P269, DOI 10.1037/xge0000258; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; De Vries H, 2006, ANIM BEHAV, V71, P585, DOI 10.1016/j.anbehav.2005.05.015; de Waal F., 2007, CHIMPANZEE POLITICS; Diamond J, 2010, NATURE, V464, P836, DOI 10.1038/464836c; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Ebel Holger, 2002, Complexity, V8, P24, DOI 10.1002/cplx.10066; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Flinn MV, 2012, HUM NATURE-INT BIOS, V23, P68, DOI 10.1007/s12110-012-9135-y; FOURNIER F, 1995, ANIM BEHAV, V49, P1449, DOI 10.1016/0003-3472(95)90066-7; Franz M, 2015, P ROY SOC B-BIOL SCI, V282, P113, DOI 10.1098/rspb.2015.1512; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Gouws EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016606; Graw B, 2007, ANIM BEHAV, V74, P507, DOI 10.1016/j.anbehav.2006.11.021; Guillams B, 2007, ENCY LIFE; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hayes B, 2002, AM SCI, V90, P400, DOI 10.1511/2002.5.400; Hemelrijk CK, 2017, ADV STUD BEHAV, V49, P361, DOI 10.1016/bs.asb.2017.02.005; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hobbes T., 1998, LEVIATHAN; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Iceland J, 2006, SOC PROBL, V53, P248, DOI 10.1525/sp.2006.53.2.248; Ispolatov S, 1998, EUR PHYS J B, V2, P267, DOI 10.1007/s100510050249; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Knobel M, 2008, J NANOSCI NANOTECHNO, V8, P2836, DOI 10.1166/jnn.2008.017; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Kunst JR, 2017, P NATL ACAD SCI USA, V114, P5407, DOI 10.1073/pnas.1616572114; Lagasse P., 2017, COLUMBIA ENCY; LAIDLER KJ, 1972, J CHEM EDUC, V49, P343, DOI 10.1021/ed049p343; Laming D., 2009, INSID PSYCHOL SCI 50; Leymann H., 1996, EUROPEAN J WORK ORG, V5, P165, DOI [10.1080/13594329608414853, DOI 10.1080/13594329608414853]; Lindquist WB, 2009, B MATH BIOL, V71, P556, DOI 10.1007/s11538-008-9371-9; Markov I. V, 2003, CRYSTAL GROWTH BEGIN, DOI [10.1142/5172, DOI 10.1142/5172]; Marmot MG, 2014, SOC HIERARCHY HEAL C; Massey D., 1993, AM APARTHEID SEGREGA; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Odagaki T, 2006, PHYSICA A, V367, P435, DOI 10.1016/j.physa.2005.11.023; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Richmond P., 2013, ECONOPHYSICS PHYS EC, V1st ed; Ruggles S, 2017, NOTE ADJUSTING DOLLA; Ruggles Steven, 2015, INTEGRATED PUBLIC US; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Sanchez-Tojar A, 2018, J ANIM ECOL, V87, P594, DOI 10.1111/1365-2656.12776; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Sapolsky RM, 2011, SCIENCE, V333, P293, DOI 10.1126/science.1209620; SAS Institute Inc, 2000, SAS INSIGHT US GUID; Scheffer M, 2017, P NATL ACAD SCI USA, V114, P13154, DOI 10.1073/pnas.1706412114; Scott J, 1999, BEHAVIOUR, V136, P1283, DOI 10.1163/156853999500721; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shayo M, 2009, AM POLIT SCI REV, V103, P147, DOI 10.1017/S0003055409090194; Shizuka D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0080; Silk JB, 2002, EVOL ANTHROPOL, V11, P221, DOI 10.1002/evan.10038; Slanina F., 2013, ESSENTIALS ECONOPHYS; Soteriades ES, 2003, AM J PUBLIC HEALTH, V93, P1155, DOI 10.2105/AJPH.93.7.1155; Statistics Canada, 2001, CENS PUBL US MICR FI; Statistics Canada, 2006, CENS CAN 2001 PUBL U; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Sutton J, 1997, J ECON LIT, V35, P40; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Tsujiguchi M, 2007, PHYSICA A, V375, P317, DOI 10.1016/j.physa.2006.08.026; Wang S. X., 2001, THESIS; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703	91	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211403	10.1371/journal.pone.0211403	http://dx.doi.org/10.1371/journal.pone.0211403			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695067	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400032
J	Watson, H; Harrop, D; Walton, E; Young, A; Soltani, H				Watson, Helen; Harrop, Deborah; Walton, Elizabeth; Young, Andy; Soltani, Hora			A systematic review of ethnic minority women's experiences of perinatal mental health conditions and services in Europe	PLOS ONE			English	Review							POSTNATAL DEPRESSION; PSYCHOLOGICAL DISTRESS; LISTENING VISITS; MOTHERS; PREGNANCY; PSYCHOSIS; SUPPORT; PERIOD; CARE; UK	Background Women from ethnic minority groups are at greater risk of developing mental health problems. Poor perinatal mental health impacts on maternal morbidity and mortality and can have a devastating impact on child and family wellbeing. It is important to ensure that services are designed to meet the unique needs of women from diverse backgrounds. Aim The aim of the review was to explore ethnic minority women's experiences of perinatal mental ill health, help-seeking and perinatal mental health services in Europe. Data sources Searches included CINAHL, Maternity and Infant Care, MEDLINE and PsycINFO with no language or date restrictions. Additional literature was identified by searching reference lists of relevant studies. Design This was a mixed method systematic review. Study selection, appraisal and data extraction were conducted by two researchers independently. A convergent approach was adopted for the analysis and the data were synthesised thematically. Results The 15 eligible studies included women from a range of minority ethnic backgrounds and were all undertaken in the United Kingdom (UK). Seven overarching themes were identified; awareness and beliefs about mental health, isolation and seeking support, influence of culture, symptoms and coping strategies, accessing mental health services, experiences of mental health services and what women want. Conclusion Lack of awareness about mental ill health, cultural expectations, ongoing stigma, culturally insensitive and fragmented health services and interactions with culturally incompetent and dismissive health providers all impact on ethnic minority women's ability to receive adequate perinatal mental health support in the UK. Future research should focus on in-depth exploration of the experiences of these women across multiple European settings and interventions to reduce health inequalities among vulnerable mothers and families affected by perinatal mental ill health.	[Watson, Helen; Harrop, Deborah; Young, Andy; Soltani, Hora] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England; [Walton, Elizabeth] Univ Sheffield, Acad Unit Primary Med Care, Sheffield, S Yorkshire, England	Sheffield Hallam University; University of Sheffield	Soltani, H (corresponding author), Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England.	h.soltani@shu.ac.uk		Walton, Elizabeth/0000-0003-0195-7886; Watson, Helen/0000-0002-5479-8527; Soltani, Hora/0000-0001-9611-6777	Sheffield Health and Social Care NHS Foundation Trust [Aa4344482]	Sheffield Health and Social Care NHS Foundation Trust	All authors received funding for this study from Sheffield Health and Social Care NHS Foundation Trust. Grant number Aa4344482. https//shsc uk/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almond P, 2011, J ADV NURS, V67, P2350, DOI 10.1111/j.1365-2648.2011.05669.x; Anderson FM, 2017, ARCH WOMEN MENT HLTH, V20, P449, DOI 10.1007/s00737-017-0723-z; Aromataris E, 2014, JOANN BRIGGS I REV M; Bentley P, 2008, CLIN MED, V8, P493, DOI 10.7861/clinmedicine.8-5-493; Bhui Kamaldeep, 2004, Transcult Psychiatry, V41, P307, DOI 10.1177/1363461504045642; Bolton HL, 1998, J PSYCHOSOM OBST GYN, V19, P202, DOI 10.3109/01674829809025698; Cantle F, 2010, ETHNICITY INEQUALITI, DOI [10.5042/eihsc.2010.0345, DOI 10.5042/EIHSC.2010.0345]; Carroll C, 2015, RES SYNTH METHODS, V6, P149, DOI 10.1002/jrsm.1128; Chew-Graham CA, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-7; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; Cooke Sam, 2012, Community Pract, V85, P34; Cooper C, 2010, J AFFECT DISORDERS, V127, P96, DOI 10.1016/j.jad.2010.04.020; Cuijpers P, 2016, EU COMPASS ACTION ME; Currer C, 1994, INT J SOC PSYCHIAT, V30, P72; de Jonge A, 2001, J ADV NURS, V36, P49, DOI 10.1046/j.1365-2648.2001.01942.x; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; DH, 2011, NO HLTH MENT HLTH CR; Dogra N., 2005, ADV PSYCHIAT TREAT, V11, P159, DOI DOI 10.1192/APT.11.3.159; Edge D, 2005, SOC SCI MED, V61, P15, DOI 10.1016/j.socscimed.2004.11.047; Edge D, 2011, BRIT J GEN PRACT, V61, P256, DOI 10.3399/bjgp11X567063; Edwards E., 2005, J MENTAL HLTH, V14, P471, DOI [DOI 10.1080/09638230500271097, 10.1080/09638230500271097]; Gardner PL, 2014, MIDWIFERY, V30, P756, DOI 10.1016/j.midw.2013.08.001; General Medical Council, 2013, GOOD MED PRACTICE; George R.E., 2015, DIVERS EQUAL HLTH CA, V12, DOI [10.21767/2049-5471.100037, DOI 10.21767/2049-5471.100037]; Hall Pauline, 2006, Community Pract, V79, P256; Hanley J, 2006, MIDWIFERY, V22, P147, DOI 10.1016/j.midw.2005.08.004; Hanley Jane, 2007, Community Pract, V80, P34; Heron J, 2012, ARCH WOMEN MENT HLTH, V15, P155, DOI 10.1007/s00737-012-0267-1; HM Government and Department of Health, 2011, NO HLTH MENT HLTH CR; Howard LM, 2014, LANCET, DOI [10.1016/S01406736(14)61276-9, DOI 10.1016/S01406736(14)61276-9]; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Independent Mental Health Taskforce, 2016, 5 YEAR FORW VIEW MEN; Jarosinski JM, 2016, NURSING-RES REV, V6, P1, DOI 10.2147/NRR.S92203; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Karlsen S, 2005, PSYCHOL MED, V35, P1795, DOI 10.1017/S0033291705005830; King L., 2012, BR J MIDWIFERY, V20, P396, DOI DOI 10.12968/BJ0M.2012.20.6.396; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Knight M., 2020, SAVING LIVES IMPROVI; Latif Z, 2014, BETTER HLTH BRIEFING; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Masood Y, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0263-5; McGrath L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-341; McLeish J., 2005, BRIT J MIDWIFERY, V13, P782, DOI [DOI 10.12968/BJ0M.2005.13.12.20125, 10.12968/BJOM.2005.13.12.20125, DOI 10.12968/BJOM.2005.13.12.20125]; Megnin-Viggars O, 2015, ARCH WOMEN MENT HLTH, V18, P745, DOI 10.1007/s00737-015-0548-6; Memon A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012337; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; National Institute for Health and Care Excellence (NICE), 2012, METH DEV NICE PUBL H, VThird; NHS England, 2013, REFR EQ DEL SYST NHS; NHS England, 2018, NHS ENGL FUND RES 20; NHS England, 2016, NATL MATERNITY REV B; NHS England, 2013, PUTT PAT 1; NICE, 2014, SICKL CELL DIS MAN A; Noor SZ, 2008, PUBLIC HEALTH NUTR, V11, P486, DOI 10.1017/S1368980007000912; Onozawa K, 2003, ARCH WOMEN MENT HLTH, V6, P551; Parvin A, 2004, FAM PRACT, V21, P254, DOI 10.1093/fampra/cmh307; Patel S, 2013, MIDWIFERY, V29, P682, DOI 10.1016/j.midw.2012.06.012; Pluye P, 2014, ANNU REV PUBL HEALTH, V35, P29, DOI 10.1146/annurev-publhealth-032013-182440; Prady SL, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0805-x; Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005; Redshaw M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1029-9; Robertson E, 2003, PSYCHOL PSYCHOTHER-T, V76, P411, DOI 10.1348/147608303770584755; Sandelowski M, 2007, SOC SCI MED, V64, P236, DOI 10.1016/j.socscimed.2006.08.041; Sandelowski Margarete, 2006, Res Sch, V13, P29; Shakespeare J, 2003, BRIT J GEN PRACT, V53, P614; Shakespeare J, 2006, J REPROD INFANT PSYC, V24, P149, DOI 10.1080/02646830600643866; Slade P, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X532611; Stanley N., 2006, PRIM HEALTH CARE RES, V7, P257, DOI [DOI 10.1191/1463423606PC2950A, 10.1191/1463423606pc295oa, DOI 10.1191/1463423606PC295OA]; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Templeton L, 2003, ETHNIC HEALTH, V8, P207, DOI 10.1080/1355785032000136425; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Turner KM, 2010, PATIENT EDUC COUNS, V78, P234, DOI 10.1016/j.pec.2009.05.022; Wallace S, 2016, AM J PUBLIC HEALTH, V106, P1294, DOI 10.2105/AJPH.2016.303121; WHO Maternal mental health, 2018, WHO MAT MENT HLTH; Williams CJ, 2016, MIDWIFERY, V35, P39, DOI 10.1016/j.midw.2016.01.015; Wittkowski A, 2011, J REPROD INFANT PSYC, V29, P480, DOI 10.1080/02646838.2011.639014	76	43	43	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210587	10.1371/journal.pone.0210587	http://dx.doi.org/10.1371/journal.pone.0210587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695019	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400011
J	Tesso, TA; Zheng, AJ; Cai, HY; Liu, GH				Tesso, Tujuba Ayele; Zheng, Aijuan; Cai, Huiyi; Liu, Guohua			Isolation and characterization of two Acinetobacter species able to degrade 3-methylindole	PLOS ONE			English	Article							INDOLIC COMPOUNDS; RING-CLEAVAGE; SKATOLE; BACTERIA; TEMPERATURE; BIOTRANSFORMATION; BIODEGRADATION; OXIDATION; PATHWAY; CULTURE	3-Methylindole (3MI) or Skatole is a volatile lipophilic organic compound produced by anoxic metabolism of L-tryptophan and associated with animal farming and industrial processing wastes. Pure cultures of bacteria capable of utilizing 3MI were isolated from chicken manure using enrichment culture techniques. The bacteria were identified as Acinetobacter toweneri NTA1-2A and Acinetobacter guillouiae TAT1-6A, based on 16S rDNA gene amplicon sequence data. The optimal temperature and pH for degradation of 3MI were established using single factor experiments. Strain tolerance was assessed over a range of initial concentrations of 3MI, and the effects of initial concentration on subsequent microbial 3MI degradation were also measured. During the degradation experiment, concentrations of 3MI were quantified by reverse-phase high-performance liquid chromatography (HPLC). The strains were capable of degrade initial concentrations of 3MI ranging from 65-200 mg/L. The degradation efficiency was >85% in 6 days for both strains when the initial concentration is less than 200 mg/L. The strains were tested for enzymatic activity using 65 mg/L 3MI. The enzyme extracts of NTA1-2A and TAT1-6A from the 3MI medium degraded 71.46% and 60.71% of 3MI respectively, but no appreciable change in 3MI concentration in the control group was witnessed. Our experiment revealed betaine and choline were identified as 3MI degradation metabolites by both strains while nitroso-pyrrolidine and beta-alaninebetaine formed by NTA1-2A and TAT1-6A strains respectively. The NTA1-2A and TAT1-6A strains removed 84.32% and 81.39% 3MI respectively from chicken manure during fermentation in 8 days and showed a statistically significant difference (P < 0.05) compared with the control group. The optimum temperature and pH were 31 degrees C and 6 respectively, for 3MI degradation by A. toweneri NTA1-2A and A. guillouiae TAT1-6A. We concluded that A. toweneri NTA1-2A and A. guillouiae TAT1-6A are potential strains of interest to degrade 3MI and control odorant in poultry and other livestock industries.	[Tesso, Tujuba Ayele; Zheng, Aijuan; Cai, Huiyi; Liu, Guohua] Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Minist Agr,Key Lab Feed Biotechnol, Beijing, Peoples R China; [Tesso, Tujuba Ayele] Mettu Univ, Fac Nat Sci, Dept Biol, Mettu, Ethiopia	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, GH (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Minist Agr,Key Lab Feed Biotechnol, Beijing, Peoples R China.	liuguohua@caas.cn			Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System	Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System	This study was funded by the Beijing Innovation Team Program for the poultry industry in Chinese Agriculture Research System, awarded to Professor Guohua Liu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON ML, 1991, ADV EXP MED BIOL, V283, P245; Arora PK, 2015, J CHEM-NY, V2015, DOI [10.1155/2015/296231, 10.1155/2015/129159]; ARORA PK, 2015, J CHEM-NY, DOI DOI 10.1155/2015/; Attwood G, 2006, J APPL MICROBIOL, V100, P1261, DOI 10.1111/j.1365-2672.2006.02896.x; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; CARLSON JR, 1972, SCIENCE, V176, P298, DOI 10.1126/science.176.4032.298; Carr BA, 2003, MOL PHARMACOL, V63, P1137, DOI 10.1124/mol.63.5.1137; Carroll NM, 2000, J CLIN MICROBIOL, V38, P1753, DOI 10.1128/JCM.38.5.1753-1757.2000; Deslandes B, 2001, LIVEST PROD SCI, V71, P193, DOI 10.1016/S0301-6226(01)00189-0; Fukuoka K, 2015, BIODEGRADATION, V26, P359, DOI 10.1007/s10532-015-9739-0; Fukuoka K, 2015, INT BIODETER BIODEGR, V97, P13, DOI 10.1016/j.ibiod.2014.11.007; Gu JD, 2002, MAR POLLUT BULL, V45, P379, DOI 10.1016/S0025-326X(02)00091-7; GU JD, 1991, APPL ENVIRON MICROB, V57, P2622, DOI 10.1128/AEM.57.9.2622-2627.1991; GU JD, 1992, APPL ENVIRON MICROB, V58, P2667, DOI 10.1128/AEM.58.8.2667-2669.1992; HAMMOND AC, 1980, VET REC, V107, P344, DOI 10.1136/vr.107.15.344; JENSEN MT, 1995, APPL ENVIRON MICROB, V61, P3180, DOI 10.1128/AEM.61.8.3180-3184.1995; KAMATH AV, 1990, APPL ENVIRON MICROB, V56, P275, DOI 10.1128/AEM.56.1.275-280.1990; Kim MH, 1999, WATER RES, V33, P562, DOI 10.1016/S0043-1354(98)00228-0; Kohda C, 1997, J GEN APPL MICROBIOL, V43, P249, DOI 10.2323/jgam.43.249; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liang C, 2003, BIORESOURCE TECHNOL, V86, P131, DOI 10.1016/S0960-8524(02)00153-0; Liu YJ, 2009, CHEM ECOL, V25, P107, DOI 10.1080/02757540902849278; LUNDSTROM K, 1988, LIVEST PROD SCI, V18, P55, DOI 10.1016/0301-6226(88)90067-X; Madsen EL, 1998, APPL ENVIRON MICROB, V54, P74; Maeng JH, 1996, J BACTERIOL, V178, P3695, DOI 10.1128/jb.178.13.3695-3700.1996; Meng X, 2013, EXP THER MED, V6, P983, DOI 10.3892/etm.2013.1251; Nakai Yutaka, 1999, Animal Science Journal, V70, P32; OCHIAI M, 1986, MUTAT RES, V172, P189, DOI 10.1016/0165-1218(86)90056-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarioglu OF, 2012, INT BIODETER BIODEGR, V71, P67, DOI 10.1016/j.ibiod.2012.04.012; SHANKER R, 1990, MICROBIAL ECOL, V20, P171, DOI 10.1007/BF02543875; Sharma N, 2015, LETT APPL MICROBIOL, V60, P298, DOI 10.1111/lam.12379; Sihag S., 2014, INT J PURE APPL BIOS, V2, P185, DOI DOI 10.1016/S0038-071700219-8; Sundberg C, 2013, WASTE MANAGE, V33, P204, DOI 10.1016/j.wasman.2012.09.017; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tang JC, 2007, J BIOSCI BIOENG, V104, P321, DOI 10.1263/jbb.104.321; Throne-Holst M, 2007, APPL ENVIRON MICROB, V73, P3327, DOI 10.1128/AEM.00064-07; Wang YL, 2005, J BASIC MICROB, V45, P83, DOI 10.1002/jobm.200410446; Whitehead TR, 2008, APPL ENVIRON MICROB, V74, P1950, DOI 10.1128/AEM.02458-07; Yin B, 2006, HUM ECOL RISK ASSESS, V12, P248, DOI 10.1080/10807030500531539; Yin B, 2005, INT BIODETER BIODEGR, V56, P243, DOI 10.1016/j.ibiod.2005.10.001; Yin B, 2006, WATER AIR SOIL POLL, V176, P185, DOI 10.1007/s11270-006-9159-1; YOKOYAMA MT, 1981, APPL ENVIRON MICROB, V41, P71, DOI 10.1128/AEM.41.1.71-76.1981; Yu XQ, 2004, WORLD J MICROB BIOT, V20, P623, DOI 10.1023/B:WIBI.0000043184.30420.20	44	14	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211275	10.1371/journal.pone.0211275	http://dx.doi.org/10.1371/journal.pone.0211275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689668	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800025
J	Ciesielska, S; Bil, P; Gajda, K; Poterala-Hejmo, A; Hudy, D; Rzeszowska-Wolny, J				Ciesielska, Sylwia; Bil, Patryk; Gajda, Karolina; Poterala-Hejmo, Aleksandra; Hudy, Dorota; Rzeszowska-Wolny, Joanna			Cell type-specific differences in redox regulation and proliferation after low UVA doses	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HYDROGEN-PEROXIDE; ROS PRODUCTION; SUPEROXIDE; OXYGEN; PROTEIN; PEROXYNITRITE; ACTIVATION; GROWTH; TETRAHYDROBIOPTERIN	Ultraviolet A (UVA) radiation is harmful for living organisms but in low doses may stimulate cell proliferation. Our aim was to examine the relationships between exposure to different low UVA doses, cellular proliferation, and changes in cellular reactive oxygen species levels. In human colon cancer (HCT116) and melanoma (Me45) cells exposed to UVA doses comparable to environmental, the highest doses (30-50 kJ/m(2)) reduced clonogenic potential but some lower doses (1 and 10 kJ/m(2)) induced proliferation. This effect was cell type and dose specific. In both cell lines the levels of reactive oxygen species and nitric oxide fluctuated with dynamics which were influenced differently by UVA; in Me45 cells decreased proliferation accompanied the changes in the dynamics of H2O2 while in HCT116 cells those of superoxide. Genes coding for proteins engaged in redox systems were expressed differently in each cell line; transcripts for thioredoxin, peroxiredoxin and glutathione peroxidase showed higher expression in HCT116 cells whereas those for glutathione transferases and copper chaperone were more abundant in Me45 cells. We conclude that these two cell types utilize different pathways for regulating their redox status. Many mechanisms engaged in maintaining cellular redox balance have been described. Here we show that the different cellular responses to a stimulus such as a specific dose of UVA may be consequences of the use of different redox control pathways. Assays of superoxide and hydrogen peroxide level changes after exposure to UVA may clarify mechanisms of cellular redox regulation and help in understanding responses to stressing factors.	[Ciesielska, Sylwia; Bil, Patryk; Gajda, Karolina; Poterala-Hejmo, Aleksandra; Hudy, Dorota; Rzeszowska-Wolny, Joanna] Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland	Silesian University of Technology	Rzeszowska-Wolny, J (corresponding author), Silesian Tech Univ, Inst Automat Control, Biosyst Grp, Gliwice, Poland.	joanna.rzeszowska@polsl.pl		Gajda, Karolina/0000-0002-0447-3628; Ciesielska, Sylwia/0000-0002-1051-0632; Rzeszowska-Wolny, Joanna/0000-0002-5804-4757; Hudy, Dorota/0000-0002-9110-2314	Polish National Science Center Grant [2015/19/B/ST7/02984]	Polish National Science Center Grant	This work was supported by the Polish National Science Center Grant #2015/19/B/ST7/02984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; [Anonymous], 2005, IARC WORK GROUP REP, V1; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Bachelor MA, 2004, SEMIN CANCER BIOL, V14, P131, DOI 10.1016/j.semcancer.2003.09.017; Bartesaghi S, 2018, REDOX BIOL, V14, P618, DOI 10.1016/j.redox.2017.09.009; Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benson MA, 2013, J BIOL CHEM, V288, P29836, DOI 10.1074/jbc.M113.493023; Berton TR, 1997, J INVEST DERMATOL, V109, P340, DOI 10.1111/1523-1747.ep12335984; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Bossi O, 2008, J CELL BIOCHEM, V105, P194, DOI 10.1002/jcb.21817; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Burdon RH, 1996, BIOCHEM SOC T, V24, P1028, DOI 10.1042/bst0241028; BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen K, 2010, BRAIN STRUCT FUNCT, V214, P219, DOI 10.1007/s00429-009-0226-4; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Foksinski M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188856; Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Grossman N, 1998, LASER SURG MED, V22, P212, DOI 10.1002/(SICI)1096-9101(1998)22:4<212::AID-LSM5>3.0.CO;2-S; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hatanaka E, 2011, CLIN EXP IMMUNOL, V163, P362, DOI 10.1111/j.1365-2249.2010.04300.x; Hatori Y, 2017, IUBMB LIFE, V69, P246, DOI 10.1002/iub.1620; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; IKEBUCHI Y, 1991, J BIOL CHEM, V266, P13233; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaksik R, 2014, MUTAT RES-GEN TOX EN, V764, P64, DOI 10.1016/j.mrgentox.2013.09.003; JANSSEN YMW, 1993, LAB INVEST, V69, P261; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kannouche P, 1998, CARCINOGENESIS, V19, P781, DOI 10.1093/carcin/19.5.781; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Krzywon A, 2018, J PHOTOCH PHOTOBIO B, V178, P505, DOI 10.1016/j.jphotobiol.2017.12.012; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Liu ZR, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/167425; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Moreira JD, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0005-2; MURRELL GAC, 1990, BIOCHEM J, V265, P659, DOI 10.1042/bj2650659; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Ozumi K, 2012, HYPERTENSION, V60, P476, DOI 10.1161/HYPERTENSIONAHA.111.189571; POU S, 1992, J BIOL CHEM, V267, P24173; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reiner M, 2001, J HISTOCHEM CYTOCHEM, V49, P1605, DOI 10.1177/002215540104901214; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Skonieczna M, 2017, OXIDATIVE MED CELLUL, V2017; Sluyter R, 2000, CARCINOGENESIS, V21, P1801, DOI 10.1093/carcin/21.10.1801; STABERG B, 1983, J INVEST DERMATOL, V81, P517, DOI 10.1111/1523-1747.ep12522855; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; Vasquez-Vivar J, 2000, FEBS LETT, V481, P305, DOI 10.1016/S0014-5793(00)02001-9; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Walbrecq G, 2015, FREE RADICAL BIO MED, V84, P215, DOI 10.1016/j.freeradbiomed.2015.02.032; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; World Health Organization (WHO), 2002, GLOB SOL UV IND; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	74	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0205215	10.1371/journal.pone.0205215	http://dx.doi.org/10.1371/journal.pone.0205215			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682016	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500007
J	Galson, SW; Stanifer, JW; Hertz, JT; Temu, G; Thielman, N; Gafaar, T; Staton, CA				Galson, Sophie W.; Stanifer, John W.; Hertz, Julian T.; Temu, Gloria; Thielman, Nathan; Gafaar, Temitope; Staton, Catherine A.			The burden of hypertension in the emergency department and linkage to care: A prospective cohort study in Tanzania	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; SUB-SAHARAN AFRICA; RISK-FACTORS; PREVALENCE; BARRIERS; DISEASE; INCOME	Objectives Globally, hypertension affects one billion people and disproportionately burdens low-and middle-income countries. Despite the high disease burden in sub-Saharan Africa, optimal care models for diagnosing and treating hypertension have not been established. Emergency departments (EDs) are frequently the first biomedical healthcare contact for many people in the region. ED encounters may offer a unique opportunity for identifying high risk patients and linking them to care. Methods Between July 2017 and March 2018, we conducted a prospective cohort study among patients presenting to a tertiary care ED in northern Tanzania. We recruited adult patients with a triage blood pressure. 140/90 mmHg in order to screen for hypertension. We explored knowledge, attitudes and practices for hypertension using a questionnaire, and assessed factors associated with successful follow-up. Hypertension was defined as a single blood pressure measurement. 160/100 mmHg or a three-time average of. 140/90 mmHg. Uncontrolled hypertension was defined as a three-time average measurement of. 160/100 mmHg. Successful follow-up was defined as seeing an outpatient provider within one month of the ED visit. Results We enrolled 598 adults (mean age 59.6 years), of whom 539 (90.1%) completed the study. The majority (78.6%) of participants were aware of having hypertension. Many (223; 37.2%) had uncontrolled hypertension. Overall, only 236 (43.8%) of participants successfully followed-up within one month. Successful follow-up was associated with a greater understanding that hypertension requires lifelong treatment (RR 1.11; 95% CI 1.03,1.21) and inversely associated with greater anxiety about the future (RR 0.80; 95% CI 0.64,0.99). Conclusion In a northern Tanzanian tertiary care ED, the burden of hypertension is high, with few patients receiving optimal outpatient care follow-up. Multi-disciplinary strategies are needed to improve linkage to care for high-risk patients from ED settings.	[Galson, Sophie W.; Hertz, Julian T.; Staton, Catherine A.] Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA; [Galson, Sophie W.; Stanifer, John W.; Hertz, Julian T.; Thielman, Nathan; Gafaar, Temitope; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Stanifer, John W.] Duke Univ, Dept Med, Div Nephrol, Durham, NC USA; [Temu, Gloria] Kilimanjaro Christian Med Coll Hosp, Dept Med, Kilimanjaro, Tanzania; [Thielman, Nathan] Duke Univ, Dept Med, Durham, NC USA; [Staton, Catherine A.] Dept Neurosurg, Div Global Neurosurg & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Galson, SW (corresponding author), Duke Univ, Dept Surg, Div Emergency Med, Durham, NC 27708 USA.; Galson, SW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.	sophie.galson@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879; Staton, Catherine/0000-0002-6468-2894; Hertz, Julian/0000-0002-7396-4789	Fogarty International Center [K01 TW010000-01A1]; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	CAS would like to acknowledge salary support funding from the Fogarty International Center(Staton, K01 TW010000-01A1, https://www.fic.nih.gov/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ajayi IO, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3789-z; [Anonymous], 2016, ICHF HLTH INS COV 10; Backer HD, 2003, ANN EMERG MED, V41, P507, DOI 10.1067/mem.2003.151; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Bitter CC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019024; BONE LR, 1989, AM J EMERG MED, V7, P16, DOI 10.1016/0735-6757(89)90077-6; Boulware LE, 2001, AM J PREV MED, V21, P221, DOI 10.1016/S0749-3797(01)00356-7; Brody A, 2015, ACAD EMERG MED, V22, P632, DOI 10.1111/acem.12660; CHERNOW SM, 1987, ANN EMERG MED, V16, P180, DOI 10.1016/S0196-0644(87)80012-4; Daniel RM, 2012, STAT METHODS MED RES, V21, P243, DOI 10.1177/0962280210394469; Demographic and Health Surveys, 2013, UN REP TANZ HIV AIDS; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Dieterle T, 2005, AM J EMERG MED, V23, P474, DOI 10.1016/j.ajem.2005.02.046; Dutta A., 2015, PROSPECTS SUSTAINABL; Galson SW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018829; Gleason-Comstock J, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0052-3; Katalambula LK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4679-8; Lee S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191738; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martin Alison, 2002, J Health Serv Res Policy, V7, P160, DOI 10.1258/135581902760082463; McNaughton CD, 2015, AM J CARDIOL, V116, P1717, DOI 10.1016/j.amjcard.2015.09.007; Miller AH, 2005, AM J EMERG MED, V23, P423, DOI 10.1016/j.ajem.2005.01.009; Ministry for health community development gender elderly and children, 2013, STAND TREATM GUID NA; Mosha NR, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1321279; Muhamedhussein MS, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/1281384; Naanyu V, 2016, J GEN INTERN MED, V31, P304, DOI 10.1007/s11606-015-3566-1; Pascasie K, 2014, AFR J EMERG MED, V4, P178, DOI 10.1016/j.afjem.2013.10.001; Pastakia SD, 2017, J GEN INTERN MED, V32, P540, DOI 10.1007/s11606-016-3918-5; Prendergast HM, 2015, PUBLIC HEALTH, V129, P604, DOI 10.1016/j.puhe.2015.02.001; Price AJ, 2018, LANCET DIABETES ENDO, V6, P208, DOI 10.1016/S2213-8587(17)30432-1; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164428; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156336; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121722; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Tan N, 2013, EMERG MED AUSTRALAS, V25, P175, DOI 10.1111/1742-6723.12060; The United Republic of Tanzania, 2013, POPULATION DISTRIBUT; Turin TC, 2013, J AM SOC NEPHROL, V24, P1661, DOI 10.1681/ASN.2012111118; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Vedanthan R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-143; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WHO, 2013, WHO GLOB BRIEF HYP; Xu WX, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h158; Zack RM, 2016, J HYPERTENS, V34, P2353, DOI 10.1097/HJH.0000000000001117	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211287	10.1371/journal.pone.0211287	http://dx.doi.org/10.1371/journal.pone.0211287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682173	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500143
J	Shimamura, H; Nagano, M; Nakajima, K; Toshima, JY; Toshima, J				Shimamura, Hiroki; Nagano, Makoto; Nakajima, Keita; Toshima, Junko Y.; Toshima, Jiro			Rab5-independent activation and function of yeast Rab7-like protein, Ypt7p, in the AP-3 pathway	PLOS ONE			English	Article							SNARE COMPLEX; NUCLEOTIDE EXCHANGE; SORTING PATHWAYS; VACUOLE FUSION; MON1-CCZ1 GEF; RAB GTPASES; LATE GOLGI; TRANSPORT; HOMOLOG; IDENTIFICATION	The small GTPases, Rab5 and Rab7, are key regulators at multiple stages of the endocytic/endolysosomal pathway, including fusion and maturation of endosomes. In yeast, Vps21p (Rab5 homolog) recruits a GEF for Rab7 and activates the downstream Ypt7p (Rab7 homolog) on endosomal membrane. Although the model of this sequential activation from Vps21p to Ypt7p in the endocytic pathway has been established, activation mechanism of Ypt7p in the Vps21p-independent pathway has not been completely clarified. Here we show that Ypt7p is activated and mediates vacuolar fusion in cells lacking all yeast Rab5 genes, VPS21, YPT52, and YPT53. We also demonstrate that deletion of both VPS21 and YPT7 genes cause severe defect in the AP-3 pathway as well as the CPY pathway although the AP-3 pathway is mostly intact in each vps21 Delta or ypt7 Delta mutant. Interestingly, in vps21 Delta ypt7 Delta mutant cargos trafficked via the VPS or endocytic pathway accumulate beside nucleus whereas cargo trafficked via the AP-3 pathway disperse in the cytosol. These findings suggest that Ypt7p is activated and plays a Rab5-independent role in the AP-3-mediated pathway.	[Shimamura, Hiroki; Nagano, Makoto; Nakajima, Keita; Toshima, Jiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo, Japan; [Toshima, Junko Y.] Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo, Japan	Tokyo University of Science; Tokyo University of Technology	Toshima, J (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo, Japan.; Toshima, JY (corresponding author), Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo, Japan.	toshimajk@stf.teu.ac.jp; jtosiscb@rs.noda.tus.ac.jp	純子, 十島 Y/GRS-7321-2022; Nagano, Makoto/J-7050-2015	Nagano, Makoto/0000-0002-1948-1591	JSPS KAKENHI [26440067, 16K07303]; Takeda Science Foundation; Novartis Foundation (Japan); Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation (Japan)(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by JSPS KAKENHI GRANT #26440067, the Takeda Science Foundation, the Novartis Foundation (Japan) to JYT and JSPS KAKENHI GRANT #16K07303, the Uehara Memorial Foundation and the Takeda Science Foundation to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Balderhaar HJK, 2010, J CELL SCI, V123, P4085, DOI 10.1242/jcs.071977; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burd CG, 1998, SEMIN CELL DEV BIOL, V9, P527, DOI 10.1006/scdb.1998.0255; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; Cabrera M, 2013, J BIOL CHEM, V288, P28704, DOI 10.1074/jbc.M113.488213; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kucharczyk R, 2000, J CELL SCI, V113, P4301; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Lawrence G, 2014, MOL BIOL CELL, V25, P1608, DOI 10.1091/mbc.E13-08-0460; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Rana M, 2015, MOL BIOL CELL, V26, P2535, DOI 10.1091/mbc.E15-02-0062; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Toshima JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4498; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210223	10.1371/journal.pone.0210223	http://dx.doi.org/10.1371/journal.pone.0210223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682048	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500029
J	Valenca-Barbosa, C; do Bomfim, TCB; Teixeira, BR; Gentile, R; Neto, SFD; Magalhaes, BSN; Balthazar, DD; da Silva, FA; Biot, R; Levy, CMD; Santos, HLC				Valenca-Barbosa, Carolina; Bergamo do Bomfim, Teresa Cristina; Teixeira, Bernardo Rodrigues; Gentile, Rosana; da Costa Neto, Socrates Fraga; Neil Magalhaes, Barbara Souza; Balthazar, Daniel de Almeida; da Silva, Fabio Alves; Biot, Renata; d'Avila Levy, Claudia Masini; Carneiro Santos, Helena Lucia			Molecular epidemiology of Blastocystis isolated from animals in the state of Rio de Janeiro, Brazil	PLOS ONE			English	Article							GENETIC DIVERSITY; ZOO ANIMALS; SCHISTOSOMA-MANSONI; HUMANS; IDENTIFICATION; SUBTYPES; HOMINIS; REGION; PCR; PHYLOGENIES	The enteric protist Blastocystis is one of the most frequently reported parasites infecting both humans and many other animal hosts worldwide. A remarkable genetic diversity has been observed in the species, with 17 different subtypes (STs) on a molecular phylogeny based on small subunit RNA genes (SSU rDNA). Nonetheless, information regarding its distribution, diversity and zoonotic potential remains still scarce, especially in groups other than primates. In Brazil, only a few surveys limited to human isolates have so far been conducted on Blastocystis STs. The aim of this study is to determine the occurrence of Blastocystis subtypes in non-human vertebrate and invertebrate animal groups in different areas of the state of Rio de Janeiro, Brazil. A total of 334 stool samples were collected from animals representing 28 different genera. Blastocystis cultivated samples were subtyped using nuclear small subunit ribosomal DNA (SSU rDNA) sequencing. Phylogenetic analyses and BLAST searches revealed six subtypes: ST5 (28.8%), ST2 (21.1%), ST1 and ST8 (19.2%), ST3 (7.7%) and ST4 (3.8%). Our findings indicate a considerable overlap between STs in humans and other animals. This highlights the importance of investigating a range of hosts for Blastocystis to understand the eco-epidemiological aspects of the parasite and its host specificity.	[Valenca-Barbosa, Carolina; d'Avila Levy, Claudia Masini; Carneiro Santos, Helena Lucia] Fiocruz MS, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, RJ, Brazil; [Bergamo do Bomfim, Teresa Cristina] Univ Rural Rio de Janeiro, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Teixeira, Bernardo Rodrigues; Gentile, Rosana; da Costa Neto, Socrates Fraga] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil; [Neil Magalhaes, Barbara Souza; Balthazar, Daniel de Almeida] Fundacao Jardim Zool Cidade Rio de Janeiro, Parque Quinta da Boa Vista, Rio De Janeiro, Brazil; [da Silva, Fabio Alves] Fiocruz MS, Inst Ciencia & Tecnol Biomodelos, Rio De Janeiro, Brazil; [Biot, Renata] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Patol, Lab Parasitol, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Santos, HLC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, RJ, Brazil.	helenalucias@ioc.fiocruz.br	Teixeira, Bernardo R/D-7664-2013; Gentile, Rosana/C-3101-2013; santos, Helena/AAA-5514-2020; d'Avila-Levy, Claudia M/O-7192-2014	Teixeira, Bernardo R/0000-0001-9013-9492; Gentile, Rosana/0000-0001-9160-1204; Valenca-Barbosa, Carolina/0000-0001-9579-8710; Santos, Helena/0000-0002-5240-5662; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.779/2015-FAPERJ]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [407768/2012-2 CNPq]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (No E-26/202.779/2015-FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (No 407768/2012-2 CNPq).	Abe N, 2002, VET PARASITOL, V106, P203, DOI 10.1016/S0304-4017(02)00050-X; Alfellani MA, 2013, PROTIST, V164, P497, DOI 10.1016/j.protis.2013.05.003; Arisue N, 2002, J EUKARYOT MICROBIOL, V49, P42, DOI 10.1111/j.1550-7408.2002.tb00339.x; Balint A, 2014, PARASITOL RES, V113, P1585, DOI 10.1007/s00436-014-3805-0; Barbosa CV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193860; Barbosa CV, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2458-0; Betts E. L., 2018, PARASITOLOGY, P1; Caceres NC, 2004, MAMM BIOL, V69, P430, DOI 10.1078/1616-5047-00165; Santos HLC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-207; Cian A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169659; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; D'Andrea PS, 2000, PARASITOLOGY, V120, P573, DOI 10.1017/S0031182099005892; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Ramirez JD, 2016, INFECT GENET EVOL, V41, P32, DOI 10.1016/j.meegid.2016.03.017; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; Eisenberg FJ, 1999, MAMMALS NEOTROPICS, V3, P624; Fayer R, 2012, PARASITOL RES, V111, P1349, DOI 10.1007/s00436-012-2971-1; Forsell J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1637-8; Freitas Simone R., 1997, Revista Brasileira de Biologia, V57, P93; GARDNER A. L., 2007, MARSUPIALS XENARTHRA, VI, p[xx, 669]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haziqah MTF, 2017, TROP BIOMED, V34, P741; Hoevers JD, 2005, PARASITOLOGY, V131, P187, DOI 10.1017/S0031182005007596; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Maldonado A, 2006, J HELMINTHOL, V80, P369, DOI 10.1017/JOH2006366; Malheiros AF, 2011, AM J TROP MED HYG, V85, P1050, DOI 10.4269/ajtmh.2011.11-0481; Mattiucci S, 2016, EPIDEMIOL INFECT, V144, P635, DOI 10.1017/S0950268815001697; Melo G. B., 2017, Parasitology Open, V3, pe3, DOI 10.1017/pao.2017.3; Meloni D, 2012, PARASITOL INT, V61, P719, DOI 10.1016/j.parint.2012.05.012; Mohamed AM, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0131-z; Nagel R, 2012, INTERN MED J, V42, P1187, DOI 10.1111/j.1445-5994.2011.02626.x; Navarro C, 2008, VET PARASITOL, V153, P347, DOI 10.1016/j.vetpar.2008.02.003; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Oliveira-Arbex AP, 2018, INFECT GENET EVOL, V57, P59, DOI 10.1016/j.meegid.2017.11.005; Paglia A.P., 2012, ARLINGTON CONSERVATI, V6, P76; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Roberts T, 2013, EUR J CLIN MICROBIOL, V32, P335, DOI 10.1007/s10096-012-1746-z; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Santori RT, 1995, MAMMALIA, V59, P511, DOI 10.1515/mamm.1995.59.4.511; Silberman JD, 1996, NATURE, V380, P398, DOI 10.1038/380398a0; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Song JK, 2017, ACTA TROP, V176, P277, DOI 10.1016/j.actatropica.2017.08.028; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2009, INT J PARASITOL, V39, P473, DOI 10.1016/j.ijpara.2008.07.006; Stensvold CR, 2013, J CLIN MICROBIOL, V51, P190, DOI 10.1128/JCM.02541-12; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tan KSW, 2004, VET PARASITOL, V126, P121, DOI 10.1016/j.vetpar.2004.09.017; Thathaisong U, 2003, J CLIN MICROBIOL, V41, P967, DOI 10.1128/JCM.41.3.967-975.2003; Vaisusuk K, 2018, ACTA TROP, V184, P78, DOI 10.1016/j.actatropica.2017.09.002; Villanueva-Garcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169637; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Yan Y, 2007, PARASITOL RES, V101, P1527, DOI 10.1007/s00436-007-0672-y; Yoshikawa H, 2004, PARASITOL RES, V94, P391, DOI 10.1007/s00436-004-1230-5; Yoshikawa H, 2004, MICROBIOL-SGM, V150, P1147, DOI 10.1099/mic.0.26899-0; Yoshikawa H, 2000, J CLIN MICROBIOL, V38, P1324, DOI 10.1128/JCM.38.4.1324-1330.2000; Yoshikawa H, 2007, J EUKARYOT MICROBIOL, V54, P33, DOI 10.1111/j.1550-7408.2006.00141.x; Yoshikawa H, 2016, PARASITOL INT, V65, P750, DOI 10.1016/j.parint.2016.04.004; Yoshikawa H, 2009, VET PARASITOL, V160, P295, DOI 10.1016/j.vetpar.2008.11.029; Zanzani SA, 2016, PARASITOL RES, V115, P307, DOI 10.1007/s00436-015-4748-9	69	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210740	10.1371/journal.pone.0210740	http://dx.doi.org/10.1371/journal.pone.0210740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682075	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500058
J	Melis, M; Tang, XH; Trasino, SE; Patel, VM; Stummer, DJ; Jessurun, J; Gudas, LJ				Melis, Marta; Tang, Xiao-Han; Trasino, Steven E.; Patel, Viral M.; Stummer, Daniel J.; Jessurun, Jose; Gudas, Lorraine J.			Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease	PLOS ONE			English	Article							SYNTHETIC RETINOID AM80; HEPATIC STELLATE CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-I; VITAMIN-A; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; ACID TREATMENT; MESSENGER-RNA; RECEPTORS	The roles of retinoids in nonalcoholic fatty liver disease (NAFLD) remain unclear and a better understanding may lead to therapies that prevent or limit NAFLD progression. We examined the actions of retinoic acid receptor (RAR) agonists- AM80 for RAR alpha and AC261066 for RAR beta 2- in a murine model of NAFLD. We fed wild type C57Bl/6 mice a chow or a 45% high fat diet (HFD) for 12 weeks, followed by 4 additional weeks with the HFD+AM80; HFD+AC261066; or HFD. The HFD+AM80 group showed greater hyperglycemia and glucose intolerance compared to other groups. Histopathological evaluation of the livers showed the highest degree of steatosis, triglycerides levels, and inflammation, assessed by F4/80 staining, in the HFD+AM80-treated compared to the HFD, the HFD+AC261066, and chow-fed mice. Liver vitamin A (retinol (ROL)) and retinyl palmitate levels were markedly lower in all HFD groups compared to chow-fed controls. HFD+AC261066-treated mice showed higher levels of a key intracellular ROL transporter, retinol-binding protein-1 (RBP1) compared to the HFD and HFD+AM80 groups. In conclusion, these data demonstrate that the selective RARa agonist AM80 exacerbates HFD-induced NAFLD and hyperglycemia. These findings should inform future studies examining the therapeutic potential of RAR agonists in HFD-related disorders.	[Melis, Marta; Tang, Xiao-Han; Trasino, Steven E.; Patel, Viral M.; Stummer, Daniel J.; Gudas, Lorraine J.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Trasino, Steven E.] CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10021 USA; [Jessurun, Jose] Weill Cornell Med, Dept Pathol, New York, NY USA; [Gudas, Lorraine J.] Weill Cornell Grad Sch Biomed Sci, New York, NY 10065 USA	Cornell University; City University of New York (CUNY) System; Hunter College (CUNY); Cornell University	Gudas, LJ (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.; Gudas, LJ (corresponding author), Weill Cornell Grad Sch Biomed Sci, New York, NY 10065 USA.	ljgudas@med.cornell.edu	TANG, XIAOHAN/AAX-1972-2020		Weill Cornell funds; NIH [R01 CA043796, R01 DK113088]; NCI [T32 CA062948]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113088] Funding Source: NIH RePORTER	Weill Cornell funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Weill Cornell funds and by NIH R01 CA043796 and R01 DK113088 to LJG. SET was supported by NCI T32 CA062948 for a portion of this research. MM was supported by NCI T32 CA062948 for a portion of this research.	Amengual J, 2008, OBESITY, V16, P585, DOI 10.1038/oby.2007.104; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Ashla AA, 2010, HEPATOL RES, V40, P594, DOI 10.1111/j.1872-034X.2010.00646.x; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bhatt HB, 2015, HEPATOL SURG NUTR, V4, P101, DOI 10.3978/j.issn.2304-3881.2015.01.03; BLANER WS, 1985, J LIPID RES, V26, P1241; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291; Faria TN, 1999, J BIOL CHEM, V274, P26783, DOI 10.1074/jbc.274.38.26783; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Green AC, 2016, J STEROID BIOCHEM, V155, P135, DOI 10.1016/j.jsbmb.2015.09.036; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; KATO S, 1992, BIOCHEM J, V286, P755, DOI 10.1042/bj2860755; Kawahara K, 2009, BIOL PHARM BULL, V32, P1307, DOI 10.1248/bpb.32.1307; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Keino H, 2011, INVEST OPHTH VIS SCI, V52, P1548, DOI 10.1167/iovs.10-5963; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Laursen KB, 2013, NUCLEIC ACIDS RES, V41, P6430, DOI 10.1093/nar/gkt367; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Lepreux S, 2004, J HEPATOL, V40, P774, DOI 10.1016/j.jhep.2004.01.008; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Lund BW, 2005, J MED CHEM, V48, P7517, DOI 10.1021/jm050891r; Lutz SZ, 2011, DIABETES, V60, P1566, DOI 10.2337/db10-0760; Mahady SE, 2012, CLIN LIVER DIS, V16, P631, DOI 10.1016/j.cld.2012.05.003; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Mcilroy GD, 2013, DIABETES, V62, P825, DOI 10.2337/db12-0458; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Miwako I, 2009, BIOL PHARM BULL, V32, P157, DOI 10.1248/bpb.32.157; Morohoshi K, 2011, CELL IMMUNOL, V270, P1, DOI 10.1016/j.cellimm.2011.05.005; Nagatsuma K, 2014, LIVER INT, V34, P243, DOI 10.1111/liv.12255; Napoli JL, 2017, PHARMACOL THERAPEUT, V173, P19, DOI 10.1016/j.pharmthera.2017.01.004; Naskar D, 2017, J IMMUNOL, V198, P1855, DOI 10.4049/jimmunol.1601776; Bono MR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060349; Saeed A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010029; Schneider SM, 2000, CANCER RES, V60, P5479; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Tacke R, 2009, CHEMMEDCHEM, V4, P1797, DOI 10.1002/cmdc.200900257; Takeshita A, 1996, ANN INTERN MED, V124, P893, DOI 10.7326/0003-4819-124-10-199605150-00006; Takeuchi M, 1998, LEUKEMIA LYMPHOMA, V31, P441, DOI 10.3109/10428199809057604; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Trasino SE, 2016, J MOL MED, V94, P1143, DOI 10.1007/s00109-016-1434-z; Trasino Steven E, 2015, Diabetes Manag (Lond), V5, P359; Trasino SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15893; Trasino SE, 2015, J BIOL CHEM, V290, P1456, DOI 10.1074/jbc.M114.616763; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Tsuchiya H, 2012, HEPATOLOGY, V56, P1319, DOI 10.1002/hep.25798; Van Rossen E, 2009, HISTOCHEM CELL BIOL, V131, P313, DOI 10.1007/s00418-008-0544-2; Villarroya F, 2004, CURR MED CHEM, V11, P795, DOI 10.2174/0929867043455747; Yun JW, 2009, LIVER INT, V29, P525, DOI 10.1111/j.1478-3231.2008.01920.x; ZOLFAGHARI R, 1995, ARCH BIOCHEM BIOPHYS, V323, P258, DOI 10.1006/abbi.1995.9966	69	7	8	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211071	10.1371/journal.pone.0211071	http://dx.doi.org/10.1371/journal.pone.0211071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677086	Green Published, gold			2022-12-27	WOS:000456700400046
J	van Maaren, MC; Kneepkens, RF; Verbaan, J; Huijgens, PC; Lemmens, VEPP; Verhoeven, RHA; Siesling, S				van Maaren, Marissa C.; Kneepkens, Robert F.; Verbaan, Joke; Huijgens, Peter C.; Lemmens, Valery E. P. P.; Verhoeven, Rob H. A.; Siesling, Sabine			A conditional model predicting the 10-year annual extra mortality risk compared to the general population: A large population-based study in Dutch breast cancer patients	PLOS ONE			English	Article							SURVIVAL; SURVIVORSHIP; CARE; NETHERLANDS; COMORBIDITY; STATISTICS; IMPACT; DEATH; WOMEN; WORK	Objective Many cancer survivors are facing difficulties in getting a life insurance; raised premiums and declinatures are common. We generated a prediction model estimating the conditional extra mortality risk of breast cancer patients in the Netherlands. This model can be used by life insurers to accurately estimate the additional risk of an individual patient, conditional on the years survived. Methodology All women diagnosed with stage I-III breast cancer in 2005-2006, treated with surgery, were selected from the Netherlands Cancer Registry. For all stages separately, multivariable logistic regression was used to estimate annual mortality risks, conditional on the years survived, until 10 years after diagnosis, resulting in 30 models. The conditional extra mortality risk was calculated by subtracting mortality rates of the general Dutch population from the patient mortality rates, matched by age, gender and year. The final model was internally and externally validated, and tested by life insurers. Results We included 23,234 patients: 10,101 stage I, 9,868 stage II and 3,265 stage III. The final models included age, tumor stage, nodal stage, lateralization, location within the breast, grade, multifocality, hormonal receptor status, HER2 status, type of surgery, axillary lymph node dissection, radiotherapy, (neo)adjuvant systemic therapy and targeted therapy. All models showed good calibration and discrimination. Testing of the model by life insurers showed that insurability using the newly-developed model increased with 13%, ranging from 0%-24% among subgroups. Conclusion The final model provides accurate conditional extra mortality risks of breast cancer patients, which can be used by life insurers to make more reliable calculations. The model is expected to increase breast cancer patients' insurability and transparency among life insurers.	[van Maaren, Marissa C.; Huijgens, Peter C.; Lemmens, Valery E. P. P.; Verhoeven, Rob H. A.; Siesling, Sabine] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands; [van Maaren, Marissa C.; Siesling, Sabine] Univ Twente, Dept Hlth Technol & Serv Res, Fac Behav Management & Social Sci, Tech Med Ctr, Enschede, Netherlands; [Kneepkens, Robert F.] Achmea Pens & Life, Tilburg, Netherlands; [Verbaan, Joke] De Hoop Life Reinsurance, The Hague, Netherlands; [Lemmens, Valery E. P. P.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	University of Twente; Erasmus University Rotterdam; Erasmus MC	van Maaren, MC (corresponding author), Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands.; van Maaren, MC (corresponding author), Univ Twente, Dept Hlth Technol & Serv Res, Fac Behav Management & Social Sci, Tech Med Ctr, Enschede, Netherlands.	m.vanmaaren@iknl.nl	Verhoeven, Rob/E-3009-2016; van Maaren, Marissa/N-3656-2018	Verhoeven, Rob/0000-0001-9678-1611; van Maaren, Marissa/0000-0002-5708-2559	Dutch Association for Insurers; Achmea Pension Life; De Hoop Life Reinsurance	Dutch Association for Insurers; Achmea Pension Life; De Hoop Life Reinsurance	This project was conducted at request of the Dutch Association for Insurers and the Dutch Federation of Cancer Patient Organisations (NFK). The project is partly funded by an unrestricted grant of the Dutch Association for Insurers. In addition, Marissa van Maaren received an award of 1000 euro at the International Committee of Insurance Medicine (ICLAM) congress to be spent on this research. Two of the co-authors have a commercial affiliation. R.F. Kneepkens is working for the Division Pension & Life at Achmea (insurance company) as chief medical officer and epidemiologist. J. Verbaan works as actuary/operational manager at De Hoop life reinsurance. Achmea Pension & Life and De Hoop Life Reinsurance provided support in the form of salaries for authors R.F. Kneepkens and J. Verbaan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amir Z, 2009, OCCUP MED-OXFORD, V59, P390, DOI 10.1093/occmed/kqn150; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Baade PD, 2011, MED J AUSTRALIA, V194, P73, DOI 10.5694/j.1326-5377.2011.tb04171.x; dos Reis FJC, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0852-3; Carbognin L, 2016, BREAST, V29, P24, DOI 10.1016/j.breast.2016.06.021; Chen LL, 2009, CANCER-AM CANCER SOC, V115, P5071, DOI 10.1002/cncr.24565; Ellison Larry F, 2011, Health Rep, V22, P21; Engelhardt EG, 2014, J CLIN ONCOL, V32, P238, DOI 10.1200/JCO.2013.50.3417; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; HENSON DE, 1995, CANCER-AM CANCER SOC, V76, P237, DOI 10.1002/1097-0142(19950715)76:2<237::AID-CNCR2820760213>3.0.CO;2-J; Islam T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S8; Janssen-Heijnen MLG, 2014, ANN ONCOL, V25, P64, DOI 10.1093/annonc/mdt424; Janssen-Heijnen MLG, 2007, EUR J CANCER, V43, P2179, DOI 10.1016/j.ejca.2007.06.008; Janssen-Heijnen MLG, 2010, J CLIN ONCOL, V28, P2520, DOI 10.1200/JCO.2009.25.9697; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Kyriakides S, 2015, BREAST, V24, pS163, DOI 10.1016/j.breast.2015.07.038; Li SR, 2017, CANCER MED-US, V6, P2586, DOI 10.1002/cam4.1224; Mazouni C, 2011, J SURG ONCOL, V103, P746, DOI 10.1002/jso.21712; Merrill RM, 2010, ONCOLOGIST, V15, P873, DOI 10.1634/theoncologist.2009-0211; Miao H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2841-9; Mols F, 2012, EUR J CANCER, V48, P2037, DOI 10.1016/j.ejca.2011.11.030; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pryce J, 2007, J OCCUP REHABIL, V17, P83, DOI 10.1007/s10926-006-9040-5; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sobin LH WC, 2002, TM CLASSIFICATION OF; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; van der Waal D, 2015, EUR J PUBLIC HEALTH, V25, P320, DOI 10.1093/eurpub/cku088; Vulto AJCM, 2006, CANCER-AM CANCER SOC, V106, P2734, DOI 10.1002/cncr.21934; Wang SJ, 2007, GASTRIC CANCER, V10, P153, DOI 10.1007/s10120-007-0424-9; Wangchinda P, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0988-0; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210887	10.1371/journal.pone.0210887	http://dx.doi.org/10.1371/journal.pone.0210887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677053	Green Published, gold			2022-12-27	WOS:000456700400032
J	Nishimura, T; Takami, T; Sasaki, R; Aibe, Y; Matsuda, T; Fujisawa, K; Matsumoto, T; Yamamoto, N; Tani, K; Taura, Y; Sakaida, I				Nishimura, Tatsuro; Takami, Taro; Sasaki, Ryo; Aibe, Yuki; Matsuda, Takashi; Fujisawa, Koichi; Matsumoto, Toshihiko; Yamamoto, Naoki; Tani, Kenji; Taura, Yasuho; Sakaida, Isao			Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CIRRHOSIS; TRANSPLANTATION; DELIVERY; MIGRATION; MICE	Background We previously reported regenerative therapies for decompensated cirrhosis based on peripheral venous drip infusion using non-cultured whole bone marrow (BM) cells, or the less invasive cultured BM-derived mesenchymal stem cells (BMSCs). Here, we assessed the efficacy and safety of hepatic arterial infusion using cultured autologous BMSCs, comparing it with peripheral infusion, using our established canine liver fibrosis model. Methods Canine BM cells were harvested and cultured, and the resultant BMSCs were returned to carbon tetrachloride (CCl4)-induced liver cirrhosis model canines via either a peripheral vein (Vein group) or hepatic artery (Artery group). A variety of assays were performed before and 4, 8, and 12 weeks after BMSC infusion, and liver fibrosis and indocyanine green (ICG) half-life (t(1/2)) were compared to those in a control group that received CCI4 but not BMSCs. The safety of this approach was evaluated by contrast-enhanced computed tomography (CT) and serial blood examinations after infusion. Results Four weeks after infusing BMSCs, a significant improvement was observed in the Vein group (n = 8) compared to outcome in the Control group (n = 10), along with a decrease in ICG t(1/2). In the Artery group (n = 4), ICG t(1/2) was significantly shorter than that in the Vein group at 8 weeks (Delta t(1/2):-3.8 +/- 1.7 min vs. +0.4 +/- 2.4 min; p < 0.01) and 12 weeks (Delta t(1/2): -4.2 +/- 1.7 min vs. +0.4 +/- 2.7 min; p < 0.01) after BMSC administration. Post-infusion contrast-enhanced CT showed no liver infarction, and blood tests showed no elevations in either serum lactate dehydrogenase concentrations or hypercoagulability. Conclusions We confirmed the efficacy and safety of the hepatic arterial infusion of cultured autologous BMSCs using a canine model, thereby providing non-clinical proof-of-concept.	[Nishimura, Tatsuro; Takami, Taro; Sasaki, Ryo; Aibe, Yuki; Matsuda, Takashi; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan; [Takami, Taro; Sakaida, Isao] Yamaguchi Univ, Ctr Regenerat & Cell Therapy, Org Res Initiat, Ube, Yamaguchi, Japan; [Fujisawa, Koichi; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Ctr Reparat Med, Ube, Yamaguchi, Japan; [Matsumoto, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi, Japan; [Yamamoto, Naoki] Yamaguchi Univ, Hlth Adm Ctr, Yamaguchi, Yamaguchi, Japan; [Tani, Kenji; Taura, Yasuho] Joint Fac Vet Med, Dept Vet Surg, Yamaguchi, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Yamaguchi University; Yamaguchi University	Takami, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi, Japan.; Takami, T (corresponding author), Yamaguchi Univ, Ctr Regenerat & Cell Therapy, Org Res Initiat, Ube, Yamaguchi, Japan.	t-takami@yamaguchi-u.ac.jp	fujisawa, koichi/AAC-1392-2022		Japanese Highway Program for the Realization of Regenerative Medicine, Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science JSPS KAKENHI [JP17H04162]	Japanese Highway Program for the Realization of Regenerative Medicine, Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The development of this model was supported by the Japanese Highway Program for the Realization of Regenerative Medicine by the Japan Science and Technology Agency (JST) and the Japan Agency for Medical Research and Development (AMED). The Project of Promotion for The Research and Development (R&D) Center on Regenerative Medicine in Yamaguchi Prefecture. Japan Society for the Promotion of Science JSPS KAKENHI Grant Numbers JP17H04162.	Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; BOOTHE DM, 1992, AM J VET RES, V53, P382; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gholamrezanezhad A, 2011, NUCL MED BIOL, V38, P961, DOI 10.1016/j.nucmedbio.2011.03.008; Hardjo M, 2009, CELL TRANSPLANT, V18, P89, DOI 10.3727/096368909788237140; Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1; Kanemoto H, 2011, VET PATHOL, V48, P839, DOI 10.1177/0300985810388523; Kim G, 2015, GUT LIVER, V9, P701, DOI 10.5009/gnl14451; Maeda M, 2012, J GASTROEN HEPATOL, V27, P104, DOI 10.1111/j.1440-1746.2011.07016.x; Makela T, 2015, CYTOTHERAPY, V17, P392, DOI 10.1016/j.jcyt.2014.12.004; Matsuda T, 2017, HEPATOL COMMUN, V1, P691, DOI 10.1002/hep4.1071; Nagaishi K, 2014, HEPATOLOGY, V59, P1816, DOI 10.1002/hep.26975; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Nanashima A, 2004, HEPATOL RES, V28, P184, DOI 10.1016/j.hepres.2003.11.010; Oishi Y, 2015, J VET MED SCI, V77, P925, DOI 10.1292/jvms.14-0469; Quintanilha LF, 2014, HEPATOL RES, V44, pE206, DOI 10.1111/hepr.12204; Shin TH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.442; Singal AK, 2011, WORLD J HEPATOL, V3, P215, DOI 10.4254/wjh.v3.i8.215; Suk KT, 2016, HEPATOLOGY, V64, P2185, DOI 10.1002/hep.28693; Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Terai S, 2011, J HEPATO-BIL-PAN SCI, V18, P23, DOI 10.1007/s00534-010-0305-1; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang Y, 2009, TRANSPL P, V41, P4352, DOI 10.1016/j.transproceed.2009.08.072	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210588	10.1371/journal.pone.0210588	http://dx.doi.org/10.1371/journal.pone.0210588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673721	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800047
J	Noguchi, K; Tomita, H; Kanayama, T; Niwa, A; Hatano, Y; Hoshi, M; Sugie, S; Okada, H; Niwa, M; Hara, A				Noguchi, Kei; Tomita, Hiroyuki; Kanayama, Tomohiro; Niwa, Ayumi; Hatano, Yuichiro; Hoshi, Masato; Sugie, Shigeyuki; Okada, Hideshi; Niwa, Masayuki; Hara, Akira			Time-course analysis of cardiac and serum galectin-3 in viral myocarditis after an encephalomyocarditis virus inoculation	PLOS ONE			English	Article							HEART-FAILURE; BINDING PROTEIN; FIBROSIS; EXPRESSION; INFLAMMATION; ASSOCIATION; MACROPHAGES; DYSFUNCTION; MARKER; MAC-2	Galectin-3 is a P-galactoside-binding lectin which is important in cell proliferation and apoptotic regulation. Recently, serum galectin-3 has been shown to have prognostic value as a biomarker in heart failure. Encephalomyocarditis virus (EMCV) can cause severe myocarditis, congestive heart failure and dilated cardiomyopathy as well as encephalitis in various animals including mice. The pathophysiological role of galectin-3 in acute myocarditis following viral infection is not fully understood. The goal of this study is to determine the cardiac localization and the time-course of galectin-3 expression in heart failure after viral inoculation with EMCV. At 12, 24, 48, 96 hours, 7 and 10 days after intraperitoneal EMCV inoculation, animals were examined histologically and analyzed for the expression of galectin-3 and lba1. Galectin-3 was up-regulated in degenerated fibrotic lesions of cardiac tissues 96 hours after viral inoculation and were followed by myocardial fibrosis. At the same time, lba1 positive macrophages were observed within the inflammatory sites. A time-course correlation between the number of galectin-3 positive cells and the cardiac area of degenerated fibrotic lesions was detected serum galectin-3 increased at 96 hours and correlated well with the number of cardiac galectin-3 positive cells. Our results indicate that galectin-3 expression may be a useful biomarker of cardiac fibrotic degeneration in acute myocarditis following viral infection. In addition, measuring serum galectin-3 levels might be an early diagnostic method for detecting cardiac degeneration in acute myocarditis.	[Noguchi, Kei; Tomita, Hiroyuki; Kanayama, Tomohiro; Niwa, Ayumi; Hatano, Yuichiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Hoshi, Masato] Fujita Hlth Univ, Grad Sch Hlth Sci, Dept Biochem & Analyt Sci, Toyoake, Aichi, Japan; [Sugie, Shigeyuki] Asahi Univ, Murakami Mem Hosp, Dept Pathol, Gifu, Japan; [Okada, Hideshi] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Niwa, Masayuki] Gifu Univ, Div Med Sci, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Fujita Health University; Asahi University; Gifu University; Gifu University	Tomita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan.	h_tomita@gifu-u.ac.jp	Tomita, Hiroyuki/L-5571-2019; Hatano, Yuichiro/K-7454-2013	Tomita, Hiroyuki/0000-0002-3291-0274; Hatano, Yuichiro/0000-0002-5121-6325; Okada, Hideshi/0000-0002-7775-4308	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K11289, 24590911]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Number: 15K11289 and 24590911) (A.H. and H.T.).	[Anonymous], 2015, EUR J HEART FAIL, V17, p[764, 985], DOI [10.1016/j.jacc.2012.04.053, DOI 10.1016/J.JACC.2012.04.053]; Besler C, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003804; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; de Boer RA, 2012, J INTERN MED, V272, P55, DOI 10.1111/j.1365-2796.2011.02476.x; Souza BSD, 2017, AM J PATHOL, V187, P1134, DOI 10.1016/j.ajpath.2017.01.016; Diaz-Alvarez L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9247574; Edelmann F, 2015, EUR J HEART FAIL, V17, P214, DOI 10.1002/ejhf.203; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Hrynchyshyn N, 2013, ARCH CARDIOVASC DIS, V106, P541, DOI 10.1016/j.acvd.2013.06.054; HUGHES RC, 1994, GLYCOBIOLOGY, V4, P5, DOI 10.1093/glycob/4.1.5; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ishibashi-Ueda H, 2017, CIRC J, V81, P417, DOI 10.1253/circj.CJ-16-0927; de Giusti CJ, 2015, J MOL CELL CARDIOL, V85, P58, DOI 10.1016/j.yjmcc.2015.05.010; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kobayashi K, 2015, NEUROSCI LETT, V592, P107, DOI 10.1016/j.neulet.2015.02.061; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Liu YH, 2009, AM J PHYSIOL-HEART C, V296, pH404, DOI 10.1152/ajpheart.00747.2008; Lopez B, 2015, J AM COLL CARDIOL, V65, P2449, DOI 10.1016/j.jacc.2015.04.026; Lopez-Andres N, 2012, EUR J HEART FAIL, V14, P74, DOI 10.1093/eurjhf/hfr151; MATSUMORI A, 1993, CLIN IMMUNOL IMMUNOP, V68, P215, DOI 10.1006/clin.1993.1121; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Sundblad V, 2011, HISTOL HISTOPATHOL, V26, P247, DOI 10.14670/HH-26.247; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061	31	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210971	10.1371/journal.pone.0210971	http://dx.doi.org/10.1371/journal.pone.0210971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673749	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800059
J	Medina-Trillo, C; Aroca-Aguilar, JD; Ferre-Fernandez, JJ; Alexandre-Moreno, S; Morales, L; Mendez-Hernandez, CD; Garcia-Feijoo, J; Escribano, J				Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian; Escribano, Julio			Role of FOXC2 and PITX2 rare variants associated with mild functional alterations as modifier factors in congenital glaucoma	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; CYTOCHROME P4501B1 CYP1B1; AXENFELD-RIEGER-SYNDROME; HEREDITARY LYMPHEDEMA; FACTOR GENE; MUTATIONS; EXPRESSION; IDENTIFICATION; UNDERLIE; FAMILIES	Congenital glaucoma (CG) is a severe and inherited childhood optical neuropathy that leads to irreversible visual loss and blindness in children. CG pathogenesis remains largely unexplained in most patients. Herein we have extended our previous studies to evaluate the role of FOXC2 and PITX2 variants in CG. Variants of the proximal promoter and transcribed sequence of these two genes were analyzed by Sanger sequencing in a cohort of 133 CG families. To investigate possible oligogenic inheritance involving FOXC2 or PITX2 and CYP1B1, we also analyzed FOXC2 and PITX2 variants in a group of 25 CG cases who were known to carry CYP1B1 glaucoma-associated genotypes. The functional effect of three identified variants was assessed by transactivation luciferase reporter assays, protein stability and subcellular localization analyses. We found eight probands (6.0%) who carried four rare FOXC2 variants in the heterozygous state. In addition, we found an elevated frequency (8%) of heterozygous and rare PITX2 variants in the group of CG cases who were known to carry CYP1B1 glaucoma-associated genotypes, and one of these PITX2 variants arose de novo. To the best of our knowledge, two of the identified variants (FOXC2: c.1183C>A, p.(H395N); and PITX2: c.535C>A, p.(P179T)) have not been previously identified. Examination of the genotype-phenotype correlation in this group suggests that the presence of the infrequent PITX2 variants increase the severity of the phenotype. Transactivation reporter analyses showed partial functional alteration of three identified amino acid substitutions (FOXC2: p.(C498R) and p.(H395N); PITX2: p.(P179T)). In summary, the increased frequency in PCG patients of rare FOXC2 and PITX2 variants with mild functional alterations, suggests they play a role as putative modifier factors in this disease further supporting that CG is not a simple monogenic disease and provides novel insights into the complex pathological mechanisms that underlie CG.	[Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain; [Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Escribano, Julio] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain; [Medina-Trillo, Cristina; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Alexandre-Moreno, Susana; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian; Escribano, Julio] Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp San Carlos, Serv Oftalmol, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Hospital Clinico San Carlos	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain.; Escribano, J (corresponding author), Univ Castilla La Mancha, Inst Invest Discapacidades Neurol IDINE, Albacete, Spain.; Escribano, J (corresponding author), Inst Salud Carlos III, Cooperat Res Network Prevent Early Detect & Treat, Madrid, Spain.	julio.escribano@uclm.es	Mendez-Hernandez, Carmen/D-6385-2017; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; Fernandez, Jesus J Ferre/AAA-3760-2021	Mendez-Hernandez, Carmen/0000-0003-3413-5248; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Fernandez, Jesus J Ferre/0000-0002-9511-2894	Instituto de Salud Carlos III/FEDER [RD12/0034/0003, RD16/0008/0019, PI11/00662, PI15/01193]	Instituto de Salud Carlos III/FEDER(Instituto de Salud Carlos IIIEuropean Commission)	This study has been supported by research grants (to JE) from the "Instituto de Salud Carlos III/FEDER" (http://www.isciii.es, RD12/0034/0003, RD16/0008/0019, PI11/00662 and PI15/01193).	Acharya M, 2011, HUM MOL GENET, V20, P1610, DOI 10.1093/hmg/ddr038; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; [Anonymous], 2013, CHILDHOOD GLAUCOMA 9; [Anonymous], 1970, CONGENITAL PEDIAT GL, P37; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Bagiyeva S, 2007, MOL VIS, V13, P1458; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Campos-Mollo E, 2009, MOL VIS, V15, P417; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Cella W, 2006, INVEST OPHTH VIS SCI, V47, P1803, DOI 10.1167/iovs.05-0979; Ceroni F, 2019, HUM GENET, V138, P1027, DOI 10.1007/s00439-018-1875-2; Chakrabarti S, 2009, INVEST OPHTH VIS SCI, V50, P75, DOI 10.1167/iovs.08-2253; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Dipple KM, 2001, MOL GENET METAB, V74, P45, DOI 10.1006/mgme.2001.3227; ELDER MJ, 1993, BRIT J OPHTHALMOL, V77, P413, DOI 10.1136/bjo.77.7.413; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferre-Fernandez JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46175; FRANCOIS J, 1980, OPHTHALMOLOGICA, V181, P61, DOI 10.1159/000309028; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gencik A, 1989, Dev Ophthalmol, V16, P76; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Hiemisch H, 1998, MECH DEVELOP, V73, P129, DOI 10.1016/S0925-4773(98)00039-2; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Medina-Trillo C, 2016, EUR J HUM GENET, V24, P672, DOI 10.1038/ejhg.2015.169; Medina-Trillo Cristina, 2015, Microrna, V4, P50; Medina-Trillo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119272; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Sampaolesi R, 2009, THE GLAUCOMAS, P1; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sarfarazi M, 2000, EYE, V14, P422, DOI 10.1038/eye.2000.126; Seifi M, 2018, CLIN GENET, V93, P1123, DOI 10.1111/cge.13148; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Souma T, 2016, J CLIN INVEST, V126, P2575, DOI 10.1172/JCI85830; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Zhang CL, 2017, CANCER LETT, V396, P66, DOI 10.1016/j.canlet.2017.03.018	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211029	10.1371/journal.pone.0211029	http://dx.doi.org/10.1371/journal.pone.0211029			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657791	gold, Green Published, Green Submitted			2022-12-27	WOS:000456017000026
J	Awasthi, S; Singh, B; Ramani, V; Xie, J; Kosanke, S				Awasthi, Shanjana; Singh, Bhupinder; Ramani, Vijay; Xie, Jun; Kosanke, Stanley			TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SURFACTANT PROTEIN-A; GRAM-NEGATIVE BACTERIA; PULMONARY SURFACTANT; LACTATE PRODUCTION; TLR4; INHIBITION; COLLECTINS; RESISTANCE; RESPONSES	Interaction between surfactant protein-A (SP-A) and toll-like receptor (TLR) 4 plays a critical role in host defense. In this work, we studied the host defense function of SPA4 peptide (amino acids GDFRYSDGTPVNYTNWYRGE), derived from the TLR4-interacting region of SP-A, against Pseudomonas aeruginosa. We determined the binding of SPA4 peptide to live bacteria, and its direct antibacterial activity against P. aeruginosa. Pro-phagocytic and antiinflammatory effects were investigated in JAWS II dendritic cells and primary alveolar macrophages. The biological relevance of SPA4 peptide was evaluated in a mouse model of acute lung infection induced by intratracheal challenge with P. aeruginosa. Our results demonstrate that the SPA4 peptide does not interact with or kill P. aeruginosa when cultured outside the host. The SPA4 peptide treatment induces the uptake and localization of bacteria in the phagolysosomes of immune cells. At the same time, the secreted amounts of TNF-alpha are significantly reduced in cell-free supernatants of SPA4 peptide-treated cells. In cells overexpressing TLR4, the TLR4-induced phagocytic response is maintained, but the levels of TLR4-stimulated TNF-alpha are reduced. Furthermore, our results demonstrate that the therapeutic administration of SPA4 peptide reduces bacterial burden, inflammatory cytokines and chemokines, intracellular signaling, and lactate levels, and alleviates lung edema and tissue damage in P. aeruginosa-infected mice. Together, our results suggest that the treatment with SPA4 peptide can help control the bacterial burden, inflammation, and tissue injury in a P. aeruginosa lung infection model.	[Awasthi, Shanjana; Singh, Bhupinder; Ramani, Vijay; Xie, Jun] OUHSC, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA; [Kosanke, Stanley] OUHSC, Dept Pathol, Oklahoma City, OK USA; [Singh, Bhupinder; Xie, Jun] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Ramani, Vijay] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Kosanke, Stanley] OUHSC, Dept Microbiol & Immunol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma Health Sciences Center	Awasthi, S (corresponding author), OUHSC, Dept Pharmaceut Sci, Oklahoma City, OK 73104 USA.	Shanjana-Awasthi@ouhsc.edu		Singh, Bhupinder/0000-0002-9185-7944	American Heart Association [11GRNT7220012]; University of Oklahoma Growth Fund; National Institute of General Medical Sciences of the National Institute of Health (NIH) [P20GM103648]; National Heart, Lung, and Blood Institute of the NIH [1R01 HL136325-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Oklahoma Growth Fund; National Institute of General Medical Sciences of the National Institute of Health (NIH); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Initital of author who received each award: SA Name of each funder and (Grant numbers): American Heart Association Grant-in-Aid (11GRNT7220012), the University of Oklahoma Growth Fund, National Institute of General Medical Sciences of the National Institute of Health (NIH; Award number P20GM103648), and National Heart, Lung, and Blood Institute of the NIH (Award number 1R01 HL136325-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalili RN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081363; Awasthi S, 1999, AM J RESP CRIT CARE, V160, P942, DOI 10.1164/ajrccm.160.3.9806061; Awasthi S, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-28; Awasthi S, 2005, J IMMUNOL, V175, P3900, DOI 10.4049/jimmunol.175.6.3900; Awasthi S, 2003, BIOTECHNIQUES, V35, P600, DOI 10.2144/03353dd03; Awasthi S, 2001, AM J RESP CRIT CARE, V163, P389, DOI 10.1164/ajrccm.163.2.2004168; Awasthi S, 2015, RSC ADV, V5, P27431, DOI 10.1039/c4ra16731g; Awasthi S, 2011, CELL IMMUNOL, V268, P87, DOI 10.1016/j.cellimm.2011.02.009; Awasthi S, 2011, J PHARMACOL EXP THER, V336, P672, DOI 10.1124/jpet.110.173765; Benincasa M, 2009, ANTIMICROB AGENTS CH, V53, P3501, DOI 10.1128/AAC.01620-08; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; DARZINS A, 1984, J BACTERIOL, V159, P9, DOI 10.1128/JB.159.1.9-18.1984; DeBacker D, 1997, AM J RESP CRIT CARE, V156, P1099, DOI 10.1164/ajrccm.156.4.9701048; Domingues MM, 2012, BIOPOLYMERS, V98, P338, DOI 10.1002/bip.22095; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hampton T, 2015, JAMA-J AM MED ASSOC, V313, P2411, DOI 10.1001/jama.2015.4738; Hickling TP, 1998, FEBS LETT, V437, P65, DOI 10.1016/S0014-5793(98)01200-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Humphries WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026626; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kellum JA, 1997, CHEST, V111, P1301, DOI 10.1378/chest.111.5.1301; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kozlowski LP, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0159-9; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Liaunardy-Jopeace A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00473; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Madhusoodhanan R., 2012, ONCOIMMUNOLOGY, V1, P1495, DOI DOI 10.4161/ONCI.22089; Mariencheck WI, 1999, AM J PHYSIOL-LUNG C, V277, pL777, DOI 10.1152/ajplung.1999.277.4.L777; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; Mehrad B, 2015, CHEST, V147, P1413, DOI 10.1378/chest.14-2171; Metkar S, 2007, INFECT IMMUN, V75, P5415, DOI 10.1128/IAI.00601-07; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mizock BA, 1999, CRIT CARE MED, V27, P2585, DOI 10.1097/00003246-199911000-00052; Peri F, 2012, BIOTECHNOL ADV, V30, P251, DOI 10.1016/j.biotechadv.2011.05.014; Piao W, 2013, J IMMUNOL, V190, P2263, DOI 10.4049/jimmunol.1202703; Qureshi ST, 1999, TRENDS GENET, V15, P291, DOI 10.1016/S0168-9525(99)01782-5; Ramani V, 2015, J LEUKOCYTE BIOL, V98, P1037, DOI 10.1189/jlb.3A1114-570R; Ramani V, 2013, INNATE IMMUN-LONDON, V19, P596, DOI 10.1177/1753425912474851; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Roy A, 2016, INT IMMUNOPHARMACOL, V40, P79, DOI 10.1016/j.intimp.2016.08.026; Schaeffer LM, 2004, INFECT IMMUN, V72, P7124, DOI 10.1128/IAI.72.12.7124-7130.2004; Schaeffer LM, 2004, J IMMUNOL, V173, P1959, DOI 10.4049/jimmunol.173.3.1959; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Vilekar P, 2012, INT IMMUNOL, V24, P455, DOI 10.1093/intimm/dxr121; Vilekar P, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-60; Vouga M, 2016, CLIN MICROBIOL INFEC, V22, P12, DOI 10.1016/j.cmi.2015.10.010; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564	58	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210979	10.1371/journal.pone.0210979	http://dx.doi.org/10.1371/journal.pone.0210979			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689633	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800017
J	Jeong, S; Kwon, H; Chang, JW; Kim, MJ; Ganbold, K; Han, Y; Kwon, TW; Cho, YP				Jeong, Seonjeong; Kwon, Hyunwook; Chang, Jai Won; Kim, Min-Ju; Ganbold, Khaliun; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil			Patency rates of arteriovenous fistulas created before versus after hemodialysis initiation	PLOS ONE			English	Article							VASCULAR ACCESS USE; DIALYSIS ACCESS; OUTCOMES; SURVIVAL; 1ST; CONSTRUCTION; CANNULATION; POPULATION; MATURATION; ADVANTAGES	In an incident hemodialysis (HD)population, we aimed to investigate whether arteriovenous fistula (AVF) creation before HD initiation was associated with improved AVF patency compared with AVF creation from a central venous catheter (CVC), and also to compare patient survival between these patients. Between January 2011 and December 2013, 524 incident HD patients with identified first predialysis vascular access with an AVF (pre-HD group, n = 191) or an AVF from a CVC (on-HD group, n = 333) were included and analyzed retrospectively. The study outcome was defined as AVF patency and all-cause mortality (time to death). On Kaplan-Meier survival analysis, primary and secondary AVF patency rates did not differ significantly between the two groups (P = 0.812 and P = 0.586, respectively), although the overall survival rate was significantly higher in the pre-HD group compared with the on-HD group (P = 0.013). On multivariate analysis, well-known patient factors were associated with decreased primary (older age and diabetes mellitus [DM]) and secondary (DM and peripheral arterial occlusive disease) AVF patency, whereas use of a CVC as the initial predialysis access (hazard ratios, 1.84; 95% confidence intervals, 1.20-2.75; P = 0.005) was significantly associated with worse survival in addition to well-known patient factors (older age, diabetes mellitus, and peripheral arterial occlusive disease). Worse survival in the on-HD group was likely confounded by selection bias because of the retrospective nature of our study. Therefore, the observed lower mortality associated with AVF creation before HD initiation is not fully attributable to CVC use, but rather, affected by other patient-level prognostic factors. There were no CVC-related complications in the pre-HD group, whereas 10.2% of CVC-related complications were noted in the on-HD group. In conclusion, among incident HD patients, compared with patients who underwent creation of an AVF from a CVC, initial AVF creation showed similar primary and secondary AVF patency rates, but lower mortality risk. We also observed that an initial CVC use was an independent risk factor associated with worse survival. A fistula-first strategy might be the best option for incident HD patients who are good candidates for AVF creation.	[Jeong, Seonjeong; Kwon, Hyunwook; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg,Div Vasc Surg, Seoul, South Korea; [Chang, Jai Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Kim, Min-Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Ganbold, Khaliun] Mongolian Natl Univ Med Sci, Dept Surg, Ulaanbaatar, Mongolia	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Mongolian National University of Medical Sciences	Cho, YP (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg,Div Vasc Surg, Seoul, South Korea.	ypcho@amc.seoul.kr						Al-Jaishi AA, 2015, CLIN J AM SOC NEPHRO, V10, P418, DOI 10.2215/CJN.06220614; Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Allon M, 2010, CLIN J AM SOC NEPHRO, V5, P2348, DOI 10.2215/CJN.06050710; [Anonymous], 2001, Am J Kidney Dis, V37, pS137; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bashar K, 2016, SURG-J R COLL SURG E, V14, P294, DOI 10.1016/j.surge.2016.02.001; Brothers TE, 1996, J SURG RES, V60, P312, DOI 10.1006/jsre.1996.0049; Bylsma LC, 2017, EUR J VASC ENDOVASC, V54, P513, DOI 10.1016/j.ejvs.2017.06.024; Chan MR, 2007, SEMIN DIALYSIS, V20, P606, DOI 10.1111/j.1525-139X.2007.00370.x; Dember LM, 2014, AM J KIDNEY DIS, V63, P104, DOI 10.1053/j.ajkd.2013.06.024; DeSilva RN, 2013, J AM SOC NEPHROL, V24, P1297, DOI 10.1681/ASN.2012060632; Foley RN, 2009, HEMODIAL INT, V13, P533, DOI 10.1111/j.1542-4758.2009.00396.x; Han YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184168; Kim SM, 2016, ANN SURG TREAT RES, V90, P224, DOI 10.4174/astr.2016.90.4.224; Ko GJ, 2020, NEPHROL DIAL TRANSPL, V35, P503, DOI 10.1093/ndt/gfy254; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Lazarides MK, 2007, J VASC SURG, V45, P420, DOI 10.1016/j.jvs.2006.10.035; Lee T, 2005, AM J KIDNEY DIS, V46, P501, DOI 10.1053/j.ajkd.2005.05.024; Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; Miller PE, 1999, KIDNEY INT, V56, P275, DOI 10.1046/j.1523-1755.1999.00515.x; Morsy M, 2011, NEPHROL DIAL TRANSPL, V26, P3666, DOI 10.1093/ndt/gfr104; National Kidney Foundation, 2006, 2006 UPD CLIN PRACT, P244; Ohira S, 2006, THER APHER DIAL, V10, P449, DOI 10.1111/j.1744-9987.2006.00410.x; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Pisoni RL, 2015, AM J KIDNEY DIS, V65, P905, DOI 10.1053/j.ajkd.2014.12.014; Praga M, 2013, NEPHRON CLIN PRACT, V124, P47, DOI 10.1159/000355694; Quarello F, 2006, J NEPHROL, V19, P265; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Richardson AI, 2009, J VASC ACCESS, V10, P199, DOI 10.1177/112972980901000311; Saad TF, 2015, SEMIN DIALYSIS, V28, P94, DOI 10.1111/sdi.12249; Sidawy AN, 2008, J VASC SURG S, V48, P25; Tamura MK, 2012, KIDNEY INT, V82, P261, DOI 10.1038/ki.2011.384; United States Renal Data System, 2016, 2016 USRDA ANN DAT R, P261; Vassalotti JA, 2012, SEMIN DIALYSIS, V25, P303, DOI 10.1111/j.1525-139X.2012.01069.x; Watorek E, 2014, HEMODIAL INT, V18, P113, DOI 10.1111/hdi.12076; Weyde W, 2006, BLOOD PURIFICAT, V24, P190, DOI 10.1159/000090518; WINDUS DW, 1993, AM J KIDNEY DIS, V21, P457, DOI 10.1016/S0272-6386(12)80391-X	39	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211296	10.1371/journal.pone.0211296	http://dx.doi.org/10.1371/journal.pone.0211296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689672	Green Submitted, Green Published, gold			2022-12-27	WOS:000457041800028
J	Omana-Zapata, I; Mutschmann, C; Schmitz, J; Gibson, S; Judge, K; Indig, MA; Lu, B; Taufman, D; Sanfilippo, AM; Shallenberger, W; Graminske, S; McLean, R; Hsen, RI; d'Empaire, N; Dean, K; O'Gorman, M				Omana-Zapata, Imelda; Mutschmann, Caren; Schmitz, John; Gibson, Sarah; Judge, Kevin; Indig, Monika Aruda; Lu, Beverly; Taufman, Doreen; Sanfilippo, Alan M.; Shallenberger, Wendy; Graminske, Sharon; McLean, Rachel; Hsen, Rubal I.; d'Empaire, Nicole; Dean, Kimberly; O'Gorman, Maurice			Accurate and reproducible enumeration of T-, B-, and NK lymphocytes using the BD FACSLyric 10-color system: A multisite clinical evaluation	PLOS ONE			English	Article							REFERENCE RANGES; HEALTHY-ADULTS; CELL; SUBSETS; TRANSPLANTATION; THERAPY	Clinical flow cytometry is a reliable methodology for whole blood cell phenotyping for different applications. The BD FACSLyric (TM) system comprises a flow cytometer available in different optical configurations, BD FACSuite (TM) Clinical software, and optional BD FACS (TM) Universal Loader. BD FACSuite Clinical software used with BD (TM) FC Beads and BD CS&T Beads enable universal setup for performance QC, instrument control, data acquisition/storage, online/offline data analysis, and instrument standardization. BD Biosciences sponsored the clinical evaluation of the BD FACSLyric 10-color configuration at seven clinical sites using delinked and de-identified blood specimens from HIV-infected and uninfected subjects to enumerate T-, B-, and NK-lymphocytes with the BD Multitest (TM) reagents (BD Multitest IMK kit and BD Multitest 6-color TBNK). Samples were analyzed on the BD FACSLyric system with BD FACSuite Clinical software, and on the BD FACSCanto (TM) II system with BD FACSCanto clinical software and BD FACS 7-Color Setup beads. For equivalency between methods, data (n = 362) were analyzed with Deming regression for absolute count and percentage of lymphocytes. Results gave R-2 >= 0.98, with slope values > 0.96, and slope ranges between 0.90-1.05. The percent (%) bias values were <10% for T- and NK cells and < 15% for B-cells. The between-site (n = 4) total precision was tested for 5 days (2 runs/day), and gave % coefficient of variation below 10% for absolute cell counts. The stability claims were confirmed (n = 186) for the two BD Multitest reagents. The reference intervals were re-established in male and female adults (n = 134). The analysis by gender showed statistically significant differences for CD3(+) and CD4(+) T-cell counts and % CD4. In summary, the BD FACSLyric and the BD FACSCanto II systems generated comparable measurements of T-, B-, and NK- cells using BD Multitest assays.	[Omana-Zapata, Imelda; Judge, Kevin; Lu, Beverly; Dean, Kimberly] BD Biosci, San Jose, CA 95131 USA; [Mutschmann, Caren; Taufman, Doreen] SYNLAB Unweltinst GmbH, Berlin, Germany; [Schmitz, John; Sanfilippo, Alan M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA; [Gibson, Sarah; Shallenberger, Wendy] Univ Pittsburgh, Med Ctr Presbyterian, Dept Pathol, Pittsburgh, PA USA; [Indig, Monika Aruda; Graminske, Sharon] BloodCtr Wisconsin, Clin Trial & Cellular Therapy Serv, Milwaukee, WI USA; [McLean, Rachel; Hsen, Rubal I.; O'Gorman, Maurice] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA; [d'Empaire, Nicole] BioCollections Inc, Miami, FL USA; [Sanfilippo, Alan M.] Beth Israel Deaconess Med Ctr, Histocompatibil Lab, Boston, MA 02215 USA	SYNLAB Group; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Versiti Blood Center of Wisconsin; Children's Hospital Los Angeles; Harvard University; Beth Israel Deaconess Medical Center	Omana-Zapata, I (corresponding author), BD Biosci, San Jose, CA 95131 USA.	imelda_omana-zapata@bd.com	Laboratory Core, HIV STD/AGD-7085-2022; Schmitz, John/HHS-0634-2022; Schmitz, John/AAF-9053-2019	Omana-Zapata, Imelda/0000-0001-5358-4490	BD Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	BD Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The studies were funded by BD Biosciences. BD Biosciences, SYNLAB Unweltinstitut GmbH and BioCollections Inc. provided support in the form of salaries for authors IOZ, KJ, BL, KD, CM, DT and NdE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1997, FED REG; Berzins SP, 2014, NAT REV IMMUNOL, V14, P640, DOI 10.1038/nri3725; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borghans JA, 2006, BLOOD, V108, P763, DOI 10.1182/blood-2006-01-009241; CDC, 1997, REV GUID PERF CD4 T; CDC, 2019, HIV SURVEILLANCE REP; CLSI, 2010, EP28 A3C DEFINING ES, VThird; CLSI, 2014, EP5A3 CLSI; CLSI, 2009, EP25A CLSI; CLSI, 2013, CLSI DOCUMENT EP09 A, V3rd; Deming W.E., 1985, STAT ADJUSTMENT DATA; Gebo KA, 2004, JAIDS-J ACQ IMM DEF, V36, P1028, DOI 10.1097/00126334-200408150-00005; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Kay AB, 2006, NEW ENGL J MED, V354, P1186, DOI 10.1056/NEJMe068024; Kook H, 1996, BLOOD, V88, P1089; Linnet K, 1998, CLIN CHEM, V44, P1024; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Melet J, 2013, ARTHRITIS RHEUM-US, V65, P2783, DOI 10.1002/art.38107; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; NIH, 2014, GUID US ANT AG HIV 1; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; O'Corman Maurice R. G., 2008, P267; Park SK, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160064; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Valiathan R, 2014, IMMUNOBIOLOGY, V219, P487, DOI 10.1016/j.imbio.2014.02.010; WHO, 2010, ANT THER HIV INF AD; WHO, 2014, CONS GUID US ANT DRU, P56; Wong WS, 2013, CLIN VACCINE IMMUNOL, V20, P602, DOI 10.1128/CVI.00476-12	28	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211207	10.1371/journal.pone.0211207	http://dx.doi.org/10.1371/journal.pone.0211207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689658	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800022
J	Wu, VCC; Kitano, T; Nabeshima, Y; Otani, K; Chu, PH; Takeuchi, M				Wu, Victor Chien-Chia; Kitano, Tetuji; Nabeshima, Yosuke; Otani, Kyoko; Chu, Pao-Hsien; Takeuchi, Masaaki			Optimal threshold of three-dimensional echocardiographic fully automated software for quantification of left ventricular volumes and ejection fraction: Comparison with cardiac magnetic resonance disk-area summation method and feature tracking method	PLOS ONE			English	Article							CHAMBER QUANTIFICATION; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; FEASIBILITY; REPRODUCIBILITY; RECOMMENDATIONS; DEFORMATION; PERFORMANCE; QUALITY	Aims Novel fully automated left chamber quantification software for three-dimensional echocardiography (3DE) has a potential for reliable measurement of left ventricular (LV) volumes and ejection fraction (LVEF). However, the optimal setting of global LV endocardial border threshold has not been settled. Methods and results We performed LV volumes and LVEF analysis using fully automated left chamber quantification software (Dynamic HeartModel(A.I.), Philips Medical Systems) in 65 patients who had undergone both 3DE and cardiac magnetic resonance (CMR) examinations on the same day. We recorded LV end-diastolic volume (LVEDV) and LV end-systolic volume (LVESV) according to the change in LV global border threshold settings from 0-point to 100-point with each increment of 10-point. These values were compared to the corresponding values of CMR with disk-area summation method and feature tracking (FT) method. Coverage probability (CP) was calculated as an index of accuracy and reliability. Fully automated software provided LV volumes and LVEF in 57 patients (Feasibility: 88%). LVEDV and LVESV increased steadily according to the increase in border threshold and reached minimal bias when border threshold setting was 80 against CMR disk-summation method and 90 against CMR FT method. Corresponding CP of LVEF was 0.74 and 0.84 against disk-area summation method and FT method. Conclusions With CMR values as a reference, LV endocardial border threshold value can be set around 80 to 90 with the same number of LV end-diastole and end-systole threshold to approximate LVEDV, LVESV and LVEF with clinically acceptable CP values of LVEF.	[Wu, Victor Chien-Chia; Otani, Kyoko; Takeuchi, Masaaki] Univ Occupat & Environm Hlth Hosp, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan; [Wu, Victor Chien-Chia; Chu, Pao-Hsien] Chang Gung Mem Hosp, Linkou Med Ctr, Div Cardiol, Taoyuan, Taiwan; [Kitano, Tetuji; Nabeshima, Yosuke] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; Chang Gung Memorial Hospital; University of Occupational & Environmental Health - Japan	Wu, VCC (corresponding author), Univ Occupat & Environm Hlth Hosp, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan.; Wu, VCC (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Div Cardiol, Taoyuan, Taiwan.	victorcwu@hotmail.com	Wu, Victor Chien-Chia/GXF-4623-2022; Chu, Pao-Hsien/P-5249-2019; Wu, Victor Chien-Chia/ABB-6872-2021	Wu, Victor Chien-Chia/0000-0002-9918-4369; Chu, Pao-Hsien/0000-0003-0361-6348; Wu, Victor Chien-Chia/0000-0002-9918-4369				Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1; Barletta V, 2018, INT J CARDIOVAS IMAG, V34, P1205, DOI 10.1007/s10554-018-1336-y; Buss SJ, 2015, EUR HEART J-CARD IMG, V16, P307, DOI 10.1093/ehjci/jeu181; Crowley AL, 2016, J AM SOC ECHOCARDIOG, V29, P1144, DOI 10.1016/j.echo.2016.08.006; Curigliano G, 2012, ANN ONCOL, V23, P155, DOI 10.1093/annonc/mds293; Daubert MA, 2015, J AM SOC ECHOCARDIOG, V28, P959, DOI 10.1016/j.echo.2015.03.004; Dorosz JL, 2012, J AM COLL CARDIOL, V59, P1799, DOI 10.1016/j.jacc.2012.01.037; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Khouri MG, 2018, J AM SOC ECHOCARDIOG, V31, P361, DOI 10.1016/j.echo.2017.11.018; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lang RM, 2012, J AM SOC ECHOCARDIOG, V25, P3, DOI 10.1016/j.echo.2011.11.010; Levy F, 2017, ARCH CARDIOVASC DIS, V110, P580, DOI 10.1016/j.acvd.2016.12.015; Medvedofsky D, 2017, EUR HEART J CARDIOVA, P1; Medvedofsky D, 2017, J AM SOC ECHOCARDIOG, V30, P879, DOI 10.1016/j.echo.2017.05.018; Otani K, 2016, J AM SOC ECHOCARDIOG, V29, P955, DOI 10.1016/j.echo.2016.06.010; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Schuster A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004077; Tamborini G, 2017, J AM SOC ECHOCARDIOG, V30, P1049, DOI 10.1016/j.echo.2017.06.026; Tsang W, 2017, ARCH CARDIOVASC DIS, V110, P577, DOI 10.1016/j.acvd.2017.05.004; Tsang W, 2016, JACC-CARDIOVASC IMAG, V9, P769, DOI 10.1016/j.jcmg.2015.12.020; Yang LT, 2016, J AM SOC ECHOCARDIOG, V29, P853, DOI 10.1016/j.echo.2016.05.001	22	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211154	10.1371/journal.pone.0211154	http://dx.doi.org/10.1371/journal.pone.0211154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689657	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800021
J	Espana, G; Hogea, C; Guignard, A; ten Bosch, QA; Morrison, AC; Smith, DL; Scott, TW; Schmidt, A; Perkins, TA				Espana, Guido; Hogea, Cosmina; Guignard, Adrienne; ten Bosch, Quirine A.; Morrison, Amy C.; Smith, David L.; Scott, Thomas W.; Schmidt, Alexander; Perkins, T. Alex			Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CULICIDAE PRODUCTION; POPULATION-DYNAMICS; PUERTO-RICO; IQUITOS; MODEL; TRANSMISSION; VECTOR; CITY	Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidates for public health implementation, but efficacy trials are subject to a known bias to estimate VE toward the null if heterogeneous exposure is not accounted for in the analysis of trial data. In light of many well-characterized sources of heterogeneity in dengue virus (DENV) transmission, our goal was to estimate the potential magnitude of this bias in VE estimates for a hypothetical dengue vaccine. To ensure that we realistically modeled heterogeneous exposure, we simulated city-wide DENV transmission and vaccine trial protocols using an agent-based model calibrated with entomological and epidemiological data from long-term field studies in Iquitos, Peru. By simulating a vaccine with a true VE of 0.8 in 1,000 replicate trials each designed to attain 90% power, we found that conventional methods underestimated VE by as much as 21% due to heterogeneous exposure. Accounting for the number of exposures in the vaccine and placebo arms eliminated this bias completely, and the more realistic option of including a frailty term to model exposure as a random effect reduced this bias partially. We also discovered a distinct bias in VE estimates away from the null due to lower detectability of primary DENV infections among seronegative individuals in the vaccinated group. This difference in detectability resulted from our assumption that primary infections in vaccinees who are seronegative at baseline resemble secondary infections, which experience a shorter window of detectable viremia due to a quicker immune response. This resulted in an artefactual finding that VE estimates for the seronegative group were approximately 1% greater than for the seropositive group. Simulation models of vaccine trials that account for these factors can be used to anticipate the extent of bias in field trials and to aid in their interpretation.	[Espana, Guido; ten Bosch, Quirine A.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Espana, Guido; ten Bosch, Quirine A.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Hogea, Cosmina; Guignard, Adrienne; Schmidt, Alexander] GlaxoSmithKline, Rockville, MD USA; [Morrison, Amy C.] US Naval Med Res Unit 6, Lima, Peru; [Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Smith, David L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of Notre Dame; University of Notre Dame; GlaxoSmithKline; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); University of California System; University of California Davis; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Espana, G; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Espana, G; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	guido.espana@nd.edu; taperkins@nd.edu	Morrison, Amy/AAU-6511-2020; Bosch, Quirine ten/H-6734-2019; Smith, David/L-8850-2013	Bosch, Quirine ten/0000-0002-5227-1406; Smith, David/0000-0003-4367-3849; Morrison, Amy/0000-0001-6224-5984; Camargo Espana, guido/0000-0002-9915-8056	US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID) [P01AI098670]; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [TL1 TR002531, UL1 TR002529]; GlaxoSmithKline Biologicals SA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001107, UL1TR002529, TL1TR002531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI098670] Funding Source: NIH RePORTER	US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID); National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; GlaxoSmithKline Biologicals SA(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	GE, QAtB, ACM, TWS, and TAP acknowledge support from a grant from the US National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH/NIAID (https://www.niaid.nih.gov/)) award number P01AI098670 (to TWS). This publication was made possible with partial support (GE) from Grant Numbers TL1 TR002531 and UL1 TR002529 (A. Shekhar, PI) from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award. GlaxoSmithKline Biologicals SA provided support in the form of salaries for authors AG, AS and CH and of funding in the post-doctoral position of GE. GlaxoSmithKline Biologicals SA, through the affiliated authors, had also a role study design by defining the research question, reviewing and inputting on the model proposal and interpretation of the results. GlaxoSmithKline Biologicals SA had no role in the decision to publish or preparation of the manuscript. Authors affiliated to GSK reviewed and approved the manuscript for publication and are therefore compliant with ICMJE criteria for authorship.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087; Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094; Clapham HE, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD; ClinicalTrials.gov, PHAS 3 TRIAL EV EFF; ClinicalTrials.gov, EFF SAF IMM TAK TETR; Coudeville L, 2016, VACCINE, V34, P6426, DOI 10.1016/j.vaccine.2016.08.050; De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437; Dengue Branch C, 2011, CRITERIA PROCESSING; Edelman Robert, 2008, Vaccine, V26, P4113, DOI 10.1016/j.vaccine.2008.05.058; Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516; Espana G, 2018, BIORXIV, DOI [10.1101/367060, DOI 10.1101/367060]; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Gessner BD, 2017, VACCINE, V35, P3452, DOI 10.1016/j.vaccine.2017.05.003; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Hadinegoro S, 2010, PROTOCOL; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Halloran ME, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0985-3; Halloran ME, 2010, STAT BIOL HEALTH, P271, DOI 10.1007/978-0-387-68636-3_13; Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Kahn R, 2019, AM J EPIDEMIOL, V188, P467, DOI 10.1093/aje/kwy239; LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038; Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702; Longini IM, 1996, J R STAT SOC C-APPL, V45, P165; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Morrow RH, 1996, SPECIAL PROGRAMME RE; O'Hagan JJ, 2014, EPIDEMIOLOGY, V25, P134, DOI 10.1097/EDE.0000000000000003; Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Paz-Soldan VA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002888; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Perkins A, 2018, BIORXIV, DOI [10.1101/276006, DOI 10.1101/276006]; Perkins A, 2018, BIORXIV, DOI [10.1101/082396, DOI 10.1101/082396]; Perkins TA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0390; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105; Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414; Reiner R, 2018, BIORXIV, DOI [10.1101/265751, DOI 10.1101/265751]; Reiner Robert C Jr, 2016, PLoS Negl Trop Dis, V10, pe0004588, DOI 10.1371/journal.pntd.0004588; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rodriguez-Barraquer I, 2013, PLOS NTD, V7, P1; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Takken W., 2003, ECOLOGICAL ASPECTS A; Team RC., 2013, R LANG ENV STAT COMP; ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965; Therneau T., 2015, PACKAGE SURVIVAL ANA; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2018, WHO VACC PIP TRACK; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210041	10.1371/journal.pone.0210041	http://dx.doi.org/10.1371/journal.pone.0210041			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682037	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500021
J	Fill, JM; Pearson, E; Knight, TM; Crandall, RM				Fill, Jennifer M.; Pearson, Eleanor; Knight, Tiffany M.; Crandall, Raelene M.			An invasive legume increases perennial grass biomass: An indirect pathway for plant community change	PLOS ONE			English	Article							LESPEDEZA-CUNEATA; DIVERSITY; RESTORATION; POPULATION; RESISTANCE; IMPACTS; DISTURBANCE; COMPETITION; HERBIVORY; DYNAMICS	The presence of native grasses in communities can suppress native forbs through competition and indirectly benefit these forbs by suppressing the invasion of highly competitive exotic species. We conducted a greenhouse experiment to examine the potential of direct and indirect interactions to influence the aboveground biomass of four native forb species in the presence of the native perennial grass Schizachyrium scoparium and exotic invasive Lespedeza cuneata. We examined patterns of growth for the invasive legume, the perennial grass, and four native species in four scenarios: 1) native species grown with the grass, 2) native species grown with the legume, 3) native species grown with both the grass and legume together, and 4) native species grown alone. Schizachyrium scoparium significantly decreased biomass of all forb species (p<0.05). In contrast, L. cuneata alone only significantly affected biomass of Asclepias tuberosa; L. cuneata increased the biomass of A. tuberosa only when the grass was present. When S. scoparium and L. cuneata were grown together, L. cuneata had significantly lower biomass (p = 0.007) and S. scoparium had significantly greater biomass (p = 0.002) than when each grew alone. These reciprocal effects suggest a potential pathway by which L. cuneata could alter forb diversity in grassland communities In this scenario, L. cuneata facilitates grass growth and competition with other natives. Our results emphasize the importance of monitoring interactions between exotic invasive plant species and dominant native species in grassland communities to understand pathways of plant community change.	[Fill, Jennifer M.; Crandall, Raelene M.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Pearson, Eleanor; Crandall, Raelene M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Knight, Tiffany M.] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany; [Knight, Tiffany M.] Martin Luther Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Knight, Tiffany M.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	State University System of Florida; University of Florida; Washington University (WUSTL); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg	Fill, JM (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.	jenna999@gmail.com			U.S.A. National Science Foundation [DEB 1145274]; Washington University Biology Summer Undergraduate Research Fellowship; National Science Foundation Advancing Informal STEM Education Program [DRL 0739874]	U.S.A. National Science Foundation(National Science Foundation (NSF)); Washington University Biology Summer Undergraduate Research Fellowship; National Science Foundation Advancing Informal STEM Education Program	Funding for this research was provided by the U.S.A. National Science Foundation (DEB 1145274 to T.M.K) and the Washington University Biology Summer Undergraduate Research Fellowship (to E.P.). Support for high school youth in the Tyson Environmental Research Fellowships (TERF) program at Tyson Research Center was provided by a grant to Washington University in St. Louis from the National Science Foundation Advancing Informal STEM Education Program (DRL 0739874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2011, THESIS; Becerra PI, 2013, APPL VEG SCI, V16, P173, DOI 10.1111/j.1654-109X.2012.01221.x; Beck A.S., 2017, THESIS; Brandon AL, 2004, BIOL INVASIONS, V6, P483, DOI 10.1023/B:BINV.0000041561.71407.f5; BRISKE DD, 1989, J ECOL, V77, P963, DOI 10.2307/2260816; Burns JH, 2013, ECOLOGY, V94, P995, DOI 10.1890/12-1310.1; Coykendall KE, 2014, BIOL INVASIONS, V16, P1735, DOI 10.1007/s10530-013-0623-8; Craine JM, 2003, PLANT ECOL, V165, P85, DOI 10.1023/A:1021414615001; Crandall R, 2015, ECOL LETT, V18, P883, DOI 10.1111/ele.12473; Crawford KM, 2017, OECOLOGIA, V183, P211, DOI 10.1007/s00442-016-3759-2; D'Antonio C, 2017, J ECOL, V105, P1459, DOI 10.1111/1365-2745.12879; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Davies KW, 2011, RESTOR ECOL, V19, P159, DOI 10.1111/j.1526-100X.2009.00548.x; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Fill JM, 2016, PLANT ECOL, V217, P331, DOI 10.1007/s11258-016-0574-0; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Foster BL, 2004, ECOLOGY, V85, P1541, DOI 10.1890/03-3165; Gould AMA, 2000, AM MIDL NAT, V144, P36, DOI 10.1674/0003-0031(2000)144[0036:EOTEIS]2.0.CO;2; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; HOLL KD, 1994, B TORREY BOT CLUB, V121, P327, DOI 10.2307/2997006; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Loydi A, 2015, BIOL INVASIONS, V17, P581, DOI 10.1007/s10530-014-0750-x; McCain KNS, 2010, RESTOR ECOL, V18, P40, DOI 10.1111/j.1526-100X.2010.00669.x; Munson SM, 2009, J VEG SCI, V20, P224, DOI 10.1111/j.1654-1103.2009.05556.x; Nelson P.W, 2010, TERRESTRIAL NATURAL; Ohlenbusch PD, 2001, SERICEA LESPEDEZA HI; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Prober Suzanne M., 2005, Ecological Management & Restoration, V6, P16, DOI 10.1111/j.1442-8903.2005.00215.x; Prober SM, 2009, BIOL INVASIONS, V11, P171, DOI 10.1007/s10530-008-9222-5; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Quinos PM, 1998, OECOLOGIA, V114, P427, DOI 10.1007/PL00008819; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Schutzenhofer MR, 2007, ECOL APPL, V17, P965, DOI 10.1890/06-1282; Schutzenhofer MR, 2009, OECOLOGIA, V161, P57, DOI 10.1007/s00442-009-1354-5; Sheley RL, 2010, INVAS PLANT SCI MANA, V3, P294, DOI 10.1614/IPSM-D-09-00056.1; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Snyman HA, 2013, AFR J RANGE FOR SCI, V30, P99, DOI 10.2989/10220119.2013.831375; Svriz M, 2013, FOREST ECOL MANAG, V289, P234, DOI 10.1016/j.foreco.2012.09.037; Vaughn KJ, 2015, ECOL APPL, V25, P791, DOI 10.1890/14-0922.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WEDIN DA, 1990, OECOLOGIA, V84, P433, DOI 10.1007/BF00328157; West JB., 2002, THESIS; Woods TM, 2009, BIOL INVASIONS, V11, P1913, DOI 10.1007/s10530-008-9369-0; Yannarell AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00127	46	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211295	10.1371/journal.pone.0211295	http://dx.doi.org/10.1371/journal.pone.0211295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682179	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500145
J	Li, XF; Rombouts, W; van der Gucht, J; de Vries, R; Dijksman, JA				Li, Xiufeng; Rombouts, Wolf; van der Gucht, Jasper; de Vries, Renko; Dijksman, Joshua A.			Mechanics of composite hydrogels approaching phase separation	PLOS ONE			English	Article							SECRETED PRODUCTION; TOUGH; GELATIN; GELS	For polymer-particle composites, limited thermodynamic compatibility of polymers and particles often leads to poor dispersal and agglomeration of the particles in the matrix, which negatively impacts the mechanics of composites. To study the impact of particle compatibility in polymer matrices on the mechanical properties of composites, we here study composite silica-protein based hydrogels. The polymer used is a previously studied telechelic protein-based polymer with end groups that form triple helices, and the particles are silica nanoparticles that only weakly associate with the polymer matrix. At 1mM protein polymer, up to 7% of silica nanoparticles can be embedded in the hydrogel. At higher concentrations the system phase separates. Oscillatory rheology shows that at high frequencies the particles strengthen the gels by acting as short-lived multivalent cross-links, while at low frequencies, the particles reduce the gel strength, presumably by sequestering part of the protein polymers in such a way that they can no longer contribute to the network strength. As is generally observed for polymer/particle composites, shear-induced polymer desorption from the particles leads to a viscous dissipation that strongly increases with increasing particle concentration. While linear rheological properties as function of particle concentration provide no signals for an approaching phase separation, this is very different for the non-linear rheology, especially fracture. Strain-at-break decreases rapidly with increasing particle concentration and vanishes as the phase boundary is approached, suggesting that the interfaces between regions of high and low particle densities in composites close to phase separation provide easy fracture planes.	[Li, Xiufeng; Rombouts, Wolf; van der Gucht, Jasper; de Vries, Renko; Dijksman, Joshua A.] Wageningen Univ & Res, Phys Chem & Soft Matter, Stippeneng 4, NL-6708WE Wageningen, Netherlands	Wageningen University & Research	Dijksman, JA (corresponding author), Wageningen Univ & Res, Phys Chem & Soft Matter, Stippeneng 4, NL-6708WE Wageningen, Netherlands.	joshua.dijksman@wur.nl	van der Gucht, Jasper/C-4639-2015	van der Gucht, Jasper/0000-0001-5525-8322; Li, Xiufeng/0000-0002-7615-4693	European Research Council [2015 CoG 682782]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever; TKI Agro-Food: Industrial Partnership Program [i41]	European Research Council(European Research Council (ERC)European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever; TKI Agro-Food: Industrial Partnership Program	This work was supported by European Research Council (2015 CoG 682782, https://cordis.europa.eu/project/rcn/204138_en.html, JvdG) and Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Unilever, TKI Agro-Food: Industrial Partnership Program i41 (https://www.nwo-i.nl/en/nwo-domain-science/research-programmes/ipp/nr-i41-hybrid-soft-materials-from-physical-mechanisms-to-designer-products/, JvdG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2008, LANGMUIR, V24, P13148, DOI 10.1021/la8015518; Balazs AC, 2007, NAT MATER, V6, P94, DOI 10.1038/nmat1820; Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; Gerth M, 2014, MACROMOL RAPID COMM, V35, P2065, DOI 10.1002/marc.201400543; GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495; Hooper JB, 2006, MACROMOLECULES, V39, P5133, DOI 10.1021/ma060577m; Hribar KC, 2014, ADV FUNCT MATER, V24, P4922, DOI 10.1002/adfm.201400274; Juby KA, 2012, CARBOHYD POLYM, V89, P906, DOI 10.1016/j.carbpol.2012.04.033; Lee JY, 2002, MACROMOLECULES, V35, P4855, DOI 10.1021/ma0200266; Lemmers M, 2012, LANGMUIR, V28, P12311, DOI 10.1021/la301917e; Pimenta AFR, 2016, INT J PHARMACEUT, V515, P467, DOI 10.1016/j.ijpharm.2016.10.047; Qiao R, 2011, J POLYM SCI POL PHYS, V49, P740, DOI 10.1002/polb.22236; Silva CIF, 2011, BIOTECHNOL BIOENG, V108, P2517, DOI 10.1002/bit.23228; Skrzeszewska PJ, 2010, MACROMOLECULES, V43, P3542, DOI 10.1021/ma1000173; Skrzeszewska PJ, 2009, SOFT MATTER, V5, P2057, DOI 10.1039/b819967a; Smallwood HM, 1944, J APPL PHYS, V15, P758, DOI 10.1063/1.1707385; Tang C, 2014, INT J PHARMACEUT, V465, P427, DOI 10.1016/j.ijpharm.2014.02.039; Teng WQ, 2014, BIOMATERIALS, V35, P8916, DOI 10.1016/j.biomaterials.2014.07.013; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x; Wang LY, 2014, SOFT MATTER, V10, P3850, DOI 10.1039/c4sm00206g; Wang Q, 2012, SOFT MATTER, V8, P6048, DOI 10.1039/c2sm07233e; Warren SC, 2007, NAT MATER, V6, P156, DOI 10.1038/nmat1819; Werten MWT, 2009, BIOMACROMOLECULES, V10, P1106, DOI 10.1021/bm801299u; Werten MWT, 2001, PROTEIN ENG, V14, P447, DOI 10.1093/protein/14.6.447; Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045; Zhang YL, 2012, CHEM COMMUN, V48, P9305, DOI 10.1039/c2cc34745h; Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]	29	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211059	10.1371/journal.pone.0211059	http://dx.doi.org/10.1371/journal.pone.0211059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682112	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500095
J	Chen, D; Tuan, HH; Zhou, EY; Liu, DH; Zhao, Y				Chen, Dian; Tuan, HsiaoHan; Zhou, Eray Yihui; Liu, Dehua; Zhao, Yi			Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community	PLOS ONE			English	Article							EPIDERMAL-CELL SUSPENSION; STABLE VITILIGO; INDEX SCORE; IMPACT	Background Vitiligo is an acquired depigmented skin disease resulting in white macules, which may significantly impair the quality of life (QoL) of the patients. Objective To estimate the QoL in Chinese vitiligo patients using camouflage with a more detailed description, and to identify the possible risk factors related to poor QoL. Methods An online survey was conducted in vitiligo patients using camouflage from a vitiligo community. Survey questions included demographic, clinical information, dermatology-and vitiligo-specific QoL questionnaires. Multivariate logistic analysis was performed to identify risk factors that related to poor QoL. Results In total, 884 respondents were included in the analyses, of which 413 (46.7%) were male. The score of DLQI was 5.83 +/- 5.75 (mean +/- SD). Age, gender, marriage status, occupational status, anogenital involvement, patient-perceived severity (presented by VAS score), symptoms as itching, pain, sunburn and koebner phenomenon, total cost of treatment and degree of satisfaction in camouflage therapy were independently associated with DLQI score (p<0.05). Conclusion Vitiligo has considerable impact on QoL of affected patients in Chinese population even when they were using camouflage. Camouflage might be helpful to improve QoL of the patients.	[Chen, Dian; Tuan, HsiaoHan; Zhou, Eray Yihui; Liu, Dehua; Zhao, Yi] Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China	Tsinghua University	Zhao, Y (corresponding author), Tsinghua Univ, Dept Dermatol, Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China.	zhaoyi@bjmu.edu.cn	Zhao, Yi/M-5881-2018; Zhou, Eray/HHC-3301-2022	Zhao, Yi/0000-0002-4531-8632; 	National Nature Science Foundation of China [81472898]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (81472898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AAA, 2016, INT J DERMATOL, V55, P608, DOI 10.1111/ijd.13198; Aust F, 2013, BEHAV RES METHODS, V45, P527, DOI 10.3758/s13428-012-0265-2; Bae JM, 2018, BRIT J DERMATOL, V178, P238, DOI 10.1111/bjd.15560; Bae JM, 2017, JAMA DERMATOL, V153, P666, DOI 10.1001/jamadermatol.2017.0002; Bin Saif GA, 2013, AM J CLIN DERMATOL, V14, P489, DOI 10.1007/s40257-013-0037-5; Budania A, 2012, BRIT J DERMATOL, V167, P1295, DOI 10.1111/bjd.12007; Dolatshahi M, 2008, INDIAN J DERMATOL VE, V74; Esmat SM, 2012, J EUR ACAD DERMATOL, V26, P1097, DOI 10.1111/j.1468-3083.2011.04215.x; Ezzedine K, 2015, LANCET, V386, P74, DOI 10.1016/S0140-6736(14)60763-7; Falabella R, 2005, DERMATOL SURG, V31, P1277, DOI 10.1097/00042728-200510000-00003; Gupta V, 2014, BRIT J DERMATOL, V171, P1084, DOI 10.1111/bjd.13093; Ingordo V, 2012, GIORN ITAL DERMAT V, V147, P83; Krishna GS, 2013, INDIAN J DERMATOL VE, V79, P205, DOI 10.4103/0378-6323.107637; Lilly E, 2013, J AM ACAD DERMATOL, V69, pE11, DOI 10.1016/j.jaad.2012.01.038; Mishra N, 2014, J CLIN DIAGN RES, V8, pYC1, DOI 10.7860/JCDR/2014/8248.4508; Ongenae K, 2006, J EUR ACAD DERMATOL, V20, P1, DOI 10.1111/j.1468-3083.2005.01369.x; Ongenae K, 2005, BRIT J DERMATOL, V152, P1165, DOI 10.1111/j.1365-2133.2005.06456.x; Ongenae K, 2005, DERMATOLOGY, V210, P279, DOI 10.1159/000084751; Parsad D, 2003, BRIT J DERMATOL, V148, P373, DOI 10.1046/j.1365-2133.2003.05097_9.x; Radtke MA, 2009, BRIT J DERMATOL, V161, P134, DOI 10.1111/j.1365-2133.2009.09091.x; Reips UD, 2008, INTERNET MEDIATED RE; Robaee AI AA, 2007, SAUDI MED J, V28, P1414; Sahni K, 2011, DERMATOL SURG, V37, P176, DOI 10.1111/j.1524-4725.2010.01847.x; Salzes C, 2016, J INVEST DERMATOL, V136, P52, DOI 10.1038/JID.2015.398; Sampogna F, 2008, BRIT J DERMATOL, V159, P351, DOI 10.1111/j.1365-2133.2008.08678.x; Senol A, 2013, DERMATOLOGY, V226, P185, DOI 10.1159/000348466; Silverberg JI, 2013, JAMA DERMATOL, V149, P159, DOI 10.1001/jamadermatol.2013.927; Singh C, 2013, BRIT J DERMATOL, V169, P287, DOI 10.1111/bjd.12325; Speeckaert R, 2017, AM J CLIN DERMATOL, P1, DOI 10.1007/S40257-016-0238-9; Tanioka M, 2010, J COSMET DERMATOL-US, V9, P72, DOI 10.1111/j.1473-2165.2010.00479.x; Wang KY, 2011, J EUR ACAD DERMATOL, V25, P429, DOI 10.1111/j.1468-3083.2010.03808.x; Wong SM, 2012, INT J DERMATOL, V51, P158, DOI 10.1111/j.1365-4632.2011.04932.x	32	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210581	10.1371/journal.pone.0210581	http://dx.doi.org/10.1371/journal.pone.0210581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677057	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400017
J	Degarege, A; Fennie, K; Degarege, D; Chennupati, S; Madhivanan, P				Degarege, Abraham; Fennie, Kristopher; Degarege, Dawit; Chennupati, Shasank; Madhivanan, Purnima			Improving socioeconomic status may reduce the burden of malaria in sub Saharan Africa: A systematic review and meta-analysis	PLOS ONE			English	Review							PLASMODIUM-FALCIPARUM INFECTION; RISK-FACTORS; PREGNANT-WOMEN; TRANSMISSION AREA; CHILDHOOD MALARIA; SCHOOL-CHILDREN; PERIURBAN AREA; YOUNG-CHILDREN; PREVALENCE; ANEMIA	Background A clear understanding of the effects of housing structure, education, occupation, income, and wealth on malaria can help to better design socioeconomic interventions to control the disease. This literature review summarizes the relationship of housing structure, educational level, occupation, income, and wealth with the epidemiology of malaria in sub-Saharan Africa (SSA). Methods A systematic review and meta-analysis was conducted following the preferred reporting items for systematic reviews and meta-analyses guidelines. The protocol for this study is registered in PROSPERO (ID=CRD42017056070), an international database of prospectively registered systematic reviews. On January 16, 2016, available literature was searched in PubMed, Embase, CINAHL, and Cochrane Library. All but case studies, which reported prevalence or incidence of Plasmodium infection stratified by socioeconomic status among individuals living in SSA, were included without any limits. Odds Ratio (OR) and Relative Risk (RR), together with 95% CI and p-values were used as effect measures. Heterogeneity was assessed using chi-square, Moran's I-2, and tau(2) tests. Fixed (I-2<30%), random (I-2 >= 30%) or log-linear dose-response model was used to estimate the summary OR or RR. Results After removing duplicates and screening of titles, abstracts, and full text, 84 articles were found eligible for systematic review, and 75 of them were included in the meta-analyses. Fifty-seven studies were cross-sectional, 12 were prospective cohort, 10 were case-control, and five were randomized control trials. The odds of Plasmodium infection increased among individuals who were living in poor quality houses (OR 2.13, 95% CI 1.56-3.23, I-2 = 27.7), were uneducated (OR 1.36, 95% CI 1.19-1.54, I-2 = 72.4.0%), and were farmers by occupation (OR 1.48, 95% CI 1.11-1.85, I-2 = 0.0%) [p<0.01 for all]. The odds of Plasmodium infection also increased with a decrease in the income (OR 1.02, 95% CI 1.01-1.03, tau(2)<0.001), and wealth index of individuals (OR 1.25, 95% CI 1.18-1.35, tau(2) = 0.028) [p<0.001 for both]. Longitudinal studies also showed an increased risk of Plasmodium infection among individuals who were living in poor quality houses (RR 1.86, 95% CI 1.47-2.25, I-2 = 0.0%), were uneducated (OR 1.27, 1.03-1.50, I-2 = 0.0%), and were farmers (OR 1.36, 1.18-1.58) [p<0.01 for all]. Conclusions Lack of education, low income, low wealth, living in poorly constructed houses, and having an occupation in farming may increase risk of Plasmodium infection among people in SSA. Public policy measures that can reduce inequity in health coverage, as well as improve economic and educational opportunities for the poor, will help in reducing the burden of malaria in SSA.	[Degarege, Abraham; Fennie, Kristopher; Chennupati, Shasank; Madhivanan, Purnima] Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Degarege, Abraham] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Degarege, Dawit] Ethiopian Minist Hlth Off, Addis Ababa, Ethiopia; [Madhivanan, Purnima] Publ Hlth Res Inst India, Mysore, Karnataka, India	State University System of Florida; Florida International University; Addis Ababa University	Degarege, A (corresponding author), Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.; Degarege, A (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	ameng002@fiu.edu	Madhivanan, Purnima/AAH-4849-2019	Madhivanan, Purnima/0000-0001-7818-3394; Degarege, Abraham/0000-0002-5738-0521; Degarege, Abraham/0000-0002-1537-6639				Adio M B L, 2004, East Afr Med J, V81, P583; Agomo CO, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-19; Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Alemu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095341; Alonso PL, 2013, NAT MED, V19, P150, DOI 10.1038/nm.3077; ALTMAN DG, 2011, BMJ BRIT MED J, V343; Amuta E, 2014, INFECT DIS REP, V6, P1, DOI 10.4081/idr.2014.5050; [Anonymous], STAT STAT SOFTW REL; [Anonymous], 2015, WORLD MALARIA REPORT; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bernard J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-65; Bikundi EM, 2017, INT J ENVIRON HEAL R, V27, P394, DOI 10.1080/09603123.2017.1359241; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Bruce-Chwatt LJ, 1980, RISE FALL MALARIA EU; Bulterys PL, 2009, TROP MED INT HEALTH, V14, P522, DOI 10.1111/j.1365-3156.2009.02270.x; Chaponda EB, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0866-1; Charlwood JD, 2015, PEERJ, V3, DOI 10.7717/peerj.1370; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Clerk CA, 2009, TROP MED INT HEALTH, V14, P688, DOI 10.1111/j.1365-3156.2009.02280.x; Coleman M, 2010, T ROY SOC TROP MED H, V104, P143, DOI 10.1016/j.trstmh.2009.07.010; COOSEMANS M, 1992, MEM I OSWALDO CRUZ, V87, P385, DOI 10.1590/S0074-02761992000700065; De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132; de Castro MC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-161; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Degarege A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005193; Degarege A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1594-2; DERIBEW A, 2012, MALARIA J, V11; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Effective Public Health Practice Project, QUAL ASS TOOL QUANT; Elmardi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-128; Ernst KC, 2009, TROP MED INT HEALTH, V14, P1258, DOI 10.1111/j.1365-3156.2009.02370.x; Florey LS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001723; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; GARCIAMARTIN G, 1972, AM J TROP MED HYG, V21, P617, DOI 10.4269/ajtmh.1972.21.617; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Gosoniu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023966; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GRIFFIN JT, 2014, NAT COMMUN, V5; Hagmann R, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-15; Haji Y, 2016, ACTA TROP, V155, P63, DOI 10.1016/j.actatropica.2015.12.009; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Homan T, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1044-1; Houngbedji CA, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-7; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; HOUSE JS, 1990, MILBANK Q, V68, P383, DOI 10.2307/3350111; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kalu K. M., 2012, Asian Journal of Epidemiology, V5, P95, DOI 10.3923/aje.2012.95.102; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Kibret S, 2010, TROP MED INT HEALTH, V15, P41, DOI 10.1111/j.1365-3156.2009.02423.x; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Knoblauch AM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-194; KORAM KA, 1995, T ROY SOC TROP MED H, V89, P146, DOI 10.1016/0035-9203(95)90471-9; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kyu HH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-14; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087358; Macintyre Kate, 2002, Malar J, V1, P14, DOI 10.1186/1475-2875-1-14; Marchant T, 2002, TROP MED INT HEALTH, V7, P149, DOI 10.1046/j.1365-3156.2002.00840.x; Mathanga DP, 2015, AM J TROP MED HYG, V93, P779, DOI 10.4269/ajtmh.14-0618; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; Mboera LEG, 2011, ACTA TROP, V120, P95, DOI 10.1016/j.actatropica.2011.06.007; Mbu RE, 2014, BMC WOMENS HLTH, V14; MMBANDO BP, 2011, MALARIA J, V10; Mmbando BP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-165; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nahum A, 2011, TROP MED INT HEALTH, V16, P131; Njama D, 2003, TROP MED INT HEALTH, V8, P685, DOI 10.1046/j.1365-3156.2003.01060.x; Njau JD, 2006, TROP MED INT HEALTH, V11, P299, DOI 10.1111/j.1365-3156.2006.01569.x; Njau JD, 2014, AM J TROP MED HYG, V91, P509, DOI 10.4269/ajtmh.13-0713; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Nkuo-Akenji Theresa, 2006, Afr J Health Sci, V13, P40; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Ojurongbe O, 2011, J RES MED SCI, V16, P680; OKEBE J, 2014, MALARIA J, V13; Omer S. A., 2011, Open Tropical Medicine Journal, V4, P6, DOI 10.2174/1874315301104010006; Omokanye L. O., 2012, International Journal of Tropical Medicine, V7, P64; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Onwujekwe O, 2006, HEALTH POLICY PLANN, V21, P10, DOI 10.1093/heapol/czj004; Onyido A. E., 2011, African Journal of Biomedical Research, V14, P175; Osterbauer B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-432; Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Ricci F, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.048; Righetti AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001889; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Rulisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069443; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Sezi CL, 2014, AFR HEALTH SCI, V14, P100, DOI 10.4314/ahs.v14i1.16; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; Skarbinski J, 2012, AM J TROP MED HYG, V86, P997, DOI 10.4269/ajtmh.2012.11-0621; Snow RW, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0254-7; Snyman K, 2015, AM J TROP MED HYG, V92, P1207, DOI 10.4269/ajtmh.14-0828; Somi MF, 2008, TROP MED INT HEALTH, V13, P354, DOI 10.1111/j.1365-3156.2008.02009.x; Somi MF, 2007, AM J TROP MED HYG, V77, P1020, DOI 10.4269/ajtmh.2007.77.1020; Sonko ST, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-449; Steinhardt LC, 2013, AM J TROP MED HYG, V88, P855, DOI 10.4269/ajtmh.12-0747; Tarimo DS, 2000, TROP MED INT HEALTH, V5, P179, DOI 10.1046/j.1365-3156.2000.00537.x; Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031409; Tonga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065876; Townes LR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-407; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; Villamor E, 2003, TROP MED INT HEALTH, V8, P1051, DOI 10.1046/j.1360-2276.2003.01134.x; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; West PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065787; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; Wolff CG, 2001, BRIT MED J, V322, P1209, DOI 10.1136/bmj.322.7296.1209; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; WOYESSA A, 2013, MALARIA J, V12; Yamamoto S, 2010, T ROY SOC TROP MED H, V104, P61, DOI 10.1016/j.trstmh.2009.07.003; Yatich NJ, 2009, AM J TROP MED HYG, V80, P896, DOI 10.4269/ajtmh.2009.80.896; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8	126	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211205	10.1371/journal.pone.0211205	http://dx.doi.org/10.1371/journal.pone.0211205			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677102	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400061
J	Frahm, N; Hecker, M; Zettl, UK				Frahm, Niklas; Hecker, Michael; Zettl, Uwe Klaus			Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study	PLOS ONE			English	Article							HEALTH; PEOPLE; ASSOCIATION; LIFE; INFLAMMATION; DISABILITY; EDUCATION; FATIGUE	Background Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Given the chronic and heterogenous nature of the disease, treatment with various therapies is a frequent scenario in clinical practice. In persons with chronic morbidity such as MS patients, polypharmacy can give rise to considerable health problems. Objectives The aim of the present study was to examine the frequency of polypharmacy among relapsing-remitting (RR) MS patients as well as to analyse sociodemographic and clinical factors, which might be associated with polypharmacy (use of five or more medications). Differences in medication between MS patients with and without secondary illnesses (PwSI and Pw/oSI), between men and women and between patients with and without polypharmacy (PwP and Pw/oP) were examined. Methods For 145 RRMS outpatients, we prospectively collected data by means of anamnesis, patient records, clinical examination and a structured patient interview. This was followed by comparative analyses of various patient subgroups (PwP vs. Pw/oP, PwSI vs. Pw/oSI, men vs. women). Results The proportion of included MS patients with polypharmacy (use of >= 5 medications) was 30.3%. PwP were significantly older than Pw/oP (45.9 vs. 41.7 years), had a lower level of education and showed a significantly higher median EDSS score (3.0 vs. 2.0). Comorbidities (p<0.001; odds ratio [OR] = 6.293) and higher EDSS scores (p = 0.029; OR = 1.440) were associated with a higher risk of polypharmacy. The proportion of polypharmacy among PwSI was approximately four times higher than among Pw/oSI (46.8% vs. 11.8%). Particularly in the use of antihypertensives, gastrointestinal drugs and dietary supplements, there were differences between Pw/oP and PwP. Conclusion We found a high burden of polypharmacy in patients with RRMS. This particularly applies to more severely disabled MS patients who suffer from comorbidities.	[Frahm, Niklas; Hecker, Michael; Zettl, Uwe Klaus] Univ Rostock, Neuroimmunol Sect, Dept Neurol, Rostock, Germany	University of Rostock	Frahm, N (corresponding author), Univ Rostock, Neuroimmunol Sect, Dept Neurol, Rostock, Germany.	niklas-frahm@gmx.de		Frahm, Niklas/0000-0002-4655-774X; Hecker, Michael/0000-0001-7015-3094				Altenhoner T, 2014, GESUNDHEITSWESEN, V76, P19, DOI 10.1055/s-0033-1333729; Ayache SS, 2015, J NEUROL SCI, V358, P351, DOI 10.1016/j.jns.2015.09.360; Bazargan M, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0558-5; Beiske GAG, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/317859; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjerrum L, 1997, EUR J CLIN PHARMACOL, V53, P7, DOI 10.1007/s002280050329; Brager R, 2005, NURSE PRACT, V30, P44, DOI 10.1097/00006205-200506000-00008; Broekmans T, 2011, MULT SCLER J, V17, P468, DOI 10.1177/1352458510391339; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Cakit BD, 2010, AM J PHYS MED REHAB, V89, P446, DOI 10.1097/PHM.0b013e3181d3e71f; Cattaneo D, 2007, CLIN REHABIL, V21, P771, DOI 10.1177/0269215507077602; Cree BAC, 2016, CURR OPIN NEUROL, V29, P263, DOI 10.1097/WCO.0000000000000332; Dargahi N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070078; Delcher A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141779; Dennison L, 2010, EXPERT REV NEUROTHER, V10, P1383, DOI [10.1586/ern.10.111, 10.1586/ERN.10.111]; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ellouzi I., 2018, PROCEEDINGS, V3, P3; Evans C, 2017, PHARMACOEPIDEM DR S, V26, P702, DOI 10.1002/pds.4207; Faries D, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-26; Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x; Gupta S, 2014, CNS DRUGS, V28, P731, DOI 10.1007/s40263-014-0173-3; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Haider SI, 2008, CLIN THER, V30, P419, DOI 10.1016/j.clinthera.2008.02.010; Houtchens MK, 2017, MULT SCLER J, V23, P757, DOI 10.1177/1352458517701314; James T, 2018, HUM MOL GENET, V27, P912, DOI 10.1093/hmg/ddy001; Jelinek GA, 2015, NEUROL RES, V37, P662, DOI 10.1179/1743132815Y.0000000036; Jorgensen T, 2001, ANN PHARMACOTHER, V35, P1004, DOI 10.1345/aph.10351; Kawachi I, 2017, J NEUROL NEUROSUR PS, V88, P137, DOI 10.1136/jnnp-2016-313300; Koutsis G, 2016, MULT SCLER RELAT DIS, V9, P140, DOI 10.1016/j.msard.2016.07.009; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laroni A, 2017, NEUROLOGY, V89, P2222, DOI 10.1212/WNL.0000000000004686; Lentjes MAH, 2018, P NUTR SOC, V78, P1; Linjakumpu T, 2002, J CLIN EPIDEMIOL, V55, P809, DOI 10.1016/S0895-4356(02)00411-0; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Markowitz CE, 2013, AM J MANAG CARE, V19, pS294; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; MATHUR R, 2011, BRIT J GEN PRACT, V61; Murphy KL, 2017, MULTIPLE SCLEROSIS: PERSPECTIVES IN TREATMENT AND PATHOGENESIS, P53, DOI 10.15586/codon.multiplesclerosis.2017.ch4; O'Brien SK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101154; O'Connor K, 2012, J NEUROL, V259, P637, DOI 10.1007/s00415-011-6226-3; Olafsson S, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0027-2; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Patejdl R, 2017, AUTOIMMUN REV, V16, P925, DOI 10.1016/j.autrev.2017.07.004; Patejdl R, 2016, AUTOIMMUN REV, V15, P210, DOI 10.1016/j.autrev.2015.11.005; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Payne RA, 2016, CLIN MED, V16, P465, DOI 10.7861/clinmedicine.16-5-465; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Riccio P, 2015, ASN NEURO, V7, DOI 10.1177/1759091414568185; Richardson K, 2011, DRUG AGING, V28, P547, DOI 10.2165/11592000-000000000-00000; Sganga F, 2015, GERIATR GERONTOL INT, V15, P141, DOI 10.1111/ggi.12241; Solaro C, 2018, CNS DRUGS, V32, P117, DOI 10.1007/s40263-018-0489-5; Thelen JM, 2014, J PSYCHOSOM RES, V76, P400, DOI 10.1016/j.jpsychores.2014.02.013; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Wingerchuk DM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3518; Zettl UK, 2018, EXPERT REV CLIN IMMU, V14, P137, DOI 10.1080/1744666X.2018.1426462	58	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211120	10.1371/journal.pone.0211120	http://dx.doi.org/10.1371/journal.pone.0211120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677078	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400051
J	Gaschler, R; Schuck, NW; Reverberi, C; Frensch, PA; Wenke, D				Gaschler, Robert; Schuck, Nicolas W.; Reverberi, Carlo; Frensch, Peter A.; Wenke, Dorit			Incidental covariation learning leading to strategy change	PLOS ONE			English	Article							SELECTIVE-ATTENTION; AGE-DIFFERENCES; INSTANCE THEORY; POWER-LAW; STIMULUS; AUTOMATICITY; KNOWLEDGE; IMPLICIT; INSTRUCTION; ACQUISITION	As they approach a traffic light, drivers and pedestrians monitor the color (instructed stimulus feature) and/or the position of the signal (covarying stimulus feature) for response selection. Many studies have pointed out that instructions can effectively determine the stimulus features used for response selection in a task. This leaves open whether and how practice with a correlating alternative stimulus feature can lead to a strategy change from an instructed to a learned variant of performing the task. To address this question, we instructed participants to respond to the position of a stimulus within a reference frame, at the same time, during task performance, an unmentioned second stimulus feature, the color, covaried with stimulus position and allowed the use of an alternative response strategy. To assess the impact of the non-instructed stimulus feature of color on response selection throughout practice, the spatial position of the stimulus was ambiguous on some trials. Group average increases in color usage were based on a mixture of (1) participants who, despite extended practice on the covariation, exclusively relied on the instructed stimulus feature and (2) those who abruptly started to rely heavily on stimulus color to select responses in ambiguous trials. When the instructed and uninstructed feature predicted different actions, choices were still biased by the uninstructed color feature, albeit more weakly. A second experiment showed that the influence of color generalized across frequently and infrequently presented combinations of position and color. Strategy changes were accompanied by awareness in both experiments. The results suggest that incidental covariation learning can trigger spontaneous voluntary strategy change involving a re-configuration of the instructed task set.	[Gaschler, Robert] Fernuniv, Dept Psychol, Hagen, Germany; [Gaschler, Robert] Humboldt Univ, Res Cluster Image Knowledge Gestaltung, Berlin, Germany; [Schuck, Nicolas W.] Max Planck Inst Human Dev, Max Planck Res Grp NeuroCode, Berlin, Germany; [Reverberi, Carlo] Univ Milano Bicocca, Dept Psychol, Milano & Milan Ctr Neurosci, Milan, Italy; [Frensch, Peter A.; Wenke, Dorit] Humboldt Univ, Dept Psychol, Berlin, Germany; [Wenke, Dorit] Private Univ Appl Sci, Gottingen, Germany	Fern University Hagen; Humboldt University of Berlin; Max Planck Society; University of Milano-Bicocca; Humboldt University of Berlin	Gaschler, R (corresponding author), Fernuniv, Dept Psychol, Hagen, Germany.; Gaschler, R (corresponding author), Humboldt Univ, Res Cluster Image Knowledge Gestaltung, Berlin, Germany.	robert.gaschler@fernuni-hagen.de	Schuck, Nicolas/E-1042-2017	Schuck, Nicolas/0000-0002-0150-8776; Reverberi, Carlo/0000-0003-3523-1055	German Research Foundation (DFG; Deutsche Forschungsgemeinschaft) [WE-2852/3-1, GA 2246/1-1, EXC1027/1]	German Research Foundation (DFG; Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The work was supported by grants of the German Research Foundation (DFG; Deutsche Forschungsgemeinschaft. Grant WE-2852/3-1 (awarded to DW; http://gepris.dfg.de/gepris/projekt/192712234) was used for designing the study and data collection. Grants GA 2246/1-1 and EXC1027/1 (awarded to RG; http://gepris.dfg.de/gepris/projekt/274870128) supported meetings for data analysis and write-up. The funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach N., 1910, ON VOLITION; Aufschnaiter S, 2008, PSYCHOL RES, V82, P230; Baker CI, 2004, PSYCHOL SCI, V15, P460, DOI 10.1111/j.0956-7976.2004.00702.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bourne LE, 2010, J EXP PSYCHOL LEARN, V36, P500, DOI 10.1037/a0018599; Braem S, 2017, J EXP PSYCHOL LEARN, V43, P394, DOI 10.1037/xlm0000310; Cleeremans A., 2002, IMPLICIT LEARNING CO, P1; Cosman JD, 2016, J EXP PSYCHOL HUMAN, V42, P2077, DOI 10.1037/xhp0000278; DEJONG R, 1994, J EXP PSYCHOL HUMAN, V20, P731, DOI 10.1037/0096-1523.20.4.731; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Dignath D, 2015, J EXP PSYCHOL LEARN, V41, P975, DOI 10.1037/xlm0000089; Doane SM, 1999, J EXP PSYCHOL HUMAN, V25, P1390, DOI 10.1037/0096-1523.25.5.1390; Doll BB, 2009, BRAIN RES, V1299, P74, DOI 10.1016/j.brainres.2009.07.007; Dreisbach G, 2008, PSYCHOL RES-PSYCH FO, V72, P355, DOI 10.1007/s00426-007-0131-5; Dreisbach G, 2009, J EXP PSYCHOL LEARN, V35, P477, DOI 10.1037/a0014647; Duncan J, 2008, J EXP PSYCHOL GEN, V137, P131, DOI 10.1037/0096-3445.137.1.131; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Edkins GD, 1997, ACCIDENT ANAL PREV, V29, P533, DOI 10.1016/S0001-4575(97)00033-X; Fan JE, 2016, J EXP PSYCHOL LEARN, V42, P970, DOI 10.1037/xlm0000209; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Forrin ND, 2017, MEM COGNITION, V45, P1206, DOI 10.3758/s13421-017-0721-4; Frober K, 2017, COGNITION, V162, P48, DOI 10.1016/j.cognition.2017.01.024; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gaschler R, 2009, PSYCHOL STUD, V54, P43; Gaschler R, 2015, Q J EXP PSYCHOL, V68, P543, DOI 10.1080/17470218.2014.961933; Gaschler R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01388; Good P, 2005, PERMUTATION PARAMETR; Haider H, 2005, CONSCIOUS COGN, V14, P495, DOI 10.1016/j.concog.2004.12.002; Haider H, 2002, J EXP PSYCHOL LEARN, V28, P392, DOI 10.1037//0278-7393.28.2.392; Haider H, 2007, METHODS, V42, P49, DOI 10.1016/j.ymeth.2006.12.004; Haider H, 2009, PSYCHOL RES-PSYCH FO, V73, P817, DOI 10.1007/s00426-008-0199-6; Harris HD, 2008, MEM COGNITION, V36, P1335, DOI 10.3758/MC.36.7.1335; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Hoffmann J, 2005, EUR J COGN PSYCHOL, V17, P449, DOI 10.1080/09541440440000203; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Lawton R, 2005, ACCIDENT ANAL PREV, V37, P235, DOI 10.1016/j.aap.2004.08.001; Lin OYH, 2018, J EXP PSYCHOL LEARN, V44, P99, DOI 10.1037/xlm0000436; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOGAN GD, 1992, J EXP PSYCHOL LEARN, V18, P883, DOI 10.1037/0278-7393.18.5.883; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Meiran N, 2017, CURR DIR PSYCHOL SCI, V26, P509, DOI 10.1177/0963721417711638; Meiran N, 2015, J EXP PSYCHOL LEARN, V41, P768, DOI 10.1037/xlm0000063; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER J, 1987, PERCEPT PSYCHOPHYS, V41, P419, DOI 10.3758/BF03203035; Mordkoff JT, 2008, PSYCHON B REV, V15, P385, DOI 10.3758/PBR.15.2.385; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OVERTON RK, 1957, AM J PSYCHOL, V70, P126, DOI 10.2307/1419244; Qian T, 2016, COGNITION, V157, P156, DOI 10.1016/j.cognition.2016.09.002; Rehder B, 2005, COGNITIVE PSYCHOL, V51, P1, DOI 10.1016/j.cogpsych.2004.11.001; Roeder JL, 2016, COGNITION, V154, P22, DOI 10.1016/j.cognition.2016.04.005; Runger D, 2008, J EXP PSYCHOL LEARN, V34, P1011, DOI 10.1037/a0012942; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schmidt JR, 2016, LEARN MOTIV, V56, P15, DOI 10.1016/j.lmot.2016.09.002; Schmidt JR, 2012, CONSCIOUS COGN, V21, P1754, DOI 10.1016/j.concog.2012.10.006; Schuck NW, 2015, NEURON, V86, P331, DOI 10.1016/j.neuron.2015.03.015; Schwager S, 2012, ADV COGN PSYCHOL, V8, P132, DOI [10.5709/acp-0110-4, 10.2478/v10053-008-0110-4]; SIEGLER RS, 1988, J EXP PSYCHOL GEN, V117, P258, DOI 10.1037/0096-3445.117.3.258; SMITH EE, 1992, COGNITIVE SCI, V16, P1, DOI 10.1207/s15516709cog1601_1; STRAYER DL, 1994, J EXP PSYCHOL LEARN, V20, P318, DOI 10.1037/0278-7393.20.2.318; Sun R, 2001, COGNITIVE SCI, V25, P203, DOI 10.1016/S0364-0213(01)00035-0; Thomaschke R, 2014, INT J HUM-COMPUT ST, V72, P358, DOI 10.1016/j.ijhcs.2013.12.004; Touron DR, 2006, PSYCHON B REV, V13, P781, DOI 10.3758/BF03193997; Touron DR, 2004, PSYCHOL AGING, V19, P452, DOI 10.1037/0882-7974.19.3.452; Touron DR, 2004, MEM COGNITION, V32, P298, DOI 10.3758/BF03196860; Tran R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179386; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tubau E, 2007, J EXP PSYCHOL GEN, V136, P43, DOI 10.1037/0096-3445.136.1.43; Weber F, 2013, HUM FACTORS, V55, P881, DOI 10.1177/0018720813475812; Wenke D, 2005, J EXP PSYCHOL HUMAN, V31, P803, DOI 10.1037/0096-1523.31.4.803; Wenke D, 2015, PSYCHOL RES-PSYCH FO, V79, P899, DOI 10.1007/s00426-014-0621-1; Woltz DJ, 2000, J EXP PSYCHOL LEARN, V26, P601, DOI 10.1037/0278-7393.26.3.601	72	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210597	10.1371/journal.pone.0210597	http://dx.doi.org/10.1371/journal.pone.0210597			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677046	Green Published, gold			2022-12-27	WOS:000456700400019
J	Han, SB; Jang, J; Yang, HK; Hwang, JM; Park, SK				Han, Sang Beom; Jang, Jieun; Yang, Hee Kyung; Hwang, Jeong-Min; Park, Sue K.			Prevalence and risk factors of myopia in adult Korean population: Korea national health and nutrition examination survey 2013-2014 (KNHANES VI)	PLOS ONE			English	Article							REFRACTIVE ERRORS; VITAMIN-D; OUTDOOR ACTIVITY; PARENTAL HISTORY; UNITED-STATES; FAMILY-HISTORY; YOUNG; ASSOCIATION; PROGRESSION; EDUCATION	Purpose To evaluate the prevalence and risk factors of myopia in adult Korean population. Methods Population-based cross-sectional data of 3,398 subjects aged 19 to 49 years was obtained using the Korea National Health and Nutrition Examination Survey 2013-2014 (KNHANES VI). Data, including refractive errors and potential risk factors were analyzed. The prevalence and risk factors of myopia, low myopia, and high myopia-defined as a spherical equivalent (SEQ) <= -0.5 diopters (D), -6.0 D < SEQ <-0.5 D, and SEQ <= -6.0 D, respectively-were evaluated. Results The prevalence of myopia and high myopia were 70.6 (standard error (SE), +/- 1.1)% and 8.0 (SE, +/- 0.6)%, respectively. In multivariable analysis, younger age, higher education (>= 12 years), parental myopia, lower serum 25-hydroxyvitamin D (25(OH)D) concentration (< 9 ng/mL), longer time spent on near work (>= 3 hours/day), and higher white blood cell (WBC) count (5-8.9 x 10(3)) were associated with increased prevalence of both myopia and high myopia. Serum 25(OH)D concentration of >= 9 ng/ml was significantly associated with decreased prevalence of high myopia in participants with near work of >= 3 hours/day, although the effect was not significant in myopia and low myopia. Conclusions The prevalence of myopia and high myopia in Korean adults was substantially high, which increased with decreasing age. In addition to parental myopia, the serum 25(OH)D concentration, near work and inflammation reflected by WBC counts may be associated with myopia.	[Han, Sang Beom] Kangwon Natl Univ, Grad Sch Med, Kangwon Natl Univ Hosp, Dept Ophthalmol, Chunchon, South Korea; [Jang, Jieun; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Hwang, JM (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	hjm@snu.ac.kr; suepark@snu.ac.kr			National Research Foundation of Korea(NRF) - Korea government(MSIP) [2017R1A2B4011450]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03029983]	National Research Foundation of Korea(NRF) - Korea government(MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korea government(MSIP) (No. 2017R1A2B4011450) & by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2017R1D1A1B03029983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, COMPLEX SURVEY DATA; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fan Q, 2014, HUM MOL GENET, V23, P546, DOI 10.1093/hmg/ddt431; Fernandez-Montero A, 2015, PREV MED, V71, P67, DOI 10.1016/j.ypmed.2014.12.005; Guggenheim JA, 2014, INVEST OPHTH VIS SCI, V55, P8550, DOI 10.1167/iovs.14-15839; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Jones-Jordan LA, 2010, INVEST OPHTH VIS SCI, V51, P115, DOI 10.1167/iovs.08-3210; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Kim EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080361; Konstantopoulos A, 2008, EYE, V22, P542, DOI 10.1038/sj.eye.6702693; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Kwon JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005012; Lam DSC, 2008, INVEST OPHTH VIS SCI, V49, P873, DOI 10.1167/iovs.06-1097; Lee JH, 2013, INVEST OPHTH VIS SCI, V54, P5466, DOI 10.1167/iovs.13-12478; Lee YY, 2013, INVEST OPHTH VIS SCI, V54, P1026, DOI 10.1167/iovs.12-10480; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; LEPPLEWIENHUES A, 1991, CURR EYE RES, V10, P983, DOI 10.3109/02713689109020335; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin HJ, 2016, EBIOMEDICINE, V10, P269, DOI 10.1016/j.ebiom.2016.07.021; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; McCarthy CS, 2007, EXP EYE RES, V84, P100, DOI 10.1016/j.exer.2006.09.018; Midelfart A, 2002, ACTA OPHTHALMOL SCAN, V80, P501, DOI 10.1034/j.1600-0420.2002.800508.x; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Muller DN, 2011, J RENIN-ANGIO-ALDO S, V12, P125, DOI 10.1177/1470320311410924; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2007, MOL VIS, V13, P1012; Mutti DO, 2011, INVEST OPHTH VIS SCI, V52, P3818, DOI 10.1167/iovs.10-6534; Mutti DO, 2011, OPTOMETRY VISION SCI, V88, P377, DOI 10.1097/OPX.0b013e31820b0385; Pan CW, 2013, AM J OPHTHALMOL, V155, P1129, DOI 10.1016/j.ajo.2013.01.009; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Read SA, 2014, OPTOMETRY VISION SCI, V91, P330, DOI 10.1097/OPX.0000000000000160; Rim TH, 2016, SEMIN OPHTHALMOL, V32; Rim Tyler Hyungtaek, 2016, Korean J Ophthalmol, V30, P214, DOI 10.3341/kjo.2016.30.3.214; Rose KA, 2002, CLIN EXP OPHTHALMOL, V30, P168, DOI 10.1046/j.1442-9071.2002.00521.x; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Saw SM, 2005, BRIT J OPHTHALMOL, V89, P1489, DOI 10.1136/bjo.2005.071118; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Shimizu N, 2003, JPN J OPHTHALMOL, V47, P6, DOI 10.1016/S0021-5155(02)00620-2; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Tarczy-Hornoch K, 2006, INVEST OPHTH VIS SCI, V47, P1845, DOI 10.1167/iovs.05-1153; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Wu PC, 2013, OPHTHALMOLOGY, V120, P1080, DOI 10.1016/j.ophtha.2012.11.009; Wu PC, 2010, OPHTHAL EPIDEMIOL, V17, P338, DOI 10.3109/09286586.2010.508347; Yazar S, 2014, INVEST OPHTH VIS SCI, V55, P4552, DOI 10.1167/iovs.14-14589	65	18	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211204	10.1371/journal.pone.0211204	http://dx.doi.org/10.1371/journal.pone.0211204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677087	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400060
J	Rosanowski, SM; Carpenter, TE; Adamson, D; Rogers, CW; Pearce, P; Burns, M; Cogger, N				Rosanowski, Sarah M.; Carpenter, Tim E.; Adamson, David; Rogers, Chris W.; Pearce, Patricia; Burns, Martin; Cogger, Naomi			An economic analysis of a contingency model utilising vaccination for the control of equine influenza in a non-endemic country	PLOS ONE			English	Article							NONCOMMERCIAL HORSE PROPERTIES; BIOSECURITY PRACTICES; OUTBREAK; SIMULATION; DISEASE; STRATEGIES; MANAGEMENT; H3N8	Background Equine influenza (EI) is an infectious respiratory disease of horses that has never been reported in New Zealand (NZ). However, the 2007 EI outbreak in Australia, previously EI free, spurred the NZ government and stakeholders into evaluating alternative EI control strategies in order to economically justify any future decision to eradicate or manage EI. To build on the policy debate, this paper presents an epinomic (epidemiologic and economic) modelling approach to evaluate alternative control strategies. An epidemiologic model to determine how alternative EI control strategies influence the distribution of EI. Model results were then input into a cost-benefit analysis framework, to identify the return and feasibility of alternative EI eradication strategies in NZ. Methods The article explores nine alternative eradication scenarios and two baseline strategies. The alternative scenarios consisted of three vaccination strategies (suppressive, protective or targeted) starting at three time points to reflect the commercial breeding-cycle. These alternatives were compared to two breeding-cycle adjusted baselines: movement restriction in the breeding season (August to January) or non-breeding season (February to July). The economic loss parameters were incursion response, impact to the commercial racing industry (breeding, sales and racing), horse morbidity and mortality, and compensation to industry participants. Results and conclusions Results suggest that the economic viability of the EI eradication programme is dependent on when within the breeding-cycle the EI outbreak occurs. If an outbreak were to occur, the return on each dollar invested for protective or suppressive vaccination strategies would be between NZD$3.67 to NZD$4.89 and between NZD$3.08 to NZD$3.50 in the breeding and non-breeding seasons, respectively. Therefore, protective or suppressive vaccination strategies could be prioritised, regardless of season. As multiple industry stakeholders benefit from these strategies, the study will enable policy development and to better formulate a user-pays eradication programme.	[Rosanowski, Sarah M.] City Univ Hong Kong, Ctr Appl One Hlth Res & Policy Advice, Jockey Club Coll Vet Med & Life Sci, Hong Kong, Peoples R China; [Rosanowski, Sarah M.; Carpenter, Tim E.; Cogger, Naomi] Massey Univ, Sch Vet Sci, Epictr, Palmerston North, New Zealand; [Adamson, David] Univ Adelaide, Fac Profess, Ctr Global Food & Resources, Adelaide, SA, Australia; [Adamson, David] Univ Liverpool, Epidemiol & Populat Hlth, Liverpool, Merseyside, England; [Rogers, Chris W.] Massey Univ, Sch Vet Sci, Anim Prod & Hlth Grp, Equine Res Ctr, Palmerston North, New Zealand; [Pearce, Patricia; Burns, Martin] New Zealand Equine Hlth Assoc, Wellington, New Zealand; [Carpenter, Tim E.] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA	City University of Hong Kong; Massey University; University of Adelaide; University of Liverpool; Massey University; University of California System; University of California Davis	Rosanowski, SM (corresponding author), City Univ Hong Kong, Ctr Appl One Hlth Res & Policy Advice, Jockey Club Coll Vet Med & Life Sci, Hong Kong, Peoples R China.; Rosanowski, SM (corresponding author), Massey Univ, Sch Vet Sci, Epictr, Palmerston North, New Zealand.	sarah.rosanowski@cityu.edu.hk	Rogers, Chris W./D-9812-2012; Rosanowski, Sarah/H-5374-2016; Adamson, David/A-5310-2011	Rogers, Chris W./0000-0002-4253-1825; Rosanowski, Sarah/0000-0002-7950-0029; Adamson, David/0000-0003-1616-968X	New Zealand Equine Trust	New Zealand Equine Trust	This study was funded by the New Zealand Equine Trust, with a project entitled "Multi Criteria Decision making to evaluate control strategies for an outbreak of equine influenza" (NC). The funder provided support in the form of partial salary for SMR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2009, EQUINE INFLUENZA 200; [Anonymous], 2010, SIZE SCOPE NZ RACING; [Anonymous], 2008, FISHERIES FORESTRY C; [Anonymous], 2017, CONS PRIC IND; Australian Racing Board, 2008, AUSTR RAC FACTB 2007; Bolwell CF, 2010, P NZ SOC ANIMAL PROD; Bolwell CF, 2018, COMMERCIAL EQUINE PR; Bolwell CF, 2016, ANIM PROD SCI, V56, P82, DOI 10.1071/AN13443; Bolwell CF, 2016, ANIM PROD SCI, V56, P77, DOI 10.1071/AN13442; Callinan I., THE AUGUST 2007 OUTB; Cogger N., 2010, 201160 MAF; Cowled B, 2009, PREV VET MED, V92, P60, DOI 10.1016/j.prevetmed.2009.08.006; Dhand NK, 2011, AUST VET J, V89, P70, DOI 10.1111/j.1751-0813.2011.00753.x; Dicken M., 2011, NZ VET J, V60, P42; George HEA, 2013, CROSS SECTIONAL SURV; GUO YJ, 1995, J GEN VIROL, V76, P2009, DOI 10.1099/0022-1317-76-8-2009; Loch A, 2014, J HYDROL, V518, P5, DOI 10.1016/j.jhydrol.2013.10.049; Matheson A, 2012, EC IMPACT REPORT NZ; Newton JR, 2006, VET REC, V158, P185, DOI 10.1136/vr.158.6.185; Rijssen J. D. van, 2010, Proceedings of the New Zealand Society of Animal Production, V70, P146; Rogers CW, 2007, NEW ZEAL VET J, V55, P302, DOI 10.1080/00480169.2007.36785; Rogers CW, 2009, P NZ AN PROD; Rosanowski SM, 2016, TRANSBOUND EMERG DIS, V63, P321, DOI 10.1111/tbed.12277; Rosanowski SM, 2015, ANIM PROD SCI, V55, P1075, DOI 10.1071/AN13345; Rosanowski SM, 2013, NEW ZEAL VET J, V61, P245, DOI 10.1080/00480169.2012.750571; Rosanowski SM, 2013, PREV VET MED, V108, P178, DOI 10.1016/j.prevetmed.2012.08.003; Rosanowski SM, 2012, PREV VET MED, V107, P85, DOI 10.1016/j.prevetmed.2012.05.001; SANSON RL, 1997, P 8 INT S VET EP EC; Smyth GB, 2011, AUST VET J, V89, P151, DOI 10.1111/j.1751-0813.2011.00777.x; Smyth GB, 2011, AUST VET J, V89, P23, DOI 10.1111/j.1751-0813.2011.00776.x; Stevenson MA, 2013, PREV VET MED, V109, P10, DOI 10.1016/j.prevetmed.2012.08.015; Ward MP, 2009, PREV VET MED, V88, P286, DOI 10.1016/j.prevetmed.2008.12.006; Webster WR, 2011, AUST VET J, V89, P3, DOI 10.1111/j.1751-0813.2011.00721.x; Yoon H, 2006, PREV VET MED, V74, P212, DOI 10.1016/j.prevetmed.2005.12.002	34	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210885	10.1371/journal.pone.0210885	http://dx.doi.org/10.1371/journal.pone.0210885			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677067	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400031
J	Brown, LB; Getahun, M; Ayieko, J; Kwarisiima, D; Owaraganise, A; Atukunda, M; Olilo, W; Clark, T; Bukusi, EA; Cohen, CR; Kamya, MR; Petersen, ML; Charlebois, ED; Havlir, DV; Camlin, CS				Brown, Lillian B.; Getahun, Monica; Ayieko, James; Kwarisiima, Dalsone; Owaraganise, Asiphas; Atukunda, Mucunguzi; Olilo, Winter; Clark, Tamara; Bukusi, Elizabeth A.; Cohen, Craig R.; Kamya, Moses R.; Petersen, Maya L.; Charlebois, Edwin D.; Havlir, Diane V.; Camlin, Carol S.			Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT OUTCOMES; GENDER-DIFFERENCES; TREATMENT PROGRAM; MASCULINITY; AFRICA; RISK; COHORT; SEX	Background Previous research indicates clinical outcomes among HIV-infected men in sub-Saharan Africa are sub-optimal. The SEARCH test and treat trial (NCT01864603) intervention included antiretroviral care delivery designed to address known barriers to HIV-care among men by decreasing clinic visit frequency and providing flexible, patient-centered care with retention support. We sought to understand facilitators and barriers to retention in care in this universal treatment setting through quantitative and qualitative data analysis. Methods We used a convergent mixed methods study design to evaluate retention in HIV care among adults (age > = 15) during the first year of the SEARCH (NCT01864603) test and treat trial. Cox proportional hazards regression was used to evaluate predictors of retention in care. Longitudinal qualitative data from n = 190 in-depth interviews with HIV-positive individuals and health care providers were analyzed to identify facilitators and barriers to HIV care engagement. Results There were 1,863 men and 3,820 women who linked to care following baseline testing. Retention in care was 89.7% (95% CI 87.0-91.8%) among men and 89.0% (86.8-90.9%) among women at one year. In both men and women older age was associated with higher rates of retention in care at one year. Additionally, among men higher CD4+ at ART initiation and decreased time between testing and ART initiation was associated with higher rates of retention. Maintaining physical health, a patient-centered treatment environment, supportive partnerships, few negative consequences to disclosure, and the ability to seek care in facilities outside of their community of residence were found to promote retention in care. Conclusions Features of the ART delivery system in the SEARCH intervention and social and structural advantages emerged as facilitators to retention in HIV care among men. Messaging around the health benefits of early ART start, decreasing logistical barriers to HIV care, support of flexible treatment environments, and accelerated linkage to care, are important to men's success in ART treatment programs. Men already benefit from increased social support following disclosure of their HIV-status. Future efforts to shift gender norms towards greater equity are a potential strategy to support high levels of engagement in care for both men and women.	[Brown, Lillian B.; Clark, Tamara; Havlir, Diane V.] Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA 94143 USA; [Brown, Lillian B.; Charlebois, Edwin D.; Camlin, Carol S.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Getahun, Monica; Cohen, Craig R.; Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Ayieko, James; Atukunda, Mucunguzi; Olilo, Winter; Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Kwarisiima, Dalsone; Owaraganise, Asiphas; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Div Biostat, Berkeley, CA 94720 USA; [Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; Makerere University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Brown, LB (corresponding author), Univ Calif San Francisco, Div HIV ID & Global Med, San Francisco, CA 94143 USA.; Brown, LB (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	lillian.brown@ucsf.edu	Olilo, Winter/AAN-2778-2020	Owaraganise, Asiphas/0000-0002-5594-0310; Cohen, Craig/0000-0001-8654-6634; Getahun, Monica/0000-0002-2116-2637; Brown, Lillian/0000-0003-1809-3762	Division of AIDS, NIAID, of the National Institutes of Health [U01AI099959]; President's Emergency Plan for AIDS Relief; Bill and Melinda Gates Foundation; Gilead Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER	Division of AIDS, NIAID, of the National Institutes of Health; President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this manuscript was supported by Division of AIDS, NIAID, of the National Institutes of Health under award number U01AI099959 (DVH) and in part by the President's Emergency Plan for AIDS Relief, the Bill and Melinda Gates Foundation, and Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckham SW, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21106; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Brown LB, 2016, AIDS, V30, P2855, DOI 10.1097/QAD.0000000000001250; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Camlin CS, 2016, AIDS, V30, P495, DOI 10.1097/QAD.0000000000000931; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Creswell JW, 2021, CONCISE INTRO MIXED; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Fleming PJ, 2016, AIDS, V30, P157, DOI 10.1097/QAD.0000000000000899; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Kahn J. G., 2016, 21 INT AIDS C DURB S; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Kwarisiima D, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.5.21673; Maeri I, 2016, AIDS CARE, V28, P59, DOI 10.1080/09540121.2016.1168917; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; Mburu G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1061; Mosha F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-38; Nyamhanga TM, 2013, TANZANIA GLOBAL HLTH, V6, P21812, DOI DOI 10.3402/GHA.V6I0.21812; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Penot P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18646; Siu GE, 2013, SOC SCI MED, V89, P45, DOI 10.1016/j.socscimed.2013.04.025; Siu GE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17368; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Staveteig S., 2013, DEMOGRAPHIC PATTERNS; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Tsai AC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001906; UNAIDS, 2015, AIDS NUMB 2015; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629	35	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210126	10.1371/journal.pone.0210126	http://dx.doi.org/10.1371/journal.pone.0210126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673744	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800032
J	Bruckbauer, ST; Trimarco, JD; Henry, C; Wood, EA; Battista, JR; Cox, MM				Bruckbauer, Steven T.; Trimarco, Joseph D.; Henry, Camille; Wood, Elizabeth A.; Battista, John R.; Cox, Michael M.			A variant of the Escherichia coli anaerobic transcription factor FNR exhibiting diminished promoter activation function enhances ionizing radiation resistance	PLOS ONE			English	Article							GENE-EXPRESSION; DOSE-RATE; RNA; REQUIREMENTS; EVOLUTION; PROTEIN; O-2	We have previously generated four replicate populations of ionizing radiation (IR)-resistant Escherichia coli though directed evolution. Sequencing of isolates from these populations revealed that mutations affecting DNA repair (through DNA double-strand break repair and replication restart), ROS amelioration, and cell wall metabolism were prominent. Three mutations involved in DNA repair explained the IR resistance phenotype in one population, and similar DNA repair mutations were prominent in two others. The remaining population, IR-3-20, had no mutations in the key DNA repair proteins, suggesting that it had taken a different evolutionary path to IR resistance. Here, we present evidence that a variant of the anaerobic metabolism transcription factor FNR, unique to and isolated from population IR-3-20, plays a role in IR resistance. The F1861 allele of FNR exhibits a diminished ability to activate transcription from FNR-activatable promoters, and furthermore reduces levels of intracellular ROS. The FNR F1861 variant is apparently capable of enhancing resistance to IR under chronic irradiation conditions, but does not increase cell survival when exposed to acute irradiation. Our results underline the importance of dose rate on cell survival of IR exposure.	[Bruckbauer, Steven T.; Trimarco, Joseph D.; Henry, Camille; Wood, Elizabeth A.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Battista, John R.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Battista, John R.] A&M Coll, Baton Rouge, LA USA	University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Bruckbauer, ST (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	steven.bruckbauer@gmail.com		Henry, Camille/0000-0002-4011-6767; Bruckbauer, Steven/0000-0002-1684-8466	National Institutes of Health [GM112757]; National Institute of General Medical Sciences (NIGMS) [GM112757]; Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison); Hilldale Undergraduate Fellowship (UW-Madison); Honors Senior Thesis Summer Research Grant (UWMadison); Biochemistry Undergraduate Summer Research Award (UW-Madison); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison); Hilldale Undergraduate Fellowship (UW-Madison); Honors Senior Thesis Summer Research Grant (UWMadison); Biochemistry Undergraduate Summer Research Award (UW-Madison); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded by the National Institutes of Health grant GM112757 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9534117&icde=39759900) awarded to MMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant GM112757 from the National Institute of General Medical Sciences (NIGMS). Steven Bruckbauer was supported by the Morgridge Biotechnology Scholarship from the Vice Chancellor's Office for Research and Graduate Education, (University of Wisconsin-Madison). Joseph Trimarco was supported by the Hilldale Undergraduate Fellowship (UW-Madison), the Honors Senior Thesis Summer Research Grant (UWMadison), and the Biochemistry Undergraduate Summer Research Award (UW-Madison).	Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boysen A, 2010, J BIOL CHEM, V285, P10690, DOI 10.1074/jbc.M109.089755; Byrne RT, 2014, ELIFE, V3, DOI 10.7554/eLife.01322; Daly Michael J, 2007, PLoS Biol, V5, pe92; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES R, 1973, J BACTERIOL, V114, P357, DOI 10.1128/JB.114.1.357-366.1973; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; Durand S, 2010, MOL MICROBIOL, V75, P1215, DOI 10.1111/j.1365-2958.2010.07044.x; ERDMAN IE, 1961, CAN J MICROBIOL, V7, P207, DOI 10.1139/m61-027; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; LAMBDEN PR, 1976, J GEN MICROBIOL, V97, P145, DOI 10.1099/00221287-97-2-145; Lamberg KE, 2002, J MOL BIOL, V315, P275, DOI 10.1006/jmbi.2001.5241; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Matsuya Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26556-5; Mettert EL, 2008, J MOL BIOL, V384, P798, DOI 10.1016/j.jmb.2008.09.080; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; PARISI A, 1974, APPL MICROBIOL, V28, P41, DOI 10.1128/AEM.28.1.41-46.1974; Piechura JR, 2015, DNA REPAIR, V26, P30, DOI 10.1016/j.dnarep.2014.12.001; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weber KD, 2005, J BACTERIOL, V187, P1724, DOI 10.1128/JB.187.5.1724-1731.2005; Williams SM, 1997, NUCLEIC ACIDS RES, V25, P4028, DOI 10.1093/nar/25.20.4028; WING HJ, 1995, J BACTERIOL, V177, P6704, DOI 10.1128/jb.177.23.6704-6710.1995; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0199482	10.1371/journal.pone.0199482	http://dx.doi.org/10.1371/journal.pone.0199482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673695	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800003
J	Kobayashi, M; Ryozawa, S; Iwano, H; Araki, R; Tanisaka, Y; Fujita, A; Kobatake, T				Kobayashi, Masanori; Ryozawa, Shomei; Iwano, Hirotoshi; Araki, Ryuichiro; Tanisaka, Yuki; Fujita, Akashi; Kobatake, Tsutomu			The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla	PLOS ONE			English	Article							PANCREATIC STENT PLACEMENT; AMPULLARY TUMORS; AMPULLECTOMY	Objectives Although endoscopic papillectomy is useful for treating papillary tumors, it is associated with a high rate of complications including pancreatitis; therefore, safer treatment options are needed. We examined the utility of wire-guided endoscopic papillectomy by comparing the pancreatic duct stenting and pancreatitis rates before and after wire-guided endoscopic papillectomy was introduced at our institution. Methods We retrospectively examined the data from 16 consecutive patients who underwent conventional endoscopic papillectomy between November 1995 and July 2005 and the data from 33 patients in whom wire-guided endoscopic papillectomy was first attempted at our institution between August 2005 and April 2017. We compared the pancreatic duct stenting and pancreatitis rates between the two groups. Results Of the 33 patients in whom wire-guided endoscopic papillectomy was first attempted, the procedure was completed in 21. Pancreatic duct stenting was possible in 30 of the 33 patients in whom wire-guided endoscopic papillectomy was attempted (91%), and this rate was significantly higher than that before the introduction of wire-guided endoscopic papillectomy (68.8%). The incidence of pancreatitis before the introduction of wire-guided endoscopic papillectomy was 12.5%, but after August 2005, the incidence was reduced by half to 6.1%, which includes those patients in whom wire-guided endoscopic papillectomy could not be completed. Conclusions Although wire-guided endoscopic papillectomy cannot be completed in some patients, we believe that this method shows some potential for reducing the total incidence of post-endoscopic papillectomy pancreatitis owing to more successful pancreatic duct stenting.	[Kobayashi, Masanori; Ryozawa, Shomei; Iwano, Hirotoshi; Tanisaka, Yuki; Fujita, Akashi; Kobatake, Tsutomu] Saitama Med Univ, Dept Gastroenterol, Int Med Ctr, Hidaka, Saitama, Japan; [Iwano, Hirotoshi] Shibetsu City Hosp, Gastroenterol & Endoscopy Ctr, Shibetsu, Hokkaido, Japan; [Araki, Ryuichiro] Saitama Med Univ, Community Hlth Sci Ctr, Moroyama, Saitama, Japan	Saitama Medical University; Saitama Medical University	Ryozawa, S (corresponding author), Saitama Med Univ, Dept Gastroenterol, Int Med Ctr, Hidaka, Saitama, Japan.	ryozawa@saitama-med.ac.jp	Tanisaka, Yuki/AAN-3037-2020	Kobayashi, Masanori/0000-0002-9067-859X				Bohnacker S, 2006, ENDOSCOPY, V38, P521, DOI 10.1055/s-2006-925263; Ceppa EP, 2013, ANN SURG, V257, P315, DOI 10.1097/SLA.0b013e318269d010; Chang WI, 2014, GUT LIVER, V8, P306, DOI 10.5009/gnl.2014.8.3.306; Chathadi KV, 2015, GASTROINTEST ENDOSC, V82, P773, DOI 10.1016/j.gie.2015.06.027; Cheng CL, 2004, GASTROINTEST ENDOSC, V60, P757, DOI 10.1016/S0016-5107(04)02029-2; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P8, DOI 10.1016/S0016-5107(03)02530-6; Harano M, 2011, J HEPATO-BIL-PAN SCI, V18, P190, DOI 10.1007/s00534-010-0327-8; Harewood GC, 2005, GASTROINTEST ENDOSC, V62, P367, DOI 10.1016/j.gie.2005.04.020; Kahaleh M, 2004, AM J GASTROENTEROL, V99, P2335, DOI 10.1111/j.1572-0241.2004.40391.x; Kang SH, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0626-5; Kim SH, 2013, ENDOSCOPY, V45, P838, DOI 10.1055/s-0033-1344392; Lee TY, 2016, J GASTROEN HEPATOL, V31, P897, DOI 10.1111/jgh.13205; Moon JH, 2005, GASTROINTEST ENDOSC, V61, P461, DOI 10.1016/S0016-5107(04)02649-5; Napoleon B, 2014, ENDOSCOPY, V46, P127, DOI 10.1055/s-0034-1364875; Suzuki K, 1983, PROG DIG ENDOSC, V23, P236; Tsuji S, 2015, J HEPATO-BIL-PAN SCI, V22, pE22, DOI 10.1002/jhbp.207	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211019	10.1371/journal.pone.0211019	http://dx.doi.org/10.1371/journal.pone.0211019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673748	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800066
J	Lauzi, J; Anders, F; Liu, HH; Pfeiffer, N; Grus, F; Thanos, S; Arnhold, S; Prokosch, V				Lauzi, Jasmin; Anders, Fabian; Liu, Hanhan; Pfeiffer, Norbert; Grus, Franz; Thanos, Solon; Arnhold, Stefan; Prokosch, Verena			Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma	PLOS ONE			English	Article							OPTIC-NERVE CRUSH; AXONAL REGENERATION; NEURITE OUTGROWTH; RAT; EXPRESSION; PATHWAY; SURVIVAL; AKT; PROTEIN-5; APOPTOSIS	Purpose To analyze the potential neuro-protective and neuro-regenerative effects of Collapsin-response-mediator-protein-5 (CRMP-5) on retinal ganglion cells (RGCs) using in vitro and in vivo animal models of glaucoma. Methods Elevated intraocular pressure (IOP) was induced in adult female Sprague-Dawley (SD) rats by cauterization of three episcleral veins. Changes in CRMP-5 expression within the retinal proteome were analyzed via label-free mass spectrometry. In vitro, retinal explants were cultured under elevated pressure (60 mmHg) within a high-pressure incubation chamber with and without addition of different concentrations of CRMP-5 (4 mu g/l, 200 mu g/l and 400 mu g/l). In addition, retinal explants were cultured under regenerative conditions with and without application of 200 mu g/l CRMP-5 after performing an optic nerve crush (ONC). Thirdly, an antibody against Protein Kinase B (PKB) was added to examine the possible effects of CRMP-5. RGC count was performed. Number and length of the axons were determined and compared. To undermine a signal-transduction pathway via CRMP-5 and PKB microarray and immunohistochemistry were performed. Results CRMP-5 was downregulated threefold in animals showing chronically elevated IOP. The addition of CRMP-5 to retinal culture significantly increased RGC numbers under pressure in a dose-dependent manner and increased and elongated outgrowing axons in retinal explants significantly which could be blocked by PKB. Especially the number of neurites longer than 400 mu m significantly increased after application of CRMP-5. CRMP-5 as well as PKB were detected higher in the experimental than in the control group. Conclusion CRMP-5 seems to play an important role in an animal model of glaucoma. Addition of CRMP-5 exerts neuro-protective and neuro-regenerative effects in vitro. This effect could be mediated via activation of PKB affecting intra-cellular apoptosis pathways.	[Lauzi, Jasmin; Anders, Fabian; Liu, Hanhan; Pfeiffer, Norbert; Grus, Franz; Prokosch, Verena] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt Ophthalmol, Mainz, Germany; [Thanos, Solon] Univ Munster, Sch Med, Dept Expt Ophthalmol, Munster, Germany; [Arnhold, Stefan] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany	Johannes Gutenberg University of Mainz; University of Munster; Justus Liebig University Giessen	Prokosch, V (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Expt Ophthalmol, Mainz, Germany.	vprokosch@gmx.de	Pfeiffer, Norbert/AAO-7586-2020		Deutsche Forschungsgemeinschaft [PR1569/1-1 PD]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft (PR1569/1-1 PD) to Dr. Verena Prokosch.	Ahmann P., 2003, IN VITRO STUDIE NEUR; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Anders F, 2017, GRAEF ARCH CLIN EXP, V255, P1395, DOI 10.1007/s00417-017-3678-x; BAHR M, 1988, EXP BRAIN RES, V73, P393; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; Bell K, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13765; Benowitz LI, 2017, EXP NEUROL, V287, P365, DOI 10.1016/j.expneurol.2015.12.015; Bohm MRR, 2015, CELL TRANSPLANT, V24, P1829, DOI 10.3727/096368914X684583; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cross SA, 2003, ANN NEUROL, V54, P38, DOI 10.1002/ana.10587; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Engelsberg K, 2004, GRAEF ARCH CLIN EXP, V242, P229, DOI 10.1007/s00417-003-0780-z; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Fischer D, 2000, INVASTIGATIVE OPHTHA, V41; FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Goldberg JL, 2016, INVEST OPHTH VIS SCI, V57, P1271, DOI 10.1167/iovs.15-18500; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Horiuchi M, 2000, FEBS LETT, V480, P283, DOI 10.1016/S0014-5793(00)01952-9; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Liu HH, 2017, INVEST OPHTH VIS SCI, V58, P5129, DOI 10.1167/iovs.17-22200; Lorber B, 2002, MOL CELL NEUROSCI, V21, P301, DOI 10.1006/mcne.2002.1175; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meyronet D, 2008, AM J SURG PATHOL, V32, P1699, DOI 10.1097/PAS.0b013e31817dc37c; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Moutal A, 2015, CANCER RES, V75, P3519, DOI 10.1158/0008-5472.CAN-14-0631; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rose K, 2004, SPEZIESSPEZIFISCHE P; SHAREEF SR, 1995, EXP EYE RES, V61, P379, DOI 10.1016/S0014-4835(05)80131-9; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan F, 2014, ONCOL LETT, V7, P1333, DOI 10.3892/ol.2014.1909; Terzic A, 2013, STEM CELLS DEV, V22, P20, DOI 10.1089/scd.2013.0448; Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Trost A, 2017, EXP EYE RES, V159, P30, DOI 10.1016/j.exer.2017.03.003; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Veyrac A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023721; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Xu P, 2010, J NEURO-ONCOL, V97, P41, DOI 10.1007/s11060-009-0007-1; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yamashita N, 2011, J NEUROSCI, V31, P1773, DOI 10.1523/JNEUROSCI.5337-10.2011; Zhen PY, 2017, EXP EYE RES, V162, P97, DOI 10.1016/j.exer.2017.06.014	56	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0207190	10.1371/journal.pone.0207190	http://dx.doi.org/10.1371/journal.pone.0207190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673694	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800007
J	Lillegraven, S; Greenberg, JD; Reed, GW; Saunders, K; Curtis, JR; Harrold, L; Hochberg, MC; Pappas, DA; Kremer, JM; Solomon, DH				Lillegraven, Siri; Greenberg, Jeffrey D.; Reed, George W.; Saunders, Katherine; Curtis, Jeffrey R.; Harrold, Leslie; Hochberg, Marc C.; Pappas, Dimitrios A.; Kremer, Joel M.; Solomon, Daniel H.			Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; GLYCOSYLATED HEMOGLOBIN; PSORIATIC-ARTHRITIS; INSULIN-RESISTANCE; DISEASE-ACTIVITY; INFLAMMATION; HYDROXYCHLOROQUINE; ASSOCIATION; MELLITUS	Objective Inflammation and anti-inflammatory treatments might influence the risk of diabetes. The objective of this study was to assess factors associated with incident diabetes in rheumatoid arthritis (RA). Methods The study population consisted of RA patients from a multi-center cohort study, Corrona. To assess risk associated with disease modifying antirheumatic drug (DMARD) exposure, we assessed five mutually exclusive DMARD groups. Additionally, we assessed the risk associated with body mass index (BMI, <25, 25-30, >30 kg/m2) and glucocorticoid usage. Incident cases of diabetes were confirmed through adjudication, and Cox regression models were fit to estimate the risk of incident diabetes. Results We identified 21,775 DMARD treatment regimens, the mean (SD) age at the index visit was 58 (13) years, disease duration 10 (10) years, and 30% used oral glucocorticoids at the time. Eighty-four incident cases of diabetes were confirmed within the treatment exposure periods. The hazard ratio (HR, 95% confidence interval) for diabetes was significantly reduced in patients receiving TNF inhibitors, HR 0.35 (0.13, 0.91), compared to patients treated with non-biologic DMARDs other than hydroxychloroquine and methotrexate. Hydroxychloroquine, methotrexate and use of other biologic DMARDs had a numerically reduced risk compared to the same group. Patients prescribed >= 7.5 mg of glucocorticoids had a HR of 2.33 (1.68, 3.22) of incident diabetes compared with patients not prescribed oral glucocorticoids. RA patients with a BMI >30 had a HR of 6.27 (2.97, 13.25) compared to patients with BMI <= 25. Conclusion DMARDs, glucocorticoids and obesity influenced the risk of incident diabetes in a large cohort of RA patients. Monitoring for the occurrence of diabetes should be part of routine RA management with a focus on specific subgroups.	[Lillegraven, Siri] Diakonhjemmet Hosp, Oslo, Norway; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY USA; [Reed, George W.; Harrold, Leslie] Corrona LLC, Worcester, MA USA; [Reed, George W.] UMass Med Sch, Worcester, MA USA; [Saunders, Katherine] Corrona LLC, Southborough, MA USA; [Curtis, Jeffrey R.] Univ Alabama Birmingham, Birmingham, AL USA; [Harrold, Leslie] Univ Massachusetts, Sch Med, Worcester, MA USA; [Hochberg, Marc C.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Kremer, Joel M.] Albany Med Coll, Albany, NY 12208 USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Solomon, Daniel H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Diakonhjemmet Hospital; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Corrona, LLC; University of Massachusetts System; University of Massachusetts Worcester; Corrona, LLC; University of Alabama System; University of Alabama Birmingham; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland Baltimore; Columbia University; Albany Medical College; Harvard University; Brigham & Women's Hospital	Lillegraven, S (corresponding author), Diakonhjemmet Hosp, Oslo, Norway.	Siri.Lillegraven@gmail.com			National Institutes of Health [K24 AR055989]; Corrona LLC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR055989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Corrona LLC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Solomon receives grant support for mentoring from the National Institutes of Health (https://www.nih.gov), K24 AR055989. Corrona LLC funded the data collection and provided support in the form of salaries for authors KS and GR, but did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Ajeganova S, 2013, ARTHRIT CARE RES, V65, P78, DOI 10.1002/acr.21710; Aletaha D, 2007, BEST PRACT RES CL RH, V21, P663, DOI 10.1016/j.berh.2007.02.004; Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; Bili A, 2011, JCR-J CLIN RHEUMATOL, V17, P115, DOI 10.1097/RHU.0b013e318214b6b5; Boers M, 2013, ANN RHEUM DIS, V72, P406, DOI 10.1136/annrheumdis-2012-202333; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Chung CP, 2008, ARTHRITIS RHEUM-US, V58, P2105, DOI 10.1002/art.23600; Chung CP, 2008, ATHEROSCLEROSIS, V196, P756, DOI 10.1016/j.atherosclerosis.2007.01.004; de Rotte MCFJ, 2014, ARTHRITIS RHEUMATOL, V66, P2026, DOI 10.1002/art.38652; den Uyl D, 2012, ARTHRITIS RHEUM-US, V64, P639, DOI 10.1002/art.33378; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Giles JT, 2008, ARTHRIT RHEUM-ARTHR, V59, P1407, DOI 10.1002/art.24109; Greenberg JD, 2011, ANN RHEUM DIS, V70, P576, DOI 10.1136/ard.2010.129916; Han CL, 2006, J RHEUMATOL, V33, P2167; Kremer JM, 2006, AUTOIMMUN REV, V5, P46, DOI 10.1016/j.autrev.2005.07.006; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Movahedi M, 2016, ARTHRITIS RHEUMATOL, V68, P1089, DOI 10.1002/art.39537; Ozen G, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209954; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Rasmussen SS, 2016, DIABETOLOGIA, V59, P989, DOI 10.1007/s00125-016-3887-6; Rekedal LR, 2010, ARTHRITIS RHEUM-US, V62, P3569, DOI 10.1002/art.27703; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Wasko MC, 2011, ARTHRIT CARE RES, V63, P512, DOI 10.1002/acr.20414; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187	31	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210459	10.1371/journal.pone.0210459	http://dx.doi.org/10.1371/journal.pone.0210459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673733	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800042
J	Cummings, KC; Kou, TD; Chak, A; Schluchter, MD; Margevicius, S; Cooper, GS; Meropol, NJ; Perry, Y; Linden, PA; Cummings, LC				Cummings, Kenneth C., III; Kou, Tzuyung Doug; Chak, Amitabh; Schluchter, Mark D.; Margevicius, Seunghee; Cooper, Gregory S.; Meropol, Neal J.; Perry, Yaron; Linden, Philip A.; Cummings, Linda C.			Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study	PLOS ONE			English	Article							TRADITIONAL PAIN MANAGEMENT; HOSPITAL VOLUME; TRANSTHORACIC ESOPHAGECTOMY; TRANSHIATAL RESECTION; FOLLOW-UP; MORTALITY; SURGERY; RECURRENCE; ADENOCARCINOMA; ANESTHESIA	Background Esophagectomy for esophageal cancer carries high morbidity and mortality, particularly in older patients. Transthoracic esophagectomy allows formal lymphadenectomy, but leads to greater perioperative morbidity and pain than transhiatal esophagectomy. Epidural analgesia may attenuate the stress response and be less immunosuppressive than opioids, potentially affecting long-term outcomes. These potential benefits may be more pronounced for transthoracic esophagectomy due to its greater physiologic impact. We evaluated the impact of epidural analgesia on survival and recurrence after transthoracic versus transhiatal esophagectomy. Methods A retrospective cohort study was performed using the linked Surveillance, Epidemiology and End Results (SEER)-Medicare database. Patients aged. 66 years with locoregional esophageal cancer diagnosed 1994-2009 who underwent esophagectomy were identified, with follow-up through December 31, 2013. Epidural receipt and surgical approach were identified from Medicare claims. Survival analyses adjusting for hospital esophagectomy volume, surgical approach, and epidural use were performed. A subgroup analysis restricted to esophageal adenocarcinoma patients was performed. Results Among 1,921 patients, 38% underwent transhiatal esophagectomy (n = 730) and 62% underwent transthoracic esophagectomy (n = 1,191). 61% (n = 1,169) received epidurals and 39% (n = 752) did not. Epidural analgesia was associated with transthoracic approach and higher volume hospitals. Patients with epidural analgesia had better 90-day survival. Five-year survival was higher with transhiatal esophagectomy (37.2%) than transthoracic esophagectomy (31.0%, p = 0.006). Among transthoracic esophagectomy patients, epidural analgesia was associated with improved 5-year survival (33.5% epidural versus 26.5% non-epidural, p = 0.012; hazard ratio 0.81, 95% confidence interval [0.70, 0.93]). Among the subgroup of esophageal adenocarcinoma patients undergoing transthoracic esophagectomy, epidural analgesia remained associated with improved 5-year survival (hazard ratio 0.81, 95% confidence interval [0.67, 0.96]); this survival benefit persisted in sensitivity analyses adjusting for propensity to receive an epidural. Conclusion Among patients undergoing transthoracic esophagectomy, including a subgroup restricted to esophageal adenocarcinoma, epidural analgesia was associated with improved survival even after adjusting for other factors.	[Cummings, Kenneth C., III] Cleveland Clin, Inst Anesthesiol, Cleveland, OH 44106 USA; [Cummings, Kenneth C., III; Chak, Amitabh; Schluchter, Mark D.; Margevicius, Seunghee; Cooper, Gregory S.; Meropol, Neal J.; Linden, Philip A.; Cummings, Linda C.] Cleveland Clin, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Cummings, Kenneth C., III] Case Western Reserve Univ, Sch Med, Dept Anesthesiol, Cleveland, OH USA; [Kou, Tzuyung Doug; Schluchter, Mark D.; Margevicius, Seunghee] Case Western Reserve Univ, Dept Quantitat & Populat Hlth Sci, Cleveland, OH 44106 USA; [Chak, Amitabh; Cooper, Gregory S.; Cummings, Linda C.] Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Chak, Amitabh; Cooper, Gregory S.; Cummings, Linda C.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Perry, Yaron; Linden, Philip A.] Univ Hosp Cleveland Med Ctr, Dept Surg, Cleveland, OH USA; [Perry, Yaron; Linden, Philip A.] Case Western Reserve Univ, Sch Med, Dept Surg, Cleveland, OH 44106 USA; [Meropol, Neal J.] Flatiron Hlth, New York, NY USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Cummings, LC (corresponding author), Cleveland Clin, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Cummings, LC (corresponding author), Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH 44106 USA.; Cummings, LC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.	linda.cummings@case.edu	Perry, Yaron/AAB-6134-2021	Perry, Yaron/0000-0002-1564-5958; Cummings, Linda/0000-0002-8767-2795	American College of Gastroenterology Junior Faculty Development Grant; National Institutes of Health [P30CA043703, U54CA163060, P50CA150964, UL1TR000439, P30DK097948]; NATIONAL CANCER INSTITUTE [U54CA163060, P50CA150964, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439, UL1TR002548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948] Funding Source: NIH RePORTER	American College of Gastroenterology Junior Faculty Development Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an American College of Gastroenterology Junior Faculty Development Grant (gi.org, awarded to LCC). AC was supported by National Institutes of Health (www.nih.gov) grants U54CA163060 and P50CA150964. GSC was supported by National Institutes of Health grants P50CA150964, UL1TR000439, P30DK097948, and P30CA043703. MDS and NJM were supported by National Institutes of Health grant P30CA043703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate E, 2010, J AM COLL SURGEONS, V210, P428, DOI 10.1016/j.jamcollsurg.2010.01.006; Anderson SA, 2007, TRANSFUSION, V47, P582, DOI 10.1111/j.1537-2995.2007.01159.x; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Ben-Eliyahu S, 1999, INT J CANCER, V80, P880; Bhayani NH, 2013, JAMA SURG, V148, P733, DOI 10.1001/jamasurg.2013.2356; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Boshier PR, 2011, ANN SURG, V254, P894, DOI 10.1097/SLA.0b013e3182263781; Brand JM, 1997, CLIN IMMUNOL IMMUNOP, V83, P190, DOI 10.1006/clin.1997.4351; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Chang AC, 2008, ANN THORAC SURG, V85, P424, DOI 10.1016/j.athoracsur.2007.10.007; Cummings KC, 2014, REGION ANESTH PAIN M, V39, P200, DOI 10.1097/AAP.0000000000000079; Cummings KC, 2012, ANESTHESIOLOGY, V116, P797, DOI 10.1097/ALN.0b013e31824674f6; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hsu PK, 2011, J GASTROINTEST SURG, V15, P558, DOI 10.1007/s11605-011-1458-1; In H, 2016, ANN SURG, V263, P286, DOI 10.1097/SLA.0000000000001215; Khullar OV, 2015, J SURG ONCOL, V112, P517, DOI 10.1002/jso.24024; Klotz R, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1306-4; Kutup A, 2014, ANN SURG, V260, P1016, DOI 10.1097/SLA.0000000000000335; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Liu Z, 2007, CLIN CANCER RES, V13, P2992, DOI 10.1158/1078-0432.CCR-06-2072; Low DE, 2015, ANN SURG, V262, P286, DOI 10.1097/SLA.0000000000001098; Melis M, 2009, J SURG RES, V153, P114, DOI 10.1016/j.jss.2008.06.005; Michelet P, 2005, CHEST, V128, P3461, DOI 10.1378/chest.128.5.3461; O'Riain SC, 2005, ANESTH ANALG, V100, P244, DOI 10.1213/01.ANE.0000143336.37946.7D; Omloo JMT, 2007, ANN SURG, V246, P992, DOI 10.1097/SLA.0b013e31815c4037; Popping DM, 2014, ANN SURG, V259, P1056, DOI 10.1097/SLA.0000000000000237; Reames BN, 2014, ANN SURG, V260, P244, DOI 10.1097/SLA.0000000000000375; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Shapiro J, 2015, LANCET ONCOL, V16, P1090, DOI 10.1016/S1470-2045(15)00040-6; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Silber JH, 2000, ANESTHESIOLOGY, V93, P152, DOI 10.1097/00000542-200007000-00026; Smit JK, 2010, AM J SURG, V200, P446, DOI 10.1016/j.amjsurg.2009.12.006; Stein HJMDF, 2005, ANN SURG, V242, P260; Stiles BM, 2011, ANN THORAC SURG, V92, P491, DOI 10.1016/j.athoracsur.2011.04.004; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Thomson IG, 2010, ANN SURG, V252, P281, DOI 10.1097/SLA.0b013e3181e909a2; van Sandick JW, 2003, ANN SURG, V237, P35, DOI 10.1097/00000658-200301000-00006; Warren JL, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv134; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Weng ML, 2016, ONCOTARGET, V7, P15262, DOI 10.18632/oncotarget.7683; Wu CL, 2006, J CLIN ANESTH, V18, P515, DOI 10.1016/j.jclinane.2006.03.005; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Zingg U, 2011, ANN SURG ONCOL, V18, P1460, DOI 10.1245/s10434-010-1474-5	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211125	10.1371/journal.pone.0211125	http://dx.doi.org/10.1371/journal.pone.0211125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668599	Green Submitted, gold, Green Published			2022-12-27	WOS:000456306400032
J	Jacobsen, JV; Steen, K; Nilssen, KJ				Jacobsen, Julianne Valla; Steen, Klemet; Nilssen, Kjell J.			Anaesthetic efficacy of Aqui-S, Benzoak, and MS-222 on lumpfish (Cyclopterus lumpus) fries. Impact from temperature, salinity, and fasting	PLOS ONE			English	Article							COD GADUS-MORHUA; CLOVE OIL; METOMIDATE; BENZOCAINE; SEDATION	Large numbers of lumpfish are produced for the Norwegian salmon industry and are used to combat sea lice infestations. Periodically high mortality of farmed lumpfish demonstrates the need to improve farming conditions and animal welfare. As part of such efforts, the present work tested the efficacy of three anaesthetic chemicals on lumpfish fries (average weight of 0.97 g). The anaesthetic impact from salinity (15 ppt-18 ppt), temperature (12 degrees C versus 7 and 18 degrees C), and fasting conditions (three days) was also examined. Surgical anaesthesia was induced within 3 to 5 min (preferred time) at concentrations of 18 mg/L (Aqui-S), 37.5 mg/L (Benzoak), and 60 mg/L (buffered MS-222). Safety margins were regarded as low when using Aqui-S; therefore, this chemical was not considered suitable for prolonged exposures. The lumpfish made a rapid recovery from both Benzoak and MS-222 even after 20 min of exposure. A 6 degrees C increase in exposure temperature (reaching 18 degrees C) was found to delay or inhibit recovery. The effect of a 5 degrees C decrease (down to 7 degrees C) significantly reduced induction time for MS-222 and was insignificant for Aqui-S, while it prolonged Benzoak induction time significantly and gave a longer recovery period. Fasting resulted in 70% recovery after 20 min of Aqui-S exposure compared to 0% in fed fish but had only minor effects on Benzoak and MS-222. Use of brackish water (15 ppt-18 ppt) gave 20% recovery from Aqui-S and significantly shorter recovery time from MS-222 exposure, while the effects on Benzoak were insignificant.	[Jacobsen, Julianne Valla] Leroy Midt AS, Sandstad, Norway; [Steen, Klemet] Leroy Seafood Grp ASA, Bergen, Norway; [Nilssen, Kjell J.] Norwegian Univ Sci & Technol, Fac Sci & Technol, Dept Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Jacobsen, JV (corresponding author), Leroy Midt AS, Sandstad, Norway.	julianne.valla.jacobsen@leroymidt.no						Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borno G, FISKEHELSERAPPORTEN, P70; Fiskeridirektoratet, 2017, OPPDR RENS; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; Gismervik K., VETERINAERINSTITUTTE; Gomes DP, 2011, AQUAC RES, V42, P878, DOI 10.1111/j.1365-2109.2011.02864.x; Grontvedt R, FISKEHELSERAPPORTEN, P49; Haya K, 2005, HANDB ENVIRON CHEM, V5, P305, DOI 10.1007/b136016; Helgesen KO, 2015, AQUACULT REP, V1, P37, DOI 10.1016/j.aqrep.2015.01.001; Iversen A., 2017, 242017 NOFIMA; Iversen M, 2003, AQUACULTURE, V221, P549, DOI 10.1016/S0044-8486(03)00111-X; Kiessling A, 2009, AQUACULTURE, V286, P301, DOI 10.1016/j.aquaculture.2008.09.037; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; MATTSON NS, 1989, AQUACULTURE, V83, P89, DOI 10.1016/0044-8486(89)90063-X; MEHNER T, 1994, J FISH BIOL, V45, P325, DOI 10.1111/j.1095-8649.1994.tb01311.x; Mylonas CC, 2005, AQUACULTURE, V246, P467, DOI 10.1016/j.aquaculture.2005.02.046; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; NEUMCKE B, 1981, PFLUG ARCH EUR J PHY, V390, P230, DOI 10.1007/BF00658267; Powell A., 2017, REV AQUACULTURE; Scanvacc, AQ S VET; Skar MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179344; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; SSB, 2017, STAT NORW; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2011, AQUAC RES, V42, P1235, DOI 10.1111/j.1365-2109.2010.02711.x; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211080	10.1371/journal.pone.0211080	http://dx.doi.org/10.1371/journal.pone.0211080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668593	Green Submitted, Green Published, gold			2022-12-27	WOS:000456306400031
J	Bartel, F; Vrenken, H; van Herk, M; de Ruiter, M; Belderbos, J; Hulshof, J; de Munck, JC				Bartel, Fabian; Vrenken, Hugo; van Herk, Marcel; de Ruiter, Michiel; Belderbos, Jose; Hulshof, Joost; de Munck, Jan C.			FAst Segmentation Through SURface Fairing (FASTSURF): A novel semi-automatic hippocampus segmentation method	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; AUTOMATED METHODS FREESURFER; ADNI HARMONIZED PROTOCOL; WHOLE-BRAIN RADIOTHERAPY; MANUAL SEGMENTATION; ATROPHY RATES; VOLUME; RELIABILITY; ROBUST; MRI	Objective The objective is to present a proof-of-concept of a semi-automatic method to reduce hippocampus segmentation time on magnetic resonance images (MRI). Materials and methods FAst Segmentation Through SURface Fairing (FASTSURF) is based on a surface fairing technique which reconstructs the hippocampus from sparse delineations. To validate FASTSURF, simulations were performed in which sparse delineations extracted from full manual segmentations served as input. On three different datasets with different diagnostic groups, FASTSURF hippocampi were compared to the original segmentations using Jaccard overlap indices and percentage volume differences (PVD). In one data set for which back-toback scans were available, unbiased estimates of overlap and PVD were obtained. Using longitudinal scans, we compared hippocampal atrophy rates measured by manual, FASTSURF and two automatic segmentations (FreeSurfer and FSL-FIRST). Results With only seven input contours, FASTSURF yielded mean Jaccard indices ranging from 72 (+/- 4.3)% to 83(+/- 2.6)% and PVDs ranging from 0.02(+/- 2.40)% to 3.2(+/- 3.40)% across the three datasets. Slightly poorer results were obtained for the unbiased analysis, but the performance was still considerably better than both tested automatic methods with only five contours. Conclusions FASTSURF segmentations have high accuracy and require only a fraction of the delineation effort of fully manual segmentation. Atrophy rate quantification based on completely manual segmentation is well reproduced by FASTSURF. Therefore, FASTSURF is a promising tool to be implemented in clinical workflow, provided a future prospective validation confirms our findings.	[Bartel, Fabian; Vrenken, Hugo; de Munck, Jan C.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [van Herk, Marcel] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci,Manchester Canc Res Ctr,Div Canc Sci, Manchester, Lancs, England; [de Ruiter, Michiel] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [Belderbos, Jose] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Hulshof, Joost] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Manchester; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Bartel, F (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	f.bartel@vumc.nl	van Herk, Marcel/P-6307-2015	van Herk, Marcel/0000-0001-6448-898X; De Munck, Jan/0000-0002-5206-0086; Vrenken, Hugo/0000-0001-9106-1172	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; ZonMW; Netherlands organisation for health research and development [104002006]; Netherlands Cancer Institute (NKI) in Amsterdam; Neurotrack Technologies; NATIONAL INSTITUTE ON AGING [P30AG010129] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW(Netherlands Organization for Health Research and Development); Netherlands organisation for health research and development(Netherlands Organization for Health Research and Development); Netherlands Cancer Institute (NKI) in Amsterdam; Neurotrack Technologies; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. This study was funded by ZonMW, the Netherlands organisation for health research and development (Grand Number: 104002006), and Netherlands Cancer Institute (NKI) in Amsterdam.	Aoyama H, 2007, INT J RADIAT ONCOL, V68, P1388, DOI 10.1016/j.ijrobp.2007.03.048; Apostolova LG, 2006, BRAIN, V129, P2867, DOI 10.1093/brain/awl274; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Bartel F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166785; Boccardi M, 2011, ADV ALZH DIS, V2, P111, DOI 10.3233/978-1-60750-793-2-111; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P126, DOI 10.1016/j.jalz.2014.02.009; Botsch M, 2010, POLYGON MESH PROCESS, V1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2015, ALZHEIMERS DEMENT, V11, P111, DOI 10.1016/j.jalz.2014.05.1756; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Germeyan SC, 2014, EPILEPSIA, V55, P1374, DOI 10.1111/epi.12694; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Giraud R, 2016, NEUROIMAGE, V124, P770, DOI 10.1016/j.neuroimage.2015.07.076; Gondi V, HIPPOCAMPAL CONTOURI; Gondi V, 2010, INT J RADIAT ONCOL, V78, P1244, DOI 10.1016/j.ijrobp.2010.01.039; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim H, 2012, NEUROIMAGE, V59, P3178, DOI 10.1016/j.neuroimage.2011.11.040; Lehmann M, 2010, NEUROIMAGE, V49, P2264, DOI 10.1016/j.neuroimage.2009.10.056; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; Oskan F, 2014, STRAHLENTHER ONKOL, V190, P337, DOI 10.1007/s00066-013-0518-8; Pardoe HR, 2009, EPILEPSIA, V50, P2586, DOI 10.1111/j.1528-1167.2009.02243.x; Patenaude B., 2007, DEP CLIN NEUROL; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Press WH, 2007, NUMERICAL RECIPES; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sanchez-Benavides G, 2010, PSYCHIAT RES-NEUROIM, V181, P219, DOI 10.1016/j.pscychresns.2009.10.011; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tanskanen P, 2005, SCHIZOPHR RES, V75, P283, DOI 10.1016/j.schres.2004.09.022; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Wu WC, 2005, AM J NEURORADIOL, V26, P1270; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210641	10.1371/journal.pone.0210641	http://dx.doi.org/10.1371/journal.pone.0210641			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657776	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000014
J	Bort, A; Sanchez, BG; Spinola, E; Mateos-Gomez, PA; Rodriguez-Henche, N; Diaz-Laviada, I				Bort, Alicia; Sanchez, Belen G.; Spinola, Elena; Mateos-Gomez, Pedro A.; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines			The red pepper's spicy ingredient capsaicin activates AMPK in HepG2 cells through CaMKK beta	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; AUTOPHAGY; GUIDELINES; ASSAYS	Capsaicin is a natural compound present in chili and red peppers and the responsible of their spicy flavor. It has recently provoked interest because of its antitumoral effects in many cell types although its action mechanism is not clearly understood. As metabolic dysregulation is one of the hallmarks of cancer cells and the key metabolic sensor in the AMP-activated kinase (AMPK), in this study we explored the ability of capsaicin to modulate AMPK activity. We found that capsaicin activated AMPK in HepG2 cells by increasing AMPK phosphorylation and its downstream target ACC. Mechanistically, we determined that capsaicin activated AMPK through the calcium/calmodulin-dependent protein kinase kinase beta, CaMKK beta as either the CaMKK inhibitor STO-609 or CaMKK knock down with siRNA abrogated the activation of AMPK. Moreover, capsaicin decreased cell viability, inhibited Akt/mTOR pathway and increased reactive oxygen species (ROS) in HepG2 cells. AMPK activation was involved in the underpinning mechanism of capsaicin-induced cell death.	[Bort, Alicia; Sanchez, Belen G.; Mateos-Gomez, Pedro A.; Rodriguez-Henche, Nieves; Diaz-Laviada, Ines] Univ Alcala, Sch Med & Hlth Sci, Dept Syst Biol, Madrid, Spain; [Spinola, Elena] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol Physiol Genet & Immunol, Univ Inst Biomed & Hlth Res IUIBS, Las Palmas Gran Canaria, Spain; [Diaz-Laviada, Ines] Univ Alcala de Henares, Chem Res Inst Andres M del Rio IQAR, Madrid, Spain	Universidad de Alcala; Universidad de Las Palmas de Gran Canaria; Universidad de Alcala	Diaz-Laviada, I (corresponding author), Univ Alcala, Sch Med & Hlth Sci, Dept Syst Biol, Madrid, Spain.; Diaz-Laviada, I (corresponding author), Univ Alcala de Henares, Chem Res Inst Andres M del Rio IQAR, Madrid, Spain.	ines.diazlaviada@uah.es	Mateos-Gomez, Pedro A/E-9924-2018; Diaz-Laviada, Ines/I-2838-2015; Rodriguez-Henche, Nieves/K-6828-2017; Bueno, Bort/AAC-1242-2019	Mateos-Gomez, Pedro A/0000-0002-5539-2289; Diaz-Laviada, Ines/0000-0001-9704-4373; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Bueno, Bort/0000-0003-1490-5823; Spinola Lasso, Elena/0000-0003-2207-5786; Belen, Sanchez Gomez/0000-0003-0971-1522	Fundacion Tatiana Perez de Guzman [Patrocinio 2013-01]; Universidad de Alcala [UAH-GC 2018-1]	Fundacion Tatiana Perez de Guzman; Universidad de Alcala	IDL has received the grants no Patrocinio 2013-01 from Fundacion Tatiana Perez de Guzman and no UAH-GC 2018-1 from Universidad de Alcala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantini C, 2016, ONCOTARGET, V7, P50180, DOI 10.18632/oncotarget.10326; Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-72; Bort A, 2017, ONCOTARGET, V8, P87684, DOI 10.18632/oncotarget.21196; Chen X, 2016, FREE RADICAL RES, V50, P744, DOI 10.3109/10715762.2016.1173689; Clark R, 2016, ANTICANCER RES, V36, P837; Diaz-Laviada I, 2014, PROG DRUG RES, V68, P181, DOI 10.1007/978-3-0348-0828-6_8; Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Friedman JR, 2018, J PHARMACOL EXP THER, V364, P462, DOI 10.1124/jpet.117.243691; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Leung FW, 2014, PROG DRUG RES, V68, P171, DOI 10.1007/978-3-0348-0828-6_7; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Narang Nithida, 2017, Pharmacogn Rev, V11, P23, DOI 10.4103/phrev.phrev_48_16; Peng M, 2017, CANCER TREAT REV, V54, P24, DOI 10.1016/j.ctrv.2017.01.005; Ramos-Torres A, 2016, ONCOTARGET, V7, P1569, DOI 10.18632/oncotarget.6415; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Scherz-Shouval R, 2019, EMBO J, V38, DOI 10.15252/embj.2019101812; Sengupta S, 2017, ONCOGENE, V36, P5709, DOI 10.1038/onc.2017.164; Shen W, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.00272; Song JX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00602; Sun LC, 2018, BBA-REV CANCER, V1870, P51, DOI 10.1016/j.bbcan.2018.06.005; Tian N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030191; Wang Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0922-0; Wang ZY, 2016, EXPERIENTIA SUPPL, V107, P203, DOI 10.1007/978-3-319-43589-3_9; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Zang YF, 2018, J AGR FOOD CHEM, V66, P6772, DOI 10.1021/acs.jafc.8b01831; Zhao HJ, 2017, IEEE T INTELL TRANSP, V18, P192, DOI 10.1109/TITS.2016.2571726	32	13	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211420	10.1371/journal.pone.0211420	http://dx.doi.org/10.1371/journal.pone.0211420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695053	Green Submitted, gold, Green Published			2022-12-27	WOS:000457046400034
J	Grover, D; Bauhoff, S; Friedman, J				Grover, Dhruv; Bauhoff, Sebastian; Friedman, Jed			Using supervised learning to select audit targets in performance-based financing in health: An example from Zambia	PLOS ONE			English	Article								Independent verification is a critical component of performance-based financing (PBF) in health care, in which facilities are offered incentives to increase the volume of specific services but the same incentives may lead them to over-report. We examine alternative strategies for targeted sampling of health clinics for independent verification. Specifically, we empirically compare several methods of random sampling and predictive modeling on data from a Zambian PBF pilot that contains reported and verified performance for quantity indicators of 140 clinics. Our results indicate that machine learning methods, particularly Random Forest, outperform other approaches and can increase the cost-effectiveness of verification activities.	[Grover, Dhruv] Univ Calif San Diego, Kavli Inst Brain & Mind, San Diego, CA 92103 USA; [Bauhoff, Sebastian] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Friedman, Jed] World Bank, Dev Res Grp, 1818 H St NW, Washington, DC 20433 USA	University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; The World Bank	Bauhoff, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	sbauhoff@cgdev.org	Friedman, Jed/AAA-1326-2020	Grover, Dhruv/0000-0001-5438-233X; Bauhoff, Sebastian/0000-0001-6017-4991	Australian Department of Foreign Affairs and Trade [72518]; Johnson Johnson [C2017001214]	Australian Department of Foreign Affairs and Trade(Australian Government); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	Resources for the data collection were provided by the Health Results Innovation Trust Fund administered by the World Bank. The Center for Global Development (CGD) is grateful for contributions from the Australian Department of Foreign Affairs and Trade (grant agreement 72518) and Johnson & Johnson (C2017001214) in support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICPA, 2017, AUD GUID AUD SAMPL; [Anonymous], 2017, MATL R2017B; Antony M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2148-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COX DR, 1958, J R STAT SOC B, V20, P215; Dua P, 2014, INTELLIGENT SYSTEMS, P261, DOI [10.1007/978-3-642-40017-9_12, DOI 10.1007/978-3-642-40017-9_12]; Forgia GL, 2012, GOVT SPONSORED HLTH; Friedman J, 2017, IMPACT EVALUATION ZA; Fritsche G., 2014, PERFORMANCE BASED FI; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; HRITF, 2015, AACH RES WOM CHILDR; Joudaki Hossein, 2015, GLOB J HLTH SCI, V7, P194, DOI [DOI 10.5539/gjhs.v7n1p194, DOI 10.5539/GJHS.V7N1P194]; Mackey TK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9547; Morton M, 2016, HEALTH AFFAIR, V35, P1792, DOI 10.1377/hlthaff.2016.0588; Naimoli J, 2010, VERIFICATION GLANCE; Provost F., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P43; Renaud A., 2013, VERIFICATION PERFORM; Russell S.J., 2016, ARTIF INTELL; Shen GC, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0179-2; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Vergeer P, 2016, VERIFICATION RESULTS; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211262	10.1371/journal.pone.0211262	http://dx.doi.org/10.1371/journal.pone.0211262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695057	gold, Green Published			2022-12-27	WOS:000457046400021
J	Grievink, H; Kuzmina, N; Chevion, M; Drenger, B				Grievink, Hilbert; Kuzmina, Natalia; Chevion, Mordechai; Drenger, Benjamin			Sevoflurane postconditioning is not mediated by ferritin accumulation and cannot be rescued by simvastatin in isolated streptozotocin-induced diabetic rat hearts	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; POSSIBLE PREDICTIVE CRITERIA; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; IRON; INHIBITION; PROTECTION; EXPRESSION; HALOTHANE	Sevoflurane postconditioning (sevo postC) is an attractive and amenable approach that can protect the myocardium against ischemia/reperfusion (I/R)-injury. Unlike ischemic preconditioning (IPC), sevo postC does not require additional induced ischemic periods to a heart that is already at risk. IPC was previously shown to generate myocardial protection against I/R-injury through regulation of iron homeostasis and de novo ferritin synthesis, a process found to be impaired in the diabetic state. The current study investigated whether alterations in iron homeostasis and ferritin mRNA and protein accumulation are also involved in the cardioprotective effects generated by sevo postC. It was also investigated whether the protective effects of sevo postC in the diabetic state can be salvaged by simvastatin, through inducing nitric oxide (NO) bioavailability/activity, in isolated streptozotocin (STZ)-induced diabetic hearts (DH). Isolated rat hearts from healthy Controls and diabetic animals were retrogradely perfused using the Langendorff configuration and subjected to prolonged ischemia and reperfusion, with and without (2.4 and 3.6%) sevo postC and/or pre-treatment with simvastatin (0.5 mg/kg). Sevo postC significantly reduced infarct size and improved myocardial function in healthy Controls but not in isolated DH. The sevo postC mediated myocardial protection against I/R-injury was not associated with de novo ferrtin synthesis. Furthermore, simvastatin aggravated myocardial injury after sevo postC in STZ-induced DHs, likely due to increasing NO levels. Despite the known mechanistic overlaps between PC and postC stimuli, distinct differences underlie the cardioprotective interventions against myocardial I/R-injury and are impaired in the DH. Sevo postC mediated cardioprotection, unlike IPC, does not involve de novo ferritin accumulation and cannot be rescued by simvastatin in STZ-induced DHs.	[Grievink, Hilbert; Kuzmina, Natalia; Drenger, Benjamin] Hadassah Hebrew Univ Hosp, Dept Anesthesiol & Crit Care & Pain Med, Jerusalem, Israel; [Grievink, Hilbert; Chevion, Mordechai] Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Jerusalem, Israel; [Grievink, Hilbert] Hadassah Med Org, Cyclotron Radiochem MicroPET Unit, Hadassah Hebrew Univ Hosp, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Grievink, H (corresponding author), Hadassah Hebrew Univ Hosp, Dept Anesthesiol & Crit Care & Pain Med, Jerusalem, Israel.; Grievink, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Jerusalem, Israel.; Grievink, H (corresponding author), Hadassah Med Org, Cyclotron Radiochem MicroPET Unit, Hadassah Hebrew Univ Hosp, Jerusalem, Israel.	hilbert@hadassah.org.il			Dr. Avraham Moshe and Pepka Bergman Memorial Fund; German-Israel Foundation for Scientific Research and Development [GIF 1061-59.2/2008]; Israel Science Foundation [ISF489/12]; Lady Davis Post-doctoral Fellowship	Dr. Avraham Moshe and Pepka Bergman Memorial Fund; German-Israel Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Lady Davis Post-doctoral Fellowship	This research was supported by research grants (awarded to MC) from the Dr. Avraham Moshe and Pepka Bergman Memorial Fund, by the German-Israel Foundation for Scientific Research and Development (GIF 1061-59.2/2008), and by the Israel Science Foundation (ISF489/12). A Lady Davis Post-doctoral Fellowship was awarded to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1092015; Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; Berenshtein E, 2002, MOL CELL BIOCHEM, V234, P283, DOI 10.1023/A:1015923202082; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Brandenburger T, 2014, SHOCK, V42, P234, DOI 10.1097/SHK.0000000000000201; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Bulvik BE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048947; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Cao J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00160; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chevion M, 2008, J MOL CELL CARDIOL, V45, P839, DOI 10.1016/j.yjmcc.2008.08.011; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Farhangkhoee H, 2003, J MOL CELL CARDIOL, V35, P1439, DOI 10.1016/j.yjmcc.2003.09.007; Ge ZD, 2018, ANESTHESIOLOGY, V128, P117, DOI 10.1097/ALN.0000000000001926; Gorbe A, 2011, AM J PHYSIOL-HEART C, V300, pH1907, DOI 10.1152/ajpheart.01242.2010; Gong JS, 2012, MOL BIOL REP, V39, P6417, DOI 10.1007/s11033-012-1447-9; Grievink H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159951; Gu WD, 2008, ANESTHESIOLOGY, V108, P634, DOI 10.1097/ALN.0b013e3181672590; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hotta H, 2010, CIRC RES, V106, P129, DOI 10.1161/CIRCRESAHA.109.205385; Huhn R, 2008, BRIT J ANAESTH, V100, P465, DOI 10.1093/bja/aen022; Kersten JR, 2001, AM J PHYSIOL-HEART C, V280, pH1744, DOI 10.1152/ajpheart.2001.280.4.H1744; Komers R, 2006, DIABETES, V55, P1651, DOI 10.2337/db05-1595; Lefer DJ, 2001, FASEB J, V15, P1454, DOI 10.1096/fj.00-0819fje; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Malone MA, 2007, METABOLISM, V56, P1118, DOI 10.1016/j.metabol.2007.04.005; Marfella R, 2006, ACTA CARDIOL, V61, P630, DOI 10.2143/AC.61.6.2017962; Marfella R, 2009, CARDIOVASC PATHOL, V18, P332, DOI 10.1016/j.carpath.2008.09.008; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Obal D, 2001, BRIT J ANAESTH, V87, P905, DOI 10.1093/bja/87.6.905; Okon EB, 2005, DIABETES, V54, P2415, DOI 10.2337/diabetes.54.8.2415; Park WK, 1996, ANESTHESIOLOGY, V84, P1166, DOI 10.1097/00000542-199605000-00019; Povlsen JA, 2009, CLIN EXP PHARMACOL P, V36, P892, DOI 10.1111/j.1440-1681.2009.05166.x; Schlack W, 1998, BRIT J ANAESTH, V81, P913, DOI 10.1093/bja/81.6.913; Schlack W, 1997, BRIT J ANAESTH, V79, P88, DOI 10.1093/bja/79.1.88; Sivaraman V, 2010, J CELL MOL MED, V14, P1740, DOI 10.1111/j.1582-4934.2009.00796.x; Smith JM, 1997, J MOL CELL CARDIOL, V29, P2393, DOI 10.1006/jmcc.1997.0474; Song T, 2011, EXP BIOL MED, V236, P1427, DOI 10.1258/ebm.2011.011165; Stockklauser-Farber K, 2000, BBA-MOL BASIS DIS, V1535, P10, DOI 10.1016/S0925-4439(00)00078-8; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Thirunavukkarasu M, 2013, INT J CARDIOL, V168, P2474, DOI 10.1016/j.ijcard.2013.03.005; Tsang A, 2005, DIABETES, V54, P2360, DOI 10.2337/diabetes.54.8.2360; Van Allen NR, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-22; Vinokur V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062948; WARLTIER DC, 1988, ANESTHESIOLOGY, V69, P552, DOI 10.1097/00000542-198810000-00016; Whittington HJ, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/845698; Yao YY, 2013, J ZHEJIANG UNIV-SC B, V14, P511, DOI 10.1631/jzus.B1200195; Yao YT, 2009, BIOL PHARM BULL, V32, P1854, DOI 10.1248/bpb.32.1854; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075927; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	58	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211238	10.1371/journal.pone.0211238	http://dx.doi.org/10.1371/journal.pone.0211238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682140	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500133
J	Morgan, TJH; Acerbi, A; van Leeuwen, EJC				Morgan, Thomas J. H.; Acerbi, Alberto; van Leeuwen, Edwin J. C.			Copy-the-majority of instances or individuals? Two approaches to the majority and their consequences for conformist decision-making	PLOS ONE			English	Article							SOCIAL NETWORKS; WILD POPULATION; TRANSMISSION; INFORMATION; PERSONALITY; TRADITIONS; CHILDREN; CONTEXT	Cultural evolution is the product of the psychological mechanisms that underlie individual decision making. One commonly studied learning mechanism is a disproportionate preference for majority opinions, known as conformist transmission. While most theoretical and experimental work approaches the majority in terms of the number of individuals that perform a behaviour or hold a belief, some recent experimental studies approach the majority in terms of the number of instances a behaviour is performed. Here, we use a mathematical model to show that disagreement between these two notions of the majority can arise when behavioural variants are performed at different rates, with different salience or in different contexts (variant overrepresentation) and when a subset of the population act as demonstrators to the whole population (model biases). We also show that because conformist transmission changes the distribution of behaviours in a population, how observers approach the majority can cause populations to diverge, and that this can happen even when the two approaches to the majority agree with regards to which behaviour is in the majority. We discuss these results in light of existing findings, ranging from political extremism on twitter to studies of animal foraging behaviour. We conclude that the factors we considered (variant overrepresentation and model biases) are plausibly widespread. As such, it is important to understand how individuals approach the majority in order to understand the effects of majority influence in cultural evolution.	[Morgan, Thomas J. H.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Morgan, Thomas J. H.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [Acerbi, Alberto] Eindhoven Univ Technol, Eindhoven, Netherlands; [van Leeuwen, Edwin J. C.] Univ St Andrews, Westburn Lane, St Andrews, Fife, Scotland; [van Leeuwen, Edwin J. C.] Max Planck Inst Psycholinguist, Wundtlaan 1, Nijmegen, Netherlands; [van Leeuwen, Edwin J. C.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Eindhoven University of Technology; University of St Andrews; Max Planck Society	Morgan, TJH (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.; Morgan, TJH (corresponding author), Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA.	Thomas.j.h.morgan@asu.edu		Morgan, Thomas/0000-0002-2848-8461; Acerbi, Alberto/0000-0001-5827-8003	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	EJCvL is supported in the capacity of postdoctoral fellow by the Research Foundation Flanders (FWO).	Amy M, 2012, ANIM COGN, V15, P763, DOI 10.1007/s10071-012-0500-3; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aplin LM, 2017, P NATL ACAD SCI USA, V114, P7830, DOI 10.1073/pnas.1621067114; Aplin LM, 2015, ANIM BEHAV, V110, pE5, DOI 10.1016/j.anbehav.2015.09.015; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Battesti M, 2015, BEHAV ECOL SOCIOBIOL, V69, P83, DOI 10.1007/s00265-014-1820-x; Blaine T, 2018, EVOL HUM BEHAV, V39, P67, DOI 10.1016/j.evolhumbehav.2017.10.001; Boyd R., 1985, CULTURE EVOLUTIONARY, DOI [10.1525/aa.1987.89.1.02a00700, DOI 10.1525/AA.1987.89.1.02A00700]; Buskell A, 2017, BIOL PHILOS, V32, P377, DOI 10.1007/s10539-017-9570-6; Cantor M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9091; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Claidiere N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099874; Claidiere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030970; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; Cronin KA, 2014, EVOL HUM BEHAV, V35, P389, DOI 10.1016/j.evolhumbehav.2014.05.004; David M, 2011, ANIM BEHAV, V82, P61, DOI 10.1016/j.anbehav.2011.03.025; de Barra M, 2016, WHY PEOPLE OVERESTIM; Deri S, 2017, J PERS SOC PSYCHOL, V113, P858, DOI 10.1037/pspa0000105; Eom YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04603; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Eriksson K, 2014, J COGN CULT, V14, P1, DOI 10.1163/15685373-12342107; Fang RL, 2015, ORGAN SCI, V26, P1243, DOI 10.1287/orsc.2015.0972; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Haun DBM, 2014, PSYCHOL SCI, V25, P2160, DOI 10.1177/0956797614553235; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Hopper LM, 2007, ANIM BEHAV, V73, P1021, DOI 10.1016/j.anbehav.2006.07.016; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Jolles JW, 2013, ANIM BEHAV, V85, P1261, DOI 10.1016/j.anbehav.2013.03.013; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Krause J, 2010, PHILOS T R SOC B, V365, P4099, DOI 10.1098/rstb.2010.0216; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; Laland KN, 2004, LEARN BEHAV, V32, P4; Lerman K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147617; Lermite F, 2017, BEHAV PROCESS, V134, P87, DOI 10.1016/j.beproc.2016.09.013; McElreath R, 2005, EVOL HUM BEHAV, V26, P483, DOI 10.1016/j.evolhumbehav.2005.04.003; Morgan TJH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00087; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Morgan TJH, 2015, DEVELOPMENTAL SCI, V18, P511, DOI 10.1111/desc.12231; Morgan TJH, 2014, EXPT STUDIES HUMAN S; Morin O, 2013, EVOL HUM BEHAV, V34, P222, DOI 10.1016/j.evolhumbehav.2013.01.004; Muthukrishna M, 2016, EVOL HUM BEHAV, V37, P10, DOI 10.1016/j.evolhumbehav.2015.05.004; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Shore J, ARXIV16070679; Snijders L, 2014, ANIM BEHAV, V98, P95, DOI 10.1016/j.anbehav.2014.09.029; Sperber D, 2004, TRENDS COGN SCI, V8, P40, DOI 10.1016/j.tics.2003.11.002; Sperber Dan, 1996, EXPLAINING CULTURE N; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; van Leeuwen EJC, 2016, ANIM BEHAV, V122, pE5, DOI 10.1016/j.anbehav.2016.09.010; van Leeuwen EJC, 2015, ANIM BEHAV, V110, pE1, DOI 10.1016/j.anbehav.2015.07.030; Ward A, 2016, SOCIALITY BEHAV GROU, DOI [10.1007/978-3-319-28585-6_1, DOI 10.1007/978-3-319-28585-6_1]; Whalen A, 2018, COGNITIVE SCI, V42, P168, DOI 10.1111/cogs.12485; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2016, ANIM BEHAV, V122, pE1, DOI 10.1016/j.anbehav.2016.04.002; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Zandberg L, 2017, BEHAV PROCESS, V134, P95, DOI 10.1016/j.beproc.2016.09.007	67	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210748	10.1371/journal.pone.0210748	http://dx.doi.org/10.1371/journal.pone.0210748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682728	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500059
J	Park, CH; Kim, TH; Lee, S; Moon, DH; Park, HS				Park, Chul Hwan; Kim, Tae Hoon; Lee, Sungsoo; Moon, Duk Hwan; Park, Heae Surng			Correlation between maximal tumor diameter of fresh pathology specimens and computed tomography images in lung adenocarcinoma	PLOS ONE			English	Article							FORMALIN FIXATION; SIZE; CT; NODULES; CANCER; ACCURACY; PET/CT	The authors compared maximal tumor diameters between fresh lung tissue and axial and multiplanar reformatted chest computed-tomography (CT) images in lung adenocarcinoma and investigated the factors affecting tumor-size discrepancies. This study included 135 surgically resected lung adenocarcinomas. An experienced pulmonary pathologist aimed to cut the largest tumor section and measured pathological tumor size (PTS) in fresh specimens. Radiological maximal tumor sizes (RTS) were retrospectively measured on axial (RTSax) and multiplanar reformatted (RTSre) chest CT images. Mean PTS, RTSax, and RTSre were 19.13 mm, 18.63 mm, and 20.80 mm, respectively. RTSre was significantly larger than PTS (mean difference, 1.68 mm; p<0.001). RTSax was also greater than PTS for 6-10-mm and 11-20-mm tumors. PTS and RTS were strongly positively correlated (RTSax, r(2) = 0.719, p<0.001; RTSre, r(2) = 0.833, p<0.001). The intraclass correlation coefficient was 0.915 between PTS and RTSax and 0.954 between PTS and RTSre. Postoperative down-staging occurred in 11.0% and 27.4% of tumors on performing radiological staging using RTSax and RTSre, respectively. Postoperative up-staging occurred in 12.3% and 1.4% of tumors on performing radiological staging using RTSax and RTSre, respectively. Multiple linear regression revealed that pleural dimpling (p = 0.024) was an independent factor affecting differences between PTS and RTSax. Specimen type (p = 0.012) and tumor location (p = 0.020) were independent factors affecting differences between PTS and RTSre. In conclusion, RTSre was significantly larger than PTS and caused postoperative down-staging in 27.4% of the tumors. Reliability analysis revealed that RTSre was more strongly correlated with PTS than RTSax. Specimen type and anatomical tumor location influenced the measured size differences between PTS and RTSre.	[Park, Chul Hwan; Kim, Tae Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol,Res Inst Radiol Sci, Seoul, South Korea; [Lee, Sungsoo; Moon, Duk Hwan] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Park, Heae Surng] Ewha Womans Univ, Mokdong Hosp, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ewha Womans University	Park, HS (corresponding author), Ewha Womans Univ, Mokdong Hosp, Dept Pathol, Seoul, South Korea.	turtle98p@naver.com		Park, Chul Hwan/0000-0002-0004-9475; Lee, Sungsoo/0000-0001-8998-9510; /0000-0003-3598-2529				Amin MB, 2017, AJCC CANC STAGING MA; Aydin F, 2013, DIAGN INTERV RADIOL, V19, P271, DOI 10.5152/dir.2013.053; Bankier AA, 2017, RADIOLOGY, V285, P584, DOI 10.1148/radiol.2017162894; Bhure UN, 2010, BRIT J RADIOL, V83, P841, DOI 10.1259/bjr/13711326; Heidinger BH, 2017, J THORAC ONCOL, V12, P1288, DOI 10.1016/j.jtho.2017.05.017; Heidinger BH, 2017, ACAD RADIOL, V24, P851, DOI 10.1016/j.acra.2017.01.009; Hsu PK, 2007, ANN THORAC SURG, V84, P1825, DOI 10.1016/j.athoracsur.2007.07.016; Isaka T, 2014, LUNG CANCER, V85, P40, DOI 10.1016/j.lungcan.2014.03.023; Jeffery NN, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-2; Lampen-Sachar K, 2012, LUNG CANCER, V75, P332, DOI 10.1016/j.lungcan.2011.08.001; Lee KH, 2014, J THORAC ONCOL, V9, P74, DOI 10.1097/JTO.0000000000000019; Lee SE, 2010, WORLD J UROL, V28, P263, DOI 10.1007/s00345-010-0511-0; Park HS, 2017, HISTOPATHOLOGY, V71, P437, DOI 10.1111/his.13237; Pawaroo D, 2011, AM J ROENTGENOL, V196, P1176, DOI 10.2214/AJR.10.4980; Ridge CA, 2013, AM J ROENTGENOL, V201, P959, DOI 10.2214/AJR.12.10033; Sica GL, 2012, SEMIN DIAGN PATHOL, V29, P116, DOI 10.1053/j.semdp.2012.06.001; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2016, J THORAC ONCOL, V11, P1204, DOI 10.1016/j.jtho.2016.03.025; Yu HM, 2009, EUR J RADIOL, V72, P104, DOI 10.1016/j.ejrad.2008.06.015	19	7	7	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211141	10.1371/journal.pone.0211141	http://dx.doi.org/10.1371/journal.pone.0211141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682110	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500110
J	Di Matteo, S; Nevi, L; Costantini, D; Overi, D; Carpino, G; Safarikia, S; Giulitti, F; Napoletano, C; Manzi, E; De Rose, AM; Melandro, F; Bragazzi, M; Berloco, PB; Giuliante, F; Grazi, G; Giorgi, A; Cardinale, V; Adorini, L; Gaudio, E; Alvaro, D				Di Matteo, S.; Nevi, L.; Costantini, D.; Overi, D.; Carpino, G.; Safarikia, S.; Giulitti, F.; Napoletano, C.; Manzi, E.; De Rose, A. M.; Melandro, F.; Bragazzi, M.; Berloco, P. B.; Giuliante, F.; Grazi, G.; Giorgi, A.; Cardinale, V.; Adorini, L.; Gaudio, E.; Alvaro, D.			The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ENDOGENOUS BILE-ACIDS; NUCLEAR RECEPTOR; DOWN-REGULATION; DIAGNOSIS; CLASSIFICATION; IDENTIFICATION; PATHOGENESIS; METABOLISM; ACTIVATION	Cholangiocarcinoma (CCA) is an aggressive cancer with high resistance to chemotherapeutics. CCA is enriched in cancer stem cells, which correlate with aggressiveness and prognosis. FXR, a member of the metabolic nuclear receptor family, is markedly down-regulated in human CCA. Our aim was to evaluate, in primary cultures of human intrahepatic CCA (iCCA), the effects of the FXR agonist obeticholic acid (OCA), a semisynthetic bile acid derivative, on their cancerogenic potential. Primary human iCCA cell cultures were prepared from surgical specimens of mucinous or mixed iCCA subtypes. Increasing concentrations (0-2.5 mu M) of OCA were added to culture media and, after 3-10 days, effects on proliferation (MTS assay, cell population doubling time), apoptosis (annexin V-FITC/propidium iodide), cell migration and invasion (wound healing response and Matrigel invasion assay), and cancerogenic potential (spheroid formation, clonogenic assay, colony formation capacity) were evaluated. Results: FXR gene expression was downregulated (RT-qPCR) in iCCA cells vs normal human biliary tree stem cells (p < 0.05) and in mucinous iCCA vs mixed iCCA cells (p < 0.05) but was upregulated by addition of OCA. OCA significantly (p < 0.05) inhibited proliferation of both mucinous and mixed iCCA cells, starting at a concentration as low as 0.05 mu M. Also, CDCA (but not UDCA) inhibited cell proliferation, although to a much lower extent than OCA, consistent with its different affinity for FXR. OCA significantly induced apoptosis of both iCCA subtypes and decreased their in vitro cancerogenic potential, as evaluated by impairment of colony and spheroid formation capacity and delayed wound healing and Matrigel invasion. In general, these effects were more evident in mixed than mucinous iCCA cells. When tested together with Gemcitabine and Cisplatin, OCA potentiated the anti-proliferative and pro-apoptotic effects of these chemotherapeutics, but mainly in mixed iCCA cells. OCA abolished the capacity of both mucinous and mixed iCCA cells to form colonies when administered together with Gemcitabine and Cisplatin. In subcutaneous xenografts of mixed iCCA cells, OCA alone or combined with Gemcitabine or Cisplatin markedly reduced the tumor size after 5 weeks of treatment by inducing necrosis of tumor mass and inhibiting cell proliferation. In conclusion, FXR is down-regulated in iCCA cells, and its activation by OCA results in anti-cancerogenic effects against mucinous and mixed iCCA cells, both in vitro and in vivo. The effects of OCA predominated in mixed iCCA cells, consistent with the lower aggressiveness and the higher FXR expression in this CCA subtype. These results, showing the FXR-mediated capacity of OCA to inhibit cholangiocarcinogenesis, represent the basis for testing OCA in clinical trials of CCA patients.	[Di Matteo, S.; Nevi, L.; Costantini, D.; Safarikia, S.; Giorgi, A.; Alvaro, D.] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy; [Overi, D.; Gaudio, E.] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy; [Carpino, G.; Giulitti, F.] Univ Rome Foro Italico, Div Hlth Sci, Dept Movement Human & Hlth Sci, Rome, Italy; [Napoletano, C.] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Manzi, E.; Grazi, G.] Regina Elena Inst Canc Res, Gastroenterol Unit, Rome, Italy; [De Rose, A. M.; Giuliante, F.] Catholic Univ, Sacred Heart Sch Med, Hepatobiliary Unit, Rome, Italy; [Melandro, F.; Berloco, P. B.] Sapienza Univ Rome, Dept Gen Surg & Organ Transplantat, Rome, Italy; [Bragazzi, M.; Cardinale, V.] Sapienza Univ Rome, Med Surg & Biotechnol Sci, Rome, Italy; [Adorini, L.] Intercept Pharmaceut, New York, NY USA	Sapienza University Rome; Sapienza University Rome; Foro Italico University of Rome; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Sapienza University Rome; Intercept Pharmaceuticals	Alvaro, D (corresponding author), Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy.	domenico.alvaro@uniroma1.it	Di Matteo, Sabina/D-1876-2017; Cardinale, Vincenzo/AAB-9296-2019; Overi, Diletta/AAP-3632-2021; melandro, fabio/AAA-1996-2019; Nevi, Lorenzo/B-3289-2017; Carpino, Guido/AAB-9692-2019; GIULIANTE, FELICE/AAC-5066-2020; ALVARO, Domenico/J-8600-2018; De Rose, Agostino Maria/V-4910-2019; Adorini, Luciano/AAE-5149-2020	Di Matteo, Sabina/0000-0002-2586-7159; Cardinale, Vincenzo/0000-0003-0234-3341; melandro, fabio/0000-0003-4056-9245; Nevi, Lorenzo/0000-0003-0924-2551; GIULIANTE, FELICE/0000-0003-2087-2589; ALVARO, Domenico/0000-0003-3771-9644; De Rose, Agostino Maria/0000-0003-3310-8088; Overi, Diletta/0000-0003-3561-8903; safarikia, samira/0000-0002-7254-0634	Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant; FIRB grants [RBAP10Z7FS_001, RBAP10Z7FS_004]; Federate Athenaeum funds from the Sapienza University of Rome; InterceptPharma (New York, USA)	Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant; FIRB grants; Federate Athenaeum funds from the Sapienza University of Rome; InterceptPharma (New York, USA)	The study was supported by an Agenzia Regionale del Lazio per i trapianti e le patologieconnesse grant, FIRB grants #RBAP10Z7FS_001 and RBAP10Z7FS_004, and Federate Athenaeum funds from the Sapienza University of Rome (all to V.C., G.C., E.G., and D.A.) and a sponsored research grant from InterceptPharma (New York, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aishima S, 2015, J HEPATO-BIL-PAN SCI, V22, P94, DOI 10.1002/jhbp.154; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Cardinale V, 2015, AM J PATHOL, V185, P1724, DOI 10.1016/j.ajpath.2015.02.010; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Carpino G, 2014, J HEPATOL, V60, P1194, DOI 10.1016/j.jhep.2014.01.026; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; Degirolamo C, 2015, HEPATOLOGY, V61, P161, DOI 10.1002/hep.27274; Deuschle U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043044; Edwards JE, 2016, CTS-CLIN TRANSL SCI, V9, P328, DOI 10.1111/cts.12421; Erice O, 2018, BBA-MOL BASIS DIS, V1864, P1335, DOI 10.1016/j.bbadis.2017.08.016; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Fraveto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142124; Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002; Gardmo C, 2011, BBA-MOL BASIS DIS, V1812, P836, DOI 10.1016/j.bbadis.2011.03.009; Giordano C, 2011, ONCOGENE, V30, P4129, DOI 10.1038/onc.2011.124; Goldstein J., 2018, LIVER INT; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Lax S, 2012, INT J CANCER, V130, P2232, DOI 10.1002/ijc.26293; Lee CH, 2016, ONCOTARGET, V7, P1215, DOI 10.18632/oncotarget.6261; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Liau JY, 2014, MODERN PATHOL, V27, P1163, DOI 10.1038/modpathol.2013.241; Liu XJ, 2015, ONCOTARGET, V6, P4226, DOI 10.18632/oncotarget.2899; Lustri AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183932; Lv B, 2018, CELL PHYSIOL BIOCHEM, V48, P158, DOI 10.1159/000491715; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419; Nevi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05858-0; Nevi L, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0492-7; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Ramadori G, 2010, ANN HEPATOL, V9, P133, DOI 10.1016/S1665-2681(19)31651-5; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Roda A, 2017, CTS-CLIN TRANSL SCI, V10, P292, DOI 10.1111/cts.12468; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011; Thompson MD, 2018, HEPATOLOGY, V67, P955, DOI 10.1002/hep.29371; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; VAQUERO J, 1990, NEUROSURGERY, V27, P235, DOI 10.1227/00006123-199008000-00011; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang W, 2016, ONCOTARGET, V7, P34617, DOI 10.18632/oncotarget.8964; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang Y, 2017, PHARM RES PERSPECT, V5; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	55	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210077	10.1371/journal.pone.0210077	http://dx.doi.org/10.1371/journal.pone.0210077			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677052	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400010
J	Romanowski, K; Campbell, JR; Oxlade, O; Fregonese, F; Menzies, D; Johnston, JC				Romanowski, Kamila; Campbell, Jonathon R.; Oxlade, Olivia; Fregonese, Federica; Menzies, Dick; Johnston, James C.			The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study	PLOS ONE			English	Article								Introduction Isoniazid-resistant, rifampin susceptible tuberculosis (INHR-TB) is the most common form of drug resistant TB globally. Treatment of INHR-TB with standard first-line therapy is associated with high rates of multidrug resistant TB (MDR-TB). We modelled the potential impact of INHR-TB detection and appropriate treatment on MDR-TB prevalence. Methods A decision analysis model was developed to compare three different strategies for the detection of TB (AFB smear, Xpert MTB/RIF, and Line-Probe Assays (LPA)), combined with appropriate treatment. The population evaluated were patients with a globally representative prevalence of newly diagnosed, drug-susceptible (88.6%), isoniazid-resistant (7.3%), and multidrug resistant (4.1%) pulmonary TB. Our primary outcome was the proportion of patients with MDR-TB after initial attempt at diagnosis and treatment within a 2-year period. Secondary outcomes were the proportion of i) individuals with detected TB who acquired MDR-TB ii) individuals who died after initial attempt at diagnosis and treatment. Results After initial attempt at diagnosis and treatment, LPA combined with appropriate INHR-TB therapy resulted in a lower proportion of prevalent MDR-TB (1.61%; 95% Uncertainty Range (UR: 2.5th and 97.5th percentiles generated from 10 000 Monte Carlo simulation trials) 1.61-1.65), when compared to Xpert (1.84%; 95% UR 1.82-1.85) and AFB smear (3.21%; 95% UR 3.19-3.26). LPA also resulted in fewer cases of acquired MDR-TB in those with detected TB (0.35%; 95% UR 0.34-0.35), when compared to Xpert (0.67%; 95% UR 0.65-0.67) and AFB smear (0.68%; 95% UR 0.67-0.69). The majority of acquired MDR-TB arose from the treatment of INHR-TB in all strategies. Xpert-based strategies resulted in a lower proportion of death (2.89%; 95% UR 2.87-2.90) compared to LPA (2.93%; 95% UR 2.91-2.94) and AFB smear (3.21%; 95% UR 3.19-3.23). Conclusion Accurate diagnosis and tailored treatment of INHR-TB with LPA led to an almost 50% relative decrease in acquired MDR-TB when compared with an Xpert MTB/RIF strategy. Continued reliance on diagnostic and treatment protocols that ignore INHR-TB will likely result in further generation of MDR-TB.	[Romanowski, Kamila; Johnston, James C.] BC Ctr Dis Control, TB Serv, Vancouver, BC, Canada; [Campbell, Jonathon R.; Oxlade, Olivia; Fregonese, Federica; Menzies, Dick; Johnston, James C.] McGill Int TB Ctr, Montreal, PQ, Canada; [Menzies, Dick] McGill Univ, Div Resp Med, Dept Med, Montreal, PQ, Canada; [Johnston, James C.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	McGill University; University of British Columbia	Johnston, JC (corresponding author), BC Ctr Dis Control, TB Serv, Vancouver, BC, Canada.; Johnston, JC (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.; Johnston, JC (corresponding author), Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada.	james.johnston@bccdc.ca	Campbell, Jonathon/AAN-4252-2021	Campbell, Jonathon/0000-0003-2341-2166; Romanowski, Kamila/0000-0002-7027-3579; JOHNSTON, JAMES/0000-0002-8879-4989				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Bae JM, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014025; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Denkinger CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084197; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/s2213-2600(17)30079-6, 10.1016/S2213-2600(17)30079-6]; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Fregonese F, 2018, LANCET RESP MED, V6, P265, DOI 10.1016/S2213-2600(18)30078-X; Gegia M, 2017, LANCET INFECT DIS, V17, P223, DOI 10.1016/S1473-3099(16)30407-8; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Manson AL, 2017, NAT GENET, V49, P395, DOI 10.1038/ng.3767; Nathavitharana RR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01075-2016; Stagg HR, 2017, INT J TUBERC LUNG D, V21, P129, DOI 10.5588/ijtld.16.0716; Steingart KR, 2013, COCHRANE DATABASE SY, V1; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, WHO TREATM GUID IS R; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2008, POL STAT, P27; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, GLOB TUB REP 2017; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915	26	7	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211355	10.1371/journal.pone.0211355	http://dx.doi.org/10.1371/journal.pone.0211355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677101	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400067
J	Toledo-Pons, N; van Boven, JFM; Roman-Rodriguez, M; Perez, N; Felices, JLV; Soriano, JB; Cosio, BG				Toledo-Pons, Nuria; van Boven, Job F. M.; Roman-Rodriguez, Miguel; Perez, Noemi; Valera Felices, Jose Luis; Soriano, Joan B.; Cosio, Borja G.			ACO: Time to move from the description of different phenotypes to the treatable traits	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COPD OVERLAP SYNDROME; BLOOD EOSINOPHILS; ASTHMA; EXACERBATIONS; FEATURES	Background Asthma-COPD overlap (ACO) is a term that encompasses patients with characteristics of two conditions, smoking asthmatics or COPD patients with asthma-like features such as high bronchodilator response or blood eosinophil count. 300 cells/mu L. The aim of this study was to compare the different phenotypes inside the ACO definition in a real-life population cohort. Methods We analyzed patients from the MAJORICA cohort who had a diagnosis of asthma and/or COPD based on current guidelines, laboratory data in 2014 and follow-up until 2015. Prevalence of ACO according to the different criteria, demographic, clinical and functional characteristics, prescriptions and use of health resources data were compared between three groups. Results We included 603 patients. Prevalence of smoking asthmatics was 14%, COPD patients with high bronchodilator response 1.5% and eosinophilic COPD patients 12%. Smoking asthmatics were younger and used more rescue inhalers, corticosteroids and health resources. Conversely, eosinophilic COPD patients were older than the other groups, often treated with corticosteroids and had lower use of health resources. Most of the COPD patients with high bronchodilator response were included in the eosinophilic COPD group. Conclusions ACO includes two conditions (smoking asthmatics and eosinophilic COPD patients) with different medication requirement and prognosis that should not be pooled together. Use of >= 300 blood eosinophils/mu L as a treatable trait should be recommended.	[Toledo-Pons, Nuria; Cosio, Borja G.] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Toledo-Pons, Nuria; Valera Felices, Jose Luis; Cosio, Borja G.] Hosp Univ Son Espases, IdISBa, Dept Resp Med, Mallorca, Spain; [van Boven, Job F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice & Elderly Care Med, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Roman-Rodriguez, Miguel] Inst Invest Sanitaria Islas Baleares IdISBa, Primary Care Resp Res Unit, Mallorca, Spain; [Perez, Noemi] Servicio Salud Islas Baleares, Gabinete Tecn Serv Cent, Mallorca, Spain; [Soriano, Joan B.] Univ Autonoma Madrid, Hop Univ Princesa, Madrid, Spain; [Soriano, Joan B.] SEPAR, Metodol & Invest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Groningen; Atencio Primaria de Mallorca; Institut Investigacio Sanitaria Illes Balears (IdISBa); Autonomous University of Madrid	Cosio, BG (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Cosio, BG (corresponding author), Hosp Univ Son Espases, IdISBa, Dept Resp Med, Mallorca, Spain.	borja.cosio@ssib.es	G.Cosio, Borja/P-4963-2017; Valera, Jose Luis/E-9615-2018; Soriano, Joan B/O-1215-2017	G.Cosio, Borja/0000-0002-6388-8209; Valera, Jose Luis/0000-0001-6360-4504; van Boven, Job/0000-0003-2368-2262; Soriano, Joan B/0000-0001-9740-2994	SEPAR travel fellowship [478/2017]	SEPAR travel fellowship	N. T.-P. was a recipient of a SEPAR travel fellowship (478/2017, https://www.separ.es/) aimed to set a collaboration with GRIAC for the purpose of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Brightling C E, 2013, Ann Am Thorac Soc, V10 Suppl, pS214, DOI 10.1513/AnnalsATS.201302-023AW; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Casanova C, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01162-2017; Cosio BG, 2016, CHEST, V149, P45, DOI 10.1378/chest.15-1055; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Gibson PG, 2015, THORAX, V70, P683, DOI 10.1136/thoraxjnl-2014-206740; GOLD G., 2015, ASTHMA COPD ASTHMA C, P1; Grootendorst Diana C, 2004, Proc Am Thorac Soc, V1, P77, DOI 10.1513/pats.2306025; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Hinds DR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010099; Kim MH, 2018, INT J CHRONIC OBSTR, V13, P1251, DOI 10.2147/COPD.S152916; Miravitlles M, 2017, EUR RESPIR J, V49, P10; Noell G, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00075-2017; Perez DLL, 2018, ARCH BRONCONEUMOL, V54, P198, DOI DOI 10.1016/j.arbres.2017.10.007; Perez-De-Llano L, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0667-x; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Soriano JB, 2008, EUR RESPIR J, V31, P695, DOI 10.1183/09031936.00017008; Suzuki M, 2016, AM J RESP CRIT CARE, V194, P1358, DOI 10.1164/rccm.201602-0353OC; Turato G, 2017, AM J RESP CRIT CARE; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; Vedel-Krogh S, 2016, AM J RESP CRIT CARE, V193, P965, DOI 10.1164/rccm.201509-1869OC; Zeki Amir A, 2011, J Allergy (Cairo), V2011, P861926, DOI 10.1155/2011/861926	24	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210915	10.1371/journal.pone.0210915	http://dx.doi.org/10.1371/journal.pone.0210915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677059	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400034
J	van Well, S; O'Doherty, JP; van Winden, F				van Well, Sonja; O'Doherty, John P.; van Winden, Frans			Relief from incidental fear evokes exuberant risk taking	PLOS ONE			English	Article							DECISION-MAKING; PROSPECT-THEORY; ROBUST; PROBABILITY; ACCURATE; EMOTION	Incidental emotions are defined as feelings that are unrelated to a decision task at hand and thereby not normatively relevant for making choices. The precise influence and formal theoretical implications of incidental emotions regarding financial risk taking are still largely unclear. An effect of incidental emotion on decision-making would challenge the main extant formal theoretical economic models because such models do not allow for an effect of incidental emotions. As financial risk taking is pervasive in modern economies, the role of incidental emotions is an important issue. The goal of this experimental study is threefold. First, we examine the impact of incidental fear on the choice between a sure and a risky monetary option. A well-validated method of fear induction, using electric shocks, is employed for that purpose. Based on emotion studies we hypothesize less risk taking under fear and more risk taking when relieved of fear. Our second goal is to investigate the relative performance of the main existing formal theoretical economic models (based on Expected Utility Theory, Prospect Theory, or the Mean-Variance model) in explaining the behavioral data. We also investigate how these models can be adjusted to accommodate any observed influence of incidental emotion. For that reason, we first theoretically model the potential pathways of incidental fear (and the relief thereof) via the valuation of the choice option rewards or risk-assessment. We then estimate the relevant parameters allowing for both additive as well as interactive effects. Our third and final goal is to explore the neural basis of any observed influence of incidental emotions on decision-making by means of a model-based fMRI analysis, using the findings of existing neuroeconomic studies as the basis for our hypotheses. Our results indicate that the relief of fear can give a substantial boost to financial risk taking (suggestive of exuberance). This impact is best captured by Prospect Theory if we allow for an increase in participants' valuation of option outcomes when relieved of fear. Moreover, this impact is manifested at the neural level by the activity of the ventromedial prefrontal cortex (vmPFC), a brain area widely regarded as being central for valuation.	[van Well, Sonja; van Winden, Frans] Univ Amsterdam, CREED Amsterdam Sch Econ, Amsterdam, Netherlands; [van Well, Sonja; van Winden, Frans] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [O'Doherty, John P.] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [O'Doherty, John P.] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	University of Amsterdam; University of Amsterdam; California Institute of Technology; California Institute of Technology	van Winden, F (corresponding author), Univ Amsterdam, CREED Amsterdam Sch Econ, Amsterdam, Netherlands.; van Winden, F (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands.	f.a.a.m.vanwinden@uva.nl			Division of the Humanities and Social Sciences (California Institute of Technology)-US National Science Foundation [1062703]; Research Priority Area Behavioral Economics (University of Amsterdam); Amsterdam Brain and Cognition (ABC) center (University of Amsterdam)	Division of the Humanities and Social Sciences (California Institute of Technology)-US National Science Foundation; Research Priority Area Behavioral Economics (University of Amsterdam); Amsterdam Brain and Cognition (ABC) center (University of Amsterdam)	The study was funded by The Division of the Humanities and Social Sciences (California Institute of Technology)-US National Science Foundation grant 1062703 to JOD, The Research Priority Area Behavioral Economics (University of Amsterdam) and the Amsterdam Brain and Cognition (ABC) center (University of Amsterdam).	Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bruhin A, 2010, ECONOMETRICA, V78, P1375, DOI 10.3982/ECTA7139; Chib VS, 2009, J NEUROSCI, V29, P12315, DOI 10.1523/JNEUROSCI.2575-09.2009; Clark L, 2012, PSYCHOPHYSIOLOGY, V49, P1436, DOI 10.1111/j.1469-8986.2012.01454.x; Dziak J. J., 2012, 12119 PENNS STAT U M; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; Fox CR, 2014, NEUROECONOMICS DECIS, P533; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GOLDSTEIN WM, 1987, PSYCHOL REV, V94, P236, DOI 10.1037/0033-295X.94.2.236; GREENSPAN A., 2008, AGE TURBULENCE ADVEN; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Keynes J.M, 1970, GEN THEORY EMPLOYMEN; Kong E, 2014, NEUROPSYCHOPHARMACOL, V39, P515, DOI 10.1038/npp.2013.191; LATTIMORE PK, 1992, J ECON BEHAV ORGAN, V17, P377, DOI 10.1016/S0167-2681(95)90015-2; Lee CJ, 2011, J MARKETING RES, V48, pS121, DOI 10.1509/jmkr.48.SPL.S121; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Loewenstein G., 2008, HDB EMOTIONS, P138, DOI DOI 10.2139/SSRN.954862; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; Reinhard G, 2006, PSYCHOPHYSIOLOGY, V43, P73, DOI 10.1111/j.1469-8986.2006.00374.x; Reinhard G, 2002, BIOL PSYCHOL, V60, P51, DOI 10.1016/S0301-0511(02)00011-X; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schmitz A, 2012, NAT PROTOC, DOI [10.1038/nprot.2012, DOI 10.1038/NPROT.2012]; Shefrin, 2002, GREED FEAR UNDERSTAN; Shiller R.J., 2005, IRRATIONAL EXUBERANC; Slovic, 2010, FEELING RISK NEW PER; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Starcke K, 2008, BEHAV NEUROSCI, V122, P1352, DOI 10.1037/a0013281; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1995, ECONOMETRICA, V63, P1255, DOI 10.2307/2171769; Visser RM, 2013, NAT NEUROSCI, V16, P388, DOI 10.1038/nn.3345; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Winecoff A, 2013, J NEUROSCI, DOI [10.1523/JNEUROSCI.4317-12, DOI 10.1523/JNEUROSCI.4317-12]; Wu G, 2004, BLACKWELL HDB JUDGME, DOI DOI 10.1002/9780470752937.CH20	46	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211018	10.1371/journal.pone.0211018	http://dx.doi.org/10.1371/journal.pone.0211018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677100	Green Published, gold, Green Accepted			2022-12-27	WOS:000456700400042
J	Liu, YL; Rodriguez-Calvo, R; Wang, SJ; Zhu, XQ; Broers, JLV; Glatz, JFC; Luiken, JJFP; Neumann, D				Liu, Yilin; Rodriguez-Calvo, Ricardo; Wang, Shujin; Zhu, Xiaoqing; Broers, Jos L. V.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Neumann, Dietbert			Fluorescent labelling of membrane fatty acid transporter CD36 (SR-B2) in the extracellular loop	PLOS ONE			English	Article							RAT CARDIAC MYOCYTES; CONTRACTILE DYSFUNCTION; SARCOLEMMAL FAT/CD36; INSULIN; PROTEIN; TRANSLOCATION; METABOLISM; DIET	Context Upon palmitate oversupply, membrane fatty acid-transporter CD36 (SR-B2) permanently translocates from endosomal storage to the sarcolemma, inducing lipotoxicity. CD36 trans location results from endosomal alkalinisation elicited by palmitate-induced disattachment of the cytoplasmic V-1-subcomplex from the membrane-integrated V-0-subcomplex of vacuolar-type H+-ATPase. Objective Develop a CD36 fluorescent labeling technique as initial step towards live cell imaging. Methods Three human CD36 (hCD36) mutants were constructed via insertion of a tetracysteine motif at different positions within the extracellular domain. Constructs were lentivirally transduced for subsequent CD36 labeling with fluorescein-arsenical hairpin-binder (FlAsH). Cell imaging was combined with V-0/V-1 immunostaining and Western blotting. Results Transduction of hCD36-wildtype and mutants yielded corresponding proteins in HL-1 cardiomyocytes. Tetracysteine mutant-2 (hCD36-TC2) showed similar fatty acid uptake to wild type. FlAsH staining revealed a speckled pattern reminiscent of endosomes. We found decreased V-1 co-localization with CD36 upon high-palmitate culturing. Conversely, V-0 consistently co-localized with CD36. Conclusion hCD36-TC2 is a possible candidate for application of biarsenical dyes in live imaging studies pending further investigation. Our data is compatible with V-0/V-1 disassembly in high-palmitate-treated cells.	[Liu, Yilin; Rodriguez-Calvo, Ricardo; Wang, Shujin; Zhu, Xiaoqing; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Neumann, Dietbert] Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Broers, Jos L. V.] Maastricht Univ, Dept Mol Cell Biol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Rodriguez-Calvo, Ricardo] Univ Rovira & Virgili, Spanish Biomed Res Ctr Diabet & Associated Metab, Inst Invest Sanitaria Pere Virgili IISPV, Res Unit Lipids & Atherosclerosis,St Joan Univ Ho, Reus, Spain; [Neumann, Dietbert] Maastricht Univ, Dept Pathol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands	Maastricht University; Maastricht University; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Maastricht University	Neumann, D (corresponding author), Maastricht Univ, Dept Mol Genet, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.; Neumann, D (corresponding author), Maastricht Univ, Dept Pathol, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Rodriguez-Calvo, Ricardo/AAB-4054-2019	Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Neumann, Dietbert/0000-0002-4316-684X	Chinese Scholarship Council; Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW) [864.10.007]	Chinese Scholarship Council(China Scholarship Council); Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW)	Y.L. and X.Z. received support from the Chinese Scholarship Council. D.N. is recipient of a Vidi Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ALW grant no. 864.10.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; Angin Y, 2012, BIOCHEM J, V448, P43, DOI 10.1042/BJ20120060; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Glatz JFC, 2016, BBA-MOL CELL BIOL L, V1861, P1461, DOI 10.1016/j.bbalip.2016.04.008; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Holleran J, 2010, CYTOM PART A, V77A, P776, DOI 10.1002/cyto.a.20925; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Liu Y, 2017, DIABETES, V66, P1521, DOI 10.2337/db16-0727; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Steinbusch LKM, 2010, AM J PHYSIOL-CELL PH, V298, pC1549, DOI 10.1152/ajpcell.00334.2009; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Vistisen B, 2004, J LIPID RES, V45, P603, DOI 10.1194/jlr.M300424-JLR200; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Zhang JS, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-24	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210704	10.1371/journal.pone.0210704	http://dx.doi.org/10.1371/journal.pone.0210704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673728	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800050
J	Rod, KA; Um, W; Colby, SM; Rockhold, ML; Strickland, CE; Han, S; Kuprat, AP				Rod, Kenton A.; Um, Wooyong; Colby, Sean M.; Rockhold, Mark L.; Strickland, Christopher E.; Han, Sangsoo; Kuprat, Andrew P.			Relative permeability for water and gas through fractures in cement	PLOS ONE			English	Article							WELL CEMENT; 2-PHASE FLOW; FLUID-FLOW; CO2; TOMOGRAPHY; EQUATION; STRESS; CURVES	Relative permeability is an important attribute influencing subsurface multiphase flow. Characterization of relative permeability is necessary to support activities such as carbon sequestration, geothermal energy production, and oil and gas exploration. Previous research efforts have largely neglected the relative permeability of wellbore cement used to seal well bores where risks of leak are significant. Therefore this study was performed to evaluate fracturing on permeability and relative permeability of wellbore cement. Studies of relative permeability of water and air were conducted using ordinary Portland cement paste cylinders having fracture networks that exhibited a range of permeability values. The measured relative permeability was compared with three models, 1) Corey-curve, often used for modeling relative permeability in porous media, 2) X-curve, commonly used to represent relative permeability of fractures, and 3) Burdine model based on fitting the Brooks-Corey function to fracture saturation-pressure data inferred from x-ray computed tomography (XCT) derived aperture distribution results. Experimentally-determined aqueous relative permeability was best described by the Burdine model. Though water phase tended to follow the Corey-curve for the simple fracture system while air relative permeability was best described by the X-curve.	[Rod, Kenton A.; Um, Wooyong; Rockhold, Mark L.; Strickland, Christopher E.] Pacific Northwest Natl Lab, Energy & Environm Directorate, Richland, WA 99354 USA; [Um, Wooyong; Han, Sangsoo] Pohang Univ Sci & Technol POSTECH, Sch Environm Engn, Div Adv Nucl Engn, Pohang, South Korea; [Colby, Sean M.; Kuprat, Andrew P.] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Pohang University of Science & Technology (POSTECH); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rod, KA; Um, W (corresponding author), Pacific Northwest Natl Lab, Energy & Environm Directorate, Richland, WA 99354 USA.; Um, W (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Environm Engn, Div Adv Nucl Engn, Pohang, South Korea.	kenton.rod@pnnl.gov; wooyongum@postech.ac.kr	Rod, Kenton/R-5743-2019	Rod, Kenton/0000-0003-1818-9094; um, wooyong/0000-0002-3826-0030; Strickland, Chris/0000-0001-8289-5482	National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program; U.S. DOE [DE-AC06-76RLO 1830]; Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea [20141720100610]	National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program; U.S. DOE(United States Department of Energy (DOE)); Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea(Korea Institute of Energy Technology Evaluation & Planning (KETEP))	Funding of this research was provided by the National Risk Assessment Partnership (NRAP) in the U.S. DOE Office of Fossil Energy's Carbon Sequestration Program. PNNL is operated by Battelle for the U.S. DOE under Contract DE-AC06-76RLO 1830. Part of this research was performed at the W.R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility at PNNL managed by the Department of Energy's Office of Biological and Environmental Research. A portion of this work was supported by the Korea Institute of Energy Technology Evaluation and Planning (KETEP) grant from the Ministry of Trade, Industry&Energy, Republic of Korea (No. 20141720100610).	Bernsen J, 1986, INT C PATT REC ICPR; Blunt MJ, 2013, ADV WATER RESOUR, V51, P197, DOI 10.1016/j.advwatres.2012.03.003; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brooks R.H., 1964, HYDROLOGY PAPERS COL, V7, P0026, DOI [10.13031/2013.40684, DOI 10.13031/2013.40684]; Brooks RH, 1966, P AM SOC CIVIL ENG, V92, P27; BURDINE NT, 1953, T AM I MIN MET ENG, V198, P71; Carey JW, 2007, INT J GREENH GAS CON, V1, P75, DOI 10.1016/S1750-5836(06)00004-1; Chen CY., 2005, LIQUID GAS RELATIVE; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; Clarkson CR, 2011, INT J COAL GEOL, V88, P204, DOI 10.1016/j.coal.2011.10.003; COREY AT, 1956, T AM I MIN MET ENG, V207, P358; Crow W, ENERGY PROCEDIA, P3561; Diomampo GP, 2001, RELATIVE PERMABILITY; FOURAR M, 1995, INT J MULTIPHAS FLOW, V21, P621, DOI 10.1016/0301-9322(95)00005-I; Hallaji M, 2015, CEMENT CONCRETE RES, V69, P10, DOI 10.1016/j.cemconres.2014.11.007; Hao L, 2010, INT J HEAT MASS TRAN, V53, P1908, DOI 10.1016/j.ijheatmasstransfer.2009.12.066; Huerta NJ, ENERGY PROCEDIA, P5398; Huo D, 2016, TRANSPORT POROUS MED, V113, P567, DOI 10.1007/s11242-016-0713-z; Iyer J, 2018, INT J GREENH GAS CON, V69, P72, DOI 10.1016/j.ijggc.2017.12.001; Jung HB, 2014, APPL GEOCHEM, V47, P1, DOI 10.1016/j.apgeochem.2014.04.010; Kabilan S, 2016, ENVIRON SCI TECHNOL, V50, P6180, DOI 10.1021/acs.est.6b00159; Kang QJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003951; Kim J, 2016, J PETROL SCI ENG, V139, P254, DOI 10.1016/j.petrol.2016.01.035; Klein NS, 2012, CEMENT CONCRETE RES, V42, P1611, DOI 10.1016/j.cemconres.2012.09.001; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P635; Krevor SCM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010859; Kuprat A, 2001, J COMPUT PHYS, V172, P99, DOI 10.1006/jcph.2001.6816; Kutchko BG, 2007, ENVIRON SCI TECHNOL, V41, P4787, DOI 10.1021/es062828c; Kutchko BG, 2011, INT J GREENH GAS CON, V5, P880, DOI 10.1016/j.ijggc.2011.02.008; LaGriT, 2013, AL GRID TOOLB; Layssi H., 2015, CONCRETE INT, V37, P41; Lorensen W, 1987, 14 ANN C COMP GRAPH; Nicholl MJ, 1999, WATER RESOUR RES, V35, P3361, DOI 10.1029/1999WR900241; Okabe H, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066135; Pan C, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002120; Pereira GG, 2011, APPL MATH MODEL, V35, P1666, DOI 10.1016/j.apm.2010.09.043; Pernites RB, 2016, CEMENT CONCRETE COMP, V72, P89, DOI 10.1016/j.cemconcomp.2016.05.018; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; Porter ML, 2009, ADV WATER RESOUR, V32, P1632, DOI 10.1016/j.advwatres.2009.08.009; SAMET H, 1988, IEEE T PATTERN ANAL, V10, P579, DOI 10.1109/34.3918; Scheibe TD, 2015, WATER RESOUR RES, V51, P1023, DOI 10.1002/2014WR015959; Scheidegger A. E, 2008, PHYS LIQUID FLOW POR; Sengul O, 2008, ACI MATER J, V105, P541; Tang JS, 2013, IEEE SYS MAN CYBERN, P3026, DOI 10.1109/SMC.2013.516; Tartakovsky AM, 2009, COMPUT PHYS COMMUN, V180, P1874, DOI 10.1016/j.cpc.2009.06.002; TSANG YW, 1984, WATER RESOUR RES, V20, P1209, DOI 10.1029/WR020i009p01209; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; WANG JSY, 1985, WATER RESOUR RES, V21, P1861, DOI 10.1029/WR021i012p01861; Watanabe N, 2015, WATER RESOUR RES, V51, P2807, DOI 10.1002/2014WR016515; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Yan CL, 2014, ROCK MECH ROCK ENG, V47, P2199, DOI 10.1007/s00603-013-0496-2	54	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210741	10.1371/journal.pone.0210741	http://dx.doi.org/10.1371/journal.pone.0210741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673742	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800051
J	Fernandes, MS; Barbisan, F; Azzolin, VF; do Prado-Lima, PAS; Teixeira, CF; Jung, IED; Assmann, CE; Riffel, RT; Duarte, MMMF; Aguiar-Ribeiro, EM; da Cruz, IBM				Fernandes, Marcelo Soares; Barbisan, Fernanda; Azzolin, Veronica Farina; Schmidt do Prado-Lima, Pedro Antonio; Teixeira, Cibele Ferreira; da Cruz Jung, Ivo Emilio; Assmann, Charles Elias; Riffel, Rogerio Tomasi; Medeiros Frescura Duarte, Marta Maria; Aguiar-Ribeiro, Ednea Maia; Manica da Cruz, Ivana Beatrice			Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED NAUSEA; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; METABOLIC SYNDROME; CANCER-CELLS; WEIGHT-GAIN; EXPRESSION; RISK; DRUG	Background Olanzapine (OLZ) is a second-generation antipsychotic drug used for treatment of schizophrenia, bipolar disorder, and other neuropsychiatric conditions. Undesirable side effects of OLZ include metabolic alterations associated with chronic oxidative-inflammation events. It is possible that lithium (Li), a mood modulator that exhibits anti-inflammatory properties may attenuate OLZ-induced oxi-inflammatory effects. Methodology To test this hypothesis we activated RAW 264.7 immortalized macrophages with OLZ and evaluated oxidation and inflammation at the gene and protein levels. Li and OLZ concentrations were determined using estimated plasma therapeutic concentrations. Results OLZ triggered a significant increase in macrophage proliferation at 72 h. Higher levels of oxidative markers and proinflammatory cytokines, such as TNF-alpha, IL-1 beta, and IL-6, with a concomitant reduction in IL-10, were observed in OLZ-exposed macrophages. Lithium (Li) exposure triggered a short and attenuated inflammatory response demonstrated by elevation of superoxide anion (SA), reactive oxygen species (ROS), IL-1 beta, and cellular proliferation followed by elevation of anti-inflammatory IL-10 levels. Li treatment of OLZ-supplemented macrophages was able to reverse elevation of oxidative and inflammatory markers and increase IL-10 levels. Conclusions Despite methodological limitations related to in vitro protocols, results suggested that Li may attenuate OLZ-induced oxidative and inflammatory responses that result from metabolic side effects associated with OLZ.	[Fernandes, Marcelo Soares; Teixeira, Cibele Ferreira; da Cruz Jung, Ivo Emilio; Medeiros Frescura Duarte, Marta Maria; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Pharmacol Grad Program, Santa Maria, RS, Brazil; [Fernandes, Marcelo Soares; Riffel, Rogerio Tomasi] Fed Univ Southern Frontier, Passo Fundo, RS, Brazil; [Barbisan, Fernanda; Azzolin, Veronica Farina; Manica da Cruz, Ivana Beatrice] Univ Fed Santa Maria, Gerontol Grad Program, Santa Maria, RS, Brazil; [Schmidt do Prado-Lima, Pedro Antonio] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst, Porto Alegre, RS, Brazil; [Assmann, Charles Elias] Univ Fed Santa Maria, Biochem Toxicol Grad Program, Santa Maria, RS, Brazil; [Riffel, Rogerio Tomasi] Hosp Clin Passo Fundo, Passo Fundo, RS, Brazil; [Medeiros Frescura Duarte, Marta Maria] Univ Luterana Brasil, Santa Maria, RS, Brazil; [Aguiar-Ribeiro, Ednea Maia] State Univ Amazonas, Open Univ Third Age, Manaus, AM, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal da Fronteira Sul; Universidade Federal de Santa Maria (UFSM); Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Luterana do Brasil	da Cruz, IBM (corresponding author), Univ Fed Santa Maria, Pharmacol Grad Program, Santa Maria, RS, Brazil.; da Cruz, IBM (corresponding author), Univ Fed Santa Maria, Gerontol Grad Program, Santa Maria, RS, Brazil.	ivana.ufsm@gmail.com	Assmann, Charles/AAM-8039-2021; Barbisan, Fernanda/L-7854-2018; da Cruz, Ivana BM/G-4329-2012; Barbisan, Fernanda/AAS-5551-2020	da Cruz, Ivana BM/0000-0003-3008-6899; Barbisan, Fernanda/0000-0002-2960-7047	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Amazonas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Fundacao de Amparo a Pesquisa do Estado do Amazonas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)" and "Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)" for Brazilian financial support (grants and fellowships).	Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Atkin T, 2017, J CHILD PSYCHOL PSYC, V58, P865, DOI 10.1111/jcpp.12735; Azzolin VF, 2016, TOXICOL IN VITRO, V32, P8, DOI 10.1016/j.tiv.2015.12.001; Baig MR, 2010, J PSYCHIATR PRACT, V16, P325, DOI 10.1097/01.pra.0000388627.36781.6a; Barbisan F, 2018, GENE, V655, P48, DOI 10.1016/j.gene.2018.02.046; Barbisan F, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4151594; Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Calevro A, 2018, PSYCHONEUROENDOCRINO, V95, P28, DOI 10.1016/j.psyneuen.2018.05.021; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Contreras-Shannon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059012; Costa F, 2017, ZYGOTE, V25, P111, DOI 10.1017/S0967199416000307; Cui DH, 2018, J CLIN INVEST, V128, P4997, DOI 10.1172/JCI93090; Cruz Jung I, 2016, PSYCHOPHARMACOLOGY, V233, P1715, DOI 10.1007/s00213-015-4079-7; Dale M, 2015, J NEUROPSYCH CLIN N, V27, P262, DOI 10.1176/appi.neuropsych.14100265; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; de Sousa RT, 2015, PSYCHOPHARMACOLOGY, V232, P245, DOI 10.1007/s00213-014-3655-6; Duarte T, 2018, CYTOKINE, V106, P101, DOI 10.1016/j.cyto.2017.10.017; Farlow MR, 2017, EUR NEUROPSYCHOPHARM, V27, P217, DOI 10.1016/j.euroneuro.2017.01.002; Ferno J, 2015, EUR NEUROPSYCHOPHARM, V25, P923, DOI 10.1016/j.euroneuro.2015.03.002; Finley PR, 2016, CLIN PHARMACOKINET, V55, P925, DOI 10.1007/s40262-016-0370-y; Flank J, 2018, SUPPORT CARE CANCER, V26, P549, DOI 10.1007/s00520-017-3864-8; Fonseka Trehani M, 2016, Mol Neuropsychiatry, V2, P1, DOI 10.1159/000441521; Jeon SW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102174; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Katagiri H, 2012, CURR MED RES OPIN, V28, P701, DOI 10.1185/03007995.2012.666961; Kim HK, 2016, J PSYCHIATR RES, V76, P59, DOI 10.1016/j.jpsychires.2016.02.001; KOMOSSA K, 2010, COCHRANE DB SYST REV, V17; Lindstrom L, 2017, J AFFECT DISORDERS, V213, P138, DOI 10.1016/j.jad.2017.02.012; Machado-Vieira R, 2018, J AFFECT DISORDERS, V233, P92, DOI 10.1016/j.jad.2017.12.026; Mauri MC, 2018, CLIN PHARMACOKINET, V57, P1493, DOI 10.1007/s40262-018-0664-3; Morabito G, 2010, BIOCHIMIE, V92, P1101, DOI 10.1016/j.biochi.2010.04.017; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mostafavi SA, 2017, J CHILD ADOL PSYCHOP, V27, P440, DOI 10.1089/cap.2016.0046; Ozasa R, 2013, CELL STRUCT FUNCT, V38, P183, DOI 10.1247/csf.13012; Pamies A, 2018, ALTEX, V35, P353, DOI [10.14573/altex.1710081, DOI 10.14573/ALTEX.1710081]; Pessina A, 2006, PHARMACOPSYCHIATRY, V39, P160, DOI 10.1055/s-2006-947212; Pessina A, 2006, PHARMACOPSYCHIATRY, V39, P20, DOI 10.1055/s-2006-931475; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rojo LE, 2015, PHARMACOL RES, V101, P74, DOI 10.1016/j.phrs.2015.07.022; Sanomachi T, 2017, ANTICANCER RES, V37, P6177, DOI 10.21873/anticanres.12067; Sarvari AK, 2014, BIOCHEM BIOPH RES CO, V450, P1383, DOI 10.1016/j.bbrc.2014.07.005; Scaini G, 2018, EUR NEUROPSYCHOPHARM, V28, P369, DOI 10.1016/j.euroneuro.2018.01.004; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Spertus J, 2018, NPJ SCHIZOPHR, V4, DOI 10.1038/s41537-018-0053-9; Stapel B, 2018, J PSYCHIATR RES, V105, P95, DOI 10.1016/j.jpsychires.2018.08.017; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Verdolini N, 2018, ACTA PSYCHIAT SCAND, V138, P196, DOI 10.1111/acps.12896; Victoriano M, 2010, BRAIN RES, V1350, P167, DOI 10.1016/j.brainres.2010.05.060; Wingard L, 2017, J AFFECT DISORDERS, V217, P16, DOI 10.1016/j.jad.2017.03.054; Yoodee J, 2017, CRIT REV ONCOL HEMAT, V112, P113, DOI 10.1016/j.critrevonc.2017.02.017; Zhang QS, 2014, J PSYCHOPHARMACOL, V28, P1161, DOI 10.1177/0269881114555250	52	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0209223	10.1371/journal.pone.0209223	http://dx.doi.org/10.1371/journal.pone.0209223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695037	Green Submitted, Green Published, gold			2022-12-27	WOS:000457046400006
J	Bono, A; Tencatt, LFC; Alonso, F; Lehmann, AP				Bono, Alessandra; Caserta Tencatt, Luiz Fernando; Alonso, Felipe; Pablo Lehmann, A.			Redescription of Corydoras undulatus Regan, 1912 (Siluriformes: Callichthyidae), with comments on the identity of Corydoras latus Pearson, 1924	PLOS ONE			English	Article							HOMOLOGY; LACEPEDE; PISCES	A redescription of Corydoras undulatus Regan, 1912 is presented. The original description of C. undulatus is very succinct, as is its diagnosis, which is based only on external morphology. Additional information in the scientific literature on this species is scarce. Specimens from the distribution area of this species were analyzed; Parana and Paraguay river basins in Argentina, Uruguay river basin in Argentina, Brazil and Uruguay, and the Laguna dos Patos system in Brazil. Morphological analysis, principal component analysis (PCA), meristic comparison and osteological description were performed. Corydoras undulatus can be distinguished from its congeners mainly by having the following combination of characters: mesethmoid short, with anterior tip short, smaller than 50% of the entire bone length; posterior margin of the pectoral-fin spine with nearly all serrations directed towards origin of spine; pectoral-fin spine with conical serrations; and its peculiar color pattern. The analysis of the material from the different basins did not indicate relevant morphological differences, suggesting that the species presents a wide distribution in La Plata and Laguna dos Patos drainages. The shared geographic distribution between these two systems is also present in other fish species. The current work presents data about the type locality, taxonomy, osteology, distribution and ontogenetic variation of color pattern in C. undulatus. Comments on the identity of a very similar congener, Corydoras latus, will also be provided.	[Bono, Alessandra; Pablo Lehmann, A.] Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil; [Caserta Tencatt, Luiz Fernando] Univ Estadual Mato Grosso Sul, Unidade Univ Coxim, Rua Gen Mendes Moraes, Coxim, MG, Brazil; [Alonso, Felipe] Consejo Nacl Invest Cient & Tecn, IBIGEO, Inst Bio & Geociencias NOA, Rosario Lerma, Salta, Argentina	Universidade do Vale do Rio dos Sinos (Unisinos); Universidade Estadual de Mato Grosso do Sul; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lehmann, AP (corresponding author), Univ Vale Rio dos Sinos, Lab Ictiol, Sao Leopoldo, RS, Brazil.	pablole@unisinos.br	Tencatt, Luiz/AAC-3595-2019; Alonso, Felipe/AAA-5717-2020; Albornoz, Pablo Lehmann/I-5602-2012	Alonso, Felipe/0000-0001-7227-2732; Albornoz, Pablo Lehmann/0000-0002-8884-4827	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [483060/2013-5, 141061/2014-6, 304997/2016-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	PLA and LFCT are partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grants #483060/2013-5 to PLA and #141061/2014-6 and #304997/2016-1 to LFCT).	Alexandrou MA, 2011, NATURE, V469, P84, DOI 10.1038/nature09660; Aquino AE, 2002, ZOOL ANZ, V241, P223, DOI 10.1078/0044-5231-00071; Arratia G, 1995, J VERTEBR PALEONTOL, V15, P482, DOI 10.1080/02724634.1995.10011243; Britto Marcelo R., 2003, Neotrop. ichthyol., V1, P83, DOI 10.1590/S1679-62252003000200002; Britz M, 2016, NEW SECUR CHALL, P1, DOI 10.1007/978-3-319-39759-7_1; Tencatt LFC, 2016, NEOTROP ICHTHYOL, V14, DOI 10.1590/1982-0224-20150063; Espindola VC, 2018, J FISH BIOL, V92, P1463, DOI 10.1111/jfb.13602; Fricke R., 2020, CATALOG FISHES GENER; Huysentruyt F, 2005, CYBIUM, V29, P261; Knaack J., 2002, AQUARISTIK AKTUELL, V2002, P50; Knaack Joachim, 2004, Zoologische Abhandlungen (Dresden), V54, P55; Koerber Stefan, 2011, Ichthyological Contributions of PecesCriollos, V18, P1; Lundberg J. G., 1970, THESIS; MORRIS P.J., 2006, ACSIMAGEBASE DIGITAL; NIJSSEN H, 1980, BIJDR DIERKD, V50, P190; NIJSSEN H, 1970, Beaufortia, V18, P1; Nijssen H, 1986, REV FR AQUARIOL, V12, P65; Nion H, 1994, 1 ENC NAC FAUN AC LI; Regan C. T., 1912, ANN MAGAZINE NATURAL, V10, P209; Reis RE, 1998, ZOOL J LINN SOC-LOND, V124, P105; Reis RE, 2003, CHECK LIST FRESHWATE, P291; Reis Roberto E., 1997, Ichthyological Exploration of Freshwaters, V7, P299; SCHAEFER SA, 1988, J ZOOL, V214, P81, DOI 10.1111/j.1469-7998.1988.tb04988.x; Schaefer SA, 2000, J MORPHOL, V246, P212, DOI 10.1002/1097-4687(200012)246:3<212::AID-JMOR5>3.0.CO;2-S; Spadella MA, 2017, NEOTROP ICHTHYOL, V15, DOI 10.1590/1982-0224-20160039; TAYLOR W R, 1985, Cybium, V9, P107; Teixeira de Mello F., 2011, PECES AGUA DULCE URU; Tencatt LF, 2015, NEOTROP ICHTHYOL, V13, P2; TENCATT LF, 2016, NEOTROP ICHTHYOL, V14, P1, DOI DOI 10.1590/1982-0224-20150089; Tencatt LF, 2017, ASPIDORAS IHERING 19; Tencatt LFC, 2013, NEOTROP ICHTHYOL, V11, P257, DOI 10.1590/S1679-62252013000200003	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211352	10.1371/journal.pone.0211352	http://dx.doi.org/10.1371/journal.pone.0211352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689676	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800031
J	Go, MA; Mueller, M; Castanares, ML; Egger, V; Daria, VR				Go, Mary Ann; Mueller, Max; Castanares, Michael Lawrence; Egger, Veronica; Daria, Vincent R.			A compact holographic projector module for high-resolution 3D multi-site two-photon photostimulation	PLOS ONE			English	Article							DENDRITIC SPINES; OPTICAL TWEEZERS; MICROSCOPY; EXCITATION; NETWORK; INTEGRATION; CALCIUM	Patterned two-photon (2P) photolysis via holographic illumination is a powerful method to investigate neuronal function because of its capability to emulate multiple synaptic inputs in three dimensions (3D) simultaneously. However, like any optical system, holographic projectors have a finite space-bandwidth product that restricts the spatial range of patterned illumination or field-of-view (FOV) for a desired resolution. Such trade-off between holographic FOV and resolution restricts the coverage within a limited domain of the neuron's dendritic tree to perform highly resolved patterned 2P photolysis on individual spines. Here, we integrate a holographic projector into a commercial 2P galvanometer-based 2D scanning microscope with an uncaging unit and extend the accessible holographic FOV by using the galvanometer scanning mirrors to reposition the holographic FOV arbitrarily across the imaging FOV. The projector system utilizes the microscope's built-in imaging functions. Stimulation positions can be selected from within an acquired 3D image stack (the volume-of-interest, VOI) and the holographic projector then generates 3D illumination patterns with multiple uncaging foci. The imaging FOV of our system is 800x800 mu m(2) within which a holographic VOI of 70x70x70 mu m(3) can be chosen at arbitrary positions and also moved during experiments without moving the sample. We describe the design and alignment protocol as well as the custom software plugin that controls the 3D positioning of stimulation sites. We demonstrate the neurobiological application of the system by simultaneously uncaging glutamate at multiple spines within dendritic domains and consequently observing summation of postsynaptic potentials at the soma, eventually resulting in action potentials. At the same time, it is possible to perform two-photon Ca2+ imaging in 2D in the dendrite and thus to monitor synaptic Ca2+ entry in selected spines and also local regenerative events such as dendritic action potentials.	[Go, Mary Ann] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England; [Mueller, Max; Egger, Veronica] Univ Regensburg, Inst Zool, Neurophysiol, D-93040 Regensburg, Germany; [Castanares, Michael Lawrence; Daria, Vincent R.] Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 0200, Australia	Imperial College London; University of Regensburg; Australian National University; John Curtin School of Medical Research	Egger, V (corresponding author), Univ Regensburg, Inst Zool, Neurophysiol, D-93040 Regensburg, Germany.; Daria, VR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Eccles Inst Neurosci, Canberra, ACT 0200, Australia.	veronica.egger@ur.de; vincent.daria@anu.edu.au		Daria, Vincent/0000-0003-4672-5333; Castanares, Michael Lawrence/0000-0002-5937-8273	German Federal Ministry of Education and Research (BMBF) [FKZ 01GQ1502]; Australian Research Council [DP140101555]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Australian Research Council(Australian Research Council)	VE received funding from the German Federal Ministry of Education and Research (BMBF) contract number FKZ 01GQ1502; VD received funding from the Australian Research Council DP140101555.; We thank Dr. Vanessa Rupprecht for initial help with the project. VE acknowledges the funding by the German Federal Ministry of Education and Research (BMBF) contract number FKZ 01GQ1502. VD also acknowledges the partial funding from the Australian Research Council DP140101555.	Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Born M., 1989, PRINCIPLES OPTICS EL; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Bywalez WG, 2015, NEURON, V85, P590, DOI 10.1016/j.neuron.2014.12.051; Choy JMC, 2017, FRONT CELL NEUROSCI, V207, P11; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Dal Maschio M, 2010, OPT EXPRESS, V18, P18720, DOI 10.1364/OE.18.018720; Daria VR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3216581; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Fisher JAN, 2015, ADV EXP MED BIOL, V859, P427, DOI 10.1007/978-3-319-17641-3_17; Go MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00231; Go MA, 2012, J BIOPHOTONICS, V5, P745, DOI 10.1002/jbio.201100101; Golan L, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066004; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hernandez O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11928; Jerome J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00095; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kirkby PA, 2010, OPT EXPRESS, V18, P13720, DOI 10.1364/OE.18.013720; Kramer RH, 2009, CURR OPIN NEUROBIOL, V19, P544, DOI 10.1016/j.conb.2009.09.004; Liesener J, 2000, OPT COMMUN, V185, P77, DOI 10.1016/S0030-4018(00)00990-1; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Losavio BE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275468; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Makara JK, 2013, NEURON, V80, P1438, DOI 10.1016/j.neuron.2013.10.033; Nadella KMNS, 2016, NAT METHODS, V13, P1001, DOI [10.1038/NMETH.4033, 10.1038/nmeth.4033]; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Ogden D, 2011, P NATL ACAD SCI USA, V108, P19504, DOI [10.1073/pnas.1109111108, DOI 10.1073/PNAS.1109111108]; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Pegard NC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01031-3; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Saghatelyan A, 2005, NEURON, V46, P103, DOI 10.1016/j.neuron.2005.02.016; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tada M, 2014, EUR J NEUROSCI, V39, P1720, DOI 10.1111/ejn.12476; Tanese D, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.3.031211; van der Horst A, 2008, OPT EXPRESS, V16, P20987, DOI 10.1364/OE.16.020987; Yang SJ, 2015, OPT EXPRESS, V23, P32573, DOI 10.1364/OE.23.032573; Yang SG, 2014, P NATL ACAD SCI USA, V111, P12919, DOI 10.1073/pnas.1405468111; Yang S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00127; Yang SG, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046002; Yang WJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32671; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210564	10.1371/journal.pone.0210564	http://dx.doi.org/10.1371/journal.pone.0210564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689635	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800007
J	Lai, SK; Zhang, KB; Li, J; Fu, WL				Lai, Sike; Zhang, Kaibo; Li, Jian; Fu, Weili			Carpal tunnel release with versus without flexor retinaculum reconstruction for carpal tunnel syndrome at short- and long-term follow up-A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							Z-PLASTY RECONSTRUCTION; MEDIAN NERVE; LIGAMENT RECONSTRUCTION; SURGERY; GRIP; DECOMPRESSION; NEUROLYSIS; STRENGTH; WRIST	Background Carpal tunnel syndrome is a common neuropathy disorder for which surgical treatment consists of release and reconstruction of the flexor retinaculum. Reports of postoperative clinical outcomes after carpal tunnel release with or without flexor retinaculum reconstruction in several studies are controversial. This meta-analysis aimed to compare the efficacy and safety of carpal tunnel release with or without flexor retinaculum reconstruction. Methods The PubMed, EMBASE, Web of Science, Ovid, Cochrane Library and Clinical Tri Org databases were searched for randomized controlled trials that compared carpal release with and without transverse carpal ligament reconstruction for carpal tunnel syndrome. Outcomes included postoperative Boston Carpal Tunnel Questionnaire Symptom Severity Scale (SSS), Functional Status Scale (FSS), grip strength and complications. The follow-up time was categorized into short-term (0-3mon) and long-term(>3mon). Results A total of 7 studies with 613 patients met the inclusion criteria and were analyzed in detail. Statistical analysis showed no significant difference between two groups on postoperative long-term grip strength (MD 5.85, 95% CI -1.05 to 12.76) long-term SSS (MD -0.31, 95% CI -0.75 to 0.13) and occurrence of complications (RR 1.14, 95% CI 0.84 to 1.54), whereas statistically significant difference was found between groups regarding short-term grip strength (MD 1.51, 95% CI 0.86 to 2.17) and long-term FSS (MD -0.34, 95% CI -0.47 to -0.21). Conclusion Carpal tunnel release with flexor retinaculum reconstruction for carpal tunnel syndrome may result in improved long-term functional status while there's no advantage regarding grip strength, symptom severity and safety over individual carpal tunnel release in short- and long-term outcomes.	[Lai, Sike; Zhang, Kaibo; Li, Jian; Fu, Weili] Sichuan Univ, Dept Orthopaed Surg, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University	Fu, WL (corresponding author), Sichuan Univ, Dept Orthopaed Surg, West China Hosp, Chengdu, Sichuan, Peoples R China.	foxwin2008@163.com		FU, Weili/0000-0003-4438-2760				ABDULLAH AF, 1995, NEUROSURGERY, V37, P931, DOI 10.1227/00006123-199511000-00012; Aboonq MS, 2015, NEUROSCIENCES, V20, P4; Amanatullah DF, 2015, ORTHOPEDICS, V38, pE72, DOI 10.3928/01477447-20150105-93; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Castro-Menendez M, 2016, Rev Esp Cir Ortop Traumatol, V60, P355, DOI 10.1016/j.recot.2016.06.007; Dias JJ, 2004, J HAND SURG-BRIT EUR, V29B, P271, DOI 10.1016/j.jhsb.2004.01.011; Doyle JR, 2001, CLIN ORTHOP RELAT R, P84; Duche R, 2010, CHIR MAIN, V29, P352, DOI 10.1016/j.main.2010.10.001; Eroglu A, 2018, WORLD J CLIN CASES, V6, P365, DOI 10.12998/wjcc.v6.i10.365; Faour-Martin O., 2014, INT J ORTHOPAEDICS, V23, P109, DOI DOI 10.6051/J.ISSN.2311-5106.2014.01.21; Fess EE, 1992, CLIN ASSESSMENT RECO, V2nd; Flores LP, 2009, J NEUROSURG, V111, P311, DOI 10.3171/2008.9.JNS08457; Gabra JN, 2016, J BIOMECH, V49, P53, DOI 10.1016/j.jbiomech.2015.11.005; Ghasemi M, 2017, IRAN J NEUROL, V16, P164; Guo X, 2009, MED ENG PHYS, V31, P188, DOI 10.1016/j.medengphy.2008.08.001; Gutierrez-Monclus RG, 2018, J HAND SURG-EUR VOL, V43, P303, DOI 10.1177/1753193417730260; Hand ASfSot. American Society for Surgery of the Hand, 1990, HAND EX DIAGN, P121; Hegmann KT, 2018, J AM ACAD ORTHOP SUR, V26, P575, DOI 10.5435/JAAOS-D-17-00034; HIGGINS JPT, 2011, BMJ BRIT MED J, V343; Hubbard ZS, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17802; HUNTER JM, 1991, HAND CLIN, V7, P491; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; JAKAB E, 1991, J HAND SURG-AM, V16A, P202, DOI 10.1016/S0363-5023(10)80097-8; Jones NF, 2012, PLAST RECONSTR SURG, V129, P683, DOI 10.1097/PRS.0b013e3182402c37; KAPANDJI A I, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P305, DOI 10.1016/S0753-9053(05)80180-2; Karlsson MK, 1997, SCAND J PLAST RECONS, V31, P65, DOI 10.3109/02844319709010507; Kim JK, 2014, CLIN ORTHOP RELAT R, V472, P2536, DOI 10.1007/s11999-014-3666-y; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Li ZM, 2014, J WRIST SURG, V3, P227, DOI 10.1055/s-0034-1394136; LLUCH AL, 1993, J HAND SURG-AM, V18A, P170, DOI 10.1016/0363-5023(93)90277-A; Loh PY, 2016, PEERJ, V4, DOI 10.7717/peerj.2510; Manley M, 2013, J HAND SURG-AM, V38A, P729, DOI 10.1016/j.jhsa.2013.01.015; Mathers B, 2016, CLIN BIOMECH, V40, P58, DOI 10.1016/j.clinbiomech.2016.10.011; Momose T, 2014, J HAND SURG-ASIAN-PA, V19, P193, DOI 10.1142/S0218810414500191; Nanno M, 2015, TOHOKU J EXP MED, V236, P233, DOI 10.1620/tjem.236.233; Netscher D, 1998, J HAND SURG-AM, V23A, P48, DOI 10.1016/S0363-5023(98)80088-9; Netscher DT, 2003, PLAST RECONSTR SURG, V111, P2020, DOI 10.1097/01.PRS.0000056836.14559.09; Pavlidis L, 2010, ANN PLAS SURG, V65, P480, DOI 10.1097/SAP.0b013e3181d9ab44; Pourmemari MH, 2018, MUSCLE NERVE, V58, P497, DOI 10.1002/mus.26145; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Saravi MS, 2016, ARCH BONE JT SURG-AB, V4, P145; Schiller JR, 2016, J WRIST SURG, V5, P222, DOI 10.1055/s-0036-1578812; Seitz WH, 2013, CURR ORTHOP PRACT, V24, P53, DOI 10.1097/BCO.0b013e3182797ac3; Shiota E, 2001, J HAND SURG-BRIT EUR, V26, P529, DOI 10.1054/jhsb.2000.0550; Simonetta C, 1977, Acta Orthop Belg, V43, P170; Vanhees M, 2015, J WRIST SURG, V4, P31, DOI 10.1055/s-0034-1398486; Xu L, 2011, J PAK MED ASSOC, V61, P1068; Yu R, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.03.006; Zhang X, 2015, BONE JOINT J, V97B, P221, DOI 10.1302/0301-620X.97B2.34423	49	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211369	10.1371/journal.pone.0211369	http://dx.doi.org/10.1371/journal.pone.0211369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689656	gold, Green Published, Green Submitted			2022-12-27	WOS:000457041800033
J	Novara, C; Boiche, J; Lebrun, C; Macgregor, A; Mateo, Y; Raffard, S				Novara, Caroline; Boiche, Julie; Lebrun, Cindy; Macgregor, Alexandra; Mateo, Yohan; Raffard, Stephane			Disgust assessment: Factorial structure and psychometric properties of the French version of the Disgust Propension and Sensibility Scale Revised-12	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ANXIETY SENSITIVITY; EUROPEAN AMERICANS; SPECIFICITY; VALIDATION; DISEASE; PHYSIOLOGY; INVENTORY; EMOTIONS; DISORDER	The present study examined the internal and external validity of the French version of the -12item Disgust Propensity and Sensitivity Scale-Revised (DPSS-12) in a nonclinical sample from the general population. Two hundred and eighty-two participants completed the DPSSf-12 questionnaire as well as the Anxiety Sensitivity Index (ASI), Anxiety Trait (STAI B), Obsessional Belief Questionnaire 44 items (OBQ 44), Obsessive Compulsive Inventory-Revised (OCI-R) and Positive and Negative Affect Schedule (PANAS). Confirmatory Factor Analysis supported a 2-factor structure after two sensitivity items were removed. The 10-item scale showed good internal consistency, construct validity and test-retest reliability. These adequate psychometric properties make the DPSSf-10 appropriate for use by researchers and practitioners.	[Novara, Caroline; Boiche, Julie; Lebrun, Cindy; Raffard, Stephane] Univ Montpellier, Univ Paul Valery Montpellier 3, EPSYLON EA, Montpellier, France; [Novara, Caroline; Mateo, Yohan] Clin RECH, Grp Ramsay Gds, Montpellier, France; [Macgregor, Alexandra; Raffard, Stephane] CHU Montpellier, Serv Univ Psychiat Adulte, Montpellier, France	Universite de Montpellier; Universite Paul-Valery; Universite de Montpellier; CHU de Montpellier	Novara, C (corresponding author), Univ Montpellier, Univ Paul Valery Montpellier 3, EPSYLON EA, Montpellier, France.; Novara, C (corresponding author), Clin RECH, Grp Ramsay Gds, Montpellier, France.	caroline.novara@etu.univ-montp3.fr	Raffard, Stéphane/K-9822-2013; Raffard, Stephane/M-3926-2019	Raffard, Stephane/0000-0001-5563-0323; novara, caroline/0000-0002-1812-6862	French Ministry of research and industry	French Ministry of research and industry	CIFRE device {2016/1119} signed with the psychiatric clinic RECH belonging to RAMSAY group, financed by the French Ministry of research and industry implemented by the French national association for research and technology.	Abe JAA, 1999, COGNITION EMOTION, V13, P523, DOI 10.1080/026999399379177; Abramowitz JS, 2014, CLIN PSYCHOL REV, V34, P206, DOI 10.1016/j.cpr.2014.01.004; [Anonymous], 2005, PSYCHOL TESTING PRAC; Armstrong T, 2011, BEHAV RES THER, V49, P756, DOI 10.1016/j.brat.2011.08.003; Berle D, 2006, PSYCHIATRY, V69, P228, DOI 10.1521/psyc.2006.69.3.228; Cavanagh K., 2000, BRIT PSYCH SOC WINCH; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cisler JM, 2007, PERS INDIV DIFFER, V42, P935, DOI 10.1016/j.paid.2006.09.004; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Darwin C, 1872, THE EXPRESSION OF TH; Davey GC., 2009, DISGUST ITS DISORDER, P169, DOI 10.1037/11856-008; Davey GCL, 2006, J BEHAV THER EXP PSY, V37, P4, DOI 10.1016/j.jbtep.2005.09.001; de Jong PJ., 2009, DISGUST ITS DISORDER, P253, DOI DOI 10.1037/11856-012; EKMAN P, 1973, STUD PSYCHOL, V15, P140; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Elwood LS., 2009, CROSS CULTURAL PERSP, P99, DOI [10.1037/11856-005, DOI 10.1037/11856-005]; Engelhard IM, 2011, J ANXIETY DISORD, V25, P58, DOI 10.1016/j.janxdis.2010.08.003; Fergus TA, 2009, J ANXIETY DISORD, V23, P703, DOI 10.1016/j.janxdis.2009.02.009; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Goetz AR, 2013, PERS INDIV DIFFER, V55, P579, DOI 10.1016/j.paid.2013.04.029; Haidt J., 1997, PSYCHOL DEV SOC, V9, P107, DOI [10.1177%2F097133369700900105, DOI 10.1177/097133369700900105]; Iwasa K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164630; Martoni RM, 2017, FRONT PSYCHOL, P8; McKay D, 2009, THE INTERSECTION OF, P211; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2005, BEHAV RES THER, V43, P1069, DOI 10.1016/j.brat.2004.08.002; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Olatunji BO, 2007, BEHAV RES THER, V45, P263, DOI 10.1016/j.brat.2006.03.004; Olatunji BO, 2006, J ANXIETY DISORD, V20, P858, DOI 10.1016/j.janxdis.2006.01.005; Olatunji BO, 2016, J ANXIETY DISORD, V44, P63, DOI 10.1016/j.janxdis.2016.10.010; Olatunji BO, 2011, J PSYCHIATR RES, V45, P1236, DOI 10.1016/j.jpsychires.2011.01.018; Olatunji BO, 2010, PSYCHIAT RES, V175, P1, DOI 10.1016/j.psychres.2009.04.007; Olatunji BO, 2009, J ANXIETY DISORD, V23, P153, DOI 10.1016/j.janxdis.2008.06.002; Page AC, 2009, DISGUST ITS DISORDER, P191; R Core Team, 2012, R LANG ENV STAT COMP; Rachman S, 1998, OBSESSIVE-COMPULSIVE DISORDER, P51; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; ROSENBERG EL, 1994, COGNITION EMOTION, V8, P201, DOI 10.1080/02699939408408938; Rozin P, 2005, COGNITION EMOTION, V19, P397, DOI 10.1080/02699930441000166; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Rozin P., 2008, HDB EMOTIONS, P637; Rozin P., 2000, HDB EMOTIONS, P637; Sinaceur M, 2005, PSYCHOL SCI, V16, P247, DOI 10.1111/j.0956-7976.2005.00811.x; Soto JA, 2016, PSYCHOPHYSIOLOGY, V53, P41, DOI 10.1111/psyp.12579; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stark R, 2005, J PSYCHOPHYSIOL, V19, P50, DOI 10.1027/0269-8803.19.1.50; Steketee G, 2005, BEHAV RES THER, V43, P1527, DOI 10.1016/j.brat.2004.07.010; Tabachnick BG., 2007, USING MULTIVARIATE S, V5, P481; Teachman BA, 2006, ANXIETY STRESS COPIN, V19, P335, DOI 10.1080/10615800601055923; Troop N., 2009, DISGUST ITS DISORDER, P229, DOI [10.1037/11856-011, DOI 10.1037/11856-011]; Tsai JL, 2002, EMOTION, V2, P380, DOI 10.1037//1528-3542.2.4.380; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021; Viar-Paxton M, 2016, EMOTION MEASUREMENT, P513, DOI 10.1016/B978-0-08-100508-8.00021-7; Vighetto A, 2003, ENCEPHALE, V29, P157; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Woody SR, 2002, J ANXIETY DISORD, V16, P543, DOI 10.1016/S0887-6185(02)00173-1	59	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210639	10.1371/journal.pone.0210639	http://dx.doi.org/10.1371/journal.pone.0210639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689643	gold, Green Published, Green Submitted			2022-12-27	WOS:000457041800009
J	Wang, RZ; Song, YW; Zhao, XJ				Wang, Runzhou; Song, Yaowu; Zhao, Xiaojun			Can self-referential information improve directed forgetting? Evidence from a multinomial processing tree model	PLOS ONE			English	Article							MEMORY; ITEM; EXPLICIT; EFFORTFUL; IMPLICIT	A large body of research has shown that self-referential processing can enhance an individual's memory of information. However, there are many arguments about how self-referential processing affects directed forgetting (DF). In this study, two experiments were designed to investigate the DF effect and its internal psychological mechanism under explicit and implicit referential conditions using the item-method DF paradigm combined with the storage-retrieval MPT model. We compare the difference in the DF effect between self-referential and other-referential conditions and explain the reasons for the difference. Our results suggest that the item-method DF effect is the result of a selective rehearsal mechanism and a retrieval inhibition mechanism working together. Both self-reference and other-reference can cause DF in explicit referential processing or implicit referential processing, although the DF effect is stronger under the self-referential condition. Furthermore, the memory advantage effect of implicit self-referential processing is stronger than that of explicit self-referential processing.	[Wang, Runzhou; Song, Yaowu; Zhao, Xiaojun] Hebei Univ, Sch Educ, Baoding, Peoples R China	Hebei University	Song, YW; Zhao, XJ (corresponding author), Hebei Univ, Sch Educ, Baoding, Peoples R China.	syw@hbu.edu.cn; psy790821@aliyun.com		Wang, Runzhou/0000-0001-8709-0026	Social Science Foundation of Hebei Province, China [HB18JY006]	Social Science Foundation of Hebei Province, China	This research was supported by Social Science Foundation of Hebei Province, China (HB18JY006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre C, 2017, FRONT PSYCHOL, V8, P1, DOI [10.3389/fpsyg.2017.00001, DOI 10.3389/FPSYG.2017.00001]; Anderson MC, 2003, J MEM LANG, V49, P415, DOI 10.1016/j.jml.2003.08.006; Bai XJ, 2005, PSYCHOL SCI, V28, P1301; [白学军 Bai Xuejun], 2012, [心理科学, Journal of Psychological Science], V35, P9; Basden BH, 1996, MEMORY, V4, P633, DOI 10.1080/741941000; BASDEN BH, 1993, J EXP PSYCHOL LEARN, V19, P603, DOI 10.1037/0278-7393.19.3.603; Batchelder WH, 1999, PSYCHON B REV, V6, P57, DOI 10.3758/BF03210812; Bjork R.A., 1972, CODING PROCESS HUM, P217; [陈祉妍 CHEN ZhiYan], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P617; Cheng SK, 2012, BIOL PSYCHOL, V89, P283, DOI 10.1016/j.biopsycho.2011.10.019; Cloutier J, 2008, CONSCIOUS COGN, V17, P125, DOI 10.1016/j.concog.2007.05.010; Fawcett JM, 2008, MEM COGNITION, V36, P1168, DOI 10.3758/MC.36.6.1168; Foster NL, 2012, J EXP PSYCHOL LEARN, V38, P1309, DOI 10.1037/a0027868; GEISELMAN RE, 1985, MEM COGNITION, V13, P57, DOI 10.3758/BF03198444; Gutchess AH, 2010, NEUROPSYCHOLOGIA, V48, P211, DOI 10.1016/j.neuropsychologia.2009.09.006; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; Hourihan KL, 2006, J EXP PSYCHOL HUMAN, V32, P1354, DOI 10.1037/0096-1523.32.6.1354; [贾喆 Jia Zhe], 2014, [心理科学, Journal of Psychological Science], V37, P840; Johnson CS, 2012, J PERS SOC PSYCHOL, V102, P32, DOI 10.1037/a0026106; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kesebir S, 2010, PSYCHOL SCI, V21, P1525, DOI 10.1177/0956797610383436; Kliegl O, 2013, MEM COGNITION, V41, P452, DOI 10.3758/s13421-012-0264-7; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Kupper CS, 2014, J EXP PSYCHOL GEN, V143, P1443, DOI 10.1037/a0036518; Li Q, 2007, PSYCHOL SCI, V30, P1601; [李文娟 Li Wenjuan], 2005, [心理学报, Acta Psychologica Sinica], V37, P476; Liang N., 2008, THESIS; MacLeod CM, 1998, INTENTIONAL FORGETTING: INTERDISCIPLINARY APPROACHES, P1; Macrae CN, 2002, PSYCHON B REV, V9, P611; Mao XR, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00187; Mao XR, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01480; Moshagen M, 2010, BEHAV RES METHODS, V42, P42, DOI 10.3758/BRM.42.1.42; [慕德芳 MU De-Fang], 2009, [心理学报, Acta Psychologica Sinica], V41, P26; Nowicka A, 2011, CEREB CORTEX, V21, P539, DOI 10.1093/cercor/bhq117; Pastotter B, 2012, MEM COGNITION, V40, P861, DOI 10.3758/s13421-012-0206-4; Perugini M, 2009, J RES PERS, V43, P747, DOI 10.1016/j.jrp.2009.03.015; Rameson LT, 2010, NEUROIMAGE, V50, P701, DOI 10.1016/j.neuroimage.2009.12.098; RIEFER DM, 1992, MEM COGNITION, V20, P601, DOI 10.3758/BF03202710; RIEFER DM, 1988, PSYCHOL REV, V95, P318, DOI 10.1037/0033-295X.95.3.318; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rouder JN, 1998, SCI PSYCH S, P195; Rummel J, 2016, J EXP PSYCHOL LEARN, V42, P1526, DOI 10.1037/xlm0000266; Symons CS, 1997, PSYCHOL BULL, V121, P371, DOI 10.1037/0033-2909.121.3.371; Turk DJ, 2008, CONSCIOUS COGN, V17, P1040, DOI 10.1016/j.concog.2008.02.004; Wang H., 1986, MODERN CHINESE FREQU; WOODWARD AE, 1971, J EXP PSYCHOL, V89, P109, DOI 10.1037/h0031188; [吴小勇 Wu Xiaoyong], 2014, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V22, P402; [杨文静 Yang Wenjing], 2014, [心理学报, Acta Psychologica Sinica], V46, P156; Yang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075190; [杨文静 Yang Wenjing], 2012, [心理科学, Journal of Psychological Science], V35, P50; Zacks RT, 1996, J EXP PSYCHOL LEARN, V22, P143, DOI 10.1037/0278-7393.22.1.143; [周爱保 Zhou Aibao], 2015, [心理学报, Acta Psychologica Sinica], V47, P757; Zhou MH, 2005, PSYCHOL SCI, V28, P117; Zhu L, 2013, EXP BRAIN RES, V228, P1, DOI 10.1007/s00221-013-3531-3; [朱倩云 Zhu Qianyun], 2009, [心理科学, Psychological Science], V32, P436; 陈曦, 1999, [心理学报, Acta Psychologica Sinica], V31, P284	57	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211280	10.1371/journal.pone.0211280	http://dx.doi.org/10.1371/journal.pone.0211280			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689674	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800026
J	Adams, JA; Uryash, A; Lopez, JR; Sackner, MA				Adams, Jose A.; Uryash, Arkady; Lopez, Jose R.; Sackner, Marvin A.			Whole body periodic acceleration improves survival and microvascular leak in a murine endotoxin model	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MYOCARDIAL DYSFUNCTION; SEPTIC SHOCK; DOUBLE-BLIND; MICE; PGZ; EXERCISE; SEPSIS; ENDOTHELIUM; INHIBITION	Sepsis is a life threatening condition which produces multi-organ dysfunction with profound circulatory and cellular derangements. Administration of E. Coli endotoxin (LPS) produces systemic inflammatory effects of sepsis including disruption of endothelial barrier, and if severe enough death. Whole body periodic acceleration (pGz) is the headward-footward motion of the body. pGz has been shown to induce pulsatile shear stress to the endothelium, thereby releasing vascular and cardio protective mediators. The purpose of this study was to determine whether or not pGz performed as a pre-treatment or post-treatment strategy improves survival in a lethal murine endotoxin model. This study was designed as a prospective randomized controlled study in mice. pGz was performed in mice as pre-treatment (pGz-LPS, 3 days prior to LPS), post-treatment (LPS-pGz, 30 min after LPS) strategies or Control (LPS-CONT), in a lethal murine model of endotoxemia. Endotoxemia was induced with intraperitoneal injection of E. Coli LPS (40mg/kg). In a separate group of mice, a nonspecific nitric oxide synthase inhibitor (L-NAME) was provided in their drinking water and pGz-LPS and LPS-pGz performed to determine the effect of nitric oxide (NO) inhibition on survival. In another subset of mice, micro vascular leakage was determined. Behavioral scoring around the clock was performed in all mice at 30 min intervals after LPS administration, until 48 hrs. survival or death. LPS induced 100% mortality in LPS-CONT animals by 30 hrs. In contrast, survival to 48 hrs. occurred in 60% of pGz-LPS and 80% of LPS-pGz. L-NAME abolished the survival effects of pGz. Microvascular leakage was markedly reduced in both pre and post pGz treated animals and was associated with increased tyrosine kinase endothelial-enriched tunica interna endothelial cell kinase 2 (TIE2) receptor and its phosphorylation (p-TIE2). In a murine model of lethal endotoxemia, pGz performed as a pre or post treatment strategy significantly improved survival, and markedly reduced microvascular leakage. The effect was modulated, in part, by NO since a non-selective inhibitor of NO abolished the pGz survival effect.	[Adams, Jose A.; Uryash, Arkady] Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA; [Lopez, Jose R.] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA; [Sackner, Marvin A.] Mt Sinai Med Ctr, Med Serv, Miami Beach, FL 33140 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Mount Sinai Medical Center	Adams, JA (corresponding author), Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA.	tony-adams@msmc.com	Adams, Jose Antonio/AAI-2342-2020; Adams, Jose Antonio/ABC-2699-2021	Adams, Jose Antonio/0000-0002-9401-2226; Adams, Jose Antonio/0000-0002-9401-2226	Florida Heart Research Institute	Florida Heart Research Institute	This study was funded in part by a grant to JAA from the Florida Heart Research Institute (https://www.floridaheart.org). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Adams JA, 2000, J APPL PHYSIOL, V89, P2447, DOI 10.1152/jappl.2000.89.6.2447; Adams JA, 2001, CRIT CARE MED, V29, P1983, DOI 10.1097/00003246-200110000-00022; Adams JA, 2008, PEDIATR RES, V64, P533, DOI 10.1203/PDR.0b013e318183f147; Adams Jose A, 2018, J Sports Med (Hindawi Publ Corp), V2018, P4340925, DOI 10.1155/2018/4340925; Adams JA, 2018, MED HYPOTHESES, V110, P144, DOI 10.1016/j.mehy.2017.12.008; Adams JA, 2010, LIFE SCI, V86, P707, DOI 10.1016/j.lfs.2010.02.022; Bassuk JA, 2008, RESUSCITATION, V77, P250, DOI 10.1016/j.resuscitation.2007.11.018; Bassuk JI, 2010, J SURG RES, V164, pE281, DOI 10.1016/j.jss.2010.07.047; Bougaki M, 2010, SHOCK, V34, P281, DOI 10.1097/SHK.0b013e3181cdc327; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Duma D, 2011, EUR J PHARMACOL, V668, P285, DOI 10.1016/j.ejphar.2011.05.065; Farah C, 2018, NAT REV CARDIOL, V15, P292, DOI 10.1038/nrcardio.2017.224; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Gross CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119918; Han S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9260; Hershey TB, 2017, NEW ENGL J MED, V376, P2311, DOI 10.1056/NEJMp1611928; Ichinose F, 2007, CIRC RES, V100, P130, DOI 10.1161/01.RES.0000253888.09574.7a; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Irahara T, 2016, J TRAUMA ACUTE CARE, V80, P933, DOI 10.1097/TA.0000000000001023; ISHIZASHI H, 1995, JPN J PHYSIOL, V45, P553, DOI 10.2170/jjphysiol.45.553; Kim YH, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-16; Leligdowicz A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00838; Lewis AJ, 2016, SURG INFECT, V17, P385, DOI 10.1089/sur.2016.021; Liaudet L, 1998, J INFECT DIS, V177, P127, DOI 10.1086/513813; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Lopez JR, 2018, MOL NEUROBIOL, V55, P8680, DOI 10.1007/s12035-018-1018-8; Lopez JR, 2017, J MOL CELL CARDIOL, V108, P149, DOI 10.1016/j.yjmcc.2017.06.004; Macdonald J, 2003, BRIT J ANAESTH, V90, P221, DOI 10.1093/bja/aeg034; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Martin AB, 2016, HEALTH AFFAIR, V35, P150, DOI 10.1377/hlthaff.2015.1194; Martin SA, 2013, BRAIN BEHAV IMMUN, V29, P113, DOI 10.1016/j.bbi.2012.12.014; Martinez A, 2008, PEPTIDES, V29, P73, DOI 10.1016/j.peptides.2007.10.021; PERSICHINI T, 2006, ANTIOXIDANTS REDOX S, V8; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Lopez JR, 2016, MED SCI SPORT EXER, V48, P1485, DOI 10.1249/MSS.0000000000000932; Reade MC, 2003, BRIT J ANAESTH, V90, P115, DOI 10.1093/bja/aeg033; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Sackner MA, 2019, EUR J APPL PHYSIOL, V119, P201, DOI 10.1007/s00421-018-4016-7; Serravite DH, 2014, INT J SPORT PHYSIOL, V9, P985, DOI 10.1123/ijspp.2013-0512; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stark RJ, 2018, FASEB J, V32, P945, DOI 10.1096/fj.201700410R; Uryash A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131392; Uryash A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121069; Uryash A, 2012, LIFE SCI, V91, P178, DOI 10.1016/j.lfs.2012.06.031; Uryash A, 2009, J APPL PHYSIOL, V106, P1840, DOI 10.1152/japplphysiol.91612.2008; van de Sandt AM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0330-8; Wang W, 2004, AM J PHYSIOL-RENAL, V287, pF1044, DOI 10.1152/ajprenal.00136.2004; Watson D, 2004, CRIT CARE MED, V32, P13, DOI 10.1097/01.CCM.0000104209.07273.FC; WU CC, 1995, BRIT J PHARMACOL, V114, P1666, DOI 10.1111/j.1476-5381.1995.tb14955.x; Wu H., 2012, CARDIOVASC ENG TECHN, V3, P292; Wu H, 2009, NITRIC OXIDE-BIOL CH, V21, P63, DOI 10.1016/j.niox.2009.05.004; Yamashita T, 2000, CIRCULATION, V101, P931, DOI 10.1161/01.CIR.101.8.931; Young Rachel, 2018, Immunohorizons, V2, P27, DOI 10.4049/immunohorizons.1700073; Zeng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20931	57	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0208681	10.1371/journal.pone.0208681	http://dx.doi.org/10.1371/journal.pone.0208681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682019	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500012
J	John, A; Sun, R; Maillart, L; Schaefer, A; Spence, EH; Perrin, MT				John, Ashley; Sun, Ruichen; Maillart, Lisa; Schaefer, Andrew; Spence, Erin Hamilton; Perrin, Maryanne T.			Macronutrient variability in human milk from donors to a milk bank: Implications for feeding preterm infants	PLOS ONE			English	Article							NUTRIENT COMPOSITION; HUMAN LACTATION; BREAST-MILK; OUTCOMES; FAT; NUTRITION; PROTEIN; GROWTH	Background and objective The composition of human milk varies widely and impacts the ability to meet nutrient requirements for preterm infants. The purpose of this study is to use a large dataset of milk composition from donors to a milk bank to: (1) describe the macronutrient variability in human milk and how it contributes to the ability to meet the protein and calorie targets for the preterm infant using fortification with commercially available multi-nutrient fortifiers; (2) assess how temporal versus subject effects explain macronutrient variability; (3) determine how macronutrient variability contributes to the nutrient distribution in pooled donor milk. Methods This is a retrospective, observational study that analyzes the macronutrient data of 1,119 human milk samples from 443 individual donors to a milk bank. We test fortification strategies with potential basic, intermediate, and high protein and calorie commercial fortifiers. Additionally, we simulate the random pooling of multiple donors to model the impact of macronutrient variability on pooled donor milk. Results Fat was the most variable nutrient and accounted for 80% of the difference in calories. A subject-effect predicted more of the variability after 4 weeks postpartum in all macronutrients (R-2 > = 0.50) than a time-effect (R-2 < = 0.28). When pooling multiple donors, variability was reduced by increasing the number of donors randomly selected for a pool or targeted pooling based on macronutrient analysis of donor pools. Over 75% of mature milk samples fortified with a basic protein fortifier did not meet daily protein targets of 3.5 g/kg without exceeding volumes of 160 ml/kg/day. Conclusion There is a strong individual signature to human milk that impacts the pooling of donor milk, and the ability to meet protein and energy requirements for the preterm infant with basic and intermediate protein and calorie fortifiers.	[John, Ashley; Sun, Ruichen; Maillart, Lisa] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA USA; [Schaefer, Andrew] Rice Univ, Dept Computat & Appl Math, Houston, TX USA; [Spence, Erin Hamilton] Mothers Milk Bank North Texas, Ft Worth, TX USA; [Perrin, Maryanne T.] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rice University; University of North Carolina; University of North Carolina Greensboro	Perrin, MT (corresponding author), Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.	mtperrin@uncg.edu	Maillart, Lisa M/L-3762-2018	Maillart, Lisa M/0000-0002-6321-2671; Perrin, Maryanne/0000-0002-1645-8310; Sun, Ruichen/0000-0002-0183-3595	National Science Foundation [1537992]	National Science Foundation(National Science Foundation (NSF))	LM and AS received funding from the National Science Foundation under Grant No. 1537992 that supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; ALLEN JC, 1991, AM J CLIN NUTR, V54, P69, DOI 10.1093/ajcn/54.1.69; Assad M, 2016, J PERINATOL, V36, P216, DOI 10.1038/jp.2015.168; Bachour P, 2012, BREASTFEED MED, V7, P179, DOI 10.1089/bfm.2011.0038; Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003; Baylor College of Medicine, 2017, GUID AC CAR NEON; Boyce C, 2016, BRIT J NUTR, V116, P1033, DOI 10.1017/S0007114516003007; Bravi F, 2016, AM J CLIN NUTR, V104, P646, DOI 10.3945/ajcn.115.120881; Christmann V, 2017, ACTA PAEDIATR, V106, P242, DOI 10.1111/apa.13669; Cooper AR, 2013, ARCH DIS CHILD-FETAL, V98, pF539, DOI 10.1136/archdischild-2013-304422; de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689; Ehrenkranz RA, 2011, PEDIATR RES, V69, P522, DOI 10.1203/PDR.0b013e318217f4f1; Fusch G, 2017, CLIN PERINATOL, V44, P209, DOI 10.1016/j.clp.2016.11.001; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; GARZA C, 1983, AM J CLIN NUTR, V37, P61, DOI 10.1093/ajcn/37.1.61; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Goes HCA, 2002, NUTRITION, V18, P590, DOI 10.1016/S0899-9007(02)00813-4; Gutierrez E, 2015, ACTA PAEDIATR, V104, P974, DOI DOI 10.1111/APA.13128; Hair AB, 2016, BREASTFEED MED, V11, P70, DOI 10.1089/bfm.2015.0134; Horbar JD, 2015, PEDIATRICS, V136, pE84, DOI 10.1542/peds.2015-0129; Khan S, 2013, J HUM LACT, V29, P81, DOI 10.1177/0890334412448841; Koletzko B, 2014, NUTR CARE PRETERM IN; Koo W, 2017, J PARENTER ENTERAL N, V2017; MICHAELSEN KF, 1990, J PEDIATR GASTR NUTR, V11, P229, DOI 10.1097/00005176-199008000-00013; Michaelsen KF, 1988, J PEDIAT GASTROENTER, V7; Mohammad MA, 2009, AM J CLIN NUTR, V89, P1821, DOI 10.3945/ajcn.2008.26877; Narang APS, 2006, INDIAN J CLIN BIOCHE, V21, P89, DOI 10.1007/BF02913072; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; Perrin MT, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12239; Perrin MT., 2017, J PEDIAT GASTROENTER; Quigley M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub3; Saarela T, 2005, ACTA PAEDIATR, V94, P1176, DOI 10.1080/08035250510036499; Sisk PM, 2017, AM J PERINAT, V34, P676, DOI 10.1055/s-0036-1597326; Sjostrom ES, 2013, ACTA PAEDIATR, V102, P1067, DOI 10.1111/apa.12359; SMITH L, 1984, BRIT MED J, V288, P283, DOI 10.1136/bmj.288.6413.283; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; US FDA, 2018, US HUM DON MILK; Wojcik KY, 2009, J AM DIET ASSOC, V109, P137, DOI 10.1016/j.jada.2008.10.008; Yahvah KM, 2015, NUTR RES, V35, P221, DOI 10.1016/j.nutres.2015.01.004; Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381	40	35	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210610	10.1371/journal.pone.0210610	http://dx.doi.org/10.1371/journal.pone.0210610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682200	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500049
J	Modai, S; Farberov, L; Herzig, E; Isakov, O; Hizi, A; Shomron, N				Modai, Shira; Farberov, Luba; Herzig, Eytan; Isakov, Ofer; Hizi, Amnon; Shomron, Noam			HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN; PATHOGENESIS; TARGETS; GENE; DETERMINANTS; PATHWAY; ROLES; RNAS	HIV-1 is the causative agent of AIDS (Autoimmune Deficiency Syndrome). HIV-1 infection results in systemic CD4(+) T cell depletion, thereby impairing cell-mediated immunity. Micro-RNAs are short (similar to 22 nucleotides long), endogenous single-stranded RNA molecules that regulate gene expression by binding to the 3' untranslated regions (3' UTR) of mRNA transcripts. The relation between HIV-1 infection and human miRNA expression profile has been previously investigated, and studies have shown that the virus can alter miRNA expression and vice versa. Here, we broaden the understanding of the HIV-1 infection process, and show that miRNA-186, 210 and 222 are up-regulated following HIV-1 infection of human Sup-T1 cells. As a result, the host miRNA target genes: Dicer1 (Double-Stranded RNA-Specific Endoribonuclease), HRB (HIV-1 Rev-binding protein) and HIV-EP2 (Human Immunodeficiency Virus Type I Enhancer Binding Protein 2), are down-regulated. Moreover, testing the miRNA-gene anti-correlation on the Jurkat and the HeLa-MAGI cell lines demonstrated the ability of the miRNAs to down-regulate viral expression as well. To conclude, we found that human miR-186, 210 and 222 directly regulate the human genes Dicer1, HRB and HIV-EP2, thus may be filling key roles during HIV-1 replication and miRNA biogenesis. This finding may contribute to the development of new therapeutic strategies.	[Modai, Shira; Farberov, Luba; Herzig, Eytan; Isakov, Ofer; Hizi, Amnon; Shomron, Noam] Tel Aviv Univ, Fac Med, Tel Aviv, Israel; [Herzig, Eytan] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	Tel Aviv University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Shomron, N (corresponding author), Tel Aviv Univ, Fac Med, Tel Aviv, Israel.	nshomron@post.tau.ac.il			Israel Science Foundation (ISF) [1852/16]; Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund	Israel Science Foundation (ISF)(Israel Science Foundation); Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness(European Commission); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund	The Shomron laboratory is supported by the Israel Science Foundation (ISF, 1852/16); Israeli Ministry of Defense, Office of Assistant Minister of Defense for Chemical, Biological, Radiological and Nuclear (CBRN) Defense; Foundation Fighting Blindness; The Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Zimin Institute for Engineering Solutions Advancing Better Lives; Tel Aviv University Breakthrough Innovative Research Grants; Tel Aviv University Richard Eimert Research Fund on Solid Tumors; Djerassi-Elias Institute of Oncology; Canada-Montreal Friends of Tel Aviv University; Harold H. Marcus; Amy Friedkin; Garber Research Fund; and a generous donation from the Adelis Foundation.	Ballegaard V, 2017, JAIDS-J ACQ IMM DEF, V74, pE104, DOI 10.1097/qai.0000000000001191; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Berkhout B, 2007, J BIOL CHEM, V282, P26641, DOI 10.1074/jbc.R700023200; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cohen J, 1997, SCIENCE, V277, P32, DOI 10.1126/science.277.5322.32; David D, 1998, P NATL ACAD SCI USA, V95, P11348, DOI 10.1073/pnas.95.19.11348; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Farberov L, 2015, J CELL SCI, V128, P1607, DOI 10.1242/jcs.167817; Fior J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037511; Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz CC, 1996, CURR BIOL, V6, P848, DOI 10.1016/S0960-9822(02)00608-5; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gong QY, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171157; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herzig E, 2015, J VIROL, V89, P8119, DOI 10.1128/JVI.00809-15; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Isakov O, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks228; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0517-y; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayama T, 2013, LANDES BIOSCIENCE; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; NOMURA N, 1991, J BIOL CHEM, V266, P8590; Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Poltronieri P, 2015, CURR GENOMICS, V16, P327, DOI 10.2174/1389202916666150707160613; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Shomron N, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/594738; Squillace N, 2014, J ANTIMICROB CHEMOTH, V69, P3067, DOI 10.1093/jac/dku264; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Swaminathan S, 2013, IMMUNOL REV, V254, P265, DOI 10.1111/imr.12077; Tozser J, 2003, CURR TOP MED CHEM, V3, P1447, DOI 10.2174/1568026033451781; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Voronin N, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-60; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Weng KF, 2014, NUCLEIC ACIDS RES, V42, P12789, DOI 10.1093/nar/gku952	53	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211111	10.1371/journal.pone.0211111	http://dx.doi.org/10.1371/journal.pone.0211111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682089	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500102
J	Williams, LA; Casbas-Hernandez, P; Nichols, HB; Tse, CK; Allott, EH; Carey, LA; Olshan, AF; Troester, MA				Williams, Lindsay A.; Casbas-Hernandez, Patricia; Nichols, Hazel B.; Tse, Chiu Kit; Allott, Emma H.; Carey, Lisa A.; Olshan, Andrew F.; Troester, Melissa A.			Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; MOLECULAR SUBTYPES; CIGARETTE-SMOKING; EPIDEMIOLOGY; MAMMOGRAPHY; HISTORY; BIOPSY; COHORT	Purpose Invasive breast cancers are thought to arise from in situ lesions, but some ductal carcinoma in situ (DCIS) are indolent with low likelihood of progressing to invasive carcinoma. Comparison of risk factor associations between DCIS and invasive disease may elucidate which factors influence early versus late stages of carcinogenesis. Therefore, we determined whether there were differences in risk factor profiles for screen-detected DCIS and invasive breast cancer among Luminal A lesions. Methods We conducted a case-control analysis using data from the Carolina Breast Cancer Study (1993-2001). Analyses were restricted to Luminal A tumors and screen-detected tumors among mammography-eligible women, to limit confounding by mode of detection (N = 108 DCIS; N = 203 invasive). Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations between risk factors and lesion type. Results In stratified analyses, we observed qualitative differences in the direction of association for ever smoking, obese BMI, high waist-to-hip-ratio (WHR), and. 10 years of oral contraceptive use between DCIS and invasive disease. Breastfeeding was inversely associated with invasive disease and was not associated with DCIS. Interaction tests for risk factor associations between Luminal A DCIS and invasive breast cancer were not statistically significant (p>0.05). Conclusions Among Luminal A tumors, established breast cancer risk factors may exert stronger effects on progression of early lesions to invasive disease, with lesser effects on risk of DCIS.	[Williams, Lindsay A.; Casbas-Hernandez, Patricia; Nichols, Hazel B.; Tse, Chiu Kit; Olshan, Andrew F.; Troester, Melissa A.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Allott, Emma H.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27515 USA; [Carey, Lisa A.; Olshan, Andrew F.; Troester, Melissa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Troester, MA (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.; Troester, MA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Troester, MA (corresponding author), Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA.	troester@unc.edu		Williams, Lindsay/0000-0003-3842-4629	Komen Graduate Training and Disparities Research Grant; Puerto Rico Science, Technology and Research Trust (Science and Technology Grant); National Cancer Institute [U54 CA163071, U54 CA163068, U01 CA179715, U54 CA156733, P30 ES010126, P50 CA058223]; RCMI [G12 MD007579]; NATIONAL CANCER INSTITUTE [P50CA058223, U54CA163071, U01CA179715, U54CA156733, U54CA163068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	Komen Graduate Training and Disparities Research Grant; Puerto Rico Science, Technology and Research Trust (Science and Technology Grant); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RCMI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by: Komen Graduate Training and Disparities Research Grant, Puerto Rico Science, Technology and Research Trust (Science and Technology Grant), the National Cancer Institute (U54 CA163071, U54 CA163068, U01 CA179715, U54 CA156733, P30 ES010126, P50 CA058223), and the RCMI program (G12 MD007579).	ALPERS CE, 1985, HUM PATHOL, V16, P796, DOI 10.1016/S0046-8177(85)80251-3; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; Anderson WF, 2004, BREAST CANCER RES TR, V88, P149, DOI 10.1007/s10549-004-1483-9; Boyd NF, 2006, CANCER EPIDEM BIOMAR, V15, P2086, DOI 10.1158/1055-9965.EPI-06-0345; Burstein HJ, 2004, NEW ENGL J MED, V350, P1430, DOI 10.1056/NEJMra031301; Butler EN, 2016, CANCER CAUSE CONTROL, V27, P775, DOI 10.1007/s10552-016-0754-1; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Casbas-Hernandez P, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3476; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Cox B, 2013, BREAST, V22, P1041, DOI 10.1016/j.breast.2013.07.046; de Roos MA, 2007, ANN SURG ONCOL, V14, P2097, DOI 10.1245/s10434-007-9395-7; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Furberg H, 2002, CANCER EPIDEM BIOMAR, V11, P829; Gapstur SM, 1999, JAMA-J AM MED ASSOC, V281, P2091, DOI 10.1001/jama.281.22.2091; Hulka BS, 2001, MATURITAS, V38, P103, DOI 10.1016/S0378-5122(00)00196-1; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P1415, DOI 10.1007/s10552-011-9814-8; Kabat GC, 2010, AM J EPIDEMIOL, V172, P591, DOI 10.1093/aje/kwq159; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kurbel S, 2014, THEOR BIOL MED MODEL, V11, P1, DOI [10.1186/1742-4682-11-1, DOI 10.1186/1742-4682-11-1]; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Longnecker MP, 1996, CANCER EPIDEM BIOMAR, V5, P961; Marshall E, 2014, SCIENCE, V343, P1454, DOI 10.1126/science.343.6178.1454; Meeske K, 2004, INT J CANCER, V110, P102, DOI 10.1002/ijc.20072; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Moorman PG, 2001, J NATL MED ASSOC, V93, P329; Nichols HB, 2007, CANCER EPIDEM BIOMAR, V16, P2262, DOI 10.1158/1055-9965.EPI-07-0456; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Park SY, 2016, CARCINOGENESIS, V37, P607, DOI 10.1093/carcin/bgw040; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips LS, 2009, CANCER EPIDEM BIOMAR, V18, P1507, DOI 10.1158/1055-9965.EPI-08-0967; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Reinier KS, 2007, BREAST CANCER RES TR, V103, P343, DOI 10.1007/s10549-006-9375-9; ROSEN P, 1970, CANCER, V26, P944, DOI 10.1002/1097-0142(197010)26:4<944::AID-CNCR2820260432>3.0.CO;2-S; Sisti JS, 2016, INT J CANCER, V138, P2346, DOI 10.1002/ijc.29968; Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128; Terry MB, 2002, ORAL CONTRACEPTIVE U, P1100; To T, 2014, INT J CANCER, V135, P1646, DOI 10.1002/ijc.28803; Trentham-Dietz A, 2000, CANCER EPIDEM BIOMAR, V9, P697; Trentham-Dietz A, 2007, EPIDEMIOLOGY, V18, P629, DOI 10.1097/EDE.0b013e318127183a; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Weiss HA, 1996, BRIT J CANCER, V73, P1298, DOI 10.1038/bjc.1996.248; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Young Erin, 2009, Tob Induc Dis, V5, P4, DOI 10.1186/1617-9625-5-4; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211488	10.1371/journal.pone.0211488	http://dx.doi.org/10.1371/journal.pone.0211488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682163	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500172
J	Navred, K; Martin, M; Ekdahl, L; Zetterberg, E; Andersson, NG; Strandberg, K; Norstrom, E				Navred, Kristoffer; Martin, Myriam; Ekdahl, Lina; Zetterberg, Eva; Andersson, Nadine Gretenkort; Strandberg, Karin; Norstrom, Eva			A simplified flow cytometric method for detection of inherited platelet disorders A comparison to the gold standard light transmission aggregometry	PLOS ONE			English	Article							DIAGNOSIS	Background Flow cytometric platelet activation has emerged as an alternative diagnostic test for inherited platelet disorders. It is, however, labor intensive and few studies have directly compared the performance of flow cytometric platelet activation (PACT) to light transmission aggregometry (LTA). The aims of this study were 1/to develop a simplified flow cytometric platelet activation assay using microtiter plates and 2/to correlate the outcome to gold standard method LTA, and to clinical bleeding assessment tool scores (BAT score). Methods The PACT method was developed in microtiter plates using adenosine diphosphate (ADP), collagen-derived peptide (CRP-XL) and thrombin receptor activator for peptide 6 (TRAP-6) as agonists. Antibodies against GPI lb-Illa activation epitope (PAC1), P-selectin (CD62P) and lysosome-associated membrane glycoprotein 3 (LAMP3; CD63) were used as platelet activation markers. Sixty-six patients referred to the coagulation unit for bleeding symptoms were included in this single-center observational study. Platelet activation was determined by PACT and LTA. The results of both methods were correlated to BAT score. Results A two-by-two analysis using Cohen's kappa analysis gave moderate agreement between LTA and PACT (82%, kappa = 0.57), when PACT analysis with ADP and CRP-XL was compared to LTA. Using LTA as reference method, positive predictive value was 70% and negative predictive value was 87%. A substantial number of patients had high BAT score and normal LTA and PACT results. Patients with abnormal LTA or PACT results had higher BAT score than patients with normal results, but the difference was not significant. Conclusions The performance in microtiter plates simplified the PACT method and enabled analysis of more patients at the same time. Our results indicate that with modification of the current PACT assay, a higher negative predictive value can be obtained. Furthermore, with comparable result to LTA the PACT could be used as a screening assay for inherited platelet disorders.	[Navred, Kristoffer; Martin, Myriam; Ekdahl, Lina; Strandberg, Karin] Skane Cty Council, Div Lab Med, Dept Clin Chem, Coagulat Lab, Malmo, Sweden; [Zetterberg, Eva; Andersson, Nadine Gretenkort] Skane Univ Hosp, Dept Haematol, Coagulat Unit, Lund, Sweden; [Norstrom, Eva] Lund Univ, Dept Translat Med, Skane Cty Council, Malmo, Sweden	Lund University; Skane University Hospital; Lund University	Norstrom, E (corresponding author), Lund Univ, Dept Translat Med, Skane Cty Council, Malmo, Sweden.	Eva.Norstrom@med.lu.se	Strandberg, Karin/AAW-2777-2021	Strandberg, Karin/0000-0001-5554-6631; Martin, Myriam/0000-0003-1526-8678	SUS foundation; Skane Council	SUS foundation; Skane Council	Funded by SUS foundation, Skane Council.	Boknas N, 2018, PLATELETS, V29, P512, DOI 10.1080/09537104.2017.1349305; Cattaneo M, 2013, J THROMB HAEMOST; Chandrashekar V, 2015, PLATELETS, V26, P699, DOI 10.3109/09537104.2015.1026318; DAVIDSON JF, 1988, J CLIN PATHOL, V41, P1322; Dovlatova N, 2014, J THROMB HAEMOST, V12, P660, DOI 10.1111/jth.12555; Gremmel T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129666; Gresele P, 2018, INT J LAB HEMATOL, V40, P34, DOI 10.1111/ijlh.12814; Gresele P, 2015, J THROMB HAEMOST, V13, P314, DOI 10.1111/jth.12792; Gresele P, 2014, J THROMB HAEMOST, V12, P1562, DOI 10.1111/jth.12650; Hayward CPM, 2018, INT J LAB HEMATOL, V40, P6, DOI 10.1111/ijlh.12822; Kehrel B, 1998, BLOOD, V91, P491; Lassila R, 2016, SEMIN THROMB HEMOST, V42, P185, DOI 10.1055/s-0036-1571307; MCNICOL A, 1994, BRIT J HAEMATOL, V86, P574, DOI 10.1111/j.1365-2141.1994.tb04789.x; MICHELSON AD, 1987, J LAB CLIN MED, V110, P346; Michelson AD, 2006, PATHOPHYSIOL HAEMO T, V35, P67, DOI 10.1159/000093547; Nurden A, 2011, J THROMB HAEMOST, V9, P76, DOI 10.1111/j.1538-7836.2011.04274.x; Podda G, 2018, PLATELETS, P1; Rubak P, 2016, PLATELETS, V27, P66, DOI 10.3109/09537104.2015.1032919; Skipper MT, 2018, PLATELETS, V29, P270, DOI 10.1080/09537104.2017.1296566; Tosetto A, 2007, BLOOD REV, V21, P89, DOI 10.1016/j.blre.2006.04.002; van Asten I, 2018, J THROMB HAEMOST, V16, P689, DOI 10.1111/jth.13952	21	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211130	10.1371/journal.pone.0211130	http://dx.doi.org/10.1371/journal.pone.0211130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673773	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800076
J	Taylor-Brown, A; Booth, R; Gillett, A; Mealy, E; Ogbourne, SM; Polkinghorne, A; Conroy, GC				Taylor-Brown, Alyce; Booth, Rosie; Gillett, Amber; Mealy, Erica; Ogbourne, Steven M.; Polkinghorne, Adam; Conroy, Gabriel C.			The impact of human activities on Australian wildlife	PLOS ONE			English	Article							SOUTH-EAST QUEENSLAND; REHABILITATION CENTER; HEALTH-CENTER; CHLAMYDIAL INFECTIONS; HEALESVILLE SANCTUARY; EURASIAN LYNX; MORTALITY; URBAN; URBANIZATION; MORBIDITY	Increasing human population size and the concomitant expansion of urbanisation significantly impact natural ecosystems and native fauna globally. Successful conservation management relies on precise information on the factors associated with wildlife population decline, which are challenging to acquire from natural populations. Wildlife Rehabilitation Centres (WRC) provide a rich source of this information. However, few researchers have conducted large-scale longitudinal studies, with most focussing on narrow taxonomic ranges, suggesting that WRC-associated data remains an underutilised resource, and may provide a fuller understanding of the anthropogenic threats facing native fauna. We analysed admissions and outcomes data from a WRC in Queensland, Australia Zoo Wildlife Hospital, to determine the major factors driving admissions and morbidity of native animals in a region experiencing rapid and prolonged urban expansion. We studied 31,626 admissions of 83 different species of native birds, reptiles, amphibians, marsupials and eutherian mammals from 2006 to 2017. While marsupial admissions were highest (41.3%), admissions increased over time for all species and exhibited seasonal variation (highest in Spring to Summer), consistent with known breeding seasons. Causes for admission typically associated with human influenced activities were dominant and exhibited the highest mortality rates. Car strikes were the most common reason for admission (34.7%), with dog attacks (9.2%), entanglements (7.2%), and cat attacks (5.3%) also high. Admissions of orphaned young and overt signs of disease were significant at 24.6% and 9.7%, respectively. Mortality rates were highest following dog attacks (72.7%) and car strikes (69.1%) and lowest in orphaned animals (22.1%). Our results show that WRC databases offer rich opportunities for wildlife monitoring and provide quantification of the negative impacts of human activities on ecosystem stability and wildlife health. The imminent need for urgent, proactive conservation management to ameliorate the negative impacts of human activities on wildlife is clearly evident from our results.	[Taylor-Brown, Alyce; Ogbourne, Steven M.; Conroy, Gabriel C.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia; [Taylor-Brown, Alyce; Polkinghorne, Adam] Univ Sunshine Coast, Anim Res Ctr, Maroochydore, Qld, Australia; [Booth, Rosie; Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Mealy, Erica] Univ Sunshine Coast, Fac Arts Business & Law, Maroochydore, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast; University of the Sunshine Coast	Conroy, GC (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia.	gconroy@usc.edu.au		Ogbourne, Steven/0000-0001-9812-4367; Polkinghorne, Adam/0000-0002-6567-2962	University of the Sunshine Coast; Australia Zoo Wildlife Hospital	University of the Sunshine Coast; Australia Zoo Wildlife Hospital	This study was funded by the University of the Sunshine Coast and the Australia Zoo Wildlife Hospital.	Abbott I, 2002, WILDLIFE RES, V29, P51, DOI 10.1071/WR01011; Ancillotto L, 2013, MAMM BIOL, V78, P369, DOI 10.1016/j.mambio.2013.01.003; Andersson MN, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00093; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; [Anonymous], 2018, AUT SURV 2018 RES BI; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bereau of Meteorology, 2018, QUEENSL DEC 2010 WET; Beyer HL, 2018, J APPL ECOL, V55, P1966, DOI 10.1111/1365-2664.13127; Bouchon-Small A., 2015, THESIS; Brahmia Z, 2013, ENVIRON POLLUT, V174, P171, DOI 10.1016/j.envpol.2012.11.028; Brand CJ, 2013, ECOHEALTH, V10, P446, DOI 10.1007/s10393-013-0897-4; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Brunton Elizabeth A., 2018, Pacific Conservation Biology, V24, P63, DOI 10.1071/PC17034; Burbidge AA, 2017, AUST J ZOOL, V65, P183, DOI 10.1071/ZO17046; Bureau of Meteorlogy, 2018, BRISB NOV 2014 HOT M; Bureau of Meteorology, 2018, ANN CLIM STAT 2017; Bureau of Meteorology, 2018, QUEENSL SPRING 2014; Bureau of Meteorology, 2018, BRISB NOV 2016 VER W; Burton DL, 2004, P 4 INT URB WILDL S; Burton E, 2016, ANIMALS, V6, DOI 10.3390/ani6090056; CANFIELD PJ, 1991, J WILDLIFE DIS, V27, P657, DOI 10.7589/0090-3558-27.4.657; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G., 2010, J COSMOL, V8, P1821; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cook TC, 2013, BIOL CONSERV, V167, P310, DOI 10.1016/j.biocon.2013.08.016; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; Currumbin Wildlife Hospital Foundation, 2018, WILDL HOSP 2018; da Rosa CA, 2012, J ENVIRON MANAGE, V97, P1, DOI 10.1016/j.jenvman.2011.11.004; Denny E., 2010, REV CAT ECOLOGY MANA; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Ellis WA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0632; Erickson WP, 2005, SUMMARY COMP BIRD MO; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Finn HC, 2017, WILDLIFE RES, V44, P377, DOI 10.1071/WR17018; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gebreab SZ, 2015, GEOSPATIAL HEALTH, V10, P205, DOI 10.4081/gh.2015.321; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Gonzalez-Astudillo V, 2017, SCI REP-UK, V7, DOI 10.1038/srep42587; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Grogan A, 2013, VET REC, V172, P211, DOI 10.1136/vr.101139; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Heigl F, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0134-z; IBM Corporation, 2016, IBM SPSS STAT WIND V; Isaksson C, 2015, FUNCT ECOL, V29, P913, DOI 10.1111/1365-2435.12477; ISO. International Organization for Standardization, PERS STOR MOD SQL PS; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kelly A, 2006, J RAPTOR RES, V40, P231, DOI 10.3356/0892-1016(2006)40[231:ADAOFE]2.0.CO;2; Lai S, 2015, OCEAN COAST MANAGE, V103, P78, DOI 10.1016/j.ocecoaman.2014.11.006; Langen TA, 2009, J WILDLIFE MANAGE, V73, P104, DOI 10.2193/2008-017; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lewis OT, 2006, PHILOS T R SOC B, V361, P163, DOI 10.1098/rstb.2005.1712; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; McDonald R, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P193; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; MCORIST S, 1992, AVIAN PATHOL, V21, P503, DOI 10.1080/03079459208418868; Mcruer DL, 2017, J WILDLIFE MANAGE, V81, P163, DOI 10.1002/jwmg.21181; Moiron M, 2015, BEHAV ECOL, V26, P843, DOI 10.1093/beheco/arv026; Molina-Lopez R, 2011, ANIMAL BIODIVERSITY, P34; Molina-Lopez RA, 2011, ANIM BIODIV CONSERV, V34, P401; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Montesdeoca N, 2017, PLOS ONE, P12, DOI [10.1371/journal.pone.1077366, DOI 10.1371/JOURNAL.PONE.1077366]; Morner T, 2002, ANN NY ACAD SCI, V969, P34; Muhldorfer K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-61; Mullineaux E, 2014, J SMALL ANIM PRACT, V55, P293, DOI 10.1111/jsap.12213; Mullineaux E, 2011, VET MICROBIOL, V151, P205, DOI 10.1016/j.vetmic.2011.02.045; NSW Government, 2018, DANG FEED LOR; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Pest & Disease Information Service, 2018, RAINB LOR MAN; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Pyke Graham H., 2018, Pacific Conservation Biology, V24, P148, DOI 10.1071/PC18003; Pyke GH, 2018, CONSERV BIOL, V32, P50, DOI 10.1111/cobi.12937; Queensland Land for Wildlife, 2017, WILDL FRIENDL FENC N; Raidal SR, 2015, AUST VET J, V93, P466, DOI 10.1111/avj.12388; Risbey DA, 2000, WILDLIFE RES, V27, P223, DOI 10.1071/WR98092; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; RSPCA, 2018, WILDL HOSP WHAT WE D; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Santos SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079967; Scheelings TF, 2016, AUST VET J, V94, P121, DOI 10.1111/avj.12417; Scheelings TF, 2015, J WILDLIFE DIS, V51, P712, DOI 10.7589/2014-09-230; Scheelings TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133638; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Schmidt-Posthaus H, 2002, J WILDLIFE DIS, V38, P84, DOI 10.7589/0090-3558-38.1.84; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Sleeman Jonathan M., 2008, P97; Steyn L, 2015, J ORNITHOL, V156, P1085, DOI 10.1007/s10336-015-1209-2; Sumasgutner P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-48; Tejera G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192731; Trocini S, 2008, NAT WILDL REH C CANB; [United Nations Department of Economic and Social Affairs PD], 2017, ESAPWP2482017 UN; Wendell MD, 2002, J WILDLIFE DIS, V38, P101, DOI 10.7589/0090-3558-38.1.101; Wimberger K, 2010, ANIM WELFARE, V19, P501; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x	99	28	32	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0206958	10.1371/journal.pone.0206958	http://dx.doi.org/10.1371/journal.pone.0206958			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673712	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800006
J	Wang, Y; Cobanoglu, MC; Li, J; Hidvegi, T; Hale, P; Ewing, M; Chu, AS; Gong, ZW; Muzumdar, R; Pak, SC; Silverman, GA; Bahar, I; Perlmutter, DH				Wang, Yan; Cobanoglu, Murat C.; Li, Jie; Hidvegi, Tunda; Hale, Pamela; Ewing, Michael; Chu, Andrew S.; Gong, Zhenwei; Muzumdar, Radhika; Pak, Stephen C.; Silverman, Gary A.; Bahar, Ivet; Perlmutter, David H.			An analog of glibenclamide selectively enhances autophagic degradation of misfolded alpha 1-antitrypsin Z	PLOS ONE			English	Article							C. ELEGANS MODEL	The classical form of alpha 1-antitrypsin deficiency (ATD) is characterized by intracellular accumulation of the misfolded variant alpha 1-antitrypsin Z (ATZ) and severe liver disease in some of the affected individuals. In this study, we investigated the possibility of discovering novel therapeutic agents that would reduce ATZ accumulation by interrogating a C. elegans model of ATD with high-content genome-wide RNAi screening and computational systems pharmacology strategies. The RNAi screening was utilized to identify genes that modify the intracellular accumulation of ATZ and a novel computational pipeline was developed to make high confidence predictions on repurposable drugs. This approach identified glibenclamide (GLB), a sulfonylurea drug that has been used broadly in clinical medicine as an oral hypoglycemic agent. Here we show that GLB promotes autophagic degradation of misfolded ATZ in mammalian cell line models of ATD. Furthermore, an analog of GLB reduces hepatic ATZ accumulation and hepatic fibrosis in a mouse model in vivo without affecting blood glucose or insulin levels. These results provide support for a drug discovery strategy using simple organisms as human disease models combined with genetic and computational screening methods. They also show that GLB and/or at least one of its analogs can be immediately tested to arrest the progression of human ATD liver disease.	[Wang, Yan; Li, Jie; Hidvegi, Tunda; Hale, Pamela; Ewing, Michael; Chu, Andrew S.; Gong, Zhenwei; Muzumdar, Radhika; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Cobanoglu, Murat C.; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Li, Jie; Hidvegi, Tunda; Hale, Pamela; Pak, Stephen C.; Silverman, Gary A.; Perlmutter, David H.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Perlmutter, DH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Perlmutter, DH (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	perlmutterd@wustl.edu	Bahar, Ivet/AAH-2921-2020; Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237	U.S. National Institutes of Health [P01DK096990]; 2015 Pinnacle Research Award in Liver Disease, AASLD (American Association for the Study of Liver Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK096990] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2015 Pinnacle Research Award in Liver Disease, AASLD (American Association for the Study of Liver Diseases); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by U.S. National Institutes of Health grants P01DK096990 and 2015 Pinnacle Research Award in Liver Disease by AASLD (American Association for the Study of Liver Diseases).	Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Filipeanu CM, 2000, FEBS LETT, V474, P107, DOI 10.1016/S0014-5793(00)01585-4; Golstein PE, 1999, PFLUG ARCH EUR J PHY, V437, P652, DOI 10.1007/s004240050829; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Li J., 2014, ELECTRON J DIFFER EQ, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089893; Long OS, 2014, HUM MOL GENET, V23, P5109, DOI 10.1093/hmg/ddu235; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Meyer M, 1999, BRIT J PHARMACOL, V128, P27, DOI 10.1038/sj.bjp.0702763; O'Reilly LP, 2014, HUM MOL GENET, V23, P5123, DOI 10.1093/hmg/ddu236; Payen L, 2001, BRIT J PHARMACOL, V132, P778, DOI 10.1038/sj.bjp.0703863; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937	19	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209748	10.1371/journal.pone.0209748	http://dx.doi.org/10.1371/journal.pone.0209748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673724	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800022
J	Zhu, HB; Peng, H; Pan, ZX				Zhu, Haibin; Peng, Hua; Pan, Zhixin			Impacts of rock properties on Danxia landform formation based on lithological experiments at Kongtongshan National Geopark, northwest China	PLOS ONE			English	Article							MT. DANXIASHAN; RED BEDS; PATTERN; BASIN	As an erosional landform, the formation processes of Danxia landform are controlled by internal and external forces as well as lithologic properties. Using field data, we studied the role of lithologic properties on the formation of Danxia landform in Kongtongshan National Geopark, northwest China, through a series of experiments, including uniaxial compressive strength, identification analysis under polarizing microscope, X-ray diffraction analysis, inductively coupled plasma-mass spectrometry analysis, and scanning electron microscopy. The results show that the diagenesis degree, mineral composition, cement composition, degree of cementation, geochemical composition and element contents, and microstructure influenced the structure and anti-weathering and anti-erosion abilities of the Danxia rock mass. Differential weathering of rock in different environments was an important force shaping the different types of Danxia landform. Weathering failure of the Danxia rock mass was the result of multiple combined factors; as well as lithology, other factors, such as those induced during tectonic uplift (i.e., faulting, jointing, and fracturing) and climate, cannot be neglected. Therefore, lithology played an important role in the structural development of Danxia landform, and different lithologies influenced its weathering rate and formation processes. Our findings can provide a reference for revealing the microscopic development of Danxia landform in arid and semi-arid areas.	[Zhu, Haibin; Peng, Hua] Sun Yat Sen Univ, Sch Geog & Planning, Guangzhou, Guangdong, Peoples R China; [Pan, Zhixin] Hainan Univ, Sch Tourism, Haikou, Hainan, Peoples R China	Sun Yat Sen University; Hainan University	Zhu, HB (corresponding author), Sun Yat Sen Univ, Sch Geog & Planning, Guangzhou, Guangdong, Peoples R China.	commitment2012@163.com; eesph@mail.sysu.edu.cn; billpan2066@gmail.com			National Natural Science Foundation of China [41771008]; Special Program for Key Basic Research of the Chinese Ministry of Science and Technology [2013FY111900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Key Basic Research of the Chinese Ministry of Science and Technology	This study was supported by National Natural Science Foundation of China (grant no. 41761002), grant receiver: Zhixin Pan, the Special Program for Key Basic Research of the Chinese Ministry of Science and Technology (project no. 2013FY111900), grant receiver: Hua Peng, and National Natural Science Foundation of China (grant no. 41771008), grant receiver Hua Peng.	Bankole OM, 2016, AM J SCI, V316, P839, DOI 10.2475/09.2016.02; Bruthans J, 2014, NAT GEOSCI, V7, P598, DOI [10.1038/NGEO2209, 10.1038/ngeo2209]; Chen GD., 1935, Q NATL U SUN YAT SEN, V6, P1; Chen LQ, 2017, J MT SCI-ENGL, V14, P926, DOI 10.1007/s11629-016-4024-1; Chen S, 2017, SCI BULL, V62, P277, DOI 10.1016/j.scib.2017.01.004; Dill HG, 2007, J ASIAN EARTH SCI, V29, P960, DOI 10.1016/j.jseaes.2006.07.006; Feng JL, 1928, ANN GUANGDONG GUANGX, V1, P38; GOUDIE AS, 1995, EARTH SURF PROC LAND, V20, P437, DOI 10.1002/esp.3290200505; Grab SW, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i1.985; [郭福生 GUO Fusheng], 2011, [山地学报, Journal of Mountain Science], V29, P195; Guo GM, 2005, B ENG GEOL ENVIRON, V64, P397, DOI 10.1007/s10064-005-0004-3; [姜勇彪 Jiang Yongbiao], 2010, [山地学报, Journal of Mountain Science], V28, P505; Kodama K, 2002, EARTH PLANET SC LETT, V201, P233, DOI 10.1016/S0012-821X(02)00691-X; Kusky TM, 2010, J EARTH SCI-CHINA, V21, P1, DOI 10.1007/s12583-010-0009-0; Ma Chunmei, 2006, Journal of Geographical Sciences, V16, P45; Ministry of Water Resources of the People's Republic of China, 2007, TEST PROC WAT CONS H; NICHOLAS RM, 1986, Z GEOMORPHOL, V30, P167; Ouyang J, 2009, J GEOGR SCI, V19, P631, DOI 10.1007/s11442-009-0631-x; Paradise TR, 2002, Z GEOMORPHOL, V46, P1; Peng H., 2013, OPEN GEOL J, V7, P54; Peng H, 2015, Z GEOMORPHOL, V59, P165, DOI 10.1127/zfg_suppl/2015/S-00179; Peng H, 2015, Z GEOMORPHOL, V59, P19, DOI 10.1127/zfg_suppl/2015/S-00173; Peters CA, 2009, CHEM GEOL, V265, P198, DOI 10.1016/j.chemgeo.2008.11.014; Qiu JT, 2015, GEOHERITAGE, V7, P307, DOI 10.1007/s12371-015-0160-1; [彭华 Peng Hua], 2013, [地理学报, Acta Geographica Sinica], V68, P1170; Soreghan GS, 2015, INT J EARTH SCI, V104, P1589, DOI 10.1007/s00531-014-1070-1; Turkington AV, 2004, EARTH SURF PROC LAND, V29, P665, DOI 10.1002/esp.1060; Yan LB, 2016, PHYS GEOGR, V37, P327, DOI 10.1080/02723646.2016.1218244; Yan ZZ, 2015, PHYS GEOGR, V36, P322, DOI 10.1080/02723646.2015.1033047; [杨华 Yang Hua], 2014, [地质论评, Geological Review], V60, P677; Young RW, 2009, SANDSTONE LANDFORMS, P223; Zeng Z X, 1978, J S CHINA NORMAL COL, P56; [赵文智 ZHAO Wenzhi], 2006, [石油勘探与开发, Petroleum Exploration and Development], V33, P6; Zhu C, 2015, J GEOGR SCI, V25, P943, DOI 10.1007/s11442-015-1212-9; Zhu C, 2010, GEOMORPHOLOGY, V123, P84, DOI 10.1016/j.geomorph.2010.07.002; Zhu C, 2009, J GEOGR SCI, V19, P615, DOI 10.1007/s11442-009-0615-x	36	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210604	10.1371/journal.pone.0210604	http://dx.doi.org/10.1371/journal.pone.0210604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673743	Green Published, gold			2022-12-27	WOS:000456442800048
J	Alikhani, M; Alikhani, M; Alansari, S; Almansour, A; Hamidaddin, MA; Khoo, E; Lopez, JA; Nervina, JM; Nho, JY; Oliveira, SM; Sangsuwon, C; Teixeira, CC				Alikhani, Mani; Alikhani, Mona; Alansari, Sarah; Almansour, Abdullah; Hamidaddin, Mohammad A.; Khoo, Edmund; Lopez, Jose A.; Nervina, Jeanne M.; Nho, Joo Y.; Oliveira, Serafim M.; Sangsuwon, Chinapa; Teixeira, Cristina C.			Therapeutic effect of localized vibration on alveolar bone of osteoporotic rats	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; FREQUENCY MECHANICAL VIBRATION; MESENCHYMAL STEM-CELLS; MINERAL DENSITY; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; ESTROGEN-DEFICIENCY; CALCIUM INTAKE; LOW-MAGNITUDE; TIBIAL BONE	Objectives Vibration, in the form of high frequency acceleration (HFA), stimulates alveolar bone formation under physiologic conditions and during healing after dental extractions. It is not known if HFA has an anabolic effect on osteoporotic alveolar bone. Our objective is to determine if HFA has a regenerative effect on osteoporotic alveolar bone. Methods and materials Adult female Sprague-Dawley rats were divided into five groups: 1) Ovariectomized Group (OVX), 2) Sham-OVX Group that received surgery without ovariectomy, 3) OVX-HFA Group that was ovariectomized and treated daily with HFA, 4) OVX+ Static Force Group that was ovariectomized and received the same force as HFA, but without vibration, and 5) Control Group that did not receive any treatment. All animals were fed a low mineral diet for 3 months. Osteoporosis was confirmed by micro-CT of the fifth lumbar vertebra and femoral head. HFA was applied to the maxillary first molar for 5 minutes/day for 28 and 56 days. Maxillae were collected for micro-CT, histology, fluorescent microscopy, protein and RNA analysis, and three-point bending mechanical testing. Results Micro-CT analysis revealed significant alveolar bone osteoporosis in the OVX group. Vibration restored the quality and quantity of alveolar bone to levels similar to the Sham-OVX group. Animals exposed to HFA demonstrated higher osteoblast activity and lower osteoclast activity. Osteogenic transcription factors (RUNX2, Foxo1, Osterix and Wnt signaling factors) were upregulated following vibration, while RANKL/RANK and Sclerostin were downregulated. HFA did not affect serum TRAcP-5b or CTx-1 levels. The osteogenic effect was highest at the point of HFA application and extended along the hemimaxillae this effect did not cross to the contra-lateral side. Conclusions Local application of vibration generated gradients of increased anabolic metabolism and decreased catabolic metabolism in alveolar bone of osteoporotic rats. Our findings suggest that HFA could be a predictable treatment for diminished alveolar bone levels in osteoporosis patients.	[Alikhani, Mani] Harvard Sch Dent Med, Dept Dev Biol, Adv Grad Educ Program Orthodont, Boston, MA USA; [Alikhani, Mani; Alansari, Sarah] Forsyth Inst, Cambridge, MA USA; [Alikhani, Mani; Alikhani, Mona; Alansari, Sarah; Almansour, Abdullah; Hamidaddin, Mohammad A.; Lopez, Jose A.; Nervina, Jeanne M.; Nho, Joo Y.; Oliveira, Serafim M.; Sangsuwon, Chinapa; Teixeira, Cristina C.] CTOR Acad, Hoboken, NJ 07030 USA; [Khoo, Edmund; Sangsuwon, Chinapa; Teixeira, Cristina C.] NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA; [Oliveira, Serafim M.] Polytech Inst Viseu, Dept Mech Engn, Viseu, Portugal; [Teixeira, Cristina C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Forsyth Institute; New York University; Instituto Politecnico de Viseu; New York University	Teixeira, CC (corresponding author), CTOR Acad, Hoboken, NJ 07030 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	cristina.teixeira@nyu.edu	de Oliveira, Serafim Paulo Melo/Y-3066-2019; Hamidaddin, Mohammad/GXF-1687-2022	de Oliveira, Serafim Paulo Melo/0000-0002-3499-6681; Hamidaddin, Mohammad/0000-0002-5092-264X	Small Business Technology Transfer Grant(STTR) [R41 DE025518]; NIDCR	Small Business Technology Transfer Grant(STTR); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by Small Business Technology Transfer Grant(STTR)#R41 DE025518 from NIDCR (nidcr.nih.gov) that was granted to Mani Alikhani and C.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2016, J DENT RES, V95, P311, DOI 10.1177/0022034515621495; Alikhani M, 2012, J DENT RES, V91, P413, DOI 10.1177/0022034512438590; Alikhani M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196540; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Brouwers JEM, 2010, J ORTHOP RES, V28, P62, DOI 10.1002/jor.20951; Civitelli R, 2002, ARCH INTERN MED, V162, P1409, DOI 10.1001/archinte.162.12.1409; Darcey J, 2013, BRIT DENT J, V214, DOI 10.1038/sj.bdj.2013.165; Du ZB, 2015, TISSUE ENG PART C-ME, V21, P458, DOI [10.1089/ten.tec.2014.0268, 10.1089/ten.TEC.2014.0268]; Ejiri S, 2008, J BONE MINER METAB, V26, P409, DOI 10.1007/s00774-008-0870-4; ELOVIC RP, 1994, J DENT RES, V73, P1735, DOI 10.1177/00220345940730110901; Ervin RB, 2009, J PUBLIC HEALTH DENT, V69, P207, DOI 10.1111/j.1752-7325.2009.00124.x; Han JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181175; Hara T, 2001, ARCH ORAL BIOL, V46, P443, DOI 10.1016/S0003-9969(00)00135-7; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Herring SW, 2007, ARCH ORAL BIOL, V52, P296, DOI 10.1016/j.archoralbio.2006.09.010; Iwasaki M, 2012, J BONE MINER METAB, V30, P447, DOI 10.1007/s00774-011-0337-x; Jiang GZ, 2003, J BONE MINER METAB, V21, P388, DOI 10.1007/s00774-003-0433-7; Jiang JMY, 2008, J NUTR, V138, P2106, DOI 10.3945/jn.108.093781; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kasturi GC, 2011, PM&R, V3, P562, DOI 10.1016/j.pmrj.2010.12.014; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Martinez H, 2001, CLIN ORAL IMPLAN RES, V12, P423, DOI 10.1034/j.1600-0501.2001.120501.x; Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020; Mavropoulos A, 2007, J BONE MINER RES, V22, P403, DOI 10.1359/JBMR.061208; Mavropoulos A, 2014, J BIOMECH, V47, P2666, DOI 10.1016/j.jbiomech.2014.05.012; Moriya Y, 1998, J Oral Sci, V40, P171; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nicopoulou-Karayianni K, 2009, J CLIN PERIODONTOL, V36, P190, DOI 10.1111/j.1600-051X.2008.01365.x; Ota T, 2016, CYTOTECHNOLOGY, V68, P2287, DOI 10.1007/s10616-016-0023-x; Passos JS, 2013, OSTEOPOROSIS INT, V24, P1275, DOI 10.1007/s00198-012-2130-7; Pavone V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00803; Payne JB, 1999, OSTEOPOROSIS INT, V10, P34, DOI 10.1007/s001980050191; Prado RFD, 2012, INT J EXP PATHOL, V93, P139, DOI 10.1111/j.1365-2613.2012.00809.x; Qing FZ, 2016, J ORTHOP RES, V34, P1147, DOI 10.1002/jor.23128; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Slatkovska L, 2011, ANN INTERN MED, V155, P668, DOI 10.7326/0003-4819-155-10-201111150-00005; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stolina M, 2014, BONE, V67, P305, DOI 10.1016/j.bone.2014.07.031; Taguchi A, 2004, MENOPAUSE, V11, P556, DOI 10.1097/01.GME.0000113845.74462.BF; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; Teixeira CC, 2010, J DENT RES, V89, P1135, DOI 10.1177/0022034510373764; Teixeira CC, 2010, J BIOL CHEM, V285, P31055, DOI 10.1074/jbc.M109.079962; Tezal M, 2000, J PERIODONTOL, V71, P1492, DOI 10.1902/jop.2000.71.9.1492; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Uusi-Rasi K, 1998, J BONE MINER RES, V13, P133, DOI 10.1359/jbmr.1998.13.1.133; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; van der Jagt OP, 2012, J BONE MINER METAB, V30, P40, DOI 10.1007/s00774-011-0293-5; Vanleene M, 2013, BONE, V53, P507, DOI 10.1016/j.bone.2013.01.023; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Yadav S, 2016, EUR J ORTHODONT, V38, P44, DOI 10.1093/ejo/cjv006; Yadav S, 2015, AM J ORTHOD DENTOFAC, V148, P440, DOI 10.1016/j.ajodo.2015.03.031; Yang J, 2003, DENTOMAXILLOFAC RAD, V32, P247, DOI 10.1259/dmfr/12560890; Yang P, 2009, AVIAT SPACE ENVIR MD, V80, P88, DOI 10.3357/ASEM.2368.2009; Yoshihara A, 2005, J ORAL REHABIL, V32, P735, DOI 10.1111/j.1365-2842.2005.01491.x; Zhou Y, 2015, BONE, V71, P17, DOI 10.1016/j.bone.2014.09.026	63	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211004	10.1371/journal.pone.0211004	http://dx.doi.org/10.1371/journal.pone.0211004			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695073	Green Submitted, Green Published, gold			2022-12-27	WOS:000457046400014
J	Turner, KJ; Hoyle, J; Valdivia, LE; Cerveny, KL; Hart, W; Mangoli, M; Geisler, R; Rees, M; Houart, C; Poole, RJ; Wilson, SW; Gestri, G				Turner, Katherine J.; Hoyle, Jacqueline; Valdivia, Leonardo E.; Cerveny, Kara L.; Hart, Wendy; Mangoli, Maryam; Geisler, Robert; Rees, Michele; Houart, Corinne; Poole, Richard J.; Wilson, Stephen W.; Gestri, Gaia			Abrogation of Stem Loop Binding Protein (Slbp) function leads to a failure of cells to transition from proliferation to differentiation, retinal coloboma and midline axon guidance deficits	PLOS ONE			English	Article							HISTONE MESSENGER-RNA; GENE-EXPRESSION; 3' END; TRIGGERS DEGRADATION; EMBRYONIC ZEBRAFISH; DROSOPHILA; MUTATIONS; NEUROGENESIS; BRAIN; WNT	Through forward genetic screening for mutations affecting visual system development, we identified prominent coloboma and cell-autonomous retinal neuron differentiation, lamination and retinal axon projection defects in eisspalte (ele) mutant zebrafish. Additional axonal deficits were present, most notably at midline axon commissures. Genetic mapping and cloning of the ele mutation showed that the affected gene is slbp, which encodes a conserved RNA stem-loop binding protein involved in replication dependent histone mRNA metabolism. Cells throughout the central nervous system remained in the cell cycle in ele mutant embryos at stages when, and locations where, post-mitotic cells have differentiated in wild-type siblings. Indeed, RNAseq analysis showed down-regulation of many genes associated with neuronal differentiation. This was coincident with changes in the levels and spatial localisation of expression of various genes implicated, for instance, in axon guidance, that likely underlie specific ele phenotypes. These results suggest that many of the cell and tissue specific phenotypes in ele mutant embryos are secondary to altered expression of modules of developmental regulatory genes that characterise, or promote transitions in, cell state and require the correct function of Slbp-dependent histone and chromatin regulatory genes.	[Turner, Katherine J.; Hoyle, Jacqueline; Valdivia, Leonardo E.; Cerveny, Kara L.; Hart, Wendy; Mangoli, Maryam; Poole, Richard J.; Wilson, Stephen W.; Gestri, Gaia] UCL, Div Biosci, Dept Cell & Dev Biol, London, England; [Hoyle, Jacqueline; Rees, Michele] UCL, Dept Paediat & Child Hlth, London, England; [Valdivia, Leonardo E.] Univ Mayor, Fac Ciencias, Ctr Integrat Biol, Santiago, Chile; [Geisler, Robert] KIT, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Houart, Corinne] Kings Coll London, Dept Dev Neurobiol, London, England; [Houart, Corinne] Kings Coll London, MRC Ctr Dev Disorders, London, England; [Cerveny, Kara L.] Reed Coll, Dept Biol, Portland, OR 97202 USA	University of London; University College London; University of London; University College London; Universidad Mayor; Helmholtz Association; Karlsruhe Institute of Technology; University of London; King's College London; University of London; King's College London; Reed College - Oregon	Wilson, SW; Gestri, G (corresponding author), UCL, Div Biosci, Dept Cell & Dev Biol, London, England.	s.wilson@ucl.ac.uk; g.gestri@ucl.ac.uk	Houart, Corinne/B-5128-2009; Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008; Geisler, Robert/K-6201-2013	Houart, Corinne/0000-0002-2062-3964; Wilson, Stephen W/0000-0002-8557-5940; Geisler, Robert/0000-0002-3909-8311; Cerveny, Kara/0000-0003-0667-827X; Gestri, Gaia/0000-0001-8854-1546; Valdivia, Leonardo E./0000-0002-9589-2114; Turner, Katherine/0000-0002-3867-2684; Poole, Richard/0000-0001-6414-2479	Medical Research Council [G0900994, MR/L003775/1]; Wellcome Trust [095722/Z/11/Z, 207483/Z/17/Z, 089227/Z09/Z, 104682/Z/14/Z]; FONDECYT [11160951]; MRC [MR/L003775/1, G0900994] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council [G0900994 and MR/L003775/1 to S.W.W. and G.G] and Wellcome Trust [095722/Z/11/Z and 207483/Z/17/Z to R.J.P, and 089227/Z09/Z and 104682/Z/14/Z to S.W.W. and FONDECYT [11160951 to L.E.V]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldiri I, 2013, DEVELOPMENT, V140, P2867, DOI 10.1242/dev.088096; Arnold DR, 2008, DEV BIOL, V313, P347, DOI 10.1016/j.ydbio.2007.10.032; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basson MA, 2015, TRENDS GENET, V31, P600, DOI 10.1016/j.tig.2015.05.009; Bazin-Lopez N, 2015, CURR OPIN GENET DEV, V32, P73, DOI 10.1016/j.gde.2015.02.004; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; BOND UM, 1991, GENE DEV, V5, P1709, DOI 10.1101/gad.5.9.1709; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; Dankert JF, 2017, CELL CYCLE, V16, P556, DOI 10.1080/15384101.2017.1284715; Doitsidou M, 2016, GENETICS, V204, P451, DOI 10.1534/genetics.115.186197; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; Dominski Z, 2005, RNA, V11, P1835, DOI 10.1261/rna.2179305; Gao JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036516; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; He WX, 2018, RNA, V24, P1738, DOI 10.1261/rna.067090.118; He YZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep16535; Husken U, 2014, CURR BIOL, V24, P2217, DOI 10.1016/j.cub.2014.08.006; Imai F, 2014, DEV BIOL, V394, P94, DOI 10.1016/j.ydbio.2014.07.020; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knock E, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0040-z; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Kodama Y, 2002, DEVELOPMENT, V129, P187; Koseoglu MM, 2008, MOL CELL BIOL, V28, P4469, DOI 10.1128/MCB.01416-07; LaFave MC, 2014, GENETICS, V198, P167, DOI 10.1534/genetics.114.166769; Lanzotti DJ, 2002, MOL CELL BIOL, V22, P2267, DOI 10.1128/MCB.22.7.2267-2282.2002; Lee RS, 2013, BRAIN PATHOL, V23, P200, DOI 10.1111/bpa.12021; Lefebvre FA, 2017, J MOL BIOL, V429, P3264, DOI 10.1016/j.jmb.2017.01.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04289; Lupo G, 2011, P NATL ACAD SCI USA, V108, P8698, DOI 10.1073/pnas.1103802108; Macdonald R, 1997, DEVELOPMENT, V124, P2397; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Marzluff WF, 2017, TRENDS GENET, V33, P745, DOI 10.1016/j.tig.2017.07.014; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; Minevich G, 2012, GENETICS, V192, P1249, DOI 10.1534/genetics.112.144204; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Obholzer N, 2012, DEVELOPMENT, V139, P4280, DOI 10.1242/dev.083931; Okano HJ, 1997, J NEUROSCI, V17, P3024; Pettitt J, 2002, J CELL SCI, V115, P857; Raphael AR, 2011, CURR TOP DEV BIOL, V97, P1, DOI 10.1016/B978-0-12-385975-4.00007-3; Rauch G. -J., 1997, TECHNICAL TIPS ONLIN, V2, P148, DOI [10.1016/S1366-2120(08)70068-0, DOI 10.1016/S1366-2120(08)70068-0]; Ritchie K, 2014, BIOL OPEN, V3, P1158, DOI 10.1242/bio.20148730; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Saldi T, 2018, GENE DEV, V32, P297, DOI 10.1101/gad.310896.117; Salzler HR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008168; SCHAUFELE F, 1986, NATURE, V323, P777, DOI 10.1038/323777a0; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Sugathan A, 2014, P NATL ACAD SCI USA, V111, pE4468, DOI 10.1073/pnas.1405266111; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner KJ, 2014, METHODS MOL BIOL, V1082, P197, DOI 10.1007/978-1-62703-655-9_14; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Wagner EJ, 2005, BIOCHEM SOC T, V33, P471, DOI 10.1042/BST0330471; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; WILSON SW, 1990, DEVELOPMENT, V108, P121; WOO K, 1995, CURR OPIN GENET DEV, V5, P439, DOI 10.1016/0959-437X(95)90046-J; Xu RH, 2000, DEV DYNAM, V218, P628, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1024>3.0.CO;2-H; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yano M, 2016, INT J DEV NEUROSCI, V55, P124, DOI 10.1016/j.ijdevneu.2016.01.002; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; Zhao XJ, 2004, J CELL SCI, V117, P6043, DOI 10.1242/jcs.01523; Zheng LX, 2003, MOL CELL BIOL, V23, P1590, DOI 10.1128/MCB.23.5.1590-1601.2003; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	78	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211073	10.1371/journal.pone.0211073	http://dx.doi.org/10.1371/journal.pone.0211073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695021	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400015
J	Stabler, M; Kempf, A; Smout, S; Temming, A				Staebler, Moritz; Kempf, Alexander; Smout, Sophie; Temming, Axel			Sensitivity of multispecies maximum sustainable yields to trends in the top (marine mammals) and bottom (primary production) compartments of the southern North Sea food-web	PLOS ONE			English	Article							EUTROPHICATION STATUS; FISHERIES MANAGEMENT; OXYGEN DEFICIENCY; CLIMATE-CHANGE; PHYTOPLANKTON; PLANKTON; COASTAL; OLIGOTROPHICATION; CONSEQUENCES; POPULATION	In marine ecosystems, maximum sustainable yield considerations are affected by any substantial changes that occur in the top and bottom compartments of the food-web. This study explores how the southern North Sea's fisheries may need to adjust their fishing efforts to maintain optimum yields of sole, plaice, cod and brown shrimps under increased marine mammal populations and a reduced primary productivity. We constructed plausible scenarios of ongoing food-web changes using the results of Bayesian age-structured population models to estimate carrying capacities of harbour porpoises (Phocoena phocoena) and grey seals (Halichoerus grypus). Losses in primary productivity were predicted by lower trophic level ecosystem models. These scenarios were implemented in a food-web model of the southern North Sea. For each scenario, we sought mixed-fleet fishing efforts that would deliver maximum yields of sole, plaice, cod and brown shrimp combined. We also did so for a baseline run with unaltered mammal and primary production, and compared the differences in optimal fishing strategies, predicted yields, and states of the stocks between the scenarios. We found stocks and yields to be far more sensitive to changes in primary productivity than to increased marine mammal predation. The latter predominantly impacted cod, and even benefitted brown shrimps compared to the baseline run. Under 30% reduced primary productivity, fishing efforts had to be reduced by 50% to still provide maximum yields, whereas the marine mammal scenario induced no need to adjust the fishing regime. This draws attention to the potential gains of incorporating bottom-up processes into long-term management considerations, while marine mammal predation may be less of a concern, in particular for flatfish fisheries in the North Sea, and may even benefit shrimp trawlers because of reduced predation on shrimp from fish predators.	[Staebler, Moritz] Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany; [Staebler, Moritz; Temming, Axel] Univ Hamburg, Inst Hydrobiol & Fishery Sci IHF, Hamburg, Germany; [Staebler, Moritz; Kempf, Alexander] Thunen Inst Sea Fisheries, Bremerhaven, Germany; [Smout, Sophie] Scottish Oceans Inst, St Andrews, Fife, Scotland	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Hamburg; Johann Heinrich von Thunen Institute; University of St Andrews	Stabler, M (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany.; Stabler, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fishery Sci IHF, Hamburg, Germany.; Stabler, M (corresponding author), Thunen Inst Sea Fisheries, Bremerhaven, Germany.	moritz.staebler@posteo.de			European Commission [289257]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors (MS, AK, SS, AT) gratefully acknowledge financial support through the European Commission's MYFISH project (Maximising yield of fisheries while balancing ecosystem, economic and social concerns, FP7/2007-2013 under grant agreement no 289257; http://myfishproject.eu), and thank its organizers for providing the opportunity to draft this study during its meetings and the 2016 Athens symposium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2015, ICES J MAR SCI, V72, P436, DOI 10.1093/icesjms/fsu149; [Anonymous], 2007, E MOD EC APPR FISH; [Anonymous], 2015, REPORT WORKING GROUP; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Beukema JJ, 2002, J SEA RES, V48, P111, DOI 10.1016/S1385-1101(02)00162-4; BEUKEMA JJ, 1986, OPHELIA, V26, P55, DOI 10.1080/00785326.1986.10421978; Boddeke R, 1996, ICES J MAR SCI, V53, P995, DOI 10.1006/jmsc.1996.0124; BURKILL PH, 1987, MAR BIOL, V93, P581, DOI 10.1007/BF00392796; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Claussen U, 2009, HYDROBIOLOGIA, V629, P49, DOI 10.1007/s10750-009-9763-3; COLEBROOK JM, 1979, MAR BIOL, V51, P23, DOI 10.1007/BF00389027; Colijn F, 2002, HYDROBIOLOGIA, V484, P133, DOI 10.1023/A:1021361206529; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; de Jong F, 2006, MARINE EUTROPHICATIO; DETHLEFSEN V, 1983, MEERESFORSCHUNG, V30, P42; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Gerdeaux D, 2006, ACTA OECOL, V30, P161, DOI 10.1016/j.actao.2006.02.007; Grosse F, 2016, BIOGEOSCIENCES, V13, P2511, DOI 10.5194/bg-13-2511-2016; HAGERMAN L, 1995, MAR BIOL, V123, P235, DOI 10.1007/BF00353614; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hilborn R, 2010, MAR POLICY, V34, P193, DOI 10.1016/j.marpol.2009.04.013; Hislop J., 1997, DATABASE REPORT STOM; Jones EL, 2015, MAR ECOL PROG SER, V534, P235, DOI 10.3354/meps11370; Kempf A, 2016, MAR POLICY, V69, P146, DOI 10.1016/j.marpol.2016.04.012; Lenhart HJ, 2010, J MARINE SYST, V81, P148, DOI 10.1016/j.jmarsys.2009.12.014; Ludsin SA, 2001, ECOL APPL, V11, P731, DOI 10.2307/3061113; MacKenzie BR, 2012, AMBIO, V41, P626, DOI 10.1007/s13280-012-0325-y; Mackinson S., 2007, 142 CEFAS; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; Miller D, 2010, COMBINED EXPOST EXAN; Niiranen S, 2013, GLOBAL CHANGE BIOL, V19, P3327, DOI 10.1111/gcb.12309; Plikshs M., 1993, 1993J22 ICES CM; REISE K, 1982, NETH J SEA RES, V16, P29, DOI 10.1016/0077-7579(82)90014-X; Rijnsdorp A, 2004, CM2004K ICES, P13; Rijnsdorp AD, 1996, ICES J MAR SCI, V53, P1199, DOI 10.1006/jmsc.1996.0145; Stabler M, OCEAN COASTAL MANAGE; Stabler M, 2016, WISSENSCHAFT ERLEBEN, V1, P12, DOI [10.1111/j.1365-2486.2009.02063.x, DOI 10.1111/J.1365-2486.2009.02063.X]; Stabler M, 2014, FISHERIES CTR RES RE, V22; Stabler M, 2016, ECOL MODEL, V331, P17, DOI 10.1016/j.ecolmodel.2016.01.020; Stockner JG, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:CO>2.0.CO;2; Stottrup JC, 2017, J SEA RES, V127, P164, DOI 10.1016/j.seares.2017.01.001; Temming A, 2015, ICES J MAR SCI, V72, P804, DOI 10.1093/icesjms/fsu194; TMAP, 2013, PAR GROUP MAR MAMM; Trites AW, 1999, LOW WAKE FI, V16, P609; Ulrich C, 2001, AQUAT LIVING RESOUR, V14, P267, DOI 10.1016/S0990-7440(01)01132-9; Ulrich C, 2012, OCEAN COAST MANAGE, V70, P38, DOI 10.1016/j.ocecoaman.2012.06.002; Vinther M, 2004, ICES J MAR SCI, V61, P1398, DOI 10.1016/j.icesjms.2004.08.018; WGNSSK, 2015, REP WORK GROUP ASS D; WGNSSK, 2014, REP WORK GROUP ASS D; WKMSYREF3, 2014, JOINT ICES MYFISH WO; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	53	6	7	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210882	10.1371/journal.pone.0210882	http://dx.doi.org/10.1371/journal.pone.0210882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689649	gold, Green Published			2022-12-27	WOS:000457041800013
J	Loza-Correa, M; Ayala, JA; Perelman, I; Hubbard, K; Kalab, M; Yi, QL; Taha, M; de Pedro, MA; Ramirez-Arcos, S				Loza-Correa, Maria; Ayala, Juan A.; Perelman, Iris; Hubbard, Keith; Kalab, Miloslav; Yi, Qi-Long; Taha, Mariam; de Pedro, Miguel A.; Ramirez-Arcos, Sandra			The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; TRANSFUSION REACTIONS; INDEPENDENT BIOFILM; EXTRACELLULAR DNA; RESISTANCE; STRAINS; ICA; ENDOPEPTIDASE; DYNAMICS; STORAGE	Staphylococcus epidermidis is a bacterium frequently isolated from contaminated platelet concentrates (PCs), a blood product used to treat bleeding disorders in transfusion patients. PCs offer an accidental niche for colonization of S. epidermidis by forming biofilms and thus avoiding clearance by immune factors present in this milieu. Using biochemical and micros-copy techniques, we investigated the structural changes of the peptidoglycan (PG) and the biofilm matrix of S. epidermidis biofilms formed in whole-blood derived PCs compared to biofilms grown in glucose-supplemented trypticase soy broth (TSBg). Both, the PG and the biofilm matrix are primary mechanisms of defense against environmental stress. Here we show that in PCs, the S. epidermidis biofilm matrix is mainly of a proteinaceous nature with extracellular DNA, in contrast to the predominant polysaccharide nature of the biofilm matrix formed in TSBg cultures. PG profile studies demonstrated that the PG of biofilm cells remodels during PC storage displaying fewer muropeptides variants than those observed in TSBg. The PG muropeptides contain two chemical modifications (amidation and O-acetylation) previously associated with resistance to antimicrobial agents by other staphylococci. Our study highlights two key structural features of S. epidermidis that are remodeled when exposed to human platelets and could be used as targets to reduce septic transfusions events.	[Loza-Correa, Maria; Perelman, Iris; Yi, Qi-Long; Taha, Mariam; Ramirez-Arcos, Sandra] Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada; [Loza-Correa, Maria; Ramirez-Arcos, Sandra] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ayala, Juan A.; de Pedro, Miguel A.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Hubbard, Keith; Kalab, Miloslav] Agr & Agri Food Canada, Ottawa, ON, Canada	Canadian Blood Services; University of Ottawa; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Agriculture & Agri Food Canada	Ramirez-Arcos, S (corresponding author), Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada.; Ramirez-Arcos, S (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	sandra.ramirez@blood.ca	Ayala, Juan A/AAI-4458-2021	Ayala, Juan A/0000-0002-0577-7498; Taha, Mariam/0000-0002-9147-4265; Ramirez-Arcos, Sandra/0000-0003-0705-4987	Canadian Blood Services; CONACyT; Canadian Blood Services and Health Canada;  [PT13/0001]	Canadian Blood Services; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Blood Services and Health Canada; 	Drs. M. Loza-Correa and M. Taha held a Postdoctoral Fellowship and a Graduate Student Scholarship from Canadian Blood Services, respectively. CONACyT provided additional funding to Dr. M. Loza-Correa for postdoctoral training. Canadian Blood Services and Health Canada provided financial support for this study; however, the views expressed herein do not necessarily represent those of the Canadian Federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the volunteer blood donors and staff at the Canadian Blood Services Network Centre for Applied Development (netCAD, Vancouver) for whole blood collection and PC manufacturing. We greatly thank Dr. D. Chabot (Ottawa Research and Development Centre, Agriculture and Agri-Food Canada) for analysis of the CLSM data and critical review of this manuscript. Molecular weight analysis by MS-MALDITOF was carried out in the CBMSO protein chemistry facility, that belongs to the ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Anti-Health System, Charlottesville, Virginia) and Dr. A.K. Brassinga (University of Manitoba, Winnipeg, Manitoba, Canada) for providing the S. epidermidis Hamburg 9142 and 9142 Delta icaA strains. Drs. S. Ramirez-Arcos and M. Loza-Correa are associated with the Department of Biochemistry, Microbiology and Immunology of the University of Ottawa.S. epidermidis PIA-specific antiserum was kindly provided by Dr. D. Mack (Swansea University, UK). The authors are thankful to Dr. C. Sifri (University of Virginia Health System, Charlottesville, Virginia) and Dr. A.K. Brassinga (University of Manitoba, Winnipeg, Manitoba, Canada) for providing the S. epidermidis Hamburg 9142 and 9142 Delta icaA strains. Drs. S. Ramirez-Arcos and M. Loza-Correa are associated with the Department of Biochemistry, Microbiology and Immunology of the University of Ottawa.	Alandullatif M, 2018, TRANSFUSION, V58, P2013, DOI 10.1111/trf.14646; Ali H, 2014, J MED MICROBIOL, V63, P884, DOI 10.1099/jmm.0.071449-0; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Baranwal G, 2017, INT J MED MICROBIOL, V307, P388, DOI 10.1016/j.ijmm.2017.08.002; Barker LM, 2010, TRANSFUSION, V50, P2731, DOI 10.1111/j.1537-2995.2010.02727.x; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Deibert J, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040033; Dengler V, 2015, J BACTERIOL, V197, P3779, DOI 10.1128/JB.00726-15; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Fagerlund A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00856; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Folkesson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001891; Foulston L, 2014, MBIO, V5, DOI 10.1128/mBio.01667-14; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Gonzalez-Leiza SM, 2011, J BACTERIOL, V193, P6887, DOI 10.1128/JB.05764-11; Greco C, 2007, TRANSFUSION, V47, P1143, DOI 10.1111/j.1537-2995.2007.01249.x; Greco CA, 2010, TRANSFUSION, V50, P2344, DOI 10.1111/j.1537-2995.2010.02726.x; Greco-Stewart VS, 2012, VOX SANG, V102, P212, DOI 10.1111/j.1423-0410.2011.01550.x; Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Hodgson SD, 2014, TRANSFUSION, V54, P461, DOI 10.1111/trf.12308; Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944; Jenkins C, 2011, TRANSFUSION, V51, P2555, DOI 10.1111/j.1537-2995.2011.03187.x; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kraus D, 2007, INFECT IMMUN, V75, P2084, DOI 10.1128/IAI.01576-06; Levin E, 2008, TRANSFUSION, V48, P2331, DOI 10.1111/j.1537-2995.2008.01836.x; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; Loza-Correa M, 2017, VOX SANG, V112, P401, DOI 10.1111/vox.12513; Loza-Correa M, 2016, TRANSFUSION, V56, P1348, DOI 10.1111/trf.13557; Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8; Martin-Lorenzo M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09042-2; Mohan KVK, 2010, TRANSFUSION, V50, P166, DOI 10.1111/j.1537-2995.2009.02376.x; Nuri R, 2015, BBA-BIOMEMBRANES, V1848, P3089, DOI 10.1016/j.bbamem.2015.05.022; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Okshevsky M, 2014, J MICROBIOL METH, V105, P102, DOI 10.1016/j.mimet.2014.07.010; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramirez-Arcos S, 2012, TRANSFUSION REACTION; Ramirez-Arcos S, 2017, TRANSFUSION, V57, P2174, DOI 10.1111/trf.14202; Ropy A, 2015, ANTIMICROB AGENTS CH, V59, P3925, DOI 10.1128/AAC.05150-14; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Singh Shriti, 2017, Open Microbiol J, V11, P53, DOI 10.2174/1874285801711010053; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Sugai M, 1997, J BACTERIOL, V179, P4311, DOI 10.1128/jb.179.13.4311-4318.1997; Taha M, 2018, J MED MICROBIOL, V67, P190, DOI 10.1099/jmm.0.000673; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Weisser M, 2010, J CLIN MICROBIOL, V48, P2407, DOI 10.1128/JCM.00492-10; Yeaman MR, 1999, DRUG RESIST UPDATE, V2, P116, DOI 10.1054/drup.1999.0069; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211132	10.1371/journal.pone.0211132	http://dx.doi.org/10.1371/journal.pone.0211132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682094	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500106
J	Mishra, AK; Placzek, C; Jones, R				Mishra, Ashish Kumar; Placzek, Christa; Jones, Rhondda			Coupled influence of precipitation and vegetation on millennial-scale erosion rates derived from Be-10	PLOS ONE			English	Article							WEAK CLIMATIC CONTROL; SITU-PRODUCED BE-10; DENUDATION RATES; SOIL-EROSION; COSMOGENIC NUCLIDES; SEDIMENT TRANSPORT; PLATEAU UPLIFT; SOUTHERN ASIA; ROCK UPLIFT; HALF-LIFE	Water is one of the main agent of erosion in many environmental settings, but erosion rates derived from beryllium-10 (Be-10) suggests that a relationship between precipitation and erosion rate is statistically non-significant on a global scale. This might be because of the strong influence of other variables on erosion rate. In this global Be-10 compilation, we examine if mean annual precipitation has a statistically significant secondary control on erosion rate. Our secondary variable assessment suggests a significant secondary influence of precipitation on erosion rate. This is the first time that the influence of precipitation on Be-10-derived erosion rate is recognized on global scale. In fact, in areas where slope is <200m/km (similar to 11 degrees), precipitation influences erosion rate as much as mean basin slope, which has been recognized as the most important variable in previous Be-10 compilations. In areas where elevation is <1000m and slope is <11 degrees, the correlation between precipitation and erosion rate improves considerably. These results also suggest that erosion rate responds to change in mean annual precipitation nonlinearly and in three regimes: 1) it increases with an increase in precipitation until similar to 1000 mm/yr; 2) erosion rate stabilizes at similar to 1000 mm/yr and decreases slightly with increased precipitation until similar to 2200 mm/yr; and 3) it increases again with further increases in precipitation. This complex relationship between erosion rate and mean annual precipitation is best explained by the interrelationship between mean annual precipitation and vegetation. Increased vegetation, particularly the presence of trees, is widely recognized to lower erosion rate. Our results suggest that tree cover of 40% or more reduces erosion rate enough to outweigh the direct erosive effects of increased rainfall. Thus, precipitation emerges as a stronger secondary control on erosion rate in hyper-arid areas, as well as in hyper-wet areas. In contrast, the regime between similar to 1000 and similar to 2200 mm/yr is dominated by opposing relationships where higher rainfall acts to increase erosion rate, but more water also increases vegetation/tree cover, which slows erosion. These results suggest that when interpreting the sedimentological record, high sediment fluxes are expected to occur when forests transition to grasslands/savannahs; however, aridification of grasslands or savannahs into deserts will result in lower sediment fluxes. This study also implies that anthropogenic deforestation, particularly in regions with high rainfall, can greatly increase erosion.	[Mishra, Ashish Kumar; Placzek, Christa] James Cook Univ, Geosci, Coll Sci & Engn, Townsville, Qld, Australia; [Mishra, Ashish Kumar; Placzek, Christa] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Townsville, Qld, Australia; [Jones, Rhondda] James Cook Univ, StatsHelp Serv, Grad Res Sch, Townsville, Qld, Australia	James Cook University; James Cook University; James Cook University	Mishra, AK (corresponding author), James Cook Univ, Geosci, Coll Sci & Engn, Townsville, Qld, Australia.; Mishra, AK (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Townsville, Qld, Australia.	ashish.mishra@my.jcu.edu.au						Acosta VT, 2015, LITHOSPHERE-US, V7, P408, DOI 10.1130/L402.1; [Anonymous], 1960, CLIMAT EROSION RELAT; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Balco G, 2009, EARTH PLANET SC LETT, V286, P570, DOI 10.1016/j.epsl.2009.07.025; Bermudez MA, 2013, LITHOSPHERE-US, V5, P3, DOI 10.1130/L212.1; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Bierman P, 1996, EARTH SURF PROC LAND, V21, P125, DOI 10.1002/(SICI)1096-9837(199602)21:2<125::AID-ESP511>3.0.CO;2-8; Bierman PR, 2002, GEOL SOC AM BULL, V114, P787, DOI 10.1130/0016-7606(2002)114<0787:CEAEHO>2.0.CO;2; Bierman PR, 2001, AM J SCI, V301, P326, DOI 10.2475/ajs.301.4-5.326; Binnie SA, 2007, GEOLOGY, V35, P743, DOI 10.1130/G23641A.1; Bochet E, 2006, EARTH SURF PROC LAND, V31, P536, DOI 10.1002/esp.1351; Bonnet S, 2003, GEOLOGY, V31, P123, DOI 10.1130/0091-7613(2003)031<0123:LRTCCI>2.0.CO;2; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Brown ET, 1998, EARTH PLANET SC LETT, V160, P723, DOI 10.1016/S0012-821X(98)00123-X; BROWN L, 1988, EARTH SURF PROC LAND, V13, P441, DOI 10.1002/esp.3290130509; Buechi MW, 2014, QUAT GEOCHRONOL, V19, P135, DOI 10.1016/j.quageo.2013.06.005; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; Carretier S, 2013, GEOLOGY, V41, P195, DOI 10.1130/G33735.1; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Cyr AJ, 2010, LITHOSPHERE-US, V2, P188, DOI 10.1130/L96.1; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Dedkov AP, 1984, EROSION SEDIMENT RUN; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; DiBiase RA, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2011JF002095; Dixon JL, 2009, GEOLOGY, V37, P975, DOI 10.1130/G30045A.1; Dixon JL, 2009, EARTH SURF PROC LAND, V34, P1507, DOI 10.1002/esp.1836; DOUGLAS I, 1967, NATURE, V215, P925, DOI 10.1038/215925a0; Zuazo VHD, 2008, AGRON SUSTAIN DEV, V28, P65, DOI [10.1051/agro:2007062, 10.1007/978-90-481-2666-8_48]; Finnegan NJ, 2008, GEOL SOC AM BULL, V120, P142, DOI 10.1130/B26224.1; Gabrovsek F, 2009, GEOMORPHOLOGY, V106, P9, DOI 10.1016/j.geomorph.2008.09.008; Garcia-Ruiz JM, 2015, GEOMORPHOLOGY, V239, P160, DOI 10.1016/j.geomorph.2015.03.008; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Grujic D, 2006, GEOLOGY, V34, P801, DOI 10.1130/G22648.1; Harel MA, 2016, GEOMORPHOLOGY, V268, P184, DOI 10.1016/j.geomorph.2016.05.035; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Heimsath AM, 2010, GEOL SOC SPEC PUBL, V346, P225, DOI 10.1144/SP346.12; Henck AC, 2011, EARTH PLANET SC LETT, V303, P71, DOI 10.1016/j.epsl.2010.12.038; Hewawasam T, 2003, GEOLOGY, V31, P597, DOI 10.1130/0091-7613(2003)031<0597:IOHONE>2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JANSSON MB, 1988, GEOGR ANN A, V70, P81, DOI 10.2307/521127; Kaspari M, 2008, FUNCT ECOL, V22, P919, DOI 10.1111/j.1365-2435.2008.01447.x; Kaspari M, 2009, ECOLOGY, V90, P3342, DOI 10.1890/08-1795.1; Kirchner JW, 2001, GEOLOGY, V29, P591, DOI 10.1130/0091-7613(2001)029<0591:MEOYKY>2.0.CO;2; KNOX JC, 1972, ANN ASSOC AM GEOGR, V62, P401, DOI 10.1111/j.1467-8306.1972.tb00872.x; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; LAL D, 1991, EARTH PLANET SC LETT, V104, P424, DOI 10.1016/0012-821X(91)90220-C; Lal R., 1990, Advances in Soil Science, V11, P129; Lal R, 2001, LAND DEGRAD DEV, V12, P519, DOI 10.1002/ldr.472; Langbein W. B., 1958, AM GEOPHYS UNION T, V39, P1076, DOI DOI 10.1029/TR039I006P01076; Matmon A, 2018, GEOMORPHOLOGY, V313, P72, DOI 10.1016/j.geomorph.2018.04.008; Matmon A, 2009, GEOL SOC AM BULL, V121, P688, DOI 10.1130/B26422.1; Meade R. H., 1988, PHYS CHEM WEATHERING, P165; Merritt WS, 2003, ENVIRON MODELL SOFTW, V18, P761, DOI 10.1016/S1364-8152(03)00078-1; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Moon S, 2011, NAT GEOSCI, V4, P469, DOI [10.1038/NGEO1159, 10.1038/ngeo1159]; Mutz SG, 2018, EARTH SURF DYNAM, V6, P271, DOI 10.5194/esurf-6-271-2018; Neyman J., 1937, PHILOS T R SOC S-A, V236, P333, DOI DOI 10.1098/RSTA.1937.0005; Nichols KK, 2014, GEOMORPHOLOGY, V224, P102, DOI 10.1016/j.geomorph.2014.07.019; NISHIIZUMI K, 1986, NATURE, V319, P134, DOI 10.1038/319134a0; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimentel D, 1998, ECOSYSTEMS, V1, P416, DOI 10.1007/s100219900035; Pimentel David, 2006, Environment Development and Sustainability, V8, P119, DOI 10.1007/s10668-005-1262-8; Placzek CJ, 2010, EARTH PLANET SC LETT, V295, P12, DOI 10.1016/j.epsl.2010.03.006; Placzek C, 2014, AM J SCI, V314, P1462, DOI 10.2475/10.2014.03; Portenga E, 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/G111A.1; Portenga EW, 2016, GEOLOGY, V44, P131, DOI 10.1130/G37257.1; Portenga EW, 2013, GEOL SOC AM BULL, V125, P201, DOI 10.1130/B30559.1; Quigley M, 2007, EARTH PLANET SC LETT, V261, P120, DOI 10.1016/j.epsl.2007.06.020; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Reusser L, 2015, GEOLOGY, V43, P171, DOI 10.1130/G36272.1; Rey F, 2003, CATENA, V50, P549, DOI 10.1016/S0341-8162(02)00121-2; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Riebe CS, 2001, GEOLOGY, V29, P511, DOI 10.1130/0091-7613(2001)029<0511:STAWCC>2.0.CO;2; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; ROGERS RD, 1991, J HYDROL, V123, P19, DOI 10.1016/0022-1694(91)90065-P; Rosenkranz R, 2018, EARTH PLANET SC LETT, V483, P39, DOI 10.1016/j.epsl.2017.11.047; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18379, DOI 10.1029/JD094iD15p18379; RUDDIMAN WF, 1989, J GEOPHYS RES-ATMOS, V94, P18409, DOI 10.1029/JD094iD15p18409; Ryb U, 2014, EARTH PLANET SC LETT, V406, P142, DOI 10.1016/j.epsl.2014.09.008; Schaller M, 2018, EARTH PLANET SC LETT, V489, P111, DOI 10.1016/j.epsl.2018.02.026; Schaller M, 2001, EARTH PLANET SC LETT, V188, P441, DOI 10.1016/S0012-821X(01)00320-X; Scherler D, 2014, J GEOPHYS RES-EARTH, V119, P83, DOI 10.1002/2013JF002955; Schumm S. A., 1963, DISPARITY PRESENT RA; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; SUMMERFIELD MA, 1994, J GEOPHYS RES-SOL EA, V99, P13871, DOI 10.1029/94JB00715; Trimble SW, 2000, SCIENCE, V289, P248, DOI 10.1126/science.289.5477.248; Tucker GE, 1998, WATER RESOUR RES, V34, P2751, DOI 10.1029/98WR01474; Tucker GE, 2000, WATER RESOUR RES, V36, P1953, DOI 10.1029/2000WR900065; Vanacker V, 2007, EARTH PLANET SC LETT, V253, P402, DOI 10.1016/j.epsl.2006.11.003; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Walling D, 1987, WATER FUTURE HYDROLO; WALLING DE, 1996, P INT S HELD EX UK 1; Walling DE, 1983, BACKGROUND PALAEOHYD, V158, P69; Whiting PJ, 2006, J AM WATER RESOUR AS, V42, P769, DOI 10.1111/j.1752-1688.2006.tb04491.x; Willenbring JK, 2013, GEOLOGY, V41, P343, DOI 10.1130/G33918.1; Wittmann H, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000729; Xu JX, 2005, CATENA, V64, P103, DOI 10.1016/j.catena.2005.07.004; Yanites BJ, 2015, NAT GEOSCI, V8, P462, DOI 10.1038/NGEO2429; Zimmermann A, 2012, J HYDROL, V428, P170, DOI 10.1016/j.jhydrol.2012.01.039	106	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211325	10.1371/journal.pone.0211325	http://dx.doi.org/10.1371/journal.pone.0211325			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682174	Green Published, gold, Green Accepted			2022-12-27	WOS:000457037500149
J	Montelin, H; Forsman, KJ; Tangden, T				Montelin, Hanna; Forsman, Karl-Johan; Tangden, Thomas			Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; DIAGNOSIS; DISEASES; SOCIETY	Objectives This study aimed to retrospectively assess the clinical outcome with nitrofurantoin and piv-mecillinam for lower urinary tract infections (UTI) in men. Patients treated with trimethoprim were also included for comparison. Methods All prescriptions of the study antibiotics to adult men in Uppsala County, Sweden, during 2012 were extracted. Data on patient characteristics, therapy, clinical outcome and microbiological results were obtained from the electronic medical records. The relative impact of antibiotic therapy, patient factors and pathogens on clinical outcome was assessed with univariate logistic regression using a 95% confidence interval (CI). Results 832 prescriptions were identified, and 171 patients treated with nitrofurantoin (n = 69), pivmecillinam (n = 57) and trimethoprim (n = 45) met the inclusion criteria. Treatment failure occurred in one patient treated with nitrofurantoin and in four patients treated with pivmecillinam. New prescriptions of UTI antibiotics and relapse within 3 months after completion of therapy were more frequent with nitrofurantoin (34% and 15%) and pivmecillinam (30% and 17%) than trimethoprim (22 and 7%). However, these differences were not statistically significant and substantial heterogeneity was noted between the treatment groups. Urinary tract catheterization was associated with a higher risk for new antibiotic prescriptions (OR 2.34, 95% CI 1.14-4.80; P = 0.022) and prostate cancer was associated with a higher incidence of relapse (OR 3.01, 95% CI 1.09-8.29; P = 0.042). Conclusions The clinical outcome with nitrofurantoin and pivmecillinam was acceptable in comparison with the results of previous studies. These antibiotics are suitable for empirical treatment of lower UTI in men considering their high activity against Escherichia coli and limited impact on the intestinal microbiota.	[Montelin, Hanna; Forsman, Karl-Johan; Tangden, Thomas] Uppsala Univ, Sect Infect Dis, Dept Med Sci, Uppsala, Sweden	Uppsala University	Tangden, T (corresponding author), Uppsala Univ, Sect Infect Dis, Dept Med Sci, Uppsala, Sweden.	thomas.tangden@medsci.uu.se						Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Grabe M., 2015, GUIDELINES UROLOGICA; Graninger W, 2003, INT J ANTIMICROB AG, V22, pS73, DOI 10.1016/S0924-8579(03)00235-8; Grigoryan L, 2014, JAMA-J AM MED ASSOC, V312, P1677, DOI 10.1001/jama.2014.12842; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Ingalsbe Michelle L, 2015, Ther Adv Urol, V7, P186, DOI 10.1177/1756287215581556; Lampri N, 2012, J ANTIMICROB CHEMOTH, V67, P2424, DOI 10.1093/jac/dks215; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Nicolle L, 2003, EXPERT OPIN PHARMACO, V4, P693, DOI 10.1517/eoph.4.5.693.22210; Nicolle LE, 2000, J ANTIMICROB CHEMOTH, V46, P35, DOI 10.1093/jac/46.suppl_1.35; Odenholt I, 2013, GUIDELINES MANAGEMEN; Pulcini C, 2012, CLIN INFECT DIS, V54, P268, DOI 10.1093/cid/cir838; Sanchez GV, 2012, ANTIMICROB AGENTS CH, V56, P2181, DOI 10.1128/AAC.06060-11; Ulleryd P, 2003, INT J ANTIMICROB AG, V22, pS89, DOI 10.1016/S0924-8579(03)00228-0	15	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211098	10.1371/journal.pone.0211098	http://dx.doi.org/10.1371/journal.pone.0211098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682092	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500099
J	Wodlej, C; Riedl, S; Rinner, B; Leber, R; Drechsler, C; Voelker, DR; Choi, JY; Lohner, K; Zweytick, D				Wodlej, Christina; Riedl, Sabrina; Rinner, Beate; Leber, Regina; Drechsler, Carina; Voelker, Dennis R.; Choi, Jae-Yeon; Lohner, Karl; Zweytick, Dagmar			Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; HOST-DEFENSE PEPTIDES; DE-NOVO PEPTIDE; ANTIMICROBIAL PEPTIDE; HUMAN LACTOFERRICIN; CANCER-CELLS; TUMOR-CELLS; GD3 GANGLIOSIDE; PEP-FOLD; APOPTOSIS	R-DIM-P-LF11-322 and DIM-LF11-318, derived from the cationic human host defense peptide lactoferricin show antitumor activity against human melanoma. While R-DIM-P-LF11-322 interacts specifically with cancer cells, the non-specific DIM-LF11-318 exhibits as well activity against non-neoplastic cells. Recently we have shown that cancer cells expose the negatively charged lipid phosphatidylserine (PS) in the outer leaflet of the plasma membrane, while non-cancer cells just expose zwitterionic or neutral lipids, such as phosphatidylcholine (PC) or cholesterol. Calorimetric and zeta potential studies with R-DIM-P-LF11-322 and cancer-mimetic liposomes composed of PS, PC and cholesterol indicate that the can-cer-specific peptide interacts specifically with PS. Cholesterol, however, reduces the effectiveness of the peptide. The non-specific DIM-LF11-318 interacts with PC and PS. Cholesterol does not affect its interaction. The dependence of activity of R-DIM-P-LF11-322 on the presence of exposed PS was also confirmed in vitro upon PS depletion of the outer leaflet of cancer cells by the enzyme PS-decarboxylase. Further corresponding to model studies, cholesterol depleted melanoma plasma membranes showed increased sensitivity to R-DIM-P-LF11-322, whereas activity of DIM-LF11-318 was unaffected. Microscopic studies using giant unilamellar vesicles and melanoma cells revealed strong changes in lateral distribution and domain formation of lipids upon addition of both peptides. Whereas R-DIM-P-LF11-322 enters the cancer cell specifically via PS and reaches an intracellular organelle, the Golgi, inducing mitochondrial swelling and apoptosis, DIM-LF11-318 kills rapidly and non-specifically by lysis of the plasma membrane. In conclusion, the specific interaction of R-DIM-P-LF11-322 with PS and sensitivity to cholesterol seem to modulate its specificity for cancer membranes.	[Wodlej, Christina; Riedl, Sabrina; Leber, Regina; Lohner, Karl; Zweytick, Dagmar] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Riedl, Sabrina; Leber, Regina; Lohner, Karl; Zweytick, Dagmar] BioTechMed Graz, Graz, Austria; [Rinner, Beate] Med Univ Graz, Med Res Ctr, Graz, Austria; [Drechsler, Carina] Univ Freiburg, BIOSS, Freiburg, Germany; [Drechsler, Carina] Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany; [Voelker, Dennis R.; Choi, Jae-Yeon] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Wodlej, Christina] Med Univ Graz, Diagnost & Res Inst Pathol, Neue Graz, Austria	University of Graz; Medical University of Graz; University of Freiburg; University of Freiburg; National Jewish Health; Medical University of Graz	Riedl, S; Zweytick, D (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria.; Riedl, S; Zweytick, D (corresponding author), BioTechMed Graz, Graz, Austria.	sabrina.riedl@uni-graz.at; dagmar.zweytick@uni-graz.at		Leber, Regina/0000-0001-5306-5834; Zweytick, Dagmar/0000-0002-4766-7713; Rinner, Beate/0000-0002-6340-4905	Austrian Science Fund [P24608-B23]; Austrian Research Promotion Agency [855671]; National Institute of Health NIH [GM104485]	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Investigations were supported by the Austrian Science Fund (grant no. P24608-B23 to DZ; https://www.fwf.ac.at/), Austrian Research Promotion Agency (grant no. 855671 to DZ; https://www.ffg.at/) and National Institute of Health NIH grant (GM104485 to DRV; https://www.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; [Anonymous], 2002, MEL TREATM PDQ HLTH; Bevers EM, 1996, LUPUS, V5, P480, DOI 10.1177/096120339600500531; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Dejgaard SY, 2001, ELS, P1; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garbe C, 2000, HAUTARZT, V51, P518, DOI 10.1007/s001050051166; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hicks SW, 2005, BBA-MOL CELL RES, V1744, P406, DOI 10.1016/j.bbamcr.2005.03.002; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jobin ML, 2013, BBA-BIOMEMBRANES, V1828, P1457, DOI 10.1016/j.bbamem.2013.02.008; Lee DK, 2015, BIOCHEMISTRY-US, V54, P1897, DOI 10.1021/bi501418m; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lohner K, 2009, GEN PHYSIOL BIOPHYS, V28, P105, DOI 10.4149/gpb_2009_02_105; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Maak M, 2011, MOL CANCER THER, V10, P1918, DOI 10.1158/1535-7163.MCT-11-0006; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Maverakis E, 2015, ACTA DERM-VENEREOL, V95, P516, DOI 10.2340/00015555-2035; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; McHenry AJ, 2012, BBA-BIOMEMBRANES, V1818, P3019, DOI 10.1016/j.bbamem.2012.07.021; MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016; OLEARY TJ, 1983, BIOCHIM BIOPHYS ACTA, V731, P47, DOI 10.1016/0005-2736(83)90396-6; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Pokorny A, 2002, BIOCHEMISTRY-US, V41, P11044, DOI 10.1021/bi020244r; Prenner EJ, 2001, BBA-BIOMEMBRANES, V1510, P83, DOI 10.1016/S0005-2736(00)00337-0; Ran S, 1998, CANCER RES, V58, P4646; Ran S, 2002, CANCER RES, V62, P6132; RAO LVM, 1992, THROMB RES, V67, P517, DOI 10.1016/0049-3848(92)90013-Z; Riedl S, 2015, BBA-BIOMEMBRANES, V1848, P2918, DOI 10.1016/j.bbamem.2015.07.018; Riedl S, 2014, BIOMETALS, V27, P981, DOI 10.1007/s10534-014-9749-0; Riedl S, 2014, BIOPHYS J, V106, p88A, DOI 10.1016/j.bpj.2013.11.558; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Riedl S, 2011, BBA-BIOMEMBRANES, V1808, P2638, DOI 10.1016/j.bbamem.2011.07.026; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Sandru A, 2014, J Med Life, V7, P572; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; Shah DJ, 2014, MAYO CLIN PROC, V89, P504, DOI 10.1016/j.mayocp.2014.02.002; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; UTSUGI T, 1991, CANCER RES, V51, P3062; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Woehlecke H, 2003, BIOCHEM J, V376, P489, DOI 10.1042/BJ20030886; Woehlecke H, 2003, INT J CANCER, V107, P721, DOI 10.1002/ijc.11444; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Won A, 2012, BBA-BIOMEMBRANES, V1818, P3072, DOI 10.1016/j.bbamem.2012.07.030; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zweytick D, 2006, BBA-BIOMEMBRANES, V1758, P1426, DOI 10.1016/j.bbamem.2006.02.032; Zweytick D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090228; Zweytick D, 2011, J BIOL CHEM, V286, P21266, DOI 10.1074/jbc.M110.195412	77	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211187	10.1371/journal.pone.0211187	http://dx.doi.org/10.1371/journal.pone.0211187			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682171	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500119
J	Anders, C; Hubner, A				Anders, Christoph; Huebner, Agnes			Influence of elastic lumbar support belts on trunk muscle function in patients with non-specific acute lumbar back pain	PLOS ONE			English	Article							INTRAABDOMINAL PRESSURE; LUMBOSACRAL ORTHOSES; RECRUITMENT PATTERNS; FIBER TYPES; STABILITY; SPINE; COCONTRACTION; POPULATION; WEIGHT	Background A well-known supportive treatment for acute nonspecific back pain, elastic back support belts, are valued for their ability to accelerate natural self-healing, but there are concerns of a deconditioning effect due to their reliance on passive stabilization. Methods To evaluate the systematic effects of elastic abdominal belts on the trunk musculature, a total of 36 persons with acute lumbar back pain (no longer than one week) were divided into two groups: an abdominal belt wearing group (B) and a non-abdominal belt wearing control group (C). All were examined over a period of three weeks at three time points: T1 just after assignment, T2 one week later, and T3 further two weeks later. Surface EMG (sEMG) was used to record trunk muscle activation when walking on a treadmill at walking speeds of 2, 3, 4, 5, and 6 km/h. Similarly, pain intensity (VAS) and functional impairment (ODI) over time were recorded in both groups. Results Over the observation period, a slight advantage for decreased pain intensity (C: p<0.05 T2 vs. T1; B: p<0.01 T2 vs. T1, p<0.05 T3 vs. T1) and decreased functional impairment (Cohen's d vs. T1, C: T2 0.45, T3 0.86; B: T2 1.1, T3 1.0) was observed for the belt group. For the belt group both oblique abdominal muscles exhibited significantly lower sEMG throughout the observation period (external abdominal oblique muscle: (T1), T2, (T3), internal abdominal oblique muscle: T1, (T2), (T3)) and the sEMG for the back muscles ranged from unchanged to slightly elevated for this group, but never reached statistical significance. Discussion The reduced abdominal amplitude levels in the belt group likely result from the permanent elastic stabilization provided by the belt: the required elevated intra-abdominal pressure to enhance spinal stability is then provided by lessened abdominal muscle activity complemented by the belt's elastic support. With regard to the back muscles, the belt, due to its movement-restricting effect, tends to activate the paravertebral musculature. In this respect, the effect of elastic abdominal belts on the trunk muscles is not uniform. Therefore, the present results suggest that the effect of elastic abdominal belts appears to be more of a temporary neutral alteration of trunk muscle coordination, with some trunk muscles becoming more active and others less, and not a case of uniform deconditioning as is suspected.	[Anders, Christoph; Huebner, Agnes] Jena Univ Hosp, Clin Trauma Hand & Reconstruct Surg, Div Motor Res Pathophysiol & Biomech, Jena, Germany; [Huebner, Agnes] EXCO GmbH, Neugasse 21, Jena, Germany	Friedrich Schiller University of Jena	Anders, C (corresponding author), Jena Univ Hosp, Clin Trauma Hand & Reconstruct Surg, Div Motor Res Pathophysiol & Biomech, Jena, Germany.	christoph.anders@med.uni-jena.de	Anders, Christoph/P-7403-2019	Anders, Christoph/0000-0002-5580-5338	Bauerfeind AG [BF14-OR-01]; Friedrich-Schiller-University Jena; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe	Bauerfeind AG; Friedrich-Schiller-University Jena; Berufsgenossenschaft Nahrungsmittel und Gastgewerbe	The work was supported by a grant (grant no.: BF14-OR-01) to CA of the Bauerfeind AG (https://www.bauerfeind.de/en/home.html). On behalf of all authors I hereby declare that the sponsor did not play any role in the study design, data collection and analysis, the decision to publish nor in the preparation of the manuscript.; The laboratory facility was kindly provided by the Center of Interdisciplinary Prevention of Diseases related to Professional Activities (KIP) funded by Friedrich-Schiller-University Jena and the Berufsgenossenschaft Nahrungsmittel und Gastgewerbe. This manuscript was edited for English language by Marcie Matthews of Polishedwords.	Azadinia F, 2017, SPINE J, V17, P589, DOI 10.1016/j.spinee.2016.12.005; Bundesarztekammer (BAK) Kassenarztliche Bundesvereinigung (KBV) Arbeitsgemeinschaft der Wis-senschaftlichen Medizinischen Fachgesellschaften (AWMF), 2017, NAT VERSORGUNGSLEITL, DOI [10.6101/AZQ/000353, DOI 10.6101/AZQ/000353]; Calmels P, 1996, REV RHUM, V63, P285; Calmels P, 2009, SPINE, V34, P215, DOI 10.1097/BRS.0b013e31819577dc; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; Cholewicki J, 1999, EUR SPINE J, V8, P388, DOI 10.1007/s005860050192; Cholewicki J, 1999, J BIOMECH, V32, P13, DOI 10.1016/S0021-9290(98)00129-8; Cholewicki J, 2002, EUR J APPL PHYSIOL, V87, P127, DOI 10.1007/s00421-002-0598-0; Cholewicki J, 2002, CLIN BIOMECH, V17, P99, DOI 10.1016/S0268-0033(01)00118-8; Cohen J., 1988, STAT POWER BEHAV SCI, DOI [10.1016/j.pain.2013.03.032, DOI 10.1016/J.PAIN.2013.03.032]; Comerford MJ, 2001, MANUAL THER, V6, P15, DOI 10.1054/math.2000.0388; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Granata KP, 2000, SPINE, V25, P1398, DOI 10.1097/00007632-200006010-00012; Greil H., 2001, WIE WEIT SIND WIR DI; HAGGMARK T, 1979, ACTA PHYSIOL SCAND, V107, P319, DOI 10.1111/j.1748-1716.1979.tb06482.x; Hemmelmann C, 2005, J NEUROSCI METH, V142, P209, DOI 10.1016/j.jneumeth.2004.08.008; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hubner A, 2017, BIOMECH OPEN LIB, V1, P7; Huebner A, 2015, J BIOMECH, V48, P1198, DOI 10.1016/j.jbiomech.2015.02.016; Jellema P, 2001, SPINE, V26, P377, DOI 10.1097/00007632-200102150-00014; Kawaguchi Yoshiharu, 2002, J Orthop Sci, V7, P483, DOI 10.1007/s007760200084; Kurustien Nopporn, 2014, Journal of the Medical Association of Thailand, V97, pS75; Lee PJ, 2006, J ELECTROMYOGR KINES, V16, P51, DOI 10.1016/j.jelekin.2005.06.006; Mannion AF, 1999, J ELECTROMYOGR KINES, V9, P363, DOI 10.1016/S1050-6411(99)00010-3; MEADE T W, 1986, Journal of Epidemiology and Community Health, V40, P12; Meade TW, 1990, BRIT MED J, V300; Morl F, 2010, 17 C INT SOC EL KIN; Ng J K, 1998, Electromyogr Clin Neurophysiol, V38, P51; Oleske DM, 2007, SPINE, V32, P2050, DOI 10.1097/BRS.0b013e3181453fcc; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Silfies SP, 2005, CLIN BIOMECH, V20, P465, DOI 10.1016/j.clinbiomech.2005.01.007; Sink C. A., 2010, COUNS OUTCOME RES EV, V1, P1, DOI [10.1177/2150137810373613, DOI 10.1177/2150137810373613]; Takasaki H, 2017, SPINE J, V17, P889, DOI 10.1016/j.spinee.2017.03.003; TESH KM, 1987, SPINE, V12, P501, DOI 10.1097/00007632-198706000-00014; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P195, DOI 10.1111/j.1748-1716.1987.tb08226.x; VALLEJONES JC, 1992, CURR MED RES OPIN, V12, P604, DOI 10.1185/03007999209111527; van Dieen JH, 2003, SPINE, V28, P834, DOI 10.1097/00007632-200304150-00018; Van Duijvenbode ICD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001823.pub3; VANTULDER MW, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001823; Vasseljen O, 2013, PAIN, V154, P1237, DOI 10.1016/j.pain.2013.03.032; Warren LP, 2001, J ORTHOP SPORT PHYS, V31, P316, DOI 10.2519/jospt.2001.31.6.316; Zink AJ, 2001, J STRENGTH COND RES, V15, P235	42	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211042	10.1371/journal.pone.0211042	http://dx.doi.org/10.1371/journal.pone.0211042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677095	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400044
J	Butler, CR; Perkins, JD; Johnson, CK; Blosser, CD; Bakthavatsalam, R; Leca, N; Sibulesky, L				Butler, Catherine R.; Perkins, James D.; Johnson, Christopher K.; Blosser, Christopher D.; Bakthavatsalam, Ramasamy; Leca, Nicolae; Sibulesky, Lena			Burden of excess mortality after implementation of the new kidney allocation system may be borne disproportionately by middle-aged recipients	PLOS ONE			English	Article							TRANSPLANTATION; PATIENT	Under the new kidney allocation system (KAS), implemented in 2014, the distribution of the best quality donor kidney grafts shifted between age groups, but it is unclear whether this change translates to meaningful differences in post-transplant outcomes. We conducted a retrospective cohort study of 20,345 deceased donor kidney transplant recipients before and 4,605 recipients after implementation of the KAS using data from the United Network of Organ Sharing. Overall, two-year mortality was greater among recipients in the post-KAS era compared with the pre-KAS era (6.31% vs 5.91% respectively, [p = 0.01]), and two-year graft loss was not significantly different between eras (9.95% and 9.65%, respectively [p = 0.13]). In analysis stratified by age group (18-45, 46-55, 56-65, and. 66 years), relative risk of mortality was 1.48 (95% confidence interval [CI] 1.09-1.98) among recipients 46-55 years old and 1.47 (95% CI 1.18-1.81) among recipients 56-65 years old. Relative risk of all-cause graft loss was 1.43 (95% CI 1.20-1.70) among recipients 56-65 years old. There were no significant differences in relative risk of mortality or graft loss associated with the KAS era among other age groups. After adjustment for recipient characteristics and characteristics of the changing donor pool, relative risk of two-year mortality and graft loss associated with the post-KAS era was attenuated for recipients aged 46-55 and 56-65 years, but remained statistically significant. In this early analysis after implementation of the KAS, there is suggestion that increased risk of mortality and graft loss may be disproportionately borne by middle-aged recipients, which is only partially accounted for by changes in recipient and donor characteristics. These findings signal a need to continue to monitor the effects of the KAS to ensure that allocation practices both maximize utility of the kidney graft pool and respect fairness between age groups.	[Butler, Catherine R.; Johnson, Christopher K.; Blosser, Christopher D.; Leca, Nicolae] Univ Washington, Med Ctr, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Perkins, James D.; Bakthavatsalam, Ramasamy; Sibulesky, Lena] Univ Washington, Dept Surg, Div Transplant Surg, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sibulesky, L (corresponding author), Univ Washington, Dept Surg, Div Transplant Surg, Med Ctr, Seattle, WA 98195 USA.	lenasi@uw.edu	Perkins, James/AAF-1323-2019	Perkins, James/0000-0002-6935-0012	National Institute of Diabetes and Digestive and Kidney Diseases [5T32DK007467-33]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007467] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007467-33). The sponsor had no role in the design and conduct of the study; in collection, management, analysis or interpretation of the data; in preparation, review or approval of the manuscript; or decision to submit for publication. The interpretation and reporting of these data are the responsibility of the authors and do not reflect the policy or interpretation of the OPTN.	[Anonymous], OPTN UNOS ETH COMM W; Baker R, 1993, Health Care Anal, V1, P139, DOI 10.1007/BF02197107; Bentas W, 2008, NEPHROL DIAL TRANSPL, V23, P2043, DOI 10.1093/ndt/gfm912; Curtis JJ, 2006, AM J TRANSPLANT, V6, P1264, DOI 10.1111/j.1600-6143.2006.01318.x; DANIELS N, 1983, MILBANK FUND Q, V61, P489, DOI 10.2307/3349870; Eidelson B, 2013, YALE LAW J, V122, P1635; Fabrizii V, 2005, TRANSPLANTATION, V80, P582, DOI 10.1097/01.tp.0000168340.05714.99; Formica RN, 2017, TRANSPLANT REV-ORLAN, V31, P61, DOI 10.1016/j.trre.2016.10.002; Frei U, 2008, AM J TRANSPLANT, V8, P50, DOI 10.1111/j.1600-6143.2007.02014.x; Friedewald J, 2011, OPTN UNOS KIDNEY TRA; Friedewald JJ, 2013, SURG CLIN N AM, V93, P1395, DOI 10.1016/j.suc.2013.08.007; Gill J, 2016, KIDNEY INT, V89, P1331, DOI 10.1016/j.kint.2016.01.028; Hart A, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14132; Hernandez RA, 2014, TRANSPLANTATION, V98, P1069, DOI 10.1097/TP.0000000000000181; Israni AK, 2014, J AM SOC NEPHROL, V25, P1842, DOI 10.1681/ASN.2013070784; Knoll GA, 2013, AM J KIDNEY DIS, V61, P790, DOI 10.1053/j.ajkd.2012.08.049; Neuberger J, 2011, TRANSPLANTATION, V92, P262, DOI 10.1097/TP.0b013e318223a3a0; Pippias M, 2017, TRANSPL INT; Ross LF, 2012, AM J TRANSPLANT, V12, P2115, DOI 10.1111/j.1600-6143.2012.04141.x; Shapiro ME, 2012, SEMIN DIALYSIS, V25, P682, DOI 10.1111/sdi.12034; Stanton J, 1999, SOC SCI MED, V49, P1169, DOI 10.1016/S0277-9536(99)00158-6; Stegall MD, 2017, HUM IMMUNOL, V78, P4, DOI 10.1016/j.humimm.2016.08.008; Stewart DE, 2018, AM J TRANSPLANT; Wilk AR, 2017, KIDNEY ALLOCATION SY; Zens TJ, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13190	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210589	10.1371/journal.pone.0210589	http://dx.doi.org/10.1371/journal.pone.0210589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677058	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400018
J	de-Mateo-Silleras, B; de-la-Cruz-Marcos, S; Alonso-Izquierdo, L; Camina-Martin, MA; Marugan-de-Miguelsanz, JM; Redondo-del-Rio, MP				de-Mateo-Silleras, Beatriz; de-la-Cruz-Marcos, Sandra; Alonso-Izquierdo, Laura; Alicia Camina-Martin, Ma; Manuel Marugan-de-Miguelsanz, Jose; Paz Redondo-del-Rio, Ma			Bioelectrical impedance vector analysis in obese and overweight children	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; DIAGNOSTIC PERFORMANCE; CLINICAL-PRACTICE; IDENTIFY OBESITY; NORMAL VALUES; ANALYSIS BIVA; FAT; BIOIMPEDANCE	Introduction BMI is the most commonly used indicator to evaluate overweight and obesity, but it cannot distinguish changes in body composition. Over recent years, it has been demonstrated that bioelectrical impedance analysis (BIA) is a more accurate method for analyzing body composition. Bioelectrical impedance vector analysis (BIVA) has revealed its effectiveness as an indicator of nutritional status and hydration. Objective To assess the usefulness of bioimpedance analysis on the study of body composition in a group of children with overweight and obesity. Materials and methods Cross-sectional observational study. The anthropometric parameters of 167 (79 were older than 12 years) overweight and obese children were recorded. Their body composition was analyzed using BIA and BIVA, and was classified based on different criteria. Concordance was analyzed (intraclass correlation coefficient, Bland-Altman analysis and weighted Kappa coefficient). The BIVA of the subgroups was compared using the Mahalanobis distance and Hotelling's T-2. Statistical significance was considered for p<0.05. Results The BMI revealed that the majority of the assessed subjects were obese, although 12% had a normal percentage of fat mass (%FM). The classification by Z-BMI and Z-%FM significantly discriminate between subjects with different levels of adiposity. In children over the age of 12, the classification of fat mass index also discriminates significantly between obesity and non-obesity. As anticipated, in the tolerance ellipses, most of the individual vectors were situated in the left lower quadrant. Conclusions BIVA reflects differences in the bioelectric patterns of children who are classified as being overweight or obese (BMI) and who have different levels of %FM and FMI. BIVA permits a fast and easy monitoring of the evolution of the nutritional state and changes associated with body composition, and it identifies those children whose body compartments may be precisely estimated using traditional BIA methods.	[de-Mateo-Silleras, Beatriz; de-la-Cruz-Marcos, Sandra; Alonso-Izquierdo, Laura; Alicia Camina-Martin, Ma; Paz Redondo-del-Rio, Ma] Valladolid Univ, Fac Med, Dept Nutr & Food Sci, Valladolid, Spain; [Manuel Marugan-de-Miguelsanz, Jose] Univ Valladolid, Hosp Clin Univ, Dept Pediat, Valladolid, Spain	Universidad de Valladolid	Redondo-del-Rio, MP (corresponding author), Valladolid Univ, Fac Med, Dept Nutr & Food Sci, Valladolid, Spain.	mpazredondorio@gmail.com	de Mateo Silleras, Beatriz/AAB-2093-2022; de la Cruz Marcos, Sandra/AAB-5680-2019; CAMINA, ALICIA/AAR-8781-2020; del Río, Paz Redondo/G-5940-2017	de Mateo Silleras, Beatriz/0000-0002-7927-0999; de la Cruz Marcos, Sandra/0000-0002-6725-5492; del Río, Paz Redondo/0000-0003-4260-2731; Camina Martin, Maria Alicia/0000-0002-0467-9343				Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Bosy-Westphal A, 2005, AM J CLIN NUTR, V82, P60, DOI 10.1093/ajcn/82.1.60; Buffa R, 2014, EUR J CLIN NUTR, V68, P1234, DOI 10.1038/ejcn.2014.170; Buffa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058533; Buffa R, 2013, NUTRITION, V29, P132, DOI 10.1016/j.nut.2012.05.007; Cole TJ, 2007, ACTA PAEDIATR, V96, P2, DOI 10.1111/j.1651-2227.2007.00162.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Munoz AD, 2016, NUTR HOSP, V33, P887, DOI 10.20960/nh.388; de Farias JC, 2009, REV SAUDE PUBL, V43, P53, DOI 10.1590/S0034-89102009000100007; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0; Bibiloni MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055849; Demerath EW, 2006, PEDIATRICS, V117, pE487, DOI 10.1542/peds.2005-0572; Deurenberg P, 2002, ASIA PAC J CLIN NUTR, V11, P1, DOI 10.1046/j.1440-6047.2002.00258.x; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fields DA, 2000, J APPL PHYSIOL, V89, P613, DOI 10.1152/jappl.2000.89.2.613; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Freedman DS, 2005, CURR OPIN CLIN NUTR, V8, P618, DOI 10.1097/01.mco.0000171128.21655.93; Guida B, 2008, NUTR METAB CARDIOVAS, V18, P133, DOI 10.1016/j.numecd.2006.08.008; Hirschler Valeria, 2006, Arch. argent. pediatr., V104, P486; Horan M, 2015, IRISH J MED SCI, V184, P53, DOI 10.1007/s11845-014-1124-1; Javed A, 2015, PEDIATR OBES, V10, P234, DOI 10.1111/ijpo.242; Kyle UG, 2015, EUR J CLIN NUTR, V69, P1298, DOI 10.1038/ejcn.2015.86; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lukaski H.C., 1991, NEW TECHNIQUES NUTR, P303; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Marini E, 2013, J NUTR HEALTH AGING, V17, P515, DOI 10.1007/s12603-012-0411-7; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; National Health and Nutrition Examination Survey (NHANES), 2007, ANTHR PROC MAN; Nicoletti CF, 2014, NUTRITION, V30, P569, DOI 10.1016/j.nut.2013.10.013; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Redondo-del-Rio MP, 2016, EXP GERONTOL, V85, P108, DOI [10.1016/j.exger.201, 10.1016/j.exger.2016.10.002]; Redondo-del-Rio MP, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22978; Piccoli A, 2002, NEFROLOGIA, V22, P228; Piccoli A, 2002, NUTRITION, V18, P153, DOI 10.1016/S0899-9007(01)00665-7; Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551; Plachta-Danielzik S, 2012, OBESITY FACTS, V5, P77, DOI 10.1159/000336780; Alvero-Cruz JR, 2010, MED CLIN-BARCELONA, V135, P8, DOI 10.1016/j.medcli.2010.01.017; Reilly JJ, 2000, INT J OBESITY, V24, P1623, DOI 10.1038/sj.ijo.0801436; Rodriguez DP, 2008, ARCH ARGENT PEDIATR, V106, P102, DOI 10.1590/S0325-00752008000200003; Rolland-Cachera MF, 2011, INT J PEDIATR OBES, V6, P325, DOI 10.3109/17477166.2011.607458; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Wells JCK, 2002, INT J OBESITY, V26, P1323, DOI 10.1038/sj.ijo.0802077; WHO, 1985, TECHNICAL REPORT SER; Wohlfahrt-Veje C, 2014, EUR J CLIN NUTR, V68, P664, DOI 10.1038/ejcn.2013.282; World Health Organization, 2017, 10 FACTS OB	51	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211148	10.1371/journal.pone.0211148	http://dx.doi.org/10.1371/journal.pone.0211148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677103	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400053
J	San, B; Rougeot, J; Voeltzke, K; van Vegchel, G; Aben, M; Andralojc, KM; Flik, G; Kamminga, LM				San, Bilge; Rougeot, Julien; Voeltzke, Kai; van Vegchel, Gertie; Aben, Marco; Andralojc, Karolina M.; Flik, Gert; Kamminga, Leonie M.			The ezh2(sa1199) mutant zebrafish display no distinct phenotype	PLOS ONE			English	Article							REPRESSIVE COMPLEX 2; MESSENGER-RNA DECAY; GROUP GENE EZH2; HISTONE METHYLTRANSFERASE; EMBRYONIC-DEVELOPMENT; POINT MUTATIONS; CELL; PROTEINS; DOMAIN; COPPER	Polycomb group (PcG) proteins are essential regulators of epigenetic gene silencing and development. The PcG protein enhancer of zeste homolog 2 (Ezh2) is a key component of the Polycomb Repressive Complex 2 and is responsible for placing the histone H3 lysine 27 trimethylation (H3K27me3) repressive mark on the genome through its methyltransferase domain. Ezh2 is highly conserved in vertebrates. We studied the role of ezh2 during development of zebrafish with the use of a mutant allele (ezh2(sa1199), R18STOP), which has a stop mutation in the second exon of the ezh2 gene. Two versions of the same line were used during this study. The first and original version of zygotic ezh2(sa1199) mutants unexpectedly retained ezh2 expression in brain, gut, branchial arches, and eyes at 3 days postfertilization (dpf), as revealed by in-situ hybridization. Moreover, the expression pattern in homozygous mutants was identical to that of wild types, indicating that mutant ezh2 mRNA is not subject to nonsense mediated decay (NMD) as predicted. Both wild type and ezh2 mutant embryos presented edemas at 2 and 3 dpf. The line was renewed by selective breeding to counter select the non-specific phenotypes and survival was assessed. In contrast to earlier studies on ezh2 mutant zebrafish, ezh2(sa1199) mutants survived until adulthood. Interestingly, the ezh2 mRNA and Ezh2 protein were present during adulthood (70 dpf) in both wild type and ezh2(sa1199) mutant zebrafish. We conclude that the ezh2 (sa1199) allele does not exhibit an ezh2 loss-of-function phenotype.	[San, Bilge; Aben, Marco; Kamminga, Leonie M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Rougeot, Julien; Voeltzke, Kai; van Vegchel, Gertie; Aben, Marco; Andralojc, Karolina M.; Kamminga, Leonie M.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Flik, Gert] Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Nijmegen, Netherlands; [Voeltzke, Kai] Heinrich Heine Univ, Med Fac, Clin Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [van Vegchel, Gertie] UMC Utrecht, Div Labs Pharm & Biomed Genet, Genet Dept, Utrecht, Netherlands; [Aben, Marco] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Andralojc, Karolina M.] Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.; Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.	l.kamminga@science.ru.nl	Rougeot, Julien/AAF-1269-2019; Kamminga, Leonie/O-5722-2019; Rougeot, Julien/GQI-4130-2022; Kamminga, Leonie M/E-1771-2012; Flik, Gert/C-8229-2011	Rougeot, Julien/0000-0001-6899-9306; Kamminga, Leonie M/0000-0002-0508-7796; Flik, Gert/0000-0001-9285-7957	Innovative Research scheme of the Netherlands Organisation for Scientific research [NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003]; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [705939]	Innovative Research scheme of the Netherlands Organisation for Scientific research; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant	The work was funded by the Innovative Research scheme of the Netherlands Organisation for Scientific research (www.nwo.nl, NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003, L.M.K.), the Radboud University Nijmegen Medical Centre tenure track fellowship (www.radboudumc.nl, L.M.K.), and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 705939, K.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IS, 2013, CURR TOP DEV BIOL, V104, P85, DOI 10.1016/B978-0-12-416027-9.00003-6; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Corey DR, 2001, GENOME BIOL, V2; Craig PM, 2017, AM J PHYSIOL-REG I, V293, pR1882; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Dupret B, 2017, BBA-GENE REGUL MECH, V1860, P1079, DOI 10.1016/j.bbagrm.2017.08.011; Guo Y, 2013, AM J HUM GENET, V93, P78, DOI 10.1016/j.ajhg.2013.05.022; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hanke N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/658270; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Hill AJ, 2004, TOXICOL SCI, V78, P78, DOI 10.1093/toxsci/kfh056; Inacio A, 2004, J BIOL CHEM, V279, P32170, DOI 10.1074/jbc.M405024200; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jeanray N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116989; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Karpanen T, 2017, CIRC RES, V120, P1263, DOI 10.1161/CIRCRESAHA.116.308813; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Koppens MAJ, 2016, GASTROENTEROLOGY, V151, P684, DOI 10.1053/j.gastro.2016.06.020; Le Faou P, 2011, GENE, V475, P10, DOI 10.1016/j.gene.2010.12.012; Li J, 1998, AQUAT TOXICOL, V43, P1, DOI 10.1016/S0166-445X(98)00047-2; Li MY, 2016, TRENDS GENET, V32, P815, DOI 10.1016/j.tig.2016.10.005; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Madsen EC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000261; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Mork L, 2015, CURR TOP DEV BIOL, V115, P235, DOI 10.1016/bs.ctdb.2015.07.001; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Panelli D, 2008, BIOCHIMIE, V90, P1452, DOI 10.1016/j.biochi.2008.04.017; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rougeot J, 2018, BIORXIV; San B, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2040019; San B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24658; Sander JD, 2011, METHOD CELL BIOL, V104, P51, DOI 10.1016/B978-0-12-374814-0.00003-3; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Seok SH, 2006, J BIOTECHNOL, V126, P406, DOI 10.1016/j.jbiotec.2006.04.029; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimizu T, 2016, J EXP MED, V213, P1479, DOI 10.1084/jem.20151136; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tsuruwaka Y, 2015, PEERJ, V3, DOI 10.7717/peerj.727; van der Velden YU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073997; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang W, 2015, MED RES REV, V35, P1220, DOI 10.1002/med.21358; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Yin J, 2015, P NATL ACAD SCI USA, V112, P15988, DOI 10.1073/pnas.1521740112; Zhong YB, 2018, NUCLEIC ACIDS RES, V46, P3382, DOI 10.1093/nar/gky101	68	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210217	10.1371/journal.pone.0210217	http://dx.doi.org/10.1371/journal.pone.0210217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677064	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400011
J	Tang, QL; Ma, KS; Chi, H; Hou, YM; Gao, XW				Tang, Qiuling; Ma, Kangsheng; Chi, Hsin; Hou, Youming; Gao, Xiwu			Transgenerational hormetic effects of sublethal dose of flupyradifurone on the green peach aphid, Myzus persicae (Sulzer) (Hemiptera: Aphididae)	PLOS ONE			English	Article							INSECTICIDE-INDUCED HORMESIS; LIFE-TABLE; BROWN PLANTHOPPER; BIOLOGICAL TRAITS; POPULATION-GROWTH; FEEDING-BEHAVIOR; REPRODUCTION; FECUNDITY; RESISTANCE; HOMOPTERA	Both inhibitory and stimulatory (known as hormesis) effects of the sublethal flupyradifurone, a butenolide insecticide, on Myzus persicae Sulzer (Hemiptera: Aphididae) were investigated for incorporating it into integrated pest management (IPM). A leaf-dip bioassay showed that flupyradifurone was very toxic against adult M. persicae with a 48 h LC50 of 8.491 mg/L. Using the age-stage two-sex life table approach, we assessed the effects of LC25 of flupyradifurone on adult M. persicae and its progeny (F-1 and F-2). On the one hand, aphids exposed to flupyradifurone had significantly negative effects on the life history traits acrossing the generations, such as reduced the adult longevity and fecundity of F-0, shortened the duration of third instar and fourth instar nymphs, preadult period and the pre-reproductive period of F-1, and decreased the reproductive days and adult longevity of F-2. On the other hand, stimulatory effects on the duration of pre-adult, adult reproductive days, and reproduction of F-1 were observed in the flupyradifurone-treated aphids. Consistently with the stimulation on individual traits, a higher net reproductive rate (R-0) of F-1 and a shorter mean generation time (T) of F-2 were observed in the flupyradifurone-treated aphids, although the other population parameters including the intrinsic rate of increase (r), finite rate of increase (lambda) and T of F-1 and R-0, r and lambda of F-2 were not significantly affected. These results revealed that adult M. persicae exposed to sublethal concentration of flupyradifurone can induce hormetic effects on F-1, and also cause negative effects on F-2. Our results would be useful for assessing the overall effects of flupyradifurone on M. persicae and the hormetic effects should take into consideration when use flupyradifurone for control M. persicae.	[Tang, Qiuling; Hou, Youming] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Tang, Qiuling; Ma, Kangsheng; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Chi, Hsin] Nidge Omer Halisdemir Univ, Dept Plant Prod & Technol, Nigde, Turkey; [Hou, Youming] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; China Agricultural University; Fujian Agriculture & Forestry University	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China.; Gao, XW (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.; Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou, Fujian, Peoples R China.	ymhou@fafu.edu.cn; gaoxiwu@263.net.cn	Chi, Hsin/L-6860-2019	Chi, Hsin/0000-0001-8130-0248	National Key Research and Development Program [2016YFD0200506]	National Key Research and Development Program	This study was supported by the National Key Research and Development Program (Contract No. 2016YFD0200506) to XG.	Akca I, 2015, J ECON ENTOMOL, V108, P1466, DOI 10.1093/jee/tov187; [Anonymous], 1993, INTRO BOOTSTRAP; Ayyanath MM, 2015, CHEMOSPHERE, V128, P245, DOI 10.1016/j.chemosphere.2015.01.061; Ayyanath MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074532; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Calabrese EJ, 2005, ENVIRON POLLUT, V138, P378, DOI 10.1016/j.envpol.2004.10.001; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Calabrese EJ, 1997, INT J TOXICOL, V16, P545, DOI 10.1080/109158197226874; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Carelli G, 2002, HUM EXP TOXICOL, V21, P113; CHELLIAH S, 1980, ENVIRON ENTOMOL, V9, P773, DOI 10.1093/ee/9.6.773; Chen XD, 2017, CROP PROT, V98, P102, DOI 10.1016/j.cropro.2017.03.017; Chen XW, 2016, ECOTOXICOLOGY, V25, P1841, DOI 10.1007/s10646-016-1732-9; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2018, TWOSEX MS CHART COMP; Cho SR, 2011, J KOREAN SOC APPL BI, V54, P889, DOI 10.3839/jksabc.2011.135; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; Desneux N, 2005, J ECON ENTOMOL, V98, P9, DOI 10.1603/0022-0493-98.1.9; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devine GJ, 1996, PESTIC SCI, V48, P57, DOI 10.1002/(SICI)1096-9063(199609)48:1&lt;57::AID-PS435&gt;3.0.CO;2-9; Duke SO, 2014, PEST MANAG SCI, V70, P689, DOI 10.1002/ps.3756; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4020; Gong YH, 2015, ECOTOXICOLOGY, V24, P1141, DOI 10.1007/s10646-015-1461-5; GORDON PL, 1984, CAN ENTOMOL, V116, P783, DOI 10.4039/Ent116783-5; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guo L, 2013, CROP PROT, V48, P29, DOI 10.1016/j.cropro.2013.02.009; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; He YX, 2013, INT J BIOL SCI, V9, P246, DOI 10.7150/ijbs.5762; Huang HW, 2018, J ECON ENTOMOL, V111, P1, DOI 10.1093/jee/tox330; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Jeschke P, 2015, PESTIC BIOCHEM PHYS, V121, P31, DOI 10.1016/j.pestbp.2014.10.011; Kerns DL, 2000, ENTOMOL EXP APPL, V94, P41, DOI 10.1023/A:1003972510397; Lashkari MR, 2007, INSECT SCI, V14, P207, DOI 10.1111/j.1744-7917.2007.00145.x; Lee CY., 2000, J BIOSCIENCES, V11, P107, DOI DOI 10.5772/66461; Liu XL, 2017, ENTOMOL GEN, V36, P285, DOI 10.1127/entomologia/2017/0480; Liu YQ, 2008, J ECON ENTOMOL, V101, P1805, DOI 10.1603/0022-0493-101.6.1805; LOWERY DT, 1986, J ECON ENTOMOL, V79, P1530, DOI 10.1093/jee/79.6.1530; Lu YH, 2016, B ENTOMOL RES, V106, P551, DOI 10.1017/S0007485316000286; LUCKEY TD, 1968, J ECON ENTOMOL, V61, P7, DOI 10.1093/jee/61.1.7; MAGGI VL, 1983, J ECON ENTOMOL, V76, P20, DOI 10.1093/jee/76.1.20; Moores GD, 1996, PESTIC BIOCHEM PHYS, V56, P102, DOI 10.1006/pest.1996.0064; Morse JG, 1998, HUM EXP TOXICOL, V17, P266, DOI 10.1191/096032798678908738; MORSE JG, 1991, J ECON ENTOMOL, V84, P1169, DOI 10.1093/jee/84.4.1169; Nauen R, 2015, PEST MANAG SCI, V71, P850, DOI 10.1002/ps.3932; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Smith HA, 2016, INSECTS, V7, DOI 10.3390/insects7040057; Sohrabi F, 2011, CROP PROT, V30, P1190, DOI 10.1016/j.cropro.2011.05.004; STEBBING ARD, 1982, SCI TOTAL ENVIRON, V22, P213, DOI 10.1016/0048-9697(82)90066-3; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Tang QL, 2017, PESTIC BIOCHEM PHYS, V143, P39, DOI 10.1016/j.pestbp.2017.09.013; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Vogt C, 2007, CHEMOSPHERE, V67, P2192, DOI 10.1016/j.chemosphere.2006.12.025; Wang XY, 2008, J APPL ENTOMOL, V132, P135, DOI 10.1111/j.1439-0418.2007.01225.x; YOKOYAMA VY, 1984, J ECON ENTOMOL, V77, P876, DOI 10.1093/jee/77.4.876; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zalizniak L, 2006, ECOTOX ENVIRON SAFE, V64, P207, DOI 10.1016/j.ecoenv.2005.03.015; Zeng XY, 2016, J ECON ENTOMOL, V109, P1595, DOI 10.1093/jee/tow104; Zhang P, 2014, PESTIC BIOCHEM PHYS, V111, P31, DOI 10.1016/j.pestbp.2014.04.003; 2007, APHIDS CROP PESTS, P1	70	39	43	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0208058	10.1371/journal.pone.0208058	http://dx.doi.org/10.1371/journal.pone.0208058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677036	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400005
J	Eichler, K; Hess, S; Twerenbold, C; Sabatier, M; Meier, F; Wieser, S				Eichler, Klaus; Hess, Sascha; Twerenbold, Claudia; Sabatier, Magalie; Meier, Flurina; Wieser, Simon			Health effects of micronutrient fortified dairy products and cereal food for children and adolescents: A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; WHEAT-FLOUR; IRON STATUS; SCHOOL-CHILDREN; ELECTROLYTIC IRON; VITAMIN-A; FORTIFICATION; ANEMIA; MILK	Introduction Micronutrient (MN) deficiencies cause a considerable burden of disease for children in many countries. Dairy products or cereals are an important food component during adolescence. Fortification of dairy products or cereals with MN may be an effective strategy to overcome MN deficiencies, but their specific impact on health in this age group is poorly documented. Methods We performed a systematic review and meta-analysis (registration number CRD42016039554) to assess the impact of MN fortified dairy products and cereal food on the health of children and adolescents (aged 5-15 years) compared with non-fortified food. We reviewed randomised controlled trials (RCT) using electronic databases (MEDLINE, EMBASE, Cochrane library; latest search: January 2018), reference list screening and citation searches. Three pairs of reviewers assessed 2048 studies for eligibility and extracted data. We assessed the risk of bias and applied GRADE to rate quality of evidence. Results We included 24 RCT (often multi MN fortification) with 30 pair-wise comparisons mainly from low- and middle income countries. A very small and non-significant increase of haemoglobin values emerged (0.09 g/dl [95%-CI:-0.01 to 0.18]; 13 RCT with iron fortification; very low quality of evidence). No significant difference was found on anaemia risk (risk ratio 0.87 [95%-CI: 0.76 to 1.01]; 12 RCT; very low quality), but a significant difference in iron deficiency anaemia favouring fortified food was found (risk ratio 0.38 [95%-CI: 0.18 to 0.81]; 5 RCT; very low quality). Similar effects were seen for fortified dairy products and cereals and different fortification strategies (mono- vs. dual- vs. multi-MN). Follow-up periods were often short and the impact on anthropometric measures was weak (low quality of evidence) Very low quality of evidence emerged for the improvement of cognitive performance, functional measures and morbidity. Conclusions Fortification of dairy products and cereal food had only marginal health effects in our sample population from 5-15 years. Further evidence is needed to better understand the health impact of fortified dairy products and cereals in this age group. Systematic review registration The study protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 26 May 2016 (registration number CRD42016039554).	[Eichler, Klaus; Hess, Sascha; Twerenbold, Claudia; Meier, Flurina; Wieser, Simon] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Sabatier, Magalie] Nestle Res Ctr, Publ Hlth Dept, Lausanne, Switzerland	Zurich University of Applied Sciences; Nestle SA	Eichler, K (corresponding author), Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland.	eich@zhaw.ch	Wieser, Simon/AAH-6581-2020; Wieser, Simon/AAC-1589-2022		Nestle Research Center, Lausanne, Switzerland; Zurich University of Applied Sciences, Switzerland	Nestle Research Center, Lausanne, Switzerland(Nestle SA); Zurich University of Applied Sciences, Switzerland	The study was partially financially supported by the Nestle Research Center, Lausanne, Switzerland (https://www.nestle.ch/de/nestleschweiz/forschung). Nestle is a producer of micronutrient fortified milk and cereal products. The funder provided support in the form of salaries for authors [MS] and commented on the final draft of the review protocol and on a draft version of the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The final responsibility was with the corresponding author. The specific roles of the authors are articulated in the 'author contributions' section. Additional funding was provided by internal sources of our Institute at the Zurich University of Applied Sciences, Switzerland. There was no additional external funding received for this study.	Allen L., 2006, GUIDELINES FOOD FORT; Allen LH, 2001, REV EFFICACY EFFECTI; Allen LH, 2012, ANN NUTR METAB, V61, P29, DOI 10.1159/000346185; Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Altman DG, 2001, STAT CONFIDENCE; Andang'o PEA, 2007, LANCET, V369, P1799, DOI 10.1016/S0140-6736(07)60817-4; Ashong J, 2012, COCHRANE LIB, DOI [10.1002/14651858, DOI 10.1002/14651858]; Bardosono S, 2009, MED J INDONES, V18; Bass SL, 2007, J BONE MINER RES, V22, P458, DOI 10.1359/JBMR.061201; Best C, 2011, NUTR REV, V69, P186, DOI 10.1111/j.1753-4887.2011.00378.x; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bouhouch RR, 2016, AM J CLIN NUTR, V104, P1318, DOI 10.3945/ajcn.115.129346; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; De-Regil L, 2016, FORTIFICATION WHEAT; Deaton A., 2013, GREAT ESCAPE HLTH WE; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Eichler K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-506; Fontaine O, 2007, FOOD NUTR BULL, V28, pS621; Ganmaa D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175237; Garcia-Casal L, 2012, FORTIFICATION MAIZE; Gera T, 2012, AM J CLIN NUTR, V96, P309, DOI 10.3945/ajcn.111.031500; Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006; Hess S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020088; Hess SY, 2009, FOOD NUTR BULL, V30, pS79, DOI 10.1177/15648265090301S106; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horton S, 2008, COPENHAGEN CONSENSUS; Karakochuk CD, 2016, SIGHT LIFE J, V30, P47; Khan KS, 2003, SYSTEMATIC REV SUPPO; Kristjansson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004676.pub2; Kuriyan R, 2016, CLIN NUTR, V35, P190, DOI 10.1016/j.clnu.2015.02.001; Le HT, 2007, BRIT J NUTR, V97, P955, DOI 10.1017/S0007114507659029; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Muthayya S, 2012, J NUTR, V142, P1997, DOI 10.3945/jn.111.155135; Nestel P, 2004, INT J VITAM NUTR RES, V74, P35, DOI 10.1024/0300-9831.74.1.35; Neyestani TR, 2013, J HUM NUTR DIET; Nga TT, 2011, AM J TROP MED HYG, V85, P333, DOI 10.4269/ajtmh.2011.10-0651; Hieu NT, 2012, BRIT J NUTR, V108, P1419, DOI 10.1017/S0007114511006945; NHS Centre for Reviews and Dissemination, 2008, 4 CRD; Nugroho HW, 2010, PAEDIATR INDONES, V50, P92, DOI 10.14238/pi50.2.2010.92-95; Ochola S, 2014, ANN NUTR METAB, V64, P24, DOI 10.1159/000365125; Pachon H, 2015, NUTR REV, V73, P780, DOI 10.1093/nutrit/nuv037; Pena-Rosas J, 2014, WHEAT FLOUR FORTIFIC; Rahman AS, 2015, MATERN CHILD NUTR, V11, P120, DOI 10.1111/mcn.12065; Rich-Edwards JW, 2011, AM J CLIN NUTR, V94, P578, DOI 10.3945/ajcn.110.008771; Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256; Saeterdal I, 2012, FORTIFICATION STAPLE; Sazawal S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-514; Shah D, 2013, FORTIFICATION STAPLE; Solon FS, 2000, AM J CLIN NUTR, V72, P738; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; Trinidad TP, 2015, TRACE ELEM ELECTROLY, V32, P112, DOI 10.5414/TEX01376; van Stuijvenberg ME, 2008, J NUTR, V138, P782, DOI 10.1093/jn/138.4.782; van Stuijvenberg ME, 2006, BRIT J NUTR, V95, P532, DOI 10.1079/BJN20051669; van Stuijvenberg ME, 1999, AM J CLIN NUTR, V69, P497; Wang XQ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030226; WHO, 2011, WHO TECH REP SER, V959, P1; World Food Programme, 2020, STAT SCH FEED WORLDW; World Health Organisation, 1994, COD AL, V4; Zhang ZQ, 2014, BONE, V65, P69, DOI 10.1016/j.bone.2014.05.007; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564; Zorzela L, 2016, BMJ-BRIT MED J, V352, DOI [10.1136/bmj.i2229, 10.1136/bmj.i157]	65	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210899	10.1371/journal.pone.0210899	http://dx.doi.org/10.1371/journal.pone.0210899			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673769	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800056
J	Samojlik, T; Fedotova, A; Niechoda, T; Rotherham, ID				Samojlik, Tomasz; Fedotova, Anastasia; Niechoda, Tomasz; Rotherham, Ian D.			Culturally modified trees or wasted timber: Different approaches to marked trees in Poland's Biatowieza Forest	PLOS ONE			English	Article							BIALOWIEZA FOREST; LAND-USE; PRIMEVAL FOREST; FIRE; BARK; ARCHAEOLOGY; MANAGEMENT; SWEDEN; 19TH	Studies of past forest use traditions are crucial in both understanding the present state of the oldest European forests, and in guiding decisions on future forest conservation and management. Current management of Poland's Biatowieza Forest (BF), one of the best preserved forests of the European lowlands, is heavily influenced by anecdotal knowledge on forest history. Therefore, it is important to gain knowledge of the forest's past in order to answer questions about its historical administration, utilisation, and associated anthropogenic changes. Such understanding can then inform future management. This study, based on surveys in Belarussian and Russian archives and a preliminary field survey in ten forest compartments of BiatowieZa National Park, focuses on culturally-modified trees (CMTs), which in this case are by-products of different forms of traditional forest use. Information about the formation of the CMTs can then be used to provide insight into former forest usage. Two types of CMTs were discovered to be still present in the contemporary BF. One type found in two forms was of 1) pine trees scorched and chopped in the bottom part of the trunk and 2) pine trees with carved beehives. A second type based on written accounts, and therefore known to be present in the past (what we call a 'ghost CMT'), was of 3) lime-trees with strips of bark peeled from the trunk. Written accounts cover the period of transition between the traditional forest management (BF as a Polish royal hunting ground, until the end of the eighteenth century) and modern, "scientific" forestry (in most European countries introduced in the second half of the nineteenth century). These accounts document that both types of CMTs and the traditional forest uses responsible for their creation were considered harmful to "rational forestry" by the nineteenth-century forest administration. Thus the practices which created CMTs were banned and the trees gradually removed from the forest. Indeed, these activities drew the attention of forest administrators for several decades, and in our view delayed the introduction of new, timber-oriented, forest management in the BF.	[Samojlik, Tomasz] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Fedotova, Anastasia] Russian Acad Sci, Inst Hist Sci & Technol, St Petersburg, Russia; [Fedotova, Anastasia] Max Planck Inst Hist Sci, Berlin, Germany; [Niechoda, Tomasz] Zespol Szkol Chem & Przemyslu Spozywczego Gen F K, Lublin, Poland; [Rotherham, Ian D.] Sheffield Hallam Univ, Dept Nat & Built Environm, Sheffield, S Yorkshire, England	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Russian Academy of Sciences; Vavilov Institute for the History of Science & Technology of the Russian Academy of Sciences; Max Planck Society; Sheffield Hallam University	Samojlik, T (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	samojlik@ibs.bialowieza.pl	Fedotova, Anastasia A./B-9844-2011	Fedotova, Anastasia A./0000-0002-6647-2866; Samojlik, Tomasz/0000-0003-3822-1311	Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland	Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland	The research was supported by the resources of the Mammal Research Institute, Polish Academy of Sciences, Bialowieza, Poland.	Adamczyk W, 1935, BADANIA DZIEJOW SPOL, V17, P152; Andersson R, 2005, VEG HIST ARCHAEOBOT, V14, P149, DOI 10.1007/s00334-005-0066-y; [Anonymous], 1898, CENTURY FOREST DEP 1, P1; [Anonymous], 1861, TITLE ERROR; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bergman I., 2014, FENNOSCANDIA ARCHAEO, VXXXI, P45; Bernadzki E, 1998, J VEG SCI, V9, P229, DOI 10.2307/3237122; Blank-Weissberg S, 1937, BARCIE KLODY POLSCE, P1; Blicharska M, 2018, SCIENCE, V359, P646, DOI 10.1126/science.aar7173; Bobrovskii P, 1863, MAT DLA GEOGRAFII ST, P404; Brincken J., 1826, MEMOIRE DESCRIPTIF F, P1; Bronovskii Y, 1861, ZH MINISTERSTVA GOSU, V78, P57; Buhrich A, 2015, AUST ARCHAEOL, P91; Callaway E, 2017, NATURE, V552, P304, DOI 10.1038/d41586-017-08493-x; Eichwald CE, 1830, NATURHISTORISCHE SKI, P1; Eldridge A., 2013, CULTURALLY MODIFIED, P113; Ericsson TS, 2003, SILVA FENN, V37, P283, DOI 10.14214/sf.507; Falinski J.B., 1986, VEGETATION DYNAMICS, V1st ed., P1; Falinski JB, 1996, THESIS, V13, P1; FALINSKI JB, 1991, NASZE DRZEWA LESNE, V15, P145; Genko N., 1902, LESNOI Z, P22; Gloger Z, 1903, BIALOWIEZA W ALBUMIE, P1; Hedemann O, 1939, ROZPRAWY SPRAWOZDA A, V1, P1; Hedemann O., 1936, ECHA LESNE, V36, p[38, 39]; Hedemann O., 1934, DAWNE PUSZCZE I WODY, P1; Holzl R, 2010, SCI CULT-UK, V19, P431, DOI 10.1080/09505431.2010.519866; Hood S, 2015, ECOLOGY, V96, P1846, DOI 10.1890/14-0487.1; Jarocki FP., 1830, PUSZCZY BIALOWIEZKIE, P1; Jedrzejewska B., 1998, PREDATION VERTEBRATE, P1; Josefsson T, 2012, NAT AREA J, V32, P54, DOI 10.3375/043.032.0107; KARCOV G, 1903, BELOVEZSKAJA PUSCA A, P1; Karpiriski JJ, 1948, SLADY DAWNEGO BARTNI, P1; Keczynski A, 2008, MATECZNIK, V3, P14; KEPPEN PI, 1841, ZH MINISTERSTVA GOSU, V4, P13; Krasnodebski D., 2005, SPRAWOZDANIA ARCHEOL, V57, P555; Krasnodebski D, 2008, WIADOMOSCI ARCHEOLOG, V60, P361; Kujawa A, 2016, FOREST RES PAPERS, V77, P302, DOI DOI 10.1515/frp-2016-0032; Latalowa M, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P243, DOI 10.1079/9781780643373.0243; Lombardero MJ, 2006, FOREST ECOL MANAG, V225, P349, DOI 10.1016/j.foreco.2006.01.010; Long A., 2003, SCARRED TREES IDENTI; MacDonald LH, 2000, ENVIRON MANAGE, V26, P299, DOI 10.1007/s002670010088; Michalczuk C., 2001, PHYTOCOENOSIS S, V13, P1; Mikusinska A, 2013, APPL VEG SCI, V16, P217, DOI 10.1111/j.1654-109X.2012.01220.x; Morrison M, 2013, J FIELD ARCHAEOL, V38, P143, DOI 10.1179/0093469013Z.00000000044; Niklasson M., 1994, VEGET HIST ARCHAEOBO, V3, P183, DOI [DOI 10.1007/BF00202025, 10.1007/BF00202025]; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Ostlund L, 2003, SCAND J FOREST RES, V18, P78, DOI 10.1080/0891060310002363; Ostlund L, 2002, ENVIRON HIST-US, V7, P48, DOI 10.2307/3985452; Paczoski J., 1928, PRZEGLAD LESNICZY, V2, P1; Potujatiski A, 1854, OPISANIE LASOW KROLE, V2, P1; RHOADS JW, 1992, WORLD ARCHAEOL, V24, P198, DOI 10.1080/00438243.1992.9980203; Samojlik T., 2004, Sylwan, V148, P37; Samojlik T., 2005, ROCZNIK DENDROLOGICZ, V53, P55; Samojlik T, 2005, CONSERVATION HUNTING, P1; Samojlik T., 2013, CULTURAL SEVERANCE E, P191; Samojlik T., 2010, LANDSC ARCHAEOL ECOL, V8, P150; SAMOJLIK T, 2006, ROCZNIK DENDROLOGICZ, V54, P7; Samojlik T, 2007, THESIS, P1; Samojlik T, 2016, AMBIO, V45, P904, DOI 10.1007/s13280-016-0795-4; Samojlik T, 2013, ENVIRON HIST-US, V18, P576, DOI 10.1093/envhis/emt039; Swetnam Thomas W., 1984, J ETHNOBIOL, V4, P177; Teplouhov A., 1862, ZH MINISTERSTVA GOSU, V79, P164; Tomialojc L, 2004, J ORNITHOL, V145, P81, DOI 10.1007/s10336-003-0017-2; Wesolowski T, 2016, VOICE DEBATE; Wicko E, 1984, PUSZCZA BIALOWIESKA, P1; Wiecko E., 1963, KWARTALNIK HIST KULT, V11, P345; Wroblewski K, 1927, ZUBR PUSZCZY BIALOWI, P98; Zackrisson O, 2000, VEG HIST ARCHAEOBOT, V9, P99, DOI 10.1007/BF01300060; Zimny M, 2015, PARKI NARODOWE REZER, V35, P3; 1862, TITLE ERROR; 1844, TITLE ERROR; 1880, TITLE ERROR; 1816, TITLE ERROR, P196; 1850, TITLE ERROR, P67; 1862, TITLE ERROR, V80, P99	75	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211025	10.1371/journal.pone.0211025	http://dx.doi.org/10.1371/journal.pone.0211025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673758	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000456442800067
J	Andersen, V; Fimland, MS; Mo, DA; Iversen, VM; Larsen, TM; Solheim, F; Saeterbakken, AH				Andersen, Vidar; Fimland, Marius S.; Mo, Dag-Andre; Iversen, Vegard M.; Larsen, Tommy M.; Solheim, Fredrik; Saeterbakken, Atle H.			Electromyographic comparison of the barbell deadlift using constant versus variable resistance in healthy, trained men	PLOS ONE			English	Article							KINETIC-ANALYSIS; STICKING POINT; ELASTIC BANDS; SQUATS; CHAIN; MUSCLE; FORCE	Variable, external resistance is proposed to increasingly augment the muscular stress throughout a dynamic movement. However, it is uncertain how different levels of variable resistance affect the activation in the deadlift. The aim of the study was to compare the electromyographic activity of the gluteus maximus, biceps femoris, semitendinosus, vastus lateralis and erector spinae muscles during the barbell deadlift with free weights (FW) alone, with two (FW-2EB), and four elastic bands (FW-4EB) to deload some of the constant external resistance. Fifteen resistance-trained men participated in a cross-over design where resistance loadings were matched using two-repetition maximum loadings in the three different conditions. For the whole movement, both repetitions were analyzed. For the phase-specific analysis, the last repetition was divided into six parts, i.e. the lower, middle and upper phase in both the ascending and descending phase of the movement. The mean deloading contributions from FW-2EB and FW-4EB were 21% and 41%, respectively. In FW-4EB, the erector spinae was activated more in the whole movement (8%, ES = 0.31, p = 0.002) compared to FW-2EB. There was also a tendency towards higher activation in FW-4EB versus FW for the whole movement (5%, ES = 0.18, p = 0.072). There were no significant differences between the conditions in any of the other phases or muscles (p = 0.106-0.926). In summary, a high contribution from variable, external resistance seems to activate the back extensors more than a low contribution.	[Andersen, Vidar; Mo, Dag-Andre; Larsen, Tommy M.; Solheim, Fredrik; Saeterbakken, Atle H.] Western Norway Univ Appl Sci, Fac Educ Arts & Sport, Sogndal, Norway; [Fimland, Marius S.] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Fimland, Marius S.] Unicare Helsefort Rehabil Ctr, Rissa, Norway; [Iversen, Vegard M.] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway	Western Norway University of Applied Sciences; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Andersen, V (corresponding author), Western Norway Univ Appl Sci, Fac Educ Arts & Sport, Sogndal, Norway.	vidar.andersen@hvl.no		Fimland, Marius Steiro/0000-0001-7167-3120				Andersen V, 2016, J STRENGTH COND RES, V30, P3456, DOI 10.1519/JSC.0000000000001451; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Ebben WP, 2002, J STRENGTH COND RES, V16, P547, DOI 10.1519/00124278-200211000-00009; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Frost DM, 2010, SPORTS MED, V40, P303, DOI 10.2165/11319420-000000000-00000; Galpin AJ, 2015, J STRENGTH COND RES, V29, P3271, DOI 10.1519/JSC.0000000000000987; Hales ME, 2009, J STRENGTH COND RES, V23, P2574, DOI 10.1519/JSC.0b013e3181bc1d2a; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Israetel MA, 2010, J STRENGTH COND RES, V24, P190, DOI 10.1519/JSC.0b013e31819b7995; Kompf J, 2017, SPORTS MED, V47, P631, DOI 10.1007/s40279-016-0615-9; Kompf J, 2016, SPORTS MED, V46, P751, DOI 10.1007/s40279-015-0460-2; Mathiassen SE, 1995, J ELECTROMYOGR KINES, V5, P197, DOI 10.1016/1050-6411(94)00014-X; Mcmaster DT, 2010, J STRENGTH COND RES, V24, P2056, DOI 10.1519/JSC.0b013e3181dc4200; Nijem RM, 2016, J STRENGTH COND RES, V30, P1177, DOI 10.1519/JSC.0000000000001351; Saeterbakken AH, 2016, J STRENGTH COND RES, V30, P945, DOI 10.1519/JSC.0000000000001178; Saeterbakken AH, 2014, J STRENGTH COND RES, V28, P3056, DOI 10.1519/JSC.0000000000000516; Swinton PA, 2011, J STRENGTH COND RES, V25, P3163, DOI 10.1519/JSC.0b013e318212e389; van den Tillaar R, 2014, J HUM KINET, V42, P63, DOI 10.2478/hukin-2014-0061; WADMAN W J, 1979, Journal of Human Movement Studies, V5, P3; Wallace BJ, 2006, J STRENGTH COND RES, V20, P268, DOI 10.1519/00124278-200605000-00006	21	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211021	10.1371/journal.pone.0211021	http://dx.doi.org/10.1371/journal.pone.0211021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668589	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000456306400026
J	Feinberg, I; Campbell, IG				Feinberg, Irwin; Campbell, Ian G.			Shorter sleep durations in adolescents reduce power density in a wide range of waking electroencephalogram frequencies	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ATTENUATION; INCREASE	Despite sleep's recognized biological importance, it has been remarkably difficult to demonstrate changes in brain physiology with reduced sleep durations. In a study of adolescents, we varied sleep durations by restricting time in bed for four nights of either 10, 8.5 or 7 h. Shorter sleep durations significantly decreased waking electroencephalogram (EEG) power in a wide range of frequencies with both eyes closed and eyes open in central and occipital leads. These findings suggest new research directions and raise the possibility that waking EEG power density could provide a non-invasive test for biologically sufficient sleep.	[Feinberg, Irwin; Campbell, Ian G.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Campbell, IG (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA.	igcampbell@ucdavis.edu			United States Public Health Service [R01-HL116490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116490] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	IF received United States Public Health Service grant R01-HL116490 for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RJ, 2009, CLIN NEUROPHYSIOL, V120, P1806, DOI 10.1016/j.clinph.2009.08.006; BUCHSBAUM MS, 1989, LIFE SCI, V45, P1349, DOI 10.1016/0024-3205(89)90021-0; Campbell IG, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx046; Campbell IG, 2011, SLEEP, V34, P83, DOI 10.1093/sleep/34.1.83; EVARTS EV, 1962, J NEUROPHYSIOL, V25, P812, DOI 10.1152/jn.1962.25.6.812; FEINBERG I, 1991, SLEEP, V14, P316; Geller AS, 2014, CLIN NEUROPHYSIOL, V125, P1764, DOI 10.1016/j.clinph.2014.01.021; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; MADSEN PL, 1991, J APPL PHYSIOL, V70, P2597, DOI 10.1152/jappl.1991.70.6.2597; MADSEN PL, 1991, BRAIN RES, V557, P217, DOI 10.1016/0006-8993(91)90137-K; MAQUET P, 1990, BRAIN RES, V513, P136, DOI 10.1016/0006-8993(90)91099-3; Moruzzi G, 1996, BRAIN CONSCIOUS EXPE, P345; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stampi C, 1995, WORK STRESS, V9, P368, DOI 10.1080/02678379508256574; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210649	10.1371/journal.pone.0210649	http://dx.doi.org/10.1371/journal.pone.0210649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668606	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400010
J	Ma, TT; Wong, ICK; Man, KKC; Chen, Y; Crake, T; Ozkor, MA; Ding, LQ; Wang, ZX; Zhang, L; Wei, L				Ma, Tian-Tian; Wong, Ian C. K.; Man, Kenneth K. C.; Chen, Yang; Crake, Thomas; Ozkor, Muhiddin A.; Ding, Ling-Qing; Wang, Zi-Xuan; Zhang, Lin; Wei, Li			Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; OPTIMAL MEDICAL THERAPY; LONG-TERM SURVIVAL; DRUG-COMBINATIONS; 1-YEAR MORTALITY; ASPIRIN; IMPACT; PREDICTORS; DISCHARGE; OUTCOMES	Background The combination pharmacotherapy of antiplatelet agents, lipid-modifiers, ACE inhibitors/ARBs and beta-blockers are recommended by international guidelines. However, data on effectiveness of the evidence-based combination pharmacotherapy (EBCP) is limited. Objectives To determine the effect of EBCP on mortality and Cardiovascular events in patients with Coronary Heart Disease (CHD) or cerebrovascular disease. Methods Publications in EMBASE and Medline up to October 2018 were searched for cohort and case-control studies on EBCP for the secondary prevention of cardiovascular disease. The main outcomes were all-cause mortality and major cardiovascular events. Meta-analyses were performed based on random effects models. Results 21 studies were included. Comparing EBCP to either monotherapy or no therapy, the pooled risk ratios were 0.60 (95% confidence interval 0.55 to 0.66) for all-cause mortality, 0.70 (0.62 to 0.79) for vascular mortality, 0.73 (0.64 to 0.83) for myocardial infarction and 0.79 (0.68 to 0.91) for cerebrovascular events. Optimal EBCP (all 4 classes of drug prescribed) had a risk ratio for all-cause mortality of 0.50 (0.40 to 0.64). This benefit became more dilute as the number of different classes of drug comprising EBCP was decreased-for 3 classes of drug prescribed the risk ratio was 0.58 (0.49 to 0.69) and for 2 classes, the risk ratio was 0.67 (0.60 to 0.76). Conclusions EBCP reduces the risk of all-cause mortality and cardiovascular events in patients with CHD or cerebrovascular disease. The different classes of drugs comprising EBCP work in an additive manner, with optimal EBCP conferring the greatest benefit.	[Ma, Tian-Tian; Wong, Ian C. K.; Man, Kenneth K. C.; Wang, Zi-Xuan; Wei, Li] UCL Sch Pharm, Res Dept Practice & Policy, London, England; [Wong, Ian C. K.; Man, Kenneth K. C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Ctr Safe Medicat Practice & Res, Hong Kong, Peoples R China; [Chen, Yang] UCL, UCL Inst Cardiovasc Sci, London, England; [Crake, Thomas; Ozkor, Muhiddin A.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Ding, Ling-Qing] Xiamen Univ, Affiliated Cardiovasc Hosp, Dept Pharm, Xiamen, Peoples R China; [Zhang, Lin] Univ Sci & Technol China, Affiliated Hosp 1, Intens Care Unit, Hefei, Anhui, Peoples R China	University of London; University College London; University of Hong Kong; University of London; University College London; University of London; Queen Mary University London; Xiamen University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wei, L (corresponding author), UCL Sch Pharm, Res Dept Practice & Policy, London, England.	l.wei@ucl.ac.uk	Ma, Tiantian/HHZ-6916-2022; Man, Kenneth/AAD-2846-2019; Li, Wei/Z-1091-2019; Chen, Yang/ABF-7660-2021	Man, Kenneth/0000-0001-8645-1942; Li, Wei/0000-0002-2015-7262; Chen, Yang/0000-0001-6032-3387; Wang, Zixuan/0000-0001-5345-2471; Wong, Ian Chi Kei/0000-0001-8242-0014	MRC [G106/1249] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Al-Zakwani I, 2012, INT J CLIN PHARM TH, V50, P418, DOI 10.5414/CP201667; Amann U, 2014, CLIN RES CARDIOL, V103, P655, DOI 10.1007/s00392-014-0688-0; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; [Anonymous], 2015, GRAPHICAL DISPLAY OF, V30, P271; Arslan F, 2018, NETH HEART J, V26, P417, DOI 10.1007/s12471-018-1134-0; Bahiru E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub3; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bauer T, 2010, EUR J CARDIOV PREV R, V17, P576, DOI 10.1097/HJR.0b013e328338e5da; BERITIC T., 1962, LIJE NI KI VJESN, V84, P679, DOI [10.1136/bmj.324.7329.71, DOI 10.1136/BMJ.324.7329.71]; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P285, DOI 10.1002/pds.4171; Bramlage P, 2010, HEART, V96, P604, DOI 10.1136/hrt.2009.188607; Buddeke J, 2017, INT J CARDIOL, V248, P382, DOI 10.1016/j.ijcard.2017.06.106; Capone ML, 2005, J AM COLL CARDIOL, V45, P1295, DOI 10.1016/j.jacc.2005.01.045; Chen SJ, 2017, J GERIATR CARDIOL, V14, P100, DOI 10.11909/j.issn.1671-5411.2017.02.004; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Danchin N, 2005, AM HEART J, V150, P1147, DOI 10.1016/j.ahj.2005.01.058; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Finsterer J, 2008, NETH J MED, V66, P327; Gouya G, 2007, EUR J EPIDEMIOL, V22, P145, DOI 10.1007/s10654-006-9087-9; Gunnell AS, 2013, HEART, V99, P1353, DOI 10.1136/heartjnl-2013-304348; He Y, 2015, ALIMENT PHARM THER, V41, P1246, DOI 10.1111/apt.13211; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1059, DOI 10.1136/bmj.330.7499.1059; Hudson M, 2005, J RHEUMATOL, V32, P1589; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kirchmayer U, 2013, PHARMACOEPIDEM DR S, V22, P649, DOI 10.1002/pds.3430; Kopel R, 2014, CARDIOLOGY, V127, P83, DOI 10.1159/000355160; Lafeber M, 2013, AM HEART J, V166, P282, DOI 10.1016/j.ahj.2013.04.011; Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009; Lv JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004136.pub3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; National Institute for Health and Care Excellence, 2013, STROK REH AD; National Institute for Health and Care Excellence (NICE), 2013, MYOC INF CARD REH PR; Park JH, 2015, NEUROLOGY, V84, P50, DOI 10.1212/WNL.0000000000001099; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Tay ELW, 2008, AM J GERIATR CARDIOL, V17, P21, DOI 10.1111/j.1076-7460.2007.07242.x; Timoteo Ana Teresa, 2006, Rev Port Cardiol, V25, P1109; van der Elst ME, 2007, HEART, V93, P1226, DOI 10.1136/hrt.2006.098053; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wang D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009580.pub2; WHO, 2002, WORLD HLTH ORG WELLC; World Health Organization, TOP 10 CAUS DEATH; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; Zeymer U, 2011, CURR MED RES OPIN, V27, P1563, DOI 10.1185/03007995.2011.590969	51	17	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210988	10.1371/journal.pone.0210988	http://dx.doi.org/10.1371/journal.pone.0210988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657781	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000024
J	Bubak, AN; Watt, MJ; Renner, KJ; Luman, AA; Costabile, JD; Sanders, EJ; Grace, JL; Swallow, JG				Bubak, Andrew N.; Watt, Michael J.; Renner, Kenneth J.; Luman, Abigail A.; Costabile, Jamie D.; Sanders, Erin J.; Grace, Jaime L.; Swallow, John G.			Sex differences in aggression: Differential roles of 5-HT2, neuropeptide F and tachykinin	PLOS ONE			English	Article							STALK-EYED FLIES; SUBSTANCE-P; DROSOPHILA-MELANOGASTER; SEROTONIN SYNTHESIS; SOCIAL-ISOLATION; RECEPTORS; BEHAVIOR; NEURONS; BRAIN; HYPOTHALAMUS	Despite the conserved function of aggression across taxa in obtaining critical resources such as food and mates, serotonin's (5-HT) modulatory role on aggressive behavior appears to be largely inhibitory for vertebrates but stimulatory for invertebrates. However, critical gaps exist in our knowledge of invertebrates that need to be addressed before definitively stating opposing roles for 5-HT and aggression. Specifically, the role of 5-HT receptor subtypes are largely unknown, as is the potential interactive role of 5-HT with other neurochemical systems known to play a critical role in aggression. Similarly, the influence of these systems in driving sex differences in aggressive behavior of invertebrates is not well understood. Here, we investigated these questions by employing complementary approaches in a novel invertebrate model of aggression, the stalk-eyed fly. A combination of altered social conditions, pharmacological manipulation and 5-HT2 receptor knockdown by siRNA revealed an inhibitory role of this receptor subtype on aggression. Additionally, we provide evidence for 5-HT2's involvement in regulating neuropeptide F activity, a suspected inhibitor of aggression. However, this function appears to be stage-specific, altering only the initiation stage of aggressive conflicts. Alternatively, pharmacologically increasing systemic concentrations of 5-HT significantly elevated the expression of the neuropeptide tachykinin, which did not affect contest initiation but instead promoted escalation via production of high intensity aggressive behaviors. Notably, these effects were limited solely to males, with female aggression and neuropeptide expression remaining unaltered by any manipulation that affected 5-HT. Together, these results demonstrate a more nuanced role for 5-HT in modulating aggression in invertebrates, revealing an important interactive role with neuropeptides that is more reminiscent of vertebrates. The sex-differences described here also provide valuable insight into the evolutionary contexts of this complex behavior.	[Bubak, Andrew N.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA; [Watt, Michael J.] Univ South Dakota, Ctr Brain & Behav Res, Basic Biomed Sci, Vermillion, SD 57069 USA; [Renner, Kenneth J.] Univ South Dakota, Biol Dept, Vermillion, SD 57069 USA; [Luman, Abigail A.; Costabile, Jamie D.; Sanders, Erin J.; Swallow, John G.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Grace, Jaime L.] Bradley Univ, Dept Biol, Peoria, IL 61625 USA; [Watt, Michael J.] Univ Otago, Dept Anat, Dunedin, New Zealand	University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Dakota; University of South Dakota; University of Colorado System; University of Colorado Denver; Bradley University; University of Otago	Swallow, JG (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	john.swallow@ucdenver.edu	Bubak, Andrew/GLR-6501-2022; Grace, Jaime/I-4407-2014	Watt, Michael/0000-0003-1164-1367; Grace, Jaime/0000-0002-8563-9182; Swallow, John/0000-0001-7107-8866	National Science Foundation [IOS 1256898, 1656465, IOS 1257679]	National Science Foundation(National Science Foundation (NSF))	This work was funded by National Science Foundation grants IOS 1256898 and 1656465 (to JGS) and IOS 1257679 (to MJW), https://www.nsf.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-khairulla H, 2003, J INSECT BEHAV, V16, P679, DOI 10.1023/B:JOIR.0000007703.84691.ad; Alekseyenko OV, 2014, CURR BIOL, V24, P2700, DOI 10.1016/j.cub.2014.09.051; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; Antonsen BL, 1997, J COMP PHYSIOL A, V181, P501, DOI 10.1007/s003590050134; Aoki M, 2016, EUR J NEUROSCI, V43, P1219, DOI 10.1111/ejn.13233; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; BAKER KG, 1991, NEUROSCIENCE, V42, P757, DOI 10.1016/0306-4522(91)90043-N; Bath E, 2015, ECOL EVOL, V5, P1826, DOI 10.1002/ece3.1467; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Boyan G, 2010, CELL TISSUE RES, V340, P13, DOI 10.1007/s00441-009-0922-7; Boyer C, 2007, BRAIN RES, V1133, P53, DOI 10.1016/j.brainres.2006.11.042; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; Bubak AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166417; Bubak AN, 2016, CURR ZOOL, V62, P257, DOI 10.1093/cz/zow040; Bubak AN, 2015, BEHAV BRAIN RES, V292, P521, DOI 10.1016/j.bbr.2015.07.028; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; Bubak AN, 2014, BEHAV BRAIN RES, V259, P137, DOI 10.1016/j.bbr.2013.10.050; Bubak AN, 2013, J NEUROSCI METH, V219, P124, DOI 10.1016/j.jneumeth.2013.07.006; BURKHARDT D, 1983, J COMP PHYSIOL, V151, P407, DOI 10.1007/BF00605457; CHAMBERLAIN SC, 1986, J COMP NEUROL, V251, P363, DOI 10.1002/cne.902510307; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Dierick HA, 2013, NAT GENET, V39, P678; Dryden S, 1996, NEUROSCIENCE, V72, P557, DOI 10.1016/0306-4522(95)00566-8; Dryden S, 1996, BRAIN RES, V724, P232, DOI 10.1016/0006-8993(96)00329-0; Dyakonova VE, 2013, J COMP PHYSIOL A, V199, P601, DOI 10.1007/s00359-013-0804-z; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Egge AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P369, DOI 10.1007/s00265-010-1054-5; Ferrari PF, 2005, EUR J PHARMACOL, V526, P259, DOI 10.1016/j.ejphar.2005.10.002; Glass JD, 2000, BRAIN RES, V859, P224, DOI 10.1016/S0006-8993(00)01963-6; Grignaschi G, 1996, BRAIN RES, V708, P173, DOI 10.1016/0006-8993(95)01373-3; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Herbert Z, 2010, J MORPHOL, V271, P1509, DOI 10.1002/jmor.10895; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P60, DOI 10.1159/000113355; Ignell R, 2001, CELL TISSUE RES, V306, P143, DOI 10.1007/s004410100434; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Juarez P, 2013, BEHAV BRAIN RES, V256, P354, DOI 10.1016/j.bbr.2013.07.044; Karl T, 2004, P NATL ACAD SCI USA, V101, P12742, DOI 10.1073/pnas.0404085101; Katsouni E, 2009, PEPTIDES, V30, P1586, DOI 10.1016/j.peptides.2009.05.001; Langworthy K, 1997, CELL TISSUE RES, V288, P191, DOI 10.1007/s004410050806; Lihoreau M, 2009, BEHAV PROCESS, V82, P81, DOI 10.1016/j.beproc.2009.03.008; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Maejima T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00040; Mann J. John, 1995, P1919; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Martin CA, 2014, NEUROCHEM INT, V73, P71, DOI 10.1016/j.neuint.2014.03.015; Momohara Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074489; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; OSBORNE NN, 1982, SCIENCE, V216, P409, DOI 10.1126/science.6176023; Panksepp JB, 2003, MICROSC RES TECHNIQ, V60, P360, DOI 10.1002/jemt.10274; Rehm KJ, 2008, J NEUROSCI, V28, P9828, DOI 10.1523/JNEUROSCI.2328-08.2008; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smialowska M, 2001, NEUROPEPTIDES, V35, P82, DOI 10.1054/npep.2001.0849; Stevenson PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074965; Summers CH, 2006, J EXP BIOL, V209, P4581, DOI 10.1242/jeb.02565; Szczuka A, 2013, ACTA NEUROBIOL EXP, V73, P495; Takahashi Aki, 2012, Curr Top Behav Neurosci, V12, P73; Takahashi A, 2011, PSYCHOPHARMACOLOGY, V213, P183, DOI 10.1007/s00213-010-2000-y; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Ueda A, 2009, J NEUROGENET, V23, P378, DOI 10.3109/01677060903063026; Vleugels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065052; WILKINSON GS, 1993, GENET RES, V62, P213, DOI 10.1017/S001667230003192X; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7	69	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0203980	10.1371/journal.pone.0203980	http://dx.doi.org/10.1371/journal.pone.0203980			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695038	Green Submitted, gold, Green Published			2022-12-27	WOS:000457046400003
J	Ozaki, Y; Yamada, H; Kikuchi, H; Hirotsu, A; Murakami, T; Matsumoto, T; Kawabata, T; Hiramatsu, Y; Kamiya, K; Yamauchi, T; Goto, K; Ueda, Y; Okazaki, S; Kitagawa, M; Takeuchi, H; Konno, H				Ozaki, Yusuke; Yamada, Hidenao; Kikuchi, Hirotoshi; Hirotsu, Amane; Murakami, Tomohiro; Matsumoto, Tomohiro; Kawabata, Toshiki; Hiramatsu, Yoshihiro; Kamiya, Kinji; Yamauchi, Toyohiko; Goto, Kentaro; Ueda, Yukio; Okazaki, Shigetoshi; Kitagawa, Masatoshi; Takeuchi, Hiroya; Konno, Hiroyuki			Label-free classification of cells based on supervised machine learning of subcellular structures	PLOS ONE			English	Article							QUANTITATIVE PHASE; REFRACTIVE-INDEX; LIGHT-SCATTERING; MICROSCOPY; CANCER; BLOOD; PROGRESSION; IMAGES	It is demonstrated that cells can be classified by pattern recognition of the subcellular structure of non-stained live cells, and the pattern recognition was performed by machine learning. Human white blood cells and five types of cancer cell lines were imaged by quantitative phase microscopy, which provides morphological information without staining quantitatively in terms of optical thickness of cells. Subcellular features were then extracted from the obtained images as training data sets for the machine learning. The built classifier successfully classified WBCs from cell lines (area under ROC curve = 0.996). This label-free, non-cytotoxic cell classification based on the subcellular structure of QPM images has the potential to serve as an automated diagnosis of single cells.	[Ozaki, Yusuke; Kikuchi, Hirotoshi; Hirotsu, Amane; Murakami, Tomohiro; Matsumoto, Tomohiro; Kawabata, Toshiki; Hiramatsu, Yoshihiro; Kamiya, Kinji; Takeuchi, Hiroya] Hamamatsu Univ Sch Med, Dept Surg 2, Hamamatsu, Shizuoka, Japan; [Yamada, Hidenao; Yamauchi, Toyohiko; Goto, Kentaro; Ueda, Yukio] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Okazaki, Shigetoshi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Inst Med Photon Res, Dept Med Spect, Hamamatsu, Shizuoka, Japan; [Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka, Japan; [Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Preeminent Med Photon Educ & Res Ctr, Lab Anim Facil & Serv, Hamamatsu, Shizuoka, Japan; [Konno, Hiroyuki] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu Photonics; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Yamada, H (corresponding author), Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan.	iwai@crl.hpk.co.jp		Hiramatsu, Yoshihiro/0000-0003-1448-1610; Kikuchi, Hirotoshi/0000-0002-1776-1020; Yamada, Hidenao/0000-0001-7091-9053	 [15K10132];  [26461974];  [15H04929]	; ; 	This work was supported in part by Grants-in-Aid for Scientific Research in Japan 15K10132 (H. Kikuchi), 26461974 (T. Kawabata), and 15H04929 (H. Konno), URL: https//www.jsps.go.jp/english/e-grants/index.html.; This work was supported in part by Grants-in-Aid for Scientific Research in Japan 15K10132 (H. Kikuchi), 26461974 (T. Kawabata), and 15H04929 (H. Konno).	Bayramoglu N, 2014, INT C PATT RECOG, P3345, DOI 10.1109/ICPR.2014.576; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bhaskar D, 2017, MORPHOLOGY BASED CEL, DOI [10.14288/1.0345604, DOI 10.14288/1.0345604]; Blasi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10256; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brauer J, 2016, HOG DESCRIPTOR COMPU; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19757; Cibas E.S., 2019, CYTOLOGY DIAGNOSTIC; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Diaz G, 1996, COMPUT METH PROG BIO, V49, P1, DOI 10.1016/0169-2607(95)01688-0; Drezek R, 2003, J BIOMED OPT, V8, P7, DOI 10.1117/1.1528950; Dunn A K, 1997, J Biomed Opt, V2, P262, DOI 10.1117/12.275219; Essa E, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2916; Essa E, 2015, IEEE ENG MED BIO, P3865, DOI 10.1109/EMBC.2015.7319237; Gero E, 1987, IMMUNOLOGICAL APPROA, P95; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Gschwendtner A, 1999, MODERN PATHOL, V12, P806; Iwai H, 2004, OPT LETT, V29, P2399, DOI 10.1364/OL.29.002399; Iwai H, 2014, OPT COMMUN, V319, P159, DOI 10.1016/j.optcom.2014.01.013; Jiang YY, 2017, LAB CHIP, V17, P2426, DOI 10.1039/c7lc00396j; Jo Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700606; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kandel ME, 2017, REAL TIME HALO CORRE, DOI [10.1101/227025, DOI 10.1101/227025]; Kang MS, 2012, PROC SPIE, V8227, DOI 10.1117/12.908070; Kasprowicz R, 2017, INT J BIOCHEM CELL B, V84, P89, DOI 10.1016/j.biocel.2017.01.004; Kim GB, 2018, J DIGIT IMAGING, V31, P415, DOI 10.1007/s10278-017-0028-9; Kobayashi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12378-4; Langehanenberg P, 2008, APPL OPTICS, V47, pD176, DOI 10.1364/AO.47.00D176; Mahjoubfar A, 2013, BIOMED OPT EXPRESS, V4, P1618, DOI 10.1364/BOE.4.001618; Martin A.F., 1997, P EUR 97 RHOD GREEC, V4, P1899; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mualla F, 2013, IEEE T MED IMAGING, V32, P2274, DOI 10.1109/TMI.2013.2280380; Neumann D, 2017, IEEE INT VEH SYM, P773, DOI 10.1109/IVS.2017.7995810; Nguyen TH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44034; Ozaki Ryota, 2013, Journal of the Japan Society for Precision Engineering, V79, P1074; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pan J, 2009, P MICR IM AN APPL BI; Park HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163045; Roitshtain D, 2017, CYTOM PART A, V91A, P482, DOI 10.1002/cyto.a.23100; Scholkopf B., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P252; Schurmann M, 2016, J BIOPHOTONICS, V9, P1068, DOI 10.1002/jbio.201500273; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Theriault DH, 2012, MACH VISION APPL, V23, P659, DOI 10.1007/s00138-011-0345-9; Xu MJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005746; Yamauchi T, 2008, OPT EXPRESS, V16, P12227, DOI 10.1364/OE.16.012227; Yamauchi T, 2018, PROC SPIE, V10503, DOI 10.1117/12.2289473; Yamauchi T, 2011, OPT EXPRESS, V19, P5536, DOI 10.1364/OE.19.005536; Yin ZZ, 2012, MED IMAGE ANAL, V16, P1047, DOI 10.1016/j.media.2011.12.006; Yoon J, 2015, BIOMED OPT EXPRESS, V6, P3865, DOI 10.1364/BOE.6.003865; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454	56	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211347	10.1371/journal.pone.0211347	http://dx.doi.org/10.1371/journal.pone.0211347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695059	Green Published, gold			2022-12-27	WOS:000457046400027
J	Goffaux, V				Goffaux, Valerie			Fixed or flexible? Orientation preference in identity and gaze processing in humans	PLOS ONE			English	Article							EMOTION RECOGNITION; INVERSION LEADS; EYE GAZE; FACE; DIRECTION; PERCEPTION; LOOKING; ME	Vision begins with the encoding of contrast at specific orientations. Several works showed that humans identify their conspecifics best based on the horizontally-oriented information contained in the face image; this range conveys the main morphological features of the face. In contrast, the vertical structure of the eye region seems to deliver optimal cues to gaze direction. The present work investigates whether the human face processing system flexibly tunes to vertical information contained in the eye region when processing gaze direction. Alternatively, face processing may invariantly rely on the horizontal range, supporting the domain specificity of orientation tuning for faces and the gateway role of horizontal content to access any type of facial information. Participants judged the gaze direction of faces staring at a range of lateral positions. They additionally performed an identification task with upright and inverted face stimuli. Across tasks, stimuli were filtered to selectively reveal horizontal (H), vertical (V), or combined (HV) information. Most participants identified faces better based on horizontal than vertical information confirming the horizontal tuning of face identification. In contrast, they showed a vertically-tuned sensitivity to gaze direction. The logistic functions fitting the "left" and "right" response proportion as a function of gaze direction were indeed steeper when based on vertical than on horizontal information. The finding of a vertically-tuned processing of gaze direction favours the hypothesis that visual encoding of face information flexibly switches to the orientation channel carrying the cues most relevant to the task at hand. It suggests that horizontal structure, though predominant in the face stimulus, is not a mandatory gateway for efficient face processing. The present evidence may help better understand how visual signals travel the visual system to enable rich and complex representations of naturalistic stimuli such as faces.	[Goffaux, Valerie] UC Louvain, Psychol Sci Res Inst IPSY, Louvain La Neuve, Belgium; [Goffaux, Valerie] UC Louvain, Inst Neurosci IONS, Brussels, Belgium; [Goffaux, Valerie] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands	Universite Catholique Louvain; Universite Catholique Louvain; Maastricht University	Goffaux, V (corresponding author), UC Louvain, Psychol Sci Res Inst IPSY, Louvain La Neuve, Belgium.; Goffaux, V (corresponding author), UC Louvain, Inst Neurosci IONS, Brussels, Belgium.; Goffaux, V (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	Valerie.goffaux@uclouvain.be	Goffaux, Valerie/H-2019-2014	Goffaux, Valerie/0000-0003-3182-7011	Belgian National fund for Research (F.R.S.-F.N.R.S.)	Belgian National fund for Research (F.R.S.-F.N.R.S.)(Fonds de la Recherche Scientifique - FNRS)	The author is supported by the Belgian National fund for Research (F.R.S.-F.N.R.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2004, PERCEPTION, V33, P1173, DOI 10.1068/p5297; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; ANSTIS SM, 1969, AM J PSYCHOL, V82, P474, DOI 10.2307/1420441; Balas B, 2015, J EXP CHILD PSYCHOL, V140, P171, DOI 10.1016/j.jecp.2015.07.006; Burton AM, 2015, PERSPECT PSYCHOL SCI, V10, P482, DOI 10.1177/1745691615583129; Cabeza R, 2000, PSYCHOL SCI, V11, P429, DOI 10.1111/1467-9280.00283; Calder AJ, 2008, J EXP PSYCHOL GEN, V137, P244, DOI 10.1037/0096-3445.137.2.244; Cheleski DJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1049; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DEVALOIS RL, 1980, ANNU REV PSYCHOL, V31, P309, DOI 10.1146/annurev.ps.31.020180.001521; Duncan J, 2017, J VISION, V17, DOI 10.1167/17.14.7; Gamer M, 2007, J EXP PSYCHOL HUMAN, V33, P705, DOI 10.1037/0096-1523.33.3.705; Goffaux V, 2008, ACTA PSYCHOL, V128, P119, DOI 10.1016/j.actpsy.2007.11.005; Goffaux V, 2007, J EXP PSYCHOL HUMAN, V33, P995, DOI 10.1037/0096-1523.33.4.995; Goffaux V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34204; Goffaux V, 2016, NEUROPSYCHOLOGIA, V81, P1, DOI 10.1016/j.neuropsychologia.2015.12.004; Goffaux V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00143; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Hashemi A, 2019, VISION RES, V157, P12, DOI 10.1016/j.visres.2018.02.006; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Huynh CM, 2014, ATTEN PERCEPT PSYCHO, V76, P1381, DOI 10.3758/s13414-014-0669-4; Jacques C, 2014, J VISION, V14, DOI 10.1167/14.2.5; Kalpadakis-Smith AV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30900-0; Keil MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000329; Konar Y, 2010, PSYCHOL SCI, V21, P38, DOI 10.1177/0956797609356508; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; Mareschal I, 2013, J VISION, V13, DOI 10.1167/13.5.18; Mareschal I, 2013, CURR BIOL, V23, P717, DOI 10.1016/j.cub.2013.03.030; Mason MF, 2004, MEMORY, V12, P637, DOI 10.1080/09658210344000152; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Pachai MV, 2019, VISION RES, V157, P24, DOI 10.1016/j.visres.2018.04.003; Pachai MV, 2018, PERCEPTION, V47, P397, DOI 10.1177/0301006618754479; Pachai MV, 2017, J VISION, V17, DOI 10.1167/17.6.5; Pachai MV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00074; Pellicano E, 2013, NEUROPSYCHOLOGIA, V51, P1504, DOI 10.1016/j.neuropsychologia.2013.03.021; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Schyns PG, 1997, PERCEPTION, V26, P1027, DOI 10.1068/p261027; Sekuler AB, 2004, CURR BIOL, V14, P391, DOI 10.1016/j.cub.2004.02.028; Smith AD, 2006, DEVELOPMENTAL SCI, V9, P465, DOI 10.1111/j.1467-7687.2006.00513.x; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Taubert J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21189; Vida MD, 2012, J EXP CHILD PSYCHOL, V112, P243, DOI 10.1016/j.jecp.2012.02.002; Yu DY, 2018, VISION RES, V150, P29, DOI 10.1016/j.visres.2018.07.001	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210503	10.1371/journal.pone.0210503	http://dx.doi.org/10.1371/journal.pone.0210503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682035	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500040
J	Kertzman, S; Kagan, A; Hegedish, O; Lapidus, R; Weizman, A				Kertzman, Semion; Kagan, Alex; Hegedish, Omer; Lapidus, Rina; Weizman, Abraham			Do young women with tattoos have lower self-esteem and body image than their peers without tattoos? A non-verbal repertory grid technique approach	PLOS ONE			English	Article							ADOLESCENTS; PERSONALITY; PIERCINGS; HARM; DISSATISFACTION; ASSOCIATIONS; PREVALENCE; APPEARANCE; BEHAVIORS; FEELINGS	Available evidence regarding the reasons for people to acquire body markers such as tattoos is contradictory. The present study was designed to investigate the relationship between self-esteem and body image in young women with tattoos. To this end, the repertory grid technique (RGT) was adapted and used to assess differences between women with and without tattoos in terms of self-esteem and body image. Sixty young women with tattoos and sixty young women without (all aged 18-35 years), performed the Color RGT in order to evaluate the relationship between self-esteem and body image. Compared to women without tattoos, women with tattoos showed significantly lower self-esteem and displayed stronger relationships between three constructs: ideal body, ideal self and tattooed woman status. No significant differences in body image were detected between the two groups. Women with tattoos were characterized by an association between body image and self-esteem, while women without tattoos did not display such a correlation. Thus, it appears that links between self-esteem, ideal body, ideal self and constructs of "woman with tattoos" may play a role in tattooing behavior in young women.	[Kertzman, Semion; Hegedish, Omer] Beer Yaakov Ness Ziona Mental Hlth Ctr, Forens Psychiat Div, Ness Ziona, Israel; [Kertzman, Semion; Weizman, Abraham] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Kagan, Alex] Bar Ilan Univ, Program Hermeneut & Cultural Studies, Interdisciplinary Studies Unit, Ramat Gan, Israel; [Kagan, Alex] RSUH, LS Vygotsky Inst Psychol, Dept Neuropathopsychol, Moscow, Russia; [Kagan, Alex] Ashkelon Acad Coll, Dept Criminol, Ashqelon, Israel; [Hegedish, Omer] Univ Haifa, Dept Psychol, Haifa, Israel; [Lapidus, Rina] Bar Ilan Univ, Comparat Literature Dept, Ramat Gan, Israel; [Weizman, Abraham] Geha Mental Hlth Ctr, Res Unit, Petah Tiqwa, Israel; [Weizman, Abraham] Felsenstein Med Res Ctr, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University; Russian State University for the Humanities; University of Haifa; Bar Ilan University; Tel Aviv University; Tel Aviv University	Kertzman, S (corresponding author), Beer Yaakov Ness Ziona Mental Hlth Ctr, Forens Psychiat Div, Ness Ziona, Israel.; Kertzman, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	kertzman@animascan.com	Weizman, Abraham/AAK-6450-2020	Weizman, Abraham/0000-0002-9765-8938				ADAMS FM, 1973, J CROSS CULT PSYCHOL, V4, P135, DOI 10.1177/002202217300400201; Armstrong ML, 2008, ARCH DERMATOL, V144, P879, DOI 10.1001/archderm.144.7.879; Armstrong Myrna L, 2002, Dermatol Nurs, V14, P317; Atkinson M, 2004, CAN REV SOC ANTHROP, V41, P125, DOI 10.1111/j.1755-618X.2004.tb02173.x; Barker ET, 2010, J EARLY ADOLESCENCE, V30, P205, DOI 10.1177/0272431609332936; Bjorklund L., 2008, RES TECHNOLOGY ED ME, P46; Black P.E., 2006, MANHATTAN DISTANCE D; Brown J. D., 2006, SELF ESTEEM ISSUES A, P4; Caputi P, 2011, PERSONAL CONSTRUCT M, P159, DOI DOI 10.1002/9781119953616.CH8; Carroll L, 2002, ADOLESCENCE, V37, P627; Cegolon L, 2010, FAM MED, V42, P273; Cipolletta Sabrina., 2010, PERSONAL CONSTRUCT T, V7, P85; Claes L, 2005, EUR EAT DISORD REV, V13, P11, DOI 10.1002/erv.612; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Curtis AM, 2008, COMMUN ASSOC INF SYS, V23, P37; D'Ambrosio A, 2013, ACT NERV SUPER REDIV, V55, P143; Davison TE, 2006, J SOC PSYCHOL, V146, P15, DOI 10.3200/SOCP.146.1.15-30; Delazar ME, 2005, DISS ABSTR INT B, V65, P5395; Delfabbro PH, 2011, J GENET PSYCHOL, V172, P67, DOI 10.1080/00221325.2010.517812; Deschesnes M, 2006, J ADOLESCENCE, V29, P379, DOI 10.1016/j.adolescence.2005.06.001; Dhossche D, 2000, J AFFECT DISORDERS, V59, P165, DOI 10.1016/S0165-0327(99)00136-6; Drews DR, 2000, PSYCHOL REP, V86, P475, DOI 10.2466/PR0.86.2.475-481; Etkind AM, 1985, THESIS; FARROW JA, 1991, AM J DIS CHILD, V145, P184, DOI 10.1001/archpedi.1991.02160020076021; Favazza ArmandoR., 1996, BODIES SIEGE SELF MU; Forbes GB, 2001, PSYCHOL REP, V89, P774, DOI 10.2466/pr0.2001.89.3.774; Fransella F, 2004, MANUAL REPERTORY GRI; Frederick CM., 2000, N AM J PSYCHOL, V2, P380; Fuller-Tyszkiewicz M, 2015, J ADOLESCENCE, V45, P11, DOI 10.1016/j.adolescence.2015.08.009; Grosz Elizabeth, 1994, VOLATILE BODIES CORP; GRUMET GW, 1983, AM J ORTHOPSYCHIAT, V53, P482, DOI 10.1111/j.1939-0025.1983.tb03392.x; Harter S., 1999, CONSTRUCTION SELF; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hemphill M, 1996, J GENET PSYCHOL, V157, P275, DOI 10.1080/00221325.1996.9914865; HICKS C, 1989, BRIT J SOC WORK, V19, P203, DOI 10.1093/bjsw/19.3.203; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Iannaccone M, 2013, EAT DISORD, V21, P130, DOI 10.1080/10640266.2013.761087; Karacaoglan U, 2012, INT J PSYCHOANAL, V93, P5, DOI 10.1111/j.1745-8315.2011.00497.x; Kelly G., 1955, PSYCHOL PERSONAL CON; Kertzman S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-278; Klonsky ED, 2003, AM J PSYCHIAT, V160, P1501, DOI 10.1176/appi.ajp.160.8.1501; Kuniansky NK, 1997, THESIS; Linton H, 1991, COLOR CONSULTING SUR; LITT IF, 1994, J ADOLESCENT HEALTH, V15, P198, DOI 10.1016/1054-139X(94)90503-7; Mahnke F., 1996, COLOR ENV HUMAN RESP; Manning M. A., 2006, CHILDRENS NEEDS, P341; Mellor D, 2010, SEX ROLES, V63, P386, DOI 10.1007/s11199-010-9812-4; Murray KM, 2011, J ADOLESCENCE, V34, P269, DOI 10.1016/j.adolescence.2010.05.004; Nathanson C, 2006, J RES PERS, V40, P779, DOI 10.1016/j.jrp.2005.09.002; Pajor AJ, 2015, PSYCHIATR POL, V49, P559, DOI 10.12740/PP/27266; Paxton SJ, 2006, J CLIN CHILD ADOLESC, V35, P539, DOI 10.1207/s15374424jccp3504_5; RASPA RF, 1990, AM FAM PHYSICIAN, V41, P1481; Stirn A, 2007, Ther Umsch, V64, P115, DOI 10.1024/0040-5930.64.2.115; Swami V., 2012, ENCY HUMAN APPEARANC, P58; Swami V, 2016, BODY IMAGE, V16, P41, DOI 10.1016/j.bodyim.2015.11.001; Swami V, 2012, PSYCHOL REP, V111, P97, DOI 10.2466/09.07.21.PR0.111.4.97-106; Swami V, 2011, BODY IMAGE, V8, P237, DOI 10.1016/j.bodyim.2011.04.005; Thompson J. K., 1999, EXACTING BEAUTY THEO, DOI [10.1037/10312-000, DOI 10.1037/10312-000]; Tiggemann Marika, 2006, Body Image, V3, P309, DOI 10.1016/j.bodyim.2006.09.002; Tiggemann M, 2011, BODY IMAGE, V8, P245, DOI 10.1016/j.bodyim.2011.03.007; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Varma S, 1996, ARCH DERMATOL, V132, P1516, DOI 10.1001/archderm.1996.03890360110023; Wangqvist M, 2013, J ADOLESCENCE, V36, P485, DOI 10.1016/j.adolescence.2013.02.002; Weber C, 2001, BRIT J MED PSYCHOL, V74, P507, DOI 10.1348/000711201161154; Wolf W, 1943, EXPRESSION PERSONALI; Wylie RC, 1961, THE SELF CONCEPT; Yousuf M, 2015, INT J COMPUTER APPL, V116, P5; Zeigler-Hill V, 2011, J CONTEMP PSYCHOTHER, V41, P157, DOI 10.1007/s10879-010-9167-8	68	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0206411	10.1371/journal.pone.0206411	http://dx.doi.org/10.1371/journal.pone.0206411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682018	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500008
J	Lin, LT; Chen, JT; Tai, MC; Chen, YH; Chen, CL; Pao, SI; Hsu, CR; Liang, CM				Lin, Le-Tien; Chen, Jiann-Torng; Tai, Ming-Cheng; Chen, Yi-Hao; Chen, Ching-Long; Pao, Shu-I; Hsu, Cherng Ru; Liang, Chang-Min			Protective effects of hypercapnic acidosis on Ischemia-reperfusion-induced retinal injury	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROGRAMMED CELL-DEATH; HEAT-SHOCK PROTEINS; OXIDATIVE-STRESS; CARBON-DIOXIDE; SIGNALING PATHWAYS; KAPPA-B; APOPTOSIS; GLUCOSAMINE; INFLAMMATION	Ischemia-reperfusion (I/R) injury is associated with numerous retinal diseases, such as diabetic retinopathy, acute glaucoma, and other vascular retinopathies. Hypercapnic acidosis (HCA) has a protective effect on lung, myocardial, and central nervous system ischemic injury models. However, no study has evaluated its protective effects in an experimental retinal I/R injury model. In this study, retinal I/R injury was induced in Sprague Dawley rats by elevating the intraocular pressure to 110 mmHg for 60 minutes. HCA was induced before and after the injury. After 24 hours, the terminal dUTP nick end labeling assay was performed. Moreover, the ratios of cleaved caspase-3/total caspase-3, phosphorylated I kappa B/I kappa B, and phosphorylated p38 were measured through Western blotting. After 7 days, the rats' aqueous humor was analyzed. In addition, electroretinography and retinal thickness measurement were performed in the rats. Moreover, the retinal neural cell line RGC-5 was exposed to 500 mu M H2O2 for 24 hours to induce a sustained oxidative stress in vitro. The effects of HCA were evaluated by comparing oxidative stress, MAPK signals, NF-kappa B signals, survival rates, and apoptosis rates in the RGC-5 cells before and after H2O2 exposure. We further investigated whether the potent I/R-protective heat shock protein (HSP) 32 contribute to protective effects of HCA. Our results indicated that HCA has protective effects against retinal I/R injury both in vivo and in vitro, at multiple levels, including antiapoptotic, anti-inflammatory, antioxidative, and functional retinal cell protection. Further research clarifying the role of HCA in retinal I/R injury prevention and treatment is warranted.	[Lin, Le-Tien] Natl Def Med Ctr, Triserv Gen Hosp, Songshan Branch, Dept Ophthalmol, Taipei, Taiwan; [Lin, Le-Tien; Chen, Jiann-Torng; Chen, Yi-Hao; Chen, Ching-Long; Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Jiann-Torng; Tai, Ming-Cheng; Chen, Yi-Hao; Chen, Ching-Long; Pao, Shu-I; Hsu, Cherng Ru; Liang, Chang-Min] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Liang, Chang-Min] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Chen, JT; Chen, YH; Liang, CM (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, JT; Chen, YH; Liang, CM (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liang, CM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	jt66chen@gmail.com; doc30879@ndmctsgh.edu.tw; doc30875@mail.ndmctsgh.edu.tw		Hsu, Cherng-Ru/0000-0002-4390-0389	Ministry of Science and Technology, Taiwan [105-2314-B-016-042]; National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan [TSGHSB10711]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan	This study was funded by the Ministry of Science and Technology, Taiwan to CML (grant no. 105-2314-B-016-042) and National Defense Medical Center, Tri-Service General Hospital Songshan Branch, Taiwan to LTL and SIP (grant no. TSGHSB10711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; ANDERSON DR, 1975, ARCH OPHTHALMOL-CHIC, V93, P267; Chang YH, 2008, INVEST OPHTH VIS SCI, V49, P5441, DOI 10.1167/iovs.08-1784; Chen L, 2015, OPHTHALMIC RES, V54, P157, DOI 10.1159/000439026; Chen YJ, 2015, INVEST OPHTH VIS SCI, V56, P1506, DOI 10.1167/iovs.14-15726; Chonghaile MN, 2008, ANESTHESIOLOGY, V109, P837, DOI 10.1097/ALN.0b013e3181895fb7; Duan HJ, 2016, J SURG RES, V203, P6, DOI 10.1016/j.jss.2016.01.035; Fujita R, 2009, CELL DEATH DIFFER, V16, P349, DOI 10.1038/cdd.2008.159; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hackbarth H, 2000, LAB ANIM-UK, V34, P91, DOI 10.1258/002367700780578055; HANGAI M, 1995, INVEST OPHTH VIS SCI, V36, P571; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; Huang CK, 2013, MOL VIS, V19, P1422; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; KENNEDY TP, 1989, J CLIN INVEST, V83, P1326, DOI 10.1172/JCI114019; Kerr NM, 2012, EXP NEUROL, V234, P144, DOI 10.1016/j.expneurol.2011.12.027; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Laffey JG, 1999, LANCET, V354, P1283, DOI 10.1016/S0140-6736(99)02388-0; Li AM, 2010, CHINESE MED J-PEKING, V123, P2254, DOI 10.3760/cma.j.issn.0366-6999.2010.16.018; Li L, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/4985323; MAINES MD, 1986, J BIOL CHEM, V261, P411; Masterson C, 2016, CRIT CARE MED, V44, pe207, DOI 10.1097/CCM.0000000000001376; McLarty JL, 2013, LIFE SCI, V92, P621, DOI 10.1016/j.lfs.2012.08.006; Meldrum DR, 1998, SURGERY, V124, P291, DOI 10.1067/msy.1998.90570; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; Moynagh PN, 2003, J ENDOCRINOL, V179, P139, DOI 10.1677/joe.0.1790139; Napankangas JP, 2012, J MOL CELL CARDIOL, V53, P906, DOI 10.1016/j.yjmcc.2012.09.011; Nardelli LM, 2015, RESP PHYSIOL NEUROBI, V205, P1, DOI 10.1016/j.resp.2014.09.007; NOMURA F, 1994, CIRCULATION, V90, P321; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pan HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096190; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; RABACCHI SA, 1994, J NEUROSCI, V14, P5292; Sirieix D, 1997, AM J RESP CRIT CARE, V155, P957, DOI 10.1164/ajrccm.155.3.9117032; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Sucher R, 2009, TRANSPL INT, V22, P922, DOI 10.1111/j.1432-2277.2009.00883.x; SZABO ME, 1991, OPHTHALMIC RES, V23, P225, DOI 10.1159/000267107; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tong NT, 2012, J OCUL PHARMACOL TH, V28, P459, DOI 10.1089/jop.2011.0218; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; VANNUCCI RC, 1995, PEDIATRICS, V95, P868; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069530	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211185	10.1371/journal.pone.0211185	http://dx.doi.org/10.1371/journal.pone.0211185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682118	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500118
J	Borges, DGL; Echeverria, JT; de Oliveira, TL; Heckler, RP; de Freitas, MG; Damasceno, GA; Carollo, CA; Borges, FD				Lino Borges, Dyego Goncalves; Echeverria, Jessica Teles; de Oliveira, Tamires Lima; Heckler, Rafael Pereira; de Freitas, Mariana Green; Damasceno-Junior, Geraldo Alves; Carollo, Carlos Alexandre; Borges, Fernando de Almeida			Discovery of potential ovicidal natural products using metabolomics	PLOS ONE			English	Article							IN-VITRO ACTIVITY; HAEMONCHUS-CONTORTUS; GASTROINTESTINAL NEMATODES; ANTHELMINTIC RESISTANCE; LARVICIDAL ACTIVITY; BEEF-CATTLE; IMPACT; HELMINTHS; EXTRACTS; SHEEP	Plant extracts are a potential source of new compounds for nematode control and may be an excellent alternative for the control gastrointestinal nematodes that are resistant to conventional anthelmintics. However, research involving natural products is a complex process. The main challenge is the identification of bioactive compounds. Online analytical techniques with universal detectors, such as high-performance liquid chromatographymass spectrometry (HPLC-MS), together with metabolomics could enable the fast, accurate evaluation of a massive amount of data, constituting a viable option for the identification of active compounds in plant extracts. This study focused on the evaluation of the ovicidal activity of ethanol extracts from 17 plants collected from the Pantanal wetland in the state of Mato Grosso do Sul, Brazil, against eggs of Haemonchus placei using the egg hatchability test. The ethanol extracts were obtained using accelerated solvent extraction. The data on ovicidal activity, mass spectrometry and metabolomics were evaluated using HPLC-DAD-MS, partial least squares regression analysis (PLS-DA) and a correlation map (univariate correlation analyses) to detect compounds that have a positive correlation with biological activity. Among the ten metabolites with the best correlation coefficients, six were phenylpropanoids, two were triterpene saponins, one was a brevipolide, and one was a flavonoid. Combinations of metabolites with high ovicidal action were also identified, such as phenylpropanoids combined with the triterpene saponins and the flavonoid, flavonoids combined with iridoid and phenylpropanoids, and saponins combined with phenylpropanoid. The positive correlation between classes of compounds in plants belonging to different genera and biological activity (as previously identified in the literature) reinforces the robustness of the statistical data and demonstrates the efficacy of this method for the selection of bioactive compounds without the need for isolation and reevaluation. The proposed method also enables the determination of synergism among the classes, which would be impracticable using traditional methods. The present investigation demonstrates that the metabolomic technique was efficient at detecting secondary metabolites with ovicidal activity against H. placei. Thus, the use of metabolomics can be a tool to accelerate and simplify bioprospecting research with plant extracts in veterinary parasitology.	[Lino Borges, Dyego Goncalves; Echeverria, Jessica Teles; de Oliveira, Tamires Lima; Heckler, Rafael Pereira; de Freitas, Mariana Green; Borges, Fernando de Almeida] Univ Fed Mato Grosso do Sul, Sch Vet Med & Anim Sci, Campo Grande, MS, Brazil; [Damasceno-Junior, Geraldo Alves] Univ Fed Mato Grosso do Sul, Inst Biosci, Campo Grande, MS, Brazil; [Carollo, Carlos Alexandre] Univ Fed Mato Grosso do Sul, Sch Pharmaceut Sci Food & Nutr, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Borges, DGL (corresponding author), Univ Fed Mato Grosso do Sul, Sch Vet Med & Anim Sci, Campo Grande, MS, Brazil.	dyegogborges@hotmail.com	Damasceno Junior, Geraldo/ABG-2834-2021; Borges, Fernando/T-6717-2019	Borges, Fernando/0000-0002-8888-6269; Echeverria, Jessica/0000-0002-7500-1230	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors declare that we have received financial support from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES), in the form of a master's degree post-graduate scholarship; of the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), that made available of funds to purchase equipment used in the metabolomics studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentieri MP, 2008, EUR J PLANT PATHOL, V120, P189, DOI 10.1007/s10658-007-9207-8; Ayouni K, 2016, IND CROP PROD, V88, P65, DOI 10.1016/j.indcrop.2016.01.001; Bizimenyera ES, 2006, VET PARASITOL, V142, P336, DOI 10.1016/j.vetpar.2006.06.013; Borges FA, 2013, TROP ANIM HEALTH PRO, V45, P723, DOI 10.1007/s11250-012-0280-4; Botura MB, 2013, VET PARASITOL, V192, P211, DOI 10.1016/j.vetpar.2012.10.012; Castillo-Mitre GF, 2017, J ETHNOPHARMACOL, V204, P125, DOI 10.1016/j.jep.2017.04.010; Chassagne F, 2018, FITOTERAPIA, V127, P226, DOI 10.1016/j.fitote.2018.02.021; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; D'Addabbo T, 2011, PHYTOCHEM REV, V10, P503, DOI 10.1007/s11101-010-9180-2; Dembogurski DSD, 2018, FOOD RES INT, V111, P661, DOI 10.1016/j.foodres.2018.05.033; Dimander SO, 2000, VET PARASITOL, V90, P271, DOI 10.1016/S0304-4017(00)00256-9; Durmic Z, 2012, ANIM FEED SCI TECH, V176, P150, DOI 10.1016/j.anifeedsci.2012.07.018; Engstrom MT, 2016, J AGR FOOD CHEM, V64, P840, DOI 10.1021/acs.jafc.5b05691; Feboli A, 2016, VET PARASITOL, V226, P65, DOI 10.1016/j.vetpar.2016.06.030; Feliz DC, 2011, THESIS, P41; Gaudencio SP, 2015, NAT PROD REP, V32, P779, DOI 10.1039/c4np00134f; GENNARI SM, 1991, VET PARASITOL, V38, P163, DOI 10.1016/0304-4017(91)90126-G; Gustine DL, 2010, STRATEGY DETECTING N; Hoste H, 2011, VET PARASITOL, V180, P144, DOI 10.1016/j.vetpar.2011.05.035; Diaz GJ, 2017, MICROB PATHOGENESIS, V109, P162, DOI 10.1016/j.micpath.2017.05.048; Kaplan RM, 2012, VET PARASITOL, V186, P70, DOI 10.1016/j.vetpar.2011.11.048; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Lino Borges Dyego Goncalves, 2016, Nematoda, V3, pe92016, DOI 10.4322/nematoda.00916; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Mengistu G, 2017, VET PARASITOL, V237, P110, DOI 10.1016/j.vetpar.2016.12.020; Molento MB, 2011, VET PARASITOL, V180, P126, DOI 10.1016/j.vetpar.2011.05.033; Mondal H, 2015, PAK VET J, V35, P58; Morais-Costa F, 2015, TROP ANIM HEALTH PRO, V47, P1321, DOI 10.1007/s11250-015-0866-8; Ramos F, 2016, INT J PARASITOL-DRUG, V6, P93, DOI 10.1016/j.ijpddr.2016.02.002; Ribeiro WLC, 2017, SMALL RUMINANT RES, V153, P146, DOI 10.1016/j.smallrumres.2017.06.001; Sandoval-Castro CA, 2012, ANIM FEED SCI TECH, V176, P192, DOI 10.1016/j.anifeedsci.2012.07.023; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; Titman CM, 2009, MOL BIOSYST, V5, P1913, DOI 10.1039/b907754e; Van Wyk IC, 2014, PARASITOLOGY, V141, P374, DOI 10.1017/S0031182013001625; WHITLOCK H. V., 1950, JOUR HELMINTHOL, V24, P47, DOI 10.1017/S0022149X00019106; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Lopes WDZ, 2014, RES VET SCI, V96, P133, DOI 10.1016/j.rvsc.2013.11.001	38	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211237	10.1371/journal.pone.0211237	http://dx.doi.org/10.1371/journal.pone.0211237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682122	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500132
J	Mamman, M; Hanapi, ZM; Abdullah, A; Muhammed, A				Mamman, Maharazu; Hanapi, Zurina Mohd; Abdullah, Azizol; Muhammed, Abdullah			Quality of Service Class Identifier (QCI) radio resource allocation algorithm for LTE downlink	PLOS ONE			English	Article							PERFORMANCE; NETWORKS; SCHEDULER	The increasing demand for network applications, such as teleconferencing, multimedia messaging and mobile TV, which have diverse requirements, has resulted in the introduction of Long Term Evolution (LTE) by the Third Generation Partnership Project (3GPP). LTE networks implement resource allocation algorithms to distribute radio resource to satisfy the bandwidth and delay requirements of users. However, the scheduling algorithm problem of distributing radio resources to users is not well defined in the LTE standard and thus considerably affects transmission order. Furthermore, the existing radio resource algorithm suffers from performance degradation under prioritised conditions because of the minimum data rate used to determine the transmission order. In this work, a novel downlink resource allocation algorithm that uses quality of service (QoS) requirements and channel conditions to address performance degradation is proposed. The new algorithm is formulated as an optimisation problem where network resources are allocated according to users' priority, whereas the scheduling algorithm decides on the basis of users' channel status to satisfy the demands of QoS. Simulation is used to evaluate the performance of the proposed algorithm, and results demonstrate that it performs better than do all other algorithms according to the measured metrics.	[Mamman, Maharazu; Hanapi, Zurina Mohd; Abdullah, Azizol; Muhammed, Abdullah] Univ Putra Malaysia, Dept Commun Technol & Networking, Fac Comp Sci & Informat Technol, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Mamman, M; Hanapi, ZM (corresponding author), Univ Putra Malaysia, Dept Commun Technol & Networking, Fac Comp Sci & Informat Technol, Upm Serdang, Selangor, Malaysia.	maharazu2003@yahoo.com; zurinamh@upm.edu.my		Mohd Hanapi, Zurina/0000-0002-8079-1791; Abdullah, Azizol/0000-0001-8321-9259	Universiti Putra Malaysia [UPM-FRGS-08-02-13-1364FR]	Universiti Putra Malaysia	This work was supported by research grant UPM-FRGS-08-02-13-1364FR from the Universiti Putra Malaysia to ZMH.; This work was supported by research grant UPM-FRGS-08-02-13-1364FR.	Ameigeiras P, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0565-9; Andrews JG, 2014, IEEE J SEL AREA COMM, V32, P1065, DOI 10.1109/JSAC.2014.2328098; Biernacki A, 2014, WIRELESS PERS COMMUN, V74, P585, DOI 10.1007/s11277-013-1308-4; Both C. C., 2016, P 8 IEEE LAT AM C CO, P1; Capozzi F, 2013, IEEE COMMUN SURV TUT, V15, P678, DOI 10.1109/SURV.2012.060912.00100; Chadchan S. M., 2013, International Journal of Computer Network and Information Security, V5, P34, DOI 10.5815/ijcnis.2013.06.05; Erpek T, 2015, 2015 INTERNATIONAL CONFERENCE ON COMPUTING, NETWORKING AND COMMUNICATIONS (ICNC), P275, DOI 10.1109/ICCNC.2015.7069354; Ferdosian N., 2014, P 1 INT C ADV DAT IN, V285, P597, DOI [DOI 10.1007/978-981-4585-18-7_67, 10.1007/978-981-4585-18-7_67.]; Fu W., 2013, APPL MECH MAT, P2468; Gayathri S, 2016, INDIAN J SCI TECHNOL, V9, DOI 10.17485/ijst/2016/v9i10/88887; Gui X, 1999, IEEE T COMMUN, V47, P1084, DOI 10.1109/26.774858; Hindia MN, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/604752; Ikuno J. C., 2010, VEH TECHN C VTC 2010, P1, DOI DOI 10.1109/VETECS.2010.5494007; Iturralde M, 2013, WIRELESS PERS COMMUN, V72, P1415, DOI 10.1007/s11277-013-1086-z; Jain R., 1984, QUANTITATIVE MEASURE, V38; Kwan R, 2009, IEEE SIGNAL PROC LET, V16, P461, DOI 10.1109/LSP.2009.2016449; Lai WK, 2013, COMPUT NETW, V57, P1689, DOI 10.1016/j.comnet.2013.02.017; Li YP, 2016, 2016 IEEE INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC), P706, DOI 10.1109/ITNEC.2016.7560452; Masoudi M, 2018, WIREL NETW, V24, P1841, DOI 10.1007/s11276-016-1442-5; Mushtaq MS, 2015, J NETW COMPUT APPL, V51, P29, DOI 10.1016/j.jnca.2014.02.001; Rebekka B, 2015, WIRELESS PERS COMMUN, V83, P1643, DOI 10.1007/s11277-015-2468-1; Sadiq B, 2009, EURASIP J WIREL COMM, V2009, P510; Sulthana SF, 2015, WIRELESS PERS COMMUN, V83, P841, DOI 10.1007/s11277-015-2429-8; Trifan RF, 2015, 2015 IEEE 81 VEH TEC, P1; TS, 2010, TS23401V8120 3GPP GP; Wang CP, 2014, IET COMMUN, V8, P3105, DOI 10.1049/iet-com.2014.0167; Wang YC, 2016, COMPUT NETW, V94, P344, DOI 10.1016/j.comnet.2015.11.002; Xu L, 2014, WIRELESS PERS COMMUN, V79, P1591, DOI 10.1007/s11277-014-2028-0; Yang HT, 2010, COMPUT SCI TECH APPL, P1	29	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210310	10.1371/journal.pone.0210310	http://dx.doi.org/10.1371/journal.pone.0210310			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682038	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500032
J	McCurdy, SR; Ntranos, V; Pachter, L				McCurdy, Shannon R.; Ntranos, Vasilis; Pachter, Lior			Deterministic column subset selection for single-cell RNA-Seq	PLOS ONE			English	Article							VISUALIZATION	Analysis of single-cell RNA sequencing (scRNA-Seq) data often involves filtering out uninteresting or poorly measured genes and dimensionality reduction to reduce noise and simplify data visualization. However, techniques such as principal components analysis (PCA) fail to preserve non-negativity and sparsity structures present in the original matrices, and the coordinates of projected cells are not easily interpretable. Commonly used thresholding methods to filter genes avoid those pitfalls, but ignore collinearity and covariance in the original matrix. We show that a deterministic column subset selection (DCSS) method possesses many of the favorable properties of common thresholding methods and PCA, while avoiding pitfalls from both. We derive new spectral bounds for DCSS. We apply DCSS to two measures of gene expression from two scRNA-Seq experiments with different clustering workflows, and compare to three thresholding methods. In each case study, the clusters based on the small subset of the complete gene expression profile selected by DCSS are similar to clusters produced from the full set. The resulting clusters are informative for cell type.	[McCurdy, Shannon R.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Ntranos, Vasilis] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Pachter, Lior] CALTECH, Dept Comp & Math Sci, Div Biol & Biol Engn, Pasadena, CA 91125 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; California Institute of Technology	McCurdy, SR (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	smccurdy@berkeley.edu		Pachter, Lior/0000-0002-9164-6231; McCurdy, Shannon/0000-0002-2813-6781	National Human Genome Research Institute [F32HG008713]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG008713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH114830] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SRM is funded by Award Number F32HG008713 from the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews T. S., 2018, BIORXIV; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Calculate and Draw Custom Venn Diagrams, CALC DRAW CUST VENN; Chatterjee S., 1986, STAT SCI, V1, P379, DOI [10.1214/ss/1177013622, DOI 10.1214/SS/1177013622]; Drineas P, 2008, SIAM J MATRIX ANAL A, V30, P844, DOI 10.1137/07070471X; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kwon H, 2017, BIORXIV; Lin PJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1188-0; Lun Aaron T L, 2016, F1000Res, V5, P2122; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Nicolae M, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-9; Ntranos V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0970-8; Papailiopoulos D., 2014, P 20 ACM SIGKDD INT, P997, DOI DOI 10.1016/J.CELL.2015.11.013; Pierson E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0805-z; Rao C.R, 1973, WILEY SERIES PROBABI, DOI [10.1002/9780470316436, DOI 10.1002/9780470316436]; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Tropp JA, 2009, PROCEEDINGS OF THE TWENTIETH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P978; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; VELLEMAN PF, 1981, AM STAT, V35, P234, DOI 10.2307/2683296; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210571	10.1371/journal.pone.0210571	http://dx.doi.org/10.1371/journal.pone.0210571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682053	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500047
J	Ogundijo, OE; Zhu, KY; Wang, XD; Anastassiou, D				Ogundijo, Oyetunji E.; Zhu, Kaiyi; Wang, Xiaodong; Anastassiou, Dimitris			A sequential Monte Carlo algorithm for inference of subclonal structure in cancer	PLOS ONE			English	Article							SOMATIC MUTATIONS; EVOLUTION; MODEL; HETEROGENEITY; LANDSCAPE; PATTERNS; PATHWAY; PIK3CA	Tumors are heterogeneous in the sense that they consist of multiple subpopulations of cells, referred to as subclones, each of which is characterized by a distinct profile of genomic variations such as somatic mutations. Inferring the underlying clonal landscape has become an important topic in that it can help in understanding cancer development and progression, and thereby help in improving treatment. We describe a novel state-space model, based on the feature allocation framework and an efficient sequential Monte Carlo (SMC) algorithm, using the somatic mutation data obtained from tumor samples to estimate the number of subclones, as well as their characterization. Our approach, by design, is capable of handling any number of mutations. Via extensive simulations, our method exhibits high accuracy, in most cases, and compares favorably with existing methods. Moreover, we demonstrated the validity of our method through analyzing real tumor samples from patients from multiple cancer types (breast, prostate, and lung). Our results reveal driver mutation events specific to cancer types, and indicate clonal expansion by manual phylogenetic analysis. MATLAB code and datasets are available to download at: https://github.com/moyanre/tumor_clones.	[Ogundijo, Oyetunji E.; Zhu, Kaiyi; Wang, Xiaodong; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Zhu, Kaiyi; Anastassiou, Dimitris] Columbia Univ, Dept Syst Biol, New York, NY USA	Columbia University; Columbia University	Wang, XD (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.	xw2008@columbia.edu	Zhu, Kaiyi/CAF-9654-2022					Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Doucet A, 2000, STAT COMPUT, V10, P197, DOI 10.1023/A:1008935410038; Doucet A., 2001, SEQUENTIAL MONTE CAR; Fischer A, 2014, CELL REP, V7, P1740, DOI 10.1016/j.celrep.2014.04.055; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hughes AEO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004462; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Lee J, 2016, STAT ANAL HIGH DIMEN, P211; Lee T, 2016, J PATHOL TRANSL MED, V50, P197, DOI 10.4132/jptm.2016.03.09; Li P, 2004, IEE P-CONTR THEOR AP, V151, P727, DOI 10.1049/ip-cta:20041008; Li P, 2003, EUR CONTR C ECC 2003, P2384; Marass F, 2016, ANN APPL STAT, V10, P2377, DOI 10.1214/16-AOAS986; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Miron A, 2010, CANCER RES, V70, P5674, DOI 10.1158/0008-5472.CAN-08-2660; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ogundijo OE, 2018, PEERJ, V6, DOI 10.7717/peerj.4838; Ogundijo OE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186167; Ogundijo OE, 2017, EURASIP J BIOINFORM, DOI 10.1186/s13637-016-0055-8; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Rudolph M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2626-1; Sarkka S, 2013, BAYESIAN FILTERING S; Sengupta S, 2015, BIOCOMPUT-PAC SYM, P467; Tserga A, 2016, VIRCHOWS ARCH, V469, P35, DOI 10.1007/s00428-016-1938-5; Unni AM, 2015, ELIFE, V4, DOI 10.7554/eLife.06907; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Wood F., 2007, P 19 INT C NEUR INF, P1513; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886; Yuan K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0592-6; Zare H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003703	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211213	10.1371/journal.pone.0211213	http://dx.doi.org/10.1371/journal.pone.0211213			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682127	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500126
J	Matiz, A; Crescentini, C; Fabbro, A; Budai, R; Bergamasco, M; Fabbro, F				Matiz, Alessio; Crescentini, Cristiano; Fabbro, Anastasia; Budai, Riccardo; Bergamasco, Massimo; Fabbro, Franco			Spontaneous eye movements during focused-attention mindfulness meditation	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; INDEPENDENT COMPONENT ANALYSIS; WORKING-MEMORY; VISUAL-IMAGERY; WANDERING MIND; EXPERIENCE; THOUGHT; NETWORK; EEG; FLUCTUATIONS	Oculometric measures have been proven to be useful markers of mind-wandering during visual tasks such as reading. However, little is known about ocular activity during mindfulness meditation, a mental practice naturally involving mind-wandering episodes. In order to explore this issue, we extracted closed-eyes ocular movement measurements via a covert technique (EEG recordings) from expert meditators during two repetitions of a 7-minute mindfulness meditation session, focusing on the breath, and two repetitions of a 7-minute instructed mind-wandering task. Power spectral density was estimated on both the vertical and horizontal components of eye movements. The results show a significantly smaller average amplitude of eye movements in the delta band (1-4 Hz) during mindfulness meditation than instructed mind-wandering. Moreover, participants' meditation expertise correlated significantly with this average amplitude during both tasks, with more experienced meditators generally moving their eyes less than less experienced meditators. These findings suggest the potential use of this measure to detect mind-wandering episodes during mindfulness meditation and to assess meditation performance.	[Matiz, Alessio; Bergamasco, Massimo; Fabbro, Franco] Scuola Super Sant Anna, PERCRO Lab, Pisa, Italy; [Crescentini, Cristiano] Univ Udine, Commun Educ & Soc, Dept Languages & Literatures, Udine, Italy; [Fabbro, Anastasia] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Fabbro, Anastasia; Fabbro, Franco] Univ Udine, Dept Med, Udine, Italy; [Budai, Riccardo] Univ Hosp S Maria Misericordia, Dept Neurosci, Udine, Italy	Scuola Superiore Sant'Anna; University of Udine; Sapienza University Rome; University of Udine; Hospital Santa Maria della Misericordia	Matiz, A (corresponding author), Scuola Super Sant Anna, PERCRO Lab, Pisa, Italy.	matiz.alessio@spes.uniud.it		CRESCENTINI, CRISTIANO/0000-0002-3154-3687; Matiz, Alessio/0000-0001-6785-3102	Scuola Superiore "Sant'Anna"	Scuola Superiore "Sant'Anna"	This work was supported by Scuola Superiore "Sant'Anna" (https://www.santannapisa.it/) Phd program to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTROBUS JS, 1964, J ABNORM SOC PSYCH, V69, P244, DOI 10.1037/h0041846; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Baird B, 2012, PSYCHOL SCI, V23, P1117, DOI 10.1177/0956797612446024; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhikkhu B, 1980, ANAPANASATI MINDFULN; Bixler R, 2016, USER MODEL USER-ADAP, V26, P33, DOI 10.1007/s11257-015-9167-1; Bloom HS, 2005, EVALUATION REV, V19, P547; Bonnet C, 2013, CLIN NEUROPHYSIOL, V124, P2216, DOI 10.1016/j.clinph.2013.05.002; Bortolussi M., 2015, INVESTIGATIONS PHENO, V81, P31, DOI [10.1007/978-3-319-14090-2_3, DOI 10.1007/978-3-319-14090-2_3]; Braboszcz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170647; Brandmeyer T, 2018, EXP BRAIN RES, V236, P2519, DOI 10.1007/s00221-016-4811-5; BRANDT SA, 1989, P IEEE EMBS, V11, P278, DOI 10.1109/IEMBS.1989.95721; Brandt SA, 1997, J COGNITIVE NEUROSCI, V9, P27, DOI 10.1162/jocn.1997.9.1.27; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cahn BR, 2013, SOC COGN AFFECT NEUR, V8, P100, DOI 10.1093/scan/nss060; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cahn BR, 2009, INT J PSYCHOPHYSIOL, V72, P51, DOI 10.1016/j.ijpsycho.2008.03.013; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Campanella F, 2014, COMPR PSYCHIAT, V55, P1269, DOI 10.1016/j.comppsych.2014.03.009; Chaumon M, 2015, J NEUROSCI METH, V250, P47, DOI 10.1016/j.jneumeth.2015.02.025; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Crescentini Cristiano, 2018, Int J MS Care, V20, P101, DOI 10.7224/1537-2073.2016-093; Crescentini C, 2016, COMPUT HUM BEHAV, V59, P304, DOI 10.1016/j.chb.2016.02.031; Crescentini C, 2015, J ADDICT DIS, V34, P75, DOI 10.1080/10550887.2014.991657; Crescentini C, 2014, CONSCIOUS COGN, V30, P266, DOI 10.1016/j.concog.2014.09.013; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; DEMENT W, 1957, J EXP PSYCHOL, V53, P339, DOI 10.1037/h0048189; Deng YQ, 2014, MINDFULNESS, V5, P124, DOI 10.1007/s12671-012-0157-7; DeRosario-Martinez H, 2015, PACKAGE PHIA VERSION; Dowiasch S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00046; Ehrlichman H, 2007, BRAIN COGNITION, V64, P7, DOI 10.1016/j.bandc.2006.10.001; Ehrlichman H, 2012, CURR DIR PSYCHOL SCI, V21, P96, DOI 10.1177/0963721412436810; Fabbro F, 2016, RICERCHE PSICOLOGIA, V4, P457, DOI DOI 10.3280/RIP2016-004001; Fabbro F, 2014, WORLD FUTURES, V70, P386; Faber M, 2018, BEHAV RES METHODS, V50, P134, DOI 10.3758/s13428-017-0857-y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Fourtassi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068560; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hartmann M, 2014, CONSCIOUS COGN, V30, P201, DOI 10.1016/j.concog.2014.09.007; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; HOLM S, 1979, SCAND J STAT, V6, P65; Johansson R, 2006, COGNITIVE SCI, V30, P1053, DOI 10.1207/s15516709cog0000_86; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kam JWY, 2011, J COGNITIVE NEUROSCI, V23, P460, DOI 10.1162/jocn.2010.21443; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kaur Chamandeep, 2015, Adv Prev Med, V2015, P614723, DOI 10.1155/2015/614723; Nguyen KV, 2014, SCI STUD READ, V18, P274, DOI 10.1080/10888438.2013.876424; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kruis A, 2016, PSYCHOPHYSIOLOGY, V53, P749, DOI 10.1111/psyp.12619; Kumari V, 2017, CONSCIOUS COGN, V48, P66, DOI 10.1016/j.concog.2016.10.008; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Laeng B, 2014, COGNITION, V131, P263, DOI 10.1016/j.cognition.2014.01.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lawrence MA, 2016, PACKAGE EZ VERSION 4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Levinson DB, 2012, PSYCHOL SCI, V23, P375, DOI 10.1177/0956797611431465; Makeig S, 1996, ADV NEUR IN, V8, P145; Malinowski P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00008; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McVay JC, 2012, J EXP PSYCHOL GEN, V141, P302, DOI 10.1037/a0025250; Micic D, 2010, BRAIN COGNITION, V74, P210, DOI 10.1016/j.bandc.2010.07.014; Mooneyham BW, 2013, CAN J EXP PSYCHOL, V67, P11, DOI 10.1037/a0031569; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramot M, 2011, NEUROIMAGE, V58, P213, DOI 10.1016/j.neuroimage.2011.06.015; Randall JG, 2014, PSYCHOL BULL, V140, P1411, DOI 10.1037/a0037428; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle ED, 2010, PSYCHOL SCI, V21, P1300, DOI 10.1177/0956797610378686; Renoult L, 2015, J COGNITIVE NEUROSCI, V27, P57, DOI 10.1162/jocn_a_00689; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schad DJ, 2012, COGNITION, V125, P179, DOI 10.1016/j.cognition.2012.07.004; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Schooler JW, 2004, THINKING AND SEEING, P203; Seli P, 2016, TRENDS COGN SCI, V20, P605, DOI 10.1016/j.tics.2016.05.010; Seli P, 2015, PSYCHOL RES-PSYCH FO, V79, P750, DOI 10.1007/s00426-014-0617-x; Short EB, 2010, EVID-BASED COMPL ALT, V7, P121, DOI 10.1093/ecam/nem163; Signorell A., 2020, DESCTOOLS TOOLS DESC; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smallwood JM, 2003, CONSCIOUS COGN, V12, P452, DOI 10.1016/S1053-8100(03)00018-7; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2007, COGNITION EMOTION, V21, P816, DOI 10.1080/02699930600911531; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smallwood J, 2009, CONSCIOUS COGN, V18, P118, DOI 10.1016/j.concog.2008.11.004; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Soltanlou M, 2017, COGN AFFECT BEHAV NE, V17, P724, DOI 10.3758/s13415-017-0508-x; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Stawarczyk D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00425; Stawarczyk D, 2011, ACTA PSYCHOL, V136, P370, DOI 10.1016/j.actpsy.2011.01.002; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2009, PHILOS T R SOC B, V364, P1317, DOI 10.1098/rstb.2008.0301; Tomasino B, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00346; Uzzaman S, 2011, CONSCIOUS COGN, V20, P1882, DOI 10.1016/j.concog.2011.09.010; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Winkler I, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035013; Winkler I, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-30	118	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210862	10.1371/journal.pone.0210862	http://dx.doi.org/10.1371/journal.pone.0210862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677056	gold, Green Published			2022-12-27	WOS:000456700400028
J	Ryanto, S; Wong, M; Czarniak, P; Parsons, R; Travers, K; Skinner, M; Sunderland, B				Ryanto, Silvia; Wong, Mandy; Czarniak, Petra; Parsons, Richard; Travers, Katherine; Skinner, Matthew; Sunderland, Bruce			The use of initial dosing of gentamicin in the management of pyelonephritis/urosepsis: A retrospective study	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; EPIDEMIOLOGY; SEPSIS; AMINOGLYCOSIDES; DEFINITIONS; PREVALENCE	Objective The primary objective was to determine if initial empirical intravenous dosing of gentamicin improved patient's outcomes in pyelonephritis/urosepsis compared with alternative IV antibiotic management. Design Retrospective cross-sectional descriptive study. Setting Public TertiaryTeaching Hospital serving adults in an urban centre. Participants All adult patient records with a recorded diagnosis of any of pyelonephritis/urosepsis, urinary tract infection, UTI, complicated urinary tract infection, bacteriuria, symptomatic bacteriuria and asymptomatic bacteriuria from 2nd February 2012 to 10th May 2014 were reviewed. Only patients treated with an empirical regimen of one or more IV antibiotics were included in the study. Main outcomes The primary outcomes were: duration of IV antibiotic treatment, time to resolution of symptoms and length of hospital stay (LOS). Secondary end points were: compliance with Therapeutic Guidelines: Antibiotic (electronic version) (eTG) for severe pyelonephritis/urosepsis and appropriateness of gentamicin use. Data analysis Univariate and multivariable associations between baseline and demographic variables and the main outcomes were performed using Chi-square tests and a General Linear Model using the SAS version 9.2 software. Results Of 295 patients reviewed 152 were prescribed one or more IV antibiotics and included in the study. Approximately half of the patients (n = 73, 48%) were prescribed IV piperacillin/tazobactam (Tazocin), while gentamicin was prescribed for 66 patients (43.4%). Of the 152 patients evaluated, 49 (32%) were given gentamicin first. Multivariable regression analysis showed that duration of IV treatment was shorter for those aged over 70 (40.2 hours vs 85.5 hours for those aged up to 70; p = 0.0074), and those who received gentamicin as first line treatment (41.3 hours vs 89.8 hours for those not receiving any gentamicin; p = 0.0312). After adjustment for age and gentamicin administration, there appeared to be no significant difference in duration of IV treatment for any other independent variables. No significant associations between the independent variables (gentamicin, age, gender, comorbidities, and eTG compliance) and either time to resolution of symptoms (median: 68 hours) or hospital LOS (median: 5 days) were observed. Conclusions Neither time to resolution of abnormal symptoms nor length of stay were significantly influenced by an initial dose of gentamicin when the data were subjected to multivariable analysis. The age of the patient and pattern of gentamicin treatment were the dominant factors associated with duration of IV antibiotics. Piperacillin/tazobactam is not recommended in treatment guidelines for pyelonephritis/urosepsis but was the most commonly prescribed IV antibiotic. This requires review by the appropriate hospital clinicians.	[Ryanto, Silvia; Wong, Mandy; Czarniak, Petra; Parsons, Richard; Sunderland, Bruce] Curtin Univ, Sch Pharm, Fac Hlth Sci, Perth, WA, Australia; [Travers, Katherine; Skinner, Matthew] Sir Charles Gairdner Hosp, Nedlands, WA, Australia	Curtin University; University of Western Australia	Sunderland, B (corresponding author), Curtin Univ, Sch Pharm, Fac Hlth Sci, Perth, WA, Australia.	B.Sunderland@curtin.edu						Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Antibiotic, ETG COMPL; Balk RA, 2000, CRIT CARE CLIN, V16, P179, DOI 10.1016/S0749-0704(05)70106-8; BARRIERE SL, 1988, CLIN PHARMACY, V7, P385; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Brunkhorst FM, 2006, ANASTH INTENSIV NOTF, V41, P43, DOI 10.1055/s-2005-921227; CUNHA BA, 1988, PHARMACOTHERAPY, V8, P334; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Doiron D, 2014, J HEALTH ECON, V37, P81, DOI 10.1016/j.jhealeco.2014.06.006; Echols RM, 1999, CLIN INFECT DIS, V29, P113, DOI 10.1086/520138; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Fraisse T, 2014, AGE AGEING, V43, P676, DOI 10.1093/ageing/afu023; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; HOLLOWAY W J, 1970, Internationale Zeitschrift fuer Klinische Pharmakologie Therapie und Toxikologie, V3, P122; HOLLOWAY WJ, 1971, J INFECT DIS, V124, pS180, DOI 10.1093/infdis/124.Supplement_1.S180; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Johansen TEB, 2007, EUR UROL, V51, P1100, DOI 10.1016/j.eururo.2006.08.012; Johnson J G, 1992, Clin Podiatr Med Surg, V9, P443; Khan Fahmi Yousef, 2012, Infect Drug Resist, V5, P17, DOI 10.2147/IDR.S27965; Kreger B, 1980, AM J MED, V68, P1589; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; Lee SS, 2011, J INFECTION, V62, P159, DOI 10.1016/j.jinf.2010.10.009; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nicolle LE, 2001, DRUG AGING, V18, P243, DOI 10.2165/00002512-200118040-00002; Rahn David D, 2008, Urol Nurs, V28, P333; Tandogdu Z, 2016, CURR OPIN INFECT DIS, V29, P73, DOI 10.1097/QCO.0000000000000228; Wagenlehner FME, 2008, EUR J CLIN INVEST, V38, P45, DOI 10.1111/j.1365-2362.2008.02008.x; Wagenlehner FME, 2007, INT J ANTIMICROB AG, V30, P390, DOI 10.1016/j.ijantimicag.2007.06.027; ZHANEL GG, 1994, CLIN PHARMACOKINET, V27, P377, DOI 10.2165/00003088-199427050-00005	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211094	10.1371/journal.pone.0211094	http://dx.doi.org/10.1371/journal.pone.0211094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673763	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800074
J	Shao, GF; Li, DY; Zhang, JF; Yang, JB; Shangguan, YL				Shao, Guifang; Li, Dongyao; Zhang, Junfa; Yang, Jianbo; Shangguan, Yali			Automatic microarray image segmentation with clustering-based algorithms	PLOS ONE			English	Article							CDNA MICROARRAY; SPOTS; MODEL; INTENSITY	Image segmentation, as a key step of microarray image processing, is crucial for obtaining the spot expressions simultaneously. However, state-of-art clustering-based segmentation algorithms are sensitive to noises. To solve this problem and improve the segmentation accuracy, in this article, several improvements are introduced into the fast and simple clustering methods (K-means and Fuzzy C means). Firstly, a contrast enhancement algorithm is implemented in image preprocessing to improve the gridding precision. Secondly, the data-driven means are proposed for cluster center initialization, instead of usual random setting. The third improvement is that the multi features, including intensity features, spatial features, and shape features, are implemented in feature selection to replace the sole pixel intensity feature used in the traditional clustering-based methods to avoid taking noises as spot pixels. Moreover, the principal component analysis is adopted for various feature extraction. Finally, an adaptive adjustment algorithm is proposed based on data mining and learning for further dealing with the missing spots or low contrast spots. Experiments on real and simulation data sets indicate that the proposed improvements made our proposed method obtains higher segmented precision than the traditional K-means and Fuzzy C means clustering methods.	[Shao, Guifang; Li, Dongyao; Zhang, Junfa; Yang, Jianbo; Shangguan, Yali] Xiamen Univ, Dept Automat, Xiamen, Peoples R China	Xiamen University	Shao, GF (corresponding author), Xiamen Univ, Dept Automat, Xiamen, Peoples R China.	gfshao@xmu.edu.cn		Yang, Jian-Bo/0000-0002-1368-5294	National Natural Science Foundation of China [61403318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with grant no. 61403318 to G.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Jesus, 2008, Image Analysis & Stereology, V27, P107, DOI 10.5566/ias.v27.p107-124; [Anonymous], 1999, GSI LUMONICS QUANTAR; [Anonymous], 2004, SPOTF ONL MAN; Athanasiadis E, 2011, COMPUT METH PROG BIO, V104, P307, DOI 10.1016/j.cmpb.2011.03.007; Axon Instruments Inc, 1997, GENEPIX 4000A US GUI; Battiato S, 2007, J ELECTRON IMAGING, V16, DOI 10.1117/1.2816445; Belean B, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0842-3; Biju V., 2012, INT J COMPUT APPL, V52, P42; Biju VG, 2017, CURR SCI INDIA, V113, P1072, DOI 10.18520/cs/v113/i06/1072-1080; Biju VG, 2015, PROCEDIA COMPUT SCI, V46, P417, DOI 10.1016/j.procs.2015.02.039; Blekas K, 2005, IEEE T MED IMAGING, V24, P901, DOI 10.1109/TMI.2005.848358; Bozinov D, 2002, BIOINFORMATICS, V18, P747, DOI 10.1093/bioinformatics/18.5.747; Buckley MJ, 2000, NON TRADITIONAL REF; Carlisle AJ, 2000, MOL CARCINOGEN, V28, P12, DOI 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q; Deepa J, 2009, WOR CONG NAT BIOL, P1468; Eisen M.B, 1997, SCANALYZE; Farouk RM, 2014, INT J ARTIFICIAL INT, V5, P21; Giannakeas N, 2013, COMPUT BIOL MED, V43, P705, DOI 10.1016/j.compbiomed.2013.03.003; Giannakeas N, 2009, COMPUT MED IMAG GRAP, V33, P40, DOI 10.1016/j.compmedimag.2008.10.003; Harikiran J, 2012, INT J COMPUTER SCI I, V9, P316; Heyer LJ, 2005, BIOINFORMATICS, V21, P2114, DOI 10.1093/bioinformatics/bti247; Ho J, 2008, IEEE T MED IMAGING, V27, P847, DOI 10.1109/TMI.2008.915697; Nguyen HN, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2111-8; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Katsigiannis S, 2017, IEEE J BIOMED HEALTH, V21, P867, DOI 10.1109/JBHI.2016.2537922; Khalilabad ND, 2017, COMPUT BIOL MED, V81, P139, DOI 10.1016/j.compbiomed.2016.12.012; Li QH, 2005, BIOINFORMATICS, V21, P2875, DOI 10.1093/bioinformatics/bti447; Li Y, 2017, THEOR COMPUT SCI, V701, P174, DOI 10.1016/j.tcs.2017.04.013; Maguluri LP, 2013, INT J EMERGING SCI E, V1, P27; Manjunath S., 2013, INT J COMPUT SCI ENG, V2, P189; Nagarajan R, 2003, IEEE T MED IMAGING, V22, P882, DOI 10.1109/TMI.2003.815063; Ni SH, 2009, ROM J INF SCI TECH, V12, P249; Raghavarao S, 2011, GLOBAL J COMPUTER SC, V11, P30; Rahnenfuhrer J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-47; Rajashekhar C. M, 2015, INT J INNOVATIVE RES, V3, P140; Rajkumar P, 2013, INT J COMPUTER SCI E, V5, P528; Ramgopal Kashyap, 2013, INT J COMPUTER SCI E, V2, P67; Saadelgawady A, 2015, INT J COMPUTER APPL, V110, P30; Shao GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133025; Thamaraimanalan P., 2014, INT J COMPUTER SCI M, V3, P353; Uslan V, 2010, MATH COMPUT APPL, V15, P240, DOI 10.3390/mca15020240; Zacharia E, 2011, EVOLUTIONARY ALGORITHMS, P459; [No title captured]	43	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210075	10.1371/journal.pone.0210075	http://dx.doi.org/10.1371/journal.pone.0210075			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668601	Green Submitted, Green Published, gold			2022-12-27	WOS:000456306400004
J	Fuentes-Hurtado, F; Diego-Mas, JA; Naranjo, V; Alcaniz, M				Fuentes-Hurtado, Felix; Diego-Mas, Jose A.; Naranjo, Valery; Alcaniz, Mariano			Automatic classification of human facial features based on their appearance	PLOS ONE			English	Article							LOCAL BINARY PATTERNS; FACE RECOGNITION; DIFFERENT SHAPES; NUMERICAL SURVEY; PROPORTIONS; SOMATOTYPE; EIGENFACES; AVATARS; PARTS	Classification or typology systems used to categorize different human body parts have existed for many years. Nevertheless, there are very few taxonomies of facial features. Ergonomics, forensic anthropology, crime prevention or new human-machine interaction systems and online activities, like e-commerce, e-learning, games, dating or social networks, are fields in which classifications of facial features are useful, for example, to create digital interlocutors that optimize the interactions between human and machines. However, classifying isolated facial features is difficult for human observers. Previous works reported low inter-observer and intra-observer agreement in the evaluation of facial features. This work presents a computer-based procedure to automatically classify facial features based on their global appearance. This procedure deals with the difficulties associated with classifying features using judgements from human observers, and facilitates the development of taxonomies of facial features. Taxonomies obtained through this procedure are presented for eyes, mouths and noses.	[Fuentes-Hurtado, Felix; Diego-Mas, Jose A.; Naranjo, Valery; Alcaniz, Mariano] Univ Politecn Valencia, I3B Inst Res & Innovat Bioengn, Valencia, Spain	Universitat Politecnica de Valencia	Diego-Mas, JA (corresponding author), Univ Politecn Valencia, I3B Inst Res & Innovat Bioengn, Valencia, Spain.	jodiemas@dpi.upv.es	Diego-Mas, Jose A/F-4758-2016; Hurtado, Félix José Fuentes/AAA-8787-2021; Alcañiz, Mariano/CAG-6569-2022	Diego-Mas, Jose A/0000-0002-3698-3411; Hurtado, Félix José Fuentes/0000-0002-4320-245X; Alcañiz, Mariano/0000-0001-9207-0636; Naranjo, Valery/0000-0002-0181-3412				Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Albin-Clark A, 2009, EG UK THEORY PRACT C; Alemany S., 2010, INPR 2010 INT C 3D B, P307; [Anonymous], COMPUTER VISION; Diego-Mas JA, 2015, COMPUT HUM BEHAV, V44, P1, DOI 10.1016/j.chb.2014.11.027; Arslan SG, 2008, AESTHET PLAST SURG, V32, P234, DOI 10.1007/s00266-007-9049-y; Ashraf AB, 2009, IMAGE VISION COMPUT, V27, P1788, DOI 10.1016/j.imavis.2009.05.007; Asmann S, 2007, ANTHR ATLAS MALE FAC; Asthana A, 2014, PROC CVPR IEEE, P1859, DOI 10.1109/CVPR.2014.240; Bag S, 2008, P 2 INT C INF PROC, P198; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Boberg M., 2008, P 3 INT C DIG INT ME, P232, DOI [DOI 10.1145/1413634.1413679, 10.1145/1413634.1413679]; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bruce V., 2013, FACE PERCEPTION; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Carvalho PVR, 2008, DISPLAYS, V29, P273, DOI 10.1016/j.displa.2007.08.010; Chihaoui M, 2016, COMPUTERS, V5, DOI 10.3390/computers5040021; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; DAMASIO AR, 1985, TRENDS NEUROSCI, V8, P132, DOI 10.1016/0166-2236(85)90051-7; DAVIDOFF J, 1990, ACTA PSYCHOL, V73, P225, DOI 10.1016/0001-6918(90)90024-A; Davis A, 2009, J ASSOC INF SYST, V10, P90, DOI 10.17705/1jais.00183; Dharejo FA, 2017, FRONT ARTIF INTEL AP, V296, P429, DOI 10.3233/978-1-61499-785-6-429; Dizaji KG, 2017, IEEE I CONF COMP VIS, P5747, DOI 10.1109/ICCV.2017.612; Donnelly N, 1999, VIS COGN, V6, P319, DOI 10.1080/135062899395000; Doukas C, 2010, IFIP ADV INF COMM TE, V339, P295; Ester M, 1996, COMPUTER LONG BEACH, DOI 10.1.1.71.1980; Fabri M., 2005, VIRTUAL SOC AGENTS, V88, P88; Ferring V, 2008, AM J ORTHOD DENTOFAC, V134, P472, DOI 10.1016/j.ajodo.2007.03.027; Hamerly G, 2004, ADV NEURAL INF PROCE, DOI 10.1.1.9.3574; Hayward WG, 2008, COGNITION, V106, P1017, DOI 10.1016/j.cognition.2007.04.002; Hochscheid H, 2015, ART MAK ANTIQ; Huang PH, 2014, INT C PATT RECOG, P1532, DOI 10.1109/ICPR.2014.272; Jee SC, 2016, INT J IND ERGONOM, V53, P10, DOI 10.1016/j.ergon.2015.10.004; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim Namsoon, 2014, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V38, P305; Klare B., 2010, BIOMETRICS THEORY AP, P1, DOI [DOI 10.1109/BTAS.2010.5634533, 10.1109/btas.2010.5634533]; Koleva M, 2002, Rev Environ Health, V17, P65; Kong SG, 2005, COMPUT VIS IMAGE UND, V97, P103, DOI 10.1016/j.cviu.2004.04.001; Laurentini A, 2014, COMPUT VIS IMAGE UND, V125, P184, DOI 10.1016/j.cviu.2014.04.006; Li SZ, 2005, HDB FACE RECOGNITION, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Lin YL, 1999, ERGONOMICS, V42, P1311, DOI 10.1080/001401399184965; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Liu L, 2016, INFORM SCIENCES, V358, P56, DOI 10.1016/j.ins.2016.04.021; Ma DS, 2015, BEHAV RES METHODS, V47, P1122, DOI 10.3758/s13428-014-0532-5; Malousaris GG, 2008, J SCI MED SPORT, V11, P337, DOI 10.1016/j.jsams.2006.11.008; Mane DR, 2010, J FORENSIC LEG MED, V17, P421, DOI 10.1016/j.jflm.2010.09.001; Massidda M, 2013, COLLEGIUM ANTROPOL, V37, P853; Meyers E, 2008, INT J COMPUT VISION, V76, P93, DOI 10.1007/s11263-007-0058-8; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Nousi P, 2017, COMMUN COMPUT PHYS, DOI [10.1126/science.aal4230, DOI 10.1126/SCIENCE.AAL4230]; Ohlrogge S, 2009, ANTHR ATLAS MALE FAC; Orvalho V, 2009, STUD HEALTH TECHNOL, V144, P96, DOI 10.3233/978-1-60750-017-9-96; Porter J P, 2001, Arch Facial Plast Surg, V3, P191; PRESTON TA, 1972, ERGONOMICS, V15, P693, DOI 10.1080/00140137208924469; Rhodes G, 2009, BRIT J PSYCHOL, V100, P717, DOI 10.1348/000712608X396503; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Ritz-Timme S, 2011, FORENSIC SCI INT, V207, p239E1, DOI 10.1016/j.forsciint.2011.01.035; Ritz-Timme S, 2011, INT J LEGAL MED, V125, P301, DOI 10.1007/s00414-010-0446-4; Robins G, 1984, GOETTINGER MISZELLEN, P31; Rojas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023323; Sarakon P, 2014, 7 2014 BIOM ENG INT, P1, DOI DOI 10.1109/BMEICON.2014.7017382; Scharff A, 2011, PSYCHON B REV, V18, P713, DOI 10.3758/s13423-011-0101-1; Sheldon W, 1970, ATLAS MEN GUIDE SOMA; Shyam R, 2015, PROCEDIA COMPUT SCI, V48, P666, DOI 10.1016/j.procs.2015.04.150; Siregar STM, 2018, IOP CONF SER-MAT SCI, V308, DOI 10.1088/1757-899X/308/1/012013; SIROVICH L, 1987, J OPT SOC AM A, V4, P519, DOI 10.1364/JOSAA.4.000519; Sukhija P, 2016, PROCEDIA COMPUT SCI, V85, P410, DOI 10.1016/j.procs.2016.05.183; Sustersic T, 2018, LECT NOTES I COMPUT, DOI [10.1007/978-3-319-74935-8_13, DOI 10.1007/978-3-319-74935-8_13]; Tamir A, 2013, J CRANIOFAC SURG, V24, P1657, DOI 10.1097/SCS.0b013e3182942b77; Tamir A, 2011, J CRANIOFAC SURG, V22, P1104, DOI 10.1097/SCS.0b013e3182108eb3; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Taubert J, 2011, VISION RES, V51, P1273, DOI 10.1016/j.visres.2011.04.002; Tavares G, 2016, COMPUT VIS IMAGE UND, V147, P102, DOI 10.1016/j.cviu.2016.02.001; Todorov A, 2011, SOCIAL NEUROSCIENCE, DOI [10.1093/acprof:oso/9780195316872.003.0004, DOI 10.1093/ACPROF:OSO/9780195316872.003.0004]; Trescak Tomas, 2012, P 18 ACM S VIRT REAL, P1, DOI [10.1145/2407336.2407338, DOI 10.1145/2407336.2407338]; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Vanezis P, 1996, J FORENSIC SCI, V41, P786; Vinue G, 2015, COMPUT STAT DATA AN, V87, P102, DOI 10.1016/j.csda.2015.01.018; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Wu J, 2013, MEAS SCI REV, V13, P122, DOI 10.2478/msr-2013-0021; Xie JY, 2016, PR MACH LEARN RES, V48; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x	83	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211314	10.1371/journal.pone.0211314	http://dx.doi.org/10.1371/journal.pone.0211314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695076	gold, Green Submitted, Green Published			2022-12-27	WOS:000457046400024
J	Ishikawa, T; Yokoyama, H; Matsuura, T; Fujiwara, Y				Ishikawa, Tomoko; Yokoyama, Hiroshi; Matsuura, Tomokazu; Fujiwara, Yoko			Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease	PLOS ONE			English	Article							NATIONAL-HEALTH; FIBROSIS; RECEPTOR; HYALURONAN; NAFLD; STEATOHEPATITIS; INFLAMMATION; PLATELETS; CIRRHOSIS	Liver sinusoidal endothelial cells (LSECs) play a pivotal role in hepatic function and homeostasis. LSEC dysfunction has been recognized to be closely involved in various liver diseases, including non-alcoholic steatohepatitis (NASH), but not much is known about the fate of the scavenger receptors in LSECs during NASH. Fc gamma receptor IIb (Fc gamma RIIb), known as a scavenger receptor, contributes to receptor-mediated endocytosis and immune complexes clearance. In this study, to elucidate the fate of Fc gamma RIIb in the progression of non-alcoholic fatty liver disease (NAFLD), we examined Fc gamma RIIb levels in NAFLD biopsy specimens by immunohistochemistry, and investigated their correlation with the exacerbation of biological indexes and clinicopathological scores of NASH. The Fc gamma RIIb expression levels indicated significant negative correlations with serum levels of blood lipids (triglyceride, total cholesterol, high-density lipoprotein-cholesterol), type 4 collagen and hyaluronic acid, which are involved in hepatic lipid metabolism disorder, fibrosis, and inflammation, respectively. However, there was no significant difference of Fc gamma RIIb expression levels among the pathological grades of NAFLD. During NAFLD progression, inflammation and fibrosis may influence the expression of Fc gamma RIIb and their scavenger functions to maintain hepatic homeostasis.	[Ishikawa, Tomoko; Fujiwara, Yoko] Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan; [Yokoyama, Hiroshi] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med,Minato Ku, Tokyo, Japan; [Yokoyama, Hiroshi; Matsuura, Tomokazu] Jikei Univ, Sch Med, Dept Lab Med, Minato Ku, Tokyo, Japan; [Fujiwara, Yoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan	Ochanomizu University; Jikei University; Jikei University; Ochanomizu University	Fujiwara, Y (corresponding author), Ochanomizu Univ, Inst Human Life Innovat, Bunkyo Ku, Tokyo, Japan.; Fujiwara, Y (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo, Japan.	fujiwara.yoko@ocha.ac.jp		Yokoyama, Hiroshi/0000-0003-4559-030X	Japan Society for the Promotion of Science [15K00810]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grant Number: 15K00810 (https./www.jsps.go.jp/english/index.html) to TI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan A, 2016, HEPATOLOGY, V64, P1774, DOI 10.1002/hep.28526; Colak Y, 2011, HEPATO-GASTROENTEROL, V58, P2087, DOI 10.5754/hge11248; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Duan XY, 2014, CANCER LETT, V345, P230, DOI 10.1016/j.canlet.2013.07.033; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Ganesan LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20646; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Ganesan LP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002281; Geraud C, 2013, LIVER INT, V33, P1428, DOI 10.1111/liv.12262; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Marrone G, 2016, J HEPATOL, V65, P608, DOI 10.1016/j.jhep.2016.04.018; Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Ni Y, 2017, WORLD J GASTROENTERO, V23, P7666, DOI 10.3748/wjg.v23.i43.7666; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nonaka H, 2007, DEV DYNAM, V236, P2258, DOI 10.1002/dvdy.21227; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Plevris JN, 2000, EUR J GASTROEN HEPAT, V12, P1121, DOI 10.1097/00042737-200012100-00009; Plevris N, 2018, ALIMENT PHARM THER, V48, P423, DOI 10.1111/apt.14897; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; SHECHTER I, 1981, J LIPID RES, V22, P63; Smedsrod B, 2009, LIVER INT, V29, P490, DOI 10.1111/j.1478-3231.2009.01979.x; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stickel F, 2003, EUR J GASTROEN HEPAT, V15, P945, DOI 10.1097/00042737-200309000-00002; Strauss O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44356; Sun Y, 2014, HEPATOL INT, V8, P567, DOI 10.1007/s12072-014-9568-y; Tanigaki K, 2015, CIRC RES, V116, P368, DOI 10.1161/CIRCRESAHA.116.302795; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Vilar-Gomez E, 2017, LIVER INT, V37, P1887, DOI 10.1111/liv.13480; Wong RJ, 2017, ALIMENT PHARM THER, V46, P974, DOI 10.1111/apt.14327; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6; Xu MX, 2017, BIOSCI TRENDS, V11, P163, DOI 10.5582/bst.2017.01007	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211543	10.1371/journal.pone.0211543	http://dx.doi.org/10.1371/journal.pone.0211543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695042	gold, Green Published, Green Submitted			2022-12-27	WOS:000457046400043
J	Varbanov, HP; Kuttler, F; Banfi, D; Turcatti, G; Dyson, PJ				Varbanov, Hristo P.; Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo; Dyson, Paul J.			Screening-based approach to discover effective platinum-based chemotherapies for cancers with poor prognosis	PLOS ONE			English	Article							IN-VITRO; DRUG; CISPLATIN; SPIRONOLACTONE; VORINOSTAT; AURANOFIN; COMPLEXES; RESPONSES; SYNERGY	Drug combinations are extensively used to treat cancer and are often selected according to complementary mechanisms. Here, we describe a cell-based high-throughput screening assay for identification of synergistic combinations between broadly applied platinum-based chemotherapeutics and drugs from a library composed of 1280 chemically and pharmacologically diverse (mostly FDA approved) compounds. The assay was performed on chemoresistant cell lines derived from lung (A549) and pancreatic (PANC-1) carcinoma, where platinum-based combination regimens are currently applied though with limited success. The synergistic combinations identified during the screening were validated by synergy quantification using the combination index method and via high content fluorescent microscopy analysis. New promising synergistic combinations discovered using this approach include compounds currently not used as anticancer drugs, such as cisplatin or carboplatin with hycanthone and cisplatin with spironolactone in pancreatic carcinoma, and carboplatin and deferoxamine in non-small cell lung cancer. Strong synergy between cisplatin or carboplatin and topotecan in PANC-1 cells, compared to A549 cells, suggests that this combination, currently used in lung cancer treatment regimens, could be applied to pancreatic carcinoma as well. Several drugs used to treat diseases other than cancer, including pyrvinium pamoate, auranofin, terfenadine and haloprogin, showed strong cytotoxicity on their own and synergistic interactions with platinum drugs. This study demonstrates that non-obvious drug combinations that would not be selected based on complementary mechanisms can be identified via high-throughput screening.	[Varbanov, Hristo P.; Dyson, Paul J.] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Kuttler, Fabien; Banfi, Damiano; Turcatti, Gerardo] Ecole Polytech Fed Lausanne, Biomol Screening Facil, Lausanne, Switzerland; [Varbanov, Hristo P.] Karl Franzens Univ Graz, Inst Chem, Graz, Austria	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Graz	Varbanov, HP; Dyson, PJ (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, Lausanne, Switzerland.; Varbanov, HP (corresponding author), Karl Franzens Univ Graz, Inst Chem, Graz, Austria.	hristo.varbanov@univie.ac.at; paul.dyson@epfl.ch	Varbanov, Hristo P./O-3973-2017; Dyson, Paul/AAB-9075-2019	Varbanov, Hristo P./0000-0003-4450-7332; Dyson, Paul/0000-0003-3117-3249; Kuttler, Fabien/0000-0003-2575-1989	Austrian Science Fund (FWF) [J3577-B13]; BSF-ACCESS screening platform at the EPFL	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); BSF-ACCESS screening platform at the EPFL	H.V. is indebted to the Austrian Science Fund (FWF) for the financial support (Schrodinger fellowship, Project number: J3577-B13). We acknowledge the Swiss National Center for Competence (NCCR) in Chemical Biology for providing access to the chemical libraries and screening facilities.; We acknowledge the BSF-ACCESS screening platform at the EPFL for support, in particular we are thankful to Julien Bortoli Chapalay for dispensing the PCL with the Echo acoustic liquid handler and to Antoine Gibelin for the quality control with LC-MS.	Adhireksan Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14860; Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Apps MG, 2015, ENDOCR-RELAT CANCER, V22, pR219, DOI 10.1530/ERC-15-0237; Armstrong-Gordon E, 2018, J CANCER RES CLIN, V144, P1561, DOI 10.1007/s00432-018-2669-6; Bar J, 2016, NEOPLASIA, V18, P525, DOI 10.1016/j.neo.2016.07.004; Barnard C, 2017, JOHNSON MATTHEY TECH, V61, P52, DOI 10.1595/205651317X693624; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Bray F, GLOBOCAN 2012 V1 0; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan E, 2016, RADIOTHER ONCOL, V119, P312, DOI 10.1016/j.radonc.2016.04.013; Cheff DM, 2017, J MED CHEM, V60, P4517, DOI 10.1021/acs.jmedchem.6b01351; Chou T.-C., 2007, COMPUSYN SOFTWARE DR; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cosaert J, 2002, BRIT J CANCER, V87, P825, DOI 10.1038/sj.bjc.6600540; DeVita VT, 2012, NEW ENGL J MED, V366, P2207, DOI 10.1056/NEJMra1204479; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Galanski M, 2005, CURR MED CHEM, V12, P2075, DOI 10.2174/0929867054637626; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; Herdrich K, 2010, SELECTED SCHEDULES T; Jaramillo ML, 2008, CANCER BIOL THER, V7, P557, DOI 10.4161/cbt.7.4.5533; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klauber N, 1996, CIRCULATION, V94, P2566, DOI 10.1161/01.CIR.94.10.2566; Michaelis M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08202; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Muggia FM, 2015, J CLIN ONCOL, V33, P4219, DOI 10.1200/JCO.2015.60.7481; National Cancer Institute, UND CANC; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; O'Brien A, 2012, ANTICANCER RES, V32, P2679; Oun R, 2018, DALTON T, V47, P6645, DOI 10.1039/c8dt00838h; OuYang PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079000; Pan CH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2888-7; Petersen GH, 2016, J CONTROL RELEASE, V232, P255, DOI 10.1016/j.jconrel.2016.04.028; Pongrakhananon V, 2013, INTECH, P65, DOI [10.5772/55381, DOI 10.5772/55381]; Price P, 2008, TREATMENT OF CANC; Quaresma M, 2015, LANCET, V385, P1206, DOI 10.1016/S0140-6736(14)61396-9; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Shahar OD, 2014, NUCLEIC ACIDS RES, V42, P5689, DOI 10.1093/nar/gku217; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Sun YC, 2018, INT J ONCOL, V53, P1237, DOI 10.3892/ijo.2018.4447; Sweetman S.C, 2009, MARTINDALE COMPLETE; Taher MA, 2013, INT J SCI NAT, V4, P683; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; Varbanov HP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171052; Varghese E, 2014, CANCERS, V6, P2243, DOI 10.3390/cancers6042243; Webb JL, 1961, ENZYMES METABOL INH, V1, P66; Weinberg BA, 2015, ONCOLOGY-NY, V29, P809; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; WHO, CANC KEY FACTS; Yi YW, 2011, DNA REPAIR, V10, P1084, DOI 10.1016/j.dnarep.2011.09.008; Yosifov DY, 2011, CANCER CHEMOTH PHARM, V67, P13, DOI 10.1007/s00280-010-1273-5; Schneider NFZ, 2017, MOLECULES, V22, DOI 10.3390/molecules22111932; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	61	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211268	10.1371/journal.pone.0211268	http://dx.doi.org/10.1371/journal.pone.0211268			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695050	gold, Green Published, Green Submitted			2022-12-27	WOS:000457046400022
J	Cano-Rocabayera, O; de Sostoa, A; Padros, F; Cardenas, L; Maceda-Veiga, A				Cano-Rocabayera, Oriol; de Sostoa, Adolfo; Padros, Francesc; Cardenas, Lorena; Maceda-Veiga, Alberto			Ecologically relevant biomarkers reveal that chronic effects of nitrate depend on sex and life stage in the invasive fish Gambusia holbrooki	PLOS ONE			English	Article							FRESH-WATER; WESTERN MOSQUITOFISH; OXYGEN-CONSUMPTION; STABLE-ISOTOPES; TOXICITY; NITRITE; NITROGEN; EXPOSURE; EUTROPHICATION; POPULATION	Agricultural intensification and shifts in precipitation regimes due to global climate change are expected to increase nutrient concentrations in aquatic ecosystems. However, the direct effects of nutrients widely present in wastewaters, such as nitrate, are poorly studied. Here, we use multiple indicators of fish health to experimentally test the effects of three ecologically relevant nitrate concentrations (<10, 50 and 250 mg NO3-/l) on wild-collected mosquitofish (Gambusia holbrooki), a species widely introduced for mosquito biocontrol in often eutrophic waters. Overall, biomarkers (histopathology, feeding assays, growth and caloric content and stable isotopes as indicators of energy content) did not detect overt signs of serious disease in juveniles, males or females of mosquitofish. However, males reduced food intake at the highest nitrate concentration compared to the controls and females. Similarly, juveniles reduced energy reserves without significant changes in growth or food intake. Calorimetry was positively associated with the number of perivisceral fat cells in juveniles, and the growth rate of females was negatively associated with delta N-15 signature in muscle. This study shows that females are more tolerant to nitrate than males and juveniles and illustrates the advantages of combing short- and long-term biomarkers in environmental risk assessment, including when testing for the adequacy of legal thresholds for pollutants.	[Cano-Rocabayera, Oriol; de Sostoa, Adolfo; Cardenas, Lorena; Maceda-Veiga, Alberto] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Inst Res Biodivers IRBio UB, Barcelona, Spain; [Padros, Francesc] Univ Autonoma Barcelona, Servei Diagnost Patol Peixos, Fac Vet, Bellaterra, Spain	University of Barcelona; Autonomous University of Barcelona	Cano-Rocabayera, O (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Inst Res Biodivers IRBio UB, Barcelona, Spain.	canorocabayera@gmail.com	Rocabayera, Oriol Cano/AAI-1851-2019; Maceda-Veiga, Alberto/F-1185-2010	Rocabayera, Oriol Cano/0000-0002-7290-4485; Maceda-Veiga, Alberto/0000-0002-1736-4631	Fundacio Barcelona Zoo [3RB 057]; University of Barcelona (APIF)	Fundacio Barcelona Zoo; University of Barcelona (APIF)	This work was finacially supported by Fundacio Barcelona Zoo (PRIC grant 3RB 057 for labware and analysis costs). OCR received a grant by the University of Barcelona (APIF) during the period 2015-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin S, 2003, TEX J SCI, V55, P255; [Anonymous], 2011, FISH DIS DIAGNOSIS T; Baker JA, 2017, CHEMOSPHERE, V168, P435, DOI 10.1016/j.chemosphere.2016.10.059; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bernier NJ, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P238, DOI 10.1079/9781845935535.0238; Bouraoui F., 2009, JOINT RES CTR SCI TE, VEUR 24002, DOI DOI 10.2788/38971; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Cano-Rocabayera O, 2015, ENVIRON BIOL FISH, V98, P925, DOI 10.1007/s10641-014-0328-6; Catalana de l'Aigua, 2014, INT APPL; CHRISTIANSEN JS, 1991, J EXP ZOOL, V260, P149, DOI 10.1002/jez.1402600203; Colin N, 2016, SCI TOTAL ENVIRON, V540, P307, DOI 10.1016/j.scitotenv.2015.06.099; Coutellec MA, 2011, ECOTOXICOLOGY, V20, P493, DOI 10.1007/s10646-011-0637-x; CRAUN GF, 1981, INT J EPIDEMIOL, V10, P309, DOI 10.1093/ije/10.4.309; Durfort M, 2006, INICIACIO A LES VEGE; Eddy FB, 1987, NITRITE FRESHWATER F, V3, P1, DOI DOI 10.1080/02757548708070832; Edwards TM, 2007, AQUAT TOXICOL, V85, P40, DOI 10.1016/j.aquatox.2007.07.014; Edwards TM, 2018, GEN COMP ENDOCR, V265, P31, DOI 10.1016/j.ygcen.2018.03.021; Ferard J. F., 2013, ENCY AQUATIC ECOTOXI; Field KL, 2004, ANIM BEHAV, V68, P1381, DOI 10.1016/j.anbehav.2003.12.022; Fields S, 2004, ENVIRON HEALTH PERSP, V112, pA556, DOI 10.1289/ehp.112-a556; Focken U, 1998, OECOLOGIA, V115, P337, DOI 10.1007/s004420050525; Fox J., 2019, R COMPANION APPL REG, V.; Freitag AR, 2015, AQUACULTURE, V436, P8, DOI 10.1016/j.aquaculture.2014.10.041; Fryxell DC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1970; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Gaye-Siessegger J, 2004, OECOLOGIA, V138, P175, DOI 10.1007/s00442-003-1429-7; Grup de Defensa del Ter, 2018, NITR CONC SPRINGS OS; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; HALLER J, 1995, NEUROSCI BIOBEHAV R, V19, P599, DOI 10.1016/0149-7634(95)00053-4; Hamlin HJ, 2008, AQUACULTURE, V281, P118, DOI 10.1016/j.aquaculture.2008.05.030; Hamlin HJ, 2006, AQUACULTURE, V253, P688, DOI 10.1016/j.aquaculture.2005.08.025; HAYNES JL, 1995, J FISH BIOL, V46, P1026, DOI 10.1111/j.1095-8649.1995.tb01407.x; Honda H., 1993, AQUAC SCI, V41, P19; Hopkins Kevin D., 1992, Journal of the World Aquaculture Society, V23, P173, DOI 10.1111/j.1749-7345.1992.tb00766.x; Hord NG, 2017, FASEB J, V31; Hrubec T., 1996, P AQUACULT ENG SOC, V1, P41; JENSEN FB, 1990, J EXP BIOL, V152, P149; Jensen FB, 1995, NITROGEN METABOLISM, P289; Johansson M, 2001, AQUAT TOXICOL, V54, P1, DOI 10.1016/S0166-445X(00)00182-X; Kestemont P, 2000, FOOD INTAKE IN FISH, P131; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kolkwitz R., 1909, INT REV GES HYDROBIO, V2, P126, DOI DOI 10.1002/IROH.19090020108; LAHTI E, 1985, COMP BIOCHEM PHYS A, V80, P337, DOI 10.1016/0300-9629(85)90047-7; Lall SP, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P202, DOI 10.1079/9781845935535.0202; Lee D. R., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, DOI 10.1079/9780851994352.0000; Maceda-Veiga A, 2017, SCI TOTAL ENVIRON, V574, P455, DOI 10.1016/j.scitotenv.2016.09.097; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Margalef R, 1983, LIMNOLOGIA; Martin BT, 2017, J ANIM ECOL, V86, P812, DOI 10.1111/1365-2656.12667; MCKIM JM, 1977, J FISH RES BOARD CAN, V34, P1148, DOI 10.1139/f77-172; Moore AP, 2018, ENVIRON POLLUT, V242, P807, DOI 10.1016/j.envpol.2018.07.047; NAKAZAWA T, 1985, JNCI-J NATL CANCER I, V75, P567; Nordlie FG, 1996, J FISH BIOL, V49, P1226; OECD, 1982, EUTR WAT MON ASS CON, DOI DOI 10.1002/IROH.19840690206; Panesar NS, 2000, TOXICOL APPL PHARM, V169, P222, DOI 10.1006/taap.2000.9079; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pereira A, 2017, AQUACULTURE, V473, P197, DOI 10.1016/j.aquaculture.2017.02.018; Perkins EJ, 1997, AQUAT TOXICOL, V37, P327, DOI 10.1016/S0166-445X(96)00825-9; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulsen R, 2018, ENVIRON SCI TECHNOL, V52, P3869, DOI 10.1021/acs.est.7b06419; PUCKETT LJ, 1995, ENVIRON SCI TECHNOL, V29, pA408, DOI 10.1021/es00009a001; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; R Core Team, 2018, R LANG ENV STAT COMP; Rodriguez-Estival J, 2010, ENVIRON RES, V110, P469, DOI 10.1016/j.envres.2010.03.008; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Scott G, 2000, ENVIRON TOXICOL CHEM, V19, P2918, DOI [10.1897/1551-5028(2000)019&lt;2918:AACTON&gt;2.0.CO;2, 10.1002/etc.5620191211]; Secondi J, 2013, BEHAV ECOL SOCIOBIOL, V67, P1757, DOI 10.1007/s00265-013-1583-9; Shimura R, 2002, ADV SPACE RES, V30, P803, DOI 10.1016/S0273-1177(02)00399-X; Sinha E, 2017, SCIENCE, V357, P405, DOI 10.1126/science.aan2409; Smallbone W, 2016, ENVIRON INT, V91, P265, DOI 10.1016/j.envint.2016.03.008; Smith CC, 2006, ANIM BEHAV, V71, P401, DOI 10.1016/j.anbehav.2005.06.003; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Stephenson JF, 2016, ECOL EVOL, V6, P2506, DOI 10.1002/ece3.2049; Stormer J, 1996, CAN J FISH AQUAT SCI, V53, P1943, DOI 10.1139/cjfas-53-9-1943; THURSTON RV, 1981, ENVIRON SCI TECHNOL, V15, P837, DOI 10.1021/es00089a012; U.S. Congress, 1974, 93 C, P93; Vargas MJ, 1996, HYDROBIOLOGIA, V341, P215, DOI 10.1007/BF00014686; Wallace P. D, 1977, Fisheries Res. tech. Rep., VNo. 35, P1; WHO, 2006, GUID DRINK WAT QUAL, V1; Wolf JC, 2015, TOXICOL PATHOL, V43, P297, DOI 10.1177/0192623314540229; Zuur Alain F., 2009, P1	83	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211389	10.1371/journal.pone.0211389	http://dx.doi.org/10.1371/journal.pone.0211389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689670	Green Submitted, Green Published, gold			2022-12-27	WOS:000457041800034
J	Chetty-Makkan, CM; Grund, JM; Munyai, R; Gadla, V; Chihota, V; Maraisane, M; Charalambous, S				Chetty-Makkan, Candice M.; Grund, Jonathan M.; Munyai, Reuben; Gadla, Vuyokazi; Chihota, Violet; Maraisane, Mpho; Charalambous, Salome			"To speak or not to speak": A qualitative analysis on the attitude and willingness of women to start conversations about voluntary medical male circumcision with their partners in a peri-urban area, South Africa	PLOS ONE			English	Article							HIV PREVENTION; MEN	Introduction Voluntary medical male circumcision (VMMC) reduces the risk of HIV infection in heterosexual men and has long-term indirect protection for women, yet VMMC uptake in South Africa remains low (49.8%) in men (25-49 years). We explored the attitude and willingness of women to start conversations on VMMC with their sexual partners in a South African periurban setting to increase VMMC uptake. Methods Thirty women with median age of 30 years (inter-quartile range 26-33 years) were interviewed in a language of their choice. Key questions included: types of approach to use, gender roles, benefits and barriers to introducing the topic of VMMC, and perceptions of VMMC. Interviews were digitally-recorded, transcribed, and translated. Through a standard iterative process, a codebook was developed (QSR NVIVO 10 software) and inductive thematic analysis applied. Results Most women were willing talk to their sexual partners about circumcision, but indicated that the decision to circumcise remained that of their sexual partner. Women felt that they should encourage their partners, show more interest in circumcision, be patient, speak in a caring and respectful tone, choose a correct time when their partner was relaxed and talk in a private space about VMMC. Using magazine/newspaper articles, pamphlets or advertisements were identified as tools that could aid their discussion. Substantial barriers to initiating conversations on VMMC included accusations by partner on infidelity, fear of gender-based violence, cultural restrictions and hesitation to speak to a mature partner about circumcision. Conclusions Women need to ensure that before talking to their partner about circumcision, the environment and approach that they use are conducive. Female social network forums could be used to educate women on conversation techniques, skills to use when talking to their partners and how to address communication challenges about circumcision. Involvement of women in VMMC awareness campaigns could encourage circumcision uptake among men.	[Chetty-Makkan, Candice M.; Munyai, Reuben; Gadla, Vuyokazi; Chihota, Violet; Maraisane, Mpho; Charalambous, Salome] Aurum Inst, Parktown, South Africa; [Grund, Jonathan M.] Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa; [Charalambous, Salome] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand	Chetty-Makkan, CM (corresponding author), Aurum Inst, Parktown, South Africa.	cchetty@auruminstitute.org	Chihota, Violet/DWH-9372-2022	Chihota, Violet/0000-0003-1444-9266; Chetty-Makkan, Candice/0000-0001-9292-9586; Charalambous, Salome/0000-0001-7143-1009	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [5U01 GH000522-02]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement Number 5U01 GH000522-02. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies.	Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVAC, 2008, M REP CIV SOC DIAL M; Baeten JM, 2009, LANCET, V374, P182, DOI 10.1016/S0140-6736(09)61311-8; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Chatzichristodoulou M, 2009, DIGIT RES ARTS HUM, P1; Feuer C., 2010, CAUTIOUS NOD CUT WOM, P63; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Grund JM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5729-6; Hallett TB, 2008, UNDERSTANDING IMPACT, V3, P1; Hankins C, 2007, REPROD HEALTH MATTER, V15, P62, DOI 10.1016/S0968-8080(07)29311-5; Hatzold K, 2015, PLOS ONE, V9, P1; Ikwegbue JN, 2007, AFR J PRIM HEALTH CA, V7, P1; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Layer EH, 2014, CULT HEALTH SEX, V16, P258, DOI 10.1080/13691058.2013.873481; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Milford C, 2015, INT J NURS STUD, V53, P1; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Pope C, 2000, BMJ-BRIT MED J, V320, P5; Riess TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097748; Ryan G.W., 2000, HDB QUALITATIVE RES; Sardi L, 2015, MCN-AM J MATERN-CHIL, V40, P110, DOI 10.1097/NMC.0000000000000112; Sawires SR, 2014, NIH PUBLIC ACCESS, V369, P708; Shisana O., 2014, AFRICAN NATL HIV P; Tiemstra JD, 2019, J AM BOARD FAM PRACT, V12, P16; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; WHO, 2007, WHO TECH REP SER, V935, P1; World Health Organization & World Health Organization, 2009, WHO HDB INDOOR RADON	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210480	10.1371/journal.pone.0210480	http://dx.doi.org/10.1371/journal.pone.0210480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682057	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500038
J	Fonseca, DA; Antunes, PE; Antunes, MJ; Cotrim, MD				Fonseca, Diogo A.; Antunes, Pedro E.; Antunes, Manuel J.; Cotrim, Maria Dulce			Histomorphometric analysis of the human internal thoracic artery and relationship with cardiovascular risk factors	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; MAMMARY ARTERY; MYOCARDIAL-INFARCTION; CAROTID WALL; ATHEROSCLEROSIS; STROKE; BYPASS; GENDER; SEX; AGE	In this study, we aimed at performing a histomorphometric analysis of human left internal thoracic artery (ITA) samples as well as at correlating the histomorphometric findings with the clinical profile, including risk factors and medication. Distal segments of ITA were obtained from 54 patients undergoing coronary artery bypass grafting. Histological observation was performed in paraffin-embedded transverse sections of ITA through four staining protocols: hematoxylin-eosin, van Gieson, Masson's trichrome and von Kossa. Morphometric analysis included the intimal width (IW), medial width (MW) and intima/media ratio (IMR). No overt atherosclerotic lesions were observed. Mild calcifications were observed across the vascular wall layers in almost all samples. Multivariable linear regression analysis showed associations between IW and IMR and the following clinical variables: age, gender, kidney function expressed as eGFR and myocardial infarction history. Age (odds ratio = 1.16, P = 0.004), female gender (odds ratio = 11.34, P = 0.011), eGFR (odds ratio = 1.03, P = 0.059) and myocardial infarction history (odds ratio = 4.81, P = 0.040) were identified as the main clinical predictors for intimal hyperplasia. Preatherosclerotic lesions in ITA samples from patients undergoing coronary revascularization were associated not only with classical cardiovascular risk factors such as age and gender, but also with other clinical variables, namely kidney function and myocardial infarction history.	[Fonseca, Diogo A.; Cotrim, Maria Dulce] Univ Coimbra, Fac Pharm, Lab Pharmacol & Pharmaceut Care, Coimbra, Portugal; [Fonseca, Diogo A.; Cotrim, Maria Dulce] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal; [Antunes, Pedro E.; Antunes, Manuel J.] Univ Hosp, Ctr Cardiothorac Surg, Coimbra, Portugal; [Antunes, Pedro E.; Antunes, Manuel J.] Fac Med Coimbra, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Fonseca, DA (corresponding author), Univ Coimbra, Fac Pharm, Lab Pharmacol & Pharmaceut Care, Coimbra, Portugal.; Fonseca, DA (corresponding author), Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal.	diogo.fonseca@ff.uc.pt	Fonseca, Diogo A./AAH-5903-2020; Antunes, Pedro E/E-8968-2013; Antunes, Pedro Engrácia/AAH-9646-2020	Fonseca, Diogo A./0000-0002-8244-139X; Antunes, Pedro E/0000-0002-6607-6978; Antunes, Pedro Engrácia/0000-0002-6607-6978				Bakuy V, 2014, ANN THORAC SURG, V97, P851, DOI 10.1016/j.athoracsur.2013.09.102; Borovic ML, 2013, HISTOL HISTOPATHOL, V28, P1299, DOI 10.14670/HH-28.1299; Borovic ML, 2010, HISTOL HISTOPATHOL, V25, P561, DOI 10.14670/HH-25.561; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Cizek SM, 2007, CARDIOVASC PATHOL, V16, P344, DOI 10.1016/j.carpath.2007.05.007; DIGNAN RJ, 1992, ANN THORAC SURG, V53, P792, DOI 10.1016/0003-4975(92)91438-F; Fonseca DA, 2017, CARDIOVASC TOXICOL, V17, P405, DOI 10.1007/s12012-017-9398-y; Fonseca DA, 2017, CORONARY ARTERY DIS, V28, P518, DOI 10.1097/MCA.0000000000000527; Fonseca DA, 2014, CORONARY ARTERY DIS, V25, P266, DOI 10.1097/MCA.0000000000000097; Grunkemeier GL, 2001, ANN THORAC SURG, V72, P323, DOI 10.1016/S0003-4975(01)02870-3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Iwamoto Y, 2012, ARTERIOSCL THROM VAS, V32, P2295, DOI 10.1161/ATVBAHA.112.249680; Kaufer E, 1997, ANN THORAC SURG, V63, P1118, DOI 10.1016/S0003-4975(96)01393-8; KAY HR, 1976, ANN THORAC SURG, V21, P504, DOI 10.1016/S0003-4975(10)63917-3; Kinoshita T, 2017, J THORAC CARDIOV SUR, V153, P317, DOI 10.1016/j.jtcvs.2016.09.037; Kinoshita T, 2014, EUR J CARDIO-THORAC, V45, P726, DOI 10.1093/ejcts/ezt430; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannacio V, 2012, ANN THORAC SURG, V94, P1934, DOI 10.1016/j.athoracsur.2012.06.040; Muir AD, 2010, OXID MED CELL LONGEV, V3, P199, DOI 10.4161/oxim.3.3.11757; Nakajima T, 2016, J THORAC CARDIOV SUR, V151, P1704, DOI 10.1016/j.jtcvs.2016.02.018; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLeary DH, 1996, STROKE, V27, P224, DOI 10.1161/01.STR.27.2.224; Omar RZ, 2004, ANN THORAC SURG, V77, P2232, DOI 10.1016/j.athoracsur.2003.10.032; Otsuka F, 2013, ANN CARDIOTHORAC SUR, V2, P519, DOI 10.3978/j.issn.2225-319X.2013.07.06; Ozkan S, 2007, J CARDIAC SURG, V22, P385, DOI 10.1111/j.1540-8191.2007.00431.x; Perrotta I, 2014, ULTRASTRUCT PATHOL, V38, P199, DOI 10.3109/01913123.2013.868568; Qureshi AR, 2015, KIDNEY INT, V88, P1356, DOI 10.1038/ki.2015.194; Reddy S, 2011, CLINICS, V66, P131, DOI 10.1590/S1807-59322011000100023; Ruengsakulrach P, 1999, CIRCULATION, V100, P139; Sahar G, 2015, J THORAC CARDIOV SUR, V149, P1042, DOI 10.1016/j.jtcvs.2014.12.028; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; SISTO T, 1989, ANN THORAC SURG, V47, P884, DOI 10.1016/0003-4975(89)90027-1; Zulli A, 2003, ARTERIOSCL THROM VAS, V23, P1308, DOI 10.1161/01.ATV.0000078902.50489.9B	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211421	10.1371/journal.pone.0211421	http://dx.doi.org/10.1371/journal.pone.0211421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682154	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500168
J	Galmes-Panades, AM; Konieczna, J; Abete, I; Colom, A; Rosique-Esteban, N; Zulet, MA; Vazquez, Z; Estruch, R; Vidal, J; Toledo, E; Babio, N; Fiol, M; Casas, R; Vera, J; Buil-Cosiales, P; de Paz, JA; Goday, A; Salas-Salvado, J; Martinez, JA; Romaguera, D; Monino, M; Morey, M; Pereira, V; Martin, MA; Yanez, A; Llobera, J; Ripoll, J; Prieto, R; Grases, F; Costa, A; Fernandez-Palomeque, C; Fortuny, E; Noris, M; Munuera, S; Tomas, F; Fiol, F; Jover, A; Janer, JM; Vallespir, C; Mattei, I; Feuerbach, N; Sureda, MD; Vega, S; Quintana, L; Fiol, A; Amador, M; Gonzalez, S; Coll, J; Moya, A; Sanmartin, TPYMD; Pena, C; Cantero, I; Cristobo, C; Ibero-Baraibar, I; Martinez, JA; Burgui, MDL; Ruiz, NG; Resano, RB; Caceres, EC; Lopez, TE; Osacain, EE; Sanz, BP; Platero, IB; Azcarate, SAA; Aznar, AG; Sesma, EU; Bilbao, BO; Jarauta, JM; Sarasa, LU; Echarte, BR; Rubio, MVG; Diaz-Lopez, A; Llaberia, RP; Gonzalez, R; Alamo, RS; Palleja, FP; Balsells, J; Roca, JM; Gallisa, TB; Vizcaino, J; Alpizarte, PL; Perpina, CA; Vernet, ML; Caballerom, C; Barco, MG; Martinez, MDM; Rossello, JG; Del Pozo, A; Calaf, CP; Zabal, PA; Floresvi, X; Benet, MC; Galindo, AP; Vila, JJC; Andres, FD; Soler, M; Vidal, MG; Ricard, JVJBCM; Saiz, F; Isach, A; Martinez, MSM; Font, EG; Luque, CL; Bullo, M; Becerra-Tomas, N; Mestres, G; Basora, J; Mena-Sanchez, G; Pinol, LB; Segura, MG; Papandreou, C; Chig, S; Cano, IA; Garcia, VR; Salas-Huetos, A; Paz, I; Niembro, LS; Hernandez, P; Hernandez, P; Camacho-Barcia, L; Garcia-Gavilan, J; Martinez-Gonzalez, MA; Ruiz-Canela, M; Razquin, C; Bes-Rastrollo, M; Tainta, AS; Aranguren, BS; Goni, E; Barrientos, I; Canales, M; Rico, A; Gortari, JB; Arellano, AG; Diez-Espino, J; Juarez, OL; Osinaga, JCC; Resano, JB; Sola-Larraza, A; Lozano-Oloriz, E; Cano-Valles, B; Eguaras, S; Roquet-Jalmar, EP; Galilea-Zabalza, I; Lancova, H; Ramallal, R; Garcia-Perez, ML; Estremera-Urabayen, V; Ariz-Arnedo, MJ; Hijos-Larraz, C; Alfaro, CF; Inigo-Martinez, B; Moreno, RV; Martin-Almendros, S; Barandiaran-Bengoetxea, L; Fuertes-Goni, C; Lezaun-Indurain, A; Guruchaga-Arcelus, MJ; Olmedo-Cruz, O; Inigo-Martinez, B; Escriche-Erviti, L; Ansorena-Ros, R; Zabaleta, RS; Apalategi-Lasa, J; Villanueva-Telleria, J; Hernandez-Espinosa, MM; Arroyo-Bergera, I; Herrera-Valdez, L; Dorronsoro-Dorronsoro, L; Reina, CM; de la Victoria, EOM; Torres, IV; Masclans, JV; Puig, JIP; Tania-Marisa; Freitas-Simoes; Domenech, M; Sierra, C; Camafort, M; Fontana, G; Castro, S; Sadurni, M; Vinas, C; Villanueva, P; Soriano, R; de la Poza, M; Cots, J; Llovet, JM; Carbonell, C; Garcia, Y; Altirriba, J; Aragunde, V; Villa, TF; Olea, SD; Fernandez, ME; Vazquez, JPF; de la Iglesia, JL; Gil, JIL; Ule, EC; Bul, MR; Sibai, AA; Hernandez, AG				Galmes-Panades, Aina M.; Konieczna, Jadwiga; Abete, Itziar; Colom, Antoni; Rosique-Esteban, Nuria; Angeles Zulet, Maria; Vazquez, Zenaida; Estruch, Ramon; Vidal, Josep; Toledo, Estefania; Babio, Nancy; Fiol, Miguel; Casas, Rosa; Vera, Josep; Buil-Cosiales, Pilar; Antonio de Paz, Jose; Goday, Albert; Salas-Salvado, Jordi; Alfredo Martinez, J.; Romaguera, Dora; Monino, Manuel; Morey, Margarita; Pereira, Veronica; Angeles Martin, Maria; Yanez, Aina; Llobera, Joan; Ripoll, Joana; Prieto, Rafael; Grases, Felix; Costa, Antonia; Fernandez-Palomeque, Carlos; Fortuny, Elena; Noris, Marta; Munuera, Susana; Tomas, Francisco; Fiol, Francisca; Jover, Antoni; Ma Janer, Juana; Vallespir, Catalina; Mattei, Isabel; Feuerbach, Natalia; del Mar Sureda, Maria; Vega, Silvia; Quintana, Lourdes; Fiol, Aina; Amador, Miriam; Gonzalez, Susana; Coll, Joan; Moya, Ana; Dolores Sanmartin, Teresa Pique y Maria; Pena, Cristina; Cantero, Irene; Cristobo, Carmen; Ibero-Baraibar, Idoia; Agreda Martinez, Javier; Lezaun Burgui, Ma Dolores; Goni Ruiz, Nuria; Bartolome Resano, Rafael; Cano Caceres, Eugenia; Elcarte Lopez, Teresa; Echarte Osacain, Elena; Perez Sanz, Beatriz; Blanco Platero, Itziar; Andueza Azcarate, Simon Antonio; Gimeno Aznar, Alvaro; Ursua Sesma, Eugenia; Ojeda Bilbao, Benito; Martinez Jarauta, Javier; Ugalde Sarasa, Lourdes; Ripodas Echarte, Blanca; Gueto Rubio, Ma Victoria; Diaz-Lopez, Andres; Pedret Llaberia, Roser; Gonzalez, Rosi; Sagarra Alamo, Ramon; Paris Palleja, Fransec; Balsells, Josep; Roca, Josep M.; Basora Gallisa, Teresa; Vizcaino, Jesus; Llobet Alpizarte, Pilar; Anguera Perpina, Carmen; Llaurado Vernet, Montse; Caballerom, Carmen; Garcia Barco, Maite; Moran Martinez, Maria Dolores; Garcia Rossello, Josep; Del Pozo, Albert; Poblet Calaf, Carmina; Arcelin Zabal, Pierre; Floresvi, Xavier; Ciutat Benet, Marta; Palau Galindo, Antonio; Cabre Vila, Josep J.; Dolz Andres, Fernando; Soler, Marc; Gracia Vidal, Mayte; Maritxell Ricard, J. Vilalta Juan Boj Casajuana; Saiz, F.; Isach, Anna; Marin Martinez, M. Sanchez; Granado Font, Esther; Lucena Luque, Carmen; Bullo, Monica; Becerra-Tomas, Nerea; Mestres, Gloria; Basora, Josep; Mena-Sanchez, Guilermo; Barrubes Pinol, Laura; Gil Segura, Marta; Papandreou, Christopher; Chig, Samira; Abellan Cano, I.; Ruiz Garcia, Veronica; Salas-Huetos, Albert; Paz, Indira; Sanchez Niembro, Laura; Hernandez, Pablo; Hernandez, Pablo; Camacho-Barcia, Lucia; Garcia-Gavilan, Jesus; Martinez-Gonzalez, Miguel A.; Ruiz-Canela, Miguel; Razquin, Cristina; Bes-Rastrollo, Maira; Sanchez Tainta, Ana; SanJulian Aranguren, Beatriz; Goni, Estibaliz; Barrientos, Irene; Canales, Maria; Rico, Anais; Basterra Gortari, Javier; Garcia Arellano, Ana; Diez-Espino, Javier; Lecea Juarez, Oscar; Cenoz Osinaga, Juan Carlos; Bartolome Resano, Javier; Sola-Larraza, Ana; Lozano-Oloriz, Elisa; Cano-Valles, Begona; Eguaras, Sonia; Pascual Roquet-Jalmar, Elena; Galilea-Zabalza, Inigo; Lancova, Hana; Ramallal, Raul; Luisa Garcia-Perez, Ma; Estremera-Urabayen, Vicente; Jose Ariz-Arnedo, Ma; Hijos-Larraz, Carmen; Fernandez Alfaro, Cristina; Inigo-Martinez, Begona; Villanueva Moreno, Ramon; Martin-Almendros, Sonia; Barandiaran-Bengoetxea, Luisa; Fuertes-Goni, Carmen; Lezaun-Indurain, Ana; Jose Guruchaga-Arcelus, Ma; Olmedo-Cruz, Oscar; Inigo-Martinez, Begona; Escriche-Erviti, Luis; Ansorena-Ros, Roberto; Sanmatin Zabaleta, Rosario; Apalategi-Lasa, Jon; Villanueva-Telleria, Jerusalen; Mar Hernandez-Espinosa, Ma; Arroyo-Bergera, Isabel; Herrera-Valdez, Lissy; Dorronsoro-Dorronsoro, Lourdes; Mestre Reina, Carla; Martinez de la Victoria, Emilio Ortega; Vinagre Torres, Irene; Viaplana Masclans, Judit; Pla Puig, Jose Ignacio; Tania-Marisa; Freitas-Simoes; Domenech, M.; Sierra, C.; Camafort, M.; Fontana, Gabriel; Castro, S.; Sadurni, M.; Vinas, C.; Villanueva, P.; Soriano, R.; de la Poza, M.; Cots, J. M.; Llovet, J. M.; Carbonell, C.; Garcia, Y.; Altirriba, J.; Aragunde, V.; Fernandez Villa, Tania; de Abajo Olea, Serafin; Escobar Fernandez, Miguel; Fernandez Vazquez, Jose Pedro; Lopez de la Iglesia, Jaime; Lopez Gil, Juan Ignacio; Carriedo Ule, Elena; Rodriguez Bul, Manuel; Adlbi Sibai, Abdurrahman; Garcia Hernandez, Alberto		PREDIMED-Plus Investigators	Lifestyle factors and visceral adipose tissue: Results from the PREDIMED-PLUS study	PLOS ONE			English	Article							MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; SEDENTARY TIME; ABDOMINAL FAT; ADHERENCE; ASSOCIATION; OVERWEIGHT; OBESITY; WOMEN	Background Visceral adipose tissue (VAT) is a strong predictor of cardiometabolic health, and lifestyle factors may have a positive influence on VAT depot. This study aimed to assess the cross-sectional associations between baseline levels of physical activity (PA), sedentary behaviours (SB) and adherence to the Mediterranean diet (MedDiet) with VAT depot in older individuals with overweight/obesity and metabolic syndrome. Methods Baseline data of the PREDIMED-Plus study including a sample of 1,231 Caucasian men and women aged 55-75 years were used. Levels of leisure-time PA (total, light, and moderate-to-vigorous, in METs. min/day) and SB (total and TV-viewing, in h/day) were evaluated using validated questionnaires. Adherence to the MedDiet was evaluated using a 17-item energy-restricted MedDiet (erMedDiet) screener. The chair-stand test was used to estimate the muscle strength. VAT depot was assessed with DXA-CoreScan. Multivariable adjusted linear regression models were used to evaluate the association between lifestyle factors and VAT. For the statistics we had used multiadjusted linear regression models. Results Total leisure-time PA (100 METs. min/day: beta -24.3g, -36.7; -11.9g), moderate-to-vigorous PA (beta -27.8g, 95% CI -40.8;-14.8g), chair-stand test (repeat: beta -11.5g, 95% CI -20.1;-2.93g) were inversely associated, and total SB (h/day: beta 38.2g, 95% CI 14.7; 61.7) positively associated with VAT. Light PA, TV-viewing time and adherence to an erMedDiet were not significantly associated with VAT. Conclusions In older adults with overweigh/obesity and metabolic syndrome, greater PA, muscle strength, and lower total SB were associated with less VAT depot. In this study, adherence to an erMedDiet was not associated with lower VAT.	[Galmes-Panades, Aina M.; Konieczna, Jadwiga; Colom, Antoni; Fiol, Miguel; Romaguera, Dora] Univ Hosp Son Espases, Balearic Isl Hlth Res Inst IdISBa, Palma De Mallorca, Spain; [Galmes-Panades, Aina M.; Konieczna, Jadwiga; Abete, Itziar; Colom, Antoni; Rosique-Esteban, Nuria; Angeles Zulet, Maria; Vazquez, Zenaida; Estruch, Ramon; Toledo, Estefania; Babio, Nancy; Fiol, Miguel; Casas, Rosa; Buil-Cosiales, Pilar; Salas-Salvado, Jordi; Alfredo Martinez, J.; Romaguera, Dora] Hlth Inst Carlos III ISCIII, CIBER Pathophysiol Obes & Nutr CIBEROBN, Madrid, Spain; [Abete, Itziar; Angeles Zulet, Maria; Alfredo Martinez, J.] Univ Navarra UNAV, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Rosique-Esteban, Nuria; Babio, Nancy; Salas-Salvado, Jordi; Diaz-Lopez, Andres; Paris Palleja, Fransec; Balsells, Josep; Roca, Josep M.; Vizcaino, Jesus; Anguera Perpina, Carmen; Llaurado Vernet, Montse; Caballerom, Carmen; Garcia Barco, Maite; Moran Martinez, Maria Dolores; Garcia Rossello, Josep; Del Pozo, Albert; Poblet Calaf, Carmina; Ciutat Benet, Marta; Palau Galindo, Antonio; Cabre Vila, Josep J.; Dolz Andres, Fernando; Soler, Marc; Gracia Vidal, Mayte; Maritxell Ricard, J. Vilalta Juan Boj Casajuana; Saiz, F.; Isach, Anna; Marin Martinez, M. Sanchez; Granado Font, Esther; Lucena Luque, Carmen; Bullo, Monica; Becerra-Tomas, Nerea; Mestres, Gloria; Basora, Josep; Mena-Sanchez, Guilermo; Barrubes Pinol, Laura; Gil Segura, Marta; Papandreou, Christopher; Abellan Cano, I.; Salas-Huetos, Albert; Paz, Indira; Sanchez Niembro, Laura; Hernandez, Pablo; Camacho-Barcia, Lucia; Garcia-Gavilan, Jesus] Rovira & Virgili Univ, Human Nutr Unit, Univ Hosp St Joan de Reus, Dept Biochem & Biotechnol,Pere Virgili Inst Hlth, Reus, Spain; [Vazquez, Zenaida; Toledo, Estefania; Buil-Cosiales, Pilar] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Estruch, Ramon; Casas, Rosa] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Internal Med, Barcelona, Spain; [Vidal, Josep] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Endocrinol, Barcelona, Spain; [Vidal, Josep] Hlth Inst Carlos III ISCIII, CIBER Diabet & Metab Dis CIBERdem, Madrid, Spain; [Vera, Josep] Inst Biomed Res August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Buil-Cosiales, Pilar] Hlth Serv Navarra Osasunbidea, Primary Care, Pamplona, Spain; [Antonio de Paz, Jose] Univ Leon, Div Prevent Med, Leon, Spain; [Goday, Albert] Municipal Inst Med Res IMIM, Lipids & Cardiovasc Epidemiol Res Unit, Barcelona, Spain; [Alfredo Martinez, J.] Madrid Inst Adv Studies IMDEA, Food Inst, Madrid, Spain; [Monino, Manuel; Morey, Margarita; Pereira, Veronica; Angeles Martin, Maria; Yanez, Aina; Llobera, Joan; Ripoll, Joana; Prieto, Rafael; Grases, Felix; Costa, Antonia; Fernandez-Palomeque, Carlos; Fortuny, Elena; Noris, Marta; Munuera, Susana; Tomas, Francisco; Fiol, Francisca; Jover, Antoni; Ma Janer, Juana; Vallespir, Catalina; Mattei, Isabel; Feuerbach, Natalia; del Mar Sureda, Maria; Vega, Silvia; Quintana, Lourdes; Fiol, Aina; Amador, Miriam; Gonzalez, Susana; Coll, Joan; Moya, Ana; Dolores Sanmartin, Teresa Pique y Maria; Pena, Cristina] Hosp Son Espases HUSE, Palma De Mallorca, Spain; [Monino, Manuel; Morey, Margarita; Pereira, Veronica; Angeles Martin, Maria; Yanez, Aina; Llobera, Joan; Ripoll, Joana; Prieto, Rafael; Grases, Felix; Costa, Antonia; Fernandez-Palomeque, Carlos; Fortuny, Elena; Noris, Marta; Munuera, Susana; Tomas, Francisco; Fiol, Francisca; Jover, Antoni; Ma Janer, Juana; Vallespir, Catalina; Mattei, Isabel; Feuerbach, Natalia; del Mar Sureda, Maria; Vega, Silvia; Quintana, Lourdes; Fiol, Aina; Amador, Miriam; Gonzalez, Susana; Coll, Joan; Moya, Ana; Dolores Sanmartin, Teresa Pique y Maria; Pena, Cristina] Inst Invest Sanitaria Illes Balea IdISBa, Palma De Mallorca, Spain; [Cantero, Irene; Cristobo, Carmen; Ibero-Baraibar, Idoia; Agreda Martinez, Javier; Lezaun Burgui, Ma Dolores; Goni Ruiz, Nuria; Bartolome Resano, Rafael; Cano Caceres, Eugenia; Elcarte Lopez, Teresa; Echarte Osacain, Elena; Perez Sanz, Beatriz; Blanco Platero, Itziar; Andueza Azcarate, Simon Antonio; Gimeno Aznar, Alvaro; Ursua Sesma, Eugenia; Ojeda Bilbao, Benito; Martinez Jarauta, Javier; Ugalde Sarasa, Lourdes; Ripodas Echarte, Blanca; Gueto Rubio, Ma Victoria] Univ Navarra, Dept Nutr Food Sci & Physiol, Ctr Nutr Res, Pamplona, Spain; [Diaz-Lopez, Andres; Pedret Llaberia, Roser; Gonzalez, Rosi; Sagarra Alamo, Ramon; Paris Palleja, Fransec; Balsells, Josep; Roca, Josep M.; Basora Gallisa, Teresa; Vizcaino, Jesus; Llobet Alpizarte, Pilar; Anguera Perpina, Carmen; Llaurado Vernet, Montse; Caballerom, Carmen; Garcia Barco, Maite; Moran Martinez, Maria Dolores; Garcia Rossello, Josep; Del Pozo, Albert; Poblet Calaf, Carmina; Arcelin Zabal, Pierre; Floresvi, Xavier; Ciutat Benet, Marta; Palau Galindo, Antonio; Cabre Vila, Josep J.; Dolz Andres, Fernando; Soler, Marc; Gracia Vidal, Mayte; Maritxell Ricard, J. Vilalta Juan Boj Casajuana; Saiz, F.; Isach, Anna; Marin Martinez, M. Sanchez; Granado Font, Esther; Lucena Luque, Carmen; Bullo, Monica; Becerra-Tomas, Nerea; Mestres, Gloria; Basora, Josep; Mena-Sanchez, Guilermo; Barrubes Pinol, Laura; Gil Segura, Marta; Papandreou, Christopher; Chig, Samira; Abellan Cano, I.; Ruiz Garcia, Veronica; Salas-Huetos, Albert; Paz, Indira; Sanchez Niembro, Laura; Camacho-Barcia, Lucia; Garcia-Gavilan, Jesus] Univ Navarra, Dept Prevent Med & Publ Hlth, Navarra Inst Hlth Res, Pamplona, Spain; [Diaz-Lopez, Andres; Pedret Llaberia, Roser; Gonzalez, Rosi; Sagarra Alamo, Ramon; Paris Palleja, Fransec; Balsells, Josep; Roca, Josep M.; Basora Gallisa, Teresa; Vizcaino, Jesus; Llobet Alpizarte, Pilar; Anguera Perpina, Carmen; Llaurado Vernet, Montse; Caballerom, Carmen; Garcia Barco, Maite; Moran Martinez, Maria Dolores; Garcia Rossello, Josep; Del Pozo, Albert; Poblet Calaf, Carmina; Arcelin Zabal, Pierre; Floresvi, Xavier; Ciutat Benet, Marta; Palau Galindo, Antonio; Cabre Vila, Josep J.; Dolz Andres, Fernando; Soler, Marc; Gracia Vidal, Mayte; Maritxell Ricard, J. Vilalta Juan Boj Casajuana; Saiz, F.; Isach, Anna; Marin Martinez, M. Sanchez; Granado Font, Esther; Lucena Luque, Carmen; Bullo, Monica; Becerra-Tomas, Nerea; Mestres, Gloria; Basora, Josep; Mena-Sanchez, Guilermo; Barrubes Pinol, Laura; Gil Segura, Marta; Papandreou, Christopher; Chig, Samira; Abellan Cano, I.; Ruiz Garcia, Veronica; Salas-Huetos, Albert; Paz, Indira; Sanchez Niembro, Laura; Camacho-Barcia, Lucia; Garcia-Gavilan, Jesus] Univ Navarra, Dept Prevent Med & Publ Hlth, Primary Care Ctr, Pamplona, Spain; [Mestre Reina, Carla; Martinez de la Victoria, Emilio Ortega; Vinagre Torres, Irene; Viaplana Masclans, Judit; Pla Puig, Jose Ignacio; Tania-Marisa; Freitas-Simoes] Hosp Clin Barcelona, Dept Endocrinol & Nutr, Barcelona, Spain; [Domenech, M.; Sierra, C.; Camafort, M.; Fontana, Gabriel; Castro, S.; Sadurni, M.; Vinas, C.; Villanueva, P.; Soriano, R.; de la Poza, M.; Cots, J. M.; Llovet, J. M.; Carbonell, C.; Garcia, Y.; Altirriba, J.; Aragunde, V.] Univ Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Hosp Clin, Dept Internal Med,Biomed Res Inst, Barcelona, Spain; [Fernandez Villa, Tania; de Abajo Olea, Serafin; Escobar Fernandez, Miguel; Fernandez Vazquez, Jose Pedro; Lopez de la Iglesia, Jaime; Lopez Gil, Juan Ignacio; Carriedo Ule, Elena; Rodriguez Bul, Manuel; Adlbi Sibai, Abdurrahman; Garcia Hernandez, Alberto] Univ Leon, Grp Invest Interacc Gen Ambiente & Salud, Leon, Spain; [Fernandez Villa, Tania; de Abajo Olea, Serafin; Escobar Fernandez, Miguel; Fernandez Vazquez, Jose Pedro; Lopez de la Iglesia, Jaime; Lopez Gil, Juan Ignacio; Carriedo Ule, Elena; Rodriguez Bul, Manuel; Adlbi Sibai, Abdurrahman; Garcia Hernandez, Alberto] Gerencia Atenc Primaria Sacyl, Leon, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Servicio Navarro de Salud - Osasunbidea; Universidad de Leon; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Navarra; University of Navarra; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Leon	Konieczna, J; Romaguera, D (corresponding author), Univ Hosp Son Espases, Balearic Isl Hlth Res Inst IdISBa, Palma De Mallorca, Spain.; Konieczna, J; Romaguera, D (corresponding author), Hlth Inst Carlos III ISCIII, CIBER Pathophysiol Obes & Nutr CIBEROBN, Madrid, Spain.	jadzia.konieczna@gmail.com; mariaadoracion.romaguera@ssib.es	Ruiz-Canela, Miguel/I-7738-2016; Prieto, Rafel M./J-3995-2017; García-Gavilán, Jesús F/ABG-9982-2020; Camacho-Barcia, Lucía/AAB-2096-2021; Razquin, Cristina/H-2366-2017; Toledo, Estefania/H-6211-2014; Fiol, Miguel/F-6793-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Vázquez-Ruiz, Zenaida/AAB-7202-2020; de Paz, José Antonio/M-4930-2015; Estruch, Ramon/AAZ-3723-2020; Salas-Huetos, Albert/A-8509-2011; Salas-Salvado, Jordi/C-7229-2017; Fernandez, Antoni Colom/ABG-1017-2021; Domenech, Monica/AFV-2635-2022; Fernandez-Palomeque, Carlos/A-4019-2011; Galmes-Panades, Aina M/AAB-8361-2021; Llovet, Josep M/ABB-6264-2021; Casas, Rosa/ABD-1915-2020; García, José Carlos Fernández/X-3910-2019; Soler, Marc/AAF-9126-2019; Yañez, Aina M/AAF-7087-2021; Konieczna, Jadwiga/AAB-2817-2020; Romaguera, Dora/ABE-7004-2020; Becerra-Tomás, Nerea/H-3937-2018; Babkowski, Miguel Camafort/AAE-3657-2021; Bes-Rastrollo, Maira/A-1329-2009; Camafort-Babkowski, Miguel/H-6310-2014; Llobera, Joan/T-9094-2017; García, José Carlos Fernández/B-3723-2013; Romaguera, Dora/AAB-2852-2020; Babio, Nancy/AAN-2715-2020; Bulló, Mònica/F-2925-2016; Moñino, Manuel/AAD-3308-2020	Ruiz-Canela, Miguel/0000-0002-7684-2787; Prieto, Rafel M./0000-0001-8814-900X; García-Gavilán, Jesús F/0000-0002-3707-5255; Camacho-Barcia, Lucía/0000-0002-5989-936X; Razquin, Cristina/0000-0003-3480-2645; Toledo, Estefania/0000-0002-6263-4434; Fiol, Miguel/0000-0002-5370-1391; Vázquez-Ruiz, Zenaida/0000-0002-6828-9627; de Paz, José Antonio/0000-0002-4389-1777; Salas-Huetos, Albert/0000-0001-5914-6862; Salas-Salvado, Jordi/0000-0003-2700-7459; Fernandez, Antoni Colom/0000-0001-5041-0778; Fernandez-Palomeque, Carlos/0000-0002-6881-4487; Galmes-Panades, Aina M/0000-0001-6977-9874; Llovet, Josep M/0000-0003-0547-2667; Casas, Rosa/0000-0002-0211-9166; García, José Carlos Fernández/0000-0003-2308-2865; Yañez, Aina M/0000-0001-8527-3937; Romaguera, Dora/0000-0002-5762-8558; Becerra-Tomás, Nerea/0000-0002-4429-6507; Bes-Rastrollo, Maira/0000-0002-9139-4206; Camafort-Babkowski, Miguel/0000-0002-8669-6410; Llobera, Joan/0000-0003-4113-4251; García, José Carlos Fernández/0000-0003-2308-2865; Babio, Nancy/0000-0003-3527-5277; Bulló, Mònica/0000-0002-0218-7046; Sagarra Alamo, Ramon/0000-0002-5544-0172; Konieczna, Jadwiga/0000-0002-2947-1338; Monino, Manuel/0000-0003-1230-8013; Buil-Cosiales, Pilar/0000-0002-8586-577X; Vidal, Josep/0000-0002-4564-4518	CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund [PI13/00462, PI13/01090, PI13/02184, PI14/00853, PI14/00728, PI14/01919, PI16/00501, PI16/00381, PI16/01522, PI17/00525, PI17/00532, PI17/00215, PI17/00926]; Especial Action Project; European Research Council [340918]; Recercaixa [2013ACUP00194]; SEMERGEN grant; International Nut & Dried Fruit Council -FESNAD [201302]; AstraZeneca Young Investigators Award in Category of Obesity; Juan de la Cierva-formacion research grant of the Spanish Ministry of Economy, Industry and Competitiveness [FJCI-2015-24058]	CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn); Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund; Especial Action Project; European Research Council(European Research Council (ERC)European Commission); Recercaixa(La Caixa Foundation); SEMERGEN grant; International Nut & Dried Fruit Council -FESNAD; AstraZeneca Young Investigators Award in Category of Obesity(AstraZeneca); Juan de la Cierva-formacion research grant of the Spanish Ministry of Economy, Industry and Competitiveness	This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (four coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00462, PI13/01090, PI13/02184, PI14/00853, PI14/00728, PI14/01919, PI16/00501, PI16/00381, PI16/01522, PI17/00525, PI17/00532, PI17/00215, PI17/00926 and the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica Cohorte PREDIMED-Plus [J.S.-S.]; the European Research Council (Advanced Research Grant 2013-2018; grant number 340918); the Recercaixa (grant number 2013ACUP00194) [J.S.-S.]; the SEMERGEN grant; International Nut & Dried Fruit Council -FESNAD (Long-term effects of an energy-restricted Mediterranean diet on mortality and cardiovascular disease 2014 -2015, No. 201302) [Miguel A. Martinez-Gonzalez]; the AstraZeneca Young Investigators Award in Category of Obesity and T2D 2017 [D.R.]; Juan de la Cierva-formacion research grant (FJCI-2015-24058) of the Spanish Ministry of Economy, Industry and Competitiveness [J.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2018, PHYS ACT OLD AD; Barnes J, 2013, MENT HEALTH PHYS ACT, V6, P55, DOI 10.1016/j.mhpa.2012.06.001; Bendall CL, 2018, CRIT REV FOOD SCI, V58, P3070, DOI 10.1080/10408398.2017.1351917; Bertoli S, 2015, CLIN NUTR, V34, P1266, DOI 10.1016/j.clnu.2015.10.003; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Chey T, 2012, J SCI MED, V15, P81; Clark BK, 2011, MED SCI SPORT EXER, V43, P822, DOI 10.1249/MSS.0b013e3182019510; Dahl-Petersen IK, 2017, MED SCI SPORT EXER, V49, P2064, DOI 10.1249/MSS.0000000000001337; Eguaras S, 2015, NUTR METAB CARDIOVAS, V25, P569, DOI 10.1016/j.numecd.2015.03.001; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fischer KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126644; Friedenreich CM, 2011, INT J OBESITY, V35, P427, DOI 10.1038/ijo.2010.147; Friedenreich CM, 2015, JAMA ONCOL, V1, P766, DOI 10.1001/jamaoncol.2015.2239; Funtikova AN, 2014, BRIT J NUTR, V111, P1481, DOI 10.1017/S0007114513003966; Gepner Y, 2018, CIRCULATION, V137, P1143, DOI 10.1161/CIRCULATIONAHA.117.030501; Gomez-Cabello A, 2012, MATURITAS, V73, P337, DOI 10.1016/j.maturitas.2012.09.001; Henson J, 2018, OBESITY, V26, P29, DOI 10.1002/oby.22034; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kaul S, 2012, OBESITY, V20, P1313, DOI 10.1038/oby.2011.393; Keating SE, 2016, J OBES, V2016, DOI 10.1155/2016/2719014; Konieczna J, 2018, CLIN NUTR, P1; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; Martinez-Gonzalez MA, 2018, INT J EPIDEMIOL, P1; Molina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168148; Murabito JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001379; Ohkawara K, 2007, INT J OBESITY, V31, P1786, DOI 10.1038/sj.ijo.0803683; Philipsen A, 2015, MED SCI SPORT EXER, V47, P983, DOI 10.1249/MSS.0000000000000504; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Riechman SE, 2002, OBES RES, V10, P1065, DOI 10.1038/oby.2002.144; Romaguera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023384; Rosique-Esteban N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172253; Saunders TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054225; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Shibata A, 2016, MED SCI SPORT EXER, V48, P633, DOI 10.1249/MSS.0000000000000803; Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vissers D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056415; Whitaker KM, 2017, MED SCI SPORT EXER, V49, P450, DOI 10.1249/MSS.0000000000001112; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; World Health Organization, 2010, GLOB STRAT DIET PHYS; Xiao T, 2015, EUR REV MED PHARMACO, V19, P1779	45	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210726	10.1371/journal.pone.0210726	http://dx.doi.org/10.1371/journal.pone.0210726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682078	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500057
J	Muench, D; Rezzoug, F; Thomas, SD; Xiao, JJ; Islam, A; Miller, DM; Sedoris, KC				Muench, David; Rezzoug, Francine; Thomas, Shelia D.; Xiao, Jingjing; Islam, Ashraful; Miller, Donald M.; Sedoris, Kara C.			Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells	PLOS ONE			English	Article							G-RICH OLIGONUCLEOTIDES; PROXIMAL PROMOTER; ANTIPROLIFERATIVE ACTIVITY; GENE-TRANSCRIPTION; NUCLEIC-ACIDS; A549 CELLS; DNA; ANGIOGENESIS; EXPRESSION; AUTOPHAGY	Background Vascular endothelial growth factor (VEGF) is commonly overexpressed in a variety of tumor types including lung cancer. As a key regulator of angiogenesis, it promotes tumor survival, growth, and metastasis through the activation of the downstream protein kinase B (AKT) and extracellular signal-regulated kinase (ERK 1/2) activation. The VEGF promoter contains a 36 bp guanine-rich sequence (VEGFq) which is capable of forming quadruplex (fourstranded) DNA. This sequence has been implicated in the down-regulation of both basal and inducible VEGF expression and represents an ideal target for inhibition of VEGF expression. Results Our experiments demonstrate sequence-specific interaction between a G-rich quadruplexforming oligonucleotide encoding a portion of the VEGFq sequence and its double stranded target sequence, suggesting that this G-rich oligonucleotide binds specifically to its complementary C-rich sequence in the genomic VEGF promoter by strand invasion. We show that treatment of A549 non-small lung cancer cells (NSCLC) with this oligonucleotide results in decreased VEGF expression and growth inhibition. The VEGFq oligonucleotide inhibits proliferation and invasion by decreasing VEGF mRNA/protein expression and subsequent ERK 1/2 and AKT activation. Furthermore, the VEGFq oligonucleotide is abundantly taken into cells, localized in the cytoplasm/nucleus, inherently stable in serum and intracellularly, and has no effect on non-transformed cells. Suppression of VEGF expression induces cytoplasmic accumulation of autophagic vacuoles and increased expression of LC3B, suggesting that VEGFq may induce autophagic cell death. Conclusion Our data strongly suggest that the G-rich VEGFq oligonucleotide binds specifically to the Crich strand of the genomic VEGF promoter, via strand invasion, stabilizing the quadruplex structure formed by the genomic G-rich sequence, resulting in transcriptional inhibition. Strand invading oligonucleotides represent a new approach to specifically inhibit VEGF expression that avoids many of the problems which have plagued the therapeutic use of oligonucleotides. This is a novel approach to specific inhibition of gene expression.	[Muench, David] Univ Cincinnati, Dept Immunobiol, Cincinnati, OH USA; [Rezzoug, Francine; Thomas, Shelia D.; Xiao, Jingjing; Miller, Donald M.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Islam, Ashraful] Univ Tabuk, Fac Med, Tabuk, Saudi Arabia; [Sedoris, Kara C.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA	University System of Ohio; University of Cincinnati; University of Louisville; University of Tabuk; University of Louisville	Miller, DM (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	donaldmi@ulh.org	Islam, Ashraful/GYR-1579-2022	Islam, Ashraful/0000-0002-1742-6804; Muench, David E./0000-0002-8723-3389	National Institutes of Health [P30GM106396, 1R21CA191663-01A1]; Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [R21CA191663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health, grant #: P30GM106396, grant #: 1R21CA191663-01A1, URL: https://www.nih.gov; Helmsley Charitable Trust, grant #: N/A, URL: https://helmsleytrust.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2011, BIOL PHARM BULL, V34, P1264, DOI 10.1248/bpb.34.1264; Adjei AA, 2005, CLIN LUNG CANCER, V7, P221, DOI 10.3816/CLC.2005.n.040; [Anonymous], 2006, CURR PROB CANCER, V30, P7, DOI 10.1016/j.currproblcancer.2005.11.001; Barr MP, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0310-8; Bates Paula J., 2009, V542, P379, DOI 10.1007/978-1-59745-561-9_21; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bikfalvi A, 2002, TRENDS PHARMACOL SCI, V23, P576, DOI 10.1016/S0165-6147(02)02109-0; Blancher C, 2000, CANCER RES, V60, P7106; Brognard J, 2002, CELL DEATH DIFFER, V9, P893, DOI 10.1038/sj.cdd.4401054; Chaires JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115580; Chen ZQ, 1997, CANCER RES, V57, P2013; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; Fontanini G, 2002, BRIT J CANCER, V86, P558, DOI 10.1038/sj.bjc.6600130; Forsha SJ, 2010, OLIGONUCLEOTIDES, V20, P277, DOI 10.1089/oli.2010.0255; Geny S, 2016, NUCLEIC ACIDS RES, V44, P2007, DOI 10.1093/nar/gkw021; Han H, 2001, ANN SURG ONCOL, V8, P72, DOI 10.1245/aso.2001.8.1.72; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; He R, 2003, CANCER GENE THER, V10, P879, DOI 10.1038/sj.cgt.7700645; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Herbst RS, 2005, J CLIN ONCOL, V23, P3243, DOI 10.1200/JCO.2005.18.853; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu PP, 2013, J CANCER RES CLIN, V139, P1157, DOI 10.1007/s00432-013-1425-1; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Islam MA, 2014, J BIOL CHEM, V289, P8521, DOI 10.1074/jbc.M113.505073; Jaboin JJ, 2009, METHOD ENZYMOL, V453, P287, DOI 10.1016/S0076-6879(08)04014-7; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Komi Y, 2010, LAB INVEST, V90, P52, DOI 10.1038/labinvest.2009.110; Kormuth KA, 2016, BIOCHEMISTRY-US, V55, P1749, DOI 10.1021/acs.biochem.6b00026; Ku MJ, 2013, BIOORG MED CHEM LETT, V23, P5609, DOI 10.1016/j.bmcl.2013.08.043; Lee YC, 2010, EUR J PHARMACOL, V632, P23, DOI 10.1016/j.ejphar.2010.01.009; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; MARTINYBARON G, 1995, CURR OPIN BIOTECH, V6, P675, DOI 10.1016/0958-1669(95)80111-1; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Murphy CT, 2014, BIOCHEMISTRY-US, V53, P5315, DOI 10.1021/bi5006859; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Oyaghire SN, 2016, BIOCHEMISTRY-US, V55, P1977, DOI 10.1021/acs.biochem.6b00055; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Rezzoug F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161588; Saintigny P, 2012, DISCOV MED, V13, P287; Schafer G, 2003, J BIOL CHEM, V278, P8190, DOI 10.1074/jbc.M211999200; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Shi Q, 2001, CANCER RES, V61, P4143; Shih YW, 2009, J AGR FOOD CHEM, V57, P3490, DOI 10.1021/jf900124r; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun D, 2008, MOL CANCER THER, V7, P880, DOI 10.1158/1535-7163.MCT-07-2119; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Toi M, 2001, LANCET ONCOL, V2, P667, DOI 10.1016/S1470-2045(01)00556-3; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Wild R, 2004, INT J CANCER, V110, P343, DOI 10.1002/ijc.20100; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yuan A, 2000, INT J CANCER, V89, P475, DOI 10.1002/1097-0215(20001120)89:6<475::AID-IJC2>3.0.CO;2-T	67	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211046	10.1371/journal.pone.0211046	http://dx.doi.org/10.1371/journal.pone.0211046			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682194	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500092
J	Qi, WJ; Allen, AS; Li, YJ				Qi, Wenjing; Allen, Andrew S.; Li, Yi-Ju			Family-based association tests for rare variants with censored traits	PLOS ONE			English	Article							AGE-AT-ONSET; QUANTITATIVE TRAITS; ALZHEIMER-DISEASE; SEQUENCING DATA; LINKAGE; MODELS; LOCI	We propose a set of family-based burden and kernel tests for censored traits (FamBAC and FamKAC). Here, censored traits refer to time-to-event outcomes, for instance, age-at-onset of a disease. To model censored traits in family-based designs, we used the frailty model, which incorporated not only fixed genetic effects of rare variants in a region of interest but also random polygenic effects shared within families. We first partitioned genotype scores of rare variants into orthogonal between- and within-family components, and then derived their corresponding efficient score statistics from the frailty model. Finally, FamBAC and FamKAC were constructed by aggregating the weighted efficient scores of the within-family components across rare variants and subjects. FamBAC collapsed rare variants within subject first to form a burden test that followed a chi-squared distribution; whereas FamKAC was a variant component test following a mixture of chi-squared distributions. For FamKAC, p-values can be computed by permutation tests or for computational efficiency by approximation methods. Through simulation studies, we showed that type I error was correctly controlled by FamBAC for various variant weighting schemes ( 0.0371 to 0.0527). However, FamKAC type I error rates based on approximation methods were deflated (max 0.0376) but improved by permutation tests. Our simulations also demonstrated that burden test FamBAC had higher power than kernel test FamKAC when high proportion (e.g. >= 80%) of causal variants had effects in the same direction. In contrast, when the effects of causal variants on the censored trait were in mixed directions, FamKAC outperformed FamBAC and had comparable or higher power than an existing method, RVFam. Our proposed framework has the flexibility to accommodate general nuclear families, and can be used to analyze sequence data for censored traits such as age-at-onset of a complex disease of interest.	[Qi, Wenjing; Allen, Andrew S.; Li, Yi-Ju] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Qi, Wenjing; Li, Yi-Ju] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Allen, Andrew S.] Duke Univ, Ctr Stat Genet & Genom, Durham, NC USA	Duke University; Duke University; Duke University	Li, YJ (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA.; Li, YJ (corresponding author), Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA.	yiju.li@duke.edu		Allen, Andrew/0000-0002-7232-2143; Li, Yi-Ju/0000-0001-6996-4834	Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University; Duke Clinical and Translational Science Institute (Duke CTSI) - Duke CTSA grant from National Institute of Health (NIH) [NIH UL1TR001117]; R01 grant from National Institute of Aging of NIH [1R01AG060472-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG060472] Funding Source: NIH RePORTER	Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University; Duke Clinical and Translational Science Institute (Duke CTSI) - Duke CTSA grant from National Institute of Health (NIH); R01 grant from National Institute of Aging of NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Faculty Methodology Award from Department of Biostatistics and Bioinformatics at Duke University and Duke Clinical and Translational Science Institute (Duke CTSI), which is supported in part by the Duke CTSA grant NIH UL1TR001117 from National Institute of Health (NIH), and the R01 grant from National Institute of Aging of NIH (1R01AG060472-01) to Y.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Cai TX, 2011, BIOMETRICS, V67, P975, DOI 10.1111/j.1541-0420.2010.01544.x; Chen H, 2014, GENET EPIDEMIOL, V38, P191, DOI 10.1002/gepi.21791; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chen MH, 2016, BIOINFORMATICS, V32, P624, DOI 10.1093/bioinformatics/btv609; Chien LC, 2017, GENET EPIDEMIOL, V41, P511, DOI 10.1002/gepi.22054; Davies RB, 1980, APPLIED STATISTICS, V29, P323, DOI DOI 10.2307/2346911; Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710; De G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048495; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hill-Burns EM, 2016, HUM MOL GENET, V25, P3849, DOI 10.1093/hmg/ddw206; Jiang D, 2014, GENET EPIDEMIOL, V38, P10, DOI 10.1002/gepi.21775; Jiang Y, 2017, GENET EPIDEMIOL, V41, P98, DOI 10.1002/gepi.22022; Jiang YX, 2014, GENET EPIDEMIOL, V38, P542, DOI 10.1002/gepi.21839; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li YJ, 2002, AM J HUM GENET, V70, P985, DOI 10.1086/339815; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Lin XY, 2011, GENET EPIDEMIOL, V35, P620, DOI 10.1002/gepi.20610; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Naj AC, 2014, JAMA NEUROL, V71, P1394, DOI 10.1001/jamaneurol.2014.1491; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schifano ED, 2012, GENET EPIDEMIOL, V36, P797, DOI 10.1002/gepi.21676; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zawistowski M, 2014, EUR J HUM GENET, V22, P1137, DOI 10.1038/ejhg.2013.297; Zhang L, 2009, AM J HUM GENET, V84, P431, DOI 10.1016/j.ajhg.2009.02.010; Zollner S, 2012, EUR J HUM GENET, V20, P1085, DOI 10.1038/ejhg.2012.58	37	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210870	10.1371/journal.pone.0210870	http://dx.doi.org/10.1371/journal.pone.0210870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682063	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500070
J	Wang, H; Zhou, LY; Guan, ZB; Zeng, WB; Zhou, LL; Liu, YN; Pan, XY				Wang, Hong; Zhou, Lin-Yu; Guan, Ze-Bing; Zeng, Wen-Bin; Zhou, Lan-Lan; Liu, Ya-Nan; Pan, Xue-Yi			Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis	PLOS ONE			English	Article							B-CELL LYMPHOMA; DNA METHYLATION; MULTIPLE GENES; HYPERMETHYLATION; KINASE; DIFFUSE; CLASSIFICATION; AGGRESSIVENESS	We aimed to characterize the clinical significance of epigenetic loss of death-associated protein kinase (DAPK) gene function through promoter methylation in the development and prognosis of lymphoma. PubMed, Web of Science and ProQuest databases were searched for relevant studies. Twelve studies involving 709 patients with lymphoma were identified. The prognostic value of DAPK methylation was expressed as risk ratio (RR) and its corresponding 95% confidence interval (CI), while the associations between DAPK methylation and the clinical characteristics of patients with lymphoma were expressed as odd ratios (ORs) and their corresponding 95% CIs. Meta-analysis showed that the 5-year survival rate was significantly lower in lymphoma patients with hypermethylated DAPK (RR = 0.85, 95% CI (0.73, 0.98), P = 0.025). Sensitivity analysis demonstrated consistent result. However, no associations were found between DAPK methylation and clinicopathological features of lymphoma, in relation to gender (OR = 1.07, 95% CI (0.72, 1.59), P = 0.751), age (OR = 1.01, 95% CI (0.66, 1.55), P = 0.974), international prognostic index (OR = 1.20, 95% CI (0.63, 2.27), P = 0.575), B symptoms (OR = 0.76, 95% CI (0.38, 1.51), P = 0.452), serum lactate dehydrogenase (OR = 1.13, 95% CI (0.62, 2.05), P = 0.683), and BCL-2 expression (OR = 1.55, 95% CI (0.91, 2.66), P = 0.106). Lymphoma patients with hypermethylated DAPK are at risk for poorer 5-year survival rate. DAPK methylation may serve as a negative prognostic biomarker among lymphoma patients, although it may not be associated with the progression of lymphoma.	[Wang, Hong; Guan, Ze-Bing; Zeng, Wen-Bin; Zhou, Lan-Lan; Liu, Ya-Nan; Pan, Xue-Yi] Guangdong Pharmaceut Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Lin-Yu] Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Sun Yat Sen University	Pan, XY (corresponding author), Guangdong Pharmaceut Univ, Dept Hematol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	xueyi.pan@yandex.com	Zeng, Wen/GPS-8058-2022		Science and Technology Planning Project of Guangdong Province, China [2014A020212415]; Natural Science Foundation of Guangdong Province [2017A030313664]; Science and Technology Project of Guangzhou Yuexiu District [2017-W S-008]	Science and Technology Planning Project of Guangdong Province, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Project of Guangzhou Yuexiu District	This work was supported by the Science and Technology Planning Project of Guangdong Province, China (2014A020212415), the Natural Science Foundation of Guangdong Province (2017A030313664), and the Science and Technology Project of Guangzhou Yuexiu District (2017-W S-008) to XYP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara K, 2008, ANN ONCOL, V19, P1774, DOI 10.1093/annonc/mdn374; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Ben Dhiab M, 2015, CELL ONCOL, V38, P453, DOI 10.1007/s13402-015-0242-8; Chan AWH, 2005, ONCOL REP, V13, P937; Chan WC, 1997, BLOOD, V89, P3909; Chu LC, 2006, INT J CANCER, V119, P2487, DOI 10.1002/ijc.22124; Cohen O, 2001, CELL DEATH DIFFER, V8, P6, DOI 10.1038/sj.cdd.4400794; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Giachelia M, 2014, J MOL DIAGN, V16, P467, DOI 10.1016/j.jmoldx.2014.03.003; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Huang Q, 2007, LEUKEMIA LYMPHOMA, V48, P1988, DOI 10.1080/10428190701573224; Jia WZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005040; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; Kondo T, 2009, INT J ONCOL, V35, P547, DOI 10.3892/ijo_00000366; Krajnovic M, 2014, CTS-CLIN TRANSL SCI, V7, P384, DOI 10.1111/cts.12162; Kristensen LS, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0261-y; Kristensen LS, 2014, ONCOTARGET, V5, P9798, DOI 10.18632/oncotarget.2394; Kristensen LS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02789; Michie AM, 2010, FEBS J, V277, P74, DOI 10.1111/j.1742-4658.2009.07414.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Munch-Petersen HD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0307-6; Nakamichi I, 2007, ANN HEMATOL, V86, P557, DOI 10.1007/s00277-007-0299-1; Raveh T, 2001, EXP CELL RES, V264, P185, DOI 10.1006/excr.2000.5134; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Rossi D, 2004, HAEMATOLOGICA, V89, P154; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Takino H, 2008, MODERN PATHOL, V21, P1517, DOI 10.1038/modpathol.2008.159; Takino H, 2013, LEUKEMIA LYMPHOMA, V54, P1742, DOI 10.3109/10428194.2013.765563; Tang XM, 2000, JNCI-J NATL CANCER I, V92, P1511, DOI 10.1093/jnci/92.18.1511	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210943	10.1371/journal.pone.0210943	http://dx.doi.org/10.1371/journal.pone.0210943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682070	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500077
J	Someya, Y; Tamura, Y; Kohmura, Y; Aoki, K; Kawai, S; Daida, H; Naito, H				Someya, Yuki; Tamura, Yoshifumi; Kohmura, Yoshimitsu; Aoki, Kazuhiro; Kawai, Sachio; Daida, Hiroyuki; Naito, Hisashi			A body mass index over 22 kg/m(2) at college age is a risk factor for future diabetes in Japanese men	PLOS ONE			English	Article							BETA-CELL FUNCTION; METABOLIC-DISORDERS; INSULIN SENSITIVITY; OBESITY; OVERWEIGHT; BMI; TAIWANESE; HEALTH	Background There is a high incidence of type 2 diabetes in Asian adults, even those with a normal body mass index (BMI) (<25.0 kg/m(2)). For example, it has been shown that a slightly increased BMI (>23 kg/m(2)) at middle age is a risk factor for type 2 diabetes in Asians. In this historical cohort study, we investigated whether a slightly increased BMI at college age was also a risk factor for future diabetes in Japanese men. Methods Six hundred and sixty-one male alumni who graduated from a physical education school between 1971 and 1991 and who responded to follow-up investigation between 2007 and 2017 were included in this study. Participants were categorized into four categories: college BMI of <21.0 kg/m(2), 21.0-22.0 kg/m(2), 22.0-23.0 kg/m(2), and >= 23.0 kg/m(2), and the incidence and risk ratio of diabetes were compared between groups. Results The median follow-up period was 32 years (interquartile range, IQR: 27-36), which included 20,983 person-years of observation. Subjects were 22 (22-22) years old at college graduation, and 55 (50-59) years old at the final follow-up investigation. During the study period, 56 men developed diabetes; the prevalence rates for the lowest to highest BMI categories were 4.4%, 7.6%, 10.5%, and 11.3%, respectively, and their adjusted hazard ratios were 1.00 (reference), 1.77 (95% CI: 0.68-4.30), 2.42 (1.00-5.84), and 2.53 (1.06-6.07), respectively (p = 0.03 for trend). Conclusion Our data suggest that a BMI over 22.0 kg/m(2) at college age is a risk factor for diabetes later in life in Japanese men.	[Someya, Yuki; Tamura, Yoshifumi] Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan; [Someya, Yuki; Tamura, Yoshifumi] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan; [Someya, Yuki; Kawai, Sachio; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Kohmura, Yoshimitsu; Aoki, Kazuhiro] Juntendo Univ, Fac Hlth & Sports Sci, Chiba, Japan; [Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiol, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Someya, Y; Tamura, Y (corresponding author), Juntendo Univ, Grad Sch Med, Sportol Ctr, Tokyo, Japan.; Someya, Y; Tamura, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Tokyo, Japan.; Someya, Y (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan.	yksomeya@juntendo.ac.jp; ys-tamur@juntendo.ac.jp	Tamura, Yoshifumi/AFK-2430-2022; Naito, Hisashi/F-5655-2011	Naito, Hisashi/0000-0002-0522-9512; Tamura, Yoshifumi/0000-0002-1685-7821; Someya, Yuki/0000-0003-1657-3199	High Technology Research Center Grant; KAKENHI [17K13229]	High Technology Research Center Grant; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the High Technology Research Center Grant and KAKENHI (Grants-in-Aid for Young Scientists (B)), 17K13229 to Dr. Yuki Someya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], 2017, J PHYS FIT SPORTS ME, DOI DOI 10.7600/JPFSM.6.167; BARRETTCONNOR EL, 1985, ANN INTERN MED, V103, P1010, DOI 10.7326/0003-4819-103-6-1010; Bjerregaard LG, 2018, NEW ENGL J MED, V378, P1302, DOI [10.1056/NEJMoa1713231, 10.1056/nejmoa1713231]; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chan JCN, 2014, DIABETES RES CLIN PR, V103, P244, DOI 10.1016/j.diabres.2013.11.012; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Gallagher D, 2004, OBES RES, V12, P440, DOI 10.1038/oby.2004.48; Heianza Y, 2014, HYPERTENSION, V64, P247, DOI 10.1161/HYPERTENSIONAHA.113.02918; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P56, DOI 10.1016/S0929-6646(09)60109-1; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Jackson AS, 2012, BRIT J NUTR, V107, P1085, DOI 10.1017/S0007114511003886; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; Koksal Burcu, 2015, Open Access Maced J Med Sci, V3, P380, DOI 10.3889/oamjms.2015.093; Moller JB, 2014, J CLIN ENDOCR METAB, V99, P4273, DOI 10.1210/jc.2014-1724; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; PAFFENBARGER RS, 1973, AM J EPIDEMIOL, V97, P314, DOI 10.1093/oxfordjournals.aje.a121511; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Power C, 2011, DIABETES CARE, V34, P1986, DOI 10.2337/dc10-1482; Sakuta Hidenari, 2008, Environmental Health and Preventive Medicine, V13, P116, DOI 10.1007/s12199-007-0010-0; Someya Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191170; Someya Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-493; Sorkin JD, 1999, AM J EPIDEMIOL, V150, P969, DOI 10.1093/oxfordjournals.aje.a010106; Takeno K, 2016, J CLIN ENDOCR METAB, V101, P3676, DOI 10.1210/jc.2016-1650; World Health Organization, 2018, THE TOP 10 CAUSES OF; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]; Yabe D, 2016, LANCET DIABETES ENDO, V4, P2, DOI 10.1016/S2213-8587(15)00389-7	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211067	10.1371/journal.pone.0211067	http://dx.doi.org/10.1371/journal.pone.0211067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677099	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400045
J	Minematsu, A; Miyazaki, T; Shimamura, S; Nishikawa, H; Nakayama, H; Takazono, T; Saijo, T; Yamamoto, K; Imamura, Y; Yanagihara, K; Kohno, S; Mukae, H; Izumikawa, K				Minematsu, Asuka; Miyazaki, Taiga; Shimamura, Shintaro; Nishikawa, Hiroshi; Nakayama, Hironobu; Takazono, Takahiro; Saijo, Tomomi; Yamamoto, Kazuko; Imamura, Yoshifumi; Yanagihara, Katsunori; Kohno, Shigeru; Mukae, Hiroshi; Izumikawa, Koichi			Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; ACIDIFICATION; MEMBRANE; ALBICANS; BAFILOMYCINS; CALCINEURIN; HOMEOSTASIS; MECHANISMS; EVOLUTION	Vacuolar proton-translocating ATPase (V-ATPase) is located in fungal vacuolar membranes. It is involved in multiple cellular processes, including the maintenance of intracellular ion homeostasis by maintaining acidic pH within the cell. The importance of V-ATPase in virulence has been demonstrated in several pathogenic fungi, including Candida albicans. However, it remains to be determined in the clinically important fungal pathogen Candida glabrata. Increasing multidrug resistance of C. glabrata is becoming a critical issue in the clinical setting. In the current study, we demonstrated that the plecomacrolide V-ATPase inhibitor bafilomycin B1 exerts a synergistic effect with azole antifungal agents, including fluconazole and voriconazole, against a C. glabrata wild-type strain. Furthermore, the deletion of the VPH2 gene encoding an assembly factor of V-ATPase was sufficient to interfere with V-ATPase function in C. glabrata, resulting in impaired pH homeostasis in the vacuole and increased sensitivity to a variety of environmental stresses, such as alkaline conditions (pH 7.4), ion stress (Na+, Ca2+, Mn2+, and Zn2+ stress), exposure to the calcineurin inhibitor FK506 and antifungal agents (azoles and amphotericin B), and iron limitation. In addition, virulence of C. glabrata Delta vph2 mutant in a mouse model of disseminated candidiasis was reduced in comparison with that of the wild-type and VPH2-reconstituted strains. These findings support the notion that V-ATPase is a potential attractive target for the development of effective antifungal strategies.	[Minematsu, Asuka; Miyazaki, Taiga; Takazono, Takahiro; Izumikawa, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Nagasaki, Japan; [Minematsu, Asuka; Miyazaki, Taiga; Shimamura, Shintaro; Nishikawa, Hiroshi; Takazono, Takahiro; Saijo, Tomomi; Yamamoto, Kazuko; Imamura, Yoshifumi; Kohno, Shigeru; Mukae, Hiroshi] Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan; [Nakayama, Hironobu] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan; [Nishikawa, Hiroshi] Otsuka Pharmaceut Co Ltd, Infect Dis Unit, Dept Med Innovat, New Drug Res Div, Tokushima, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Otsuka Pharmaceutical	Miyazaki, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Infect Dis, Nagasaki, Japan.; Miyazaki, T (corresponding author), Nagasaki Univ Hosp, Dept Resp Med, Nagasaki, Japan.	taiga-m@nagasaki-u.ac.jp		Takazono, Takahiro/0000-0002-0696-5386	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) [JP18fk0108008]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was partially supported by the Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development (AMED) (https://www.amed.go.jp/en/program/list/01/06/002.html) (grant number JP18fk0108008 to T.M. and S.K.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arendrup MC, 2017, J INFECT DIS, V216, pS445, DOI 10.1093/infdis/jix131; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CLINICAL AND LABORATORY STANDARDS INSTITUTE (CLSI), 2012, REFERENCE METHOD BRO, V4th; Committee for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Graham LA, 1999, J BIOENERG BIOMEMBR, V31, P39, DOI 10.1023/A:1005492429471; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hayek SR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00004; HEMENWAY CS, 1995, GENETICS, V141, P833; Hilty J, 2008, MOL MICROBIOL, V70, P127, DOI 10.1111/j.1365-2958.2008.06395.x; HIRATA R, 1993, J BIOL CHEM, V268, P961; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Jia N, 2002, ANTIMICROB AGENTS CH, V46, P947, DOI 10.1128/AAC.46.4.947-957.2002; Johnson MD, 2004, ANTIMICROB AGENTS CH, V48, P693, DOI 10.1128/AAC.48.3.693-715.2004; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Nagayoshi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180990; Nishikawa H, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow054; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Patenaude C, 2013, J BIOL CHEM, V288, P26256, DOI 10.1074/jbc.M113.494815; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rahman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055704; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Whaley SG, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02173; Wiederhold NP, 2017, INFECT DRUG RESIST, V10, P249, DOI 10.2147/IDR.S124918; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	45	9	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210883	10.1371/journal.pone.0210883	http://dx.doi.org/10.1371/journal.pone.0210883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673768	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800055
J	Mir, RA; Kleinhenz, MD; Coetzee, JF; Allen, HK; Kudva, IT				Mir, Raies A.; Kleinhenz, Michael D.; Coetzee, Johann F.; Allen, Heather K.; Kudva, Indira T.			Fecal microbiota changes associated with dehorning and castration stress primarily affects light-weight dairy calves	PLOS ONE			English	Article							PLASMA-CORTISOL; LOCAL-ANESTHESIA; HEAT-STRESS; RESPONSES; CATTLE; PAIN; INFECTION; BEHAVIOR; DISTRESS; PIPELINE	Gastrointestinal tract (GIT) microbiota and stress can impact animal health. Studies have shown that perturbations in the GIT microbiota can influence host health and productivity by affecting physiological homeostasis, metabolism, hematopoiesis and inflammation. The present study aimed to evaluate possible effects of dehorning and castration stress on the GIT microbiota of dairy calves. Dehorning and castration are routinely performed on over 90% of dairy farms, and analgesics like flunixin meglumine (FLU) are given at the time of these procedures to reduce pain. We analyzed fecal microbiota of 24 weaned male dairy calves at two different stages in their life (at 10 weeks for dehorning and 36 weeks age for castration) to determine any GIT microbiota changes due to these stressful procedures and the FLU treatment. Dehorning was performed using an electrocautery dehorner applied to the horn for 10 seconds, and surgical castration was used as the castration method. Our analysis showed that the Shannon diversity index was significantly higher in animals that were not dehorned compared to dehorned animals. Castration stress also resulted in a significant decrease in Shannon diversity index, which was more pronounced in lower weight calves. Body weight and stress had significant effects on the taxonomic profiles of the GIT microbiota. There was a significant difference in the GIT bacterial community structure between heavy- and light-weight calves at Day 3 after castration but not at Day 0 (prior to castration). Our results indicate that dehorning and castration stress reduced microbial diversity of the GIT microbiota, but only in light-weight calves. This work is important for elucidating biological effects of stress on dairy calves and identifying potential modulation points in the microbiota of these food-producing animals to improve animal health and production.	[Mir, Raies A.; Allen, Heather K.; Kudva, Indira T.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Mir, Raies A.] ARS, ORISE, Res Participat Program, Oak Ridge, TN USA; [Kleinhenz, Michael D.] Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med, Ames, IA USA; [Kleinhenz, Michael D.; Coetzee, Johann F.] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Iowa State University; Kansas State University	Allen, HK; Kudva, IT (corresponding author), ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	Heather.Allen@ars.usda.gov; Indira.Kudva@ars.usda.gov	Kleinhenz, Michael/AAD-4696-2021; Coetzee, Hans/GOK-3477-2022	Coetzee, Hans/0000-0003-1802-3991	USDA-ARS CRIS projects [5030-32000-112-00D, 5030-32000-004-00D]	USDA-ARS CRIS projects(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by USDA-ARS CRIS projects 5030-32000-112-00D and 5030-32000-004-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich P, 2007, OMICS, V11, P413, DOI 10.1089/omi.2007.0023; Allen Heather K, 2016, BMC Res Notes, V9, P380, DOI 10.1186/s13104-016-2172-6; Auffret MD, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0378-z; Ballou MA, 2013, VET IMMUNOL IMMUNOP, V151, P285, DOI 10.1016/j.vetimm.2012.11.018; Bates AJ, 2016, NEW ZEAL VET J, V64, P282, DOI 10.1080/00480169.2016.1196626; Baumgard LH, 2011, J DAIRY SCI, V94, P5620, DOI 10.3168/jds.2011-4462; Burrow HM, 1997, AUST J EXP AGR, V37, P407, DOI 10.1071/EA96148; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; CHASE CC, 1995, J ANIM SCI, V73, P975; Chen LM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01688; Chen Y, 2015, ANIMALS-BASEL, V5, P1268, DOI 10.3390/ani5040411; Coetzee JF, 2011, APPL ANIM BEHAV SCI, V135, P192, DOI 10.1016/j.applanim.2011.10.016; Cox LM, 2016, ANIM FRONT, V6, P8, DOI 10.2527/af.2016-0028; Deng LX, 2017, ANIM SCI J, V88, P790, DOI 10.1111/asj.12615; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Eshar D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-62; Fisher AD, 2001, AUST VET J, V79, P279, DOI 10.1111/j.1751-0813.2001.tb11981.x; FUQUAY JW, 1981, J ANIM SCI, V52, P164, DOI 10.2527/jas1981.521164x; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Huazano-Garcia A, 2017, NUTRIENTS, V9, DOI [10.3390/nu9090821, 10.3390/nu9080821]; Khan MA, 2016, J DAIRY SCI, V99, P885, DOI 10.3168/jds.2015-9975; KING BD, 1991, CAN J ANIM SCI, V71, P257, DOI 10.4141/cjas91-033; Kleinhenz MD, 2018, LIVEST SCI, V212, P1, DOI 10.1016/j.livsci.2018.03.016; Kleinhenz MD, 2017, J ANIM SCI, V95, P1993, DOI 10.2527/jas.2016.1138; Kling-Eveillard F, 2015, LIVEST SCI, V179, P12, DOI 10.1016/j.livsci.2015.05.012; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Lyte M, 2006, PHYSIOL BEHAV, V89, P350, DOI 10.1016/j.physbeh.2006.06.019; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; McGlone J, 2010, GUIDE CARE USE AGRIC, P1; Meale SJ, 2017, J DAIRY SCI, V100, P5984, DOI 10.3168/jds.2016-12474; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Moggy MA, 2017, J ANIM SCI, V95; Noel SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173819; Paz HA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01206; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Rea K, 2016, NEUROBIOL STRESS, V4, P23, DOI 10.1016/j.ynstr.2016.03.001; ROBERTSON IS, 1994, RES VET SCI, V56, P8, DOI 10.1016/0034-5288(94)90189-9; Rogers MAM, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.003; Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09; Salas-Mani A, 2018, J ANIM SCI, V96, P3102, DOI 10.1093/jas/sky193; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Stilwell G, 2010, RES VET SCI, V88, P188, DOI 10.1016/j.rvsc.2009.06.012; Stock ML, 2015, J DAIRY SCI, V98, P6058, DOI 10.3168/jds.2014-8877; Syer SD, 2015, J GASTROENTEROL, V50, P387, DOI 10.1007/s00535-014-1032-1; Sylvester SP, 1998, AUST VET J, V76, P118, DOI 10.1111/j.1751-0813.1998.tb14542.x; Thompson NM, 2017, J DAIRY SCI, V100, P4941, DOI 10.3168/jds.2016-12099; Underwood WJ, 2002, J AM VET MED ASSOC, V221, P208, DOI 10.2460/javma.2002.221.208; USDA APHIS, 2014, 3 USDA APHIS CO US, P62; Voisinet BD, 1997, J ANIM SCI, V75, P892; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yun Y, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1052-0	57	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210203	10.1371/journal.pone.0210203	http://dx.doi.org/10.1371/journal.pone.0210203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673718	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800034
J	Tuanthap, S; Vongpunsawad, S; Luengyosluechakul, S; Sakkaew, P; Theamboonlers, A; Amonsin, A; Poovorawan, Y				Tuanthap, Supansa; Vongpunsawad, Sompong; Luengyosluechakul, Supol; Sakkaew, Phanlert; Theamboonlers, Apiradee; Amonsin, Alongkorn; Poovorawan, Yong			Genome constellations of 24 porcine rotavirus group A strains circulating on commercial Thai swine farms between 2011 and 2016	PLOS ONE			English	Article							GENETIC DIVERSITY; PROVIDES EVIDENCE; CHIANG-MAI; DIARRHEA; ORIGIN; CLASSIFICATION; REVEALS; PIGLETS; MC323; RARE	Rotavirus A (RVA) infection is a major cause of diarrhea-related illness in young children. RVA is also one of the most common enteric viruses detected on pig farms and contributes to substantial morbidity and mortality in piglets. Long-term multi-site surveillance of RVA on Thai swine farms to determine the diversity of RVA strains in circulation is currently lacking. In this study, we characterized the 11 segments of the RVA genome from 24 Thai porcine RVA strains circulating between 2011 and 2016. We identified G9 (15/24) and P[13] (12/24) as the dominant genotypes. The dominant G and P combinations were G9P[13] (n = 6), G9P[23] (n = 6), G3P[13] (n = 5), G9P[19] (n = 3), G4P[6] (n = 2), G4P[19] (n = 1), and G5P [13] (n = 1). Genome constellation of the Thai strains showed the predominance of Wa-like genotype (Gx-P[x]-11/15-R1-C1-M1-A8-N1-T1/T7-E1/E9-H1) with evidence of reassortment between the porcine and human RVA strains (e.g., G4-P[6]-I1-R1-C1-M1-A8-N1-T1-E1-H1 and G9-P[19]-15-R1-C1-M1-A8-N1-T7-E9-H1). To assess the potential effectiveness of rotavirus vaccination, the Thai RVA strains were compared to the RVA strains represented in the swine rotavirus vaccine, which showed residue variations in the antigenic epitope on VP7 and shared amino acid identity below 90% for G4 and G5 strain. Several previous studies suggested these variations might effect on virus neutralization specificity and vaccine efficacy. Our study illustrates the importance of RVA surveillance beyond the G/P genotyping on commercial swine farms, which is crucial for controlling viral transmission.	[Tuanthap, Supansa] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program Biomed Sci, Bangkok, Thailand; [Vongpunsawad, Sompong; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Luengyosluechakul, Supol] Chulalongkorn Univ, Dept Vet Med, Fac Vet Sci, Bangkok, Thailand; [Sakkaew, Phanlert] Chulalongkorn Univ, Dept Vet Publ Hlth, Fac Vet Sci, Bangkok, Thailand; [Amonsin, Alongkorn] Chulalongkorn Univ, Ctr Excellence Emerging & Reemerging Infect Dis A, Fac Vet Sci, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand.; Amonsin, A (corresponding author), Chulalongkorn Univ, Ctr Excellence Emerging & Reemerging Infect Dis A, Fac Vet Sci, Bangkok, Thailand.	alongkom.a@chula.ac.th; yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; Tuanthap, Supansa/0000-0001-9167-194X; vongpunsawad, sompong/0000-0001-7520-8728	100th Anniversary Chulalongkorn University Fund; Research Chair Grant from NSTDA [P-15-50004]; Thailand Research Fund [RTA6080012]; Center of Excellence in Clinical Virology [GCE 59- 009-30-005]	100th Anniversary Chulalongkorn University Fund; Research Chair Grant from NSTDA; Thailand Research Fund(Thailand Research Fund (TRF)); Center of Excellence in Clinical Virology	This work was supported by The 100th Anniversary Chulalongkorn University Fund for doctoral scholarship to Supansa Tuanthap, The Research Chair Grant from NSTDA (P-15-50004), Thailand Research Fund (RTA6080012), and The Center of Excellence in Clinical Virology (GCE 59- 009-30-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Khamrin P, 2008, EMERG INFECT DIS, V14, P686, DOI 10.3201/eid1404.071111; Komoto S, 2017, J GEN VIROL, V98, P532, DOI 10.1099/jgv.0.000722; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Maneekarn N, 2006, J CLIN MICROBIOL, V44, P4113, DOI 10.1128/JCM.00954-06; Martel-Paradis O, 2013, VET MICROBIOL, V162, P94, DOI 10.1016/j.vetmic.2012.08.028; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Naseer O, 2017, VIROLOGY, V507, P53, DOI 10.1016/j.virol.2017.03.008; Okitsu S, 2013, INFECT GENET EVOL, V18, P74, DOI 10.1016/j.meegid.2013.05.005; Okitsu S, 2011, J CLIN MICROBIOL, V49, P442, DOI 10.1128/JCM.02263-10; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Pesavento JB, 2006, CURR TOP MICROBIOL, V309, P189; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Saif LJ, 1996, J INFECT DIS, V174, pS98, DOI 10.1093/infdis/174.Supplement_1.S98; Saikruang W, 2013, VET MICROBIOL, V161, P255, DOI 10.1016/j.vetmic.2012.07.036; Shi HY, 2012, ARCH VIROL, V157, P1897, DOI 10.1007/s00705-012-1363-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2014, CLIN INFECT DIS, V59, P1291, DOI 10.1093/cid/ciu564; Theuns S, 2015, J VIROL, V89, P1043, DOI 10.1128/JVI.02513-14; Tuanthap S, 2018, PEERJ, V6, DOI 10.7717/peerj.4724; URASAWA S, 1992, J INFECT DIS, V166, P227, DOI 10.1093/infdis/166.2.227; Vesikari T, 2012, CLIN MICROBIOL INFEC, V18, P57, DOI 10.1111/j.1469-0691.2012.03981.x; Vlasova AN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030048; Yodmeeklin A, 2017, INFECT GENET EVOL, V47, P99, DOI 10.1016/j.meegid.2016.11.021; Yodmeeklin A, 2016, ARCH VIROL, V161, P2843, DOI 10.1007/s00705-016-2976-7	32	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211002	10.1371/journal.pone.0211002	http://dx.doi.org/10.1371/journal.pone.0211002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673764	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800063
J	Yadav, MK; Aravindan, S; Ngangkham, U; Raghu, S; Prabhukarthikeyan, SR; Keerthana, U; Marndi, BC; Adak, T; Munda, S; Deshmukh, R; Pramesh, D; Samantaray, S; Rath, PC				Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Raghu, S.; Prabhukarthikeyan, S. R.; Keerthana, U.; Marndi, B. C.; Adak, Totan; Munda, Susmita; Deshmukh, Rupesh; Pramesh, D.; Samantaray, Sanghamitra; Rath, P. C.			Blast resistance in Indian rice landraces: Genetic dissection by gene specific markers	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; ORYZA-SATIVA L.; DURABLE RESISTANCE; REPEAT PROTEIN; IDENTIFICATION; SOFTWARE; DISEASE; GENOMICS; ENCODES; COMPLEX	Understanding of genetic diversity is important to explore existing gene in any crop breeding program. Most of the diversity preserved in the landraces which are well known reservoirs of important traits for biotic and abiotic stresses. In the present study, the genetic diversity at twenty-four most significant blast resistance gene loci using twenty-eight gene specific markers were investigated in landraces originated from nine diverse rice ecologies of India. Based on phenotypic evaluation, landraces were classified into three distinct groups: highly resistant (21), moderately resistant (70) and susceptible (70). The landraces harbour a range of five to nineteen genes representing blast resistance allele with the frequency varied from 4.96% to 100%. The cluster analysis grouped entire 161 landraces into two major groups. Population structure along with other parameters was also analyzed to understand the evolution of blast resistance gene in rice. The population structure analysis and principal coordinate analysis classified the landraces into two sub populations. Analysis of molecular variance showed maximum (93%) diversity within the population and least (7%) between populations. Five markers viz; K3957, Pikh, Pi2-i, RM212and RM302 were strongly associated with blast disease with the phenotypic variance of 1.4% to 7.6%. These resistant land races will serve as a valuable genetic resource for future genomic studies, host pathogen interaction, identification of novel R genes and rice improvement strategies.	[Yadav, Manoj Kumar; Aravindan, S.; Ngangkham, Umakanta; Raghu, S.; Prabhukarthikeyan, S. R.; Keerthana, U.; Marndi, B. C.; Adak, Totan; Munda, Susmita; Samantaray, Sanghamitra; Rath, P. C.] ICAR Natl Rice Res Inst, Cuttack, Orissa, India; [Deshmukh, Rupesh] Natl Agri Food Biotechnol Inst NABI, Mohali, Punjab, India; [Pramesh, D.] Univ Agr Sci, AICRIP, Rice Pathol Lab, Raichur, India; [Ngangkham, Umakanta] ICAR Res Complex North East Hill Reg, Umiam, Meghalaya, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Indian Council of Agricultural Research (ICAR); ICAR - ICAR Research Complex for NEH Region	Yadav, MK (corresponding author), ICAR Natl Rice Res Inst, Cuttack, Orissa, India.	m.yadav14@gmail.com	Devanna, Pramesh/AAE-2090-2021; Adak, Totan/K-4221-2012; Deshmukh, Rupesh Kailasrao/C-6479-2012	Devanna, Pramesh/0000-0002-5229-443X; Adak, Totan/0000-0001-5971-1008; Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; Ngangkham, Umakanta/0000-0001-5792-0615				Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Berruyer R, 2003, THEOR APPL GENET, V107, P1139, DOI 10.1007/s00122-003-1349-2; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Campbell MA, 2004, PHYTOPATHOLOGY, V94, P302, DOI 10.1094/PHYTO.2004.94.3.302; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fuentes JL, 2008, EUPHYTICA, V160, P295, DOI 10.1007/s10681-007-9497-0; Fukuoka S, 2012, THEOR APPL GENET, V125, P551, DOI 10.1007/s00122-012-1852-4; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gao LiJun, 2010, Southwest China Journal of Agricultural Sciences, V23, P77; Ghaley BB, 2012, EUPHYTICA, V184, P119, DOI 10.1007/s10681-011-0582-z; Hayashi K, 2010, THEOR APPL GENET, V121, P1357, DOI 10.1007/s00122-010-1393-7; Hayashi K, 2006, JPN J OPHTHALMOL, V50, P345, DOI 10.1007/s10384-006-0335-z; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Imam J, 2014, EUPHYTICA, V196, P199, DOI 10.1007/s10681-013-1024-x; Ingole KD, 2014, INDIAN J GENET PL BR, V74, P378, DOI 10.5958/0975-6906.2014.00857.8; Jeon JS, 2003, MOL GENET GENOMICS, V269, P280, DOI 10.1007/s00438-003-0834-2; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Jia YL, 2002, CROP SCI, V42, P2145, DOI 10.2135/cropsci2002.2145; Jiang HC, 2012, MOL BREEDING, V30, P1679, DOI 10.1007/s11032-012-9751-6; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Koide Y, 2010, PLANT BREEDING, V129, P670, DOI 10.1111/j.1439-0523.2010.01781.x; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu XQ, 2005, MOL GENET GENOMICS, V274, P394, DOI 10.1007/s00438-005-0032-5; Liu Y, 2013, THEOR APPL GENET, V126, P985, DOI 10.1007/s00122-012-2031-3; Mahender A., 2012, African Journal of Biotechnology, V11, P1321; Marathi B, 2015, EUPHYTICA, V201, P1, DOI 10.1007/s10681-014-1251-9; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Ngangkham U, 2010, MOL BREEDING, V26, P275, DOI 10.1007/s11032-010-9397-1; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Ramkumar G, 2011, MOL BREEDING, V27, P129, DOI 10.1007/s11032-010-9538-6; RoyChowdhury M, 2012, PHYTOPATHOLOGY, V102, P700, DOI 10.1094/PHYTO-02-12-0026-R; RoyChowdhury M, 2012, EUPHYTICA, V184, P35, DOI 10.1007/s10681-011-0481-3; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Shikari AB, 2014, INDIAN J GENET PL BR, V74, P286, DOI 10.5958/0975-6906.2014.00846.3; Singh AK, 2015, PLANT PATHOLOGY J, V31, P12, DOI 10.5423/PPJ.OA.06.2014.0054; Su J, 2015, THEOR APPL GENET, V128, P2213, DOI 10.1007/s00122-015-2579-9; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Vasudevan K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00915; WANG GL, 1994, GENETICS, V136, P1421; Warschefsky E, 2014, AM J BOT, V101, P1791, DOI 10.3732/ajb.1400116; Wu JL, 2005, THEOR APPL GENET, V111, P50, DOI 10.1007/s00122-005-1971-2; Yadav MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176236; Yang YY, 2017, EUR J PLANT PATHOL, V148, P567, DOI 10.1007/s10658-016-1112-6; Zhai C, 2011, NEW PHYTOL, V189, P321, DOI 10.1111/j.1469-8137.2010.03462.x; Zheng WJ, 2016, THEOR APPL GENET, V129, P1035, DOI 10.1007/s00122-016-2681-7; Zhu D, 2016, RICE, V9, DOI 10.1186/s12284-016-0116-3; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433; 조영찬, 2007, Journal of Crop Science and Biotechnology, V10, P265	62	17	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211061	10.1371/journal.pone.0211061	http://dx.doi.org/10.1371/journal.pone.0211061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673751	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800071
J	Crizzle, AM; Dykeman, C; Laberge, S; MacLeod, A; Olsen-Lynch, E; Brunet, F; Andrews, A				Crizzle, Alexander M.; Dykeman, Cathy; Laberge, Sarah; MacLeod, Ann; Olsen-Lynch, Ellen; Brunet, France; Andrews, Angela			A public health approach to mobilizing community partners for injury prevention: A scoping review	PLOS ONE			English	Review							COALITIONS	Objectives Reducing injuries in adults requires work with diverse stakeholders across many sectors and at multiple levels. At the local level, public health professionals need to effectively bring together, facilitate, and support community partners to initiate evidence-based efforts. However, there has been no formal review of the literature to inform how these professionals can best create action among community partners to address injuries in adults. Thus, this scoping review aims to identify theories, models or frameworks that are applicable to a community-based approach to injury prevention. Methods Searches of scientific and less formal literature identified 13,756 relevant items published in the English language between 2000 and 2016 in North America, Europe and Australia. After screening and review, 10 publications were included that (1) identified a theory, framework or model related to mobilizing partners; and (2) referred to community-based adult injury prevention. Results Findings show that use of theories, frameworks and models in community-based injury prevention programs is rare and often undocumented. One theory and various conceptual models and frameworks exist for mobilizing partners to jointly prevent injuries; however, there are few evaluations of the processes to create community action. Conclusions Successful community-based injury prevention must build on what is already understood about creating partnership action. Evaluating local public health professional injury prevention practice based on available theories, models and frameworks will identify successes and challenges to inform process improvements. We propose a logic model to more specifically guide and evaluate how public health can work locally with community partners.	[Crizzle, Alexander M.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada; [Crizzle, Alexander M.; Laberge, Sarah] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Dykeman, Cathy] Halton Reg Hlth Dept, Oakville, ON, Canada; [MacLeod, Ann; Olsen-Lynch, Ellen] Trent Univ, Trent Fleming Sch Nursing, Peterborough, ON, Canada; [Brunet, France] Eastern Ontario Hlth Unit, Cornwall, ON, Canada; [Andrews, Angela] Pine Ridge Dist Hlth Unit, Port Hope, ON, Canada	University of Saskatchewan; University of Waterloo; Trent University	Crizzle, AM (corresponding author), Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.; Crizzle, AM (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	alex.crizzle@usask.ca		Crizzle, Alexander/0000-0002-5289-7257	Public Health Ontario's Locally Driven Collaborative Projects Grant [LDCP-R4-23]	Public Health Ontario's Locally Driven Collaborative Projects Grant	This project was funded by the Public Health Ontario's Locally Driven Collaborative Projects Grant (PI: Crizzle; LDCP-R4-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrante JP, 2010, EPIDEMIOL BIOSTAT PU, V7, P24; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Atlantic Collaborative on Injury Prevention, 2012, SOC DET INJ; Bartholomew LK, 1998, HEALTH EDUC BEHAV, V25, P545, DOI 10.1177/109019819802500502; Batan M, 2011, NON TRADITIONAL REF; Burrows S, 2012, ACCIDENT ANAL PREV, V45, P99, DOI 10.1016/j.aap.2011.11.010; Butterfoss F.D., 2002, EMERGING THEORIES HL, V1st ed; BUTTERFOSS FD, 1993, HEALTH EDUC RES, V8, P315, DOI 10.1093/her/8.3.315; Corbin JH, 2018, HEALTH PROMOT INT, V33, P4, DOI 10.1093/heapro/daw061; Dahlgren G., 2006, WHO COLLABORATIVE CT, V3; Denzin N., 1970, RES ACT SOCIOLOGY TH; Donaldson A, 2017, INJURY PREV, V23, P273, DOI 10.1136/injuryprev-2015-041737; Downey LM, 2008, HEALTH PROMOT PRACT, V9, P130, DOI 10.1177/1524839907311573; Dykeman CS, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0725-3; Fawcett S, 2010, PREV CHRONIC DIS, V7; Finch CF, 2016, INJURY PREV, V22, P386, DOI 10.1136/injuryprev-2015-041922; Fixsen D, 2011, J SAFETY RES, V42, P419, DOI 10.1016/j.jsr.2011.10.002; Florida Department of Health, 2013, NON TRADITIONAL REF; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Glanz K., 2008, HLTH BEHAV HLTH ED T; Himmelman AT, 2001, AM J COMMUN PSYCHOL, V29, P277, DOI 10.1023/A:1010334831330; Institute of Medicine, 2002, NON TRADITIONAL REF; Laflamme L, 2009, SOCIOECONOMIC DIFFER; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Markle-Reid M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2089-3; Markle-Reid MF, 2015, CAN J PUBLIC HEALTH, V106, pE189, DOI 10.17269/cjph.106.4776; Mays GP, 2010, PREV CHRONIC DIS, V7; McClure RJ, 2016, INJURY PREV, V22, P226, DOI 10.1136/injuryprev-2015-041838; Meyers DC, 2012, AM J COMMUN PSYCHOL, V50, P462, DOI 10.1007/s10464-012-9522-x; Minkler M, 2008, HLTH BEHAV HLTH ED T, P287; Moller J, 2004, INJURY PREV, V10, P2, DOI 10.1136/ip.2003.004606; National Association of County and City Health Officials, 2001, NON TRADITIONAL REF; Nilsen P, 2007, SAFETY SCI, V45, P501, DOI 10.1016/j.ssci.2006.07.009; Norris T, 2009, NON TRADITIONAL REF; Ontario Ministry of Health and Long Term Care, 2018, INJ PREV GUID; Parachute, 2015, COST INJ CAN; Patton M.Q., 2008, ESSENTIALS UTILIZATI, V4th; Pittman MA, 2010, PREV CHRONIC DIS, V7; Polit D., 1995, NURSING RES PRINCIPL; Public Health Agency of Canada, 2014, 2 PUBL HLTH AG CAN; Rosella LC, 2017, METATOOL QUALITY APP; Stackpool Gai, 2006, Health Promot J Austr, V17, P12; Trifiletti LB, 2005, HEALTH EDUC RES, V20, P298, DOI 10.1093/her/cyg126; Vollman AR, 2012, CANADIAN COMMUNITY P; Weiss ES, 2002, HEALTH EDUC BEHAV, V29, P683, DOI 10.1177/109019802237938; Woulfe J, 2010, PREV CHRONIC DIS, V7	46	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210734	10.1371/journal.pone.0210734	http://dx.doi.org/10.1371/journal.pone.0210734			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668594	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400012
J	Illanes, A; Esmaeili, N; Poudel, P; Balakrishnan, S; Friebe, M				Illanes, Alfredo; Esmaeili, Nazila; Poudel, Prabal; Balakrishnan, Sathish; Friebe, Michael			Parametrical modelling for texture characterization-A novel approach applied to ultrasound thyroid segmentation	PLOS ONE			English	Article							LESION CLASSIFICATION; NODULES; BENIGN; COMBINATION; FEATURES; CANCER	Texture analysis is an important topic in Ultrasound (US) image analysis for structure segmentation and tissue classification. In this work a novel approach for US image texture feature extraction is presented. It is mainly based on parametrical modelling of a signal version of the US image in order to process it as data resulting from a dynamical process. Because of the predictive characteristics of such a model representation, good estimations of texture features can be obtained with less data than generally used methods require, allowing higher robustness to low Signal-to-Noise ratio and a more localized US image analysis. The usability of the proposed approach was demonstrated by extracting texture features for segmenting the thyroid in US images. The obtained results showed that features corresponding to energy ratios between different modelled texture frequency bands allowed to clearly distinguish between thyroid and non-thyroid texture. A simple k-means clustering algorithm has been used for separating US image patches as belonging to thyroid or not. Segmentation of thyroid was performed in two different datasets obtaining Dice coefficients over 85%.	[Illanes, Alfredo; Esmaeili, Nazila; Poudel, Prabal; Balakrishnan, Sathish; Friebe, Michael] Otto von Guericke Univ, INKA, Inst Med Technol, Magdeburg, Germany	Otto von Guericke University	Illanes, A (corresponding author), Otto von Guericke Univ, INKA, Inst Med Technol, Magdeburg, Germany.	alfredo.illanes@ovgu.de	Friebe, Michael/E-3187-2015	Friebe, Michael/0000-0002-8624-0800; Illanes, Alfredo/0000-0002-0118-0483	Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research) [03IPT7100X]	Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research)	This work was supported by Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research) - 03IPT7100X.	Acharya UR, 2011, TECHNOL CANCER RES T, V10, P371, DOI 10.7785/tcrt.2012.500214; Acharya UR, 2016, KNOWL-BASED SYST, V107, P235, DOI 10.1016/j.knosys.2016.06.010; Acharya UR, 2014, TECHNOL CANCER RES T, V13, P289, DOI 10.7785/tcrt.2012.500381; Acharya UR, 2013, P I MECH ENG H, V227, P284, DOI 10.1177/0954411912472422; Acharya UR, 2012, COMPUT METH PROG BIO, V107, P233, DOI 10.1016/j.cmpb.2011.10.001; Acharya UR, 2012, ULTRASONICS, V52, P508, DOI 10.1016/j.ultras.2011.11.003; Acharya UR., 2007, ADV CARDIAC SIGNAL P; Ardakani AA, 2015, J ULTRAS MED, V34, P1983, DOI 10.7863/ultra.14.09057; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chi JN, 2017, J DIGIT IMAGING, V30, P477, DOI 10.1007/s10278-017-9997-y; Debarghya C, 2018, IEEE J BIOMEDICAL HL; Iakovidis DK, 2010, ARTIF INTELL MED, V50, P33, DOI 10.1016/j.artmed.2010.04.004; Koprowski R, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-91; Koundal D, 2013, ADV INTELL SYST, V177, P459; Manolakis D.G., 2000, STAT ADAPTIVE SIGNAL; Mirmehdi M., 2008, HDB TEXTURE ANAL; Ozyilmaz L, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P2033, DOI 10.1109/ICONIP.2002.1199031; Poudel P., 2018, P IEEE ENG MED BIOL; Poudel P, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/8087624; Raghavendra U, 2018, COMPUT BIOL MED, V95, P55, DOI 10.1016/j.compbiomed.2018.02.002; Raghavendra U, 2017, ULTRASONICS, V77, P110, DOI 10.1016/j.ultras.2017.02.003; Selvathi D., 2011, Proceedings 2011 International Conference on Signal Processing, Communication, Computing and Networking Technologies (ICSCCN 2011), P836, DOI 10.1109/ICSCCN.2011.6024666; Sheeja A, 2012, INT J EMERGING TECHN, V2; Sollini M, 2018, EUR J RADIOL, V99, P1, DOI 10.1016/j.ejrad.2017.12.004; Wunderling T, 2017, PROC SPIE, V10133, DOI 10.1117/12.2254234	25	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211215	10.1371/journal.pone.0211215	http://dx.doi.org/10.1371/journal.pone.0211215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695052	Green Submitted, Green Published, gold			2022-12-27	WOS:000457046400020
J	Nakayama, A; Abe, H; Kunita, A; Saito, R; Kanda, T; Yamashita, H; Seto, Y; Ishikawa, S; Fukayama, M				Nakayama, Atsuhito; Abe, Hiroyuki; Kunita, Akiko; Saito, Ruri; Kanda, Teru; Yamashita, Hiroharu; Seto, Yasuyuki; Ishikawa, Shumpei; Fukayama, Masashi			Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma	PLOS ONE			English	Article							EBV; DNA; CANCER	Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC), one of four major gastric cancer types, consists of clonal growth of EBV-infected epithelial cells. However, the significance of viral loads in each tumor cell has not been evaluated. EBV-DNA is stably maintained in episomal form in the nucleus of each cancer cell. To estimate EBV copy number per genome (EBV-CN), qPCR of viral EBNA1 and host GAPDH, standardized by Namalwa DNA (one copy/genome), was applied to the formalin-fixed paraffin embedded (FFPE) surgically resected EBVaGC specimens (n = 43) and EBVaGC cell lines (SNU-719 and NCC-24). In surgical specimens, the cancer cell ratio (CCR) was determined with image analysis, and EBV-CN was obtained by adjusting qPCR value with CCR. Fluorescent in situ hybridization (FISH) was also applied to the FFPE sections using the whole EBVgenome as a probe. In surgical specimens, EBV-CN obtained by qPCR/CCR was between 1.2 and 185 copies with a median of 9.9. EBV-CN of SNU-719 and NCC-24 was 42.0 and 1.1, respectively. A linear correlation was observed with qPCR/CCR data up to 20 copies/genome (40 signals/nucleus), the limit of FISH analysis. In addition, substantial variation in the number of EBV foci was observed. Based on qPCR/CCR, high EBV-CN (> 10 copies) correlated with PD-L1 expression in cancer cells (P = 0.015), but not with other pathological indicators. Furthermore, EBVaGC with high EBV-CN showed worse disease-specific survival (P = 0.041). Our findings suggest that cancer cell viral loads may contribute to expression of the immune checkpoint molecule and promotion of cancer progression in EBVaGC.	[Nakayama, Atsuhito; Abe, Hiroyuki; Kunita, Akiko; Saito, Ruri; Ishikawa, Shumpei; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Kanda, Teru] Tohoku Med & Pharmaceut Univ, Dept Microbiol, Sendai, Miyagi, Japan; [Yamashita, Hiroharu; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo; Tohoku Medical & Pharmaceutical University; University of Tokyo	Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan.	mfukayama-tky@umin.org	Kanda, Teru/J-7313-2019; Yamashita, Hiroharu/E-7058-2011	Yamashita, Hiroharu/0000-0002-9468-3716; Fukayama, Masashi/0000-0002-0460-064X; Kanda, Teru/0000-0002-1391-3349; Nakayama, Atsuhito/0000-0002-9832-9415	Japan Society for the Promotion of Science [26253021]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant Number 26253021, Japan Society for the Promotion of Science, URL: https://www.jsps.go.jp/, to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, PATHOBIOLOGY, V82, P212, DOI 10.1159/000434683; Anastasiadou E, 2019, LEUKEMIA, V33, P132, DOI 10.1038/s41375-018-0178-x; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Chen HS, 2014, J VIROL, V88, P1703, DOI 10.1128/JVI.02209-13; Derks S, 2016, ONCOTARGET, V7, P32925, DOI 10.18632/oncotarget.9076; Feng WH, 2002, CANCER RES, V62, P1920; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Grywalska E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140178; Hohaus S, 2011, CLIN CANCER RES, V17, P2885, DOI 10.1158/1078-0432.CCR-10-3327; Kanda T, 2007, J CELL SCI, V120, P1529, DOI 10.1242/jcs.03434; Kanda T, 2016, J VIROL, V90, P4383, DOI 10.1128/JVI.00060-16; Khoja L, 2017, ANN ONCOL, V28, P2377, DOI 10.1093/annonc/mdx286; Kuzushima K, 1999, J CLIN INVEST, V104, P163, DOI 10.1172/JCI6062; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; LAWRENCE JB, 1988, CELL, V52, P51; Li ZW, 2016, HUM PATHOL, V55, P182, DOI 10.1016/j.humpath.2016.05.012; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Liu Y, 2016, ONCOTARGET, V7, P4903, DOI 10.18632/oncotarget.6751; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pyzer AR, 2017, LEUKEMIA, V31, P2780, DOI 10.1038/leu.2017.163; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Ryan JL, 2009, LAB INVEST, V89, P80, DOI 10.1038/labinvest.2008.103; Saito R, 2017, MODERN PATHOL, V30, P427, DOI 10.1038/modpathol.2016.202; Sasaki S, 2019, GASTRIC CANCER, V22, P486, DOI 10.1007/s10120-018-0880-4; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Veroni C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0353-1	28	24	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211358	10.1371/journal.pone.0211358	http://dx.doi.org/10.1371/journal.pone.0211358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695048	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400029
J	Santacruz-Castro, AM				Santacruz-Castro, Adriana Maria			Regional variability in reproductive traits of the Acropora hyacinthus species complex in the Western Pacific Region	PLOS ONE			English	Article							CORAL PORITES-ASTREOIDES; SEXUAL REPRODUCTION; LIFE-HISTORY; COLONY SIZE; SOFT CORAL; TRADE-OFF; SEASONALITY; RECRUITMENT; POPULATIONS; BOUNDARIES	Understanding natural variations in the life history traits of reef-building corals under different environmental conditions is an area of active research. This study compares variability in the reproductive and genetic traits of the hermaphroditic broadcast spawning coral Acropora hyacinthus, from the Western Pacific Region, across six different latitudes [Japan (33 degrees and 31 degrees N), Taiwan (23 degrees, 22 degrees and 21 degrees N), and Indonesia (5 degrees S)]. Egg sizes among corals in the lowest latitude studied were significantly larger than those at high latitudes, while the mean number of eggs were significantly different only among high latitude and two out of the three mid latitude locations studied. Egg numbers were significantly negatively correlated with egg and testis volumes, indicating reproductive trade-offs across locations. Female gonad volumes were smaller at high latitudes but significantly larger at lower latitudes, being positively correlated with seawater temperatures. Furthermore, high genetic similarities among populations suggest active gene flow among low-, mid- and high-latitude locations. An exception to this trend, the mid- latitude location of Penghu (off western Taiwan) formed an independent group with highly similar genetic and reproductive traits, suggesting reproductive isolation with local adaptations. This study reports natural spatial variations in the reproductive traits of A. hyacinthus at different latitudinal locations, which may serve as baseline information to predict how the life histories of corals in general respond to the impacts of climate change.	[Santacruz-Castro, Adriana Maria] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Santacruz-Castro, Adriana Maria] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan	National Taiwan Normal University; Academia Sinica - Taiwan	Santacruz-Castro, AM (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.; Santacruz-Castro, AM (corresponding author), Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei, Taiwan.	adrianamsc@gmail.com			Taiwan International Graduate Student Program in Academia Sinica; Taiwan Ministry of Science and Technology	Taiwan International Graduate Student Program in Academia Sinica; Taiwan Ministry of Science and Technology	This study was sponsored by two grants, the Taiwan International Graduate Student Program in Academia Sinica and the Taiwan Ministry of Science and Technology.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta A, 1997, MAR BIOL, V128, P141, DOI 10.1007/s002270050077; Airi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091792; [Anonymous], 2021, LANG ENV STAT COMP; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Baird AH, 2000, P 9 INT COR REEF S B, P23; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BENAYAHU Y, 1986, BIOL BULL, V170, P32, DOI 10.2307/1541378; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; CLARKE A, 1992, INVERTEBR REPROD DEV, V22, P175, DOI 10.1080/07924259.1992.9672270; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; Crook E, 2013, BIOGEOSCIENCES DISCU, V10, P7761; Dahan M, 1997, MAR BIOL, V129, P573, DOI 10.1007/s002270050198; Dai C, 2009, SCLERACTINIA FAUNA T; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; de Putron SJ, 2011, B MAR SCI, V87, P75, DOI 10.5343/bms.2009.1027; de Putron SJ, 2017, CORAL REEFS, V36, P383, DOI 10.1007/s00338-016-1527-8; DeBoer Jason A., 2015, Great Plains Research, V25, P25; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Fan TY, 2005, B MAR SCI, V76, P143; Fan TY, 1999, MAR ECOL PROG SER, V190, P297, DOI 10.3354/meps190297; Fernandez M, 2009, ECOL LETT, V12, P601, DOI 10.1111/j.1461-0248.2009.01315.x; FLEMING IA, 1990, ECOLOGY, V71, P1, DOI 10.2307/1940241; Foster T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03175-2; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Harii S, 2001, CORAL REEFS, V20, P19; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hartmann AC, 2017, CONSERVATION LETT; HELMUTH B, 1993, J EXP MAR BIOL ECOL, V165, P251, DOI 10.1016/0022-0981(93)90109-2; Hwang SJ, 2012, ANIM CELLS SYST, V16, P135, DOI 10.1080/19768354.2011.622486; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Kasyanov VL, 2001, REPROD STRATEGY MARI; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Kruger A, 1998, MAR BIOL, V131, P423, DOI 10.1007/s002270050335; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ladner JT, 2012, MOL ECOL, V21, P2224, DOI 10.1111/j.1365-294X.2012.05528.x; Ladner JT, 2012, HIDDEN DIVERSITY COR; Laptikhovsky V, 2006, MAR ECOL-EVOL PERSP, V27, P7, DOI 10.1111/j.1439-0485.2006.00077.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Marshall DJ, 2015, ECOL LETT, V18, P174, DOI 10.1111/ele.12402; Mezaki T., 2007, KUROSHIO BIOSPHERE, V3, P33; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nozawa Y, 2014, CORAL REEFS, V33, P1057, DOI 10.1007/s00338-014-1185-7; Nozawa Y, 2012, BIOL BULL-US, V222, P192, DOI 10.1086/BBLv222n3p192; Padilla-Gamino JL, 2013, CORAL REEFS, V32, P137, DOI 10.1007/s00338-012-0957-1; Permata D, 2012, CORAL REEFS, V31, P907, DOI 10.1007/s00338-012-0909-9; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Shieh Ying-Tzung, 1995, Acta Oceanographica Taiwanica, V34, P73; SIER CJS, 1994, MAR BIOL, V118, P713, DOI 10.1007/BF00347520; Simonini R, 2003, J EXP MAR BIOL ECOL, V291, P79, DOI 10.1016/S0022-0981(03)00099-6; Suzuki G, 2016, CORAL REEFS, V35, P1419, DOI 10.1007/s00338-016-1484-2; Tsounis G, 2006, MAR BIOL, V148, P513, DOI 10.1007/s00227-005-0100-8; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; VANWOESIK R, 1995, CORAL REEFS, V14, P119, DOI 10.1007/BF00303433; Veron J. E., 2000, CORALS WORLD, V1-3, P404; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Waller RG, 2002, CORAL REEFS, V21, P325, DOI 10.1007/s00338-002-0252-7; Wei NV, 2012, ZOOL STUD, V51, P85; Zuur Alain F., 2009, P1	66	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0208605	10.1371/journal.pone.0208605	http://dx.doi.org/10.1371/journal.pone.0208605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695041	Green Submitted, Green Published, gold			2022-12-27	WOS:000457046400005
J	[Anonymous]				[Anonymous]			Ramentaceone, a Naphthoquinone Derived from Drosera sp, Induces Apoptosis by Suppressing PI3K/Akt Signaling in Breast Cancer Cells (Expression of Concern of Vol 11, art no E0147718, 2016)	PLOS ONE			English	Expression of Concern																		Kawiak A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147718	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211655	10.1371/journal.pone.0211655	http://dx.doi.org/10.1371/journal.pone.0211655			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695056	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400044
J	Howard, NP; Tillman, J; Vanderzande, S; Luby, JJ				Howard, Nicholas P.; Tillman, John; Vanderzande, Stijn; Luby, James J.			Genetics of zonal leaf chlorosis and genetic linkage to a major gene regulating skin anthocyanin production (MdMYB1) in the apple (Malus x domestica) cultivar Honeycrisp	PLOS ONE			English	Article							CROP LOAD; STARCH; TRAITS; MUTANT	'Honeycrisp' is a widely grown and acclaimed apple cultivar that is commonly used in breeding programs. It also has a well-documented tendency to develop the physiological disorder, zonal leaf chlorosis (ZLC). This disorder causes reduced photosynthetic capacity and is thought to be due to a problem with phloem loading, although the underlying genetics of the disorder have not previously been discerned. In order to understand the breeding implications of the disorder, six families with 'Honeycrisp' as a parent and one family with 'Honeycrisp' as both a maternal and paternal grandparent were evaluated for ZLC incidence over two years. One major quantitative trait locus (QTL) for ZLC incidence was identified on linkage group (LG) 9. A haplotype in 'Honeycrisp' that originated from grandparent 'Duchess of Oldenburg' was associated with increased ZLC incidence in offspring in both years and all families evaluated. The LG9 QTL was 5 to 10 cM from MdMYB1, which is a major gene regulating fruit skin anthocyanin production. 'Honeycrisp' is heterozygous for red fruit skin overcolor at MdMYB1. The 'Honeycrisp' haplotype at the LG9 QTL associated with increased ZLC is in linkage phase with the allele at MdMYB1 associated with red color. Selection for the red allele from 'Honeycrisp' at MdMYB1 will result in most offspring also inheriting the haplotype at the LG9 QTL associated with high ZLC. The occurrence of two copies of this haplotype was sub-lethal in seedlings of a family where both parents inherited both the red overcolor allele at MdMYB1 and the haplotype at the LG9 QTL associated with high ZLC. This is the first study to have identified a genetic component of ZLC with clear breeding implications.	[Howard, Nicholas P.; Tillman, John; Luby, James J.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Howard, Nicholas P.] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany; [Vanderzande, Stijn] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA	University of Minnesota System; University of Minnesota Twin Cities; Carl von Ossietzky Universitat Oldenburg; Washington State University	Howard, NP (corresponding author), Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA.; Howard, NP (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, Oldenburg, Germany.	howar622@umn.edu			USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae" [2009-51181-05808]; USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" [2014-51181-22378]; EU [265582]	USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae"; USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars"; EU(European Commission)	This work was partially supported by the USDA National Institute of Food and Agriculture-Specialty Crop Research Initiative projects, "RosBREED: Enabling marker-assisted breeding in Rosaceae" (2009-51181-05808) and "RosBREED: Combining disease resistance with horticultural quality in new rosaceous cultivars" (2014-51181-22378). Some genetic data was provided by the FruitBreedomics project: Integrated approach for increasing breeding efficiency in fruit tree crops (http://fruitbreedomics.com/), which was co-funded by the EU seventh Framework Programme, project No 265582.	Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Bedford D, 2016, United States patent US, Patent No. PP26412; Bedford DS, 2008, United States patent, Patent No. [US PP18812, PP18812]; Bink MCAM, 2008, EUPHYTICA, V161, P85, DOI 10.1007/s10681-007-9516-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chen LS, 2010, ACTA PHYSIOL PLANT, V32, P253, DOI 10.1007/s11738-009-0402-4; Cheng FS, 1996, THEOR APPL GENET, V93, P222, DOI 10.1007/BF00225749; Clark MD, 2014, EUR J PLANT PATHOL, V140, P69, DOI 10.1007/s10658-014-0444-3; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Das SB, 1998, CROP SCI, V38, P722, DOI 10.2135/cropsci1998.0011183X003800030018x; DAYTON DF, 1979, HORTSCIENCE, V14, P551; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Evans K., 2011, ACTA HORTIC, V945, P233; Fleck S, 2008, 9 INT S INT CAN ROOT, V903, P767; Gallardo RK, 2015, HORTTECHNOLOGY, V25, P575, DOI 10.21273/HORTTECH.25.4.575; Gao ZS, 2006, EUPHYTICA, V151, P123, DOI 10.1007/s10681-005-9082-3; Howard NP, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-017-1216-y; Howard NP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.3; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Mann H, 2005, HORTSCIENCE, V40, P1815, DOI 10.21273/HORTSCI.40.6.1815; McKay SJ, 2011, J AM SOC HORTIC SCI, V136, P408, DOI 10.21273/JASHS.136.6.408; Moriya S, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1864-x; R Core Team, R LANG ENV STAT COMP; Rippke G, 2016, FARM PROGR REPORTS, V2015, P57; Rom Curt R., 1998, Hortscience, V33, P531; Rosenberger D. A., 2001, NY FRUIT Q, V9, P9; SCHAFFER AA, 1986, J PLANT PHYSIOL, V124, P111, DOI 10.1016/S0176-1617(86)80183-3; Schupp J., 2001, Compact Fruit Tree, V34, P107; Schupp JR, 2003, NEW YORK FRUIT Q, V11, P3; Simko I, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0022-5; Snyder-Leiby TE, 2008, HORTSCIENCE, V43, P1819, DOI 10.21273/HORTSCI.43.6.1819; Takle B, 2017, FARM PROGR REPORTS, V2016, P44; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Tong CBS, 2003, HORTSCIENCE, V38, P1153, DOI 10.21273/HORTSCI.38.6.1153; Trujillo DI, 2012, TREE GENET GENOMES, V8, P27, DOI 10.1007/s11295-011-0417-z; Wang HC, 2010, PLANTA, V232, P511, DOI 10.1007/s00425-010-1194-x; Yue CY, 2011, HORTTECHNOLOGY, V21, P376, DOI 10.21273/HORTTECH.21.3.376; Zeeman SC, 1998, PLANT CELL, V10, P1699, DOI 10.1105/tpc.10.10.1699	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210611	10.1371/journal.pone.0210611	http://dx.doi.org/10.1371/journal.pone.0210611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689634	Green Submitted, gold, Green Published			2022-12-27	WOS:000457041800008
J	Appleby, RN; Moghul, I; Khan, S; Yee, M; Manousou, P; Neal, TD; Walters, JRF				Appleby, Richard N.; Moghul, Iman; Khan, Shahid; Yee, Michael; Manousou, Pinelope; Neal, Tracy Dew; Walters, Julian R. F.			Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study	PLOS ONE			English	Article							GROWTH-FACTOR 19; MALABSORPTION; FGF19; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; PATHOPHYSIOLOGY; POPULATION; PREVALENCE; DIAGNOSIS; FIBROSIS; OBESITY	Background Non-alcoholic fatty liver disease (NAFLD) may be associated with changes in bile acid (BA) metabolism. Hepatic BA production, measured by serum levels of the precursor 7 alpha-hydroxy-4-cholesten-3-one (C4), is regulated by the farnesoid-X-receptor (FXR)-dependent ileal hormone fibroblast growth factor 19 (FGF19). Low FGF19 and high C4 are features of chronic BA diarrhea. Obeticholic acid, an FXR agonist, stimulates FGF19 and has shown therapeutic potential in both BA diarrhea and in NAFLD. We hypothesized there are associations of FGF19, C4 and BA diarrhea with NAFLD. Methods and findings 127 patients with known NAFLD were recruited prospectively. Clinical features, including metformin use, markers of NAFLD severity and BA synthesis were analyzed. The overall incidence of chronic diarrhea was 25%, with features of BA diarrhea in 12%. FGF19 negatively correlated with C4 (r(s) = -0.43, p = 0.001) and with alanine aminotransferase (r(s) = -0.22, p = 0.03), but not with either NAFLD fibrosis or Fibroscan scores. High C4 was associated with a higher NAFLD fibrosis score (p < 0.05), and with diarrhea (p = 0.001). The median NAFLD fibrosis score was higher in those with diarrhea (p = 0.002). Metformin use, in 44% overall, was particularly associated with diarrhea (in 36% vs 17%, p = 0.02), and a lower median FGF19 (74 vs 105 pg/mL, p < 0.05). Conclusions Increased hepatic BA production and diarrhea, but not low FGF19, were associated with increased NAFLD fibrosis score, indicating dysregulation of the FXR-FGF19 axis and suggesting hepatic FGF19 resistance. Metformin use was an important factor in a subgroup, lowering FGF19, and resulting in bile acid diarrhea.	[Appleby, Richard N.; Moghul, Iman; Khan, Shahid; Manousou, Pinelope; Walters, Julian R. F.] Imperial Coll London, Div Digest Dis, London, England; [Yee, Michael] Imperial Coll Healthcare NHS Trust, Dept Diabet & Endocrinol, London, England; [Neal, Tracy Dew] Kings Coll Hosp NHS Trust, Dept Biochem, London, England	Imperial College London; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Walters, JRF (corresponding author), Imperial Coll London, Div Digest Dis, London, England.	julian.walters@imperial.ac.uk	Walters, Julian/D-5189-2009	Walters, Julian/0000-0001-9720-5835; Manousou, Pinelopi/0000-0002-5363-1565; Appleby, Richard/0000-0001-5887-8922; Neal, Tracy/0000-0002-4667-6335	Intercept Pharmaceuticals	Intercept Pharmaceuticals	RA was funded by a grant from Intercept Pharmaceuticals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Appleby RN, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000178; Brydon WG, 2011, CAN J GASTROENTEROL, V25, P319, DOI 10.1155/2011/701287; Brydon WG, 1996, EUR J GASTROEN HEPAT, V8, P117, DOI 10.1097/00042737-199602000-00005; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Eren F, 2012, CLIN BIOCHEM, V45, P655, DOI 10.1016/j.clinbiochem.2012.03.019; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; HEATON KW, 1992, GUT, V33, P818, DOI 10.1136/gut.33.6.818; Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307; Johnston IM, 2016, AM J GASTROENTEROL, V111, P423, DOI 10.1038/ajg.2015.424; Lien F, 2014, J CLIN INVEST, V124, P1037, DOI 10.1172/JCI68815; Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pattni SS, 2013, ALIMENT PHARM THER, V38, P967, DOI 10.1111/apt.12466; Pattni SS, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.10; Pournaras DJ, 2012, ENDOCRINOLOGY, V153, P3613, DOI 10.1210/en.2011-2145; Roesch SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116928; Sauter GH, 1999, DIGEST DIS SCI, V44, P14, DOI 10.1023/A:1026681512303; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; SCIARRETTA G, 1987, GUT, V28, P970, DOI 10.1136/gut.28.8.970; Sellin JH, 2008, NAT CLIN PRACT GASTR, V5, P162, DOI 10.1038/ncpgasthep1054; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4; Vijayvargiya P, 2019, CLIN GASTROENTEROL H, V17, P922, DOI 10.1016/j.cgh.2018.05.050; Walters JRF, 2009, CLIN GASTROENTEROL H, V7, P1189, DOI 10.1016/j.cgh.2009.04.024; Wedlake L, 2009, ALIMENT PHARM THER, V30, P707, DOI 10.1111/j.1365-2036.2009.04081.x; Wojcik M, 2012, J PEDIATR ENDOCR MET, V25, P1089, DOI 10.1515/jpem-2012-0253; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312	32	25	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211348	10.1371/journal.pone.0211348	http://dx.doi.org/10.1371/journal.pone.0211348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682184	Green Published, gold			2022-12-27	WOS:000457037500153
J	Forgacs, A; Kallos-Balogh, P; Nagy, F; Krizsan, AK; Garai, I; Tron, L; Dahlbom, M; Balkay, L				Forgacs, Attila; Kallos-Balogh, Piroska; Nagy, Ferenc; Krizsan, Aron K.; Garai, Ildiko; Tron, Lajos; Dahlbom, Magnus; Balkay, Laszlo			Activity painting: PET images of freely defined activity distributions applying a novel phantom technique	PLOS ONE			English	Article							TEXTURE ANALYSIS; RECONSTRUCTION; HETEROGENEITY; FEATURES; QUANTIFICATION; VALIDATION; STRATEGIES; MOTION	The aim of this work was to develop a novel phantom that supports the construction of highly reproducible phantoms with arbitrary activity distributions for PET imaging. It could offer a methodology for answering questions related to texture measurements in PET imaging. The basic idea is to move a point source on a 3-D trajectory in the field of view, while continuously acquiring data. The reconstruction results in a 3-D activity concentration map according to the pathway of the point source. A Na-22 calibration point source was attached to a high precision robotic arm system, where the 3-D movement was software controlled. 3-D activity distributions of a homogeneous cube, a sphere, a spherical shell and a heart shape were simulated. These distributions were used to measure uniformity and to characterize reproducibility. Two potential applications using the lesion simulation method are presented: evaluation in changes of textural properties related to the position in the PET field of view; scanner comparison based on visual and quantitative evaluation of texture features. A lesion with volume of 50x50x50 mm(3) can be simulated during approximately 1 hour. The reproducibility of the movement was found to be >99%. The coefficients of variation of the voxels within a simulated homogeneous cube was 2.34%. Based on 5 consecutive and independent measurements of a 36 mm diameter hot sphere, the coefficient of variation of the mean activity concentration was 0.68%. We obtained up to 18% differences within the values of investigated textural indexes, when measuring a lesion in different radial positions of the PET field of view. In comparison of two different human PET scanners the percentage differences between heterogeneity parameters were in the range of 5-55%. After harmonizing the voxel sizes this range reduced to 2-16%. The general activity distributions provided by the two different vendor show high similarity visually. For the demonstration of the flexibility of this method, the same pattern was also simulated on a small animal PET scanner giving similar results, both quantitatively and visually. 3-D motion of a point source in the PET field of view is capable to create an irregular shaped activity distribution with high reproducibility.	[Forgacs, Attila; Nagy, Ferenc; Krizsan, Aron K.; Garai, Ildiko] Scanomed Nucl Med Ctr, Debrecen, Hungary; [Forgacs, Attila; Kallos-Balogh, Piroska; Garai, Ildiko; Tron, Lajos; Balkay, Laszlo] Univ Debrecen, Div Nucl Med, Dept Med Imaging, Fac Med, Debrecen, Hungary; [Dahlbom, Magnus] Univ Calif Los Angeles, Ahmanson Translat Imaging Div, Los Angeles, CA USA	Scanomed; University of Debrecen; University of California System; University of California Los Angeles	Forgacs, A (corresponding author), Scanomed Nucl Med Ctr, Debrecen, Hungary.; Forgacs, A (corresponding author), Univ Debrecen, Div Nucl Med, Dept Med Imaging, Fac Med, Debrecen, Hungary.	attilaforgacsem@gmail.com						Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Alessio AM, 2010, IEEE T MED IMAGING, V29, P938, DOI 10.1109/TMI.2010.2040188; Barbee DL, 2010, PHYS MED BIOL, V55, P221, DOI 10.1088/0031-9155/55/1/013; Berthon B, 2015, EJNMMI PHYS, V2, DOI 10.1186/s40658-015-0116-1; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Carles M, 2017, PHYS MED BIOL, V62, P652, DOI 10.1088/1361-6560/62/2/652; Castro P, 2017, REV ESP MED NUCL, DOI [10.1016/j.remnie.2017.10.025, DOI 10.1016/J.REMNIE.2017.10.025]; Cook G., 2018, INT ENCY ANTHR, P1, DOI [10.1002/9781118924396.wbiea1294, DOI 10.1002/9781118924396.WBIEA1294]; D'Alessandro B, 2011, SEMIN NUCL MED, V41, P437, DOI 10.1053/j.semnuclmed.2011.06.007; El-Ali H, 2003, CANCER BIOTHER RADIO, V18, P201, DOI 10.1089/108497803765036364; Forgacs A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164113; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Hatt M, 2017, J NUCL MED, V58, P365, DOI 10.2967/jnumed.116.184655; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hsu DFC, 2017, J NUCL MED, V58, P1511, DOI 10.2967/jnumed.117.189514; Koopman D, 2016, EJNMMI PHYS, V3, DOI 10.1186/s40658-016-0158-z; Lajtos I, 2014, PHYS MED BIOL, V59, P2727, DOI 10.1088/0031-9155/59/11/2727; Lambin P, 2015, P SPIE INT SOC OPTIC, V73, P389, DOI DOI 10.1016/J.EJCA.2011.11.036.RADI0MICS; Liinssjukhus NA, 1992, POINT SOURCE SCANNER, P20; Lucht R, 1996, PHYS MED BIOL, V41, P2207, DOI 10.1088/0031-9155/41/10/025; Makris NE, 2013, EUR J NUCL MED MOL I, V40, P1507, DOI 10.1007/s00259-013-2465-0; Markiewicz PJ, 2011, PHYS MED BIOL, V56, pN247, DOI 10.1088/0031-9155/56/21/N01; Miller MA, 2007, IEEE NUCL SCI CONF R, P4252, DOI 10.1109/NSSMIC.2007.4437056; Murata T, 2016, EJNMMI PHYS, V3, DOI 10.1186/s40658-016-0162-3; Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065; Nyflot MJ, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.4.041002; Orlhac F, 2018, J NUCL MED, V59, P1321, DOI 10.2967/jnumed.117.199935; Orlhac F, 2017, J NUCL MED, V58, P387, DOI 10.2967/jnumed.116.181859; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Papadimitroulas P, 2013, MED PHYS, V40, DOI 10.1118/1.4826162; Rousset OG, 1998, J NUCL MED, V39, P904; Shiri I, 2017, EUR RADIOL, V27, P4498, DOI 10.1007/s00330-017-4859-z; Soffientini CD, 2017, MED PHYS, V44, P221, DOI 10.1002/mp.12014; Takeshita T, 2016, ANN NUCL MED, V30, P393, DOI 10.1007/s12149-016-1071-1; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vallieres M, 2018, J NUCL MED, V59, P189, DOI 10.2967/jnumed.117.200501; Yip S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115510; Zito F, 2012, MED PHYS, V39, P5353, DOI 10.1118/1.4736812; Zwanburg A, 2016, INITIATIVE IBS IMAGE	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0207658	10.1371/journal.pone.0207658	http://dx.doi.org/10.1371/journal.pone.0207658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682024	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500010
J	Latini, F; Fahlstrom, M; Berntsson, SG; Larsson, EM; Smits, A; Ryttlefors, M				Latini, Francesco; Fahlstrom, Markus; Berntsson, Shala G.; Larsson, Elna-Marie; Smits, Anja; Ryttlefors, Mats			A novel radiological classification system for cerebral gliomas: The Brain-Grid	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; WHITE-MATTER TRACTS; DEFINITION FIBER TRACTOGRAPHY; CENTRAL-NERVOUS-SYSTEM; MATHEMATICAL-MODEL; II GLIOMAS; TUMOR; GROWTH; ATLAS; SURGERY	Purpose Standard radiological/topographical classifications of gliomas often do not reflect the real extension of the tumor within the lobar-cortical anatomy. Furthermore, these systems do not provide information on the relationship between tumor growth and the subcortical white matter architecture. We propose the use of an anatomically standardized grid system (the Brain-Grid) to merge serial morphological magnetic resonance imaging (MRI) scans with a representative tractographic atlas. Two illustrative cases are presented to show the potential advantages of this classification system. Methods MRI scans of 39 patients (WHO grade II and III gliomas) were analyzed with a standardized grid created by intersecting longitudinal lines on the axial, sagittal, and coronal planes. The anatomical landmarks were chosen from an average brain, spatially normalized to the Montreal Neurological Institute (MNI) space and the Talairach space. Major white matter pathways were reconstructed with a deterministic tracking algorithm on a reference atlas and analyzed using the Brain-Grid system. Results In all, 48 brain grid voxels (areas defined by 3 coordinates, axial (A), coronal (C), sagittal (S) and numbers from 1 to 4) were delineated in each MRI sequence and on the tractographic atlas. The number of grid voxels infiltrated was consistent, also in the MNI space. The subcortical insula/basal ganglia (A3-C2-S2) and the fronto-insular region (A3-C2-S1) were most frequently involved. The inferior fronto-occipital fasciculus, anterior thalamic radiation, uncinate fasciculus, and external capsule were the most frequently associated pathways in both hemispheres. Conclusions The Brain-Grid based classification system provides an accurate observational tool in all patients with suspected gliomas, based on the comparison of grid voxels on a morphological MRI and segmented white matter atlas. Important biological information on tumor kinetics including extension, speed, and preferential direction of progression can be observed and even predicted with this system. This novel classification can easily be applied to both prospective and retrospective cohorts of patients and increase our comprehension of glioma behavior.	[Latini, Francesco; Ryttlefors, Mats] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Fahlstrom, Markus; Larsson, Elna-Marie] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Berntsson, Shala G.; Smits, Anja] Uppsala Univ, Dept Neurosci, Neurol, Uppsala, Sweden; [Smits, Anja] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci, Sahlgrenska Acad, Gothenburg, Sweden	Uppsala University; Uppsala University; Uppsala University; University of Gothenburg	Latini, F (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.	francesco.latini@neuro.uu.se	Latini, Francesco/GQP-2206-2022; FahlstrÃm, Markus/AAT-4041-2020	Latini, Francesco/0000-0002-4702-526X; FahlstrÃm, Markus/0000-0002-2502-6026				Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Alfonso JCL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0490; Berntsson SG, 2013, J NEURO-ONCOL, V114, P241, DOI 10.1007/s11060-013-1178-3; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Duffau H, 2004, CANCER-AM CANCER SOC, V100, P2622, DOI 10.1002/cncr.20297; Duffau H, 2014, WORLD NEUROSURG, V82, pE43, DOI 10.1016/j.wneu.2013.08.054; Duffau H, 2014, WORLD NEUROSURG, V81, P56, DOI 10.1016/j.wneu.2013.01.116; Duma CM, 2016, J NEUROSURG, V125, P40, DOI 10.3171/2016.7.GKS161460; Engwer C, 2015, J MATH BIOL, V71, P551, DOI 10.1007/s00285-014-0822-7; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; Gimenez U, 2016, NMR BIOMED, V29, P1553, DOI 10.1002/nbm.3608; Gungor A, 2017, J NEUROSURG, V126, P945, DOI 10.3171/2016.1.JNS152082; Guthrie B L, 1990, Neurosurg Clin N Am, V1, P37; Harsh GR, 1990, NEUROLOGICAL SURGERY, V5, P3040; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Jakola AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051450; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jbabdi S, 2005, MAGN RESON MED, V54, P616, DOI 10.1002/mrm.20625; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Lasocki A, 2018, J CLIN NEUROSCI, V47, P168, DOI 10.1016/j.jocn.2017.09.007; Latini F, 2017, CLIN NEURORADIOL, V27, P145, DOI 10.1007/s00062-015-0481-0; Latini F, 2017, BRAIN RES, V1675, P102, DOI 10.1016/j.brainres.2017.09.005; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Mandonnet E, 2006, J NEURO-ONCOL, V78, P179, DOI 10.1007/s11060-005-9084-y; Martino J, 2015, J NEUROSURG, V123, P1081, DOI 10.3171/2014.11.JNS141992; Meola A, 2016, NEUROSURGERY, V79, P437, DOI 10.1227/NEU.0000000000001224; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/nov189, 10.1093/neuonc/noaa200, 10.1093/neuonc/noab200]; Pallud J, 2014, BRAIN, V137, P449, DOI 10.1093/brain/awt345; Pallud J, 2013, NEURO-ONCOLOGY, V15, P595, DOI 10.1093/neuonc/nos331; Pallud J, 2010, ANN NEUROL, V68, P727, DOI 10.1002/ana.22106; Parisot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144200; Potgieser ARE, 2014, CLIN NEUROL NEUROSUR, V124, P51, DOI 10.1016/j.clineuro.2014.06.009; Pujol S, 2015, J NEUROIMAGING, P1; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schucht P, 2013, J NEUROSURG, V119, P318, DOI 10.3171/2013.5.JNS122235; Schulter M, 2005, INT J MED ROBOT COMP, V1, P80; SCHWARTZ MS, 1991, CANCER RES, V51, P3595; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Swanson KR, 2002, BRIT J CANCER, V86, P14, DOI 10.1038/sj.bjc.6600021; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Zetterling M, 2016, J NEUROSURG, V125, P1155, DOI 10.3171/2015.10.JNS15583	59	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211243	10.1371/journal.pone.0211243	http://dx.doi.org/10.1371/journal.pone.0211243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677090	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400066
J	Lim, HK; Ha, HI; Hwang, HJ; Lee, K				Lim, Hyun Kyung; Ha, Hong Il; Hwang, Hye Jeon; Lee, Kwanseop			High-pitch, 120 kVp/30 mAs, low-dose dual-source chest CT with iterative reconstruction: Prospective evaluation of radiation dose reduction and image quality compared with those of standard-pitch low-dose chest CT in healthy adult volunteers	PLOS ONE			English	Article							FILTERED BACK-PROJECTION; COMPUTED-TOMOGRAPHY; LUNG-CANCER; 1 MSV; ANGIOGRAPHY; EXPOSURE; ARTIFACTS; ALGORITHM; PROTOCOLS; ROUTINE	Purpose Objective of this study was to evaluate the effectiveness of the iterative reconstruction of high-pitch dual-source chest CT (IR-HP-CT) scanned with low radiation exposure compared with low dose chest CT (LDCT). Materials and methods This study was approved by the institutional review board. Thirty healthy adult volunteers (mean age 44 years) were enrolled in this study. All volunteers underwent both IR-HP-CT and LDCT. IR-HP-CT was scanned with 120 kVp tube voltage, 30 mAs tube current and pitch 3.2 and reconstructed with sinogram affirmed iterative reconstruction. LDCT was scanned with 120 kVp tube voltage, 40 mAs tube current and pitch 0.8 and reconstructed with B50 filtered back projection. Image noise, and signal to noise ratio (SNR) of the infraspinatus muscle, subcutaneous fat and lung parenchyma were calculated. Cardiac motion artifact, overall image quality and artifacts was rated by two blinded readers using 4-point scale. The dose-length product (DLP) (mGy.cm) were obtained from each CT dosimetry table. Scan length was calculated from the DLP results. The DLP parameter was a metric of radiation output, not of patient dose. Size-specific dose estimation (SSDE, mGy) was calculated using the sum of the anteroposterior and lateral dimensions and effective radiation dose (ED, mSv) were calculated using CT dosimetry index. Results Approximately, mean 40% of SSDE (2.1 +/- 0.2 mGy vs. 3.5 +/- 0.3 mGy) and 34% of ED (1.0 +/- 0.1 mSv vs. 1.5 +/- 0.1 mSv) was reduced in IR-HP-CT compared to LDCT (P < 0.0001). Image noise was reduced in the IR-HP-CT (16.8 +/- 2.8 vs. 19.8 +/- 3.4, P = 0.0001). SNR of lung and aorta of IR-HP-CT showed better results compared with that of LDCT (22.2 +/- 5.9 vs. 33.0 +/- 7.8, 1.9 +/- 0.4 vs 1.1 +/- 0.3, P < 0.0001). The score of cardiac pulsation artifacts were significantly reduced on IR-HP-CT (3.8 +/- 0.4, 95% confidence interval, 3.7-4.0) compared with LDCT (1.6 +/- 0.6, 95% confidence interval, 1.3-1.8) (P < 0.0001). SNR of muscle and fat, beam hardening artifact and overall subjective image quality of the mediastinum, lung and chest wall were comparable on both scans (P >= 0.05). Conclusion IR-HP-CT with 120 kVp and 30 mAs tube setting in addition to an iterative reconstruction reduced cardiac motion artifact and radiation exposure while representing similar image quality compared with LDCT.	[Lim, Hyun Kyung] Soonchunhyang Univ Hosp Seoul, Dept Radiol, Seoul, South Korea; [Ha, Hong Il; Hwang, Hye Jeon; Lee, Kwanseop] Hallym Univ, Med Ctr, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Hallym University	Ha, HI (corresponding author), Hallym Univ, Med Ctr, Sacred Heart Hosp, Dept Radiol, Anyang Si, Gyeonggi Do, South Korea.	ha.hongil@gmail.com			Soonchunhyang University Research Fund; Bracco Imaging Korea; Bracco Imaging Korea Research Fund	Soonchunhyang University Research Fund; Bracco Imaging Korea; Bracco Imaging Korea Research Fund	Hyun Kyung Lim received the Soonchunhyang University Research Fund, about 3,000 USD. This Soonchunhyang University Research Fund was used in manuscript preparation and publication fee. Hye Jeon Hwang received the Bracco Imaging Korea Research Fund, about 18,000 USD. This fund was used as a cost of volunteers' CT exam fee and insurance. The Bracco Imaging Korea funder had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; [Anonymous], 2008, 96 AAPM TASK GROUP; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Bolen MA, 2012, AM J ROENTGENOL, V198, P931, DOI 10.2214/AJR.11.6921; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Flohr TG, 2009, MED PHYS, V36, P5641, DOI 10.1118/1.3259739; Geleijns J, 2006, EUR RADIOL, V16, P2334, DOI 10.1007/s00330-006-0217-2; Geyer LL, 2015, RADIOLOGY, V276, P338, DOI 10.1148/radiol.2015132766; Hardie AD, 2011, J COMPUT ASSIST TOMO, V35, P353, DOI 10.1097/RCT.0b013e31821a02c8; Hata A, 2016, EUR RADIOL, V26, P4457, DOI 10.1007/s00330-016-4307-5; Hur S, 2012, KOREAN J RADIOL, V13, P152, DOI [10.3348/kjr.2012.13.2.152, 10.7874/kja.2012.16.3.152]; Hwang HJ, 2013, J COMPUT ASSIST TOMO, V37, P610, DOI 10.1097/RCT.0b013e31828f4dae; Kalisz K, 2016, RADIOGRAPHICS, V36, P2064, DOI 10.1148/rg.2016160079; Khawaja RDA, 2014, J COMPUT ASSIST TOMO, V38, P613, DOI 10.1097/RCT.0000000000000087; Korn A, 2012, AM J NEURORADIOL, V33, P218, DOI 10.3174/ajnr.A2749; Laqmani A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162429; Lee SW, 2014, EUR RADIOL, V24, P817, DOI 10.1007/s00330-013-3090-9; Lell M, 2009, INVEST RADIOL, V44, P728, DOI 10.1097/RLI.0b013e3181b9df7e; Lell MM, 2011, INVEST RADIOL, V46, P116, DOI 10.1097/RLI.0b013e3181f33b1d; Leschka S, 2009, EUR RADIOL, V19, P2896, DOI 10.1007/s00330-009-1618-9; Lim HK, 2016, DIAGN INTERV IMAG, V97, P443, DOI 10.1016/j.diii.2016.01.007; Machida H, 2015, RADIOGRAPHICS, V35, P991, DOI 10.1148/rg.2015140181; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Morsbach F, 2013, EUR RADIOL, V23, P2687, DOI 10.1007/s00330-013-2885-z; Moser JB, 2017, CLIN RADIOL, V72, P407, DOI 10.1016/j.crad.2016.11.021; Nagata K, 2015, EUR RADIOL, V25, P221, DOI 10.1007/s00330-014-3350-3; Neefjes LA, 2011, RADIOLOGY, V261, P779, DOI 10.1148/radiol.11110606; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Padole A, 2014, AM J ROENTGENOL, V203, P772, DOI 10.2214/AJR.13.12312; Petersilka M, 2008, EUR J RADIOL, V68, P362, DOI 10.1016/j.ejrad.2008.08.013; Pontana F, 2011, EUR RADIOL, V21, P627, DOI 10.1007/s00330-010-1990-5; Raman SP, 2013, J AM COLL RADIOL, V10, P37, DOI 10.1016/j.jacr.2012.06.025; Sauter A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162716; Scharf M, 2011, JACC-CARDIOVASC IMAG, V4, P602, DOI 10.1016/j.jcmg.2011.02.014; Schell B, 2011, EUR RADIOL, V21, P107, DOI 10.1007/s00330-010-1892-6; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sommer WH, 2010, INVEST RADIOL, V45, P64, DOI 10.1097/RLI.0b013e3181c15842; Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779; TARVER RD, 1988, AM J ROENTGENOL, V151, P1117, DOI 10.2214/ajr.151.6.1117; Xu Y, 2013, CLIN RADIOL, V68, P902, DOI 10.1016/j.crad.2013.03.024; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Zhu XH, 2004, AM J ROENTGENOL, V183, P809, DOI 10.2214/ajr.183.3.1830809	44	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211097	10.1371/journal.pone.0211097	http://dx.doi.org/10.1371/journal.pone.0211097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677082	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400048
J	Mai, ZL; Li, XX; Jiang, CH; Liu, YD; Chen, YW; Wu, WQ; Zeng, G				Mai, Zanlin; Li, Xiaoxia; Jiang, Chonghe; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua			Comparison of metabolic changes for stone risks in 24-hour urine between non- and postmenopausal women	PLOS ONE			English	Article							KIDNEY-STONES; MAGNESIUM; CALCIUM; PREVALENCE; ESTROGEN; EXCRETION; CITRATE; TRENDS	Background To explore the differences of 24-hour urine compositions associated with urolithiasis between non-and postmenopausal females. Methods The 24-hour urine samples of female participants were collected from May 2013 to July 2014 along with national cross-sectional study of urolithiasis among adults aged >= 18 years in China. The exclusion criteria for the participants were: serum creatinine > 133 mu mol/L, with urinary tract infection, gout, hyperthyroidism, malignancy, had a history of cancer, kidney stones, enterectomy, had taken thiazide diuretics, allopurinol, vitamin supplement, potassium citrate or calcium supplements during the past two weeks. The compositions associated with urinary stone in 24-hour urine were measured and compared between non-and postmenopausal women. Results A total of 603 24-hour urine samples of female participants were analyzed. 354 women with a mean age of 52.5 +/- 14.03 (range 19-84) years met the criteria, including 160 non-menopausal women and 194 postmenopausal women. Compared to the non-menopausal women, postmenopausal women had a lower secretion of citrate (p = 0.043), magnesium (p = 0.001) and creatinine (p = 0.001) in 24h urine. Multivariate linear regression analysis showed that the menopause status was associated with the changes in magnesium (p = 0.003) and creatinine (p = 0.002) secretion, whereas not with the changes in citrate (p = 0.402) secretion. Conclusions Postmenopausal women have a significant lower secretion of magnesium in their 24-hour urine than non-menopausal ones. We suppose that might be associated with increased risk of urinary stone formation among postmenopausal women.	[Mai, Zanlin; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Mai, Zanlin; Li, Xiaoxia; Liu, Yongda; Chen, Yiwen; Wu, Wenqi; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaoxia] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Jiang, Chonghe] Guangzhou Med Univ, Affiliated Hosp 6, Dept Urol, Qingyuan, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Zeng, G (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, G (corresponding author), Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	wwqwml@163.com; gzgyzgh@vip.sina.com			National Natural Science Foundation of China [81370804, 81670643]; Science and Technology Project in Guangdong, China [2014A020209085]; Guangzhou Science Technology and Innovation Commission [201604020001, 201704020193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project in Guangdong, China; Guangzhou Science Technology and Innovation Commission	This work was financed by grants from National Natural Science Foundation of China (No. 81370804 and No. 81670643), http://www.nsfc.gov.cn/; the Science and Technology Project in Guangdong, China (No. 2014A020209085), http://www.gdstc.gov.cn/and Guangzhou Science Technology and Innovation Commission (No. 201604020001 and No. 201704020193) http://www.gzsi.gov.cn/.	Aydin H, 2010, BIOL TRACE ELEM RES, V133, P136, DOI 10.1007/s12011-009-8416-8; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Classen H G, 1990, Fortschr Med, V108, P198; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Dey J, 2002, J UROLOGY, V167, P169, DOI 10.1016/S0022-5347(05)65405-5; Ganz PA, 2005, AM J MED, V118, P1410, DOI 10.1016/j.amjmed.2005.10.024; Ghanchilar N, 2005, J TABRIZ U MED SCI, V37, P54; Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388; HALLSON PC, 1982, CLIN SCI, V62, P17, DOI 10.1042/cs0620017; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hong YH, 2010, UROLOGY, V75, P1294, DOI 10.1016/j.urology.2009.08.061; Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163; Jaszmann L.J.B., 1976, MANAGEMENT MENOPAUSE, P11; Kramer HJM, 2003, J AM SOC NEPHROL, V14, P1272, DOI 10.1097/01.ASN.0000060682.25472.C3; LINDSAY R, 1980, CLIN SCI, V58, P255, DOI 10.1042/cs0580255; NICAR MJ, 1983, UROLOGY, V21, P8, DOI 10.1016/0090-4295(83)90113-9; Nordin BEC, 1999, OSTEOPOROSIS INT, V9, P351, DOI 10.1007/s001980050158; NORMAN RW, 1984, J UROLOGY, V132, P1137, DOI 10.1016/S0022-5347(17)50064-6; Padubidri VG, 2004, SHAWS TXB GYNECOLOGY, P56; Rude RK, 2012, MODERN NUTR HLTH DIS, P159; Sonu Y, 2016, INDIAN J CLIN BIOCHE, V31, P326, DOI 10.1007/s12291-015-0532-y; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Tiselius HG, 2002, ENDOCRIN METAB CLIN, V31, P1031, DOI 10.1016/S0889-8529(02)00027-0; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Zeng GH, 2017, BJU INT, V120, P109, DOI 10.1111/bju.13828; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	27	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0208893	10.1371/journal.pone.0208893	http://dx.doi.org/10.1371/journal.pone.0208893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677034	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400006
J	Infante, T; Forte, E; Schiano, C; Punzo, B; Cademartiri, F; Cavaliere, C; Salvatore, M; Napoli, C				Infante, Teresa; Forte, Ernesto; Schiano, Concetta; Punzo, Bruna; Cademartiri, Filippo; Cavaliere, Carlo; Salvatore, Marco; Napoli, Claudio			Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by Cardiac Computed Tomography	PLOS ONE			English	Article							BINDING PROTEIN (SREBP)-2; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; ARTERY-DISEASE; CT-ANGIOGRAPHY; ATHEROSCLEROSIS; PLAQUE; EXTENT; MACROPHAGES; CHALLENGES	Circulating biomarkers available in clinical practice do not allow to stratify patients with coronary heart disease (CHD) prior the onset of a clinically relevant event. We evaluated the methylation status of specific genomic segments and gene expression in peripheral blood of patients undergoing Cardiac Computed Tomography (CCT) for CHD (n = 95). We choose to investigate cholesterol metabolism. Methylation and gene expression of low density lipoprotein receptor (LDLR), sterol regulatory element-binding factor 2 (SREBF2) and ATP-binding cassette transporter 1 (ABCA1) were evaluated by qRT-PCR. Calcium score (CACS), stenosis degree, total plaque volume (TPV), calcified plaque volume (CPV), non-calcified plaque volume (NCPV) and plaque burden (PB) were assessed in all CHD patients (n = 65). The percentage of methylation at the specific analyzed segment of LDLR promoter was higher in CHD patients vs healthy subjects (HS) (n = 30) (p = 0.001). LDLR, SREBF2 and ABCA1 mRNAs were up-regulated in CHD patients vs HS (p = 0.02; p = 0.019; p = 0.008). SREBF2 was overexpressed in patients with coronary stenosis >50% vs subjects with stenosis <50% (p = 0.036). After adjustment for risk factors and clinical features, ABCA1 (p = 0.005) and SREBF2 (p = 0.010) gene expression were identified as independent predictors of CHD and severity. ROC curve analysis revealed a good performance of ABCA1 on predicting CHD (AUC = 0.768; p<0.001) and of SREBF2 for the prediction of disease severity (AUC = 0.815; p<0.001). Moreover, adjusted multivariate analysis demonstrated SREBF2 as independent predictor of CPV, NCPV and TPV (p = 0.022; p = 0.002 and p = 0.006) and ABCA1 as independent predictor of NCPV and TPV (p = 0.002 and p = 0.013). CHD presence and characteristics are related to selected circulating transcriptional and epigenetic-sensitive biomarkers linked to cholesterol pathway. More extensive analysis of CHD phenotypes and circulating biomarkers might improve and personalize cardiovascular risk stratification in the clinical settings.	[Infante, Teresa; Forte, Ernesto; Schiano, Concetta; Punzo, Bruna; Cademartiri, Filippo; Cavaliere, Carlo; Salvatore, Marco; Napoli, Claudio] IRCCS SDN, Naples, Italy; [Napoli, Claudio] Univ Campania Luigi Vanvitelli, Dept Med Surg Neurol Metab & Geriatr Sci, Naples, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli	Infante, T (corresponding author), IRCCS SDN, Naples, Italy.	tinfante@sdn-napoli.it	Punzo, Bruna/Z-3067-2019; Schiano, Concetta/GOE-4310-2022; Cademartiri, Filippo/H-7336-2015; Infante, Teresa/K-8735-2016; Salvatore, Marco/K-8083-2016	Punzo, Bruna/0000-0003-0915-4682; Cademartiri, Filippo/0000-0002-0579-3279; Infante, Teresa/0000-0002-1764-9610; Salvatore, Marco/0000-0001-9734-7702	Italian Ministry of Health [GR-2011-02349436]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by Italian Ministry of Health grants "Giovani Ricercatori 2011-12", project code GR-2011-02349436 (TI) and "Ricerca Corrente 2013-15" (CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg F, 2012, INT J CARDIOVAS IMAG, V28, P183, DOI 10.1007/s10554-010-9773-2; Bobryshev YV, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9582430; Cademartiri F, 2017, HEART, V103, P975, DOI 10.1136/heartjnl-2016-310473; Canpolat U, 2013, INT J CARDIOVAS IMAG, V29, P1371, DOI 10.1007/s10554-013-0209-7; Chen HH, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0634-x; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Dalen JE, 2014, AM J MED, V127, P807, DOI 10.1016/j.amjmed.2014.04.015; De Castro-Oros I, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-17; de Nigris F, 2018, JAMA CARDIOL, V3, P1184, DOI 10.1001/jamacardio.2018.3546; Demina EP, 2011, MOL BIOL+, V45, P258, DOI 10.1134/S0026893310061019; Duan L, 2018, GENE, V646, P91, DOI 10.1016/j.gene.2017.12.033; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fan YM, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-17; Forte E, 2017, EUR HEART J-CARD IMG, V18, P1229, DOI 10.1093/ehjci/jew218; Forte E, 2016, SURG RADIOL ANAT, V38, P987, DOI 10.1007/s00276-016-1634-9; Friedlander Y, 2008, ATHEROSCLEROSIS, V196, P896, DOI 10.1016/j.atherosclerosis.2007.02.006; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grimaldi V, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0476-3; Guaricci AI, 2017, EUR HEART J-CARD IMG, V18, P1049, DOI 10.1093/ehjci/jew173; Harada K, 2013, INT J CARDIOVAS IMAG, V29, P1149, DOI 10.1007/s10554-013-0181-2; Heo SH, 2018, J STROKE, V20, P80, DOI 10.5853/jos.2017.02390; Infante T, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00209; Infante T, 2017, AM J TRANSL RES, V9, P3148; Kontaraki JE, 2014, HELL J CARDIOL, V55, P119; Kunita E, 2012, CIRC J, V76, P1687, DOI 10.1253/circj.CJ-11-1442; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032060; Liu HF, 2012, EXP THER MED, V4, P297, DOI 10.3892/etm.2012.576; Maiwald S, 2013, CURR OPIN CLIN NUTR, V16, P411, DOI 10.1097/MCO.0b013e32836236f9; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Mirabelli P, 2017, OPEN J BIORES, V4, P2, DOI [10.5334/ojb.26, DOI 10.5334/OJB.26]; Miserez AR, 2002, ATHEROSCLEROSIS, V164, P15, DOI 10.1016/S0021-9150(01)00762-6; Mozzini C, 2014, FREE RADICAL BIO MED, V68, P178, DOI 10.1016/j.freeradbiomed.2013.12.017; Muller PY, 2002, J MED GENET, V39, P271, DOI 10.1136/jmg.39.4.271; Napoli C, 2016, WORLD J CARDIOL, V8, P211, DOI 10.4330/wjc.v8.i2.211; Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787; Rienzo M, 2013, CLIN TRANSL ONCOL, V15, P211, DOI 10.1007/s12094-012-0904-1; Rizvi A, 2017, ATHEROSCLEROSIS, V258, P145, DOI 10.1016/j.atherosclerosis.2017.01.018; Romano M, 2010, ATHEROSCLEROSIS, V210, P493, DOI 10.1016/j.atherosclerosis.2009.11.051; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Schiano C, 2015, TRENDS PHARMACOL SCI, V36, P226, DOI 10.1016/j.tips.2015.02.005; Shchelkunova TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063374; Sinnaeve PR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007037; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Strang AC, 2009, AM J CARDIOL, V104, p22E, DOI 10.1016/j.amjcard.2009.09.016; Tabas I, 2017, IMMUNITY, V47, P621, DOI 10.1016/j.immuni.2017.09.008; ten Kate GJR, 2013, ATHEROSCLEROSIS, V227, P334, DOI 10.1016/j.atherosclerosis.2012.12.016; Voros S, 2014, ATHEROSCLEROSIS, V233, P284, DOI 10.1016/j.atherosclerosis.2013.12.045; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730	52	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210909	10.1371/journal.pone.0210909	http://dx.doi.org/10.1371/journal.pone.0210909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673762	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800057
J	Alves, MI; Macagnan, KL; Piecha, CR; Torres, MM; Perez, IA; Kesserlingh, SM; Rodrigues, RD; de Oliveira, PD; Moreira, AD				Alves, Mariane Igansi; Macagnan, Karine Laste; Piecha, Camila Rios; Torres, Matheus Marques; Perez, Izadora Almeida; Kesserlingh, Sonia Maria; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira			Optimization of Ralstonia solanacearum cell growth using a central composite rotational design for the P(3HB) production: Effect of agitation and aeration	PLOS ONE			English	Article							PHB PRODUCTION; POLY(3-HYDROXYBUTYRATE); POLY-3-HYDROXYBUTYRATE; POLYHYDROXYALKANOATES; FERMENTATION; DENSITY	The intracellular accumulation of polyhydroxyalkanoates (PHAs) normally occurs after cell growth, during the second fermentation stage and under nutrient-limited conditions in the presence of a carbon excess. However, some microorganisms are able to accumulate PHAs as poly(3-hydroxybutyrate) [P(3HB)] during the first fermentation stage, the cell growth phase, without nutrient limitation, once they have been reported to utilize type II metabolism during the polymer accumulation phase. This study evaluated the effect of aeration and agitation on cell growth and P(3HB) accumulation in Ralstonia solanacearum RS, performed in a bioreactor for 24h at 32 degrees C. A 2 2 central composite rotational design (CCRD) was used, with agitation (150 to 250 rpm) and aeration (0.3 to 1 vvm) as independent variables and optical density (OD600nm), dry cell weight (DCW), and P(3HB) yield as dependent variables. A significant polymer accumulation, until 70% of P(3HB), was observed, proving that R. solanacearum RS exhibited metabolism type II, regardless of the aeration process. The best results were obtained for 1 vvm and 250 rpm (+1, +1), with values of OD600nm (18.04) and DCW (4.82 g.L-1).	[Alves, Mariane Igansi; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira] Univ Fed Pelotas, Eliseu Maciel Fac Agron, Dept Food Sci & Technol, Pelotas, RS, Brazil; [Macagnan, Karine Laste; Piecha, Camila Rios; Torres, Matheus Marques; Moreira, Angelita da Silveira] Univ Fed Pelotas, Technol Dev Ctr, Biotechnol, Pelotas, RS, Brazil; [Perez, Izadora Almeida; Rodrigues, Rosane da Silva; de Oliveira, Patricia Diaz; Moreira, Angelita da Silveira] Univ Fed Pelotas, Ctr Chem Pharmaceut & Food Sci, Pelotas, RS, Brazil; [Kesserlingh, Sonia Maria] Co PHB Ind, Serrana, SP, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Moreira, AD (corresponding author), Univ Fed Pelotas, Eliseu Maciel Fac Agron, Dept Food Sci & Technol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Technol Dev Ctr, Biotechnol, Pelotas, RS, Brazil.; Moreira, AD (corresponding author), Univ Fed Pelotas, Ctr Chem Pharmaceut & Food Sci, Pelotas, RS, Brazil.	angelitadasilveiramoreira@gmail.com	Kesserlingh, Sônia/U-1518-2019; Macagnan, Karine Laste/N-9398-2018; Diaz, Patrícia Silva/L-9364-2017; da S. Moreira, Angelita/L-8545-2017	Macagnan, Karine Laste/0000-0002-8643-3397; Diaz, Patrícia Silva/0000-0001-9601-296X; da S. Moreira, Angelita/0000-0001-8711-6521; Kesserlingh, Sonia Maria/0000-0003-4545-835X				AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Alves FG, 2010, APPL BIOCHEM BIOTECH, V160, P1528, DOI 10.1007/s12010-009-8683-z; Alves Mariane I., 2017, IND BIOTECHNOLOGY, V13, P192, DOI [DOI 10.1089/IND.2017.0013, 10.1089/ind.2017.0013]; Alves-Gauterio FG, 2015, REV BRASILEIRA TECNO, V9, P1821; Barros BN, 2001, COMO FAZER EXPT PESQ; BARROS NB, 1995, PLANEJAMENTO OTIMIZA; Brito GF., 2011, REV ELETRON MAT PROC, V6, P127; Burkert JFD, 2005, J CHEM TECHNOL BIOT, V80, P61, DOI 10.1002/jctb.1157; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Carvell JP, 2006, CYTOTECHNOLOGY, V50, P35, DOI 10.1007/s10616-005-3974-x; Chakraborty P, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/506153; Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014; Chioccioli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097269; Chisti Y., 2004, HDB MICROALGAL CULTU, P57; Crochemore A. G., 2012, African Journal of Biotechnology, V11, P15144; de Almeida A, 2010, APPL ENVIRON MICROB, V76, P2036, DOI 10.1128/AEM.02706-09; Du GC, 2001, J BIOTECHNOL, V88, P59, DOI 10.1016/S0168-1656(01)00266-8; El-Sayed A.A., 2009, J APPL SCI RES, V5, P556; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Haaland PD, 1989, EXPT DESIGN BIOTECHN; JEANES A, 1974, FOOD TECHNOL-CHICAGO, V28, P34; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Kemavongse K, 2008, WORLD J MICROB BIOT, V24, P2073, DOI 10.1007/s11274-008-9712-8; Khuri AI, 1996, RESPONSE SURFACE DES; Lee SY, 1999, INT J BIOL MACROMOL, V25, P31, DOI 10.1016/S0141-8130(99)00012-4; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Macagnan KL, 2017, QUIM NOVA, V40, P125, DOI 10.21577/0100-4042.20160162; Macagnan KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180563; Franchetti SM, 2006, QUIM NOVA, V29, P811, DOI 10.1590/S0100-40422006000400031; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montoro SR, 2010, POLIMEROS, V20, P19, DOI 10.1590/S0104-14282010005000005; Mozumder MSI, 2015, BIORESOURCE TECHNOL, V191, P213, DOI 10.1016/j.biortech.2015.04.110; National Geographic, WHOPP 91 PLAST ISNT; Park SJ, 2012, BIOTECHNOL ADV, V30, P1196, DOI 10.1016/j.biotechadv.2011.11.007; Pereira D. D., 2001, Revista Cientifica Rural, V6, P22; Prescott L. M., 2003, MICROBIOLOGIE; Ramadas NV, 2010, APPL BIOCHEM BIOTECH, V162, P996, DOI 10.1007/s12010-009-8807-5; RAMSAY J A, 1990, Biotechnology Techniques, V4, P221, DOI 10.1007/BF00158833; Rodrigues AA, 2015, REV BRASILEIRA TECNO, V9, P1771; Rodriguez-Contreras A, 2013, J APPL MICROBIOL, V114, P1378, DOI 10.1111/jam.12151; Rodriguez-Contreras A, 2015, BIOCHEM ENG J, V94, P50, DOI 10.1016/j.bej.2014.11.007; Rosa CFC, 2015, INT J ENG RES APPL, V5, P41; Sathish A, 2014, J POLYM ENVIRON, V22, P272, DOI 10.1007/s10924-014-0647-x; Schaad NW, 2001, LAB GUIDE IDENTIFICA, V3, P373; Squio CR, 2004, QUIM NOVA, V27, P615, DOI 10.1590/S0100-40422004000400016; Tripathi AD, 2013, BIOMASS BIOENERG, V55, P243, DOI 10.1016/j.biombioe.2013.02.017; Wu Q, 2001, ANTON LEEUW INT J G, V80, P111, DOI 10.1023/A:1012222625201; Xiong ZQ, 2008, J BIOSCI BIOENG, V105, P409, DOI 10.1263/jbb.105.409; Zafar M, 2012, J IND MICROBIOL BIOT, V39, P987, DOI 10.1007/s10295-012-1102-4	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211211	10.1371/journal.pone.0211211	http://dx.doi.org/10.1371/journal.pone.0211211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695062	gold, Green Submitted, Green Published			2022-12-27	WOS:000457046400019
J	Belete, W; Deressa, T; Feleke, A; Menna, T; Moshago, T; Abdella, S; Hebtesilassie, A; Getaneh, Y; Demissie, M; Zula, Y; Lemma, I; Mamo, G; Workalemahu, E; Kifle, T; Abate, E				Belete, Wudinesh; Deressa, Tekalign; Feleke, Altaye; Menna, Takele; Moshago, Tezera; Abdella, Saro; Hebtesilassie, Abebe; Getaneh, Yimam; Demissie, Minilik; Zula, Yonas; Lemma, Israel; Mamo, Girmachew; Workalemahu, Endale; Kifle, Tsigereda; Abate, Ebba			Evaluation of diagnostic performance of non-invasive HIV self-testing kit using oral fluid in Addis Ababa, Ethiopia: A facility-based cross-sectional study	PLOS ONE			English	Article								Background Human immunodeficiency virus (HIV) testing is critical for early linkage to treatment and care services. However, there is a substantial gap in HIV testing, particularly in resource limited settings due to low accessibility of HIV testing sites, inconvenient testing hours, and concerns about loss of confidentiality. Thus, adopting new strategies such as HIV self-testing (HIVST) could overcome these barriers and increases HIV testing uptake. Objective The aim of this study was to evaluate the diagnostic performance of non-invasive HIVST kit using oral fluid for HIV diagnosis. This study also aimed to assess the ability of clients in interpretation of OraQuick HIVST results. Method Between December 2017 and February 2018, a total of 400 study participants were enrolled into the study to assess a diagnostic accuracy of Oral fluid-based HIVST kit ( OraQuick) in 15 public health facilities in Addis Ababa, Ethiopia. Participants were provided with instructions and visual aids on how to perform HIVST and interpret results. They also underwent a blood-based rapid HIV antibody test as per the current national algorithm. The results of HIVST were interpreted independently by the participants and respective health care workers (HCWs). The sensitivity, specificity, positive predictive value (PPV), Negative predictive value (NPV) and inter-rater agreement of the test were computed. Results Out of 200 participants who tested positive on the national algorithm testing, oral fluid-based self-testing was positive in 199 (99.5%), false negative in 1 (0.5%). Of 200 participants who tested negative on the national algorithm testing, self-testing was negative in 200 (100%). There were no false positive and invalid tests. The sensitivity and specificity of the OraQuick HIVST were 99.5% (95%CI: 97.26-99.99) and 100% (95%CI: 98.18-100.0), respectively. The overall agreement between the two tests was high (kappa value = 0.995). The PPV and NPV of OraQuick test were 100% and 99.5% (95%CI: 96.59-99.93) respectively. Conclusion This study showed a high diagnostic performance of OraQuick HIV self-test and suggests that OraQuick HIVST kit has a potential to be used for HIV testing in Ethiopia along with the national algorithm.	[Belete, Wudinesh; Deressa, Tekalign; Feleke, Altaye; Menna, Takele; Moshago, Tezera; Abdella, Saro; Hebtesilassie, Abebe; Getaneh, Yimam; Demissie, Minilik; Kifle, Tsigereda; Abate, Ebba] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Zula, Yonas; Lemma, Israel; Mamo, Girmachew; Workalemahu, Endale] Populat Serv Int E, Addis Ababa, Ethiopia		Deressa, T (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	tekalign09@gmail.com	Demissie, Minilik/U-7256-2019	Amogne, minilik/0000-0002-9342-4747				Branson BM, 2013, JAIDS-J ACQ IMM DEF, V63, pS117, DOI 10.1097/QAI.0b013e3182986f25; CDC/ WHO/ APHL:, GUID APPR EV HIV TES; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Ethiopia-Country/ Regional Operational Plan (COP/ ROP), 2016, STRAT DIR SUMM; Gichangi A, 2016, 21 INT AIDS C 18 22; Green K, 2016, 21 INT AIDS C 18 22; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Homers RL, 2008, JAIDS-J ACQ IMM DEF, V48, P116, DOI 10.1097/QAI.0b013e31816bcdcf; Jamil M, 2016, 21 INT AIDS C 18 22; Katz D, 2015, 8 INT AIDS SOC C 19; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000367; Pai NP, 2007, EXPERT REV MOL DIAGN, V7, P325, DOI 10.1586/14737159.7.4.325; Sophie J., 2009, AIDS PATIENT CARE ST, V23, P7; Stemler S.E., 2004, PRACT ASSESS RES EVA, V9, P4; The Joint United Nations Programme on HIV/AIDS, 2016, GLOB AIDS UPD; UNAIDS, 90 90 90 AMB TREATM; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; WHO Prequalification of In Vitro Diagnostics, 015905501 PQDX WHO; World Health Organization, CONS GUID HIV TEST S; World Health Organization, HIV AIDS FACTSH; World Health Organization, 2016, CONS GUID US ANT THE; World Health Organziation, GUID HIV SELF TEST P; Zachary D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-183	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210866	10.1371/journal.pone.0210866	http://dx.doi.org/10.1371/journal.pone.0210866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682062	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500069
J	Biggs, PR; Whatling, GM; Wilson, C; Metcalfe, AJ; Holt, CA				Biggs, Paul Robert; Whatling, Gemma Marie; Wilson, Chris; Metcalfe, Andrew John; Holt, Cathy Avril			Which osteoarthritic gait features recover following total knee replacement surgery?	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; ARTHROPLASTY; BIOMECHANICS; HIP; PATTERNS; WALKING; SPEED; CLASSIFICATION; IMPROVEMENT; SEVERITY	Background Gait analysis can be used to measure variations in joint function in patients with knee osteoarthritis (OA), and is useful when observing longitudinal biomechanical changes following Total Knee Replacement (TKR) surgery. The Cardiff Classifier is an objective classification tool applied previously to examine the extent of biomechanical recovery following TKR. In this study, it is further developed to reveal the salient features that contribute to recovery towards healthy function. Methods Gait analysis was performed on 30 patients before and after TKR surgery, and 30 healthy controls. Median TKR follow-up time was 13 months. The combined application of principal component analysis (PCA) and the Cardiff Classifier defined 18 biomechanical features that discriminated OA from healthy gait. Statistical analysis tested whether these features were affected by TKR surgery and, if so, whether they recovered to values found for the controls. Results The Cardiff Classifier successfully discriminated between OA and healthy gait in all 60 cases. Of the 18 discriminatory features, only six (33%) were significantly affected by surgery, including features in all three planes of the ground reaction force (p<0.001), ankle dorsiflexion moment (p<0.001), hip adduction moment (p = 0.003), and transverse hip angle (p = 0.007). All but two (89%) of these features remained significantly different to those of the control group after surgery. Conclusions This approach was able to discriminate gait biomechanics associated with knee OA. The ground reaction force provided the strongest discriminatory features. Despite increased gait velocity and improvements in self-reported pain and function, which would normally be clinical indicators of recovery, the majority of features were not affected by TKR surgery. This TKR cohort retained pre-operative gait patterns; reduced sagittal hip and knee moments, decreased knee flexion, increased hip flexion, and reduced hip adduction. The changes that were associated with surgery were predominantly found at the ankle and hip, rather than at the knee.	[Biggs, Paul Robert; Whatling, Gemma Marie; Holt, Cathy Avril] Cardiff Univ, Coll Phys Sci, Cardiff Sch Engn, Cardiff, S Glam, Wales; [Biggs, Paul Robert; Whatling, Gemma Marie; Wilson, Chris; Metcalfe, Andrew John; Holt, Cathy Avril] Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff, S Glam, Wales; [Wilson, Chris] Univ Hosp Wales, Cardiff, S Glam, Wales; [Metcalfe, Andrew John] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England	Cardiff University; Cardiff University; Cardiff University; University of Warwick	Biggs, PR (corresponding author), Cardiff Univ, Coll Phys Sci, Cardiff Sch Engn, Cardiff, S Glam, Wales.; Biggs, PR (corresponding author), Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff, S Glam, Wales.	biggsp1@cardiff.ac.uk	Whatling, Gemma/V-4957-2019; Whatling, Gemma M/J-2474-2012; Holt, Catherine/F-3565-2010	Whatling, Gemma/0000-0001-6912-9580; Holt, Catherine/0000-0002-0428-8078; Metcalfe, Andrew/0000-0002-4515-8202; Biggs, Paul/0000-0002-8846-0858	Arthritis Research UK as part of the Arthritis Research UK Biomechanics and Bioengineering Centre [20781]	Arthritis Research UK as part of the Arthritis Research UK Biomechanics and Bioengineering Centre	This study was supported by funding from Arthritis Research UK as part of the Arthritis Research UK Biomechanics and Bioengineering Centre. Grant reference number Grant reference number 20781. URL: https://www.arthritisresearchuk.org/research/grant-tracker-items/2016/arthritis-research-uk-biomechanics-and-bioengineering-centre.aspx. The grant funded a postdoctoral position which was awarded to author PRB. All other co-authors were named principal or co-investigators on the grant. Sponsors were not involved in the collection, analysis or interpretation of the data or manuscript.	Al-Zahrani KS, 2002, DISABIL REHABIL, V24, P275, DOI 10.1080/09638280110087098; Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Amin AK, 2006, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000224052.01873.20; Arnold JB, 2015, J ORTHOP RES, V33, P1818, DOI 10.1002/jor.22969; Astephen JL, 2008, J ORTHOP RES, V26, P332, DOI 10.1002/jor.20496; Bade MJ, 2010, J ORTHOP SPORT PHYS, V40, P559, DOI 10.2519/jospt.2010.3317; Beynon MJ, 2006, IEEE T SYST MAN CY A, V36, P173, DOI 10.1109/TSMCA.2006.859098; Bonnefoy-Mazure A, 2017, J ARTHROPLASTY, V32, P793, DOI 10.1016/j.arth.2016.03.050; Brandon SCE, 2013, J ELECTROMYOGR KINES, V23, P1304, DOI 10.1016/j.jelekin.2013.09.010; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chen SS, 2016, IEEE J BIOMED HEALTH, V20, P1521, DOI 10.1109/JBHI.2016.2608720; Culvenor A, 2018, BJSM BMJ, DOI 10.1136/bjsports-2018-099257; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Hamilton DF, 2018, J ARTHROPLASTY, V33, P2392, DOI 10.1016/j.arth.2018.03.062; Han H-S, 2017, KNEE SURG SPORT TR A, P1; Harris K, 2013, QUAL LIFE RES, V22, P2561, DOI 10.1007/s11136-013-0393-x; Hatfield GL, 2011, J ARTHROPLASTY, V26, P309, DOI 10.1016/j.arth.2010.03.021; Huang SC, 2008, MED ENG PHYS, V30, P997, DOI 10.1016/j.medengphy.2008.02.006; Jones L, 2006, J BIOMECH, V39, P2512, DOI 10.1016/j.jbiomech.2005.07.024; Kerrigan DC, 1998, ARCH PHYS MED REHAB, V79, P317, DOI 10.1016/S0003-9993(98)90013-2; Kerrigan DC, 2000, AM J PHYS MED REHAB, V79, P247, DOI 10.1097/00002060-200005000-00006; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Levinger P, 2013, J ARTHROPLASTY, V28, P994, DOI 10.1016/j.arth.2012.10.018; Liebensteiner MC, 2008, KNEE, V15, P461, DOI 10.1016/j.knee.2008.07.001; Losina E, 2012, ARTHRITIS RHEUMATOL, DOI [10.1002/art.33371/full, DOI 10.1002/ART.33371/FULL]; McClelland JA, 2007, KNEE, V14, P253, DOI 10.1016/j.knee.2007.04.003; Metcalfe AJ, 2013, BONE JOINT J, V95B, P348, DOI 10.1302/0301-620X.95B3.30850; Metcalfe A. J., 2017, GAIT POSTURE; Mizner RL, 2011, J ARTHROPLASTY, V26, P728, DOI 10.1016/j.arth.2010.06.004; Mundermann A, 2005, ARTHRITIS RHEUM-US, V52, P2835, DOI 10.1002/art.21262; Muniz AMS, 2009, GAIT POSTURE, V29, P31, DOI 10.1016/j.gaitpost.2008.05.015; Naili JE, 2017, KNEE SURG SPORT TR A, V25, P3378, DOI 10.1007/s00167-016-4234-7; Nilsdotter AK, 2009, ACTA ORTHOP, V80, P55, DOI 10.1080/17453670902805007; Ouellet D, 2002, ARTHRIT RHEUM-ARTHR, V47, P484, DOI 10.1002/art.10652; Pataky TC, 2016, J BIOMECH, V49, P1468, DOI 10.1016/j.jbiomech.2016.03.032; Perry J., 2010, J SPORTS SCI MED, V9, P353, DOI 10.1097/01241398-199211000-00023; Rahman J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0525-2; Smith AJ, 2004, J ORTHOP RES, V22, P260, DOI 10.1016/S0736-0266(03)00184-0; Turcot K, 2013, J ARTHROPLASTY, V28, P1297, DOI 10.1016/j.arth.2013.01.031; Vahtrik D, 2014, KNEE, V21, P216, DOI 10.1016/j.knee.2013.05.002; Vincent H, 2012, AGING MUSCULOSKELETA; Watelain E, 2001, ARCH PHYS MED REHAB, V82, P1705, DOI 10.1053/apmr.2001.26812; Wiik AV, 2017, WORLD J ORTHOP, V8, P322, DOI 10.5312/wjo.v8.i4.322; Wilson JLA, 2012, CLIN BIOMECH, V27, P210, DOI 10.1016/j.clinbiomech.2011.09.009; Worsley PR, 2016, COMPUT METHOD BIOMEC, V19, P418, DOI 10.1080/10255842.2015.1034115; Xu Yi-ming, 2010, Journal of Shanghai Jiaotong University (English Edition), V15, P632, DOI 10.1007/s12204-010-1060-9; Yoshida Y, 2012, J ORTHOP SPORT PHYS, V42, P1039, DOI 10.2519/jospt.2012.3763	47	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0203417	10.1371/journal.pone.0203417	http://dx.doi.org/10.1371/journal.pone.0203417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682010	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000457037500003
J	Haddad, M; Prince, MS; Zarrouk, N; Tabben, M; Behm, DG; Chamari, K				Haddad, Monoem; Prince, Mohammad Shoaib; Zarrouk, Nidhal; Tabben, Montassar; Behm, David G.; Chamari, Karim			Dynamic stretching alone can impair slower velocity isokinetic performance of young male handball players for at least 24 hours	PLOS ONE			English	Article							VERTICAL JUMP PERFORMANCE; WARM-UP; STATIC STRETCH; SPRINT PERFORMANCE; FORCE-VELOCITY; MUSCLE DAMAGE; REACTION-TIME; JOINT-ANGLE; PEAK TORQUE; ACUTE BOUT	There are many adult studies reporting static stretch (SS)-induced deficits and dynamic stretch (DS) performance improvements shortly after the intervention. However, there is only a single study examining stretch-induced performance changes with youth at 24 hours' post-stretch. The objective of this study was to examine physiological responses of young trained athletes at 24-hours after experiencing SS or DS protocols. Eight young male, elite handball players (age: 16.1 +/- 5.1 years) were tested prior to-, 3-minutes and 24-hours following the three conditions (DS, SS, Control) in a randomized and counterbalanced order. Similar volumes of SS (2 repetitions of 75s for each leg) and DS (5 repetitions of 30s for each leg) involved one stretch each for the quadriceps and hamstrings. Tests included (i) two 4s maximal voluntary isometric contractions (MVC) at 60 degrees of knee flexion with 2-min rest, (ii) two maximal isokinetic contractions each at 60 degrees/sec and 300 degrees/sec with 1-min rest, and (iii) two drop jumps with 30-sec rest. To simulate a full warm-up, dynamic activity including 5 minutes of aerobic cycling (70 rpm; 1 kilopond), 4 submaximal isometric contractions and 4 drop jumps were instituted before the pre-tests and following the interventions. Two-way repeated measures ANOVAs revealed that 1) both the SS and control conditions exhibited knee extensor 60 degrees.s(-1) (SS:-10.3%; p = 0.04, Control: -8.7%; p = 0.07) and 300 degrees.s(-1) (SS: -12.9%; p = 0.005, Control: -16.3%; p = 0.02) isokinetic deficits at post-test, 2) DS impaired knee flexor 60 degrees.s(-1) isokinetic work and power-related measures at post-test (Work: -10.1%; p = 0.0006; Power: -19.1%; p = 0.08) and at 24-hours' post-test (Work: 9.9%; p = 0.023; Power: -9.6%; p = 0.01), 3) DS (12.07% and 10.47%) and SS (13.7% and 14.6%) enhanced knee flexor 300 degrees.s(-1) isokinetic force and power-related measures compared to control. In conclusion, testing-induced knee extensor isokinetic impairments were counterbalanced by DS, however the hip flexion DS could have produced minor muscle damage for at least 24-hours decreasing knee flexor forces and power at 60 degrees.s(-1).	[Haddad, Monoem; Prince, Mohammad Shoaib] Qatar Univ, Coll Arts & Sci, Sport Sci Program, Doha, Qatar; [Zarrouk, Nidhal] Aspetar Orthoped & Sports Med Hosp, Excellence Football Project, Natl Sports Med Programme, Doha, Qatar; [Tabben, Montassar] Aspetar Orthoped & Sports Med Hosp, ASPREV Dept, Doha, Qatar; [Behm, David G.] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada; [Chamari, Karim] Qatar Orthopaed & Sports Med Hosp, Aspetar, AHP Res Ctr, Doha, Qatar	Qatar University; Aspetar Orthopaedic & Sports Medicine Hospital; Aspetar Orthopaedic & Sports Medicine Hospital; Memorial University Newfoundland; Aspetar Orthopaedic & Sports Medicine Hospital	Behm, DG (corresponding author), Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada.	dbehm@mun.ca	Behm, David George/I-6509-2019; Haddad, Monoem/D-4999-2014; CHAMARI, Karim/AAJ-7938-2021	Behm, David George/0000-0002-9406-6056; Haddad, Monoem/0000-0001-5989-1627; CHAMARI, Karim/0000-0001-9178-7678	Qatar University - University Grant [QUUG-CAS-DSSP-15\16-15]; Qatar National Library	Qatar University - University Grant; Qatar National Library(Qatar National Research Fund (QNRF))	This work was supported by Qatar University - University Grant QUUG-CAS-DSSP-15\16-15. The publication of this article was funded by the Qatar National Library.	Alter M.J., 1996, SCI FLEXIBILITY; Ayala F, 2014, J SPORT SCI, V32, P817, DOI 10.1080/02640414.2013.861606; Behm DG, 2007, EUR J APPL PHYSIOL, V101, P587, DOI 10.1007/s00421-007-0533-5; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Behm DG, 2016, EUR J APPL PHYSIOL, V116, P241, DOI 10.1007/s00421-015-3270-1; Behm DG, 2006, J SPORT SCI MED, V5, P33; Behm DG, 2004, MED SCI SPORT EXER, V36, P1397, DOI 10.1249/01.MSS.0000135788.23012.5F; Behm DG, 2004, CAN J APPL PHYSIOL, V29, P274, DOI 10.1139/h04-019; Behm DG, 2001, CAN J APPL PHYSIOL, V26, P261, DOI 10.1139/h01-017; Behm DG, 2001, J STRENGTH COND RES, V15, P255; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Blazevich AJ, 2018, MED SCI SPORT EXER, V50, P1258, DOI 10.1249/MSS.0000000000001539; Bradley PS, 2007, J STRENGTH COND RES, V21, P223, DOI 10.1519/00124278-200702000-00040; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Chaouachi A, 2008, EUR J APPL PHYSIOL, V104, P515, DOI 10.1007/s00421-008-0799-2; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Costa PB, 2014, MED SCI SPORT EXER, V46, P586, DOI 10.1249/MSS.0000000000000138; Costa PB, 2009, J STRENGTH COND RES, V23, P141, DOI 10.1519/JSC.0b013e31818eb052; Cramer JT, 2007, J ORTHOP SPORT PHYS, V37, P130, DOI 10.2519/jospt.2007.2389; Cramer JT, 2004, J STRENGTH COND RES, V18, P236, DOI 10.1519/00124278-200405000-00006; Curry BS, 2009, J STRENGTH COND RES, V23, P1811, DOI 10.1519/JSC.0b013e3181b73c2b; de Hoyo M, 2016, J SPORT SCI, V34, P1363, DOI 10.1080/02640414.2016.1150603; DEKONING FL, 1985, EUR J APPL PHYSIOL O, V54, P89, DOI 10.1007/BF00426305; Duncan M.J., 2006, J EXERC PHYSL, V9, P9; Faigenbaum AD, 2010, PEDIATR EXERC SCI, V22, P266, DOI 10.1123/pes.22.2.266; Falk B, 2006, EXERC SPORT SCI REV, V34, P107, DOI 10.1249/00003677-200607000-00004; Fletcher IM, 2007, J STRENGTH COND RES, V21, P784; Fletcher IM, 2010, EUR J APPL PHYSIOL, V109, P491, DOI 10.1007/s00421-010-1386-x; Fletcher IM, 2004, J STRENGTH COND RES, V18, P885; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Haddad M, 2014, J STRENGTH COND RES, V28, P140, DOI 10.1519/JSC.0b013e3182964836; Haghshenas R T-B I., 2014, INT J SPORT STUDIES, V4, P907; Halperin I, 2018, INT J SPORT PHYSIOL, V13, P127, DOI 10.1123/ijspp.2017-0322; Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632; Hermens HJ., 1999, EUROPEAN RECOMMENDAT, DOI DOI 10.1016/S1050-6411(00)00027-4; Hough PA, 2009, J STRENGTH COND RES, V23, P507, DOI 10.1519/JSC.0b013e31818cc65d; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; INGEMANNHANSEN T, 1979, SCAND J REHABIL MED, V11, P85; Jaggers JR, 2008, J STRENGTH COND RES, V22, P1844, DOI 10.1519/JSC.0b013e3181854a3d; Janes WCI, 2016, APPL PHYSIOL NUTR ME, V41, P1052, DOI 10.1139/apnm-2016-0241; Kay AD, 2008, EUR J SPORT SCI, V8, P41, DOI 10.1080/17461390701855505; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Kay AD, 2010, J APPL PHYSIOL, V108, P637, DOI 10.1152/japplphysiol.01135.2009; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; Kirmizigil B, 2014, J STRENGTH COND RES, V28, P1263, DOI 10.1519/JSC.0000000000000268; Kokkonen J, 1998, RES Q EXERCISE SPORT, V69, P411, DOI 10.1080/02701367.1998.10607716; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Murphy JR, 2014, EUR J APPL PHYSIOL, V114, P825, DOI 10.1007/s00421-013-2809-2; Nelson AG, 2005, J SPORT SCI, V23, P449, DOI 10.1080/02640410410001730205; Nelson AG, 2001, RES Q EXERCISE SPORT, V72, P415, DOI 10.1080/02701367.2001.10608978; Nelson AG, 2001, RES Q EXERCISE SPORT, V72, P68, DOI 10.1080/02701367.2001.10608934; Papadopoulos G, 2005, ISOKINET EXERC SCI, V13, P285, DOI 10.3233/IES-2005-0216; Pearce AJ, 2009, EUR J APPL PHYSIOL, V105, P175, DOI 10.1007/s00421-008-0887-3; Perrier ET, 2011, J STRENGTH COND RES, V25, P1925, DOI 10.1519/JSC.0b013e3181e73959; PERRINE JJ, 1978, MED SCI SPORT EXER, V10, P159; PERRY J, 1981, CRIT REV BIOMED ENG, V7, P1; Power K, 2004, MED SCI SPORT EXER, V36, P1389, DOI 10.1249/01.MSS.0000135775.51937.53; Ratel S, 2006, SPORTS MED, V36, P1031, DOI 10.2165/00007256-200636120-00004; Reid JJ, 2016, PEDIAT EXERC SCI; Reid JC, 2018, EUR J APPL PHYSIOL, V118, P1427, DOI 10.1007/s00421-018-3874-3; SOLOMONOW M, 1990, Electromyography and Clinical Neurophysiology, V30, P141; Torres EM, 2008, J STRENGTH COND RES, V22, P1279, DOI 10.1519/JSC.0b013e31816eb501; Torres JB, 2009, BIOMED HUM KINET, V1, P52, DOI 10.2478/v10101-009-0013-y; Turki O, 2011, J STRENGTH COND RES, V25, P2453, DOI 10.1519/JSC.0b013e31822a5a79; Weir DE, 2005, EUR J APPL PHYSIOL, V93, P614, DOI 10.1007/s00421-004-1265-4; Winchester JB, 2009, RES Q EXERCISE SPORT, V80, P257, DOI 10.1080/02701367.2009.10599560; Yamaguchi T, 2005, J STRENGTH COND RES, V19, P677; Yamaguchi T, 2007, J STRENGTH COND RES, V21, P1238, DOI 10.1519/00124278-200711000-00044; Young WB, 2002, STRENGTH COND J, V24, P33, DOI 10.1519/1533-4295(2002)024<0033:SSSBUD>2.0.CO;2	73	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210318	10.1371/journal.pone.0210318	http://dx.doi.org/10.1371/journal.pone.0210318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682044	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500034
J	Mifune, N; Inamasu, K; Kohama, S; Ohtsubo, Y; Tago, A				Mifune, Nobuhiro; Inamasu, Kazunori; Kohama, Shoko; Ohtsubo, Yohsuke; Tago, Atsushi			Social dominance orientation as an obstacle to intergroup apology	PLOS ONE			English	Article							RECONCILIATION; PERSONALITY; IDEOLOGY; CLOSURE; NEEDS	Social Dominance Orientation (SDO) has engaged the interest of social and personality psychologists as it has deep implications for the psychology of intergroup conflict, particularly regarding factors such as prejudice and discrimination, as well as international conflict resolution. Nevertheless, few studies have directly assessed how SDO relates to intergroup reconciliation. This study (effective N = 819) measured participants' SDO along with their attitudes toward various governmental apologies to test the hypothesis that SDO is associated with unwillingness to issue intergroup apologies. The results showed that SDO was negatively correlated with supportive attitudes toward government-issued international apologies. This negative correlation remained intact after controlling for the effects of political conservatism and militarism.	[Mifune, Nobuhiro] Kochi Univ Technol, Sch Econ & Management, Kochi, Kochi, Japan; [Inamasu, Kazunori] Kwansei Gakuin Univ, Sch Sociol, Nishinomiya, Hyogo, Japan; [Kohama, Shoko] Hokkaido Univ, Publ Policy Sch, Sapporo, Hokkaido, Japan; [Ohtsubo, Yohsuke] Kobe Univ, Grad Sch Humanities, Dept Psychol, Kobe, Hyogo, Japan; [Tago, Atsushi] Waseda Univ, Sch Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan; [Tago, Atsushi] Peace Res Inst Oslo PRIO, Oslo, Norway	Kochi University Technology; Kwansei Gakuin University; Hokkaido University; Kobe University; Waseda University; Peace Research Institute Oslo (PRIO)	Mifune, N (corresponding author), Kochi Univ Technol, Sch Econ & Management, Kochi, Kochi, Japan.	n.mifune@gmail.com	Tago, Atsushi/ABB-1124-2021; Kohama, Shoko/N-2951-2019	Tago, Atsushi/0000-0002-9932-3728; Kohama, Shoko/0000-0001-5174-7313; Inamasu, Kazunori/0000-0002-6618-6536	Japan Society for the Promotion of Science [17H06189]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by funding from the Japan Society for the Promotion of Science ("https://www.jsps.go.jp", 17H06189 to A.T.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno Theodor W, 1950, AUTHORITARIAN PERSON; Altemeyer B, 1998, ADV EXP SOC PSYCHOL, V30, P47, DOI 10.1016/S0065-2601(08)60382-2; Blatz CW, 2014, CAN J BEHAV SCI, V46, P337, DOI 10.1037/a0031729; Blatz CW, 2010, SOC PERSONAL PSYCHOL, V4, P995, DOI 10.1111/j.1751-9004.2010.00318.x; Blatz CW, 2009, POLIT PSYCHOL, V30, P219, DOI 10.1111/j.1467-9221.2008.00689.x; BORNSTEIN G, 1992, J PERS SOC PSYCHOL, V62, P597, DOI 10.1037/0022-3514.62.4.597; Ekehammar B, 2004, EUR J PERSONALITY, V18, P463, DOI 10.1002/per.526; Esses VM, 1998, J SOC ISSUES, V54, P699, DOI 10.1111/0022-4537.911998091; Fehr R, 2010, PSYCHOL BULL, V136, P894, DOI 10.1037/a0019993; Haidt Jonathan., 2012, RIGHTEOUS MIND; Hornsey MJ, 2017, SOC PSYCHOL PERS SCI, V8, P827, DOI 10.1177/1948550617691096; Howell AJ, 2012, PERS INDIV DIFFER, V53, P917, DOI 10.1016/j.paid.2012.06.021; Howell AJ, 2011, PERS INDIV DIFFER, V51, P509, DOI 10.1016/j.paid.2011.05.009; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jou W, 2016, ASIAN POLIT POLICY, V8, P456, DOI 10.1111/aspp.12270; Kabashima Ikuo, 1996, GENDAI NIHONJIN NO I; Mifune N., 2018, JAPANESE J SOCIAL PS, V34, P94, DOI [DOI 10.14966/JSSP.1725, 10.14966/jssp.1725]; Philpot CR, 2008, PERS SOC PSYCHOL B, V34, P474, DOI 10.1177/0146167207311283; Philpot CR, 2011, EUR J SOC PSYCHOL, V41, P96, DOI 10.1002/ejsp.741; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Pratto F, 2000, J CROSS CULT PSYCHOL, V31, P369, DOI 10.1177/0022022100031003005; Pratto F., 2006, EUROPEAN REV SOCIAL, V17, P271, DOI [10.1080/10463280601055772, DOI 10.1080/10463280601055772]; Roets A, 2015, ADV EXP SOC PSYCHOL, V52, P221, DOI 10.1016/bs.aesp.2015.01.001; Roets A, 2012, EUR J PERSONALITY, V26, P350, DOI 10.1002/per.843; Schelling ThomasC., 1968, STRATEGY CONFLICT; SHERIF M, 1958, AM J SOCIOL, V63, P349, DOI 10.1086/222258; Shnabel N, 2015, CURR DIR PSYCHOL SCI, V24, P477, DOI 10.1177/0963721415601625; Sibley CG, 2007, PERS SOC PSYCHOL B, V33, P160, DOI 10.1177/0146167206294745; Sidanius J., 1999, SOCIAL DOMINANCE; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Taka F., 2015, RACISM WO KAIBOSURU; Van Assche J, 2017, PSYCHOL BELG, V57, P132, DOI 10.5334/pb.333; Van Hiel A, 2004, PERS SOC PSYCHOL B, V30, P824, DOI 10.1177/0146167204264333; Waltz Kenneth, 2001, MAN STATE WAR THEORE; Whitley BE, 1999, J PERS SOC PSYCHOL, V77, P126, DOI 10.1037/0022-3514.77.1.126	36	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211379	10.1371/journal.pone.0211379	http://dx.doi.org/10.1371/journal.pone.0211379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682192	Green Published, gold			2022-12-27	WOS:000457037500160
J	Nolde, JM; Laupenmuhlen, J; Al-Zubaidi, A; Heldmann, M; Munte, TF; Jauch-Chara, K				Nolde, Janis Marc; Laupenmuehlen, Jana; Al-Zubaidi, Arkan; Heldmann, Marcus; Muente, Thomas F.; Jauch-Chara, Kamila			Endocrine responses and food intake in fasted individuals under the influence of glucose ingestion	PLOS ONE			English	Article							SOLUBLE LEPTIN RECEPTOR; WEIGHT-LOSS; DIETARY-COMPOSITION; ADIPONECTIN LEVELS; CIRCULATING ADIPONECTIN; CALORIC RESTRICTION; ENERGY RESTRICTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; OBESITY	Introduction Different metabolic conditions can affect what and how much we eat. Hormones of glucose metabolism and adipokines such as adiponectin take part in the control of these decisions and energy balance of the body. However, a comprehensive understanding of how these endocrine and metabolic factors influence food intake has not been reached. We hypothesised that the amount of food a person consumes differs substantially after a fasting period even after the energy deficit was partially removed by glucose ingestion and endocrine signals like insulin and C-peptide indicated a high glucose metabolic status. Furthermore, the macronutrient composition of the consumed food and a possible association with adiponectin under the influence of glucose ingestion was assessed. Methods In a within-subject design, 24 healthy males participated in both a fasting (42 h) and control (non-fasting) condition. A total of 20 blood samples from each subject were collected during each condition to assess serum levels of adiponectin, insulin, C-peptide, cortisol and ACTH. At the end of each condition food intake was measured with an ad libitum buffet after the acute energy deficit was compensated using a carbohydrate-rich drink. Results The total amount of caloric intake and single macronutrients was higher after the fasting intervention after replenishment with glucose. All recorded hormone levels, except for adiponectin, were significantly different for at least one of the study intervals. The relative proportions of the macronutrient composition of the consumed food were stable in both conditions under the influence of glucose ingestion. In the non-fasting condition, the relative amount of protein intake correlated with adiponectin levels during the experiment. Discussion and conclusion An anabolic glucose metabolism after glucose ingestion following a fasting intervention did not even out energy ingestion compared to a control group with regular food intake and glucose ingestion. Anorexigenic hormones like insulin in this context were not able despite higher levels than in the control condition to ameliorate the drive for food intake to normal or near normal levels. Relative macronutrient intake remains stable under these varying metabolic conditions and glucose influence. Serum adiponectin levels showed a positive association with the relative protein intake in the non-fasting condition under the influence of glucose although adiponectin levels overall did not differ in between the conditions.	[Nolde, Janis Marc; Al-Zubaidi, Arkan; Heldmann, Marcus; Muente, Thomas F.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Laupenmuehlen, Jana] Univ Lubeck, Dept Psychiat, Lubeck, Germany; [Jauch-Chara, Kamila] Univ Kiel, Dept Psychiat, Kiel, Germany	University of Lubeck; University of Lubeck; University of Kiel	Nolde, JM (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.; Jauch-Chara, K (corresponding author), Univ Kiel, Dept Psychiat, Kiel, Germany.	janis.m.nolde@gmail.com; kamila.jauch-chara@uksh.de		Al-Zubaidi, Arkan/0000-0002-5893-2527	Deutsche Forschungsgemeinschaft [1957, T-CRC 134]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) (Research Training Group 1957; Adipocyte Brain Crosstalk [KJC, TFM] and T-CRC 134 project C1, Ingestive Behavior (https://sfb134.de/en/team.html) [TFM]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x; Agus MSD, 2000, AM J CLIN NUTR, V71, P901; Anderlova K, 2006, PHYSIOL RES, V55, P277, DOI 10.33549/physiolres.930779; Anderson ML, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.1.152; Austin J, 2009, HORMONAL REGULATORS, DOI [10.1016/j.appet.2008.09.015, DOI 10.1016/J.APPET.2008.09.015]; BERNARDINI J, 1993, BRAIN RES BULL, V32, P543, DOI 10.1016/0361-9230(93)90305-U; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Blundell JE, 2000, BRIT J NUTR, V83, pS33; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Chowdhury EA, 2016, INT J OBESITY, V40, P305, DOI 10.1038/ijo.2015.154; Clayton DJ, 2016, INT J OBESITY, V40, P1662, DOI 10.1038/ijo.2016.106; Ding Q, 2012, J NUTR BIOCHEM, V23, P867, DOI 10.1016/j.jnutbio.2011.04.011; Dougkas A, 2016, J NUTR, V146, P637, DOI 10.3945/jn.115.217224; Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003; Dulloo AG, 2012, P NUTR SOC, V71, P379, DOI 10.1017/S0029665112000225; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Frank P, 2013, AM J PHYSIOL-ENDOC M, V304, pE436, DOI 10.1152/ajpendo.00416.2012; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Hall KD, 2017, GASTROENTEROLOGY, V152, P1718, DOI 10.1053/j.gastro.2017.01.052; Hallschmid M, 2010, DIABETES, V59, P1101, DOI 10.2337/db09-1493; Imbeault P, 2004, CLIN ENDOCRINOL, V60, P429, DOI 10.1111/j.1365-2265.2004.01997.x; Imbeault P, 2007, APPL PHYSIOL NUTR ME, V32, P505, DOI 10.1139/H07-017; Jauch-Chara K, 2014, PROG NEUROBIOL, V114, P84, DOI 10.1016/j.pneurobio.2013.12.001; Johnson NA, 2006, EXP PHYSIOL, V91, P693, DOI 10.1113/expphysiol.2006.033399; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3; Kotidis EV, 2006, OBES SURG, V16, P1425, DOI 10.1381/096089206778870058; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Macdonald IA, 2016, EUR J NUTR, V55, pS17, DOI 10.1007/s00394-016-1340-8; Mars M, 2005, AM J CLIN NUTR, V81, P570; McVay MA, 2015, J HUM NUTR DIET, V28, P16, DOI 10.1111/jhn.12188; Merl V, 2005, INT J OBESITY, V29, P998, DOI 10.1038/sj.ijo.0802971; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Rajaie S, 2013, ANN NUTR METAB, V63, P159, DOI 10.1159/000354868; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; Shand B, 2006, CLIN CHEM LAB MED, V44, P1264, DOI 10.1515/CCLM.2006.227; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692; Summer SS, 2011, OBESITY, V19, P2198, DOI 10.1038/oby.2011.60; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Wolfe BE, 2004, CLIN ENDOCRINOL, V61, P332, DOI 10.1111/j.1365-2265.2004.02101.x	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211514	10.1371/journal.pone.0211514	http://dx.doi.org/10.1371/journal.pone.0211514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682147	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500173
J	Shahwan, AJ; Abed, Y; Desormais, I; Magne, J; Preux, PM; Aboyans, V; Lacroix, P				Shahwan, Amal Jamee; Abed, Yehia; Desormais, Ileana; Magne, Julien; Preux, Pierre Marie; Aboyans, Victor; Lacroix, Philippe			Epidemiology of coronary artery disease and stroke and associated risk factors in Gaza community - Palestine	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; PREVALENCE; MORTALITY; OBESITY	Aim of study To determine the prevalence of cardiovascular disease and associated risk factors in the population of Gaza strip in Palestine. Methods A cross-sectional stratified cluster sample design was applied in this study. A sample of 2240 participant (1121 males and 1119 females) aged. 25 years participated in the study. For each individual, trained staff administered a questionnaire, where all variables of interest followed WHO's STEP wise approach to surveillance chronic disease risk factors (STEPS) (WHO, 2001). Sociodemographic data, anthropometric measure (body mass index, blood pressure), and biochemical test (blood sugar and lipids profiles) were measured. Short International Physical Activity (IPAQ) questionnaire form was used. Bivariate analysis and logistic regression were used with SPSS (version 22.0) to analyze the data. Results The most common condition was coronary artery disease (8.3%), followed by stroke events (3%). The associated risk factors were obesity (47.8%), hypertension (28.4%), current smoking account for (23.2%), diabetes mellitus (19.1%), high cholesterol level (8.8%), and high triglycerides level (40.2%). Additionally, the proportion of being physical active was found to be low (48.3%); particularly with increasing age. More than 30% of the population has less than 4 days of consumption of fruit and vegetables per week and 65.9% has less than 2 servings per day. Conclusion The burden of CVDs and their associated risk factors is considerable in Gaza and represents a major public health concern. Effective strategies in management, education and	[Shahwan, Amal Jamee; Desormais, Ileana; Magne, Julien; Preux, Pierre Marie; Aboyans, Victor; Lacroix, Philippe] INSERM, UMR 1094, Trop Neuroepidemiol, Limoges, France; [Shahwan, Amal Jamee; Desormais, Ileana; Magne, Julien; Preux, Pierre Marie; Aboyans, Victor; Lacroix, Philippe] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS,FR 3503 GEIST, Limoges, France; [Shahwan, Amal Jamee] Minist Hlth, Dept Cardiol, Gaza, Palestine; [Abed, Yehia] Univ Al Quods, Gaza, Palestine; [Desormais, Ileana; Lacroix, Philippe] Dupuytren Univ Hosp, Dept Thorac & Vasc Surg Vasc Med, Limoges, France; [Magne, Julien; Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Limoges; CHU Limoges; CHU Limoges	Shahwan, AJ (corresponding author), INSERM, UMR 1094, Trop Neuroepidemiol, Limoges, France.; Shahwan, AJ (corresponding author), Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS,FR 3503 GEIST, Limoges, France.; Shahwan, AJ (corresponding author), Minist Hlth, Dept Cardiol, Gaza, Palestine.	dr_amal08@yahoo.fr	Aboyans, Victor/AAN-8308-2020	jamee, Amal/0000-0002-0146-091X				Abdul-Rahim HF, 2001, INT J OBESITY, V25, P1736, DOI 10.1038/sj.ijo.0801799; Al-Nozha MM, 2004, SAUDI MED J, V25, P1165; American Diabetes Association, 2016, ADA DIAB MAN GUID A1; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], WHO CARD DIS CVDS; [Anonymous], 2018, NONCOMMUNICABLE DIS; [Anonymous], 2008, REP WHO EXP WHO WAIS; Benamer HTS, 2009, J NEUROL SCI, V284, P18, DOI 10.1016/j.jns.2009.04.029; CDC, 2017, CDC WORKS; Chen YQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-52; El-Hajj M, 2016, EUR STROKE J, V1, P180, DOI 10.1177/2396987316654338; Farah R, 2015, INT J STROKE, V10, P83, DOI 10.1111/ijs.12563; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kahan David, 2015, Prev Med Rep, V2, P71, DOI 10.1016/j.pmedr.2014.12.007; Kaluski DN, 2005, OBES REV, V6, P115, DOI 10.1111/j.1467-789X.2005.00168.x; Khattab A, 2012, RESP MED, V106, pS16, DOI 10.1016/S0954-6111(12)70011-2; Khudairy LA, 2015, CIRCULATION, V131, pAP263; Maatoug J, 2013, ADVISING OBESE ADULT; Mabry RM, 2010, OBES REV, V11, P457, DOI 10.1111/j.1467-789X.2009.00655.x; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mohannad N., 2008, Eastern Mediterranean Health Journal, V14, P818; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Radaideh G, 2017, INT CARDIOVASC FORUM, V11; Roth GA, 2015, CIRCULATION, V132, P1667, DOI 10.1161/CIRCULATIONAHA.114.008720; Saeed AA, 2015, PREVALENCE PHYS ACTI; Sawalha A., 2009, LIBYAN J MED, V4; Seita A, 2017, UNRWA HLTH ANN REPOR; Sibai AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009881; Sweileh Waleed M, 2008, J Stroke Cerebrovasc Dis, V17, P406, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.008; WHO, WORLD HLTH STAT 2011; WHO, 2017, WHO CARD DIS CVDS; WHO, 2016, HLTH SOC EFF NONM CA, P2; WHO hypertension, 2015, WHO HYP WHO Q AS HYP; Zeidan RK, 2016, VASC HEALTH RISK MAN, V12, P75, DOI 10.2147/VHRM.S97252; Zynia L R, 2000, BURDEN DIS W BANK GA	42	20	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211131	10.1371/journal.pone.0211131	http://dx.doi.org/10.1371/journal.pone.0211131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682090	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500105
J	Soh, YQ; Lim, GPS; Htoon, HM; Gong, X; Mootha, VV; Vithana, EN; Kocaba, V; Mehta, JS				Soh, Yu Qiang; Lim, Gary Peh Swee; Htoon, Hla Myint; Gong, Xin; Mootha, V. Vinod; Vithana, Eranga Nishanthie; Kocaba, Viridiana; Mehta, Jodhbir Singh			Trinucleotide repeat expansion length as a predictor of the clinical progression of Fuchs' Endothelial Corneal Dystrophy	PLOS ONE			English	Article							TCF4 GENE; ASSOCIATION; CTG18.1; SEVERITY; DISEASE	Purpose To determine if CTG18.1 TNR expansion length prognosticates the clinical progression of Fuchs' Endothelial Corneal Dystrophy (FECD). Methods This was a prospective cohort study. A total of 51 patients with newly diagnosed FECD were recruited and followed-up over a period of 12 years, from November 2004 to April 2016. Baseline clinical measurements included central corneal thickness (CCT), endothelial cell density (ECD) and CTG18.1 TNR expansion length from peripheral leukocytes, with yearly repeat measurements of CCT and ECD. A patient was defined to have experienced significant clinical progression and to have developed Threshold Disease if any of these criteria were fulfilled in either eye: a) CCT increased to > 700 mu m, b) ECD decreased to < 700 cells/mm(2), or c) underwent keratoplasty for treatment of FECD. Results Patients were categorized as having at least one allele whose maximum allele length was equal to or greater than 40 repeats (L >= 40, n = 22, 43.1%), or having both alleles shorter than 40 repeats (L< 40). Threshold Disease rates at the 5-year time point were 87.5% for the L >= 40 group and 47.8% for the L<40 group (p = 0.012). This difference narrowed and was no longer statistically significant at the 8-years (92.9% vs 78.9%, p = 0.278) and 10-years (92.9% vs 84.2%, p = 0.426) time points. Conclusions L >= 40 patients are at greater risk of FECD progression and development of Threshold Disease within the first 5 years following diagnosis.	[Soh, Yu Qiang; Lim, Gary Peh Swee; Kocaba, Viridiana; Mehta, Jodhbir Singh] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Soh, Yu Qiang; Mehta, Jodhbir Singh] Singapore Natl Eye Ctr, Singapore, Singapore; [Lim, Gary Peh Swee; Vithana, Eranga Nishanthie; Mehta, Jodhbir Singh] Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore; [Htoon, Hla Myint] Singapore Eye Res Inst, Singapore, Singapore; [Gong, Xin; Mootha, V. Vinod] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX USA; [Mootha, V. Vinod] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Mootha, V. Vinod; Vithana, Eranga Nishanthie] Singapore Eye Res Inst, Ocular Genet Res Grp, Singapore, Singapore; [Mehta, Jodhbir Singh] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore; [Mehta, Jodhbir Singh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; Singapore National Eye Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Ophthalmol Acad Clin Program, Singapore, Singapore.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore.; Mehta, JS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore.	jodmehta@gmail.com	Kocaba, Viridiana/A-1871-2016	Kocaba, Viridiana/0000-0002-3044-5057	NMRC/CSA grant - National Medical Research Council, Ministry of Health, Singapore; National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America [R01EY022161]; NATIONAL EYE INSTITUTE [R01EY022161] Funding Source: NIH RePORTER	NMRC/CSA grant - National Medical Research Council, Ministry of Health, Singapore; National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by the NMRC/CSA grant provided by the National Medical Research Council, Ministry of Health, Singapore; and the R01EY022161 (VVM) grant provided by the National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Ang M, 2015, CASE REP OPHTHALMOL, V2015, DOI 10.1155/2015/506251; Chua J, 2014, OPHTHALMOLOGY, V121, P2013, DOI 10.1016/j.ophtha.2014.04.041; Eghrari AO, 2017, CORNEA, V36, P40, DOI 10.1097/ICO.0000000000001049; Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X; Eye Bank Association of America, 2015, 2015 EYE BANK STAT R, P1; Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010; Fujimoto H, 2014, INVEST OPHTH VIS SCI, V55, P5090, DOI 10.1167/iovs.14-14249; Hafezi F, 2010, BRIT J OPHTHALMOL, V94, P660, DOI 10.1136/bjo.2009.162479; Hamzaoglu EC, 2015, OPHTHALMOLOGY, V122, P2193, DOI 10.1016/j.ophtha.2015.07.003; HENTHORN P, 1990, NUCLEIC ACIDS RES, V18, P678, DOI 10.1093/nar/18.3.678; Jirka S, 2015, CURR OPIN NEUROL, V28, P515, DOI 10.1097/WCO.0000000000000235; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kopplin LJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P433, DOI 10.1001/archopthalmol.2011.1626; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Luther M, 2016, KLIN MONATSBL AUGENH, V233, P187, DOI 10.1055/s-0035-1546138; Mahdy MAES, 2012, CLIN OPHTHALMOL, V6, P503, DOI 10.2147/OPTH.S29865; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakano M, 2015, INVEST OPHTH VIS SCI, V56, P4865, DOI 10.1167/iovs.15-17082; Nanda GG, 2014, INVEST OPHTH VIS SCI, V55, P7674, DOI 10.1167/iovs.14-15297; Read SA, 2009, OPTOMETRY VISION SCI, V86, P170, DOI 10.1097/OPX.0b013e3181981b7e; Soliman AZ, 2015, JAMA OPHTHALMOL, V133, P1386, DOI 10.1001/jamaophthalmol.2015.3430; Urbanek MO, 2016, BBA-MOL BASIS DIS, V1862, P1513, DOI 10.1016/j.bbadis.2016.05.015; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Wacker K, 2015, OPHTHALMOLOGY, V122, P1645, DOI 10.1016/j.ophtha.2015.05.005; Watanabe S, 2015, OPHTHALMOLOGY, V122, P2103, DOI 10.1016/j.ophtha.2015.06.019; Wieben ED, 2014, INVEST OPHTH VIS SCI, V55, P6101, DOI 10.1167/iovs.14-14958; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; WILSON SE, 1988, CORNEA, V7, P2; Xing C, 2014, INVEST OPHTH VIS SCI, V55, P7073, DOI 10.1167/iovs.14-15390	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210996	10.1371/journal.pone.0210996	http://dx.doi.org/10.1371/journal.pone.0210996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682148	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500087
J	Stenehjem, DD; Hahn, AW; Gill, DM; Albertson, D; Gowrishankar, B; Merriman, J; Agarwal, AM; Thodima, V; Harrington, EB; Au, TH; Maughan, BL; Houldsworth, J; Pal, SK; Agarwal, N				Stenehjem, David D.; Hahn, Andrew W.; Gill, David M.; Albertson, Daniel; Gowrishankar, Banumathy; Merriman, Joseph; Agarwal, Archana M.; Thodima, Venkata; Harrington, Erik B.; Au, Trang H.; Maughan, Benjamin L.; Houldsworth, Jane; Pal, Sumanta K.; Agarwal, Neeraj			Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma	PLOS ONE			English	Article							BIOMARKERS; MUTATIONS; SUNITINIB	Background First-line treatment for metastatic renal cell carcinoma (mRCC) is rapidly changing. It currently includes VEGF targeted therapies (TT), multi-target tyrosine kinase inhibitors (TKIs), mTOR inhibitors, and immunotherapy. To optimize outcomes for individual patients, genomic markers of response to therapy are needed. Here, we aim to identify tumor-based genomic markers of response to VEGF TT to optimize treatment selection. Methods From an institutional database, primary tumor tissue was obtained from 79 patients with clear cell mRCC, and targeted sequencing was performed. Clinical outcomes were obtained retrospectively. Progression-free survival (PFS) on first-line VEGF TT was correlated to genomic alterations (GAs) using Kaplan-Meier methodology and Cox proportional hazard models. A composite model of significant GAs predicting PFS in the first-line setting was developed. Results Absence of VHL mutation was associated with inferior PFS on first-line VEGF TT. A trend for inferior PFS was observed with GAs in TP53 and FLT1 C/C variant. A composite model of these 3 GAs was associated with inferior PFS in a dose-dependent manner. Conclusion In mRCC, a composite model of TP53 mutation, wild type VHL, and FLT1 C/C variant strongly predicted PFS on first-line VEGF TT in a dose-dependent manner. These findings require external validation.	[Stenehjem, David D.] Univ Minnesota, Coll Pharm, Duluth, MN 55812 USA; [Hahn, Andrew W.; Gill, David M.; Merriman, Joseph; Maughan, Benjamin L.; Agarwal, Neeraj] Univ Utah, Dept Internal Med, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Albertson, Daniel; Agarwal, Archana M.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Albertson, Daniel; Agarwal, Archana M.] ARUP Labs, Salt Lake City, UT USA; [Gowrishankar, Banumathy; Thodima, Venkata; Houldsworth, Jane] Canc Genet Inc, Rutherford, NJ USA; [Harrington, Erik B.; Au, Trang H.] Univ Utah, Coll Pharm, PORC, Salt Lake City, UT 84112 USA; [Houldsworth, Jane] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Pal, Sumanta K.] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA	University of Minnesota System; University of Minnesota Duluth; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Icahn School of Medicine at Mount Sinai; City of Hope	Agarwal, N (corresponding author), Univ Utah, Dept Internal Med, Div Med Oncol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	neeraj.agarwal@hci.utah.edu		Stenehjem, David/0000-0002-1831-285X	Pfizer; EMD Serono; Eisai	Pfizer(Pfizer); EMD Serono; Eisai(Eisai Co Ltd)	NA receives salary support from Pfizer, Exelixis, Merck, Argos, EMD Serono, and Eisai, and he receives research funding from Pfizer, EMD Serono, and Eisai. SKP receives salary support from Exelixis, BMS, GSK, Novartis, Pfizer, Astellas, and Genentech. BG, VT, and JH have received salary support from Cancer Genetics, Inc. The funders provided support in the form of salaries for authors NA, SKP, BG, VT, and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beuselinck B, 2016, BJU INT, V118, P890, DOI 10.1111/bju.13585; Beuselinck B, 2014, ACTA ONCOL, V53, P103, DOI 10.3109/0284186X.2013.770600; Carlo MI, 2017, KIDNEY CANCER, V1, P49, DOI 10.3233/KCA-160003; Che M, 2007, INT J RADIAT ONCOL, V69, P1117, DOI 10.1016/j.ijrobp.2007.04.070; Choueiri TK, 2008, J UROLOGY, V180, P860, DOI 10.1016/j.juro.2008.05.015; Choueiri TK, 2013, CLIN CANCER RES, V19, P5218, DOI 10.1158/1078-0432.CCR-13-0491; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Escudier B, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4511; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Ho TH, 2016, EUR UROL FOCUS, V2, P204, DOI 10.1016/j.euf.2015.11.007; Hsieh JJ, 2017, EUR UROL, V71, P405, DOI 10.1016/j.eururo.2016.10.007; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Ko JJ, 2015, LANCET ONCOL, V16, P293, DOI 10.1016/S1470-2045(14)71222-7; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; McKay RR, 2018, J CLIN ONCOL, V36, P3615, DOI 10.1200/JCO.2018.79.0253; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pal SK, 2017, EUR UROL, V72, P557, DOI 10.1016/j.eururo.2017.03.046; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210415	10.1371/journal.pone.0210415	http://dx.doi.org/10.1371/journal.pone.0210415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682039	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500035
J	Walker, FR; Thomson, A; Pfingst, K; Vlemincx, E; Aidman, E; Nalivaiko, E				Walker, Frederick R.; Thomson, Ashley; Pfingst, Kane; Vlemincx, Elke; Aidman, Eugene; Nalivaiko, Eugene			Habituation of the electrodermal response - A biological correlate of resilience?	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FEAR-POTENTIATED STARTLE; HEART-RATE; PHYSIOLOGICAL REACTIVITY; RESPIRATORY VARIABILITY; VIETNAM VETERANS; PANIC DISORDER; SCALES DASS; DEPRESSION; ANXIETY	Current approaches to quantifying resilience make extensive use of self-reported data. Problematically, this type of scales is plagued by response distortions-both deliberate and unintentional, particularly in occupational populations. The aim of the current study was to develop an objective index of resilience. The study was conducted in 30 young healthy adults. Following completion of the Connor-Davidson Resilience Scale (CD-RISC) and Depression/Anxiety/Stress Scale (DASS), they were subjected to a series of 15 acoustic startle stimuli (95 dB, 50 ms) presented at random intervals, with respiration, skin conductance and ECG recorded. As expected, resilience (CD-RISC) significantly and negatively correlated with all three DASS subscales-Depression (r = -0.66, p<0.0001), Anxiety (r = -0.50, p<0.005) and Stress (r = -0.48, p<0.005). Acoustic stimuli consistently provoked transient skin conductance (SC) responses, with SC slopes indexing response habituation. This slope significantly and positively correlated with DASS-Depression (r = 0.59, p<0.005), DASS-Anxiety (r = 0.35, p<0.05) and DASS-Total (r = 0.50, p<0.005) scores, and negatively with resilience score (r = -0.47; p = 0.006), indicating that high-resilience individuals are characterized by steeper habituation slopes compared to low-resilience individuals. Our key finding of the connection between habituation of the skin conductance responses to repeated acoustic startle stimulus and resilience-related psychometric constructs suggests that response habituation paradigm has the potential to characterize important attributes of cognitive fitness and well-being-such as depression, anxiety and resilience. With steep negative slopes reflecting faster habituation, lower depression/anxiety and higher resilience, and slower or no habituation characterizing less resilient individuals, this protocol may offer a distortion-free method for objective assessment and monitoring of psychological resilience.	[Walker, Frederick R.; Thomson, Ashley; Nalivaiko, Eugene] Univ Newcastle, Newcastle, NSW, Australia; [Pfingst, Kane] Australian Army, Canberra, ACT, Australia; [Vlemincx, Elke] Queen Mary Univ London, London, England; [Aidman, Eugene] DST Grp, Adelaide, SA, Australia	University of Newcastle; University of London; Queen Mary University London	Nalivaiko, E (corresponding author), Univ Newcastle, Newcastle, NSW, Australia.	Eugene.nalivaiko@newcastle.edu.au		AIDMAN, Eugene/0000-0002-7711-794X; Thomson, Ashley/0000-0002-4489-6588; Nalivaiko, Eugene/0000-0002-6449-8181				Abelson JL, 2001, BIOL PSYCHIAT, V49, P588, DOI 10.1016/S0006-3223(00)01078-7; Aidman E., 2017, J SCI MED SPORT, V20, pS50, DOI [10.1016/j.jsams.2017.09.159, DOI 10.1016/J.JSAMS.2017.09.159]; BARTLETT D, 1971, RESP PHYSIOL, V12, P230, DOI 10.1016/0034-5687(71)90055-7; Bell HJ, 2009, AM J PHYSIOL-REG I, V296, pR334, DOI 10.1152/ajpregu.90680.2008; Beutel ME, 2010, AGING MALE, V13, P32, DOI 10.3109/13685530903296698; BLANCHARD EB, 1989, BEHAV THER, V20, P535, DOI 10.1016/S0005-7894(89)80132-7; Blechert J, 2007, PSYCHOSOM MED, V69, P935, DOI 10.1097/PSY.0b013e31815a8f6b; Block J., 1950, THESIS; BOITEN FA, 1994, INT J PSYCHOPHYSIOL, V17, P103, DOI 10.1016/0167-8760(94)90027-2; Brady KT, 2000, J CLIN PSYCHIAT, V61, P22; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burrell BD, 2001, J NEUROSCI, V21, P1401; Carnevali L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00228; Carson MA, 2007, J TRAUMA STRESS, V20, P657, DOI 10.1002/jts.20218; Charney Dennis S, 2003, Dialogues Clin Neurosci, V5, P207; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Davis M, 1984, HABITUATION SENSITIZ, P283; Donaldson SI, 2002, J BUS PSYCHOL, V17, P245, DOI 10.1023/A:1019637632584; EMBREE BG, 1993, J STUD ALCOHOL, V54, P334, DOI 10.15288/jsa.1993.54.334; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; FERRIS BG, 1960, J CLIN INVEST, V39, P143, DOI 10.1172/JCI104012; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Fowles DC., 1986, PSYCHOPHYSIOLOGY SYS, V1, P51, DOI DOI 10.1016/J.NEUBIOREV.2013.03.024; FREDRIKSON M, 1982, BIOL PSYCHOL, V15, P63, DOI 10.1016/0301-0511(82)90031-X; Freud S., 1921, GROUP PSYCHOL ANAL E; Gillie BL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00758; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Hegney DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01613; Jones-Alexander J, 2005, APPL PSYCHOPHYS BIOF, V30, P115, DOI 10.1007/s10484-005-4307-8; Jovanovic T, 2009, INT J PSYCHOPHYSIOL, V71, P264, DOI 10.1016/j.ijpsycho.2008.10.007; Joyce S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017858; Keane TM, 1998, J CONSULT CLIN PSYCH, V66, P914, DOI 10.1037/0022-006X.66.6.914; Keary TA, 2009, INT J PSYCHOPHYSIOL, V73, P257, DOI 10.1016/j.ijpsycho.2009.04.003; Koch M, 1999, PROG NEUROBIOL, V59, P107, DOI 10.1016/S0301-0082(98)00098-7; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; McDonagh-Coyle A, 2001, J TRAUMA STRESS, V14, P667, DOI 10.1023/A:1013081803429; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; MCILROY MB, 1962, J APPL PHYSIOL, V17, P701, DOI 10.1152/jappl.1962.17.4.701; Metzger LJ, 1999, J ABNORM PSYCHOL, V108, P347, DOI 10.1037/0021-843X.108.2.347; MORGAN CA, 1995, BIOL PSYCHIAT, V38, P378, DOI 10.1016/0006-3223(94)00321-S; Orr S.P., 2004, ASSESSING PSYCHOL TR, P289; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; Phillips AC, 2011, PSYCHOPHYSIOLOGY, V48, P142, DOI 10.1111/j.1469-8986.2010.01045.x; Pole N, 2003, J TRAUMA STRESS, V16, P471, DOI 10.1023/A:1025758411370; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; Sahar T, 2001, BIOL PSYCHIAT, V49, P637, DOI 10.1016/S0006-3223(00)01045-3; Schwartz GE, 1996, ANXIETY, V2, P145, DOI 10.1002/(SICI)1522-7154(1996)2:3<145::AID-ANXI6>3.0.CO;2-O; Seppala EM, 2014, J TRAUMA STRESS, V27, P397, DOI 10.1002/jts.21936; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Steiner GZ, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00014; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; Vlemincx E, 2010, PHYSIOL BEHAV, V101, P67, DOI 10.1016/j.physbeh.2010.04.015; Vlemincx E, 2016, PHYSIOL BEHAV, V165, P127, DOI 10.1016/j.physbeh.2016.07.004; Vlemincx E, 2015, PSYCHOPHYSIOLOGY, V52, P657, DOI 10.1111/psyp.12396; Vlemincx E, 2013, BIOL PSYCHOL, V93, P24, DOI 10.1016/j.biopsycho.2012.12.001; Vlemincx E, 2012, PHYSIOL BEHAV, V107, P1, DOI 10.1016/j.physbeh.2012.05.013; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Walker FR, 2017, NEUROSCI BIOBEHAV R, V74, P310, DOI 10.1016/j.neubiorev.2016.05.003; Widjaja D., 2013, COMPUT MATH METHODS, V2013, DOI DOI 10.1155/2013/451857; Wilhelm FH, 2001, PSYCHOSOM MED, V63, P638, DOI 10.1097/00006842-200107000-00017; Wilhelm FH, 2001, BIOL PSYCHIAT, V49, P596, DOI 10.1016/S0006-3223(00)01000-3; Wilhelm FH, 2001, BIOL PSYCHIAT, V49, P606, DOI 10.1016/S0006-3223(00)01014-3; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	67	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210078	10.1371/journal.pone.0210078	http://dx.doi.org/10.1371/journal.pone.0210078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682040	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500022
J	Cameron, A; Barbieri, R; Read, R; Church, D; Adator, EH; Zaheer, R; McAllister, TA				Cameron, Andrew; Barbieri, Ruth; Read, Ron; Church, Deirdre; Adator, Emelia H.; Zaheer, Rahat; McAllister, Tim A.			Functional screening for triclosan resistance in a wastewater metagenome and isolates of Escherichia coli and Enterococcus spp. from a large Canadian healthcare region	PLOS ONE			English	Article							AEROMONAS-HYDROPHILA; CLINICAL STRAINS; ENOYL REDUCTASE; BIOCIDE; IDENTIFICATION; INHIBITION; SEQUENCE; FABV	The biocide triclosan is in many consumer products and is a frequent contaminant of wastewater (WW) such that there is concern that triclosan promotes resistance to important antibiotics. This study identified functional mechanisms of triclosan resistance (TCSR) in WW metagenomes, and assessed the frequency of TCSR in WW-derived and clinical isolates of Escherichia coli and Enterococcus spp. Metagenomic DNA extracted from WW was used to profile the microbiome and construct large-insert cosmid libraries, which were screened for TCSR. Resistant cosmids were sequenced and the TCSR determinant identified by transposon mutagenesis. Wastewater Enterococcus spp. (N = 94) and E. coli (N = 99) and clinical Enterococcus spp. (N = 146) and vancomycin-resistant E. faecium (VRE; N = 149) were collected and tested for resistance to triclosan and a comprehensive drug panel. Functional metagenomic screening revealed diverse FabV homologs as major WW TCSR determinants. Resistant clones harboured sequences likely originating from Aeromonas spp., a common WW microbe. The triclosan MIC90s for E. coli, E. faecalis, and E. faecium isolates were 0.125, 32, and 32 mg/L, respectively. For E. coli, there was no correlation between the triclosan MIC and any drug tested. Negative correlations were detected between the triclosan MIC and levofloxacin resistance for E. faecalis, and between triclosan and vancomycin, teicoplanin, and ampicillin resistance for E. faecium. Thus, FabV homologs were the major contributor to the WW triclosan resistome and high-level TCSR was not observed in WW or clinical isolates. Elevated triclosan MICs were not positively correlated with antimicrobial resistance to any drug tested.	[Cameron, Andrew] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Cameron, Andrew; Barbieri, Ruth; Zaheer, Rahat; McAllister, Tim A.] Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Read, Ron; Church, Deirdre] Univ Calgary, Fac Med, Calgary, AB, Canada; [Church, Deirdre] Calgary Lab Serv, Calgary, AB, Canada; [Adator, Emelia H.] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Manitoba	McAllister, TA (corresponding author), Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada.	tim.mcallister@canada.ca			Alberta Agriculture and Forestry Strategic Research and Development; Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster; GRDI program of Agriculture and Agri-Food Canada; University of Manitoba; Calgary Laboratory Services; NSERC Postdoctoral Fellowship	Alberta Agriculture and Forestry Strategic Research and Development; Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster; GRDI program of Agriculture and Agri-Food Canada; University of Manitoba; Calgary Laboratory Services; NSERC Postdoctoral Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by funding from Alberta Agriculture and Forestry Strategic Research and Development and the Beef Cattle Research Council (BCRC)-Agriculture and Agri-Food Canada beef cluster, and the GRDI program of Agriculture and Agri-Food Canada. A. C. is supported by an NSERC Postdoctoral Fellowship. E.H.A. is supported by a Graduate Fellowship from the University of Manitoba. Calgary Laboratory Services provided support in the form of salaries for D.L.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmyr M, 2006, SCI TOTAL ENVIRON, V372, P87, DOI 10.1016/j.scitotenv.2006.08.007; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calafat AM, 2003, ENVIRON HEALTH PERSP, V111, P151, DOI 10.1289/ehp.5644; Carey DE, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00780; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Clinical and Laboratory Standards Institute (CLSI), 2015, PERF STAND ANT DISK, V12th; CLSI, 2021, M100 PERF STAND ANT; Cullinan MP, 2012, SCI TOTAL ENVIRON, V416, P75, DOI 10.1016/j.scitotenv.2011.11.063; Darzentas N., 2010, BIOINFORMATICS, V26; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Freundlich JS, 2009, CHEMMEDCHEM, V4, P241, DOI 10.1002/cmdc.200800261; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goodman M, 2018, CRIT REV TOXICOL, V48, P1, DOI 10.1080/10408444.2017.1350138; Halden RU, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1788; Hinther A, 2011, ENVIRON SCI TECHNOL, V45, P5395, DOI 10.1021/es1041942; Ikram A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34254-5; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057075; Khan R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192277; Khan R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32322; Khan R, 2015, J MICROBIOL BIOTECHN, V25, P511, DOI 10.4014/jmb.1407.07021; Lam KN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01196; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Li H., 2013, ARXIV PREPRINT; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; Persson S, 2015, J CLIN MICROBIOL, V53, P653, DOI 10.1128/JCM.01963-14; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Taupp Marcus, 2009, J Vis Exp, DOI 10.3791/1387; USEPA, 2002, 1600 USEPA OFF WAT W; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117821; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Zaheer R, 2012, J MICROBIOL METH, V89, P174, DOI 10.1016/j.mimet.2012.03.012; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	45	11	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211144	10.1371/journal.pone.0211144	http://dx.doi.org/10.1371/journal.pone.0211144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677104	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400052
J	Hariono, M; Choi, SB; Roslim, RF; Nawi, MS; Tan, ML; Kamarulzaman, EE; Mohamed, N; Yusof, R; Othman, S; Abd Rahman, N; Othman, R; Wahab, HA				Hariono, Maywan; Choi, Sy Bing; Roslim, Ros Fatihah; Nawi, Mohamed Sufian; Tan, Mei Lan; Kamarulzaman, Ezatul Ezleen; Mohamed, Nornisah; Yusof, Rohana; Othman, Shatrah; Abd Rahman, Noorsaadah; Othman, Rozana; Wahab, Habibah A.			Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling	PLOS ONE			English	Article							DENGUE VIRUS PROTEASE; SERINE-PROTEASE; NS3 PROTEASE; ANTIVIRAL ACTIVITY; PEPTIDE-HYBRIDS; DISCOVERY; TYPE-2; IDENTIFICATION; OPTIMIZATION; FLAVONOIDS	Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 mu M) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 mu M and 16 mu M, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174.	[Hariono, Maywan; Choi, Sy Bing; Roslim, Ros Fatihah; Nawi, Mohamed Sufian; Kamarulzaman, Ezatul Ezleen; Mohamed, Nornisah; Wahab, Habibah A.] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia; [Hariono, Maywan] Sanata Dharma Univ, Fac Pharm, Sleman, Yogyakarta, Indonesia; [Choi, Sy Bing] Perdana Univ, Sch Data Sci, Blok B & D1,MARDI Complex,Jalan MAEPS Perdana, Serdang, Selangor, Malaysia; [Nawi, Mohamed Sufian] Int Islamic Univ Malaysia, Kulliyah Pharm, Dept Pharmaceut Chem, Kuantan, Pahang, Malaysia; [Tan, Mei Lan] Univ Sains Malaysia, Adv Med & Dent Inst, Bertam, Pulau Pinang, Malaysia; [Yusof, Rohana] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Othman, Shatrah; Abd Rahman, Noorsaadah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Othman, Rozana] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Wahab, Habibah A.] Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bayan Lepas, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Perdana University; International Islamic University Malaysia; Universiti Sains Malaysia; Universiti Malaya; Universiti Malaya; Universiti Malaya	Wahab, HA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia.; Wahab, HA (corresponding author), Minist Sci Technol & Innovat, Malaysian Inst Pharmaceut & Nutraceut, Bayan Lepas, Pulau Pinang, Malaysia.	habibahw@usm.my	Choi, Sy Bing/AGZ-6475-2022; Wahab, Habibah A/D-2976-2011; Wahab, Habibah A/AAJ-6267-2020; OTHMAN, SHATRAH/B-9768-2010; OTHMAN, ROZANA/B-9628-2010; Rahman, Noorsaadah Abd./B-9291-2010; Tan, Mei Lan/E-3500-2012	Wahab, Habibah A/0000-0002-8353-8679; OTHMAN, ROZANA/0000-0002-8260-9252; Rahman, Noorsaadah Abd./0000-0001-5847-8961; Choi, Sy Bing/0000-0003-3189-904X; Tan, Mei Lan/0000-0001-6565-699X	Science Fund Grant [02-05-23-SF0019]; Research University Grant for Team (RUT) [1001/PKIMIA/855006]; Universiti Sains Malaysia; Malaysian Ministry of Science and Technology Innovation [02-05-23-SF0019]	Science Fund Grant; Research University Grant for Team (RUT); Universiti Sains Malaysia(Universiti Sains Malaysia); Malaysian Ministry of Science and Technology Innovation	This work is funded under Science Fund Grant No. 02-05-23-SF0019 and Research University Grant for Team (RUT) No. 1001/PKIMIA/855006. MH thanked Universiti Sains Malaysia for the USM Fellowship Award (2011-2012) and the Malaysian Ministry of Science and Technology Innovation for research assistantship under ScienceFund Grant No. 02-05-23-SF0019 (2014-2015). We thank National Cancer Institute, US for the complementary samples of the 20 NCI hit compounds.	ADAMSON PC, 1994, LEUKEMIA RES, V18, P805, DOI 10.1016/0145-2126(94)90159-7; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; [Anonymous], HYPERCHEM TM PROF 8; Aravapalli S, 2012, BIOORGAN MED CHEM, V20, P4140, DOI 10.1016/j.bmc.2012.04.055; Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653; Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441; Behnam MAM, 2014, ACS MED CHEM LETT, V5, P1037, DOI 10.1021/ml500245v; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; Chaput L, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0167-x; Chuang S-J, 2018, SCI REP, V8, P1, DOI DOI 10.1038/s41598-017-17765-5; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8; de Sousa LRF, 2015, BIOORGAN MED CHEM, V23, P466, DOI 10.1016/j.bmc.2014.12.015; Frimayanti Neni, 2011, In Silico Biology, V11, P29, DOI 10.3233/ISB-2012-0442; Galula JU, 2014, J VIROL, V88, P10813, DOI 10.1128/JVI.00810-14; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hariono M, 2014, ACTA CRYSTALLOGR E, V70, pO288, DOI 10.1107/S1600536814001986; Hariono M, 2012, ACTA CRYSTALLOGR E, V68, pO35, DOI 10.1107/S1600536811051269; Heh CH, 2013, CHEM BIOL DRUG DES, V82, P1, DOI 10.1111/cbdd.12122; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Katzenmeier G., 2004, Dengue Bulletin, V28, P58; Kiat TS, 2006, BIOORG MED CHEM LETT, V16, P3337, DOI 10.1016/j.bmcl.2005.12.075; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee Y.K., 2007, ASIA PAC J MOL BIOL, V15, P53; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Liu HL, 2014, BIOORGAN MED CHEM, V22, P6344, DOI 10.1016/j.bmc.2014.09.057; Morris GM, 2009, J COMPUT CHEM, V28, P73; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002; Nitsche C, 2013, J MED CHEM, V56, P8389, DOI 10.1021/jm400828u; Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008; Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061; Normile D., 2013, HEALTH; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Othman Rozana, 2007, In Silico Biology, V7, P215; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; PRAKASH C, 1983, ANAL BIOCHEM, V128, P41, DOI 10.1016/0003-2697(83)90341-X; Prusis P, 2013, BIOCHEM BIOPH RES CO, V434, P767, DOI 10.1016/j.bbrc.2013.03.139; Qiagen, 2003, QIA EXPR HDB HIGH LE; Rahman N. A., 2006, Dengue Bulletin, V30, P260; Ramajayam R, 2010, BIOORG MED CHEM LETT, V20, P3569, DOI 10.1016/j.bmcl.2010.04.118; Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x; Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314; Rothan HA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251482; Saudi M, 2014, EUR J MED CHEM, V87, P529, DOI 10.1016/j.ejmech.2014.09.062; Shityakov Sergey, 2014, Adv Appl Bioinform Chem, V7, P23, DOI 10.2147/AABC.S63749; Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103; Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015; Steuer C, 2009, J BIOMOL SCREEN, V14, P1102, DOI 10.1177/1087057109344115; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Viswanathan U, 2014, J CHEM INF MODEL, V54, P2816, DOI 10.1021/ci500531r; Wahab HA, 2007, CURR COMPUT-AID DRUG, V3, P101, DOI 10.2174/157340907780809499; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; WHO, 2009, WHO TECH REP SER, V958, P1; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h; Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049; Yotmanee P, 2015, J MOL GRAPH MODEL, V60, P24, DOI 10.1016/j.jmgm.2015.05.008; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963; Yusof R, 2008, DESIGN CHEMOTHERAPEU; Zandi K, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-91	67	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210869	10.1371/journal.pone.0210869	http://dx.doi.org/10.1371/journal.pone.0210869			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677071	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000456700400029
J	Matsuzaki, R; Nozaki, H; Takeuchi, N; Hara, Y; Kawachi, M				Matsuzaki, Ryo; Nozaki, Hisayoshi; Takeuchi, Nozomu; Hara, Yoshiaki; Kawachi, Masanobu			Taxonomic re-examination of "Chloromonas nivalis (Volvocales, Chlorophyceae) zygotes" from Japan and description of C-muramotoi sp. nov.	PLOS ONE			English	Article							UPSTATE NEW-YORK; SNOW ALGA; MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; GENUS CHLOROMONAS; LIFE-HISTORY; COMB-NOV; REVISION; ITS2; ECOLOGY	Recent molecular data has strongly suggested that field-collected cysts of snow algae that are morphologically identifiable as the zygotes of Chloromonas nivalis are composed of multiple species. Motile vegetative cells, however, have not been directly obtained from these cysts because of the difficulties involved in inducing their germination. Recently, our comparative molecular analyses, using both field-collected and cultured materials, demonstrated that one Japanese lineage of "C. nivalis zygotes" belongs to C. miwae. Herein, we examined another Japanese lineage of field-collected "C. nivalis zygotes" and a new strain originating from Japan. Our molecular data demonstrated that these two different life cycle stages are conspecific, and that they represent a new species that we herein describe as C. muramotoi sp. nov., based on the vegetative and asexual morphological characteristics of the strain. Multigene phylogenetic analyses showed that this new species was sister to C. miwae. Scanning electron microscopy demonstrated that the cysts of C. muramotoi are different from those of C. miwae, based on the arrangement of the flanges developing on the cell wall.	[Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Takeuchi, Nozomu] Chiba Univ, Grad Sch Sci, Dept Earth Sci, Inage Ward, Chiba, Chiba, Japan; [Hara, Yoshiaki] Yamagata Univ, Inst Arts & Sci, Yamagata, Yamagata, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Chiba University; Yamagata University	Matsuzaki, R (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	matsuzaki.ryo@nies.go.jp	Takeuchi, Nozomu/Q-7869-2016	Takeuchi, Nozomu/0000-0002-3267-5534; Matsuzaki, Ryo/0000-0002-8989-5933; Kawachi, Masanobu/0000-0001-9911-0688	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [16J09828]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	RM was supported by Grant-in-Aid for JSPS Research Fellow (No. 16J09828) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, NON TRADITIONAL REF; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Ettl H., 1970, Beih. Nova Hedwigia, VNo. 34, P1; Ettl H., 1961, ARCH PROTISTENKD, V105, P273; Ettl H, 1983, SUSSWASSERFLORA MITT, V9; HOHAM R W, 1975, Phycologia, V14, P213, DOI 10.2216/i0031-8884-14-4-213.1; Hoham R.W., 1980, Developments in Marine Biology, V2, P61; HOHAM R W, 1977, Phycologia, V16, P53, DOI 10.2216/i0031-8884-16-1-53.1; Hoham RW, 2008, ARCT ANTARCT ALP RES, V40, P355, DOI 10.1657/1523-0430(07-038)[HOHAM]2.0.CO;2; Hoham Ronald W., 2001, P168; HOHAM RW, 1978, PHYCOLOGIA, V17, P106, DOI 10.2216/i0031-8884-17-1-106.1; Hoham RW, 2006, PHYCOLOGIA, V45, P319, DOI 10.2216/04-103.1; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; HOHAM RW, 1979, PHYCOLOGIA, V18, P55, DOI 10.2216/i0031-8884-18-1-55.1; Kawachi M, 2013, LIST OF STRAINS; Kawai-Toyooka H, 2004, PLANT CELL PHYSIOL, V45, P1648, DOI 10.1093/pcp/pch186; Kol E, 1968, BINNENGEWASSER, P1; Komarek Jiri, 2007, V11; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; Matsuzaki R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193603; Matsuzaki R, 2015, PHYCOLOGIA, V54, P491, DOI 10.2216/15-33.1; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; Matsuzaki R, 2013, PHYCOLOGIA, V52, P239, DOI 10.2216/12-083.1; Matsuzaki R, 2012, PHYCOLOGIA, V51, P74, DOI 10.2216/11-18.1; Muller T, 1998, POLAR BIOL, V20, P14, DOI 10.1007/s003000050272; Muramoto K, 2008, CYTOLOGIA, V73, P91, DOI 10.1508/cytologia.73.91; Muramoto K, 2010, EUR J PHYCOL, V45, P27, DOI 10.1080/09670260903272607; Nakada T, 2008, J PHYCOL, V44, P751, DOI 10.1111/j.1529-8817.2008.00525.x; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; Nakada T, 2016, J PHYCOL, V52, P283, DOI 10.1111/jpy.12397; Nakada T, 2010, J PLANT RES, V123, P67, DOI 10.1007/s10265-009-0266-0; Nozaki H, 2002, J MOL EVOL, V55, P414, DOI 10.1007/s00239-002-2338-9; Nozaki H, 2010, J PHYCOL, V46, P195, DOI 10.1111/j.1529-8817.2009.00773.x; Prochazkova L, 2018, FOTTEA, V18, P1, DOI 10.5507/fot.2017.010; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Proschold T., 2007, TAXON, V56, P595; Remias D, 2018, PHYCOLOGIA, V57, P581, DOI 10.2216/18-45.1; Remias D, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P175, DOI 10.1007/978-3-7091-0136-0_13; Remias D, 2010, PROTOPLASMA, V243, P73, DOI 10.1007/s00709-010-0123-y; Schultz J, 2005, RNA, V11, P361, DOI 10.1261/rna.7204505; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Segawa T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05521-w; Segawa T, 2011, POLAR SCI, V5, P41, DOI 10.1016/j.polar.2010.12.002; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; SEIBEL PN, 2006, BMC BIOINFORMATICS, V7; Wawrik F., 1974, Nova Hedwigia, V25, P665; Wille N., 1903, Nyt Magazin for Naturvidenskaberne, Vxli, P89	49	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210986	10.1371/journal.pone.0210986	http://dx.doi.org/10.1371/journal.pone.0210986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677063	Green Submitted, gold, Green Published			2022-12-27	WOS:000456700400039
J	Abdallah, AM; Weerdenburg, EM; Guan, QT; Ummels, R; Borggreve, S; Adroub, SA; Malas, TB; Naeem, R; Zhang, HM; Otto, TD; Bitter, W; Pain, A				Abdallah, Abdallah M.; Weerdenburg, Eveline M.; Guan, Qingtian; Ummels, Roy; Borggreve, Stephanie; Adroub, Sabir A.; Malas, Tareq B.; Naeem, Raeece; Zhang, Huoming; Otto, Thomas D.; Bitter, Wilbert; Pain, Arnab			Integrated transcriptomic and proteomic analysis of pathogenic mycobacteria and their esx-1 mutants reveal secretion -dependent regulation of ESX-1 substrates and WhiB6 as a transcriptional regulator	PLOS ONE			English	Article							BOVIS BCG; CELL-DIVISION; GENE-CLUSTER; TUBERCULOSIS; VIRULENCE; MARINUM; PROTEIN; SYSTEM; ESAT-6; MICE	The mycobacterial type VII secretion system ESX-1 is responsible for the secretion of a number of proteins that play important roles during host infection. The regulation of the expression of secreted proteins is often essential to establish successful infection. Using transcriptome sequencing, we found that the abrogation of ESX-1 function in Mycobacterium marinum leads to a pronounced increase in gene expression levels of the espA operon during the infection of macrophages. In addition, the disruption of ESX-1-mediated protein secretion also leads to a specific down-regulation of the ESX-1 substrates, but not of the structural components of this system, during growth in culture medium. This effect is observed in both M. marinum and M. tuberculosis. We established that down-regulation of ESX-1 substrates is the result of a regulatory process that is influenced by the putative transcriptional regulator whib6, which is located adjacent to the esx-1 locus. In addition, the overexpression of the ESX-1-associated PE35/PPE68 protein pair resulted in a significantly increased secretion of the ESX-1 substrate EsxA, demonstrating a functional link between these proteins. Taken together, these data show that WhiB6 is required for the secretion dependent regulation of ESX-1 substrates and that ESX-1 substrates are regulated independently from the structural components, both during infection and as a result of active secretion.	[Abdallah, Abdallah M.; Guan, Qingtian; Adroub, Sabir A.; Malas, Tareq B.; Naeem, Raeece; Pain, Arnab] King Abdullah Univ Sci & Technol, BESE Div, Pathogen Genom Lab, Thuwal Jeddah, Saudi Arabia; [Weerdenburg, Eveline M.; Ummels, Roy; Borggreve, Stephanie; Bitter, Wilbert] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal Jeddah, Saudi Arabia; [Otto, Thomas D.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England	King Abdullah University of Science & Technology; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; King Abdullah University of Science & Technology; Wellcome Trust Sanger Institute	Abdallah, AM; Pain, A (corresponding author), King Abdullah Univ Sci & Technol, BESE Div, Pathogen Genom Lab, Thuwal Jeddah, Saudi Arabia.; Bitter, W (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.	abdallah.abdallah@kaust.edu.sa; w.bitter@vumc.nl; arnab.pain@kaust.edu.sa	Bitter, W/CAJ-5778-2022; Abdallah, Abdallah Musa/AAW-1826-2020; Bitter, Wilbert/AAA-6872-2019; Bitter, Wilbert/ABG-3726-2020; Otto, Thomas/ABE-7632-2020; Pain, Arnab/L-5766-2015	Bitter, Wilbert/0000-0001-8347-6511; Abdallah, Abdallah Musa/0000-0002-9773-8700; Pain, Arnab/0000-0002-1755-2819; Zhang, Huoming/0000-0001-5416-0358; Otto, Thomas/0000-0002-1246-7404; Guan, Qingtian/0000-0001-5903-1774	KAUST faculty baseline fund [BAS/1/1020-01-01]	KAUST faculty baseline fund	Work in AP's laboratory is supported by the KAUST faculty baseline fund (BAS/1/1020-01-01).	Abdallah AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15443; Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Ates LS, 2018, NAT MICROBIOL, V3, P181, DOI 10.1038/s41564-017-0090-6; Ates LS, 2017, MOL MICROBIOL, V103, P7, DOI 10.1111/mmi.13579; Ates LS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005696; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bosserman RE, 2017, P NATL ACAD SCI USA, V114, pE10772, DOI 10.1073/pnas.1710167114; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Broset E, 2015, MBIO, V6, DOI 10.1128/mBio.01289-15; Cao GX, 2015, MICROBIOL-SGM, V161, P477, DOI 10.1099/mic.0.000023; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Chen ZK, 2016, CELL REP, V16, P2512, DOI 10.1016/j.celrep.2016.07.080; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Das C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027980; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; Groschel MI, 2017, CELL REP, V18, P2752, DOI 10.1016/j.celrep.2017.02.057; Groschel MI, 2016, NAT REV MICROBIOL, V14, P677, DOI 10.1038/nrmicro.2016.131; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hunt DM, 2012, J BACTERIOL, V194, P2307, DOI 10.1128/JB.00142-12; Jamwal SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep23089; Joshi SA, 2012, CHEM BIOL, V19, P372, DOI 10.1016/j.chembiol.2012.01.008; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Ma Y, 2015, J BIOL CHEM, V290, P7314, DOI 10.1074/jbc.M114.622076; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pang XH, 2013, J BACTERIOL, V195, P66, DOI 10.1128/JB.01067-12; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Phan TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007247; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Simeone R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004650; Solans L, 2014, INFECT IMMUN, V82, P3446, DOI 10.1128/IAI.01824-14; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stoop EJM, 2011, DIS MODEL MECH, V4, P526, DOI 10.1242/dmm.006676; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Leeuwen LM, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12858; van Winden VJC, 2016, MBIO, V7, DOI 10.1128/mBio.01471-16; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Weerdenburg EM, 2015, INFECT IMMUN, V83, P1778, DOI 10.1128/IAI.03050-14; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Zhang M, 2014, MOL MICROBIOL, V93, P1057, DOI 10.1111/mmi.12718; Zheng F, 2012, CELL BIOCHEM BIOPHYS, V63, P103, DOI 10.1007/s12013-012-9348-z; Zhu J, 2014, PROTEOMICS, V14, P1688, DOI 10.1002/pmic.201400009	75	9	11	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211003	10.1371/journal.pone.0211003	http://dx.doi.org/10.1371/journal.pone.0211003			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673778	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000456442800064
J	Barbiero, C; Montico, M; Lonciari, I; Monasta, L; Penge, R; Vio, C; Tressoldi, PE; Carrozzi, M; De Petris, A; De Cagno, AG; Crescenzi, F; Tinarelli, G; Leccese, A; Pinton, A; Belacchi, C; Tucci, R; Musinu, M; Tossali, ML; Antonucci, AM; Perrone, A; Graziano, ML; Ronfani, L; Aiello, R; Andreuzzi, P; Ansuini, V; Ardu, S; Arnesano, D; Arrivas, M; Aventaggiato, F; Baciarelli, M; Barberini, MT; Bigoni, A; Bruni, L; Carloni, L; Ciufici, S; Corrias, A; D'Amato, C; Delogu, MV; Di Campli, I; Di Girolamo, MR; Di Sano, S; Dosso, G; Epifanio, G; Falciglia, G; Fancello, G; Fascetti, G; Fazioli, S; Ferluga, V; Filauri, AV; Fornaseri, R; Gambella, T; Gennaro, E; Gentile, F; Gialluca, E; Ghilardi, MS; Lauri, E; Legge, MP; Leonio, F; Lopez, M; Manca, S; Mancini, L; Mariani, E; Mirone, S; Mocci, A; Monasterio, M; Mura, MA; Nonne, G; Oneddu, T; Pagini, K; Palladino, D; Pieretti, M; Plevano, W; Rossini, G; Sansonetti, R; Santoro, S; Sau, G; Signoretto, R; Strever, G; Tullio, A; Veste, A; Zaccaria, A; Zamponi, FM				Barbiero, Chiara; Montico, Marcella; Lonciari, Isabella; Monasta, Lorenzo; Penge, Roberta; Vio, Claudio; Tressoldi, Patrizio Emanuele; Carrozzi, Marco; De Petris, Anna; De Cagno, Anna Giulia; Crescenzi, Flavia; Tinarelli, Giovanna; Leccese, Antonella; Pinton, Alessandra; Belacchi, Carmen; Tucci, Renzo; Musinu, Maria; Tossali, Maria Letizia; Antonucci, Anna Maria; Perrone, Anna; Graziano, Mara Lentini; Ronfani, Luca; Aiello, Rosaria; Andreuzzi, Paola; Ansuini, Valeria; Ardu, Stefania; Arnesano, Daniela; Arrivas, Marina; Aventaggiato, Federica; Baciarelli, Manuela; Barberini, Maria Teresa; Bigoni, Anna; Bruni, Lavinia; Carloni, Laura; Ciufici, Sandro; Corrias, Alessandra; D'Amato, Carmina; Delogu, Maria Vittoria; Di Campli, Irene; Di Girolamo, Maria Rosaria; Di Sano, Sergio; Dosso, Giulia; Epifanio, Giuseppina; Falciglia, Giuseppina; Fancello, Graziella; Fascetti, Giulia; Fazioli, Sonia; Ferluga, Valentina; Filauri, Anna Vittoria; Fornaseri, Raffaella; Gambella, Tommaso; Gennaro, Elena; Gentile, Francesca; Gialluca, Emanuela; Ghilardi, Marzia Selene; Lauri, Elisa; Legge, Maria Pia; Leonio, Franca; Lopez, Michela; Manca, Silvia; Mancini, Lucia; Mariani, Enrica; Mirone, Sara; Mocci, Anna; Monasterio, Mara; Mura, Maria Angelica; Nonne, Grazia; Oneddu, Teresa; Pagini, Karol; Palladino, Dominga; Pieretti, Manuela; Plevano, Wilma; Rossini, Giovanna; Sansonetti, Rosanna; Santoro, Stefania; Sau, Giovanna; Signoretto, Roberta; Strever, Giulia; Tullio, Alessia; Veste, Adele; Zaccaria, Antonella; Zamponi, Francesco Matteo		EpiDIt Epidemiology Dyslexia Italy	The lost children: The underdiagnosis of dyslexia in Italy. A cross-sectional national study	PLOS ONE			English	Article							QUALITY-OF-LIFE; READING-DISABILITY; LEARNING-DISABILITIES; PREVALENCE; DISORDERS; STIGMA; SAMPLE; BOYS	Background Developmental dyslexia is one of the most common neurobehavioral disorders affecting children, but prevalence data on this condition are poor. The objective of the present study is to determine the prevalence of dyslexia in Italy in an unselected school population, using clearly defined diagnostic criteria and methods. Methods Cross-sectional study carried out in nine Italian Regions: two located in Northern Italy (Friuli Venezia Giulia and Veneto), three in Central Italy (Marche, Lazio and Umbria) and four in Southern Italy (Abruzzo, Molise, Puglia and Sardegna). Three consecutive levels of screening were carried out: the first two at school, to screen the population and identify children with suspect dyslexia; the last in centers with multi-professional staff specialized in learning disabilities to confirm the diagnosis. The key outcome measure is the prevalence of dyslexia, defined as the ratio between the number of children confirmed positive at the third level of screening and the total number of children enrolled in the study. Results We finally recruited 11094 children aged 8-10 years, of which 9964 constituted the final working sample after applying exclusion criteria and including only children who received parents' consent to participate. The prevalence of dyslexia in the whole sample was 3.5% (95% CI 3.2-3.9%), with little differences between Northern, Central and Southern Italy (respectively 3.6%, 3.2% and 3.7%). In almost two out of three children with dyslexia the disorder had not been previously diagnosed. Conclusions This study confirms that in primary school children at the age of 8-10 years in Italy dyslexia is widely underestimated. Reliable data on dyslexia prevalence are needed to allocate necessary human and financial resources both to Health Services and Schools, ensuring timely support to children and families.	[Barbiero, Chiara; Montico, Marcella; Monasta, Lorenzo; Ronfani, Luca] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Barbiero, Chiara; Lonciari, Isabella; Carrozzi, Marco] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Child Neurol & Psychiat Ward, Trieste, Italy; [Penge, Roberta] UOC NPI B La Sapienza Univ, Child Neuropsychiat Dept, Rome, Italy; [Vio, Claudio] Hosp San Dona di Piave, Child Neuropsychiat Unit, San Dona Di Piave, Italy; [Tressoldi, Patrizio Emanuele] Univ Padua, Dept Gen Psychol, Padua, Italy; [De Petris, Anna] Santo Spirito Hosp, Dept Otolaryngol & Head & Neck Surg, Pescara, Italy; [De Cagno, Anna Giulia; Crescenzi, Flavia] ASL Rm3, Rome, Italy; [Tinarelli, Giovanna] Ctr Neuropsicol Clin Eta Evolut Giorgio Sabbadini, Perugia, Italy; [Leccese, Antonella; Pinton, Alessandra] SSLI, Campobasso, Italy; [Belacchi, Carmen] Univ Urbino Carlo Bo, Dept Commun Sci Humanities & Int Studies, Urbino, Italy; [Tucci, Renzo] Studio Psicol & Logopedia, Verona, Italy; [Musinu, Maria] AIRIPA, Padua, Italy; [Tossali, Maria Letizia] Unita Operat Complessa NPI ASL Viterbo, Civita Castellana, Italy; [Antonucci, Anna Maria; Perrone, Anna; Graziano, Mara Lentini] Assoc Italiana Dislessia, Bologna, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; ULSS 4 Veneto Orientale; Ospedale di San Dona di Piave; University of Padua; University of Urbino	Ronfani, L (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy.	luca.ronfani@burlo.trieste.it	Montico, Marcella/B-5290-2013; Monasta, Lorenzo/B-1388-2012; gennaro, elena/ABC-2425-2020	Montico, Marcella/0000-0003-0377-8232; Monasta, Lorenzo/0000-0001-7774-548X; Carrozzi, Marco/0000-0001-6282-4417	Regional Health Agency of Friuli Venezia Giulia Region [42]; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project [63/07]; Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA); Foundation "Banca del Monte"	Regional Health Agency of Friuli Venezia Giulia Region; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project; Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA); Foundation "Banca del Monte"	The study in the Friuli Venezia Giulia Region received a grant by the Regional Health Agency of Friuli Venezia Giulia Region Resolution no 42, April 4, 2008 and by internal research funds of the Institute for Maternal and Child Health, IRCCS "Burlo Garofolo" Research Project 63/07. Furthermore, the study received a donation from the heirs of Mrs. Iole Vicinanza that allowed us to cover the cost of local supervision in the areas involved. The study in the Marche and Veneto Regions received a grant from the Associazione Italiana per la Ricerca e l'Intervento nella Psicopatologia dell'Apprendimento (AIRIPA). The Italian Dyslexia Association (Associazione Italiana Dislessia-AID) Foggia received a grant by the Foundation "Banca del Monte" to carry out the study in the Puglia Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldini G, 1958, INFANZIA ANORMALE, V26, P167; Barbiero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048082; Belacchi C., 2008, CPM COLOURED PROGRES; BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; Bisiacchi P, 1978, FORMAZIONE CAMBIAMEN, V1, P3; Cappa C, 2012, DISLESSIA, V9, P1; Cassini A., 1984, ETA EVOLUTIVA, V18, P66; Chan Y, 2017, RES DEV DISABIL, V68, P131, DOI 10.1016/j.ridd.2017.07.014; Cornoldi C., 2010, DISLESSIA, V7, P89; Cornoldi C, 2004, PROVE DI LETTURA MT; Coscarella C, 2001, PSICHIATRIA INFANZIA, V68, P7; Daniel SS, 2006, J LEARN DISABIL-US, V39, P507, DOI 10.1177/00222194060390060301; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Faglioni P., 1967, INFANZIA ANORMALE, V81, P628; Feola A, 2015, CLIN TER, V166, pE177, DOI [10.7417/CT.2015.1851, 10.7417/T.2015.1851]; Gibson S, 2010, SUPPORT LEARN, V25, P187, DOI 10.1111/j.1467-9604.2010.01465.x; Ginieri-Coccossis M, 2013, CHILD CARE HLTH DEV, V39, P581, DOI 10.1111/j.1365-2214.2012.01369.x; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Interagency Commission on Learning Disabilities, 1987, LEARNING DISABILITIE; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Levi G., 1982, NEUROPSICHIATRIA INF, V250, P439; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Masala C., 1998, PSICHIATRIA INFANZIA, V65, P648; MCGEE R, 1986, J CHILD PSYCHOL PSYC, V27, P597, DOI 10.1111/j.1469-7610.1986.tb00185.x; Mugnaini D, 2009, WORLD J PEDIATR, V5, P255, DOI 10.1007/s12519-009-0049-7; Nelson JM, 2011, J LEARN DISABIL-US, V44, P3, DOI 10.1177/0022219409359939; Orsini A, 2006, WISC III CONTRIBUTO; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Raven JC., 2006, CPM COLOURED PROGRES; Roberto M., 2005, DISLESSIA, V2, P135; RUTTER M, 1974, ARCH DIS CHILD, V49, P249, DOI 10.1136/adc.49.4.249; Sartori G, 2007, DDE 2 BATTERIA PER L; Sava D, 1981, GIORNALE ITALIANO PS, V8, P405; SHAYWITZ SE, 1994, TOP LANG DISORD, V14, P1, DOI 10.1097/00011363-199408000-00003; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shifrer D, 2013, J HEALTH SOC BEHAV, V54, P462, DOI 10.1177/0022146513503346; Toro Krisztina, 2015, Neuropsychopharmacol Hung, V17, P99; Toro KT, 2018, J LEARN DISABIL-US, V51, P158, DOI 10.1177/0022219417704169; Tressoldi PE, 2000, BATTERIA PER LA VALU; Wechsler D, 2006, WISC III WECHSLER IN; WHITAKER S, 2004, BRIT J LEARNING DISA, V32, P139, DOI DOI 10.1111/J.1468-3156.2004.00264.X; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210448	10.1371/journal.pone.0210448	http://dx.doi.org/10.1371/journal.pone.0210448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673720	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800041
J	Costa, MJ; Fuentes-Perez, JF; Boavida, I; Tuhtan, JA; Pinheiro, AN				Costa, M. J.; Fuentes-Perez, J. F.; Boavida, I.; Tuhtan, J. A.; Pinheiro, A. N.			Fish under pressure: Examining behavioural responses of Iberian barbel under simulated hydropeaking with instream structures	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; TROUT SALVELINUS-FONTINALIS; LATERAL-LINE; BROWN TROUT; RAINBOW-TROUT; PASSAGE PERFORMANCE; FLUCTUATING FLOW; STREAM FISHES; RIVER; TURBULENCE	Hydropeaking is the rapid change in the water flow downstream of a hydropower plant, driven by changes in daily electricity demand. These fluctuations may produce negative effects in freshwater fish. To minimize these impacts, previous studies have proposed habitat enhancement structures as potential mitigation measures for salmonids. However, the recommendation of these mitigation measures for cyprinids remains scarce and their effects unknown. In this study, the effects of potential habitat mitigation structures under simulated hydropeaking and base-flow conditions are examined for Iberian barbel (Luciobarbus bocagel) in an indoor flume. Solid triangular pyramids and v-shaped structures were evaluated as potential flow-refuging areas and compared with a configuration without structures. A novel, interdisciplinary approach is applied to investigate individual and group responses to rapidly changing flows, by assessing physiological (glucose and lactate), movement behaviour (structure use, sprints and drifts) and the pressure distribution using a fish-inspired artificial lateral line flow sensor. The major findings of this study are four-fold: 1) Under hydropeaking conditions, the v-shaped structures triggered a lactate response and stimulated individual structure use, whereas solid structures did not elicit physiological adjustments and favoured individual and group structure use. Overall, both solid structures and their absence stimulated sprints and drifts. 2) The hydrodynamic conditions created in hydropeaking did not always reflect increased physiological responses or swimming activity. 3) Each event-structure combination resulted in unique hydrodynamic conditions which were reflected in the different fish responses. 4) The most relevant flow variable measured was the pressure asymmetry, which is caused by the vortex size and shedding frequency of the structures. Considering the non-uniform nature of hydropeaking events, and the observation that the fish responded differently to specific flow event-structure combinations, a diverse set of instream structures should be considered for habitat-based hydropeaking mitigation measures for Iberian barbel.	[Costa, M. J.; Boavida, I.; Pinheiro, A. N.] Univ Lisbon, Inst Super Tecn, Civil Engn Res & Innovat Sustainabil, Lisbon, Portugal; [Costa, M. J.] Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal; [Fuentes-Perez, J. F.; Tuhtan, J. A.] Tallinn Univ Technol, Ctr Biorobot, Tallinn, Estonia	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Tallinn University of Technology	Costa, MJ (corresponding author), Univ Lisbon, Inst Super Tecn, Civil Engn Res & Innovat Sustainabil, Lisbon, Portugal.; Costa, MJ (corresponding author), Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal.	mariajcosta@tecnico.ulisboa.pt	Pinheiro, António N./E-2520-2012; Costa, Maria João F R/I-2781-2017; Tuhtan, Jeffrey Andrew/AAQ-5037-2020; Fuentes, Juan Francisco/N-3312-2015; Boavida, Isabel/F-5306-2012	Pinheiro, António N./0000-0002-1423-5391; Costa, Maria João F R/0000-0001-6395-6868; Tuhtan, Jeffrey Andrew/0000-0003-0832-7334; Fuentes, Juan Francisco/0000-0003-2384-9085; Boavida, Isabel/0000-0001-6005-3751	FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia [SFRH/BD/52517/2014]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/90832/2012]; European Union's Horizon 2020 research and innovation programme [727830]; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements" [PUT1690]; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Octavo" [B53]	FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Union's Horizon 2020 research and innovation programme; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements"; Sihtasutus Eesti Teadusagentuur (ETAg), Estonia, through the project "Octavo"	MJC was funded by the FLUVIO - River Restoration and Management Doctoral Programme from the Fundacao para a Ciencia e Tecnologia, https://www.fct.pt/, Portugal (grant No SFRH/BD/52517/2014). IB was funded by Fundacao para a Ciencia e Tecnologia, https://www.fct.pt/, Portugal (grant No SFRH/BPD/90832/2012). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 727830, http://www.fithydro.eu/.JAT contribution has been funded in part by the Sihtasutus Eesti Teadusagentuur (ETAg), https://www.etis.ee/, Estonia, through the projects "Bioinspired Ecohydraulic Sensor Array for Laboratory and Insitu Flow Measurements" (grant agreement No PUT1690) and "Octavo" (grant agreement No B53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; [Anonymous], R LANG ENV STAT COMP; Arnekleiv JV, 2004, J FISH BIOL, V64, P541, DOI 10.1111/j.0022-1112.2004.00320.x; Auer S, 2017, SCI TOTAL ENVIRON, V575, P1515, DOI 10.1016/j.scitotenv.2016.10.029; Barton BA, 2002, BIOLOGICAL INDICATORS OF AQUATIC ECOSYSTEM STRESS, P111; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; Bejarano MD, 2018, BIOL REV, V93, P658, DOI 10.1111/brv.12362; Bejarano MD, 2017, J HYDROL, V550, P186, DOI 10.1016/j.jhydrol.2017.04.023; Bleckmann H, 2008, J COMP PHYSIOL A, V194, P145, DOI 10.1007/s00359-007-0282-2; Bleckmann H, 1994, PROGRESS IN ZOOLOGY; Boavida I, 2017, HYDROBIOLOGIA, V785, P261, DOI 10.1007/s10750-016-2931-3; Boavida I, 2015, J HYDRO-ENVIRON RES, V9, P237, DOI 10.1016/j.jher.2014.07.009; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Borcard D., 2011, MATISSE, V77, P332, DOI DOI 10.1007/978-1-4419-7976-6; Branco P, 2013, HYDROBIOLOGIA, V714, P145, DOI 10.1007/s10750-013-1532-7; Branco P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065089; Bruno M, 2014, 10 ISE 2014 TRONDH N; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burnett NJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P587, DOI 10.1086/677219; Capra H, 2017, SCI TOTAL ENVIRON, V578, P109, DOI 10.1016/j.scitotenv.2016.10.155; Casas-Mulet R, 2015, RIVER RES APPL, V31, P433, DOI 10.1002/rra.2827; CEN, 2003, WAT QUAL SAMPL FISH, P1; Chan M.D., 2001, FISH ECOMORPHOLOGY P; Chen K, 2017, IEEE T INSTRUM MEAS, V66, P651, DOI 10.1109/TIM.2017.2658278; Chun SN, 2011, ENVIRON BIOL FISH, V90, P43, DOI 10.1007/s10641-010-9716-8; CollaresPereira MJ, 1996, FOLIA ZOOL, V45, P65; Costa MJ, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1983; Costa MJ, 2019, ECOL ENG, V127, P567, DOI 10.1016/j.ecoleng.2018.07.029; COSTA MJ, 2017, J ECOHYDRAUL, V2, P68, DOI DOI 10.1080/24705357.2017.1287531; CUSHMAN R M, 1985, North American Journal of Fisheries Management, V5, P330, DOI 10.1577/1548-8659(1985)5<330:ROEEOR>2.0.CO;2; De Vocht A., 2003, 5 C FISH TEL, P35; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Enders EC, 2005, CAN J FISH AQUAT SCI, V62, P1079, DOI 10.1139/F05-007; Flodmark LEW, 2006, ECOL FRESHW FISH, V15, P57, DOI 10.1111/j.1600-0633.2006.00127.x; Flodmark LEW, 2002, J FISH BIOL, V60, P238, DOI 10.1006/jfbi.2001.1845; Fuentes-Perez JF, 2018, ECOL ENG, V125, P131, DOI 10.1016/j.ecoleng.2018.10.014; Fuentes-Perez JF, 2015, ECOL ENG, V85, P296, DOI 10.1016/j.ecoleng.2015.10.008; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Goettel MT, 2015, ECOL ENG, V74, P230, DOI 10.1016/j.ecoleng.2014.10.012; Greimel F, 2018, AQUAT ECOL SER, V8, P91, DOI 10.1007/978-3-319-73250-3_5; Harby A, 2013, ECOHYDRAULICS: AN INTEGRATED APPROACH, P323; Harvey-Lavoie S, 2016, ECOHYDROLOGY, V9, P1687, DOI 10.1002/eco.1758; Heimerl S, 2008, HYDROBIOLOGIA, V609, P197, DOI 10.1007/s10750-008-9414-0; Jones NE, 2015, RIVER RES APPL, V31, P1109, DOI 10.1002/rra.2810; Kelly B, 2017, ECOL FRESHW FISH, V26, P666, DOI 10.1111/eff.12310; Kemp PS, 2003, RIVER RES APPL, V19, P569, DOI 10.1002/rra.727; Korman J, 2011, T AM FISH SOC, V140, P487, DOI 10.1080/00028487.2011.572015; Krimmer AN, 2011, J FISH BIOL, V79, P707, DOI 10.1111/j.1095-8649.2011.03053.x; Larranaga N, 2018, RIVER RES APPL, V34, P348, DOI 10.1002/rra.3256; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liao JC, 2006, J EXP BIOL, V209, P4077, DOI 10.1242/jeb.02487; Liao JC, 2004, J EXP BIOL, V207, P3495, DOI 10.1242/jeb.01125; MAGALHAES MF, 1992, J FISH BIOL, V40, P123, DOI 10.1111/j.1095-8649.1992.tb02559.x; Martinez Capel F., 1999, Limnetica, V17, P71; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Monk SK., 2012, THESIS; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Oksanen J., 2020, COMMUNITY ECOL PACKA; Oksanen J., 2015, MULTIVARIATE ANAL EC, P43; Oliveira JM, 2002, J APPL ICHTHYOL, V18, P134, DOI 10.1046/j.1439-0426.2002.00333.x; Pankhurst NW, 2011, GEN COMP ENDOCR, V170, P265, DOI 10.1016/j.ygcen.2010.07.017; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Popper AN, 1996, MAR FRESHW BEHAV PHY, V27, P95, DOI 10.1080/10236249609378957; Ribi JM, 2014, AQUAT SCI, V76, P527, DOI 10.1007/s00027-014-0351-x; Ribi J-M, 2010, PROCEEDINGS OF THE 8, P675; RODRIGUEZRUIZ A, 1992, J FISH BIOL, V41, P545, DOI 10.1111/j.1095-8649.1992.tb02682.x; Romao F, 2018, WATER-SUI, V10, DOI 10.3390/w10040395; Salumae T, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2012.0671; Santos JM, 2018, AQUAT CONSERV, V28, P26, DOI 10.1002/aqc.2839; Santos JM, 2014, ECOL ENG, V73, P335, DOI 10.1016/j.ecoleng.2014.09.065; Sauterleute JF, 2014, ENVIRON MODELL SOFTW, V55, P266, DOI 10.1016/j.envsoft.2014.02.004; Schmutz S, 2015, RIVER RES APPL, V31, P919, DOI 10.1002/rra.2795; Schreck CB, 2000, BIOLOGY OF ANIMAL STRESS, P147, DOI 10.1079/9780851993591.0147; Scruton DA, 2005, N AM J FISH MANAGE, V25, P964, DOI 10.1577/M04-133.1; Scruton DA, 2003, RIVER RES APPL, V19, P577, DOI 10.1002/rra.733; Shen Y, 2010, J HYDRAUL ENG, V136, P1053, DOI 10.1061/(ASCE)HY.1943-7900.0000112; Silva AT, 2011, RIVER RES APPL, V27, P360, DOI 10.1002/rra.1363; Smith DL, 2014, REV FISH SCI AQUAC, V22, P123, DOI 10.1080/10641262.2013.803516; Smith DL, 2005, T AM FISH SOC, V134, P741, DOI 10.1577/T04-069.1; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Stevenson C, 2009, FISH PASSAGE AUCKLAN; Stoot L.J., 2014, CONSERV PHYSIOL, V2, P1, DOI DOI 10.1093/C0NPHYS/C0U011; Sumpter J.P., 1997, P95; Tang M, 2000, CAN J FISH AQUAT SCI, V57, P1482, DOI 10.1139/cjfas-57-7-1482; Tanner RK, 2010, EUR J APPL PHYSIOL, V109, P551, DOI 10.1007/s00421-010-1379-9; Taylor MK, 2014, RIVER RES APPL, V30, P756, DOI 10.1002/rra.2673; Taylor MK, 2014, ECOHYDROLOGY, V7, P1079, DOI 10.1002/eco.1429; Taylor MK, 2012, ENVIRON REV, V20, P211, DOI [10.1139/A2012-009, 10.1139/a2012-009]; Taylor MK, 2012, ECOL FRESHW FISH, V21, P609, DOI 10.1111/j.1600-0633.2012.00582.x; Thompson LC, 2011, ENVIRON BIOL FISH, V90, P253, DOI 10.1007/s10641-010-9738-2; Tonolla D, 2017, SCI TOTAL ENVIRON, V574, P594, DOI 10.1016/j.scitotenv.2016.09.101; Tudorache C, 2008, ECOL FRESHW FISH, V17, P284, DOI 10.1111/j.1600-0633.2007.00280.x; Tuhtan, 2017, HYDROSENSOFT INT S E, P1; Tuhtan JA, 2011, PHYS LIFE REV, V8, P253, DOI 10.1016/j.plrev.2011.07.002; Tuhtan JA, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aabc79; Tuhtan JA, 2017, FLOW MEAS INSTRUM, V54, P1, DOI 10.1016/j.flowmeasinst.2016.10.017; van Netten SM, 2014, SPRINGER HANDB AUDIT, V48, P99, DOI 10.1007/2506_2013_14; Vehanen T, 2000, J FISH BIOL, V56, P923, DOI 10.1111/j.1095-8649.2000.tb00882.x; Beecham RV, 2006, N AM J AQUACULT, V68, P291, DOI 10.1577/A05-074.1; Walters K, 2006, J EXP MAR BIOL ECOL, V330, P81, DOI 10.1016/j.jembe.2005.12.018; Wang H, 2018, RIVER RES APPL, V34, P244, DOI 10.1002/rra.3245; Young PS, 2011, REV FISH BIOL FISHER, V21, P713, DOI 10.1007/s11160-011-9211-0; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zimmerman JKH, 2010, RIVER RES APPL, V26, P1246, DOI 10.1002/rra.1324; Zolezzi G, 2011, ECOHYDROLOGY, V4, P564, DOI 10.1002/eco.132	105	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211115	10.1371/journal.pone.0211115	http://dx.doi.org/10.1371/journal.pone.0211115			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673767	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800075
J	Hansen, SG; Womack, J; Scholz, I; Renner, A; Edgel, KA; Xu, GW; Ford, JC; Grey, M; St Laurent, B; Turner, JM; Planer, S; Legasse, A; Richie, TL; Aguiar, JC; Axthelm, MK; Villasante, ED; Weiss, W; Edlefsen, PT; Picker, LJ; Fruh, K				Hansen, Scott G.; Womack, Jennie; Scholz, Isabel; Renner, Andrea; Edgel, Kimberly A.; Xu, Guangwu; Ford, Julia C.; Grey, Mikayla; St Laurent, Brandyce; Turner, John M.; Planer, Shannon; Legasse, Al W.; Richie, Thomas L.; Aguiar, Joao C.; Axthelm, Michael K.; Villasante, Eileen D.; Weiss, Walter; Edlefsen, Paul T.; Picker, Louis J.; Fruh, Klaus			Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge	PLOS ONE			English	Article							HIGHLY PATHOGENIC SIV; T-CELL RESPONSES; MALARIA VACCINE; RHESUS-MONKEYS; STERILE PROTECTION; ME-TRAP; IMMUNIZATION; FALCIPARUM; NAIVE; EFFICACY	The development of a sterilizing vaccine against malaria remains one of the highest priorities for global health research. While sporozoite vaccines targeting the pre-erythrocytic stage show great promise, it has not been possible to maintain efficacy long-term, likely due to an inability of these vaccines to maintain effector memory T cell responses in the liver. Vaccines based on human cytomegalovirus (HCMV) might overcome this limitation since vectors based on rhesus CMV (RhCMV), the homologous virus in rhesus macaques (RM), elicit and indefinitely maintain high frequency, non-exhausted effector memory T cells in extralymphoid tissues, including the liver. Moreover, RhCMV strain 68-1 elicits CD8+ T cells broadly recognizing unconventional epitopes exclusively restricted by MHC-II and MHC-E. To evaluate the potential of these unique immune responses to protect against malaria, we expressed four Plasmodium knowlesi (Pk) antigens (CSP, AMA1, SSP2/TRAP, MSP1c) in RhCMV 68-1 or in Rh189-deleted 68-1, which additionally elicits canonical MHC-la-restricted CD8+ T cells. Upon inoculation of RM with either of these Pk Ag expressing RhCMV vaccines, we obtained T cell responses to each of the four Pk antigens. Upon challenge with Pk sporozoites we observed a delayed appearance of blood stage parasites in vaccinated RM consistent with a 75-80% reduction of parasite release from the liver. Moreover, the Rh189-deleted RhCMV/Pk vectors elicited sterile protection in one RM. Once in the blood, parasite growth was not affected. In contrast to T cell responses induced by Pk infection, RhCMV vectors maintained sustained T cell responses to all four malaria antigens in the liver post-challenge. The delayed appearance of blood stage parasites is thus likely due to a T cell-mediated inhibition of liver stage parasite development. As such, this vaccine approach can be used to efficiently test new T cell antigens, improve current vaccines targeting the liver stage and complement vaccines targeting erythrocytic antigens.	[Hansen, Scott G.; Womack, Jennie; Scholz, Isabel; Xu, Guangwu; Ford, Julia C.; Grey, Mikayla; Axthelm, Michael K.; Picker, Louis J.; Fruh, Klaus] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA; [Hansen, Scott G.; Turner, John M.; Planer, Shannon; Legasse, Al W.; Axthelm, Michael K.; Picker, Louis J.; Fruh, Klaus] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Renner, Andrea; Edgel, Kimberly A.; Richie, Thomas L.; Aguiar, Joao C.; Villasante, Eileen D.; Weiss, Walter] Naval Med Res Ctr, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [St Laurent, Brandyce] NIH, Lab Malaria & Vector Res, Malaria Pathogenesis & Human Immun Unit, Rockville, MD USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Scholz, Isabel] Olology, Frederick, MD USA; [Renner, Andrea] USAMRMC, Ft Detrick, MD USA; [Richie, Thomas L.] Sanaria Inc, Rockville, MD USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; Fred Hutchinson Cancer Center; Sanaria Inc.	Fruh, K (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97239 USA.	fruehk@ohsu.edu		St. Laurent, Brandyce/0000-0002-2957-5364; Frueh, Klaus/0000-0001-8014-3877; Richie, Thomas/0000-0002-2946-5456	Military Infectious Disease Research Program [F0351_13_NM]; Naval Medical Research Center [N62645-13-D-4021]; National Institute of Health [R21AI103498, R01AI059457, R01AI123182]; National Center for Research Resources; Office of Research Infrastructure Programs of the NIH [P510D011092]; NIH Nonhuman Primate Reagent Resource [R24 RR016001]; National Institute of Allergy and Infectious Diseases [HHSN 2722000900037C];  [A1256]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059457, R21AI103498, R01AI123182, R56AI059457] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Military Infectious Disease Research Program; Naval Medical Research Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nonhuman Primate Reagent Resource; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported/funded by work unit number A1256, by the Military Infectious Disease Research Program project number F0351_13_NM, Naval Medical Research Center grant N62645-13-D-4021, and by the National Institute of Health grants R21AI103498, R01AI059457 and R01AI123182. This project was also supported by the National Center for Research Resources and the Office of Research Infrastructure Programs of the NIH through grant P510D011092 as well as NIH Nonhuman Primate Reagent Resource (R24 RR016001) and National Institute of Allergy and Infectious Diseases contract (HHSN 2722000900037C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2015, FUTURE MICROBIOL, V10, P1553, DOI 10.2217/fmb.15.90; Aguiar JC, 2001, VACCINE, V20, P275, DOI 10.1016/S0264-410X(01)00273-0; Aguiar Joao C, 2015, PLoS One, V10, pe0136109, DOI 10.1371/journal.pone.0136109; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Bijker EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112910; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Cicin-Sain L, 2007, P NATL ACAD SCI USA, V104, P19960, DOI 10.1073/pnas.0705905104; Cicin-Sain L, 2011, J IMMUNOL, V187, P1722, DOI 10.4049/jimmunol.1100560; Davies DH, 2015, VACCINE, V33, P7496, DOI 10.1016/j.vaccine.2015.09.059; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Douradinha Bruno, 2011, J Immune Based Ther Vaccines, V9, P6, DOI 10.1186/1476-8518-9-6; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Epstein JE, 2013, CURR OPIN INFECT DIS, V26, P420, DOI 10.1097/QCO.0000000000000002; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; FRUH K, 1991, INFECT IMMUN, V59, P1319; Fruh K, 2017, CURR OPIN IMMUNOL, V47, P52, DOI 10.1016/j.coi.2017.06.010; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Gupta S, 2005, CURR OPIN MICROBIOL, V8, P428, DOI 10.1016/j.mib.2005.06.011; Hansen SG, 2018, NAT MED, V24, P130, DOI 10.1038/nm.4473; Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-312; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Murphy JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-215; Offeddu V, 2012, INT J PARASITOL, V42, P535, DOI 10.1016/j.ijpara.2012.03.011; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Pichyangkul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171826; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Rieckmann K H, 1979, Bull World Health Organ, V57 Suppl 1, P261; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schmidt NW, 2011, J IMMUNOL, V186, P3836, DOI 10.4049/jimmunol.1003949; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Team RC., 2013, R LANG ENV STAT COMP; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; 2013, WORLD MAL REP 2013, P1	60	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210252	10.1371/journal.pone.0210252	http://dx.doi.org/10.1371/journal.pone.0210252			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673723	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800035
J	Yokoya, M; Higuchi, Y				Yokoya, Masana; Higuchi, Yukito			Day length may make geographical difference in body size and proportions: An ecological analysis of Japanese children and adolescents	PLOS ONE			English	Article							LIGHT EXPOSURE; GROWTH; SEASONALITY; HORMONE	There is a north-south gradient in the body heights of Japanese children. A hypothesis had previously been proposed that differences in thyroid hormone activity induced by geographical differences in effective day length (duration of photoperiod exceeding a predetermined light intensity) might cause the differences in height. If thyroid hormone is involved, the effect should extend to body weight. This study examined whether geographical differences in body height and weight can be explained in terms of thyroid hormone activity induced by geographical differences in the photoperiodic environment using prefecture-level anatomical data and Japanese Mesh Climatic Data. Multiple regression analysis demonstrated that the combination of effective day length and weight was statistically significant as a predictor of height. Controlling for body weight revealed that effective day length was inversely correlated with height. Multiple regression analysis revealed that a combination of effective day length and height was statistically significant as a predictor of weight. Controlling for height demonstrated that effective day length was positively correlated with weight. Assuming an inverse correlation between effective day length and thyroid hormone activity, these results appear to show that short day-length will increase the activity of thyroid hormone and contribute to increasing height, but will inhibit weight gain; in contrast, long day-length will decrease the activity of thyroid hormone and contribute to increasing weight but will inhibit height gain. Geographical differences in height, and weight, and part of the prevalence of obesity in Japanese children and early adolescents may be explained by geographical differences in effective day length.	[Yokoya, Masana] Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan; [Higuchi, Yukito] Kyushu Kyoritsu Univ, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan		Yokoya, M (corresponding author), Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan.	m.yokoya@shimonoseki-jc.ac.jp		Yokoya, Masana/0000-0002-1122-9500				Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; CABELLO G, 1989, REPROD NUTR DEV, V29, P387, DOI 10.1051/rnd:19890401; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; De Leonibus C, 2016, PHARMACOGENOMICS J, V16, P540, DOI 10.1038/tpj.2015.67; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; Edwards L., 2002, LIT REV EFFECTS NATU; ENDO A, 1993, AM J PHYS ANTHROPOL, V91, P299, DOI 10.1002/ajpa.1330910305; Kooijman S, 2015, P NATL ACAD SCI USA, V112, P6748, DOI 10.1073/pnas.1504239112; Kouchi M, 1983, B U MUSEUM U TOKYO, V22, P1; Land C, 2005, EUR J ENDOCRINOL, V152, P727, DOI 10.1530/eje.1.01899; Laurberg P, 2012, EUR THYROID J, V1, P159, DOI 10.1159/000342994; Matsuda S, 1998, J BIOSOC SCI, V30, P85, DOI 10.1017/S0021932098000856; Mesh Climatic Data, 2000, MESH CLIM DAT 2000; Ministry of Education, 2013, CULT SPORTS SCI TECH; Reid KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092251; SAVIDES TJ, 1986, PHYSIOL BEHAV, V38, P571, DOI 10.1016/0031-9384(86)90427-0; Shulman DI, 2013, INT J PEDIAT ENDOCRI, V2; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Yokoya Masana, 2016, Journal of Circadian Rhythms, V14, P7, DOI 10.5334/jcr.142; Yokoya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050994; Yokoya M, 2011, INT J ENV RES PUB HE, V8, P4272, DOI 10.3390/ijerph8114272	22	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210265	10.1371/journal.pone.0210265	http://dx.doi.org/10.1371/journal.pone.0210265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668608	Green Submitted, gold, Green Published			2022-12-27	WOS:000456306400007
J	Murali, KM; Mullan, J; Roodenrys, S; Hassan, HC; Lambert, K; Lonergan, M				Murali, Karumathil M.; Mullan, Judy; Roodenrys, Steven; Hassan, Hicham C.; Lambert, Kelly; Lonergan, Maureen			Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials	PLOS ONE			English	Review							BEHAVIORAL GROUP-APPROACH; HEMODIALYSIS-PATIENTS; EDUCATIONAL INTERVENTION; PHOSPHATE LEVELS; RENAL-DISEASE; MANAGEMENT; HYPERPHOSPHATEMIA; RESTRICTIONS; EFFICACY; OSTEODYSTROPHY	Background In patients with end stage kidney disease (ESKD) on dialysis, treatment non-adherence is common and results in poor health outcomes. However, the clinical benefits of interventions to improve adherence in dialysis patients are difficult to evaluate since trialled interventions and reported outcomes are highly diverse/heterogeneous. This review summarizes existing literature on randomized controlled trials (RCTs) evaluating adherence interventions in ESKD patients focusing on the intervention category, outcome efficacy and persistence of benefit beyond the intervention. Methods We performed electronic database searches in Medline, Embase & Cochrane CENTRAL upto 1 st July 2018 for RCTs evaluating interventions to improve diet, fluid, medication or dialysis adherence in ESKD patients. Study characteristics including category of interventions, outcomes, efficacy and follow-up were assessed. Meta-analysis was used to compute pooled estimates of the effects on the commonest reported outcome measures. Results From 1311 citations, we included 36 RCTs (13 cluster-randomized trials), recruiting a total of 3510 dialysis patients (mean age 55.1 +/- 5.8 years, males 58.1%). Overall risk of bias was 'high' for 24 and of 'some concern' for 12 studies. Most interventions (33 trials, 92%) addressed patient related factors, and included educational/cognitive (N = 11), behavioural /counselling (N = 4), psychological/affective (N = 4) interventions or a combination (N = 14) of the above. A majority of (28/36) RCTs showed improvement in some reported outcomes.Surrogate measures like changes in phosphate (N = 19) and inter-dialytic weight gain (N = 15) were the most common reported outcomes and both showed significant improvement in the meta-analysis. Sixteen trials reported follow-up (1-12 months) beyond intervention and the benefits waned or were absent in nine trials within 12 months post-intervention. Conclusions Interventions to improve treatment adherence result in modest short-term benefits in surrogate outcome measures in dialysis patients, but significant improvements in trial design and outcome reporting are warranted to identify strategies that would achieve meaningful and sustainable clinical benefits. Limitations Poor methodological quality of trials. Frequent use of surrogate outcomes measures. Low certainly of evidence.	[Murali, Karumathil M.; Hassan, Hicham C.; Lonergan, Maureen] Wollongong Hosp, Dept Nephrol, Wollongong, NSW, Australia; [Mullan, Judy; Lambert, Kelly] Univ Wollongong, CHRISP, Wollongong, NSW, Australia; [Roodenrys, Steven] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	Wollongong Hospital; University of Wollongong; University of Wollongong	Murali, KM (corresponding author), Wollongong Hosp, Dept Nephrol, Wollongong, NSW, Australia.	karumathil.murali@health.nsw.gov.au	Hassan, Hicham Cheikh/AAH-2977-2019; Mullan, Judy R/G-6642-2015; Lambert, Kelly/A-3940-2015	Hassan, Hicham Cheikh/0000-0002-9198-6092; Mullan, Judy R/0000-0003-3772-7986; Lambert, Kelly/0000-0001-5935-7328				Ashurst ID, 2003, J RENAL NUTR, V13, P267, DOI 10.1053/S1051-2276(03)00116-X; Baraz S, 2010, J ADV NURS, V66, P60, DOI 10.1111/j.1365-2648.2009.05142.x; BRANTLEY PJ, 1990, HEALTH PSYCHOL, V9, P103, DOI 10.1037/0278-6133.9.1.103; Chen W, 2006, J RENAL NUTR, V16, P132, DOI 10.1053/j.jrn.2006.01.009; Cho MK, 2013, NURS HEALTH SCI, V15, P86, DOI 10.1111/nhs.12003; Cukor D, 2014, J AM SOC NEPHROL, V25, P196, DOI 10.1681/ASN.2012111134; CUMMINGS K M, 1981, Journal of Behavioral Medicine, V4, P111; De Bleser L, 2009, TRANSPL INT, V22, P780, DOI 10.1111/j.1432-2277.2009.00881.x; De Vries H, 1998, PSYCHOL HEALTH, V13, P369, DOI 10.1080/08870449808406757; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford JC, 2004, J RENAL NUTR, V14, P36, DOI 10.1053/j.jrn.2003.09.008; FU R, 2013, AHRQ PUBLICATION; Ghimire S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144119; Griva K, 2018, AM J KIDNEY DIS, V71, P371, DOI 10.1053/j.ajkd.2017.09.014; Haq N, 2014, INT UROL NEPHROL, V46, P113, DOI 10.1007/s11255-013-0418-y; Hare J, 2014, NEPHROL DIAL TRANSPL, V29, P555, DOI 10.1093/ndt/gft477; Higgins J.P.T.S.J., 2016, REVISED TOOL ASSESSI; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; [Hou Yongmei 侯永梅], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P5869; Howren MB, 2016, ANN BEHAV MED, V50, P167, DOI 10.1007/s12160-015-9741-0; Karavetian M, 2015, PATIENT EDUC COUNS, V98, P1116, DOI 10.1016/j.pec.2015.05.005; Karavetian M, 2014, NUTR REV, V72, P471, DOI 10.1111/nure.12115; Karavetian M, 2013, J RENAL CARE, V39, P19, DOI 10.1111/j.1755-6686.2012.00327.x; Kauric-Klein Z, 2012, NEPHROL NURS J, V39, P217; Lou LM, 2012, CLIN NEPHROL, V77, P476, DOI 10.5414/CN107218; Manera KE, 2017, PERITON DIALYSIS INT, V37, P639, DOI 10.3747/pdi.2017.00022; Matteson ML, 2013, OUTCOMES ASSESSMENT IN END - STAGE KIDNEY DISEASE - MEASUREMENTS AND APPLICATIONS IN CLINICAL PRACTICE, P138; Matteson ML, 2010, HEMODIAL INT, V14, P370, DOI 10.1111/j.1542-4758.2010.00462.x; Milazi Molly, 2017, JBI Database System Rev Implement Rep, V15, P971, DOI 10.11124/JBISRIR-2017-003360; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Molaison EF, 2003, PATIENT EDUC COUNS, V49, P5, DOI 10.1016/S0738-3991(02)00036-8; Morey B, 2008, NEPHRON CLIN PRACT, V109, pC173, DOI 10.1159/000145462; Murali KM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0449-1; Neumann CL, 2013, TELEMED E-HEALTH, V19, P480, DOI 10.1089/tmj.2012.0188; Ogna VF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/104892; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pasyar N, 2015, COMPLEMENT THER MED, V23, P38, DOI 10.1016/j.ctim.2014.10.011; Reese PP, 2015, J RENAL NUTR, V25, P510, DOI 10.1053/j.jrn.2015.06.001; de Araujo LPR, 2010, REV ESC ENFERM USP, V44, P927, DOI 10.1590/S0080-62342010000400010; SabatU E., 2003, ADHERENCE LONG TERM; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schunemann H. J., 2013, GRADE HDB GRADING QU; Sehgal AR, 2002, JAMA-J AM MED ASSOC, V287, P1961, DOI 10.1001/jama.287.15.1961; Sharp J, 2005, AM J KIDNEY DIS, V45, P1046, DOI 10.1053/j.ajkd.2005.02.032; Sherman RA, 2016, AM J KIDNEY DIS, V67, P182, DOI 10.1053/j.ajkd.2015.07.035; Shi YX, 2013, J CLIN NURS, V22, P1189, DOI 10.1111/jocn.12159; SKOUTAKIS VA, 1978, AM J HOSP PHARM, V35, P62, DOI 10.1093/ajhp/35.1.62; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Tanner J L, 1998, J Ren Nutr, V8, P203, DOI 10.1016/S1051-2276(98)90019-X; Tong A, 2017, AM J KIDNEY DIS, V69, P97, DOI 10.1053/j.ajkd.2016.05.022; Tsay SL, 2003, J ADV NURS, V43, P370, DOI 10.1046/j.1365-2648.2003.02725.x; Welch JL, 2013, RES NURS HEALTH, V36, P284, DOI 10.1002/nur.21539; Wileman V, 2016, PSYCHOL HEALTH, V31, P100, DOI 10.1080/08870446.2015.1073729; Wileman V, 2014, ANN BEHAV MED, V48, P275, DOI 10.1007/s12160-014-9597-8; Wong FKY, 2010, INT J NURS STUD, V47, P268, DOI 10.1016/j.ijnurstu.2009.07.001; Yokum D, 2008, J RENAL NUTR, V18, P521, DOI 10.1053/j.jrn.2008.05.003	56	34	34	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211479	10.1371/journal.pone.0211479	http://dx.doi.org/10.1371/journal.pone.0211479			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695068	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400037
J	Tang, CX; Luan, L; Zhang, L; Wang, Y; Liu, XF; Wang, J; Xiong, Y; Wang, D; Huang, LY; Gao, DS				Tang, Chuan-Xi; Luan, Lan; Zhang, Lin; Wang, Yue; Liu, Xin-Feng; Wang, Jie; Xiong, Ye; Wang, Dan; Huang, Lin-Yan; Gao, Dian-Shuai			Golgin-160 and GMAP210 play an important role in U251 cells migration and invasion initiated by GDNF	PLOS ONE			English	Article							MICROTUBULE NUCLEATION; MEMBRANE TRAFFICKING; POLARIZATION; FIBROBLASTS; CENTROSOME; APPARATUS; PLATFORM; RECEPTOR; GROWTH; EDGE	Gliomas are the most common malignant tumors of the brain and are characteristic of severe migration and invasion. Glial cell line-derived neurotrophic factor (GDNF) promotes glioma development process. However, the regulatory mechanisms of promoting occurrence and development of glioma have not yet been clearly elucidated. In the present study, the mechanism by which GDNF promotes glioma cell migration and invasion through regulating the dispersion and location of the Golgi apparatus (GA) is described. Following GDNF treatment, a change in the volume and position of GA was observed. The stack area of the GA was enlarged and it was more concentrated near the nucleus. Golgin-160 and Golgi microtubule-associated protein 210 (GMAP210) were identified as target molecules regulating GA positioning. In the absence of either golgin-160 or GMAP210 using lentivirus, the migration and invasion of U251 cells were decreased, while it was increased following GDNF. It was also found that the GA was decreased in size and dispersed following golgin-160 or GMAP210 knockdown, as determined by GA green fluorescence assay. Once GDNF was added, the above phenomenon would be twisted, and the concentrated location and volume of the GA was restored. In combination, the present data suggested that the regulation of the position and size of the GA by golgin-160 and GMAP210 play an important role in U251 cell migration and invasion.	[Tang, Chuan-Xi; Wang, Yue; Wang, Jie; Xiong, Ye; Gao, Dian-Shuai] Xuzhou Med Univ, Xuzhou Key Lab Neurobiol, Dept Neurobiol & Anat, Xuzhou, Jiangsu, Peoples R China; [Luan, Lan; Zhang, Lin] Xuzhou Med Univ, Sch Nursing, Xuzhou, Jiangsu, Peoples R China; [Liu, Xin-Feng] Xuzhou Med Univ, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Wang, Dan] Xuzhou Med Univ, Sch Med Informat, Xuzhou, Jiangsu, Peoples R China; [Huang, Lin-Yan] Xuzhou Med Univ, Sch Med Technol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Gao, DS (corresponding author), Xuzhou Med Univ, Xuzhou Key Lab Neurobiol, Dept Neurobiol & Anat, Xuzhou, Jiangsu, Peoples R China.	gds@xzhmu.edu.cn		Gao, DianShuai/0000-0001-8567-0238	National Natural Science Research Foundation of China [81372698, 81402918]; Jiangsu University Natural Science Foundation [17KJB310015]	National Natural Science Research Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University Natural Science Foundation	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the National Natural Science Research Foundation of China (grant Nos. 81372698, 81402918) and Jiangsu University Natural Science Foundation funded project (17KJB310015. Dan Wang: Funding, Lin-Yan Huang: Funding, experimental guidance, Dian-Shuai Gao: Funding, project supervision, study conception and design.	BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; CHAKRABORTY M, 1992, CELL MOL NEUROBIOL, V12, P589, DOI 10.1007/BF00711238; Cuccioli V, 2015, HIPPOCAMPUS, V25, P486, DOI 10.1002/hipo.22386; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Darido C, 2013, ADV WOUND CARE, V2, P87, DOI 10.1089/wound.2011.0352; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Ghezali G, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155275; Gilbert CE, 2014, INT J MOL SCI, V15, P2929, DOI 10.3390/ijms15022929; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Iochmann S, 2009, CLIN EXP METASTAS, V26, P457, DOI 10.1007/s10585-009-9245-z; Kim MS, 2015, BIOCHEM BIOPH RES CO, V460, P255, DOI 10.1016/j.bbrc.2015.03.021; Kimura M, 2018, EXP CELL RES, V367, P73, DOI 10.1016/j.yexcr.2018.03.024; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Millarte V, 2012, SCI WORLD J, DOI 10.1100/2012/498278; Ong ST, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00397; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Petry S, 2015, NAT CELL BIOL, V17, P1089, DOI 10.1038/ncb3220; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Procter DJ, 2018, DEV CELL, V45, P83, DOI 10.1016/j.devcel.2018.03.010; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roboti P, 2015, J CELL SCI, V128, P1595, DOI 10.1242/jcs.166710; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Xiong Y, 2017, ONCOTARGET, V8, P24902, DOI 10.18632/oncotarget.15302; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang ZK, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa7677; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Zhu RJ, 2018, SEMIN CELL DEV BIOL, V82, P41, DOI 10.1016/j.semcdb.2017.11.006	36	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211501	10.1371/journal.pone.0211501	http://dx.doi.org/10.1371/journal.pone.0211501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695072	gold, Green Published, Green Submitted			2022-12-27	WOS:000457046400039
J	Turney, PD; Mohammad, SM				Turney, Peter D.; Mohammad, Saif M.			The natural selection of words: Finding the features of fitness	PLOS ONE			English	Article							EVOLUTION; LANGUAGE; CULTURE	We introduce a dataset for studying the evolution of words, constructed from WordNet and the Google Books Ngram Corpus. The dataset tracks the evolution of 4,000 synonym sets (synsets), containing 9,000 English words, from 1800 AD to 2000 AD. We present a supervised learning algorithm that is able to predict the future leader of a synset: the word in the synset that will have the highest frequency. The algorithm uses features based on a word's length, the characters in the word, and the historical frequencies of the word. It can predict change of leadership (including the identity of the new leader) fifty years in the future, with an F-score considerably above random guessing. Analysis of the learned models provides insight into the causes of change in the leader of a synset. The algorithm confirms observations linguists have made, such as the trend to replace the -ise suffix with -ize, the rivalry between the -ity and -ness suffixes, and the struggle between economy (shorter words are easier to remember and to write) and clarity (longer words are more distinctive and less likely to be confused with one another). The results indicate that integration of the Google Books Ngram Corpus with WordNet has significant potential for improving our understanding of how language evolves.	[Turney, Peter D.] Ronin Inst, Montclair, NJ 07042 USA; [Mohammad, Saif M.] Natl Res Council Canada, Ottawa, ON, Canada	National Research Council Canada	Turney, PD (corresponding author), Ronin Inst, Montclair, NJ 07042 USA.; Mohammad, SM (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	peter.turney@ronininstitute.org; saif.mohammad@nrc-cnrc.gc.ca	Turney, Peter/AAI-8278-2021	Turney, Peter/0000-0003-0909-4085				Amato R, 2018, P NATL ACAD SCI USA, V115, P8260, DOI 10.1073/pnas.1721059115; Arndt-Lappe S, 2014, ENGL LANG LINGUIST, V18, P497, DOI 10.1017/S136067431400015X; Bolinger Dwight, 1953, AM SCHOLAR, V22, P323; Bowers N, 2016, LINGUA EN SYLLABLE; BRANDON R, 1996, CONCEPTS METHODS EVO; Cuskley CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102882; Darwin C., 1877, ORIGIN SPECIES; Darwin C., 1871, DESCENT MAN SELECTIO; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Ghanbarnejad F, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.1044; Godfrey-Smith P, 2007, J PHILOS, V104, P489, DOI 10.5840/jphil2007104103; Gray Russell D., 2007, Biological Theory, V2, P360, DOI 10.1162/biot.2007.2.4.360; Habash N, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P96; Hawker T, 2006, P 2006 AUSTR LANG TE, P11; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Lewis D. D., 1995, SIGIR Forum, P246; Magnus M, 2001, WHATS WORD STUDIES P; Mesoudi A, 2011, CULTURAL EVOLUTION; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mihalcea R., 2012, P 50 ANN M ASS COMP, V2, P259; Mitra S, 2015, NAT LANG ENG, V21, P773, DOI 10.1017/S135132491500011X; Newberry MG, 2017, NATURE, V551, P223, DOI 10.1038/nature24455; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Pechenick EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137041; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Skousen R., 1992, ANALOGY STRUCTURE; Turney P, 2019, NATURAL SELECTION WO; van Wyhe J, 2005, ENDEAVOUR, V29, P94, DOI 10.1016/j.endeavour.2005.07.002; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Vossen P., 1997, P DELOS WORKSH CROSS; Vossen P., 2001, EUROWORDNET BUILDING; Witten IH, 2011, MOR KAUF D, P1; Xu Y, 2015, P 37 ANN M COGN SCI, V2703-2708	37	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211512	10.1371/journal.pone.0211512	http://dx.doi.org/10.1371/journal.pone.0211512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689665	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800037
J	Bui, JK; Cyktor, JC; Fyne, E; Campellone, S; Mason, SW; Mellors, JW				Bui, John K.; Cyktor, Joshua C.; Fyne, Elizabeth; Campellone, Shalyn; Mason, Stephen W.; Mellors, John W.			Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4(+) T cells of individuals on suppressive ART	PLOS ONE			English	Article							ANTI-PD-L1 ANTIBODY; IMMUNE ACTIVATION; IN-VIVO; PHASE-I; NIVOLUMAB; EXHAUSTION; RESERVOIR; IPILIMUMAB; SAFETY; PERSISTENCE	Blockade of the programmed cell death protein/ligand 1 (PD-1/PD-L1) pathway with monoclonal antibodies (mAb) is now commonly used for cancer immunotherapy and has therapeutic potential in chronic viral infections including HIV-1. PD-1/PD-L1 blockade could augment HIV-1-specific immune responses and reverse HIV-1 latency, but the latter effect has not been clearly shown. We tested the ability of the human anti-PD-L1 mAb BMS-936559 and the human anti-PD-1 mAb nivolumab to increase HIV-1 virion production ex vivo from different peripheral blood mononuclear cell populations obtained from donors on suppressive antiretroviral therapy (ART). Fresh peripheral blood mononuclear cells (PBMC), CD8-depleted PBMC, total CD4(+) T cells, and resting CD4(+) T cells were purified from whole blood of HIV-1-infected donors and cultured in varying concentrations of BMS-936559 (20, 5, or 1.25 mu g/mL) or nivolumab (5 or 1.25 mu g/mL), with or without anti-CD3/CD28 stimulatory antibodies. Culture supernatants were assayed for virion HIV-1 RNA by qRT-PCR. Ex vivo exposure to BMS-936559 or nivolumab, with or without anti-CD3/CD28 stimulation, did not consistently increase HIV-1 virion production from blood mononuclear cell populations. Modest (2-fold) increases in virus production were observed in a subset of donors and in some cell types but were not reproducible in longitudinal samples. Cell surface expression of PD-1 and PD-L1 were not associated with changes in virus production. Ex vivo blockade of the PD-1 axis alone has limited effects on HIV-1 latency.	[Bui, John K.; Cyktor, Joshua C.; Fyne, Elizabeth; Mellors, John W.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Bui, John K.] Howard Hughes Med Inst, Howard Hughes Med Res Fellows Program, Bethesda, MD 20817 USA; [Campellone, Shalyn; Mason, Stephen W.] Bristol Myers Squibb, Discovery Virol, Wallingford, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; Bristol-Myers Squibb	Mellors, JW (corresponding author), Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	jwm1@pitt.edu		Mason, Stephen/0000-0002-6662-9624	Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program; Bristol-Myers Squibb (BMS) Company	Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program; Bristol-Myers Squibb (BMS) Company	Bristol-Myers Squibb (BMS) Company provided support for the salaries of authors SC and SWM, and funding for some of the experimental work performed at the University of Pittsburgh. BMS also provided proprietary anti-PD-L1 and anti-PD-1 monoclonal antibodies at no cost. SC provided technical assistance in performing some flow of the data from cytometric assays of PD-1 and PDL1 expression that are included in the paper. Other flow cytometric assays of PD-1 and PD-L1 expression were performed by authors JB and JC from the University of Pittsburgh. Author EF from the University of Pittsburgh provided technical expertise in designing and conducting experiments and reviewed the manuscript. SWM provided input in the design of some of the experiments but did not generate data or analyze it. He reviewed and provided some edits of the manuscript and approved it for submission. Additional funding was provided from the Howard Hughes Medical Institute (HHMI) Medical Research Fellows Program to John K Bui.	Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Bui JK, 2015, AIDS, V29, P1911, DOI 10.1097/QAD.0000000000000788; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Chew GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005349; Chomont N., 2013, INT WORKSH HIV HEP V; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cillo AR, 2018, AIDS, V32, P699, DOI [10.1097/QAD.0000000000001748, 10.1097/qad.0000000000001748]; Cillo AR, 2014, J CLIN MICROBIOL, V52, P3944, DOI 10.1128/JCM.02060-14; DAFONSECA S, 2010, J INT AIDS SOC, V13, pO15; Davar D, 2015, CASE REP ONCOL MED, V2015, DOI 10.1155/2015/737389; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Eron J. J., 2016, C RETR OPP INF CROI; Finnefrock AC, 2009, J IMMUNOL, V182, P980, DOI 10.4049/jimmunol.182.2.980; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Gay CL, 2017, J INFECT DIS, V215, P1725, DOI 10.1093/infdis/jix191; Grabmeier-Pfistershammer K, 2017, CLIN IMMUNOL, V183, P167, DOI 10.1016/j.clim.2017.09.002; Guihot A, 2018, ANN ONCOL, V29, P517, DOI 10.1093/annonc/mdx696; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Heppt MV, 2017, ANN ONCOL, V28, P3104, DOI 10.1093/annonc/mdx538; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Hong FY, 2016, J CLIN MICROBIOL, V54, P902, DOI 10.1128/JCM.02904-15; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hurst J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9495; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le Garff G, 2017, AIDS, V31, P1048, DOI 10.1097/QAD.0000000000001429; Mason S, 2013, 6 HIV PERS WORKSH SE; Morris VK, 2017, LANCET ONCOL, V18, P446, DOI 10.1016/S1470-2045(17)30104-3; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Pallikkuth S, 2016, J VIROL, V90, P2718, DOI 10.1128/JVI.02883-15; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sachdeva M, 2010, JAIDS-J ACQ IMM DEF, V54, P447, DOI 10.1097/QAI.0b013e3181e0c7d0; Samri A, IMMUNOVIROLOGICAL EV; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Tomsitz D, 2018, J EUR ACAD DERMATOL, V32, pE26, DOI 10.1111/jdv.14450; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yamamoto N, 2017, INVEST NEW DRUG, V35, P207, DOI 10.1007/s10637-016-0411-2; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826	65	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211112	10.1371/journal.pone.0211112	http://dx.doi.org/10.1371/journal.pone.0211112			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682108	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500103
J	Conroy, GC; Shimizu-Kimura, Y; Lamont, RW; Ogbourne, SM				Conroy, Gabriel C.; Shimizu-Kimura, Yoko; Lamont, Robert W.; Ogbourne, Steven M.			A multidisciplinary approach to inform assisted migration of the restricted rainforest tree, Fontainea rostrata	PLOS ONE			English	Article							TRIUNIA-ROBUSTA PROTEACEAE; CLIMATE-CHANGE; SPECIES DISTRIBUTION; GENETIC DIVERSITY; COMPUTER-PROGRAM; POPULATION-STRUCTURE; HUMID TROPICS; CONSERVATION; RARE; BIODIVERSITY	Assisted migration can aid in the conservation of narrowly endemic species affected by habitat loss, fragmentation and climate change. Here, we employ a multidisciplinary approach by examining the population genetic structure of a threatened, dioecious rainforest tree of the subtropical notophyll vine forests of eastern Australia, Fontainea rostrata, and its potential requirements for population enhancement and translocation to withstand the effects of anthropogenic fragmentation and climate change. We used microsatellite markers to gain an understanding of the way genetic diversity is partitioned within and among the nine extant populations of F. rostrata identified in this study. We combined the results with species distribution modelling to identify populations vulnerable to possible future range shifts based on climate change projections. We found regional differences between the species' main distribution in the south and a disjunct northern population cluster (F-RT = 0.074, F-SR = 0.088, F-ST = 0.155), in mean allelic richness (A(R) = 2.77 vs 2.33, p < 0.05), expected heterozygosity (H-E = 0.376 vs 0.328), and inbreeding (F = 0.116 vs 0.219). Species distribution models predicted that while southern populations of F. rostrata are likely to persist for the next 50 years under the RCP6.0 climate change scenario, with potential for a small-scale expansion to the south-east, the more highly inbred and less genetically diverse northern populations will come under increasing pressure to expand southwards as habitat suitability declines. Given the species' genetic structure and with the aim to enhance genetic diversity and maximise the likelihood of reproductive success, we recommend that plant reintroductions to supplement existing populations should be prioritised over translocation of the species to new sites. However, future conservation efforts should be directed at translocation to establish new sites to increase population connectivity, focussing particularly on habitat areas identified as persisting under conditions of climate change.	[Conroy, Gabriel C.; Shimizu-Kimura, Yoko; Lamont, Robert W.; Ogbourne, Steven M.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia	University of the Sunshine Coast	Conroy, GC (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia.	gconroy@usc.edu.au		Ogbourne, Steven/0000-0001-9812-4367	Burnett-Mary Regional Group; University of the Sunshine Coast	Burnett-Mary Regional Group; University of the Sunshine Coast	The authors wish to thank the Burnett-Mary Regional Group and the University of the Sunshine Coast for financial support.	Agostini C, 2013, MOL ECOL RESOUR, V13, P966, DOI 10.1111/1755-0998.12140; Tiscar PA, 2018, FOREST ECOL MANAG, V409, P719, DOI 10.1016/j.foreco.2017.12.014; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bonebrake TC, 2014, CONSERV BIOL, V28, P1057, DOI 10.1111/cobi.12253; Broadhurst L, 2017, DIVERS DISTRIB, V23, P41, DOI 10.1111/ddi.12505; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Byrne M, 1996, AUST J BOT, V44, P331, DOI 10.1071/BT9960331; CLIMsystems Ltd, 2013, SIMCLIM 2013 DAT MAN; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Costion CM, 2015, BIOL CONSERV, V191, P322, DOI 10.1016/j.biocon.2015.07.022; Department of Natural Resources and Mines, 2007, MET DRAIN 25K QUEENS; Department of Natural Resources and Mines, 2011, MET DET SOL GEOL QUE; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finger A, 2011, MOL ECOL, V20, P3773, DOI 10.1111/j.1365-294X.2011.05228.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Forster Paul I., 1997, Austrobaileya, V5, P29; Forster PI, CENSUS QUEENSLAND FL; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Frankham R., 2002, INTRO CONSERVATION G; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2013, TRENDS ECOL EVOL, V28, P187, DOI 10.1016/j.tree.2013.01.002; Gitzendanner MA, 2000, AM J BOT, V87, P783, DOI 10.2307/2656886; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Grant EL, 2017, IND CROP PROD, V108, P416, DOI 10.1016/j.indcrop.2017.07.013; Halbur MM, 2014, CONSERV GENET, V15, P679, DOI 10.1007/s10592-014-0569-0; Harden G.J., 2006, RAINFOREST TREES SHR; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Hulce D, 2011, J BIOMOL TECH, V22, pS35, DOI DOI 10.1111/J.1556-4029.2010.01565.X; IPCC, 2013, CLIMATE CHANGE 2022; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones TH, 2007, MOL ECOL, V16, P697, DOI 10.1111/j.1365-294X.2006.03180.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karron JD, 1987, EVOL ECOL, V1, P47, DOI 10.1007/BF02067268; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Kramer AT, 2009, TRENDS PLANT SCI, V14, P599, DOI 10.1016/j.tplants.2009.08.005; Lamont RW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0743-2; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu J, 2014, GENET MOL RES, V13, P4579, DOI 10.4238/2014.June.17.10; Louys J, 2014, ECOL EVOL, V4, P4380, DOI 10.1002/ece3.1287; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maggini R., 2013, PROTECTING RESTORING; MANTEL N, 1967, CANCER RES, V27, P209; Martins E, 2015, CONSERV GENET, V16, P1, DOI 10.1007/s10592-014-0635-7; McKenzie N., 2000, CSIRO LAND WATER TEC, V11, P1; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Memmott J, 2007, ECOL LETT, V10, P1; Monks L, 2012, PLANT REINTRODUCTION; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; NEI M, 1974, GENETICS, V76, P379; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; O'Connor K, 2015, BIOL CONSERV, V191, P504, DOI 10.1016/j.biocon.2015.08.001; Ouborg NJ, 2006, J ECOL, V94, P1233, DOI 10.1111/j.1365-2745.2006.01167.x; Park A, 2018, CLIMATIC CHANGE, P1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Possley J, 2009, RESTOR ECOL, V17, P668, DOI 10.1111/j.1526-100X.2008.00395.x; Powell M, 2005, BIOL CONSERV, V123, P165, DOI 10.1016/j.biocon.2004.11.004; Pritchard JK, 2000, GENETICS, V155, P945; Queensland Herbarium, 2013, SURV MAPP 2011 VEG C; Ren H, 2010, PLANT SPEC BIOL, V25, P43, DOI 10.1111/j.1442-1984.2009.00261.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetto M, 2005, J ECOL, V93, P906, DOI 10.1111/j.1365-2745.2005.01046.x; Rossetto M, 2015, P R SOC B; Rossetto M, 2008, AM J BOT, V95, P321, DOI 10.3732/ajb.95.3.321; Rossetto M, 2015, J BIOGEOGR, V42, P2172, DOI 10.1111/jbi.12571; Shimizu-Kimura Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46399; Shoo LP, 2014, REG ENVIRON CHANGE, V14, P435, DOI 10.1007/s10113-012-0385-3; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Webb L. J., 1994, AUSTR VEGETATION, P87; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	90	7	7	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210560	10.1371/journal.pone.0210560	http://dx.doi.org/10.1371/journal.pone.0210560			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682049	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500046
J	Feng, HJ; Larrivee, CL; Demireva, EY; Xie, HR; Leipprandt, JR; Neubig, RR				Feng, Huijie; Larrivee, Casandra L.; Demireva, Elena Y.; Xie, Huirong; Leipprandt, Jeff R.; Neubig, Richard R.			Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes	PLOS ONE			English	Article							DE-NOVO MUTATIONS; G-PROTEINS; EPILEPTIC ENCEPHALOPATHY; PARKINSONS-DISEASE; POINT MUTATION; ALPHA-SUBUNIT; ANIMAL-MODELS; MURINE MODEL; GNAO1; RECEPTOR	Background Infants and children with dominant de novo mutations in GNAO1 exhibit movement disorders, epilepsy, or both. Children with loss-of-function (LOF) mutations exhibit Epileptiform Encephalopathy 17 (EIEE17). Gain-of-function (GOF) mutations or those with normal function are found in patients with Neurodevelopmental Disorder with Involuntary Movements (NEDIM). There is no animal model with a human mutant GNAO1 allele. Objectives Here we develop a mouse model carrying a human GNAO1 mutation (G203R) and determine whether the clinical features of patients with this GNAO1 mutation, which includes both epilepsy and movement disorder, would be evident in the mouse model. Methods A mouse Gnao1 knock-in GOF mutation (G203R) was created by CRISPR/Cas9 methods. The resulting offspring and littermate controls were subjected to a battery of behavioral tests. A previously reported GOF mutant mouse knock-in (Gnao1(+/G184S)), which has not been found in patients, was also studied for comparison. Results Gnao1(+/G203R) mutant mice are viable and gain weight comparably to controls. Homozygotes are non-viable. Grip strength was decreased in both males and females. Male Gnao1(+/G203R) mice were strongly affected in movement assays (RotaRod and DigiGait) while females were not. Male Gnao1(+/G203R) mice also showed enhanced seizure propensity in the pentylenetetrazole kindling test. Mice with a G184S GOF knock-in also showed movement-related behavioral phenotypes but females were more strongly affected than males. Conclusions Gnao(1+/G203R) mice phenocopy children with heterozygous GNAO1G203R mutations, showing both movement disorder and a relatively mild epilepsy pattern. This mouse model should be useful in mechanistic and preclinical studies of GNAO1-related movement disorders.	[Feng, Huijie; Leipprandt, Jeff R.; Neubig, Richard R.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Larrivee, Casandra L.] Michigan State Univ, Coll Vet Med, E Lansing, MI USA; [Demireva, Elena Y.; Xie, Huirong] Michigan State Univ, Transgen & Genome Editing Facil, E Lansing, MI USA	Michigan State University; Michigan State University; Michigan State University	Neubig, RR (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.	rneubig@msu.edu		Leipprandt, Jeffrey/0000-0002-1721-0472; Feng, Huijie/0000-0002-1835-6190; Neubig, Richard/0000-0003-0501-0008	Bow Foundation; American Epilepsy Society Predoctoral Fellowship [508430]; Michigan State University MSU-CTSI Seed Grant	Bow Foundation; American Epilepsy Society Predoctoral Fellowship; Michigan State University MSU-CTSI Seed Grant	This work was supported by funding from The Bow Foundation and Michigan State University MSU-CTSI Seed Grant. Huijie Feng was supported by the American Epilepsy Society Predoctoral Fellowship (508430).	Ananth AL, 2016, PEDIATR NEUROL, V59, P81, DOI 10.1016/j.pediatrneurol.2016.02.018; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Arya R, 2017, EPILEPTIC DISORD, V19, P67, DOI 10.1684/epd.2017.0888; Bromberg KD, 2008, FRONT BIOSCI-LANDMRK, V13, P4544, DOI 10.2741/3022; Bruun TUJ, 2018, GENET MED, V20, P486, DOI 10.1038/gim.2017.129; Danti FR, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000143; Deacon RM, 2013, J VIS EXP; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dietel T., 2016, NEUROPEDIATRICS, V47, P1, DOI DOI 10.1055/S-0035-1571260; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feng H, 2018, NEUROBIOL DIS; Feng HJ, 2017, NEUROLOGY, V89, P762, DOI 10.1212/WNL.0000000000004262; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; Fu Y, 2004, METHOD ENZYMOL, V389, P229; Gawlinski P, 2016, PEDIATR NEUROL, V60, P83, DOI 10.1016/j.pediatrneurol.2016.03.011; Gazi L, 2003, BRIT J PHARMACOL, V138, P775, DOI 10.1038/sj.bjp.0705116; Gillies GE, 2004, PHARMACOL BIOCHEM BE, V78, P513, DOI 10.1016/j.pbb.2004.04.022; Goldenstein BL, 2009, MOL PHARMACOL, V75, P1222, DOI 10.1124/mol.108.054296; Grecksch G, 2004, N-S ARCH PHARMACOL, V369, P287, DOI 10.1007/s00210-004-0870-4; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hansen ST, 2013, PHARMACOL BIOCHEM BE, V103, P582, DOI 10.1016/j.pbb.2012.10.010; Hirata H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147887; Honey CM, 2018, J CHILD NEUROL, V33, P413, DOI 10.1177/0883073818756134; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iyer V, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007503; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; Kehrl JM, 2014, MAMM GENOME, V25, P202, DOI 10.1007/s00335-014-9509-z; Kompoliti K, 1999, CLIN NEUROPHARMACOL, V22, P318; Kulkarni N, 2016, J CHILD NEUROL, V31, P211, DOI 10.1177/0883073815587945; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Law CY, 2015, CLIN CHIM ACTA, V451, P292, DOI 10.1016/j.cca.2015.10.011; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lorenzen A, 1998, BIOCHEM PHARMACOL, V56, P1287, DOI 10.1016/S0006-2952(98)00207-X; Madalan A, 2012, LEARN MEMORY, V19, P26, DOI 10.1101/lm.024802.111; Marce-Grau A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0416-0; Menke LA, 2016, J CHILD NEUROL, V31, P1598, DOI 10.1177/0883073816666474; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Oleas J, 2013, MOVEMENT DISORD, V28, P990, DOI 10.1002/mds.25583; Parr T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15249-0; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Saitsu H, 2016, EUR J HUM GENET, V24, P129, DOI 10.1038/ejhg.2015.92; Schorling DC, 2017, NEUROPEDIATRICS, V48, P371, DOI 10.1055/s-0037-1603977; Schorling DC, 2017, NEUROPEDIATRICS; Schutsky K, 2011, LEARN MEMORY, V18, P598, DOI 10.1101/lm.2302811; Smith KM, 2014, EXP NEUROL, V259, P44, DOI 10.1016/j.expneurol.2014.03.010; Solis Gonzalo P, 2018, Oncotarget, V9, P23846, DOI 10.18632/oncotarget.22067; Song CH, 2012, NEUROBIOL DIS, V48, P66, DOI 10.1016/j.nbd.2012.05.009; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; Stroobants S, 2013, BEHAV BRAIN RES, V241, P32, DOI 10.1016/j.bbr.2012.11.034; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; TIAN WN, 1994, MOL PHARMACOL, V45, P524; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Waak M, 2018, J NEUROL NEUROSUR PS, V89, P220, DOI 10.1136/jnnp-2017-315653; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Wilson BK, 2013, MOVEMENT DISORD, V28, P982, DOI 10.1002/mds.25526; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Xiong Juan, 2018, Zhongguo Dang Dai Er Ke Za Zhi, V20, P154; Yilmaz S, 2016, CHILD NERV SYST, V32, P1567, DOI 10.1007/s00381-016-3139-6; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	64	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211066	10.1371/journal.pone.0211066	http://dx.doi.org/10.1371/journal.pone.0211066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682176	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500096
J	Ibrahim, N; Honein-AbouHaidar, G; Jomaa, L				Ibrahim, Nadiya; Honein-AbouHaidar, Gladys; Jomaa, Lamis			Perceived impact of community kitchens on the food security of Syrian refugees and kitchen workers in Lebanon: Qualitative evidence in a displacement context	PLOS ONE			English	Article							COLLECTIVE KITCHENS; HEALTH-PROMOTION; CANADA; INCOME; PERU	Community kitchens (CKs) have been recommended as public health strategies with social and nutritional health benefits for low-income participants and their families in different settings. The benefit of CKs in improving the food security status of participants in the context of conflict and displacement is less conclusive. This study aimed to qualitatively explore the impact of CKs on the food security status of community kitchen workers (CWs) and Syrian refugee (SR) families in Lebanon. An exploratory qualitative descriptive approach was adopted. Focus group discussions were conducted with 15 CWs and 49 SRs, and transcripts were analyzed thematically. Emerging themes included: motivation to join the CKs (CWs only), perception towards CKs, impact of these CKs, and their sustainability (both groups). Motivating factors for CWs included financial, internal and societal drivers, and the favorable type of work in kitchens. The perception towards CKs was overall positive among CWs and SR beneficiaries. Both groups reported the positive impact of CKs on their food security and financial status, which in turn affected positively their psychological health. At the social level, CWs indicated that the kitchen's friendly atmosphere increased social cohesion and companionship between Syrians and Lebanese within the kitchen. In addition, CWs reported increased sense of empathy towards SRs benefiting from the CK services. According to study participants, the positive impact of the CKs was almost completely reversed when their operation and services were interrupted for two months. Both CWs and SRs identified facilitators and barriers that can affect the sustainability of the kitchens, including financial and entrepreneurial skills. In conclusion, findings from this study highlight that CKs can be promising programs to improve the food security and livelihoods of participants, while also increasing social cohesion and integration of refugees within host communities in protracted crisis contexts.	[Ibrahim, Nadiya] Amer Univ Beirut, Fac Agr & Food Sci, Rural & Community Dev Program, Beirut, Lebanon; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Rafic Hariri Sch Nursing, Beirut, Lebanon; [Honein-AbouHaidar, Gladys; Jomaa, Lamis] Amer Univ Beirut, Global Hlth Inst, Refugee Hlth Program, Beirut, Lebanon; [Jomaa, Lamis] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Jomaa, L (corresponding author), Amer Univ Beirut, Global Hlth Inst, Refugee Hlth Program, Beirut, Lebanon.; Jomaa, L (corresponding author), Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.	lj18@aub.edu.lb	Honein-AbouHaidar, Gladys N./M-4308-2013	Honein-AbouHaidar, Gladys N./0000-0001-6208-7859; Jomaa, Lamis/0000-0002-3046-4581	University Research Board at the American University of Beirut, Lebanon	University Research Board at the American University of Beirut, Lebanon	This project was funded by the University Research Board at the American University of Beirut, Lebanon. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Mourad TA, 2004, PUBLIC HEALTH, V118, P131, DOI 10.1016/j.puhe.2003.09.002; [Anonymous], 2018, SYR REG REF RESP; Bhattacharyya J., 2004, J COMMUNITY DEV SOC, V34, P5, DOI DOI 10.1080/15575330409490110; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Cherri Z, 2016, RISK MANAG HEALTHC P, V9, P165, DOI 10.2147/RMHP.S106068; Colorafi KJ, 2016, HERD-HEALTH ENV RES, V9, P16, DOI 10.1177/1937586715614171; Crawford S, 1997, CAN J DIET PRACT RES; El Harake MD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070913; Engler-Stringer R, 2005, CAN J DIET PRACT RES, V66, P246, DOI 10.3148/66.4.2005.246; Engler-Stringer R, 2007, QUAL HEALTH RES, V17, P75, DOI 10.1177/1049732306296451; Engler-Stringer R, 2006, CAN J DIET PRACT RES, V67, P178, DOI 10.3148/67.4.2006.178; Fano TJ, 2004, CAN J DIET PRACT RES, V65, P72, DOI 10.3148/65.2.2004.72; Freedman DA, 2013, J COMMUNITY PRACT, V21, P379, DOI 10.1080/10705422.2013.842197; Ghattas H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130724; Iacovou M, 2013, PUBLIC HEALTH NUTR, V16, P535, DOI 10.1017/S1368980012002753; Immink MDC, 2001, ECOL FOOD NUTR, V40, P699, DOI 10.1080/03670244.2001.9991678; International Orthodox Christian Charities (IOCC), COMM KITCH ADDR MALN; Johnson L, 2006, GENDER PLACE CULT, V13, P647, DOI 10.1080/09663690601019802; Kukrety N, 2018, POVERTY INEQUALITY S; Lee JH, 2010, HEALTH PROMOT J AUST, V21, P183; Linkogle S., 1998, B LAT AM RES, V17, P93; Marquis S, 2001, CAN J DIET PRACT RES, V62, P130; Maxwell D, 2012, P NATL ACAD SCI USA, V109, P12321, DOI 10.1073/pnas.0913215108; Mundel E, 2010, HEALTH PROMOT INT, V25, P166, DOI 10.1093/heapro/daq016; REACH. Lebanese Communities Hosting Syrain Refugees, 2018, LEB COMM HOST SYR RE; Schroeder K, 2006, GENDER PLACE CULT, V13, P663, DOI 10.1080/09663690601019844; Spence F, 2005, INT J HEALTH PROMOT, V43, P59, DOI 10.1080/14635240.2005.10708040; Tarasuk V, 1999, CAN J DIET PRACT RES, V60, P11; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tufford L, 2012, QUAL SOC WORK, V11, P80, DOI 10.1177/1473325010368316; UNHCR & Government of Lebanon, 2018, LEB CRIS RESP PLAN 2; United Nations High Commissioner for Refugees (UNHCR), 2017, REG REF RES PLAN 201; World Food Programme (WFP), 2018, VASYR 2017 VULN ASS	33	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210814	10.1371/journal.pone.0210814	http://dx.doi.org/10.1371/journal.pone.0210814			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682079	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500064
J	Kim, HJ; Park, JY; Lee, TS; Song, IH; Cho, YL; Chae, JR; Kang, H; Lim, JH; Lee, JH; Kang, WJ				Kim, Hyun Jeong; Park, Jun Young; Lee, Tae Sup; Song, In Ho; Cho, Ye Lim; Chae, Ju Ri; Kang, Hyungu; Lim, Jong Hoon; Lee, Jung Hwan; Kang, Won Jun			PET imaging of HER2 expression with an F-18-fluoride labeled aptamer	PLOS ONE			English	Article							N-SUCCINIMIDYL; SYSTEMATIC EVOLUTION; BREAST-CANCER; RNA MOLECULES; DNA APTAMERS; TENASCIN-C; CELL; BIND; DISCOVERY; SELECTION	Background/Purpose Aptamers are oligonucleotide or peptide molecules that bind to a target molecule with high affinity and specificity. The present study aimed to evaluate the target specificity and applicability for in vivo molecular imaging of an aptamer labeled with a radioisotope. Methods The human epidermal growth factor receptor 2 (HER2/ErbB2) aptamer was radiolabeled with F-18-fluoride. HER2-positive tumor cell uptake of the aptamer was evaluated in comparison to negative controls by flow cytometry and confocal microscopy. Using F-18-labeled HER2-specific aptamer positron emission tomography (PET), in vivo molecular images of BT474 tumor-bearing mice were taken at 60, 90 and 120 minutes after injection. Results In flow cytometric analysis, HER2 aptamer showed strong binding to HER2-positive BT474 cells, while binding to HER2-negative MDA-MB231 cells was quite low. Likewise, in confocal microscopic images, the aptamer was bound to HER2-positive breast cancer cells, with minimal binding to HER2-negative cells. In vivo PET molecular imaging of BT474 tumor-bearing mice revealed significant higher uptake of the F-18-labeled HER2 specific aptamer into the tumor compared to the that of HER2-negative cell tumor(p = 0.033). HER2 aptamer was able to preferentially bind to HER2-positive breast cancer cells both in vitro and in vivo, by recognizing HER2 structure on the surface of these cells. Conclusion The F-18-labeled aptamer enabled appropriate visualization of HER2 expression by human breast cancer cells. The results suggest that a radiolabeled HER2 aptamer could potentially	[Kim, Hyun Jeong] Yonsei Univ, Gangnam Severance Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea; [Park, Jun Young; Cho, Ye Lim; Chae, Ju Ri; Kang, Won Jun] Yonsei Univ, Coll Med, Severance Hosp, Dept Nucl Med, Seoul, South Korea; [Lee, Tae Sup; Song, In Ho] Korea Inst Radiol & Med Sci, Res Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Kang, Hyungu] Bundang CHA Med Ctr, R&D Strateg Planning, Seongnam, Gyeonggi Do, South Korea; [Lim, Jong Hoon; Lee, Jung Hwan] INTEROligo Corp, Ulwang Si, Gyeonggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Institute of Radiological & Medical Sciences	Kang, WJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Nucl Med, Seoul, South Korea.	MDKWJ@yuhs.ac		kim, hyunjeong/0000-0002-3116-8848; Lee, Tae Sup/0000-0002-8266-7380; Kang, Won Jun/0000-0002-2107-8160; Park, Jun Young/0000-0003-3403-2767	Ministry of Health and Welfare of Republic of Korea [HI17C1491]; Yonsei University College of Medicine [6-2016-0102]; National Research Foundation - Korea government (MSIT) [2018R1A2B6004651]	Ministry of Health and Welfare of Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Yonsei University College of Medicine(General Electric); National Research Foundation - Korea government (MSIT)	This study was funded by Ministry of Health and Welfare of Republic of Korea (HI17C1491), Yonsei University College of Medicine (6-2016-0102), and National Research Foundation funded by Korea government (MSIT) (2018R1A2B6004651). INTEROLOGP Coporation provided support in the form of salaries for JH Lim and JH Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dassie JP, 2014, MOL THER, V22, P1910, DOI 10.1038/mt.2014.117; Dastjerdi K, 2011, BIOTECHNOL APPL BIOC, V58, P226, DOI 10.1002/bab.36; Dausse E, 2009, CURR OPIN PHARMACOL, V9, P602, DOI 10.1016/j.coph.2009.07.006; Doggrell SA, 2005, EXPERT OPIN PHARMACO, V6, P1421, DOI 10.1517/14656566.6.8.1421; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Flagothier J, 2012, APPL RADIAT ISOTOPES, V70, P1549, DOI 10.1016/j.apradiso.2012.04.022; Hicke BJ, 2006, J NUCL MED, V47, P668; Hu H, 2013, NANOSCALE, V5, P10447, DOI 10.1039/c3nr03490a; Jacobson O, 2015, J NUCL MED, V56, P616, DOI 10.2967/jnumed.114.149484; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; James W, 2007, J GEN VIROL, V88, P351, DOI 10.1099/vir.0.82442-0; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Lim EK, 2014, J BIOMED MATER RES A, V102, P49, DOI 10.1002/jbm.a.34678; Liu Z, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-148; Lupold SE, 2002, CANCER RES, V62, P4029; Mahlknecht G, 2015, METHODS MOL BIOL, V1317, P3, DOI 10.1007/978-1-4939-2727-2_1; Mahlknecht G, 2013, P NATL ACAD SCI USA, V110, P8170, DOI 10.1073/pnas.1302594110; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Moosavian SA, 2015, IRAN J BASIC MED SCI, V18, P576; Pala K, 2014, INT J NANOMED, V9, P67, DOI 10.2147/IJN.S52539; Ramenda T, 2013, AMINO ACIDS, V44, P1167, DOI 10.1007/s00726-012-1450-4; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Scott PJH, 2010, J LABELLED COMPD RAD, V53, P586, DOI 10.1002/jlcr.1785; Spiridonova VA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P706, DOI 10.1023/A:1016110724564; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sun HG, 2015, MOLECULES, V20, P11959, DOI 10.3390/molecules200711959; Sun HG, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.32; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Tang G, 2008, J LABELLED COMPD RAD, V51, P68, DOI 10.1002/jlcr.1481; Tang GH, 2010, J LABELLED COMPD RAD, V53, P543, DOI 10.1002/jlcr.1758; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Varmira K, 2014, J DRUG TARGET, V22, P116, DOI 10.3109/1061186X.2013.839688; Xu WJ, 2013, BIOMATERIALS, V34, P5244, DOI 10.1016/j.biomaterials.2013.03.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	23	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211047	10.1371/journal.pone.0211047	http://dx.doi.org/10.1371/journal.pone.0211047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682091	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500093
J	Sannelli, C; Vidaurre, C; Muller, KR; Blankertz, B				Sannelli, Claudia; Vidaurre, Carmen; Mueller, Klaus-Robert; Blankertz, Benjamin			A large scale screening study with a SMR-based BCI: Categorization of BCI users and differences in their SMR activity	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SPATIAL FILTERS; DIFFERENT REFERENCES; MU-RHYTHMS; EEG; PERFORMANCE; CLASSIFICATION; MOVEMENT; IMAGERY; DESYNCHRONIZATION	Brain-Computer Interfaces (BCIs) are inefficient for a non-negligible part of the population, estimated around 25%. To understand this phenomenon in Sensorimotor Rhythm (SMR) based BCIs, data from a large-scale screening study conducted on 80 novice participants with the Berlin BCI system and its standard machine-learning approach were investigated. Each participant performed one BCI session with resting state Encephalography, Motor Observation, Motor Execution and Motor Imagery recordings and 128 electrodes. A significant portion of the participants (40%) could not achieve BCI control (feedback performance > 70%). Based on the performance of the calibration and feedback runs, BCI users were stratified in three groups. Analyses directed to detect and elucidate the differences in the SMR activity of these groups were performed. Statistics on reactive frequencies, task prevalence and classification results are reported. Based on their SMR activity, also a systematic list of potential reasons leading to performance drops and thus hints for possible improvements of BCI experimental design are given. The categorization of BCI users has several advantages, allowing researchers 1) to select subjects for further analyses as well as for testing new BCI paradigms or algorithms, 2) to adopt a better subject-dependent training strategy and 3) easier comparisons between different studies.	[Sannelli, Claudia; Blankertz, Benjamin] Tech Univ Berlin, Dept Neurotechnol, Berlin, Germany; [Vidaurre, Carmen; Mueller, Klaus-Robert] Tech Univ Berlin, Dept Machine Learning, Berlin, Germany; [Vidaurre, Carmen] Univ Publ Navarra, Dept Math, Pamplona, Spain; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Saarbrucken, Germany	Technical University of Berlin; Technical University of Berlin; Universidad Publica de Navarra; Korea University; Max Planck Society	Blankertz, B (corresponding author), Tech Univ Berlin, Dept Neurotechnol, Berlin, Germany.; Muller, KR (corresponding author), Tech Univ Berlin, Dept Machine Learning, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	klaus-robert.mueller@tu-berlin.de; benjamin.blankertz@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Blankertz, Benjamin/0000-0002-2437-4846; Vidaurre, Carmen/0000-0003-3740-049X	German Ministry for Education and Research (BMBF) [01IS14013A-E, 01GQ1115, 01GQ0850]; Deutsche Forschungsgesellschaft (DFG) [MU 987/19-1, MU987/14-1]; DFG [MU 987/3-2]; Brain Korea 21 Plus Program; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]; Spanish Ministry of Economy [RYC-2014-15671]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Brain Korea 21 Plus Program; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); Spanish Ministry of Economy(Spanish Government)	This work was supported by German Ministry for Education and Research (BMBF) under Grants 01IS14013A-E, 01GQ1115 and 01GQ0850; Deutsche Forschungsgesellschaft (DFG) under Grant MU 987/19-1, MU987/14-1 and DFG MU 987/3-2; Brain Korea 21 Plus Program and by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451); and Spanish Ministry of Economy RYC-2014-15671.	Acqualagna L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148886; Ahn M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00848; Ahn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080886; Allison B, 2010, IEEE T NEUR SYS REH, V18, P107, DOI 10.1109/TNSRE.2009.2039495; Ang KK, 2011, CLIN EEG NEUROSCI, V42, P253, DOI 10.1177/155005941104200411; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Birbaumer N, 2009, INT REV NEUROBIOL, V86, P107, DOI 10.1016/S0074-7742(09)86008-X; Blankertz B., 2008, ADV NEURAL INFORM PR, V20, P113; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00530; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, FRONT COLLECT, P113, DOI 10.1007/978-3-642-02091-9_7; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Botrel L, 2017, INT J PSYCHOPHYSIOL, V121, P29, DOI 10.1016/j.ijpsycho.2017.08.007; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Dornhege G., 2007, BRAIN COMPUTER INTER; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; Grosse-Wentrup M, 2009, IEEE T BIO-MED ENG, V56, P1209, DOI 10.1109/TBME.2008.2009768; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Halder S, 2013, FRONT HUM NEUROSCI, P7; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Holzapfel S, 1998, PRADIKTOREN SELBSTRE; Hu S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00297; Hu S, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa13f; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Jeunet C, 2016, PROG BRAIN RES, V228, P3, DOI 10.1016/bs.pbr.2016.04.002; Jeunet C, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036024; Jeunet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143962; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kai Keng Ang, 2013, Journal of Computing Science and Engineering, V7, P139, DOI 10.5626/JCSE.2013.7.2.139; Kawanabe M, 2014, NEURAL COMPUT, V26, P349, DOI 10.1162/NECO_a_00544; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2006, IEEE T NEUR SYS REH, V14, P131, DOI 10.1109/TNSRE.2006.875585; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Li Y, 2010, IEEE T BIO-MED ENG, V57, P1318, DOI 10.1109/TBME.2009.2039997; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lorenz R, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035007; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; McFarland DJ, 2015, INT J PSYCHOPHYSIOL, V97, P271, DOI 10.1016/j.ijpsycho.2014.07.009; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Mora N, 2017, MED BIOL ENG COMPUT, V55, P1339, DOI 10.1007/s11517-016-1596-4; Muller JS, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa620b; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Myrden A, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00308; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nierhaus T, 2018, IMMEDIATE BRAIN PLAS; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Nijboer F, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00055; Nijholt A, 2008, IEEE INTELL SYST, V23, P72, DOI 10.1109/MIS.2008.41; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pineda JA, 2000, IEEE T REHABIL ENG, V8, P219, DOI 10.1109/86.847822; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Samek W, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa8232; Samek W, 2016, NEUROIMAGE, V141, P291, DOI 10.1016/j.neuroimage.2016.06.056; Samek Wojciech, 2014, IEEE Rev Biomed Eng, V7, P50, DOI 10.1109/RBME.2013.2290621; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Sannelli C, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046003; Sannelli C, 2012, IEEE ENG MED BIO, P4744, DOI 10.1109/EMBC.2012.6347027; Sannelli C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025012; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sugiyama M, 2007, J MACH LEARN RES, V8, P985; Suk HI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087056; Thompson M. C., 2018, SCI ENG ETHICS, P1; Tomioka R, 2010, NEUROIMAGE, V49, P415, DOI 10.1016/j.neuroimage.2009.07.045; Varkuti B, 2011, P 5 INT BCI C, P104; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yao DZ, 2005, PHYSIOL MEAS, V26, P173, DOI 10.1088/0967-3334/26/3/003; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	95	41	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0207351	10.1371/journal.pone.0207351	http://dx.doi.org/10.1371/journal.pone.0207351			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682025	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500009
J	Straatmann, VS; Almquist, YB; Oliveira, AJ; Veiga, GV; Rostila, M; Lopes, CS				Straatmann, Viviane S.; Almquist, Ylva B.; Oliveira, Aldair J.; Veiga, Gloria V.; Rostila, Mikael; Lopes, Claudia S.			Stability and bidirectional relationship between physical activity and sedentary behaviours in Brazilian adolescents: Longitudinal findings from a school cohort study	PLOS ONE			English	Article							CHILDHOOD; TRACKING; TIME; ASSOCIATION; ADULTHOOD; PROGRESS; CHILDREN; TRENDS; YOUTH	Purpose We investigated the stability, correlations and bidirectional relationship of light physical activities (PA), moderate and vigorous PA (MVPA), television viewing (TV) and video game/computer use (VG) in Brazilian adolescents. Methods Adolescent Nutritional Assessment Longitudinal Study-ELANA is a middle school cohort study conducted in Rio de Janeiro-Brazil in 2010-2012. Self-reported data on PA (International Physical Activity Questionnaire-IPAQ) and screen activities were obtained from 810 adolescents (mean ages of 10.9 years old (SD 0.78) for girls; 11 years old (SD 0.85) for boys) to perform autoregressive cross-lagged structural equation models in two time points for PA and three time points for screen activities. Results There was no significant stability of light PA and MVPA for boys and girls. Moderate stability of screen activities were found for both genders, with a significant coefficient of TV for boys (T1-T2:0.29; T2-T3:0.27 p<0.001); and VG for boys (T1-T2:0.33; T2-T3:0.35 p<0.001) and girls (T1-T2:0.26; T2-T3:0.37 p<0.01). Significant lagged effects were obtained only among girls:light PA had effect on VG (-0.10 p<0.01), as well as in the opposite direction of TV on light PA (-0.03 p<0.01) and TV on MVPA (-0.11 p<0.01). Conclusion The light PA, MVPA and screen activities (among girls) did not demonstrate stability over time. A warning scenario was suggested by the stability of high amounts of screen activities among boys over time. Screen activities had bidirectional association with light PA and MVPA among girls over time.	[Straatmann, Viviane S.] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Straatmann, Viviane S.] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Almquist, Ylva B.; Rostila, Mikael] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Oliveira, Aldair J.] UFRRJ, Lab Social Dimens Appl Phys Act & Sport LABSAFE, Seropedica, Brazil; [Veiga, Gloria V.] Fed Univ Rio de Janeiro UFRJ, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Lopes, Claudia S.] State Univ Rio de Janeiro UERJ, Inst Social Med, Rio De Janeiro, Brazil	University of Liverpool; Karolinska Institutet; Stockholm University; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Straatmann, VS (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.; Straatmann, VS (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	v.schultz-straatmann@liv.ac.uk; gveiga@nutricao.ufrj.br	J Oliveira, Aldair/AAE-7422-2022; de Souza Lopes, Claudia/H-9150-2013	J Oliveira, Aldair/0000-0002-2714-0615; de Souza Lopes, Claudia/0000-0002-0401-689X; Straatmann, Viviane/0000-0003-2355-1174	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq) [47667/2011-9]; Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ) [E26/110.626/2011, E-26/110.774/2013, E26/110.847/2009]; Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES) [23038.007702/2011-5]	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ); Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The ELANA was supported by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico- CNPq) (grant 47667/2011-9), the Research Support Foundation of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro- FAPERJ) (grants E26/110. 847/2009, E26/110.626/2011 and E-26/110.774/2013) and Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior- CAPES) (grant 23038.007702/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associac Brasileira de Empresas de Pesquisa, 2008, COD GUIAS ABEP CRIT; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Bucksch J, 2016, J ADOLESCENT HEALTH, V58, P417, DOI 10.1016/j.jadohealth.2015.11.014; Chaput JP, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.14; Currie C, 2008, HLTH POLICY CHILDREN, V5, P206; Ferrari GLD, 2015, J PEDIAT-BRAZIL, V91, P574, DOI 10.1016/j.jped.2015.01.009; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Ekelund U, 2016, LANCET, V388, pE6; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Epstein LH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-13; Epstein LH, 2005, ANN BEHAV MED, V29, P200, DOI 10.1207/s15324796abm2903_6; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Guedes Dartagnan Pinto, 2005, Rev Bras Med Esporte, V11, P151, DOI 10.1590/S1517-86922005000200011; Guerra PH, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050006307; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; IPAQ, 2005, GUIDELINES DATA PROC; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Junior GC, 2016, REV BRAS CIENC ESPOR, V38, P179; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kwon S, 2015, JAMA PEDIATR, V169, P666, DOI 10.1001/jamapediatrics.2015.0327; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Ling JY, 2014, AM J HEALTH BEHAV, V38, P881, DOI 10.5993/AJHB.38.6.10; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Rauner A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1731-4; Raustorp A, 2018, J PHYS ACT HEALTH, V15, P7, DOI 10.1123/jpah.2017-0146; Saito MI, 1984, PEDIATRICA, V6, P111; Sturm R, 2004, AM J PREV MED, V27, P126, DOI 10.1016/j.amepre.2004.06.013; Szwarcwald Célia Landmann, 2005, Rev. Bras. Saude Mater. Infant., V5, ps11, DOI 10.1590/S1519-38292005000500002; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Taveras EM, 2007, PEDIATRICS, V119, pE314, DOI 10.1542/peds.2005-2974; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Tremblay MS, 2016, APPL PHYSIOL NUTR ME, V41, pS311, DOI [10.1139/apnm-2016-0151, 10.1139/apnm-2016-0203]; van den Eijnden RJJM, 2008, DEV PSYCHOL, V44, P655, DOI 10.1037/0012-1649.44.3.655; Vicente-Rodriguez G, 2008, NUTRITION, V24, P654, DOI 10.1016/j.nut.2008.03.011; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Young DR, 2018, J ADOLESCENT HEALTH, V63, P466, DOI 10.1016/j.jadohealth.2018.05.023; Yvonne Laird, 2018, J QUAL STUD HLTH WEL, V13, P1	46	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211470	10.1371/journal.pone.0211470	http://dx.doi.org/10.1371/journal.pone.0211470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682158	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500171
J	Jeong, BH; Na, SJ; Lee, DS; Chung, CR; Suh, GY; Jeon, K				Jeong, Byeong-Ho; Na, Soo Jin; Lee, Dae-Sang; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman			Readmission and hospital mortality after ICU discharge of critically ill cancer patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; AFTER-HOURS DISCHARGE; RISK-FACTORS; OUTCOMES; MALIGNANCIES; ADMISSION; INCREASES; SEVERITY; ILLNESS	Background Intensive care unit (ICU) readmission is generally associated with increased hospital stays and increased mortality. However, there are limited data on ICU readmission in critically ill cancer patients. Method We conducted a retrospective cohort study based on the prospective registry of all critically ill cancer patients admitted to the oncology medical ICU between January 2012 and December 2013. After excluding patients who were discharged to another hospital or decided to end-of-life care, we divided the enrolled patients into four groups according to the time period from ICU discharge to unexpected events (ICU readmission or ward death) as follows: no (without ICU readmission or death, n = 456), early (within 2 days, n = 42), intermediate (between 2 and 7 days, n = 64), and late event groups (after 7 days of index ICU discharge, n = 129). The independent risk factors associated with ICU readmission or unexpected death after ICU discharge were also analyzed using multinomial logistic regression model. Results There were no differences in the reasons for ICU readmission across the groups. ICU mortality did not differ among the groups, but hospital mortality was significantly higher in the late event group than in the early event group. Mechanical ventilation during ICU stay, tachycardia, decreased mental status, and thrombocytopenia on the day of index ICU discharge increased the risk of early ICU readmission or unexpected ward death, while admission through the emergency room and sepsis and respiratory failure as the reasons for index ICU admission were associated with increased risk of late readmission or unexpected ward death. Interestingly, recent chemotherapy within 4 weeks before index ICU admission was inversely associated with the risk of late readmission or unexpected ward death. Conclusion In critically ill cancer patients, patient characteristics predicting ICU readmission or unexpected ward death were different according to the time period between index ICU discharge and the events.	[Jeong, Byeong-Ho; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Div Pulm & Crit Care Med, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Na, Soo Jin; Lee, Dae-Sang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Div Pulm & Crit Care Med, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Jeong, Byeong-Ho/0000-0002-3124-1718	Samsung Medical Center grant [OTA1602901]	Samsung Medical Center grant(Samsung)	This work was supported by a Samsung Medical Center grant (OTA1602901) to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Baldwin MR, 2014, J CRIT CARE, V29, P401, DOI 10.1016/j.jcrc.2013.12.019; Benoit DD, 2006, INTENS CARE MED, V32, P93, DOI 10.1007/s00134-005-2836-5; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; Darmon M, 2005, CRIT CARE MED, V33, P2488, DOI 10.1097/01.CCM.0000181728.13354.0A; Frost SA, 2009, RESUSCITATION, V80, P505, DOI 10.1016/j.resuscitation.2009.02.015; Gantner D, 2014, INTENS CARE MED, V40, P1528, DOI 10.1007/s00134-014-3438-x; Hosein FS, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0715-6; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Lee DS, 2015, CRIT CARE MED, V43, P1439, DOI 10.1097/CCM.0000000000000989; Lee H, 2015, ANAESTH INTENS CARE, V43, P175, DOI 10.1177/0310057X1504300206; Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856; Ouanes I, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.003; Pilcher DV, 2007, ANAESTH INTENS CARE, V35, P477, DOI 10.1177/0310057X0703500403; Ponzoni CR, 2017, ANN AM THORAC SOC, V14, P1312, DOI 10.1513/AnnalsATS.201611-851OC; Ranzani OT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.013; Renton J, 2011, INTENS CARE MED, V37, P1800, DOI 10.1007/s00134-011-2318-x; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Rodrigues Cinthia Mendes, 2016, Rev. bras. ter. intensiva, V28, P33, DOI 10.5935/0103-507X.20160011; Rosa RG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143127; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Shankar-Hari M, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0544-7; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Song JU, 2011, SUPPORT CARE CANCER, V19, P491, DOI 10.1007/s00520-010-0841-x; Song SW, 2007, ANN THORAC SURG, V84, P1838, DOI 10.1016/j.athoracsur.2007.06.074; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Town JA, 2014, CRIT CARE MED, V42, P2037, DOI 10.1097/CCM.0000000000000401; van Vliet M, 2014, INTENS CARE MED, V40, P1275, DOI 10.1007/s00134-014-3373-x; VANSLUISVELD N, 2017, BMC HEALTH SERV RES, V17, P46319; Yoo H, 2013, CRIT CARE, V17, DOI 10.1186/cc12829	33	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211240	10.1371/journal.pone.0211240	http://dx.doi.org/10.1371/journal.pone.0211240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677085	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400064
J	Sayas, CL; Medina, M; Cuadros, R; Olla, I; Garcia, E; Perez, M; Ferrer, I; Hernandez, F; Avila, J				Laura Sayas, C.; Medina, Miguel; Cuadros, Raquel; Olla, Ivanna; Garcia, Esther; Perez, Mar; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus			Role of tau N-terminal motif in the secretion of human tau by End Binding proteins	PLOS ONE			English	Article							EXTRACELLULAR TAU; MICROTUBULES; PHOSPHORYLATION; OVEREXPRESSION; TRANSMISSION; FILAMENT; TRACKING; EB3	For unknown reasons, humans appear to be particular susceptible to developing tau pathology leading to neurodegeneration. Transgenic mice are still undoubtedly the most popular and extensively used animal models for studying Alzheimer's disease and other tauopathies. While these murine models generally overexpress human tau in the mouse brain or specific brain regions, there are differences between endogenous mouse tau and human tau protein. Among them, a main difference between human and mouse tau is the presence of a short motif spanning residues 18 to 28 in the human tau protein that is missing in murine tau, and which could be at least partially responsible for that different susceptibility across species. Here we report novel data using affinity chromatography analysis indicating that the sequence containing human tau residues 18 to 28 acts a binding motif for End Binding proteins and that this interaction could facilitate tau secretion to the extracellular space.	[Laura Sayas, C.] ULL, Inst Biomed Technol ITB, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain; [Medina, Miguel; Olla, Ivanna; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain; [Medina, Miguel; Olla, Ivanna; Ferrer, Isidro; Hernandez, Felix; Avila, Jesus] CIEN Fdn, Queen Sofia Fdn Alzheimer Ctr, Madrid, Spain; [Cuadros, Raquel; Garcia, Esther; Hernandez, Felix; Avila, Jesus] UAM, CSIC, CBMSO, Madrid, Spain; [Perez, Mar] UAM, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Ferrer, Isidro] Bellvitge Univ Hosp, Serv Pathol Anat, Barcelona, Spain; [Ferrer, Isidro] Univ Barcelona, Inst Neurosci, Lhospitalet De Llobregat, Spain	Universidad de la Laguna; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona	Avila, J (corresponding author), Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain.; Avila, J (corresponding author), CIEN Fdn, Queen Sofia Fdn Alzheimer Ctr, Madrid, Spain.; Avila, J (corresponding author), UAM, CSIC, CBMSO, Madrid, Spain.	javila@cbm.csic.es	Hernandez, Felix/L-2114-2015; Medina, Miguel/J-1642-2019; Avila, Jesus/I-2610-2015; Mar, Perez/Y-2055-2019; Medina, Miguel/H-5676-2012	Hernandez, Felix/0000-0001-8753-8249; Avila, Jesus/0000-0002-6288-0571; Mar, Perez/0000-0002-8477-9554; Medina, Miguel/0000-0002-7016-5340	Spanish Ministry of Economy and Competitiveness [SAF-2014-53040-P, SAF2016-78603-R, BFU2016-77885-P]; Fundacion Ramon Areces; Banco Santander; Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Ramon Areces; Banco Santander; Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII)	This study was funded by grants from the Spanish Ministry of Economy and Competitiveness (SAF-2014-53040-P (Jesus Avila), SAF2016-78603-R (Miguel Medina) and BFU2016-77885-P (Felix Hernandez), the Centro de Investigascion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII) (Jesus Avila). Institutional grants from the Fundacion Ramon Areces and Banco Santander to the CBMSO are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILA J, 1994, INT J DEV BIOL, V38, P13; Bolos M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0200-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; DEGARCINI EM, 1994, MOL CELL BIOCHEM, V130, P187; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Leon-Espinosa G, 2013, J NEUROSCI RES, V91, P954, DOI 10.1002/jnr.23220; Leterrier C, 2011, P NATL ACAD SCI USA, V108, P8826, DOI 10.1073/pnas.1018671108; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Medina M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00113; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Nelson PT, 1996, J NEUROCHEM, V67, P1622; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Ramirez-Rios S, 2016, MOL BIOL CELL, V27, P2924, DOI 10.1091/mbc.E16-01-0029; Santa-Maria I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-17; Sayas CL, 2015, J NEUROCHEM, V133, P653, DOI 10.1111/jnc.13091; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Skrabana R, 2006, CELL MOL NEUROBIOL, V26, P1085, DOI 10.1007/s10571-006-9083-3; Stepanova T, 2010, CURR BIOL, V20, P1023, DOI 10.1016/j.cub.2010.04.024; van de Willige D, 2016, CELL MOL LIFE SCI, V73, P2053, DOI 10.1007/s00018-016-2168-3; Wang LJ, 2014, J BIOL CHEM, V289, P29322, DOI 10.1074/jbc.M114.559153	30	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210864	10.1371/journal.pone.0210864	http://dx.doi.org/10.1371/journal.pone.0210864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668577	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400020
J	Haven, TL; Tijdink, JK; Martinson, BC; Bouter, LM				Haven, Tamarinde L.; Tijdink, Joeri K.; Martinson, Brian C.; Bouter, Lex M.			Perceptions of research integrity climate differ between academic ranks and disciplinary fields: Results from a survey among academic researchers in Amsterdam	PLOS ONE			English	Article							ORGANIZATIONAL-CLIMATE; SCIENTIFIC MISCONDUCT; RESPONSE RATES; METAANALYSIS; JUSTICE; SCIENCE; BIAS	Breaches of research integrity have shocked the academic community. Initially explanations were sought at the level of individual researchers but over time increased recognition emerged of the important role that the research integrity climate may play in influencing researchers' (mis) behavior. In this study we aim to assess whether researchers from different academic ranks and disciplinary fields experience the research integrity climate differently. We sent an online questionnaire to academic researchers in Amsterdam using the Survey of Organizational Research Climate. Bonferroni corrected mean differences showed that junior researchers (PhD students, postdocs and assistant professors) perceive the research integrity climate more negatively than senior researchers (associate and full professors). Junior researchers note that their supervisors are less committed to talk about key research integrity principles compared to senior researchers (MD = -.39, CI = -.55, -.24). PhD students perceive more competition and suspicion among colleagues (MD = -.19, CI = -.35, -.05) than associate and full professors. We found that researchers from the natural sciences overall express a more positive perception of the research integrity climate. Researchers from social sciences as well as from the humanities perceive less fairness of their departments' expectations in terms of publishing and acquiring funding compared to natural sciences and biomedical sciences (MD = -.44, CI = -.74, -.15; MD = -.36, CI = -.61, -.11). Results suggest that department leaders in the humanities and social sciences should do more to set fairer expectations for their researchers and that senior scientists should ensure junior researchers are socialized into research integrity practices and foster a climate in their group where suspicion among colleagues has no place.	[Haven, Tamarinde L.; Tijdink, Joeri K.; Bouter, Lex M.] Vrije Univ, Dept Philosophy, Amsterdam, Netherlands; [Tijdink, Joeri K.; Bouter, Lex M.] Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [Martinson, Brian C.] Univ Minnesota, Dept Med, HealthPartners Inst, Res, Box 736 UMHC, Minneapolis, MN 55455 USA; [Martinson, Brian C.] Univ Minnesota, Dept Med, Minneapolis Vet Affairs Hlth Care Syst, Ctr Care Delivery & Outcomes Res, Box 736 UMHC, Minneapolis, MN 55455 USA	Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Haven, TL (corresponding author), Vrije Univ, Dept Philosophy, Amsterdam, Netherlands.	t.l.haven@vu.nl	Martinson, Brian C/AAX-2860-2020; Bouter, Lex/X-1003-2019	Martinson, Brian C/0000-0002-4255-5595; Bouter, Lex/0000-0002-2659-5482; Haven, Tamarinde/0000-0002-4702-2472; Tijdink, Joeri/0000-0002-1826-2274	Templeton World Charity Foundation [TWCF0163/AB106]	Templeton World Charity Foundation(Templeton World Charity Foundation)	LB, JT and TH were partly supported by the Templeton World Charity Foundation (https://www.templetonworldcharity.org/) under the grant #TWCF0163/AB106. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Bouter Lex M, 2016, Res Integr Peer Rev, V1, P17, DOI 10.1186/s41073-016-0024-5; Bouter LM, 2015, ACCOUNT RES, V22, P148, DOI 10.1080/08989621.2014.950253; Casadevall A, 2016, MBIO, V7, DOI 10.1128/mBio.01256-16; Casadevall A, 2012, INFECT IMMUN, V80, P891, DOI 10.1128/IAI.06183-11; Cohen J., 1995, STAT POWER ANAL BEHA; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Crain AL, 2013, SCI ENG ETHICS, V19, P835, DOI 10.1007/s11948-012-9409-0; Cull WL, 2005, HEALTH SERV RES, V40, P213, DOI 10.1111/j.1475-6773.2005.00350.x; De Vries R, 2006, J EMPIR RES HUM RES, V1, P43, DOI 10.1525/jer.2006.1.1.43; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; GREENBERG J, 1978, US SOC PSYCHOL, V41, P337; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hox JJ, 2010, MULTILEVEL ANAL TECH; IOM, 2002, INT SCI RES CREAT EN; Kornfeld DS, 2012, ACAD MED, V87, P877, DOI 10.1097/ACM.0b013e318257ee6a; Levecque K, 2017, RES POLICY, V46, P868, DOI 10.1016/j.respol.2017.02.008; Levelt Committee Noort Committee Drenth Committee, 2012, FLAW SCI FRAUD RES P; Martinez-Crego B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156848; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; Martinson Brian C, 2017, AJOB Empir Bioeth, V8, P211, DOI 10.1080/23294515.2017.1363318; Martinson BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151571; Martinson BC, 2013, SCI ENG ETHICS, V19, P813, DOI 10.1007/s11948-012-9410-7; Martinson BC, 2010, J EMPIR RES HUM RES, V5, P67, DOI 10.1525/jer.2010.5.3.67; Mentzelopoulos SD, 2017, JAMA-J AM MED ASSOC, V318, P1221, DOI 10.1001/jama.2017.11790; Mumford MD, 2007, ETHICS BEHAV, V17, P337, DOI 10.1080/10508420701519510; Peluso DL, 2011, CAN J BEHAV SCI, V43, P119, DOI 10.1037/a0022624; Peter R, 1998, J EPIDEMIOL COMMUN H, V52, P540, DOI 10.1136/jech.52.9.540; Schneider B, 2013, ANNU REV PSYCHOL, V64, P361, DOI 10.1146/annurev-psych-113011-143809; Shaw D., 2018, SCI ENG ETHICS; Siegrist, 2015, HIST CURR PERSPECT S, V2, P261; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Smith G., 2008, 501717 ERIC, P1; Sovacool BK, 2008, J BIOETHIC INQ, V5, P271, DOI 10.1007/s11673-008-9113-6; Steneck NH, 2006, SCI ENG ETHICS, V12, P53, DOI 10.1007/PL00022268; Steneck Nicholas H, 2002, Am J Bioeth, V2, P51, DOI 10.1162/152651602320957574; Stroebe W, 2012, PERSPECT PSYCHOL SCI, V7, P670, DOI 10.1177/1745691612460687; Sweeney PD, 1997, J ORGAN BEHAV, V18, P83, DOI 10.1002/(SICI)1099-1379(199701)18:1<83::AID-JOB779>3.0.CO;2-3; Thrush CR, 2007, J EMPIR RES HUM RES, V2, P35, DOI 10.1525/jer.2007.2.4.35; Thrush CR, 2011, USERS MANUAL SURVEY; Tijdink JK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008681; Tijdink JK, 2014, QUAL LIFE RES, V23, P2055, DOI 10.1007/s11136-014-0643-6; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; van Dalen HP, 2012, J AM SOC INF SCI TEC, V63, P1282, DOI 10.1002/asi.22636; Wells JA, 2014, J EMPIR RES HUM RES, V9, P72, DOI 10.1177/1556264614552798	46	28	28	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210599	10.1371/journal.pone.0210599	http://dx.doi.org/10.1371/journal.pone.0210599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657778	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000012
J	Ali, SA; Niu, B; Cheah, KSE; Alman, B				Ali, Shabana Amanda; Niu, Ben; Cheah, Kathryn S. E.; Alman, Benjamin			Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes	PLOS ONE			English	Article							CHONDROSARCOMA CELLS; HEDGEHOG PATHWAY; READ ALIGNMENT; EXPRESSION; INHIBITOR; CARTILAGE; RECEPTOR; ELEMENTS; ENCODE	Excessive Hedgehog (Hh) signaling in chondrocytes is sufficient to cause formation of enchondroma-like lesions which can progress to chondrosarcoma. To elucidate potential underlying mechanisms, we identified GLI1 and GLI2 target genes in human chondrosarcoma. Using chromatin immunoprecipitation (ChIP) sequencing and microarray data, in silico analyses were conducted to identify and characterize unique and overlapping GLI1 and GLI2 binding regions in neoplastic chondrocytes. After overlaying microarray data from human chondrosarcoma, 204 upregulated and 106 downregulated genes were identified as Hh-responsive Gli binding targets. After overlaying published Gli ChIP-on-chip data from mouse, 48 genes were identified as potential direct downstream targets of Hedgehog signaling with shared GLI binding regions in evolutionarily conserved DNA elements. Among these was BMP2, pointing to potential cross-talk between TGF beta signaling and Hh signaling. Our identification of potential target genes that are unique and common to GLI1 and GLI2 in neoplastic chondrocytes contributes to elucidating potential pathways through which Hh signaling impacts cartilage tumor biology.	[Ali, Shabana Amanda] Krembil Res Inst, Genet & Dev, Toronto, ON, Canada; [Niu, Ben; Cheah, Kathryn S. E.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Alman, Benjamin] Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA	Krembil Research Institute; University of Hong Kong; Duke University	Alman, B (corresponding author), Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA.	ben.alman@duke.edu		Ali, Shabana/0000-0002-4339-9467	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01 AR066765]; Hong Kong Research Grants Council [T12-708/12N]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066765] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research contributions by B.A. and S.A.A. in this publication were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number: R01 AR066765. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Research contributions by K.S.E.C. and B.N. are supported by Hong Kong Research Grants Council project no: T12-708/12N.	Ali SA, 2016, ARTHRITIS RHEUMATOL, V68, P127, DOI 10.1002/art.39337; Ali SA, 2012, ANAL BIOCHEM, V429, P39, DOI 10.1016/j.ab.2012.06.028; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Boeuf S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-488; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Campbell VT, 2014, MOL CANCER THER, V13, P1259, DOI 10.1158/1535-7163.MCT-13-0731; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Hou CH, 2009, BONE, V44, P233, DOI 10.1016/j.bone.2008.09.021; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim S, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.33; Koers-Wunrau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070709; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Onishi Anne C., 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/381564; Park HL, 2000, DEVELOPMENT, V127, P1593; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahman MS, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.5; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2015, P NATL ACAD SCI USA, V112, P4678, DOI 10.1073/pnas.1502301112; Tan ZJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007346; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tiet TD, 2006, AM J PATHOL, V168, P321, DOI 10.2353/ajpath.2006.050001; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang C, 2018, ELIFE, V7, DOI 10.7554/eLife.37673; Wang JY, 2015, ONCOTARGET, V6, P20636, DOI 10.18632/oncotarget.4114; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211333	10.1371/journal.pone.0211333	http://dx.doi.org/10.1371/journal.pone.0211333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695055	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400025
J	Nickels, S; Hopf, S; Pfeiffer, N; Schuster, AK				Nickels, Stefan; Hopf, Susanne; Pfeiffer, Norbert; Schuster, Alexander K.			Myopia is associated with education: Results from NHANES 1999-2008	PLOS ONE			English	Article							REFRACTIVE ERRORS; RISK-FACTORS; ASIAN POPULATION; UNITED-STATES; PREVALENCE; PARAMETERS; LEVEL; EPIDEMIOLOGY; METAANALYSIS; BLINDNESS	Purpose Myopia is increasing worldwide and possibly linked to education. In this study, we analyse the association of myopia and education in the U.S. and investigate its age-dependency. Methods We conducted a secondary data analysis using the public use files from the cross-sectional study National Health and Nutrition Examination Survey of the period from 1999 to 2008. 19,756 participants aged 20 to 85 years were included with data on education and ophthalmic parameters (distance visual acuity, objective refraction and keratometry). Spherical equivalent, astigmatism, corneal power and corneal astigmatism were evaluated for an association with education using linear regression analysis with adjustment of potential confounders. Results Analysis revealed an association between spherical equivalent and educational level in the univariate analysis (P <.001), and in the adjusted model (P <.001). Subjects who attend school to less than 9th grade had a mean spherical equivalent of 0.34 D, subjects with 9-11th grade -0.14 D, subjects that finished high school -0.33 D, subjects with partial college education -0.70 D, subjects that graduated from college or a higher formal education -1.22 D. Subjects that graduated from college or above were -1.47 D more myopic compared to subjects that completed less than 9 th grade school in the adjusted analyses. Astigmatism and corneal curvature was not associated with education. Conclusions Myopia is associated with higher education in the U. S. Our analysis shows that corneal curvature does not contribute to this association, therefore axial elongation or lens power are likely to contribute to myopia.	[Nickels, Stefan; Schuster, Alexander K.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Ctr Ophthalm Epidemiol & Healthcare Res, Mainz, Germany; [Hopf, Susanne; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schuster, AK (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Ctr Ophthalm Epidemiol & Healthcare Res, Mainz, Germany.	alexander.schuster@uni-mainz.de	Pfeiffer, Norbert/AAO-7586-2020	Pfeiffer, Norbert/0000-0002-5766-2617; Hopf, Susanne/0000-0002-7989-9420				Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Cheng CY, 2003, INVEST OPHTH VIS SCI, V44, P4630, DOI 10.1167/iovs.03-0169; Cumberland PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139780; Dandona R, 1999, INVEST OPHTH VIS SCI, V40, P2810; Eong K. G. Au, 1993, Singapore Medical Journal, V34, P489; Fan Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11008; Fan Q, 2014, HUM MOL GENET, V23, P546, DOI 10.1093/hmg/ddt431; Foster PJ, 2014, EYE, V28, P202, DOI 10.1038/eye.2013.280; Guggenheim JA, 2015, MOL VIS, V21, P621; Guo Y, 2013, OPHTHALMOLOGY, V120, P277, DOI 10.1016/j.ophtha.2012.07.086; Hashemi H, 2016, OPHTHAL PHYSL OPT, V36, P671, DOI 10.1111/opo.12317; Holladay JT, 1997, J REFRACT SURG, V13, P388; Hwang HS, 2018, ACTA OPHTHALMOLOGICA; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Jacobsen N, 2007, ACTA OPHTHALMOL SCAN, V85, P165, DOI 10.1111/j.1600-0420.2006.00789.x; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Jonas JB, 2016, CORNEA, V35, P1333, DOI 10.1097/ICO.0000000000000854; Jonas JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154554; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kinge B, 1999, ACTA OPHTHALMOL SCAN, V77, P648, DOI 10.1034/j.1600-0420.1999.770608.x; Lee KE, 1960, ARCH OPHTHALMOL-CHIC, VIll, P127; Li SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134514; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Mirshahi A, 2016, INVEST OPHTH VIS SCI, V57, P5230, DOI 10.1167/iovs.16-19507; Mirshahi A, 2014, OPHTHALMOLOGY, V121, P2047, DOI 10.1016/j.ophtha.2014.04.017; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Morgan IG, 2013, OPHTHAL PHYSL OPT, V33, P329, DOI 10.1111/opo.12040; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2017, PHOTOCH PHOTOBIO SCI, V16, P426, DOI 10.1039/c6pp00292g; Pan CW, 2013, AM J OPHTHALMOL, V155, P1129, DOI 10.1016/j.ajo.2013.01.009; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rim Tyler Hyungtaek, 2016, Korean J Ophthalmol, V30, P214, DOI 10.3341/kjo.2016.30.3.214; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Saw SM, 2004, INVEST OPHTH VIS SCI, V45, P2943, DOI 10.1167/iovs.03-1296; Scragg R, 2008, AM J EPIDEMIOL, V168; Scragg R, 2008, AM J EPIDEMIOL, V168, P577, DOI 10.1093/aje/kwn163; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Tan CSH, 2011, EYE, V25, P1294, DOI 10.1038/eye.2011.144; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; Varma R, 2017, AM J OPHTHALMOL, V175, P201, DOI 10.1016/j.ajo.2016.10.002; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Williams KM, 2015, OPHTHALMOLOGY, V122, P1489, DOI 10.1016/j.ophtha.2015.03.018; Won SJ, 2010, J ADV ACAD, V21, P628, DOI 10.1177/1932202X1002100404; Wu HM, 2001, OPTOMETRY VISION SCI, V78, P234, DOI 10.1097/00006324-200104000-00012; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P721, DOI 10.1007/s00417-009-1233-0	54	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211196	10.1371/journal.pone.0211196	http://dx.doi.org/10.1371/journal.pone.0211196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695049	Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400017
J	Patel, BB; Lebensohn, AM; Pusapati, GV; Carette, JE; Salzman, J; Rohatgi, R				Patel, Bhaven B.; Lebensohn, Andres M.; Pusapati, Ganesh V.; Carette, Jan E.; Salzman, Julia; Rohatgi, Rajat			Discovery of gene regulatory elements through a new bioinformatics analysis of haploid genetic screens	PLOS ONE			English	Article							SEQUENCE-SPECIFIC CONTROL; CRISPR; TRANSCRIPTION	The systematic identification of regulatory elements that control gene expression remains a challenge. Genetic screens that use untargeted mutagenesis have the potential to identify protein-coding genes, non-coding RNAs and regulatory elements, but their analysis has mainly focused on identifying the former two. To identify regulatory elements, we conducted a new bioinformatics analysis of insertional mutagenesis screens interrogating WNT signaling in haploid human cells. We searched for specific patterns of retroviral gene trap integrations (used as mutagens in haploid screens) in short genomic intervals overlapping with introns and regions upstream of genes. We uncovered atypical patterns of gene trap insertions that were not predicted to disrupt coding sequences, but caused changes in the expression of two key regulators of WNT signaling, suggesting the presence of cis-regulatory elements. Our methodology extends the scope of haploid genetic screens by enabling the identification of regulatory elements that control gene expression.	[Patel, Bhaven B.; Lebensohn, Andres M.; Pusapati, Ganesh V.; Salzman, Julia; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Patel, Bhaven B.; Lebensohn, Andres M.; Rohatgi, Rajat] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Carette, Jan E.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA; [Salzman, Julia] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Lebensohn, Andres M.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lebensohn, AM; Salzman, J; Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.; Lebensohn, AM; Rohatgi, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.; Salzman, J (corresponding author), Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA.; Lebensohn, AM (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	andres.lebensohn@nih.gov; julia.salzman@stanford.edu; rrohatgi@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566; Carette, Jan/0000-0002-5187-8070; Patel, Bhaven/0000-0002-1746-3277	National Cancer Institute [R00 CA168987-03]; National Institute of General Medical Sciences [R01 GM116847]; Joint Initiative for Metrology in Biology seed grant; National Science Foundation CAREER Award; McCormick-Gabilan Fellowship; Baxter Family Fellowship; National Institutes of Health [DP2 AI104557, DP2 GM105448, R35 GM118082]; Stanford Cancer Institute; Stanford Bio-X Undergraduate Summer Research Program; Stanford University Office of Undergraduate Advising and Research; Stanford Dean's Postdoctoral Fellowship; Stanford Cancer Biology Program Training Grant; Novartis from the Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE [R00CA168987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118082, R01GM116847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Joint Initiative for Metrology in Biology seed grant; National Science Foundation CAREER Award(National Science Foundation (NSF)); McCormick-Gabilan Fellowship; Baxter Family Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Cancer Institute; Stanford Bio-X Undergraduate Summer Research Program; Stanford University Office of Undergraduate Advising and Research; Stanford Dean's Postdoctoral Fellowship; Stanford Cancer Biology Program Training Grant; Novartis from the Helen Hay Whitney Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a National Cancer Institute (https://www.cancer.gov) grant R00 CA168987-03, a National Institute of General Medical Sciences (https.//www.nigms.nih.gov) grant R01 GM116847, a Joint Initiative for Metrology in Biology (http://jimb.stanford.edu) seed grant, a National Science Foundation (https://www.nsf.gov) CAREER Award, a McCormick-Gabilan Fellowship and a Baxter Family Fellowship (all to JS), by National Institutes of Health (https://www.nih.gov) grants DP2 AI104557 (JEC), DP2 GM105448 (RR), R35 GM118082 (RR) and by startup funds from the Stanford Cancer Institute (RR). BBP was supported by the Stanford Bio-X Undergraduate Summer Research Program and a Major Grant from the Stanford University Office of Undergraduate Advising and Research. AM L was supported by the Stanford Dean's Postdoctoral Fellowship, the Stanford Cancer Biology Program Training Grant and the Novartis sponsored Fellowship from the Helen Hay Whitney Foundation (http://hhwf.org).JEC is a David and Lucile Packard Foundation (https://www.packard.org) fellow, JS is an Alfred P. Sloan Foundation (https://sloan.org) fellow in Computational & Evolutionary Molecular Biology, and RR is a Josephine Q. Berry Faculty Scholar in Cancer Research at Stanford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2018, NAT METHODS, V15, P505, DOI 10.1038/s41592-018-0014-2; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Canver MC, 2017, NAT GENET; Carette JE, 2011, NAT BIOTECHNOL, V29, P542, DOI 10.1038/nbt.1857; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egawa T, 2011, P NATL ACAD SCI USA, V108, P14873, DOI 10.1073/pnas.1112293108; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Lebensohn AM, 2016, ELIFE, V5, DOI 10.7554/eLife.21459; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Pellicelli M, 2018, BBA-GENE REGUL MECH, V1861, P61, DOI 10.1016/j.bbagrm.2018.01.008; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Vrljicak P, 2016, G3-GENES GENOM GENET, V6, P805, DOI 10.1534/g3.115.026849; Wright JB, 2016, TRENDS GENET, V32, P526, DOI 10.1016/j.tig.2016.06.004; Zid BM, 2014, NATURE, V514, P117, DOI 10.1038/nature13578	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0198463	10.1371/journal.pone.0198463	http://dx.doi.org/10.1371/journal.pone.0198463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695034	Green Submitted, Green Published, gold			2022-12-27	WOS:000457046400001
J	Evrard, L; Audigie, F; Bertoni, L; Jacquet, S; Denoix, JM; Busoni, V				Evrard, Laurence; Audigie, Fabrice; Bertoni, Lelia; Jacquet, Sandrine; Denoix, Jean-Marie; Busoni, Valeria			Low field magnetic resonance imaging of the equine distal interphalangeal joint: Comparison between weight-bearing and non-weight-bearing conditions	PLOS ONE			English	Article							CARTILAGE CONTACT DEFORMATION; ARTICULAR-CARTILAGE; FOOT PAIN; SUBCHONDRAL BONE; THICKNESS; HORSES; MRI; ARTHROGRAPHY; RELAXATION; VALIDATION	This descriptive study aimed to compare the magnetic resonance appearance of the distal interphalangeal joint articular cartilage between standing weight-bearing and non-weightbearing conditions. Ten forefeet of live horses were scanned in a standing low-field magnetic resonance system (0.27 T). After euthanasia for reasons unrelated to the study, the non-weight-bearing isolated feet were scanned in a vertical positioning reproducing limb orientation in live horses. The same acquisition settings as during the weight-bearing examination were used. Thickness and cross-sectional area of the distal interphalangeal articular cartilage and joint space were measured on tridimensional T1-weighted gradient echo high resolution frontal and sagittal images at predetermined landmarks in both conditions and were compared using a linear mixed-effects model. Frontal images were randomized and submitted to 9 blinded readers with 3 different experience levels for identification of weight-bearing versus non-weight-bearing acquisitions based on cartilage appearance. Weight-bearing limbs had significantly thinner distal interphalangeal cartilage (p = 0.0001) than non-weight-bearing limbs. This change was greater in the distal phalanx cartilage than that of the middle phalanx. Blinded readers correctly identified 83% (range 65 to 95%) of the images as weight-bearing or non-weight-bearing acquisitions, with significantly different results observed among the different readers (p < 0.001) and groups (p < 0.001). These results indicate that distal interphalangeal articular cartilage and particularly cartilage of the distal phalanx thins when weight-bearing compared to the non-weight-bearing standing postmortem conditions and suggest that cartilage abnormalities may be more difficult to identify on weight-bearing standing magnetic resonance imaging.	[Evrard, Laurence; Busoni, Valeria] Univ Liege, Equine Div, Diagnost Imaging Sect, Dept Clin Sci Compan Anim & Equids, Liege, Belgium; [Audigie, Fabrice; Bertoni, Lelia; Jacquet, Sandrine; Denoix, Jean-Marie] Ecole Natl Vet Alfort, CIRALE, Unite 957, Normandie Equine Vallee,BPLC, Goustranville, France	University of Liege; Ecole Nationale Veterinaire d'Alfort (ENVA)	Evrard, L (corresponding author), Univ Liege, Equine Div, Diagnost Imaging Sect, Dept Clin Sci Compan Anim & Equids, Liege, Belgium.	levrard@ulg.ac.be	Evrard, Laurence/AAY-9971-2021	Evrard, Laurence/0000-0001-5581-4093; Bertoni, Lelia/0000-0001-6367-3040				Anastasiou A, 2003, VET RADIOL ULTRASOUN, V44, P501, DOI 10.1111/j.1740-8261.2003.tb00498.x; Bingham JT, 2008, RHEUMATOLOGY, V47, P1622, DOI 10.1093/rheumatology/ken345; Bischofberger AS, 2018, AM J VET RES, V79, P287, DOI 10.2460/ajvr.79.3.287; Brama PAJ, 2000, EQUINE VET J, V32, P19, DOI 10.2746/042516400777612062; Bushberg JT, 2012, ESSENTIAL PHYS MED I, P449; Carstens A, 2013, VET RADIOL ULTRASOUN, V54, P365, DOI 10.1111/vru.12030; Carstens A, 2013, VET RADIOL ULTRASOUN, V54, P139, DOI 10.1111/vru.12002; Chan DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19220; Chen SS, 2001, OSTEOARTHR CARTILAGE, V9, P561, DOI 10.1053/joca.2001.0424; Contino EK, 2014, JAVMA-J AM VET MED A, V244, P1186, DOI 10.2460/javma.244.10.1186; Cotofana S, 2011, EUR RADIOL, V21, P1127, DOI 10.1007/s00330-011-2057-y; Dyson S, 2007, EQUINE VET J, V39, P340, DOI 10.2746/042516407X185566; Dyson SJ, 2005, EQUINE VET J, V37, P113, DOI 10.2746/0425164054223804; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x; Gahunia HK, 2012, ORTHOP CLIN N AM, V43, P187, DOI 10.1016/j.ocl.2012.03.001; Greaves LL, 2009, J BIOMECH, V42, P349, DOI 10.1016/j.jbiomech.2008.11.025; Hontoir F, 2014, VET J, V199, P115, DOI 10.1016/j.tvjl.2013.10.021; Hosseini A, 2010, OSTEOARTHR CARTILAGE, V18, P909, DOI 10.1016/j.joca.2010.04.011; Kersting UG, 2005, OSTEOARTHR CARTILAGE, V13, P925, DOI 10.1016/j.joca.2005.06.005; Kladny B, 1996, OSTEOARTHR CARTILAGE, V4, P181, DOI 10.1016/S1063-4584(96)80014-8; Lee H, 2015, J TRIBOL, V137, P1; Lee H, 2014, CONNECT TISSUE RES, V55, P339, DOI 10.3109/03008207.2014.949698; Liu F, 2010, J BIOMECH, V43, P658, DOI 10.1016/j.jbiomech.2009.10.028; Lyyra T, 1999, J BIOMED MATER RES, V48, P482, DOI 10.1002/(SICI)1097-4636(1999)48:4<482::AID-JBM13>3.0.CO;2-M; McGibbon CA, 2003, MAGN RESON MATER PHY, V16, P1, DOI 10.1007/s10334-003-0001-0; McKnight AL, 2012, J EQUINE VET SCI, V32, P667, DOI DOI 10.1016/J.JEVS.2012.08.213; Murray RC, 2009, VET REC, V165, P281, DOI 10.1136/vr.165.10.281; Murray RC, 2005, AM J VET RES, V66, P1999, DOI 10.2460/ajvr.2005.66.1999; Neu CP, 2014, OSTEOARTHR CARTILAGE, V22, P1349, DOI 10.1016/j.joca.2014.05.016; Olive J, 2010, VET RADIOL ULTRASOUN, V51, P259, DOI 10.1111/j.1740-8261.2009.01663.x; Olive J, 2010, VET RADIOL ULTRASOUN, V51, P107, DOI 10.1111/j.1740-8261.2009.01633.x; Pease A, 2012, VET CLIN N AM-EQUINE, V28, P637, DOI 10.1016/j.cveq.2012.08.004; Porter EG, 2016, VET RADIOL ULTRASOUN, V57, P515, DOI 10.1111/vru.12390; Sampson SN, 2009, VET RADIOL ULTRASOUN, V50, P339, DOI 10.1111/j.1740-8261.2009.01547.x; Sherlock CE, 2007, VET REC, V161, P739, DOI 10.1136/vr.161.22.739; Smith MA, 2012, EQUINE VET J, V44, P684, DOI 10.1111/j.2042-3306.2012.00561.x; Spriet M, 2014, VET RADIOL ULTRASOUN, V55, P5, DOI 10.1111/vru.12110_1; Subburaj K, 2012, J ORTHOP RES, V30, P919, DOI 10.1002/jor.22031; Szarko Matthew, 2012, Open J Orthop, V2, DOI 10.4236/ojo.2012.22007; The R Core Team, 2015, R J, V7, P227; Wan L, 2008, J ORTHOP RES, V26, P1081, DOI 10.1002/jor.20593; Wang HS, 2015, J BIOMECH, V48, P2934, DOI 10.1016/j.jbiomech.2015.08.006; Werpy NM, 2011, VET RADIOL ULTRASOUN, V52, P154, DOI 10.1111/j.1740-8261.2010.01761.x; Werpy NM., 2011, EQUINE MRI, P81; Wong BL, 2010, J BIOMECH, V43, P1689, DOI 10.1016/j.jbiomech.2010.02.035	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211101	10.1371/journal.pone.0211101	http://dx.doi.org/10.1371/journal.pone.0211101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689659	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800020
J	Lumley, S; Green, C; Rafferty, H; Smith, C; Harber, M; O'Beirne, J; Jones, G; Thorburn, D; Marshall, A; Shah, T; Zuhair, M; Rothwell, E; Atabani, S; Haque, T; Griffiths, P				Lumley, Sheila; Green, Cameron; Rafferty, Hannah; Smith, Colette; Harber, Mark; O'Beirne, James; Jones, Gareth; Thorburn, Douglas; Marshall, Aileen; Shah, Tina; Zuhair, Mohamed; Rothwell, Emily; Atabani, Sowsan; Haque, Tanzina; Griffiths, Paul			Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation	PLOS ONE			English	Article							RECIPIENTS; KINETICS; DISEASE	Background Human cytomegalovirus (HCMV) can be managed by monitoring HCMV DNA in the blood and giving valganciclovir when viral load exceeds a defined value. We hypothesised that such pre-emptive therapy should occur earlier than the standard 3000 genomes/ml (2520 IU/ml) when a seropositive donor transmitted virus to a seronegative recipient (D+R-) following solid organ transplantation (SOT). Methods Our local protocol was changed so that D+R-SOT patients commenced valganciclovir once the viral load exceeded 200 genomes/ml; 168 IU/ml (new protocol). The decision point remained at 3000 genomes/ml (old protocol) for the other two patient subgroups (D+R+, D-R+). Virological outcomes were assessed three years later, when 74 D+R- patients treated under the old protocol could be compared with 67 treated afterwards. The primary outcomes were changes in peak viral load, duration of viraemia and duration of treatment in the D+R-group. The secondary outcome was the proportion of D+R- patients who developed subsequent viraemia episodes. Findings In the D+R- patients, the median values of peak viral load (30,774 to 11,135 genomes/ml, p<0.0215) were significantly reduced on the new protocol compared to the old, but the duration of viraemia and duration of treatment were not. Early treatment increased subsequent episodes of viraemia from 33/58 (57%) to 36/49 (73%) of patients (p<0.0743) with a significant increase (p = 0.0072) in those episodes that required treatment (16/58; 27% versus 26/49; 53%). Median peak viral load increased significantly (2,103 to 3,934 genomes/ml, p<0.0249) in the D+R+ but not in the D-R+ patient subgroups. There was no change in duration of viraemia or duration of treatment for any patient subgroup. Interpretation Pre-emptive therapy initiated at the first sign of viraemia post-transplant significantly reduced the peak viral load but increased later episodes of viraemia, consistent with the hypothesis of reduced antigenic stimulation of the immune system.	[Lumley, Sheila; Green, Cameron; Rafferty, Hannah; Zuhair, Mohamed; Rothwell, Emily; Atabani, Sowsan; Haque, Tanzina; Griffiths, Paul] UCL, Med Sch, Ctr Virol, London, England; [Smith, Colette] UCL, Inst Global Hlth, London, England; [Harber, Mark; Jones, Gareth] Royal Free Hosp, Renal Transplant Unit, London, England; [O'Beirne, James; Thorburn, Douglas; Marshall, Aileen; Shah, Tina] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London, England; [Lumley, Sheila] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [O'Beirne, James] Sunshine Coast Univ Hosp, Birtinya, Qld, Australia; [Atabani, Sowsan] Univ Hosp Birmingham, Natl Infect Serv, Publ Hlth England Birmingham Lab, Birmingham, W Midlands, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Oxford University Hospitals NHS Foundation Trust; University of Birmingham	Griffiths, P (corresponding author), UCL, Med Sch, Ctr Virol, London, England.	p.griffiths@ucl.ac.uk	O'Beirne, James/I-8251-2019	O'Beirne, James/0000-0003-3400-2816; Rafferty, Hannah/0000-0002-0398-1567; Braddy-Green, Cameron/0000-0002-5288-1044; Smith, Colette/0000-0003-2847-3355; Lumley, Sheila/0000-0001-6825-9324	Wellcome Trust [078332]	Wellcome Trust(Wellcome TrustEuropean Commission)	No specific research grant was obtained for this audit, but CMV research is supported by the Wellcome Trust through grant 078332 to PDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GUIDE MANAGING ETHIC; Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x; Cope AV, 1997, J INFECT DIS, V176, P1484, DOI 10.1086/514145; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Emery VC, 1999, J EXP MED, V190, P177, DOI 10.1084/jem.190.2.177; Fisher CE, 2017, CLIN INFECT DIS, V65, P57, DOI 10.1093/cid/cix259; Fryer JF., 2010, EXPERT COMMITTEE BIO; Griffiths PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163722; Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0; Humar A, 2010, AM J TRANSPLANT, V10, P1228, DOI 10.1111/j.1600-6143.2010.03074.x; Kotton CN, 2013, TRANSPLANTATION, V96, P333, DOI 10.1097/TP.0b013e31829df29d; Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668; Mattes FM, 2005, J INFECT DIS, V191, P89, DOI 10.1086/425905; Natori Y, 2018, CLIN INFECT DIS, V66, P617, DOI 10.1093/cid/cix793; Owers DS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005133.pub3; Singh N, 2006, REV MED VIROL, V16, P281, DOI 10.1002/rmv.513	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210420	10.1371/journal.pone.0210420	http://dx.doi.org/10.1371/journal.pone.0210420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682032	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500036
J	Opoka, RO; Ssemata, AS; Oyang, W; Nambuya, H; John, CC; Karamagi, C; Tumwine, JK				Opoka, Robert O.; Ssemata, Andrew S.; Oyang, William; Nambuya, Harriet; John, Chandy C.; Karamagi, Charles; Tumwine, James K.			Adherence to clinical guidelines is associated with reduced inpatient mortality among children with severe anemia in Ugandan hospitals	PLOS ONE			English	Article							KENYAN HOSPITALS; SERIOUS ILLNESS; PEDIATRIC CARE; QUALITY; MALARIA; SCORE	Background In resource limited settings, there is variability in the level of adherence to clinical guidelines in the inpatient management of children with common conditions like severe anemia. However, there is limited data on the effect of adherence to clinical guidelines on inpatient mortality in children managed for severe anemia. Methods We analyzed data from an uncontrolled before and after in-service training intervention to improve quality of care in Lira and Jinja regional referral hospitals in Uganda. Inpatient records of children aged 0 to 5 years managed as cases of ` severe anemia (SA)' were reviewed to ascertain adherence to clinical guidelines and compare inpatient deaths in SA children managed versus those not managed according to clinical guidelines. Logistic regression analysis was conducted to evaluate the relationship between clinical care factors and inpatient deaths amongst patients managed for SA. Results A total of 1,131 children were assigned a clinical diagnosis of ` severe anemia' in the two hospitals. There was improvement in the level of care after the in-service training intervention with more children being managed according to clinical guidelines compared to the period before, 218/510 (42.7%) vs 158/621 (25.4%) (p < 0.001). Overall, children managed according to clinical guidelines had reduced risk of inpatient mortality compared to those not managed according to clinical guidelines, [OR 0.28, (95%, CI 0.14, 0.55), p = 0.001]. Clinical care factors associated with decreased risk of inpatient death included, having pre-transfusion hemoglobin done to confirm diagnosis [OR 0.5; 95% CI 0.29, 0.87], a co-morbid diagnosis of severe malaria [OR 0.4; 95% CI 0.25, 0.76], and being reviewed after admission by a clinician [OR 0.3; 95% CI 0.18, 0.59], while a co-morbid diagnosis of severe acute malnutrition was associated with increased risk of inpatient death [OR 4.2; 95% CI 2.15, 8.22]. Conclusion Children with suspected SA who are managed according to clinical guidelines have lower in-hospital mortality than those not managed according to the guidelines. Efforts to reduce inpatient mortality in SA children in resource-limited settings should focus on training and supporting health workers to adhere to clinical guidelines.	[Opoka, Robert O.; Karamagi, Charles; Tumwine, James K.] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Ssemata, Andrew S.] Makerere Univ, Dept Psychiat, Coll Hlth Sci, Kampala, Uganda; [Oyang, William] Lira Reg Referral Hosp, Childrens Ward, Lira, Uganda; [Nambuya, Harriet] Jinja Reg Referral Hosp, Nalufenya Childrens Ward, Jinja, Uganda; [John, Chandy C.] Indiana Univ Sch Med, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA	Makerere University; Makerere University; Indiana University System; Indiana University Bloomington	Opoka, RO (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	opokabob@yahoo.com	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411; Opoka, Robert/0000-0003-3240-2058	National Institutes of Health [D43TW010132]; Fogarty International Centre [D43 NS078280]; FOGARTY INTERNATIONAL CENTER [D43TW010132, D43TW010928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by funding from grant number D43TW010132 from National Institutes of Health and a Fogarty International Centre grant number D43 NS078280, awarded to CCJ. The funders played not role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bachou Hanifa, 2006, BMC Pediatr, V6, P7, DOI 10.1186/1471-2431-6-7; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; English M, 2011, ARCH DIS CHILD, V96, P285, DOI 10.1136/adc.2010.189126; Ernest S K, 2002, West Afr J Med, V21, P177; Hoque DME, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-197; Hospital Care for Children, 2013, GUID MAN COMM CHILDH; Hossain M, 2017, J PAEDIATR CHILD H, V53, P474, DOI 10.1111/jpc.13443; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro Richard, 2004, Afr Health Sci, V4, P50; Irimu G, 2008, ARCH DIS CHILD, V93, P799, DOI 10.1136/adc.2007.126508; Irimu GW, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-59; Irimu GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039964; Kiggundu VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082455; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Muoneke VU, 2012, INDIAN PEDIATR, V49, P119, DOI 10.1007/s13312-012-0026-4; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Nzinga J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-45; Okechukwu A A, 2011, Niger J Med, V20, P109; Opoka RO, 2017, J PEDIATR INFECT DIS, V6, pE41, DOI 10.1093/jpids/piw060; Opondo C, 2018, LANCET GLOB HEALTH, V6, pE203, DOI 10.1016/S2214-109X(17)30484-9; Opondo C, 2016, TROP MED INT HEALTH, V21, P1334, DOI 10.1111/tmi.12752; Sears D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127192; Shari Catherine R, 2017, BMC Hematol, V17, P19, DOI 10.1186/s12878-017-0091-y; Tuyisenge L, 2014, ARCH DIS CHILD, V99, P993, DOI 10.1136/archdischild-2014-306078	28	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210982	10.1371/journal.pone.0210982	http://dx.doi.org/10.1371/journal.pone.0210982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682097	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000457037500084
J	Pasznik, P; Rutkowska, E; Niewieczerzal, S; Cielecka-Piontek, J; Latek, D				Pasznik, Pawel; Rutkowska, Ewelina; Niewieczerzal, Szymon; Cielecka-Piontek, Judyta; Latek, Dorota			Potential off-target effects of beta-blockers on gut hormone receptors: In silico study including GUT-DOCK-A web service for small-molecule docking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GLUCAGON-LIKE PEPTIDE-1; DIABETES-MELLITUS; BINDING-AFFINITY; MEMBRANE-BUILDER; ACCURATE DOCKING; SCORING FUNCTION; AUTODOCK VINA; SOFTWARE NEWS; HYPERTENSION	The prolonged use of many currently available drugs results in the severe side effect of the disruption of glucose metabolism leading to type 2 diabetes mellitus (T2DM. Gut hormone receptors including glucagon receptor (GCGR) and the incretin hormone receptors: glucagon-like peptide 1 receptor (GLP1R) and gastric inhibitory polypeptide receptor (GIPR) are important drug targets for the treatment of T2DM, as they play roles in the regulation of glucose and insulin levels and of food intake. In this study, we hypothesized that we could compensate for the negative influences of specific drugs on glucose metabolism by the positive incretin effect enhanced by the off-target interactions with incretin GPCR receptors. As a test case, we chose to examine beta-blockers because beta-adrenergic receptors and incretin receptors are expressed in a similar location, making off-target interactions possible. The binding affinity of drugs for incretin receptors was approximated by using two docking scoring functions of Autodock VINA (GUT-DOCK) and Glide (Schrodinger) and juxtaposing these values with the medical information on drug-induced T2DM. We observed that beta-blockers with the highest theoretical binding affinities for gut hormone receptors were reported as the least harmful to glucose homeostasis in clinical trials. Notably, a recently discovered beta-blocker compound 15 ([4-((2S)-3-(((S)-3-(3-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-2-(2-cyclohexyl-2-phenylacetamido)-3-oxopropyl)benzamide was among the top-scoring drugs, potentially supporting its use in the treatment of hypertension in diabetic patients. Our recently developed web service GUT-DOCK (gut-dock.miningmembrane.com) allows for the execution of similar studies for any drug-like molecule. Specifically, users can compute the binding affinities for various class B GPCRs, gut hormone receptors, VIPR1 and PAC1R.	[Pasznik, Pawel; Rutkowska, Ewelina; Niewieczerzal, Szymon; Latek, Dorota] Univ Warsaw, Fac Chem, Warsaw, Poland; [Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Poznan, Poland	University of Warsaw; Poznan University of Medical Sciences	Latek, D (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	dlatek@chem.uw.edu.pl		Latek, Dorota/0000-0002-0429-0637; Cielecka-Piontek, Judyta/0000-0003-0891-5419	National Science Centre in Poland [DEC-2012/07/D/NZ1/04244]	National Science Centre in Poland(National Science Centre, Poland)	DL acknowledges National Science Centre in Poland (https://www.ncn.gov.pl) for financing (Grant No. DEC-2012/07/D/NZ1/04244) and Faculty of Chemistry (http://www.chem.uw.edu.pl), Biological and Chemical Research Centre (http://cnbch.uw.edu.pl) of University of Warsaw for providing the infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2017, P NATL ACAD SCI USA, V114, P1708, DOI 10.1073/pnas.1620645114; Anyanwagu U, 2016, CLIN PHARMACOL THER, V99, P390, DOI 10.1002/cpt.274; Bakris GL, 2006, KIDNEY INT, V70, P1905, DOI 10.1038/sj.ki.5001835; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006; Ceriello A, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0440-3; Chen WJ, 2016, INT J MED SCI, V13, P955, DOI 10.7150/ijms.17290; Choi YJ, 2016, CARDIOVASC THER, V34, P268, DOI 10.1111/1755-5922.12197; Cordomi A, 2016, CURR OPIN PHARMACOL, V31, P63, DOI 10.1016/j.coph.2016.09.001; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; DiNicolantonio JJ, 2015, OPEN HEART, V2, DOI [10.1136/openhrt-2015-000326, 10.1136/openhrt-2014-000230]; Edgerton DS, 2011, DIABETES, V60, P377, DOI 10.2337/db10-1594; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Fan F, 2015, TOXICOL SCI, V145, P283, DOI 10.1093/toxsci/kfv052; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hirst JA, 2015, BRIT J CLIN PHARMACO, V79, P733, DOI 10.1111/bcp.12543; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Imatoh T, 2017, J CLIN PHARM THER, V42, P215, DOI 10.1111/jcpt.12499; Izzedine Hassane, 2005, Expert Opin Drug Saf, V4, P1097, DOI 10.1517/14740338.4.6.1097; Jaghoori MM, 2016, J COMPUT AID MOL DES, V30, P237, DOI 10.1007/s10822-016-9900-9; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kalsbeek A, 2014, MOL METAB, V3, P372, DOI 10.1016/j.molmet.2014.03.002; Kim D, 2016, BIOCHEM BIOPH RES CO, V469, P399, DOI 10.1016/j.bbrc.2015.11.095; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Labbe CM, 2015, NUCLEIC ACIDS RES, V43, pW448, DOI 10.1093/nar/gkv306; Ladage D, 2013, CARDIOVASC THER, V31, P76, DOI 10.1111/j.1755-5922.2011.00306.x; Latek D, 2018, DRUG INDUCED DIABETE; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Latek D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056742; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lexa KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093323; Liu JF, 2013, J CHEM INF MODEL, V53, P1306, DOI 10.1021/ci400067c; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ong KL, 2014, AM HEART J, V167, P421, DOI 10.1016/j.ahj.2013.12.025; Ozyildiz AG, 2017, J CARDIOVASC PHARM T, V22, P65, DOI 10.1177/1074248416644987; Paoletta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097858; Pissarek M., 2015, WORLD J NEUROSCIENCE, V5, P364; Ren JY, 2010, NUCLEIC ACIDS RES, V38, pW724, DOI 10.1093/nar/gkq503; Rentzsch R, 2015, BRIEF BIOINFORM, V16, P1045, DOI 10.1093/bib/bbv008; Riddy DM, 2018, PHARMACOL REV, V70, P39, DOI 10.1124/pr.117.014373; Sandal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074092; Sander GE, 2011, J CLIN HYPERTENS, V13, P296, DOI 10.1111/j.1751-7176.2011.00454.x; Sassoon DJ, 2017, DIABETES, V66, P2230, DOI 10.2337/db16-1206; Schneider G, 2017, EXPERT OPIN DRUG DIS, V12, P271, DOI 10.1080/17460441.2017.1274727; Shepherd G, 2006, AM J HEALTH-SYST PH, V63, P1828, DOI 10.2146/ajhp060041; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Sowers JR, 2010, J HYPERTENS, V28, P1761, DOI 10.1097/HJH.0b013e32833af380; Strange PG, 2008, BRIT J PHARMACOL, V153, P1353, DOI 10.1038/sj.bjp.0707672; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; van Waterschoot RAB, 2018, NAT REV DRUG DISCOV, V17, P299, DOI 10.1038/nrd.2018.26; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 2013, AAPS J, V15, P53, DOI 10.1208/s12248-012-9413-y; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Warshaviak DT, 2014, J CHEM INF MODEL, V54, P1941, DOI 10.1021/ci500175r; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang XM, 2014, SAUDI MED J, V35, P165	73	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210705	10.1371/journal.pone.0210705	http://dx.doi.org/10.1371/journal.pone.0210705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682072	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500053
J	Rodriguez-Sanchez, L; Fernandez-Navarro, P; Lopez-Abente, G; Nunez, O; de Larrea-Baz, NF; Jimenez-Moleon, JJ; Borda, AP; Pollan, M; Perez-Gomez, B				Rodriguez-Sanchez, Lara; Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Juan Jimenez-Moleon, Jose; Paez Borda, Alvaro; Pollan, Marina; Perez-Gomez, Beatriz			Different spatial pattern of municipal prostate cancer mortality in younger men in Spain	PLOS ONE			English	Article							GENETIC RISK; PESTICIDES; SURVIVAL; SELENIUM; OBESITY; DEATH	Background Prostate cancer (PC) primarily affects elderly men. However, the specific features of cases diagnosed at younger ages (<65 years) suggest that they may represent a different clinical subtype. Our aim was to assess this suggestion by contrasting the geographical PC mortality and hospital admissions patterns in Spain for all ages to those in younger men. Methods The Spanish National Institute of Statistics supplied data on PC mortality, hospital admission, and population data. We estimated the expected town-specific number of deaths and calculated the standardized mortality ratios. Spatial autoregressive models of Besag-York-Mollie provided smoother municipal estimators of PC mortality risk (all ages; < 65 years). We computed the provincial age-standardized rate ratios of PC hospital admissions (all men; < 60 years) using Spanish rates as the reference. Results A total of 29,566 PC deaths (6% among those < 65 years) were registered between 2010-2014, with three high-mortality risk zones: Northwest Spain; Southwest Andalusia & Granada; and a broad band extending from the Pyrenees Mountains to the north of Valencia. In younger men, the spatial patterns shared the high risk of mortality in the Northwest but not the central band. The PC hospital discharge rates confirmed a North-South gradient but also low mortality/high admission rates in Madrid and Barcelona and the opposite in Southwest Andalusia. Conclusion The consistent high PC mortality/morbidity risk in the Northwest of Spain indicates an area with a real excess of risk. The different spatial pattern in younger men suggests that some factors associated with geographical risk might have differential effects by age. Finally, the regional divergences in mortality and morbidity hint at clinical variability as a source of inequity within Spain.	[Rodriguez-Sanchez, Lara; Paez Borda, Alvaro] Fuenlabrada Gen Hosp, Urol Dept, Fuenlabrada, Spain; [Rodriguez-Sanchez, Lara; Paez Borda, Alvaro] Rey Juan Carlos Univ, Mostoles, Spain; [Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Pollan, Marina; Perez-Gomez, Beatriz] Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Fernandez-Navarro, Pablo; Lopez-Abente, Gonzalo; Nunez, Olivier; Fernandez de larrea-Baz, Nerea; Juan Jimenez-Moleon, Jose; Pollan, Marina; Perez-Gomez, Beatriz] CIBERESP, Madrid, Spain; [Juan Jimenez-Moleon, Jose] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain; [Juan Jimenez-Moleon, Jose] Complejo Hosp Univ, Granada, Spain; [Juan Jimenez-Moleon, Jose] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Perez-Gomez, Beatriz] Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Cardiovasc & Metab Dis Unit, Natl Ctr Epidemiol, Madrid, Spain	Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Instituto de Salud Carlos III	Perez-Gomez, B (corresponding author), Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Perez-Gomez, B (corresponding author), CIBERESP, Madrid, Spain.; Perez-Gomez, B (corresponding author), Carlos III Inst Hlth, Dept Epidemiol Chron Dis, Cardiovasc & Metab Dis Unit, Natl Ctr Epidemiol, Madrid, Spain.	bperez@isciii.es	Perez-Gomez, Beatriz/C-4715-2012; Jimenez-Moleon, Jose J/O-2519-2016; Pollan, Marina/M-3259-2014	Perez-Gomez, Beatriz/0000-0002-4299-8214; Jimenez-Moleon, Jose J/0000-0001-7917-6145; Pollan, Marina/0000-0002-4328-1565; RODRIGUEZ SANCHEZ, LARA/0000-0001-6939-2645; Nunez, Olivier/0000-0002-6651-8879	Spanish Health Research Fund ISCIII - FEDER funds -a way to build Europe [FIS PI11/00871, FIS PI12/00150, PI17CIII/00034, PI14CIII/00050, PI15/00914]; Joint Action InfAct (European Commission) [HP-JA-06-2017]	Spanish Health Research Fund ISCIII - FEDER funds -a way to build Europe; Joint Action InfAct (European Commission)	The study was supported by research grants from the Spanish Health Research Fund ISCIII cofunded by FEDER funds -a way to build Europe (http://www.isciii.es/): PFN: FIS PI11/00871, BPG: FIS PI12/00150, PI17CIII/00034, GLA: PI14CIII/00050, JJJM: PI15/00914; Joint Action InfAct (European Commission): BPG: HP-JA-06-2017, PFN: HP-JA-06-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and there was no additional external funding received for this study.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Aranceta-Bartrina J, 2016, REV ESP CARDIOL, V69, P579, DOI [10.1016/j.rec.2016.02.009, 10.1016/j.recesp.2016.02.010]; Benafif S, 2016, BRIT MED BULL, V120, P75, DOI 10.1093/bmb/ldw039; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Casta MSL, 2015, ARCH ESP UROL, V68, P554; Castello A, 2018, J UROLOGY, V199, P430, DOI 10.1016/j.juro.2017.08.087; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; Chirlaque MD, 2018, CLIN TRANSL ONCOL, V20, P201, DOI 10.1007/s12094-017-1710-6; Clark LC, 1998, BRIT J UROL, V81, P730; CNE-ISCIII, MORT CANC OTR CAUS E; Diet nutrition physical activity and breast cancer, 2018, DIET NUTR PHYS ACT C; Ding YC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006477; European Union, 2018, ECIS EUR CANC INF SY; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Ferlay, 2016, CANC TODAY; Galceran J, 2014, ESTIMACIONES INCIDEN; Hoffman RM, 2003, ANN EPIDEMIOL, V13, P450, DOI 10.1016/S1047-2797(02)00439-8; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU; Jedroszka D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188842; Ribal MJ, 2015, PROSTATE CANCER, V2015, DOI 10.1155/2015/186740; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lange EM, 2016, CANCER EPIDEM BIOMAR, V25, P766, DOI 10.1158/1055-9965.EPI-14-0995; Larranaga N, 2010, ANN ONCOL, V21, piii83, DOI 10.1093/annonc/mdq087; Lewis-Mikhael AM, 2016, OCCUP ENVIRON MED, V73, P134, DOI 10.1136/oemed-2014-102692; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Locutura JF, ATLAS GEOQUIMICO MAD; Loeb S, 2015, CANCER EPIDEM BIOMAR, V24, P213, DOI 10.1158/1055-9965.EPI-14-0786-T; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-874; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-535; MAPAMA, PAN CONS AL; Ministerio de Sanidad Servicios Sociales e Igualdad, 2013, ENC NAC SALUD ESP 20; Mnif W, 2011, INT J ENV RES PUB HE, V8, P2265, DOI 10.3390/ijerph8062265; Nunez O, 2016, ENVIRON SCI POLLUT R, V23, P17664, DOI 10.1007/s11356-016-6806-y; Oliva G, 2009, VARIACIONES HOSP CIR; Perez-Cornago A, 2017, BRIT J CANCER, V117, P1562, DOI 10.1038/bjc.2017.312; Perez-Gomez Beatriz, 2006, Gac Sanit, V20 Suppl 3, P42, DOI 10.1157/13101089; Pollan M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-78; Preston MA, 2014, EUR UROL, V66, P1012, DOI 10.1016/j.eururo.2014.04.027; Ramis R, 2011, ENVIRON INT, V37, P577, DOI 10.1016/j.envint.2010.12.001; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Salinas CA, 2014, NAT REV UROL, V11, P317, DOI 10.1038/nrurol.2014.91; Szymanski KM, 2010, AM J CLIN NUTR, V92, P1223, DOI 10.3945/ajcn.2010.29530; Thorstenson A, 2017, J UROLOGY, V197, P61, DOI 10.1016/j.juro.2016.06.080; Vidal AC, 2014, CANCER EPIDEM BIOMAR, V23, P2936, DOI 10.1158/1055-9965.EPI-14-0795; Zeegers MPA, 2003, CANCER-AM CANCER SOC, V97, P1894, DOI 10.1002/cncr.11262; Zhou CK, 2016, INT J CANCER, V138, P1388, DOI 10.1002/ijc.29894	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210980	10.1371/journal.pone.0210980	http://dx.doi.org/10.1371/journal.pone.0210980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682085	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500083
J	Solvang, HK; Subbey, S				Solvang, Hiroko Kato; Subbey, Sam			An improved methodology for quantifying causality in complex ecological systems	PLOS ONE			English	Article							CAPELIN; MODEL; FEEDBACK	This paper provides a statistical methodology for quantifying causality in complex dynamical systems, based on analysis of multidimensional time series data of the state variables. The methodology integrates Granger's causality analysis based on the log-likelihood function expansion (Partial pair-wise causality), and Akaike's power contribution approach over the whole frequency domain (Total causality). The proposed methodology addresses a major drawback of existing methodologies namely, their inability to use time series observation of state variables to quantify causality in complex systems. We first perform a simulation study to verify the efficacy of the methodology using data generated by several multivariate auto-regressive processes, and its sensitivity to data sample size. We demonstrate application of the methodology to real data by deriving inter-species relationships that define key food web drivers of the Barents Sea ecosystem. Our results show that the proposed methodology is a useful tool in early stage causality analysis of complex feedback systems.	[Solvang, Hiroko Kato] Inst Marine Res, Marine Mammals Res Grp, Bergen, Norway; [Subbey, Sam] Inst Marine Res, Res Grp Fisheries Dynam, Bergen, Norway; [Subbey, Sam] Cornell Univ, Dept Nat Resources, Fernow Hall, Ithaca, NY 14853 USA	Institute of Marine Research - Norway; Institute of Marine Research - Norway; Cornell University	Solvang, HK (corresponding author), Inst Marine Res, Marine Mammals Res Grp, Bergen, Norway.	hiroko.solvang@hi.no			IMR Research Programs-MarPro-PROVEN [14412]; Barents Sea Program (Management Strategies for the Barents Sea) [84126]; Reduced Uncertainty in Stock Assessments (REDUS, Project) [14809-01]	IMR Research Programs-MarPro-PROVEN; Barents Sea Program (Management Strategies for the Barents Sea); Reduced Uncertainty in Stock Assessments (REDUS, Project)	This work has been partly funded by the following IMR Research Programs-MarPro-PROVEN (Project #14412), the Barents Sea Program (Management Strategies for the Barents Sea, Project #84126) and Reduced Uncertainty in Stock Assessments (REDUS, Project #14809-01).	AKAIKE H, 1968, ANN I STAT MATH, V20, P425, DOI 10.1007/BF02911655; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1994, PRACTICE TIME SERIES; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bogstad B, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00029; Bosch-Bayard J, 2012, FORMATH, V11, P121; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Francis T., 2014, PLOS ONE, V9, P425; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Gjosaeter H, 2002, ICES J MAR SCI, V59, P1086, DOI 10.1006/jmsc.2002.1238; Gjosaeter H, 2009, MAR BIOL RES, V5, P40, DOI 10.1080/17451000802454866; Gjosteater H, 2015, ICES J MAR SCI; GLASS L, 1988, MATH BIOSCI, V90, P111, DOI 10.1016/0025-5564(88)90060-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hallfredsson EH, 2009, CAN J FISH AQUAT SCI, V66, P1693, DOI 10.1139/F09-105; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Hjermann DO, 2004, MAR ECOL PROG SER, V273, P229, DOI 10.3354/meps273229; Johannesen E, 2012, ICES J MAR SCI, V69, P880, DOI 10.1093/icesjms/fss046; Kato H, 1996, J ECONOMETRICS, V75, P147, DOI 10.1016/0304-4076(95)01774-7; Kolmogorov A. N., 1941, B ACAD SCI USSR    M, P3; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Ozaki T., 2012, TIME SERIES MODELING; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tanokura Y., 2004, ADV APPL STAT, V4, P65; Tett P, 2013, MAR ECOL PROG SER, V494, P1, DOI 10.3354/meps10539; Ushakov NG., 2003, P 10 NORW RUSS S BER, P8; Wiener N., 1956, MODERN MATH ENG, P165	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0208078	10.1371/journal.pone.0208078	http://dx.doi.org/10.1371/journal.pone.0208078			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682020	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500011
J	Loman, JGB; de Vries, SA; Kukken, N; van Baaren, RB; Buijzen, M; Muller, BCN				Loman, Jeroen G. B.; de Vries, Sarah A.; Kukken, Niels; van Baaren, Rick B.; Buijzen, Moniek; Muller, Barbara C. N.			Quick question or intensive inquiry: The role of message elaboration in the effectiveness of self-persuasive anti-alcohol posters	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; MENTAL CONTAMINATION; PERIPHERAL ROUTES; VISUAL-ATTENTION; HEALTH CAMPAIGNS; DRINKING; ADVERTISEMENTS; DETERMINANT; INFORMATION; INVOLVEMENT	Self-persuasion (i.e., generating your own arguments) is often more persuasive than direct persuasion (i.e., being provided with arguments), even when the technique is applied in media messages by framing the message as a question. It is unclear, however, if these messages are more persuasive when viewed for a long period to allow more elaboration about the message, or for a short period to reduce elaboration. In the current experiment, this is addressed by examining whether anti-alcohol posters framed as a statement (direct persuasion) or an open-ended question (self-persuasion) are more effective to reduce alcohol consumption under conditions of short-or long message exposure, compared to a control condition (no poster). Additionally, the potentially moderating roles of self-perceived alcohol identity and self-esteem on both types of persuasion are examined. Participants (N = 149) were exposed to a self-persuasion or direct persuasion anti-alcohol poster, either briefly before or continuously during a bogus beer taste task. The amount of alcohol consumed was the covert dependent variable. Contrary to expectations, both posters failed to affect alcohol consumption, regardless of exposure length. No moderation effects for self-perceived alcohol identity and self-esteem of the participants were found. Possible explanations are discussed.	[Loman, Jeroen G. B.; van Baaren, Rick B.; Buijzen, Moniek; Muller, Barbara C. N.] Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Gelderland, Netherlands; [de Vries, Sarah A.] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford, England; [Kukken, Niels] Eberhard Karls Univ Tubingen, Social Cognit & Decis Sci, Baden Wurttemberg, Germany	Radboud University Nijmegen; University of Oxford; Eberhard Karls University of Tubingen	Loman, JGB (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, Nijmegen, Gelderland, Netherlands.	j.loman@bsi.ru.nl	, Barbara/O-4912-2019	, Barbara/0000-0003-1812-8531				Agostinelli G, 2002, ALCOHOL RES HEALTH, V26, P15; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Aronson E, 1999, AM PSYCHOL, V54, P875, DOI 10.1037/h0088188; Babor TF., ALCOHOL NO ORDINARY; Beaglehole R, 2009, LANCET, V373, P2173, DOI 10.1016/S0140-6736(09)61168-5; Bernritter SF, 2017, EUR J MARKETING, V51, P1075, DOI 10.1108/EJM-04-2015-0213; BLACKWELL RT, 1985, COGNITIVE THER RES, V9, P399, DOI 10.1007/BF01173089; Brinol P, 2012, J PERS SOC PSYCHOL, V102, P925, DOI 10.1037/a0027231; BROCKNER J, 1985, J EXP SOC PSYCHOL, V21, P346, DOI 10.1016/0022-1031(85)90035-6; Brown KG, 2016, ALCOHOL ALCOHOLISM, V51, P354, DOI 10.1093/alcalc/agv104; Buijzen M, 2010, COMMUN THEOR, V20, DOI 10.1111/j.1468-2885.2010.01370.x; Carpenter CJ, 2015, HUM COMMUN RES, V41, P501, DOI 10.1111/hcre.12054; CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752; Clarkson JJ, 2011, J EXP SOC PSYCHOL, V47, P449, DOI 10.1016/j.jesp.2010.12.003; Conner M, 1999, J APPL SOC PSYCHOL, V29, P1676, DOI 10.1111/j.1559-1816.1999.tb02046.x; Damen TGE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128635; DICKERSON CA, 1992, J APPL SOC PSYCHOL, V22, P841, DOI 10.1111/j.1559-1816.1992.tb00928.x; Engels RCME, 2000, ADDICT BEHAV, V25, P435, DOI 10.1016/S0306-4603(98)00123-3; Engels RCME, 1999, SUBST USE MISUSE, V34, P1261, DOI 10.3109/10826089909039408; Field A., 2018, DISCOVERING STAT USI, V5th ed.; FRIEDRICH J, 1990, TEACH PSYCHOL, V17, P23, DOI 10.1207/s15328023top1701_5; Frings D, 2018, ALCOHOL ALCOHOLISM, V53, P46, DOI 10.1093/alcalc/agx076; GEORGE WH, 1988, J STUD ALCOHOL, V49, P450, DOI 10.15288/jsa.1988.49.450; Glock S, 2013, J HEALTH PSYCHOL, V18, P252, DOI 10.1177/1359105312439734; GREENWALD AG, 1968, J PERS SOC PSYCHOL, V8, P31, DOI 10.1037/h0021237; Grimes A, 2007, INT J MARKET RES, V49, P191, DOI 10.1177/147078530704900205; Heath R. G., 2000, INT J ADVERT, V19, P287, DOI [10.1080/02650487.2000.11104802, DOI 10.1080/13527260]; Hendriks H, 2012, BRIT J HEALTH PSYCH, V17, P843, DOI 10.1111/j.2044-8287.2012.02080.x; JANIS IL, 1954, J PERS, V22, P504, DOI 10.1111/j.1467-6494.1954.tb01870.x; JANIS IL, 1954, J ABNORM SOC PSYCH, V49, P211, DOI 10.1037/h0056957; Jeffreys H., 1939, OXFORD CLASSIC TEXTS; Jones A, 2016, PSYCHOPHARMACOLOGY, V233, P917, DOI 10.1007/s00213-015-4171-z; Kersbergen I, 2017, PSYCHOL ADDICT BEHAV, V31, P435, DOI 10.1037/adb0000284; KING BT, 1956, HUM RELAT, V9, P177, DOI 10.1177/001872675600900202; Krischler M, 2015, ADDICT RES THEORY, V23, P343, DOI 10.3109/16066359.2015.1009829; Kuendig H, 2012, ALCOHOL CLIN EXP RES, V36, P732, DOI 10.1111/j.1530-0277.2011.01663.x; Loman JGB, 2018, J EXP PSYCHOL-APPL, V24, P81, DOI 10.1037/xap0000162; MADDUX JE, 1980, J PERS SOC PSYCHOL, V39, P235; Maio GR, 2007, PERS SOC PSYCHOL REV, V11, P46, DOI 10.1177/1088868306294589; Meyers-Levy J, 1999, J MARKETING, V63, P45, DOI 10.2307/1252100; Moss AC, 2015, ADDICT BEHAV, V44, P94, DOI 10.1016/j.addbeh.2014.11.035; Muller BCN, 2017, SOC PSYCHOL-GERMANY, V48, P113, DOI 10.1027/1864-9335/a000293; Muller BCN, 2016, J HEALTH PSYCHOL, V21, P60, DOI 10.1177/1359105314522083; Muller BCN, 2009, ADDICT BEHAV, V34, P427, DOI 10.1016/j.addbeh.2008.12.016; Mussweiler T, 2000, J EXP SOC PSYCHOL, V36, P194, DOI 10.1006/jesp.1999.1415; Petty R.E., 1986, ADV EXP SOC PSYCHOL, DOI DOI 10.1016/S0065-2601(08)60214-2; PETTY RE, 1981, J PERS SOC PSYCHOL, V40, P432, DOI 10.1037/0022-3514.40.3.432; PETTY RE, 1984, J PERS SOC PSYCHOL, V46, P69, DOI 10.1037/0022-3514.46.1.69; PETTY RE, 1983, J CONSUM RES, V10, P135, DOI 10.1086/208954; PETTY RE, 1981, J PERS SOC PSYCHOL, V41, P847, DOI 10.1037/0022-3514.41.5.847; Petty RE, 2002, J PERS SOC PSYCHOL, V82, P722, DOI 10.1037//0022-3514.82.5.722; Petty RE, 2009, ATTITUDES INSIGHTS F; R Development Core Team, 2009, R LANG ENV STAT COMP; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI DOI 10.1515/9781400876136; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; STAUTZ K, 2016, BMC PUBLIC HEALTH, V16; STEELE CM, 1981, J PERS SOC PSYCHOL, V41, P831, DOI 10.1037/0022-3514.41.5.831; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wanke M, 1996, PERS SOC PSYCHOL B, V22, P1105, DOI 10.1177/01461672962211002; WHO, 2014, GLOB STAT REP ALC HL; WILSON TD, 1994, PSYCHOL BULL, V116, P117, DOI 10.1037/0033-2909.116.1.117; Wood AM, 2018, LANCET, V391, P1513, DOI 10.1016/S0140-6736(18)30134-X	67	3	3	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211030	10.1371/journal.pone.0211030	http://dx.doi.org/10.1371/journal.pone.0211030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677084	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400043
J	Sakai, D; Harada, K; Shibata, H; Kawaguchi, K; Nishii, J				Sakai, Daisuke; Harada, Kenji; Shibata, Hiroyuki; Kawaguchi, Keiga; Nishii, Junji			Surface relief hologram formed by selective SiO2 deposition on soda-lime silicate glass	PLOS ONE			English	Article							CORONA DISCHARGE; GRATINGS; FABRICATION; LASER	We propose the fabrication of surface relief holograms via selective SiO2 deposition on soda-lime silicate glass substrates. Initially, the original hologram was recorded on an azobenzene photosensitive polymer film coated on the soda-lime silicate glass by irradiation with a conventional continuous wave Ar+ laser with a wavelength of 514.5 nm. The hologram was transferred to the soda-lime silicate glass surface via a corona discharge treatment as an index modulation hologram, which was created by partial substitution of protons for sodium ions during the corona discharge treatment in air. After the corona discharge treatment, the polymer film was removed from the substrate. The diffraction efficiency of the index hologram on the soda-lime silicate glass was estimated to be 5.8 x 10(-2) % at a wavelength of 532 nm. Finally, the glass substrate was subjected to corona discharge treatment in air with vaporized cyclic siloxane. A surface relief hologram with the diffraction efficiency of 2.3% was successfully fabricated on the soda-lime silicate glass.	[Sakai, Daisuke; Harada, Kenji] Kitami Inst Technol, Sch Reg Innovat & Social Design Engn, Fac Engn, Kitami, Hokkaido, Japan; [Shibata, Hiroyuki] Kitami Inst Technol, Sch Earth Energy & Environm Engn, Fac Engn, Kitami, Hokkaido, Japan; [Kawaguchi, Keiga; Nishii, Junji] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Kitami Institute of Technology; Kitami Institute of Technology; Hokkaido University	Sakai, D (corresponding author), Kitami Inst Technol, Sch Reg Innovat & Social Design Engn, Fac Engn, Kitami, Hokkaido, Japan.	d_sakai@mail.kitami-it.ac.jp			Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials" Research Program in the "Network Joint Research Center for Materials and Devices" [20173010]; JSPS KAKENHI [JP 18K04765]; Japan Society for the Promotion of Science (JSPS), Japan	Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials" Research Program in the "Network Joint Research Center for Materials and Devices"; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Part of this work was performed under the "Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials" Research Program in the "Network Joint Research Center for Materials and Devices" (20173010) (DS, JN). Part of this work was also supported by JSPS KAKENHI "Grant-in-Aid for Scientific Research (C)", Grant Number JP 18K04765 (DS), by the Japan Society for the Promotion of Science (JSPS), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG BJ, 1979, APPL OPTICS, V18, P2407, DOI 10.1364/AO.18.002407; CLOSE DH, 1969, APPL PHYS LETT, V14, P159, DOI 10.1063/1.1652756; Dussauze M, 2010, J PHYS CHEM C, V114, P12754, DOI 10.1021/jp1033905; Enami Y, 2000, APPL PHYS LETT, V76, P1086, DOI 10.1063/1.125947; Ikeda H, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817760; Kawaguchi K, 2014, APPL SURF SCI, V300, P149, DOI 10.1016/j.apsusc.2014.02.024; Kawamura K, 2000, APPL PHYS B-LASERS O, V71, P119, DOI 10.1007/s003400000335; KIM DY, 1995, APPL PHYS LETT, V66, P1166, DOI 10.1063/1.113845; LEITH EN, 1963, J OPT SOC AM, V53, P1377, DOI 10.1364/JOSA.53.001377; Munakata K, 2001, OPT LETT, V26, P4, DOI 10.1364/OL.26.000004; Nastas AM, 2016, J NON-CRYST SOLIDS, V438, P7, DOI 10.1016/j.jnoncrysol.2016.02.004; Nastas AM, 2009, TECH PHYS+, V54, P305, DOI 10.1134/S1063784209020236; Niino H, 2006, J LASER MICRO NANOEN, V1, P39, DOI 10.2961/jlmn.2006.01.0008; Reinke N, 2004, APPL PHYS B-LASERS O, V78, P205, DOI 10.1007/s00340-003-1369-2; ROCHON P, 1995, APPL PHYS LETT, V66, P136, DOI 10.1063/1.113541; Sakai D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2459675; Sakai D, 2008, JPN J APPL PHYS, V47, P7929, DOI 10.1143/JJAP.47.7929; Sakai D, 2016, SCI REP-UK, V6, DOI 10.1038/srep27767; Sakai D, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.01AE01; Suzuki T, 2016, J NON-CRYST SOLIDS, V452, P125, DOI 10.1016/j.jnoncrysol.2016.08.037	20	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210340	10.1371/journal.pone.0210340	http://dx.doi.org/10.1371/journal.pone.0210340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677070	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400012
J	Bentley, RF; Jones, JH; Hirai, DM; Zelt, JT; Giles, MD; Raleigh, JP; Quadrilatero, J; Gurd, BJ; Neder, JA; Tschakovsky, ME				Bentley, Robert F.; Jones, Joshua H.; Hirai, Daniel M.; Zelt, Joel T.; Giles, Matthew D.; Raleigh, James P.; Quadrilatero, Joe; Gurd, Brendon J.; Neder, J. Alberto; Tschakovsky, Michael E.			Submaximal exercise cardiac output is increased by 4 weeks of sprint interval training in young healthy males with low initial (Q) over dot-(V) over dot O-2: Importance of cardiac response phenotypeis	PLOS ONE			English	Article							PERCEIVED EXERTION; BLOOD-FLOW; OLDER MEN; ENDURANCE; MUSCLE; VARIABILITY; RATINGS; REST; LEG	Cardiovascular adaptations to exercise, particularly at the individual level, remain poorly understood. Previous group level research suggests the relationship between cardiac output and oxygen consumption ((Q) over dot-(V) over dot O-2) is unaffected by training as submaximal (Q) over dot is unchanged. We recently identified substantial inter-individual variation in the exercise (Q) over dot-(V) over dot O-2 relationship that was correlated to stroke volume (SV) as opposed to arterial oxygen content. Therefore we explored the effects of sprint interval training (SIT) on modulating (Q) over dot-(V) over dot O-2 given an individual's specific (Q) over dot-(V) over dot O-2 relationship. 22 (21 +/- 2 yrs) healthy, recreationally active males participated in a 4-week SIT (8, 20 second sprints; 4x/week, 170% of the work rate at (V) over dot O-2 peak) study with progressive exercise tests (PET) until exhaustion. Cardiac output ((Q) over dot L/min; inert gas rebreathe, Finometer Modelflow (TM)), oxygen consumption ((V) over dot O-2 L/min; breath-by-breath pulmonary gas exchange), quadriceps oxygenation (near infrared spectroscopy) and exercise tolerance (6-20; Borg Scale RPE) were measured throughout PET both before and after training. Data are mean Delta from bsl +/- SD. Higher (Q) over dot (H(Q) over dot) and lower (Q) over dot (L(Q) over dot) responders were identified post hoc (n = 8/group). SIT increased the (Q) over dot-(V) over dot O-2 post-training in L(Q) over dot (3.8 +/- 0.2 vs. 4.7 +/- 0.2; P = 0.02) while H(Q) over dot was unaffected (5.8 +/- 0.1 vs. 5.3 +/- 0.6; P = 0.5). Delta(Q) over dot was elevated beyond 80 watts in L(Q) over dot due to a greater increase in SV (all P<0.04). Peak (V) over dot O-2 (ml/kg/min) was increased in L(Q) over dot (39.7 +/- 6.7 vs. 44.5 +/- 7.3; P = 0.015) and H(Q) over dot (47.2 +/- 4.4 vs. 52.4 +/- 6.0; P = 0.009) following SIT, with H(Q) over dot having a greater peak (V) over dot O-2 both pre (P = 0.02) and post (P = 0.03) training. Quadriceps muscle oxygenation and RPE were not different between groups (all P>0.1). In contrast to H(Q) over dot, L(Q) over dot responders are capable of improving submaximal (Q) over dot-(V) over dot O-2 in response to SIT via increased SV. However, the increased submaximal exercise (Q) over dot does not benefit exercising muscle oxygenation.	[Bentley, Robert F.; Tschakovsky, Michael E.] Queens Univ, Sch Kinesiol & Hlth Studies, Human Vasc Control Lab, Kingston, ON, Canada; [Jones, Joshua H.; Hirai, Daniel M.; Zelt, Joel T.; Neder, J. Alberto] Queens Univ, Dept Med, Div Respirol, Lab Clin Exercise Physiol, Kingston, ON, Canada; [Giles, Matthew D.; Raleigh, James P.; Gurd, Brendon J.] Queens Univ, Queens Muscle Physiol Lab, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Quadrilatero, Joe] Univ Waterloo, Dept Kinesiol, Muscle Biol & Cell Death Lab, Waterloo, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Waterloo	Tschakovsky, ME (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Human Vasc Control Lab, Kingston, ON, Canada.	mt29@queensu.ca		M. Hirai, Daniel/0000-0002-7861-637X; Tschakovsky, Michael/0000-0002-6461-8534	Natural Sciences and Engineering Research Council (NSERC) of Canada [250367-11, EQPEQ0407690-11]; Canadian Foundation for Innovation; Ontario Innovation Trust; NSERC Post Graduate Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; NSERC Post Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant 250367-11 and Research Tools and Instruments Grant EQPEQ0407690-11, as well as infrastructure grants from the Canadian Foundation for Innovation and the Ontario Innovation Trust to M.E. Tschakovsky. R.F. Bentley was supported by an NSERC Post Graduate Scholarship.	Abbiss CR, 2015, SPORTS MED, V45, P1235, DOI 10.1007/s40279-015-0344-5; Adami A, 2014, RESP PHYSIOL NEUROBI, V193, P55, DOI 10.1016/j.resp.2014.01.007; Agostoni P, 2005, J AM COLL CARDIOL, V46, P1779, DOI 10.1016/j.jacc.2005.08.005; ANDREW GM, 1966, J APPL PHYSIOL, V21, P603, DOI 10.1152/jappl.1966.21.2.603; ARMSTRONG RB, 1987, J APPL PHYSIOL, V62, P1285, DOI 10.1152/jappl.1987.62.3.1285; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; Bentley RF, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13570; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Calbet JAL, 2015, SCAND J MED SCI SPOR, V25, P144, DOI 10.1111/sms.12604; COX ML, 1986, J APPL PHYSIOL, V61, P926, DOI 10.1152/jappl.1986.61.3.926; CUMMIN ARC, 1986, J PHYSIOL-LONDON, V370, P567, DOI 10.1113/jphysiol.1986.sp015951; DONEVAN RE, 1962, J APPL PHYS, V17, P487; EIKEN O, 1987, ACTA PHYSIOL SCAND, V131, P339, DOI 10.1111/j.1748-1716.1987.tb08248.x; EKBLOM B, 1968, J APPL PHYSIOL, V24, P518, DOI 10.1152/jappl.1968.24.4.518; Esaki K, 2005, EUR J APPL PHYSIOL, V95, P361, DOI 10.1007/s00421-005-0008-5; Eves ND, 2002, ERGONOMICS, V45, P840, DOI 10.1080/00140130210159995; FAULKNER JA, 1977, MED SCI SPORT EXER, V9, P148; Faulkner J, 2007, EUR J APPL PHYSIOL, V101, P613, DOI 10.1007/s00421-007-0536-2; Fontana P, 2009, INT J SPORTS MED, V30, P747, DOI 10.1055/s-0029-1225340; Gillen JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154075; Gratton E, 1997, PHILOS T ROY SOC B, V352, P727, DOI 10.1098/rstb.1997.0055; HARTLEY LH, 1969, SCAND J CLIN LAB INV, V24, P335, DOI 10.3109/00365516909080170; Hepple RT, 2002, CAN J APPL PHYSIOL, V27, P56, DOI 10.1139/h02-004; Keller DM, 2003, J APPL PHYSIOL, V94, P542, DOI 10.1152/japplphysiol.00817.2002; Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013; MacNutt MJ, 2015, APPL PHYSIOL NUTR ME, V40, P155, DOI 10.1139/apnm-2014-0297; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; Montero D, 2015, MED SCI SPORT EXER, V47, P2024, DOI 10.1249/MSS.0000000000000640; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Nalcakan GR, 2014, J HUM KINET, V44, P97, DOI 10.2478/hukin-2014-0115; Peyton Philip J, 2004, J Clin Monit Comput, V18, P373, DOI 10.1007/s10877-005-1589-6; Proctor DN, 1998, J APPL PHYSIOL, V84, P599, DOI 10.1152/jappl.1998.84.2.599; REEVES JT, 1961, J APPL PHYSIOL, V16, P283, DOI 10.1152/jappl.1961.16.2.283; ROWELL LB, 1964, J CLIN INVEST, V43, P1677, DOI 10.1172/JCI105043; Saltin B., 1968, CIRCULATION, V38, P1, DOI 10.1161/01.CIR.38.1.1; Sarkin JA, 1997, MED SCI SPORTS EXERC, V29, pS91; Scharf M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002566; SEALS DR, 1984, J APPL PHYSIOL, V57, P1024, DOI 10.1152/jappl.1984.57.4.1024; Snyder EM, 2006, J PHYSIOL-LONDON, V571, P121, DOI 10.1113/jphysiol.2005.098558; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Tam E, 2004, CLIN SCI, V106, P371, DOI 10.1042/CS20030302; Trilk JL, 2011, EUR J APPL PHYSIOL, V111, P1591, DOI 10.1007/s00421-010-1777-z; YAMAGUCHI I, 1986, J APPL PHYSIOL, V61, P2168, DOI 10.1152/jappl.1986.61.6.2168	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0195458	10.1371/journal.pone.0195458	http://dx.doi.org/10.1371/journal.pone.0195458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673702	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800001
J	Hill, AO; Bavinton, BR; Armstrong, G				Hill, Adam O.; Bavinton, Benjamin R.; Armstrong, Gregory			Prevalence and correlates of lifetime and recent HIV testing among men who have sex with men (MSM) who use mobile geo-social networking applications in Greater Tokyo	PLOS ONE			English	Article							RISK BEHAVIOR; BISEXUAL MEN; YOUNG MEN; PREVENTION; INFECTIONS; APPS; GAY; PARTNERS; SEEKING; COHORT	Men who have sex with men (MSM) are disproportionately burdened by the human immunodeficiency virus (HIV), accounting for 78% of all Japanese male HIV cases in 2016. Over 30% of newly identified HIV infections in Japan are diagnosed as AIDS annually, suggesting a large proportion of people living with HIV were unaware of their own infection status. An estimated two-thirds of Japanese men who have sex with men (MSM) are not attached to the gay community, and previous studies have largely sampled gay venues, thus, previous studies have likely failed to reach many men in this population. This study therefore examined HIV testing prevalence and correlates among MSM in Greater Tokyo who use gay mobile geo-social networking applications (gay mobile apps), which have been found to increase access to MSM not traditionally accessible through venue-based surveys. Among a sample of 1657 MSM recruited through advertisements on gay mobile apps, the prevalence of lifetime and six-monthly HIV testing was 72.8% and 29.7% respectively. In multiple regression analysis, higher lifetime HIV testing was associated with older age, education, HIV knowledge, anal intercourse with regular and casual male partners, and gay venue attendance. Testing was negatively associated with regular male partner condom use, marriage, residing outside central Tokyo and having both male and female partners. These results indicated that MSM who use gay mobile apps in Greater Tokyo do not meet the CDC yearly testing recommendations for high risk populations. Considering limited HIV prevention funding in Japan for MSM, moderate lifetime and recent testing, and the large number of gay mobile app users, utilization of popular gay mobile apps to promote nearby HIV testing facilities may be an effective prevention policy to target non-community attached MSM, particularly at-risk youth and individuals at risk of sudden-onset AIDS.	[Hill, Adam O.] Univ Melbourne, Fac Arts, Sch Social & Polit Sci, Parkville, Vic, Australia; [Bavinton, Benjamin R.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Armstrong, Gregory] Univ Melbourne, Nossal Inst Global Hlth, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia	University of Melbourne; University of New South Wales Sydney; Kirby Institute; University of Melbourne	Hill, AO (corresponding author), Univ Melbourne, Fac Arts, Sch Social & Polit Sci, Parkville, Vic, Australia.	orlandohill@gmail.com	Armstrong, Gregory/K-1068-2015	Armstrong, Gregory/0000-0002-8073-9213; Bavinton, Benjamin Robert/0000-0001-5834-8278; hill, adam/0000-0001-5874-9821	Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship; University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences; National Health and Medical Research Council in Australia [APP1138096]	Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship; University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences; National Health and Medical Research Council in Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors wish to acknowledge the funding and support of the Australian Government Research Training Program (RTP) Stipend Scholarship & International Postgraduate Research Scholarship, and the University of Melbourne Faculty of Arts Graduate School of Social and Political Sciences. Additionally, Dr Gregory Armstrong is funded by an Early Career Fellowship with the National Health and Medical Research Council in Australia (APP1138096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, NON TRADITIONAL REF; Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Bien CH, 2015, AIDS BEHAV, V19, P941, DOI 10.1007/s10461-014-0994-6; Brito AM, 2015, PMID, V10, DOI [10.1371/journal.pone.0130445, DOI 10.1186/1471-2458-13-1236]; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; CDC FACT SHEET, 2014, HIV AFR AM, P1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; DiStefano AS, 2016, SSM-POPUL HLTH, V2, P436, DOI 10.1016/j.ssmph.2016.05.010; Down I, 2017, AIDS BEHAV, V21, P2543, DOI 10.1007/s10461-017-1747-0; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Goedel WC, 2016, J URBAN HEALTH, V93, P400, DOI 10.1007/s11524-016-0043-z; Grindr. Grindr, 2018, ANNUAL REPORT OF A R; Grosskopf NA, 2014, AM J MENS HEALTH, V8, P510, DOI 10.1177/1557988314527311; HIV/AIDS in Japan, 2016, IASR; Hoff CC, 2012, AIDS PATIENT CARE ST, V26, P738, DOI 10.1089/apc.2012.0198; Holloway IW, 2014, AIDS BEHAV, V18, P285, DOI 10.1007/s10461-013-0671-1; Holt M, 2012, AIDS BEHAV, V16, P13, DOI 10.1007/s10461-010-9872-z; ICHIKAWA S., 2017, J AIDS RES, V19, P71; Inoue Yoji, 2015, Nihon Koshu Eisei Zasshi, V62, P106, DOI 10.11236/jph.62.3_106; Jin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kirwan P. D., 2016, HIV in the UK: 2016 report; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Lehmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086603; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McKenney J, 2017, AIDS BEHAV; Mor Z, 2011, SEX TRANSM INFECT, V87, P532, DOI 10.1136/sextrans-2011-050048; Munoz FA, 2010, AIDS EDUC PREV, V22, P455, DOI 10.1521/aeap.2010.22.5.455; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Nishijima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143874; Page C., 2014, FRAUD ON THE LINE JA, P21; Page C., 2014, KYUSHU ASS EC SCI, V52, P21; Phillips G, 2014, AIDS BEHAV, V18, P1630, DOI 10.1007/s10461-014-0760-9; Pottie K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006859; Rendina HJ, 2014, AIDS BEHAV, V18, P41, DOI 10.1007/s10461-013-0573-2; Rhodes SD, 2016, CLIN INFECT DIS, V62, P1450, DOI 10.1093/cid/ciw127; Rice E., 2012, Journal of AIDS and Clinical Research, P005; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rolander A., 2014, THESIS; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Shiono S., 2013, ANN REPORT RES GROUP, P247; Shiono Satoshi, 2013, Nihon Koshu Eisei Zasshi, V60, P639; Sohn Aeree, 2012, Osong Public Health Res Perspect, V3, P156, DOI 10.1016/j.phrp.2012.07.001; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tateyama M, 2013, KOKURITSU KANSEN KEN; TATEYAMA M, 2013, NIHONJIJOUHO; UNAIDS, 2014, 90 90 90 AMB TREATM; Witzel TC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011372; Yehadji D, 2015, THESIS; Young SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103790; Zhang L, 2013, SEX TRANSM DIS, V40, P235, DOI 10.1097/OLQ.0b013e31827ca6b9; Zou HC, 2017, ARCH SEX BEHAV, V46, P885, DOI 10.1007/s10508-016-0709-3	57	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209933	10.1371/journal.pone.0209933	http://dx.doi.org/10.1371/journal.pone.0209933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673729	Green Published, gold			2022-12-27	WOS:000456442800025
J	Igarashi, K; Kikutani, T; Tamura, F				Igarashi, Kumi; Kikutani, Takeshi; Tamura, Fumiyo			Survey of suspected dysphagia prevalence in home-dwelling older people using the 10-Item Eating Assessment Tool (EAT-10)	PLOS ONE			English	Article							OROPHARYNGEAL DYSPHAGIA; HOSPITALIZED-PATIENTS; ASPIRATION PNEUMONIA; SWALLOWING DISORDERS; QUESTIONNAIRE; ASSOCIATION; PHARYNGEAL; PREDICTORS; CRITERIA; QUALITY	Objective This study was carried out to determine the prevalence of suspected dysphagia and its features in both independent and dependent older people living at home. Materials and methods The 10-Item Eating Assessment Tool (EAT-10) questionnaire was sent to 1,000 independent older people and 2,000 dependent older people living at home in a municipal district of Tokyo, Japan. The participants were selected by stratified randomization according to age and care level. We set the cut-off value of EAT-10 at a score of >3. The percentage of participants with an EAT-10 score >3 was defined as the prevalence of suspected dysphagia. The chi-square test was used for analyzing prevalence in each group. Analysis of the distribution of EAT-10 scores, and comparisons among items, age groups, and care levels to identify symptom features were performed using the Kruskal-Wallis test and Mann-Whitney U test. Results Valid responses were received from 510 independent older people aged 65 years or older (mean age 75.0 +/- 7.2) and 886 dependent older people (mean age 82.3 +/- 6.7). The prevalences of suspected dysphagia were 25.1% and 53.8%, respectively, and showed significant increases with advancing age and care level. In both groups, many older people assigned high scores to the item about coughing, whereas individuals requiring high-level care assigned higher scores to the items about not only coughing but also swallowing of solids and quality of life. Conclusion In independent people, approximately one in four individuals showed suspected dysphagia and coughing was the most perceivable symptom. In dependent people, approximately one in two individuals showed suspected dysphagia and their specifically perceivable symptoms were coughing, difficulties in swallowing solids and psychological burden.	[Igarashi, Kumi; Kikutani, Takeshi] Nippon Dent Univ Tokyo, Div Clin Oral Rehabil, Grad Sch Life Dent, Tokyo, Japan; [Kikutani, Takeshi; Tamura, Fumiyo] Nippon Dent Univ Tokyo, Tama Oral Rehabil Clin, Tokyo, Japan; [Tamura, Fumiyo] Nippon Dent Univ Tokyo, Div Rehabil Speech & Swallowing Disorders, Tokyo, Japan	Nippon Dental University; Nippon Dental University; Nippon Dental University	Kikutani, T (corresponding author), Nippon Dent Univ Tokyo, Div Clin Oral Rehabil, Grad Sch Life Dent, Tokyo, Japan.; Kikutani, T (corresponding author), Nippon Dent Univ Tokyo, Tama Oral Rehabil Clin, Tokyo, Japan.	kikutani@tky.ndu.ac.jp	田中, 公美/ABC-4309-2020; Kikutani, Takeshi/ABA-3337-2020; Tamura, Fumiyo/ABA-9984-2020	田中, 公美/0000-0002-1912-2628; Kikutani, Takeshi/0000-0003-3815-5545	Comprehensive Research on Aging and Health [15dk0107010h0002]; Japan Agency for Medical Research and Development (AMED)	Comprehensive Research on Aging and Health; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work is supported by the Comprehensive Research on Aging and Health (15dk0107010h0002) from Japan Agency for Medical Research and Development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GN, 1996, GASTROENTEROLOGY, V110, P383, DOI 10.1053/gast.1996.v110.pm8566584; Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919, DOI 10.1177/000348940811701210; Bergamaschi R, 2008, J NEUROL SCI, V269, P49, DOI 10.1016/j.jns.2007.12.021; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Carrion S, 2015, CLIN NUTR, V34, P436, DOI 10.1016/j.clnu.2014.04.014; Chen PH, 2009, DYSPHAGIA, V24, P1, DOI 10.1007/s00455-008-9156-1; Clave P, 2004, REV ESP ENFERM DIG, V96, P119, DOI 10.4321/s1130-01082004000200005; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fujita K, 2006, J EPIDEMIOL, V16, P261, DOI 10.2188/jea.16.261; Izawa S, 2007, CLIN NUTR, V26, P764, DOI 10.1016/j.clnu.2007.08.007; Izawa S, 2006, CLIN NUTR, V25, P962, DOI 10.1016/j.clnu.2006.05.006; Kawashima K, 2004, DYSPHAGIA, V19, P266, DOI 10.1007/s00455-004-0013-6; Kazuya M., 2011, JPEN J PARENTER ENTE, V26, P1265, DOI [10.11244/jjspen.26.1265, DOI 10.11244/JJSPEN.26.1265]; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; MARTIN JH, 1994, ANN OTO RHINOL LARYN, V103, P749, DOI 10.1177/000348949410301001; Matsuda S., 2011, ASIAN PACIFIC J DIS, V5, P65, DOI [10.7223/j.1365-2842.2007.01741.x, DOI 10.7223/J.1365-2842.2007.01741.X, 10.7223/apjdm.5.65, DOI 10.7223/APJDM.5.65]; Ministry of Health, LAB WELF DEM STAT AN; Ministry of Health, 2007, PERC DISTR MAJ CAUS, V19; Ministry of Internal Affairs and Communications, 2016, JAP STAT YB; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Miura H, 2007, J ORAL REHABIL, V34, P422, DOI 10.1111/j.1365-2842.2007.01741.x; Nogueira D, 2013, CLIN INTERV AGING, V8, P221, DOI 10.2147/CIA.S39452; Otto DM, 2016, CODAS, V28, P724, DOI 10.1590/2317-1782/20162015139; Park YH, 2013, GERIATR NURS, V34, P212, DOI 10.1016/j.gerinurse.2013.02.014; Roy N, 2007, ANN OTO RHINOL LARYN, V116, P858, DOI 10.1177/000348940711601112; Schiele JT, 2013, EUR J CLIN PHARMACOL, V69, P937, DOI 10.1007/s00228-012-1417-0; Serra-Prat M, 2011, J AM GERIATR SOC, V59, P186, DOI 10.1111/j.1532-5415.2010.03227.x; Speyer R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/458678; Sura L, 2012, CLIN INTERV AGING, V7, P287, DOI 10.2147/CIA.S23404; Swan K, 2015, QUAL LIFE RES, V24, P2447, DOI 10.1007/s11136-015-0990-y; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Vivanti AP, 2009, J HUM NUTR DIET, V22, P148, DOI 10.1111/j.1365-277X.2009.00944.x; Wakabayashi H, 2014, J FRALITY AGING, V3, P97, DOI 10.14283/jfa.2014.8; Wakabayashi H., 2014, JJSPEN, V29, P871, DOI [10.11244/jjspen.29.871, DOI 10.11244/JJSPEN.29.871]; Wijnhoven HAH, 2012, CLIN NUTR, V31, P351, DOI 10.1016/j.clnu.2011.10.013; Xue QL, 2008, J GERONTOL A-BIOL, V63, P984, DOI 10.1093/gerona/63.9.984	37	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211040	10.1371/journal.pone.0211040	http://dx.doi.org/10.1371/journal.pone.0211040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673750	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800068
J	Kobelt, G; Teich, V; Cavalcanti, M; Canzonieri, AM				Kobelt, Gisela; Teich, Vanessa; Cavalcanti, Marcela; Canzonieri, Ana Maria			Burden and cost of multiple sclerosis in Brazil	PLOS ONE			English	Article							LIFE	Background The objective of this study was to estimate costs to society and patients' quality of life (QoL) at all levels of disease severity (measured with the Expanded Disability Status Scale, EDSS) in Brazil. Methods The study was part of an international, cross-sectional burden-of-illness study carried out in collaboration with national MS patient organizations. All information was collected directly from patients using a validated questionnaire. Direct costs were estimated both from societal and payer perspectives, while total costs are presented as societal costs. Results The survey included 694 patients (response rate 21%; mean age 40.8 years). 95% of patients were of working age, and around half were working. The mean EDSS score was 3.2 (62.5% of patients with EDSS <3). Relapses were reported by 18.9% of patients. Fatigue affected almost all patients (94%) regardless of EDSS level, and cognitive difficulties were reported by 69.1% of patients. Mean utility ranged from 0.77 at EDSS 0 to negative values at EDSS 9, with a mean score of 0.58; utility was affected by relapses. Total mean annual cost was R$33,872 ((sic) 8,000) per patient in the societal perspective, with direct costs representing 81% (R$ 27,355, (sic) 6,500). Direct costs for the payer amounted to R$ 16,793 ((sic) 4,000)/patient. Conclusions This study included a population with relatively mild and early disease, with a majority of patients with relapsing disease and thus on DMD treatment. It is not possible to conclude directly on the total cost of MS in Brazil. Nevertheless, resource quantities used, QoL and MS symptoms are very similar to what was seen in the European survey.	[Kobelt, Gisela] European Hlth Econ, Stockholm, Sweden; [Teich, Vanessa; Cavalcanti, Marcela] Sense Co, Sao Paulo, Brazil; [Canzonieri, Ana Maria] ABEM, Sao Paulo, Brazil		Kobelt, G (corresponding author), European Hlth Econ, Stockholm, Sweden.	gk@healtheconomics.se			Biogen	Biogen(Biogen)	The authors disclose the following financial support for the research, authorship and publication of this article: The study was funded through an investigator-initiated study grant from Biogen to Sense Company of which V Teich and M Cavalcanti were employees. Neither the funder (Biogen) nor Sense Company did play a role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2018, RECOMMENDATION REPOR; *BRAZ I GEOGR STAT, GDP PER CAPITA 2010, P2010; Brazilian Institute of Geography and Statistics, PRICES PANEL; DAGPEREIRA A, 2015, MULT SCLER RELAT DIS, V4, P572; Fragoso YD, 2010, ARQ NEURO-PSIQUIAT, V68, P914, DOI 10.1590/S0004-282X2010000600016; Kobelt G, 2017, MULT SCLER J, V23, P4, DOI 10.1177/1352458517708097; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Machado S., 2012, ATLAS MULTIPLE SCLER; *MIN HLTH, 2017, RECOMMENDATION REPOR, P286; *MIN HLTH, 2009, ECONOMIC EVALUATION; Ministerio da Saude (Brasil). Secretaria de Atenc Saude, 2015, APROVA O PROTOCOLO C, P1; Ministry of Health. Secretary of Science Technology and Strategic Inputs, ACADEMIA BRASILEIRA; Ministry of Health. Secretary of Science Technology and Strategic Inputs, 2017, ORDINANCE N 391; Ministry of Health. Secretary of Science Technology and Strategic Inputs, MANAGEMENT SYSTEM OF; Ministry of Planning Development and Management, INFORMATICS DEPARTME; SAU P, 2015, PORTARIA, P1; Takemoto MLS, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0318-1; Takemoto ML, 2015, OFFICIAL JOURNAL, V13, P119; Viegas Andrade Monica, 2013, Value Health Reg Issues, V2, P405, DOI 10.1016/j.vhri.2013.01.009; World Health Organization (WHO) Multiple Sclerosis Inernational Federation, 2008, PORTARIA	21	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208837	10.1371/journal.pone.0208837	http://dx.doi.org/10.1371/journal.pone.0208837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673707	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800011
J	Reynard, F; Christe, D; Terrier, P				Reynard, Fabienne; Christe, David; Terrier, Philippe			Postural control in healthy adults: Determinants of trunk sway assessed with a chest-worn accelerometer in 12 quiet standing tasks	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; SEX-DIFFERENCES; BALANCE CONTROL; BODY-WEIGHT; STABILITY; GAIT; HIP; AGE; INDIVIDUALS; INSTABILITY	Many diseases and conditions decrease the ability to control balance. In clinical settings, there is therefore a major interest in the assessment of postural control. Trunk accelerometry is an easy, low-cost method used for balance testing and constitutes an alternative method to the posturography using force platforms. The objective was to assess the responsiveness of accelerometry in a battery of 12 quiet standing tasks. We evaluated the balance of 100 healthy adults with an accelerometer fixed onto the sternum. We used the average amplitude of acceleration as an indirect measure of postural sways. The tasks of increased difficulty were realized with or without vision. The battery of tasks was repeated four times on two different days to assess reliability. We analyzed the extent to which the task difficulty and the absence of vision affected the trunk sway. The influence of individual characteristics (age, height, mass, sex, and physical activity level) was also assessed. The reliability analysis revealed that four repetitions of the battery of tasks are needed to reach a high accuracy level (mean ICC = 0.85). The results showed that task difficulty had a very large effect on trunk sways and that the removal of vision further increased sways. Concerning the effects of individual characteristics, we observed that women tended to oscillate more than men did in tasks of low difficulty. Age and physical activity level also had significant effects, whereas height and mass did not. In conclusion, age, sex, and physical fitness are confounders that should be considered when assessing patients' balance. A battery of simple postural tasks measured by upper-trunk accelerometry can be a useful method for simple balance evaluation in clinical settings.	[Reynard, Fabienne; Terrier, Philippe] Clin Romande Readaptat, Sion, Switzerland; [Christe, David] Swiss Fed Inst Technol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Terrier, P (corresponding author), Clin Romande Readaptat, Sion, Switzerland.	Philippe.Terrier@crr-suva.ch	Terrier, Philippe/H-3831-2012	Terrier, Philippe/0000-0002-3693-4505				Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; [Anonymous], P 2011 C AUSTR SOC S; Asseman F, 2005, INT J SPORTS MED, V26, P116, DOI 10.1055/s-2004-830529; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Brown J., 2001, PHYSIOTHERAPY, V87, P489, DOI DOI 10.1016/S0031-9406(05)60696-7; Dalton A, 2013, GAIT POSTURE, V37, P49, DOI 10.1016/j.gaitpost.2012.05.028; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Deliagina TG, 2006, PHYSIOLOGY, V21, P216, DOI 10.1152/physiol.00001.2006; Era P, 2006, GERONTOLOGY, V52, P204, DOI 10.1159/000093652; Friedman J H, 1995, Stat Methods Med Res, V4, P197, DOI 10.1177/096228029500400303; FURMAN JM, 1994, BAILLIERE CLIN NEUR, V3, P501; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Gints Jekabsons, 2016, ARESLAB ADAPTIVE REG; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hart Joseph M, 2007, Res Sports Med, V15, P147, DOI 10.1080/15438620701405289; HASSELKUS BR, 1975, J GERONTOL, V30, P661, DOI 10.1093/geronj/30.6.661; Heebner NR, 2015, GAIT POSTURE, V41, P535, DOI 10.1016/j.gaitpost.2014.12.009; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hess JA, 2005, J MANIP PHYSIOL THER, V28, P582, DOI 10.1016/j.jmpt.2005.08.013; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; Hoffman M, 1998, J ATHL TRAINING, V33, P319; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; HYTONEN M, 1993, ACTA OTO-LARYNGOL, V113, P119, DOI 10.3109/00016489309135778; Jacobs CA, 2007, J ATHL TRAINING, V42, P76; Kamen G, 1998, GERONTOLOGY, V44, P40, DOI 10.1159/000021981; Kim JW, 2011, GERIATR GERONTOL INT, V11, P333, DOI 10.1111/j.1447-0594.2011.00693.x; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Kitabayashi Tamotsu, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P111, DOI 10.2114/jpa.23.111; Ku PX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041539; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; LeClair K, 1996, CLIN BIOMECH, V11, P176, DOI 10.1016/0268-0033(95)00027-5; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Maffiuletti NA, 2005, J ENDOCRINOL INVEST, V28, P2, DOI 10.1007/BF03345521; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; Mayagoitia RE, 2002, GAIT POSTURE, V16, P55, DOI 10.1016/S0966-6362(01)00199-0; Mendiguchia J, 2011, SPORTS MED, V41, P541, DOI 10.2165/11589140-000000000-00000; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P328, DOI 10.1016/S0268-0033(98)00090-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nguyen AD, 2007, J ORTHOP SPORT PHYS, V37, P389, DOI 10.2519/jospt.2007.2487; Nicholas SC, 1998, J VESTIBUL RES-EQUIL, V8, P187, DOI 10.1016/S0957-4271(97)00031-1; O'Sullivan M, 2009, AGE AGEING, V38, P308, DOI 10.1093/ageing/afp009; Parreira RB, 2017, GAIT POSTURE, V57, P161, DOI 10.1016/j.gaitpost.2017.06.008; Patel M, 2008, GAIT POSTURE, V28, P649, DOI 10.1016/j.gaitpost.2008.04.018; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Preuss R, 2008, J ELECTROMYOGR KINES, V18, P815, DOI 10.1016/j.jelekin.2007.03.003; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Reynard F, 2017, J BIOMECH, V65, P212, DOI 10.1016/j.jbiomech.2017.10.020; Riemann BL, 2003, ARCH PHYS MED REHAB, V84, P90, DOI 10.1053/apmr.2003.50004; Riva D., 2013, J AGING RES, V2013, P14, DOI [10.1155/2013/561695, DOI 10.1155/2013/561695]; Rogind H, 2003, CLIN PHYSIOL FUNCT I, V23, P171, DOI 10.1046/j.1475-097X.2003.00492.x; Terrier P, 2014, J APPL BIOMECH, V30, P305, DOI 10.1123/jab.2013-0142; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; TROPP H, 1988, J ORTHOPAED RES, V6, P833, DOI 10.1002/jor.1100060607; Turcot K, 2009, CLIN BIOMECH, V24, P716, DOI 10.1016/j.clinbiomech.2009.07.003; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wolfson L, 1996, J AM GERIATR SOC, V44, P498, DOI 10.1111/j.1532-5415.1996.tb01433.x	68	15	15	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211051	10.1371/journal.pone.0211051	http://dx.doi.org/10.1371/journal.pone.0211051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673753	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800069
J	Cobussen, M; Stassen, PM; Posthouwer, D; van Tiel, FH; Savelkoul, PHM; Havenith, T; Haeseker, MB				Cobussen, Maarten; Stassen, Patricia M.; Posthouwer, Dirk; van Tiel, Frank H.; Savelkoul, Paul H. M.; Havenith, Thomas; Haeseker, Michiel B.			Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department	PLOS ONE			English	Article							SEPTIC SHOCK; PHARMACOKINETICS; THERAPY; PROGRAM; DEFINITIONS; EXPERIENCE; RISK	Objective To achieve an optimal effect in patients with sepsis at the emergency department (ED), the gentamicin peak-concentration should be sufficiently high (i.e. peak-concentration/MIC >= 8-10). ICU patients with sepsis often need higher gentamicin doses to achieve sufficiently high peak-concentrations. The aim of this study is to investigate which dose is needed to reach adequate peak-concentrations in patients presenting with sepsis at the ED. Methods Patients with sepsis at the ED were included from August 2015 until February 2017. Peak-concentrations were measured in blood 30 minutes after the first gentamicin dose. The study consisted of three phases. In the first phase, peak-concentrations were measured after a standard dose of 5mg/kg. In the second phase, a simulation ((peak-concentration/actual dose) x simulated dose) was performed to determine which dose was needed to reach adequate gentamicin peak-concentrations of >= 16mg/L. In the third phase, peak-concentrations were measured for the best simulated dose. Results In phase one, of 86 patients who received a dose of 5mg/kg, 34 (39.5%) patients did not reach the target peak-concentration of >= 16mg/L, and 73 (84.9%) did not reach >= 20mg/L. In phase two, the simulation showed that with a dose of 7mg/kg 83 (96.5%) patients would reach peak-concentrations >= 16mg/L, and 67 (77.9%) of >= 20mg/L. In phase three, 53 patients received a dose of 7mg/kg, of whom 45 (84.9%) reached peak-concentrations of >= 16mg/L, and 31 (58.5%) of >= 20mg/L. Conclusion Patients with sepsis at the ED need higher doses of gentamicin. A dose of 7mg/kg is needed to achieve adequate peak-concentrations in the majority of patients.	[Cobussen, Maarten; van Tiel, Frank H.; Savelkoul, Paul H. M.; Haeseker, Michiel B.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [Stassen, Patricia M.; Posthouwer, Dirk] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Havenith, Thomas] Maastricht Univ, Med Ctr, Dept Clin Pharm, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Cobussen, M (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	maarten.cobussen@mumc.nl		Haeseker, Michiel/0000-0001-7902-2744				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Blot SI, 2014, ADV DRUG DELIVER REV, V77, P3, DOI 10.1016/j.addr.2014.07.006; Buijk SE, 2002, INTENS CARE MED, V28, P936, DOI 10.1007/s00134-002-1313-7; Cobussen M, 2016, INFECT DIS-NOR, V48, P274, DOI 10.3109/23744235.2015.1109136; DASTA JF, 1988, CRIT CARE MED, V16, P327, DOI 10.1097/00003246-198804000-00004; de Greeff SC., 2017, NETHMAP 2017 CONSUMP; Dutch Working Party on Antibiotic Policy (SWAB), 2010, SWAB GUIDELINES ANTI; European Centre for Disease Prevention and Control, 2017, ANN REP EUR ANT RES; European Society of Clinical Microbiology and Infectious Diseases (EUCAST), 2009, GENT RAT EUCAST CLIN; Goncalves-Pereira J, 2010, CLIN MICROBIOL INFEC, V16, P1258, DOI 10.1111/j.1469-0691.2009.03074.x; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kashuba ADM, 1999, ANTIMICROB AGENTS CH, V43, P623, DOI 10.1128/AAC.43.3.623; Lacy MK, 1998, CLIN INFECT DIS, V27, P23, DOI 10.1086/514620; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MOORE RD, 1984, ANN INTERN MED, V100, P352, DOI 10.7326/0003-4819-100-3-352; NICOLAU DP, 1995, ANTIMICROB AGENTS CH, V39, P650, DOI 10.1128/AAC.39.3.650; Ong DSY, 2017, CLIN INFECT DIS, V64, P1731, DOI 10.1093/cid/cix186; Rea RS, 2008, THER DRUG MONIT, V30, P674, DOI 10.1097/FTD.0b013e31818b6b2f; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tang GJ, 1999, ACTA ANAESTH SCAND, V43, P726, DOI 10.1034/j.1399-6576.1999.430707.x; TRAYNOR AM, 1995, ANTIMICROB AGENTS CH, V39, P545, DOI 10.1128/AAC.39.2.545	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210012	10.1371/journal.pone.0210012	http://dx.doi.org/10.1371/journal.pone.0210012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668571	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400003
J	ElZohary, L; Weglicki, WB; Chmielinska, JJ; Kramer, JH; Mak, IT				ElZohary, Lama; Weglicki, William B.; Chmielinska, Joanna J.; Kramer, Jay H.; Mak, I. Tong			Mg-supplementation attenuated lipogenic and oxidative/nitrosative gene expression caused by Combination Antiretroviral Therapy (cART) in HIV-1-transgenic rats	PLOS ONE			English	Article							OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; F-2-ISOPROSTANE LEVELS; MAGNESIUM INTAKE; HIV-1; DISEASES; PLASMA; INFLAMMATION; TOXICITY; HEART	We determined if HIV-1 expression in transgenic (HIV-1-Tg) rats enhanced hepatic genomic changes related to oxidative/nitrosative stress and lipogenesis during cART-treatment, and assessed effects of Mg-supplementation. A clinically used cART (atazanavir-ritonavir+Truvada) was given orally to control and HIV-1-Tg rats (18 weeks) with normal or 6-fold dietary-Mg. Oxidative/nitrosative and lipogenic genes were determined by real-time RT-PCR. cART induced a 4-fold upregulation of sterol regulatory element-binding protein-1 (SREBP-1) in HIV-1-Tg-rats, but not in controls; Tg rats displayed a 2.5-fold higher expression. Both were completely prevented by Mg-supplementation. Nrf2 (Nuclear erythroid-derived factor 2), a master transcription factor controlling redox homeostasis, was down-regulated 50% in HIV-Tg rats, and reduced further to 25% in Tg+cART-rats. Two downstream antioxidant genes, heme oxygenase-1(HmOX1) and Glutathione-S-transferase(GST), were elevated in HIV-Tg alone but were suppressed by cART treatment. Decreased Nrf2 in Tg +/- cART were normalized by Mg-supplementation along with the reversal of altered HmOX1 and GST expression. Concomitantly, iNOS (inducible nitric oxide synthase) was upregulated 2-fold in Tg+cART rats, which was reversed by Mg-supplementation. In parallel, cART-treatment led to substantial increases in plasma 8-isoprostane, nitrotyrosine, and RBC-GSSG (oxidized glutathione) levels in HIV-1-Tg rats; all indices of oxidative/nitrosative stress were suppressed by Mg-supplementation. Both plasma triglyceride and cholesterol levels were elevated in Tg+cART rats, but were lowered by Mg-supplementation. Thus, the synergistic effects of cART and HIV-1 expression on lipogenic and oxidative/nitrosative effects were revealed at the genomic and biochemical levels. Down-regulation of Nrf2 in the Tg+cART rats suggested their antioxidant response was severely compromised; these abnormal metabolic and oxidative stress effects were effectively attenuated by Mg-supplementation at the genomic level.	[ElZohary, Lama; Weglicki, William B.; Chmielinska, Joanna J.; Kramer, Jay H.; Mak, I. Tong] George Washington Univ, Schoold Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA	George Washington University	Mak, IT (corresponding author), George Washington Univ, Schoold Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA.	itmak@gwu.edu			NIH [R21-HL-125038]; George Washington University McCormick Genomic & Proteomic Center Supplemental Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Washington University McCormick Genomic & Proteomic Center Supplemental Fund	The study was funded by NIH R21-HL-125038 (to I.T. Mak), and in part by The George Washington University McCormick Genomic & Proteomic Center Supplemental Fund (to I.T. Mak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOT J, 1990, CAN J CHEM, V68, P1537, DOI 10.1139/v90-237; Arts EJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007161; Borsa M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0298-0; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chacko SA, 2010, DIABETES CARE, V33, P304, DOI 10.2337/dc09-1402; Chen X, 2014, FREE RADICAL BIO MED, V69, P77, DOI 10.1016/j.freeradbiomed.2014.01.011; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; Fan X, 2013, AM J PHYSIOL-LUNG C, V305, P1267, DOI 10.1152/ajplung.00288.2012; Fan Y, 2016, J BIOL CHEM, V291, P22819, DOI 10.1074/jbc.M116.731828; FDA, 2005, EST MAX SAF START DO; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; Global HIV & AIDS statistics-2018 fact sheet, NON TRADITIONAL REF; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Haynes RL, 2009, ACTA NEUROPATHOL, V118, P391, DOI 10.1007/s00401-009-0540-1; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; Letendre Scott, 2011, Top Antivir Med, V19, P137; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mak IT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082409; Mak IT, 2013, AM J PHYSIOL-REG I, V305, pR1102, DOI 10.1152/ajpregu.00268.2013; Mak IT, 2009, CARDIOVASC TOXICOL, V9, P78, DOI 10.1007/s12012-009-9040-8; Mak IT, 2000, CELL MOL BIOL, V46, P1337; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Pokan R, 2006, BRIT J SPORT MED, V40, P773, DOI 10.1136/bjsm.2006.027250; Poorolajal J, 2016, PUBLIC HEALTH, V139, P3, DOI 10.1016/j.puhe.2016.05.004; Rathbun RC, 2018, MEDSCAPE; Redhage LA, 2009, HIV CLIN TRIALS, V10, P181, DOI 10.1310/hct1003-181; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Shah A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18929; Sharp PM, 2010, PHILOS T R SOC B, V365, P2487, DOI 10.1098/rstb.2010.0031; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Song YQ, 2007, AM J CLIN NUTR, V85, P1068, DOI 10.1093/ajcn/85.4.1068; Sontia B, 2007, ARCH BIOCHEM BIOPHYS, V458, P33, DOI 10.1016/j.abb.2006.05.005; Staitieh BS, 2017, J LEUKOCYTE BIOL, V102, P517, DOI 10.1189/jlb.4A0616-282RR; Taha AY, 2012, PROSTAG LEUKOTR ESS, V87, P91, DOI 10.1016/j.plefa.2012.07.006; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027; van 't Erve TJ, 2017, REDOX BIOL, V12, P582, DOI 10.1016/j.redox.2017.03.024; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zhao MM, 2015, J PHARMACOL SCI, V129, P143, DOI 10.1016/j.jphs.2015.08.001	43	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210107	10.1371/journal.pone.0210107	http://dx.doi.org/10.1371/journal.pone.0210107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668566	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400006
J	Englert, C; Koroma, D; Bertrams, A; Martarelli, CS				Englert, Chris; Koroma, Dennis; Bertrams, Alex; Martarelli, Corinna S.			Testing the validity of the attention control video: An eye-tracking approach of the ego depletion effect	PLOS ONE			English	Article							SELF-CONTROL; STRENGTH MODEL; GLUCOSE; WILLPOWER; ENERGY	The attention control video has been frequently applied to test the ego depletion effect. However, its validity has never been tested, a shortcoming we address in this preregistered study. In the first task, self-control strength was temporarily depleted in the depletion condition (n = 56) but remained intact in the control condition (n = 56). The attention control video served as the secondary task, and we assumed that the depletion condition would perform significantly worse compared to the control condition. Attention regulation was measured with an eye-tracking device. The results revealed that the gaze behavior in the two conditions differed statistically significantly; however, the actual difference was small, indicating that the attention control video may not be an optimal measure of self-control.	[Englert, Chris; Koroma, Dennis; Bertrams, Alex] Univ Bern, Inst Sci Educ, Bern, Switzerland; [Englert, Chris] Goethe Univ Frankfurt, Inst Sport Sci, Frankfurt, Germany; [Koroma, Dennis] Univ Bern, Inst Psychol, Bern, Switzerland; [Martarelli, Corinna S.] Swiss Distance Learning Univ, Brig, Switzerland	University of Bern; Goethe University Frankfurt; University of Bern	Englert, C (corresponding author), Univ Bern, Inst Sci Educ, Bern, Switzerland.; Englert, C (corresponding author), Goethe Univ Frankfurt, Inst Sport Sci, Frankfurt, Germany.	Englert@sport.uni-frankfurt.de	Englert, Chris/V-7995-2017; Martarelli, Corinna/AAJ-2990-2021	Englert, Chris/0000-0002-4757-8040; Martarelli, Corinna/0000-0001-9160-793X				Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Baumeister RF, 2016, PERSPECT PSYCHOL SCI, V11, P574, DOI 10.1177/1745691616652878; Bertrams A, 2014, Z ENTWICKLUNGSPSYCHO, V46; Bertrams A, 2010, J RES PERS, V44, P738, DOI 10.1016/j.jrp.2010.09.005; Bertrams A, 2009, DIAGNOSTICA, V55, P2, DOI 10.1026/0012-1924.55.1.2; Carter E.C., 2018, ADV METHODS PRACT PS; Carter EC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00823; Carter EC, 2013, BEHAV BRAIN SCI, V36, P683, DOI 10.1017/S0140525X13000952; Dang Junhua, 2018, Psychol Res, V82, P645, DOI 10.1007/s00426-017-0862-x; DeWall CN, 2008, PERS SOC PSYCHOL B, V34, P1653, DOI 10.1177/0146167208323981; Dummel S, 2016, J COGN PSYCHOL, V28, P374, DOI 10.1080/20445911.2015.1135929; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Freeman N, 2010, SOC PSYCHOL PERS SCI, V1, P175, DOI 10.1177/1948550609360421; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Gino F, 2011, ORGAN BEHAV HUM DEC, V115, P191, DOI 10.1016/j.obhdp.2011.03.001; Govorun O, 2006, SOC COGNITION, V24, P111, DOI 10.1521/soco.2006.24.2.111; Hagger M. S., 2016, FRONTIERS PSYCHOL, V7; Hagger MS, 2016, PERSPECT PSYCHOL SCI, V11, P546, DOI 10.1177/1745691616652873; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hoang Duc A, 2008, PROGR BRAIN RES; Job V, 2013, P NATL ACAD SCI USA, V110, P14837, DOI 10.1073/pnas.1313475110; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lange F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00572; Lange F, 2014, APPETITE, V75, P54, DOI 10.1016/j.appet.2013.12.020; Lindner C, 2017, PLOS ONE, V12; Lurquin JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147770; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Pearson DG, 2003, Q J EXP PSYCHOL A; Schmeichel B.J., 2010, EFFORTLESS ATTENTION, P29, DOI DOI 10.7551/MITPRESS/9780262013840.003.0002; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wiesner CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170245; Wolff W, 2013, SUBST ABUS TREAT PRE; Wolff W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199554; Xu XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096780, 10.1371/journal.pone.0109950]	39	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211181	10.1371/journal.pone.0211181	http://dx.doi.org/10.1371/journal.pone.0211181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668604	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400033
J	Trotta, MC; Maisto, R; Guida, F; Boccella, S; Luongo, L; Balta, C; D'Amico, G; Herman, H; Hermenean, A; Bucolo, C; D'Amico, M				Trotta, Maria Consiglia; Maisto, Rosa; Guida, Francesca; Boccella, Serena; Luongo, Livio; Balta, Cornel; D'Amico, Giovanbattista; Herman, Hildegard; Hermenean, Anca; Bucolo, Claudio; D'Amico, Michele			The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome	PLOS ONE			English	Article							JUNCTION INTERCELLULAR COMMUNICATION; NICOTINIC-ACID; CONNEXIN-43 EXPRESSION; PUMA-G; APOPTOSIS; INSULIN; GPR109A; CELL; IDENTIFICATION; RELEVANCE	Objective The role of the hydroxycarboxylic acid receptor 2 (HCA(2)) in the retinal damage induced by diabetes has never been explored. In this context, the present study highlights an upregulation of retinal HCA2 receptors in diabetic C57BL6J mice. Moreover, we illustrate that HCA(2) receptors exert an anti-inflammatory effect on the retinal damage induced by diabetes when activated by the endogenous ligand beta-hydroxybutyrate, Methodology Seven-to-10-week-old C57BL6J mice were rendered diabetic by a single intraperitoneal injection of streptozotocin (75 mg/kg of body weight) and monitored intermittently over a 10-week period extending from the initial diabetes assessment. Mice with a fasting blood glucose level higher than 250 mg/dl for 2 consecutive weeks after streptozotocin injection were treated twice a week with intraperitoneal injections of 25-50-100 mg/kg beta-hydroxybutyrate. Results Interestingly, while the retinal endoplasmic reticulum stress markers (pPERK, pIRE1, ATF-6 alpha) were elevated in diabetic C57BL6J mice, their levels were significantly reduced by the systemic intraperitoneal treatment with 50 mg/kg and 100 mg/kg beta-hydroxybutyrate. These mice also exhibited high NLRP3 inflammasome activity and proinflammatory cytokine levels. In fact, the elevated levels of retinal NLRP3 inflammasome activation markers (NLRP3, ASC, caspase-1) and of the relative proinflammatory cytokines (IL-1 beta, IL-18) were significantly reduced by 50 mg/kg and 100 mg/kg beta-hydroxybutyrate treatment. These doses also reduced the high apoptotic cell number exhibited by the diabetic mice in the retinal outer nuclear layer (ONL) and increased the ONL low connexin 43 expression, leading to an improvement in retinal permeability and homeostasis. Conclusions These data suggest that the systemic treatment of diabetic C57BL6J mice with BHB activates retinal HCA(2) and inhibits local damage.	[Trotta, Maria Consiglia; Maisto, Rosa; Guida, Francesca; Boccella, Serena; Luongo, Livio; D'Amico, Michele] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Balta, Cornel; D'Amico, Giovanbattista; Herman, Hildegard; Hermenean, Anca] Vasile Goldis Western Univ Arad, Inst Life Sci, Arad, Romania; [Hermenean, Anca] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest, Romania; [Bucolo, Claudio] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy; [Bucolo, Claudio] Univ Catania, Ctr Res Ocular Pharmacol CERFO, Catania, Italy	Universita della Campania Vanvitelli; Vasile Goldis Western University of Arad; University of Bucharest; University of Catania; University of Catania	D'Amico, M (corresponding author), Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy.	michele.damico@unicampania.it	Luongo, Livio/GXV-1993-2022; Herman, Hildegard/H-8449-2016; Hermenean, Anca/G-5360-2010; Balta, Cornel/AAS-6798-2021	Herman, Hildegard/0000-0002-6741-0245; Hermenean, Anca/0000-0001-8510-6653; Balta, Cornel/0000-0001-5734-0071; Trotta, Maria Consiglia/0000-0001-9813-5955; maisto, rosa/0000-0003-2952-8493; Bucolo, Claudio/0000-0002-4879-4140				Ahmed Kashan, 2011, Front Endocrinol (Lausanne), V2, P51, DOI 10.3389/fendo.2011.00051; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; ALM A, 1985, OPHTHALMIC RES, V17, P181, DOI 10.1159/000265371; Bae HR, 2016, ONCOTARGET, V7, P66444, DOI 10.18632/oncotarget.12119; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Boccella S, 2019, FASEB J, V33, P1062, DOI 10.1096/fj.201801033R; Chaurasia SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21198-z; Chen H, 2018, INVEST OPHTH VIS SCI, V59, P978, DOI 10.1167/iovs.17-22816; Chiu R. W. K., 2002, Hong Kong Medical Journal, V8, P172; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260; Demirtas L, 2016, INDIAN J MED RES, V144, P515, DOI 10.4103/0971-5916.200887; Deng Yaqin, 2018, Biophys Rep, V4, P39, DOI 10.1007/s41048-018-0048-0; Detrick B, 2010, IMMUNOL RES, V47, P153, DOI 10.1007/s12026-009-8146-1; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Eledrisi MS, 2006, AM J MED SCI, V331, P243, DOI 10.1097/00000441-200605000-00002; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Goubaeva F, 2007, BIOCHEM BIOPH RES CO, V352, P97, DOI 10.1016/j.bbrc.2006.10.177; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Guo M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00086; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Iacobas DA, 2008, CELL COMMUN ADHES, V15, P195, DOI 10.1080/15419060802014222; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jing-Xu, 2018, CELL PHYSIOL BIOCHEM, V48, P705, DOI 10.1159/000491897; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Klen J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/616747; Kostylina G, 2008, CELL DEATH DIFFER, V15, P134, DOI 10.1038/sj.cdd.4402238; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Li AF, 2003, INVEST OPHTH VIS SCI, V44, P5376, DOI 10.1167/iovs.03-0360; Li AF, 2009, INVEST OPHTH VIS SCI, V50, P1400, DOI 10.1167/iovs.07-1519; Loukovaara S, 2017, ACTA OPHTHALMOL, V95, P803, DOI 10.1111/aos.13427; Ma WX, 2016, ADV EXP MED BIOL, V854, P73, DOI 10.1007/978-3-319-17121-0_11; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Maisto R, 2017, J CELL MOL MED, V21, P968, DOI 10.1111/jcmm.13036; Martin PM, 2009, MOL VIS, V15, P362; Muto T, 2014, INVEST OPHTH VIS SCI, V55, P4327, DOI 10.1167/iovs.14-14606; Patel Nishal, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P222; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Polotsky VY, 2001, AM J RESP CRIT CARE, V163, P624, DOI 10.1164/ajrccm.163.3.2007120; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rose KL, 2007, PEDIATR RES, V61, P301, DOI 10.1203/pdr.0b013e318030d193; Rossi S, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7368389; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schaub A, 2001, EUR J IMMUNOL, V31, P3714, DOI 10.1002/1521-4141(200112)31:12<3714::AID-IMMU3714>3.0.CO;2-1; Shao BZ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00262; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tang H, 2008, BIOCHEM BIOPH RES CO, V375, P562, DOI 10.1016/j.bbrc.2008.08.041; Trotta Maria Consiglia, 2018, Oncotarget, V9, P17257, DOI 10.18632/oncotarget.23270; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; Yamanashi T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08055-1; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu AL, 2014, CURR EYE RES, V39, P487, DOI 10.3109/02713683.2013.848900; Zheng YY, 2013, GENE, V530, P151, DOI 10.1016/j.gene.2013.07.082	66	28	29	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211005	10.1371/journal.pone.0211005	http://dx.doi.org/10.1371/journal.pone.0211005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657794	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000025
J	Bogdanova, EN; Mariandyshev, AO; Balantcev, GA; Eliseev, PI; Nikishova, EI; Gaida, AI; Enarson, D; Detjen, A; Dacombe, R; Phillips, PPJ; Squire, SB; Gospodarevskaya, E				Bogdanova, E. N.; Mariandyshev, A. O.; Balantcev, G. A.; Eliseev, P. I.; Nikishova, E. I.; Gaida, A. I.; Enarson, D.; Detjen, A.; Dacombe, R.; Phillips, P. P. J.; Squire, S. B.; Gospodarevskaya, E.			Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation	PLOS ONE			English	Article							DIAGNOSTIC PERFORMANCE; PULMONARY TUBERCULOSIS; GENOTYPE MTBDRPLUS; XPERT(R) MTB/RIF; DRUG-RESISTANCE; CULTURE; TB	Background The development of new diagnostic tools allows for faster detection of both tuberculosis (TB) and multidrug-resistant (MDR) TB and should lead to reduced transmission by earlier initiation of anti TB therapy. The research conducted in the Arkhangelsk region of the Russian Federation in 2012-14 included economic evaluation of Line Probe Assay (LPA) implementation in MDR-TB diagnostics compared to existing culture-based diagnostics of Lowenstein Jensen (LJ) and BacTAlert. Clinical superiority of LPA was demonstrated and results were reported elsewhere. Study aim The PROVE-IT Russia study aimed to report the outcomes of the cost minimization analysis. Methods Costs of LPA-based diagnostic algorithm (smear positive (SSm+) and for smear negative (SSm-) culture confirmed TB patients by Bactec MGIT or LJ were compared with conventional culture-based algorithm (LJ-for SSm-and SSm+ patients and BacTAlert-for SSm+patients). Cost minimization analysis was conducted from the healthcare system, patient and societal perspectives and included the direct and indirect costs to the healthcare system (microscopy and drug susceptibility test (DST), hospitalization, medications obtained from electronic medical records) and non-hospital direct costs (patient's travel cost, additional expenses associated with hospitalization, supplementary medicine and food) collected at the baseline and two subsequent interviews using the WHO-approved questionnaire. Results Over the period of treatment the LPA-based diagnostic corresponded to lesser direct and indirect costs comparing to the alternative algorithms. For SSm+ LPA-based diagnostics resulted in the costs 4.5 times less (808.21 US$) than LJ (3593.81 US$) and 2.5 times less than BacTAlert liquid culture (2009.61 US$). For SSm-LPA in combination with Bactec MGIT (1480.75 US$) vs LJ (1785.83 US$) showed the highest cost minimization compared to LJ (2566.09 US$). One-way sensitivity analyses of the key parameters and threshold analyses were conducted and demonstrated that the results were robust to variations in the cost of hospitalization, medications and length of stay. Conclusion From the perspective of Russian Federation healthcare system, TB diagnostic algorithms incorporating LPA method proved to be both more clinically effective and less expensive due to reduction in the number of hospital days to the correct MDR-TB diagnosis and treatment initiation. LPA diagnostics comparing conventional culture diagnostic algorithm MDR-TB was a cost minimizing strategy for both patients and healthcare system.	[Bogdanova, E. N.; Balantcev, G. A.] Northern Arctic Fed Univ, Arkhangelsk, Russia; [Mariandyshev, A. O.; Eliseev, P. I.] Northern State Med Univ, Arkhangelsk, Russia; [Nikishova, E. I.; Gaida, A. I.] Arkhangelsk Clin AntiTB Dispensary, Arkhangelsk, Russia; [Enarson, D.; Detjen, A.] Int Union TB & Lung Dis, Paris, France; [Dacombe, R.; Squire, S. B.; Gospodarevskaya, E.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Phillips, P. P. J.] UCL, MRC Clin Trials Unit, London, England; [Gospodarevskaya, E.] Deakin Univ, Melbourne, Vic, Australia	Northern Arctic Federal University; Northern State Medical University; Liverpool School of Tropical Medicine; Medical Research Council Clinical Trials Unit; University of London; University College London; Deakin University	Bogdanova, EN (corresponding author), Northern Arctic Fed Univ, Arkhangelsk, Russia.	e.n.bogdanova@narfu.ru	Mariandyshev, Andrei/D-1744-2018; Bogdanova, Elena/AAC-7516-2019; Eliseev, Platon I/I-2944-2018; Nikishova, Elena/AAE-9181-2019; Bogdanova, Elena/AAY-1394-2021; Gaida, Anastasia/GWD-0656-2022	Mariandyshev, Andrei/0000-0002-8485-5625; Eliseev, Platon I/0000-0001-9039-4557; Nikishova, Elena/0000-0002-1542-6958; Bogdanova, Elena/0000-0001-9610-4709; Squire, Stephen/0000-0001-7173-9038	United States Agency for International Development (USAID) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	PROVE IT was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB - Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID.	Acuna-Villaorduna C, 2008, CLIN INFECT DIS, V47, P487, DOI 10.1086/590010; Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; [Anonymous], 2008, GEN MTBDRPLUS; [Anonymous], 2010, BACT AL US MAN; Balabanova Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007129; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Dowdy DW, 2014, ELIFE, V3, DOI 10.7554/eLife.02565; Drobniewski F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-190; Eliseev P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152761; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Husereau D, 2013, BJOG-INT J OBSTET GY, V120, P765, DOI 10.1111/1471-0528.12241; Idrees F, 2017, INT J MYCOBACT, V6, P122, DOI 10.4103/ijmy.ijmy_42_17; Jacobs B, 2002, INT J TUBERC LUNG D, V6, P396; Joob B, 2017, INT J MYCOBACT, V6, P322, DOI 10.4103/ijmy.ijmy_105_17; Khaparde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184270; Kuznetsov V, 2016, PUBLIC HEALTH ACTION, V6, P181, DOI 10.5588/pha.16.0033; Liu Q, 2017, CHINESE MED J-PEKING, V130, P1521, DOI 10.4103/0366-6999.208248; Mann G, 2010, INT J TUBERC LUNG D, V14, P1518; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Michael J, 2011, POPUL RES POLICY REV, V30, P839, DOI [10.1007/s11113-011-9213-6, DOI 10.1007/S11113-011-9213-6]; Miller TL, 2010, ANN EPIDEMIOL, V20, P1, DOI 10.1016/j.annepidem.2009.09.004; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Molicotti P, 2014, J INFECT DEV COUNTR, V8, P24, DOI 10.3855/jidc.3295; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Pang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069267; Pinto M, 2016, INT J TUBERC LUNG D, V20, P611, DOI 10.5588/ijtld.15.0455; Salman H, 2006, MGIT PROCEDURE MANUA; Schmid KB, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0678-x; Shah M, 2013, AIDS, V27, P2883, DOI 10.1097/QAD.0000000000000008; Tagliani E, 2015, J CLIN MICROBIOL, V53, P2961, DOI 10.1128/JCM.01257-15; Tans-Kersten J, 2016, PUBLIC HEALTH REP, V131, P117, DOI 10.1177/003335491613100118; van den Hof S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1802-x; Vassall A, 2017, LANCET GLOB HEALTH, V5, pE710, DOI [10.1016/S2214-109X(17)30205-X, 10.1016/s2214-109x(17)30205-x]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2016, GLOB TUB REP; WHO: World Health Organization, 2017, GLOBAL STRATEGY ACTI, P56; World Health Organization, RESP QUEST; World Health Organization, 2011, GUID PROGR MAN DRUG, P33; World Health Organization, 2008, GUID PROGR MAN DRUG, P272; World Health Organization, 2014, GLOB TUB REP; Yacoob FL, 2016, J PATHOG, V2016, DOI 10.1155/2016/6235618	45	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211203	10.1371/journal.pone.0211203	http://dx.doi.org/10.1371/journal.pone.0211203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695043	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000457046400018
J	Cheong, ML; Lai, TH; Wu, WB				Cheong, Mei-Leng; Lai, Tsung-Hsuan; Wu, Wen-Bin			Connective tissue growth factor mediates transforming growth factor beta-induced collagen expression in human endometrial stromal cells	PLOS ONE			English	Article							TGF-BETA; FIBROSIS; CCN2; MYOFIBROBLAST; HSP47	Background Adenomyosis is a medical condition defined by the abnormal presence of endometrial tissue within the myometrium, in which fibrosis occurs with new collagen deposition and myofibroblast differentiation. In this study, the effect of several mediators and growth factors on collagen expression was investigated on human endometrial stromal cells (fibroblasts) derived from adenomyotic endometrium. Experimental approach RT-PCR, Western blot analysis, pharmacological interventions and siRNA interference were applied to primary cultured human endometrial stromal cells (fibroblasts). Immunohistochemistry was used to analyze protein expression in adenomyotic endometrium tissue specimens. Results Of the tested mediators, transforming growth factor beta 1 (TGF beta 1) and its isoforms were effective to induce collagen and connective tissue growth factor (CTGF) expression. Collagen and CTGF induction by TGF beta 1 could be reduced by the inhibitors targeting DNA transcription, protein translation, and Smad2/3 signaling. Interestingly, TGF beta 1 induced Smad2/3 phosphorylation and CTGF mRNA expression, but not collagen mRNA expression, suggesting that TGF beta 1 mediates collagen expression through CTGF induction and Smad2/3 activation. In parallel, TGF beta 1 and CTGF also induced expression of heat shock protein (HSP) 47, a protein required for the synthesis of several types of collagens. However, only CTGF siRNA knockdown, could compromise TGF beta 1-induced collagen expression. Finally, the immunohistochemistry revealed vimentin- and alpha-SMA-positive staining for (myo) fibroblasts, TGF beta 1, collagen, and CTGF in the subepithelial stroma region of human adenomyotic endometria. Conclusion and implications We reveal here that TGF beta 1, collagen, and CTGF are expressed in the stroma of adenomyotic endometria and demonstrate that TGF beta 1 can induce collagen production in endometrium-derived fibroblasts through cellular Smad2/3-dependent signaling pathway and CTGF expression, suggesting that endometrial TGF beta may take part in the pathogenesis of adenomyosis and ectopic endometrium may participate in uterine adenomyosis.	[Cheong, Mei-Leng; Lai, Tsung-Hsuan] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Cheong, Mei-Leng] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Lai, Tsung-Hsuan; Wu, Wen-Bin] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Wu, Wen-Bin] Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Fu Jen Catholic University; Fu Jen Catholic University	Wu, WB (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.; Wu, WB (corresponding author), Fu Jen Catholic Univ, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan.	wenbin@mail.fju.edu.tw	Wu, Wen-Bin/GLT-4711-2022		Cathay General Hospital, Taipei City, Taiwan [102-CGH-FJU-07]	Cathay General Hospital, Taipei City, Taiwan	The work was supported by the research grant (102-CGH-FJU-07) from Cathay General Hospital, Taipei City, Taiwan to WBW. There was no additional external funding received for this study.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blaauboer ME, 2013, MATRIX BIOL, V32, P424, DOI 10.1016/j.matbio.2013.04.005; BONGSO A, 1988, HUM REPROD, V3, P705, DOI 10.1093/oxfordjournals.humrep.a136770; Bonniaud P, 2004, AM J RESP CELL MOL, V31, P510, DOI 10.1165/rcmb.2004-0158OC; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Ding D, 2015, HUM REPROD, V30, P812, DOI 10.1093/humrep/dev025; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; FUJITA M, 1985, Hokkaido Journal of Medical Science, V60, P602; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Ibrahim MG, 2017, REPROD SCI, V24, P1410, DOI 10.1177/1933719116687855; Ikegami A, 1992, Nihon Sanka Fujinka Gakkai Zasshi, V44, P336; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kishi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189522; Kishi Y, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.027; Lai TH, 2015, INT J NANOMED, V10, P5925, DOI 10.2147/IJN.S88514; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Leppert PC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/783289; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Liu XS, 2016, HUM REPROD, V31, P734, DOI 10.1093/humrep/dew018; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Matsuzaki S, 2014, HUM REPROD, V29, P1677, DOI 10.1093/humrep/deu123; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Ota H, 1997, J Obstet Gynaecol Res, V23, P485; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Ryan ST, 2003, J VASC RES, V40, P37, DOI 10.1159/000068937; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Shen MH, 2016, HUM REPROD, V31, P355, DOI 10.1093/humrep/dev314; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Van Bruaene N, 2012, CLIN EXP ALLERGY, V42, P883, DOI 10.1111/j.1365-2222.2011.03898.x; Vannuccini S, 2017, REPROD BIOMED ONLINE, V35, P592, DOI 10.1016/j.rbmo.2017.06.016; Xiao HB, 2012, AM J PHYSIOL-RENAL, V303, pF757, DOI 10.1152/ajprenal.00470.2011	38	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210765	10.1371/journal.pone.0210765	http://dx.doi.org/10.1371/journal.pone.0210765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695033	Green Submitted, gold, Green Published			2022-12-27	WOS:000457046400013
J	Montanier, N; Bernard, L; Lambert, C; Pereira, B; Desbiez, F; Terral, D; Abergel, A; Bohatier, J; Rosset, E; Schmidt, J; Sautou, V; Hadjadj, S; Batisse-Lignier, M; Tauveron, I; Maqdasy, S; Roche, B				Montanier, Nathanaelle; Bernard, Lise; Lambert, Celine; Pereira, Bruno; Desbiez, Francoise; Terral, Daniel; Abergel, Armand; Bohatier, Jerome; Rosset, Eugenio; Schmidt, Jeannot; Sautou, Valerie; Hadjadj, Samy; Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan; Roche, Beatrice			Prospective evaluation of a dynamic insulin infusion algorithm for non critically-ill diabetic patients: A before-after study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; TIGHT GLYCEMIC CONTROL; GLUCOSE CONTROL; HOSPITALIZED-PATIENTS; HYPERGLYCEMIA; PROTOCOL; MORTALITY; MANAGEMENT; HYPOGLYCEMIA; ASSOCIATION	Introduction Insulin infusion is recommended during management of diabetic patients in critical care units to rapidly achieve glycaemic stability and reduce the mortality. The application of an easy-to-use standardized protocol, compatible with the workload is preferred. Glycaemic target must quickly be reached, therefore static algorithms should be replaced by dynamic ones. The dynamic algorithm seems closer to the physiological situation and appreciates insulin sensitivity. However, the protocol must meet both safety and efficiency requirements. Indeed, apprehension from hypoglycaemia is the main deadlock with the dynamic algorithms, thus their application remains limited. In contrary to the critical care units, to date, no prospective study evaluated a dynamic algorithm of insulin infusion in non-critically ill patients. Aim This study primarily aimed to evaluate the efficacy of a dynamic algorithm of intravenous insulin therapy in non-critically-ill patients, and addressed its safety and feasibility in different departments of our university hospital. Methods A "before-after" study was conducted in five hospital departments (endocrinology and four "non-expert" units) comparing a dynamic algorithm (during the "after" period-P2) to the static protocol (the "before" period-P1). Static protocol is based on determining insulin infusion according to an instant blood glycaemia (BG) level at a given time. In the dynamic algorithm, insulin infusion rate is determined according to the rate of change of the BG (the previous and actual BG under a specific insulin infusion rate). Additionally, two distinct glycaemic targets were defined according to the patients' profile: 100-180 mg/dl (5.5-10 mmol/l) for vigorous patients and 140-220 mg/dl (7.8-12.2 mmol/l) for frail ones. Different BG measurements for each patient were collected and recorded in a specific database (e-CRF) in order to analyse the rates of hypo- and hyperglycaemia. A satisfaction survey was also performed. A study approval was obtained from the institutional revision board before starting the study. Results Over 8 months, 72 and 66 patients during P1 and P2 were respectively included. The dynamic algorithm was more efficient, with reduced time to control hyperglycaemia (P1 vs P2:8.3 vs 5.3 hours; HR: 2.02 [1.27; 3.21]; p<0.01), increased the number of in-target BG measurements (P1 vs P2: 37.0% vs 41.8%; p<0.05), and reduced the glycaemic variability related to each patient (P1 vs P2, %CV: 40.9 vs 38.2; p<0.05, Index Correlation Class:0.30 vs 0.14; p<0.05). In patients after the first event of hypoglycemia after having started the infusion, new events were lower (P1 vs P2: 19.4 vs 11.4; p<0.001) thanks to an earlier reaction to hypoglycaemia (8.3% during P1 vs 44.3% during P2; p=0.004). With the dynamic algorithm, the percentage of recurrence of mild hypoglycaemia was significantly lower in frail patients (20.5% vs 10.2%; p<0.001), and in patients managed in the non-expert units (18 vs 7.1%, p<0.001). The % CV was significantly improved in frail patients (36.9%). Mean BG measurements for each patient/day were 5.5 +/- 1.1 during P1 and 6.0 +/- 1.6 during P2 (p=0.6). The threat from hypoglycaemia and the difficulty in using dynamic algorithm are barriers for nurses' adherence. Conclusions This dynamic algorithm for non-critically-ill patients is more efficient and safe than the static protocol, and adapted for frail patients and non-expert units.	[Montanier, Nathanaelle; Desbiez, Francoise; Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan; Roche, Beatrice] CHU Clermont Ferrand, Serv Endocrinol Diabetol & Malad Metab, Clermont Ferrand, France; [Bernard, Lise; Sautou, Valerie] CHU Clermont Ferrand, Pole Pharm, Clermont Ferrand, France; [Lambert, Celine; Pereira, Bruno] CHU Clermont Ferrand, DRCI, Clermont Ferrand, France; [Terral, Daniel] CHU Clermont Ferrand, Serv Pediat Gen, Clermont Ferrand, France; [Abergel, Armand] CHU Clermont Ferrand, Serv Med Digest, Clermont Ferrand, France; [Bohatier, Jerome] CHU Clermont Ferrand, Serv Court Sejour Geriatr, Riom, France; [Rosset, Eugenio] CHU Clermont Ferrand, Serv Chirurg Vasc, Clermont Ferrand, France; [Schmidt, Jeannot] CHU Clermont Ferrand, Pole Urgences, Clermont Ferrand, France; [Hadjadj, Samy] CHU Poitiers, Serv Med Interne Endocrinol & Malad Metab, Poitiers, France; [Batisse-Lignier, Marie; Tauveron, Igor; Maqdasy, Salwan] Univ Clermont Auvergne, Lab GReD, UMR, CNRS 6293,INSERM U1103, Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Maqdasy, S (corresponding author), CHU Clermont Ferrand, Serv Endocrinol Diabetol & Malad Metab, Clermont Ferrand, France.; Maqdasy, S (corresponding author), Univ Clermont Auvergne, Lab GReD, UMR, CNRS 6293,INSERM U1103, Clermont Ferrand, France.	smaqdasy@chu-clermontferrand.fr		SAUTOU, Valerie/0000-0002-3944-3752; MAQDASY, Salwan/0000-0001-5164-9879; Terral, Daniel/0000-0003-3706-6786				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2009, ANN FR ANESTH, V28, P410, DOI DOI 10.1016/J.ANNFAR.2009.02.020; Balkin M, 2007, DIABETES-METAB RES, V23, P49, DOI 10.1002/dmrr.673; Bernard L, 2016, J EVAL CLIN PRACT, V22, P683, DOI 10.1111/jep.12517; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Clergeau A, 2017, DIABETES TECHNOL THE, V19, P115, DOI 10.1089/dia.2016.0314; DeSantis Anthony J, 2006, Endocr Pract, V12, P491; DHondt NJ, 2008, DIABETES SPECTRUM, V21, P255; Dickerson RN, 2012, NUTRITION, V28, P1008, DOI 10.1016/j.nut.2012.01.010; Egi M, 2016, INTENS CARE MED, V42, P562, DOI 10.1007/s00134-016-4216-8; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Furnary Anthony P, 2004, Endocr Pract, V10 Suppl 2, P21; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Kelly Janet L, 2014, Diabetes Spectr, V27, P218, DOI 10.2337/diaspect.27.3.218; Kelly JL, 2006, SEMIN THORAC CARDIOV, V18, P346, DOI 10.1053/j.semtcvs.2006.06.004; Krikorian A, 2010, CURR OPIN CLIN NUTR, V13, P198, DOI 10.1097/MCO.0b013e32833571db; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2017, ENDOCR PRACT, V23, P318, DOI 10.4158/EP161532.OR; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Ku SY, 2005, JT COMM J QUAL PATIE, V31, P141, DOI 10.1016/S1553-7250(05)31019-1; Lien Lillian F, 2005, Endocr Pract, V11, P240; Malesker MA, 2007, AM J CRIT CARE, V16, P589; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; McCreedy EM, 2018, J AM BOARD FAM MED, V31, P192, DOI 10.3122/jabfm.2018.02.170141; Meijering S, 2006, CRIT CARE, V10, DOI 10.1186/cc3981; Miller I, 2015, J CLIN ENDOCR METAB, V100, pE1428, DOI 10.1210/jc.2015-2312; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Monnier L, 2017, DIABETES CARE, V40, P832, DOI 10.2337/dc16-1769; Murad MH, 2012, J CLIN ENDOCR METAB, V97, P49, DOI 10.1210/jc.2011-2100; Noordzij PG, 2007, EUR J ENDOCRINOL, V156, P137, DOI 10.1530/eje.1.02321; Papak J, 2012, AM J CARDIOL, V110, p24B, DOI 10.1016/j.amjcard.2012.08.034; Passarelli AJ, 2016, DIABETES TECHNOL THE, V18, P93, DOI 10.1089/dia.2015.0046; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Rood E, 2005, J AM MED INFORM ASSN, V12, P172, DOI 10.1197/jamia.M1598; Smiley D, 2010, J HOSP MED, V5, P212, DOI 10.1002/jhm.646; Umpierrez G, 2015, DIABETES CARE, V38, P1665, DOI 10.2337/dc15-0303; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211425	10.1371/journal.pone.0211425	http://dx.doi.org/10.1371/journal.pone.0211425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689675	gold, Green Published, Green Submitted			2022-12-27	WOS:000457041800035
J	Weiland-Brauer, N; Malek, I; Schmitz, RA				Weiland-Braeuer, Nancy; Malek, Irene; Schmitz, Ruth A.			Metagenomic quorum quenching enzymes affect biofilm formation of Candida albicans and Staphylococcus epidermidis	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; COLONIZATION; INFECTIONS; INHIBITION; ICA	Biofilm formation in the clinical environment is of increasing concern since a significant part of human infections is associated, and caused by biofilm establishment of (opportunistic) pathogens, for instance Candida albicans and Staphylococcus epidermidis. The rapidly increasing number of antibiotic-resistant biofilms urgently requires the development of novel and effective strategies to prevent biofilm formation ideally targeting a wide range of infectious microorganisms. Both, synthesis of extracellular polymeric substances and quorum sensing are crucial for biofilm formation, and thus potential attractive targets to combat undesirable biofilms. We evaluated the ability of numerous recently identified metagenome-derived bacterial quorum quenching (QQ) proteins to inhibit biofilm formation of C. albicans and S. epidermidis. Here, proteins QQ-5 and QQ-7 interfered with the morphogenesis of C. albicans by inhibiting the yeast-to-hyphae transition, ultimately leading to impaired biofilm formation. Moreover, QQ5 and QQ-7 inhibited biofilm formation of S. epidermidis; in case of QQ7 most likely due to induced expression of the icaR gene encoding the repressor for polysaccharide intercellular adhesin (PIA) synthesis, the main determinant for staphylococcal biofilm formation. Our results indicate that QQ-5 and QQ-7 are attractive potential anti-biofilm agents in the prevention and treatment of C. albicans and S. epidermidis mono-species biofilms, and potentially promising anti-biofilm drugs in also combating multi-species infections.	[Weiland-Braeuer, Nancy; Malek, Irene; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, Kiel, Germany	University of Kiel	Schmitz, RA (corresponding author), Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Weiland-Bräuer, Nancy/ABC-5876-2020	Weiland-Bräuer, Nancy/0000-0001-8284-1222; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	Bundesministerium fur Bildung und Forschung [0315587B]; Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean" [CP1136]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean"	This research was funded by the Bundesministerium fur Bildung und Forschung, grant number 0315587B, https://www.bmbf.de/, and the Deutsche Forschungsgemeinschaft - Exzellenzinitiative "The Future Ocean", grant number CP1136 to RAS, http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031; Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; BURCHARD KW, 1983, ARCH SURG-CHICAGO, V118, P217; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Deep Antariksh, 2011, J Lab Physicians, V3, P4, DOI 10.4103/0974-2727.78553; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dominguez E. G., 2017, CANDIDA BIOFILM TOLE, P77; Dutronc H, 2010, SCAND J INFECT DIS, V42, P890, DOI 10.3109/00365548.2010.498023; Fetzner S, 2015, J BIOTECHNOL, V201, P2, DOI 10.1016/j.jbiotec.2014.09.001; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grandclament C, 2016, FEMS MICROBIOL REV; Herriott MM, 2011, TRENDS MICROBIOL, V19, P557, DOI 10.1016/j.tim.2011.07.004; Kalia V. C., 2015, QUORUM SENSING VS QU, DOI DOI 10.1007/978-81-322-1982-8_26; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Lohse MB, 2018, NAT REV MICROBIOL, V16, P19, DOI 10.1038/nrmicro.2017.107; Lonn-Stensrud J, 2012, FEMS IMMUNOL MED MIC, V65, P326, DOI 10.1111/j.1574-695X.2012.00964.x; MacFaddin JF., 1985, MEDIA ISOLATION CULT, P1; MACK DR, 1995, PEDIATR RES, V37, P75, DOI 10.1203/00006450-199501000-00015; Malek I, 2016, J MATER CHEM B, V4, P5228, DOI 10.1039/c6tb00942e; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Oduwole KO, 2010, J ORTHOP RES, V28, P1252, DOI 10.1002/jor.21110; Olson ME, 2014, J BACTERIOL; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Peyratout CS, 2004, ANGEW CHEM INT EDIT, V43, P3762, DOI 10.1002/anie.200300568; Pujalte MJ, 2005, INT J SYST EVOL MICR, V55, P631, DOI 10.1099/ijs.0.63442-0; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Reiter KC, 2014, INT J ANTIMICROB AG, V43, P248, DOI 10.1016/j.ijantimicag.2013.12.003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Romero Manuel, 2012, Recent Pat Biotechnol, V6, P2; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STEWART PS, 1995, WATER RES, V29, P2006, DOI 10.1016/0043-1354(94)00339-9; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Thein ZM, 2009, MYCOSES, V52, P467, DOI 10.1111/j.1439-0507.2009.01719.x; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Weiland-Brauer N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01098; Weiland-Brauer N, 2015, APPL ENVIRON MICROB, V81, P1477, DOI 10.1128/AEM.03290-14; Weiland-Brauer N, 2017, QUENCHING BACTERIAL; Weiland-Brauer N, QUENCHING BACTERIAL, P62017; Wolfmeier H, 2018, ACS INFECT DIS, V4, P93, DOI 10.1021/acsinfecdis.7b00170; Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006; Xue T, 2015, MICROBES INFECT, V17, P345, DOI 10.1016/j.micinf.2015.01.003	55	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211366	10.1371/journal.pone.0211366	http://dx.doi.org/10.1371/journal.pone.0211366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689669	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800032
J	Ashari, ZE; Brayton, KA; Broschat, SL				Ashari, Zhila Esna; Brayton, Kelly A.; Broschat, Shira L.			Using an optimal set of features with a machine learning-based approach to predict effector proteins for Legionella pneumophila	PLOS ONE			English	Article							IV SECRETED EFFECTORS; TRANSLOCATED SUBSTRATE; SYSTEM; IDENTIFICATION; MACROPHAGES; REGULATOR; ALGORITHM	Type IV secretion systems exist in a number of bacterial pathogens and are used to secrete effector proteins directly into host cells in order to change their environment making the environment hospitable for the bacteria. In recent years, several machine learning algorithms have been developed to predict effector proteins, potentially facilitating experimental verification. However, inconsistencies exist between their results. Previously we analysed the disparate sets of predictive features used in these algorithms to determine an optimal set of 370 features for effector prediction. This study focuses on the best way to use these optimal features by designing three machine learning classifiers, comparing our results with those of others, and obtaining de novo results. We chose the pathogen Legionella pneumophila strain Philadelphia-1, a cause of Legionnaires' disease, because it has many validated effector proteins and others have developed machine learning prediction tools for it. While all of our models give good results indicating that our optimal features are quite robust, Model 1, which uses all 370 features with a support vector machine, has slightly better accuracy. Moreover, Model 1 predicted 472 effector proteins that are deemed highly probable to be effectors and include 94% of known effectors. Although the results of our three models agree well with those of other researchers, their models only predicted 126 and 311 candidate effectors.	[Ashari, Zhila Esna; Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Ashari, ZE (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	z.esnaashariesfahan@wsu.edu		Esna Ashari, Zhila/0000-0003-0454-7794	National Institutes of Health [R01AI042792]; Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01AI042792 by National Institutes of Health (K.A.B.) and by the Carl M. Hansen Foundation (Z.E.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; An Y, 2018, BRIEF BIOINFORM, V19, P148, DOI 10.1093/bib/bbw100; An Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41031; Ashari ZE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197041; Ashari ZE, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P346, DOI 10.1145/3107411.3107416; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Bi DX, 2013, NUCLEIC ACIDS RES, V41, pD660, DOI 10.1093/nar/gks1248; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burstein D, 2009, INT J BIOCHEM CELL B, V5, DOI [10.1371/journal.ppat.1000508, DOI 10.1371/JOURNAL.PPAT.1000508]; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Han N, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/9415459; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lockwood S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027724; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Perry J.W., 1955, J ASSOCIAT INFORMAT, V6, P242, DOI DOI 10.1002/ASI.5090060411; Shohdy N, 2005, P NATL ACAD SCI, V102; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Wang J, 2017, BRIEF BIOINFORM, V1-21, DOI [10.1093/bib/bbw003, DOI 10.1093/BIB/BBW003]; Wang JW, 2018, BIOINFORMATICS, V34, P2546, DOI 10.1093/bioinformatics/bty155; Wang JW, 2017, BIOINFORMATICS, V33, P2756, DOI 10.1093/bioinformatics/btx302; Wang JM, 2018, LECT NOTES COMPUT SC, V10968, P3, DOI 10.1007/978-3-319-94301-5_1; Wang YJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-50; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng C, 2017, BRIEF BIOINFORM, V1-20, DOI [10.1093/bib/bbw003, DOI 10.1093/BIB/BBW003]; Zou LY, 2013, BIOINFORMATICS, V29, P3135, DOI 10.1093/bioinformatics/btt554; Zusman T, 2008, INFECT IMMUN, V76, P4581, DOI 10.1128/IAI.00337-08; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	40	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0202312	10.1371/journal.pone.0202312	http://dx.doi.org/10.1371/journal.pone.0202312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682021	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500002
J	Gomez, MA; Lago, C; Gomez, MT; Furley, P				Gomez, Miguel-Angel; Lago, Carlos; Gomez, Maria-Teresa; Furley, Philip			Analysis of elite soccer players' performance before and after signing a new contract	PLOS ONE			English	Article							EMPIRICAL-EVIDENCE; FOOTBALL; LEAGUE; STATISTICS; PARAMETERS; EVOLUTION; SHIRKING	The aim of the current study was to analyse performance differences of football players 2-years prior and the year after signing a new contract (the following year) while taking playing position, nationality, player's role, team ability, and age into account. The sample was comprised of 249 players (n = 109 defenders, n = 113 midfielders; and n = 27 forwards) from four of the major European Leagues (Bundesliga, English FA Premier League, Ligue 1, and La Liga) during the seasons 2008 to 2015. The dependent variables studied were: shooting accuracy, defense (the sum of defensive actions, tackles, blocks, and interceptions), yellow cards, red cards, passing accuracy, tackle success, and minutes played per match. Twostep cluster analysis allowed classifying the sample into three groups of defenders (national important, foreign important, and less important players) and four groups of midfielders and forwards (national important, foreign important, national less important, and foreign less important players). Magnitude Based Inference (MBI) was used to test the differences between player's performances during the years of analyses. The main results (very likely and most likely effects) showed better performance in the year prior to signing a new contract than the previous year for foreign important defenders (decreased number of red cards), national important midfielders (increased number of minutes played), foreign important forwards (increased minutes played and defense), and national important forwards (increased minutes played). In addition, performance was lower the year after signing the contract compared to the previous one for less important defenders (decreasing defense), national less important midfielders (decreased minutes played), and foreign less important forwards (decreased defense). On the other hand, the players showed better performance in defense and more minutes played the year after signing the contract for less important defenders, national less important midfielders, and foreign less important forwards. These results may assist coaches to decide on when a new contract should be signed or the duration of the contract.	[Gomez, Miguel-Angel; Gomez, Maria-Teresa] Tech Univ Madrid, Fac Phys Act & Sports Sci, Madrid, Spain; [Lago, Carlos] Univ Vigo, Fac Educ & Sport Sci, Pontevedra, Spain; [Furley, Philip] German Sport Univ Cologne, Inst Cognit & Team Racket Sport Res, Cologne, Germany	Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); Universidade de Vigo; German Sport University Cologne	Gomez, MA (corresponding author), Tech Univ Madrid, Fac Phys Act & Sports Sci, Madrid, Spain.	magor_2@yahoo.es	Gómez, Miguel Ángel Sánchez/Z-5549-2019; Furley, Philip/V-2921-2019; Gomez, Miguel-Angel/I-2606-2012; LAGO-PENAS, CARLOS/E-3957-2016	Gómez, Miguel Ángel Sánchez/0000-0002-8940-6271; Gomez, Miguel-Angel/0000-0002-9585-3158; Furley, Philip/0000-0002-1230-2220; LAGO-PENAS, CARLOS/0000-0002-1626-2035	Ministry of Economy and competitiveness of Spain [DEP2016-75785-R]	Ministry of Economy and competitiveness of Spain(Spanish Government)	The present study was supported by the Ministry of Economy and competitiveness of Spain with the project "Diseno y desarrollo de un software para el analisis del rendimiento en futbol" (DEP2016-75785-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Berri DJ, 2006, ECON INQ, V44, P536, DOI 10.1093/ei/cbj033; Bradley PS, 2014, INT J SPORT PHYSIOL, V9, P415, DOI [10.1123/ijspp.2013-0304, 10.1123/IJSPP.2013-0304]; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Bullough S, 2016, INT J SPORTS SCI COA, V11, P662, DOI 10.1177/1747954116667104; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Bush MD, 2015, INT J SPORT PHYSIOL, V10, P865, DOI 10.1123/ijspp.2014-0484; Della Torre E, 2018, EUR MANAG REV, V15, P121, DOI 10.1111/emre.12136; Dellal A, 2010, INT SPORTMED J, V11, P278; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Frick B, 2007, SCOT J POLIT ECON, V54, P422, DOI 10.1111/j.1467-9485.2007.00423.x; Frick B, 2011, INT J SPORT FINANC, V6, P87; Gomez MA, 2016, INT J PERF ANAL SPOR, V16, P553, DOI 10.1080/24748668.2016.11868908; Gramm CL, 1997, FOLLOWING LEADER RAC; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; King Gary, 1994, DESIGNING SOCIAL INQ; Lago-Penas C, 2017, INT J PERF ANAL SPOR, V17, P86, DOI 10.1080/24748668.2017.1304024; Lago-Penas C, 2016, INT J PERF ANAL SPOR, V16, P792, DOI 10.1080/24748668.2016.11868928; LEHN K, 1982, J LAW ECON, V25, P343, DOI 10.1086/467020; Liu HY, 2016, J SPORT SCI, V34, P509, DOI 10.1080/02640414.2015.1117121; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P803, DOI 10.1080/24748668.2013.11868690; Mackenzie R, 2013, J SPORT SCI, V31, P639, DOI 10.1080/02640414.2012.746720; Marburger D. R., 2003, Journal of Sports Economics, V4, P19, DOI 10.1177/1527002502239656; Maxcy J. G., 2002, Journal of Sports Economics, V3, P246, DOI 10.1177/1527002502003003002; Schuth G, 2016, J SPORT SCI, V34, P501, DOI 10.1080/02640414.2015.1127402; SCOGGINS JF, 1993, SOUTHERN ECON J, V60, P239, DOI 10.2307/1059947; Thelwell R, 2005, J APPL SPORT PSYCHOL, V17, P326, DOI 10.1080/10413200500313636	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211058	10.1371/journal.pone.0211058	http://dx.doi.org/10.1371/journal.pone.0211058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682101	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500094
J	Goupy, F; Supiot, S; Pasquier, D; Latorzeff, I; Schick, U; Monpetit, E; Martinage, G; Herve, C; Le Proust, B; Castelli, J; de Crevoisier, R				Goupy, Flora; Supiot, Stephane; Pasquier, David; Latorzeff, Igor; Schick, Ulrike; Monpetit, Erik; Martinage, Geoffrey; Herve, Chloe; Le Proust, Bernadette; Castelli, Joel; de Crevoisier, Renaud			Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysis	PLOS ONE			English	Article							ADJUVANT ANDROGEN DEPRIVATION; EXTERNAL-BEAM RADIOTHERAPY; RATE BRACHYTHERAPY BOOST; PHASE-III TRIAL; RADIATION-THERAPY; RADICAL PROSTATECTOMY; RANDOMIZED-TRIAL; PROGNOSTIC-SIGNIFICANCE; DOSE-RESPONSE; INVASION	Objectives No study has reported clinical results of external-beam radiotherapy specifically for T3b prostate cancer. The possibility of escalating the dose to the involved seminal vesicles (ISV) while respecting the dose constraints in the organs at risk is thus so far not clearly demonstrated. The objective of the study was to analyze the dose distribution and the clinical outcome in a large series of patients who received IMRT for T3b prostate cancer. Materials and methods This retrospective analysis included all patients who received IMRT and androgen deprivation therapy for T3b prostate cancer, between 2008 and 2017, in six French institutions, with available MRI images and dosimetric data. Results A total of 276 T3b patients were included. The median follow-up was 26 months. The median (range) prescribed doses (Gy) to the prostate and to the ISV were 77 (70-80) and 76 (46-80), respectively. The dose constraint recommendations were exceeded in less than 12% of patients for the rectum and the bladder. The 5-year risks of biochemical and clinical recurrences and cancer-specific death were 24.8%, 21.7%, and 10.3%, respectively. The 5year risks of local, pelvic lymph node, and metastatic recurrences were 6.4%, 11.3%, and 15%, respectively. The number of involved lymph nodes (<= 2 or >= 3) on MRI was the only significant prognostic factor in clinical recurrence (HR 9.86) and death (HR 2.78). Grade. 2 acute and 5-year late toxicity rates were 13.2% and 12% for digestive toxicity, and 34% and 31.5% for urinary toxicity, respectively. The dose to the pelvic lymph node and the age were predictive of late digestive toxicity. Conclusion IMRT for T3b prostate cancer allows delivery of a curative dose in the ISV, with a moderate digestive toxicity but a higher urinary toxicity. Lymph node involvement increases the risk of recurrence and death.	[Goupy, Flora; Herve, Chloe; Castelli, Joel; de Crevoisier, Renaud] CLCC Eugene Marquis, Radiat Dept, Rennes, France; [Supiot, Stephane] CLCC Rene Gauducheau, Radiat Dept, Nantes, France; [Pasquier, David; Martinage, Geoffrey] CLCC Oscar Lambret, Radiat Dept, Lille, France; [Latorzeff, Igor] Clin Pasteur, Radiat Dept, Toulouse, France; [Schick, Ulrike] Univ Hosp Cavale Blanche, Radiat Dept, Brest, France; [Monpetit, Erik] Clin St Yves, Radiat Dept, Vannes, France; [Le Proust, Bernadette] CLCC Eugene Marquis, Med Imaging Dept, Rennes, France; [Castelli, Joel; de Crevoisier, Renaud] Univ Rennes 1, LTSI, Inserm U1099, Rennes, France	UNICANCER; Centre Eugene Marquis; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Centre Oscar Lambret; CHU Brest; UNICANCER; Centre Eugene Marquis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	de Crevoisier, R (corresponding author), CLCC Eugene Marquis, Radiat Dept, Rennes, France.; de Crevoisier, R (corresponding author), Univ Rennes 1, LTSI, Inserm U1099, Rennes, France.	r.de-crevoisier@rennes.unicancer.fr	Supiot, Stéphane/M-1586-2015; CASTELLI, joël/P-6142-2018; de Crevoisier, Renaud/ABD-7321-2020; Pasquier, David/O-8004-2014	Supiot, Stéphane/0000-0003-2094-1708; CASTELLI, joël/0000-0001-6128-1836; Pasquier, David/0000-0001-6019-7309				Abdollah F, 2018, EUR UROL, V74, P253, DOI 10.1016/j.eururo.2018.04.017; Amini A, 2016, J UROLOGY, V195, P1453, DOI 10.1016/j.juro.2015.11.005; Bastide C, 2012, BJU INT, V109, P525, DOI 10.1111/j.1464-410X.2011.10332.x; Beckendorf V, 2011, INT J RADIAT ONCOL, V80, P1056, DOI 10.1016/j.ijrobp.2010.03.049; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Brajtbord JS, 2011, BJU INT, V107, P1419, DOI 10.1111/j.1464-410X.2010.09599.x; Broughman JR, 2017, SEMIN RADIAT ONCOL, V27, P79, DOI 10.1016/j.semradonc.2016.08.006; Cahlon O, 2008, INT J RADIAT ONCOL, V71, P330, DOI 10.1016/j.ijrobp.2007.10.004; Cahlon O, 2008, SEMIN RADIAT ONCOL, V18, P48, DOI 10.1016/j.semradonc.2007.09.007; Cornud F, 2002, RADIOLOGY, V224, P203, DOI 10.1148/radiol.2241011001; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dayes IS, 2017, INT J RADIAT ONCOL, V99, P90, DOI 10.1016/j.ijrobp.2017.05.013; de Rooij M, 2016, EUR UROL, V70, P233, DOI 10.1016/j.eururo.2015.07.029; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ennis RD, 2018, J CLIN ONCOL, V36, P1192, DOI 10.1200/JCO.2017.75.9134; Fiorino C, 2009, RADIOTHER ONCOL, V93, P153, DOI 10.1016/j.radonc.2009.08.004; Freedland SJ, 2004, CANCER-AM CANCER SOC, V100, P1633, DOI 10.1002/cncr.20122; Grivas N, 2018, EUR J RADIOL, V98, P107, DOI 10.1016/j.ejrad.2017.11.013; Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023; Hoskin PJ, 2012, RADIOTHER ONCOL, V103, P217, DOI 10.1016/j.radonc.2012.01.007; Jang WS, 2017, ANN SURG ONCOL, V24, P1143, DOI 10.1245/s10434-016-5653-x; Koutrouvelis PG, 2003, RADIOTHER ONCOL, V67, P303, DOI 10.1016/S0167-8140(03)00079-3; Kristiansen A, 2017, PATHOLOGY, V49, P715, DOI 10.1016/j.pathol.2017.08.008; Lee HJ, 2016, INT J UROL, V23, P758, DOI 10.1111/iju.13144; Liang J, 2009, INT J RADIAT ONCOL, V73, P935, DOI 10.1016/j.ijrobp.2008.10.019; Lin CC, 2015, J NATL CANC I, V107; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; McMahon CJ, 2010, RADIOLOGY, V254, P31, DOI 10.1148/radiol.2541090361; Michalski JM, 2018, JAMA ONCOL, V4, DOI 10.1001/jamaoncol.2018.0039; Michalski JM, 2005, INT J RADIAT ONCOL, V62, P706, DOI 10.1016/j.ijrobp.2004.11.028; Mikel Hubanks J, 2014, UROL ONCOL, V32; Morlacco A, 2017, EUR UROL, V71, P701, DOI 10.1016/j.eururo.2016.08.015; Moschini M, 2017, BJU INT, V120, P69, DOI 10.1111/bju.13683; Pagano MJ, 2016, PROSTATE, V76, P226, DOI 10.1002/pros.23114; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Pierorazio PM, 2011, J UROLOGY, V185, P1691, DOI 10.1016/j.juro.2010.12.059; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Rades D, 2007, STRAHLENTHER ONKOL, V183, P398, DOI 10.1007/s00066-007-1643-z; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Rodda S, 2017, INT J RADIAT ONCOL, V98, P286, DOI 10.1016/j.ijrobp.2017.01.008; Rusthoven CG, 2014, INT J RADIAT ONCOL, V88, P1064, DOI 10.1016/j.ijrobp.2014.01.008; Ryu JK, 2002, INT J RADIAT ONCOL, V54, P1036, DOI 10.1016/S0360-3016(02)03006-7; Salembier C, 2018, RADIOTHER ONCOL, V127, P49, DOI 10.1016/j.radonc.2018.01.014; Salomon L, 2003, UROLOGY, V62, P304, DOI 10.1016/S0090-4295(03)00373-X; Secin FP, 2006, CANCER-AM CANCER SOC, V106, P2369, DOI 10.1002/cncr.21895; Seisen T, 2017, EUR UROL; Sheng Y, 2017, INT J RADIAT ONCOL, V98, P473, DOI 10.1016/j.ijrobp.2017.02.089; Siddiqui SA, 2011, BJU INT, V107, P383, DOI 10.1111/j.1464-410X.2010.09565.x; Sofer M, 2003, J UROLOGY, V169, P153, DOI 10.1016/S0022-5347(05)64057-8; Soylu FN, 2013, RADIOLOGY, V267, P797, DOI 10.1148/radiol.13121319; Spratt DE, 2013, INT J RADIAT ONCOL, V85, P686, DOI 10.1016/j.ijrobp.2012.05.023; Stone NN, 2012, BRACHYTHERAPY, V11, P334, DOI 10.1016/j.brachy.2011.12.008; Stone NN, 2018, BJU INT, V54; Swanson GP, 2008, J UROLOGY, V180, P2453, DOI 10.1016/j.juro.2008.08.037; Touijer KA, 2018, EUR UROL, V73, P890, DOI 10.1016/j.eururo.2017.09.027; Tsumura H, 2017, PROSTATE, V77, P1520, DOI 10.1002/pros.23430; van der Burgt M, 2015, RADIOTHER ONCOL, V117, P283, DOI 10.1016/j.radonc.2015.09.031; Van Hemelryk A, 2016, INT J RADIAT ONCOL, V96, P323, DOI 10.1016/j.ijrobp.2016.06.011; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044	59	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210514	10.1371/journal.pone.0210514	http://dx.doi.org/10.1371/journal.pone.0210514			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682036	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500042
J	Nilsson, MI; Bourgeois, JM; Nederveen, JP; Leite, MR; Hettinga, BP; Bujak, AL; May, L; Lin, E; Crozier, M; Rusiecki, DR; Moffatt, C; Azzopardi, P; Young, J; Yang, YF; Nguyen, J; Adler, E; Lan, L; Tarnopolsky, MA				Nilsson, Mats I.; Bourgeois, Jacqueline M.; Nederveen, Joshua P.; Leite, Marlon R.; Hettinga, Bart P.; Bujak, Adam L.; May, Linda; Lin, Ethan; Crozier, Michael; Rusiecki, Daniel R.; Moffatt, Chris; Azzopardi, Paul; Young, Jacob; Yang, Yifan; Nguyen, Jenny; Adler, Ethan; Lan, Lucy; Tarnopolsky, Mark A.			Lifelong aerobic exercise protects against inflammaging and cancer	PLOS ONE			English	Article							MITOCHONDRIAL-LYSOSOMAL AXIS; TIME PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; ENZYME REPLACEMENT; MORTALITY; EXPRESSION; OBESITY; SPARC	Biological aging is associated with progressive damage accumulation, loss of organ reserves, and systemic inflammation ('inflammaging'), which predispose for a wide spectrum of chronic diseases, including several types of cancer. In contrast, aerobic exercise training (AET) reduces inflammation, lowers all-cause mortality, and enhances both health and lifespan. In this study, we examined the benefits of early-onset, lifelong AET on predictors of health, inflammation, and cancer incidence in a naturally aging mouse model (C57BL/J6). Lifelong, voluntary wheel-running (O-AET; 26-month-old) prevented age-related declines in aerobic fitness and motor coordination vs. age-matched, sedentary controls (O-SED). AET also provided partial protection against sarcopenia, dynapenia, testicular atrophy, and overall organ pathology, hence augmenting the 'physiologic reserve' of lifelong runners. Systemic inflammation, as evidenced by a chronic elevation in 17 of 18 pro- and anti-inflammatory cytokines and chemokines (P < 0.05 O-SED vs. 2-month-old Y-CON), was potently mitigated by lifelong AET (P < 0.05 O-AET vs. O-SED), including master regulators of the cytokine cascade and cancer progression (IL-1 beta, TNF-alpha, and IL-6). In addition, circulating SPARC, previously known to be upregulated in metabolic disease, was elevated in old, sedentary mice, but was normalized to young control levels in lifelong runners. Remarkably, malignant tumours were also completely absent in the O-AET group, whereas they were present in the brain (pituitary), liver, spleen, and intestines of sedentary mice. Collectively, our results indicate that early-onset, lifelong running dampens inflammaging, protects against multiple cancer types, and extends healthspan of naturally-aged mice.	[Nilsson, Mats I.] McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Nilsson, Mats I.; Hettinga, Bart P.; Bujak, Adam L.; Rusiecki, Daniel R.; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Exerkine Corp, Hamilton, ON, Canada; [Bourgeois, Jacqueline M.; Nederveen, Joshua P.; Leite, Marlon R.; May, Linda; Lin, Ethan; Crozier, Michael; Moffatt, Chris; Azzopardi, Paul; Young, Jacob; Yang, Yifan; Nguyen, Jenny; Adler, Ethan; Lan, Lucy; Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Nilsson, MI (corresponding author), McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Nilsson, MI (corresponding author), McMaster Univ, Med Ctr, Exerkine Corp, Hamilton, ON, Canada.	mnilsson7714@gmail.com	Nilsson, Mats/AAG-2068-2021; Azzopardi, Paul/C-5694-2013; Rusiecki, Daniel/ABA-4010-2020	Nilsson, Mats/0000-0001-5656-5578; Azzopardi, Paul/0000-0001-7386-8191; Rusiecki, Daniel/0000-0002-8092-4427; Lin, Ethan/0000-0002-0101-7934; Lan, Lucy/0000-0003-4474-6018	CIHR [143325]; Exerkine Corporation	CIHR(Canadian Institutes of Health Research (CIHR)); Exerkine Corporation	This work was supported by CIHR 143325 Dr. Mark A. Tarnopolsky: "Characterization of novel exersomes that mediate the systemic prometabolic effects in exercise in aging and neuromuscular disorders", and Exerkine Corporation. Exerkine Corporation provided support in the form of salaries for authors [MIN, BPH, ALB, LM, and DR]. The specific roles of these authors are articulated in the 'author contributions' section. The funders of this study did not have additional roles in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Ashcraft KA, 2016, CANCER RES, V76, P4032, DOI 10.1158/0008-5472.CAN-16-0887; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Baylis D, 2013, AGE, V35, P963, DOI 10.1007/s11357-012-9396-8; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bloom DE, 2015, LANCET, V385, P649, DOI 10.1016/S0140-6736(14)61464-1; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Cahill LS, 2017, BRAIN STRUCTURE FUNC, P1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638; Cheng AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067970; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Dethlefsen C, 2017, CANCER RES, V77, P4894, DOI 10.1158/0008-5472.CAN-16-3125; Dinarello C., 1992, IMMUNOL REV, V127, P119; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Flynn MG, 2007, AM J LIFESTYLE MED, V1, P220, DOI 10.1177/1559827607300283; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2000, EXP GERONTOL, V35, P879, DOI 10.1016/S0531-5565(00)00172-8; Franceschi C, 2017, TRENDS ENDOCRIN MET, V28, P199, DOI 10.1016/j.tem.2016.09.005; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Franco OH, 2005, ARCH INTERN MED, V165, P2355, DOI 10.1001/archinte.165.20.2355; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Garcia-Valles Rebeca, 2013, Longev Healthspan, V2, P14, DOI 10.1186/2046-2395-2-14; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hayflick L, 2007, PLOS GENET, V3, P2351, DOI 10.1371/journal.pgen.0030220; Hojman P, 2017, BIOCHEM SOC T, V45, P905, DOI 10.1042/BST20160466; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Jorgensen LH, 2017, AM J PATHOL, V187, P457, DOI 10.1016/j.ajpath.2016.10.013; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Konopka AR, 2014, EXERC SPORT SCI REV, V42, P53, DOI 10.1249/JES.0000000000000007; Kos K, 2010, NAT REV ENDOCRINOL, V6, P225, DOI 10.1038/nrendo.2010.18; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Kwak JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26617-9; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; LeckaCzernik B, 1996, EXP GERONTOL, V31, P159, DOI 10.1016/0531-5565(95)02014-4; Lee D, 2017, I S BIOMED IMAGING, P15, DOI 10.1109/ISBI.2017.7950457; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Lee SH, 2013, OBESITY, V21, P2296, DOI 10.1002/oby.20183; Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003; Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959; Mazzolini G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18981-9; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Nilsson MI, 2015, FREE RADICAL BIO MED, V87, P98, DOI 10.1016/j.freeradbiomed.2015.05.019; Nilsson MI, 2012, MOL GENET METAB, V107, P469, DOI 10.1016/j.ymgme.2012.09.010; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Ost M, 2016, FREE RADICAL BIO MED, V98, P78, DOI 10.1016/j.freeradbiomed.2016.02.018; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Peake JM, 2015, EXERC IMMUNOL REV, V21, P8; Pedersen L, 2016, CELL METAB, V23, P554, DOI 10.1016/j.cmet.2016.01.011; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Powell KE, 2011, ANNU REV PUBL HEALTH, V32, P349, DOI 10.1146/annurev-publhealth-031210-101151; Prince MJ, 2014, LANCET; Radak Z, 2008, AGEING RES REV, V7, P34, DOI 10.1016/j.arr.2007.04.004; Radak Z, 2017, REDOX BIOL, V12, P285, DOI 10.1016/j.redox.2017.02.015; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062008; Reimers C D, 2012, J Aging Res, V2012, P243958, DOI 10.1155/2012/243958; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Scheler M, 2013, AM J PHYSIOL-CELL PH, V305, pC877, DOI 10.1152/ajpcell.00043.2013; Schmid D, 2015, EUR J EPIDEMIOL, V30, P397, DOI 10.1007/s10654-015-0017-6; Shiba H, 2000, MECH AGEING DEV, V117, P69, DOI 10.1016/S0047-6374(00)00140-8; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Swain DP, 2006, AM J CARDIOL, V97, P141, DOI 10.1016/j.amjcard.2005.07.130; Tarnopolsky M., 2015, CELL METAB, V25, P978; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Trombetta JM, 2010, J HISTOCHEM CYTOCHEM, V58, P871, DOI 10.1369/jhc.2010.956144; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Williams PT, 2014, MED SCI SPORT EXER, V46, P927, DOI 10.1249/MSS.0000000000000176; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zinger A, 2017, AGING DIS, V8, P611, DOI 10.14336/AD.2016.1230; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	99	40	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210863	10.1371/journal.pone.0210863	http://dx.doi.org/10.1371/journal.pone.0210863			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682077	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500068
J	Shili-Masmoudi, S; Sogni, P; de Ledinghen, V; Esterle, L; Valantin, MA; Poizot-Martin, I; Simon, A; Rosenthal, E; Lacombe, K; Pialoux, G; Bouchaud, O; Gervais-Hasenknoff, A; Goujard, C; Piroth, L; Zucman, D; Dominguez, S; Raffi, F; Alric, L; Bani-Sadr, F; Lascoux-Combe, C; Garipuy, D; Miailhes, P; Vittecoq, D; Duvivier, C; Aumaitre, H; Neau, D; Morlat, P; Dabis, F; Salmon, D; Wittkop, L; Wittkop, L; Salmon, D; Sogni, P; Esterle, L; Trimoulet, P; Izopet, J; Serfaty, L; Paradis, V; Spire, B; Carrieri, P; Valantin, MA; Pialoux, G; Chas, J; Poizot-Martin, I; Alric, L; Barange, K; Naqvi, A; Rosenthal, E; Bicart-See, A; Bouchaud, O; Gervais, A; Lascoux-Combe, C; Goujard, C; Lacombe, K; Duvivier, C; Neau, D; Morlat, P; Bani-Sadr, F; Meyer, L; Boufassa, F; Autran, B; Roque, AM; Solas, C; Fontaine, H; Costagliola, D; Piroth, L; Simon, A; Zucman, D; Boue, F; Miailhes, P; Billaud, E; Aumaitre, H; Rey, D; Peytavin, G; Petrov-Sanchez, V; Cagnot, C; Salmon, D; Usubillaga, R; Sogni, P; Terris, B; Tremeaux, P; Katlama, C; Valantin, MA; Stitou, H; Simon, A; Cacoub, P; Nafissa, S; Benhamou, Y; Charlotte, F; Fourati, S; Poizot-Martin, I; Zaegel, O; Laroche, H; Tamalet, C; Pialoux, G; Chas, J; Callard, P; Bendjaballah, F; Amiel, C; Le Pendeven, C; Marchou, B; Alric, L; Barange, K; Metivier, S; Selves, J; Larroquette, F; Rosenthal, E; Naqvi, A; Rio, V; Haudebourg, J; Saint-Paul, MC; De Monte, A; Giordanengo, V; Partouche, C; Bouchaud, O; Martin, A; Ziol, M; Baazia, Y; Iwaka-Bande, V; Gerber, A; Uzan, M; Bicart-See, A; Garipuy, D; Ferro-Collados, MJ; Selves, J; Nicot, F; Gervais, A; Yazdanpanah, Y; Adle-Biassette, H; Alexandre, G; Peytavin, G; Lascoux-Combe, C; Molina, JM; Bertheau, P; Chaix, ML; Delaugerre, C; Maylin, S; Lacombe, K; Bottero, J; Krause, J; Girard, PM; Wendum, D; Cervera, P; Adam, J; Viala, C; Vittecocq, D; Goujard, C; Quertainmont, Y; Teicher, E; Pallier, C; Lortholary, O; Duvivier, C; Rouzaud, C; Lourenco, J; Touam, F; Louisin, C; Avettand-Fenoel, V; Gardiennet, E; Melard, A; Neau, D; Ochoa, A; Blanchard, E; Castet-Lafarie, S; Cazanave, C; Malvy, D; Dupon, M; Dutronc, H; Dauchy, F; Lacaze-Buzy, L; Desclaux, A; Bioulac-Sage, P; Trimoulet, P; Reigadas, S; Morlat, P; Lacoste, D; Bonnet, F; Bernard, N; Hessamfar, M; Paccalin, JF; Martell, C; Pertusa, MC; Vandenhende, M; Mercie, P; Malvy, D; Pistone, T; Receveur, MC; Mechain, M; Duffau, P; Rivoisy, C; Faure, I; Caldato, S; Bioulac-Sage, P; Trimoulet, P; Reigadas, S; Bellecave, P; Tumiotto, C; Pellegrin, JL; Viallard, JF; Lazzaro, E; Greib, C; Bioulac-Sage, P; Trimoulet, P; Reigadas, S; Zucman, D; Majerholc, C; Brollo, M; Farfour, E; Boue, F; Devoto, JP; Kansau, I; Chambrin, V; Pignon, C; Berroukeche, L; Fior, R; Martinez, V; Abgrall, S; Favier, M; Deback, C; Levy, Y; Dominguez, S; Lelievre, JD; Lascaux, AS; Melica, G; Billaud, E; Raffi, F; Allavena, C; Reliquet, V; Boutoille, D; Biron, C; Lefebvre, M; Hall, N; Bouchez, S; Rodallec, A; Le Guen, L; Hemon, C; Miailhes, P; Peyramond, D; Chidiac, C; Ader, F; Biron, F; Boibieux, A; Cotte, L; Ferry, T; Perpoint, T; Koffi, J; Zoulim, F; Bailly, F; Lack, P; Maynard, M; Radenne, S; Amiri, M; Valour, F; Koffi, J; Zoulim, F; Bailly, F; Lack, P; Maynard, M; Radenne, S; Augustin-Normand, C; Scholtes, C; Le-Thi, TT; Piroth, L; Chavanet, P; Van Huyen, MD; Buisson, M; Waldner-Combernoux, A; Mahy, S; Binois, R; Simonet-Lann, AL; Croisier-Bertin, D; Rousseau, AS; Martins, C; Aumaitre, H; Galim, S; Bani-Sadr, F; Lambert, D; Nguyen, Y; Berger, JL; Hentzien, M; Brodard, V; Rey, D; Partisani, M; Batard, ML; Cheneau, C; Priester, M; Bernard-Henry, C; de Mautort, E; Gantner, P; Fafi-Kremer, S; Roustant, F; Platterier, P; Kmiec, I; Traore, L; Lepuil, S; Parlier, S; Sicart-Payssan, V; Bedel, E; Anriamiandrisoa, S; Pomes, C; Touam, F; Louisin, C; Mole, M; Bolliot, C; Catalan, P; Mebarki, M; Adda-Lievin, A; Thilbaut, P; Ousidhoum, Y; Makhoukhi, FZ; Braik, O; Bayoud, R; Gatey, C; Pietri, MP; Le Baut, V; Ben Rayana, R; Bornarel, D; Chesnel, C; Beniken, D; Pauchard, M; Akel, S; Caldato, S; Lions, C; Ivanova, A; Ritleg, AS; Debreux, C; Chalal, L; Zelie, J; Hue, H; Soria, A; Cavellec, M; Breau, S; Joulie, A; Fisher, P; Gohier, S; Croisier-Bertin, D; Ogoudjobi, S; Brochier, C; Thoirain-Galvan, V; Cam, M; Aurousseau, A; Carrieri, P; Chalouni, M; Conte, V; Dequae-Merchadou, L; Desvallees, M; Douiri, N; Esterle, L; Gilbert, C; Knight, R; Lemboub, FT; Marcellin; Michel, L; Mora, M; Nordmann, S; Protopopescu, C; Roux, P; Rousseau-Gillet, S; Spire, B; Tezkratt, S; Vilotitch, A; Yaya, I; Wittkop, L				Shili-Masmoudi, Sarah; Sogni, Philippe; de Ledinghen, Victor; Esterle, Laure; Valantin, Marc-Antoine; Poizot-Martin, Isabelle; Simon, Anne; Rosenthal, Eric; Lacombe, Karine; Pialoux, Gilles; Bouchaud, Olivier; Gervais-Hasenknoff, Anne; Goujard, Cecile; Piroth, Lionel; Zucman, David; Dominguez, Stephanie; Raffi, Francois; Alric, Laurent; Bani-Sadr, Firouze; Lascoux-Combe, Caroline; Garipuy, Daniel; Miailhes, Patrick; Vittecoq, Daniel; Duvivier, Claudine; Aumaitre, Hugues; Neau, Didier; Morlat, Philippe; Dabis, Francois; Salmon, Dominique; Wittkop, Linda; Wittkop, L.; Salmon, D.; Sogni, P.; Esterle, L.; Trimoulet, P.; Izopet, J.; Serfaty, L.; Paradis, V.; Spire, B.; Carrieri, P.; Valantin, M. A.; Pialoux, G.; Chas, J.; Poizot-Martin, I.; Alric, L.; Barange, K.; Naqvi, A.; Rosenthal, E.; Bicart-See, A.; Bouchaud, O.; Gervais, A.; Lascoux-Combe, C.; Goujard, C.; Lacombe, K.; Duvivier, C.; Neau, D.; Morlat, P.; Bani-Sadr, F.; Meyer, L.; Boufassa, F.; Autran, B.; Roque, A. M.; Solas, C.; Fontaine, H.; Costagliola, D.; Piroth, L.; Simon, A.; Zucman, D.; Boue, F.; Miailhes, P.; Billaud, E.; Aumaitre, H.; Rey, D.; Peytavin, G.; Petrov-Sanchez, V.; Cagnot, C.; Salmon, D.; Usubillaga, R.; Sogni, P.; Terris, B.; Tremeaux, P.; Katlama, C.; Valantin, M. A.; Stitou, H.; Simon, A.; Cacoub, P.; Nafissa, S.; Benhamou, Y.; Charlotte, F.; Fourati, S.; Poizot-Martin, I.; Zaegel, O.; Laroche, H.; Tamalet, C.; Pialoux, G.; Chas, J.; Callard, P.; Bendjaballah, F.; Amiel, C.; Le Pendeven, C.; Marchou, B.; Alric, L.; Barange, K.; Metivier, S.; Selves, J.; Larroquette, F.; Rosenthal, E.; Naqvi, A.; Rio, V.; Haudebourg, J.; Saint-Paul, M. C.; De Monte, A.; Giordanengo, V.; Partouche, C.; Bouchaud, O.; Martin, A.; Ziol, M.; Baazia, Y.; Iwaka-Bande, V.; Gerber, A.; Uzan, M.; Bicart-See, A.; Garipuy, D.; Ferro-Collados, M. J.; Selves, J.; Nicot, F.; Gervais, A.; Yazdanpanah, Y.; Adle-Biassette, H.; Alexandre, G.; Peytavin, G.; Lascoux-Combe, C.; Molina, J. M.; Bertheau, P.; Chaix, M. L.; Delaugerre, C.; Maylin, S.; Lacombe, K.; Bottero, J.; Krause, J.; Girard, P. M.; Wendum, D.; Cervera, P.; Adam, J.; Viala, C.; Vittecocq, D.; Goujard, C.; Quertainmont, Y.; Teicher, E.; Pallier, C.; Lortholary, O.; Duvivier, C.; Rouzaud, C.; Lourenco, J.; Touam, F.; Louisin, C.; Avettand-Fenoel, V.; Gardiennet, E.; Melard, A.; Neau, D.; Ochoa, A.; Blanchard, E.; Castet-Lafarie, S.; Cazanave, C.; Malvy, D.; Dupon, M.; Dutronc, H.; Dauchy, F.; Lacaze-Buzy, L.; Desclaux, A.; Bioulac-Sage, P.; Trimoulet, P.; Reigadas, S.; Morlat, P.; Lacoste, D.; Bonnet, F.; Bernard, N.; Hessamfar, M.; Paccalin, J. F.; Martell, C.; Pertusa, M. C.; Vandenhende, M.; Mercie, P.; Malvy, D.; Pistone, T.; Receveur, M. C.; Mechain, M.; Duffau, P.; Rivoisy, C.; Faure, I.; Caldato, S.; Bioulac-Sage, P.; Trimoulet, P.; Reigadas, S.; Bellecave, P.; Tumiotto, C.; Pellegrin, J. L.; Viallard, J. F.; Lazzaro, E.; Greib, C.; Bioulac-Sage, P.; Trimoulet, P.; Reigadas, S.; Zucman, D.; Majerholc, C.; Brollo, M.; Farfour, E.; Boue, F.; Devoto, J. Polo; Kansau, I.; Chambrin, V.; Pignon, C.; Berroukeche, L.; Fior, R.; Martinez, V.; Abgrall, S.; Favier, M.; Deback, C.; Levy, Y.; Dominguez, S.; Lelievre, J. D.; Lascaux, A. S.; Melica, G.; Billaud, E.; Raffi, F.; Allavena, C.; Reliquet, V.; Boutoille, D.; Biron, C.; Lefebvre, M.; Hall, N.; Bouchez, S.; Rodallec, A.; Le Guen, L.; Hemon, C.; Miailhes, P.; Peyramond, D.; Chidiac, C.; Ader, F.; Biron, F.; Boibieux, A.; Cotte, L.; Ferry, T.; Perpoint, T.; Koffi, J.; Zoulim, F.; Bailly, F.; Lack, P.; Maynard, M.; Radenne, S.; Amiri, M.; Valour, F.; Koffi, J.; Zoulim, F.; Bailly, F.; Lack, P.; Maynard, M.; Radenne, S.; Augustin-Normand, C.; Scholtes, C.; Le-Thi, T. T.; Piroth, L.; Chavanet, P.; Van Huyen, M. Duong; Buisson, M.; Waldner-Combernoux, A.; Mahy, S.; Binois, R.; Simonet-Lann, A. L.; Croisier-Bertin, D.; Rousseau, A. Salmon; Martins, C.; Aumaitre, H.; Galim, S.; Bani-Sadr, F.; Lambert, D.; Nguyen, Y.; Berger, J. L.; Hentzien, M.; Brodard, V.; Rey, D.; Partisani, M.; Batard, M. L.; Cheneau, C.; Priester, M.; Bernard-Henry, C.; de Mautort, E.; Gantner, P.; Fafi-Kremer, S.; Roustant, F.; Platterier, P.; Kmiec, I.; Traore, L.; Lepuil, S.; Parlier, S.; Sicart-Payssan, V.; Bedel, E.; Anriamiandrisoa, S.; Pomes, C.; Touam, F.; Louisin, C.; Mole, M.; Bolliot, C.; Catalan, P.; Mebarki, M.; Adda-Lievin, A.; Thilbaut, P.; Ousidhoum, Y.; Makhoukhi, F. Z.; Braik, O.; Bayoud, R.; Gatey, C.; Pietri, M. P.; Le Baut, V.; Ben Rayana, R.; Bornarel, D.; Chesnel, C.; Beniken, D.; Pauchard, M.; Akel, S.; Caldato, S.; Lions, C.; Ivanova, A.; Ritleg, A-S.; Debreux, C.; Chalal, L.; Zelie, J.; Hue, H.; Soria, A.; Cavellec, M.; Breau, S.; Joulie, A.; Fisher, P.; Gohier, S.; Croisier-Bertin, D.; Ogoudjobi, S.; Brochier, C.; Thoirain-Galvan, V.; Le Cam, M.; Aurousseau, A.; Carrieri, P.; Chalouni, M.; Conte, V.; Dequae-Merchadou, L.; Desvallees, M.; Douiri, N.; Esterle, L.; Gilbert, C.; Knight, R.; Lemboub, F. T.; Marcellin; Michel, L.; Mora, M.; Nordmann, S.; Protopopescu, C.; Roux, P.; Rousseau-Gillet, S.; Spire, B.; Tezkratt, S.; Vilotitch, A.; Yaya, I.; Wittkop, L.		ANRS CO13 HEPAVIH Study Grp	Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTING ANTIVIRAL REGIMENS; ANTIRETROVIRAL THERAPY; FIBROSIS PROGRESSION; HIV; INDIVIDUALS; DEATH	Background The association between liver stiffness measurements (LSM) and mortality has not been fully described. In particular the effect of LSM on all-cause mortality taking sustained virological response (SVR) into account needs further study. Methods HIV/HCV participants in the French nation-wide, prospective, multicenter ANRS CO13 HEPAVIH cohort, with. 1 LSM by FibroScan (FS) and a detectable HCV RNA when the first valid FS was performed were included. Cox proportional hazards models with delayed entry were performed to determine factors associated with all-cause mortality. LSM and SVR were considered as time dependent covariates. Results 1,062 patients were included from 2005 to 2015 (69.8% men, median age 45.7 years (IQR 42.4-49.1)). 21.7% had baseline LSM > 12.5 kPa. Median follow-up was 4.9 years (IQR 3.2-6.1). 727 (68.5%) were ever treated for HCV: 189 of them (26.0%) achieved SVR. 76 deaths were observed (26 liver-related, 10 HIV-related, 29 non-liver-non-HIV-related, 11 of unknown cause). At the age of 50, the mortality rate was 4.5% for patients with LSM. 12.5 kPa and 10.8% for patients with LSM > 12.5 kPa. LSM > 12.5 kPa (adjusted Hazard Ratio [aHR] = 3.35 [2.06; 5.45], p<0.0001), history of HCV treatment (aHR = 0.53 [0.32; 0.90], p = 0.01) and smoking (past (aHR = 5.69 [1.56; 20.78]) and current (3.22 [0.93; 11.09]) versus never, p = 0.01) were associated with all-cause mortality independently of SVR, age, sex, alcohol use and metabolic disorders. Conclusion Any LSM > 12.5 kPa was strongly associated with all-cause mortality independently of SVR and other important covariates. Our results suggest that close follow-up of these patients should remain a priority even after achieving SVR.	[Shili-Masmoudi, Sarah; Esterle, Laure; Morlat, Philippe; Dabis, Francois; Wittkop, Linda; Wittkop, L.; Esterle, L.; Morlat, P.] Univ Bordeaux, ISPED, Inserm Bordeaux Populat Hlth, Team MORPH3EUS,UMR 1219,CIC EC 1401, F-33000 Bordeaux, France; [Shili-Masmoudi, Sarah; de Ledinghen, Victor] Hop Haut Leveque, Ctr Hosp Univ Bordeaux, Serv Hepatol, Bordeaux, France; [Sogni, Philippe; Sogni, P.] Hop Cochin, AP HP, Serv Hepatol, Paris, France; [Sogni, Philippe; Sogni, P.] Inst Pasteur, INSERM, U1223, Paris, France; [Sogni, Philippe; Salmon, Dominique; Salmon, D.; Sogni, P.] Univ Paris 05, Paris, France; [de Ledinghen, Victor] Univ Bordeaux, INSERM, UMR 1053, Bordeaux, France; [Valantin, Marc-Antoine; Valantin, M. A.] Hop La Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, Paris, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, APHM St Marguerite, Serv Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] INSERM, U912, SESSTIM, Marseille, France; [Simon, Anne; Simon, A.] Hop La Pitie Salpetriere, AP HP, Dept Med Interne & Immunol Clin, Paris, France; [Rosenthal, Eric] Hop Archet, Serv Med Interne & Cancerol, Ctr Hosp Univ Nice, Nice, France; [Rosenthal, Eric] Univ Nice Sophia Antipolis, Nice, France; [Lacombe, Karine] Hop St Antoine, AP HP, Serv Malad Infect & Trop, Paris, France; [Lacombe, Karine] UMPC Univ Pierre & Marie Curie, UMR S1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Pialoux, Gilles; Pialoux, G.] Hop Tenon, AP HP, Serv Malad Infect & Trop, Paris, France; [Bouchaud, Olivier] Hop Avicenne, AP HP, Serv Malad Infect & Trop Bobigny, Bobigny, France; [Bouchaud, Olivier] Univ Paris 13 Nord, Bobigny, France; [Gervais-Hasenknoff, Anne] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France; [Goujard, Cecile] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Goujard, Cecile; Vittecoq, Daniel] Univ Paris Sud, Le Kremlin Bicetre, France; [Piroth, Lionel; Piroth, L.] Ctr Hosp Univ Dijon, Dept Infectiol, Dijon, France; [Piroth, Lionel; Piroth, L.] Univ Bourgogne, Dijon, France; [Zucman, David; Zucman, D.] Hop Foch, Unite VIH, Suresnes, France; [Dominguez, Stephanie] Hop Henri Mondor, AP HP, Serv Immunol Clin & Malad Infect, Immunol Clin, Creteil, France; [Raffi, Francois; Billaud, E.] Ctr Hosp Univ Nantes, Serv Malad Infect & Trop, Nantes, France; [Alric, Laurent] Hop Purpan, Ctr Hosp Univ Toulouse, Med Interne, Toulouse, France; [Alric, Laurent] Univ Toulouse III Paul Sabatier, Toulouse, France; [Bani-Sadr, Firouze] Ctr Hosp Univ Reims, Serv Med Interne Malad Infect & Immunol Clin, Reims, France; [Bani-Sadr, Firouze] Univ Reims, Reims, France; [Lascoux-Combe, Caroline] Hop St Louis, AP HP, Serv Malad Infect & Trop, Paris, France; [Garipuy, Daniel] Hop Purpan, Ctr Hosp Univ Toulouse, Malad Infect & Trop, Toulouse, France; [Miailhes, Patrick] Hop Croix Rousse, CHU Lyon, Serv Malad Infect & Trop, Lyon, France; [Garipuy, Daniel] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Malad Infect & Trop, Le Kremlin Bicetre, France; [Duvivier, Claudine] Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop, Paris, France; [Duvivier, Claudine] Ctr Infectiol Necker Pasteur, Paris, France; [Aumaitre, Hugues; Aumaitre, H.] Ctr Hosp Perpignan, Serv Malad Infect & Trop, Perpignan, France; [Neau, Didier] Hop Pellegrin, Ctr Hosp Univ Bordeaux, Serv Malad Infect & Trop Bordeaux, Bordeaux, France; [Morlat, Philippe; Morlat, P.] Hop St Andre, Ctr Hosp Univ Bordeaux, Serv Med Interne, Bordeaux, France; [Dabis, Francois; Wittkop, Linda; Wittkop, L.] Ctr Hosp Univ Bordeaux, Pole Sante Publ, F-33000 Bordeaux, France; [Salmon, Dominique] Hop Cochin, AP HP, Serv Malad Infect & Trop, Paris, France; [Wittkop, L.] Univ Bordeaux, ISPED, Inserm Bordeaux Populat Hlth, Team MORPH3EUS,UMR 1219,CIC EC 1401, F-33000 Bordeaux, France; [Salmon, D.] HU Paris Ctr, AP HP, Serv Malad Infect & Trop, Paris, France; [Trimoulet, P.] Hop Pellegrin, CHU Bordeaux, Lab Virol, F-33000 Bordeaux, France; [Izopet, J.] Hop Purpan, CHU Toulouse, Lab Virol, Toulouse, France; [Izopet, J.] Toulouse Univ Paul Sabatier, CNRS, UMR5282, INSERM,U1043,CPTP, Toulouse, France; [Serfaty, L.] CHU Strasbourg, Hop Hautepierre, Serv Malad Foie, Strasbourg, France; [Paradis, V.] Beaujon Hosp, AP HP, Dept Pathol, Clichy, France; [Paradis, V.] Paris Diderot Univ, INSERM, UMR 1149, Inflammat Res Ctr, Paris, France; [Spire, B.; Carrieri, P.] INSERM, UMR912, Econ & Social Sci Appl Hlth & Anal Med Informat S, F-13000 Marseille, France; [Spire, B.; Carrieri, P.] Aix Marseille Univ, UMRS912, IRD, F-13000 Marseille, France; [Spire, B.; Carrieri, P.] Southeastern Hlth Reg Observ, ORS PACA, F-13000 Marseille, France; [Poizot-Martin, I.] Aix Marseille Univ, APHM St Marguerite, Serv Immunohemat Clin, Inserm,U912,SESSTIM, Marseille, France; [Barange, K.] CHU Toulouse, Serv Hepatol & Gastoenterol, Toulouse, France; [Naqvi, A.] Hop Archet, Ctr Hosp Univ Nice, Serv Infectiol, F-06100 Nice, France; [Bicart-See, A.] Hop Joseph Ducuing, Equipe Mobile Infectiol, Toulouse, France; [Bouchaud, O.] Hop Avicenne, AP HP, Serv Malad Infect & Trop, Bobigny, France; [Bouchaud, O.] Univ Paris 13 Nord, Bobigny, France; [Gervais, A.] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France; [Lascoux-Combe, C.] Hop St Louis, AP HP, Serv Malad Infect & Trop, Paris, France; [Goujard, C.] Hop Univ Paris Sud, Hop Bicetre, AP HP, Serv Med Interne & Immunol Clin, Le Kremlin Bicetre, France; [Goujard, C.] Univ Paris Sud, Le Kremlin Bicetre, France; [Neau, D.] Univ Bordeaux, Bordeaux, France; [Meyer, L.; Boufassa, F.] Univ Paris Sud, INSERM, U1018, CESP, Le Kremlin Bicetre, France; [Autran, B.] UPMC, AP HP, Dept Immunol, Paris, France; [Autran, B.] INSERM, U1135, CIMI, Paris, France; [Autran, B.] UPMC, Sorbonne Univ, Paris, France; [Roque, A. M.] Hop Paul Brousse, AP HP, Paris Sud, Ctr Hepatobiliaire,CNR Hepatite A, F-94800 Villejuif, France; [Roque, A. M.] Univ Paris Sud, Unite Mixte Rech Sci 785, F-92296 Chatenay Malabry, France; [Roque, A. M.] INSERM, U785, F-94800 Villejuif, France; [Solas, C.] Hop La Timone, APHM, Lab Pharmacocinet & Toxicol, Marseille, France; [Fontaine, H.] Univ Paris 05, Hop Cochin, AP HP, Unite Hepatol,USM20,Inst Pasteur, Paris, France; [Costagliola, D.] UPMC Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMRS 113, Paris, France; [Boue, F.] Univ Paris Sud, Hop Antoine Beclere, AP HP, Serv Med Interne & Immunol, F-92140 Clamart, France; [Miailhes, P.] Hop Croix Rousse, CHU Lyon, Serv Malad Infect & Trop, Lyon, France; [Rey, D.] Nouvel Hop Civil, Ctr Soins Infect VIH, Le Trait Union, Strasbourg, France; [Peytavin, G.] Hop Bichat Claude Bernard, AP HP, Lab Pharmacol, Paris, France; [Petrov-Sanchez, V.; Cagnot, C.] ANRS, 101 Rue Tolbiac, F-75013 Paris, France; [Salmon, D.; Usubillaga, R.; Sogni, P.; Terris, B.; Tremeaux, P.] Hop Univ Paris Ctr, AP HP, Paris, France; [Katlama, C.; Valantin, M. A.; Stitou, H.; Simon, A.; Cacoub, P.; Nafissa, S.; Benhamou, Y.; Charlotte, F.; Fourati, S.] APHP Pitie Salpetriere, Paris, France; [Poizot-Martin, I.; Zaegel, O.; Laroche, H.; Tamalet, C.] APHM St Marguerite, Marseille, France; [Pialoux, G.; Chas, J.; Callard, P.; Bendjaballah, F.; Amiel, C.; Le Pendeven, C.] APHP Tenon, Paris, France; [Marchou, B.; Alric, L.; Barange, K.; Metivier, S.; Selves, J.; Larroquette, F.] CHU Purpan, Toulouse, France; [Rosenthal, E.; Naqvi, A.; Rio, V.; Haudebourg, J.; Saint-Paul, M. C.; De Monte, A.; Giordanengo, V.; Partouche, C.] CHU Archet, Nice, France; [Bouchaud, O.; Martin, A.; Ziol, M.; Baazia, Y.; Iwaka-Bande, V.; Gerber, A.] APHP Avicenne, Bobigny, France; [Uzan, M.; Bicart-See, A.; Garipuy, D.; Ferro-Collados, M. J.; Selves, J.; Nicot, F.] Hop Joseph Ducuing, Toulouse, France; [Gervais, A.; Yazdanpanah, Y.; Adle-Biassette, H.; Alexandre, G.; Peytavin, G.] APHP Bichat Claude Bernard, Paris, France; [Lascoux-Combe, C.; Molina, J. M.; Bertheau, P.; Chaix, M. L.; Delaugerre, C.; Maylin, S.] APHP St Louis, Paris, France; [Lacombe, K.; Bottero, J.; Krause, J.; Girard, P. M.; Wendum, D.; Cervera, P.; Adam, J.; Viala, C.] APHP St Antoine, Paris, France; [Goujard, C.; Vittecocq, D.; Quertainmont, Y.; Teicher, E.; Pallier, C.] Hop Paris Sud, AP HP, Paris, France; [Duvivier, C.; Lortholary, O.; Rouzaud, C.; Lourenco, J.; Touam, F.; Louisin, C.; Avettand-Fenoel, V.; Gardiennet, E.; Melard, A.] APHP Necker, Paris, France; [Trimoulet, P.; Neau, D.; Ochoa, A.; Blanchard, E.; Castet-Lafarie, S.; Cazanave, C.; Malvy, D.; Dupon, M.; Dutronc, H.; Dauchy, F.; Lacaze-Buzy, L.; Desclaux, A.; Bioulac-Sage, P.; Reigadas, S.] CHU Bordeaux Hop Pellegrin, Bordeaux, France; [Trimoulet, P.; Morlat, P.; Malvy, D.; Bioulac-Sage, P.; Reigadas, S.; Lacoste, D.; Bonnet, F.; Bernard, N.; Hessamfar, M.; Paccalin, J. F.; Martell, C.; Pertusa, M. C.; Vandenhende, M.; Mercie, P.; Pistone, T.; Receveur, M. C.; Mechain, M.; Duffau, P.; Rivoisy, C.; Faure, I.; Caldato, S.; Bellecave, P.; Tumiotto, C.] Hop St Andre, CHU Bordeaux, Bordeaux, France; [Trimoulet, P.; Bioulac-Sage, P.; Reigadas, S.; Pellegrin, J. L.; Viallard, J. F.; Lazzaro, E.; Greib, C.] Hop Haut Leveque, CHU Bordeaux, Bordeaux, France; [Zucman, D.; Majerholc, C.; Brollo, M.; Farfour, E.] Hop FOCH, Suresnes, France; [Boue, F.; Devoto, J. Polo; Kansau, I.; Chambrin, V.; Pignon, C.; Berroukeche, L.; Fior, R.; Martinez, V.; Abgrall, S.; Favier, M.; Deback, C.] APHP Antoine Beclere, Clamart, France; [Levy, Y.; Dominguez, S.; Lelievre, J. D.; Lascaux, A. S.; Melica, G.] CHU Henri Mondor, Creteil, France; [Billaud, E.; Raffi, F.; Allavena, C.; Reliquet, V.; Boutoille, D.; Biron, C.; Lefebvre, M.; Hall, N.; Bouchez, S.; Rodallec, A.; Le Guen, L.; Hemon, C.] CHU Nantes, Hop Hotel Dieu, Nantes, France; [Miailhes, P.; Peyramond, D.; Chidiac, C.; Ader, F.; Biron, F.; Boibieux, A.; Cotte, L.; Ferry, T.; Perpoint, T.; Koffi, J.; Zoulim, F.; Bailly, F.; Lack, P.; Maynard, M.; Radenne, S.; Amiri, M.; Valour, F.; Augustin-Normand, C.; Scholtes, C.; Le-Thi, T. T.] Hop Croix Rousse, Lyon, France; [Piroth, L.; Chavanet, P.; Van Huyen, M. Duong; Buisson, M.; Waldner-Combernoux, A.; Mahy, S.; Binois, R.; Simonet-Lann, A. L.; Croisier-Bertin, D.; Rousseau, A. Salmon; Martins, C.] CHU Dijon, Dijon, France; [Aumaitre, H.; Galim, S.] CH Perpignan, Perpignan, France; [Bani-Sadr, F.; Lambert, D.; Nguyen, Y.; Berger, J. L.; Hentzien, M.; Brodard, V.] CHU Robert Debre, Reims, France; [Rey, D.; Partisani, M.; Batard, M. L.; Cheneau, C.; Priester, M.; Bernard-Henry, C.; de Mautort, E.; Gantner, P.; Fafi-Kremer, S.] CHRU Strasbourg, Strasbourg, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CHU Dijon Bourgogne; Universite de Bourgogne; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); CHU Bordeaux; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Toulouse; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; CHU Lyon; CHU Dijon Bourgogne; CHU de Reims; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wittkop, L (corresponding author), Univ Bordeaux, ISPED, Inserm Bordeaux Populat Hlth, Team MORPH3EUS,UMR 1219,CIC EC 1401, F-33000 Bordeaux, France.; Wittkop, L (corresponding author), Ctr Hosp Univ Bordeaux, Pole Sante Publ, F-33000 Bordeaux, France.	Linda.Wittkop@u-bordeaux.fr	Allavena, Clotilde/AAH-4310-2019; DABIS, FRANCOIS/S-9298-2019; Fourati, Slim/B-2756-2016; Deback, Claire/T-3054-2019; MALVY, Denis/T-7930-2019; Adle-Biassette, Homa/AAG-2751-2019; Scholtès, Caroline/B-9039-2011; DEBACK, Claire/GQP-1022-2022; Hentzien, Maxime/H-8730-2019; , Lelievre/AAB-1398-2020; Deback, Claire/B-2787-2014; Avettand-Fenoel, Véronique/O-6285-2017; Ziol, Marianne/AAC-5801-2019; Ferry, Tristan/M-5108-2014; Cazanave, Charles/AHE-5492-2022; Bonnet, Fabrice/T-3254-2019; Vandenhende, Marie-Anne/T-6625-2019; Dauchy, Frédéric-Antoine/T-4652-2019; Paradis, Valerie/X-9097-2019; Wittkop, Linda/E-3319-2014; Boutoille, David/AAH-6909-2019; Tumiotto, Camille/AAD-5003-2022; DEBACK, Claire/GRE-8739-2022; Zoulim, Fabien/ABD-5594-2021; Spire, Bruno/F-5546-2013; DEBACK, Claire/GQP-1189-2022	DABIS, FRANCOIS/0000-0002-1614-8857; Deback, Claire/0000-0001-9465-2381; Scholtès, Caroline/0000-0003-0691-8480; Hentzien, Maxime/0000-0003-2729-9420; Deback, Claire/0000-0001-9465-2381; Avettand-Fenoel, Véronique/0000-0002-7022-2990; Ziol, Marianne/0000-0001-5117-4842; Wittkop, Linda/0000-0003-2403-0960; DEBACK, Claire/0000-0001-9465-2381; Zoulim, Fabien/0000-0002-2245-0083; Spire, Bruno/0000-0002-3546-8020; Esterle, Laure/0000-0002-1017-1327; BANI-SADR, Firouze/0000-0001-8268-866X; Carrieri, Patrizia/0000-0002-6794-4837; Poizot-Martin, Isabelle/0000-0002-5676-5411; IZOPET, JACQUES/0000-0002-8462-3234	French national agency for HIV and hepatitis research (ANRS)	French national agency for HIV and hepatitis research (ANRS)	The official sponsor of the study is the French national agency for HIV and hepatitis research (ANRS) (LW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Berenguer J, 2014, JAIDS-J ACQ IMM DEF, V66, P280, DOI 10.1097/QAI.0000000000000156; Berenguer J, 2012, CLIN INFECT DIS, V55, P728, DOI 10.1093/cid/cis500; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Butt AA, 2009, HEPATOLOGY, V50, P387, DOI 10.1002/hep.23000; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150512; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; Gjaerde LI, 2016, CLIN INFECT DIS, V63, P821, DOI 10.1093/cid/ciw380; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Grint D, 2015, AIDS, V29, P1205, DOI 10.1097/QAD.0000000000000674; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klein MB, 2014, AIDS, V28, P1957, DOI 10.1097/QAD.0000000000000377; Kovari H, 2015, J HEPATOL, V63, P573, DOI 10.1016/j.jhep.2015.04.019; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Lo Re V, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv109; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Casado JL, 2015, DIGEST DIS SCI, V60, P3473, DOI 10.1007/s10620-015-3773-y; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mira JA, 2013, CLIN INFECT DIS, V56, P1646, DOI 10.1093/cid/cit103; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; Osinusi A, 2015, JAMA-J AM MED ASSOC, V313, P1232, DOI 10.1001/jama.2015.1373; Peters MG, 2016, AIDS, V30, P723, DOI 10.1097/QAD.0000000000000975; Piroth L, 2017, J HEPATOL, V67, P23, DOI 10.1016/j.jhep.2017.02.012; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Proust-Lima C, 2009, BIOSTATISTICS, V10, P535, DOI 10.1093/biostatistics/kxp009; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Rizopoulos D, 2010, J STAT SOFTW, V35, P1; Salmon D, 2015, AIDS, V29, P1821, DOI 10.1097/QAD.0000000000000787; Sanmartin R, 2014, HIV MED, V15, P203, DOI 10.1111/hiv.12105; Sanmartin R, 2012, AIDS RES HUM RETROV, V28, P1235, DOI 10.1089/aid.2011.0322; Schmid P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138838; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sogni P, 2016, CLIN INFECT DIS, V63, P763, DOI 10.1093/cid/ciw379; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211286	10.1371/journal.pone.0211286	http://dx.doi.org/10.1371/journal.pone.0211286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682180	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500142
J	van der Pol, CW; van Roovert-Reijrink, IAM; Maatjens, CM; Gussekloo, SWS; Kranenbarg, S; Wijnen, J; Pieters, RPM; Schipper, H; Kemp, B; van den Brand, H				van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; Maatjens, Conny M.; Gussekloo, Sander W. S.; Kranenbarg, Sander; Wijnen, Jan; Pieters, Remco P. M.; Schipper, Henk; Kemp, Bas; van den Brand, Henry			Light-dark rhythms during incubation of broiler chicken embryos and their effects on embryonic and post hatch leg bone development	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; HATCHABILITY PERFORMANCE; TIBIAL DYSCHONDROPLASIA; MONOCHROMATIC LIGHT; HORMONE-SECRETION; GROWTH; MELATONIN; TEMPERATURE; PERIOD; EGGS	There are indications that lighting schedules applied during incubation can affect leg health at hatching and during rearing. The current experiment studied effects of lighting schedule: continuous light (24L), 12 hours of light, followed by 12 hours of darkness (12L:12D), or continuous darkness (24D) throughout incubation of broiler chicken eggs on the development and strength of leg bones, and the role of selected hormones in bone development. In the tibiatarsus and femur, growth and ossification during incubation and size and microstructure at day (D) 0, D21, and D35 post hatching were measured. Plasma melatonin, growth hormone, and IGF-I were determined perinatally. Incidence of tibial dyschondroplasia, a leg pathology resulting from poor ossification at the bone's epiphyseal plates, was determined at slaughter on D35. 24L resulted in lower embryonic ossification at embryonic day (E) 13 and E14, and lower femur length, and lower tibiatarsus weight, length, cortical area, second moment of area around the minor axis, and mean cortical thickness at hatching on D0 compared to 12L: 12D especially. Results were long term, with lower femur weight and tibiatarsus length, cortical and medullary area of the tibiatarsus, and second moment of area around the minor axis, and a higher incidence of tibial dyschondroplasia for 24L. Growth hormone at D0 was higher for 24D than for 12L: 12D, with 24L intermediate, but plasma melatonin and IGF-I did not differ between treatments, and the role of plasma melatonin, IGF-I, and growth hormone in this process was therefore not clear. To conclude, in the current experiment, 24L during incubation of chicken eggs had a detrimental effect on embryonic leg bone development and later life leg bone strength compared to 24D and 12L: 12D, while the light-dark rhythm of 12L: 12D may have a stimulating effect on leg health.	[van der Pol, Carla W.; van Roovert-Reijrink, Inge A. M.; Maatjens, Conny M.; Wijnen, Jan] HatchTech BV, Res Dept, Veenendaal, Netherlands; [van der Pol, Carla W.; Maatjens, Conny M.; Wijnen, Jan; Kemp, Bas; van den Brand, Henry] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Gussekloo, Sander W. S.; Kranenbarg, Sander; Pieters, Remco P. M.; Schipper, Henk] Wageningen Univ & Res, Expt Zool Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Pol, CW (corresponding author), HatchTech BV, Res Dept, Veenendaal, Netherlands.; van der Pol, CW (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.	cvdpol@hatchtech.nl	van der Pol, Carla/GQP-0559-2022; Gussekloo, Sander/AGI-4222-2022; Gussekloo, Sander W.S./D-4886-2012	van der Pol, Carla/0000-0001-7388-9734; Gussekloo, Sander/0000-0002-9691-4661; Gussekloo, Sander W.S./0000-0002-9691-4661; Wijnen, Jan H. J./0000-0003-1832-2078				Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aota Y, 2013, SPINE J, V13, P1607, DOI 10.1016/j.spinee.2013.05.017; Archer GS, 2014, APPL ANIM BEHAV SCI, V152, P44, DOI 10.1016/j.applanim.2013.12.010; Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; Bessei W, 2006, WORLD POULTRY SCI J, V62, P455, DOI 10.1079/WPS2005108; Cardinali DP, 2003, J PINEAL RES, V34, P81, DOI 10.1034/j.1600-079X.2003.00028.x; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; HARGEST TE, 1985, AM J PATHOL, V119, P175; Heetkamp MJW, 2015, INDIRECT CALORIMETRY: TECHNIQUES, COMPUTATIONS AND APPLICATIONS, P35, DOI 10.3920/978-90-8686-261-0_2; Herzog A, 2011, AM J PHYSIOL-REG I, V301, pR140, DOI 10.1152/ajpregu.00134.2011; Huth JC, 2015, POULTRY SCI; Jin EH, 2011, ANAT REC, V294, P1233, DOI 10.1002/ar.21408; KESTIN SC, 1992, VET REC, V131, P190, DOI 10.1136/vr.131.9.190; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurtul I, 2009, KAFKAS UNIV VET FAK, V15, P869; Leach RM, 2007, POULTRY SCI, V86, P2053, DOI 10.1093/ps/86.10.2053; MACHIDA M, 1995, J BONE JOINT SURG BR, V77B, P134, DOI 10.1302/0301-620X.77B1.7822371; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; MILGROM C, 1989, J BIOMECH, V22, P1243, DOI 10.1016/0021-9290(89)90226-1; Ostrowska Z, 2002, NEUROENDOCRINOL LETT, V23, P417; Oviedo-Rondon EO, 2008, BRIT POULTRY SCI, V49, P666, DOI 10.1080/00071660802433149; Ozkan S, 2012, POULTRY SCI, V91, P2912, DOI 10.3382/ps.2012-02426; PECHAK DG, 1986, BONE, V7, P441, DOI 10.1016/8756-3282(86)90004-9; PECHAK DG, 1986, BONE, V7, P459, DOI 10.1016/8756-3282(86)90005-0; Potthoff T., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P35; Roach HI, 1997, J BONE MINER RES, V12, P795, DOI 10.1359/jbmr.1997.12.5.795; Robson H, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000023494.70201.1C; Rozenboim I, 2004, POULTRY SCI, V83, P1413, DOI 10.1093/ps/83.8.1413; Sanotra GS, 2001, WORLD POULTRY SCI J, V57, P55, DOI 10.1079/WPS20010006; Shafey TM, 2004, BRIT POULTRY SCI, V45, P223, DOI 10.1080/00071660410001715821; Shafey TM, 2002, ASIAN AUSTRAL J ANIM, V15, P1702, DOI 10.5713/ajas.2002.1702; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Yalcin S, 2007, POULTRY SCI, V86, P1772, DOI 10.1093/ps/86.8.1772; Zeman M, 1999, J PINEAL RES, V26, P28, DOI 10.1111/j.1600-079X.1999.tb00563.x; Zeman M, 1999, DOMEST ANIM ENDOCRIN, V17, P199, DOI 10.1016/S0739-7240(99)00037-5	35	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210886	10.1371/journal.pone.0210886	http://dx.doi.org/10.1371/journal.pone.0210886			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682088	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500071
J	Berg, L; Eckardt, J; Masseck, OA				Berg, Laura; Eckardt, Josephine; Masseck, Olivia Andrea			Enhanced activity of pyramidal neurons in the infralimbic cortex drives anxiety behavior	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ELEVATED PLUS-MAZE; VENTRAL HIPPOCAMPUS; MICE LACKING; SEROTONIN; RECEPTORS; FEAR; AUTORECEPTOR; PROJECTIONS; MODULATION	We show that in an animal model of anxiety the overall excitation, particularly in the infralimbic region of the medial prefrontal cortex (IL), is increased and that the activity ratio between excitatory pyramidal neurons and inhibitory interneurons (AR PN/IN) is shifted towards excitation. The same change in AR PN/IN is evident for wildtype mice, which have been exposed to an anxiety stimulus. We hypothesize, that an elevated activity and the imbalance of excitation (PN) and inhibition (IN) within the neuronal microcircuitry of the prefrontal cortex is responsible for anxiety behaviour and employed optogenetic methods in freely moving mice to verify our findings. Consistent with our hypothesis elevation of pyramidal neuron activity in the infralimbic region of the prefrontal cortex significantly enhanced anxiety levels in several behavioural tasks by shifting the AR PN/IN to excitation, without affecting motor behaviour, thus revealing a novel mechanism by which anxiety is facilitated.	[Berg, Laura; Masseck, Olivia Andrea] Ruhr Univ Bochum, Adv Fluorescence Microscopy, Bochum, Germany; [Eckardt, Josephine] Ruhr Univ Bochum, Dept Syst Neurosci, Bochum, Germany; [Masseck, Olivia Andrea] Univ Bremen, Synthet Biol, Bremen, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Bremen	Masseck, OA (corresponding author), Ruhr Univ Bochum, Adv Fluorescence Microscopy, Bochum, Germany.; Masseck, OA (corresponding author), Univ Bremen, Synthet Biol, Bremen, Germany.	masseck@uni-bremen.de		Ansorge, Josephine/0000-0002-1821-9698; Masseck, Olivia Andrea/0000-0002-1541-2388	DFG [MA4692/3-2]	DFG(German Research Foundation (DFG))	This work received support from a Grant awarded to Olivia Masseck (MA4692/3-2) from the DFG, http://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision t publish, or preparation of the manuscript.	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Albert PR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00199; Altieri SC, 2013, ACS CHEM NEUROSCI, V4, P72, DOI 10.1021/cn3002174; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Bi LL, 2013, NEUROPHARMACOLOGY, V72, P148, DOI 10.1016/j.neuropharm.2013.04.048; Blier P, 2007, INT J PSYCHIAT CLIN, V11, P16, DOI 10.1080/13651500701388310; Bruening S, 2006, J NEUROCHEM, V99, P892, DOI 10.1111/j.1471-4159.2006.04129.x; Bystritsky A, 2001, NEUROREPORT, V12, P3953, DOI 10.1097/00001756-200112210-00020; Cassano Giovanni B, 2002, Dialogues Clin Neurosci, V4, P271; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Felix-Ortiz AC, 2016, NEUROSCIENCE, V321, P197, DOI 10.1016/j.neuroscience.2015.07.041; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Forster GL, 2012, AMYGDALA - A DISCRETE MULTITASKING MANAGER, P61, DOI 10.5772/50323; Fuchikami M, 2015, P NATL ACAD SCI USA, V112, P8106, DOI 10.1073/pnas.1414728112; Garcia-Garcia AL, 2014, PSYCHOPHARMACOLOGY, V231, P623, DOI 10.1007/s00213-013-3389-x; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Gonzalez LE, 2000, BRAIN RES, V887, P7, DOI 10.1016/S0006-8993(00)02931-0; Gordon JA, 2005, J NEUROSCI, V25, P6509, DOI 10.1523/JNEUROSCI.1211-05.2005; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Jinks AL, 1997, BRAIN RES, V772, P181, DOI 10.1016/S0006-8993(97)00810-X; Johnson NJT, 1996, PSYCHOPHARMACOLOGY, V124, P355, DOI 10.1007/BF02247441; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kjaerby C, 2016, CELL REP, V17, P2882, DOI 10.1016/j.celrep.2016.11.036; Klein J, 2010, BEHAV BRAIN RES, V213, P73, DOI 10.1016/j.bbr.2010.04.036; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lacroix L, 2000, BEHAV NEUROSCI, V114, P1119, DOI 10.1037//0735-7044.114.6.1119; Lisboa SF, 2010, NEUROSCIENCE, V171, P760, DOI 10.1016/j.neuroscience.2010.09.048; Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010; Llado-Pelfort L, 2012, CEREB CORTEX, V22, P1487, DOI 10.1093/cercor/bhr220; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Marek R, 2018, NAT NEUROSCI, V21, P384, DOI 10.1038/s41593-018-0073-9; Meunier CNJ, 2013, NEUROPHARMACOLOGY, V71, P37, DOI 10.1016/j.neuropharm.2013.03.003; Meunier Claire N J, 2017, Front Synaptic Neurosci, V9, P2, DOI 10.3389/fnsyn.2017.00002; Narboux-Neme N, 2011, NEUROPSYCHOPHARMACOL, V36, P2538, DOI 10.1038/npp.2011.142; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Padilla-Coreano N, 2016, NEURON, V89, P857, DOI 10.1016/j.neuron.2016.01.011; Parfitt GM, 2017, NEUROPSYCHOPHARMACOL, V42, P1715, DOI 10.1038/npp.2017.56; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Suzuki S, 2016, BEHAV BRAIN RES, V304, P120, DOI 10.1016/j.bbr.2016.01.044; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668	53	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210949	10.1371/journal.pone.0210949	http://dx.doi.org/10.1371/journal.pone.0210949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677060	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400036
J	Almeida, C; Maniti, O; Di Pisa, M; Swiecicki, JM; Ayala-Sanmartin, J				Almeida, Claudia; Maniti, Ofelia; Di Pisa, Margherita; Swiecicki, Jean-Marie; Ayala-Sanmartin, Jesus			Cholesterol re-organisation and lipid de packing by arginine-rich cell penetrating peptides: Role in membrane translocation	PLOS ONE			English	Article							LARGE UNILAMELLAR VESICLES; SOLID-STATE NMR; PLASMA-MEMBRANE; DEPENDENT TRANSLOCATION; DOMAIN SEPARATION; PORE FORMATION; INTERNALIZATION; ORGANIZATION; MECHANISM; BILAYERS	Cell penetrating peptides (CPPs) are able to transport hydrophilic molecules inside cells. To reach the cytosol, the peptide associated with a cargo must cross the plasma or the endosomal membrane. Different molecular mechanisms for peptide internalisation into cells have been proposed and it is becoming clear that the cellular internalisation mechanisms are different depending on the peptide sequence and structure and the target membrane. Herein, the penetration of three peptides into large unilamellar vesicles were studied: the homeodomain derived 16-residues penetratin, nona-arginine (R9), and a small peptide containing 6 arginine and 3 tryptophan residues (RW9). The membrane models were composed of phospholipids from natural sources containing different molecular species. We observed that among the three peptides, only the amphipathic peptide RW9 was able to cross the membrane vesicles in the liquid disordered state. The changes in the distribution of the previously characterized cholesterol-pyrene probe show that cholesterol-pyrene molecules dissociate from clusters upon membrane interaction with the three peptides and that the cholesterol environment becomes more disordered in the presence of RW9. Finally, we studied the effect of the peptides on lipid ordering on giant plasma membrane vesicles. The amphipathic peptides RW9 and its longer homologue RW16 induced lipid de-packing in plasma membrane vesicles. Overall, the data suggest that a disordered membrane favours the translocation of RW9, that the membrane cholesterol is redistributed during peptide interaction, and that the peptide amphipathic character is important to increase membrane fluidity and peptide membrane translocation.	[Almeida, Claudia; Maniti, Ofelia; Di Pisa, Margherita; Swiecicki, Jean-Marie; Ayala-Sanmartin, Jesus] Sorbonne Univ, Univ PSL, Ecole Normale Super, CNRS,Lab Biomol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Ayala-Sanmartin, J (corresponding author), Sorbonne Univ, Univ PSL, Ecole Normale Super, CNRS,Lab Biomol, Paris, France.	jesus.ayala-sanmartin@sorbonne-universite.fr	DE ALMEIDA, CARLOS CAETANO/K-4265-2016; Maniti, Ofélia/AAQ-5624-2021	DE ALMEIDA, CARLOS CAETANO/0000-0002-3215-5731; Ayala-Sanmartin, Jesus/0000-0002-1215-0159				Alhakamy NA, 2013, LANGMUIR, V29, P15336, DOI 10.1021/la403370p; Almeida C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201373; Almeida C, 2016, BBA-BIOMEMBRANES, V1858, P2584, DOI 10.1016/j.bbamem.2016.07.012; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Amaro M, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa5dbc; Arsov Z, 2008, J PEPT SCI, V14, P1303, DOI 10.1002/psc.1062; Avci FG, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030077; Ayala-Sanmartin J, 2004, ANNEXINS, V1, P19; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Delaroche D, 2010, J BIOL CHEM, V285, P7712, DOI 10.1074/jbc.M109.045872; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Di Pisa M, 2015, BIOCHEMISTRY-US, V54, P194, DOI 10.1021/bi501392n; Dinic J, 2011, BBA-BIOMEMBRANES, V1808, P298, DOI 10.1016/j.bbamem.2010.10.002; Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Futaki S, 2017, ACCOUNTS CHEM RES, V50, P2449, DOI 10.1021/acs.accounts.7b00221; Gomara MJ, 2003, BBA-BIOMEMBRANES, V1612, P83, DOI 10.1016/S0005-2736(03)00107-X; Hedegaard SF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24154-z; Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Illien F, 2012, BBA-BIOMEMBRANES, V1818, P2892, DOI 10.1016/j.bbamem.2012.07.012; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; Kauffman WB, 2015, TRENDS BIOCHEM SCI, V40, P749, DOI 10.1016/j.tibs.2015.10.004; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamaziere A, 2010, BBA-BIOMEMBRANES, V1798, P2223, DOI 10.1016/j.bbamem.2009.12.024; Lamaziere Antonin, 2009, Commun Integr Biol, V2, P223; Lamaziere Antonin, 2006, Journal de la Societe de Biologie, V200, P229, DOI 10.1051/jbio:2006026; Le Guyader L, 2007, BIOPHYS J, V93, P4462, DOI 10.1529/biophysj.107.112821; Levental I, 2016, J MOL BIOL, V428, P4749, DOI 10.1016/j.jmb.2016.08.022; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lorents A, 2018, BIOCONJUGATE CHEM, V29, P1168, DOI 10.1021/acs.bioconjchem.7b00805; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Maniti O, 2014, INT J BIOCHEM CELL B, V50, P73, DOI 10.1016/j.biocel.2014.02.017; Maniti O, 2012, INT J BIOCHEM CELL B, V44, P869, DOI 10.1016/j.biocel.2012.02.010; Maniti O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015819; Mishra VK, 1996, BIOCHEMISTRY-US, V35, P11210, DOI 10.1021/bi960760f; Murayama T, 2017, ANGEW CHEM INT EDIT, V56, P7644, DOI 10.1002/anie.201703578; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Pae J, 2014, J CONTROL RELEASE, V192, P103, DOI 10.1016/j.jconrel.2014.07.002; Pan JJ, 2016, J PHYS CHEM B, V120, P4625, DOI 10.1021/acs.jpcb.6b02332; PASENKIEWICZGIERULA M, 1991, BIOCHIMIE, V73, P1311, DOI 10.1016/0300-9084(91)90094-H; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Saalik P, 2011, J CONTROL RELEASE, V153, P117, DOI 10.1016/j.jconrel.2011.03.011; Sakagami K, 2018, MOL PHARMACEUT, V15, P1332, DOI 10.1021/acs.molpharmaceut.7b01130; Schmid F, 2017, BBA-BIOMEMBRANES, V1859, P509, DOI 10.1016/j.bbamem.2016.10.021; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sharmin S, 2016, BIOCHEMISTRY-US, V55, P4154, DOI 10.1021/acs.biochem.6b00189; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Su Y, 2008, J AM CHEM SOC, V130, P8856, DOI 10.1021/ja802383t; Swiecicki JM, 2015, BIOPOLYMERS, V104, P533, DOI 10.1002/bip.22652; Swiecicki JM, 2014, CHEMBIOCHEM, V15, P884, DOI 10.1002/cbic.201300742; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Via MA, 2018, LANGMUIR, V34, P3102, DOI 10.1021/acs.langmuir.7b04038; Walrant A, 2012, BBA-BIOMEMBRANES, V1818, P1755, DOI 10.1016/j.bbamem.2012.02.024; Witte K, 2013, BBA-BIOMEMBRANES, V1828, P824, DOI 10.1016/j.bbamem.2012.11.014; Zhou L, 2014, COLLOID SURFACE B, V123, P419, DOI 10.1016/j.colsurfb.2014.09.037	62	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210985	10.1371/journal.pone.0210985	http://dx.doi.org/10.1371/journal.pone.0210985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673771	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800060
J	Falconer, CJ; Lobmaier, JS; Christoforou, M; Kamboj, SK; King, JA; Gilbert, P; Brewin, CR				Falconer, Caroline J.; Lobmaier, Janek S.; Christoforou, Marina; Kamboj, Sunjeev K.; King, John A.; Gilbert, Paul; Brewin, Chris R.			Compassionate faces: Evidence for distinctive facial expressions associated with specific prosocial motivations	PLOS ONE			English	Article							PRO-SOCIAL BEHAVIOR; SELF-COMPASSION; PERSONAL DISTRESS; RECOGNITION; SYMPATHY; GENDER; AVOIDANCE; ANXIETY; PAIN	Compassion is a complex cognitive, emotional and behavioural process that has important real-world consequences for the self and others. Considering this, it is important to understand how compassion is communicated. The current research investigated the expression and perception of compassion via the face. We generated exemplar images of two compassionate facial expressions induced from two mental imagery tasks with different compassionate motivations (Study 1). Our kind- and empathic compassion faces were perceived differently and the empathic-compassion expression was perceived as best depicting the general definition of compassion (Study 2). Our two composite faces differed in their perceived happiness, kindness, sadness, fear and concern, which speak to their underling motivation and emotional resonance. Finally, both faces were accurately discriminated when presented along a compassion continuum (Study 3). Our results demonstrate two perceptually and functionally distinct facial expressions of compassion, with potentially different consequences for the suffering of others.	[Falconer, Caroline J.; Christoforou, Marina; Kamboj, Sunjeev K.; King, John A.; Brewin, Chris R.] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Lobmaier, Janek S.] Univ Bern, Inst Psychol, Bern, Switzerland; [Gilbert, Paul] Univ Derby, Mental Hlth Res Unit, Derby, England	University of London; University College London; University of Bern; University of Derby	Brewin, CR (corresponding author), UCL, Dept Clin Educ & Hlth Psychol, London, England.	c.brewin@ucl.ac.uk	Brewin, Chris R/C-4566-2008	Brewin, Chris R/0000-0002-7462-4460; Gilbert, paul/0000-0001-8431-9892; Kamboj, Sunjeev/0000-0003-2197-0826; King, John/0000-0002-0269-3790; Christoforou, Marina/0000-0003-4841-2736	UK Medical Research Council [MR/J009210/1]; Swiss National Science Foundation [PP00P1_163758/1]; MRC [MR/J009210/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CRB, PG, JAK and CJF were supported (MR/J009210/1) by the UK Medical Research Council (https://mrc.ukri.org/).JSL was supported by a grant (PP00P1_163758/1) from the Swiss National Science Foundation (www.snf.ch).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; Bluth K, 2017, J YOUTH ADOLESCENCE, V46, P840, DOI 10.1007/s10964-016-0567-2; Brown SL, 2015, NEUROSCI BIOBEHAV R, V55, P1, DOI 10.1016/j.neubiorev.2015.04.004; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5; Calvo MG, 2016, EMOTION, V16, P1186, DOI 10.1037/emo0000192; Calvo MG, 2012, COGNITION, V125, P373, DOI 10.1016/j.cognition.2012.07.021; Condon P, 2013, EMOTION, V13, P817, DOI 10.1037/a0033747; Dalai Lama., 1995, PATH ENLIGHTMENT; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; Eisenberg N, 1998, DEV PSYCHOL, V34, P910, DOI 10.1037/0012-1649.34.5.910; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; EISENBERG N, 1988, DEV PSYCHOL, V24, P766, DOI 10.1037/0012-1649.24.6.766; EISENBERG N, 1988, PERS SOC PSYCHOL B, V14, P298, DOI 10.1177/0146167288142008; Falconer CJ, 2016, BJPSYCH OPEN, V2, P74, DOI 10.1192/bjpo.bp.115.002147; Gerdes ABM, 2012, INT J PSYCHOPHYSIOL, V85, P161, DOI 10.1016/j.ijpsycho.2012.06.002; Germer C. K., 2012, WISDOM COMPASSION PS; Gilbert P., 1989, HUMAN NATURE SUFFERI; Gilbert P., 2010, COMPASSION FOCUSED T; Gilbert P., 2013, MINDFUL COMPASSION; Gilbert P., 2009, ADV PSYCHIAT TREATME, V15, P199, DOI [DOI 10.1192/APT.BP.107.005264, 10.1192/apt.bp.107.005264]; Gilbert P, 2015, SOC PERSONAL PSYCHOL, V9, P239, DOI 10.1111/spc3.12176; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Godinho F, 2008, EUR J NEUROSCI, V27, P2219, DOI 10.1111/j.1460-9568.2008.06196.x; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Golle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058248; Gurthrie IK, 1997, MOTIV EMOTION, V21, P87, DOI 10.1023/A:1024478415317; Haidt J, 1999, COGNITION EMOTION, V13, P225, DOI 10.1080/026999399379267; Heuer K, 2007, BEHAV RES THER, V45, P2990, DOI 10.1016/j.brat.2007.08.010; Kaltvvasser L, 2017, EVOL HUM BEHAV, V38, P298, DOI 10.1016/j.evolhumbehav.2016.10.011; Kaltwasser L, 2017, MOTIV EMOTION, V41, P532, DOI 10.1007/s11031-017-9624-8; Keltner D, 1996, COGNITION EMOTION, V10, P155, DOI 10.1080/026999396380312; Kirby JN, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00040; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; McEwan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088783; Neff KD, 2013, SELF IDENTITY, V12, P78, DOI 10.1080/15298868.2011.639548; Nichols S, 2001, MIND LANG, V16, P425, DOI 10.1111/1468-0017.00178; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Preston SD, 2013, PSYCHOL BULL, V139, P1305, DOI 10.1037/a0031755; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Schug J, 2010, EVOL HUM BEHAV, V31, P87, DOI 10.1016/j.evolhumbehav.2009.09.006; Singer T., 2013, COMPASSION BRIDGING; Sousa R, 2017, PERS INDIV DIFFER, V117, P182, DOI 10.1016/j.paid.2017.06.003; Sprecher S, 2005, J SOC PERS RELAT, V22, P629, DOI 10.1177/0265407505056439; Sprecher S, 2007, SEX ROLES, V56, P543, DOI 10.1007/s11199-007-9192-6; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075	53	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210283	10.1371/journal.pone.0210283	http://dx.doi.org/10.1371/journal.pone.0210283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673735	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800038
J	Caruso, G; Zarco-Tejada, PJ; Gonzalez-Dugo, V; Moriondo, M; Tozzini, L; Palai, G; Rallo, G; Hornero, A; Primicerio, J; Gucci, R				Caruso, Giovanni; Zarco-Tejada, Pablo J.; Gonzalez-Dugo, Victoria; Moriondo, Marco; Tozzini, Letizia; Palai, Giacomo; Rallo, Giovanni; Hornero, Alberto; Primicerio, Jacopo; Gucci, Riccardo			High-resolution imagery acquired from an unmanned platform to estimate biophysical and geometrical parameters of olive trees under different irrigation regimes	PLOS ONE			English	Article							OLEA-EUROPAEA L.; AERIAL VEHICLE UAV; WATER REQUIREMENTS; CROP COEFFICIENTS; RANGING LIDAR; AIRBORNE; OIL; ORCHARDS; FRUIT; EVAPOTRANSPIRATION	The experiments were conducted in a fully-productive olive orchard (cv. Frantoio) at the experimental farm of University of Pisa at Venturina (Italy) in 2015 to assess the ability of an unmanned aerial vehicle (UAV) equipped with RGB-NIR cameras to estimate leaf area index (LAI), tree height, canopy diameter and canopy volume of olive trees that were either irrigated or rainfed. Irrigated trees received water 4-5 days a week (1348 m(3) ha(-1)), whereas the rainfed ones received a single irrigation of 19 m(3) ha(-1) to relieve the extreme stress. The flight altitude was 70 m above ground level (AGL), except for one flight (50 m AGL). The Normalized Difference Vegetation Index (NDVI) was calculated by means of the map algebra technique. Canopy volume, canopy height and diameter were obtained from the digital surface model (DSM) obtained through automatic aerial triangulation, bundle block adjustment and camera calibration methods. The NDVI estimated on the day of the year (DOY) 130 was linearly correlated with both LAI and leaf chlorophyll measured on the same date (R-2 = 0.78 and 0.80, respectively). The correlation between the on ground measured canopy volumes and the ones by the UAV-RGB camera techniques yielded an R-2 of 0.71-0.86. The monthly canopy volume increment estimated from UAV surveys between (DOY) 130 and 244 was highly correlated with the daily water stress integral of rainfed trees (R-2 = 0.99). The effect of water stress on the seasonal pattern of canopy growth was detected by these techniques in correspondence of the maximum level of stress experienced by the rainfed trees. The highest level of accuracy (RMSE = 0.16 m) in canopy height estimation was obtained when the flight altitude was 50 m AGL, yielding an R-2 value of 0.87 and an almost 1:1 ratio of measured versus estimated canopy height.	[Caruso, Giovanni; Tozzini, Letizia; Palai, Giacomo; Rallo, Giovanni; Gucci, Riccardo] Univ Pisa, Dipartimento Sci Agr Alimentari & Agroambientali, Pisa, Italy; [Zarco-Tejada, Pablo J.; Gonzalez-Dugo, Victoria; Hornero, Alberto] CSIC, IAS, Cordoba, Spain; [Zarco-Tejada, Pablo J.] Univ Melbourne, FVAS, Sch Agr & Food, Melbourne, Vic, Australia; [Zarco-Tejada, Pablo J.] Univ Melbourne, MSE, Dept Infrastruct Engn, Melbourne, Vic, Australia; [Moriondo, Marco; Primicerio, Jacopo] CNR, IBIMET, Ist Biometeorol, Florence, Italy; [Hornero, Alberto] Swansea Univ, Dept Geog, Swansea, W Glam, Wales	University of Pisa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of Melbourne; University of Melbourne; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Swansea University	Caruso, G (corresponding author), Univ Pisa, Dipartimento Sci Agr Alimentari & Agroambientali, Pisa, Italy.	giovanni.caruso@unipi.it	PRIMICERIO, JACOPO/AAD-2660-2022; Moriondo, Marco/H-5279-2019; Caruso, Giovanni/O-1428-2015; Zarco-Tejada, Pablo J./A-6874-2012; Zarco-Tejada, Pablo J./AAZ-3704-2020; Rallo, Giovanni/D-2358-2013; Hornero, Alberto/AAB-1123-2021	PRIMICERIO, JACOPO/0000-0001-8707-9185; Moriondo, Marco/0000-0002-8356-7517; Caruso, Giovanni/0000-0002-9694-7180; Zarco-Tejada, Pablo J./0000-0003-1433-6165; Rallo, Giovanni/0000-0002-8405-8618; Hornero, Alberto/0000-0002-8434-2168; PALAI, GIACOMO/0000-0002-6666-5764	UNAPROL-Italy projects [867/2008]	UNAPROL-Italy projects	Research supported by UNAPROL-Italy projects Reg. EU no. 867/2008. The funder had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Ben-Gal A, 2011, IRRIGATION SCI, V29, P253, DOI 10.1007/s00271-010-0237-1; Berenguer MJ, 2006, HORTSCIENCE, V41, P427, DOI 10.21273/HORTSCI.41.2.427; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Caruso G, 2017, VITIS, V56, P63, DOI 10.5073/vitis.2017.56.63-70; Caruso G, 2017, J SCI FOOD AGR, V97, P3530, DOI 10.1002/jsfa.8207; Caruso G, 2014, AGR WATER MANAGE, V134, P94, DOI 10.1016/j.agwat.2013.12.003; Caruso G, 2013, IRRIGATION SCI, V31, P37, DOI 10.1007/s00271-011-0286-0; Cherbiy-Hoffmann SU, 2013, SCI HORTIC-AMSTERDAM, V150, P110, DOI 10.1016/j.scienta.2012.10.027; Connor DJ, 2005, AUST J AGR RES, V56, P1181, DOI 10.1071/AR05169; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Edson C, 2011, REMOTE SENS-BASEL, V3, P2494, DOI 10.3390/rs3112494; Escola A, 2017, PRECIS AGRIC, V18, P111, DOI 10.1007/s11119-016-9474-5; Gomez JA, 2011, AGRON J, V103, P644, DOI 10.2134/agronj2010.0449; Grattan SR, 2006, AGR WATER MANAGE, V85, P133, DOI 10.1016/j.agwat.2006.04.001; Gucci R., 2000, PRUNING TRAINING SYS; Hernandez-Clemente R, 2014, REMOTE SENS-BASEL, V6, P11627, DOI 10.3390/rs61111627; Iniesta F, 2009, EUR J AGRON, V30, P258, DOI 10.1016/j.eja.2008.12.004; Jimenez-Brenes FM, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0205-3; Li WK, 2012, PHOTOGRAMM ENG REM S, V78, P75, DOI 10.14358/PERS.78.1.75; Lichtenthaler H.K., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lim C, 2007, THESIS; Lovell JL, 2003, CAN J REMOTE SENS, V29, P607, DOI 10.5589/m03-026; Marra FP, 2016, IRRIGATION SCI, V34, P313, DOI 10.1007/s00271-016-0505-9; Mateos L, 2013, AGR WATER MANAGE, V125, P81, DOI 10.1016/j.agwat.2012.11.005; Miranda-Fuentes A, 2015, SENSORS-BASEL, V15, P3671, DOI 10.3390/s150203671; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; MYERS BJ, 1988, TREE PHYSIOL, V4, P315, DOI 10.1093/treephys/4.4.315; Nardino M, 2013, PHOTOSYNTHETICA, V51, P63, DOI 10.1007/s11099-012-0079-6; Niblack W., 1986, INTRO DIGITAL IMAGE; Orgaz F, 2006, IRRIGATION SCI, V24, P77, DOI 10.1007/s00271-005-0012-x; ORGAZ F, 1999, CULTIVO OLIVO, P269; Orgaz F, 2007, FUNCT PLANT BIOL, V34, P178, DOI 10.1071/FP06306; Perez-Lopez D, 2007, AGR WATER MANAGE, V89, P297, DOI 10.1016/j.agwat.2007.01.015; Rosell JR, 2012, COMPUT ELECTRON AGR, V81, P124, DOI 10.1016/j.compag.2011.09.007; Rouse Jr J.W., 1974, P 3 EARTH RESOURCES, DOI DOI 10.1002/MRM.26868; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Scandellari F, 2016, EUR J HORTIC SCI, V81, P106, DOI 10.17660/eJHS.2016/81.2.4; Selby S.M., 1973, CRC STANDARD MATH TA; Testi L, 2006, IRRIGATION SCI, V24, P69, DOI 10.1007/s00271-005-0011-y; Tognetti R, 2006, EUR J AGRON, V25, P356, DOI 10.1016/j.eja.2006.07.003; Torres-Sanchez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130479; TURNER NC, 1988, IRRIGATION SCI, V9, P289, DOI 10.1007/BF00296704; Verma NK, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050388; VILLALOBOS FJ, 1995, AGR FOREST METEOROL, V73, P29, DOI 10.1016/0168-1923(94)02175-J; WELLES JM, 1991, AGRON J, V83, P818, DOI 10.2134/agronj1991.00021962008300050009x; Zaman Q. U., 2005, Precision Agriculture, V6, P467, DOI 10.1007/s11119-005-4243-x; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004	47	38	38	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210804	10.1371/journal.pone.0210804	http://dx.doi.org/10.1371/journal.pone.0210804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668591	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400014
J	Chen, F; Wang, L; Peng, G; Yan, N; Pan, XJ				Chen, Fei; Wang, Lan; Peng, Gang; Yan, Nan; Pan, Xiaojie			Development and evaluation of a 3-D virtual pronunciation tutor for children with autism spectrum disorders	PLOS ONE			English	Article							COMPUTER-ASSISTED-INSTRUCTION; HIGH-FUNCTIONING AUTISM; LANGUAGE DISORDERS; ANIMATED TUTOR; SPEECH; COMMUNICATION; PERCEPTION; VOCABULARY; INDIVIDUALS; ACQUISITION	The deficit in speech sound production in some children with autism spectrum disorder (ASD) adds to their communication barriers. The 3-D virtual environments have been implemented to improve their communication abilities. However, there were no previous studies on the use of a 3-D virtual pronunciation tutor designed specifically to train pronunciation for children with ASD. To fill this research gap, the current study developed and evaluated a 3D virtual tutor which served as a multimodal and real-data-driven speech production tutor to present both places and manners of Mandarin articulation. Using an eye-tracking technique (RED 5 Eye Tracker), Experiment 1 objectively investigated children's gauged attention distribution online while learning with our computer-assisted 3-D virtual tutor in comparison to a real human face (HF) tutor. Eye-tracking results indicated most participants showed more interests in the visual speech cues of the 3-D tutor, and paid some degree of absolute attention to the additional visual speech information of both articulatory movements and airflow changes. To further compare treatment outcomes, training performance was evaluated in Experiment 2 with the ASD learners divided into two groups, with one group learning from the HF tutor and the other from the 3-D tutor (HF group vs. 3-D group). Both groups showed improvement with the help of computer-based training in the post-intervention test based on the calculation of a 5-point Likert scale. However, the 3-D group showed much higher gains in producing Mandarin stop and affricate consonants, and apical vowels. We conclude that our 3-D virtual imitation intervention system provides an effective approach of audiovisual pronunciation training for children with ASD.	[Chen, Fei; Wang, Lan; Peng, Gang; Yan, Nan] Shenzhen Inst Adv Technol, CAS Key Lab Human Machine Intelligence Synergy Sy, Shenzhen, Peoples R China; [Chen, Fei; Peng, Gang] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Peoples R China; [Pan, Xiaojie] Shenzhen Aixin Zhihui Rehabil Ctr Children Specia, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Hong Kong Polytechnic University	Wang, L; Peng, G (corresponding author), Shenzhen Inst Adv Technol, CAS Key Lab Human Machine Intelligence Synergy Sy, Shenzhen, Peoples R China.; Peng, G (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Peoples R China.	lan.wang@siat.ac.cn; gpeng@polyu.edu.hk	ARSLAN, Okan/AAA-3232-2020	CHEN, Fei/0000-0002-4500-2590; Peng, Gang/0000-0002-1465-1301	National Natural Science Foundation of China [NSFC: U1736202, 61771461, 11474300, NSFC: U1736203]; Shenzhen Fundamental Research Program [JCYJ20160429184226930, JCYJ20170413161611534]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research Program	This work was partly supported by grants from National Natural Science Foundation of China (NSFC: U1736202, 61771461, 11474300) (http://www.nsfc.gov.cn/), and Shenzhen Fundamental Research Program (JCYJ20160429184226930, JCYJ20170413161611534) (http://www.szsti.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by grants from National Natural Science Foundation of China (NSFC: U1736203, 61771461, 11474300), and Shenzhen Fundamental Research Program: JCYJ20160429184226930; JCYJ20170413161611534. We sincerely thank all the child participants with ASD from Shenzhen Aixin Zhihui Rehabilitation Centre for Children with Special Needs, the TD children from Taoyuan Zhuoya Primary School, and their parents for their participation and cooperation. The authors have no conflict of interest regarding the contents of this manuscript.	Ali AZM, 2015, EDUC TECHNOL SOC, V18, P313; Association A.P., 2013, DIAGNOSTIC STAT MANU; Baltaxe C., 1977, J PEDIATR PSYCHOL, V2, P176, DOI [10.1093/jpepsy/2.4.176, DOI 10.1093/JPEPSY/2.4.176]; Baron-Cohen S, 1995, MINDBLINDNESS AN ESS; BARTAK L, 1975, BRIT J PSYCHIAT, V126, P127, DOI 10.1192/bjp.126.2.127; BARTOLUCCI G, 1976, J AUTISM CHILD SCHIZ, V6, P303, DOI 10.1007/BF01537908; Behrmann M, 2006, TRENDS COGN SCI, V10, P258, DOI 10.1016/j.tics.2006.05.001; Bellani M, 2011, EPIDEMIOL PSYCH SCI, V20, P235, DOI 10.1017/S2045796011000448; Bosseler, 2003, J DEV LEARNING DISOR, V7, P111; Bosseler A, 2003, J AUTISM DEV DISORD, V33, P653, DOI 10.1023/B:JADD.0000006002.82367.4f; BOUCHER J, 1976, J AUTISM CHILD SCHIZ, V6, P297, DOI 10.1007/BF01537907; Chen F, 2017, IEEE-ACM T AUDIO SPE, V25, P2399, DOI 10.1109/TASLP.2017.2755400; Chen F, 2016, INT CONF ACOUST SPEE, P6130, DOI 10.1109/ICASSP.2016.7472855; Chen KL, 2011, J AUTISM DEV DISORD, V41, P1658, DOI 10.1007/s10803-011-1201-5; Cleland J, 2010, INT J SPEECH-LANG PA, V12, P69, DOI 10.3109/17549500903469980; COLBY KM, 1973, J AUTISM CHILD SCHIZ, V3, P254, DOI 10.1007/BF01538283; Constantin A, 2017, COMPUT HUM BEHAV, V75, P404, DOI 10.1016/j.chb.2017.05.030; Ding, 2008, FRONT MED-PRC, V2, P344, DOI [10.1007/s11684-008-0065-3, DOI 10.1007/S11684-008-0065-3]; Eigsti IM, 2011, RES AUTISM SPECT DIS, V5, P681, DOI 10.1016/j.rasd.2010.09.001; Fu CP, 2010, RES AUTISM SPECT DIS, V4, P89, DOI 10.1016/j.rasd.2009.09.002; Fulton ML, 2013, J AUTISM DEV DISORD, V43, P2460, DOI 10.1007/s10803-013-1794-y; Gilliam J.E., 2006, GILLIAM AUTISM RATIN, DOI DOI 10.1016/j.heares.2016.06.001; Gillon G, 2017, FOLIA PHONIATR LOGO, V69, P8, DOI 10.1159/000479063; Goldstein H, 2002, J AUTISM DEV DISORD, V32, P373, DOI 10.1023/A:1020589821992; Haesen B, 2011, RES AUTISM SPECT DIS, V5, P701, DOI 10.1016/j.rasd.2010.11.006; Hamdan MN, 2015, 2015 INTERNATIONAL CONFERENCE ON SCIENCE IN INFORMATION TECHNOLOGY (ICSITECH), P58, DOI 10.1109/ICSITech.2015.7407777; Happe F, 2006, BRAIN COGNITION, V61, P25, DOI 10.1016/j.bandc.2006.03.004; HEIMANN M, 1995, J AUTISM DEV DISORD, V25, P459, DOI 10.1007/BF02178294; Holmqvist K., 2011, EYE TRACKING A COMPR; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Koegel LK, 2000, J AUTISM DEV DISORD, V30, P383, DOI 10.1023/A:1005539220932; KOEGEL RL, 1988, J AUTISM DEV DISORD, V18, P525, DOI 10.1007/BF02211871; Koegel RL, 2009, J AUTISM DEV DISORD, V39, P1587, DOI 10.1007/s10803-009-0765-9; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Liu XF, 2016, C HUM SYST INTERACT, P56, DOI 10.1109/HSI.2016.7529609; Liu XQ, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION (ICIA), P191, DOI 10.1109/ICInfA.2013.6720294; Massaro D.W., 1998, PERCEIVING TALKING F; Massaro DW, 2006, AUTISM, V10, P495, DOI 10.1177/1362361306066599; Massaro DW, 2004, J SPEECH LANG HEAR R, V47, P304, DOI 10.1044/1092-4388(2004/025); McCleery JP, 2006, J COMMUN DISORD, V39, P217, DOI 10.1016/j.jcomdis.2005.12.002; Miller N, 2018, BEHAV INTERVENT, V33, P3, DOI 10.1002/bin.1507; Moore M, 2000, J AUTISM DEV DISORD, V30, P359, DOI 10.1023/A:1005535602064; Mori M, 2012, IEEE ROBOT AUTOM MAG, V19, P98, DOI 10.1109/MRA.2012.2192811; Naranjo CA, 2017, PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON EDUCATION TECHNOLOGY AND COMPUTERS (ICETC 2017), P41, DOI 10.1145/3175536.3175582; Navarra J, 2007, PSYCHOL RES-PSYCH FO, V71, P4, DOI 10.1007/s00426-005-0031-5; Nordgren PM, 2015, J INTERACT RES COM D, V6, P25, DOI 10.1558/jircd.v6i1.25; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Paul R, 2005, J AUTISM DEV DISORD, V35, P861, DOI 10.1007/s10803-005-0031-8; Peng XL, 2018, INT J HUM-COMPUT ST, V109, P26, DOI 10.1016/j.ijhcs.2017.08.001; Rapin I, 2003, BRAIN DEV-JPN, V25, P166, DOI 10.1016/S0387-7604(02)00191-2; Rapin I, 2009, DEV NEUROPSYCHOL, V34, P66, DOI 10.1080/87565640802564648; Rathinavelu A, 2007, LECT NOTES COMPUT SC, V4554, P786; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; ROBINSON P, 1995, LANG LEARN, V45, P283, DOI 10.1111/j.1467-1770.1995.tb00441.x; Root JR, 2017, J AUTISM DEV DISORD, V47, P275, DOI 10.1007/s10803-016-2947-6; Schoen E, 2011, AUTISM RES, V4, P177, DOI 10.1002/aur.183; Schopler E., 2005, EXAMINERS MANUAL PSY, V3; Schopler E., 2002, CHILDHOOD AUTISM RAT; Seferoglu G, 2005, BRIT J EDUC TECHNOL, V36, P303, DOI 10.1111/j.1467-8535.2005.00459.x; Shriberg LD, 2011, J AUTISM DEV DISORD, V41, P405, DOI 10.1007/s10803-010-1117-5; Shriberg LD, 2001, J SPEECH LANG HEAR R, V44, P1097, DOI 10.1044/1092-4388(2001/087); Vashdi E., 2014, INT J CHILD HLTH HUM, V7, P198; Volkmar F.R., 2005, HDB AUTISM PERVASIVE; Wan CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025505; Wang WSY, 1978, LINGUISTICS 70S DIRE, V8, P63; Wang X., 2014, P 10 INT SEMINAR SPE, P449; Williams JHG, 2004, RES DEV DISABIL, V25, P559, DOI 10.1016/j.ridd.2004.01.008; Wolk L, 2000, J COMMUN DISORD, V33, P371, DOI 10.1016/S0021-9924(00)00021-6; Wolk L., 2013, SPEECH LANG HEARING, V16, P239, DOI [10.1179/2050572813Y.0000000020, DOI 10.1179/2050572813Y.0000000020]; Wolk L, 2016, SPEECH LANG HEARING, V19, P121, DOI 10.1080/2050571X.2015.1133488; Zhang D, 2014, 2014 9TH INTERNATIONAL SYMPOSIUM ON CHINESE SPOKEN LANGUAGE PROCESSING (ISCSLP), P299, DOI 10.1109/ISCSLP.2014.6936629; Zheng Z, IEEE INT C ROB AUT I; Zheng Z, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P72, DOI 10.1109/ICAR.2015.7251436; Zhou Y, 2016, 10 INT S CHIN SPOK L	78	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210858	10.1371/journal.pone.0210858	http://dx.doi.org/10.1371/journal.pone.0210858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689645	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800012
J	Calvete, CL; Martho, KF; Felizardo, G; Paes, A; Nunes, JM; Ferreira, CO; Vallim, MA; Pascon, RC				Calvete, Crislaine Lambiase; Martho, Kevin Felipe; Felizardo, Gabrielle; Paes, Alexandre; Nunes, Joao Miguel; Ferreira, Camila Oliveira; Vallim, Marcelo A.; Pascon, Renata C.			Amino acid permeases in Cryptococcus neoformans are required for high temperature growth and virulence; and are regulated by Ras signaling	PLOS ONE			English	Article							GENE-EXPRESSION; METABOLISM; MECHANISMS; PATHWAY; BIOSYNTHESIS; RESISTANCE; MENINGITIS; ADAPTATION; SYNTHASE; HOMOLOG	Cryptococcosis is an Invasive Fungal Infection (IFI) caused by Cryptococcus neoformans, mainly in immunocompromised patients. Therapeutic failure due to pathogen drug resistance, treatment inconstancy and few antifungal options is a problem. The study of amino acid biosynthesis and uptake represents an opportunity to explore possible development of novel antifungals. C. neoformans has 10 amino acids permeases, two of them (Aap3 and Aap7) not expressed at the conditions tested, and five were studied previously (Aap2, Aap4, Aap5, Mup1 and Mup3). Our previous results showed that Aap4 and Aap5 are major permeases with overlapping functions. The aap4 Delta/aap5 Delta double mutant fails to grow in amino acids as sole nitrogen source and is avirulent in animal model. Here, we deleted the remaining amino acid permeases (AAP1, AAP6, AAP8) that showed gene expression modulation by nutritional condition and created a double mutant (aap1 Delta/aap2 Delta). We studied the virulence attributes of these mutants and explored the regulatory mechanism behind amino acid uptake in C. neoformans. The aap1 Delta/aap2 Delta strain had reduced growth at 37 degrees C in L-amino acids, reduced capsule production and was hypovirulent in the Galleria mellonella animal model. Our data, along with previous studies, (i) complement the analysis for all 10 amino acid permeases mutants, (ii) corroborate the idea that these transporters behave as global permeases, (iii) are required during heat and nutritional stress, and (iv) are important for virulence. Our study also indicates a new possible link between Ras1 signaling and amino acids uptake.	[Calvete, Crislaine Lambiase] Univ Sao Paulo, Biotechnol Grad Program, Sao Paulo, SP, Brazil; [Calvete, Crislaine Lambiase; Martho, Kevin Felipe; Felizardo, Gabrielle; Paes, Alexandre; Nunes, Joao Miguel; Ferreira, Camila Oliveira; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema, Diadema, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Dept Biol Sci, Campus Diadema, Diadema, SP, Brazil.	renata.pascon@gmail.com	Alves Nunes, João Miguel/ABC-1125-2021; Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Alves Nunes, João Miguel/0000-0001-7733-4349; Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/14542-8, 2015/04400-9, 2016/23890-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grants 2016/14542-8 to Dr. Renata C Pascon, 2015/04400-9 to Dr Marcelo Afonso Vallim, 2016/23890-0 to Joao Miguel Nunes), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (awarded to Ms Crislaine Lambiase Calvete and Kevin Felipe Martho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abdallah Q, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00234-16; Alspaugh JA, 2015, FUNGAL GENET BIOL, V78, P55, DOI 10.1016/j.fgb.2014.09.004; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Amich J, 2016, CURR OPIN MICROBIOL, V32, P151, DOI 10.1016/j.mib.2016.06.003; Ballou ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003687; Casadevall A, 1998, MED MYCOL, V36, P95; Casadevall A, 2003, TRENDS MICROBIOL, V11, P157, DOI 10.1016/S0966-842X(03)00008-8; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Coelho C, 2014, ADV APPL MICROBIOL, V87, P1, DOI 10.1016/B978-0-12-800261-2.00001-3; Coelho C, 2014, ANNU REV PATHOL-MECH, V9, P219, DOI 10.1146/annurev-pathol-012513-104653; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Martho KFC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163919; de Aguiar PADF, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759013, 10.1590/S1678-9946201759013]; Do E, 2016, BIOCHEM BIOPH RES CO, V477, P706, DOI 10.1016/j.bbrc.2016.06.123; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Feretzaki M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003688; Fu JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003335; Garcia-Rodas R, 2012, FEMS IMMUNOL MED MIC, V64, P147, DOI 10.1111/j.1574-695X.2011.00871.x; Gournas C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051398; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Janbon G, 2004, FEMS YEAST RES, V4, P765, DOI 10.1016/j.femsyr.2004.04.003; Jauniaux JC, 1990, FEBS J, V190, P39; Jung KW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7757; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; KISHORE GM, 1988, ANNU REV BIOCHEM, V57, P627, DOI 10.1146/annurev.bi.57.070188.003211; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kraidlova L, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00284-16; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000953; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Mourad A, 2018, J FUNGI, V4, DOI 10.3390/jof4030079; Mourad A, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170391; Mourad A, 2018, J ANTIMICROB CHEMOTH, V73, pi26, DOI 10.1093/jac/dkx446; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nazi I, 2007, ANTIMICROB AGENTS CH, V51, P1731, DOI 10.1128/AAC.01400-06; Nichols CB, 2007, MOL MICROBIOL, V63, P1118, DOI 10.1111/j.1365-2958.2006.05566.x; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Pentland DR, 2018, MICROB CELL, V5, P63, DOI 10.15698/mic2018.02.612; Perfect JR, 2002, INFECT DIS CLIN N AM, V16, P837, DOI 10.1016/S0891-5520(02)00064-8; Phadke SS, 2013, EUKARYOT CELL, V12, P1155, DOI 10.1128/EC.00147-13; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Ramachandra S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092734; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rhodes J, 2017, G3-GENES GENOM GENET, V7, P1165, DOI 10.1534/g3.116.037499; Fernandes JDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132369; Schneider RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043773; Schrevens S, 2018, MOL MICROBIOL, V109, P415, DOI 10.1111/mmi.14065; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Velez N, 2016, MEM I OSWALDO CRUZ, V111, P642, DOI 10.1590/0074-02760160201; Waugh MS, 2003, FUNGAL GENET BIOL, V38, P110, DOI 10.1016/S1087-1845(02)00518-2; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68	82	7	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211393	10.1371/journal.pone.0211393	http://dx.doi.org/10.1371/journal.pone.0211393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682168	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500165
J	Enlund, KB; Brunius, C; Hanson, J; Hagman, R; Hoglund, OV; Gustas, P; Pettersson, A				Enlund, Karolina Brunius; Brunius, Carl; Hanson, Jeanette; Hagman, Ragnvi; Hoglund, Odd Viking; Gustas, Pia; Pettersson, Ann			Development and validation of two questionnaires: Dental home care and dental health in Swedish dogs	PLOS ONE			English	Article							PERIODONTAL-DISEASE; PREVALENCE; FREQUENCY	Background Dental disease is one of the most common health problems in dogs. However, no studies have investigated the attitudes, opinions and practices of dog owners, veterinarians and veterinary nurses regarding dental health and preventative dental home care in dogs. The objective of this study was therefore to develop and validate questionnaires for this purpose, in accordance with survey methodology guidelines. Methods Questionnaire items were determined based on the authors' academic knowledge and clinical experience, and modified throughout the validation process. Several measures were taken to reduce sampling, coverage, measurement and non-response errors. Content validity was assessed by Subject-Matter Experts (SME) and cognitive interviews were conducted in accordance with the "think-aloud protocol". Non-response analysis was performed using several methods. Results Constructs were identified using exploratory factor analysis and two predefined constructs from the dog owner questionnaire were confirmed "Dog owners' attitudes towards brushing their dog's teeth" (Cronbach's alpha = 0.86) and "Dog owners' assessment of their dog's dental health" (alpha = 0.76). Additionally, exploratory factor analysis identified three potential constructs. In the veterinary health practitioner questionnaire, two constructs were identified: "Veterinary health practitioners' attitudes towards dental chews and dental feed" (alpha = 0.78) and "Veterinary health practitioners' attitudes and opinions on dental problems and dental cleaning" (alpha = 0.73). Non-response analysis showed a higher proportion of women in the sample of dog owners and veterinarians compared to the target populations. Veterinarians in the sample were also younger. In contrast, gender and age distributions in veterinary nurses did not differ between sample and target. Conclusion The validation presented in this work showed that the developed questionnaires could be used as accurate and reliable tools for measuring attitudes and practices regarding dental home care in dogs among Swedish dog owners, veterinarians and veterinary nurses.	[Enlund, Karolina Brunius; Hanson, Jeanette; Hagman, Ragnvi; Hoglund, Odd Viking; Gustas, Pia; Pettersson, Ann] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Enlund, Karolina Brunius] Anicura Albano Anim Hosp, Stockholm, Sweden; [Brunius, Carl] Chalmers Univ Technol, Dept Biol & Biol Engn Food & Nutr Sci, Gothenburg, Sweden	Swedish University of Agricultural Sciences; Chalmers University of Technology	Enlund, KB (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden.; Enlund, KB (corresponding author), Anicura Albano Anim Hosp, Stockholm, Sweden.	karolina.enlund@slu.se	Höglund, Odd Viking/I-2492-2016; Gustås, Pia/HDO-6309-2022; Hanson, Jeanette/Q-9283-2018	Höglund, Odd Viking/0000-0003-0978-836X; Hanson, Jeanette/0000-0001-5596-9538	Greater Stockholm Veterinary Hospital Foundation; Swedish Association for the Protection of Animals	Greater Stockholm Veterinary Hospital Foundation; Swedish Association for the Protection of Animals	The Greater Stockholm Veterinary Hospital Foundation (major contributor) and The Swedish Association for the Protection of Animals (minor contributor). Publication fee: Svelands Stiftelse. No grant numbers are available. URLs: http://stiftelsendjursjukhus.se/ and http://www.djurskydd.org/ and http://svelandstiftelse.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Berntson E., 2016, ENKATMETODIK, V1; Bradburn NM., 2004, ASKING QUESTIONS DEF, VRev. edn; Choi Bernard C K, 2005, Prev Chronic Dis, V2, pA13; DEMEIJER LM, 1991, TIJDSCHR DIERGENEESK, V116, P777; Deutskens E, 2004, MARKET LETT, V15, P21, DOI 10.1023/B:MARK.0000021968.86465.00; Dillman D.A., 2014, TAILORED DESIGN METH; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Ejlertsson G., 2005, ENKATEN PRAKTIKEN HD; Ekman A, 2007, EUR J EPIDEMIOL, V22, P293, DOI 10.1007/s10654-006-9091-0; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fernandes Natalia Alves, 2012, Rev. Ceres, V59, P446; Fowler F.J, 1995, IMPROVING SURVEY QUE; Gorrel C, 1996, J Vet Dent, V13, P139; Gorrel C, 2000, CLIN TECH SMALL AN P, V15, P226, DOI 10.1053/svms.2000.21625; Groves R. M., 2012, NONRESPONSE HOUSEHOL; HAMP SE, 1984, VET RADIOLOGY, V25, P86, DOI 10.1111/j.1740-8261.1984.tb01916.x; Harvey C E, 1994, J Vet Dent, V11, P94; Harvey C, 2015, J VET DENT, V32, P16, DOI 10.1177/089875641503200102; IIS, 2018, SVENSK INT 2017; Johnston N, 2012, VET TIMES       1105, P10; Kline R.B., 2011, PRINCIPLES PRACTICE; Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Niemiec B., 2012, VET PERIODONTOLOGY, DOI [DOI 10.1002/9781118705018, 10.1002/9781118705018]; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; SCB, 2016, BEF UTB; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Sweden S, 2004, DESIGN YOUR QUESTION; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Tromp JA, 1986, CLIN FINDINGS J CLIN, V13, P190, DOI DOI 10.1111/J.1600-051X.1986.TB01458.X; TROMP JAH, 1986, J CLIN PERIODONTOL, V13, P164, DOI 10.1111/j.1600-051X.1986.tb01451.x; Wiggs RB., 1997, VET DENT PRINCIPLES, P165; WSAVA, 2021, COVID 19 UPD WSAVA M; 2010, HDB SURVEY RES, P1	37	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0204581	10.1371/journal.pone.0204581	http://dx.doi.org/10.1371/journal.pone.0204581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682017	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500006
J	Guerra, J; Mogollon, D; Gonzalez, D; Sanchez, R; Rueda, ZV; Parra-Lopez, CA; Murcia, MI				Guerra, Julio; Mogollon, Daniel; Gonzalez, Deccy; Sanchez, Ricardo; Vanessa Rueda, Zulma; Parra-Lopez, Carlos A.; Isabel Murcia, Martha			Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; PULMONARY TUBERCULOSIS; PREVALENCE; INFECTION; SITUATION; DIAGNOSIS; TIME; TB	Introduction Active tuberculosis (TB) and latent tuberculosis infection (LTBI) are a public health threat in prisons around the world. The objectives of the study were to estimate the prevalence of LTBI and TB as well as to investigate TB transmission inside one prison, in Colombia. Methods A Cross-sectional study was conducted in inmates who agreed to participate. Inmates with respiratory symptoms (RS) of any duration underwent to medical evaluation and three sputum samples were taken for smear microscopy and culture for TB diagnosis. Drug susceptibility was analyzed using BACTEC MGIT 960 and GenoType MTBDRplus. Molecular genotyping of Mycobacterium tuberculosis isolates was performed by 24-Locus MIRU-VNTR and spoligotyping. LTBI was evaluated according to the result of the tuberculin skin test (TST). Close contact investigation was conducted inside the prison for inmates that shared the cell with the index TB case. Results Among 301/2,020 (15%) inmates with RS of any duration, 8% were diagnosed with active TB. The prevalence of active TB was 1,026 cases/100,000 inmates. We isolated M. tuberculosis in 19/24 (79%) TB cases, 94.7% were susceptible to first line drugs and only one was monoresistant to isoniazid. The most prevalent sub-lineage was Haarlem (68.4%), followed by LAM (26.3%) and T superfamily (5.3%). 24-Locus MIRU-VNTR typing results alone or in combination with spoligotyping identified three clusters containing two isolates each. Two clusters corresponded to inmates that shared the same cell, but each one was located in different blocks of the prison. Inmates from the last cluster were in the same block in nearby cells. TST reading was performed in 95.6% inmates, and 67.6% had a positive reaction. Conclusions The prevalence of LTBI and TB was higher in prison than in the general population. Molecular genotyping suggests that TB in this prison is mainly caused by strains imported by inmates or endogenous reactivation.	[Guerra, Julio; Mogollon, Daniel; Parra-Lopez, Carlos A.; Isabel Murcia, Martha] Univ Nacl Colombia, Grp MICOBAC UN, Fac Med, Dept Microbiol, Bogota, Colombia; [Gonzalez, Deccy] Secretaria Salud Cundinamarca, Programa TB & Lepra, Bogota, Colombia; [Sanchez, Ricardo] Univ Nacl Colombia, Fac Med, Dept Psiquiatria, Bogota, Colombia; [Vanessa Rueda, Zulma] Univ Pontificia Bolivariana, Fac Med, Medellin, Antioquia, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Pontificia Bolivariana	Murcia, MI (corresponding author), Univ Nacl Colombia, Grp MICOBAC UN, Fac Med, Dept Microbiol, Bogota, Colombia.	mimurciaa@unal.edu.co	Rueda, Zulma Vanessa/AAH-4650-2019	Rueda, Zulma Vanessa/0000-0001-6342-1812	Sanatorio Agua de Dios, a social support entity of the state [30.09.48.296]; Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota [30.09.48.296]; Secretaria de Salud de Cundinamarca, Bogota, DC [1347]	Sanatorio Agua de Dios, a social support entity of the state; Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota; Secretaria de Salud de Cundinamarca, Bogota, DC	This work was supported by the inter-administrative cooperation agreement no. 30.09.48.296 between Sanatorio Agua de Dios, a social support entity of the state and Universidad Nacional de Colombia -Facultad de Medicina, sede Bogota. Sanatorio Agua de Dios obtained the funding for this project from Secretaria de Salud de Cundinamarca, Bogota, DC; through inter-administrative cooperation agreement no. 1347 in 2013.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Abrahao RMCM, 2006, INT J TUBERC LUNG D, V10, P203; Al-Darraji HAA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-22; [Anonymous], 2010, TREATM TUB GUID; [Anonymous], 2015, 007 MIN SAL PROT SOC; [Anonymous], WHO VACC PREV DIS MO; [Anonymous], 2004, GUID APPL GEN TUB PR; [Anonymous], 2012, TUB GEN; [Anonymous], 2018, ESQ VAUN; [Anonymous], 2012, TUB SKIN TEST TB; Arbelaez MP, 2004, INT J HEALTH PLAN M, V19, pS25, DOI 10.1002/hpm.775; Arroyave L, 2017, EPIDEMIOL INFECT, V145, P2491, DOI 10.1017/S0950268817001558; Arroyave L, 2019, J IMMIGR MINOR HEALT, V21, P578, DOI 10.1007/s10903-018-0746-1; Assefzadeh M, 2009, East Mediterr Health J, V15, P258; Banu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010759; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; BD, 2016, BACTEC MGIT 960 SIRE; Bone A., 2000, TUBERCULOSIS CONTROL; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001; Center FJCNT, 2008, TUB CONT INV JAIL FA; Chee CBE, 2005, INT J TUBERC LUNG D, V9, P1248; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Chigbu LN, 2010, J HEALTH POPUL NUTR, V28, P327; Couvin D, 2014, EUROREFERENCE CAHIER, V2014, P36; Dara M, 2009, GUIDELINES CONTROL T; Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Fuge Terefe G, 2016, BMC Res Notes, V9, P201, DOI 10.1186/s13104-016-2005-7; Gómez Ingrid T, 2015, Rev. salud pública, V17, P97, DOI 10.15446/rsap.v17n1.50937; Huerga H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051336; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Instituto Nacional do Cancer, 2018, INF EV TUB COL 2017, P1; Jagielski T, 2016, CLIN MICROBIOL REV, V29, P239, DOI 10.1128/CMR.00055-15; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Koole O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018502; Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012; Lobato MN, 2005, INT J TUBERC LUNG D, V9, P1179; Maggard KR, 2015, B WORLD HEALTH ORGAN, V93, P93, DOI 10.2471/BLT.14.135285; Mancuso JD, 2017, CHEST, V152, P282, DOI 10.1016/j.chest.2017.01.001; Medeiros TF, 2018, INFECT GENET EVOL, V58, P34, DOI 10.1016/j.meegid.2017.12.010; Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009; Moreira-Oliveira MS, 2008, BRAZ J INFECT DIS, V12, P487, DOI 10.1590/S1413-86702008000600009; Murcia MPLCA, 2012, TUBERCULOSIS PRISON; Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080; Nyasulu Peter, 2015, Tuberc Res Treat, V2015, P752709, DOI 10.1155/2015/752709; Ongen Gul, 2013, Tuberk Toraks, V61, P21; Prisons FBo, 2010, MAN TUB CLIN PRACT G; Puerto G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124308; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Research IfCP, 2017, WORLD PRIS BRIEF DAT; Rueda Z, 2013, THESIS, P77; Rueda ZV, 2014, INT J TUBERC LUNG D, V18, P1166, DOI 10.5588/ijtld.14.0179; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8; ScreenItalia, 2016, HIV 1 2 O RAP TEST C; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; Toungoussova OS, 2003, CLIN INFECT DIS, V37, P665, DOI 10.1086/377205; Rueda ZV, 2015, INT J INFECT DIS, V33, P82, DOI 10.1016/j.ijid.2015.01.004; Rueda ZV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080592; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2013, SYST SCREEN ACT TUB	68	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209895	10.1371/journal.pone.0209895	http://dx.doi.org/10.1371/journal.pone.0209895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682199	gold, Green Submitted, Green Published			2022-12-27	WOS:000457037500017
J	Li, NY; Fu, QL; Guo, B; Liu, C; Li, H; Ding, YZ				Li, Ningyu; Fu, Qinglin; Guo, Bin; Liu, Chen; Li, Hua; Ding, Yongzhen			Adsorption of Pb2+ by ameliorated alum plasma in water and soil	PLOS ONE			English	Article							HEAVY-METAL IMMOBILIZATION; CONTAMINATED SOILS; RED MUD; CADMIUM; STABILIZATION; REMEDIATION; POLLUTANTS; AMENDMENTS; ISOTHERMS; REMOVAL	Four methods, including hot acid treatment, hot alkali treatment, calcination treatment and sulfhydrylation treatment, were applied to activate alum plasma in order to obtain new Pb2+ adsorbents. The corresponding adsorption isotherm satisfies the Langmuir equation, and the maximum adsorption of the alum plasma after hot acid treatment, hot alkali treatment and high-temperature calcination were 18.9, 57.3 and 10.9 mg.g(-1), respectively, and in the range of 1.23-6.57 times greater than the adsorption capacity of the original alum plasma. The soil culture experiments indicated that the effective Pb content in the soils treated with hot alkali ameliorated alum plasma was significantly lower (p < 0.05) than those treated with the other three types of alum plasma. For example, if the additive content is 5.0%, after a storage period of 16 weeks, the effective Pb content becomes 19.87 mg.kg(-1), which corresponds to a reduction of 60.9% in comparison with the control sample. In addition, Specific surface area (BET), Scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FIR) were used to characterize the microstructure of alum plasma before and after amelioration. It was evident that hot alkali treatment of alum plasma resulted in smaller particles, a significantly higher specific area and lower mineral crystallinity, which improved the adsorption performance of Pb2+. In conclusion, hot alkali treatment of alum plasma indicates relatively good Pb2+ adsorption ability, and is a promising novel adsorbents that could ameliorate soils that have been polluted by heavy metal Pb.	[Li, Ningyu; Fu, Qinglin; Guo, Bin; Liu, Chen; Li, Hua] Zhejiang Acad Agr Sci, Inst Environm Resource Soil & Fertilizer, Hangzhou, Zhejiang, Peoples R China; [Ding, Yongzhen] Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China	Zhejiang Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Ding, YZ (corresponding author), Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China.	dingyongzhen@caas.cn	Fu, Qinglin/R-2887-2019	li, ningyu/0000-0003-1561-1683	National Natural Science Foundation of China [41501340]; Zhejiang Provincial Natural Science Foundation of China [LQ16D010007]; National Science and Technology Support Program of China [2015BAL01B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Science and Technology Support Program of China	The study is jointly supported by the grants from National Natural Science Foundation of China (No. 41501340 to NL), and the Zhejiang Provincial Natural Science Foundation of China (No. LQ16D010007). It is also financed by the National Science and Technology Support Program of China (2015BAL01B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaroai YA, 2014, ENVIRON EARTH SCI, V71, P1289, DOI 10.1007/s12665-013-2533-6; Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Bhatnagar A, 2011, ENVIRON TECHNOL, V32, P231, DOI 10.1080/09593330.2011.560615; Bolan N, 2014, J HAZARD MATER, V266, P141, DOI 10.1016/j.jhazmat.2013.12.018; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; BUCHTER B, 1989, SOIL SCI, V148, P370, DOI 10.1097/00010694-198911000-00008; Cao XD, 2009, J HAZARD MATER, V164, P555, DOI 10.1016/j.jhazmat.2008.08.034; Castaldi P, 2005, CHEMOSPHERE, V60, P365, DOI 10.1016/j.chemosphere.2004.11.098; Chrysochoou M, 2006, J HAZARD MATER, V136, P20, DOI 10.1016/j.jhazmat.2005.11.008; Daorattanachai P, 2015, CHEM ENG J, V278, P92, DOI 10.1016/j.cej.2014.12.029; ELPRINCE AM, 1981, SOIL SCI SOC AM J, V45, P277, DOI 10.2136/sssaj1981.03615995004500020010x; Gray CW, 2006, ENVIRON POLLUT, V142, P530, DOI 10.1016/j.envpol.2005.10.017; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; [李凝玉 Li Ningyu], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1526; Lin CF, 1998, J HAZARD MATER, V60, P217, DOI 10.1016/S0304-3894(98)00092-2; Liu YJ, 2011, GEODERMA, V163, P1, DOI 10.1016/j.geoderma.2011.04.002; Mitch ML, 2002, J ENVIRON QUAL, V31, P109; Nagodavithane CL, 2014, SOIL RES, V52, P155, DOI 10.1071/SR13187; Ogura M, 2001, APPL CATAL A-GEN, V219, P33, DOI 10.1016/S0926-860X(01)00645-7; Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2; Papageorgiou SK, 2009, J HAZARD MATER, V162, P1347, DOI 10.1016/j.jhazmat.2008.06.022; Pentrak M, 2009, CLAY MINER, V44, P511, DOI 10.1180/claymin.2009.044.4.511; SCHULTHESS CP, 1990, SOIL SCI SOC AM J, V54, P679, DOI 10.2136/sssaj1990.03615995005400030008x; Tica D, 2011, CHEMOSPHERE, V85, P577, DOI 10.1016/j.chemosphere.2011.06.085; Usman A, 2005, J SOIL SEDIMENT, V5, P245, DOI 10.1065/jss2005.05.141; Valipour M, 2016, CLEAN-SOIL AIR WATER, V44, P572, DOI 10.1002/clen.201300827; Verwilghen C, 2004, ENVIRON CHEM LETT, V2, P15, DOI 10.1007/s10311-003-0050-7; Wang P, 2015, J HAZARD MATER, V286, P533, DOI 10.1016/j.jhazmat.2014.12.034; Wen J, 2016, J ENVIRON MANAGE, V178, P63, DOI 10.1016/j.jenvman.2016.04.046	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210614	10.1371/journal.pone.0210614	http://dx.doi.org/10.1371/journal.pone.0210614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682059	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500050
J	Carrasco, JM; Gomez-Baceiredo, B; Navas, A; Krawczyk, M; Garcia, M; Centeno, C				Miguel Carrasco, Jose; Gomez-Baceiredo, Beatriz; Navas, Alejandro; Krawczyk, Marian; Garcia, Miriam; Centeno, Carlos			Social representation of palliative care in the Spanish printed media: A qualitative analysis	PLOS ONE			English	Article							COVERAGE; BARRIERS	Background Lack of social awareness is a major barrier to the development of palliative care. Mass media influences public opinion, and frequently deal with palliative care contributing to its image and public understanding. Aim To analyse how palliative care is portrayed in Spanish newspapers, as well as the contribution made by the press to its social representation. Design Based on criteria of scope and editorial plurality, four print newspapers were selected. Using the newspaper archive MyNews (www.mynews.es), articles published between 2009 and 2014 containing the words "palliative care" or "palliative medicine" were identified. Sociological discourse analysis was performed on the identified texts on two levels: a) contextual analysis, focusing on the message as a statement; b) interpretative analysis, considering the discourse as a social product. Results We examined 262 articles. Politician and healthcare professionals were the main representatives transmitting messages on palliative care. The discourses identified were characterised by: strong ideological and moral content focusing on social debate, strong ties linking palliative care and death and, to a lesser degree, as a healthcare service. The messages transmitted by representatives with direct experience in palliative care (professionals, patients and families) contributed the most to building a positive image of this healthcare practice. Overall, media reflect different interests in framing public understanding about palliative care. Conclusion The knowledge generated about how palliative care is reflected in the printed media may help to understand better one of the main barriers to its development not only in Spain, but also in other contexts.	[Miguel Carrasco, Jose; Centeno, Carlos] Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain; [Gomez-Baceiredo, Beatriz] Univ Navarra, Sch Commun, Journalism Projects Dept, Pamplona, Spain; [Navas, Alejandro] Univ Navarra, Sch Commun, Publ Commun Dept, Pamplona, Spain; [Krawczyk, Marian] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Krawczyk, Marian] Trinity Western Univ, Langley, BC, Canada; [Garcia, Miriam] Errea Comunicac, Pamplona, Spain; [Centeno, Carlos] Univ Navarra, Univ Navarra Clin, Pamplona, Spain; [Centeno, Carlos] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; Trinity Western University; University of Navarra	Carrasco, JM (corresponding author), Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain.	jmcarrascog@unav.es	Gomez, Beatriz/AAF-1391-2021; Centeno, Carlos/H-3430-2013; Krawczyk, Marian/AAC-1956-2019; Carrasco, Jose Miguel/I-3482-2015	Gomez, Beatriz/0000-0001-5332-0698; Centeno, Carlos/0000-0003-3395-7039; Carrasco, Jose Miguel/0000-0002-3847-8312	Institute for Culture and Society (ICS) of the University Navarra	Institute for Culture and Society (ICS) of the University Navarra	Support for this work was received from the Institute for Culture and Society (ICS) of the University Navarra. The funder provided support in the form of salaries for authors [JMC, CC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors [MG] is employed by a commercial company [Errea Comunicacion], but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguiar F, 2013, ADV APPL SOCIOLOGY, V3, P124; Akintola O, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0051-6; Asociacion para la investigacion de medios de comunicacion, 2011, PRENS DIG VS PAP; Asociacion para la Investigacion de Medios de Comunicacion, 2014, EST GEN MED; Berger P., 1967, SOCIAL CONSTRUCTION; Brown P, 2001, SOCIOL HEALTH ILL, V23, P747, DOI 10.1111/1467-9566.00274; Centeno C, 2016, PALLIATIVE MED, V30, P351, DOI 10.1177/0269216315598671; Conde F, 2009, CUADERNOS METODOLOGI, P43; Daw JR, 2013, HEALTH POLICY, V110, P67, DOI 10.1016/j.healthpol.2013.01.006; De Leon E, 2014, J MED INTERNET RES, V16, P119, DOI 10.2196/jmir.2837; Doblado R, 2006, DIRECTORIO RECURSOS; Duran M.A., 2004, REV ESP INVESTIG SOC, V106, P9; Gysels M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034188; Habermas J., 1981, HIST CRITICA OPINION; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Khaw KT, 1999, BRIT MED J, V319, P1350, DOI 10.1136/bmj.319.7221.1350; Lupton D., 1999, HEALTH, V3, P259, DOI [10.177/136345939900300301, DOI 10.1177/136345939900300301]; Lynch T, 2010, PALLIATIVE MED, V24, P812, DOI 10.1177/0269216310368578; Lynch T, 2009, J PAIN SYMPTOM MANAG, V37, P305, DOI 10.1016/j.jpainsymman.2008.03.011; Lyons A C, 2000, J Health Psychol, V5, P349, DOI 10.1177/135910530000500307; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; McIlfatrick S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-34; Carrasco JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184806; Muszbek K, 2007, J PAIN SYMPTOM MANAG, V33, P605, DOI 10.1016/j.jpainsymman.2007.02.027; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4846; Peel E, 2014, SOCIOL HEALTH ILL, V36, P885, DOI 10.1111/1467-9566.12122; Ruiz J. R., 2009, FORUM QUALITATIVE SO, V10, P2; Strydom P, 2000, SOCIOLOGICAL DISCOUR; Taiwo R., 2007, PERSPECTIVES MEDIA D; Taylor Steven, 2016, INTRO QUALITATIVE RE, V4th; Van den Berg R, 2011, EUR J GEN PRACT, V17, P14, DOI 10.3109/13814788.2010.549224; van Dijk T.A., 1988, NEWS DISCOURSE; World Health Organization, 2013, EUR HLTH REP 2012 CH; World Health Organization, 2014, DEF PALL CAR, DOI [10.1186/1472-684X-13-34, DOI 10.1186/1472-684X-13-34]; World Palliative Care Alliance World Health Organization, 2014, GLOBAL ATLAS PALLIAT; Wurz A, 2013, J HEALTH COMMUN, V18, P1566, DOI 10.1080/10810730.2013.840698; 2013, WORLD MAL REP 2013, P1	39	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211106	10.1371/journal.pone.0211106	http://dx.doi.org/10.1371/journal.pone.0211106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682109	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000457037500101
J	Xie, LQ; Zhu, YH; Li, YH; Su, TC				Xie, Liquan; Zhu, Yehui; Li, YanHong; Su, Tsung-Chow			Experimental study on bed pressure around geotextile mattress with sloping plate	PLOS ONE			English	Article							LOCAL SCOUR; PROTECTION; PREDICTION; MECHANICS	A geotextile mattress with sloping curtain is a newly proposed countermeasure against river and estuarine scour. In previous laboratory experiments, a geotextile mattress with sloping curtain was capable of protecting the bed downstream from scour and stimulating sediment deposition on both sides. However, the seepage scour under its geotextile mattress is inadequately researched at present. In this study, the Geotextile Mattress with Sloping Plate (GMSP) is proposed based on the simplification of the geotextile mattress with sloping curtain with the construction feasibility considered. A series of experiments was conducted to investigate the pressure distribution around the GMSP and the averaged seepage hydraulic gradient beneath its mattress. The results indicate remarkable pressure difference on two sides of the GMSP. The minimum bed pressure appears about 1.3 times the plate height downstream to the GMSP. The averaged seepage hydraulic gradient beneath the mattress increases with the sloping angle increasing from 35 degrees to 60 degrees in general. The averaged hydraulic gradient also ascends as the relative plate height increases, but reduces as the opening ratio increases at opening ratios greater than 0.143. The safety boundary for the averaged hydraulic gradient under the geotextile mattress of the GMSP could get much smaller than the critical hydraulic gradient of piping and can easily be overwhelmed. This phenomenon can mainly be attributed to the discontinuous contact between the mattress and the seabed. A suggestion for the parametric design of the GMSP is to extend the width of the mattress to reduce the risk of seepage failure.	[Xie, Liquan; Zhu, Yehui] Tongji Univ, Coll Civil Engn, Shanghai, Peoples R China; [Li, YanHong] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Shanghai, Peoples R China; [Su, Tsung-Chow] Florida Atlantic Univ, Dept Ocean & Mech Engn, Boca Raton, FL 33431 USA	Tongji University; Shanghai Jiao Tong University; State University System of Florida; Florida Atlantic University	Xie, LQ (corresponding author), Tongji Univ, Coll Civil Engn, Shanghai, Peoples R China.	xie_liquan@tongji.edu.cn		Xie, Liquan/0000-0001-8287-9706	National Natural Science Foundation of China [50979071, 51479137]; China Scholarship Council [201806260166]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This study was supported by the National Natural Science Foundation of China (Grant Nos. 50979071, 51479137) for experiment and data analysis. Recipient: LX, url: http://www.nsfc.gov.cn/; And China Scholarship Council grant 201806260166 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter A, 2013, J HYDRAUL ENG, V139, P865, DOI 10.1061/(ASCE)HY.1943-7900.0000735; Brandimarte L, 2006, J HYDRAUL ENG, V132, P493, DOI 10.1061/(ASCE)0733-9429(2006)132:5(493); Briaud JL, 1999, J GEOTECH GEOENVIRON, V125, P237, DOI 10.1061/(ASCE)1090-0241(1999)125:4(237); Chang J, 2012, CHINA CONSTRUCT 0716; Chen B, 2012, INT J OFFSHORE POLAR, V22, P276; CHIEW YM, 1990, J HYDRAUL ENG-ASCE, V116, P515, DOI 10.1061/(ASCE)0733-9429(1990)116:4(515); Deng Z. D., 2016, ALTERNATIVE ENERGY S, P404, DOI [10. 1002/9781119066354. ch38, DOI 10.1002/9781119066354.CH38]; Galan A, 2015, J HYDRAUL ENG, V141, DOI 10.1061/(ASCE)HY.1943-7900.0001003; Gu S, 2015, ADV ENG RES, V6, P18; Kuang CP, 2014, J COASTAL RES, V30, P598, DOI 10.2112/JCOASTRES-D-13-00173.1; Li Heming, 2005, International Electric Machines and Drives Conference (IEEE Cat. No.05EX1023C), P1, DOI 10.1109/IEMDC.2005.195692; Li YH, 2009, CHINA OCEAN ENG, V23, P565; Melville BW, 1999, J HYDRAUL ENG-ASCE, V125, P59, DOI 10.1061/(ASCE)0733-9429(1999)125:1(59); Narayan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154735; Nielsen AW, 2007, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON OFFSHORE MECHANICS AND ARCTIC ENGINEERING, VOL 5, P399; Pourzangbar A, 2017, COAST ENG, V121, P107, DOI 10.1016/j.coastaleng.2016.12.008; Qin J, 2017, ADV WATER RESOUR, V108, P44, DOI 10.1016/j.advwatres.2017.07.015; Rice J, GEOCONGRESS 2013 STA, VIII, P1044; Rivier A, 2016, OCEAN DYNAM, V66, P1285, DOI 10.1007/s10236-016-0983-6; Shields FD, 2000, ENVIRON MANAGE, V26, P317; Sumer BM, 2001, COAST ENG, V42, P313, DOI 10.1016/S0378-3839(00)00066-1; Tian Y, 2016, INT J SUST DEV WORLD, V23, P333, DOI 10.1080/13504509.2015.1127862; VANRHEE C, 1992, J GEOTECH ENG-ASCE, V118, P1236, DOI 10.1061/(ASCE)0733-9410(1992)118:8(1236); Whitehouse RJS, 2011, MAR POLLUT BULL, V62, P73, DOI 10.1016/j.marpolbul.2010.09.007; Wu YS, 2013, J PIPELINE SYST ENG, V4, P3, DOI 10.1061/(ASCE)PS.1949-1204.0000118; Xie L, 2013, GEOSYNTH INT, V20, P389, DOI 10.1680/gein.13.00026; Xie L, 11 ISOPE PAC AS OFFS; Xie LQ, 2015, J COASTAL RES, P35, DOI 10.2112/SI73-007.1; Xie LQ, 2010, PROCEEDINGS OF THE ASME 29TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2010, VOL 1, P839; Yoshida K, 2018, APPL OCEAN RES, V80, P181, DOI 10.1016/j.apor.2018.09.001	30	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211312	10.1371/journal.pone.0211312	http://dx.doi.org/10.1371/journal.pone.0211312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682145	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500148
J	Govender, A; Groeneveld, J; Singh, S; Willows-Munro, S				Govender, Ashrenee; Groeneveld, Johan; Singh, Sohana; Willows-Munro, Sandi			The design and testing of mini-barcode markers in marine lobsters	PLOS ONE			English	Article							OXIDASE SUBUNIT-I; PHYLOGENETIC-RELATIONSHIPS; DECAPODA ACHELATA; DNA; IDENTIFICATION; MITOCHONDRIAL; SPINY; PHYLLOSOMA; GLYPHEIDEA; ASTACIDEA	Full-length mitochondrial cytochrome c oxidase I (COI) sequence information from lobster phyllosoma larvae can be difficult to obtain when DNA is degraded or fragmented. Primers that amplify smaller fragments are also more useful in metabarcoding studies. In this study, we developed and tested a method to design a taxon-specific mini-barcode primer set for marine lobsters. The shortest, most informative portion of the COI gene region was identified in silico, and a DNA barcode gap analysis was performed to assess its reliability as species diagnostic marker. Primers were designed, and cross-species amplification success was tested on DNA extracted from a taxonomic range of spiny-, clawed-, slipper-and blind lobsters. The mini-barcode primers successfully amplified both adult and phyllosoma COI fragments, and were able to successfully delimit all species analyzed. Previously published universal primer sets were also tested and sometimes failed to amplify COI from phyllosoma samples. The newly designed taxon-specific mini-barcode primers will increase the success rate of species identification in bulk environmental samples and add to the growing DNA metabarcoding toolkit.	[Govender, Ashrenee; Groeneveld, Johan; Willows-Munro, Sandi] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa; [Govender, Ashrenee; Groeneveld, Johan; Singh, Sohana] Oceanog Res Inst, Durban, KwaZulu Natal, South Africa	University of Kwazulu Natal	Willows-Munro, S (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	willows-munro@ukzn.ac.za		Govender, Ashrenee/0000-0002-2860-4610; Willows-Munro, Sandi/0000-0003-0572-369X; Singh, Sohana/0000-0003-3484-7800				Arif IA, 2011, GENET MOL RES, V10, P3559, DOI 10.4238/2011.October.31.3; Baird DJ, 2011, J N AM BENTHOL SOC, V30, P125, DOI 10.1899/10-013.1; BAR W, 1988, FORENSIC SCI INT, V39, P59, DOI 10.1016/0379-0738(88)90118-1; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Berry PF, 1974, PALINURID SCYLLARID; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038215; Bracken-Grissom HD, 2014, SYST BIOL, V63, P457, DOI 10.1093/sysbio/syu008; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Chan TY, 2010, RAFFLES B ZOOL, P153; Chow S, 2006, MAR BIOTECHNOL, V8, P260, DOI 10.1007/s10126-005-5151-9; Dabboor M, 2014, INT J REMOTE SENS, V35, P6859, DOI 10.1080/01431161.2014.960614; Dong WP, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0138-z; Dubey B, 2011, FORENSIC SCI INT-GEN, V5, P181, DOI 10.1016/j.fsigen.2010.03.001; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Genis-Armero R, 2017, ZOOTAXA, V4306, P325, DOI 10.11646/zootaxa.4306.3.2; Hajibabaei M, 2012, METHODS MOL BIOL MET; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holthuis LB, 1991, FAO FISH SYNOP, V13, pI; Jeena NS, 2016, MITOCHONDRIAL DNA A, V27, P2700, DOI 10.3109/19401736.2015.1046160; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Modave E, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix052; O'Rorke R, 2013, J EXP MAR BIOL ECOL, V441, P1, DOI 10.1016/j.jembe.2013.01.003; Palero F, 2016, ZOOTAXA, V4139, P481, DOI 10.11646/zootaxa.4139.4.2; Palero F, 2009, MOL PHYLOGENET EVOL, V50, P152, DOI 10.1016/j.ympev.2008.10.003; Phillips BF, 1980, BIOL MANAGEMENT LOBS; Prasad RR, 1975, J MAR BIOL ASSOC IND, V17, P56; Proutski V, 1998, BIOINFORMATICS, V14, P467, DOI 10.1093/bioinformatics/14.5.467; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trigg S, 2001, INT J REMOTE SENS, V22, P2641, DOI 10.1080/01431160110053185; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Zwickl D, 2006, THESIS U TEXAS AUSTI	48	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210492	10.1371/journal.pone.0210492	http://dx.doi.org/10.1371/journal.pone.0210492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677051	Green Published, gold			2022-12-27	WOS:000456700400016
J	Niu, SF; Kuo, SF; Tsai, HT; Kao, CC; Traynor, V; Chou, KR				Niu, Shu-Fen; Kuo, Shu-Fen; Tsai, Hsiu-Ting; Kao, Ching-Chiu; Traynor, Victoria; Chou, Kuei-Ru			Prevalence of workplace violent episodes experienced by nurses in acute psychiatric settings	PLOS ONE			English	Article							MENTAL-HEALTH NURSES; AGGRESSIVE-BEHAVIOR; CARE WORKERS; RISK-FACTORS; PREVENTION; EXPOSURE; CLIMATE; STRESS; WARDS	Nurses who experience workplace violence exhibit compromised care quality and decreased work morale, which may increase their turnover rate. This study explored prevalence of workplace violence, the reaction of victims, and workplace strategies adopted to prevent violence among acute psychiatric settings in northern Taiwan. A cross-sectional study was conducted, which consisted of 429 nurses who completed the Chinese version of the Workplace Violence Survey Questionnaire developed by the International Labor Office, International Council of Nurses, World Health Organization, and Public Services International. The rates of physical and psychological violence were 55.7% and 82.1%, respectively. Most perpetrator of the workplace violence were patients. Most victims responded by instructing the perpetrator to stop, followed by narrating the incident to friends, family, and colleagues. Only 4.9%-12% of the victims completed an incident or accident form, and the main reason for not reporting these violent incidents was the belief that reporting such incidents was useless or unimportant. The major strategies adopted by workplaces to prevent violence were security measures, patient protocols, and training. Institutions should train staff to handle violence, provide a therapeutic environment, simplify the reporting process, and encourage reporting of all types of violence.	[Niu, Shu-Fen; Tsai, Hsiu-Ting] Taipei Med Univ, Coll Nursing, Postbaccalaureate Program Nursing, Taipei, Taiwan; [Niu, Shu-Fen; Chou, Kuei-Ru] Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, Taipei, Taiwan; [Kuo, Shu-Fen] Taipei Med Univ, Coll Nursing, Taipei, Taiwan; [Kao, Ching-Chiu] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Traynor, Victoria] Univ Wollongong, Sch Nursing Sci Med & Hlth, Wollongong, NSW, Australia; [Chou, Kuei-Ru] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Chou, Kuei-Ru] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; University of Wollongong; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chou, KR (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Nursing, Taipei, Taiwan.; Chou, KR (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.; Chou, KR (corresponding author), Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan.	kueiru@tmu.edu.tw	Traynor, Victoria/U-2130-2017	Traynor, Victoria/0000-0003-4515-7602; chou, kueiru/0000-0002-4882-3503				Arnetz J, 2018, J OCCUP ENVIRON MED, V60, P693, DOI 10.1097/JOM.0000000000001345; Becher Jennifer, 2012, Medsurg Nurs, V21, P210; Bilgin Hulya, 2009, Issues Ment Health Nurs, V30, P252, DOI 10.1080/01612840802710464; Carr VJ, 2008, AUST NZ J PSYCHIAT, V42, P267, DOI 10.1080/00048670701881520; Chen XM, 2018, APPL NURS RES, V40, P122, DOI 10.1016/j.apnr.2018.01.003; Cheng WJ, 2017, OCCUP ENVIRON MED, V74, P483, DOI 10.1136/oemed-2016-103898; Cowman S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-1988-7; d'Ettorre G, 2017, SAF HEALTH WORK-KR, V8, P337, DOI [10.1016/j.shaw.2017.01.004., 10.1016/j.shaw.2017.01.004]; Di Martino V., 2003, RELATIONSHIP WORK ST; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Foster C, 2007, J ADV NURS, V58, P140, DOI 10.1111/j.1365-2648.2007.04169.x; Friis K, 2019, EUR J WORK ORGAN PSY, V28, P101, DOI 10.1080/1359432X.2018.1548437; Gadegaard CA, 2018, J INTERPERS VIOLENCE, V33, P1096, DOI 10.1177/0886260515614558; Giovannetti P., 2016, CANADIAN J NURSING R, V32; International Labor Office International Council of Nurses World Health Organization and Public Services International, 2003, WORKSPL VIOL HLTH SE; International Labour Office/International Council of Nurses/World Health Organization/Public Services International, 2002, FRAM GUID ADDR WORKP; Iozzino L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128536; Itzhaki M, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00059; Jiao ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006719; Kwan SSM, 2016, EUR J WORK ORGAN PSY, V25, P133, DOI 10.1080/1359432X.2014.982102; Lantta T, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0059-5; Lin YH, 2005, INT J NURS STUD, V42, P773, DOI 10.1016/j.ijnurstu.2004.11.010; Liu WH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019525; Magnavita N, 2014, J NURS SCHOLARSHIP, V46, P366, DOI 10.1111/jnu.12088; Magnavita N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-108; Magnavita N, 2011, INT J OCCUP ENV HEAL, V17, P336, DOI 10.1179/oeh.2011.17.4.336; Middelboe T, 2001, ACTA PSYCHIAT SCAND, V103, P212, DOI 10.1034/j.1600-0447.2001.00102.x; Muskett C, 2014, INT J MENT HEALTH NU, V23, P51, DOI 10.1111/inm.12012; Occupational Safety and Health Administration, 2016, 314806R OSHA; Pai HC, 2011, J CLIN NURS, V20, P1405, DOI 10.1111/j.1365-2702.2010.03650.x; Pekurinen V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101245; Pien LC, 2019, J ADV NURS, V75, P793, DOI 10.1111/jan.13887; Pihl-Thingvad J, 2018, WORKPLACE HEALTH SAF, V66, P453, DOI 10.1177/2165079917752714; Renwick L, 2016, INT J MENT HEALTH NU, V25, P355, DOI 10.1111/inm.12201; Sato K, 2013, INT J NURS STUD, V50, P1368, DOI 10.1016/j.ijnurstu.2012.12.011; Stevenson KN, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0079-5; Tonso MA, 2016, INT J MENT HEALTH NU, V25, P444, DOI 10.1111/inm.12232; Yang BX, 2018, ARCH PSYCHIAT NURS, V32, P31, DOI 10.1016/j.apnu.2017.09.013; Yang LQ, 2012, INT J NURS STUD, V49, P1091, DOI 10.1016/j.ijnurstu.2012.03.006; [No title captured]	40	34	35	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211183	10.1371/journal.pone.0211183	http://dx.doi.org/10.1371/journal.pone.0211183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677077	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400056
J	Song, XY; Grilo, SA; Mathur, S; Lutalo, T; Ssekubugu, R; Nalugoda, F; Santelli, JS				Song, Xiaoyu; Grilo, Stephanie A.; Mathur, Sanyukta; Lutalo, Tom; Ssekubugu, Robert; Nalugoda, Fred; Santelli, John S.			Differential Impacts of HIV status on short-term fertility desires among couples in Rakai, Uganda	PLOS ONE			English	Article							DECISION-MAKING; INTENTIONS; MEN	Background Fertility desires of female and male partners in current relationships are often correlated. We examined the influence of HIV seropositive status of female and male partners on short-term fertility desires in Rakai, Uganda, a setting with high fertility and HIV infection rates. Methods Participants were couples (15-49 years old) enrolled in the Rakai Community Cohort Study, from 2011 to 2013 (n = 2,291). Cohen's kappa coefficient was used to measure the correlation of female and male partners' short-term fertility desires (measured as 'wanting a child in the next 12 months'), in both total sample and stratified serostatus groups. HIV serostatus and additional characteristics of female and male partners were included in Poisson regression models to estimate the rate ratios (RR) for each partner's short-term fertility desires. Individual and partner characteristics included HIV status, partner HIV status, age in years, partner age in years, educational attainment, number of living children, community of residence, and socioeconomic status (SES). Results Short-term fertility desires among female and male partners were moderately associated (Kappa = 0.37, p-value<0.001). The association was weakest among female sero-positive and male sero-negative couples (Kappa = 0.29, p-value<0.001). When adjusting for parity and other covariates in the model, women's short-term fertility desires were significantly associated with their positive sero-status regardless of male partners' sero-status (adjRR = 1.58, p<0.001 for F+M-; adjRR = 1.33, p = 0.001 for F+M+; in comparison with F-M-). Men's short-term fertility desires were significantly associated with their positive sero-status, in addition to their female partners' positive sero-status (adjRR = 1.23 with p-value = 0.022 for F-M+; adjRR = 1.42 with p-value<0.001 for F+M-; adjRR = 1.26 with p-value<0.001 for F+M+; in comparison with F-M-). When the differential effect of parity was included in the model, similar associations remained for both female and male partners when the number of living children was small, but largely reduced when the number of living children was large (3 or more). Conclusion Female and male partners in couple dyads demonstrated moderate agreements about short-term fertility desires. The HIV seropositive status of female partners was most strongly associated with short-term fertility desires of both genders, and this association was even stronger for women who had few or no living children.	[Song, Xiaoyu] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Song, Xiaoyu] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Grilo, Stephanie A.; Santelli, John S.] Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA; [Grilo, Stephanie A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA; [Mathur, Sanyukta] Populat Council, Washington, DC USA; [Lutalo, Tom; Ssekubugu, Robert; Nalugoda, Fred] RHSP, Rakai Dist, Uganda	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Population Council	Grilo, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Heilbrunn Dept Populat & Family Hlth, New York, NY 10032 USA.; Grilo, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10032 USA.	Sag2179@cumc.columbia.edu	Santelli, John/AAG-3046-2021	Song, Xiaoyu/0000-0003-1909-6244	National Institute of Child Health and Human Development [1 RO1 Hd072595-01]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development, 1 RO1 Hd072595-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT POP HOUS CENS 20; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; DeRose LF, 2010, POPUL RES POLICY REV, V29, P423, DOI 10.1007/s11113-009-9151-8; Galiwango RM, 2013, J VIROL METHODS, V192, P25, DOI 10.1016/j.jviromet.2013.04.003; Heck CJ, 2018, IT IS MY BUSINESS MI; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kagulire SC, 2011, INT J STD AIDS, V22, P308, DOI 10.1258/ijsa.2009.009352; Kanniappan S, 2008, AIDS CARE, V20, P625, DOI 10.1080/09540120701660361; Makumbi F, 2010, AFRICAN J REPROD HLT, V14; Makumbi FE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/519492; Maternowska M. Catherine, 2006, REPROD INEQUITIES PO; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Myer L, 2009, JAIDS-J ACQ IMM DEF, V52, pS52, DOI 10.1097/QAI.0b013e3181bbc818; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Rispel LC, 2015, SAHARA J-J SOC ASP H, V12, P10, DOI 10.1080/17290376.2015.1014403; Rutenberg N, 2000, INT FAM PLAN PERSPEC, V26, P124, DOI 10.2307/2648301; SCOTT JW, 1986, AM HIST REV, V91, P1053, DOI 10.2307/1864376; StataCorp, 2015, STAT SOFTW REL 14; Stephens Sharon, 1995, CONCEIVING NEW WORLD, P270; UNAIDS, COUNTR FACTSH UGANDA; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; World Bank, FERT RAT TOT BIRTHS	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210935	10.1371/journal.pone.0210935	http://dx.doi.org/10.1371/journal.pone.0210935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677068	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400035
J	Spitzer, SA; Vail, D; Tennakoon, L; Rajasingh, C; Spain, DA; Weiser, TG				Spitzer, Sarabeth A.; Vail, Daniel; Tennakoon, Lakshika; Rajasingh, Charlotte; Spain, David A.; Weiser, Thomas G.			Readmission risk and costs of firearm injuries in the United States, 2010-2015	PLOS ONE			English	Article							HOSPITALIZATIONS; VIOLENCE	Background In 2015 there were 36,252 firearm-related deaths and 84,997 nonfatal injuries in the United States. The longitudinal burden of these injuries through readmissions is currently underestimated. We aimed to determine the 6-month readmission risk and hospital costs for patients injured by firearms. Methods We used the Nationwide Readmission Database 2010-2015 to assess the frequency of readmissions at 6 months, and hospital costs associated with readmissions for patients with firearm-related injuries. We produced nationally representative estimates of readmission risks and costs. Results Of patients discharged following a firearm injury, 15.6% were readmitted within 6 months. The average annual cost of inpatient hospitalizations for firearm injury was over $911 million, 9.5% of which was due to readmissions. Medicare and Medicaid covered 45.2% of total costs for the 5 years, and uninsured patients were responsible for 20.1%. Conclusions From 2010-2015, the average total cost of hospitalization for firearm injuries per patient was $32,700, almost 10% of which was due to readmissions within 6 months. Government insurance programs and the uninsured shouldered most of this.	[Spitzer, Sarabeth A.; Vail, Daniel] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Tennakoon, Lakshika; Rajasingh, Charlotte; Spain, David A.; Weiser, Thomas G.] Stanford Div Gen Surg, Sect Trauma & Crit Care, Stanford, CA USA	Stanford University	Spitzer, SA (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	spitzers@stanford.edu	Weiser, Thomas G/AAC-4609-2022	Weiser, Thomas G/0000-0002-3118-3888; Vail, Daniel/0000-0001-8769-2369	Stanford Medical Scholars Research Program	Stanford Medical Scholars Research Program	Sarabeth A. Spitzer was funded by the Stanford Medical Scholars Research Program for this work.	Agency for Healthcare Research and Quality, 2017, HEALTHC COSTS UT PRO; [Anonymous], 2013, INT CLASS DIS 9 REV; [Anonymous], 2017, NRD OV HEALTHC COST; [Anonymous], 2017, NRD DAT DOC HEALTHC; [Anonymous], 2017, HEALTHC COST UT PROJ; [Anonymous], BUR LAB STAT DAT HOS; Centers for Disease Control and Prevention, 2003, WEB BAS INJ STAT QUE; Clark DE OT, 2010, ICDPIC STATA MODULE; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Follman M., 2018, MOTHER JONES; Fowler KA, 2015, PREV MED, V79, P5, DOI 10.1016/j.ypmed.2015.06.002; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Ponzer S, 1996, PUBLIC HEALTH, V110, P41, DOI 10.1016/S0033-3506(96)80034-5; Rattan R, 2018, ANN SURG, V267, P810, DOI 10.1097/SLA.0000000000002529; Salemi JL, 2015, FAM MED COMMUNITY HE, V3, P8, DOI 10.15212/FMCH.2015.0115; Smith M, 2018, INJURY PREV, V24, P332, DOI 10.1136/injuryprev-2017-042373; Spitzer SA, 2017, AM J PUBLIC HEALTH, V107, P770, DOI 10.2105/AJPH.2017.303684; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; WINTEMUTE GJ, 1992, J TRAUMA, V33, P556, DOI 10.1097/00005373-199210000-00011; Yoon F, 201701 HCUP US AG HE	21	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0209896	10.1371/journal.pone.0209896	http://dx.doi.org/10.1371/journal.pone.0209896			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677032	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400008
J	Alitto, RAD; Amaral, ACZ; de Oliveira, LD; Serrano, H; Seger, KR; Guilherme, PDB; Di Domenico, M; Christensen, AB; Lourenco, LB; Tavares, M; Borges, M				dos Santos Alitto, Renata Aparecida; Zacagnini Amaral, Antonia Cecilia; de Oliveira, Leticia Dias; Serrano, Helena; Seger, Karin Regina; Borges Guilherme, Pablo Damian; Di Domenico, Maikon; Christensen, Ana Beardsley; Lourenco, Luciana Bolsoni; Tavares, Marcos; Borges, Michela			Atlantic West Ophiothrix spp. in the scope of integrative taxonomy: Confirming the existence of Ophiothrix trindadensis Tommasi, 1970	PLOS ONE			English	Article							BRITTLE STARS ECHINODERMATA; SYSTEMATIC POSITION; OPHIUROIDEA; RATES; BABY	We re-describe and confirm the validity of Ophiothrix trindadensis Tommasi, 1970 (Echinodermata: Ophiuroidea). This is a native species from Brazil, however it lacked a type series deposited in scientific collections. The recognition of O. trindadensis was made possible using integrative taxonomy applied to many specimens from the type locality (Trindade Island) as well as from different locations along the Brazilian coast (Araca Bay and Estuarine Complex of Paranagua). Initially, 835 specimens were studied and divided into four candidate species (CS) inferred from external morphological characters. Afterwards, the CSs were compared using integrative taxonomy based on external morphology, arm microstructures morphology (arm ossicle), morphometry, and molecular studies (fragments of the mitochondrial genes 16S and COI). Analyses indicated CS1 and CS2 as O. trindadensis, and CS3 as O. angulata, both valid species. CS4 remains O. cf. angulata as more data, including their ecology and physiology, are needed to be definitively clarified. Our integrative investigation using specimens from the type locality overcame the lack of type specimens and increased the reliable identification of O. trindadensis and O. angulata.	[dos Santos Alitto, Renata Aparecida; de Oliveira, Leticia Dias; Serrano, Helena; Seger, Karin Regina; Borges, Michela] Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil; [dos Santos Alitto, Renata Aparecida; Zacagnini Amaral, Antonia Cecilia; de Oliveira, Leticia Dias; Serrano, Helena; Borges, Michela] Univ Estadual Campinas, Museu Zool Adao Jose Cardoso, Campinas, SP, Brazil; [Seger, Karin Regina; Lourenco, Luciana Bolsoni] Univ Estadual Campinas, Dept Biol Celular, Campinas, SP, Brazil; [Borges Guilherme, Pablo Damian] Univ Estadual Parana, Lab Biol Marinha, Paranagua, Parana, Brazil; [Di Domenico, Maikon] Univ Fed Parana, Ctr Estudos Mar, Pontal Do Parana, Parana, Brazil; [Christensen, Ana Beardsley] Lamar Univ, Dept Biol, Beaumont, TX 77710 USA; [Tavares, Marcos] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal do Parana; Texas State University System; Lamar University; Universidade de Sao Paulo	Alitto, RAD (corresponding author), Univ Estadual Campinas, Dept Biol Anim, Campinas, SP, Brazil.; Alitto, RAD (corresponding author), Univ Estadual Campinas, Museu Zool Adao Jose Cardoso, Campinas, SP, Brazil.	renataalitto@gmail.com	Lourenço, Luciana Bolsoni/AAD-4667-2021; Alitto, Renata/AAE-2297-2019; Tavares, Marcos/F-7151-2012; Lourenço, Luciana B/B-5971-2013; Guilherme, Pablo Damian Borges/C-1584-2014	Alitto, Renata/0000-0001-9732-4877; Tavares, Marcos/0000-0002-7186-5787; Lourenço, Luciana B/0000-0001-6602-6850; Guilherme, Pablo Damian Borges/0000-0001-7471-6907; Serrano, Helena/0000-0003-0656-6526; Borges, Michela/0000-0001-6261-5228; Christensen, Ana/0000-0003-2513-7479	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/50317-5, 2011/50724-0]; Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX) [2101/16]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [403940/2012-5, 303122/2016-1]; FAPESP [2016/06877-0, 2016/08869-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CAPES [PDSE-88881.131940/2016-01]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The development of this study was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Proc. No. 2011/50317-5 to ACZA and 2011/50724-0 to MB; Fundo de Apoio ao Ensino, a Pesquisa e Extensao da Unicamp (FAEPEX) Proc. No. 2101/16 to MB; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) ProTrindade Project Proc. No. 403940/2012-5 to MT and 303122/2016-1 to MT. In addition, FAPESP provided fellowships for LDO (Proc. No. 2016/06877-0 to LDO) and for HS (Proc. No. 2016/08869-4 to HS). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. CAPES also provided a fellowship for RASA (Proc. No. PDSE-88881.131940/2016-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUQUERQUE MN, 1991, B MUSEU NACL, V353, P1; ALBUQUERQUE MN, 1986, THESIS; Alitto RAS, 2018, ZOOTAXA, V4405, P1, DOI 10.11646/zootaxa.4405.1.1; Almeida F.F.M., 2006, TERRAE DID ATICA, V2, P3, DOI [10.1007/BF01915460, DOI 10.20396/TD.V2I1.8637462]; Amaral ACZ., 2016, LIFE ARACA BAY DIVER; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anker A, 2016, ZOOTAXA, V4138, P1, DOI 10.11646/zootaxa.4138.1.1; [Anonymous], 1995, SEA STARS SEA URCHIN; Arribas P, 2013, ZOOL SCR, V42, P182, DOI 10.1111/zsc.12000; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baric S, 1999, MOL PHYLOGENET EVOL, V11, P157, DOI 10.1006/mpev.1998.0551; Thuy B, 2011, ZOOTAXA, P1; Borges M., 2005, MANUAL IDENTIFICACAO, P237; Borges Michela, 2002, Biota Neotrop., V2, P1, DOI 10.1590/S1676-06032002000200010; Borges M, 2015, REV BIOL TROP, V63, P361, DOI 10.15517/rbt.v63i2.23170; CLARK AM, 1966, ANN MAG NAT HIST, V9, P637, DOI 10.1080/00222936608651676; de Barros Lima Eduardo Jose, 2009, Revista Brasileira de Zoociencias, V11, P55; De Moura Barboza Carlos Alberto, 2015, Marine Biodiversity Records, V8, pe16, DOI 10.1017/S1755267214001511; Barboza CAD, 2012, ZOOTAXA, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS A, 1983, J BIOGEOGR, V10, P65, DOI 10.2307/2844583; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hart MW, 2005, MOL PHYLOGENET EVOL, V34, P438, DOI 10.1016/j.ympev.2004.09.011; Hendler G, 2005, CARIBB J SCI, V41, P583; Hotchkiss FHC, 2012, ZOOSYMPOSIA, V7, P121, DOI 10.11646/zoosymposia.7.1.12; Hotchkiss Frederick H. C., 2007, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V63, P3; ICZN, 1999, INT CODE ZOOLOGICAL; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kokorin AI, 2014, PALEONTOL J+, V48, P1532, DOI 10.1134/S0031030114140056; Kokorin Aleksandr, 2015, Cuadernos del Museo Geominero, V19, P83; Korshunova T, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.717.21885; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lana PC, 2001, ECOL STU AN, V144, P131; LeClair EE, 1996, J ZOOL, V240, P245, DOI 10.1111/j.1469-7998.1996.tb05283.x; LeClair EE, 1997, BIOL BULL, V193, P77, DOI 10.2307/1542737; LITVINOVA NM, 1994, ECHINODERMS THROUGH TIME, P449; Ludwig H, 1882, MEMOIRES COURONNES S, V44, P1; Martynov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139463; Martynov Alexander, 2010, Zootaxa, V2697, P1; Muths D, 2009, AQUAT BIOL, V5, P117, DOI 10.3354/ab00138; O'Hara TD, 2018, EUR J TAXON, V416, P1, DOI 10.5852/ejt.2018.416; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Perez-Portela R, 2013, ZOOL SCR, V42, P151, DOI 10.1111/j.1463-6409.2012.00573.x; R Development Core Team, 2018, R A LANGUAGE AND ENV; Santana A, 2017, ZOOTAXA, V4344, P291, DOI 10.11646/zootaxa.4344.2.5; Say T., 1825, J ACAD NATURAL SCI P, V5, P141; Schobbenhaus C, 2002, SITIOS GEOLOGICOS PA, V1st, P369; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S, 2008, ZOOL J LINN SOC-LOND, V153, P545; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Taboada S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32425; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The University of Texas at Austin, TEX HIGH SCH COAST M; Thuy B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156140; TOMMASI L R, 1970, Contribuicoes Avulsas do Instituto Oceanografico Sao Paulo, P1; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Viana DL, 2017, PETER PAUL ARCHIPELA; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; WRIGHT S, 1978, P580; Amaral ACZ, 2010, BIOTA NEOTROP, V10, P219, DOI 10.1590/S1676-06032010000100022; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	65	10	12	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210331	10.1371/journal.pone.0210331	http://dx.doi.org/10.1371/journal.pone.0210331			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673722	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800040
J	Lara, B; Ruiz-Moreno, C; Salinero, JJ; Del Coso, J				Lara, Beatriz; Ruiz-Moreno, Carlos; Jose Salinero, Juan; Del Coso, Juan			Time course of tolerance to the performance benefits of caffeine	PLOS ONE			English	Article							ENERGY DRINKS; ADENOSINE RECEPTORS; EXERCISE ENDURANCE; INGESTION; QUANTIFICATION; CONSUMPTION; METABOLISM	The ergogenic effect of acute caffeine ingestion has been widely investigated; however, scientific information regarding tolerance to the performance benefits of caffeine, when ingested on a day-to-day basis, is scarce. The aim of this investigation was to determine the time course of tolerance to the ergogenic effects of a moderate dose of caffeine. Eleven healthy active participants took part in a cross-over, double-blind, placebo-controlled experiment. In one treatment, they ingested 3 mg/kg/day of caffeine for 20 consecutive days while in another they ingested a placebo for 20 days. Each substance was administered daily in an opaque unidentifiable capsule, and the experimental trials started 45 min after capsule ingestion. Two days before, and three times per week during each 20-day treatment, aerobic peak power was measured with an incremental test to volitional fatigue (25 W/min) and aerobic peak power was measured with an adapted version of the Wingate test (15 s). In comparison to the placebo, the ingestion of caffeine increased peak cycling power in the incremental exercise test by similar to 4.0 +/- 1.3% for the first 15 days (P<0.05) but then this ergo genic effect lessened. Caffeine also increased peak cycling power during the Wingate test on days 1, 4, 15, and 18 of ingestion by similar to 4.9 +/- 0.9% (P<0.05). In both tests, the magnitude of the ergogenic effect of caffeine vs. placebo was higher on the first day of ingestion and then progressively decreased. These results show a continued ergogenic effect with the daily ingestion of caffeine for 15-18 days; however, the changes in the magnitude of this effect suggest progressive tolerance.	[Lara, Beatriz; Ruiz-Moreno, Carlos; Jose Salinero, Juan; Del Coso, Juan] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Lara, Beatriz/AAQ-5269-2021; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; Salinero, Juan J./GLT-1243-2022; Ruiz Moreno, Carlos/ABE-9834-2021; Del Coso, Juan/AAC-7117-2020	MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Salinero, Juan J./0000-0003-4153-5100; Del Coso, Juan/0000-0002-5785-984X; Ruiz, Carlos/0000-0003-0644-8132; Lara, Beatriz/0000-0001-5516-4852				AMMON HPT, 1991, ARCH PHARM, V324, P261, DOI 10.1002/ardp.19913240502; Areta JL, 2017, J APPL PHYSIOL, V123, P1414, DOI 10.1152/japplphysiol.00489.2017; Attwood AS, 2007, PSYCHOPHARMACOLOGY, V190, P469, DOI 10.1007/s00213-006-0643-5; Beaumont R, 2017, J SPORT SCI, V35, P1920, DOI 10.1080/02640414.2016.1241421; Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002; CHOU DT, 1985, LIFE SCI, V36, P2347, DOI 10.1016/0024-3205(85)90325-X; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2013, AMINO ACIDS, V44, P1511, DOI 10.1007/s00726-013-1473-5; Del Coso J, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-21; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031380; DODD SL, 1991, EUR J APPL PHYSIOL O, V62, P424, DOI 10.1007/BF00626615; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Edvardsen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085276; El Yacoubi M, 2000, BRIT J PHARMACOL, V129, P1465, DOI 10.1038/sj.bjp.0703170; Elmenhorst D, 2012, J NUCL MED, V53, P1723, DOI 10.2967/jnumed.112.105114; Evans M., 2017, INT J SPORT NUTR EXE, P221, DOI [10.1123/ijsnem.2017-0057, DOI 10.1123/IJSNEM.2017-0057, 10.1123/ijsnem.2017-0217, DOI 10.1123/IJSNEM.2017-0217]; FREDHOLM BB, 1982, ACTA PHYSIOL SCAND, V115, P283, DOI 10.1111/j.1748-1716.1982.tb07078.x; FREDHOLM BB, 1980, TRENDS PHARMACOL SCI, V1, P129; Fredholm BB, 2017, MOL ASPECTS MED, V55, P20, DOI 10.1016/j.mam.2016.11.011; Glaister M, 2018, INT J SPORT PHYSIOL, V13, P402, DOI 10.1123/ijspp.2017-0312; Goncalves LD, 2017, J APPL PHYSIOL, V123, P213, DOI 10.1152/japplphysiol.00260.2017; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Grgic J, 2017, EUR J SPORT SCI, P1, DOI [10.1080/17461391.2016.1218939, DOI 10.1080/17461391.2016.1218939]; Grgic J, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0216-0; Hachana Y, 2012, J STRENGTH COND RES, V26, P1324, DOI 10.1519/JSC.0b013e3182305485; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Inbar O, 1996, WINGATE ANAEROBIC TE; Irwin C, 2011, J SPORT SCI, V29, P509, DOI 10.1080/02640414.2010.541480; Kamimori GH, 1999, EUR J CLIN PHARMACOL, V55, P445, DOI 10.1007/s002280050654; Lara B, 2015, BRIT J NUTR, V114, P908, DOI 10.1017/S0007114515002573; McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001; Perez-Lopez A, 2015, MED SCI SPORT EXER, V47, P850, DOI 10.1249/MSS.0000000000000455; Salinero JJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030269; Salinero JJ, 2014, BRIT J NUTR, V112, P1494, DOI 10.1017/S0007114514002189; Sokmen B, 2008, J STRENGTH COND RES, V22, P978, DOI 10.1519/JSC.0b013e3181660cec; Souza DB, 2017, EUR J NUTR, V56, P13, DOI 10.1007/s00394-016-1331-9; Stadheim HK, 2014, MED SCI SPORT EXER, V46, P1787, DOI 10.1249/MSS.0000000000000288; Svenningsson P, 1999, J NEUROSCI, V19, P4011; Tarnopolsky M, 2000, J APPL PHYSIOL, V89, P1719, DOI 10.1152/jappl.2000.89.5.1719; Van Soeren MH, 1998, J APPL PHYSIOL, V85, P1493, DOI 10.1152/jappl.1998.85.4.1493	43	79	79	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210275	10.1371/journal.pone.0210275	http://dx.doi.org/10.1371/journal.pone.0210275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673725	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800037
J	Rarau, P; Pulford, J; Gouda, H; Phuanukoonon, S; Bullen, C; Scragg, R; Pham, BN; McPake, B; Oldenburg, B				Rarau, Patricia; Pulford, Justin; Gouda, Hebe; Phuanukoonon, Suparat; Bullen, Chris; Scragg, Robert; Bang Nguyen Pham; McPake, Barbara; Oldenburg, Brian			Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey	PLOS ONE			English	Article							DISEASE; GLOBALIZATION; STROKE; HEALTH	Background Risk factors for cardiovascular disease (CVD) are negatively correlated with socio-economic status (SES) in high-income countries (HIC) but there has been little research on their distribution by household SES within low-and middle-income countries (LMICs). Considering the limited data from LMICs, this paper examines the association between behavioural and cardiovascular risk factors and household SES in Papua New Guinea (PNG). Methods Reported here are results of 671 participants from the 900 randomly selected adults aged 15-65 years. These adults were recruited from three socioeconomically and geographically diverse surveillance sites (peri-urban community, rural Highland and an Island community) in PNG in 2013-2014. We measured their CVD risk factors (behavioural and metabolic) using a modified WHO STEPS risk factor survey and analysis of blood samples. We assessed SES by education, occupation and creating a household wealth index based on household assets. We calculated risk ratios (RR) and their 95% confidence intervals (CI) using a generalized linear model to assess the associations between risks and SES. Findings Elevated CVD risk factors were common in all SES groups but the CVD metabolic risk factors were most prevalent among homemakers, peri-urban and rural highlands, and the highest (4th and 5th) wealth quintile population. Adults in the highest wealth quintile had high risks of obesity, elevated HbA1c and metabolic syndrome (MetS) that were greater than those in the lowest quintile although those in the highest wealth quintiles were less likely to smoke tobacco. Compared to people from the Island community, peri-urban residents had increased risks of increased waist circumference (WC) (RR: 1.67, 95%Cl: 1.21-2.31), hypertension (RR: 2.29, 95%Cl: 1.89-4.56), high cholesterol (RR: 2.22, 95%Cl: 1.20-4-10), high triglycerides (RR: 1.49, 95%Cl: 1.17-1-91), elevated HbA1c (RR: 5.54, 95`)/X1: 1.3621-56), and Metabolic syndrome (MetS) (RR: 2.04, 95%Cl: 1.25-3.32). Similarly, Rural Highland residents had increased risk of obesity (Waist Circumference RR: 1.70, 95%Cl: 1.21-3-38, Waist-Hip-Ratio RR:1.48, 95%Cl: 1.28-1-70), hypertension (RR: 2.60, 95`)/X1: 1.71-3-95), high triglycerides (RR: 1.34, 95%Cl: 1.06-1-70) and MetS (RR: 1.88, 95%Cl: 1.12-3-16) compared to those in the rural Island site. Interpretation CVD risk factors are common in PNG adults but their association with SES varies markedly and by location. Our findings show that all community members are at risk of CVD weather they are part of high or low SES groups. These results support the notion that the association between CVD risk factors and SES differ greatly accordingly to the type of SES measure used, risk factors and the population studied. In addition, our findings contribute further to the limited literature in LMIC. Longitudinal studies are needed to monitor changes in rapidly changing societies such as PNG to inform public health policy for control and prevention of NCDs in the country.	[Rarau, Patricia; Pulford, Justin; Gouda, Hebe; Phuanukoonon, Suparat; Bang Nguyen Pham] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Bullen, Chris; Scragg, Robert] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [McPake, Barbara] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Rarau, Patricia; Oldenburg, Brian] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Pulford, Justin] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Gouda, Hebe] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Phuanukoonon, Suparat] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	PNG Institute Of Medical Research; University of Auckland; University of Melbourne; University of Melbourne; Liverpool School of Tropical Medicine; University of Liverpool; University of Queensland; Mahidol University	Rarau, P (corresponding author), Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea.; Rarau, P (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	patricia.rarau@gmail.com	Bullen, Chris/E-4594-2017; McPake, Barbara/AAE-8655-2021; Fazli, Ghazal/AAE-8320-2022	Bullen, Chris/0000-0001-6807-2930; McPake, Barbara/0000-0002-9904-1077; Rarau, Patricia/0000-0003-0795-4686; Pulford, Justin/0000-0003-4756-8480	PNG ExxonMobil Partnerships 2013-2014; Melbourne Research, University of Melbourne, PhD Nossal Scholarship for Global Health	PNG ExxonMobil Partnerships 2013-2014; Melbourne Research, University of Melbourne, PhD Nossal Scholarship for Global Health	Unrestricted grant from PNG ExxonMobil Partnerships 2013-2014. Melbourne Research, University of Melbourne, PhD Nossal Scholarship for Global Health, Dr. Patricia Rarau. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of this manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Al Ali R, 2011, INT J PUBLIC HEALTH, V56, P653, DOI 10.1007/s00038-011-0278-0; ALLEN L, 2017, PUBMED, V2, P15; American Diabetes Association, 2010, DIABETES CARE S1, V33, pS1; [Anonymous], 2018, GROUP; Bank World., 2017, SERV DEL HLTH FAC PA; Benediktsson K, 2002, HARVESTING DEVELOPME; BOYCE AJ, 1978, PROC R SOC SER B-BIO, V202, P269, DOI 10.1098/rspb.1978.0067; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cornish M, 2015, PNG SURVEY OF RECENT; Federation ID, 2006, REPORT NO; FILMER D, 2011, DEMOGRAPHY, V12, P3; Gouda H, 2013, REPORT; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Gwatkin D, 2007, SOCIO ECONOMIC DIFFE; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; HOSSEINPOOR AR, 2012, BMC PUBLIC HEALTH, V12; Howes S, 2014, REPORT NO; Javed F, 2010, SCAND J PUBLIC HEALT, V38, P838, DOI 10.1177/1403494810379291; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kar S, 2010, RISK FACTORS FOR CAR; Kerr GD, 2011, CEREBROVASC DIS, V31, P57, DOI 10.1159/000320855; Kessaram T, 2015, AUST NZ J PUBL HEAL, V39, P336, DOI 10.1111/1753-6405.12398; Kinra S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4974; Kuper H, 2007, STROKE, V38, P27, DOI 10.1161/01.STR.0000251805.47370.91; Kwon YJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2091; Makoutode M, 2013, J OBESITY, V2013; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MOHAN I, 2016, PLOS ONE, V11, P2; National Statistical Office, 2009, W PROV SOC EC URB SU; Peugh JL, 2004, REV EDUC RES, V74, P525, DOI 10.3102/00346543074004525; PNG NDoH HOPE Worldwide P WHO, 2014, PAPUA NEW GUINEA NCD; PNG NSO, 2013, 2009 2010 PAPUA NEW; Rarau P, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000221; Roth GA, 2014, AMERICAN; Rutstein SO, 2004, DHS WEALTH ASSET IND, V6; Samuel P, 2015, INT J EPIDEMIOLOGY, V41, P1315, DOI 10.1093/ije/dys001; Saweri W., 2001, Papua New Guinea Medical Journal, V44, P151; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; WHO, 2011, ORGANIZATION; WHO, 2017, CARDIOVASCULAR DISEA; WHO, 2014, GLOBAL STATUS REPORT; WHO, STEPWISE APPROACH TO; WHO EC, 2011, REPORT; WHO WPR, 2014, WESTERN PACIFIC REGI; Wilkinson RG, 2003, ORGANIZATION; Wilson PWF, 2008, INT J OBESITY, V32, pS17, DOI 10.1038/ijo.2008.30; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; WURM SA, 1983, J HUM EVOL, V12, P25, DOI 10.1016/S0047-2484(83)80011-6; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x; Zimmet PZ, 2006, OBESITY, V14, P1, DOI 10.1038/oby.2006.1	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211068	10.1371/journal.pone.0211068	http://dx.doi.org/10.1371/journal.pone.0211068			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673755	Green Published, Green Accepted, gold			2022-12-27	WOS:000456442800073
J	Duran, GE; Sikic, BI				Duran, George E.; Sikic, Branimir I.			The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONFERS PACLITAXEL RESISTANCE; EXPRESSION; CELLS; TUBULIN; CHEMORESISTANCE; FORMULATIONS; MECHANISMS; LEADS	In a previously published study, higher levels of spleen tyrosine kinase (Syk) were observed in recurrent post-chemotherapy ovarian cancers compared to primary tumors. Syk inhibition was found to stabilize microtubules and potentiate paclitaxel activity in cellular models of taxane-resistant ovarian cancers. We further studied the effects of Syk inhibition on paclitaxel activity in Syk(+) ovarian cancer cell models and in variants selected for taxane resistance. Syk inhibition was accomplished using RNAi and by exposure to the small molecule competitive inhibitor R406, the active metabolite of fostamatinib. Exposure to R406 or to a SYK-specific pool of siRNAs did not alter taxane activity in the OVCAR-3 cell line, which has the most Syk content in our panel of nine human ovarian cancer cell lines. However, treatment with R406 sensitised the multidrug resistant (MDR) variants MES-SA/Dx5 and SKOV-3/TR to paclitaxel in a dose-dependent manner resulting from the inhibition of the ABCB1/P-glycoprotein (P-gp) drug transporter. These observations are Syk-independent since both MDR cell models are Syk negative. R406 modulated resistance to other known P-gp substrates, and we observed orthovanadate-sensitive ATPase stimulation resulting from treatment with R406. These data indicate that the chemo-sensitizing effect of R406 in taxane-resistant cells previously reported was not associated with Syk but resulted from the modulation of P-gp-mediated MDR.	[Duran, George E.; Sikic, Branimir I.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University	Duran, GE (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA.	george.duran@stanford.edu			U. S. National Institutes of Health (NIH) through the National Cancer Institute [R01 CA184968]; NATIONAL CANCER INSTITUTE [R01CA184968] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH) through the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the U. S. National Institutes of Health (NIH) through the National Cancer Institute (Grant R01 CA184968 to BIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyerinas B, 2011, INT J CANC; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Dumontet C, 1996, CANCER RES, V56, P1091; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; Faruki S, 2000, J CELL SCI, V113, P2557; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; HARKER WG, 1985, CANCER RES, V45, P4091; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Huisman MT, 2005, INT J CANCER, V116, P824, DOI 10.1002/ijc.21013; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; Jaffrezou JP, 1995, ONCOL RES, V7, P517; Kajiyama H, 2007, INT J ONCOL, V31, P277; Kavallaris M, 1999, BRIT J CANCER, V80, P1020, DOI 10.1038/sj.bjc.6690507; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Lancet JE, 2009, LEUKEMIA RES, V33, P1055, DOI 10.1016/j.leukres.2008.09.015; Malofeeva EV, 2012, CANCER RES, V72, P6457, DOI 10.1158/0008-5472.CAN-12-1340; Quinn JE, 2003, CANCER RES, V63, P6221; Spicakova T, 2010, MOL CANCER THER, V9, P2970, DOI 10.1158/1535-7163.MCT-10-0780; Strobel T, 1998, CANCER RES, V58, P4776; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Sung M, 2013, ONCOGENE, P1; TANG C, 1994, LEUKEMIA, V8, P1960; Wang YC, 2006, GENE CHROMOSOME CANC, V45, P365, DOI 10.1002/gcc.20300; Wei W, 2015, CANCER CELL, V28, P7, DOI 10.1016/j.ccell.2015.06.008; Yadav S, 2009, CANCER CHEMOTH PHARM, V63, P711, DOI 10.1007/s00280-008-0790-y; Yang Q, 2014, BRIT J CANCER, V110, P1958, DOI 10.1038/bjc.2014.136; Yang XQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08509; Yu Y, 2015, CANCER CELL, V28, P82, DOI 10.1016/j.ccell.2015.05.009	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210879	10.1371/journal.pone.0210879	http://dx.doi.org/10.1371/journal.pone.0210879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668583	Green Submitted, gold, Green Published			2022-12-27	WOS:000456306400023
J	Gaupp, R; Dinius, J; Drazic, I; Korner, M				Gaupp, Rainer; Dinius, Julia; Drazic, Ivana; Koerner, Mirjam			Long-term effects of an e-learning course on patient safety: A controlled longitudinal study with medical students	PLOS ONE			English	Article							ATTITUDES; EDUCATION	Background To improve patient safety, educational interventions on all system levels, including medical school are necessary. Sound theoretical knowledge on elements influencing patient safety (such as error management or team work) is the basis for behavioral changes of health care professionals. Methods A controlled, quasi-experimental study with repeated measures was deployed. The intervention group participated in a mandatory e-learning course on patient safety (ELPAS) between October 2016 and December 2016. The control group did not receive any didactic session on patient safety. In both groups we measured technical knowledge and attitudes towards patient safety before the intervention (T0), directly after the intervention (T1) and one year after the intervention (T2). Participants were 309 third-year medical students in the intervention group and 154 first-and second-year medical students in the control group. Results Technical knowledge in the intervention group (but not the control group) improved significantly after the intervention and remained high after one year (F(2, 84) = 13.506, p < .001, eta(2) = .243). Students of the intervention group felt better prepared for safe patient practice, even one year after the intervention F(2, 85) = 6.743, p < .002, eta(2) =.137). There was no sustainable significant effect on attitudes towards patient safety. Conclusion This study shows, that eLearning interventions can produce significant long-term effects on patient safety knowledge, however, the study did not show long-term effects on attitudes towards patient safety. Our study implies two potential developments for future research: e-learning might be used in combination with face-to-face sessions, or more intensive (in terms of frequency and duration) e-learning sessions may be needed to achieve lasting changes in attitude.	[Gaupp, Rainer; Dinius, Julia; Koerner, Mirjam] Freiburg Univ, Med Fac, Med Psychol & Med Sociol, Hebelstr, Freiburg, Germany; [Drazic, Ivana] SRH Univ Berlin, Ernst Reuter Pl, Berlin, Germany	University of Freiburg	Gaupp, R (corresponding author), Freiburg Univ, Med Fac, Med Psychol & Med Sociol, Hebelstr, Freiburg, Germany.	rainer.gaupp@mps.uni-freiburg.de			German Research Foundation (DFG); University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam F, 2016, ADV HEALTH SCI EDUC, V21, P789, DOI 10.1007/s10459-016-9666-9; Allegranzi B, 2017, SCHWEIZERISCHE EIDGE; [Anonymous], ERR IS HUMAN BUILDIN; [Anonymous], 2018, TOKIOTER ERKLARUNG P; Baker DP, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.036129; Benbassat J, 2013, ADV HEALTH SCI EDUC, V18, P527, DOI 10.1007/s10459-012-9389-5; Biasutti M, 2017, COMPUT EDUC, V111, P158, DOI 10.1016/j.compedu.2017.04.006; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Brown A, 2018, BMJ QUAL SAF, V27, P576, DOI 10.1136/bmjqs-2017-007566; Buhner M., 2009, STAT PSYCHOL SOZIALW, V1; Chen DCR, 2012, MED TEACH, V34, P305, DOI 10.3109/0142159X.2012.644600; Clancy CM, 2009, AM J MED QUAL, V24, P525, DOI 10.1177/1062860609349728; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Dankbaar MEW, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-016-0836-5; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Fabrigar LR, 2006, J PERS SOC PSYCHOL, V90, P556, DOI 10.1037/0022-3514.90.4.556; Feldman SS, 2018, JMIR MED INF, V6, P190, DOI 10.2196/10264; Ferreira-Valente A, 2017, ADV HEALTH SCI EDUC, V22, P1293, DOI 10.1007/s10459-016-9704-7; Gaupp R, 2018, INT J MED EDUC, V9, P189, DOI 10.5116/ijme.5b39.d5a8; Gaupp R, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0691-4; George PP, 2014, J GLOB HEALTH, V4, DOI 10.7189/jogh.04.010406; Gordon M, 2012, MED EDUC, V46, P1042, DOI 10.1111/j.1365-2923.2012.04343.x; Hagen Janne, 2011, Information Management & Computer Security, V19, P140, DOI 10.1108/09685221111153537; Hsu Y-C., 2014, HDB RES ED COMMUNICA, P747, DOI DOI 10.1007/978-1-4614-3185-5_60; Illingworth J., 2015, CONTINUOUS IMPROVEME; Kiesewetter J, 2018, GMS J MED EDU, V35, DOI 10.3205/zma001162; Kiesewetter J, 2014, MED TEACH, V36, P505, DOI 10.3109/0142159X.2014.891008; King HB., 2008, ADV PATIENT SAFETY N; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Krupat E, 2015, MED SCI ED, V26, P61, DOI [10.1007/S40670-015-0190-Y, DOI 10.1007/S40670-015-0190-Y]; Kulier R, 2012, JAMA-J AM MED ASSOC, V308, P2218, DOI 10.1001/jama.2012.33640; Labeau SO, 2016, INFECT CONT HOSP EP, V37, P1052, DOI 10.1017/ice.2016.107; Lou Wenjie, 2017, Biostat Epidemiol, V1, P20, DOI 10.1080/24709360.2017.1306156; Ludtke O, 2007, PSYCHOL RUNDSCH, V58, P103, DOI 10.1026/0033-3042.58.2.103; MAM, 2014, PAT WIRD NAT GES; MFT, 2015, NAT KOMP LERNZ; Miller RD, 2015, MILLERS ANESTHESIA, P3270; Moltner A., 2006, GMS Z MED AUSBILD, V23, pDoc53; Myung SJ, 2012, J SURG EDUC, V69, P659, DOI 10.1016/j.jsurg.2012.04.012; Parand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005055; Patey R, 2007, QUAL SAF HEALTH CARE, V16, P256, DOI 10.1136/qshc.2006.021014; Patientensicherheit A., 2014, WEGE PATIENTENSICHER; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Reason JT, 2001, QUAL HEALTH CARE, V10, P21; Reason JT, 2013, MANAGING RISKS ORG A; Rice HE, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000630; Roter DL, 2017, BMJ QUAL SAF, V26, P508, DOI 10.1136/bmjqs-2016-005489; Salas E, 2005, SMALL GR RES, V36, P555, DOI 10.1177/1046496405277134; Samuriwo R, 2018, MED EDUC, V52, P685, DOI 10.1111/medu.13608; Schrappe M., 2018, APS WEISSBUCH PATIEN; Schrappe M, 2015, BUNDESGESUNDHEITSBLA, V58, P4, DOI 10.1007/s00103-014-2082-5; Schwappach D, 2018, BMJ QUAL SAF, V27, P827, DOI 10.1136/bmjqs-2017-007388; Sheikh A, 2017, B WORLD HEALTH ORGAN, V95, P546, DOI 10.2471/BLT.17.198002; Taylor-Adams S, 2005, SYSTEMS ANAL CLIN IN; Tvedt C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001967; Van Lancker A, 2016, J ADV NURS, V72, P2054, DOI 10.1111/jan.12967; Voutilainen A, 2017, NURS EDUC TODAY, V50, P97, DOI 10.1016/j.nedt.2016.12.020; Weick KE, 2015, MANAGING THE UNEXPECTED: SUSTAINED PERFORMANCE IN A COMPLEX WORLD, 3RD EDITION, P1, DOI 10.1002/9781119175834; Wilcox MV, 2017, PERSPECT MED EDUC, V6, P44, DOI 10.1007/s40037-016-0317-x; World Health Organization, 2011, PAT SAF CURR GUID; Yates S, 2018, CHANDOS INF PROF SER, P97, DOI 10.1016/B978-0-08-102084-5.00009-2; Young M, 2017, PERSPECT MED EDUC, V6, P21, DOI 10.1007/s40037-016-0322-0	62	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210947	10.1371/journal.pone.0210947	http://dx.doi.org/10.1371/journal.pone.0210947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657782	Green Published, Green Submitted, gold			2022-12-27	WOS:000456017000023
J	Song, TT; Li, KT; Wu, T; Wang, Y; Zhang, XZ; Xu, XF; Yao, YC; Han, ZH				Song, Tingting; Li, Keting; Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Yao, Yuncong; Han, Zhenhai			Identification of new regulators through transcriptome analysis that regulate anthocyanin biosynthesis in apple leaves at low temperatures	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; COLD TOLERANCE; GENE-EXPRESSION; RED COLORATION; COLORFUL MODEL; R2R3 MYB; UV-B; ACCUMULATION; STRESS	Anthocyanin pigments play many roles in plants, including providing protection against biotic and abiotic stresses. To identify new regulatory genes in apple (Malus domestica) that may be involved in regulating low temperature induced anthocyanin biosynthesis, we performed RNA-seq analysis of leaves from the 'Gala' apple cultivar following exposure to a low temperature (16 degrees C). A visible red color appeared on the upper leaves and the anthocyanin content increased significantly after the low temperature treatment. Genes from the flavonoid biosynthesis pathway were significantly enriched among the differentially expressed genes, and the expression of several transcription factors was shown by WGCNA (weighted gene co-expression network analysis) to correlate with anthocyanin accumulation, including members of the MYB, MADS, WRKY, WD40, Zinc Finger and HB-ZIP families. Three MYB transcription factors (MdMYB12, MdMYB22 and MdMYB114), which had several CBF/DREB response elements in their promoters, were significantly induced by low temperature exposure and their expression also correlated highly with anthocyanin accumulation. We hypothesize that they may act as regulators of anthocyanin biosynthesis and be regulated by CBF/DREB transcription factors in apple leaves under low temperature conditions. The analyses presented here provide insights into the molecular mechanisms underlying anthocyanin accumulation during low temperature exposure.	[Song, Tingting; Li, Keting; Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Han, Zhenhai] China Agr Univ, Coll Hort, Beijing, Peoples R China; [Song, Tingting; Yao, Yuncong] Beijing Univ Agr, Plant Sci & Technol Coll, Beijing, Peoples R China; [Wu, Ting; Wang, Yi; Zhang, Xinzhong; Xu, Xuefeng; Yao, Yuncong; Han, Zhenhai] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China	China Agricultural University; Beijing University of Agriculture	Han, ZH (corresponding author), China Agr Univ, Coll Hort, Beijing, Peoples R China.; Han, ZH (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.	rschan@cau.edu.cn			National Natural Science Foundation of China [31772263]; Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing [5045243001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing	Financial support was provided by the 'National Natural Science Foundation of China' (31772263), and 'Beijing Municipal Commission of Education Supporting Plan for Cultivating High Level Teachers in Colleges and Universities in Beijing' (5045243001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; An JP, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.23; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andino GK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3130-3; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Beck EH, 2004, J BIOSCIENCES, V29, P449, DOI 10.1007/BF02712118; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabello JV, 2012, PLANT J, V69, P141, DOI 10.1111/j.1365-313X.2011.04778.x; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; Crifo T, 2011, GENE, V476, P1, DOI 10.1016/j.gene.2011.02.005; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Gu XB, 2015, PLANT PHYSIOL BIOCH, V89, P31, DOI 10.1016/j.plaphy.2015.02.004; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jin YM, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/5480617; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kim JH, 2013, J PLANT PHYSIOL, V170, P1461, DOI 10.1016/j.jplph.2013.05.011; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Korn M, 2008, PLANT CELL ENVIRON, V31, P813, DOI 10.1111/j.1365-3040.2008.01800.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HG, 2015, PLANT J, V82, P962, DOI 10.1111/tpj.12866; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lv Y, 2017, PLANT PHYSIOL, V173, P1475, DOI 10.1104/pp.16.01725; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marczak L, 2008, RAPID COMMUN MASS SP, V22, P3949, DOI 10.1002/rcm.3819; Middleton E, 1986, FLAVONOIDS ADV RES 1, V1993, P619; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Revilla E, 2000, J CHROMATOGR A, V881, P461, DOI 10.1016/S0021-9673(00)00269-7; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Schulz E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34027; Shen JZ, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-017-0010-1; Shvarts M, 1997, PHYSIOL PLANTARUM, V99, P67, DOI 10.1034/j.1399-3054.1997.990110.x; Steiner-Lange S, 2003, PLANT J, V34, P519, DOI 10.1046/j.1365-313X.2003.01745.x; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tian J, 2015, HORTSCIENCE, V50, P640, DOI 10.21273/HORTSCI.50.5.640; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang N, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0084-4; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie XB, 2012, PLANT CELL ENVIRON, V35, P1884, DOI 10.1111/j.1365-3040.2012.02523.x; Xu HF, 2018, BIOCHEM BIOPH RES CO, V500, P405, DOI 10.1016/j.bbrc.2018.04.088; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079729; Zhan JP, 2015, PLANT CELL, V27, P513, DOI 10.1105/tpc.114.135657; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhou LJ, 2017, PLANT CELL ENVIRON, V40, P2068, DOI 10.1111/pce.12978	77	25	26	17	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0210672	10.1371/journal.pone.0210672	http://dx.doi.org/10.1371/journal.pone.0210672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695036	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400012
J	Yoon, CH; Ritchie, SR; Duffy, EJ; Thomas, MG; McBride, S; Read, K; Chen, R; Humphrey, G				Yoon, Chang Ho; Ritchie, Stephen R.; Duffy, Eamon J.; Thomas, Mark G.; McBride, Stephen; Read, Kerry; Chen, Rachel; Humphrey, Gayl			Impact of a smartphone app on prescriber adherence to antibiotic guidelines in adult patients with community acquired pneumonia or urinary tract infections	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; SUPPORT; HOSPITALS; DISEASES; AMERICA; PROGRAM; SOCIETY; TOOL	Background Mobile phone apps have been shown to enhance guideline adherence by prescribers, but have not been widely evaluated for their impact on guideline adherence by prescribers caring for inpatients with infections. Objectives To determine whether providing the Auckland City Hospital (ACH) antibiotic guidelines in a mobile phone app increased guideline adherence by prescribers caring for inpatients with community acquired pneumonia (CAP) or urinary tract infections (UTIs). Methods We audited antibiotic prescribing during the first 24 hours after hospital admission in adults admitted during a baseline and an intervention period to determine whether provision of the app increased the level of guideline adherence. To control for changes in prescriber adherence arising from other factors, we performed similar audits of adherence to antibiotic guidelines in two adjacent hospitals. Results The app was downloaded by 145 healthcare workers and accessed a total of 3985 times during the three month intervention period. There was an increase in adherence to the ACH antibiotic guidelines by prescribers caring for patients with CAP from 19% (37/199) to 27% (64/237) in the intervention period (p = 0.04); but no change in guideline adherence at an adjacent hospital. There was no change in adherence to the antibiotic guidelines by prescribers caring for patients with UTI at ACH or at the two adjacent hospitals. Conclusions Provision of antibiotic guidelines in a mobile phone app can significantly increase guideline adherence by prescribers. However, providing an app which allows easy access to antibiotic guidelines is not sufficient to achieve high levels of prescriber adherence.	[Yoon, Chang Ho; Ritchie, Stephen R.; Duffy, Eamon J.; Thomas, Mark G.] Auckland Dist Hlth Board, Auckland, New Zealand; [Ritchie, Stephen R.; Thomas, Mark G.] Univ Auckland, Sch Med Sci, Auckland, New Zealand; [McBride, Stephen] Counties Manukau Dist Hlth Board, Auckland, New Zealand; [Read, Kerry] Waitemata Dist Hlth Board, Auckland, New Zealand; [Chen, Rachel; Humphrey, Gayl] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand	Auckland District Health Board; University of Auckland; University of Auckland	Ritchie, SR (corresponding author), Auckland Dist Hlth Board, Auckland, New Zealand.; Ritchie, SR (corresponding author), Univ Auckland, Sch Med Sci, Auckland, New Zealand.	s.ritchie@auckland.ac.nz	Duffy, Eamon/I-4535-2019	Duffy, Eamon/0000-0002-4515-5116; Read, Kerry/0000-0001-7239-6276; Chen, Rachel Xiucui/0000-0003-1689-1170	Health Research Council Research Partnerships for NZ Health Delivery grant [15/665]; ACH A+ Research grant [6969]	Health Research Council Research Partnerships for NZ Health Delivery grant; ACH A+ Research grant	The research was supported by a Health Research Council Research Partnerships for NZ Health Delivery grant (grant number 15/665) and an ACH A+ Research grant (grant number 6969). No funding sources had any role in study design, data collection, or preparation of the manuscript.	Ahmed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080378; Aikman Kiri L., 2013, Journal of Pharmacy Practice and Research, V43, P272; Batista Michael A, 2013, Virtual Mentor, V15, P947, DOI 10.1001/virtualmentor.2013.15.11.stas1-1311; Brennan N, 2013, BRIT J CLIN PHARMACO, V75, P359, DOI 10.1111/j.1365-2125.2012.04397.x; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Charani E, 2017, J ANTIMICROB CHEMOTH, V72, P1825, DOI 10.1093/jac/dkx040; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-29; Charanil E, 2013, J ANTIMICROB CHEMOTH, V68, P960, DOI 10.1093/jac/dks492; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Curtis CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183062; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Field LC, 2014, RESUSCITATION, V85, P138, DOI 10.1016/j.resuscitation.2013.09.013; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Markley JD, 2017, AM J INFECT CONTROL, V45, P317, DOI 10.1016/j.ajic.2016.09.026; McKay R, 2016, ANTIMICROB AGENTS CH, V60, P4106, DOI 10.1128/AAC.00209-16; Mol PGM, 2004, EMERG INFECT DIS, V10, P522, DOI 10.3201/eid1003.030292; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Panesar P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154202; Sbarbaro JA, 2001, CLIN INFECT DIS, V33, pS240, DOI 10.1086/321856; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Trivedi MH, 2004, PSYCHIAT SERV, V55, P879, DOI 10.1176/appi.ps.55.8.879; Walls G, 2015, NEW ZEAL MED J, V128, P16	25	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211157	10.1371/journal.pone.0211157	http://dx.doi.org/10.1371/journal.pone.0211157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695078	Green Published, gold			2022-12-27	WOS:000457046400016
J	Bhattacharya, AA; Umar, N; Audu, A; Felix, H; Allen, E; Schellenberg, JRM; Marchant, T				Bhattacharya, Antoinette Alas; Umar, Nasir; Audu, Ahmed; Felix, Habila; Allen, Elizabeth; Schellenberg, Joanna R. M.; Marchant, Tanya			Quality of routine facility data for monitoring priority maternal and newborn indicators in DHIS2: A case study from Gombe State, Nigeria	PLOS ONE			English	Article							HEALTH INFORMATION-SYSTEM; ELECTRONIC MEDICAL-RECORD; CHILD; INTERVENTION; MANAGEMENT; MOZAMBIQUE; DISTRICTS; COVERAGE; LEVEL; CARE	Introduction Routine health information systems are critical for monitoring service delivery. District Heath Information System, version 2 (DHIS2) is an open source software platform used in more than 60 countries, on which global initiatives increasingly rely for such monitoring. We used facility-reported data in DHIS2 for Gombe State, north-eastern Nigeria, to present a case study of data quality to monitor priority maternal and neonatal health indicators. Methods For all health facilities in DHIS2 offering antenatal and postnatal care services (n = 497) and labor and delivery services (n = 486), we assessed the quality of data for July 2016-June 2017 according to the World Health Organization data quality review guidance. Using data from DHIS2 as well as external facility-level and population-level household surveys, we reviewed three data quality dimensions-completeness and timeliness, internal consistency, and external consistency-and considered the opportunities for improvement. Results Of 14 priority maternal and neonatal health indicators that could be tracked through facility-based data, 12 were included in Gombe's DHIS2. During July 2016-June 2017, facility-reported data in DHIS2 were incomplete at least 40% of the time, under-reported 10%-60% of the events documented in facility registers, and showed inconsistencies over time, between related indicators, and with an external data source. The best quality data elements were those that aligned with Gombe's health program priorities, particularly older health programs, and those that reflected contact indicators rather than indicators related to the provision of commodities or content of care. Conclusion This case study from Gombe State, Nigeria, demonstrates the high potential for effective monitoring of maternal and neonatal health using DHIS2. However, coordinated action at multiple levels of the health system is needed to maximize reporting of existing data; rationalize data flow; routinize data quality review, feedback, and supervision; and ensure ongoing maintenance of DHIS2.	[Bhattacharya, Antoinette Alas; Umar, Nasir; Schellenberg, Joanna R. M.; Marchant, Tanya] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Audu, Ahmed; Felix, Habila] State Primary Hlth Care Dev Agcy, Gombe, Nigeria; [Allen, Elizabeth] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhattacharya, AA (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	antoinette.bhattacharya@lshtm.ac.uk	Umar, Nasir/ABG-1847-2020	Marchant, Tanya/0000-0002-4228-4334; Schellenberg, Joanna/0000-0002-0708-3676	Bill & Melinda Gates Foundation; IDEAS project at the London School of Hygiene and Tropical Medicine	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); IDEAS project at the London School of Hygiene and Tropical Medicine	This work was supported through a grant made by the Bill & Melinda Gates Foundation to the IDEAS project at the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Adedini, 2016, MATERNAL HLTH NIGERI; Admon AJ, 2013, PUBLIC HEALTH ACTION, V3, P56, DOI 10.5588/pha.12.0071; Ahanhanzo YG, 2015, HEALTH POLICY PLANN, V30, P837, DOI 10.1093/heapol/czu067; Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; [Anonymous], 2017, DAT QUAL REV TOOLK F; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Bosch-Capblanch X, 2009, TROP MED INT HEALTH, V14, P2, DOI 10.1111/j.1365-3156.2008.02181.x; Brouwer HJ, 2006, FAM PRACT, V23, P529, DOI 10.1093/fampra/cml040; Bryce J, 2008, COUNTD 2015 TRACK PR; Carvajal-Aguirre L, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020101; Chilundo B, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-3; Countdown, 2015, COUNTD 2015 DEC TRAC; Demographic and Health Survey, DEM HLTH SURV DHS SU; District Health Information System, 2017, DISTR HLTH INF SYST; Every Woman Every Child and Partnership for Maternal Newborn & Child Health, 2017, PROGR PARTN 2017 PRO; Federal Ministry of Health of Nigeria, 2016, NIG EV NEWB ACT PLAN; Federal Ministry of Health of Nigeria, 2013, NAT ROUT IMM STRAT P; Federal Ministry of Health of Nigeria, 2014, NAT HLTH INF SYST ST; Gimbel S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2660-y; Gimbel S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-12; Gombe State Government, 2018, HIST GOMB STAT NIG 2; Hahn D, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21424; Hotchkiss D., 2012, CAN ROUTINE HLTH INF; Hotchkiss DR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-188; Kiberu VM, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-40; Ledikwe JH, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-7; Lippeveld T., 2001, WORKSH ISS INN ROUT; Maina I, 2017, B WORLD HEALTH ORGAN, V95, P683, DOI 10.2471/BLT.17.194399; Makinde O. A., 2014, ONLINE J PUBLIC HLTH, V6, pe184, DOI [10.5210/ojphi.v6i2.5287, DOI 10.5210/OJPHI.V6I2.5287]; Makombe SD, 2008, B WORLD HEALTH ORGAN, V86, P310, DOI 10.2471/BLT.07.044685; Maokola W, 2011, TROP MED INT HEALTH, V16, P721, DOI 10.1111/j.1365-3156.2011.02751.x; Marchant T, 2016, CHANGE MATERNAL NEWB; Marchant T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126840; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; Mlambo MG, 2014, HEALTH SA GESONDHEID, V19, DOI 10.4102/hsag.v19i1.774; Moran A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020307; Moran AC, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1035-4; Moxon SG, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S8; Mphatswe W, 2012, B WORLD HEALTH ORGAN, V90, P176, DOI 10.2471/BLT.11.092759; Munos MK, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010801; Mutale W, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S9; Muthee V, 2016, ANN GLOB HEALTH, V82, P460; National Bureau of Statistics United Nations Children's Fund, 2017, MULT IND CLUST SURV; National Population Commission of Nigeria, 2014, NIG DEM HLTH SURV 20; Nicol E, 2013, STUDIES HLTH TECHNOL, P192; Nisingizwe MP, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25829; Nutley T, 2012, IMPROVING DATA USE D; O'Hagan R, 2017, GLOB HEALTH-SCI PRAC, V5, P367, DOI 10.9745/GHSP-D-17-00177; Ohiri K, 2016, HEALTH SYST REFORM, V2, P319, DOI 10.1080/23288604.2016.1234864; Omoleke SA, 2017, PAN AFR MED J, V27, DOI 10.11604/pamj.2017.27.239.11875; Osika, 2012, ASSESSMENT ROUTINE H; Puttkammer N, 2016, INT J MED INFORM, V86, P104, DOI 10.1016/j.ijmedinf.2015.11.003; Ronveaux O, 2005, B WORLD HEALTH ORGAN, V83, P503; Roomaney RA, 2017, J AM MED INFORM ASSN, V24, pE194, DOI 10.1093/jamia/ocw075; Routine Health Information Network, 2017, EL HLTH MAN INF SYST; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Rowe AK, 2009, AM J TROP MED HYG, V80, P971, DOI 10.4269/ajtmh.2009.80.971; Stausberg J, 2015, STUD HEALTH TECHNOL, V210, P712, DOI 10.3233/978-1-61499-512-8-712; UNGA, 2015, SUST DEV AG, DOI DOI 10.1201/B20466-7; United Nations Children's Fund, MULT IND CLUST SURV; Victora C, 2016, LANCET GLOB HEALTH, V4, pE775, DOI 10.1016/S2214-109X(16)30204-2; Wagenaar BH, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0043-3; WHO, 2011, ASS HLTH FAC DAT QUA; WHO, 2015, LEV TRENDS CHILD MOR; WHO (World Health Organization), 2015, STRAT END PREV MAT M; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2015, SERV AV READ ASS SAR; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; World Health Organization Department of Planning and Health Information of the Cambodia Ministry of Health, 2013, ASS HLTH FAC DAT QUA; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Yourkavitch J, 2016, HEALTH POLICY PLANN, V31, P1162, DOI 10.1093/heapol/czw047	76	48	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211265	10.1371/journal.pone.0211265	http://dx.doi.org/10.1371/journal.pone.0211265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682130	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000457037500138
J	Bornmann, L; Wohlrabe, K; Gralka, S				Bornmann, Lutz; Wohlrabe, Klaus; Gralka, Sabine			The graduation shift of German universities of applied sciences	PLOS ONE			English	Article							HIGHER-EDUCATION; EFFICIENCY-EVIDENCE	In research into higher education, the evaluation of completion and dropout rates has generated a steady stream of interest for decades. While most studies only calculate quotes using student and graduate numbers for both phenomena, we propose to additionally consider the budget available to universities. We transfer the idea of the excellence shift indicator [(1) under bar] from the research to the teaching area, in particular to the completion rate of educational entities. The graduation shift shows the institutions' ability to produce graduates as measured against their basic academic teaching efficiency. It is an important advantage of the graduation shift that it avoids the well-known heterogeneity problem in efficiency measurements. Our study is based on German universities of applied science. Given their politically determined focus on education, this dataset is well-suited for introducing and evaluating the graduation shift. Using a comprehensive dataset covering the years 2008 to 2013, we show that the graduation shift produces results, which correlate closely with the results of the well-known graduation rate and standard Data Envelopment Analysis (DEA). Compared to the graduation rate, the graduation shift is preferable because it allows to take the budget of institutions into account. Compared to the DEA, the computation of the graduation shift is easy, the results are robust, and non-economists can understand them results. Thus, we recommend the graduation shift as an alternative method of efficiency measurement in the teaching area.	[Bornmann, Lutz] Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany; [Wohlrabe, Klaus] Ifo Inst, Munich, Germany; [Gralka, Sabine] Tech Univ Dresden, Dresden, Germany	Max Planck Society; Ifo Institut; Technische Universitat Dresden	Bornmann, L (corresponding author), Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany.	bornmann@gv.mpg.de	Bornmann, Lutz/A-3926-2008; Wohlrabe, Klaus/R-9102-2016; Gralka, Sabine/U-4901-2019	Bornmann, Lutz/0000-0003-0810-7091; Wohlrabe, Klaus/0000-0002-5651-2641; Gralka, Sabine/0000-0001-8303-4297				Agasisti T, 2017, TRANSIENT PERSISTENT, p[14, 17]; Agasisti T, 2016, HIGH EDUC Q, V70, P81, DOI 10.1111/hequ.12066; Agasisti T, 2016, INT REV APPL ECON, V30, P48, DOI 10.1080/02692171.2015.1070130; Agasisti T, 2009, HIGH EDUC, V57, P477, DOI 10.1007/s10734-008-9157-x; Aulck L., 2016, 2016 ICML WORKSHOPS, P16; Baskaya S., 2014, J BUS ECON STAT, V5, P2085, DOI [10.15341/jbe(2155-7950)/11.05.2014/013, DOI 10.15341/JBE(2155-7950)/11.05.2014/013]; Bogetoft P, 2010, BENCHMARKING DEA SFA, V157; Bornmann L, 2017, SCIENTOMETRICS, V112, P1859, DOI 10.1007/s11192-017-2446-3; CARTER CF, 1972, HIGH EDUC, V1, P77, DOI 10.1007/BF01956882; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; De Witte K, 2017, J OPER RES SOC, V68, P339, DOI 10.1057/jors.2015.92; Destatis, 2016, HOCHSCH EIN BLICK 20, P1; E. Commission, 2015, ECTS US GUID, P1; Gnewuch M, 2018, ED EC, P1; Gralka S, 2018, EDUC ECON, V26, P373, DOI 10.1080/09645292.2017.1420754; Heublein U, 2014, EUR J EDUC, V49, P497, DOI 10.1111/ejed.12097; Johnes G, 2011, EDUC ECON, V19, P487, DOI 10.1080/09645291003726442; Johnes G, 2009, ECON EDUC REV, V28, P107, DOI 10.1016/j.econedurev.2008.02.001; Kempkes G, 2010, APPL ECON, V42, P2063, DOI 10.1080/00036840701765361; Kyvik S., 2004, HIGHER ED EUROPE, V29, P393, DOI DOI 10.1080/0379772042000331679; Olivares M., 2011, CESIFO ECON STUD, V60, P653; Rhaiem M, 2017, SCIENTOMETRICS, V110, P581, DOI 10.1007/s11192-016-2173-1; SADLAK J, 1978, HIGH EDUC, V7, P213, DOI 10.1007/BF00129419; Sav G.T., 2012, INT J BUS MANAG EC R, V3, P633; Theune K, 2015, HIGH EDUC, V70, P725, DOI 10.1007/s10734-015-9864-z; TINTO V, 1975, REV EDUC RES, V45, P89, DOI 10.2307/1170024; Wilson PW, 2013, US DEP EC CLEMSON U, P2; Wissenschaftsrat, 2010, EMPF ROLL FACHH HOCH, P1; Zoghbi AC, 2013, ECON MODEL, V31, P94, DOI 10.1016/j.econmod.2012.11.018	29	1	1	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210160	10.1371/journal.pone.0210160	http://dx.doi.org/10.1371/journal.pone.0210160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682052	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500026
J	Coutand, C; Adam, B; Ploquin, S; Moulia, B				Coutand, Catherine; Adam, Boris; Ploquin, Stephane; Moulia, Bruno			A method for the quantification of phototropic and gravitropic sensitivities of plants combining an original experimental device with model-assisted phenotyping: Exploratory test of the method on three hardwood tree species	PLOS ONE			English	Article							AVENA COLEOPTILES; SHAPE REGULATION; GROWTH STRESSES; SIMULATE; TROPISMS	Perception of inclination in the gravity field and perception of light direction are two important environmental signals implicated in the control of plant shape and habit. However, their quantitative study in light-grown plants remains a challenge. We present a novel method here to determine the sensitivities to gravitropism and phototropism. The method combines: (i) an original experimental device of isotropic light to disentangle gravitropic and phototropic plant responses; and (ii) model-assisted phenotyping using recent models of tropism perception-the AC model for gravitropism alone and the ArC model for gravitropism combined with phototropism. We first assessed the validity of the AC and ArC models on poplar, the classical species model for woody plants. We then tested the method on three woody species contrasted by their habit and tolerance to shade: poplar (Populus tremula* alba), oak (Quercus petraea) and beech (Fagus sylvatica). The method was found to be effective to quantitatively discriminate the tested species by their ratio of tropistic sensitivities. The method thus appears as an interesting tool to quantitatively determine tropistic sensitivities, a prerequisite for assessing the role of tropisms in the control of the variability of the habit and/or tolerance to shade of woody species in the future.	[Coutand, Catherine] INRA, UR 1115 PSH, Avignon, France; [Adam, Boris; Ploquin, Stephane; Moulia, Bruno] Univ Clermont Auvergne, INRA, PIAF, Clermont Ferrand, France	INRAE; INRAE; Universite Clermont Auvergne (UCA)	Coutand, C (corresponding author), INRA, UR 1115 PSH, Avignon, France.	catherine.coutand@inra.fr			Agence Nationale de la Recherche [ANR-11-BSV7-0012 TROPIC]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, ANR-11-BSV7-0012 TROPIC.	Almeras T, 2009, J THEOR BIOL, V256, P370, DOI 10.1016/j.jtbi.2008.10.011; Bastien R, 2014, FRONT PLANT SCI, V2014, P127; Bastien R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004037; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Collet C, 2011, ANN BOT-LONDON, V107, P1345, DOI 10.1093/aob/mcr058; Correll MJ, 2002, J PLANT GROWTH REGUL, V21, P89, DOI 10.1007/s003440010056; Coutand C, 2007, PLANT PHYSIOL, V144, P1166, DOI [10.1104/pp.106.088153, 10.1104/PP.106.088153]; Coutand C, 2011, J THEOR BIOL, V273, P115, DOI 10.1016/j.jtbi.2010.12.027; DenDulk J. A., 1989, INTERPRETATION REMOT; Digby J, 2002, J EXP BOT, V53, P377, DOI 10.1093/jexbot/53.367.377; Digby J, 1995, PLANT CELL ENVIRON, V18, P1434, DOI 10.1111/j.1365-3040.1995.tb00205.x; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P31, DOI 10.1007/s00468-002-0203-5; Fourcaud T, 2003, TREES-STRUCT FUNCT, V17, P23, DOI 10.1007/s00468-002-0202-6; Fournier Meriem, 1994, Biomimetics, V2, P229; Galland P, 2002, PLANTA, V215, P779, DOI 10.1007/s00425-002-0813-6; Galland P, 2002, J PLANT RES, V115, P131, DOI 10.1007/s102650200018; Iino M, 2006, CURR OPIN PLANT BIOL, V9, P89, DOI 10.1016/j.pbi.2005.11.012; Matsuzaki J, 2007, PLANT CELL ENVIRON, V30, P646, DOI 10.1111/j.1365-3040.2007.01656.x; Matsuzaki J, 2006, ANN BOT-LONDON, V98, P573, DOI 10.1093/aob/mcl127; Moulia B, 2009, J EXP BOT, V60, P461, DOI 10.1093/jxb/ern341; Nicolini E, 1991, THESIS; Pot G, 2014, TREES-STRUCT FUNCT, V28, P1235, DOI 10.1007/s00468-014-1033-y; Pouliquen O, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa6876; Sierra-De-Grado R, 2008, TREE PHYSIOL, V28, P835, DOI 10.1093/treephys/28.6.835; SierradeGrado R, 1997, TREES-STRUCT FUNCT, V11, P455, DOI 10.1007/s004680050107; SILK WK, 1978, AM J BOT, V65, P310, DOI 10.2307/2442271; SILK WK, 1984, ANNU REV PLANT PHYS, V35, P479, DOI 10.1146/annurev.pp.35.060184.002403; Vandenbrink JP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00563	28	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209973	10.1371/journal.pone.0209973	http://dx.doi.org/10.1371/journal.pone.0209973			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682051	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500019
J	Kumagai, G; Wada, K; Kudo, H; Asari, T; Chiba, D; Ota, S; Takeda, O; Koyama, K; Nakaji, S; Ishibashi, Y				Kumagai, Gentaro; Wada, Kanichiro; Kudo, Hitoshi; Asari, Toru; Chiba, Daisuke; Ota, Seiya; Takeda, On; Koyama, Kazushige; Nakaji, Shigeyuki; Ishibashi, Yasuyuki			Associations between cervical disc degeneration and muscle strength in a cross-sectional population-based study	PLOS ONE			English	Article							ROENTGENOGRAPHIC FINDINGS; NECK SYMPTOMS; SPINE; AGE; PREVALENCE; LUMBAR; PAIN	The physical and biochemical factors related to cervical disc degeneration (CDD), which is involved in several spinal disorders, remain uncertain. We investigated associations between CDD and muscle strength in a general Japanese population. We used mid-sagittal-plane MRIs to assess CDD in 344 subjects recruited from participants in our community health-check project, and measured body mass index (BMI),skeletal muscle index (SMI), and muscle strength in the neck, trunk, hands, and legs. CDD was scored based on the prevalence and severity of intravertebral disc degeneration. Spearman correlation coefficients were used to evaluate whether the SMI or muscle-strength values were correlated with the disc degenerative score. Stepwise multiple linear regression analyses were then conducted with the CDD score as the dependent variable, and age, sex, BMI, and muscle strength as independent variables, for each gender. These analyses used the muscle strength parameters that were found to be correlated with the CDD scores in the single correlation analyses. The CDD scores were similar in men and women. Men had significantly more muscle strength in the neck, trunk, hands, and legs. There was a significant negative corelation between the CDD score and the trunk strength in both sexes, handgrip in men, and leg strength in women in the single-variable correlation analysis. Including age and the limb- or trunk-muscle strength comprehensively, multiple linear regression analyses showed that age was the strongest factor that was independently associated with CDD in both sexes, and that the effects were attenuated by limb and trunk muscle strength.	[Kumagai, Gentaro; Wada, Kanichiro; Kudo, Hitoshi; Asari, Toru; Chiba, Daisuke; Ota, Seiya; Takeda, On; Koyama, Kazushige; Ishibashi, Yasuyuki] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan; [Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Kumagai, G (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan.	gen722@hirosaki-u.ac.jp		Takeda, On/0000-0001-5212-8813	Ministry of Education, Culture, Sports, Science and Technology of Japan [18200044]; Japanese Society for the Promotion of Science [21500676]; JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 18200044), by the Japanese Society for the Promotion of Science (No. 21500676), and by JOA-Subsidized Science Project Research from the Japanese Orthopaedic Association (No.2015-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; BRAIN WR, 1948, P ROY SOC MED, V41, P509; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Chiba D, 2016, J ORTHOP SCI, V21, P366, DOI 10.1016/j.jos.2016.02.006; Gore DR, 2001, SPINE, V26, P2463, DOI 10.1097/00007632-200111150-00013; GORE DR, 1986, SPINE, V11, P521, DOI 10.1097/00007632-198607000-00003; Hakkaku T, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117735830; Inoue R, 2011, OSTEOARTHR CARTILAGE, V19, P51, DOI 10.1016/j.joca.2010.10.021; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kumagai G, 2018, J ORTHOP SCI, V23, P277, DOI 10.1016/j.jos.2017.11.002; Kumagai G, 2014, J ORTHOP SCI, V19, P390, DOI 10.1007/s00776-014-0549-8; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Matsumoto M, 2013, EUR SPINE J, V22, P708, DOI 10.1007/s00586-012-2500-z; Muhle C, 1998, AM J NEURORADIOL, V19, P1763; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; NURICK S, 1972, BRAIN, V95, P87; Okada E, 2011, EUR SPINE J, V20, P1567, DOI 10.1007/s00586-011-1774-x; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Omair A, 2016, EUR SPINE J, V25, P2, DOI 10.1007/s00586-015-4181-x; Sasaki E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192687; Sun D, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1522-4; Takamiya Y, 2006, J ORTHOP SCI, V11, P235, DOI 10.1007/s00776-006-1005-1; Teichtahl AJ, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1297-z; Teraguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147565; Wada K, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2055-1	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210802	10.1371/journal.pone.0210802	http://dx.doi.org/10.1371/journal.pone.0210802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682082	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500063
J	Li, XY; Peng, P; Liu, XY; Chen, WL; Liu, JT; Yang, JQ; Bian, XM				Li, Xiaoyan; Peng, Ping; Liu, Xinyan; Chen, Weilin; Liu, Juntao; Yang, Jianqiu; Bian, Xuming			The pregnancy outcomes of patients with rudimentary uterine horn: A 30-year experience	PLOS ONE			English	Article							LAPAROSCOPIC MANAGEMENT; UNICORNUATE UTERUS; CLINICAL PRESENTATION; RUPTURE; DIAGNOSIS; ANOMALIES	Objectives To evaluate the presentation, assessment, treatment, and pregnancy outcomes of 22 women with a rudimentary uterine horn. Methods We reviewed the data regarding the outcomes of patients with a rudimentary horn pregnancy (RHP) who were managed at Peking Union Medical College Hospital over the last 30 years. Twenty-two pregnant patients with a rudimentary horn have been treated at our institute over the last 30 years. All patients with RHP were divided into two groups: Type A (n = 4), a rudimentary horn with a cavity that communicated with the uterus; and Type B (n = 7), a rudimentary horn with a cavity that did not communicate with the uterus. We classified all 22 patients into communicating group or noncommunicating group according to the anatomical connection of the rudimentary horn to the contralateral hemiuterus. Results The mean gestational age of Type A patients (23.5 weeks) was significantly higher (P = 0.046) than that of Type B patients (10 weeks). The rudimentary uterine horn carried 4 of 5 (80%) pregnancies in the communicating group. Three case of rudimentary horn pregnancies ruptured before a gestational age of 12 weeks, and one abortion occurred after a gestational age of 12 weeks. In the noncommunicating group, 7 of 17 (41.2%) cases were RHPs, and 3 ruptured after a gestational age of 12 weeks. Conclusions The diagnosis and management of the rudimentary uterine horn continues to be challenging. Medical and radiological personnel must maintain a high degree of alertness to prevent the morbidity associated with this condition. In particular, patients with RHP (Type A), who have a higher chance being misdiagnosed before 12 gestational weeks, have a higher risk of potential complications. If pregnancy in the rudimentary horn is diagnosed, excision of the pregnant horn is recommended, regardless of the type of unicornuate uterus.	[Li, Xiaoyan; Peng, Ping; Liu, Xinyan; Chen, Weilin; Liu, Juntao; Yang, Jianqiu; Bian, Xuming] Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Li, Xiaoyan] 1 Shuaifuyuan, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Peng, P (corresponding author), Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China.	magiclynn@vip.sina.com	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		2016 pumch science fund for junior faculty [pumch-2016-2.7]	2016 pumch science fund for junior faculty	This study was funded by the 2016 pumch science fund for junior faculty, pumch-2016-2.7 to Dr. Xiaoyan Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar ME, 2005, AUST NZ J OBSTET GYN, V45, P148, DOI 10.1111/j.1479-828X.2005.00346.x; Arslan T, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.08.027; Basbug M, 1997, INT J GYNECOL OBSTET, V57, P199; Caserta Donatella, 2014, J Med Case Rep, V8, P130, DOI 10.1186/1752-1947-8-130; CHANG JC, 1992, ACTA OBSTET GYN SCAN, V71, P235, DOI 10.3109/00016349209009926; Chopra S, 2009, ARCH GYNECOL OBSTET, V280, P907, DOI 10.1007/s00404-009-1013-4; Contreras KR, 2008, J MINIM INVAS GYN, V15, P644, DOI 10.1016/j.jmig.2008.06.008; Cutner A, 2004, EUR J OBSTET GYN R B, V113, P106, DOI 10.1016/j.ejogrb.2003.09.020; Daskalakis G, 2002, OBSTET GYNECOL, V100, P1108, DOI 10.1016/S0029-7844(02)02153-1; Dicker D, 1998, HUM REPROD, V13, P2643, DOI 10.1093/humrep/13.9.2643; Edelman AB, 2003, AM J OBSTET GYNECOL, V189, P886, DOI 10.1067/S0002-9378(03)00121-2; Elsayegh A, 1998, HUM REPROD, V13, P3566, DOI 10.1093/humrep/13.12.3566; Falcone T, 1997, HUM REPROD, V12, P263, DOI 10.1093/humrep/12.2.263; Fedele L, 2005, FERTIL STERIL, V83, P432, DOI 10.1016/j.fertnstert.2004.07.966; Goel Poonam, 2007, Indian J Med Sci, V61, P23; Grimbizis GF, 2016, GYNECOL SURG, V13, P1, DOI 10.1007/s10397-015-0909-1; Jayasinghe Y, 2005, OBSTET GYNECOL, V105, P1456, DOI 10.1097/01.AOG.0000161321.94364.56; Khati NJ, 2012, J ULTRAS MED, V31, P319, DOI 10.7863/jum.2012.31.2.319; Kuscu NK, 2002, EUR J OBSTET GYN R B, V102, P209, DOI 10.1016/S0301-2115(01)00600-5; Sanchez-Ferrer ML, 2018, TAIWAN J OBSTET GYNE, V57, P110, DOI 10.1016/j.tjog.2017.12.018; Marten K, 2003, CLIN IMAG, V27, P346, DOI 10.1016/S0899-7071(02)00587-9; Nahum GG, 2002, J REPROD MED, V47, P151; Nahum GG, 1998, J REPROD MED, V43, P877; NEZHAT F, 1994, SURG LAPAROSC ENDOSC, V4, P155; Nishi Hirotaka, 2003, Archives of Gynecology and Obstetrics, V268, P224, DOI 10.1007/s00404-002-0310-y; Oral B., 2001, Archives of Gynecology and Obstetrics, V265, P100, DOI 10.1007/s004040000140; Pados G, 2014, EUR J OBSTET GYN R B, V182, P33, DOI 10.1016/j.ejogrb.2014.08.023; Reichman D, 2009, FERTIL STERIL, V91, P1886, DOI 10.1016/j.fertnstert.2008.02.163; Romano S, 2000, HUM REPROD, V15, P1578, DOI 10.1093/humrep/15.7.1578; Sawada M, 2018, J OBSTET GYNAECOL RE, V44, P1080, DOI 10.1111/jog.13622; Siwatch S, 2013, ARCH GYNECOL OBSTET, V287, P687, DOI 10.1007/s00404-012-2625-7; Smolders D, 2002, EUR RADIOL, V12, P121, DOI 10.1007/s003300100939; Sonmezer Murat, 2006, JSLS, V10, P396; Troiano RN, 2004, RADIOLOGY, V233, P19, DOI 10.1148/radiol.2331020777; Tsafrir A, 2005, J ULTRAS MED, V24, P219, DOI 10.7863/jum.2005.24.2.219; TSUDA H, 1994, EUR J OBSTET GYN R B, V56, P143, DOI 10.1016/0028-2243(94)90273-9; Yahata T, 1998, J REPROD MED, V43, P223; Yoo EH, 1999, ACTA OBSTET GYN SCAN, V78, P167; ZAIDI J, 1994, ACTA OBSTET GYN SCAN, V73, P359, DOI 10.3109/00016349409015781	39	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210788	10.1371/journal.pone.0210788	http://dx.doi.org/10.1371/journal.pone.0210788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682068	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500062
J	Moon, YJ; Kim, JW; Bang, YS; Lim, YS; Ki, Y; Sang, BH				Moon, Young-Jin; Kim, Jung-Won; Bang, Yun-Sic; Lim, Young Su; Ki, Yumin; Sang, Bo-Hyun			Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment	PLOS ONE			English	Article							HEART-FAILURE; EUROPEAN-ASSOCIATION; EJECTION FRACTION; AMERICAN-SOCIETY; E/A RATIO; DYSFUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; IMPACT	Although pretransplant cardiac dysfunction is considered a major predictor of poor outcomes after liver transplantation (LT), the ability of left ventricular (LV) systolic/diastolic function (LVSF/LVDF), together or individually, to predict mortality after LT is poorly characterized. We retrospectively evaluated pretransplant clinical and Doppler echocardiographic data of 839 consecutive LT recipients from 2009 to 2012 aged 18-60 years. The primary endpoint was all-cause mortality at 4 years. The overall survival rate was 91.2%. In multivariate Cox analysis, reduced LV ejection fraction (LVEF, P = 0.014) and decreased transmitral E/A ratio(P = 0.022) remained significant prognosticators. In LVSF analysis, patients with LVEF <= 60% (quartile [Q]1) had higher mortality than those with LVEF>60% (hazard ratio = 1.90, 95% confidence interval = 1.15-3.15, P = 0.012). In LVDF analysis, patients with an E/A ratio<0.9(Q1) had a 2.19-fold higher risk of death (95% confidence interval = 1.11-4.32, P = 0.024) than those with an E/A ratio>1.4(Q4). In combined LVDF and LVSF analysis, patients with an E/A ratio<0.9 and LVEF <= 60% had poorer survival outcomes than patients with an E/A ratio >= 0.9 and LVEF>60% (79.5% versus 93.3%, P = 0.001). Patients with an early mitral inflow velocity/annular velocity (E/e' ratio) >11.5(Q4) and LV stroke volume index (LVSVI)< 33mL/m(2) (Q1) showed worse survival than those with an E/e' ratio. 11.5 and LVSVI. 33mL/m(2) (78.4% versus 92.2%, P = 0.003). A combination of LVSF and LVDF is a better predictor of survival than LVSF or LVDF alone.	[Moon, Young-Jin] Univ Ulsan, Dept Anesthesiol & Pain Med, Lab Cardiovasc Dynam, Asan Med Ctr,Coll Med, Seoul, South Korea; [Kim, Jung-Won; Bang, Yun-Sic; Lim, Young Su; Sang, Bo-Hyun] Catholic Kwandong Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Int St Marys Hosp, Incheon, South Korea; [Ki, Yumin] CHA Univ, Dept Anesthesiol & Pain Med, CHA Bundang Med Ctr, Seongnam, South Korea	University of Ulsan; Asan Medical Center; Catholic Kwandong University; Pochon Cha University	Sang, BH (corresponding author), Catholic Kwandong Univ Korea, Coll Med, Dept Anesthesiol & Pain Med, Int St Marys Hosp, Incheon, South Korea.	perhaps125@naver.com		Moon, Young-Jin/0000-0003-3719-1691; Sang, Bo-Hyun/0000-0001-6890-4629				Abeles RD, 2007, GUT, V56, P1642; Bianchi G, 2008, LIVER TRANSPLANT, V14, P1648, DOI 10.1002/lt.21588; Choi Jin-Oh, 2015, J Cardiovasc Ultrasound, V23, P158, DOI 10.4250/jcu.2015.23.3.158; Dowsley TF, 2012, TRANSPLANTATION, V94, P646, DOI 10.1097/TP.0b013e31825f0f97; Flu WJ, 2010, ANESTHESIOLOGY, V112, P1316, DOI 10.1097/ALN.0b013e3181da89ca; Garg A, 2013, JACC-CARDIOVASC IMAG, V6, P105, DOI 10.1016/j.jcmg.2012.11.002; Higashi M, 2013, ACTA ANAESTH SCAND, V57, P1154, DOI 10.1111/aas.12168; Josefsson A, 2012, LIVER INT, V32, P1262, DOI 10.1111/j.1478-3231.2012.02818.x; Kong YG, 2015, BRIT J ANAESTH, V114, P437, DOI 10.1093/bja/aeu384; Kuwaki H, 2014, JACC-CARDIOVASC IMAG, V7, P749, DOI 10.1016/j.jcmg.2014.05.002; Landesberg G, 2012, EUR HEART J, V33, P895, DOI 10.1093/eurheartj/ehr351; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lavi R, 2007, ANESTHESIOLOGY, V107, P1018, DOI 10.1097/01.anes.0000287613.49204.94; Licker M, 2010, CRIT CARE, V14, DOI 10.1186/cc9040; Mahadevan G, 2008, HEART, V94, P426, DOI 10.1136/hrt.2007.123877; Mittal C, 2014, DIGEST DIS SCI, V59, P674, DOI 10.1007/s10620-013-2955-8; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Qureshi W, 2013, LIVER TRANSPLANT, V19, P701, DOI 10.1002/lt.23654; Rabie RN, 2009, AM J GASTROENTEROL, V104, P2458, DOI 10.1038/ajg.2009.321; Raevens S, 2014, ACTA CARDIOL, V69, P273, DOI 10.1080/AC.69.3.3027830; Raval Z, 2011, J AM COLL CARDIOL, V58, P223, DOI 10.1016/j.jacc.2011.03.026; Ruiz-del-Arbol L, 2013, HEPATOLOGY, V58, P1732, DOI 10.1002/hep.26509; SPIRITO P, 1988, BRIT HEART J, V59, P672; Tajik AJ, 2014, JACC-CARDIOVASC IMAG, V7, P759, DOI 10.1016/j.jcmg.2014.05.003; Therapondos G, 2004, LIVER TRANSPLANT, V10, P1441, DOI 10.1002/lt.20298; Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016; VanWagner LB, 2014, LIVER TRANSPLANT, V20, P1306, DOI 10.1002/lt.23950; Wiese S, 2014, NAT REV GASTRO HEPAT, V11, P177, DOI 10.1038/nrgastro.2013.210; Yip GW, 2002, CLIN SCI, V102, P515, DOI 10.1042/CS20010196; Yu CM, 2007, J AM COLL CARDIOL, V49, P1903, DOI 10.1016/j.jacc.2007.01.078; Yuksel V, 2015, J CARDIOVASC SURG, V56, P655; Zambruni A, 2006, J HEPATOL, V44, P994, DOI 10.1016/j.jhep.2005.10.034; Zardi EM, 2010, J AM COLL CARDIOL, V56, P539, DOI 10.1016/j.jacc.2009.12.075	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209100	10.1371/journal.pone.0209100	http://dx.doi.org/10.1371/journal.pone.0209100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682022	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500013
J	Muller, M; Dahdal, S; Saffarini, M; Uehlinger, D; Arampatzis, S				Mueller, Martin; Dahdal, Suzan; Saffarini, Mo; Uehlinger, Dominik; Arampatzis, Spyridon			Evaluation of Nutrition Risk Screening Score 2002 (NRS) assessment in hospitalized chronic kidney disease patient	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; MALNUTRITION; MULTICENTER; PREVALENCE; OUTCOMES; ASSOCIATION; LENGTH; COSTS; STAY	Background Although chronic kidney disease (CKD) patients are particularly prone to malnutrition, systematic nutritional screening is rarely routinely performed during hospitalization. The primary aim of this study was to determine the prevalence of malnutrition (as captured by the nutritional screening score NRS) in hospitalized CKD patients and explore the impact of malnutrition on hospital mortality. Methods All patients admitted to the tertiary nephrology department of the University hospital of Bern Inselspital over a period of 12 months were included in this observational study. The risk for malnutrition was assessed within 24h of admission by the NRS. Demographic, clinical, and outcome data were extracted from the patient database. The primary outcome was in-hospital mortality. The secondary outcomes were length of hospitalization and hospitalization costs. Multilevel mixed-effect logistic regression model analysis was performed to determine the association of in-hospital mortality and risk of malnutrition (NRS score >= 3). Results We included 696 eligible hospitalizations of 489 CKD patients. Hospitalized patients had a median age of 64 years (interquartile range (IQR), 52-72), 35.6% were at risk of malnutrition (NRS >= 3). After adjustment for the identified confounders (Case weight, Barthel index, and CKD stage) multivariate analysis confirmed an independent and significant association between higher in-hospital mortality with NRS >= 3 [OR 2.92 (95% CI: 1.33-6.39), P<0.001]. Furthermore, in multivariate analysis the risk of malnutrition was associated with longer length of hospitalization [Geometric mean ratio: 1.8 (95% CI: 1.5-2.0), p<0.001] and with increased hospitalization costs [Geometric mean ratio: 1.7 (95% CI: 1.5-1.9), p<0.001]). Conclusions Malnutrition in CKD patients, as captured by NRS>3, is highly prevalent among hospitalized CKD patient and associated with prolonged hospital stay and increased in-hospital mortality.	[Mueller, Martin] Univ Bern, Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland; [Dahdal, Suzan; Uehlinger, Dominik; Arampatzis, Spyridon] Univ Bern, Bern Univ Hosp, Dept Nephrol Hypertens & Clin Pharmacol, Inselspital, Bern, Switzerland; [Saffarini, Mo] ReSurg SA, Chemin Vuarpilliere 35, Nyon, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Arampatzis, S (corresponding author), Univ Bern, Bern Univ Hosp, Dept Nephrol Hypertens & Clin Pharmacol, Inselspital, Bern, Switzerland.	spiros.arampatzis@insel.ch			Gottfried and Julia Bangerter-Rhyner-Foundation; Swiss Academy of Medical Sciences through the "Young Talents in Clinical research" grant [TCR 14/17]	Gottfried and Julia Bangerter-Rhyner-Foundation; Swiss Academy of Medical Sciences through the "Young Talents in Clinical research" grant	MM was funded by the Gottfried and Julia Bangerter-Rhyner-Foundation and the Swiss Academy of Medical Sciences through the "Young Talents in Clinical research" grant (TCR 14/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; Benoit K., 2011, LONDON SCH EC, V22, P23; Borek P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030287; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Chen ZY, 2015, EUR J CLIN NUTR, V69, P552, DOI 10.1038/ejcn.2014.239; Chima CS, 1997, J AM DIET ASSOC, V97, P975, DOI 10.1016/S0002-8223(97)00235-6; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; Dai L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186659; Desbrow B, 2005, J RENAL NUTR, V15, P211, DOI 10.1053/j.jrn.2004.10.005; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Fassett RG, 2014, CLIN INTERV AGING, V9, P191, DOI 10.2147/CIA.S39763; Felder S, 2015, NUTRITION, V31, P1385, DOI 10.1016/j.nut.2015.06.007; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Imoberdorf R, 2010, CLIN NUTR, V29, P38, DOI 10.1016/j.clnu.2009.06.005; Kelly IE, 2000, QJM-MON J ASSOC PHYS, V93, P93, DOI 10.1093/qjmed/93.2.93; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kruizenga HM, 2003, CLIN NUTR, V22, P147, DOI 10.1054/clnu.2002.0611; Leandro-Merhi VA, 2015, CLIN NUTR, V34, P647, DOI 10.1016/j.clnu.2014.07.001; Ljungqvist O, 2009, NUTR HOSP, V24, P369; MAHONEY F I, 1965, Md State Med J, V14, P61; MOWE M, 1991, J AM GERIATR SOC, V39, P1089, DOI 10.1111/j.1532-5415.1991.tb02874.x; Mowe M, 2008, CLIN NUTR, V27, P196, DOI 10.1016/j.clnu.2007.10.014; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Reignier J, 2018, LANCET, V391, P133, DOI [10.1016/S0140-6736(17)32146-3, 10.1016/s0140-6736(17)32146-3]; Sinoff G, 1997, J AM GERIATR SOC, V45, P832, DOI 10.1111/j.1532-5415.1997.tb01510.x; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Studley H O, 2001, Nutr Hosp, V16, P141; Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243; Zhang Y, 2018, INT UROL NEPHROL, V50, P1319, DOI 10.1007/s11255-018-1828-7	30	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211200	10.1371/journal.pone.0211200	http://dx.doi.org/10.1371/journal.pone.0211200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677081	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400059
J	Belloti, JC; Okamura, A; Scheeren, J; Faloppa, F; de Moraes, VY				Belloti, Joao Carlos; Okamura, Aldo; Scheeren, Jordana; Faloppa, Flavio; de Moraes, Vinicius Ynoe			A systematic review of the quality of distal radius systematic reviews: Methodology and reporting assessment	PLOS ONE			English	Review							STATIC EXTERNAL FIXATION; VOLAR LOCKING PLATE; INTERNAL-FIXATION; COCHRANE REVIEWS; OPEN REDUCTION; FRACTURES; METAANALYSES; COMPLICATIONS; EFFICACY; OUTCOMES	Background Many systematic reviews (SRs) have been published about the various treatments for distal radius fractures (DRF). The heterogeneity of SRs results may come from the misuse of SR methods, and literature overviews have demonstrated that SRs should be considered with caution as they may not always be synonymous with high-quality standards. Our objective is to evaluate the quality of published SRs on the treatment of DRF through these tools. Methods The methods utilized in this review were previously published in the PROSPERO database. We considered SRs of surgical and nonsurgical interventions for acute DRF in adults. A comprehensive search strategy was performed in the MEDLINE database (inception to May 2017) and we manually searched the grey literature for non-indexed research. Data were independently extracted by two authors. We assessed SR internal validity and reporting using AMSTAR (Assessing the Methodological Quality of Systematic Reviews and PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes). Scores were calculated as the sum of reported items. We also extracted article characteristics and provided Spearman's correlation measurements. Results Forty-one articles fulfilled the eligibility criteria. The mean score for PRISMA was 15.90 (CI 95%, 13.9-17.89) and AMSTAR was 6.48 (CI 95% 5.72-7.23). SRs that considered only RCTs had better AMSTAR [7.56 (2.1) vs. 5.62 (2.3); p = 0.014] and PRISMA scores [18.61 (5.22) vs. 13.93 (6.47), p = 0.027]. The presence of meta-analysis on the SRs altered PRISMA scores [19.17 (4.75) vs. 10.21 (4.51), p = 0.001] and AMSTAR scores [7.68 (1.9) vs. 4.39 (1.66), p = 0.001]. Journal impact factor or declaration of conflict of interest did not change PRISMA and AMSTAR scores. We found substantial inter observer agreement for PRISMA (0.82, 95% CI 0.62-0.94; p = 0.01) and AMSTAR (0.65, 95% CI 0.43-0.81; p = 0.01), and moderate correlation between PRISMA and AMSTAR scores (0.83, 95% CI 0.62-0.92; p = 0.01). Conclusions DRF RCT-only SRs have better PRISMA and AMSTAR scores. These tools have substantial inter-observer agreement and moderate inter-tool correlation. We exposed the current research panorama and pointed out some factors that can contribute to improvements on the topic.	[Belloti, Joao Carlos; Okamura, Aldo; Scheeren, Jordana; Faloppa, Flavio; de Moraes, Vinicius Ynoe] Univ Fed Sao Paulo, Dept Orthoped & Traumatol, Div Hand Surg, Sao Paulo, Brazil; [Belloti, Joao Carlos; Okamura, Aldo; Faloppa, Flavio; de Moraes, Vinicius Ynoe] Hosp Alvorada Moema, Grp Cirurgia Mao & Microcirurgia, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	de Moraes, VY (corresponding author), Univ Fed Sao Paulo, Dept Orthoped & Traumatol, Div Hand Surg, Sao Paulo, Brazil.; de Moraes, VY (corresponding author), Hosp Alvorada Moema, Grp Cirurgia Mao & Microcirurgia, Sao Paulo, SP, Brazil.	vymoraes@gmail.com	PPGCT, Ortop/ABC-3666-2021; Belloti, João Carlos/F-7164-2012; Okamura, Aldo/AAN-8389-2020	Okamura, Aldo/0000-0003-0115-2236; Belloti, joao/0000-0002-1439-6064				Adie S, 2015, ANN SURG, V261, P94, DOI [10.1097/SLA.0000000000000765, DOI 10.1097/SLA.0000000000000765]; Asadollahi S, 2013, J ORTHOP TRAUMATOL, V14, P227, DOI 10.1007/s10195-013-0245-z; Azzi AJ, 2017, PLAST RECONSTR SURG, V139, p717E, DOI 10.1097/PRS.0000000000003076; Baradaran A, 2016, J HAND SURG EUR, V42; Bentohami A, 2014, J HAND SURG-EUR VOL, V39, P745, DOI 10.1177/1753193413511936; Biondi-Zoccai GGL, 2006, BMJ-BRIT MED J, V332, P202, DOI 10.1136/bmj.38693.516782.7C; Chaudhry H, 2015, CLIN ORTHOP RELAT R, V473, P3017, DOI 10.1007/s11999-015-4347-1; Chen YH, 2016, J HAND SURG-AM, V41, P404, DOI 10.1016/j.jhsa.2015.12.008; Cui Z, 2012, INJURY, V43, P1006, DOI 10.1016/j.injury.2011.11.018; Cui Z, 2011, INT ORTHOP, V35, P1333, DOI 10.1007/s00264-011-1300-0; Cullis PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175213; de Moraes VY, 2014, ACTA ORTOP BRAS, V22, DOI 10.1590/1413-78522014220601009; Diaz-Garcia RJ, 2011, J HAND SURG-AM, V36A, P824, DOI 10.1016/j.jhsa.2011.02.005; Dijkman BG, 2010, J BONE JOINT SURG AM, V92A, P48, DOI 10.2106/JBJS.I.00251; Esposito J, 2013, INJURY, V44, P409, DOI 10.1016/j.injury.2012.12.003; Farrar NG, 2008, EMERG MED J, V25, P224, DOI 10.1136/emj.2008.058198; Franzin FM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/534738; Gu WL, 2016, J ORTHOP SCI, V21, P24, DOI 10.1016/j.jos.2015.10.021; Handoll H H, 2002, Cochrane Database Syst Rev, pCD003320, DOI 10.1002/14651858.CD003320; Handoll H H, 2003, Cochrane Database Syst Rev, pCD003763; Handoll HHG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006080; Handoll HHG, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000434.pub4, 10.1002/14651858.CD003209.pub2]; Handoll HHG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003324.pub3; Handoll HH., 2003, COCHRANE DB SYST REV, V2, pCD000314, DOI [10.1002/14651858.CD000314, DOI 10.1002/14651858.CD000314]; Hoang-Kim A, 2009, ARCH ORTHOP TRAUM SU, V129, P105, DOI 10.1007/s00402-008-0661-3; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jordan RW, 2015, BONE JOINT J, V97B, P1370, DOI 10.1302/0301-620X.97B10.35297; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Ju JH, 2015, LANGENBECK ARCH SURG, V400, P767, DOI 10.1007/s00423-015-1324-9; Keizer RJOD, 2017, STRATEG TRAUMA LIMB, V12, P77, DOI 10.1007/s11751-017-0284-8; Li-Hai Z, 2014, J SURG RES, P1; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Margaliot Z, 2005, J HAND SURG-AM, V30A, P1185, DOI 10.1016/j.jhsa.2005.08.009; McGee RG, 2013, J PAEDIATR CHILD H, V49, P319, DOI 10.1111/jpc.12156; Modi CS, 2010, INJURY, V41, P1006, DOI 10.1016/j.injury.2010.02.030; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1823, LANCET, V1, P353; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mulders MAM, 2017, STRATEG TRAUMA LIMB, V12, P181, DOI 10.1007/s11751-017-0288-4; Paksima N, 2004, BULL HOSP JT DIS, P62; Parker MJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000093.pub4; Poolman RW, 2007, ACTA ORTHOP, V78, P162, DOI 10.1080/17453670710013636; Qiu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15318; Minguez DR, 2017, ANESTH ANALG, V125, P1348, DOI 10.1213/ANE.0000000000002227; Ring D, 2005, OSTEOPOROSIS INT, V16, pS80, DOI 10.1007/s00198-004-1808-x; Sabesan VJ, 2015, AGING CLIN EXP RES, V27, P539, DOI 10.1007/s40520-014-0295-y; Schulz K.F., 2010, PLOS MED, V7; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith Dean W, 2004, J Hand Ther, V17, P43, DOI 10.1197/j.jht.2003.10.006; Suhm N, 2008, J ORTHOP TRAUMA, V22, pS121, DOI 10.1097/BOT.0b013e3181830d13; Tao KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027611; Trevisan C, 2013, AGING CLIN EXP RES, V25, pS83, DOI 10.1007/s40520-013-0075-0; Valdes K, 2014, J HAND THER, P1; Walenkamp MMJ, 2013, STRATEG TRAUMA LIMB, V8, P67, DOI 10.1007/s11751-013-0169-4; Wang J, 2016, J HAND SURG-EUR VOL, V41, P543, DOI 10.1177/1753193415625606; Wang J, 2013, ORTHOP TRAUMATOL-SUR, V99, P321, DOI 10.1016/j.otsr.2012.11.018; Wei DH, 2012, J ORTHOP TRAUMA, V26, P386, DOI 10.1097/BOT.0b013e318225f63c; Wei J, 2013, J INT MED RES, V41, P265, DOI 10.1177/0300060513476438; Wijffels MME, 2014, INJURY, V45, P1889, DOI 10.1016/j.injury.2014.08.007; Xie XT, 2013, ACTA ORTHOP, V84, P286, DOI 10.3109/17453674.2013.792029; Xu GY, 2015, AM J THER, P1; Yu GS, 2014, ULUS TRAVMA ACIL CER, V20, P19; Zhang B, 2017, INT ORTHOP, V41, P2161, DOI 10.1007/s00264-017-3460-z; Zhang QY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003661; Zong SL, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0252-2	67	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0206895	10.1371/journal.pone.0206895	http://dx.doi.org/10.1371/journal.pone.0206895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673700	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800005
J	Houle, SKD; Eurich, DT				Houle, Sherilyn K. D.; Eurich, Dean T.			Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada	PLOS ONE			English	Article							INTERNATIONAL TRAVELERS; PREVENTABLE DISEASES; PATIENT ACCESS; CHILDREN	Pharmacists in a number of countries are being trained in the administration of injections with the aim of improving access and adherence to vaccinations. However, little is known about population-level adherence to multiple-dose travel vaccines, and whether the availability of pharmacist immunizers is associated with adherence. Health administrative data from Alberta, Canada, from April 2008 to May 2017 identified adults dispensed at least one vaccine for hepatitis A, hepatitis B, Japanese encephalitis, or rabies. Individuals were coded as completers or non-completers of the vaccine series based on the number of doses dispensed over a time period comprising the duration of the standard series plus 6 months to account for late doses. The association between the proportion of Alberta pharmacists with injection authorization (according to pharmacist registration data) and completion of vaccine series was assessed using linear regression. Over the study period, 24,164 patients initiated a vaccine series for hepatitis A monovalent, 195,480 for hepatitis B monovalent, 169,802 for combined hepatitis A&B, 1,726 for Japanese encephalitis, and 1,908 for rabies. There were fewer than 5 individuals receiving Japanese encephalitis vaccine per year from 2008-2010 or rabies vaccine from 2008-2009. While statistically significant positive associations were seen across all vaccines except for Japanese encephalitis, the magnitude of these associations was small. Each 1% increase in the proportion of injections-authorized pharmacists saw a corresponding increase in the proportion of individuals with completed vaccine series by 0.31% for hepatitis A monovalent, 0.19% for hepatitis B monovalent, 0.22% for combined hepatitis A&B, and 0.21% for rabies. This may suggest that challenges remain with implementing reminder systems to ensure adherence among travellers. Strategies to develop or improve patient and clinician reminder systems in pharmacies for travel vaccines should therefore be explored.	[Houle, Sherilyn K. D.] Univ Waterloo, Sch Pharm, Waterloo, ON, Canada; [Eurich, Dean T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Waterloo; University of Alberta	Houle, SKD (corresponding author), Univ Waterloo, Sch Pharm, Waterloo, ON, Canada.	sherilyn.houle@uwaterloo.ca			International Society for Travel Medicine; 2016/2017 International Society of Travel Medicine Research Award	International Society for Travel Medicine; 2016/2017 International Society of Travel Medicine Research Award	Both authors received funding for this study from the International Society for Travel Medicine Research Award (2016/2017 cycle, http://www.istm.org/researchgrantsactivities).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a 2016/2017 International Society of Travel Medicine Research Award. This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the Government nor Alberta Health express any opinion in relation to this study.	Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009; Centers for Disease Control (CDC), 2017, CDC YELL BOOK 2020 H; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; Eilers R, 2014, PREV MED, V69, P224, DOI 10.1016/j.ypmed.2014.10.017; Foong EAL, 2017, CAN PHARM J, V150, P387, DOI 10.1177/1715163517732089; Gai YW, 2017, J AM PHARM ASSOC, V57, P474, DOI 10.1016/j.japh.2017.03.011; Gautret P, 2012, CLIN MICROBIOL INFEC, V18, P77, DOI 10.1111/j.1469-0691.2012.03940.x; Goad JA, 2013, ANN FAM MED, V11, P429, DOI 10.1370/afm.1542; Grabenstein JD, 1998, VACCINE, V16, P1705, DOI 10.1016/S0264-410X(98)00131-5; Heywood AE, 2016, J TRAVEL MED, V24; Houle SKD, 2019, J AM PHARM ASSOC, V59, P89, DOI [10.1016/j.japh.2018.07.002, 10.1177/1715163518811065]; Houle Sherilyn K D, 2013, Can Pharm J (Ott), V146, P353, DOI 10.1177/1715163513506369; International Pharmaceutical Federation (FIP), 2016, AN OVERVIEW OF CURRE; Isenor JE, 2016, VACCINE, V34, P5708, DOI 10.1016/j.vaccine.2016.08.085; Jacob L, 2017, CLIN MICROBIOL INFEC, V23, P460, DOI 10.1016/j.cmi.2017.01.012; Kennedy A, 2011, PEDIATRICS, V127, pS92, DOI 10.1542/peds.2010-1722N; Lane S, 2018, VACCINE, V36, P3861, DOI 10.1016/j.vaccine.2018.03.063; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Papastergiou John, 2014, Can Pharm J (Ott), V147, P359, DOI 10.1177/1715163514552557; del Corro MR, 2009, HUM VACCINES, V5, P98, DOI 10.4161/hv.5.2.6588; Shah PD, 2018, CANCER EPIDEM BIOMAR, V27, P970, DOI 10.1158/1055-9965.EPI-18-0380; Statistics Canada, 2017, ALB CAN TABL CENS PR; Steffen R, 2015, J TRAVEL MED, V22, P1, DOI 10.1111/jtm.12171; Wu SS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017459	24	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211006	10.1371/journal.pone.0211006	http://dx.doi.org/10.1371/journal.pone.0211006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673765	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800065
J	Northrop, EJ; Rich, JJJ; Rhoades, JR; Perry, GA				Northrop, Emmalee J.; Rich, Jerica J. J.; Rhoades, Jim R.; Perry, George A.			Comparison of two bovine serum pregnancy tests in detection of artificial insemination pregnancies and pregnancy loss in beef cattle	PLOS ONE			English	Article							EMBRYONIC MORTALITY-RATES; PREOVULATORY ESTRADIOL; PLASMA PROFILES; PROTEIN-B; COWS; FERTILIZATION; PROGESTERONE; GLYCOPROTEINS; DEATH; ESTABLISHMENT	Blood tests for early detection of pregnancy in cattle based on pregnancy-associated glycoproteins (PAGs) are commercially available. The objective of these studies were to compare the accuracy of blood tests to transrectal ultrasonography in detecting Al pregnancies, and to compare the accuracy of blood tests in predicting pregnancy loss. Beef cattle from 6 herds were synchronized using a recommended CIDR based protocol (Study 1: n=460; Study 2: n=472). Pregnancy status was determined by transrectal ultrasonography between days 28-40 following Al, blood samples were collected at this time. In study 2 a final pregnancy determination was performed at the end of the breeding season to determine pregnancy loss. Each serum sample was examined for PAG concentrations using a microtiter plate reader and/or scored by two technicians blind to pregnancy status and pregnancy loss. For study 1 Cohen's kappa statistics were calculated to assess the agreement between each test and transrectal ultrasonography. For study 2 data was analyzed using the GLIMMIX procedure of SAS with herd as a random effect, and loss, age, and their interaction included in the model. Agreement was good to very good for each test. There was no difference (P=0.79) in sensitivity, but a difference (P<0.01) in specificity of the assays (88%, 64%, 87%, 90%) and in the overall percent correct (93%, 84%, 93%, 93%). There was an effect of pregnancy loss (P=0.04), age (P=0.0002), and their interaction (P=0.06) on PAG concentrations. In conclusion both pregnancy tests were accurate at detecting Al pregnancies, and were in very good agreement with transrectal ultrasonography. Both tests detected differences in PAGs among females that maintained and lost pregnancy; however, prediction proved to be difficult as most females were above the threshold and would have been considered pregnant on the day of testing.	[Northrop, Emmalee J.; Rich, Jerica J. J.; Perry, George A.] South Dakota State Univ, Dept Anim Sci, Brookings, SD 57007 USA; [Rhoades, Jim R.] IDEXX Labs, Westbrook, ME USA	South Dakota State University	Perry, GA (corresponding author), South Dakota State Univ, Dept Anim Sci, Brookings, SD 57007 USA.	George.Perry@sdstate.edu		Perry, George/0000-0002-0102-9046; Rhoades, Jim/0000-0003-0829-6574	South Dakota State University	South Dakota State University	The salaries for Emmalee Northrop, Jerica Rich, and George Perry were provided through state and federally appropriated funds to South Dakota State University. Jim Rhoades is employed by IDEXX laboratories. IDEXX laboratories also provided both of the blood pregnancy tests used in these studies. All other supplies were purchased with funds from South Dakota State University Hatch funds.; This project was supported by South Dakota State University Experiment Station Hatch funds. The authors would also like to acknowledge IDEXX laboratories for the donation of the bovine pregnancy tests and rapid visual tests, and the cooperator herds for the use of their cattle.	ABBITT B, 1978, J AM VET MED ASSOC, V173, P973; Ball L., 1980, Current therapy in theriogenology: diagnosis, treatment and prevention of reproductive diseases in animals., P229; BEARDEN HJ, 1956, J DAIRY SCI, V39, P312, DOI 10.3168/jds.S0022-0302(56)94750-6; Bridges GA, 2012, ANIM REPROD SCI, V133, P16, DOI 10.1016/j.anireprosci.2012.06.013; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; DISKIN MG, 1980, J REPROD FERTIL, V59, P463, DOI 10.1530/jrf.0.0590463; Giordano JO, 2012, J DAIRY SCI, V95, P683, DOI 10.3168/jds.2011-4609; Green JA, 2005, THERIOGENOLOGY, V63, P1481, DOI 10.1016/j.theriogenology.2004.07.011; Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624; Inskeep EK, 2005, VET CLIN N AM-FOOD A, V21, P437, DOI 10.1016/j.cvfa.2005.02.002; Kasimanickam R., 2011, Clinical Theriogenology, V3, P43; KIDDER HE, 1954, J DAIRY SCI, V37, P691, DOI 10.3168/jds.S0022-0302(54)91314-4; KING GJ, 1980, J REPROD FERTIL, V59, P95, DOI 10.1530/jrf.0.0590095; KIRACOFE GH, 1993, J ANIM SCI, V71, P2199, DOI 10.2527/1993.7182199x; Lamb GC, 2010, J ANIM SCI, V88, pE181, DOI 10.2527/jas.2009-2349; Lobago F, 2009, REPROD DOMEST ANIM, V44, P685, DOI 10.1111/j.1439-0531.2007.01049.x; Madsen CA, 2015, ANIM REPROD SCI, V158, P96, DOI 10.1016/j.anireprosci.2015.05.006; MAURER RR, 1983, J ANIM SCI, V56, P1186, DOI 10.2527/jas1983.5651186x; Northrop EJ, 2018, BIOL REPROD, V99, P629, DOI 10.1093/biolre/ioy086; ODDE KG, 1990, J ANIM SCI, V68, P817; Perry G. A., 2016, Professional Animal Scientist, V32, P154, DOI 10.15232/pas.2015-01446; Peters A. R., 1996, Animal Breeding Abstracts, V64, P587; Pohler KG, 2016, J DAIRY SCI, V99, P1584, DOI 10.3168/jds.2015-10192; Ricci A, 2015, J DAIRY SCI, V98, P2502, DOI 10.3168/jds.2014-8974; ROCHE JF, 1981, VET REC, V109, P401, DOI 10.1136/vr.109.18.401; Romano JE, 2010, THERIOGENOLOGY, V74, P932, DOI 10.1016/j.theriogenology.2010.04.018; Ruder C. A., 1986, J ANIM SCI S1, V63; SASSER RG, 1986, BIOL REPROD, V35, P936, DOI 10.1095/biolreprod35.4.936; Shaw R, 1984, 10 INT C AN REPR ART; SREENAN JM, 1983, VET REC, V112, P517, DOI 10.1136/vr.112.22.517; Szenci O, 2000, VET J, V159, P287, DOI 10.1053/tvjl.1999.0399; Szenci O, 2003, VET J, V165, P307, DOI 10.1016/S1090-0233(02)00180-6; WATHES DC, 1980, AM J ANAT, V159, P285, DOI 10.1002/aja.1001590305; WIMSATT WA, 1951, AM J ANAT, V89, P233, DOI 10.1002/aja.1000890204; WOODING FBP, 1984, AM J ANAT, V170, P233, DOI 10.1002/aja.1001700208; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O	37	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211179	10.1371/journal.pone.0211179	http://dx.doi.org/10.1371/journal.pone.0211179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673760	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800078
J	Adedimeji, A; Sinayobye, JD; Asiimwe-Kateera, B; Chaudhry, J; Buzinge, L; Gitembagara, A; Murenzi, G; Mugenzi, P; Patel, VV; Castle, PE; Mutesa, L; Palefsky, J; Anastos, KM				Adedimeji, Adebola; Sinayobye, Jean d'Amour; Asiimwe-Kateera, Brenda; Chaudhry, Junaid; Buzinge, Lydia; Gitembagara, Andre; Murenzi, Gad; Mugenzi, Pacifique; Patel, Viraj V.; Castle, Philip E.; Mutesa, Leon; Palefsky, Joel; Anastos, Kathryn M.			Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; SAN-FRANCISCO; BLACK-MEN; SUPPORT; WOMEN; PARTNERSHIPS; PREVALENCE; PREVENTION; INFECTION; INSIGHTS	Introduction Men who have sex with men (MSM) are disproportionately impacted by HIV/AIDS resulting from risky sexual behaviors. Social and contextual factors are known to mediate risk behaviors, but there is limited information about the prevalence of risky sexual practices of Rwandan MSM and the concomitant socio-contextual determinants making it difficult to assess implications for preventing HIV/STI transmission in this key population. Methods Using exploratory qualitative design, we obtained socio-contextual information regarding prevalence of risky sexual behavior and assessed implications for HIV/STIs transmission and preventive measures taken by MSM to improve sexual health and wellbeing. Thirty MSM were recruited to participate in in-depth interviews using respondent-driven sampling from LGBT associations in Kigali. Data were analyzed using standard qualitative data analysis procedures. Results Respondents' were between 18-40 years old; all completed primary education and are mostly low-socioeconomic status. Risky sexual practices were common, but differed by peculiar individual and contextual factors. Older MSM often reported occasional sexual relations with women to avoid suspicion and social stigma. Younger MSM's risky sexual practices are mostly transactional and mediated by the need for social acceptance and support. Knowledge of STIs was poor, but prevalence, especially of HPV was high. The options for improving sexual wellbeing are limited and mostly clandestine. Conclusion Risky sexual behavior of Rwandan MSM has major implications for HIV/STI transmission. An environment of intense social stigma and social isolation makes it difficult to obtain information or services to improve sexual health. Effective interventions that address individual and contextual determinants of risk and access to health services are urgently needed to limit the consequence of MSM as a bridge for HIV transmission to the general population.	[Adedimeji, Adebola; Chaudhry, Junaid; Castle, Philip E.; Anastos, Kathryn M.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Sinayobye, Jean d'Amour; Buzinge, Lydia; Murenzi, Gad; Mugenzi, Pacifique] Rwanda Mil Hosp, Div Res & Med Educ, Kanombe, Kigali, Rwanda; [Asiimwe-Kateera, Brenda] AIDS Healthcare Fdn Rwanda, Kigali, Rwanda; [Gitembagara, Andre] Rwanda Nurses & Midwives Union, Kigali, Rwanda; [Patel, Viraj V.] Albert Einstein Coll Med, Montefiore Hlth Syst, Div Gen Internal Med, Bronx, NY 10467 USA; [Mutesa, Leon] Univ Rwanda, Coll Hlth Sci, Kigali, Rwanda; [Palefsky, Joel] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Rwanda; University of California System; University of California San Francisco	Adedimeji, A (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	adebola.adedimeji@einstein.yu.edu	Castle, Philip/AAP-6395-2020	Castle, Philip/0000-0003-1082-6554; Murenzi, Gad/0000-0002-5513-5522; Asiimwe Kateera, Brenda/0000-0001-6134-1042	National Institutes of Health/National Cancer Institute [1 U54 CA 190163-01]; NATIONAL CANCER INSTITUTE [U54CA190163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, P30AI124414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH102118] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for the study was received from the National Institutes of Health/National Cancer Institute (1 U54 CA 190163-01) for the HIV malignancies research capacity building program.	Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baxter C, 2016, AJAR-AFR J AIDS RES, V15, P109, DOI 10.2989/16085906.2016.1196224; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Chapman J, 2011, AIDS CARE, V23, P449, DOI 10.1080/09540121.2010.507758; Cowan FM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21101; Fernando D, 2017, PREV MED, V105, P368, DOI 10.1016/j.ypmed.2017.06.013; Garcia J, 2016, HEALTH EDUC BEHAV, V43, P217, DOI 10.1177/1090198115599398; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Lapinski MK, 2010, J HOMOSEXUAL, V57, P610, DOI 10.1080/00918361003712020; Levy ME, 2016, AIDS CARE, V28, P660, DOI 10.1080/09540121.2015.1120266; Maksut JL, 2016, J BEHAV MED, V39, P665, DOI 10.1007/s10865-016-9734-x; Mantell JE, 2016, GLOB PUBLIC HEALTH, V11, P953, DOI 10.1080/17441692.2016.1142592; Mayer KH, 2016, J ACQUIR IMMUNE D S3, V72; Muraguri N., 2012, J SAHARA J J SOCIAL, V9; Pando MA, 2013, AIDS BEHAV, V17, P1305, DOI 10.1007/s10461-012-0404-x; Parker CM, 2017, CULT HEALTH SEX, V19, P323, DOI 10.1080/13691058.2016.1216604; Phillips G, 2016, LGBT HEALTH, V3, P225, DOI 10.1089/lgbt.2015.0122; Pope Z, 2017, AIDS CARE, V29, P782, DOI 10.1080/09540121.2016.1255706; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Provalis Research, QDA MIN; Raymond HF, 2013, JAIDS-J ACQ IMM DEF, V62, P584, DOI 10.1097/QAI.0b013e318285febf; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Republic of Rwanda, COUNTR OP PLAN COP 2; Republic of Rwanda Ministry of Health, RWAND HIV AIDS NAT S; Sathane I, 2016, AIDS BEHAV, V20, P2296, DOI 10.1007/s10461-016-1390-1; Scheer S, 2008, SEX TRANSM INFECT, V84, P493, DOI 10.1136/sti.2008.031823; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Smith AD, 2015, AIDS, V29, pS201, DOI 10.1097/QAD.0000000000000889; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stahlman S, 2016, INT J SOC PSYCHIATR, V62, P522, DOI 10.1177/0020764016663969; Stahlman S, 2015, REPROD HEALTH MATTER, V23, P127, DOI 10.1016/j.rhm.2015.11.017; Stall R, 2009, AIDS BEHAV, V13, P615, DOI 10.1007/s10461-008-9509-7; Storholm ED, 2017, PREV SCI, V18, P737, DOI 10.1007/s11121-017-0799-8; Suominen T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2203-5; The Demographic and Health Survey Program/ ICF International, RWAND DEM HLTH SURV; Truong HHM, 2015, SEX TRANSM INFECT, V91, P220, DOI 10.1136/sextrans-2014-051660; van Griensven F, 2009, J ACQUIR IMMUNE DEFI; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211099	10.1371/journal.pone.0211099	http://dx.doi.org/10.1371/journal.pone.0211099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657797	gold, Green Submitted, Green Published			2022-12-27	WOS:000456017000030
J	Silk, TJ; Malpas, CB; Beare, R; Efron, D; Anderson, V; Hazell, P; Jongeling, B; Nicholson, JM; Sciberras, E				Silk, Timothy J.; Malpas, Charles B.; Beare, Richard; Efron, Daryl; Anderson, Vicki; Hazell, Philip; Jongeling, Brad; Nicholson, Jan M.; Sciberras, Emma			A network analysis approach to ADHD symptoms: More than the sum of its parts	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DSM-IV; HETEROGENEITY; CENTRALITY; PRESCHOOL; STRENGTHS; CHILDREN	In interpreting attention-deficit/hyperactivity disorder (ADHD) symptoms, categorical and dimensional approaches are commonly used. Both employ binary symptom counts which give equal weighting, with little attention to the combinations and relative contributions of individual symptoms. Alternatively, symptoms can be viewed as an interacting network, revealing the complex relationship between symptoms. Using a novel network modelling approach, this study explores the relationships between the 18 symptoms in the Diagnostic Statistical Manual (DSM-5) criteria and whether network measures are useful in predicting outcomes. Participants were from a community cohort, the Children's Attention Project. DSM ADHD symptoms were recorded in a face-to-face structured parent interview for 146 medication naive children with ADHD and 209 controls (aged 6-8 years). Analyses indicated that not all symptoms are equal. Frequencies of endorsement and configurations of symptoms varied, with certain symptoms playing a more important role within the ADHD symptom network. In total, 116,220 combinations of symptoms within a diagnosis of ADHD were identified, with 92% demonstrating a unique symptom configuration. Symptom association networks highlighted the relative importance of hyperactive/impulsive symptoms in the symptom network. In particular, the 'motoric'-type symptoms as well as interrupts as a marker of impulsivity in the hyperactive domain, as well as loses things and does not follow instructions in the inattentive domain, had high measures of centrality. Centrality-measure weighted symptom counts showed significant association with clinical but not cognitive outcomes, however the relationships were not significantly stronger than symptom count alone. The finding may help to explain heterogeneity in the ADHD phenotype.	[Silk, Timothy J.; Sciberras, Emma] Deakin Univ, Sch Psychol, Geelong, Vic, Australia; [Silk, Timothy J.; Malpas, Charles B.; Beare, Richard; Efron, Daryl; Anderson, Vicki; Nicholson, Jan M.; Sciberras, Emma] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Silk, Timothy J.; Efron, Daryl; Sciberras, Emma] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Malpas, Charles B.] Univ Melbourne, Melbourne Med Sch, Dept Med Educ, Melbourne, Vic, Australia; [Efron, Daryl; Anderson, Vicki; Sciberras, Emma] Royal Childrens Hosp, Melbourne, Vic, Australia; [Hazell, Philip] Univ Sydney, Discipline Psychiat, Sydney, NSW, Australia; [Jongeling, Brad] Joondalup Child Dev Ctr, Perth, WA, Australia; [Jongeling, Brad] Univ Western Australia, Dept Paediat, Perth, WA, Australia; [Nicholson, Jan M.] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia	Deakin University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Sydney; University of Western Australia; La Trobe University	Silk, TJ (corresponding author), Deakin Univ, Sch Psychol, Geelong, Vic, Australia.; Silk, TJ (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Silk, TJ (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	tim.silk@deakin.edu.au	Silk, Tim/K-4295-2019	Beare, Richard/0000-0002-7530-5664; Silk, Tim/0000-0002-7290-512X; Jongeling, Brad/0000-0002-1832-9387; Malpas, Charles/0000-0003-0534-3718; Nicholson, Jan/0000-0002-0305-0017	National Medical Health and Research Council of Australia [1008522]; Collier Foundation; Murdoch Children's Research Institute; Royal Children's Hospital; Royal Children's Hospital Foundation; Department of Paediatrics at The University of Melbourne; Victorian Government's Operational Infrastructure Support Program; NHMRC [1065895, 1079478, 1037159, 1110688]; Australian Communities Foundation through the Roberta Holmes Chair for the Transition to Contemporary Parenthood Program (Coronella sub-fund)	National Medical Health and Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Collier Foundation; Murdoch Children's Research Institute; Royal Children's Hospital; Royal Children's Hospital Foundation; Department of Paediatrics at The University of Melbourne; Victorian Government's Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Communities Foundation through the Roberta Holmes Chair for the Transition to Contemporary Parenthood Program (Coronella sub-fund)	The Children's Attention Project was as funded by the National Medical Health and Research Council of Australia (Project grant #1008522) and a grant from the Collier Foundation. The research was supported by the Murdoch Children's Research Institute, The Royal Children's Hospital, The Royal Children's Hospital Foundation, Department of Paediatrics at The University of Melbourne and the Victorian Government's Operational Infrastructure Support Program. TS and CM were supported by NHMRC project grant (1065895). VA was supported by an NHMRC Senior Practitioner Fellowship (1079478). JN was funded by the Australian Communities Foundation through the Roberta Holmes Chair for the Transition to Contemporary Parenthood Program (Coronella sub-fund). ES was supported by NHMRC Early Career (1037159) and Career Development (1110688) Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Borsboom D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027407; Boschloo L, 2016, PSYCHOTHER PSYCHOSOM, V85, P183, DOI 10.1159/000442001; Byrne JM, 2000, J CHILD NEUROL, V15, P533, DOI 10.1177/088307380001500807; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Curchack-Lichtin JT, 2014, J ABNORM CHILD PSYCH, V42, P993, DOI 10.1007/s10802-013-9834-9; Dijkstra EW, 1959, NUMERISCHE MATHEMATI; Epskamp S, 2012, JOURNAL OF STATISTIC; Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Fried EI, 2017, SOC PSYCH PSYCH EPID, V52, P1, DOI 10.1007/s00127-016-1319-z; Fried EI, 2016, J AFFECT DISORDERS, V189, P314, DOI 10.1016/j.jad.2015.09.005; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gresham FM, 2010, PSYCHOL ASSESSMENT, V22, P809, DOI 10.1037/a0020255; Guloksuz S, 2017, PSYCHOL MED, V47, P2743, DOI 10.1017/S0033291717001350; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kendler KS, 2013, JAMA PSYCHIAT; Lahey BB, 2010, J CLIN CHILD ADOLESC, V39, P761, DOI 10.1080/15374416.2010.517173; Landgraf JM, 1996, CHILD HLTH QUESTIONN, DOI [10.1002/(SICI)1097-0215(1999)83:39::AID-3.0.CO;2-7/full, DOI 10.1002/SICI1097-0215(1999)83:39::AID-3.0.CO;2-7/FULL]; Lux V, 2010, PSYCHOLOGICAL MEDICI; Martel MM, 2016, CLIN PSYCHOL SCI, V4, P988, DOI 10.1177/2167702615618664; McNally RJ, 2015, CLIN PSYCHOL SCI, V3, P836, DOI 10.1177/2167702614553230; Myung W, 2012, PSYCHIAT RES, V198, P400, DOI 10.1016/j.psychres.2011.12.037; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ostergaard SD, 2011, ACTA PSYCHIAT SCAND, V124, P495, DOI 10.1111/j.1600-0447.2011.01744.x; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Robertson G, 2006, WIDE RANGE ACHIEVEME; Rosales AG, 2015, EUR CHILD ADOLES PSY, V24, P1325, DOI 10.1007/s00787-015-0683-7; Sciberras E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-18; Semel E, 2004, CLINICAL EVALUATION; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Statistics ABO, 2011, CAT NO 2033 0 55 001; Steinhausen HC, 2009, ACTA PSYCHIAT SCAND, V120, P392, DOI 10.1111/j.1600-0447.2009.01446.x; Stringaris A, 2012, J CHILD PSYCHOL PSYC, V53, P1109, DOI 10.1111/j.1469-7610.2012.02561.x; Wahlstedt C, 2009, J ABNORM CHILD PSYCH, V37, P551, DOI 10.1007/s10802-008-9286-9; Wechsler D., 1999, WECHSLER INTELLIGENC, V1; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	42	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211053	10.1371/journal.pone.0211053	http://dx.doi.org/10.1371/journal.pone.0211053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HH8XI	30657783	gold, Green Submitted, Green Published			2022-12-27	WOS:000456017000029
J	Wu, PX; Wu, FM; Yan, S; Liu, C; Shen, ZJ; Xiong, XF; Li, Z; Zhang, QW; Liu, XX				Wu, Pengxiang; Wu, Fengming; Yan, Shuo; Liu, Chang; Shen, Zhongjian; Xiong, Xiaofei; Li, Zhen; Zhang, Qingwen; Liu, Xiaoxia			Developmental cost of leg-regenerated Coccinella septempunctata (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							IMAGINAL DISCS; LIMB REGENERATION; ECDYSTEROID TITERS; INDUCED DELAY; DROSOPHILA; LARVAL; GROWTH; MUTANTS; CELL; PUPARIATION	As larval cannibalism is common under intensive rearing conditions, leg regeneration can help ladybugs adapt to the competitive environment, but whether the leg regeneration leads to side effects on development remains unclear. To analyze the potentially developmental cost of leg regeneration, the developmental period and weight of leg-regenerated Coccinella septempunctata were studied in the laboratory. The results showed that, when the time intervals between the emergency of 4th-instar larva and leg amputation increased, the developmental period of leg-regenerated 4th-instar larvae was gradually prolonged. Significantly developmental delay were also examined at prepupal and pupal stages, and various timings of leg amputation affected the periods of leg-regenerated prepupae/pupae similarly. After the leg was amputated at different larval instars, the developmental delay only occurred at the larval instar when the leg was amputated, whereas other larval instars failed to be extended, and the developmental periods of leg-regenerated prepupae/pupae were affected similarly by the instars of leg amputation. Developmental delays possibly resulted in more consumption by leg-regenerated larvae, and then weight gains at prepupal/pupal stages, but different larval instars of leg amputation affected the weight gain similarly. Both the developmental delay (at 4th-instar larval, prepupal and pupal stages) and weight gain (at pupal and adult stages) in complete/bilateral amputation were longer or greater than those in half/unilateral amputation. However, the thoracic locations of leg amputation impacted the developmental delay and weight gain similarly. Our study indicates that although leg regeneration triggers the developmental cost decreasing the competitive superiority or agility, C. septempunctata larvae still choose to completely regenerate the leg to adapt to complex environments. Thus, in order to remain competitive at adult stages, leg-impaired larvae may make an investment tradeoff between leg regeneration and developmental cost.	[Wu, Pengxiang; Wu, Fengming; Yan, Shuo; Shen, Zhongjian; Xiong, Xiaofei; Li, Zhen; Zhang, Qingwen; Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Liu, Chang] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Wu, Fengming] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Wu, Fengming] Univ Chinese Acad Sci, Beijing, Peoples R China	China Agricultural University; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing, Peoples R China.	liuxiaoxia611@cau.edu.cn			National Key Research and Development program of China [2017YFD0201900]	National Key Research and Development program of China	This study was funded by the National Key Research and Development program of China (2017YFD0201900 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; Atli E, 2006, INT J RADIAT BIOL, V82, P435, DOI 10.1080/09553000600798849; BODENSTEIN D, 1957, J EXP ZOOL, V136, P89, DOI 10.1002/jez.1401360107; BOHN H, 1974, J EMBRYOL EXP MORPH, V32, P81; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BOURGIN RC, 1956, RADIAT RES, V5, P657, DOI 10.2307/3570585; Brindley H, 1897, ZOOL SOC P, P907, DOI [10.1111/j.1096-3642.1898.tb01392.x, DOI 10.1111/J.1096-3642.1898.TB01392.X]; BRYANT PJ, 1971, DEV BIOL, V26, P606, DOI 10.1016/0012-1606(71)90146-1; BRYANT PJ, 1971, DEV BIOL, V24, P233, DOI 10.1016/0012-1606(71)90097-2; Bulliere D, 1985, REGENERATION COMPREH, P371; Chen Shuchun, 1999, Acta Entomologica Sinica, V42, P159; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; DEWES E, 1973, ROUX ARCH DEV BIOL, V172, P349, DOI 10.1007/BF00577885; DEWES E, 1975, ROUX ARCH DEV BIOL, V178, P167, DOI 10.1007/BF00848395; Emmel VE, 1907, SCIENCE, V26, P83, DOI 10.1126/science.26.655.83; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; French V, 1976, DEV GENES EVOL, V179, P57, DOI [10.1007/BF00857640, DOI 10.1007/BF00857640]; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Hackney JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049105; Hadorn E, 1937, P NATL ACAD SCI USA, V23, P478, DOI 10.1073/pnas.23.9.478; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Johnson SA, 1999, ANIM BEHAV, V57, P957, DOI 10.1006/anbe.1998.1058; KISS I, 1980, J INSECT PHYSIOL, V26, P391, DOI 10.1016/0022-1910(80)90010-4; KNOBLOCH CA, 1988, J INSECT PHYSIOL, V34, P507, DOI 10.1016/0022-1910(88)90192-8; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; LAKES R, 1989, J EXP ZOOL, V250, P176, DOI 10.1002/jez.1402500209; Lee AK, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-20; Li Hua, 2007, Chinese Bulletin of Entomology, V44, P419; MADHAVAN K, 1969, BIOL BULL-US, V137, P321, DOI 10.2307/1540104; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MALA J, 1987, ARCH INSECT BIOCHEM, V4, P113, DOI 10.1002/arch.940040205; MALEVILLE A, 1981, J INSECT PHYSIOL, V27, P35, DOI 10.1016/0022-1910(81)90029-9; MARKS EP, 1970, SCIENCE, V167, P61, DOI 10.1126/science.167.3914.61; Marsh JL, 1999, SEMIN CELL DEV BIOL, V10, P365, DOI 10.1006/scdb.1999.0323; MARTIN P, 1977, DEV BIOL, V55, P213, DOI 10.1016/0012-1606(77)90168-3; O'FARRELL A. F., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P406; OFARRELL AF, 1954, AUST J BIOL SCI, V7, P525, DOI 10.1071/BI9540525; OFARRELL AF, 1953, AUST J BIOL SCI, V6, P485, DOI 10.1071/BI9530485; PARVIN DE, 1968, ANN ENTOMOL SOC AM, V61, P784, DOI 10.1093/aesa/61.3.784; Pohley H, 1965, REGENERATION ANIMALS, P324; Pohley J, 1959, DEV GENES EVOL, V151, P323; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; RAHN P, 1972, ROUX ARCH DEV BIOL, V170, P48, DOI 10.1007/BF00575521; RIDDIFORD LM, 1993, AM ZOOL, V33, P340; Saxena S, 2016, J ASIA-PAC ENTOMOL, V19, P829, DOI 10.1016/j.aspen.2016.07.012; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; Shah MV, 2011, MECH DEVELOP, V128, P342, DOI 10.1016/j.mod.2011.07.001; SHAW VK, 1974, J INSECT PHYSIOL, V20, P1849, DOI 10.1016/0022-1910(74)90214-5; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Shi W, 2003, GENETICS, V165, P1869; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Shock BC, 2009, J CRUSTACEAN BIOL, V29, P293, DOI 10.1651/08-2990.1; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; SIMPSON P, 1975, ROUX ARCH DEV BIOL, V178, P247, DOI 10.1007/BF00848432; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; STEVENS ME, 1986, GENETICS, V112, P217; STEWART M, 1972, DEV BIOL, V27, P71, DOI 10.1016/0012-1606(72)90113-3; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; STOCK A, 1954, AUST J BIOL SCI, V7, P302, DOI 10.1071/BI9540302; SZABAD J, 1982, DEV BIOL, V93, P240, DOI 10.1016/0012-1606(82)90256-1; Tan LF, 2013, B INSECTOL, V66, P173; Tan Liang-Fei, 2004, Acta Entomologica Sinica, V47, P719; TANAKA A, 1987, GROWTH, V51, P282; TRUBY PR, 1983, J EMBRYOL EXP MORPH, V75, P151; VILLEE CA, 1946, J EXP ZOOL, V101, P261, DOI 10.1002/jez.1401010206; WADDINGT.CH, 1969, NATURE, V221, P933, DOI 10.1038/221933a0; Wang S, 2015, B ENTOMOL RES, V105, P245, DOI 10.1017/S0007485315000036; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Wu PX, 2015, FLA ENTOMOL, V98, P193, DOI 10.1653/024.098.0133; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yi M., 2002, DEV BIOL	79	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210615	10.1371/journal.pone.0210615	http://dx.doi.org/10.1371/journal.pone.0210615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657777	gold, Green Published, Green Submitted			2022-12-27	WOS:000456017000013
J	Bauer, B; Horbowy, J; Rahikainen, M; Kulatska, N; Muller-Karulis, B; Tomczak, MT; Bartolino, V				Bauer, Barbara; Horbowy, Jan; Rahikainen, Mika; Kulatska, Nataliia; Mueller-Karulis, Barbel; Tomczak, Maciej T.; Bartolino, Valerio			Model uncertainty and simulated multispecies fisheries management advice in the Baltic Sea	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; ECOSYSTEM MODELS; COD RECRUITMENT; FISH STOCKS; REFERENCE POINTS; FORAGE FISH; DYNAMICS; ECOPATH; ECOSIM; EUTROPHICATION	Different ecosystem models often provide contrasting predictions (model uncertainty), which is perceived to be a major challenge impeding their use to support ecosystem-based fisheries management (EBFM). The focus of this manuscript is to examine the extent of model disagreements which could impact management advice for EBFM in the central Baltic Sea. We compare how much three models (EwE, Gadget and a multispecies stock production model) differ in 1) their estimates of fishing mortality rates (Fs) satisfying alternative hypothetical management scenario objectives and 2) the outcomes of those scenarios in terms of performance indicators (spawning stock biomasses, catches, profits). Uncertainty in future environmental conditions affecting fish was taken into account by considering two seal population growth scenarios and two nutrient load scenarios. Differences in the development of the stocks, yields and profits exist among the models but the general patterns are also sufficiently similar to appear promising in the context of strategic fishery advice. Thus, we suggest that disagreements among the ecosystem models will not impede their use for providing strategic advice on how to reach management objectives that go beyond the traditional maximum yield targets and for informing on the potential consequences of pursuing such objectives. This is especially true for scenarios aiming at exploiting forage fish sprat and herring, for which the agreement was the largest among our models. However, the quantitative response to altering fishing pressure differed among models. This was due to the diverse environmental covariates and the different number of trophic relationships and their functional forms considered in the models. This suggests that ecosystem models can be used to provide quantitative advice only after more targeted research is conducted to gain a deeper understanding into the relationship between trophic links and fish population dynamics in the Baltic Sea.	[Bauer, Barbara; Mueller-Karulis, Barbel; Tomczak, Maciej T.] Stockholm Univ, Balt Sea Ctr, Stockholm, Sweden; [Bauer, Barbara] German Ctr Integrat Biodivers Res iDiv, Halle Jena Leipzig, Germany; [Horbowy, Jan] Natl Marine Fisheries Res Inst, Dept Fisheries Resources, Gdynia, Poland; [Rahikainen, Mika] Univ Helsinki, Ecosyst & Environm Res Programme, Helsinki, Finland; [Rahikainen, Mika] Nat Resources Inst Finland, Helsinki, Finland; [Kulatska, Nataliia; Bartolino, Valerio] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden	Stockholm University; National Marine Fisheries Research Institute; University of Helsinki; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences	Bauer, B (corresponding author), Stockholm Univ, Balt Sea Ctr, Stockholm, Sweden.; Bauer, B (corresponding author), German Ctr Integrat Biodivers Res iDiv, Halle Jena Leipzig, Germany.	barbara.bauer@su.se	Bauer, Barbara/ABD-8980-2020; Bauer, Barbara/AAH-2454-2019	Bauer, Barbara/0000-0003-2688-2788; Rahikainen, Mika/0000-0002-1516-2868; Bartolino, Valerio/0000-0002-4506-4329; Muller-Karulis, Barbel/0000-0001-5718-4726	European Union [613571]; BONUS BalticAPP (Well-being from the Baltic Sea - applications combining natural science and economics) project from BONUS; European Union's Seventh Programme for research, technological development and demonstration [Art 185]; Swedish Research Council (FORMAS); Swedish Agency for Marine and Water Management [1: 11]; Ministry of Science and Higher Education from Poland	European Union(European Commission); BONUS BalticAPP (Well-being from the Baltic Sea - applications combining natural science and economics) project from BONUS; European Union's Seventh Programme for research, technological development and demonstration; Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); Swedish Agency for Marine and Water Management; Ministry of Science and Higher Education from Poland	This work was funded by the European Union's 7th Framework Programme project MareFrame (Co-creating Ecosystem-based Fisheries Management Solutions)' under grant agreement no. 613571. BB was also funded by the BONUS BalticAPP (Well-being from the Baltic Sea - applications combining natural science and economics) project which have received funding from BONUS (www.bonusportal.org), the joint Baltic Sea research and development programme (Art 185), funded jointly from the European Union's Seventh Programme for research, technological development and demonstration and from the Swedish Research Council (FORMAS). BMK was funded by the EU's Horizon 2020 project ClimeFish under grant agreement no. 677039. BB and BMK are employed by the Baltic Nest Institute at Baltic Sea Centre, which is supported by the Swedish Agency for Marine and Water Management (www.havochvatten.se) through their grant 1: 11Measures for marine and water environment. MTT is employed by the Baltic Sea Center Stockholm University Baltic Eye, a strategic partnership between Stockholm University and the BalticSea2020 foundation (balticsea2020. org). JH acknowledges the financial contribution of Ministry of Science and Higher Education from Poland (https://www.gov.pl/web/nauka/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN K P, 1977, Meddelelser fra Danmarks Fiskeri- og Havundersogelser, V7, P319; Bartolino V, 2011, FISH RES, V107, P75, DOI 10.1016/j.fishres.2010.10.010; Bauer B, 2018, ICES J MAR SCI, DOI [10.1093/icesjms/fsx225, DOI 10.1093/ICESJMS/FSX225]; Begley J., 2017, MARINE RES I REPORT, P106; Benson AJ, 2018, FISH FISH, V19, P40, DOI 10.1111/faf.12235; Casini M, 2004, ICES J MAR SCI, V61, P1267, DOI 10.1016/j.icesjms.2003.12.011; Casini M, 2011, POPUL ECOL, V53, P511, DOI 10.1007/s10144-011-0269-2; Casini M, 2010, MAR ECOL PROG SER, V413, P241, DOI 10.3354/meps08592; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Collie JS, 2016, FISH FISH, V17, P101, DOI 10.1111/faf.12093; Collie JS, 2001, CAN J FISH AQUAT SCI, V58, P2167, DOI 10.1139/cjfas-58-11-2167; Eero M, 2016, AMBIO, V45, P649, DOI 10.1007/s13280-016-0788-3; Elvarsson BT., 2016, RGADGET R PACKAGE GA; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Essington TE, 2004, B MAR SCI, V74, P563; Fay G, 2013, ECOL MODEL, V265, P45, DOI 10.1016/j.ecolmodel.2013.05.016; Forrest RE, 2008, CAN J FISH AQUAT SCI, V65, P286, DOI 10.1139/F07-156; Forrest RE, 2015, FISH RES, V167, P293, DOI 10.1016/j.fishres.2015.03.010; Fulton EA, 2004, AFR J MAR SCI, V26, P219, DOI 10.2989/18142320409504059; Gardmark A, 2013, ECOL APPL, V23, P742, DOI 10.1890/12-0267.1; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Gustafsson BG, 2003, A TIME DEPENDENT COU; Gustafsson BG, 2012, AMBIO, V41, P534, DOI 10.1007/s13280-012-0318-x; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Heikinheimo O, 2011, ECOL MODEL, V222, P1731, DOI 10.1016/j.ecolmodel.2011.03.005; Hill SL, 2007, FISH FISH, V8, P315, DOI 10.1111/j.1467-2979.2007.00257.x; Hobday AJ, 2010, PROG OCEANOGR, V86, P291, DOI 10.1016/j.pocean.2010.04.023; Horbowy J, 2005, J APPL ICHTHYOL, V21, P198, DOI 10.1111/j.1439-0426.2005.00596.x; Horbowy J, 1996, CAN J FISH AQUAT SCI, V53, P2115, DOI 10.1139/cjfas-53-9-2115; Horbowy J, 2012, CAN J FISH AQUAT SCI, V69, P1468, DOI 10.1139/F2012-070; Howell D, 2010, ICES J MAR SCI, V67, P1998, DOI 10.1093/icesjms/fsq135; Hyder K, 2015, MAR POLICY, V61, P291, DOI 10.1016/j.marpol.2015.07.015; ICES, 2013, C2013ACOM ICES, V10, P747; ICES, 2016, 2016ACOM11 ICES, P593; ICES, 2016, WORKSH SPAT AN BALT, V13, P37; Jones-Farrand DT, 2011, ECOL APPL, V21, P2269, DOI 10.1890/10-1047.1; Jordan F., 2003, Applied Ecology and Environmental Research, V1, P1; Kaplan IC, 2013, ENVIRON CONSERV, V40, P380, DOI 10.1017/S0376892913000052; Koster FW, 2017, ICES J MAR SCI, V74, P3, DOI 10.1093/icesjms/fsw172; Koster F, 2001, CAN J FISH AQUAT SCI, V58, P1534, DOI 10.1139/cjfas-58-8-1534; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Kulatska N, 2019, FISH RES, V211, P338, DOI 10.1016/j.fishres.2018.11.023; Lehuta S, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016022; Lentin J., 2014, MFDB MAREFRAME DB QU; Levin P. S., 2008, NMFSNWFSC92 NOAA; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2012, PROG OCEANOGR, V102, P102, DOI 10.1016/j.pocean.2012.03.008; Long RD, 2015, MAR POLICY, V57, P53, DOI 10.1016/j.marpol.2015.01.013; Longo C, 2015, MAR ECOL PROG SER, V538, P257, DOI 10.3354/meps11502; Lundstrom K, 2010, ICES J MAR SCI, V67, P1230, DOI 10.1093/icesjms/fsq022; Lynam CP, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00182; Mackinson S, 2003, MAR MAMMAL SCI, V19, P661, DOI 10.1111/j.1748-7692.2003.tb01123.x; Marshall KN, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12367; MAY RM, 1979, SCIENCE, V205, P267, DOI 10.1126/science.205.4403.267; Meier HEM, 2012, CLIM DYNAM, V39, P2421, DOI 10.1007/s00382-012-1339-7; Michielsens CGJ, 2008, CAN J FISH AQUAT SCI, V65, P962, DOI 10.1139/F08-015; Mollmann C, 2014, ICES J MAR SCI, V71, P1187, DOI 10.1093/icesjms/fst123; Mollmann C, 2000, J PLANKTON RES, V22, P2015, DOI 10.1093/plankt/22.11.2015; Mollmann C, 2004, J FISH BIOL, V65, P1563, DOI 10.1111/j.0022-1112.2004.00566.x; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nielsen JR, 2018, FISH FISH, V19, P1, DOI 10.1111/faf.12232; Olsen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146467; Parmanne Raimo, 1994, Dana, V10, P29; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Payne MR, 2016, ICES J MAR SCI, V73, P1272, DOI 10.1093/icesjms/fsv231; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pinnegar JK, 2005, ECOL MODEL, V184, P229, DOI 10.1016/j.ecolmodel.2004.09.003; Plaganyi EE, 2004, AFR J MAR SCI, V26, P261, DOI 10.2989/18142320409504061; Plaganyi EE, 2004, 477 FAO; Plaganyi EE, 2014, FISH FISH, V15, P1, DOI 10.1111/j.1467-2979.2012.00488.x; Plaganyi Eva Elizabeth, 2013, Proc Natl Acad Sci U S A, V110, P3639, DOI 10.1073/pnas.1217822110; Quaas MF, 2012, ECOL ECON, V82, P45, DOI 10.1016/j.ecolecon.2012.08.002; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramirez-Monsalve P, 2016, MAR POLICY, V66, P83, DOI 10.1016/j.marpol.2015.12.030; Rudstam Lars G., 1994, Dana, V10, P105; Scott F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154922; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Smith MD, 2015, AFR J MAR SCI, V37, P65, DOI 10.2989/1814232X.2015.1013501; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STECF, 2015, 27232 STECF EUR EN; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Tittensor DP, 2018, GEOSCI MODEL DEV, V11, P1421, DOI 10.5194/gmd-11-1421-2018; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Uusitalo L, 2016, CONT SHELF RES, V121, P48, DOI 10.1016/j.csr.2015.11.002; Voss R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107811; Voss R, 2014, MAR ECOL PROG SER, V498, P1, DOI 10.3354/meps10639; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Weijerman M, 2015, PROG OCEANOGR, V138, P559, DOI 10.1016/j.pocean.2014.12.017; Whipple SJ, 2000, FISH FISH, V1, P22, DOI 10.1046/j.1467-2979.2000.00007.x	91	16	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211320	10.1371/journal.pone.0211320	http://dx.doi.org/10.1371/journal.pone.0211320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3AL	30689653	gold, Green Published, Green Submitted			2022-12-27	WOS:000457041800030
J	Horstman, AMH; Backx, EMP; Smeets, JSJ; Marzuca-Nassr, GN; van Kranenburg, J; de Boer, D; Dolmans, J; Snijders, T; Verdijk, LB; de Groot, LCPGM; van Loon, LJC				Horstman, Astrid M. H.; Backx, Evelien M. P.; Smeets, Joey S. J.; Marzuca-Nassr, Gabriel N.; van Kranenburg, Janneau; de Boer, Douwe; Dolmans, John; Snijders, Tim; Verdijk, Lex B.; de Groot, Lisette C. P. G. M.; van Loon, Luc J. C.			Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SKELETAL-MUSCLE; ANABOLIC-STEROIDS; LEG IMMOBILIZATION; OLDER-ADULTS; BED-REST; MASS; STRENGTH; HEALTHY; 19-NORTESTOSTERONE	Background A few days of bed rest or immobilization following injury, disease, or surgery can lead to considerable loss of skeletal muscle mass and strength. It has been speculated that such short, successive periods of muscle disuse may be largely responsible for the age-related loss of muscle mass throughout the lifespan. Objective To assess whether a single intramuscular injection of nandrolone decanoate prior to immobilization can attenuate the loss of muscle mass and strength in vivo in humans. Design, setting and participants Thirty healthy (22 +/- 1 years) men were subjected to 7 days of one-legged knee immobilization by means of a full leg cast with (NAD, n = 15) or without (CON, n = 15) prior intramuscular nandrolone decanoate injection (200 mg). Measures Before and immediately after immobilization, quadriceps muscle cross-sectional area (CSA) (by means of single-slice computed tomography (CT) scans of the upper leg) and one-legged knee extension strength (one-repetition maximum [1-RM]) were assessed for both legs. Furthermore, muscle biopsies from the immobilized leg were taken before and after immobilization to assess type I and type II muscle fiber cross-sectional area. Results Quadriceps muscle CSA decreased during immobilization in both CON and NAD (-6 +/- 1% and -6 +/- 1%, respectively; main effect of time P< 0.01), with no differences between the groups (time x treatment interaction, P = 0.59). Leg muscle strength declined following immobilization (-6 +/- 2% in CON and -7 +/- 3% in NAD; main effect of time, P< 0.05), with no differences between groups (time x treatment interaction, P = 0.55). Conclusions This is the first study to report that nandrolone decanoate administration does not preserve skeletal muscle mass and strength during a short period of leg immobilization in vivo in humans.	[Horstman, Astrid M. H.; Backx, Evelien M. P.; Smeets, Joey S. J.; Marzuca-Nassr, Gabriel N.; van Kranenburg, Janneau; Snijders, Tim; Verdijk, Lex B.; van Loon, Luc J. C.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands; [Backx, Evelien M. P.; de Groot, Lisette C. P. G. M.] Wageningen Univ, Dept Human Nutr, Wageningen, Netherlands; [de Boer, Douwe] Maastricht Univ, Dept Clin Chem, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands; [Dolmans, John] Maastricht Univ, Dept Surg, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Wageningen University & Research; Maastricht University; Maastricht University	van Loon, LJC (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Med Ctr, Maastricht, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J.C./ABG-9158-2020; Verdijk, Lex B/H-4468-2016; Marzuca-Nassr, Gabriel/S-5901-2019; van Loon, Luc J C/G-5920-2010	van Loon, Luc J.C./0000-0002-6768-9231; Verdijk, Lex B/0000-0002-9196-8767; van Loon, Luc J C/0000-0002-6768-9231; Smeets, Joey/0000-0003-2877-0114; de Groot, Lisette/0000-0003-2778-2789				Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Backx EMP, 2017, SPORTS MED, V47, P1661, DOI 10.1007/s40279-016-0670-2; Bagchus WM, 2005, J CLIN ENDOCR METAB, V90, P2624, DOI 10.1210/jc.2004-1526; Batterham MJ, 2001, INT J ANDROL, V24, P232, DOI 10.1046/j.1365-2605.2001.00291.x; BELKIEN L, 1985, J STEROID BIOCHEM, V22, P623, DOI 10.1016/0022-4731(85)90215-8; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Biolo G, 2007, AM J CLIN NUTR, V86, P366, DOI 10.1093/ajcn/86.2.366; CHRISTENSEN T, 1982, BRIT J SURG, V69, P417, DOI 10.1002/bjs.1800690721; Creutzberg EC, 2003, CHEST, V124, P1733, DOI 10.1378/chest.124.5.1733; DEITRICK JE, 1948, B NEW YORK ACAD MED, V24, P364; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dirks ML, 2015, CLIN SCI, V128, P357, DOI 10.1042/CS20140447; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; Fisher SR, 2010, ARCH INTERN MED, V170, P1942, DOI 10.1001/archinternmed.2010.422; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Glover EI, 2010, CURR OPIN CLIN NUTR, V13, P630, DOI 10.1097/MCO.0b013e32833f1ae5; Gold J, 1996, AIDS, V10, P745, DOI 10.1097/00002030-199606001-00008; HARUNA Y, 1994, ACTA PHYSIOL SCAND, V150, P43; HASSAGER C, 1989, MATURITAS, V11, P305, DOI 10.1016/0378-5122(89)90027-3; Hohmann E, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-93; Johansen KL, 1999, JAMA-J AM MED ASSOC, V281, P1275, DOI 10.1001/jama.281.14.1275; Liu XH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13520; Minto CF, 1997, J PHARMACOL EXP THER, V281, P93; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Qin WP, 2015, MOL CELL ENDOCRINOL, V399, P336, DOI 10.1016/j.mce.2014.09.025; REZNIK Y, 1987, J CLIN ENDOCR METAB, V64, P1086, DOI 10.1210/jcem-64-5-1086; Sattler FR, 1999, J CLIN ENDOCR METAB, V84, P1268, DOI 10.1210/jc.84.4.1268; SCHOLS AMWJ, 1995, AM J RESP CRIT CARE, V152, P1268, DOI 10.1164/ajrccm.152.4.7551381; Schroeder ET, 2003, AM J PHYSIOL-ENDOC M, V285, pE16, DOI 10.1152/ajpendo.00032.2003; Singh GKS, 2014, J CLIN ENDOCR METAB, V99, P2592, DOI 10.1210/jc.2014-1243; Stein TP, 1999, NUTRITION, V15, P656, DOI 10.1016/S0899-9007(99)00120-3; Storer TW, 2005, J CLIN ENDOCR METAB, V90, P4474, DOI 10.1210/jc.2005-0275; Strandberg Soren, 2010, BMC Med Imaging, V10, P18, DOI 10.1186/1471-2342-10-18; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001; Urban Randall J, 2014, Trans Am Clin Climatol Assoc, V125, P27; Velema MS, 2012, CURR OPIN PULM MED, V18, P118, DOI 10.1097/MCP.0b013e32834e9001; Verdijk LB, 2009, J SPORT SCI, V27, P59, DOI 10.1080/02640410802428089; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wall BT, 2014, SPORTS MED, V44, pS185, DOI 10.1007/s40279-014-0258-7; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; Wall BT, 2013, NUTR REV, V71, P195, DOI 10.1111/nure.12019; WIJNAND HP, 1985, ACTA ENDOCRINOL-COP, V110, P19, DOI 10.1530/acta.0.109S00019; Wright TJ, 2018, J CACHEXIA SARCOPENI, V9, P482, DOI 10.1002/jcsm.12295	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210823	10.1371/journal.pone.0210823	http://dx.doi.org/10.1371/journal.pone.0210823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689637	Green Submitted, Green Published, gold			2022-12-27	WOS:000457041800011
J	Ichimiya, I; Ichimiya, H				Ichimiya, Issei; Ichimiya, Hiroko			Complex tone stimulation may induce binaural diplacusis with low-tone hearing loss	PLOS ONE			English	Article							ENDOLYMPHATIC HYDROPS; PITCH	To clarify the possible mechanism causing binaural diplacusis with low-tone hearing loss, two psychoacoustic experiments were performed with 20 healthy subjects, using harmonic complex tones. In the first experiment, two tones were presented unilaterally, either from the right or left side. One of the tones presented was higher in frequency in terms of the fundamental component, but lower or equal in frequency in terms of the highest component, than the other tone. The subjects were asked which tone was higher in pitch after listening to both tones. They were also asked to compare tones in which low-tone components were eliminated. In the second experiment, the subjects heard these complex tones binaurally, with low-tone components eliminated in one ear. In the first experiment, most subjects perceived pitch direction, that is, higher or lower, in a reverse way when low-tone components were eliminated from the complex tones. In the second experiment, approximately half of all subjects heard the tones at different pitches in both ears. Under certain conditions, complex tone stimulation may induce binaural diplacusis when low-tone hearing is lost in one ear.	[Ichimiya, Issei; Ichimiya, Hiroko] Ichimiya Clin, Kitsuki City, Oita, Japan		Ichimiya, I (corresponding author), Ichimiya Clin, Kitsuki City, Oita, Japan.	ich-oit@umin.ac.jp		Ichimiya, Issei/0000-0002-1004-175X				Brannstrom KJ, 2008, INT J AUDIOL, V47, P675, DOI 10.1080/14992020802215870; Colin D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159975; DEUTSCH D, 1974, NATURE, V251, P307, DOI 10.1038/251307a0; GAETH JH, 1965, J SPEECH HEAR RES, V8, P63, DOI 10.1044/jshr.0801.63; Goebel JA, 2016, OTOLARYNG HEAD NECK, V154, P403, DOI 10.1177/0194599816628524; ICHIMIYA I, 1994, ANN OTO RHINOL LARYN, V103, P457; Ichimiya I, 2016, AURIS NASUS LARYNX, V43, P68, DOI 10.1016/j.anl.2015.07.002; Ladd DR, 2013, J EXP PSYCHOL HUMAN, V39, P1386, DOI 10.1037/a0031261; Moore BCJ, 2013, INTRO PSYCHOL HEARIN, DOI [10.1121/1.4978009, DOI 10.1121/1.4978009]; Ogura M, 2003, INT J AUDIOL, V42, P297, DOI 10.3109/14992020309101321; PAPARELLA MM, 1991, ACTA OTO-LARYNGOL, P26; Reiss LAJ, 2017, J ACOUST SOC AM, V141, P1909, DOI 10.1121/1.4978009; SCHUKNECHT HF, 1983, ANN OTO RHINOL LARYN, V92, P1; TONNDORF J, 1976, ARCH OTO-RHINO-LARYN, V212, P293, DOI 10.1007/BF00453677	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210939	10.1371/journal.pone.0210939	http://dx.doi.org/10.1371/journal.pone.0210939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682080	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500076
J	Kinlay, S; Bundy, M; Chin, M; Tobin, D; Quinn, M; Do, JM; Johnson, S; Temiyasathit, S; Ly, S				Kinlay, Scott; Bundy, Mariah; Chin, Melissa; Tobin, Desiree; Quinn, Margot; Do, Jacquelyn-My; Johnson, Shannon; Temiyasathit, Sara; Ly, Samantha			Reproducibility and validity of a novel invasive method of assessing peripheral microvascular vasomotor function	PLOS ONE			English	Article							NITRIC-OXIDE; VASODILATION; RESISTANCE; VESSELS; HUMANS	In healthy arteries, blood flow is regulated by microvascular tone assessed by changes in blood flow volume and vascular resistance to endothelium-dependent and -independent vasodilators. We developed a novel method of using intravascular ultrasound (IVUS) and a Doppler flow wire to measure changes in blood flow volume and vascular resistance of the profunda arterial bed. We assessed the variability over 6 months in measuring microvascular endothelium-dependent dilation to acetylcholine and endothelium-independent dilation to adenosine in 20 subjects who were part of a larger study of Gulf War Illness without obstructive peripheral artery disease. Vasomotor function was assessed by Infusions of control (dextrose), acetylcholine (10(-6) M), adenosine (50 mu g), and nitroglycerin (25 mu g/ml). 400 IVUS and 240 flow velocity images were measured a mean 6 (SD = 2) months apart blind to measurement and infusion stage. The mean (SD) baseline profunda flow was 227 (172) ml/min and vascular resistance 4.6 x 10(4) (2.4 x 10(4)) dynes-s/cm(5). The intraclass correlation coefficients for 6-month variability for vascular function were excellent (range 0.827-0.995). Bland-Altman analyses showed mean differences of less than 2% for microvascular endothelium-dependent function (flow volume and resistance) and less than 1% for macrovascular endothelium-dependent function with acceptable limits of agreement. In 49 subjects assessing concurrent validity of the technique against atherosclerosis risk factors, we observed greater impairment in microvascular endothelium-dependent function per year of age (flow volume = - 1.4% (p = 0.018), vascular resistance = 1.5% (p = 0.015)) and current smoking (flow volume = - 36.7% (p =.006), vascular resistance = 50.0% (p<0.001)). This novel method of assessing microvascular vasomotor function had acceptable measurement reproducibility and validity.	[Kinlay, Scott; Bundy, Mariah; Chin, Melissa; Tobin, Desiree; Quinn, Margot; Do, Jacquelyn-My; Johnson, Shannon; Temiyasathit, Sara; Ly, Samantha] Vet Affairs Boston Healthcare Syst, Dept Med, Div Cardiovasc, West Roxbury Campus, Boston, MA 02109 USA; [Kinlay, Scott] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Kinlay, Scott] Harvard Med Sch, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kinlay, S (corresponding author), Vet Affairs Boston Healthcare Syst, Dept Med, Div Cardiovasc, West Roxbury Campus, Boston, MA 02109 USA.; Kinlay, S (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.; Kinlay, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	scott.kinlay@va.gov		Kinlay, Scott/0000-0001-7687-9136	VA Clinical Science Research and Development Awards [1/21CX000793, 1/01CX001549]; Defense for Health Affairs, through the Gulf War Illness Research Program [W81XWH-15-1-0216]; Veterans Affairs [I01CX001549] Funding Source: NIH RePORTER	VA Clinical Science Research and Development Awards; Defense for Health Affairs, through the Gulf War Illness Research Program; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by the VA Clinical Science Research and Development Awards 1/21CX000793 and 1/01CX001549 to author SK, and Assistant Secretary of Defense for Health Affairs, through the Gulf War Illness Research Program under award W81XWH-15-1-0216 to author SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank A J, 1994, J Card Fail, V1, P35, DOI 10.1016/1071-9164(94)90006-X; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Hasdai D, 1997, CIRCULATION, V96, P3390; Kashyap VS, 2013, J VASC SURG, V58, P1259, DOI 10.1016/j.jvs.2013.05.029; Kinlay S, 2001, HYPERTENSION, V38, P1049, DOI 10.1161/hy1101.095329; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIAO JK, 1991, CIRC RES, V68, P1027, DOI 10.1161/01.RES.68.4.1027; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; Nichols WW, 1998, MCDONALDS BLOOD FLOW, P22; QUYYUMI AA, 1995, CIRCULATION, V92, P320, DOI 10.1161/01.CIR.92.3.320; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; ZEIHER AM, 1995, CIRCULATION, V91, P2345, DOI 10.1161/01.CIR.91.9.2345	12	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211152	10.1371/journal.pone.0211152	http://dx.doi.org/10.1371/journal.pone.0211152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682202	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500114
J	Gietzen, T; Brylka, R; Achenbach, J; zum Hebel, K; Schomer, E; Botsch, M; Schwanecke, U; Schulze, R				Gietzen, Thomas; Brylka, Robert; Achenbach, Jascha; zum Hebel, Katja; Schoemer, Elmar; Botsch, Mario; Schwanecke, Ulrich; Schulze, Ralf			A method for automatic forensic facial reconstruction based on dense statistics of soft tissue thickness	PLOS ONE			English	Article							REGISTRATION; ADULTS	In this paper, we present a method for automated estimation of a human face given a skull remain. Our proposed method is based on three statistical models. A volumetric (tetrahedral) skull model encoding the variations of different skulls, a surface head model encoding the head variations, and a dense statistic of facial soft tissue thickness (FSTT). All data are automatically derived from computed tomography (CT) head scans and optical face scans. In order to obtain a proper dense FSTT statistic, we register a skull model to each skull extracted from a CT scan and determine the FSTT value for each vertex of the skull model towards the associated extracted skin surface. The FSTT values at predefined landmarks from our statistic are well in agreement with data from the literature. To recover a face from a skull remain, we first fit our skull model to the given skull. Next, we generate spheres with radius of the respective FSTT value obtained from our statistic at each vertex of the registered skull. Finally, we fit a head model to the union of all spheres. The proposed automated method enables a probabilistic face-estimation that facilitates forensic recovery even from incomplete skull remains. The FSTT statistic allows the generation of plausible head variants, which can be adjusted intuitively using principal component analysis. We validate our face recovery process using an anonymized head CT scan. The estimation generated from the given skull visually compares well with the skin surface extracted from the CT scan itself.	[Gietzen, Thomas; Brylka, Robert; Schwanecke, Ulrich] RheinMain Univ Appl Sci Wiesbaden Russelsheim, Comp Vis & Mixed Real Grp, Wiesbaden, Germany; [Achenbach, Jascha; Botsch, Mario] Bielefeld Univ, Comp Graph Grp, Bielefeld, Germany; [zum Hebel, Katja] Johannes Gutenberg Univ Mainz, Dept Prosthet Dent, Univ Med Ctr, Mainz, Germany; [Schoemer, Elmar] Johannes Gutenberg Univ Mainz, Inst Comp Sci, Mainz, Germany; [Schulze, Ralf] Johannes Gutenberg Univ Mainz, Sect Oral Radiol, Univ Med Ctr, Mainz, Germany	University of Bielefeld; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Gietzen, T (corresponding author), RheinMain Univ Appl Sci Wiesbaden Russelsheim, Comp Vis & Mixed Real Grp, Wiesbaden, Germany.	thomas.gietzen@hs-rm.de	Schulze, Ralf/S-9500-2019	Schulze, Ralf/0000-0002-7880-0046; Botsch, Mario/0000-0001-9954-120X	Federal Ministry of Education and Research (BMBF); Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University - German Research Foundation (DFG)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University - German Research Foundation (DFG)	The results from this study are part of the research projects "Kephalos" and "KogniHome" funded by the Federal Ministry of Education and Research (BMBF https://www.bmbf.de/).The work was also supported by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG http://www.dfg.de/).We gratefully acknowledge the Department of Diagnostic and Interventional Radiology (http://www.unimedizin-mainz.de/radiologie/startseite.html), University Medical Center of the Johannes Gutenberg University Mainz, Germany for providing us with the DICOM-data of the human heads.; The results from this study are part of the research projects "Kephalos" and "KogniHome" funded by the Federal Ministry of Education and Research (BMBF). The work was also supported by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (DFG). We gratefully acknowledge the Department of Diagnostic and Interventional Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Germany for providing us with the DICOM data of the human heads.	Achenbach J, 2017, P ACM S VIRT REAL SO, P1; Achenbach J., 2015, P VIS MOD VIS, P1; Ackerman J L, 1999, Clin Orthod Res, V2, P49; Aspert N, 2002, IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL I AND II, PROCEEDINGS, P705, DOI 10.1109/ICME.2002.1035879; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Caple J, 2016, INT J LEGAL MED, V130, P863, DOI 10.1007/s00414-015-1292-1; Cha KS, 2013, KOREAN J ORTHOD, V43, P178, DOI 10.4041/kjod.2013.43.4.178; Claes P., 2006, Journal of Computing and Information Technology - CIT, V14, P21, DOI 10.2498/cit.2006.01.03; Deuss Mario, 2015, SHAPEOP ROBUST EXTEN, P505, DOI DOI 10.1007/978-3-319-24208-8_42; Garland M., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P209, DOI 10.1145/258734.258849; Gietzen T, 2017, INFORM 2017 GESELLSC, P891; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Hwang HS, 2015, J FORENSIC SCI, V60, P957, DOI 10.1111/1556-4029.12766; Kahler K, 2003, ACM T GRAPHIC, V22, P554, DOI 10.1145/882262.882307; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Miranda GE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196770; Romeiro R, 2014, 2014 27TH SIBGRAPI CONFERENCE ON GRAPHICS, PATTERNS AND IMAGES (SIBGRAPI), P266, DOI 10.1109/SIBGRAPI.2014.25; Rynn C, 2010, FORENSIC SCI MED PAT, V6, P20, DOI 10.1007/s12024-009-9124-6; Shui WY, 2017, COMPUT BIOL MED, V90, P33, DOI 10.1016/j.compbiomed.2017.08.023; Shui WY, 2016, FORENSIC SCI INT, V266, DOI 10.1016/j.forsciint.2016.07.017; Stephan CN, 2008, J FORENSIC SCI, V53, P1257, DOI 10.1111/j.1556-4029.2008.00852.x; Stephan CN, 2017, FORENSIC SCI INT, V280, P113, DOI 10.1016/j.forsciint.2017.09.016; Tu P., 2007, P IEEE C COMP VIS PA, P1, DOI [10.1109/CVPR.2007.383060, DOI 10.1109/CVPR.2007.383060]; Turner WD, 2005, FORENSIC SCI INT, V154, P149, DOI 10.1016/j.forsciint.2004.10.003; Utsuno H, 2014, FORENSIC SCI INT, V236, P175, DOI 10.1016/j.forsciint.2013.12.040; Wilkinson C, 2010, J ANAT, V216, P235, DOI 10.1111/j.1469-7580.2009.01182.x; Zhou QY, 2016, LECT NOTES COMPUT SC, V9906, P766, DOI 10.1007/978-3-319-46475-6_47	27	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210257	10.1371/journal.pone.0210257	http://dx.doi.org/10.1371/journal.pone.0210257			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673719	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800036
J	Imaeda, T; Nakada, T; Abe, R; Oda, S				Imaeda, Taro; Nakada, Taka-aki; Abe, Ryuzo; Oda, Shigeto			Decreased total iron binding capacity upon intensive care unit admission predicts red blood cell transfusion in critically ill patients	PLOS ONE			English	Article							ANEMIA; ERYTHROPOIETIN; HEPCIDIN; SEPSIS; SERUM	Introduction Red blood cell (RBC) transfusion is associated with poor clinical outcome in critically ill patients. We investigated the predictive value of biomarkers on intensive care units (ICU) admission for RBC transfusion within 28 days. Methods Critically ill patients (n = 175) who admitted to our ICU with organ dysfunction and an expected stay of >= 48 hours, without hemorrhage, were prospectively studied (derivation cohort, n = 121; validation cohort, n = 54). Serum levels of 12 biomarkers (hemoglobin, creatinine, albumin, interleukin-6 [IL-6], erythropoietin, Fe, total iron binding capacity [TIBC], transferrin, ferritin, transferrin saturation, folate, and vitamin B12) were measured upon ICU admission, days 7, 14, 21 and 28. Results Among the 12 biomarkers measured upon ICU admission, levels of hemoglobin, albumin, IL-6, TIBC, transferrin and ferritin were statistically different between transfusion and non-transfusion group. Of 6 biomarkers, TIBC upon ICU admission had the highest area under the curve value (0.835 [95% confidence interval] = 0.765-0.906) for predicting RBC transfusion (cut-off value = 234.5 mu g/dL; sensitivity = 0.906, specificity = 0.632). This result was confirmed in validation cohort, whose sensitivity and specificity were 0.888 and 0.694, respectively. Measurement of these biomarkers every seven days revealed that albumin, TIBC and transferrin were statistically different between groups throughout hospitalization until 28 days. In validation cohort, patients in the transfusion group had significantly higher serum hepcidin levels than those in the non-transfusion group (P = 0.004). In addition, joint analysis across derivation and validation cohorts revealed that the serum IL-6 levels were higher in the transfusion group (P = 0.0014). Conclusion Decreased TIBC upon ICU admission has high predictive value for RBC transfusion unrelated to hemorrhage within 28 days.	[Imaeda, Taro; Nakada, Taka-aki; Abe, Ryuzo; Oda, Shigeto] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan	Chiba University	Nakada, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba, Japan.	taka.nakada@chiba-u.jp			JSPS KAKENHI [JP15K15660]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K15660 to SO (https://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI Grant Number JP15K15660.	[Anonymous], 1999, Crit Care Med, V27, P639; Astin R, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-4; Corwin HL, 2004, CRIT CARE, V8, pS42, DOI 10.1186/cc2411; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Elliot JM, 2003, CRIT CARE, V7, pR35, DOI 10.1186/cc2185; ERSLEV AJ, 1991, NEW ENGL J MED, V324, P1339, DOI 10.1056/NEJM199105093241907; Fernandez R, 2010, ANESTHESIOLOGY, V112, P1211, DOI 10.1097/ALN.0b013e3181d74f87; Gambino R, 1997, CLIN CHEM, V43, P2408; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Hayden SJ, 2012, AM J RESP CRIT CARE, V185, P1049, DOI 10.1164/rccm.201110-1915CI; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc9992; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Juffermans NP, 2011, SHOCK, V35, P355, DOI 10.1097/SHK.0b013e3182086094; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; Khorramian E, 2017, SHOCK, V48, P490, DOI 10.1097/SHK.0000000000000886; Lasocki S, 2011, ANESTHESIOLOGY, V114, P688, DOI 10.1097/ALN.0b013e3182065c57; Lasocki S, 2010, INTENS CARE MED, V36, P1044, DOI 10.1007/s00134-010-1794-8; Litton E, 2016, INTENSIVE CARE MED; Loftus TJ, 2018, AM J RESP CRIT CARE; Maynor L, 2007, ANN PHARMACOTHER, V41, P1476, DOI 10.1345/aph.1K187; Mukhopadhyay A, 2010, CRIT CARE, V14, DOI 10.1186/cc8859; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Ramsay WNM, 1997, CLIN CHIM ACTA, V259, P25, DOI 10.1016/S0009-8981(96)06489-3; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Rodriquez RM, 2001, J CRIT CARE, V16, P36, DOI 10.1053/jcrc.2001.21795; Salisbury AC, 2011, ARCH INTERN MED, V171, P1646, DOI 10.1001/archinternmed.2011.361; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vincent JL, 2014, SHOCK, V41, P98, DOI 10.1097/SHK.0000000000000090; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210067	10.1371/journal.pone.0210067	http://dx.doi.org/10.1371/journal.pone.0210067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673726	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800030
J	Rosel, JF; Jara, P; Machancoses, FH; Pallares, J; Torrente, P; Puchol, S; Canales, JJ				Rosel, Jesus F.; Jara, Pilar; Machancoses, Francisco H.; Pallares, Jacinto; Torrente, Pedro; Puchol, Sara; Canales, Juan J.			Intensive longitudinal modelling predicts diurnal activity of salivary alpha-amylase	PLOS ONE			English	Article							POOLED TIME-SERIES; STRESS; PSYCHOLOGY; BEHAVIOR	Salivary alpha-amylase (sAA) activity has been widely used in psychological and medical research as a surrogate marker of sympathetic nervous system activation, though its utility remains controversial. The aim of this work was to compare alternative intensive longitudinal models of sAA data: (a) a traditional model, where sAA is a function of hour (hr) and hr squared (sAA(j,t) = f(hr, hr(2)), and (b) an autoregressive model, where values of sAA are a function of previous values (sAA(j,t) = f(sAA(j,t-1), sAA(j/t-2), sAA(j,t-p)). Nineteen normal subjects (9 males and 10 females) participated in the experiments and measurements were performed every hr between 9:00 and 21:00 hr. Thus, a total of 13 measurements were obtained per participant. The Napierian logarithm of the enzymatic activity of sAA was analysed. Data showed that a second-order autoregressive (AR(2)) model was more parsimonious and fitted better than the traditional multilevel quadratic model. Therefore, sAA follows a process whereby, to forecast its value at any given time, sAA values one and two hr prior to that time (sAA(j,t)=f(SAA(j,t-1), SAA(j,t-2)) are most predictive, thus indicating that sAA has its own inertia, with a "memory" of the two previous hr. These novel findings highlight the relevance of intensive longitudinal models in physiological data analysis and have considerable implications for physiological and biobehavioural research involving sAA measurements and other stress-related biomarkers.	[Rosel, Jesus F.; Jara, Pilar; Pallares, Jacinto; Torrente, Pedro] Univ Jaume 1, Dept Dev Educ & Social Psychol & Methodol, Castellon de La Plana, Spain; [Machancoses, Francisco H.] FABIS, Huelva, Spain; [Puchol, Sara] CSIC, IATS, Torre De La Sal, Spain; [Canales, Juan J.] Univ Tasmania, Sch Med, Div Psychol, Hobart, Tas, Australia	Universitat Jaume I; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University of Tasmania	Canales, JJ (corresponding author), Univ Tasmania, Sch Med, Div Psychol, Hobart, Tas, Australia.	juan.canales@utas.edu.au	Machancoses, Francisco Herrero/O-7744-2014	Machancoses, Francisco Herrero/0000-0003-0280-5972; Canales, Juan J./0000-0003-2884-5227; , SARA/0000-0003-4881-0478				Andre&beta; HJ., 2013, APPL PANEL DATA ANAL; [Anonymous], 2013, DECL HELS ETH PRINC; [Anonymous], 2012, BASIC ECONOMETRICS; [Anonymous], 2009, HDB ADV MULTILEVEL A; [Anonymous], 2014, APPL REGRESSION ANAL; Banuelos Maria S, 2017, J Undergrad Neurosci Educ, V16, pA23; Bear MF, 2007, NEUROSCIENCE EXPLORI, DOI [10.1093/brain/awm203, DOI 10.1093/BRAIN/AWM203]; Bolger N, 2013, INTENSIVE LONGITUDIN; Bollen KA, 2004, SOCIOL METHOD RES, V32, P336, DOI 10.1177/0049124103260222; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Box G. E. P., 2016, TIME SERIES ANAL FOR; Brown H, 2015, APPL MIXED MODELS ME, DOI [10.1097/MD.0000000000000683, DOI 10.1097/MD.0000000000000683]; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Claeskens, 2010, MODEL SELECTION MODE; Curran PJ, 2001, DECADE BEHAV, P107, DOI 10.1037/10409-004; CZEISLER CA, 1986, SCIENCE, V233, P667, DOI 10.1126/science.3726555; DAWES C, 1974, International Journal of Chronobiology, V2, P253; DIELMAN TE, 1989, POOLED CROSS SECTION; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Freedman D, 2009, STAT MODELS CAUSAL I; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; GOLDSTEIN H, 1994, STAT MED, V13, P1643, DOI 10.1002/sim.4780131605; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goodwin MS, 2008, BEHAV RES METHODS, V40, P328, DOI 10.3758/BRM.40.1.328; Hedeker D., 2006, LONGITUDINAL DATA AN; Hoeppner BB, 2007, MULTIVAR BEHAV RES, V42, P707, DOI 10.1080/00273170701755291; Hox JJ, 2010, MULTILEVEL TECHNIQUE; Johnson DR, 1995, J MARRIAGE FAM, V57, P1065, DOI 10.2307/353423; Kang Y, 2010, NURS HEALTH SCI, V12, P477, DOI 10.1111/j.1442-2018.2010.00562.x; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Klein EG, 2009, PREV SCI, V10, P168, DOI 10.1007/s11121-009-0122-4; Kmenta J., 1971, ELEMENTS ECONOMETRIC, V2nd; Leyland AH, 2001, MULTILEVEL MODELLING; McGirr A, 2010, J PSYCHIATR NEUROSCI, V35, P399, DOI 10.1503/jpn.090121; Messerli-Burgy N, 2018, DEV PSYCHOBIOL, V60, P1009, DOI 10.1002/dev.21782; MIKLICH DR, 1975, AM PSYCHOL, V30, P419; Miller AL, 2015, PSYCHONEUROENDOCRINO, V53, P40, DOI 10.1016/j.psyneuen.2014.12.011; MOORE KJ, 1994, J CONSULT CLIN PSYCH, V62, P718, DOI 10.1037/0022-006X.62.4.718; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rodrigues M. I., 2015, EXPT DESIGN PROCESS; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rosel J, 2000, HEALTH PLACE, V6, P309, DOI 10.1016/S1353-8292(00)00012-5; Rovine M.J., 2006, MODELS INTENSIVE LON; Sayrs LS., 1989, CHARACTERISTICS GPCO; Singer J.D., 2003, APPL LONGITUDINAL DA; Snijders T, 2011, RB MULTILEVEL ANAL I; Soliday E, 2002, J PEDIATR PSYCHOL, V27, P67, DOI 10.1093/jpepsy/27.1.67; SPEIRS RL, 1974, ARCH ORAL BIOL, V19, P747, DOI 10.1016/0003-9969(74)90161-7; SPSS, 2015, IBM SPSS STAT 23; StataCorp, 2015, DATA PROTECTION DESI; Sun YM, 2002, J MARRIAGE FAM, V64, P472, DOI 10.1111/j.1741-3737.2002.00472.x; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; van Veen JF, 2008, PSYCHONEUROENDOCRINO, V33, P1313, DOI 10.1016/j.psyneuen.2008.07.004; Velicer W. F., 2013, HDB PSYCHOL, V2, P628; VELICER WF, 1997, SCI PREVENTION METHO, P211; Walls T. A., 2006, MODELS INTENSIVE LON; Walls TA, 2013, OXFORD HDB QUANTITAT, V2; Wilcox RR, 2014, PHYSIOL BEHAV, V129, P11, DOI 10.1016/j.physbeh.2014.02.012; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	64	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209475	10.1371/journal.pone.0209475	http://dx.doi.org/10.1371/journal.pone.0209475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673704	Green Published, gold, Green Accepted			2022-12-27	WOS:000456442800018
J	Morales-Cano, D; Callejo, M; Barreira, B; Mondejar-Parreno, G; Esquivel-Ruiz, S; Ramos, S; Martin, MA; Cogolludo, A; Moreno, L; Perez-Vizcaino, F				Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Ramos, Sonia; Angeles Martin, Maria; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco			Elevated pulmonary arterial pressure in Zucker diabetic fatty rats	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; KV7 CHANNELS; HYPERTENSION; INSULIN; OBESITY; LEPTIN; ASSOCIATION; ACTIVATION; EXPRESSION; GUIDELINES	Diabetes is a very strong predictor of chronic systemic vascular diseases and acute cardiovascular events. Recently, associations between metabolic disorders and pulmonary hypertension have also been reported in both humans and animal models. In order to get some further insight into the relationship of pulmonary hypertension with obesity, insulin resistance and hyperglycemia, herein we have used the Zucker diabetic fatty rats (ZDF/clr-lepr fa) at 20 weeks fed a standard diet and compared to their lean Zucker littermates (ZL). ZDF rats were obese, had elevated plasma glucose levels and insulin resistance, i.e. a clinically relevant model of type 2 diabetes. They presented elevated systolic, diastolic and mean pulmonary arterial pressures and a parallel increase in the Fulton index. Systemic arterial pressures were also increased but the left ventricle plus septum weight was similar in both groups and the heart rate was reduced. Wall media thickening was observed in the small pulmonary arteries from the ZDF rats. Isolated pulmonary arteries mounted in a wire myograph showed similar vasoconstrictor responses to phenylephrine and 5-HT and similar responses to the endothelium-dependent vasodilator acetylcholine. However, the iNOS inhibitor 1400W enhanced the vasoconstrictor responses in ZDF but not in ZL rats. The protein expression of eNOS and iNOS was not significantly different in the lungs of the two groups. The lung expression of Bmpr2 mRNA was downregulated. However, the mRNA expression of Kcna5, Kcnk3, Kcnq1, Kcnq4 or Kcnq5, which encode for the potassium channels Kv1.5, TASK-1, Kv7.1, Kv7.4 and Kv7.5, respectively, was similar in ZL and ZDF rats. In conclusion, ZDF rats show increased pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arterial medial thickening and downregulated lung Bmpr2 despite leptin resistance. These changes were mild but are consistent with the view that diabetes is a risk factor for pulmonary hypertension.	[Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] Univ Complutense Madrid, Sch Med, Dept Pharmacol & Toxicol, Madrid, Spain; [Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] Ciber Enfermedades Resp Ciberes, Madrid, Spain; [Morales-Cano, Daniel; Callejo, Maria; Barreira, Bianca; Mondejar-Parreno, Gema; Esquivel-Ruiz, Sergio; Cogolludo, Angel; Moreno, Laura; Perez-Vizcaino, Francisco] IISGM, Madrid, Spain; [Ramos, Sonia; Angeles Martin, Maria] CSIC, Inst Food Sci & Technol & Nutr ICTAN, Dept Metab & Nutr, Madrid, Spain; [Angeles Martin, Maria] Ciber Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Perez-Vizcaino, F (corresponding author), Univ Complutense Madrid, Sch Med, Dept Pharmacol & Toxicol, Madrid, Spain.; Perez-Vizcaino, F (corresponding author), Ciber Enfermedades Resp Ciberes, Madrid, Spain.; Perez-Vizcaino, F (corresponding author), IISGM, Madrid, Spain.	fperez@med.ucm.es	Cano, Daniel Morales/A-3550-2017; Perez-Vizcaino, Francisco/A-9735-2011; Martín, María/HDL-9512-2022; Moreno, Laura/A-9433-2010; Ramos, Sonia/K-4594-2012; Martín, Maria Angeles/C-5768-2014; Cogolludo, Angel/A-6129-2011	Cano, Daniel Morales/0000-0002-1692-4633; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Moreno, Laura/0000-0001-9028-2299; Ramos, Sonia/0000-0003-2649-2616; Martín, Maria Angeles/0000-0001-8173-4521; Mondejar Parreno, Gema/0000-0001-9514-8961; Barreira, Bianca/0000-0002-0338-8456	Ministerio de Economia y Competitividad (Mineco) [SAF2016-77222-R, AGL2015-67087-R]; Instituto de Salud Carlos III [PI15/01100]; European Union (Fondo Europeo de Desarrollo Regional FEDER); Universidad Complutense; Ciberes; Fundacion Contra la Hipertension Pulmonar (Enpathy); FPU grant from Ministerio de Educacion	Ministerio de Economia y Competitividad (Mineco); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (Fondo Europeo de Desarrollo Regional FEDER)(European Commission); Universidad Complutense; Ciberes; Fundacion Contra la Hipertension Pulmonar (Enpathy); FPU grant from Ministerio de Educacion(German Research Foundation (DFG))	This study was supported by grants from Ministerio de Economia y Competitividad (Mineco, https://sede.micinn.gob.es SAF2016-77222-R to FPV and AC and AGL2015-67087-R to SR and MAM), Instituto de Salud Carlos III (www.isciii.es, PI15/01100 to LM), with funds from the European Union (Fondo Europeo de Desarrollo Regional FEDER). M.C., G.M-P. and S.E-R. are funded by Universidad Complutense (www.ucm.es) and Ciberes (www.Ciberes.org) grant with funds from Fundacion Contra la Hipertension Pulmonar (Enpathy, www.fchp.es) and a FPU grant from Ministerio de Educacion (www.mecd.gob.es), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Austin ED, 2014, CIRC RES, V115, P189, DOI 10.1161/CIRCRESAHA.115.303404; Benson L, 2014, PULM CIRC, V4, P311, DOI 10.1086/675994; Briancon-Marjollet A, 2016, EXP PHYSIOL, V101, P1432, DOI 10.1113/EP085783; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Corpe C, 2001, DIGESTION, V63, P116, DOI 10.1159/000051879; Corsetti JP, 2000, ATHEROSCLEROSIS, V148, P231, DOI 10.1016/S0021-9150(99)00265-8; Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; Ferreira L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/592760; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Huertas A, 2015, EUR RESPIR J, V45, P1066, DOI 10.1183/09031936.00193014; Huertas A, 2012, EUR RESPIR J, V40, P895, DOI 10.1183/09031936.00159911; Irwin DC, 2014, PULM CIRC, V4, P638, DOI 10.1086/678510; Kawaguchi M, 1999, EUR J ENDOCRINOL, V140, P341, DOI 10.1530/eje.0.1400341; Lesniewski LA, 2008, AM J PHYSIOL-HEART C, V294, pH1840, DOI 10.1152/ajpheart.00692.2007; Lopez-Lopez JG, 2008, AM J PHYSIOL-LUNG C, V295, pL727, DOI 10.1152/ajplung.90354.2008; Lopez-Lopez JG, 2011, J PHARMACOL EXP THER, V338, P400, DOI 10.1124/jpet.111.179515; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Mondejar-Parreno G, 2019, J PHYSIOL-LONDON, V597, P1185, DOI 10.1113/JP276054; Moral-Sanz J, 2014, CURR VASC PHARMACOL, V12, P473, DOI 10.2174/1570161112666140423222808; Moral-Sanz J, 2012, EXP PHYSIOL, V97, P676, DOI 10.1113/expphysiol.2011.062257; Moral-Sanz J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-51; Morales-Cano D, 2016, CLIN SCI, V130, P1823, DOI 10.1042/CS20160141; Morales-Cano D, 2015, CARDIOVASC RES, V106, P98, DOI 10.1093/cvr/cvv020; Morales-Cano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114492; Movahed MR, 2005, CHEST, V128, P3568, DOI 10.1016/S0012-3692(15)52932-2; Robbins IM, 2009, CHEST, V136, P31, DOI 10.1378/chest.08-2008; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Schleinitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016155; Segersvaerd R, 2008, OBESITY, V16, P23, DOI 10.1038/oby.2007.27; Tan Y, 2017, WORLD J GASTROENTERO, V23, P3805, DOI 10.3748/wjg.v23.i21.3805; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wong YY, 2011, EUR J HEART FAIL, V13, P1290, DOI 10.1093/eurjhf/hfr140; Yeh CH, 2009, HORM METAB RES, V41, P605, DOI 10.1055/s-0029-1220736; Zafrir B, 2013, RESP MED, V107, P139, DOI 10.1016/j.rmed.2012.10.019; Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508; Zimmet PZ, 2016, DIABETES CARE, V39, P878, DOI 10.2337/dc16-0273	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211281	10.1371/journal.pone.0211281	http://dx.doi.org/10.1371/journal.pone.0211281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689673	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800027
J	Gardinier, JD; Daly-Seiler, C; Rostami, N; Kundal, S; Zhang, CB				Gardinier, Joseph D.; Daly-Seiler, Conor; Rostami, Niloufar; Kundal, Siddharth; Zhang, Chunbin			Loss of the PTH/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise	PLOS ONE			English	Article							PARATHYROID-HORMONE PTH; BONE MASS; CORTICAL BONE; MAINTENANCE; PEPTIDE; DIFFERENTIATION; HEDGEHOG; SYSTEM; CELLS; MICE	Exercise and physical activity are critical to maintain bone mass and strength throughout life. Both exercise and physical activity subject bone to a unique combination of stimuli in the forms of dynamic loading and a systemic increase in parathyroid hormone (PTH). Although dynamic loading is considered to be the primary osteogenic stimuli, the influence of increasing PTH levels remains unclear. We hypothesize that activation of the PTH/PTH-related peptide type 1 receptor (PPR) along the osteoblast lineage facilitates bone formation and improved mechanical properties in response to exercise. To test this hypothesis, conditional PPR-knockout mice (PPRcKO) were generated in which PPR expression was deleted along the osteoblast lineage under the osterix promoter. At 8-weeks of age, both PPRfl/fl and PPR cKO mice were subjected to treadmill running or sedentary conditions for 5-weeks. Under sedentary conditions, PPRcKO mice displayed significantly less bone mass as well as smaller structural-level strength (yield-load and ultimate load), while tissue level properties were largely unaffected. However, PPRcKO mice exposed to exercise displayed significantly less structural-level and tissue-level mechanical properties when compared to exercised PPRfl/fl mice. Overall, these data demonstrate that PPR expression along the osteoblast lineage is essential for exercise to improve the mechanical properties of cortical bone. Furthermore, the influence of PPR activation on material properties is unique to exercise and not during normal growth and development.	[Gardinier, Joseph D.; Daly-Seiler, Conor; Rostami, Niloufar; Zhang, Chunbin] Henry Ford Hosp, Bone & Joint Ctr, Detroit, MI 48202 USA; [Kundal, Siddharth] Wayne State Univ, Biomed Phys Dept, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Gardinier, JD (corresponding author), Henry Ford Hosp, Bone & Joint Ctr, Detroit, MI 48202 USA.	jgardin2@hfhs.org		Locke, Conor/0000-0002-4463-0173; Gardinier, Joseph/0000-0002-8651-8913	Henry Ford Health System [A20041]	Henry Ford Health System	;The Osx-Cre mice in the study were provided by Dr. Yuji Mishina at the University of Michigan and the PPRfl/fl mice were provided by Dr. Henry Kronenberg at the Massachusetts General Hospital. Further funding from the Henry Ford Health System (grant number A20041). These contributors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Chow JWM, 1998, AM J PHYSIOL-ENDOC M, V274, pE146, DOI 10.1152/ajpendo.1998.274.1.E146; Cupp ME, 2013, J PHARMACOL EXP THER, V345, P404, DOI 10.1124/jpet.112.199752; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Delgado-Calle J, 2017, J BONE MINER RES, V32, P522, DOI 10.1002/jbmr.3011; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Gardinier JD, 2018, BONE, V117, P130, DOI 10.1016/j.bone.2018.09.019; Gardinier Joseph D, 2018, Bone Rep, V8, P29, DOI 10.1016/j.bonr.2018.01.003; Gardinier JD, 2016, MATRIX BIOL, V52-54, P162, DOI 10.1016/j.matbio.2016.02.010; Gardinier JD, 2015, J BONE MINER RES, V30, P1053, DOI 10.1002/jbmr.2432; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Goltzman D, 2018, HISTOCHEM CELL BIOL, V149, P305, DOI 10.1007/s00418-018-1648-y; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Maimoun L, 2005, BRIT J SPORT MED, V39, P497, DOI 10.1136/bjsm.2004.013151; Maimoun L, 2009, J SCI MED SPORT, V12, P463, DOI 10.1016/j.jsams.2008.05.004; Maimoun L, 2009, CALCIFIED TISSUE INT, V85, P277, DOI 10.1007/s00223-009-9277-z; Maycas M, 2015, J BONE MINER RES, V30, P1231, DOI 10.1002/jbmr.2439; McNerny EMB, 2015, BONE, V81, P327, DOI 10.1016/j.bone.2015.07.030; Nakamichi Y, 2017, J BONE MINER RES, V32, P1297, DOI 10.1002/jbmr.3096; NISHIYAMA S, 1988, CALCIFIED TISSUE INT, V43, P150, DOI 10.1007/BF02571312; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Qiu T, 2015, J BONE MINER RES, V30, P309, DOI 10.1002/jbmr.2327; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Reginster JY, 2006, BONE, V38, pS2, DOI 10.1016/j.bone.2006.01.150; Reimann DA, 1997, APPL RADIAT ISOTOPES, V48, P1433, DOI 10.1016/S0969-8043(97)00139-5; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rong H, 1997, SCAND J MED SCI SPOR, V7, P152; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Schluter KD, 1999, NEWS PHYSIOL SCI, V14, P243; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211076	10.1371/journal.pone.0211076	http://dx.doi.org/10.1371/journal.pone.0211076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682096	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500098
J	Liu, WH; Chang, PY; Chang, SC; Lu, JJ; Wu, CM				Liu, Wei-Hsiu; Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih; Wu, Che-Ming			Mutation screening in non-syndromic hearing loss patients with cochlear implantation by massive parallel sequencing in Taiwan	PLOS ONE			English	Article							ACTG1 MUTATIONS; DFNA20/26 FAMILY; DEAFNESS; DOMINANT; CHILDREN; GENE; IMPAIRMENT; PERFORMANCE; SPECTRUM; OUTCOMES	Objectives To explore the molecular epidemiology of rare deafness genes in Taiwanese sensorineural hearing impairment (SNHI) patients with cochlear implantation (CI) by performing massive parallel sequencing (MPS) and correlating genetic factors and CI outcomes. Methods We enrolled 41 Taiwanese non-syndromic deafness patients with CI that lacked known mutations in common deafness genes. All probands were screened by a targeted exon amplification method that used massively parallel sequencing to screen a customized panel that included 40 relatively rare non-syndromic deafness genes. Results Thirteen candidate variants in nine relatively rare deafness genes (MYO15A, TMC1, MYH14, MYO3A, ACTG1, COL11A2, DSPP, GRHL2, and WFS1) were identified in 24.4% (10/41) of the non-syndromic deafness probands with CI. According to the ACMG Standards and Guidelines, five variants in MYO15A and ACTG1 were classified as likely pathogenic variants. Two of three multi-generational pedigrees exhibiting deafness were analyzed for the segregation of the disorder with the possible disease-causing variants. Patients with variants detected in most of the identified variant-bearing genes showed relatively good CI outcomes. Conclusions We successfully identified candidate variants in partially deaf Taiwanese probands who lacked the known mutations in common deafness genes. Comparing the progress of hearing rehabilitation in CI patients with their apparent causative variants and the expression profiles of their altered genes allowed us to speculate on how alterations in specific gene sets may influence outcomes in hearing rehabilitation after CI.	[Liu, Wei-Hsiu] Chang Gung Univ, Dept Lab Med, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan; [Liu, Wei-Hsiu; Wu, Che-Ming] Chang Gung Univ, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Dept Med Res, Chang Gung Mem Hosp, Taoyuan, Taiwan; [Chang, Pi-Yueh; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Wu, CM (corresponding author), Chang Gung Univ, Dept Otolaryngol Head & Neck Surg, Chang Gung Mem Hosp, Linkou Branch,Coll Med, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Dept Med Res, Chang Gung Mem Hosp, Taoyuan, Taiwan.; Lu, JJ (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	jjlpcp@adm.cgmh.org.tw; bobwu506@hotmail.com		CHE-MING, WU/0000-0001-5245-0482	Chang-Gung Memorial Hospital Research Program [CMRPG3C1403]	Chang-Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital)	This study was supported by the Chang-Gung Memorial Hospital Research Program CMRPG3C1403 to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen C, 2001, OTOL NEUROTOL, V22, P631, DOI 10.1097/00129492-200109000-00012; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Archbold S, 1998, BRIT J AUDIOL, V32, P7, DOI 10.3109/03005364000000045; Brownstein Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-245; Chang Mun Young, 2014, Korean J Audiol, V18, P45, DOI 10.7874/kja.2014.18.2.45; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Cullen RD, 2004, LARYNGOSCOPE, V114, P2218, DOI 10.1097/01.mlg.0000149462.88327.7f; Dahl HHM, 2003, AUDIOL NEURO-OTOL, V8, P263, DOI 10.1159/000071998; de Heer AMR, 2009, ANN OTO RHINOL LARYN, V118, P382, DOI 10.1177/000348940911800511; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; Eppsteiner RW, 2012, HEARING RES, V292, P51, DOI 10.1016/j.heares.2012.08.007; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hogewind BFT, 2010, MOL VIS, V16, P26; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu P, 2008, J GENET GENOMICS, V35, P553, DOI 10.1016/S1673-8527(08)60075-2; Mhatre AN, 2004, J NEUROSCI RES, V76, P296, DOI 10.1002/jnr.20065; Miyagawa M, 2016, OTOL NEUROTOL, V37, pE126, DOI 10.1097/MAO.0000000000000936; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p158S, DOI 10.1177/0003489415575058; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p148S, DOI 10.1177/0003489415575055; Miyagawa M, 2015, ANN OTO RHINOL LARYN, V124, p84S, DOI 10.1177/0003489415575057; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071381; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nikolopoulos TP, 1999, LARYNGOSCOPE, V109, P595, DOI 10.1097/00005537-199904000-00014; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Papsin Blake C, 2005, Laryngoscope, V115, P1, DOI 10.1097/00005537-200501001-00001; Rendtorff ND, 2006, EUR J HUM GENET, V14, P1097, DOI 10.1038/sj.ejhg.5201670; Rennels M, 2005, LANCET, V365, P2085, DOI 10.1016/S0140-6736(05)66724-4; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Sinnathuray AR, 2003, OTOL NEUROTOL, V24, P418, DOI 10.1097/00129492-200305000-00012; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walton J, 2008, OTOL NEUROTOL, V29, P302, DOI 10.1097/MAO.0b013e318164d0f6; Waltzman SB, 2005, PEDIATRICS, V116, pE487, DOI 10.1542/peds.2005-0282; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Wu CC, 2008, ARCH PEDIAT ADOL MED, V162, P269, DOI 10.1001/archpediatrics.2007.59; Wu CC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001073; Wu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057369; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Wu CC, 2009, LARYNGOSCOPE, V119, P2411, DOI 10.1002/lary.20621; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85	53	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211261	10.1371/journal.pone.0211261	http://dx.doi.org/10.1371/journal.pone.0211261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682115	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500137
J	Crisostomo, L; Soriano, AM; Mendez, M; Graves, D; Pelka, P				Crisostomo, Leandro; Soriano, Andrea Michelle; Mendez, Megan; Graves, Drayson; Pelka, Peter			Temporal dynamics of adenovirus 5 gene expression in normal human cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MESSENGER-RNAS; TRANSCRIPTION; E1A; PROMOTER	Adenovirus executes a finely tuned transcriptional program upon infection of a cell. To better understand the temporal dynamics of the viral transcriptional program we performed highly sensitive digital PCR on samples extracted from arrested human lung fibroblasts infected with human adenovirus 5 strain dl309. We show that the first transcript made from viral genomes is the virus associated non-coding RNA, in particular we detected abundant levels of virus associated RNA II four hours after infection. Activation of E1 and E4 occurred nearly simultaneously later in infection, followed by other early genes as well as late genes. Our study determined that genomes begin to replicate between 29 and 30 hours after infection. This study provides a comprehensive view of viral mRNA steady-state kinetics in arrested human cells using digital PCR.	[Crisostomo, Leandro; Soriano, Andrea Michelle; Mendez, Megan; Graves, Drayson; Pelka, Peter] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Pelka, Peter] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Pelka, P (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.; Pelka, P (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	peter.pelka@umanitoba.ca			Natural Sciences and Engineering Research Council [RGPIN/435375-2013]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (Grant number: RGPIN/435375-2013, http://www.nserccrsng.gc.ca/Professors-Professeurs/Grants-Subs/index_eng.asp) to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUSJARVI G, 1981, NATURE, V292, P420, DOI 10.1038/292420a0; AKUSJARVI G, 1985, J VIROL, V56, P879; Berk AJ, 2013, FIELDS VIROLOGY; BETT AJ, 1995, VIRUS RES, V39, P75; BINGER MH, 1984, VIROLOGY, V136, P387, DOI 10.1016/0042-6822(84)90175-2; Crisostomo L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120387; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Etemadi MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176947; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; FLINT SJ, 1976, J MOL BIOL, V106, P749, DOI 10.1016/0022-2836(76)90263-1; Frost JR, 2018, J VIROL, V92, DOI 10.1128/JVI.00439-18; Frost JR, 2017, VIROLOGY, V500, P11, DOI 10.1016/j.virol.2016.10.004; GLENN GM, 1988, VIRUS RES, V9, P73, DOI 10.1016/0168-1702(88)90051-2; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; Jung R, 2016, J VIROL, V90, P1931, DOI 10.1128/JVI.02392-15; Kallsten M, 2017, VIROLOGY, V511, P240, DOI 10.1016/j.virol.2017.08.032; Krzywkowski T, 2017, J VIROL, V91, DOI 10.1128/JVI.00166-17; MATHEWS MB, 1975, CELL, V6, P223, DOI 10.1016/0092-8674(75)90013-6; Miller DL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r58; MONTELL C, 1982, NATURE, V295, P380, DOI 10.1038/295380a0; NEVINS JR, 1978, J VIROL, V25, P811, DOI 10.1128/JVI.25.3.811-823.1978; PILDER S, 1986, MOL CELL BIOL, V6, P470, DOI 10.1128/MCB.6.2.470; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Radko S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140124; Radko S, 2014, J VIROL, V88, P13469, DOI 10.1128/JVI.02538-14; REICH NC, 1983, VIROLOGY, V128, P480, DOI 10.1016/0042-6822(83)90274-X; REICHEL PA, 1985, NATURE, V313, P196, DOI 10.1038/313196a0; SHAW AR, 1980, CELL, V22, P905, DOI 10.1016/0092-8674(80)90568-1; SODERLUND H, 1976, CELL, V7, P585, DOI 10.1016/0092-8674(76)90209-9; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P3426, DOI 10.1073/pnas.71.9.3426; WINBERG G, 1984, EMBO J, V3, P1907, DOI 10.1002/j.1460-2075.1984.tb02066.x; Zhao HX, 2014, VIROLOGY, V456, P329, DOI 10.1016/j.virol.2014.04.006; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006; ZIFF EB, 1978, CELL, V15, P1463, DOI 10.1016/0092-8674(78)90070-3	37	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211192	10.1371/journal.pone.0211192	http://dx.doi.org/10.1371/journal.pone.0211192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677073	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400058
J	Mirab, F; Kang, YJ; Majd, S				Mirab, Fereshtehsadat; Kang, You Jung; Majd, Sheereen			Preparation and characterization of size-controlled glioma spheroids using agarose hydrogel microwells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; CELL; ARRAYS; DP44MT	Treatment of glioblastoma, the most common and aggressive type of primary brain tumors, is a major medical challenge and the development of new alternatives requires simple yet realistic models for these tumors. In vitro spheroid models offer attractive platforms to mimic the tumor behavior in vivo and have thus, been increasingly applied for assessment of drug efficacy in various tumors. The aim of this study was to produce and characterize size-controlled U251 glioma spheroids towards application in glioma drug evaluation studies. To this end, we fabricated agarose hydrogel microwells with cylindrical shape and diameters of 70700 mu m and applied these wells without any surface modification for glioma spheroid formation. The resultant spheroids were homogeneous in size and shape, exhibited high cell viability (>90%), and had a similar growth rate to that of natural brain tumors. The final size of spheroids depended on cell seeding density and microwell size. The spheroids' volume increased linearly with the cell seeding density and the rate of this change increased with the well size. Lastly, we tested the therapeutic effect of an anti-cancer drug, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT) on the resultant glioma spheroids and demonstrated the applicability of this spheroid model for drug efficacy studies.	[Mirab, Fereshtehsadat; Majd, Sheereen] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Kang, You Jung] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Majd, S (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	smajd9@uh.edu		Majd, Sheereen/0000-0002-3131-9845; Mirab, Fereshtehsadat/0000-0002-2178-3863				Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050491; Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257; Fan YT, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2410277; Ferreira LP, 2018, ACTA BIOMATER, V75, P11, DOI 10.1016/j.actbio.2018.05.034; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Gallego O, 2015, CURR ONCOL, V22, pE273, DOI 10.3747/co.22.2436; Gencoglu MF, 2018, ACS BIOMATER SCI ENG, V4, P410, DOI 10.1021/acsbiomaterials.7b00069; Gong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130348; Holley C K, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P5733, DOI 10.1109/EMBC.2018.8513598; Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557; Kang YJ, 2017, IEEE ENG MED BIO, P309, DOI 10.1109/EMBC.2017.8036824; Kang YJ, 2013, ADV MATER, V25, P6834, DOI 10.1002/adma.201303290; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Li YF, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas8998; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Madhankumar AB, 2009, MOL CANCER THER, V8, P648, DOI 10.1158/1535-7163.MCT-08-0853; Majd S, 2005, ANGEW CHEM INT EDIT, V44, P6697, DOI 10.1002/anie.200502189; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Noulsri E, 2009, AM J HEMATOL, V84, P170, DOI 10.1002/ajh.21350; Peela N, 2016, BIOMATERIALS, V81, P72, DOI 10.1016/j.biomaterials.2015.11.039; Stensjoen AL, 2015, NEURO-ONCOLOGY, V17, P1402, DOI 10.1093/neuonc/nov029; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Tang YD, 2016, MICROELECTRON ENG, V158, P41, DOI 10.1016/j.mee.2016.03.009; Tekin H, 2010, LAB CHIP, V10, P2411, DOI 10.1039/c004732e; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wlodkowic D., 2009, FLOW CYTOMETRY BASED, P19; Yuan XG, 2018, BIOCHEM ENG J, V131, P39, DOI 10.1016/j.bej.2017.12.011	35	38	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211078	10.1371/journal.pone.0211078	http://dx.doi.org/10.1371/journal.pone.0211078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677075	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400047
J	Xiao, T; Yu, H; Song, YB; Jiang, YP; Zeng, B; Dong, M				Xiao, Tao; Yu, Hua; Song, Yao-Bin; Jiang, Yue-Ping; Zeng, Bo; Dong, Ming			Nutrient enhancement of allelopathic effects of exotic invasive on native plant species	PLOS ONE			English	Article							ALTERNANTHERA-PHILOXEROIDES; NITROGEN DEPOSITION; COMPETITIVE ABILITY; ECOSYSTEM SERVICES; FRESH-WATER; EUTROPHICATION; SUCCESS; PHOSPHORUS; ENRICHMENT; MECHANISM	Many ecosystems may suffer from both nutrient enrichment and exotic plant invasions simultaneously. Much has been known that nutrient inputs can promote growth and expansion of exotic invasive plants in wetlands, and that allelopathic effects of the exotic invasive plants can inhibit the growth of coexisting native plants, contributing to their invasion success. Thus, we hypothesized that allelopathic effects of exotics on natives in invaded ecosystems can be enhanced by nutrient enrichment. To test this hypothesis, we conducted two greenhouse hydroponic experiments. One is the monoculture experiment in which a widespread exotic invasive perennial Alternanthera philoxeroides and a native perennial Ludwigia peploides subsp. stipulacea in monoculture were subjected to five levels of nutrient supply. The other is the mixture experiment in which the two species in mixture were subjected to five levels of nutrient supply, each with and without activated carbon addition. Both A. philoxeroides and L. peploides grew better under higher level of nutrient availability in monoculture experiment. In the mixture experiment, A. philoxeroides formed less total and root biomass while L. peploides formed more in response to activated carbon addition and all of the responses had larger degree at higher level of nutrient availability, indicating A. philoxeroides had significant allelopathic effects on L. peploides and the effects was significantly enhanced by nutrient enrichment. Such results support our hypothesis and reveal a novel mechanism for exotic plant invasion in eutrophicated and invaded wetlands, i.e. nutrient enhancement of allelopathic effects of exotics on natives.	[Xiao, Tao; Zeng, Bo; Dong, Ming] Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China; [Xiao, Tao; Yu, Hua; Song, Yao-Bin; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Jiang, Yue-Ping] Hangzhou Xixi Natl Wetland Pk Res Ctr Ecol Sci, Hangzhou, Zhejiang, Peoples R China	Southwest University - China; Hangzhou Normal University	Zeng, B; Dong, M (corresponding author), Southwest Univ, Chongqing Key Lab Plant Ecol & Resources Three Go, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Sch Life Sci, Chongqing, Peoples R China.; Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China.	bzeng@swu.edu.cn; dongming@hznu.edu.cn			National Key R&D Program of China [2017YFC0506200]; National Natural Science Foundation of China [316704290, 31700475]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China (http://service.most.gov.cn/; grant: 2017YFC0506200) and National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grants: 316704290 and 31700475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra PI, 2018, GLOBAL ECOL BIOGEOGR, V27, P68, DOI 10.1111/geb.12676; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Bradley BA, 2012, FRONT ECOL ENVIRON, V10, P20, DOI 10.1890/110145; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bridgham SD, 1998, ECOLOGY, V79, P1545, DOI 10.1890/0012-9658(1998)079[1545:CNAPMI]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Dodds WK, 2016, INLAND WATERS, V6, P155, DOI 10.5268/IW-6.2.909; Ehrenfeld JG, 2008, J APPL ECOL, V45, P1160, DOI 10.1111/j.1365-2664.2008.01476.x; Fleming JP, 2015, HYDROBIOLOGIA, V746, P23, DOI 10.1007/s10750-014-2026-y; Gao C, 2010, AMBIO, V39, P385, DOI 10.1007/s13280-010-0040-5; Grasset C, 2016, FRESHWATER BIOL, V61, P1405, DOI 10.1111/fwb.12780; Gruntman M, 2016, OIKOS, V125, P59, DOI 10.1111/oik.02109; He WM, 2011, ECOGRAPHY, V34, P1059, DOI 10.1111/j.1600-0587.2011.06835.x; Hettiarachchi M, 2013, ENVIRON CONSERV, V41, P276, DOI [10.1017/80376892913000519, DOI 10.1017/80376892913000519]; Hobbie SE, 2017, P NATL ACAD SCI USA, V114, P4177, DOI 10.1073/pnas.1618536114; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Jarchow ME, 2009, PLANT ECOL, V204, P113, DOI 10.1007/s11258-009-9573-8; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep39468; McInnes RJ, 2017, WETLANDS, V37, P123, DOI 10.1007/s13157-016-0849-1; Meza-Lopez MM, 2017, PLANT ECOL, V218, P835, DOI 10.1007/s11258-017-0733-y; Ning L, 2016, BIOL INVASIONS, V18, P3481, DOI 10.1007/s10530-016-1239-6; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Qin TJ, 2018, MAR FRESHWATER RES, V69, P811, DOI [10.1071/MF17335, 10.1071/mf17335]; Rickey MA, 2004, J APPL ECOL, V41, P888, DOI 10.1111/j.0021-8901.2004.00948.x; Roley SS, 2018, FRESHWATER BIOL, V63, P353, DOI 10.1111/fwb.13073; Sanchez-Carrillo S, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P195, DOI 10.1007/978-90-481-9625-8_9; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Street LE, 2015, NEW PHYTOL, V206, P682, DOI 10.1111/nph.13265; Sun Y, 2017, J VEG SCI, V28, P1250, DOI 10.1111/jvs.12582; Svensson JR, 2013, J ECOL, V101, P140, DOI 10.1111/1365-2745.12028; Tyler AC, 2007, ECOL APPL, V17, P1886, DOI 10.1890/06-0822.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Wang BR, 2005, AQUAT BOT, V81, P277, DOI 10.1016/j.aquabot.2005.01.004; Ye WH, 2003, WEED RES, V43, P297, DOI 10.1046/j.1365-3180.2003.00346.x; You WH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00568; You WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097246; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zhang HJ, 2017, ENVIRON EXP BOT, V135, P118, DOI 10.1016/j.envexpbot.2016.12.014; Zheng YL, 2015, NEW PHYTOL, V205, P1350, DOI 10.1111/nph.13135; Zuo SP, 2012, WEED BIOL MANAG, V12, P123, DOI 10.1111/j.1445-6664.2012.00443.x	45	4	5	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0206165	10.1371/journal.pone.0206165	http://dx.doi.org/10.1371/journal.pone.0206165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673697	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800004
J	Backman, C; Johnston, S; Oelke, ND; Burns, KK; Hughes, L; Gifford, W; Lacroix, J; Forster, AJ				Backman, Chantal; Johnston, Sharon; Oelke, Nelly D.; Burns, Katharina Kovacs; Hughes, Linda; Gifford, Wendy; Lacroix, Jeanie; Forster, Alan J.			Safe and effective person- and family-centered care practices during transitions from hospital to home-A web-based Delphi technique	PLOS ONE			English	Article							PATIENT SAFETY; INTERVENTIONS; INFORMATION	Background Research has shown that adverse events during care transitions from hospital to home can have a significant impact on patients' outcomes, leading to readmission, delayed healing or even death. Gaps exist in the ways of monitoring care during transition periods and there is a need to help organizations better implement and monitor safe person- and family-centered care. Value statements are a way to obtain narratives in lay terms about how well care, treatment and support is organized to meet the needs and preferences of patients/families. The purpose of this study was to identify the value statements that are perceived by decisio-nmakers and patients/families to best signify safe person- and family-centered care during transitions from hospital to home. Methods Between January and September 2017, a web-based Delphi was used to survey key stake-holders in acute care and home care organizations across Canada. Results Decision-makers (n = 22) and patients/families (n = 24) from five provinces participated in the Delphi. Following Round 1, 45 perceived value statements were identified. In Round 2, consensus was received on 33/45 (73.3%) by decision-makers, and 30/45 (66.7%) by patients/families. In Round 3, additional value statements reached consensus in the decision-makers' survey (3) and in the patients/families' survey (2). A total of 30 high priority value statements achieved consensus derived from both the decision-makers' and patients/families' perspectives. Conclusion This study was an important first step in identifying key consensus-based priority value statements for monitoring care transitions from the perspective of both decision-makers and patients/families. Future research is needed to test their usability and to determine whether these value statements are actually suggestive of safe person- and family-centered care transition interventions from hospital to home.	[Backman, Chantal; Gifford, Wendy] Univ Ottawa, Sch Nursing, Fac Hlth Sci, Ottawa, ON, Canada; [Backman, Chantal; Forster, Alan J.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Backman, Chantal; Johnston, Sharon] Bruyere Res Inst, Ottawa, ON, Canada; [Johnston, Sharon; Forster, Alan J.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Oelke, Nelly D.] Univ British Columbia, Sch Nursing, Fac Hlth & Social Dev, Kelowna, BC, Canada; [Burns, Katharina Kovacs; Hughes, Linda] Patients Patient Safety Canada, Edmonton, AB, Canada; [Burns, Katharina Kovacs] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Lacroix, Jeanie] Canadian Inst Hlth Informat, Toronto, ON, Canada; [Backman, Chantal] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of British Columbia; University of Alberta; Canadian Institute Health Information; University of Ottawa	Backman, C (corresponding author), Univ Ottawa, Sch Nursing, Fac Hlth Sci, Ottawa, ON, Canada.; Backman, C (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Backman, C (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.; Backman, C (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.	chantal.backman@uottawa.ca	Backman, Chantal/AAV-1661-2020; Kovacs Burns, Katharina/AAA-5993-2022	Backman, Chantal/0000-0001-7431-8159; Kovacs Burns, Katharina/0000-0002-6322-0778	Canadian Patient Safety Institute; Accreditation Canada; Canadian Home Care Association; Patients for Patient Safety Canada; Registered Nurses' Association of Ontario	Canadian Patient Safety Institute; Accreditation Canada; Canadian Home Care Association; Patients for Patient Safety Canada; Registered Nurses' Association of Ontario	We would like to thank the Canadian Patient Safety Institute, Accreditation Canada, the Canadian Home Care Association, Patients for Patient Safety Canada, and the Registered Nurses' Association of Ontario for financially supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-346; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; [Anonymous], 2010, DELPHI TECHNIQUE NUR; Backman C, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0554-z; Bate P, 2006, QUAL SAF HEALTH CARE, V15, P307, DOI 10.1136/qshc.2005.016527; Boivin A, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-24; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Charmel P, 2008, HEALTHC FINANC MANAG, pI; CIHI, 2013, PUBL ENG SUMM REP HL; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Entwistle V A, 1998, J Health Serv Res Policy, V3, P100; Epstein R, 2010, HLTH AFF, V9, P1489; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gerhardt Geoffrey, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.02.b01; Graham C., 2013, DEV MEASURES PEOPLES; Institute for Patient- and Family-Centered Care (IPFCC), WHAT IS PAT FAM CTR; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Laugaland K, 2012, WORK, V41, P2915, DOI 10.3233/WOR-2012-0544-2915; Li J, 2014, CLEV CLIN J MED, V81, P312, DOI 10.3949/ccjm.81a.13106; McMurray J, 2013, HEALTH INFORM J, V19, P218, DOI 10.1177/1460458212467547; Medicare C for Baltimore MS 7500 SB Usa M, 2016, READM RED PROGR; Naylor MD, 2010, SCALING BRING TRANSI, P103; Osborn R, 2012, J AMBUL CARE MANAG, V35, P118, DOI 10.1097/JAC.0b013e31824a579b; Parrish MM, 2009, PROF CASE MANAG, V14, P282, DOI 10.1097/NCM.0b013e3181c3d380; Redding D, 2013, J INTEGR CARE, V21, P315, DOI 10.1108/JICA-06-2013-0018; Registered Nurses' Association of Ontario (RNAO), 2015, CLIN BEST PRACT GUID; RNAO, 2014, CLIN BEST PRACT GUID; Wier LM, 2006, HEALTHCARE COST UTIL	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211024	10.1371/journal.pone.0211024	http://dx.doi.org/10.1371/journal.pone.0211024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668588	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400027
J	Church, B; Wall, E; Webb, JR; Cameron, CE				Church, Brigette; Wall, Erika; Webb, John R.; Cameron, Caroline E.			Interaction of Treponema pallidum, the syphilis spirochete, with human platelets	PLOS ONE			English	Article							LYME-DISEASE; INTEGRIN ALPHA(IIB)BETA(3); BORRELIA-BURGDORFERI; OCULAR SYPHILIS; FIBRONECTIN; ACTIVATION; ATTACHMENT; NEUTROPHILS; METASTASIS; CLEARANCE	Extracellular bacteria that spread via the vasculature employ invasive mechanisms that mirror those of metastatic tumor cells, including intravasation into the bloodstream and survival during hematogenous dissemination, arrestation despite blood flow, and extravasation into distant tissue sites. Several invasive bacteria have been shown to exploit normal platelet function during infection. Due to their inherent ability to interact with and influence other cell types, platelets play a critical role in alteration of endothelial barrier permeability, and their role in cancer metastasis has been well established. The highly invasive bacterium and causative agent of syphilis, Treponema pallidum subspecies pallidum, readily crosses the endothelial, blood-brain and placental barriers. However, the mechanisms underlying this unusual and important aspect of T. pallidum pathogenesis are incompletely understood. In this study we use darkfield microscopy in combination with flow cytometry to establish that T. pallidum interacts with platelets. We also investigate the dynamics of this interaction and show T. pallidum is able to activate platelets and preferentially interacts with activated platelets. Platelet-interacting treponemes consistently exhibit altered kinematic (movement) parameters compared to free treponemes, and T. pallidum-platelet interactions are reversible. This study provides insight into host cell interactions at play during T. pallidum infection and suggests that T. pallidum may exploit platelet function to aid in establishment of disseminated infection.	[Church, Brigette; Wall, Erika; Webb, John R.; Cameron, Caroline E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Webb, John R.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada	University of Victoria; British Columbia Cancer Agency	Cameron, CE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	caroc@uvic.ca	Cameron, Caroline/HIR-2880-2022	Cameron, Caroline/0000-0002-8786-4359; Church, Brigette/0000-0003-0054-7607	Public Health Service Grant from the National Institutes of Health [AI-051334]; Natural Sciences and Engineering Research Council of Canada [327186]; Canadian Institutes for Health Research Canada Research Chair program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051334, R37AI051334] Funding Source: NIH RePORTER	Public Health Service Grant from the National Institutes of Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research Canada Research Chair program(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a Public Health Service Grant (AI-051334) from the National Institutes of Health to CEC and a Discovery Grant (327186) from the Natural Sciences and Engineering Research Council of Canada. CEC gratefully acknowledges the Canadian Institutes for Health Research Canada Research Chair program for salary support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed Sudheer, 2009, Oman Med J, V24, P134, DOI 10.5001/omj.2009.29; Alugupalli KR, 2003, BLOOD, V102, P2843, DOI 10.1182/blood-2003-02-0426; Alugupalli KR, 2001, MOL MICROBIOL, V39, P330, DOI 10.1046/j.1365-2958.2001.02201.x; [Anonymous], 2011, PREVALENCE INCIDENCE; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Bhat P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095248; Binsker U, 2018, THROMB HAEMOSTASIS, V118, P745, DOI 10.1055/s-0038-1637735; Blaschitz A, 2015, PLACENTA, V36, P1333, DOI 10.1016/j.placenta.2015.09.002; Bodis J, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-55; Boulaftali Y, 2018, RES PRACT THROMB HAE, V2, P228, DOI 10.1002/rth2.12092; Centers for Disease Control & Prevention, 2017, 2016 SEX TRANSM DIS; Cloutier N, 2012, BLOOD, V120, P1334, DOI 10.1182/blood-2012-02-413047; COBURN J, 1993, P NATL ACAD SCI USA, V90, P7059, DOI 10.1073/pnas.90.15.7059; COBURN J, 1994, INFECT IMMUN, V62, P5559, DOI 10.1128/IAI.62.12.5559-5567.1994; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; COX DL, 1990, APPL ENVIRON MICROB, V56, P3063, DOI 10.1128/AEM.56.10.3063-3072.1990; COX DL, 1994, METHOD ENZYMOL, V236, P390; Dai T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1586-z; de Voux A, 2017, MMWR-MORBID MORTAL W, V66, P349, DOI 10.15585/mmwr.mm6613a1; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; FIELDSTEEL AH, 1981, INFECT IMMUN, V32, P908, DOI 10.1128/IAI.32.2.908-915.1981; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; FITZGERALD TJ, 1977, INFECT IMMUN, V18, P467, DOI 10.1128/IAI.18.2.467-478.1977; FITZGERALD TJ, 1984, BRIT J VENER DIS, V60, P357; FITZGERALD TJ, 1975, INFECT IMMUN, V11, P1133; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Golebiewska EM, 2015, BLOOD REV, V29, P153, DOI 10.1016/j.blre.2014.10.003; Gros A, 2015, BLOOD, V126, P1017, DOI 10.1182/blood-2014-12-617159; Haemmerle M, 2018, CANCER CELL, V33, P965, DOI 10.1016/j.ccell.2018.03.002; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Handtke S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00017; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Haworth JA, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12667; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Jones LD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151702; Joo SJ, 2012, KOREAN CIRC J, V42, P295, DOI 10.4070/kcj.2012.42.5.295; Jun HK, 2008, INFECT IMMUN, V76, P2428, DOI 10.1128/IAI.01128-07; Kahn F, 2013, MICROBES INFECT, V15, P669, DOI 10.1016/j.micinf.2013.05.003; Kerrigan SW, 2015, PLATELETS, V26, P293, DOI 10.3109/09537104.2014.997690; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Leblanc R, 2016, BLOOD, V128, P24, DOI 10.1182/blood-2016-01-636399; Li NL, 2016, INT J CANCER, V138, P2078, DOI 10.1002/ijc.29847; Liu LL, 2012, J NEUROL SCI, V317, P35, DOI 10.1016/j.jns.2012.03.003; Lukehart S. A., 2007, CURT PROTOC MICROBIO, V12, P1, DOI DOI 10.1002/9780471729259.MC12A01S7; LUKEHART SA, 1988, ANN INTERN MED, V109, P855, DOI 10.7326/0003-4819-109-11-855; Ma RS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04773-8; Malawista SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001633; Manfredi AA, 2010, CURR OPIN HEMATOL, V17, P3, DOI 10.1097/MOH.0b013e3283324f97; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; McNicol A, 2015, PLATELETS, V26, P309, DOI 10.3109/09537104.2015.1014470; Menter DG, 2017, CANCER METAST REV, V36, P199, DOI 10.1007/s10555-017-9682-0; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Nair Madhavan, 2015, J Alcohol Drug Depend, V3, P182; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Niddam AF, 2017, P NATL ACAD SCI USA, V114, pE3490, DOI 10.1073/pnas.1615007114; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; Parker ML, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005919; Paulo N, 2012, INTERACT CARDIOV TH, V14, P223, DOI 10.1093/icvts/ivr067; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Radolf JD, 2016, NAT REV MICROBIOL, V14, P744, DOI 10.1038/nrmicro.2016.141; Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881; Roberts WC, 2015, AM J CARDIOL, V116, P1298, DOI 10.1016/j.amjcard.2015.07.030; Rondina M., 2017, PLATELETS THROMBOTIC, P1071; Sanchez-Cortes J, 2009, CHEM BIOL, V16, P990, DOI 10.1016/j.chembiol.2009.08.012; Santis M. de, 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P430585, DOI 10.1155/2012/430585; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlesinger M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0669-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen J, 2015, INT J CLIN EXP MED, V8, P7770; Shin EK, 2017, BIOMOL THER, V25, P223, DOI 10.4062/biomolther.2016.138; Singh AK, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00774-16; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; SZANTO SF, 1971, BRIT J VENER DIS, V47, P14; Tesfamariam B, 2016, PHARMACOL THERAPEUT, V157, P112, DOI 10.1016/j.pharmthera.2015.11.005; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Tuominen-Gustafsson H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-92; Yakovenko O, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00160-18; Yun SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9060143; Zhao JJ, 2015, INT J BIOCHEM CELL B, V68, P176, DOI 10.1016/j.biocel.2015.08.007; Zuchtriegel G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002459	82	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210902	10.1371/journal.pone.0210902	http://dx.doi.org/10.1371/journal.pone.0210902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657796	Green Published, gold, Green Submitted			2022-12-27	WOS:000456017000022
J	Duarte, LN; Coelho, FJRC; Oliveira, V; Cleary, DFR; Martins, P; Gomes, NCM				Duarte, Leticia N.; Coelho, Francisco J. R. C.; Oliveira, Vanessa; Cleary, Daniel F. R.; Martins, Patricia; Gomes, Newton C. M.			Characterization of bacterioplankton communities from a hatchery recirculating aquaculture system (RAS) for juvenile sole (Solea senegalensis) production	PLOS ONE			English	Article							LIVE FEED; SP NOV.; WATER; BACTERIUM; PROBIOTICS; PATHOGEN; SURVIVAL; CULTURE; SEA	There is a growing consensus that future technological developments of aquaculture systems should account for the structure and function of microbial communities in the whole system and not only in fish guts. In this study, we aimed to investigate the composition of bacterioplankton communities of a hatchery recirculating aquaculture system (RAS) used for the production of Senegalese sole (Solea senegalensis) juveniles. To this end, we used a 16S rRNA gene based denaturing gradient gel electrophoresis (DGGE) and pyrosequencing analyses to characterize the bacterioplankton communities of the RAS and its water supply. Overall, the most abundant orders were Alteromonadales, Rhodobacterales, Oceanospirillales, Vibrionales, Flavobacteriales, Lactobacillales, Thiotrichales, Burkholderiales and Bdellovibrionales. Although we found a clear distinction between the RAS and the water supply bacterioplankton communities, most of the abundant OTUs (>= 50 sequences) in the hatchery RAS were also present in the water supply. These included OTUs related to Pseudoalteromonas genus and the Roseobacter clade, which are known to comprise bacterial members with activity against Vibrio fish pathogens. Overall, in contrast to previous findings for sole grow-out RAS, our results suggest that the water supply may influence the bacterioplankton community structure of sole hatchery RAS. Further studies are needed to investigate the effect of aquaculture practices on RAS bacterioplankton communities and identification of the key drivers of their structure and diversity.	[Gomes, Newton C. M.] Univ Aveiro, Dept Biol, Aveiro, Portugal; Univ Aveiro, CESAM, Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Gomes, NCM (corresponding author), Univ Aveiro, Dept Biol, Aveiro, Portugal.	gomesncm@ua.pt	Martins, Patricia/W-8942-2019; Cleary, Daniel/ABA-9393-2021; Gomes, Newton Carlos Marcial/AAV-4603-2021; Oliveira, Vanessa/K-4593-2014; Martins, Paulo N./AAO-5680-2021; Gomes, Newton Carlos Marcial/K-3211-2015; Coelho, Francisco JRC/M-3561-2018; Gomes, Newton CM/F-7430-2012	Martins, Patricia/0000-0002-3815-7922; Cleary, Daniel/0000-0002-6143-3390; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Oliveira, Vanessa/0000-0003-4223-0851; Martins, Paulo N./0000-0001-9333-0233; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Coelho, Francisco JRC/0000-0001-7638-8628; Gomes, Newton CM/0000-0003-1934-0091	CNPq, National Council of Scientific and Technological Development - Brazil; CAPES on CsF Program [BEX 1287-13-3]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/92366/2013, SFRH/BPD/101919/2014]; project AQUASAFE - PROMAR (Operational Programme for Fisheries) [PROMAR 31-03-05-FEP-0016]; AquaHeal - MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF) [MAR-02.01.01-FEAMP-0031]; CESAM [UID/AMB/50017]; FCT/MEC; FEDER; FEDER, within the Compete 2020	CNPq, National Council of Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES on CsF Program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); project AQUASAFE - PROMAR (Operational Programme for Fisheries); AquaHeal - MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF); CESAM; FCT/MEC; FEDER(European Commission); FEDER, within the Compete 2020	Leticia N. Duarte was supported by the CNPq, National Council of Scientific and Technological Development - Brazil and CAPES on CsF Program (BEX 1287-13-3). Francisco J.R.C. Coelho (SFRH/BPD/92366/2013) and Vanessa Oliveira (SFRH/BPD/101919/2014) were supported by postdoctoral scholarships financed by the Portuguese Foundation for Science and Technology (FCT). This study has been carried out with the financial support of the project AQUASAFE (PROMAR 31-03-05-FEP-0016) funded by PROMAR (Operational Programme for Fisheries) and AquaHeal (MAR-02.01.01-FEAMP-0031) funded by MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF). We are also grateful for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ricardo Calado for helpful discussions. Leticia N. Duarte was supported by the CNPq, National Council of Scientific and Technological Development-Brazil and CAPES on CsF Program (BEX 1287-13-3). Francisco J.R.C. Coelho (SFRH/BPD/92366/2013) and Vanessa Oliveira (SFRH/BPD/101919/2014) were supported by postdoctoral scholarships financed by the Portuguese Foundation for Science and Technology (FCT). This study has been carried out with the financial support of the project AQUASAFE (PROMAR 31-03-05-FEP-0016) funded by PROMAR (Operational Programme for Fisheries) and AquaHeal (MAR-02.01.01-FEAMP-0031) funded by MAR2020, Operational Programme for the European Maritime and Fisheries Fund (EMFF). We are also grateful for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020.	Actis LA, 2011, FISH DIS DISORDERS, V3, DOI 10.1079/9781845935542.0000; [Anonymous], 2009, POPUL DEV REV, V35, P837; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Auclair J, 2010, ISME J, V4, P1302, DOI 10.1038/ismej.2010.47; Birkbeck TH, 2011, J FISH DIS, V34, P173, DOI 10.1111/j.1365-2761.2010.01226.x; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Bourne DG, 2004, AQUACULTURE, V242, P31, DOI 10.1016/j.aquaculture.2004.08.047; Bowman J.P., 2005, BERGEYS MANUAL SYSTE, P443; Bregnballe J., 2015, GUIDE RECIRCULATION; Byun SO, 2009, ANAL BIOCHEM, V385, P174, DOI 10.1016/j.ab.2008.10.024; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Cleary DFR, 2015, COMPOSITION PREDICTE, DOI [10.1007/s10482-014-0375-1, DOI 10.1007/S10482-014-0375-1]; Coelho FJRC, 2015, GLOBAL CHANGE BIOL, V21, P1871, DOI 10.1111/gcb.12801; D'Alvise PW, 2010, APPL ENVIRON MICROB, V76, P2366, DOI 10.1128/AEM.02717-09; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Emami K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00104; FAO, 2016, CONTRIBUTING FOOD SE; Garrity GM, 2005, BERGEYS MANUAL SYSTE, DOI [10.1007/978-0-387-29298-7_2, DOI 10.1007/978-0-387-29298-7_2]; Giatsis C, 2015, SCI REP-UK, V5, DOI 10.1038/srep18206; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2008, FEMS MICROBIOLOGY EC, DOI [10.1111/j.15746941.2008.00519.x, DOI 10.1111/J.15746941.2008.00519.X]; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Howell B., 2009, AQUACULTURE EUROPE, V34, P24; Ishimaru K, 1996, INT J SYST BACTERIOL, V46, P155, DOI 10.1099/00207713-46-1-155; Kandel PP, 2014, FEMS MICROBIOL ECOL, V89, P149, DOI 10.1111/1574-6941.12342; Kasai H, 2002, FISHERIES SCI, V68, P821, DOI 10.2331/fishsci.68.sup1_821; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kesarcodi-Watson A, 2012, AQUACULTURE, V344, P29, DOI 10.1016/j.aquaculture.2012.02.029; Kim HS, 2016, INT J SYST EVOL MICR, V66, P3293, DOI 10.1099/ijsem.0.001188; Kreitmann L, 2015, EMERG INFECT DIS, V21, P2260, DOI 10.3201/eid2112.150615; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Labatut RA, 2004, AQUACULT ENG, V32, P113, DOI 10.1016/j.aquaeng.2004.05.008; Lee DE, 2016, J MICROBIOL, V54, P296, DOI 10.1007/s12275-016-5571-4; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; Martins P, 2018, AQUACULTURE, DOI [10.1016/j.aquaculture.2018.02.049, DOI 10.1016/J.AQUACULTURE.2018.02.049]; Martins P, 2015, AQUACULTURE, V435, P137, DOI 10.1016/j.aquaculture.2014.09.028; Martins P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080847; Matos A, 2011, AQUAC RES, V42, P1308, DOI 10.1111/j.1365-2109.2010.02719.x; McIntosh D, 2008, AQUACULTURE, V275, P42, DOI 10.1016/j.aquaculture.2007.12.021; Merrifield DL, 2014, AQUACULTURE NUTRITION: GUT HEALTH, PROBIOTICS AND PREBIOTICS, P185; Moriarty DJW, 1997, AQUACULTURE, V151, P333, DOI 10.1016/S0044-8486(96)01487-1; Nocker A, 2004, APPL ENVIRON MICROB, V70, P6834, DOI 10.1128/AEM.70.11.6834-6845.2004; NSW Government Department of Primary Industries, 2016, OZ REC AQ SYST; Nubel U, 1996, J BACTERIOL, V178, P5636; Oksanen J, 2011, VEGAN ECOLOGICAL DIV; Powell A, 2015, AQUACULT ENG, V64, P20, DOI 10.1016/j.aquaeng.2014.11.005; Pulkkinen K, 2010, P ROY SOC B-BIOL SCI, V277, P593, DOI 10.1098/rspb.2009.1659; Ramachandran K., 2016, BENEFICIAL MICROBES; Richards GP, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00175-17; Rodrigues S, 2015, PROBIOTICS ANTIMICRO, V7, P45, DOI 10.1007/s12602-014-9173-3; Rud I, 2017, AQUACULT ENG, V78, P50, DOI 10.1016/j.aquaeng.2016.10.003; Salvesen I, 1999, AQUACULTURE, V175, P337, DOI 10.1016/S0044-8486(99)00110-6; SCHOEFFIELD AJ, 1990, APPL ENVIRON MICROB, V56, P230, DOI 10.1128/AEM.56.1.230-236.1990; Sharifah E.N., 2012, AQUAC SCI, V60, P39, DOI [10.11233/aquaculturesci.60.39, DOI 10.11233/AQUACULTURESCI.60.39]; Skjermo J, 2015, AQUACULTURE, V438, P17, DOI 10.1016/j.aquaculture.2014.12.027; SOROKIN DY, 1995, MICROBIOLOGY+, V64, P295; Tal Y, 2009, AQUACULTURE, V286, P28, DOI 10.1016/j.aquaculture.2008.08.043; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Valladao GMR, 2015, J VET PHARMACOL THER, V38, P417, DOI 10.1111/jvp.12202; Voget S, 2015, ISME J, V9, P371, DOI 10.1038/ismej.2014.134; Wang Y, 2009, PLOS ONE, DOI [10.1371/journal.pone.007401, DOI 10.1371/JOURNAL.PONE.007401]; Wang Y, 2012, ANTON LEEUW INT J G, V101, P787, DOI 10.1007/s10482-011-9693-8; Wawrik B, 2012, FEMS MICROBIOL ECOL, V79, P400, DOI 10.1111/j.1574-6941.2011.01226.x; Webster NS, 2006, ENVIRON MICROBIOL, V8, P1177, DOI 10.1111/j.1462-2920.2006.01007.x; Welsh RM, 2016, ISME J, V10, P1540, DOI 10.1038/ismej.2015.219; Wesseling W, 2015, AQUACULTURE, V446, P57, DOI 10.1016/j.aquaculture.2015.04.017; Zhang DC, 2008, INT J SYST EVOL MICR, V58, P1384, DOI 10.1099/ijs.0.65708-0	72	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211209	10.1371/journal.pone.0211209	http://dx.doi.org/10.1371/journal.pone.0211209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682196	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500124
J	Legido-Quigley, H; Naheed, A; de Silva, HA; Jehan, I; Haldane, V; Cobb, B; Tavajoh, S; Chakma, N; Kasturiratne, A; Siddiqui, S; Jafar, TH; Clemens, JD; Hasnat, M; Hameed, A; Khan, AZ; Ranasinha, C; Finkelstein, E; Bilger, M; Pryseley, A; Gandhi, M; Ebrahim, S; Turner, E				Legido-Quigley, Helena; Naheed, Aliya; de Silva, H. Asita; Jehan, Imtiaz; Haldane, Victoria; Cobb, Benjamin; Tavajoh, Saeideh; Chakma, Nantu; Kasturiratne, Anuradhani; Siddiqui, Sahar; Jafar, Tazeen H.; Clemens, John D.; Hasnat, M.; Hameed, Aamir; Khan, Ayesha Z.; Ranasinha, Channa; Finkelstein, Eric; Bilger, Marcel; Pryseley, Assam; Gandhi, Mihir; Ebrahim, Shah; Turner, Elizabeth		COBRA-BPS Study Grp	Patients' experiences on accessing health care services for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: A qualitative study	PLOS ONE			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN	Hypertension is the leading risk factor for cardiovascular disease and leading cause of premature death globally. In 2008, approximately 40% of adults were diagnosed with hypertension, with more than 1.5 billion people estimated to be affected globally by 2025. Hypertension disproportionally affects low-and middle-income countries, where the prevalence is higher and where the health systems are more fragile. This qualitative study explored patients' experiences on the management and control of hypertension in rural Bangladesh, Sri Lanka and Pakistan. We conducted sixty semi-structured interviews, with 20 participants in each country. Hypertensive individuals were recruited based on age, gender and hypertensive status. Overall, patients' reported symptoms across the three countries were quite similar, although perceptions of hypertension were mixed. The majority of patients reported low knowledge on how to prevent or treat hypertension. The main barriers to accessing health services, as reported by participants, were inadequate services and poor quality of existing facilities, shortage of medicine supplies, busyness of doctors due to high patient load, long travel distance to facilities, and long waiting times once facilities were reached. Patients also mentioned that cost was a barrier to accessing services and adhering to medication. Many patients, when asked for areas of improvement, reported on the importance of the provider-patient relationship and mentioned valuing doctors who spent time with them, provided advice, and could be trusted. However, most patients reported that, especially at primary health care level and in government hospitals, the experience with their doctor did not meet their expectations. Patients in the three countries reported desire for good quality local medical services, the need for access to doctors, medicine and diagnostics and decreased cost for medication and medical services. Patients also described welcoming health care outreach activities near their homes. Areas of improvement could focus on reorienting community health workers' activities; involving family members in comprehensive counseling for medication adherence; providing appropriate training for health care staff to deliver effective information and services for controlling hypertension to patients; enhancing primary health care and specialist services; improving supplies of hypertensive medication in public facilities; taking into account patients' cultural and social background when providing services; and facilitating access and treatment to those who are most vulnerable.	[Legido-Quigley, Helena; Haldane, Victoria] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Naheed, Aliya; Chakma, Nantu; Clemens, John D.; Hasnat, M.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [de Silva, H. Asita; Kasturiratne, Anuradhani] Univ Kelaniya, Fac Med, Clin Trials Unit, Dept Pharmacol, Kelaniya, Sri Lanka; [Jehan, Imtiaz; Siddiqui, Sahar] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Cobb, Benjamin; Jafar, Tazeen H.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Tavajoh, Saeideh; Jafar, Tazeen H.] Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Hameed, Aamir; Khan, Ayesha Z.] Aga Khan Univ, Karachi, Pakistan; [Ranasinha, Channa] Univ Kelaniya, Colombo, Sri Lanka; [Finkelstein, Eric; Bilger, Marcel; Pryseley, Assam; Gandhi, Mihir] Duke NUS Med Sch, Singapore, Singapore; [Ebrahim, Shah] London Sch Hyg & Trop Med, London, England; [Turner, Elizabeth] Duke Global Hlth Inst, Durham, NC USA	National University of Singapore; International Centre for Diarrhoeal Disease Research (ICDDR); University Kelaniya; Aga Khan University; Duke University; National University of Singapore; Aga Khan University; University Kelaniya; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Duke University	Jafar, TH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA.; Jafar, TH (corresponding author), Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore.	tazeen.jafar@duke-nus.edu.sg	A, Naheed/AHB-2940-2022; A, Naheed/AHB-2941-2022	A, Naheed/0000-0002-6016-5603; A, Naheed/0000-0002-6016-5603; Chakma, Nantu/0000-0003-4535-9503	MRC/DFId/Wellcome Trust, UK [MR/N006178/1]; MRC [MR/N006178/1] Funding Source: UKRI	MRC/DFId/Wellcome Trust, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is supported by a research award: Grant Ref No: MR/N006178/1 from the MRC/DFId/Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ECONOMIST; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Jafar TH, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2018-0; Jafar TH, 2016, J HYPERTENS, V34, P1872, DOI 10.1097/HJH.0000000000001014; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Jin C, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0195-6; Katulanda P, 2014, CLIN EXP HYPERTENS, V36, P484, DOI 10.3109/10641963.2013.863321; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Legido-Quigley H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122112; Legido-Quigley H, 2014, SOCIOL HEALTH ILL, V36, P1243, DOI 10.1111/1467-9566.12163; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Meehan SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2173-8; Misra A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1420; Olsen MH, 2016, LANCET, V388, P2665, DOI 10.1016/S0140-6736(16)31134-5; Melo ECP, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0435-4; Qureshi NN, 2007, BMJ-BRIT MED J, V335, P1030, DOI 10.1136/bmj.39360.617986.AE; Rahman Mosiur, 2015, JRSM Open, V6, p2054270415608118, DOI 10.1177/2054270415608118; Ranawaka UK, 2016, CEYLON MED J, V61, P11, DOI 10.4038/cmj.v61i1.8253; Szczech LA, 2010, NEPHROL DIAL TRANSPL, V25, P2368, DOI 10.1093/ndt/gfq218; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Bank Group, 2016, SRI LANK COUNTR PROF; World Bank Group, 2016, BANGL COUNTR PROF; World Bank Group, 2016, PAK COUNTR PROF; WPRO, 2015, PEOPL REP BANGL HIT	28	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211100	10.1371/journal.pone.0211100	http://dx.doi.org/10.1371/journal.pone.0211100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682093	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500100
J	Mullers, Y; Meiser, I; Stracke, F; Riemann, I; Lautenschlager, F; Neubauer, JC; Zimmermann, H				Muellers, Yannik; Meiser, Ina; Stracke, Frank; Riemann, Iris; Lautenschlaeger, Franziska; Neubauer, Julia C.; Zimmermann, Heiko			Quantitative analysis of F-actin alterations in adherent human mesenchymal stem cells: Influence of slow-freezing and vitrification-based cryopreservation	PLOS ONE			English	Article							MEMBRANE-CYTOSKELETON COMPLEX; CELLULAR ADHESION; TISSUE-CULTURE; STROMAL CELLS; APOPTOSIS; SHOCK; DIFFERENTIATION; ORGANIZATION; MORPHOLOGY; MICROSCOPY	Cryopreservation is an essential tool to meet the increasing demand for stem cells in medical applications. To ensure maintenance of cell function upon thawing, the preservation of the actin cytoskeleton is crucial, but so far there is little quantitative data on the influence of cryopreservation on cytoskeletal structures. For this reason, our study aims to quantitatively describe cryopreservation induced alterations to F-actin in adherent human mesenchymal stem cells, as a basic model for biomedical applications. Here we have characterised the actin cytoskeleton on single-cell level by calculating the circular standard deviation of filament orientation, F-actin content, and average filament length. Cryo-induced alterations of these parameters in identical cells pre and post cryopreservation provide the basis of our investigation. Differences between the impact of slow-freezing and vitrification are qualitatively analyzed and highlighted. Our analysis is supported by live cryo imaging of the actin cytoskeleton via two photon microscopy. We found similar actin alterations in slow-frozen and vitrified cells including buckling of actin filaments, reduction of F-actin content and filament shortening. These alterations indicate limited functionality of the respective cells. However, there are substantial differences in the frequency and time dependence of F-actin disruptions among the applied cryopreservation strategies; immediately after thawing, cytoskeletal structures show least disruption after slow freezing at a rate of 1 degrees C/min. As post-thaw recovery progresses, the ratio of cells with actin disruptions increases, particularly in slow frozen cells. After 120 min of recovery the proportion of cells with an intact actin cytoskeleton is higher in vitrified than in slow frozen cells. Freezing at 10 degrees C/min is associated with a high ratio of impaired cells throughout the post-thawing culture.	[Muellers, Yannik; Meiser, Ina; Stracke, Frank; Riemann, Iris; Neubauer, Julia C.; Zimmermann, Heiko] Fraunhofer Inst Biomed Engn IBMT, Dept Cryo & Stem Cell Technol, Joseph Von Fraunhofer Weg 1, Sulzbach, Germany; [Lautenschlaeger, Franziska] Leibniz Inst New Mat, Div Cytoskeletal Fibers, Campus D2 2, Saarbrucken, Germany; [Lautenschlaeger, Franziska] Saarland Univ, Chair Expt Phys, Saarbrucken, Germany; [Neubauer, Julia C.] Fraunhofer Project Ctr Stem Cell Proc Engn, Neunerpl 2, Wurzburg, Germany; [Zimmermann, Heiko] Saarland Univ, Chair Mol & Cellular Biotechnol, Saarbrucken, Germany; [Zimmermann, Heiko] Univ Catolica Norte, Fac Marine Sci, Coquimbo, Chile	Fraunhofer Gesellschaft; Leibniz Institut fur Neue Materialien (INM); Saarland University; Saarland University; Universidad Catolica del Norte	Zimmermann, H (corresponding author), Fraunhofer Inst Biomed Engn IBMT, Dept Cryo & Stem Cell Technol, Joseph Von Fraunhofer Weg 1, Sulzbach, Germany.; Zimmermann, H (corresponding author), Saarland Univ, Chair Mol & Cellular Biotechnol, Saarbrucken, Germany.; Zimmermann, H (corresponding author), Univ Catolica Norte, Fac Marine Sci, Coquimbo, Chile.	heiko.zimmermann@ibmt.fraunhofer.de	; Lautenschlager, Franziska/L-3484-2016	Neubauer, Julia/0000-0001-6876-1453; Lautenschlager, Franziska/0000-0001-8263-3386; Zimmermann, Heiko/0000-0001-8595-1304				Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; Beier AF, 2013, CRYOBIOLOGY, V66, P8, DOI 10.1016/j.cryobiol.2012.10.001; Beier AFJ, 2011, CRYOBIOLOGY, V63, P175, DOI 10.1016/j.cryobiol.2011.06.003; Beil M, 2005, J MICROSC-OXFORD, V220, P84, DOI 10.1111/j.1365-2818.2005.01505.x; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906; Cancer W, 2016, STEM CELLS, V34, P2429, DOI [10.1002/stem.2415, DOI 10.1002/STEM.2415]; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chinnadurai R, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.003; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doerr Daniel, 2009, Biotechnology Journal, V4, P1215, DOI 10.1002/biot.200800212; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fahy GM, 2015, METHODS MOL BIOL, V1257, P21, DOI 10.1007/978-1-4939-2193-5_2; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Genesca M, 2006, APOPTOSIS, V11, P563, DOI 10.1007/s10495-006-4937-1; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623; Katkov I., 2011, STEM CELLS INT, V2011, P1; Katsen-Globa A, 2014, J MATER SCI-MATER M, V25, P857, DOI 10.1007/s10856-013-5108-x; Keung E, 2013, STEM CELLS, V30, P804; LAMPUGNANI MG, 1987, EXP CELL RES, V172, P385, DOI 10.1016/0014-4827(87)90396-X; Malpique R, 2009, TISSUE ENG PART C-ME, V15, P373, DOI 10.1089/ten.tec.2008.0410; Mardones R, 2017, J HIP PRESERV SURG, V4, P159, DOI 10.1093/jhps/hnx011; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4; MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mullins PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063141; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Pollock K, 2017, J TISSUE ENG REGEN M, V11, P2806, DOI 10.1002/term.2175; Pollock K, 2015, CYTOTHERAPY, V17, P38, DOI 10.1016/j.jcyt.2014.06.008; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Ragoonanan V, 2013, CRYOBIOLOGY, V66, P96, DOI 10.1016/j.cryobiol.2012.10.008; Ragoonanan V, 2010, CRYOBIOLOGY, V61, P335, DOI 10.1016/j.cryobiol.2010.10.160; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Slaninova I, 2000, ARCH MICROBIOL, V173, P245, DOI 10.1007/s002030000136; TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Valojerdi MR, 2009, J ASSIST REPROD GEN, V26, P347, DOI 10.1007/s10815-009-9318-6; VINCENT C, 1990, MOL REPROD DEV, V26, P227, DOI 10.1002/mrd.1080260306; WEISS L, 1972, EXP CELL RES, V74, P21, DOI 10.1016/0014-4827(72)90477-6; Wesley-Smith J, 2015, ANN BOT-LONDON, V115, P991, DOI 10.1093/aob/mcv009; Wu YN, 2015, CRYOLETTERS, V36, P325; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; Xu X, 2010, BIOTECHNOL PROGR, V26, P781, DOI 10.1002/btpr.358; Yousaf MN, 2001, ANGEW CHEM INT EDIT, V40, P1093, DOI 10.1002/1521-3773(20010316)40:6<1093::AID-ANIE10930>3.3.CO;2-H	60	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211382	10.1371/journal.pone.0211382	http://dx.doi.org/10.1371/journal.pone.0211382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682146	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500162
J	Pugliese, M; Ramsay, T; Shamloul, R; Mallet, K; Zakutney, L; Corbett, D; Dukelow, S; Stotts, G; Shamy, M; Wilson, K; Guerinet, J; Dowlatshahi, D				Pugliese, Michael; Ramsay, Tim; Shamloul, Rany; Mallet, Karen; Zakutney, Lise; Corbett, Dale; Dukelow, Sean; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Guerinet, Julien; Dowlatshahi, Dar			RecoverNow: A mobile tablet-based therapy platform for early stroke rehabilitation	PLOS ONE			English	Article							POSTSTROKE DEPRESSION; CLINICAL-TRIALS; TELEREHABILITATION	Introduction Stroke survivors frequently experience a range of post-stroke deficits. Specialized stroke rehabilitation improves recovery, especially if it is started early post-stroke. However, resource limitations often preclude early rehabilitation. Mobile technologies may provide a platform for stroke survivors to begin recovery when they might not be able to otherwise. The study objective was to demonstrate the feasibility of RecoverNow, a tablet-based stroke recovery platform aimed at delivering speech and cognitive therapy. Methods We recruited a convenience sample of 30 acute stroke patients to use RecoverNow for up to 3 months. Allied health professionals assigned specific applications based on standard of care assessments. Participants were encouraged to take home the RecoverNow tablets upon discharge from acute care. The study team contacted participants to return for a follow-up interview 3 months after enrollment. The primary outcome of interest was feasibility, defined using 5 facets: recruitment rate, adherence rate, retention rate, the proportion of successful follow-up interventions, and protocol deviations. We tracked barriers to tablet-based care as a secondary outcome. Results We successfully recruited 30 of 62 eligible patients in 15 weeks (48% recruitment rate). Participants were non-adherent to tablet-based therapy inside and outside of acute care, using RecoverNow for a median of 12 minutes a day. Retention was high with 23 of 30 patients participating in follow-up interviews (77% retention rate) and all but 3 of the 23 interviews (87%) were successfully completed. Only 2 major protocol deviations occurred: one enrollment failure and one therapy protocol violation. Barriers to tablet-based care were frequently encountered by study participants with many expressing the assigned applications were either too easy or too difficult. Conclusions Acute stroke patients are interested in attempting tablet-based stroke rehabilitation and are easily recruited early post-stroke. However, tablet-based therapy may be challenging due to patient, device and system-related barriers. Reducing the frequency of common barriers will be essential to keeping patients engaged in tablet-based therapy.	[Pugliese, Michael; Ramsay, Tim; Wilson, Kumanan; Dowlatshahi, Dar] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Ramsay, Tim; Shamloul, Rany; Mallet, Karen; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Guerinet, Julien; Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Mallet, Karen; Zakutney, Lise; Stotts, Grant; Shamy, Michel; Dowlatshahi, Dar] Champlain Reg Stroke Network, Ottawa, ON, Canada; [Mallet, Karen; Zakutney, Lise; Stotts, Grant; Shamy, Michel; Wilson, Kumanan; Dowlatshahi, Dar] Ottawa Hosp, Ottawa, ON, Canada; [Mallet, Karen; Corbett, Dale; Dukelow, Sean; Dowlatshahi, Dar] Canadian Partnership Stroke Recovery, Ottawa, ON, Canada; [Corbett, Dale] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Corbett, Dale; Stotts, Grant; Dowlatshahi, Dar] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Dukelow, Sean] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Calgary	Pugliese, M (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	mpugl038@uottawa.ca		Pugliese, Michael/0000-0003-2794-1436; Dowlatshahi, Dar/0000-0003-1379-3612	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	This work was supported by a Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award (http://www.cihr-irsc.gc.ca/e/49440.html; M.P.), a University of Ottawa Ontario Graduate Scholarship (https://www.uottawa.ca/graduate-studies/students/awards/ontario-graduate-scholarship; M.P.), the University of Ottawa Brain and Mind Research Institute (https://www.uottawa.ca/brain/; D.D), the Canadian Partnership for Stroke Recovery (http://www.canadianstroke.ca/en/; D.D.), and the University of Ottawa Department of Medicine (https://med.uottawa.ca/en; D.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MORBITY MORTAL WKLY, V56, P504; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Burton LJ, 2015, PSYCHOL MED, V45, P29, DOI 10.1017/S0033291714000336; Carabeo CGG, 2014, SIMULAT GAMING, V45, P151, DOI 10.1177/1046878114531102; Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Crotty M, 2014, J TELEMED TELECARE, V20, P370, DOI 10.1177/1357633X14552382; de Man-van Ginkel JM, 2012, NURS RES, V61, P333, DOI 10.1097/NNR.0b013e31825d9e9e; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Faltynek P, 2018, EVIDENCE BASED REV S; Heart and Stroke Foundation, 2014, TOG RIS TID ADV STRO; Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990; Hussein N., 2018, EVIDENCE BASED REV S; Jang SH, 2016, SOMATOSENS MOT RES, V33, P124, DOI 10.1080/08990220.2016.1197117; Katalinic O, 2013, J TELEMED TELECARE, V19, P418, DOI 10.1177/1357633X13506513; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Krakauer JW, 2015, GETTING NEUROREHABIL, V26, P923, DOI [10.1177/1545968312440745.Getting, DOI 10.1177/1545968312440745.GETTING]; Kurland J, 2014, CLIN APHASIOLOGY C, V35, P51; Lavoie M, 2016, NEUROCASE, V22, P109, DOI 10.1080/13554794.2015.1051055; MAHONEY F I, 1965, Md State Med J, V14, P61; Mallet K, 2019, INT J STROKE, V14, P174, DOI 10.1177/1747493018790031; Mallet KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167950; Meader N, 2014, J NEUROL NEUROSUR PS, V85, P198, DOI 10.1136/jnnp-2012-304194; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Pugliese M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191566; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Rand D., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P109, DOI 10.1109/ICVR.2013.6662068; Routhier S, 2016, APHASIOLOGY, V30, P269, DOI 10.1080/02687038.2014.973361; Salter K, 2018, EVIDENCE BASED REV S; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Swartz RH, 2016, INT J STROKE, V11, P509, DOI 10.1177/1747493016641968; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876; Zhou X, 2018, TOP STROKE REHABIL, V25, P489, DOI 10.1080/10749357.2018.1482446	37	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210725	10.1371/journal.pone.0210725	http://dx.doi.org/10.1371/journal.pone.0210725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682076	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500056
J	Arnaldo, P; Cambe, MI; Magaco, A; Chicumbe, S; Rovira-Vallbona, E; Rosanas-Urgell, A; Enosse, SM				Arnaldo, Paulo; Cambe, Maria Isabel; Magaco, Amilcar; Chicumbe, Sergio; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna; Enosse, Sonia M.			Access to and use of preventive intermittent treatment for Malaria during pregnancy: A qualitative study in the Chokwe district, Southern Mozambique	PLOS ONE			English	Article								Background Malaria remains a significant health problem in Mozambique, particularly in the case of pregnant women and children less than five years old. Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPT-SP) is recommended for preventing malaria in pregnancy (MiP). Despite the widespread use and cost-effectiveness of IPTp-SP, coverage remains low. In this study, we explored factors limiting access to and use of IPTp-SP in a rural part of Mozambique. Methods and findings We performed a qualitative study using semi-structured interviews to collect data from 46 pregnant women and four health workers in Chokwe, a rural area of southern Mozambique. Data were transcribed, translated where appropriate, manually coded, and the content analyzed according to key themes. The women interviewed were not aware of the risks of MiP or the benefits of its prevention. Delays in accessing antenatal care, irregular attendance of visits, and insufficient time for proper antenatal care counselling by health workers were driving factors for inadequate IPTp delivery. Conclusions Pregnant women face substantial barriers in terms of optimal IPTp-SP uptake. Health system barriers and poor awareness of the risks and consequences of MiP and of the measures available for its prevention were identified as the main factors influencing access to and use of IPTp-SP. Implementation of MiP prevention strategies must be improved through intensive community health education and increased access to other sources of information. Better communication between health workers and ANC clients and better knowledge of national ANC and IPTp policies are important.	[Arnaldo, Paulo; Enosse, Sonia M.] Inst Nacl Saude, Plataforma Parasitol Mol, Maputo, Mozambique; [Arnaldo, Paulo; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Arnaldo, Paulo] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Cambe, Maria Isabel; Magaco, Amilcar; Chicumbe, Sergio] Inst Nacl Saude, Programa Sistemas Saude, Maputo, Mozambique	Institute of Tropical Medicine (ITM); University of Antwerp	Arnaldo, P (corresponding author), Inst Nacl Saude, Plataforma Parasitol Mol, Maputo, Mozambique.; Arnaldo, P (corresponding author), Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium.; Arnaldo, P (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	pauloarnaldo554@hotmail.com	Chicumbe, Sergio Antonio Rodrigues/GXA-1921-2022	Chicumbe, Sergio Antonio Rodrigues/0000-0002-2498-9373; Enosse, Sonia Maria Mauricio/0000-0002-2586-2083; Rovira-Vallbona, Eduard/0000-0002-4765-1076	Flemish International Cooperation Agency under the BICMINS project ITM-INS; "Fundo National de Investigacao" (FNI)	Flemish International Cooperation Agency under the BICMINS project ITM-INS; "Fundo National de Investigacao" (FNI)	This research was undertaken as part of PhD program which is supported by the Flemish International Cooperation Agency under the BICMINS project ITM-INS and the "Fundo National de Investigacao" (FNI). None of the funders had a role in study design, data collection, and analysis, the decision to publish and/or manuscript conception.	Andrews KG, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1033-4; [Anonymous], 2004, STRATEGIC FRAMEWORK; Arnaldo P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2255-z; Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038; Brabin L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-25; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881; Florey L, 2013, DHS ANAL STUDIES, V39, P1; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Hurley EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160008; Mason L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0453-z; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; MISAU, 2006, NORMAS MANEJO CASOS; MISAU INE ICF, 2018, INQ IND IM MAL HIV S; Mubyazi GM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-54; Munguambe K, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0141-0; Onoka CA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-317; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; PNCM, 2015, REL AN PROGR NAC CON; PNCM inform and LSHTM, 2017, MOZ PROF MAL CONTR E; Pool R, 2012, SOCIAL CULTURAL FACT, V6, DOI [10.1371/journal.pone.0022452, DOI 10.1371/JOURNAL.PONE.0022452]; Rassi C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1589-7; Sangare LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015066; Some TD, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-3; Stephen AAI, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.1.6169; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; WHO, 2013, UPD WHO POL REC INT; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, GLOB HEP REP, DOI DOI 10.1071/EC12504	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0203740	10.1371/journal.pone.0203740	http://dx.doi.org/10.1371/journal.pone.0203740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677039	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400002
J	Huang, KC; Tsay, YS; Lin, FM; Lee, CC; Chang, JW				Huang, Kun-Chih; Tsay, Yaw-Shyan; Lin, Fang-Ming; Lee, Ching-Chang; Chang, Jung-Wei			Efficiency and performance tests of the sorptive building materials that reduce indoor formaldehyde concentrations	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; INITIAL EMITTABLE CONCENTRATION; COMPOUNDS EMISSION; VOC EMISSIONS; TEMPERATURE; IMPACT; MODEL; PARTICLEBOARD; VALIDATION; HUMIDITY	The adsorption of volatile organic compounds by building materials reduces the pollutant concentrations in indoor air. We collected three interior building materials with adsorption potentials-latex paint, micro-carbonized plywood, and moisture-buffering siding-used the sorptive building materials test (SBMT) to determine how much they reduced indoor formaldehyde (HCHO) concentrations, and then assessed the consequent reduction in human cancer risk from HCHO inhalation. Adsorption of HCHO by building materials significantly improved the effective ventilation efficiency. For example, the equivalent ventilation rate for Celite siding-used for humidity control-was 1.44 m(3)/(m(2).h) at 25 degrees C, 50% relative humidity (RH); the loading factor (L) was 0.4 m(2)/m(3), and the HCHO concentration was 0.2 ppm; this effect is equivalent to a higher ventilation rate of approximately 0.6 air changes per hour in a typical Taiwanese dwelling. There was also a substantial reduction of risk in Case MCP-2 (C-in,C-te: 245 mu g/m(3), 30 degrees C, 50% RH): males: down 5.73 x 10(-4); females: down 4.84 x 10(-4)). The selection of adsorptive building materials for interior surfaces, therefore, significantly reduces human inhalation of HCHO. Our findings should encourage developing and using innovative building materials that help improve indoor air quality and thus provide building occupants with healthier working and living environments.	[Huang, Kun-Chih; Tsay, Yaw-Shyan] Natl Cheng Kung Univ, Coll Engn, Dept Architecture, Tainan, Taiwan; [Lin, Fang-Ming] Natl Pingtung Univ Sci & Technol, Dept Wood Sci & Design, Pingtung, Taiwan; [Lee, Ching-Chang] Natl Cheng Kung Univ, Med Coll, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Chang, Jung-Wei] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan	National Cheng Kung University; National Pingtung University Science & Technology; National Cheng Kung University; National Yang Ming Chiao Tung University	Lee, CC (corresponding author), Natl Cheng Kung Univ, Med Coll, Dept Environm & Occupat Hlth, Tainan, Taiwan.; Chang, JW (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan.	cclee@mail.ncku.edu.tw; jungwei723@gmail.com	Tsay, Yaw-Shyan/M-5980-2017	Tsay, Yaw-Shyan/0000-0001-6935-784X	Architecture and Building Research Institute, Taiwan Ministry of the Interior	Architecture and Building Research Institute, Taiwan Ministry of the Interior	This work was funded by Architecture and Building Research Institute, Taiwan Ministry of the Interior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ASTDR), 1999, TOX PROF FORM; ANDERSEN I, 1975, ATMOS ENVIRON, V9, P1121, DOI 10.1016/0004-6981(75)90188-2; [Anonymous], 2009, 1600023 ISO; [Anonymous], 2007, A19051 JIS, P6568, DOI [10.1016/j.biortech.2010.03.059, DOI 10.1016/J.BIORTECH.2010.03.059]; [Anonymous], 2006, ASTM INT STAND; [Anonymous], 2001, D664601 ASTM; [Anonymous], 2002, 600702 ASTM; [Anonymous], [No title captured]; [Anonymous], 2006, E133390 ASTM; [Anonymous], 2006, 1600011 ISO; [Anonymous], 2004, 7171 EN; Anses, 2008, TOX FORM ET CONN CAR; Arts JHE, 2006, REGUL TOXICOL PHARM, V44, P144, DOI 10.1016/j.yrtph.2005.11.006; BACHMANN MO, 1995, SOC SCI MED, V40, P245, DOI 10.1016/0277-9536(94)E0068-4; Chiang CM, 2011, ADV MATER RES-SWITZ, V314-316, P1435, DOI 10.4028/www.scientific.net/AMR.314-316.1435; Chiang CM, 1994, J HOUSING STUDIES, V2, P107; Cox SS, 2002, ENVIRON SCI TECHNOL, V36, P709, DOI 10.1021/es010802+; Crawford S, 2011, SCI TOTAL ENVIRON, V409, P3403, DOI 10.1016/j.scitotenv.2011.05.042; Dar UI, 2015, BUILD SIMUL-CHINA, V8, P499, DOI 10.1007/s12273-015-0230-y; Deng QQ, 2009, ATMOS ENVIRON, V43, P2080, DOI 10.1016/j.atmosenv.2008.12.052; Deng QQ, 2011, BUILD SCI, V27; Deng QQ, 2009, HVAC, V39; DOH, 2008, COMP EXP FACT; Fabi V, 2013, BUILD SIMUL-CHINA, V6, P415, DOI 10.1007/s12273-013-0119-6; Frihart C.R., 2010, P INT CONV SOC WOOD, P1; Frihart CR, 2012, FOREST PROD J, V62, P551; HCN, 2003, FORM REP 2003, V2003; Health Canada, 2006, RES IND AIR QUAL GUI; Hsu Yu-Lun, 2007, THESIS; Huang H, 2002, BUILD ENVIRON, V37, P1349, DOI 10.1016/S0360-1323(01)00116-0; Huang KC, 2011, IND AIR 12 INT C TEX, V6, pa719; Huang SD, 2015, ENVIRON SCI TECHNOL, V49, P1537, DOI 10.1021/es5051875; Kato S, 2002, P IND AIR 2002 9 INT, V2, P658; Kato S, 2001, ANN M J ARCHIT D, VD-2, P809; Kim S, 2010, BIORESOURCE TECHNOL, V101, P6562, DOI 10.1016/j.biortech.2010.03.059; Lin CC, 2009, BUILD ENVIRON, V44, P525, DOI 10.1016/j.buildenv.2008.04.015; LITTLE JC, 1994, ATMOS ENVIRON, V28, P227, DOI 10.1016/1352-2310(94)90097-3; Liu WW, 2012, CHINESE SCI BULL, V57, P2533, DOI 10.1007/s11434-012-5208-x; MATTHEWS TG, 1987, ENVIRON SCI TECHNOL, V21, P629, DOI 10.1021/es00161a002; MYERS GE, 1981, WOOD SCI, V13, P140; MYERS GE, 1985, FOREST PROD J, V35, P20; NEG, 2003, NORD EXP GROUP CRIT, V132; Nielsen GD, 2010, ARCH TOXICOL, V84, P423, DOI 10.1007/s00204-010-0549-1; Parthasarathy S, 2011, J AIR WASTE MANAGE, V61, P689, DOI 10.3155/1047-3289.61.6.689; Saeki K, 2014, J HUM HYPERTENS, V28, P482, DOI 10.1038/jhh.2014.4; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Schulte A, 2006, N850000 BFR CAS; Seo J., 2008, J ENV ENG T AIJ, V73, P751; Seo J, 2009, BUILD ENVIRON, V44, P207, DOI 10.1016/j.buildenv.2008.02.013; Shen XZ, 2010, BUILD ENVIRON, V45, P1470, DOI 10.1016/j.buildenv.2009.12.010; Shyng JH, 2005, THESIS; Sima E, 2015, BUILD SIMUL-CHINA, V8, P711, DOI 10.1007/s12273-015-0247-2; USEPA, 2005, TOX REV TOL SUPP SUM; USEPA, 1989, EPA600889043; USEPA, 1988, EPA6001085362 ENV CR; Wadden RA, 1983, INDOOR AIR POLLUTION, P105; WHO, 1989, IND AIR QUAL ORG POL; Won DY, 2001, ATMOS ENVIRON, V35, P4479, DOI 10.1016/S1352-2310(01)00223-0; World Health Organization, 2000, AIR QUALITY GUIDELIN, V2nd; Xiong J, 2010, INDOOR AIR, V20, P523, DOI 10.1111/j.1600-0668.2010.00675.x; Xiong JY, 2013, ENVIRON SCI TECHNOL, V47, P8540, DOI 10.1021/es401173d; Xu J, 2011, BUILD ENVIRON, V46, P1785, DOI 10.1016/j.buildenv.2011.02.007; Xu Y, 2003, ATMOS ENVIRON, V37, P2497, DOI 10.1016/S1352-2310(03)00160-2; Yang X, 2001, ATMOS ENVIRON, V35, P1291, DOI 10.1016/S1352-2310(00)00397-6; Zhang YP, 2007, ATMOS ENVIRON, V41, P3203, DOI 10.1016/j.atmosenv.2006.10.081	65	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210416	10.1371/journal.pone.0210416	http://dx.doi.org/10.1371/journal.pone.0210416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677054	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400014
J	Lande, MS; Rosenvinge, JH; Skeie, G; Rylander, C				Lande, Marie Sigstad; Rosenvinge, Jan H.; Skeie, Guri; Rylander, Charlotta			Prevalence and correlates of self-reported disordered eating: A cross-sectional study among 90 592 middle-aged Norwegian women	PLOS ONE			English	Article							QUESTIONNAIRE EDE-Q; BODY-MASS INDEX; ANOREXIA-NERVOSA; PHYSICAL-ACTIVITY; PSYCHIATRIC COMORBIDITY; SUBSTANCE USE; TIME TRENDS; COMMUNITY; VALIDITY; WEIGHT	Disordered eating (DE) is extensively studied among adolescents and young women. However, there is growing evidence that DE as well as the clinical eating disorders may occur at any age from childhood to advanced years. This study aimed to determine the prevalence and correlates of DE in a representative sample of middle-aged women from Norway. The study included 90 592 women (median age: 55 years) from the Norwegian Women and Cancer study who responded to a questionnaire between the years 2002-2005. Correlates of self-reported DE were assessed by logistic regression analyses. The overall period prevalence of DE between 2002-2005 was 0.28 (95% confidence interval 0.25-0.31) %, and was highest among women > 66 years: 0.65 (0.60-0.70) %. DE was strongly associated with depression (Odds ratio [OR] 3.34 [95% confidence interval 2.53-4.41]), being unemployed (OR 1.78 [1.32-2.40]) and single (OR 1.66 [1.25-2.20]). Women with DE were more likely to report low energy intake (OR 1.41 [1.08-1.86]) and were less likely to be moderately physically active (OR 0.67 [0.47-0.95]). Using the largest study sample in the literature, the present findings confirm smaller studies showing that DE do occur in women in mid-life and older age as well. Our results contribute to address a somewhat under-communicated community health problem that needs attention in terms of age-specific treatment and prevention.	[Lande, Marie Sigstad; Skeie, Guri; Rylander, Charlotta] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Rosenvinge, Jan H.] UiT Arctic Univ Norway, Dept Psychol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Rylander, C (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	charlotta.rylander@uit.no	Rylander, Charlotta/AAE-2033-2022		UiT The Arctic University of Norway	UiT The Arctic University of Norway	This study was funded by a summer grant from UiT The Arctic University of Norway. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannon KL, 2009, INT J EAT DISORDER, V42, P118, DOI 10.1002/eat.20588; Beck D, 1996, INT J EAT DISORDER, V20, P389; Becker CB, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-6; Borch KB, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-2; Bratland-Sanda S, 2010, INT J EAT DISORDER, V43, P88, DOI 10.1002/eat.20753; Cederlof M, 2015, WORLD PSYCHIATRY, V14, P333, DOI 10.1002/wps.20251; Conceicao EM, 2017, INT J EAT DISORDER, V50, P793, DOI 10.1002/eat.22700; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Ebneter DS, 2013, J NERV MENT DIS, V201, P281, DOI 10.1097/NMD.0b013e318288e23f; Eik-Nes T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008125; Eiliv L, 2003, CANCER CAUSE CONTROL, V14, P1001, DOI 10.1023/B:CACO.0000007982.18311.2e; El Ghoch M, 2013, INT J EAT DISORDER, V46, P709, DOI 10.1002/eat.22140; Fairburn Christopher G., 1993, P317; Fouladi F, 2015, EUR EAT DISORD REV, V23, P531, DOI 10.1002/erv.2410; Gadalla T, 2007, ARCH WOMEN MENT HLTH, V10, P133, DOI 10.1007/s00737-007-0184-x; Gadalla T, 2008, WOMEN HEALTH, V48, P467, DOI 10.1080/03630240802575104; Gadalla T, 2008, ARCH WOMEN MENT HLTH, V11, P357, DOI 10.1007/s00737-008-0031-8; Gagne DA, 2012, INT J EAT DISORDER, V45, P832, DOI 10.1002/eat.22030; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Harris M, 2006, J PSYCHOSOC NURS MEN, V44, P21, DOI 10.3928/02793695-20060401-06; Hay P, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0056-0; Hechler T, 2008, ADAPT PHYS ACT Q, V25, P159, DOI 10.1123/apaq.25.2.159; Hjartaker A, 2007, PUBLIC HEALTH NUTR, V10, P1094, DOI 10.1017/S1368980007702872; Hoek HW, 2016, CURR OPIN PSYCHIATR, V29, P336, DOI 10.1097/YCO.0000000000000282; Hsu LKG, 1988, INT J EAT DISORDER, P32, DOI [10.1016/j.jpsychires.2009.04.003, DOI 10.1016/J.JPSYCHIRES.2009.04.003]; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Janelli L M, 1986, Rehabil Nurs, V11, P6; Lapid MI, 2010, INT PSYCHOGERIATR, V22, P523, DOI 10.1017/S1041610210000104; Litmanen J, 2017, NORD J PSYCHIAT, V71, P61, DOI 10.1080/08039488.2016.1224272; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; Mangweth-Matzek B, 2006, INT J EAT DISORDER, V39, P583, DOI 10.1002/eat.20327; Mangweth-Matzek B, 2014, INT J EAT DISORDER, V47, P320, DOI 10.1002/eat.22232; McCabe RE, 2001, INT J EAT DISORDER, V29, P59, DOI 10.1002/1098-108X(200101)29:1&lt;59::AID-EAT9&gt;3.0.CO;2-#; Meyer C, 2009, EUR EAT DISORD REV, V17, P366, DOI 10.1002/erv.950; Micali N, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0766-4; Mitchison D, 2014, CLIN EPIDEMIOL, V6, P89, DOI 10.2147/CLEP.S40841; Mond JM, 2004, BEHAV RES THER, V42, P551, DOI 10.1016/S0005-7967(03)00161-X; MURRAY S, 1990, INT J EAT DISORDER, V9, P87, DOI 10.1002/1098-108X(199001)9:1&lt;87::AID-EAT2260090110&gt;3.0.CO;2-2; Ng ISF, 2013, J AGING HEALTH, V25, P1106, DOI 10.1177/0898264313494798; Pettersen Gunn, 2008, Eat Disord, V16, P204, DOI 10.1080/10640260802016696; Preti A, 2009, J PSYCHIATR RES, V43, P1125, DOI 10.1016/j.jpsychires.2009.04.003; Ro O, 2012, EAT BEHAV, V13, P158, DOI 10.1016/j.eatbeh.2011.12.001; Roehrig JP, 2010, INT J EAT DISORDER, V43, P671, DOI 10.1002/eat.20760; Rosenvinge J.H., 2015, ADV EAT DISORD, V3, P198, DOI [DOI 10.1080/21662630.2014.940549, 10.1080/21662630.2014.940549]; Runfola CD, 2013, EUR EAT DISORD REV, V21, P52, DOI 10.1002/erv.2201; Seigel K, 2001, Eat Weight Disord, V6, P32; Skeie G, 2015, CLIN EPIDEMIOL, V7, P313, DOI 10.2147/CLEP.S83839; Slane JD, 2014, INT J EAT DISORDER, V47, P793, DOI 10.1002/eat.22329; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P845, DOI 10.1002/eat.22402; Stewart MC, 2006, INT J EAT DISORDER, V39, P320, DOI 10.1002/eat.20262; Swanson SA, 2011, ARCH GEN PSYCHIAT, V68, P714, DOI 10.1001/archgenpsychiatry.2011.22; Veierod MB, 2012, MED STAT CLIN EPIDEM, DOI [10.1111/j.1467-789X.2007.00347.x, DOI 10.1111/J.1467-789X.2007.00347.X]; Welch E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0840-7	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211056	10.1371/journal.pone.0211056	http://dx.doi.org/10.1371/journal.pone.0211056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673772	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800070
J	Masenga, GG; Shayo, BC; Msuya, S; Rasch, V				Masenga, Gileard G.; Shayo, Benjamin C.; Msuya, Sia; Rasch, Vibeke			Urinary incontinence and its relation to delivery circumstances: A population-based study from rural Kilimanjaro, Tanzania	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; CONTINENCE SOCIETY; OBSTETRIC FISTULA; PREVALENCE; WOMEN; TERMINOLOGY; STANDARDIZATION; QUESTIONNAIRE; ASSOCIATION	Objectives To investigate the prevalence and risk factors of urinary incontinence (UI), the different UI subtypes and the association between UI and delivery circumstances. Design Cross-sectional population-based study conducted in Kilimanjaro Region, Tanzania. Participants and settings 1048 women aged 18-90 women living in rural Kilimanjaro. Simple random sampling was done to select villages, households and participants. Community health workers helped in identifying eligible women and trained nurses/midwives conducted face-to-face interviews. Data were analysed using descriptive statistics and Univariate and Multivariate logistic regression modelling. Results The overall prevalence rate of UI was 42%. When focusing on the different types of UI, 17% of the women had stress UI, 9% had urge UI and 16% had mixed UI. Only one woman (0.1%) with vesico-vaginal fistula was identified. UI was found to be significantly associated with increasing parity (OR = 2.41 (1.55-3.74). In addition, women who in relation to their first delivery had delivered at home or had been in labour for more than 24 hours, had increased adjusted ORs of 1.70(1.08-2.68) and 2.10(1.08-4.10), respectively, for having UI. Conclusion UI is common in rural Tanzania and of the subtypes of UI, Stress Urinary Incontinence (SUI) is the commonest followed by Mixed Urinary Incontinence (MUI). Home delivery, prolonged labour and increasing parity especially having 5 or more deliveries are associated with increased risk for developing UI.	[Masenga, Gileard G.; Msuya, Sia] Kilimanjaro Christian Med Univ Coll, Moshi, Klimanjaro, Tanzania; [Masenga, Gileard G.; Shayo, Benjamin C.] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Klimanjaro, Tanzania; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Kilimanjaro Christian Medical Centre; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Masenga, GG (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Klimanjaro, Tanzania.; Masenga, GG (corresponding author), Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Klimanjaro, Tanzania.	drgmasenga@yahoo.com	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Shayo, Benjamin C/0000-0001-8544-437X	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	This research was conducted under the auspices of the Building Stronger University (BSU), which is funded by DANIDA (the Danish International Development Agency). The funders had no role in study design, data collection and analysis, manuscript preparation or decision to publish.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Barber MD, 2006, AM J OBSTET GYNECOL, V194, P1492, DOI 10.1016/j.ajog.2006.01.076; Basak T, 2013, INT NURS REV, V60, P448, DOI 10.1111/inr.12048; Biadgilign S, 2013, REPROD HEALTH, V10, DOI [10.1186/1742-4755-10-14, 10.1186/1742-4755-10-52]; Botlero R, 2011, J UROLOGY, V185, P1331, DOI 10.1016/j.juro.2010.11.080; Brown SJ, 2011, BJOG-INT J OBSTET GY, V118, P991, DOI 10.1111/j.1471-0528.2011.02928.x; Bulchandani S, 2015, BJOG-INT J OBSTET GY, V122, P1157, DOI 10.1111/1471-0528.13431; Cerruto MA, 2013, UROL INT, V90, P1, DOI 10.1159/000339929; Cowgill KD, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0592-2; Espuna Pons M, 2007, Actas Urol Esp, V31, P502; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Haylen BT, 2009, INT UROGYNECOL J, V20, pS87; Hunskaar S, 2004, BJU INT, V93, P324, DOI 10.1111/j.1464-410X.2003.04609.x; Jansova M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189842; Jokhio AH, 2013, BJOG-INT J OBSTET GY, V120, P180, DOI 10.1111/1471-0528.12074; Matthews CA, 2014, CURR OPIN OBSTET GYN, V26, P393, DOI 10.1097/GCO.0000000000000094; Megabiaw B, 2013, INT UROGYNECOL J, V24, P1135, DOI 10.1007/s00192-012-1981-y; Melah GS, 2007, J OBSTET GYNAECOL, V27, P819, DOI 10.1080/01443610701709825; Minassian VA, 2008, OBSTET GYNECOL, V111, P324, DOI 10.1097/01.AOG.0000267220.48987.17; Muleta M, 2004, ETHIOPIAN MED J, V42, P9; Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698; National Bureau of statistics, 2016, KEY FIND 2015 2016 T; Niang L, 2010, PROG UROL, V20, P1213, DOI 10.1016/j.purol.2010.01.014; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Obioha KC, 2015, INT UROGYNECOL J, V26, P1347, DOI 10.1007/s00192-015-2690-0; Ojengbede OA, 2011, BJU INT, V107, P1793, DOI 10.1111/j.1464-410X.2010.09758.x; Okonkwo JEN, 2001, INT J GYNECOL OBSTET, V74, P301, DOI 10.1016/S0020-7292(01)00378-2; Patrick DL, 2013, CLIN THER, V35, P836, DOI 10.1016/j.clinthera.2013.04.013; Pedersen LS, 2017, ACTA OBSTET GYN SCAN, V96, P939, DOI 10.1111/aogs.13149; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Van Kessel K, 2001, AM J OBSTET GYNECOL, V184, P1571, DOI 10.1067/mob.2001.114856; Walker GJA, 2011, INT UROGYNECOL J, V22, P127, DOI 10.1007/s00192-010-1215-0; Weber AM, 2001, INT UROGYNECOL J PEL, V12, P178, DOI 10.1007/PL00004033; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531	35	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208733	10.1371/journal.pone.0208733	http://dx.doi.org/10.1371/journal.pone.0208733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673696	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800008
J	Chen, XC; Riley, BT; de Veer, SJ; Hoke, DE; Van Haeften, J; Leahy, D; Swedberg, JE; Brattsand, M; Hartfield, PJ; Buckle, AM; Harris, JM				Chen, Xingchen; Riley, Blake T.; de Veer, Simon J.; Hoke, David E.; Van Haeften, Jessica; Leahy, Darren; Swedberg, Joakim E.; Brattsand, Maria; Hartfield, Perry J.; Buckle, Ashley M.; Harris, Jonathan M.			Potent, multi-target serine protease inhibition achieved by a simplified beta-sheet motif	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; LEKTI; PARAMETERS; MECHANISM; DESIGN; LIBRARY; CASCADE	Engagement of an extended beta-sheet is a common substrate/inhibitor interaction at the active site of serine proteases and is an important feature of Laskowski mechanism inhibitors that present a substrate-like loop to a target protease. This loop is cleaved but subsequently relegated forming a stable inhibitor/protease complex. Laskowski inhibitors are ubiquitous in nature and are used extensively in serine protease inhibitor design. However, most studies concentrate on introducing new sidechain interactions rather than the direct contributions of the substrate-like beta-sheet to enzyme inhibition. Here we report the crystal structure of an simplified beta-sheet inhibitory motif within the Sunflower Trypsin Inhibitor (SFTI) in complex with trypsin. We show that the intramolecular hydrogen bond network of this SFTI variant (SFTI-TCTR) engages the inhibitor sidechains that would normally interact with a target protease, giving mainchain interactions a more prominent role in complex formation. Despite having reduced sidechain interactions, this SFTI variant is remarkably potent and inhibits a diverse range of serine proteases. Crystal structural analysis and molecular modelling of SFTI-TCTR complexes again indicates an interface dominated by beta-sheet interactions, highlighting the importance of this motif and the adaptability of SFTI as a scaffold for inhibitor design.	[Chen, Xingchen; Van Haeften, Jessica; Leahy, Darren; Hartfield, Perry J.; Harris, Jonathan M.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Riley, Blake T.; Hoke, David E.; Buckle, Ashley M.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [de Veer, Simon J.; Swedberg, Joakim E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Brattsand, Maria] Umea Univ, Dept Med Biosci, Umea, Sweden	Queensland University of Technology (QUT); Monash University; University of Queensland; Umea University	Harris, JM (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia.	j2.harris@qut.edu.au	Riley, Blake T./ABD-8129-2020; Brattsand, Maria/AAG-7777-2019	Riley, Blake T./0000-0003-2176-0503; Brattsand, Maria/0000-0001-7175-1336; Buckle, Ashley/0000-0003-2943-9044	Australian National Health and Medical Research Council [1059410]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australian National Health and Medical Research Council to JMH, #1059410. The organization played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Case D.A., 2022, AMBER; Chan WC, 2000, FMOC SOLID PHASE PEP; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; de Veer SJ, 2015, BIOCHEM J, V469, P243, DOI 10.1042/BJ20150412; de Veer SJ, 2013, BIOPOLYMERS, V100, P510, DOI [10.1002/bip.22231, 10.1002/peps.22231]; Debela M, 2007, P NATL ACAD SCI USA, V104, P16086, DOI 10.1073/pnas.0707811104; Debowski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089465; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; deVeer SJ, 2016, J INVESTIGATIVE DERM; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fortugno P, 2011, J INVEST DERMATOL, V131, P2223, DOI 10.1038/jid.2011.174; Gitlin A, 2015, CHEMBIOCHEM, V16, P1601, DOI 10.1002/cbic.201500200; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jones E., 2001, SCIPY OPEN SOURCE SC; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Oliveira JPC, 2014, ACS MED CHEM LETT, V5, P128, DOI 10.1021/ml4003698; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Scott CJ, 2010, BIOCHIMIE, V92, P1681, DOI 10.1016/j.biochi.2010.03.010; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Swedberg JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019302; Swedberg JE, 2010, BIOL CHEM, V391, P357, DOI 10.1515/BC.2010.037; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205	53	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210842	10.1371/journal.pone.0210842	http://dx.doi.org/10.1371/journal.pone.0210842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668585	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400019
J	Hindberg, K; Hannig, J; Godtliebsen, F				Hindberg, Kristian; Hannig, Jan; Godtliebsen, Fred			A novel scale-space approach for multinormality testing and the k-sample problem in the high dimension low sample size scenario	PLOS ONE			English	Article							GOODNESS-OF-FIT; VARIANCE TEST; MULTIVARIATE; NORMALITY; SHAPIRO; UNIVARIATE; POWERFUL; WILK	Two classical multivariate statistical problems, testing of multivariate normality and the k-sample problem, are explored by a novel analysis on several resolutions simultaneously. The presented methods do not invert any estimated covariance matrix. Thereby, the methods work in the High Dimension Low Sample Size situation, i.e. when n <= p. The output, a significance map, is produced by doing a one-dimensional test for all possible resolution/position pairs. The significance map shows for which resolution/position pairs the null hypothesis is rejected. For the testing of multinormality, the Anderson-Darling test is utilized to detect potential departures from multinormality at different combinations of resolutions and positions. In the k-sample case, it is tested whether k data sets can be said to originate from the same unspecified discrete or continuous multivariate distribution. This is done by testing the k vectors corresponding to the same resolution/position pair of the k different data sets through the k-sample Anderson-Darling test. Successful demonstrations of the new methodology on artificial and real data sets are presented, and a feature selection scheme is demonstrated.	[Hindberg, Kristian; Godtliebsen, Fred] Univ Tromso, Dept Math & Stat, Tromso, Norway; [Hannig, Jan] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA	UiT The Arctic University of Tromso; University of North Carolina; University of North Carolina Chapel Hill	Hindberg, K (corresponding author), Univ Tromso, Dept Math & Stat, Tromso, Norway.	kristian.hindberg@uit.no	Hannig, Jan/T-1862-2019	Hannig, Jan/0000-0002-4164-0173	National Science Foundation of the United States [1512945, 1633074l]; eVita program of the Norwegian Research Council [176872/V30]	National Science Foundation of the United States(National Science Foundation (NSF)); eVita program of the Norwegian Research Council	J.H. received funding from the National Science Foundation of the United States (https://www.nsf.gov/) under Grant No. 1512945 and 1633074l. F.G. received funding from the eVita program (grant number 176872/V30) of the Norwegian Research Council (https://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Aslan B, 2005, NUCL INSTRUM METH A, V537, P626, DOI 10.1016/j.nima.2004.08.071; Baringhaus L, 2004, J MULTIVARIATE ANAL, V88, P190, DOI 10.1016/S0047-259X(03)00079-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chaudhuri P, 2000, ANN STAT, V28, P408, DOI 10.1214/aos/1016218224; Chaudhuri P, 1999, J AM STAT ASSOC, V94, P807, DOI 10.2307/2669996; COX DR, 1994, APPL STAT-J ROY ST C, V43, P347, DOI 10.2307/2986025; DAgostino R. B., 1986, GOODNESS OF FIT TECH, V68; Doornik JA, 2008, OXFORD B ECON STAT, V70, P927, DOI 10.1111/j.1468-0084.2008.00537.x; Farrell PJ, 2007, J STAT COMPUT SIM, V77, P1053, DOI 10.1080/10629360600878449; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Godtliebsen F, 2004, IMAGE VISION COMPUT, V22, P1093, DOI 10.1016/j.imavis.2004.05.002; Godtliebsen F, 2002, J COMPUT GRAPH STAT, V11, P1, DOI 10.1198/106186002317375596; Hall P, 2002, BIOMETRIKA, V89, P359, DOI 10.1093/biomet/89.2.359; Hanusz Z, 2012, J STAT COMPUT SIM, V82, P1743, DOI 10.1080/00949655.2011.594051; Hastie T., 2009, UNSUPERVISED LEARNIN; HENZE N, 1988, ANN STAT, V16, P772, DOI 10.1214/aos/1176350835; Hochberg Y., 1987, WILEY SERIES PROBABI; Holmstrom L, 2017, INT STAT REV, V85, P1, DOI 10.1111/insr.12155; JARQUE CM, 1980, ECON LETT, V6, P255, DOI 10.1016/0165-1765(80)90024-5; KIEFER J, 1959, ANN MATH STAT, V30, P420, DOI 10.1214/aoms/1177706261; Lehmann E.L., 1998, ELEMENTS LARGE SAMPL; LEWIS PA, 1961, ANN MATH STAT, V32, P1118, DOI 10.1214/aoms/1177704850; Liang JJ, 2009, COMPUT STAT DATA AN, V53, P3883, DOI 10.1016/j.csda.2009.04.016; Liang JJ, 2000, J STAT PLAN INFER, V86, P129, DOI 10.1016/S0378-3758(99)00168-8; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; LOONEY SW, 1995, AM STAT, V49, P64, DOI 10.2307/2684816; Lopes M., 2011, ADV NEURAL INFORM PR, P1206; MAAG UR, 1966, BIOMETRIKA, V53, P579; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Marsaglia G, 2005, J STAT SOFTW, V14; Mecklin CJ, 2004, INT STAT REV, V72, P123; Oigard TA, 2006, COMPUT STAT DATA AN, V51, P1719, DOI 10.1016/j.csda.2006.07.034; PEARSON ES, 1977, BIOMETRIKA, V64, P231; PETTITT AN, 1976, BIOMETRIKA, V63, P161, DOI 10.2307/2335097; Rahman MM, 1997, J APPL STAT, V24, P219, DOI 10.1080/02664769723828; ROMEU JL, 1993, J MULTIVARIATE ANAL, V46, P309, DOI 10.1006/jmva.1993.1063; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; SHAPIRO SS, 1972, J AM STAT ASSOC, V67, P215, DOI 10.2307/2284728; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SINCLAIR CD, 1988, J AM STAT ASSOC, V83, P1190, DOI 10.2307/2290155; Sorbye SH, 2009, COMPUT STAT DATA AN, V53, P3746, DOI 10.1016/j.csda.2009.03.020; STEPHENS MA, 1968, BIOMETRIKA, V55, P428, DOI 10.2307/2334889; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; STEPHENS MA, 1965, BIOMETRIKA, V52, P309, DOI 10.1093/biomet/52.3-4.309; Surucu B, 2006, COMMUN STAT-THEOR M, V35, P1319, DOI 10.1080/03610920600628999; Szekely G.J., 2004, INTERSTAT, V5, P1; Thode H.C., 2002, TESTING NORMALITY; Alva JAV, 2009, COMMUN STAT-THEOR M, V38, P1870, DOI 10.1080/03610920802474465; Wand M.P., 1995, MONOGRAPHS STAT APPL, V60; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135; Wei S, 2016, J COMPUT GRAPH STAT, V25, P549, DOI 10.1080/10618600.2015.1027773; Witkin AP, IEEE INT C ICASSP 84, V9, P150; Witkin AP, 8 INT JOINT C ART IN, P1010	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0211044	10.1371/journal.pone.0211044	http://dx.doi.org/10.1371/journal.pone.0211044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668596	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400028
J	Yu, J; Hu, QW; Tang, DL; Zhao, H; Chen, PM				Yu, Jing; Hu, Qiwei; Tang, Danling; Zhao, Hui; Chen, Pimao			Response of Sthenoteuthis oualaniensis to marine environmental changes in the north-central South China Sea based on satellite and in situ observations	PLOS ONE			English	Article							DOSIDICUS-GIGAS CEPHALOPODA; PURPLEBACK FLYING SQUID; DAYA BAY; BIOLOGY; OMMASTREPHIDAE; CATCH; MODEL	In the South China Sea (SCS), Sthenoteuthis oualaniensis (S. oualaniensis) generally has the highest stock density in spring and occupies an important position in fisheries. The responses of S. oualaniensis to marine environments in the north-central SCS in spring (March to May) from 2006 to 2010 were analyzed using satellite and in situ observations, with generalized additive models (GAMs). A high proportion variation in catch per unit effort (CPUE) was explained by environmental variables, including sea surface temperature (SST; explaining 13.8%) and the interaction between SST and chlorophyll a (Chl-a) concentration (explaining 16.9%). SSTs within the range of 24-28 degrees C and Chl-a concentrations within 0.10-0.35 mg/m(3) had positive effects on S. oualaniensis CPUE, and SST within 28-29.5 degrees C and Chl-a concentrations within 0.05-0.20 mg/m(3) had negative effects. In addition, the response time of the maximum standardized catch per unit effort (SCPUE) in May to the maximum Chl-a in March was approximately six ten-day time step. The higher Chl-a and smaller stock size of S. oualaniensis in early March 2008 were partly associated with climatic anomalies caused by La Nina in spring and the limitation of S. oualaniensisby low temperature in 2008. The findings in this study can help better protect and manage S. oualaniensis resources in the SCS.	[Yu, Jing; Hu, Qiwei; Chen, Pimao] Chinese Acad Fishery Sci, Guangdong Prov Key Lab Fishery Ecol & Environm, Sci Observing & Expt Stn South China Sea Fishery, Minist Agr & Rural Affairs,South China Sea Fisher, Guangzhou, Guangdong, Peoples R China; [Tang, Danling] Chinese Acad Sci, South China Sea Inst Oceanog, Key Lab Ocean Remote Sensing, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Zhao, Hui] Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Guangdong Ocean University	Yu, J (corresponding author), Chinese Acad Fishery Sci, Guangdong Prov Key Lab Fishery Ecol & Environm, Sci Observing & Expt Stn South China Sea Fishery, Minist Agr & Rural Affairs,South China Sea Fisher, Guangzhou, Guangdong, Peoples R China.	yujing@scsfri.ac.cn			Central Public-interest Scientific Institution Basal Research Fund, CAFS [2018HY-ZD0104]; National Key R&D Program of China [2018YFD0900901]; Natural Science Foundation of Guangdong Province, China [2018A030313120]; International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China [2015KGJHZ017]; National Natural Science Foundation of China [41376125]; State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences [LTO1806]	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Key R&D Program of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences	This study was supported by the following funds: (1) Central Public-interest Scientific Institution Basal Research Fund, CAFS (2018HY-ZD0104), (2) National Key R&D Program of China (2018YFD0900901), (3) Natural Science Foundation of Guangdong Province, China (2018A030313120), (4) International Scientific & Technological Cooperation Project of Department of Education of Guangdong Province, China (2015KGJHZ017), (5) National Natural Science Foundation of China (grants 41376125), (6) State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences (LTO1806).	ARKHIPKIN A, 1992, J EXP MAR BIOL ECOL, V163, P261, DOI 10.1016/0022-0981(92)90054-E; Bacha M, 2017, FISH OCEANOGR, V8, P12; Bacha M, 2017, FISH OCEANOGR, V26, P282, DOI 10.1111/fog.12192; Basir S, 2000, BIOL FEATURE OCEANIC, P135; Bower JR, 1999, MAR ECOL PROG SER, V185, P203, DOI 10.3354/meps185203; Burnham KP, 2002, J WILDLIFE MANAGE, V67, P175, DOI DOI 10.2307/2669574; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Chen XJ, 2007, ICES J MAR SCI, V64, P1152, DOI 10.1093/icesjms/fsm103; Chen XJ, 2007, FISH RES, V83, P98, DOI 10.1016/j.fishres.2006.09.005; Diekman R, 2002, BERICHTE I MEERESKUN, V326, P1; Fan Jiang-tao, 2013, Guangdong Agricultural Sciences, V40, P122; Fan JT, 2016, S CHINA FISHERIES SC, V12, P7; Fu DY, 2017, GEOMAT NAT HAZ RISK, V8, P1034, DOI 10.1080/19475705.2017.1292559; GAVARIS S, 1980, CAN J FISH AQUAT SCI, V37, P2272, DOI 10.1139/f80-273; Hinton M. G., 2004, ICCAT COL VOL SCI PA, V56, P169; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; [胡启伟 Hu Qiwei], 2016, [海洋学报, Acta Oceanologica Sinica], V38, P66; Kang L, 2016, MAR FISH, V12, P64; Klemas V, 2013, FISH RES, V148, P124, DOI 10.1016/j.fishres.2012.02.027; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Li Bin, 2016, Nanfang Shuichan, V12, P28; [林东明 Lin Dongming], 2006, [海洋科学进展, Advances in Marine Science], V24, P546; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Nateewathana A., 2000, P 3 TECHN SEM MAR FI, P76; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Qian W.G., 2006, MAR FISH, V28, P265; Siriraksophon S., 2000, P 3 TECHN SEM MAR FI, P101; Su Li, 2016, Nanfang Shuichan, V12, P96; Tafur R, 2001, FISH RES, V54, P33, DOI 10.1016/S0165-7836(01)00379-4; Tang DL, 2018, CHINA SCI B, V63, DOI [10.1360/N972017-00440, DOI 10.1360/N972017-00440]; Tian SQ, 2006, B OCEANOL LIMN, P51; Wang JJ, 2014, DEEP-SEA RES PT II, V101, P120, DOI 10.1016/j.dsr2.2013.09.020; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Worms J., 1983, FAO Fisheries Technical Paper, V231, P1; Yan H., 2012, HIGH RESOLUTION CLIM, P25; [晏磊 Yan Lei], 2016, [中国水产科学, Journal of Fishery Sciences of China], V23, P469; [颜云榕 Yan Yunrong], 2012, [海洋与湖沼, Oceanologia et Limnologia Sinica], V43, P1177; [杨德康 Yang Dekang], 2002, [上海水产大学学报, Journal of Shanghai fisheries university], V11, P176; [杨晓明 YANG Xiaoming], 2006, [水产学报, Journal of Fisheries of China], V30, P669; Ye HJ, 2018, INT J REMOTE SENS, V39, P4360, DOI 10.1080/01431161.2017.1399479; YOUNG R E, 1990, Pacific Science, V44, P71; Yu J, 2017, HAIYANG XUEBAO, V39, P72, DOI [10.3969/j.issn.0253-4193.2017.06.007, DOI 10.3969/J.ISSN.0253-4193.2017.06.007]; Yu J, 2007, TERR ATMOS OCEAN SCI, V18, P1011, DOI 10.3319/TAO.2007.18.5.1011(Oc); Yu J, 2015, ADV SPACE RES, V55, P2315, DOI 10.1016/j.asr.2015.02.001; Yu J, 2010, TERR ATMOS OCEAN SCI, V21, P393, DOI 10.3319/TAO.2009.05.26.01(Oc); Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122997; [张培群 Zhang Peiqun], 2009, [气象, Meteorological Monthly], V35, P112; Zhang YM, 2013, J GUANGDONG OCEAN U, V13, P56; Zhang ZM, 2001, NINO NINA EVENTS THE, P20; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0	50	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211474	10.1371/journal.pone.0211474	http://dx.doi.org/10.1371/journal.pone.0211474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695066	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400036
J	Heinzel, A; Marhold, M; Mayer, P; Schwarz, M; Tomasich, E; Lukas, A; Krainer, M; Perco, P				Heinzel, Andreas; Marhold, Maximilian; Mayer, Paul; Schwarz, Michael; Tomasich, Erwin; Lukas, Arno; Krainer, Michael; Perco, Paul			Synthetic lethality guiding selection of drug combinations in ovarian cancer	PLOS ONE			English	Article							1ST-LINE TREATMENT; PHASE-II; CHEMOTHERAPY; BEVACIZUMAB; CELLS; MULTICENTER; OLAPARIB; CYTOTOXICITY; TRASTUZUMAB; RESISTANCE	Background Synthetic lethality describes a relationship between two genes where single loss of either gene does not trigger significant impact on cell viability, but simultaneous loss of both gene functions results in lethality. Targeting synthetic lethal interactions with drug combinations promises increased efficacy in tumor therapy. Materials and methods We established a set of synthetic lethal interactions using publicly available data from yeast screens which were mapped to their respective human orthologs using information from orthology databases. This set of experimental synthetic lethal interactions was complemented by a set of predicted synthetic lethal interactions based on a set of protein metadata like e.g. molecular pathway assignment. Based on the combined set, we evaluated drug combinations used in late stage clinical development (clinical phase III and IV trials) or already in clinical use for ovarian cancer with respect to their effect on synthetic lethal interactions. We furthermore identified a set of drug combinations currently not being tested in late stage ovarian cancer clinical trials that however have impact on synthetic lethal interactions thus being worth of further investigations regarding their therapeutic potential in ovarian cancer. Results Twelve of the tested drug combinations addressed a synthetic lethal interaction with the anti-VEGF inhibitor bevacizumab in combination with paclitaxel being the most studied drug combination addressing the synthetic lethal pair between VEGFA and BCL2. The set of 84 predicted drug combinations for example holds the combination of the PARP inhibitor olaparib and paclitaxel, which showed efficacy in phase II clinical studies. Conclusion A set of drug combinations currently not tested in late stage ovarian cancer clinical trials was identified having impact on synthetic lethal interactions thus being worth of further investigations regarding their therapeutic potential in ovarian cancer.	[Heinzel, Andreas; Mayer, Paul; Lukas, Arno; Perco, Paul] Emergentec Biodev GmbH, Vienna, Austria; [Heinzel, Andreas] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria; [Marhold, Maximilian; Schwarz, Michael; Tomasich, Erwin; Krainer, Michael] Med Univ Vienna, Dept Oncol, Div Internal Med 1, Vienna, Austria; [Perco, Paul] Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria	Emergentec Biodevelopment GmbH; Medical University of Vienna; Medical University of Vienna; Medical University of Innsbruck	Perco, P (corresponding author), Emergentec Biodev GmbH, Vienna, Austria.; Krainer, M (corresponding author), Med Univ Vienna, Dept Oncol, Div Internal Med 1, Vienna, Austria.; Perco, P (corresponding author), Med Univ Innsbruck, Dept Internal Med 4, Innsbruck, Austria.	michael.krainer@meduniwien.ac.at; paul.perco@emergentec.com	Perco, Paul/U-2489-2019; Marhold, Maximilian/AAF-4671-2021	Perco, Paul/0000-0003-2087-5691; Schwarz, Michael/0000-0002-2587-1385	European Community [279113]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement no. 279113 (OCTIPS).	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Andorfer P, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0278-z; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bronte G, 2016, THER ADV MED ONCOL, V8, P188, DOI 10.1177/1758834016630976; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Candelaria M, 2007, ANN ONCOL, V18, P1529, DOI 10.1093/annonc/mdm204; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dallinger C, 2016, J CLIN PHARMACOL, V56, P1387, DOI 10.1002/jcph.752; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; DOBZHANSKY T, 1946, GENETICS, V31, P269; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fechete R., 2013, J COMPUT SCI SYST BI, V6, P73; Fechete R, 2011, MOL BIOSYST, V7, P200, DOI 10.1039/c0mb00082e; Forment JV, 2017, NAT CHEM BIOL, V13, P12, DOI [10.1038/NCHEMBIO.2226, 10.1038/nchembio.2226]; Fotopoulou C, 2014, ANN ONCOL, V25, P160, DOI 10.1093/annonc/mdt515; Fuh KC, 2015, GYNECOL ONCOL, V139, P413, DOI 10.1016/j.ygyno.2015.06.041; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hijaz M, 2016, GYNECOL ONCOL, V142, P323, DOI 10.1016/j.ygyno.2016.06.005; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kersey PJ, 2014, NUCLEIC ACIDS RES, V42, pD546, DOI 10.1093/nar/gkt979; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Li YF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00058; Liu N, 2011, INT IMMUNOPHARMACOL, V11, P212, DOI 10.1016/j.intimp.2010.11.021; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Meulendijks D, 2016, INVEST NEW DRUG, V34, P119, DOI 10.1007/s10637-015-0309-4; Nijman SMB, 2011, FEBS LETT, V585, P1, DOI 10.1016/j.febslet.2010.11.024; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Papanikolaou V, 2015, CELL ONCOL, V38, P155, DOI 10.1007/s13402-014-0213-5; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Schwartzberg LS, 2014, CLIN BREAST CANCER, V14, P161, DOI 10.1016/j.clbc.2013.12.003; Sollner J, 2012, MOL BIOSYST, V8, P3197, DOI 10.1039/c2mb25256b; Sollner Johannes, 2008, Immunome Res, V4, P1, DOI 10.1186/1745-7580-4-1; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang YF, 2015, TARGET ONCOL, V10, P575, DOI 10.1007/s11523-015-0370-0; Yilmaz A, 2016, WSPOLCZESNA ONKOL, V20, P28, DOI 10.5114/wo.2016.58498; Zhang S, 2011, GYNECOL ONCOL, V121, P25, DOI [10.1038/nrc3144, DOI 10.1038/NRC3144]	47	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210859	10.1371/journal.pone.0210859	http://dx.doi.org/10.1371/journal.pone.0210859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682083	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500067
J	Lado-Codesido, M; Perez, CM; Mateos, R; Olivares, JM; Caballero, AG				Lado-Codesido, Maria; Mendez Perez, Cristina; Mateos, Raimundo; Manuel Olivares, Jose; Garcia Caballero, Alejandro			Improving emotion recognition in schizophrenia with "VOICES": An on-line prosodic self-training	PLOS ONE			English	Article							COGNITIVE ENHANCEMENT THERAPY; SOCIAL COGNITION; DOSE EQUIVALENTS; VOCAL AFFECT; HIGH-RISK; PERCEPTION; EXPRESSION; DEFICITS; PEOPLE; SPEECH	Introduction Emotion recognition (ER) deficits have been extensively demonstrated in schizophrenia. These deficiencies are not only restricted to facial emotion recognition but also include emotional prosody (tone of the voice) recognition deficits. They have been significantly associated with symptom severity and poor social functioning. The aim of this study was to test the efficacy, in real clinical conditions, of an online self-training prosodic game included in the Social Cognition rehabilitation program e-Motional Training. Method A randomized, single-blind multicenter clinical trial was conducted with 50 outpatients with schizophrenia or schizoaffective disorder. The control group was treated with Treatment-asusual (TAU), based on drug therapy, case management and individual and group psychotherapy (not focused on Social Cognition). The intervention group was treated with TAU plus the employment of Voices, an online self-training program devised for prosodic rehabilitation. Statistical analysis Linear regression was used to evaluate the effectiveness of the intervention in emotion recognition measured with the Reading the Mind in the Voice-Spanish Version (RMV-SV). Results There were statistically significant differences between the intervention and control group measured with RMV-SV (beta = 3,6[IC 95%], p<0.001), with a response variable in RMV post R-2 = 0,617. Discussion Voices, a prosodic rehabilitation game included in e-Motional Training, seems to be a promising tool for improving emotional voice recognition deficits in schizophrenia, filling the need for such interventions.	[Lado-Codesido, Maria] Univ Santiago de Compostela, Santiago De Compostela, Spain; [Lado-Codesido, Maria] Donostia Univ Hosp, San Sebastian, Spain; [Mendez Perez, Cristina] Univ Hosp Complex Vigo, Vigo, Spain; [Mateos, Raimundo; Garcia Caballero, Alejandro] Univ Santiago de Compostela, Sch Med, Dept Psychiat, Santiago De Compostela, Spain; [Manuel Olivares, Jose] Univ Hosp Complex Vigo, Biomed Res Ctr Mental Hlth Network CIBERSAM, Biomed Inst Galicia Sur, Dept Psychiat, Pontevedra, Spain; [Garcia Caballero, Alejandro] Univ Hosp Complex Ourense, Biomed Res Ctr Mental Hlth Network CIBERSAM, Biomed Inst Galicia Sur, Dept Psychiat, Orense, Spain	Universidade de Santiago de Compostela; University Hospital Donostia; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras	Caballero, AG (corresponding author), Univ Santiago de Compostela, Sch Med, Dept Psychiat, Santiago De Compostela, Spain.; Caballero, AG (corresponding author), Univ Hosp Complex Ourense, Biomed Res Ctr Mental Hlth Network CIBERSAM, Biomed Inst Galicia Sur, Dept Psychiat, Orense, Spain.	alejandro.alberto.garcia.caballero@sergas.es	CABALLERO, ALEJANDRO GARCIA-/ABF-5326-2020; Mateos, Raimundo/AAV-6808-2020	CABALLERO, ALEJANDRO GARCIA-/0000-0001-5714-8266; Mateos, Raimundo/0000-0002-6327-7010; , IIS Galicia Sur/0000-0003-3812-7413; Olivares, Jose M/0000-0003-2480-4356; Lado Codesido, Maria/0000-0003-3799-7222	Grant: PRIS'16 (Pre-commercial Development of Research Results of the Public Health System of Galicia)	Grant: PRIS'16 (Pre-commercial Development of Research Results of the Public Health System of Galicia)	This work was supported by Grant: PRIS'16 (Pre-commercial Development of Research Results of the Public Health System of Galicia), Funder website: https://www.sergas.es/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2012, SCHIZOPHR RES, V140, P87, DOI 10.1016/j.schres.2012.06.012; Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; Allott KA, 2015, SCHIZOPHR RES, V161, P322, DOI 10.1016/j.schres.2014.12.010; Amminger GP, 2012, EARLY INTERV PSYCHIA, V6, P450, DOI 10.1111/j.1751-7893.2012.00362.x; Baltaxe CAM, 1995, SCHIZOPHRENIA BULL, V21, P677, DOI 10.1093/schbul/21.4.677; Biagianti B, 2016, NEUROPSYCHOLOGY, V30, P998, DOI 10.1037/neu0000311; Bigelow NO, 2006, SCHIZOPHR RES, V83, P257, DOI 10.1016/j.schres.2005.12.856; Bora E, 2009, BRIT J PSYCHIAT, V195, P475, DOI 10.1192/bjp.bp.108.055731; Bozikas VP, 2006, J NEUROPSYCH CLIN N, V18, P81, DOI 10.1176/jnp.18.1.81; Bozikas VP, 2004, J INT NEUROPSYCH SOC, V10, P549, DOI 10.1017/S1355617704104074; Brazo P, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00120; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Dondaine T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00900; Eack SM, 2007, SCHIZOPHR RES, V89, P308, DOI 10.1016/j.schres.2006.08.018; Eack SM, 2009, PSYCHIAT SERV, V60, P1468, DOI 10.1176/appi.ps.60.11.1468; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; Elijah RB, 2016, BIOL PSYCHOL, V120, P88, DOI 10.1016/j.biopsycho.2016.09.001; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Fuller MA, 2009, DRUG INFORM HDB PSYC; Genevsky Alexander, 2010, Dialogues Clin Neurosci, V12, P416; Golan O, 2007, J AUTISM DEV DISORD, V37, P1096, DOI 10.1007/s10803-006-0252-5; Gold R, 2012, AM J PSYCHIAT, V169, P424, DOI 10.1176/appi.ajp.2011.11081230; Grant N, 2017, CLIN PSYCHOL REV, V56, P55, DOI 10.1016/j.cpr.2017.06.001; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Hails R, 2002, MODERN STAT LIFE SCI, V59, P206; HASKINS B, 1995, SCHIZOPHR RES, V15, P291, DOI 10.1016/0920-9964(94)00081-I; Hoekert M, 2007, SCHIZOPHR RES, V96, P135, DOI 10.1016/j.schres.2007.07.023; Hoertnagl CM, 2014, SCHIZOPHR RES, V158, P100, DOI 10.1016/j.schres.2014.07.019; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; IBM Corp, 2017, IBM SPSS STAT WINDOW; Ito F, 2013, PSYCHIAT CLIN NEUROS, V67, P526, DOI 10.1111/pcn.12103; Kantrowitz JT, 2015, J NEUROSCI, V35, P14909, DOI 10.1523/JNEUROSCI.4603-14.2015; Kantrowitz JT, 2013, SCHIZOPHRENIA BULL, V39, P86, DOI 10.1093/schbul/sbr060; Kar SK, 2016, J NEUROSCI RURAL PRA, V7, P412, DOI 10.4103/0976-3147.176185; Kaufman A. S., 1994, K BIT TEST BREVE INT; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; KERR SL, 1993, J ABNORM PSYCHOL, V102, P312, DOI 10.1037/0021-843X.102.2.312; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kucharska-Pietura K, 2005, BRIT J PSYCHIAT, V187, P523, DOI 10.1192/bjp.187.6.523; Law ELC, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P719; Leentjens AFG, 1998, J NEUROL NEUROSUR PS, V64, P375, DOI 10.1136/jnnp.64.3.375; Leitman DI, 2005, BIOL PSYCHIAT, V58, P56, DOI 10.1016/j.biopsych.2005.02.034; Leucht S, 2015, SCHIZOPHRENIA BULL, V41, P1397, DOI 10.1093/schbul/sbv037; Leucht S, 2014, SCHIZOPHRENIA BULL, V40, P314, DOI 10.1093/schbul/sbu001; Martinez-Sanchez F, 2015, SPAN J PSYCHOL, V18, DOI 10.1017/sjp.2015.85; MURPHY D, 1990, J NEUROL NEUROSUR PS, V53, P727, DOI 10.1136/jnnp.53.9.727; Nahum Mor, 2014, Schizophr Res Cogn, V1, pe11; Ostrom T. M., 1984, HDB SOCIAL COGNITION, V1, P1; Penn D, 2005, SCHIZOPHR RES, V80, P357, DOI 10.1016/j.schres.2005.07.011; Pinheiro AP, 2014, SCHIZOPHR RES, V152, P235, DOI 10.1016/j.schres.2013.10.042; Poole JH, 2000, J INT NEUROPSYCH SOC, V6, P649, DOI 10.1017/S135561770066602X; Ramos-Loyo J., 2012, SCHIZOPHR RES TREAT, V2012, P1; Rauschenberger M, 2013, INT J INTERACT MULTI, V2, P39, DOI 10.9781/ijimai.2013.215; Rose A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0510-1; Ross ED, 2001, J NEUROL NEUROSUR PS, V70, P597, DOI 10.1136/jnnp.70.5.597; Rossell SL, 2005, SCHIZOPHR RES, V78, P95, DOI 10.1016/j.schres.2005.06.002; Rothe PH, 2018, SCHIZOPHR RES, V193, P23, DOI 10.1016/j.schres.2017.07.033; Ruiz-Ruiz J. C., 2006, APUNTES PSICOL, V24, P137, DOI DOI 10.1590/S0004-282X2007000200022; Sacks Stephanie, 2013, Clin Schizophr Relat Psychoses, V7, P78, DOI 10.3371/CSRP.SAFI.012513; Savla GN, 2013, SCHIZOPHRENIA BULL, V39, P979, DOI 10.1093/schbul/sbs080; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; SCHNEIDER F, 1995, SCHIZOPHR RES, V17, P67, DOI 10.1016/0920-9964(95)00031-G; Scholten MRM, 2008, PSYCHOL MED, V38, P887, DOI 10.1017/S0033291707001742; Shaw RJ, 1999, SCHIZOPHR RES, V37, P245, DOI 10.1016/S0920-9964(98)00172-8; Simpson C, 2013, SCHIZOPHR RES, V151, P102, DOI 10.1016/j.schres.2013.09.026; Thomas ML, 2017, JAMA PSYCHIAT, V74, P37, DOI 10.1001/jamapsychiatry.2016.2980; Van Rijn S, 2007, THESIS; Vaskinn A, 2007, ACTA PSYCHIAT SCAND, V116, P263, DOI 10.1111/j.1600-0447.2007.00991.x; Ventura J, 2013, SCHIZOPHR RES, V151, P78, DOI 10.1016/j.schres.2013.10.015; Vogel BD, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0913-7; Woods SW, 2011, CHLORPROMAZINE EQUIV, P34	75	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210816	10.1371/journal.pone.0210816	http://dx.doi.org/10.1371/journal.pone.0210816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682067	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500065
J	Marcelo, C; Warwick, M; Marcelo, C; Qayyum, R				Marcelo, Carolyn; Warwick, Melissa; Marcelo, Catherine; Qayyum, Rehan			The association between urinary genistein levels and mortality among adults in the United States	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BREAST-CANCER SURVIVAL; CARDIOVASCULAR-DISEASE; FLAVONOID INTAKE; HEART-DISEASE; SOY; RISK; HEALTH; ISOFLAVONES; PHYTOESTROGENS	Background Current research on the relationship between phytoestrogens and mortality has been inconclusive. We explored the relationship between genistein, a phytoestrogen, and mortality in a large cohort representative of the United States population. Methods Data were analyzed from the National Health and Nutrition Examination Survey (NHANES) from 1999-2010. Normalized urinary genistein (nUG) was analyzed as a log-transformed continuous variable and in quartiles. Mortality data were obtained from the National Death Index and matched to the NHANES participants. Survival analyses were conducted using the Kaplan-Meier analysis. Cox proportional hazard models were constructed for all-cause and cause-specific mortality without and with adjustment for potential confounding variables. Results Of 11,497 participants, 944 died during the 64,443 person-years follow-up. The all-cause mortality rate was significantly lower in the lowest quartile compared to the highest quartile (incidence rate ratio = 2.14, 95% CI = 1.76 to 2.60). Compared to the lowest quartile, the highest quartile had significantly higher adjusted all-cause (HR = 1.57, 95% CI = 1.23 to 2.00), cardiovascular (HR = 1.67, 95% CI = 1.04 to 2.68), and other-cause (HR = 1.85, 95% CI = 1.33 to 2.57) mortality. Conclusion We found that high urinary genistein levels were associated with increased risk of all-cause, cardiovascular, and other-cause mortality. This is contrary to popular opinion on the health benefits of genistein and needs further research.	[Marcelo, Carolyn; Warwick, Melissa; Marcelo, Catherine; Qayyum, Rehan] Virginia Commonwealth Univ, Sch Med, Div Hosp Med, Dept Internal Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Marcelo, C (corresponding author), Virginia Commonwealth Univ, Sch Med, Div Hosp Med, Dept Internal Med, Richmond, VA 23284 USA.	carolyn.marcelo@vcuhealth.org		Qayyum, Rehan/0000-0003-3086-8014				Anderson D, 1997, TERATOGEN CARCIN MUT, V17, P29, DOI 10.1002/(SICI)1520-6866(1997)17:1<29::AID-TCM5>3.0.CO;2-H; Arai Y, 2000, J Epidemiol, V10, P127; Baechler SA, 2016, TOXICOL LETT, V243, P88, DOI 10.1016/j.toxlet.2015.12.009; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Boos G, 2000, TOXICOL LETT, V116, P7, DOI 10.1016/S0378-4274(00)00192-2; Caan BJ, 2011, CANCER EPIDEM BIOMAR, V20, P854, DOI 10.1158/1055-9965.EPI-10-1041; Chavez-Suarez KM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101078; Di Virgilio AL, 2004, TOXICOL LETT, V151, P151, DOI 10.1016/j.toxlet.2004.04.005; Fink BN, 2007, CANCER EPIDEM BIOMAR, V16, P2285, DOI 10.1158/1055-9965.EPI-07-0245; Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189; Grace PB, 2004, CANCER EPIDEM BIOMAR, V13, P698; Guglielmini P, 2012, BREAST CANCER RES TR, V132, P661, DOI 10.1007/s10549-011-1881-8; Kang XM, 2010, CAN MED ASSOC J, V182, P1857, DOI 10.1503/cmaj.091298; Kim Y, 2017, CLIN NUTR ESPEN, V20, P68, DOI 10.1016/j.clnesp.2017.03.004; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; Kokubo Y, 2007, CIRCULATION, V116, P2553, DOI 10.1161/CIRCULATIONAHA.106.683755; Kyro C, 2015, BREAST CANCER RES TR, V154, P389, DOI 10.1007/s10549-015-3595-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Milder IEJ, 2006, AM J CLIN NUTR, V84, P400; Nagata C, 2002, AM J EPIDEMIOL, V156, P824, DOI 10.1093/aje/kwf118; Nagata C, 2000, INT J EPIDEMIOL, V29, P832, DOI 10.1093/ije/29.5.832; Olsen A, 2011, BREAST CANCER RES TR, V128, P883, DOI 10.1007/s10549-011-1397-2; Pool-Zobel BL, 2000, CARCINOGENESIS, V21, P1247, DOI 10.1093/carcin/21.6.1247; Reger MK, 2016, EUR J NUTR, V55, P1029, DOI 10.1007/s00394-015-0917-y; Rienks J, 2017, NUTR REV, V75, P616, DOI 10.1093/nutrit/nux021; Rietjens IMCM, 2017, BRIT J PHARMACOL, V174, P1263, DOI 10.1111/bph.13622; Seibold P, 2014, INT J CANCER, V135, P923, DOI 10.1002/ijc.28729; Talaei M, 2014, J NUTR, V144, P921, DOI 10.3945/jn.114.190454; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; THOMAS LJ, 1975, T AM SOC ART INT ORG, V21, P516; Vanharanta M, 2003, ARCH INTERN MED, V163, P1099, DOI 10.1001/archinte.163.9.1099; Yang Z, 2012, ANTI-CANCER AGENT ME, V12, P1264, DOI 10.2174/187152012803833107; Yellayi S, 2003, J ENDOCRINOL, V176, P267, DOI 10.1677/joe.0.1760267; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199; Zhang FF, 2017, CANCER-AM CANCER SOC, V123, P2070, DOI 10.1002/cncr.30615; Zhang YF, 2012, ASIAN PAC J CANCER P, V13, P479, DOI 10.7314/APJCP.2012.13.2.479	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211368	10.1371/journal.pone.0211368	http://dx.doi.org/10.1371/journal.pone.0211368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682197	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500156
J	Mohammed, SH; Habtewold, TD; Tegegne, BS; Birhanu, MM; Sissay, TA; Larijani, B; Esmaillzadeh, A				Mohammed, Shimels Hussien; Habtewold, Tesfa Dejenie; Tegegne, Balewgizie Sileshi; Birhanu, Mulugeta Molla; Sissay, Tesfamichael Awoke; Larijani, Bagher; Esmaillzadeh, Ahmad			Dietary and non-dietary determinants of linear growth status of infants and young children in Ethiopia: Hierarchical regression analysis	PLOS ONE			English	Article							COUNTRIES	Introduction Childhood growth faltering remains a major public health problem in developing countries. We aimed to identify the distal, underlying, and proximal dietary and non-dietary factors associated with length-for-age (LFA) of infants and young children in Ethiopia. Methods We used a nationally representative sample of 2,932 children aged 6-23 months from the Ethiopian demographic and health survey (EDHS) conducted in 2016. Hierarchical regression analysis was done to identify the factors associated with LFA. Findings Pastoral residence (adjusted (a beta) = -0.56, 95% CI = -0.82, -0.31, P< 0.001) and poorest household wealth category (a beta = -0.57, 95% CI = -0.66, -0.48, P< 0.001) were the basic factors negatively associated with LFA. Among underlying factors, maternal wasting (a beta = -0.43, 95% CI = -0.58, -0.28, P< 0.001), and unimproved toilet facility (a beta = -0.48, 95% CI = -0.73, -0.23, P< 0.001) were negatively associated with LFA. Proximal factors found positively associated with LFA were dietary diversity (a beta = 0.09, 95% CI = 0.043, 0.136, P< 0.001), meal frequency (a beta = 0.04, 95% CI = 0.00, 0.08, P = 0.042), and vitamin A supplementation (a beta = 0.16, 95% CI = 0.03, 0.29, P = 0.020). Male sex (a beta = -0.26, 95% CI = -0.39, -0.14, P< 0.001), age (a beta = -0.12, 95% CI = -0.13, -0.10, P = 0.001), small birth size (a beta = -0.45, 95% CI = -0.62, -0.29, P< 0.001), and not currently breastfeeding (a beta = -0.29, 95% CI = -0.47, -0.11, P = 0.003) were negatively associated with LFA. Conclusion LFA was associated with various influences at distal, underlying, and proximal levels. A multi-pronged approach, addressing the various factors comprehensively, would represent an important consideration to promote linear growth in early childhood in Ethiopia.	[Mohammed, Shimels Hussien] TUMS IC, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran; [Habtewold, Tesfa Dejenie; Tegegne, Balewgizie Sileshi; Sissay, Tesfamichael Awoke] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Birhanu, Mulugeta Molla] Mekelle Univ, Sch Nursing, Coll Hlth Sci, Mekelle, Ethiopia; [Larijani, Bagher] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Esmaillzadeh, Ahmad] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran; [Esmaillzadeh, Ahmad] Isfahan Univ Med Sci, Dept Community Nutr, Food Secur Res Ctr, Esfahan, Iran	University of Groningen; Mekelle University; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Isfahan University Medical Science	Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Obes & Eating Habits Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, Tehran, Iran.; Esmaillzadeh, A (corresponding author), Isfahan Univ Med Sci, Dept Community Nutr, Food Secur Res Ctr, Esfahan, Iran.	a.esmaillzadeh@gmail.com	Mohammed, Shimels Hussien/G-4569-2017; Esmaillzadeh, Ahmad/N-5704-2014; larijani, Bagher/ABE-3315-2020; Tegegne, Balewgizie Sileshi/K-6117-2016	Mohammed, Shimels Hussien/0000-0001-8231-4158; Esmaillzadeh, Ahmad/0000-0002-8735-6047; larijani, Bagher/0000-0001-5386-7597; Birhanu, Mulugeta/0000-0003-0364-279X; Habtewold, Tesfa Dejenie/0000-0003-4476-518X; Tegegne, Balewgizie Sileshi/0000-0001-9420-0043				Agize A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7204562; Aheto JMK, 2015, PAEDIATR PERINAT EP, V29, P552, DOI 10.1111/ppe.12222; Akombi BJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080863; [Anonymous], 2020, BMC PUBLIC HEALTH; [Anonymous], NAT NUTR PROGR; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Danaei G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002164; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Derso T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0848-2; Endris N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6587853; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Fikadu T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-800; Geberselassie SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195361; GREENLAND S, 1994, ENVIRON HEALTH PERSP, V102, P33, DOI 10.1289/ehp.94102s833; Jelenkovic A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28496; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Liu J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003150; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mohammed SH, 2017, BRIT J NUTR, V118, P730, DOI 10.1017/S0007114517002677; Sachdev HPS, 2006, PUBLIC HEALTH NUTR, V9, P904, DOI 10.1017/PHN2005918; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; UNICEF, 1991, INDIAN J PEDIATR, V58, P13, DOI [10.1007/BF02810402, DOI 10.1007/BF02810402]; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Woodruff BA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12307; World Health Organization, 2014, GLOBAL NUTR TARGETS; World Health Organization, 2013, ESS NUTR ACT IMPR MA	33	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0209220	10.1371/journal.pone.0209220	http://dx.doi.org/10.1371/journal.pone.0209220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682027	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500014
J	Paczkowska, M; Szymanowska-Powalowska, D; Mizera, M; Siakowska, D; Blaszczak, W; Piotrowska-Kempisty, H; Cielecka-Piontek, J				Paczkowska, Magdalena; Szymanowska-Powalowska, Daria; Mizera, Mikolaj; Siakowska, Dominika; Blaszczak, Wioletta; Piotrowska-Kempisty, Hanna; Cielecka-Piontek, Judyta			Cyclodextrins as multifunctional excipients: Influence of inclusion into beta-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; INTESTINAL-ABSORPTION; MOLECULAR INCLUSION; LACTAM ANTIBIOTICS; SOLID-STATE; IN-VITRO; COMPLEXATION; CARBAPENEMS; DEGRADATION; MECHANISMS	A novel approach for drug design based on the oral carbapenem analog tebipenem pivoxil (TP) has been proposed. The formation of the tebipenem pivoxil-beta-cyclodextrin (TP-beta-CD) complex resulted in changes concerning physicochemical properties of TP, which is significant for planning the development of an innovative pharmaceutical formulation as well as in the modifications of biological activity profile of the studied delivery system. The inclusion of TP into beta-cyclodextrin (beta-CD) was confirmed by spectral (infrared and Raman spectroscopies) and thermal method (differential scanning calorimetry). Precise indications of TP domains responsible for interaction with beta-CD were possible through a theoretical approach. The most important physicochemical modifications obtained as an effect of TP inclusion were changes in solubility and its rate depending on acceptor fluids, and an increase in chemical stability in the solid state. Biologically essential effects of TP and beta-CD interactions were decreased TP permeability through Caco-2 cell monolayers with the use of efflux effect inhibition and increased antibacterial activity. The proposed approach is an opportunity for development of the treatment in resistant bacterial infections, in which along with physicochemical modifications induced by a drug carrier impact, a carrier synergy with a pharmacological potential of an active pharmaceutical substance could be used.	[Paczkowska, Magdalena; Mizera, Mikolaj; Siakowska, Dominika; Cielecka-Piontek, Judyta] Poznan Univ Med Sci, Dept Pharmacognosy, Poznan, Poland; [Szymanowska-Powalowska, Daria] Poznan Univ Life Sci, Dept Biotechnol & Food Microbiol, Poznan, Poland; [Blaszczak, Wioletta] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima, Olsztyn, Poland; [Piotrowska-Kempisty, Hanna] Poznan Univ Med Sci, Fac Pharm, Dept Toxicol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Poznan University of Medical Sciences	Cielecka-Piontek, J (corresponding author), Poznan Univ Med Sci, Dept Pharmacognosy, Poznan, Poland.	jpiontek@ump.edu.pl	; BLASZCZAK, Wioletta/H-7161-2017	Piotrowska-Kempisty, Hanna/0000-0002-8904-2885; BLASZCZAK, Wioletta/0000-0002-5989-7858; Paczkowska-Walendowska, Magdalena/0000-0002-0418-9336; Cielecka-Piontek, Judyta/0000-0003-0891-5419	National Science Centre (Preludium) [2015/17/N/NZ7/00937]; JC-P, Infrastruktura PL-Grid drugmod5; Polpharma Scientific Foundation	National Science Centre (Preludium); JC-P, Infrastruktura PL-Grid drugmod5; Polpharma Scientific Foundation	This study was supported by a grant from the National Science Centre (Preludium, 2015/17/N/NZ7/00937) to MP and JC-P, Infrastruktura PL-Grid drugmod5 to MM, and Polpharma Scientific Foundation to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem O, 2008, J PHARMACEUT BIOMED, V47, P535, DOI 10.1016/j.jpba.2008.02.006; [Anonymous], GAUSSIAN 09; [Anonymous], 1996, P INT C HARM ICH COM; Athanassiou G, 2003, J PHARM PHARMACOL, V55, P291, DOI 10.1211/002235702649; Bhargava S., 2008, Current Drug Delivery, V5, P1; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Cielecka-Piontek J, 2015, J CHROMATOGR SCI, V53, P325, DOI 10.1093/chromsci/bmu063; Cielecka-Piontek J, 2011, CURR PHARM ANAL, V7, P213, DOI 10.2174/157341211797457989; Cielecka-Piontek J, 2011, REACT KINET MECH CAT, V102, P37, DOI 10.1007/s11144-010-0249-0; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Dua K, 2011, J PHARM BIOALLIED SC, V3, P417, DOI 10.4103/0975-7406.84457; Eida EEM, 2011, CARBOHYDRPOLYM, V83, P1701; Flanner H.H., 1996, PHARM TECHNOL, V20, P64; GANAPATHY ME, 1995, J BIOL CHEM, V270, P25672, DOI 10.1074/jbc.270.43.25672; Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088234; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Karginov VA, 2013, CURR OPIN PHARMACOL, V13, P717, DOI 10.1016/j.coph.2013.08.007; Kato K, 2010, MOL PHARMACEUT, V7, P1747, DOI 10.1021/mp100130b; Kijima Koji, 2009, Jpn J Antibiot, V62, P214; Lennernas H, 1996, INT J PHARM, V127, P103, DOI 10.1016/0378-5173(95)04204-0; Manosroi J, 2016, CHIANG MAI J SCI, V43, P631; Meletis G, 2012, HIPPOKRATIA, V16, P303; Merkys A, 2016, J APPLCRYST, V49; Mizera M, 2015, TALANTA, V137, P174, DOI 10.1016/j.talanta.2015.01.032; Morrill HJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv050; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Ono S, 2005, ANTIMICROB AGENTS CH, V49, P2954, DOI 10.1128/AAC.49.7.2954-2958.2005; Paczkowska M, 2017, J MOL STRUCT, V1134, P135, DOI 10.1016/j.molstruc.2016.12.074; Paczkowska M, 2016, EUR J PHARM BIOPHARM, V99, P24, DOI 10.1016/j.ejpb.2015.10.013; Prochowicz D, 2016, COORDIN CHEM REV, V306, P331, DOI 10.1016/j.ccr.2015.07.016; Ragle BE, 2010, ANTIMICROB AGENTS CH, V54, P298, DOI 10.1128/AAC.00973-09; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Sato N, 2008, DRUG METAB PHARMACOK, V23, P434, DOI 10.2133/dmpk.23.434; Sun HK., 2011, AM J MICROBIOL, V2, P1, DOI DOI 10.3844/AJMSP.2011.1.8; Talaczynska A, 2016, DRUG DEV IND PHARM, V42, P238, DOI 10.3109/03639045.2015.1044902; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120395; Wang Y, 2006, DRUG FUTURE, V31, P676, DOI 10.1358/dof.2006.031.08.1015461; Yao Q, 2016, MOLECULES, V21, DOI 10.3390/molecules21010062; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210694	10.1371/journal.pone.0210694	http://dx.doi.org/10.1371/journal.pone.0210694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682086	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500052
J	Tsujimoto, Y; Aoki, T; Shinohara, K; So, R; Suganuma, AM; Kimachi, M; Yamamoto, Y; Furukawa, TA				Tsujimoto, Yasushi; Aoki, Takuya; Shinohara, Kiyomi; So, Ryuhei; Suganuma, Aya M.; Kimachi, Miho; Yamamoto, Yosuke; Furukawa, Toshi A.			Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: A secondary analysis of a randomized controlled trial	PLOS ONE			English	Article							VALIDATION; MEDICINE	Objectives Little is known about the physician characteristics associated with appraisal skills of research evidence, especially the assessment of the validity of study methodology. This study aims to explore physician characteristics associated with proper assessment of overstated conclusions in research abstracts. Design A secondary analysis of a randomized controlled trial. Setting and participants We recruited 567 volunteers from the Japan Primary Care Association. Methods Participants were randomly assigned to read the abstract of a research paper, with or without an overstatement, and to rate its validity. Our primary outcome was proper assessment of the validity of its conclusions. We investigated the association of physician characteristics and proper assessment using logistic regression models and evaluated the interaction between the associated characteristics and overstatement. Results We found significant associations between proper assessment and post-graduate year (odds ratio [OR] = 0.67, 95% confidence interval [CI] 0.49 to 0.91, for every 10-year increase) and research experience as a primary investigator (PI; OR = 2.97, 95% CI 1.65 to 5.34). Post-graduate year and PI had significant interaction with overstatement (P = 0.015 and < 0.001, respectively). Among participants who read abstracts without an overstatement, post-graduate year was not associated with proper assessment (OR = 1.04, 95% CI 0.82 to 1.33), and PI experience was associated with lower scores of the validity (OR = 0.58, 95% CI 0.35 to 0.96). Conclusion Physicians who have been in practice longer should be trained in distinguishing overstatements in abstract conclusions. Physicians with research experience might be informed that they tend to rate the validity of research lower regardless of the presence or absence of overstatements.	[Tsujimoto, Yasushi; Aoki, Takuya; Kimachi, Miho; Yamamoto, Yosuke] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Tsujimoto, Yasushi] Kyoritsu Hosp, Dept Nephrol & Dialysis, Kawanishi, Hyogo, Japan; [Shinohara, Kiyomi; So, Ryuhei; Suganuma, Aya M.; Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto, Japan	Kyoto University; Kyoto University	Yamamoto, Y (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.	yamamoto.yosuke.5n@kyoto-u.ac.jp	YAMAMOTO, Yosuke/HCH-0666-2022; Furukawa, Toshi A./B-9259-2011; Shinohara, Kiyomi/AAC-6963-2021	Furukawa, Toshi A./0000-0003-2159-3776; Shinohara, Kiyomi/0000-0003-3527-4004; Tsujimoto, Yasushi/0000-0002-7214-5589	Japan Primary Care Association [28-01-001]	Japan Primary Care Association	This work was supported by Japan Primary Care Association grant number 28-01-001. https://www.primary-care.or.jp/jpca_eng/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2016, FAM PRACT, V33, P112, DOI 10.1093/fampra/cmv087; Boutron I, 2014, J CLIN ONCOL, V32, P4120, DOI 10.1200/JCO.2014.56.7503; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Burke DT, 2002, AM J PHYS MED REHAB, V81, P779, DOI 10.1097/00002060-200210000-00011; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Cook D J, 1992, J Intensive Care Med, V7, P275; Dawes Martin, 2005, BMC Med Educ, V5, P1; Hadley Julie A, 2007, BMC Med Educ, V7, P11, DOI 10.1186/1472-6920-7-11; Kahwati L, 2017, J CONTIN EDUC HEALTH, V37, P129, DOI 10.1097/CEH.0000000000000150; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Paulsen J, 2018, ADV MED EDUC PRACT, V9, P287, DOI 10.2147/AMEP.S157792; Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sasaki Hidenao, 2008, Rinsho Shinkeigaku, V48, P556; Shinohara K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018355; Shinohara K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184786; Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	19	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211206	10.1371/journal.pone.0211206	http://dx.doi.org/10.1371/journal.pone.0211206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682128	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500123
J	Snodderly, DM; Ellisid, KM; Lieberman, SR; Link, A; Fernandez-Duque, E; Di Fiore, A				Snodderly, D. Max; Ellisid, Kelsey M.; Lieberman, Sarina R.; Link, Andres; Fernandez-Duque, Eduardo; Di Fiore, Anthony			Initiation of feeding by four sympatric Neotropical primates (Ateles belzebuth, Lagothrix lagotricha poeppigii, Plecturocebus (Callicebus) discolor, and Pithecia aequatorialis) in Amazonian Ecuador: Relationships to photic and ecological factors	PLOS ONE			English	Article							MARMOSETS CALLITHRIX-GEOFFROYI; LUMINANCE CONTRAST SENSITIVITY; COLOR-VISION; BEHAVIORAL THERMOREGULATION; SPIDER MONKEYS; FORAGING ADVANTAGE; WOOLLY MONKEYS; PATTERNS; FOREST; TIME	We examined photic and ecological factors related to initiation of feeding by four sympatric primates in the rain forest of Amazonian Ecuador. With rare exceptions, morning activities of all taxa began only after the onset of nautical twilight, which occurred 47-48 min before sunrise. The larger spider and woolly monkeys, Ateles belzebuth and Lagothrix lagotricha poeppigii, left their sleeping trees before sunrise about half the time, while the smaller sakis and titi monkeys, Pithecia aequatorialis and Plecturocebus (formerly Callicebus) discolor, did not emerge until sunrise or later. None of the four taxa routinely began feeding before sunrise. Pithecia began feeding a median 2.17 h after sunrise, at least 0.8 h later than the median feeding times of the other three taxa. The early movement of Ateles and Lagothrix, and late initiation of feeding by Pithecia are consistent with temporal niche partitioning. Among most New World primate species, all males and many females, have dichromatic color vision, with only two cone photopigments, while some females are trichromats with three cone photopigments. Current evidence indicates that the dichromats have a foraging advantage in dim light, which could facilitate utilization of twilight periods and contribute to temporal niche partitioning. However, in our study, dichromatic males did not differentially exploit the dim light of twilight, and times of first feeding bouts of female Ateles and Lagothrix were similar to those of males. First feeding bouts followed a seasonal pattern, occurring latest in May-August, when ripe fruit abundance and ambient temperature were both relatively low. The most frugivorous taxon, Ateles, exhibited the greatest seasonality, initiating feeding 1.4 h later in May-August than in January-April. This pattern may imply a strategy of conserving energy when ripe fruit is scarcer, but starting earlier to compete successfully when fruit is more abundant. Lower temperatures were associated with later feeding of Ateles (by 26 min / degrees C) and perhaps Pithecia, but not Lagothrix or Plecturocebus. The potential for modification of temporal activity patterns and temporal niche partitioning by relatively small changes in temperature should be considered when predicting the effects of climate change.	[Snodderly, D. Max; Lieberman, Sarina R.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Ellisid, Kelsey M.; Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Link, Andres] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Link, Andres] Univ Los Andes, Sch Management, Bogota, Colombia; [Fernandez-Duque, Eduardo] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Yale University	Snodderly, DM (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	dmsnodderly@gmail.com		Snodderly, Donald/0000-0002-3428-609X	National Science Foundation [BCS-1062540, IOS-0843354, BCS-1638822, BCS-DDRI-1540403]; Wenner-Gren Foundation for Anthropological Research; L.S.B. Leakey Foundation; Harry Frank Guggenheim Foundation; J. William Fulbright Scholar Program; Primate Conservation, Inc.; Idea Wild; National Geographic Society; New York Consortium in Evolutionary Primatology; New York University; Zoological Society of San Diego; University of Pennsylvania; University of Texas at Austin; Yale University	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation for Anthropological Research; L.S.B. Leakey Foundation; Harry Frank Guggenheim Foundation; J. William Fulbright Scholar Program; Primate Conservation, Inc.; Idea Wild; National Geographic Society(National Geographic Society); New York Consortium in Evolutionary Primatology; New York University; Zoological Society of San Diego; University of Pennsylvania; University of Texas at Austin; Yale University	This project received financial support from the National Science Foundation (https://www.nsf.gov/) (Grants BCS-1062540 (ADF, AL), IOS-0843354 (DMS, SRL), BCS-1638822 (ADF), BCS-DDRI-1540403 (KME, ADF); the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org/) (Grants to AD, AD & EFD, ADF & AL), L.S.B. Leakey Foundation (https://leakeyfoundation.org/) (Grants to ADF, EFD & AD, KME), and Harry Frank Guggenheim Foundation (http://www.hfg.org/) (ADF & AL); the J. William Fulbright Scholar Program (https://www.cies.org/) (ADF); Primate Conservation, Inc. (http://www.primate.org/) (KE); Idea Wild (http://www.ideawild.org/) (KME); the National Geographic Society (https://www.nationalgeographic.org/) (Grants to EFD, ADF, AL); the New York Consortium in Evolutionary Primatology (ADF, AL); New York University (ADF, AL); the Zoological Society of San Diego (EFD); the University of Pennsylvania (EFD): the University of Texas at Austin (ADF, KME, DMS, SRL); and Yale University (EFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2021, LANG ENV STAT COMP; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Bennie JJ, 2014, P NATL ACAD SCI USA, V111, P13727, DOI 10.1073/pnas.1216063110; Boinski S, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P43; Boyle SA, 2016, AM J PRIMATOL, V78, P493, DOI 10.1002/ajp.22422; Caine NG, 2010, BIOL LETTERS, V6, P36, DOI 10.1098/rsbl.2009.0591; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Caselli CB, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22688; Caselli CB, 2011, PRIMATES, V52, P351, DOI 10.1007/s10329-011-0266-2; CAVENEY S, 1995, OECOLOGIA, V103, P444, DOI 10.1007/BF00328682; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; CHAPMAN CA, 1989, AM J PRIMATOL, V18, P53, DOI 10.1002/ajp.1350180106; Cisneros-Heredia DF., 2005, NEOTROP PRIMATES, V13, P11, DOI [10.1896/1413-4705.13.3.11, DOI 10.1896/1413-4705.13.3.11, DOI 10.11606/T.47.2011]; de Luna AG, 2010, FOLIA PRIMATOL, V81, P86, DOI 10.1159/000314948; DEVALOIS RL, 1974, VISION RES, V14, P53, DOI 10.1016/0042-6989(74)90116-3; DEVALOIS RL, 1974, VISION RES, V14, P75, DOI 10.1016/0042-6989(74)90118-7; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Di Fiore A, 2004, INT J PRIMATOL, V25, P767, DOI 10.1023/B:IJOP.0000029122.99458.26; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Donati G, 2011, AM J PHYS ANTHROPOL, V144, P355, DOI 10.1002/ajpa.21415; Fernandez-Duque E, 2006, FOLIA PRIMATOL, V77, P123, DOI 10.1159/000089699; Fernandez-Duque Eduardo, 2012, P43; Finlay BL, 2008, VISUAL NEUROSCI, V25, P289, DOI 10.1017/S0952523808080371; FLEAGLE JG, 1980, AM J PHYS ANTHROPOL, V52, P301, DOI 10.1002/ajpa.1330520302; Gestich CC, 2014, ETHOLOGY, V120, P331, DOI 10.1111/eth.12203; Hanya G, 2007, AM J PRIMATOL, V69, P802, DOI 10.1002/ajp.20397; Hanya G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190631; Hart D, 2007, DEV PRIMATOL-PROG PR, P27, DOI 10.1007/978-0-387-34810-0_2; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Hill RA, 2006, AM J PHYS ANTHROPOL, V129, P242, DOI 10.1002/ajpa.20264; Isbell LA, 2017, AM J PHYS ANTHR; Jacobs GH, 2008, VISUAL NEUROSCI, V25, P619, DOI 10.1017/S0952523808080760; JACOBS GH, 1973, AM J PHYS ANTHROPOL, V38, P371, DOI 10.1002/ajpa.1330380235; Janaky M, 2014, VISUAL NEUROSCI, V31, P99, DOI 10.1017/S0952523813000400; Janmaat KRL, 2014, P NATL ACAD SCI USA, V111, P16343, DOI 10.1073/pnas.1407524111; Kawamura S, 2016, GENES GENOM, P1; Kelley EA, 2016, AM J PRIMATOL, V78, P745, DOI 10.1002/ajp.22538; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; Korstjens AH, 2016, INTRODUCTION TO PRIMATE CONSERVATION, P175, DOI 10.1093/acprof:oso/9780198703389.003.0011; Kosheleff VP, 2009, AM J PHYS ANTHROPOL, V139, P172, DOI 10.1002/ajpa.20970; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Link A, 2013, AM J PHYS ANTHROPOL, V150, P579, DOI 10.1002/ajpa.22230; Lopes KGD, 2017, J THERM BIOL, V69, P104, DOI 10.1016/j.jtherbio.2017.06.010; Martin GR, 2017, SENSORY ECOLOGY BIRD; Melin A. D., 2017, P NATL ACAD SCI USA; Melin AD, 2007, ANIM BEHAV, V73, P205, DOI 10.1016/j.anbehav.2006.07.003; Melin AD, 2010, CURR ZOOL, V56, P300, DOI 10.1093/czoolo/56.3.300; MERIGAN WH, 1976, VISION RES, V16, P375, DOI 10.1016/0042-6989(76)90199-1; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Ni QY, 2015, PRIMATES, V56, P351, DOI 10.1007/s10329-015-0481-3; Norconk MA, 2007, PRIMATES PERSPECTIVE, P123, DOI DOI 10.1017/CBO9781139034210.023.; Palacios E, 2013, EVOLUTIONARY BIOL CO; Pessoa DMA, 2005, AM J PRIMATOL, V67, P487, DOI 10.1002/ajp.20202; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Porter AM, 2015, FOLIA PRIMATOL, V86, P455, DOI 10.1159/000441811; Saito A, 2005, AM J PRIMATOL, V67, P471, DOI 10.1002/ajp.20201; Saito A, 2005, AM J PRIMATOL, V67, P425, DOI 10.1002/ajp.20197; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Sha JCM, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22694; Sheth SN, 2009, J TROP ECOL, V25, P571, DOI 10.1017/S0266467409990216; Smith AC, 2003, J EXP BIOL, V206, P3159, DOI 10.1242/jeb.00536; Smith AC, 2012, ANIM BEHAV, V83, P479, DOI 10.1016/j.anbehav.2011.11.023; Snodderly M, 2018, AM J PHYS ANTHROPOL, V165, P258; Souza-Alves JP, 2011, AM J PRIMATOL, V73, P1199, DOI 10.1002/ajp.20990; Spence-Aizenberg A, 2016, PRIMATES, V57, P103, DOI 10.1007/s10329-015-0489-8; STEVENSON PR, 1994, AM J PRIMATOL, V32, P123, DOI 10.1002/ajp.1350320205; Stevenson PR., 2004, CALADONIA, V26, P125; STRIER KB, 1992, AM J PHYS ANTHROPOL, V88, P515, DOI 10.1002/ajpa.1330880407; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; SYMINGTON MM, 1988, BEHAVIOUR, V105, P117; Takemoto H, 2004, AM J PHYS ANTHROPOL, V124, P81, DOI 10.1002/ajpa.10342; Terborgh J., 1986, Tasks for Vegetation Science, V15, P371; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Van Belle S, 2018, AM J PHYS ANTHROPOL, V167, P701, DOI 10.1002/ajpa.23645; Van Belle S, 2016, AM J PRIMATOL, V78, P204, DOI 10.1002/ajp.22493; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Veiga LM, 2013, EVOLUTIONARY BIOL CO; Veilleux CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep38418; Yamashita N, 2005, BEHAV ECOL SOCIOBIOL, V58, P618, DOI 10.1007/s00265-005-0936-4; Youlatos D, 1999, ANN SCI NAT ZOOL, V20, P161, DOI 10.1016/S0003-4339(00)88884-X	86	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210494	10.1371/journal.pone.0210494	http://dx.doi.org/10.1371/journal.pone.0210494			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673746	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800045
J	Alzamora, MT; Fores, R; Pera, G; Baena-Diez, JM; Valverde, M; Toran, P				Teresa Alzamora, M.; Fores, Rosa; Pera, Guillem; Miguel Baena-Diez, Jose; Valverde, Marta; Toran, Pere			Low, borderline and normal ankle-brachial index as a predictor of incidents outcomes in the Mediterranean based-population ARTPER cohort after 9 years follow-up	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; CARDIOVASCULAR-DISEASE; MORTALITY; RISK; EVENTS; ASSOCIATION	Background Guidelines recommended adopting the same cardiovascular risk modification strategies used for coronary disease in case of low Ankle-brachial index (ABI), but here exist few studies on long-term cardiovascular outcomes in patients with borderline ABI and even fewer on the general population. Aim The aim of the present study was to analyze the relationship between long-term cardiovascular events and low, borderline and normal ABI after a 9-year follow up of a Mediterranean population with low cardiovascular risk. Design and setting A population-based prospective cohort study was performed in the province of Barcelona, Spain. Method A total of 3,786 subjects >49 years were recruited from 2006-2008. Baseline ABI was 1.08 +/- 0.16. Subjects were followed from the time of enrollment to the end of follow-up in 2016 via phone calls every 6 months, systematic reviews of primary-care and hospital medical records and analysis of the SIDIAP (Information System for Primary Care Research) database to confirm the possible appearance of cardiovascular events. Results 3146 individuals participated in the study. 2,420 (77%) subjects had normal ABI, 524 (17%) had borderline ABI, and 202 (6.4%) had low ABI. In comparison with normal and borderline subjects, patients with lower ABI had more comorbidities, such as hypertension, hypercholesterolemia and diabetes. Cumulative MACE incidence at 9 years was 20% in patients with low ABI, 6% in borderline ABI and 5% in normal ABI. The annual MACE incidence after 9 years follow-up was significantly higher in people with low ABI (26.9/1000py) (p<0.001) than in borderline (6.6/1000py) and in normal ABI (5.6/1000py). Subjects with borderline ABI are at significantly higher risk for coronary disease (HR: 1.58; 95% CI: 1.02-2, 43; p = 0,040) compared to subjects with normal ABI, after adjustment. Conclusion The results of the present study support that low ABI was independently associated with higher incidence of MACE, ICE, cardiovascular and no cardiovascular mortality; while borderline ABI had significantly moderate risk for coronary disease than normal ABI.	[Teresa Alzamora, M.; Fores, Rosa] Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain; [Teresa Alzamora, M.; Fores, Rosa; Pera, Guillem; Toran, Pere] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain; [Fores, Rosa] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Miguel Baena-Diez, Jose] Inst Catala Salut, Direccio Atencio Primaria Barcelona Ciutat, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Miguel Baena-Diez, Jose; Valverde, Marta] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona, Barcelona, Spain; [Valverde, Marta] Hosp Nostra Senyora de Meritxell, Escaldes Engordany, Andorra	Autonomous University of Barcelona	Alzamora, MT (corresponding author), Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain.; Alzamora, MT (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain.	maiteal2007@gmail.com	Torán-Monserrat, Pere/AAY-4396-2021	Torán-Monserrat, Pere/0000-0002-9865-7427; Fores Raurell, Rosa/0000-0001-7803-7442; Alzamora, M Teresa/0000-0002-0094-6547; Pera, Guillem/0000-0003-3188-7268	Instituto de Salud Carlos III [PI15/00510, PI11/00765, PI07/90415]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding was provided by Instituto de Salud Carlos III (PI15/00510, PI11/00765, PI07/90415) to MTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2018, REV ESP CARDIOL, V71, P111, DOI 10.1016/j.rec.2017.12.014; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; ANKLE B, ATHEROSCLEROSIS; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; DAVIES J, 2017, BR J GEN PRACT, V67, P655; Davies Jane H, 2017, CG147, V67; Diehm C, 2006, EUR HEART J, V27, P1743, DOI 10.1093/eurheartj/ehl092; FORE P, 2018, PLOS ONE, V16, P13; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Hajibandeh S, 2017, VASCULAR, V25, P208, DOI 10.1177/1708538116658392; J, GROUP; Kojima I, 2014, J ATHEROSCLER THROMB, V21, P966, DOI 10.5551/jat.22608; McDermott MM, 2005, AM J EPIDEMIOL, V162, P33, DOI 10.1093/aje/kwi167; Menke A, 2006, AM J CARDIOL, V98, P1226, DOI 10.1016/j.amjcard.2006.05.056; Meves SH, 2010, CEREBROVASC DIS, V29, P546, DOI 10.1159/000306640; Miura T, 2017, ATHEROSCLEROSIS, V12, DOI 10.1371/journal.pone.0177609; MIURA T, 2017, PLOS ONE, V12, P6; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Natsuaki C, 2014, ATHEROSCLEROSIS, V234, P360, DOI 10.1016/j.atherosclerosis.2014.03.018; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Tanaka S, 2016, ATHEROSCLEROSIS, V250, P69, DOI 10.1016/j.atherosclerosis.2016.05.014; Alzamora MT, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-015-0170-6; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209163	10.1371/journal.pone.0209163	http://dx.doi.org/10.1371/journal.pone.0209163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673706	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800013
J	Trifonova, N; Karnauskas, M; Kelble, C				Trifonova, Neda; Karnauskas, Mandy; Kelble, Christopher			Predicting ecosystem components in the Gulf of Mexico and their responses to climate variability with a dynamic Bayesian network model	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; BROWN SHRIMP; FISH PRODUCTION; SHIFTS; CONSEQUENCES; DIAGNOSIS; KNOWLEDGE; IMPACTS; HYPOXIA; AZTECUS	The Gulf of Mexico is an ecologically and economically important marine ecosystem that is affected by a variety of natural and anthropogenic pressures. These complex and interacting pressures, together with the dynamic environment of the Gulf, present challenges for the effective management of its resources. The recent adoption of Bayesian networks to ecology allows for the discovery and quantification of complex interactions from data after making only a few assumptions about observations of the system. In this study, we apply Bayesian network models, with different levels of structural complexity and a varying number of hidden variables to account for uncertainty when modeling ecosystem dynamics. From these models, we predict focal ecosystem components within the Gulf of Mexico. The predictive ability of the models varied with their structure. The model that performed best was parameterized through data-driven learning techniques and accounted for multiple ecosystem components' associations and their interactions with human and natural pressures over time. Then, we altered sea surface temperature in the best performing model to explore the response of different ecosystem components to increased temperature. The magnitude and even direction of predicted responses varied by ecosystem components due to heterogeneity in driving factors and their spatial overlap. Our findings suggest that due to varying components' sensitivity to drivers, changes in temperature will potentially lead to trade-offs in terms of population productivity. We were able to discover meaningful interactions between ecosystem components and their environment and show how sensitive these relationships are to climate perturbations, which increases our understanding of the potential future response of the system to increasing temperature. Our findings demonstrate that accounting for additional sources of variation, by incorporating multiple interactions and pressures in the model layout, has the potential for gaining deeper insights into the structure and dynamics of ecosystems.	[Trifonova, Neda] Univ Miami, CIMAS, Miami, FL 33149 USA; [Trifonova, Neda; Kelble, Christopher] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Karnauskas, Mandy] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); National Oceanic Atmospheric Admin (NOAA) - USA	Trifonova, N (corresponding author), Univ Miami, CIMAS, Miami, FL 33149 USA.; Trifonova, N (corresponding author), NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA.	nitrifo@gmail.com	Kelble, Christopher R/A-8511-2008	Kelble, Christopher R/0000-0003-0914-4134; Karnauskas, Mandy/0000-0002-6631-0592; Trifonova, Neda/0000-0003-3332-4901	Cooperative Institute for Marine and Atmospheric Studies (CIMAS); Cooperative Institute of the University of Miami; National Oceanic and Atmospheric Administration [NA10OAR4320143]; National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program	Cooperative Institute for Marine and Atmospheric Studies (CIMAS); Cooperative Institute of the University of Miami; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program	This research was carried out in part under the auspices of the Cooperative Institute for Marine and Atmospheric Studies (CIMAS), a Cooperative Institute of the University of Miami and the National Oceanic and Atmospheric Administration, cooperative agreement #NA10OAR4320143. This paper is NOAA IEA Program contribution #2018_4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was carried out in part under the auspices of the Cooperative Institute for Marine and Atmospheric Studies (CIMAS), a Cooperative Institute of the University of Miami and the National Oceanic and Atmospheric Administration, cooperative agreement #NA10OAR4320143. This paper is a result of research, supported by the National Oceanic and Atmospheric Administration's Integrated Ecosystem Assessment (NOAA IEA) Program. This paper is NOAA IEA Program contribution #2018_4.	Adams CM, 2004, OCEAN COAST MANAGE, V47, P565, DOI 10.1016/j.ocecoaman.2004.12.002; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Barile P. J., 2013, SEDAR38DW07; Bilmes J. A., 1998, INT COMPUTER SCI I, V4, P126, DOI DOI 10.1080/0042098032000136147; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Bo P, 2004, IEEE T BIO-MED ENG, V51, P1803, DOI 10.1109/TBME.2004.831534; Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; Ceccon S, 2011, LECT NOTES COMPUT SC, V7014, P101, DOI 10.1007/978-3-642-24800-9_12; Chen SH, 2012, ENVIRON MODELL SOFTW, V37, P134, DOI 10.1016/j.envsoft.2012.03.012; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cofino AS, 2002, FR ART INT, V77, P695; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Elliott DT, 2012, J PLANKTON RES, V34, P602, DOI 10.1093/plankt/fbs029; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Faisal A, 2010, ECOL INFORM, V5, P451, DOI 10.1016/j.ecoinf.2010.06.005; Fernandes JA, 2013, GLOBAL CHANGE BIOL, V19, P2596, DOI 10.1111/gcb.12231; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Franco C, 2016, ENVIRON MODELL SOFTW, V80, P132, DOI 10.1016/j.envsoft.2016.02.029; Friedman N, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1300; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ghahramani Z, 1996, ADV NEUR IN, V8, P472; Hamilton SH, 2015, ECOL MODEL, V299, P64, DOI 10.1016/j.ecolmodel.2014.12.004; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1; Jensen FV, 2001, SERIES STAT ENG INFO; JOHNSON AG, 1994, FISH B-NOAA, V92, P91; Karnauskas M, 2017, ECOSYSTEM STATUS REP, V706, P56; Karnauskas M, 2015, GLOBAL CHANGE BIOL, V21, P2554, DOI 10.1111/gcb.12894; Keister JE, 2012, ZOOPLANKTON POPULATI, P347; Krivtsov V, 2004, ECOL MODEL, V174, P37, DOI 10.1016/j.ecolmodel.2003.12.042; Levontin P, 2011, ICES J MAR SCI, V68, P632, DOI 10.1093/icesjms/fsr004; Li JK, 2005, ESTUAR COAST SHELF S, V64, P261, DOI 10.1016/j.ecss.2005.02.019; Little S, 2017, UN BOUNDED BOUNDARIE, P311; Liu YY, 2015, J MARINE SYST, V148, P56, DOI 10.1016/j.jmarsys.2015.01.007; Morley JW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196127; Murphy K., 2001, COMPUTING SCI STAT, V33, P1024; Nielsen A, 2014, FISH RES, V158, P96, DOI 10.1016/j.fishres.2014.01.014; Nikovski D, 2000, IEEE T KNOWL DATA EN, V12, P509, DOI 10.1109/69.868904; Nye JA, 2014, J MARINE SYST, V133, P103, DOI 10.1016/j.jmarsys.2013.02.006; Ogden JC, 2014, ECOL INDIC, V44, P148, DOI 10.1016/j.ecolind.2014.03.007; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Powers SP, 2018, T AM FISH SOC, DOI [10.1002/tafs.10051, DOI 10.1002/TAFS.10051]; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Sanchez-Rubio G, 2015, FISHERY B, V113; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Tam JC, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00282; Trifonova N, 2017, ICES J MAR SCI, V74, P1334, DOI 10.1093/icesjms/fsw231; Trifonova N, 2015, ECOL INFORM, V30, P142, DOI 10.1016/j.ecoinf.2015.10.003; Tucker A., 2004, Intelligent Data Analysis, V8, P469; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Uusitalo L, 2012, INTEGR ENVIRON ASSES, V8, P445, DOI 10.1002/ieam.180; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; ZEINELDIN ZP, 1986, MAR FISH REV, V48, P9	60	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209257	10.1371/journal.pone.0209257	http://dx.doi.org/10.1371/journal.pone.0209257			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673705	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800015
J	Jolliffe, CD; Mccauley, RD; Gavrilov, AN; Jenner, KCS; Jenner, MNM; Duncan, AJ				Jolliffe, Capri D.; Mccauley, Robert D.; Gavrilov, Alexander N.; Jenner, K. Curt S.; Jenner, Micheline-Nicole M.; Duncan, Alec J.			Song variation of the South Eastern Indian Ocean pygmy blue whale population in the Perth Canyon, Western Australia	PLOS ONE			English	Article							RESIDENT KILLER WHALES; HUMPBACK WHALES; BALAENOPTERA-MUSCULUS; MEGAPTERA-NOVAEANGLIAE; BEHAVIOR; CULTURE; SIZE; CLASSIFICATION; VARIABILITY; REPERTOIRE	Sea noise collected over 2003 to 2017 from the Perth Canyon, Western Australia was analysed for variation in the South Eastern Indian Ocean pygmy blue whale song structure. The primary song-types were: P3, a three unit phrase (I, II and III) repeated with an inter-song interval (ISI) of 170-194 s; P2, a phrase consisting of only units II & III repeated every 84-96 s; and P1 with a phrase consisting of only unit II repeated every 45-49 s. The different ISI values were approximate multiples of each other within a season. When comparing data from each season, across seasons, the ISI value for each song increased significantly through time (all fits had p << 0.001), at 0.30 s/Year (95% CI 0.217-0.383), 0.8 s/Year (95% CI 0.655-1.025) and 1.73 s/Year (95% CI 1.264-2.196) for the P1, P2 and P3 songs respectively. The proportions of each song-type averaged at 21.5, 24.2 and 56% for P1, P2 and P3 occurrence respectively and these ratios could vary by up to +/- 8% (95% CI) amongst years. On some occasions animals changed the P3 ISI to be significantly shorter (120-160 s) or longer (220-280 s). Hybrid song patterns occurred where animals combined multiple phrase types into a repeated song. In recent years whales introduced further complexity by splitting song units. This variability of song-type and proportions implies abundance measure for this whale sub population based on song detection needs to factor in trends in song variability to make data comparable between seasons. Further, such variability in song production by a sub population of pygmy blue whales raises questions as to the stability of the song types that are used to delineate populations. The high level of song variability may be driven by an increasing number of background whale callers creating 'noise' and so forcing animals to alter song in order to 'stand out' amongst the crowd.	[Jolliffe, Capri D.; Mccauley, Robert D.; Gavrilov, Alexander N.; Duncan, Alec J.] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA, Australia; [Jenner, K. Curt S.; Jenner, Micheline-Nicole M.] Ctr Whale Res WA Inc, Fremantle, WA, Australia	Curtin University	Mccauley, RD (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, Perth, WA, Australia.	r.mccauley@cmst.curtin.edu.au	Duncan, Alec J/B-7514-2015	Duncan, Alec J/0000-0002-2179-727X; Gavrilov, Alexander/0000-0003-1907-458X; McCauley, Robert/0000-0002-7401-8751				Adi K, 2010, J ACOUST SOC AM, V127, P874, DOI 10.1121/1.3273887; Agafonov AV, 2017, ZH OBSHCH BIOL, V78, P38; [Anonymous], 2010, R LANG ENV STAT COMP; Attard CRM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.170925; Attard CRM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1037; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Bottcher A, 2018, J ACOUST SOC AM, V144, P365, DOI 10.1121/1.5047657; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Brunel-Pons O, 2011, ANIM BEHAV, V81, P231, DOI 10.1016/j.anbehav.2010.10.010; Buchan SJ, 2014, ENDANGER SPECIES RES, V23, P241, DOI 10.3354/esr00566; Cantor M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9091; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cholewiak DM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171298; Creanza N, 2016, EVOL ECOL, V30, P285, DOI 10.1007/s10682-015-9796-1; Deecke VB, 2000, ANIM BEHAV, V60, P629, DOI 10.1006/anbe.2000.1454; Double MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093578; Dunlop RA, 2017, J ACOUST SOC AM, V141, P2204, DOI 10.1121/1.4978615; Dunlop RA, 2016, BEHAV ECOL SOCIOBIOL, V70, P2149, DOI 10.1007/s00265-016-2218-8; Erbe C, 2015, PROG OCEANOGR, V137, P38, DOI 10.1016/j.pocean.2015.05.015; Filatova OA, 2015, BEHAVIOUR, V152, P2001, DOI 10.1163/1568539X-00003317; Galef BG, 2001, BEHAV BRAIN SCI, V24, P335, DOI 10.1017/S0140525X01343960; Garland EC, 2017, J ACOUST SOC AM, V142, P460, DOI 10.1121/1.4991320; Garland EC, 2017, P NATL ACAD SCI USA, V114, P7822, DOI 10.1073/pnas.1621072114; Garland EC, 2015, CONSERV BIOL, V29, P1198, DOI 10.1111/cobi.12492; Gavrilov A.N., 2012, P 11 EUR C UND AC JU, V3, P34; Gavrilov AN, 2014, ACOUST AUST, V42, P190; Gavrilov AN, 2013, J ACOUST SOC AM, V134, P2505, DOI 10.1121/1.4816576; Hammond P, 2017, NAT HIST, V125, P30; Hedwig D, 2015, AM J PRIMATOL, V77, P1239, DOI 10.1002/ajp.22462; Helweg DA, 1998, BEHAVIOUR, V135, P1; Herman LM, 2017, BIOL REV, V92, P1795, DOI 10.1111/brv.12309; Herman LM, 2013, BEHAV ECOL SOCIOBIOL, V67, P1653, DOI 10.1007/s00265-013-1576-8; Janik VM, 2014, CURR OPIN NEUROBIOL, V28, P60, DOI 10.1016/j.conb.2014.06.010; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Janik VM, ADV STUDY BEHAV, V26, P59; Kershenbaum A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1370; Lewis LA, 2018, MAR MAMMAL SCI, V34, P311, DOI 10.1111/mms.12458; Ljungblad Donald K., 1998, Report of the International Whaling Commission, V48, P439; Lucas JR, 1996, ANIM BEHAV, V51, P501, DOI 10.1006/anbe.1996.0056; Mann J, 2017, DEEP THINKERS; Marler P, 1997, J NEUROBIOL, V33, P501; McCauley RD, 2010, SC62SH26 INT WHAL CO; McCauley RD, 2006, J ACOUST SOC AM, V120, P3266, DOI DOI 10.1121/1.4776880; McCauley RD, 2004, R200429 CURT U TECHN; McCauley RD, 2018, DEEP-SEA RES PT II, V157, P154, DOI 10.1016/j.dsr2.2018.09.006; McCauley RD, 2017, ACOUST AUST, V45, P301, DOI 10.1007/s40857-017-0113-8; McDonald MA, 2003, SCIENCE, V55; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Mercado E, 2018, FRONT PSYCHOL, V9, P20; Mori C, 2018, SCI REP, V8, P10; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Oleson EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115678; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Rehn N, 2007, BEHAVIOUR, V144, P307, DOI 10.1163/156853907780425703; Rekdahl ML, 2013, J ACOUST SOC AM, V133, P1785, DOI 10.1121/1.4789941; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; Riesch R, 2006, ANIM BEHAV, V71, P79, DOI 10.1016/j.anbehav.2005.03.026; Ronald KL, 2015, ETHOLOGY, V121, P1104, DOI 10.1111/eth.12425; Samaran F., 2008, CAN ACOUST, V36, P93; Siegel S., 1988, NONPARAMETRIC STAT B; Sirovic A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09979-4; Smith R, 2014, ENTROPY-SWITZ, V16, P526, DOI 10.3390/e16010526; Stafford KM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0056; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Tripovich JS, 2015, J MAMMAL, V96, P603, DOI 10.1093/jmammal/gyv065; Truskanov N, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0050; Ward S, 2003, ANIM BEHAV, V66, P893, DOI 10.1006/anbe.2003.2250; Whitehead H., 2014, CULTURAL LIVES WHALE; Whiteway T. G., 2009, GEOSCI AUSTR REC; Wiggins GA, 2015, PHILOS T R SOC B, V370, P129, DOI 10.1098/rstb.2014.0099	74	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0208619	10.1371/journal.pone.0208619	http://dx.doi.org/10.1371/journal.pone.0208619			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668600	gold, Green Submitted, Green Published			2022-12-27	WOS:000456306400001
J	Szpitalak, M; Polczyk, R				Szpitalak, Malwina; Polczyk, Romuald			Inducing resistance to the misinformation effect by means of reinforced self-affirmation: The importance of positive feedback	PLOS ONE			English	Article							EYEWITNESS IDENTIFICATION; SEMANTIC INTEGRATION; MEMORY; SUGGESTIBILITY; CONFIDENCE; ACCURACY; INFORMATION; PSYCHOLOGY; REMEMBER	The misinformation effect is one of the major threats for the quality of witness testimony. It involves including of information that is inconsistent with the course of an event, and which originates from sources other than the event itself, into a witness's report of the event. In the present article research is presented aiming at reducing the tendency to rely on misinformation. After viewing a video clip, participants received a post-event narrative describing the events in the film which in the misled group included some incorrect information about the clip. They were then administered reinforced self-affirmation (RSA), a technique aiming at boosting self-confidence in order to increase the tendency to rely on own memory instead of external cues. This technique consists of self-affirmation by means of writing down one's greatest achievements in life and manipulated positive feedback. Feedback about memory, perception and independence of judgements was analyzed. All types of feedback effectively reduced the misinformation effect. Mediation analyzes confirmed that RSA operates via increased self-confidence or self-independence.	[Szpitalak, Malwina; Polczyk, Romuald] Jagiellonian Univ, Inst Psychol, Krakow, Poland	Jagiellonian University	Polczyk, R (corresponding author), Jagiellonian Univ, Inst Psychol, Krakow, Poland.	romuald.polczyk@uj.edu.pl			Narodowe Centrum Nauki [National Science Centre], Poland [UMO-2016/23/D/HS6/01677]	Narodowe Centrum Nauki [National Science Centre], Poland	This study was supported by a grant from the Narodowe Centrum Nauki [National Science Centre], Poland: 'Mechanisms of reinforced self-affirmation effect', Nr UMO-2016/23/D/HS6/01677, for Malwina Szpitalak. All the funding for the present study was obtained from this source. There was no additional external funding received for this study.; This study was supported by a grant from the Narodowe Centrum Nauki [National Science Centre], Poland: 'Mechanisms of reinforced self-affirmation effect', Nr UMO-2016/23/D/HS6/01677, for Malwina Szpitalak. All the funding for the present study was obtained from this source. There was no additional external funding received for this study. Ethical approval for both experiments was obtained.	[Anonymous], 2013, POL PSYCHOL BULL, DOI [DOI 10.2478/PPB-2013-0009, 10.2478/ppb-2013-0009]; Asumeng, 2013, INT J MANAGEMENT, V30, P373; Ayers MS, 1998, PSYCHON B REV, V5, P1, DOI 10.3758/BF03209454; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Baumeister RF, 2007, PERS SOC PSYCHOL REV, V11, P167, DOI 10.1177/1088868307301033; BEKERIAN DA, 1983, J EXP PSYCHOL LEARN, V9, P139, DOI 10.1037/0278-7393.9.1.139; Blank H, 1998, MEMORY, V6, P481, DOI 10.1080/741943086; BRAINERD CJ, 1984, DEV REV, V4, P311, DOI 10.1016/0273-2297(84)90021-2; Brewer N, 2011, CURR DIR PSYCHOL SCI, V20, P24, DOI 10.1177/0963721410389169; Clark N. K., 1986, SOCIAL BEHAVIOUR, V1, P83; Compte O, 2004, AM ECON REV, V94, P1536, DOI 10.1257/0002828043052204; Coupe T, CRIME DETECTION PREV, V77; CUTLER BL, 1989, J APPL PSYCHOL, V74, P650, DOI 10.1037/0021-9010.74.4.650; Fishbach A, 2010, SOC PERSONAL PSYCHOL, V4, P517, DOI 10.1111/j.1751-9004.2010.00285.x; GOLDSTEIN AG, 1989, B PSYCHONOMIC SOC, V27, P71; Gudjonsson G.H., 1997, GUDJONSSON SUGGESTIB; Hayes A. F., 2018, INTRO MEDIATION MODE; Hupbach A, 2009, MEMORY, V17, P502, DOI 10.1080/09658210902882399; Keppel G., 2004, DESIGN AND ANAL; Klein WMP, 2011, J EXP SOC PSYCHOL, V47, P1237, DOI 10.1016/j.jesp.2011.05.005; Leippe MR, 2006, BASIC APPL SOC PSYCH, V28, P201, DOI 10.1207/s15324834basp2803_1; LINDSAY DS, 1990, J EXP PSYCHOL LEARN, V16, P1077, DOI 10.1037/0278-7393.16.6.1077; LINDSAY DS, 1989, MEM COGNITION, V17, P349, DOI 10.3758/BF03198473; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; LOFTUS EF, 1989, J EXP PSYCHOL GEN, V118, P100, DOI 10.1037/0096-3445.118.1.100; LOFTUS EF, 1978, J EXP PSYCHOL-HUM L, V4, P19, DOI 10.1037/0278-7393.4.1.19; Luna K, 2012, APPL COGNITIVE PSYCH, V26, P687, DOI 10.1002/acp.2845; Mazzoni G, 2007, SOC COGNITION, V25, P203, DOI 10.1521/soco.2007.25.1.203; MCCARTY PA, 1986, ACAD MANAGE J, V29, P840, DOI 10.2307/255950; MCCLOSKEY M, 1985, J EXP PSYCHOL GEN, V114, P1, DOI 10.1037/0096-3445.114.1.1; METCALFE J, 1990, J EXP PSYCHOL GEN, V119, P145, DOI 10.1037/0096-3445.119.2.145; Penrod S, 1995, PSYCHOL PUBLIC POL L, V1, P817, DOI 10.1037/1076-8971.1.4.817; Penrod S., 1982, PSYCHOL COURTROOM, P119; PEZDEK K, 1977, J EXP PSYCHOL-HUM L, V3, P515, DOI 10.1037/0278-7393.3.5.515; Polczyk R, 2017, POL PSYCHOL B, V48; Polczyk R, 2007, MECH EFEKTU DEZINFOR; Rosnow R. L., 1985, CONTRASTS ANAL FOCUS; Rosnow RL, 1992, METHODOLOGICAL ISSUE, P337; Saunders J, 2002, J EXP PSYCHOL-APPL, V8, P127, DOI 10.1037//1076-898X.8.2.127; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schimel J, 2004, SOC COGNITION, V22, P75, DOI 10.1521/soco.22.1.75.30984; Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5; Stankov L, 1997, INTELLIGENCE, V25, P93, DOI 10.1016/S0160-2896(97)90047-7; Szpitalak M, 2012, EFEKT WZMOCNIONEJ AU, V50, P63; Szpitalak M., 2011, PROBLEMS FORENSIC SC, V85, P40; Szpitalak M, INDUCE RESISTANCE MI; Szpitalak M, 2012, MOTYWACYJNE MECH EFE; Szpitalak M, 2016, PSYCHIAT PSYCHOL LAW, V23, P512, DOI 10.1080/13218719.2015.1081088; Szpitalak M, 2015, PSYCHOL CRIME LAW, V21, P911, DOI 10.1080/1068316X.2015.1077243; TATA PR, 1990, PERS INDIV DIFFER, V11, P1079, DOI 10.1016/0191-8869(90)90136-F; Thorley C, 2017, PSYCHOL CRIME LAW, V23, P342, DOI 10.1080/1068316X.2016.1258471; van Bergen S, 2010, APPL COGNITIVE PSYCH, V24, P885, DOI 10.1002/acp.1595; Vrij A, 2000, PSYCHOL CRIME LAW, V6, P127, DOI 10.1080/10683160008410837; Wells GL, 1998, J APPL PSYCHOL, V83, P360, DOI 10.1037/0021-9010.83.3.360; Wells GL., 1984, EYEWITNESS TESTIMONY, P155; Zaragoza M.S., 2007, DO JUSTICE LET SKY F, P35; ZARAGOZA MS, 1994, J EXP PSYCHOL LEARN, V20, P934, DOI 10.1037/0278-7393.20.4.934	57	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210987	10.1371/journal.pone.0210987	http://dx.doi.org/10.1371/journal.pone.0210987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668576	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400025
J	Campbell, CL; Saavedra-Rodriguez, K; Kubik, TD; Lenhart, A; Lozano-Fuentes, S; Black, WC				Campbell, Corey L.; Saavedra-Rodriguez, Karla; Kubik, Tristan D.; Lenhart, Audrey; Lozano-Fuentes, Saul; Black, William C.			Vgsc-interacting proteins are genetically associated with pyrethroid resistance in Aedes aegypti 1	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; MOSQUITO AEDES-AEGYPTI; INSECTICIDE RESISTANCE; MEMBRANE SKELETON; SYNAPTOTAGMIN-I; MESSENGER-RNA; DROSOPHILA; EXPRESSION; ANKYRIN; PUMILIO	Association mapping of factors that condition pyrethroid resistance in Aedes aegypti has consistently identified genes in multiple functional groups. Toward better understanding of the mechanisms involved, we examined high throughput sequencing data (HTS) from two Aedes aegypti aegypti collections from Merida, Yucatan, Mexico treated with either permethrin or deltamethrin. Exome capture enrichment for coding regions and the AaegL5 annotation were used to identify genes statistically associated with resistance. The frequencies of single nucleotide polymorphisms (SNPs) were compared between resistant and susceptible mosquito pools using a contingency chi(2) analysis. The -log(10)(chi(2) p value) was calculated at each SNP site, with a weighted average determined from all sites in each gene. Genes with -log(10)(chi(2) p value). 4.0 and present among all 3 treatment groups were subjected to gene set enrichment analysis (GSEA). We found that several functional groups were enriched compared to all coding genes. These categories were transport, signal transduction and metabolism, in order from highest to lowest statistical significance. Strikingly, 21 genes with demonstrated association to synaptic function were identified. In the high association group (n = 1,053 genes), several genes were identified that also genetically or physically interact with the voltage-gated sodium channel (VGSC). These genes were eg., CHARLATAN (CHL), a transcriptional regulator, several ankyrin-domain proteins, PUMILIO (PUM), a translational repressor, and NEDD4 (E3 ubiquitin-protein ligase). There were 13 genes that ranked among the top 10%: these included VGSC; CINGULIN, a predicted neuronal gap junction protein, and the aedine ortholog of NERVY (NVY), a transcriptional regulator. Silencing of CHL and NVY followed by standard permethrin bottle bioassays validated their association with permethrin resistance. Importantly, VGSC levels were also reduced about 50% in chl- or nvy-dsRNA treated mosquitoes. These results are consistent with the contribution of a variety of neuronal pathways to pyrethroid resistance in Ae. aegypti.	[Campbell, Corey L.; Saavedra-Rodriguez, Karla; Kubik, Tristan D.; Lozano-Fuentes, Saul; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Lenhart, Audrey] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA USA	Colorado State University; Centers for Disease Control & Prevention - USA	Campbell, CL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	corey.campbell@colostate.edu	; Lozano, Saul/H-4324-2011	Lenhart, Audrey/0000-0002-9156-4228; Saavedra-Rodriguez, Karla/0000-0001-8511-3327; Campbell, Corey L./0000-0002-6384-1259; Lozano, Saul/0000-0003-1517-6853	National Institutes of Health (NIH) [R01A10833680]; NIH/National Institute of Allergy and Infectious Diseases [RO1AI121211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121211] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) R01A10833680 and NIH/National Institute of Allergy and Infectious Diseases (RO1AI121211) awards to WCB4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2014, DEVELOPMENT, V141, P4716, DOI 10.1242/dev.113308; Arora D, 2016, LIFE SCI, V160, P72, DOI 10.1016/j.lfs.2016.04.025; Badiou A, 2008, ECOTOX ENVIRON SAFE, V69, P246, DOI 10.1016/j.ecoenv.2006.11.020; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Black W. C. IV, 1997, The molecular biology of insect disease vectors: a methods manual., P361; Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0; Breckenridge CB, 2009, NEUROTOXICOLOGY, V30, pS17, DOI 10.1016/j.neuro.2009.09.002; Brinzer RA, 2015, INSECT BIOCHEM MOLEC, V67, P74, DOI 10.1016/j.ibmb.2015.09.009; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Campbell CL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4348-4; Chandor-Proust A, 2013, BIOCHEM J, V455, P75, DOI 10.1042/BJ20130577; Chen ML, 2017, INSECT BIOCHEM MOLEC, V82, P1, DOI 10.1016/j.ibmb.2017.01.007; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; CORRIGAN JJ, 1963, J INSECT PHYSIOL, V9, P1, DOI 10.1016/0022-1910(63)90079-9; Cui F, 2015, PESTIC BIOCHEM PHYS, V121, P88, DOI 10.1016/j.pestbp.2014.12.016; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Dickson LB, 2017, G3-GENES GENOM GENET, V7, P571, DOI 10.1534/g3.116.036053; Driscoll HE, 2013, J NEUROSCI, V33, P9644, DOI 10.1523/JNEUROSCI.0921-13.2013; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; FEINSTEIN PG, 1995, GENETICS, V140, P573; FENG GL, 1992, PESTIC BIOCHEM PHYS, V42, P64, DOI 10.1016/0048-3575(92)90074-A; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Julio AHF, 2017, COMP BIOCHEM PHYS C, V195, P27, DOI 10.1016/j.cbpc.2017.01.011; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673; GANETZKY B, 1986, ANNU REV GENET, V20, P13; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771; Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harms E, 2000, GENETICS, V155, P1831; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; He J, 2016, P NATL ACAD SCI USA, V113, P6029, DOI 10.1073/pnas.1605707113; Howlett IC, 2013, G3-GENES GENOM GENET, V3, P1399, DOI 10.1534/g3.113.006130; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jenson LJ, 2016, PESTIC BIOCHEM PHYS, V130, P59, DOI 10.1016/j.pestbp.2015.11.012; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Juneja P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004765; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17772; Lin WH, 2017, DIS MODEL MECH, V10, P141, DOI 10.1242/dmm.027045; Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485; Lynn BD, 2012, J MEMBRANE BIOL, V245, P303, DOI 10.1007/s00232-012-9451-5; Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014; MANSINGH AJAL, 1965, J INSECT PHYSIOL, V11, P1389, DOI 10.1016/0022-1910(65)90176-9; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z; Mee CJ, 2004, J NEUROSCI, V24, P8695, DOI 10.1523/JNEUROSCI.2282-04.2004; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; Nix P, 2014, J NEUROSCI, V34, P629, DOI 10.1523/JNEUROSCI.3859-13.2014; NOM, 2010, NOM032SSA22010; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; Otali D, 2014, B ENTOMOL RES, V104, P323, DOI 10.1017/S0007485314000091; Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0; Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shao DM, 2009, INT J BIOCHEM CELL B, V41, P1471, DOI 10.1016/j.biocel.2009.01.016; SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Streit AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148461; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terhzaz S, 2015, INSECT BIOCHEM MOLEC, V67, P38, DOI 10.1016/j.ibmb.2015.06.002; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yan Y, 2011, TOXICOL LETT, V201, P258, DOI 10.1016/j.toxlet.2011.01.009; ZERBA E, 1988, PARASITOL TODAY, V4, pS3, DOI 10.1016/0169-4758(88)90079-8; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zhang YV, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00207; Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615	98	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211497	10.1371/journal.pone.0211497	http://dx.doi.org/10.1371/journal.pone.0211497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695054	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400038
J	Ivic, I; Balasko, M; Fulop, BD; Hashimoto, H; Toth, G; Tamas, A; Juhasz, T; Koller, A; Reglodi, D; Solymar, M				Ivic, Ivan; Balasko, Marta; Fulop, Balazs D.; Hashimoto, Hitoshi; Toth, Gabor; Tamas, Andrea; Juhasz, Tamas; Koller, Akos; Reglodi, Dora; Solymar, Margit			VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; CEREBRAL-ARTERIES; PHARMACOLOGICAL CHARACTERIZATION; PITUITARY; VIP; NEUROPEPTIDE; EXPRESSION; CORONARY; HORMONE	Background PACAP and VIP are closely related neuropeptides with wide distribution and potent effect in the vasculature. We previously reported vasomotor activity in peripheral vasculature of male wild type (WT) and PACAP-deficient (KO) mice. However, female vascular responses are still unexplored. We hypothesized that PACAP-like activity is maintained in female PACAP KO mice and the mechanism through which it is regulated differs from that of male PACAP KO animals. Methods We investigated the vasomotor effects of VIP and PACAP isoforms and their selective blockers in WT and PACAP KO female mice in carotid and femoral arteries. The expression and level of different PACAP receptors in the vessels were measured by RT-PCR and Western blot. Results In both carotid and femoral arteries of WT mice, PACAP1-38, PACAP1-27 or VIP induced relaxation, without pronounced differences between them. Reduced relaxation was recorded only in the carotid arteries of KO mice as compared to their WT controls. The specific VPAC1R antagonist completely blocked the PACAP/VIP-induced relaxation in both arteries of all mice, while PAC1R antagonist affected relaxation only in their femoral arteries. Conclusion In female WT mice, VPAC1 receptors appear to play a dominant role in PACAP-induced vasorelaxation both in carotid and in femoral arteries. In the PACAP KO group PAC1R activation exerts vasorelaxation in the femoral arteries but in carotid arteries there is no significant effect of the activation of this receptor. In the background of this regional difference, decreased PAC1R and increased VPAC1R availability in the carotid arteries was found.	[Ivic, Ivan; Fulop, Balazs D.; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Med Sch, MTA PTE PACAP Res Grp, Dept Anat, Pecs, Hungary; [Ivic, Ivan] Univ JJ Strossmayer, Med Sch Osijek, Dept Physiol & Immunol, Osijek, Croatia; [Balasko, Marta; Solymar, Margit] Univ Pecs, Inst Translat Med, Med Sch, Pecs, Hungary; [Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, Inst Databil Sci, Div Biosci, Suita, Osaka, Japan; [Toth, Gabor] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Juhasz, Tamas] Univ Debrecen, Dept Anat Histol & Embryol, Fac Med, Debrecen, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Koller, Akos] Univ Pecs, Med Sch, Dept Neurosurg, Pecs, Hungary; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Res Grp Sportgenet & Sportgerontol, Budapest, Hungary	University of Pecs; University of JJ Strossmayer Osijek; University of Pecs; Osaka University; Osaka University; Osaka University; Szeged University; University of Debrecen; New York Medical College; University of Pecs; University of Physical Education	Solymar, M (corresponding author), Univ Pecs, Inst Translat Med, Med Sch, Pecs, Hungary.	margit.solymar@aok.pte.hu	Juhasz, Tamas/M-6878-2019; Hashimoto, Hitoshi/D-1209-2010; Ákos, Koller/Q-4672-2019	Juhasz, Tamas/0000-0003-0489-5676; Hashimoto, Hitoshi/0000-0001-6548-4016; Solymar, Margit/0000-0001-6667-6263	Operative Program for the Development of Human Resources [EFOP-3.6.3-VEKOP-16-15 2017-00008, EFOP-3.6.3-VEKOP-16-2017-00009]; Hungarian National Science Research Fund (OTKA) [K115874, K104984, K119759, KTIA_13_NAP-A-III/5, GINOP-2.3.2-15-2016-00050 "PEPSYS", EFOP-3.6.1.-16-2016-00004]; "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs; Janos Bolyai Scholarship; New National Excellence Program of the Ministry of Human Capacities [UNKP-16-4-IV]; University of Pecs Medical School [PTE-AOK-KA-2015-14]; MTA-TKI; FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN; JSPS KAKENHI [JP26293020, JP17H03989]; SRPBS; Brain/MINDS from AMED; Hungarian Academy of Science; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]; Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary [20765-3/2018/FEKUTSTRAT];  [OTKA K108444]	Operative Program for the Development of Human Resources; Hungarian National Science Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs; Janos Bolyai Scholarship(Hungarian Academy of Sciences); New National Excellence Program of the Ministry of Human Capacities; University of Pecs Medical School; MTA-TKI; FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SRPBS; Brain/MINDS from AMED; Hungarian Academy of Science(Hungarian Academy of Sciences); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary; 	This work was supported by the Operative Program for the Development of Human Resources EFOP-3.6.3-VEKOP-16-15 2017-00008 "The role of neuro-inflammation in neurodegeneration: from molecules to clinics" and EFOP-3.6.3-VEKOP-16-2017-00009 and the Hungarian National Science Research Fund (OTKA) K115874, K104984, K119759, KTIA_13_NAP-A-III/5, GINOP-2.3.2-15-2016-00050 "PEPSYS", EFOP-3.6.1.-16-2016-00004, "Comprehensive Development for Implementing Smart Specialization Strategies" at the University of Pecs (D.R., A.T.), OTKA K108444 (A.K.); Janos Bolyai Scholarship (A.T., T.J.) and New Excellence Program (A.T., T.J), UNKP-16-4-IV, New National Excellence Program of the Ministry of Human Capacities (A. T.), University of Pecs Medical School PTE-AOK-KA-2015-14 (M. S.); MTA-TKI (D.R., T.A.) and FP7 Marie Sklodowska Curie project-Small Artery Remodeling (SmART) ITN (I.I, A.K.), in part by JSPS KAKENHI Grant Numbers JP26293020 (H.H.), JP17H03989 (H.H.); and the SRPBS and Brain/MINDS from AMED (H.H.), Magyary Zoltan Funds by Hungarian Academy of Science and the European Union and the State of Hungary (T.J.), co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 "National Excellence Program" (T.J.). Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the 20765-3/2018/FEKUTSTRAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; Almli LM, 2013, AM J MED GENET B, V162B, P262, DOI 10.1002/ajmg.b.32145; ANZAI M, 1995, EUR J PHARMACOL, V285, P173, DOI 10.1016/0014-2999(95)00404-9; Banki E, 2015, J GERONTOL A-BIOL, V70, P665, DOI 10.1093/gerona/glu116; Baun M, 2011, EUR J PHARMACOL, V670, P186, DOI 10.1016/j.ejphar.2011.08.016; BROYART JP, 1981, J CLIN ENDOCR METAB, V52, P715, DOI 10.1210/jcem-52-4-715; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CAMPBELL RM, 1992, GROWTH REGULAT, V2, P175; CARDELL LO, 1991, REGUL PEPTIDES, V36, P379, DOI 10.1016/0167-0115(91)90071-N; Chan KY, 2011, CEPHALALGIA, V31, P181, DOI 10.1177/0333102410375624; CHARTREL N, 1991, ENDOCRINOLOGY, V129, P3367, DOI 10.1210/endo-129-6-3367; CHENG DY, 1993, EUR J PHARMACOL, V243, P79, DOI 10.1016/0014-2999(93)90170-M; Dalsgaard T, 2003, REGUL PEPTIDES, V110, P179, DOI 10.1016/S0167-0115(02)00205-7; Erdling A, 2013, NEUROPEPTIDES, V47, P85, DOI 10.1016/j.npep.2012.12.005; Fahrenkrug J, 2000, J CEREBR BLOOD F MET, V20, P1205, DOI 10.1097/00004647-200008000-00006; Farkas J, 2017, J MOL NEUROSCI, V61, P468, DOI 10.1007/s12031-017-0887-z; Fulop B, 2018, J MOL NEUROSCI, P1; Hoover DB, 2009, J PHARMACOL EXP THER, V331, P197, DOI 10.1124/jpet.109.155747; Hoyle CHV, 1998, REGUL PEPTIDES, V73, P1, DOI 10.1016/S0167-0115(97)01073-2; HUANG M, 1993, PEPTIDES, V14, P755, DOI 10.1016/0196-9781(93)90109-T; Ivic I, 2017, J VASC RES, V54, P180, DOI 10.1159/000457798; Ivic I, 2017, J GERONTOL A-BIOL, V72, P481, DOI 10.1093/gerona/glw085; Jackson DN, 2005, J PHYSIOL-LONDON, V562, P285, DOI 10.1113/jphysiol.2004.076141; Jozsa R, 2005, PEPTIDES, V26, P2344, DOI 10.1016/j.peptides.2005.03.054; Karacay B, 2001, J MOL NEUROSCI, V17, P311, DOI 10.1385/JMN:17:3:311; Kiss P, 2007, GEN COMP ENDOCR, V152, P225, DOI 10.1016/j.ygcen.2006.12.012; Knutsson M, 2002, NEUROREPORT, V13, P507, DOI 10.1097/00001756-200203250-00030; Koide M, 2014, J MOL NEUROSCI, V54, P443, DOI 10.1007/s12031-014-0301-z; Kovacs-Valasek A, 2017, NEUROSCIENCE, V348, P1, DOI 10.1016/j.neuroscience.2017.02.003; KOVES K, 1991, NEUROENDOCRINOLOGY, V54, P159, DOI 10.1159/000125864; Laburthe M, 2002, REGUL PEPTIDES, V108, P165, DOI 10.1016/S0167-0115(02)00099-X; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; LAM KSL, 1990, BRAIN RES, V526, P135, DOI 10.1016/0006-8993(90)90259-E; Laughlin MH, 1985, J APPL PHYSIOL, V2001, P90; LEGRADI G, 1994, NEUROSCI LETT, V176, P193, DOI 10.1016/0304-3940(94)90080-9; Lutz EM, 1999, BRIT J PHARMACOL, V128, P934, DOI 10.1038/sj.bjp.0702872; Markovics A, 2012, NEUROBIOL DIS, V45, P633, DOI 10.1016/j.nbd.2011.10.010; Mercer A, 2004, J NEUROSCI RES, V76, P205, DOI 10.1002/jnr.20038; Mercer KB, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.241; MINKES RK, 1992, AM J PHYSIOL, V263, pH1659, DOI 10.1152/ajpheart.1992.263.6.H1659; Mori H, 2010, CIRC J, V74, P1183, DOI 10.1253/circj.CJ-09-1024; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nakamachi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12034; NANDHA KA, 1991, J ENDOCRINOL, V129, P69, DOI 10.1677/joe.0.1290069; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Reglodi D, 2018, J PATHOLOGY; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROSSASCUITTO NT, 1993, PEDIATR RES, V34, P323, DOI 10.1203/00006450-199309000-00017; Rubio-Beltran E, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0893-8; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Syed AU, 2012, J MOL NEUROSCI, V48, P574, DOI 10.1007/s12031-012-9851-0; Tamas A, 2012, INT J MOL SCI, V13, P8430, DOI 10.3390/ijms13078430; Vamos Z, 2014, J MOL NEUROSCI, V54, P535, DOI 10.1007/s12031-014-0349-9; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Vollesen A.L.H., 2018, NEUROTHERAPEUTICS, P1, DOI DOI 10.1007/S13311-018-0604-9; Zagami AS, 2014, ANN CLIN TRANSL NEUR, V1, P1036, DOI 10.1002/acn3.113	57	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211433	10.1371/journal.pone.0211433	http://dx.doi.org/10.1371/journal.pone.0211433			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682157	gold, Green Accepted, Green Published			2022-12-27	WOS:000457037500170
J	Kim, JY; Seo, C; Hong, S; Lee, S; Eo, SH				Kim, Jin-Yong; Seo, Changwan; Hong, Seungbum; Lee, Sanghun; Eo, Soo Hyung			Altitudinal range-size distribution of breeding birds and environmental factors for the determination of species richness: An empirical test of altitudinal Rapoport's rule and non-directional rescue effect on a local scale	PLOS ONE			English	Article							ELEVATIONAL GRADIENTS; GEOGRAPHICAL RANGE; PATTERNS; DIVERSITY; IMPACTS; DENSITY; ENERGY	Range-size distributions are important for understanding species richness patterns and led to the development of the controversial Rapoport's rule and Rapoport-rescue effect. This study aimed to understand the relationship between species richness and range-size distribution in relation to environmental factors. The present study tested the following: (1) altitudinal Rapoport's rule, and a subsequent test on climatic and ambient energy hypotheses, (2) non-directional rescue effect, and a subsequent test on effect of environmental factors associated with the distribution of narrowest to widest-range species. Altitudinal species range-size distribution increased with increasing altitude and showed a negative relationship with climatic variables. These results support the altitudinal Rapoport's rule and climatic hypothesis; however, they do not fully support the ambient energy hypothesis. Results from testing the non-directional rescue effect showed that the inflow intensity of species from both directions (high and low elevations) affected species richness. And we found that the species with intermediate range-size, rather than narrowest or widest range-size were the main cause of a mid-peak of species richness and the non-directional rescue effect. Additionally, the richness of species with intermediate range-size was highly related to minimum temperature, habitat heterogeneity, or primary productivity. Although altitudinal range-size distribution results were similar to the phenomenon of altitudinal Rapoport's rule, the mid-peak pattern of species richness could not be explained by the underlying mechanism of Rapoport's-rescue effect; however, the non-directional rescue effect could explain a mid-peak pattern of species richness along altitudinal gradient.	[Kim, Jin-Yong; Hong, Seungbum] Natl Inst Ecol, Div Ecosyst Serv & Res Planning, Seocheon, South Korea; [Kim, Jin-Yong; Eo, Soo Hyung] Kongju Natl Univ, Dept Forest Resources, Chungnam, South Korea; [Seo, Changwan] Natl Inst Ecol, Div Ecol Assessment Res, Seocheon, South Korea; [Lee, Sanghun] Natl Inst Ecol, Div Basic Ecol, Seocheon, South Korea	National Institute of Ecology; Kongju National University; National Institute of Ecology; National Institute of Ecology	Eo, SH (corresponding author), Kongju Natl Univ, Dept Forest Resources, Chungnam, South Korea.	eosh@kongju.ac.kr			National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea [NIE-BR-2019-11, NIE-BR-2015-11]; Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project - Korea Ministry of Environment [2014001310009]	National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea; Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project - Korea Ministry of Environment	This study was supported by the National Institute of Ecology through the project of assessment of climate change risk for ecosystem in Korea (NIE-BR-2019-11; NIE-BR-2015-11) and Korea Environment Industry & Technology Institute (KEITI) through the climate change response technology project, funded by Korea Ministry of Environment (2014001310009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeida-Neto M, 2006, J BIOGEOGR, V33, P361, DOI 10.1111/j.1365-2699.2005.01389.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Chan WP, 2016, SCIENCE, V351, P1437, DOI 10.1126/science.aab4119; Cho HH, 2018, PEERJ, V6, DOI 10.7717/peerj.5982; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Hawkins BA, 2006, GLOBAL ECOL BIOGEOGR, V15, P461, DOI 10.1111/j.1466-822x.2006.00243.x; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; Lepczyk CA, 2008, CONSERV BIOL, V22, P405, DOI 10.1111/j.1523-1739.2008.00881.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luo ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027975; McCain CM, 2013, GLOBAL ECOL BIOGEOGR, V22, P750, DOI 10.1111/geb.12014; Pan XY, 2016, PEERJ, V4, DOI 10.7717/peerj.2636; Presley S.J., 2018, ENCY ANTHROPOCENE, V1-5, P13, DOI [10.1016/B978-0-12-809665-9.09809-8, DOI 10.1016/B978-0-12-809665-9.09809-8]; ROHDE K, 1993, AM NAT, V142, P1, DOI 10.1086/285526; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; ROY K, 1994, P NATL ACAD SCI USA, V91, P8871, DOI 10.1073/pnas.91.19.8871; Royall R, 2017, STAT EVIDENCE LIKELI, DOI [10.1201/9780203738665, DOI 10.1201/9780203738665]; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; White RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121849; Williams YM, 2006, BIOL LETT-UK, V2, P532, DOI 10.1098/rsbl.2006.0541	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0203511	10.1371/journal.pone.0203511	http://dx.doi.org/10.1371/journal.pone.0203511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682009	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500004
J	Mancosu, M; Bobba, G				Mancosu, Moreno; Bobba, Giuliano			Using deep-learning algorithms to derive basic characteristics of social media users: The Brexit campaign as a case study	PLOS ONE			English	Article							POLITICAL-PARTICIPATION; FACEBOOK; ONLINE; TWITTER; AGE; ENGAGEMENT; TWEET; PREFERENCES; DIVIDE; VOTE	A recurrent criticism concerning the use of online social media data in political science research is the lack of demographic information about social media users. By employing a face-recognition algorithm to the profile pictures of Facebook users, the paper derives two fundamental demographic characteristics (age and gender) of a sample of Facebook users who interacted with the most relevant British parties in the two weeks before the Brexit referendum of 23 June 2016. The article achieves the goals of (i) testing the precision of the algorithm, (ii) testing its validity, (iii) inferring new evidence on digital mobilisation, and (iv) tracing the path for future developments and application of the algorithm. The findings show that the algorithm is reliable and that it can be fruitfully used in political and social sciences both to confirm the validity of survey data and to obtain information from populations that are generally unavailable within traditional surveys.	[Mancosu, Moreno; Bobba, Giuliano] Coll Carlo Alberto, Turin, Italy; [Bobba, Giuliano] Univ Turin, Dept Cultures Polit & Soc, Turin, Italy	Collegio Carlo Alberto; University of Turin	Mancosu, M (corresponding author), Coll Carlo Alberto, Turin, Italy.	moreno.mancosu@carloalberto.org	Mancosu, Moreno/ABF-1348-2020					Aldrich JH, 2016, PARTY POLIT, V22, P165, DOI 10.1177/1354068815605304; Auter ZJ, 2018, SOC SCI QUART, V99, P185, DOI 10.1111/ssqu.12391; Barbera P, 2017, R PACKAGE VERSION 0; Barbera P, 2015, POLIT ANAL, V23, P76, DOI 10.1093/pan/mpu011; Bekafigo MA, 2013, SOC SCI COMPUT REV, V31, P625, DOI 10.1177/0894439313490405; Bishop CM., 1995, NEURAL NETWORKS PATT; Bode L, J POLITICAL MARKETIN; Bond R, 2015, AM POLIT SCI REV, V109, P62, DOI 10.1017/S0003055414000525; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Burnap P, 2016, ELECT STUD, V41, P230, DOI 10.1016/j.electstud.2015.11.017; Carlisle JE, 2013, POLIT RES QUART, V66, P883, DOI 10.1177/1065912913482758; Ceron A, 2014, NEW MEDIA SOC, V16, P340, DOI 10.1177/1461444813480466; Chen SX, 2017, PROC CVPR IEEE, P742, DOI 10.1109/CVPR.2017.86; Cho H, 2014, INT J ADV ROBOT SYST, V11, DOI 10.5772/58473; Coffe H, 2010, SEX ROLES, V62, P318, DOI 10.1007/s11199-009-9729-y; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dehghan A, 2017, ARXIV170204280; Del Vicario M, 2017, SOC NETWORKS, V50, P6, DOI 10.1016/j.socnet.2017.02.002; DiGrazia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079449; Facebook Help Centre, 2017, DO I REP CHILD AG 13; Fieldhouse E., 2016, BRIT ELECTION STUDY, P1, DOI DOI 10.15127/1.293723; Freelon D, COMPUTATIONAL RES PO; Freeman B, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2521517; Gayo-Avello D., 2012, ARXIV PREPRINT ARXIV, DOI DOI 10.1234/12345678; Gayo-Avello D., 2011, 5 INT AAAI C WEBL SO; Gentry J, 2016, R PACK VERS 1 1 9; Gerodimos R, 2015, J INF TECHNOL POLITI, V12, P113, DOI 10.1080/19331681.2014.982266; Goodwin MJ, 2016, POLIT QUART, V87, P323, DOI 10.1111/1467-923X.12285; Guo GD, 2012, STUD COMPUT INTELL, V409, P101; Gustafsson N, 2012, NEW MEDIA SOC, V14, P1111, DOI 10.1177/1461444812439551; Halpern D, 2013, COMPUT HUM BEHAV, V29, P1159, DOI 10.1016/j.chb.2012.10.008; Hobolt SB, 2016, J EUR PUBLIC POLICY, V23, P1259, DOI 10.1080/13501763.2016.1225785; Howard PN, 2016, EARLYVIEW; Huberty M, 2015, INT J FORECASTING, V31, P992, DOI 10.1016/j.ijforecast.2014.08.005; Hum NJ, 2011, COMPUT HUM BEHAV, V27, P1828, DOI 10.1016/j.chb.2011.04.003; Hurlimann M, 2016, P 12 INT C SEM SYST, DOI DOI 10.1145/2993318.2993350; Jung S. G., 2018, INT AAAI C WEB SOC M, P624; Krizhevsky A., P 25 INT C NEUR INF, P1097; Levi Gil, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P34, DOI 10.1109/CVPRW.2015.7301352; Lian JW, 2014, COMPUT HUM BEHAV, V37, P133, DOI 10.1016/j.chb.2014.04.028; Loader BD, 2014, INFORM COMMUN SOC, V17, P143, DOI 10.1080/1369118X.2013.871571; McKelvey K, 2014, INFORM COMMUN SOC, V17, P436, DOI 10.1080/1369118X.2014.892149; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Mislove A, P 5 INT AAAI C WEBL, P554; NIU ZX, 2016, PROC CVPR IEEE, P4920, DOI DOI 10.1109/CVPR.2016.532; Norris P., 2004, YOUNG PEOPLE POLITIC; Pfeil U, 2009, COMPUT HUM BEHAV, V25, P643, DOI 10.1016/j.chb.2008.08.015; Rothe R, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOP (ICCVW), P252, DOI 10.1109/ICCVW.2015.41; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Seaton J, 2016, POLIT QUART, V87, P333, DOI 10.1111/1467-923X.12296; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Si J, 2015, LECT NOTES COMPUT SC, V9428, P677, DOI 10.1007/978-3-319-25417-3_79; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Smets K, 2012, J ELECT PUBLIC OPIN, V22, P407, DOI 10.1080/17457289.2012.728221; Thimm C, 2014, MEDIATIZED WORLDS: CULTURE AND SOCIETY IN A MEDIA AGE, P253; Vaccari C, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305116664221; Vaccari C, 2017, POLIT COMMUN, V34, P69, DOI 10.1080/10584609.2016.1201558; Vaccari C, 2015, J COMPUT-MEDIAT COMM, V20, P221, DOI 10.1111/jcc4.12108; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Vinyals O, 2015, PROC CVPR IEEE, P3156, DOI 10.1109/CVPR.2015.7298935; Vissers S, 2014, INFORM COMMUN SOC, V17, P937, DOI 10.1080/1369118X.2013.867356; Weaver J, 2013, SEMANT WEB, V4, P245, DOI 10.3233/SW-2012-0078; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Yamamoto M, 2015, NEW MEDIA SOC, V17, P880, DOI 10.1177/1461444813518390	67	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211013	10.1371/journal.pone.0211013	http://dx.doi.org/10.1371/journal.pone.0211013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682111	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500090
J	Pereira, F; Rettel, M; Stein, F; Savitski, MM; Collinson, I; Romisch, K				Pereira, Fabio; Rettel, Mandy; Stein, Frank; Savitski, Mikhail M.; Collinson, Ian; Roemisch, Karin			Effect of Sec61 interaction with Mpd1 on endoplasmic reticulum-associated degradation	PLOS ONE			English	Article							MISFOLDED SECRETORY PROTEIN; QUALITY-CONTROL; MEMBRANE-PROTEINS; TRANSLOCATION; GENE; ERAD; CHANNEL; EXPRESSION; TRANSPORT; EXPORT	Proteins that misfold in the endoplasmic reticulum (ER) are transported back to the cytosol for ER-associated degradation (ERAD). The Sec61 channel is one of the candidates for the retrograde transport conduit. Channel opening from the ER lumen must be triggered by ERAD factors and substrates. Here we aimed to identify new lumenal interaction partners of the Sec61 channel by chemical crosslinking and mass spectrometry. In addition to known Sec61 interactors we detected ERAD factors including Cue1, Ubc6, Ubc7, Asi3, and Mpd1. We show that the CPY* ERAD factor Mpd1 binds to the lumenal Sec61 hinge region. Deletion of the Mpd1 binding site reduced the interaction between both proteins and caused an ERAD defect specific for CPY* without affecting protein import into the ER or ERAD of other substrates. Our data suggest that Mpd1 binding to Sec61 is a prerequisite for CPY* ERAD and confirm a role of Sec61 in ERAD of misfolded secretory proteins.	[Pereira, Fabio; Roemisch, Karin] Saarland Univ, Fac Nat Sci & Technol, Saarbrucken, Germany; [Rettel, Mandy; Stein, Frank; Savitski, Mikhail M.] EMBL, Prote Core Facil, Heidelberg, Germany; [Collinson, Ian] Univ Bristol, Sch Biochem, Bristol, Avon, England	Saarland University; European Molecular Biology Laboratory (EMBL); University of Bristol	Romisch, K (corresponding author), Saarland Univ, Fac Nat Sci & Technol, Saarbrucken, Germany.	k.roemisch@mx.uni-saarland.de	Römisch, Karin/AAO-1210-2021	Römisch, Karin/0000-0003-0415-6558; Collinson, Ian/0000-0002-3931-0503; Stein, Frank/0000-0001-9695-1692	Saarland University; BBSRC [BB/M003604/1, BB/N015126/1]	Saarland University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	KR received core funding from the Saarland University; IC received funding from the BBSRC, BB/M003604/1 and BB/N015126/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, IN VITRO MUTAGENESIS, P177; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Braunstein I, 2015, MOL BIOL CELL, V26, P3719, DOI 10.1091/mbc.E15-02-0085; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Gatto L, 2012, BIOINFORMATICS, V28, P288, DOI 10.1093/bioinformatics/btr645; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HUBER W, 2002, BIOINFORMATICS S1, V18; Jadhav B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10133; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kaiser ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117260; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; MEHNERT M, 2013, CELL, V16, P77, DOI DOI 10.1038/; Neal S, 2018, MOL CELL, V69, P306, DOI 10.1016/j.molcel.2017.12.012; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Pilla E, 2017, ANNU REV CELL DEV BI, V33, P439, DOI 10.1146/annurev-cellbio-111315-125334; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1999, J CELL SCI, V112, P4123; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romisch K, 2017, TRENDS BIOCHEM SCI, V42, P171, DOI 10.1016/j.tibs.2016.10.005; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Scheper W, 2003, J BIOL CHEM, V278, P37998, DOI 10.1074/jbc.M300176200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Servas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082058; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tretter T, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-56; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Voorhees R, 2016, STRUCTURE MAMMALIAN; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545	48	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211180	10.1371/journal.pone.0211180	http://dx.doi.org/10.1371/journal.pone.0211180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682149	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500117
J	Ehler, J; Petzold, A; Wittstock, M; Kolbaske, S; Gloger, M; Henschel, J; Heslegrave, A; Zetterberg, H; Lunn, MP; Rommer, PS; Grossmann, A; Sharshar, T; Richter, G; Noldge-Schomburg, G; Sauer, M				Ehler, Johannes; Petzold, Axel; Wittstock, Matthias; Kolbaske, Stephan; Gloger, Martin; Henschel, Joerg; Heslegrave, Amanda; Zetterberg, Henrik; Lunn, Michael P.; Rommer, Paulus S.; Grossmann, Annette; Sharshar, Tarek; Richter, Georg; Noeldge-Schomburg, Gabriele; Sauer, Martin			The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; SEPTIC SHOCK; BRAIN-INJURY; SERUM; CARE; BIOMARKERS; PROTEIN; RELIABILITY; SEVERITY; VALIDITY	Sepsis-associated encephalopathy (SAE) contributes to mortality and neurocognitive impairment of sepsis patients. Neurofilament (Nf) light (NfL) and heavy (NfH) chain levels as biomarkers for neuroaxonal injury were not evaluated in cerebrospinal fluid (CSF) and plasma of patients with sepsis-associated encephalopathy (SAE) before. We conducted a prospective, pilot observational study including 20 patients with septic shock and five patients without sepsis serving as controls. The assessment of SAE comprised a neuropsychiatric examination, electroencephalography (EEG), magnetic resonance imaging (MRI) and delirium screening methods including the confusion assessment method for the ICU (CAM-ICU) and the intensive care delirium screening checklist (ICDSC). CSF Nf measurements in sepsis patients and longitudinal plasma Nf measurements in all participants were performed on days 1, 3 and 7 after study inclusion. Plasma NfL levels increased in sepsis patients over time (p = 0.0063) and remained stable in patients without sepsis. Plasma NfL values were significantly higher in patients with SAE (p = 0.011), significantly correlated with the severity of SAE represented by ICDSC values (R = 0.534, p = 0.022) and correlated with a poorer functional outcome after 100 days (R = -0.535, p = 0.0003). High levels of CSF Nf were measured in SAE patients. CSF NfL levels were higher in non-survivors (p = 0.012) compared with survivors and correlated with days until death (R = -0.932, p<0.0001) and functional outcome after 100 days (R = -0.749, p<0.0001). The present study showed for the first time that Nf levels provide complementary prognostic information in SAE patients indicating a higher chance of death and poorer functional/cognitive outcome in survivors.	[Ehler, Johannes; Richter, Georg; Noeldge-Schomburg, Gabriele; Sauer, Martin] Univ Med Ctr Rostock, Dept Anesthesiol & Intens Care Med, Rostock, Germany; [Ehler, Johannes; Petzold, Axel; Lunn, Michael P.] UCL, Inst Neurol, Dept Neuroimmunol, London, England; [Petzold, Axel] Natl Hosp Neurol & Neurosurg, Moorfields Eye Hosp, London, England; [Wittstock, Matthias; Kolbaske, Stephan] Univ Med Ctr Rostock, Dept Neurol, Rostock, Germany; [Gloger, Martin; Henschel, Joerg] Univ Med Ctr Rostock, Intens Care Unit, Dept Internal Med, Rostock, Germany; [Heslegrave, Amanda; Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Heslegrave, Amanda; Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Rommer, Paulus S.] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Grossmann, Annette] Univ Med Ctr Rostock, Inst Diagnost & Intervent Radiol, Rostock, Germany; [Sharshar, Tarek] Paris Decartes Univ, St Anne Teaching Hosp, Dept Neuroanesthesiol & Intens Care Med, Paris, France; [Sharshar, Tarek] Inst Pasteur, Lab Human Histopathol & Anim Models, Paris, France	University of Rostock; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Rostock; University of Rostock; University of London; University College London; University of London; University College London; University of Gothenburg; Sahlgrenska University Hospital; Medical University of Vienna; University of Rostock; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ehler, J (corresponding author), Univ Med Ctr Rostock, Dept Anesthesiol & Intens Care Med, Rostock, Germany.; Ehler, J (corresponding author), UCL, Inst Neurol, Dept Neuroimmunol, London, England.	johannes.ehler@med.uni-rostock.de	Petzold, Axel/C-1090-2009; Sauer, Martin/GZK-4547-2022; Richter, Georg/GZK-4472-2022; Sharshar, Tarek/ABF-4117-2021	Petzold, Axel/0000-0002-0344-9749; Lunn, Michael/0000-0003-3174-6027	University of Rostock; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology; MRC [UKDRI-1003] Funding Source: UKRI	University of Rostock; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The University of Rostock supported the department of anesthesiology and intensive care medicine with institutional departmental funds for biomarker measurements and for EEG recordings.; Dr. Petzold is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital National Health Service (NHS) Foundation Trust and University College London Institute of Ophthalmology.	Anderson BJ, 2016, J CRIT CARE, V36, P18, DOI 10.1016/j.jcrc.2016.06.012; Chaudhry Neera, 2014, Adv Med, V2014, P762320, DOI 10.1155/2014/762320; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Cotena S, 2012, TRANSL MED UNISA, V2, P20; Della Pietra GL, 2011, STROKE, V42, P2077, DOI 10.1161/STROKEAHA.111.613521; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ehler J, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1850-7; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Evered L, 2018, JAMA NEUROL, V75, P542, DOI 10.1001/jamaneurol.2017.4913; Feng Q, 2017, Zhonghua Nei Ke Za Zhi, V56, P747, DOI 10.3760/cma.j.issn.0578-1426.2017.10.008; Feng Q, 2019, J INTENSIVE CARE MED, V34, P938, DOI 10.1177/0885066617719750; Flierl MA, 2010, CRIT CARE, V14, DOI 10.1186/cc9035; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Girard TD, 2016, ANNU REV MED, V67, P497, DOI 10.1146/annurev-med-050913-015722; Guenther U, 2010, J CRIT CARE, V25, P144, DOI 10.1016/j.jcrc.2009.08.005; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Heming N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1643-z; Hosokawa K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0674-y; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Khanal K, 2016, INDIAN J CRIT CARE M, V20, P473, DOI 10.4103/0972-5229.188199; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Oddo M, 2015, MINERVA ANESTESIOL, V81, P776; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2005, CRIT CARE MED, V33, P1464, DOI 10.1097/01.CCM.0000166866.47020.E5; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2003, J NEUROIMMUNOL, V138, P45, DOI 10.1016/S0165-5728(03)00092-4; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Piva Simone, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P10; Polito A, 2013, CRIT CARE, V17, DOI 10.1186/cc12899; Rabinstein AA, 2006, J NEUROL NEUROSUR PS, V77, P711, DOI 10.1136/jnnp.2006.089581; Schramm P, 2012, CRIT CARE, V16, DOI 10.1186/cc11665; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Sharshar T, 2002, CRIT CARE MED, V30, P2371, DOI 10.1097/00003246-200210000-00031; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Skillback T, 2014, NEUROLOGY, V83, P1945, DOI 10.1212/WNL.0000000000001015; Sonneville R, 2017, INTENS CARE MED, V43, P1075, DOI 10.1007/s00134-017-4807-z; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; Villa P, 2016, J AM GERIATR SOC, V64, P536, DOI 10.1111/jgs.14031; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Zenaide Paula Veriato, 2013, Rev. bras. ter. intensiva, V25, P56, DOI 10.1590/S0103-507X2013000100011	54	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211184	10.1371/journal.pone.0211184	http://dx.doi.org/10.1371/journal.pone.0211184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677080	Green Submitted, Green Published, gold			2022-12-27	WOS:000456700400057
J	Kwon, J; Kim, S; Yoo, H; Lee, E				Kwon, Jeongyoon; Kim, Seungyeon; Yoo, Hyejin; Lee, Euni			Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis	PLOS ONE			English	Review							INDUCED LIVER-INJURY; ADVERSE DRUG-REACTIONS; INDUCED HEPATITIS; FAILURE; NSAIDS; RISK; DISPROPORTIONALITY; PHARMACOVIGILANCE; TRANSPLANTATION; INHIBITORS	Objective This study aimed to evaluate the risk for hepatotoxicity with nimesulide, a non-steroidal anti-inflammatory drug (NSAID) available in Republic of Korea but withdrawn from the market in several countries. Methods A systematic review and meta-analysis were conducted of studies retrieved from PubMed, EMBASE, Cochrane, the Research Information Sharing Service and ClinicalTrials.gov up to September 2017. All studies reporting nimesulide-associated hepatotoxicity in patients as compared with the unexposed or the exposed to other NSAIDs were included. Studies using spontaneous reporting databases were included to estimate reporting odds ratio (ROR) of hepatotoxicity associated with nimesulide exposure. The association between nimesulide use and hepatotoxicity was estimated using relative risk (RR) and ROR with 95% confidence interval (CI). Results A total of 25 observational studies were eligible for review. In a meta-analysis of five observational studies, nimesulide was significantly associated with hepatotoxicity [RR 2.21, 95% CI 1.72-2.83]. From studies using spontaneous reporting databases (n = 6), rates of reported hepatotoxicity were significantly higher in patients using nimesulide, compared with those treated with other NSAIDs [pooled ROR 3.99, 95% CI 2.86-5.57]. Of a total of 33 patients from case studies and series, the majority (n = 28, 84.8%) were female, and the mean age (+/- standard deviation) was 56.8 (+/- 15.6) years. Almost half of the patients on nimesulide (45.5%) either required liver transplantation or died due to fulminant hepatic failure, of whom a third developed hepatotoxicity within less than 15 days of nimesulide administration. Conclusions Our study findings support previous reports of an increased risk for hepatotoxicity with nimesulide use and add to existing literature by providing risk estimates for nimesulide-associated hepatotoxicity. As the limited number of studies with primarily observational study designs were included in the analysis, more studies are needed to further describe the effects of dose and length of treatment on the risk for hepatotoxicity.	[Kwon, Jeongyoon; Kim, Seungyeon; Yoo, Hyejin; Lee, Euni] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kwon, Jeongyoon; Kim, Seungyeon; Yoo, Hyejin; Lee, Euni] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, E (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	eunilee@snu.ac.kr		Lee, Euni/0000-0002-4487-4450	Creative-Pioneering Researchers Program through Seoul National University	Creative-Pioneering Researchers Program through Seoul National University	This work was supported by Creative-Pioneering Researchers Program through Seoul National University. (http://www.snu.ac.kr/index.html, recipient: EL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud G, 2007, DRUG SAFETY, V30, P277, DOI 10.2165/00002018-200730040-00001; Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006; Bennett A, 2001, Expert Opin Pharmacother, V2, P1859; Bessone F, 1997, HEPATOLOGY, V26, P1417; Bok Chae Hee, 2000, KOREAN J INTERN MED, V59, P114; Chafterjee S, 2008, J POSTGRAD MED, V54, P150; Cholongitas E, 2003, ANN GASTROENTEROL, V16, P359; Danan G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010014; Dastis SN, 2007, EUR J GASTROEN HEPAT, V19, P919, DOI 10.1097/MEG.0b013e3282eeb4cc; Donati M, 2016, BRIT J CLIN PHARMACO, V82, P238, DOI 10.1111/bcp.12938; Egberts ACG, 2002, DRUG SAFETY, V25, P453, DOI 10.2165/00002018-200225060-00010; EMA, ASS REP NIM CONT MED; EMEA, COMM PROPR MED PROD; Gallelli L, 2005, CLIN DRUG INVEST, V25, P421, DOI 10.2165/00044011-200525060-00008; Gulmez SE, 2013, DRUG SAFETY, V36, P135, DOI 10.1007/s40264-012-0013-7; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; Hussaini SH, 2007, EXPERT OPIN DRUG SAF, V6, P673, DOI 10.1517/14740338.6.6.673; IMB, IMB SUSP MARK NIM CO; Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895; Kress HG, 2016, CURR MED RES OPIN, V32, P23, DOI 10.1185/03007995.2015.1100986; Lacroix I, 2004, FUND CLIN PHARMACOL, V18, P201, DOI 10.1111/j.1472-8206.2004.00224.x; Lapeyre-Mestre M, 2006, FUND CLIN PHARMACOL, V20, P391, DOI 10.1111/j.1472-8206.2006.00416.x; Lapeyre-Mestre M, 2013, FUND CLIN PHARMACOL, V27, P223, DOI 10.1111/j.1472-8206.2011.00991.x; Lee CH, 2010, PHARMACOEPIDEM DR S, V19, P708, DOI 10.1002/pds.1966; Licata A, 2010, DIGEST LIVER DIS, V42, P143, DOI 10.1016/j.dld.2009.06.009; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Merlani G, 2001, EUR J CLIN PHARMACOL, V57, P321, DOI 10.1007/s002280100312; Mitchell SJ, 2010, THER ADV DRUG SAF, V1, P65, DOI 10.1177/2042098610386281; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montastruc JL, 2011, BRIT J CLIN PHARMACO, V72, P905, DOI 10.1111/j.1365-2125.2011.04037.x; Motola D, 2007, EUR J CLIN PHARMACOL, V63, P73, DOI 10.1007/s00228-006-0222-z; Page M, 2008, ANN FR ANESTH, V27, P742, DOI 10.1016/j.annfar.2008.04.023; Rodrigo L, 2002, SCAND J GASTROENTERO, V37, P1341, DOI 10.1080/003655202761020650; Sabate M, 2007, ALIMENT PHARM THER, V25, P1401, DOI 10.1111/j.1365-2036.2007.03338.x; Sanchez-Matienzo D, 2006, CLIN THER, V28, P1123, DOI 10.1016/j.clinthera.2006.08.014; Sbeit W, 2001, ANN PHARMACOTHER, V35, P1049, DOI 10.1177/106002800103500901; Schattner A, 2000, J INTERN MED, V247, P153, DOI 10.1046/j.1365-2796.2000.00612.x; Suzuki A, 2010, DRUG SAFETY, V33, P503, DOI 10.2165/11535340-000000000-00000; Tan H. H., 2007, SMJ Singapore Medical Journal, V48, P582; Traversa G, 2003, BMJ-BRIT MED J, V327, P18, DOI 10.1136/bmj.327.7405.18; van Hunsel F, 2010, PHARMACOEPIDEM DR S, V19, P26, DOI 10.1002/pds.1865; Van Steenbergen W, 1998, J HEPATOL, V29, P135, DOI 10.1016/S0168-8278(98)80188-8; Varallo FR, 2014, REV ESC ENFERM USP, V48, P739, DOI 10.1590/S0080-623420140000400023; Venegoni M, 2010, ANN I SUPER SANITA, V46, P153, DOI 10.4415/ANN_10_02_08; Walker SL, 2008, PHARMACOEPIDEM DR S, V17, P1108, DOI 10.1002/pds.1665; Weiss P, 1999, ISRAEL MED ASSOC J, V1, P89; Wells GA, THE NEWCASTLE OTTAWA; Wober W, 1999, RHEUMATOLOGY, V38, P33, DOI 10.1093/rheumatology/38.suppl_1.33; Zhou L, 2017, DRUG METAB DISPOS, V45, P441, DOI 10.1124/dmd.116.074104	49	14	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0209264	10.1371/journal.pone.0209264	http://dx.doi.org/10.1371/journal.pone.0209264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677025	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400007
J	de la Fuente-Tomas, L; Arranz, B; Safont, G; Sierra, P; Sanchez-Autet, M; Garcia-Blanco, A; Garcia-Portilla, MP				de la Fuente-Tomas, Lorena; Arranz, Belen; Safont, Gemma; Sierra, Pilar; Sanchez-Autet, Monica; Garcia-Blanco, Ana; Garcia-Portilla, Maria P.			Classification of patients with bipolar disorder using k-means clustering	PLOS ONE			English	Article							VS. LATE-STAGE; METABOLIC SYNDROME; SPANISH VERSIONS; QUALITY; MODEL; DEPRESSION; ILLNESS; RELIABILITY; COGNITION	Introduction Bipolar disorder (BD) is a heterogeneous disorder needing personalized and shared decisions. We aimed to empirically develop a cluster-based classification that allocates patients according to their severity for helping clinicians in these processes. Methods Naturalistic, cross-sectional, multicenter study. We included 224 subjects with BD (DSM-IV-TR) under outpatient treatment from 4 sites in Spain. We obtained information on sociodemography, clinical course, psychopathology, cognition, functioning, vital signs, anthropometry and lab analysis. Statistical analysis: k-means clustering, comparisons of between group variables, and expert criteria. Results and discussion We obtained 12 profilers from 5 life domains that classified patients in five clusters. The profilers were: Number of hospitalizations and of suicide attempts, comorbid personality disorder, body mass index, metabolic syndrome, the number of comorbid physical illnesses, cognitive functioning, being permanently disabled due to BD, global and leisure time functioning, and patients' perception of their functioning and mental health. We obtained preliminary evidence on the construct validity of the classification: (1) all the profilers behaved correctly, significantly increasing in severity as the severity of the clusters increased, and (2) more severe clusters needed more complex pharmacological treatment. Conclusions We propose a new, easy-to-use, cluster-based severity classification for BD that may help clinicians in the processes of personalized medicine and shared decision-making.	[de la Fuente-Tomas, Lorena; Arranz, Belen; Safont, Gemma; Garcia-Portilla, Maria P.] Fondos FEDER, Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain; [de la Fuente-Tomas, Lorena; Garcia-Portilla, Maria P.] Univ Oviedo, Dept Psychiat, Oviedo, Spain; [Arranz, Belen; Sanchez-Autet, Monica] Parc Sanitari St Joan Deu, Barcelona, Spain; [Arranz, Belen; Safont, Gemma; Sanchez-Autet, Monica] Univ Barcelona, Barcelona, Spain; [Safont, Gemma] Univ Hosp Mutua Terrassa, Barcelona, Spain; [Sierra, Pilar; Garcia-Blanco, Ana] La Fe Univ & Polytech Hosp, Valencia, Spain; [Sierra, Pilar; Garcia-Blanco, Ana] Univ Valencia, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of Oviedo; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Valencia	Garcia-Portilla, MP (corresponding author), Fondos FEDER, Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain.; Garcia-Portilla, MP (corresponding author), Univ Oviedo, Dept Psychiat, Oviedo, Spain.	albert@uniovi.es	de la Fuente-Tomás, Lorena/O-6300-2018; García-Blanco, Ana/I-1928-2017; Garcia-Portilla, Paz/AAC-8272-2020; Sanchez, Monica/ABI-6419-2020	García-Blanco, Ana/0000-0002-7840-000X; Garcia-Portilla, Paz/0000-0003-3643-1622; Sanchez-Autet, Monica/0000-0003-1349-9042; de la Fuente-Tomas, Lorena/0000-0001-8220-5007; Safont, Gemma/0000-0001-5122-9161	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness [FIS PI11/02493]; Fondos Europeos de Desarrollo Regional (FEDER); Principado de Asturias Goberment	Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness; Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Principado de Asturias Goberment	This research was supported by grant FIS PI11/02493 (PI: Maria Paz Garcia-Portilla) of the Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness and Fondos Europeos de Desarrollo Regional (FEDER). Lorena de la Fuente-Tomas has received a Severo Ochoa grant supported by Principado de Asturias Goberment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2016, J PSYCHIATR NEUROSCI, V41, P291, DOI 10.1503/jpn.160151; American Psychiatric Association, 1987, DSM IIIR DIAGN STAT; Anaya C, 2016, ACTA PSYCHIAT SCAND, V133, P386, DOI 10.1111/acps.12535; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Berk M, 2007, BIPOLAR DISORD, V9, P671, DOI 10.1111/j.1399-5618.2007.00484.x; Berk M, 2017, WORLD PSYCHIATRY, V16, P236, DOI 10.1002/wps.20441; Berk M, 2014, BIPOLAR DISORD, V16, P471, DOI 10.1111/bdi.12099; Berk M, 2011, BIPOLAR DISORD, V13, P87, DOI 10.1111/j.1399-5618.2011.00889.x; Bernardo M, 2018, REV PSIQUIATR SALUD, V11, P66, DOI 10.1016/j.rpsm.2017.09.002; Birner A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172699; Bobes J, 2003, MED CLIN-BARCELONA, V120, P693, DOI 10.1157/13047695; Bobes J., 2000, PSICOTHEMA, V12, P107; Cao B, 2016, J PSYCHIATR RES, V73, P102, DOI 10.1016/j.jpsychires.2015.12.012; Castaño-Ramírez Oscar Mauricio, 2018, rev.colomb.psiquiatr., V47, P119, DOI 10.1016/j.rcp.2017.01.004; Colom F, 2002, MED CLIN-BARCELONA, V119, P366, DOI 10.1016/S0025-7753(02)73419-2; Cosci F, 2013, PSYCHOTHER PSYCHOSOM, V82, P20, DOI 10.1159/000342243; Duffy A, 2014, CAN J PSYCHIAT, V59, P659, DOI 10.1177/070674371405901208; Ferensztajn E, 2014, PSYCHIATR POL, V48, P1127, DOI 10.12740/PP/24239; Fernandes BS, 2017, REV BRAS PSIQUIATR, V39, P88, DOI 10.1590/1516-4446-2017-3902; First MB, 2002, STRUCTURED CLIN INTE; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Garcia-Portilla MP, 2008, J AFFECT DISORDERS, V106, P197, DOI 10.1016/j.jad.2007.06.002; Garcia-Portilla MP, 2009, J AFFECT DISORDERS, V115, P302, DOI 10.1016/j.jad.2008.09.008; Goi PD, 2015, REV BRAS PSIQUIATR, V37, P121, DOI 10.1590/1516-4446-2014-1554; Gomez-Benito J, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-127; Grande I, 2014, ACTA PSYCHIAT SCAND, V129, P437, DOI 10.1111/acps.12268; Grande I, 2012, PHYSIOL BEHAV, V106, P46, DOI 10.1016/j.physbeh.2011.10.029; Guidi J, 2017, J CLIN PSYCHIAT, V78, P456, DOI 10.4088/JCP.16r10736; Guy W., 1976, EARLY CLIN DRUG EVAL; Joyce K, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-016-0060-6; Kapczinski F, 2014, ACTA PSYCHIAT SCAND, V130, P354, DOI 10.1111/acps.12305; Kapczinski F, 2009, EXPERT REV NEUROTHER, V9, P957, DOI [10.1586/ern.09.31, 10.1586/ERN.09.31]; Kapczinski F, 2009, PROG NEURO-PSYCHOPH, V33, P1366, DOI 10.1016/j.pnpbp.2009.07.027; Kauer-Sant'Anna M, 2009, INT J NEUROPSYCHOPH, V12, P447, DOI 10.1017/S1461145708009310; Lobo A, 2002, MED CLIN-BARCELONA, V118, P493, DOI 10.1016/S0025-7753(02)72429-9; Magalhaes PV, 2012, AUST NZ J PSYCHIAT, V46, P1058, DOI 10.1177/0004867412460593; McGorry P, 2014, WORLD PSYCHIATRY, V13, P211, DOI 10.1002/wps.20144; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Muneer A, 2016, CLIN PSYCHOPHARM NEU, V14, P117, DOI 10.9758/cpn.2016.14.2.117; Mwangi Benson, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P186; Passos IC, 2015, INT J BIPOLAR DISORD, V3, DOI 10.1186/s40345-015-0033-1; Passos IC, 2017, EXPERT REV NEUROTHER, V17, P93, DOI 10.1080/14737175.2017.1268532; Garcia-Portilla MP, 2011, J SEX MED, V8, P1371, DOI 10.1111/j.1743-6109.2010.02043.x; Pozon SR, 2016, REV PSIQUIATR SALUD, V9, P175, DOI 10.1016/j.rpsm.2016.01.003; Reinares M, 2013, J AFFECT DISORDERS, V144, P65, DOI 10.1016/j.jad.2012.06.005; Reininghaus EZ, 2016, BIPOLAR DISORD, V18, P155, DOI 10.1111/bdi.12380; Rosa AR, 2012, ACTA PSYCHIAT SCAND, V125, P335, DOI 10.1111/j.1600-0447.2011.01830.x; Rosa Adriane R, 2007, Clin Pract Epidemiol Ment Health, V3, P5, DOI 10.1186/1745-0179-3-5; Rosa AR, 2014, J CLIN PSYCHIAT, V75, pE450, DOI 10.4088/JCP.13m08625; Samalin L, 2016, BIPOLAR DISORD, V18, P164, DOI 10.1111/bdi.12376; Sierra P, 2005, BIPOLAR DISORD, V7, P159, DOI 10.1111/j.1399-5618.2005.00186.x; Siwek M, 2017, MOL NEUROBIOL, V54, P5883, DOI 10.1007/s12035-016-0124-8; Soria V, 2018, REV PSIQUIATR SALUD, V11, P115, DOI 10.1016/j.rpsm.2017.07.006; Tatay-Manteiga A, 2017, PROG NEURO-PSYCHOPH, V77, P194, DOI 10.1016/j.pnpbp.2017.04.028; Vancampfort D, 2016, J AFFECT DISORDERS, V201, P145, DOI 10.1016/j.jad.2016.05.020; Verduijn J, 2015, J CLIN PSYCHIAT, V76, P1200, DOI 10.4088/JCP.14m09272; Vieta E, 2013, EUR PSYCHIAT, V28, P21, DOI 10.1016/j.eurpsy.2011.11.007; Weber NS, 2011, PSYCHIAT SERV, V62, P1152, DOI 10.1176/ps.62.10.pss6210_1152	58	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210314	10.1371/journal.pone.0210314	http://dx.doi.org/10.1371/journal.pone.0210314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673717	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800039
J	Egan, AN; Moore, S; Stellari, GM; Kang, BC; Jahn, MM				Egan, Ashley N.; Moore, Shanna; Stellari, Giulia Marina; Kang, Byoung-Cheorl; Jahn, Molly M.			Tandem gene duplication and recombination at the AT3 locus in the Solanaceae, a gene essential for capsaicinoid biosynthesis in Capsicum	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; PHYLOGENETIC-RELATIONSHIPS; PROVIDES INSIGHTS; EXPRESSION ANALYSIS; MOSAIC STRUCTURE; GENOME SEQUENCE; DNA-SEQUENCES; PUNGENCY; EVOLUTION; TOMATO	Capsaicinoids are compounds synthesized exclusively in the genus Capsicum and are responsible for the burning sensation experienced when consuming hot pepper fruits. To date, only one gene, AT3, a member of the BAHD family of acyltransferases, is currently known to have a measurable quantitative effect on capsaicinoid biosynthesis. Multiple AT3 paralogs exist in the Capsicum genome, but their evolutionary relationships have not been characterized well. Recessive alleles at this locus result in absence of capsaicinoids in pepper fruit. To explore the evolution of AT3 in Capsicum and the Solanaceae, we sequenced this gene from diverse Capsicum genotypes and species, along with a number of representative solanaceous taxa. Our results revealed that the coding region of AT3 is highly conserved throughout the family. Further, we uncovered a tandem duplication that predates the diversification of the Solanaceae taxa sampled in this study. This pair of tandem duplications were designated AT3-1 and AT3-2. Sequence alignments showed that the AT3-2 locus, a pseudogene, retains regions of amino acid conservation relative to AT3-1. Gene tree estimation demonstrated that AT3-1 and AT3-2 form well supported, distinct clades. In C. rhomboideum, a non-pungent basal Capsicum species, we describe a recombination event between AT3-1 and AT3-2 that modified the putative active site of AT3-1, also resulting in a frame-shift mutation in the second exon. Our data suggest that duplication of the original AT3 representative, in combination with divergence and pseudogene degeneration, may account for the patterns of sequence divergence and punctuated amino acid conservation observed in this study. Further, an early rearrangement in C. rhomboidium could account for the absence of pungency in this Capsicum species.	[Egan, Ashley N.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA; [Moore, Shanna] Cornell Univ, Dept Phys, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Stellari, Giulia Marina] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Hort, Seoul, South Korea; [Jahn, Molly M.] Univ Wisconsin, Dept Agron, USDA FPL, 1575 Linden Dr, Madison, WI 53706 USA	George Washington University; Cornell University; Howard Hughes Medical Institute; Cornell University; Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison	Jahn, MM (corresponding author), Univ Wisconsin, Dept Agron, USDA FPL, 1575 Linden Dr, Madison, WI 53706 USA.	molly.jahn@wisc.edu	Egan, Ashley N/AAZ-1187-2021; Kang, Byoung-Cheorl/Q-6174-2019	Egan, Ashley N/0000-0001-7803-4444; Jahn, Molly/0000-0003-0181-0374; Moore, Shanna/0000-0001-5578-8868	NSF Metabolic Biochemistry Award [0412056]; USDA NRI Plant Genome [2004-35300-14596]; NSF Graduate Research Fellowship; SUNY Stony Brook	NSF Metabolic Biochemistry Award; USDA NRI Plant Genome(United States Department of Agriculture (USDA)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); SUNY Stony Brook	Funding for this work was provided by: NSF Metabolic Biochemistry Award No. 0412056, https://www.nsf.gov/[MMJ]; USDA NRI Plant Genome Award No. 2004-35300-14596, https://www.usda.gov/[MMJ, SM]; NSF Graduate Research Fellowship, https://www.nsf.gov/[GMS]; The Dean's fund at SUNY Stony Brook, https://www.stonybrook.edu/[GMS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bohs L, 1997, SYST BOT, V22, P5, DOI 10.2307/2419674; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Garcia CC, 2016, ANN BOT-LONDON, V118, P35, DOI 10.1093/aob/mcw079; Chapa-Oliver AM, 2016, MOLECULES, V21, DOI 10.3390/molecules21080931; D'Auria JC, 2002, PLANT PHYSIOL, V130, P466, DOI 10.1104/pp.006460; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan AN, 2010, SYST BIOL, V59, P534, DOI 10.1093/sysbio/syq041; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Garces-Claver A, 2007, THEOR APPL GENET, V115, P907, DOI 10.1007/s00122-007-0617-y; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gottlieb LD, 1997, MOL BIOL EVOL, V14, P125, DOI 10.1093/oxfordjournals.molbev.a025745; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hayman M., 2008, CURR ANAESTH CRIT CA, V19, P338, DOI [10.1016/j.cacc.2008.07.003, DOI 10.1016/J.CACC.2008.07.003]; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hill TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056200; Hulse-Kemp AM, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-017-0011-0; Johnson DA, 2007, MOL BIOL EVOL, V24, P2412, DOI 10.1093/molbev/msm184; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Lang YQ, 2006, BREEDING SCI, V56, P55, DOI 10.1270/jsbbs.56.55; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lynch M, 2000, GENETICS, V154, P459; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martins TR, 2005, SYST BOT, V30, P435, DOI 10.1600/0363644054223675; Moore S, 2005, J EXP BOT, V56, P2885, DOI 10.1093/jxb/eri283; Ogawa K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0476-7; Ohno S., 1970, EVOLUTION GENE DUPLI; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaldaferro MA, 2013, GENET RESOUR CROP EV, V60, P693, DOI 10.1007/s10722-012-9867-x; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SMITH JM, 1992, J MOL EVOL, V34, P126; Spalink D, 2018, MOL PHYLOGENET EVOL, V126, P293, DOI 10.1016/j.ympev.2018.04.030; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stellari GM, 2010, HEREDITY, V104, P460, DOI 10.1038/hdy.2009.131; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stewart C, 2007, J EXP BOT, V58, P979, DOI 10.1093/jxb/erl243; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tasma IM, 2008, PLANT PHYSIOL BIOCH, V46, P627, DOI 10.1016/j.plaphy.2008.04.015; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; VOELKER TA, 1986, EMBO J, V5, P3075, DOI 10.1002/j.1460-2075.1986.tb04613.x; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; WEBBER H, 1911, AM BREED ASS ANN REP, V7, P188; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep34121	62	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210510	10.1371/journal.pone.0210510	http://dx.doi.org/10.1371/journal.pone.0210510			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673734	gold, Green Published			2022-12-27	WOS:000456442800046
J	Laas, E; Hamy, AS; Michel, AS; Panchbhaya, N; Faron, M; Lam, T; Carrez, S; Pierga, JY; Rouzier, R; Lerebours, F; Feron, JG; Reyal, F				Laas, Enora; Hamy, Anne-Sophie; Michel, Anne-Sophie; Panchbhaya, Nabilah; Faron, Matthieu; Lam, Thanh; Carrez, Sophie; Pierga, Jean-Yves; Rouzier, Roman; Lerebours, Florence; Feron, Jean-Guillaume; Reyal, Fabien			Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR RECURRENCE; PREOPERATIVE CHEMOTHERAPY; LOCOREGIONAL RECURRENCES; PROGNOSTIC-SIGNIFICANCE; CONSERVATIVE SURGERY; DISTANT METASTASES; THERAPY; RECOMMENDATIONS; CARCINOMA	Background We studied the relationship between time to ipsilateral breast tumor recurrence (IBTR) and distant metastasis-free survival (DMFS) in patients with breast cancer treated by neoadjuvant chemotherapy (NAC). Methods Between 2002 and 2012, 1199 patients with primary breast cancer were treated with NAC. Clinical, radiological and pathological data were retrieved from medical records. Multivariate analysis was performed with the random survival forest (RSF) method, to evaluate the relationship between time to local recurrence and DMFS. Results Time to IBTR, local recurrence and molecular subtype were the factors most strongly associated with DMFS. In the total population, DMFS increased linearly with recurrence time, up to 50 months. For recurrences after 50 months, DMFS was similar for all times to recurrence. Considering molecular subtypes separately, the threshold was similar for the TNBC subtype (50 months), but appeared to occur later for the luminal and HER2-positive subtypes (75 months). Conclusion A threshold of 50 months seems to differentiate between early and late recurrences and could be used to guide the medical management of local breast tumour recurrences.	[Laas, Enora; Michel, Anne-Sophie; Panchbhaya, Nabilah; Carrez, Sophie; Rouzier, Roman; Feron, Jean-Guillaume; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Hamy, Anne-Sophie; Reyal, Fabien] PSL Res Univ, Translat Res Dept, Inst Curie, RT2Lab, Paris, France; [Hamy, Anne-Sophie; Reyal, Fabien] INSERM, Immun & Canc U932, Paris, France; [Faron, Matthieu] Inst Gustave Roussy, Dept Surg, Villejuif, France; [Lam, Thanh] Geneva Univ Hosp, Dept Obstet & Gynaecol, Geneva, Switzerland; [Pierga, Jean-Yves; Lerebours, Florence] Inst Curie, Dept Med Oncol, Paris, France; [Pierga, Jean-Yves] Paris Descartes Univ, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; University of Geneva; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), PSL Res Univ, Translat Res Dept, Inst Curie, RT2Lab, Paris, France.; Reyal, F (corresponding author), INSERM, Immun & Canc U932, Paris, France.	fabien.reyal@curie.fr			Roche France; ITMO-INSERM-AVIESAN cancer translational research grant; Roche* France	Roche France(Roche Holding); ITMO-INSERM-AVIESAN cancer translational research grant; Roche* France(Roche Holding)	This work was supported by Roche France: financial support for the construction of the Institut Curie neoadjuvant database (NEOREP), http://www.roche.fr, the funder had no role in study design, analysis, decision to publish, or preparation of the manuscript, the only role was for data collection; ITMO-INSERM-AVIESAN cancer translational research grant, https://www.aviesan.fr (ASH), the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Roche* France for financial support for the construction of the Institut Curie neoadjuvant database (NEOREP). The funding source had no role in data analysis and interpretation or in the writing of the manuscript.; AS Hamy was supported by an ITMO-INSERM-AVIESAN cancer translational research grant.	Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Balaton AJ, 1999, ANN PATHOL, V19, P336; Baulies S, 2015, BRIT J CANCER, V113, P30, DOI 10.1038/bjc.2015.174; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Datema FR, 2012, HEAD NECK-J SCI SPEC, V34, P50, DOI 10.1002/hed.21698; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Fortin A, 1999, J CLIN ONCOL, V17, P101, DOI 10.1200/JCO.1999.17.1.101; Fredriksson I, 2002, EUR J CANCER, V38, P1860, DOI 10.1016/S0959-8049(02)00219-8; Friedel G, 2013, ANTICANCER RES, V33, P1609; Ghadiani Mohammad Hassan, 2012, Arab J Nephrol Transplant, V5, P19; Gosset M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159888; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; Hamidi O, 2016, IRAN J PUBLIC HEALTH, V45, P27; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Karabicak I, 2011, CLIN TRANSPLANT, V25, pE264, DOI 10.1111/j.1399-0012.2011.01412.x; KURTZ JM, 1990, INT J RADIAT ONCOL, V18, P87, DOI 10.1016/0360-3016(90)90271-K; Lee JS, 2011, J BREAST CANCER, V14, P191, DOI 10.4048/jbc.2011.14.3.191; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mauriac L, 1999, ANN ONCOL, V10, P47, DOI 10.1023/A:1008337009350; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Mogensen UB, 2012, J STAT SOFTW, V50, P1; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Rouzier R, 2001, J CLIN ONCOL, V19, P3828, DOI 10.1200/JCO.2001.19.18.3828; Savignoni A, 2012, STAT MED, V31, P4444, DOI 10.1002/sim.5631; Touboul E, 1999, INT J RADIAT ONCOL, V43, P25, DOI 10.1016/S0360-3016(98)00365-4; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; van der Sangen MJC, 2006, EJSO-EUR J SURG ONC, V32, P34, DOI 10.1016/j.ejso.2005.10.005; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19; Voogd AC, 1999, CANCER-AM CANCER SOC, V85, P437, DOI 10.1002/(SICI)1097-0142(19990115)85:2<437::AID-CNCR23>3.0.CO;2-1; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0208807	10.1371/journal.pone.0208807	http://dx.doi.org/10.1371/journal.pone.0208807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673703	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800010
J	Lee, B; Lee, KM; Yang, JS				Lee, Bokwon; Lee, Kyu-Min; Yang, Jae-Suk			Network structure reveals patterns of legal complexity in human society: The case of the Constitutional legal network	PLOS ONE			English	Article							UNIVERSALITY; MULTISCALE; LAW	Complexity in nature has been broadly found not only in physical and biological systems but also in social and economic systems. Although many studies have examined complex systems and helped us understand real-world complexity, the investigation to the legal complexity has not been thoroughly investigated. Here we introduce a novel approach to studying complex legal systems using complex network approaches. On the basis of the bipartite relations among Constitution articles and Court decisions, we built a complex legal network and found the system shows the heterogeneous structure as generally observed in many complex social systems. By treating legal networks as unique political regimes, we examine whether structural properties of the systems have been influenced as the society changes, or not. On one hand, there is a core structure in all legal networks regardless of any social circumstances. On the other hand, with relative comparison among different regimes' networks, we could identify characteristic structural properties that reveal their identity. Our analysis would contribute to provide a better understanding of legal complexity and practical guidelines for use in various legal and social applications.	[Lee, Bokwon; Lee, Kyu-Min; Yang, Jae-Suk] Korea Adv Inst Sci & Technol, Moon Soul Grad Sch Future Strategy, Daejeon, South Korea; [Lee, Bokwon] Minist Strategy & Finance, Sejong Govt Complex, Sejong, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Yang, JS (corresponding author), Korea Adv Inst Sci & Technol, Moon Soul Grad Sch Future Strategy, Daejeon, South Korea.	yang@kaist.ac.kr	Yang, Jae-Suk/F-2332-2015; LEE, BOKWON/AAM-5136-2021	Yang, Jae-Suk/0000-0001-9595-5229; lee, bokwon/0000-0001-9920-7455	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2016S1A5A8019490]; BizData, Inc. [G01180535]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); BizData, Inc.	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2016S1A5A8019490), and BizData, Inc. (G01180535).	Adami C, 2002, BIOESSAYS, V24, P1085, DOI 10.1002/bies.10192; Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anderson P, 1999, ORGAN SCI, V10, P216, DOI 10.1287/orsc.10.3.216; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; Battiston S, 2016, SCIENCE, V351, P818, DOI 10.1126/science.aad0299; Bommarito MJ, 2010, PHYSICA A, V389, P4195, DOI 10.1016/j.physa.2010.05.057; Caldarelli G., 2007, SCALE FREE NETWORKS; Cohen R., 2010, COMPLEX NETWORKS STR; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Eidsaa M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062819; Fowler JH, 2007, POLIT ANAL, V15, P324, DOI 10.1093/pan/mpm011; Gleditsch KS, 2002, J CONFLICT RESOLUT, V46, P712, DOI 10.1177/002200202236171; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; HARRISON NEIL E., 2012, COMPLEXITY WORLD POL; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Katz DM, 2014, ARTIF INTELL LAW, V22, P337, DOI 10.1007/s10506-014-9160-8; Katz DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174698; Kauffman S.A., 1993, ORIGINS ORDER; Koniaris M, 2018, J COMPLEX NETW, V6, P243, DOI 10.1093/comnet/cnx029; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mazzega P., 2009, P INT C ART INT LAW; Menichetti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097857; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Min B, 2015, CHAOS SOLITON FRACT, V72, P49, DOI 10.1016/j.chaos.2014.12.016; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; NEWMAN MEJ, 2004, PHYS REV E 2, V70; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Ruhl JB, 2017, SCIENCE, V355, P1377, DOI 10.1126/science.aag3013; Ruhl JB, 2015, IOWA LAW REV, V101, P191; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Schelling TC, 1978, MICROMOTIVES AND MAC; Schiff D.N., 1976, MOD LAW REV, V39, P287, DOI [10.1111/j.1468-2230.1976.tb01458.x, DOI 10.1111/J.1468-2230.1976.TB01458.X]; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Tomlins C, 2007, ANNU REV LAW SOC SCI, V3, P45, DOI 10.1146/annurev.lawsocsci.3.081806.112741; Unger Roberto Mangabeira, 1977, LAW MODERN SOC; Vicsek T, 2002, NATURE, V418, P131, DOI 10.1038/418131a; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber M., 1968, ECON SOC; Yook SH, 2001, PHYS REV LETT, V86, P5835, DOI 10.1103/PhysRevLett.86.5835; Zhou CS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.034101; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209844	10.1371/journal.pone.0209844	http://dx.doi.org/10.1371/journal.pone.0209844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673731	Green Submitted, Green Published, gold			2022-12-27	WOS:000456442800024
J	Lee, HY; Yang, HK; Song, HJ; Chang, HJ; Kang, JY; Lee, SH; Han, S; Kim, YK				Lee, Hea Yon; Yang, Hae Kyung; Song, Ho Jin; Chang, Hee Jae; Kang, Ji Young; Lee, Sang Haak; Han, Solji; Kim, Young Kyoon			Metabolic health is more closely associated with decrease in lung function than obesity	PLOS ONE			English	Article							BODY-MASS INDEX; NORMAL-WEIGHT MONW; NATIONAL-HEALTH; CARDIOVASCULAR MORTALITY; VENTILATORY FUNCTION; BLOOD-PRESSURE; RISK; POPULATION; PARADOX; DISEASE	Objective Previous studies have evaluated the link between metabolic syndrome and obesity with impaired lung function, however findings have been controversial. We aimed to compare lung function among subjects with different metabolic health and obesity status. Methods Total 10,071 participants were evaluated at the Health Promotion Center in Seoul St. Mary's Hospital between January 2012 and December 2014. Being metabolically healthy was defined as having fewer than three of the following risk factors: high blood pressure, high fasting blood glucose, high triglyceride, low high-density lipoprotein cholesterol and abdominal obesity. Obesity status was defined as body mass index (BMI) higher than 25 kg/m(2). Analyses of pulmonary function were performed in four groups divided according to metabolic health and obesity: metabolically healthy non-obese (MHNO), metabolically health obese (MHO), metabolically unhealthy non-obese (MUHNO), and metabolically unhealthy obese (MUHO). Results Metabolically unhealthy subjects were more prone to decreased lung function compared with their metabolically healthy counterparts, regardless of obesity status. When multinomial logistic regression analysis was performed according to quartiles of forced vital capacity (FVC) or forced expiratory volume in 1 second (FEV1) (% pred), after adjusting for age, sex, and smoking status, odds ratio (OR) for the lowest FVC and FEV1 (% pred) quartiles were significantly higher in MUHO subjects (1.788 [95% CI, 1.531-2.089] and 1.603 [95% CI, 1.367-1.881]) and lower in MHO subjects (0.768 [95% CI, 0.654-0.902] and 0.826 [95% CI, 0.700-0.976]) with MHNO group as the reference, when OR for highest FVC and FEV1 quartiles were considered as 1.0 Conclusion Metabolic health is more closely associated with impaired lung function than obesity.	[Lee, Hea Yon; Song, Ho Jin; Chang, Hee Jae] Catholic Univ Korea, Coll Med, Dept Hlth Promot Med, Seoul, South Korea; [Lee, Hea Yon; Yang, Hae Kyung] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Ji Young; Lee, Sang Haak; Kim, Young Kyoon] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Med, Seoul, South Korea; [Han, Solji] Yonsei Univ, Dept Appl Stat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Yonsei University	Kim, YK (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulm Med, Seoul, South Korea.	youngkim@catholic.ac.kr		Lee, Heayon/0000-0001-7389-2343				Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Aung K, 2014, J CLIN ENDOCR METAB, V99, P462, DOI 10.1210/jc.2013-2832; Baffi CW, 2016, CHEST, V149, P1525, DOI 10.1016/j.chest.2015.12.034; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Tran BT, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3936-6; BJORNTORP P, 1987, ANN NY ACAD SCI, V499, P66, DOI 10.1111/j.1749-6632.1987.tb36198.x; Brumpton BM, 2013, EUR RESPIR J, V42, P1495, DOI 10.1183/09031936.00046013; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Conus F, 2004, J CLIN ENDOCR METAB, V89, P5013, DOI 10.1210/jc.2004-0265; Cotes JE, 2001, THORAX, V56, P839, DOI 10.1136/thorax.56.11.839; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Dekkers BGJ, 2009, AM J RESP CELL MOL, V41, P494, DOI 10.1165/rcmb.2008-0251OC; Engstrom G, 2002, DIABETIC MED, V19, P167, DOI 10.1046/j.1464-5491.2002.00652.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Jeon YK, 2015, OSTEOPOROSIS INT, V26, P2423, DOI 10.1007/s00198-015-3152-8; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lavie CJ, 2015, JACC-HEART FAIL, V3, P927, DOI 10.1016/j.jchf.2015.07.009; Lazarus R, 1998, AM J CLIN NUTR, V68, P35, DOI 10.1093/ajcn/68.1.35; Lazarus R, 1998, EUR RESPIR J, V12, P635, DOI 10.1183/09031936.98.12030635; Lee EJ, 2009, J ASTHMA, V46, P339, DOI 10.1080/02770900802660931; Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Lee SH, 2011, CLIN ENDOCRINOL, V75, P475, DOI 10.1111/j.1365-2265.2011.04085.x; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moon JH, 2015, J KOREAN MED SCI, V30, P1682, DOI 10.3346/jkms.2015.30.11.1682; Morkedal B, 2011, EUR J EPIDEMIOL, V26, P457, DOI 10.1007/s10654-011-9572-7; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Price GM, 2006, AM J CLIN NUTR, V84, P449; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Sin DD, 2003, THORAX, V58, P695, DOI 10.1136/thorax.58.8.695; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Soutar A, 1997, THORAX, V52, P166, DOI 10.1136/thx.52.2.166; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 2013, DIABETES CARE, V36, pS282, DOI 10.2337/dcS13-2040; Steier J, 2014, THORAX, V69, P752, DOI 10.1136/thoraxjnl-2014-205148; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wang B, 2015, HORM METAB RES, V47, P839, DOI 10.1055/s-0035-1559767; WHO, 2008, WAIST CIRCUMFERENCE; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yang HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30329	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209575	10.1371/journal.pone.0209575	http://dx.doi.org/10.1371/journal.pone.0209575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673715	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800019
J	Wagner, J; Eiken, B; Haubitz, I; Lichthardt, S; Matthes, N; Lob, S; Klein, I; Germer, CT; Wiegering, A				Wagner, Johanna; Eiken, Barbara; Haubitz, Imme; Lichthardt, Sven; Matthes, Niels; Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin			Suprapubic bladder drainage and epidural catheters following abdominal surgery-A risk for urinary tract infections?	PLOS ONE			English	Article							ENHANCED RECOVERY; EARLY REMOVAL; PREVENTION; MANAGEMENT	Background Epidural catheters are state of the art for postoperative analgesic in abdominal surgery. Due to neurolysis it can lead to postoperative urinary tract retention (POUR), which leads to prolonged bladder catheterization, which has an increased risk for urinary tract infections (UTI). Our aim was to identify the current perioperative management of urinary catheters and, second, to identify the optimal time of suprapubic bladder catheter removal in regard to the removal of the epidural catheter. Methods We sent a questionnaire to 102 German hospitals and analyzed the 83 received answers to evaluate the current handling of bladder drainage and epidural catheters. Then, we conducted a retrospective study including 501 patients, who received an epidural and suprapubic catheter after abdominal surgery at the University Hospital Wurzburg. We divided the patients into three groups according to the point in time of suprapubic bladder drainage removal in regard to the removal of the epidural catheter and analyzed the onset of a UTI. Results Our survey showed that in almost all hospitals (98.8%), patients received an epidural catheter and a bladder drainage after abdominal surgery. The point in time of urinary catheter removal was equally distributed between before, simultaneously and after the removal of the epidural catheter (respectively:-28-29%). The retrospective study showed a catheter-associated UTI in 6.7%. Women were affected significantly more often than men (10,7% versus 2,5%, p<0.001). There was a non-significant trend to more UTIs when the suprapubic catheter was removed after the epidural catheter (before: 5.7%, after: 8.4%). Conclusion The point in time of suprapubic bladder drainage removal in relation to the removal of the epidural catheter does not seem to correlate with the rate of UTIs. The current handling in Germany is inhomogeneous, so further studies to standardize treatment are recommended.	[Wagner, Johanna; Eiken, Barbara; Haubitz, Imme; Lichthardt, Sven; Matthes, Niels; Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin] Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany; [Loeb, Stefan; Klein, Ingo; Germer, Christoph-Thomas; Wiegering, Armin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Core Unit Bioinformat, Bioctr, Wurzburg, Germany; [Wiegering, Armin] Univ Wurzburg, Theodor Boveri Inst, Bioctr, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Wagner, J (corresponding author), Univ Hosp Wurzburg, Dept Gen Visceral Vasc & Pediat Surg, Wurzburg, Germany.	Wagner_J6@ukw.de	Wagner, Johanna/AAN-2289-2020; Klein, Ingo/AAY-3371-2020; Wiegering, Armin/X-7541-2018	Wagner, Johanna/0000-0002-2999-6900; Klein, Ingo/0000-0003-1097-0986; Wiegering, Armin/0000-0001-7777-0909	University of Wuerzburg	University of Wuerzburg	This publication was funded by the University of Wuerzburg in the funding program Open Access Publishing.	Benoist S, 1999, SURGERY, V125, P135, DOI 10.1067/msy.2099.94988; Bonkat G, 2013, WORLD J UROL, V31, P565, DOI 10.1007/s00345-012-0930-1; Bouchet-Doumenq C, 2016, INT J COLORECTAL DIS, V31, P511, DOI 10.1007/s00384-015-2471-8; Branagan GW, 2002, DIS COLON RECTUM, V45, P1104, DOI 10.1007/s10350-004-6368-9; GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599; GIVENS CD, 1980, J UROLOGY, V124, P646, DOI 10.1016/S0022-5347(17)55596-2; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hoffmann H, 2012, EUR SURG RES, V49, P24, DOI 10.1159/000339859; Hu Y, 2014, J CARDIOTHOR VASC AN, V28, P1302, DOI 10.1053/j.jvca.2014.05.009; Hughes MJ, 2014, JAMA SURG, V149, P1224, DOI 10.1001/jamasurg.2014.210; Jorgensen H., 2000, COCHRANE DATABASE SY; Kim JY, 2006, BRIT J ANAESTH, V97, P414, DOI 10.1093/bja/ael172; Kuipers PW, 2004, ANESTHESIOLOGY, V100, P1497, DOI 10.1097/00000542-200406000-00023; Kwaan MR, 2015, DIS COLON RECTUM, V58, P401, DOI 10.1097/DCR.0000000000000317; Niel-Weise BS, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005428; Orikasa S, 2012, INT J UROL, V19, P587, DOI 10.1111/j.1442-2042.2012.02980.x; RAWAL N, 1983, ANESTH ANALG, V62, P641; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Statistisches Bundesamt, 2016, FALLP KRANK DRG STAT; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; Tenke P, 2014, CURR OPIN INFECT DIS, V27, P102, DOI 10.1097/QCO.0000000000000031; Wald HL, 2008, ARCH SURG-CHICAGO, V143, P551, DOI 10.1001/archsurg.143.6.551	22	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209825	10.1371/journal.pone.0209825	http://dx.doi.org/10.1371/journal.pone.0209825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673740	Green Submitted, gold, Green Published			2022-12-27	WOS:000456442800023
J	Weitzman, ER; Salimian, PK; Rabinow, L; Levy, S				Weitzman, Elissa R.; Salimian, Parissa K.; Rabinow, Lily; Levy, Sharon			Perspectives on substance use among youth with chronic medical conditions and implications for clinical guidance and prevention: A qualitative study	PLOS ONE			English	Article							HEALTH-CARE PREFERENCES; ADOLESCENTS PERCEPTIONS; ALCOHOL EXPECTANCIES; YOUNG-ADULTS; RISK-TAKING; DRINKING; BEHAVIOR; TRANSITION; PATTERNS; SERVICES	Increasing numbers of youth globally live with a chronic illness. These youth use alcohol and marijuana at levels equal to or greater than their healthy peers and, when using, are at elevated risk for regular or problem use and adverse consequences to their condition. Little is known about whether behavioral theories commonly invoked to explain adolescent substance use apply to this group, limiting our ability to develop, tailor and target preventive interventions. We interviewed youth ages 16-19 years in care for a chronic disease to gain knowledge of this group's perspectives on substance use risk, decision-making, and preferences for clinical guidance. Interviews were transcribed and thematically analyzed. Three principal themes emerged: first, having a chronic disease frames understanding of and commitment to health protecting behaviors and impacts decisions to avoid behaviors that carry risks for disease complications and flares; second, developmental impulses typical of adolescence can amplify an adolescent's propensity to take risks despite medical vulnerability and direct youth toward maladaptive choices to mitigate risk; and third, poor knowledge about effects of substance use on specific features of a disease shapes perceived risk and undermines health protecting decisions. Youth navigate these issues variously including by avoiding substance use at a specific time or entirely, using while cognitively discounting risks and/or adjusting treatment outside of medical advice. Their perceptions about substance use are complex and reveal tension among choices reflecting a chronic illness frame, developmental impulses, and knowledge gaps. Delivery of targeted guidance in healthcare settings may help youth navigate this complexity and connect patient -centered goals to optimize health with health protecting behavioral decisions.	[Weitzman, Elissa R.] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA 02115 USA; [Weitzman, Elissa R.; Levy, Sharon] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Salimian, Parissa K.; Rabinow, Lily; Levy, Sharon] Boston Childrens Hosp, Div Dev Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Weitzman, ER (corresponding author), Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA 02115 USA.; Weitzman, ER (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	elissa.weitzman@childrens.harvard.edu			National Institute on Alcohol Abuse and Alcoholism [1R01AA021913-01]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grant #1R01AA021913-01 from The National Institute on Alcohol Abuse and Alcoholism.	AAS H, 1992, SCAND J PSYCHOL, V33, P315, DOI 10.1111/j.1467-9450.1992.tb00920.x; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barnard K, 2012, DIABETIC MED, V29, P434, DOI 10.1111/j.1464-5491.2012.03579.x; Beck KH, 1996, ADDICT BEHAV, V21, P633, DOI 10.1016/0306-4603(95)00087-9; Berry JG, 2013, J PEDIATR NEUROL, V11, P211, DOI 10.3233/JPN-130624; Bloom DE, 2011, GLOBAL EC BURDEN NON; Britto MT, 2007, J ADOLESCENT HEALTH, V40, P334, DOI 10.1016/j.jadohealth.2006.10.020; Britto MT, 2004, PEDIATRICS, V114, P1272, DOI 10.1542/peds.2003-1134-L; Britto MT, 1999, ARCH PEDIAT ADOL MED, V153, P27; Britto MT, 2000, ARCH PEDIAT ADOL MED, V154, P478, DOI 10.1001/archpedi.154.5.478; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; CHEN MJ, 1994, ADDICT BEHAV, V19, P521, DOI 10.1016/0306-4603(94)90007-8; CHENG TL, 1993, JAMA-J AM MED ASSOC, V269, P1404, DOI 10.1001/jama.269.11.1404; CHRISTIANSEN BA, 1982, J CONSULT CLIN PSYCH, V50, P336, DOI 10.1037/0022-006X.50.3.336; CHRISTIANSEN BA, 1989, J CONSULT CLIN PSYCH, V57, P93, DOI 10.1037/0022-006X.57.1.93; Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Engelgau MM, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8724-5; Ferrer RA, 2016, ANN BEHAV MED, V50, P653, DOI 10.1007/s12160-016-9790-z; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gibbs G., 2007, ANAL QUALITATIVE DAT, DOI DOI 10.4135/9781849208574; GINSBURG KR, 1995, JAMA-J AM MED ASSOC, V273, P1913, DOI 10.1001/jama.273.24.1913; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Goldberg JH, 2002, HEALTH PSYCHOL, V21, P477, DOI 10.1037//0278-6133.21.5.477; Griffin KW, 2010, CHILD ADOL PSYCH CL, V19, P505, DOI 10.1016/j.chc.2010.03.005; Harris SK, 2017, J ADOLESCENT HEALTH, V60, P249, DOI 10.1016/j.jadohealth.2016.10.005; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Holder HD, 2004, REDUCING UNDERAGE DR; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Levy S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156240; Marschall-Levesque S, 2014, ADDICT BEHAV, V39, P48, DOI 10.1016/j.addbeh.2013.09.025; Miles M., 2013, QUALITATIVE DATA ANA; Murthy VH, 2016, FACING ADDICTION AM, DOI [10.1001/jama.2016.18215, DOI 10.1001/JAMA.2016.18215]; Nash AA, 1998, ARTHRIT CARE RES, V11, P391, DOI 10.1002/art.1790110510; Nikolic IA, HEAL NUTR POPUL DISC; Olds RS, 2001, J SCHOOL HEALTH, V71, P223, DOI 10.1111/j.1746-1561.2001.tb01322.x; Osilla KC, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-38; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; PETRAITIS J, 1995, PSYCHOL BULL, V117, P67, DOI 10.1037/0033-2909.117.1.67; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Schwenk HT, 2014, INFLAMM BOWEL DIS, V20, P1618, DOI 10.1097/MIB.0000000000000124; Sharma A, 2016, CHILD ADOL PSYCH CL, V25, P367, DOI 10.1016/j.chc.2016.02.001; Simons-Morton BG, 2010, J PRIM PREV, V31, P191, DOI 10.1007/s10935-010-0220-x; SMALL SA, 1993, J YOUTH ADOLESCENCE, V22, P73, DOI 10.1007/BF01537905; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Strauss A., 1994, GROUNDED THEORY METH, P3; Stuckey H.L., 2015, J SOC HLTH DIABETES, V3, P7, DOI [10.4103/2321-0656.140875, DOI 10.4103/2321-0656.140875]; Substance Abuse and Mental Health Services Administration, PREV APPR 2016; Substance Abuse and Mental Health Services Administration, 2017, HHS PUBL; Substance Abuse and Mental Health Services Administration, DAWN REP ALC DRUG CO; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, NSDUH REP TRENDS AD; Taylor SJ., 1998, INTRO QUALITATIVE RE; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U.S. Department of Health and Human Services Health Resources and Services Administration Maternal and Child Health Bureau., 2013, NAT SURV CHILDR SPEC; U.S. Department of Health and Human Services (HHS) Office of the Surgeon General, 2016, SURG GEN REP ALC DRU; UNFPA-United Nations Population Fund, 2014, STATE WORLD POPULATI; US Census Bureau, 2016, QUICKFACTS; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Weitzman ER, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2017-4026; Weitzman ER, 2015, PEDIATRICS, V136, P450, DOI 10.1542/peds.2015-0722; WHO, 2011, GLOBAL STATUS REPORT; WHO, 2012, TOB FREE IN; Wisk LE, 2017, J ADOLESCENT HEALTH, V61, P461, DOI 10.1016/j.jadohealth.2017.04.006; Wisk LE, 2016, AM J PREV MED, V51, P33, DOI 10.1016/j.amepre.2016.01.029; Wisk LE, 2017, SOC ADOLESC HEAL MED; Wong NCH, 2009, J APPL COMMUN RES, V37, P1, DOI 10.1080/00909880802593928; World Bank, 2011, GROW DANG NONC DIS A	70	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209963	10.1371/journal.pone.0209963	http://dx.doi.org/10.1371/journal.pone.0209963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673730	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800026
J	Reshmi, RS; Dinachandra, K; Bhanot, A; Unisa, S; Menon, GT; Agrawal, N; Bhatia, V; Ruikar, M; Daniel, A; Bhattacharjee, S; Parhi, RN; Sachdev, HPS; Gope, RK; De Wagt, A; Sethi, V				Reshmi, R. S.; Dinachandra, Konsam; Bhanot, Arti; Unisa, Sayeed; Menon, Gopinath T.; Agrawal, Neeraj; Bhatia, Vikas; Ruikar, Manisha; Daniel, Abner; Bhattacharjee, Sourav; Parhi, Rabi N.; Sachdev, H. P. S.; Gope, Raj Kumar; De Wagt, Arjan; Sethi, Vani			Context for layering women's nutrition interventions on a large scale poverty alleviation program: Evidence from three eastern Indian states	PLOS ONE			English	Article								Over 70 million women of reproductive age are undernourished in India. Most poverty alleviation programs have not been systematically evaluated to assess impact on women's empowerment and nutrition outcomes. National Rural Livelihoods Mission's poverty alleviation and livelihoods generation initiative is an opportune platform to layer women's nutrition interventions being tapped by project Swabhimaan in three eastern Indian states-Bihar, Chhattisgarh and Odisha. A cross-sectional baseline survey covering 8755 mothers of children under-two years of age, one of the three primary target groups of program are presented. Standardized questionnaire was administered and anthropometric measurements were undertaken from October 2016 to January 2017. 21 indicators on women's empowerment, Body Mass Index and Mid-upper Arm Circumference for nutrition status, food insecurity indicators as per the Food Insecurity Experience Scale and selected indicators for assessing women's access to basic health services were included. National Rural Livelihoods Mission operates in contexts with stark social and gender inequalities. Self-help group members exhibited better control on financial resources and participation in community activities than non-members. Using Body Mass Index, at least 45% mothers were undernourished irrespective of their enrolment in self-help groups. Higher proportion of self-help group members (77%-87%) belonged to food insecure households than non-members (66%-83%). Proportion of mothers reporting receipt of various components of antenatal care service package varied from over 90% for tetanus toxoid vaccination to less than 10% for height measurement. Current use of family planning methods was excruciatingly low (8.2%-32.4%) in all states but positively skewed towards self-help group members. Participation in monthly fixed day health camps was a concern in Bihar. Layering women's nutrition interventions as stipulated under Swabhimaan may yield better results for women's empowerment and nutrition status under National Rural Livelihoods Mission. While this opportunity exists in all three states, Bihar with a higher proportion of matured self-help groups offers more readiness for Swabhimaan implementation.	[Reshmi, R. S.; Dinachandra, Konsam; Unisa, Sayeed] Int Inst Populat Sci, Mumbai, India; [Menon, Gopinath T.] SPARSH Ctr Participatory Learning, Mumbai, India; [Agrawal, Neeraj] AIIMS, Patna, Bihar, India; [Bhatia, Vikas] AIIMS, Bhubaneswar, India; [Ruikar, Manisha] AIIMS, Raipur, Madhya Pradesh, India; [Daniel, Abner; De Wagt, Arjan; Sethi, Vani] UNICEF India, Country Off, Nutr Sect, New Delhi, India; [Bhattacharjee, Sourav] UNICEF India, Field Off Odisha, Bhubaneswar, India; [Parhi, Rabi N.] UNICEF India, Field Off Bihar, Patna, Bihar, India; [Sachdev, H. P. S.] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Gope, Raj Kumar] Ekjut, Jharkhand, India	International Institute for Population Sciences; All India Institute of Medical Sciences (AIIMS) Patna; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Raipur; Sitaram Bhartia Institute of Science & Research	Sethi, V (corresponding author), UNICEF India, Country Off, Nutr Sect, New Delhi, India.	vsethi@unicef.org	Unisa, Sayeed/AAS-9588-2020; Ruikar, Manisha/AAD-8926-2022	Dinachandra Singh, Konsam/0000-0001-9071-0601; Sachdev, Harshpal Singh/0000-0002-4956-9391; Ruikar, Manisha/0000-0003-3928-4576	UNICEF, India	UNICEF, India	UNICEF, India. The funders helped in the study design and preparation of manuscript.	[Anonymous], 1995, Bull World Health Organ, V73 Suppl, P1; [Anonymous], 2017, SWABH 2016 202 UNPUB; [Anonymous], 2012, NAT RUR LIV MISS; [Anonymous], 2018, MAT NUTR CAR NRC; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Central TB. Division Ministry of Health and Family Welfare, 2017, GUID DOC NUTR CAR SU; Datta U, SOCIOECONOMIC EFFECT; Deininger K, 2013, WORLD DEV, V43, P149, DOI 10.1016/j.worlddev.2012.09.019; FAO, 2017, FOOD INS EXP SCAL ME; George V, 2017, KUDUMBASHREE RETHINK; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE, P370; Inter-Parliamentary Union and World Health Organization, 2016, CHILD EARL FORC MARR; International Institute of Population Sciences, 2017, NAT FAM HLTH SURV 4; KAMALADOSS T, 1992, Indian Journal of Pediatrics, V59, P299, DOI 10.1007/BF02821792; Kishor S., 2004, EC POLITICAL WEEKLY, V39, P694; Kumar N, 2018, GLOB FOOD SECUR-AGR, V17, P172, DOI 10.1016/j.gfs.2017.11.002; Kumar P, 2018, INDIAN J COMMUN MED, V43, P132, DOI 10.4103/ijcm.IJCM_248_17; Ministry of Health and Family Welfare, 2015, HLTH FAM WELF STAT I; Park A, 2010, DP7856 CEPR; Sethi V, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0099-8; Tang AM., 2016, DETERMINING GLOBAL M; Wodon Q, 2017, EC IMPACTS CHILD MAR; World Health Organization (WHO), 1995, WHO TECHN RES SER	23	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210836	10.1371/journal.pone.0210836	http://dx.doi.org/10.1371/journal.pone.0210836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668595	Green Submitted, Green Published, gold			2022-12-27	WOS:000456306400018
J	Bigaut, K; Achard, S; Hemmert, C; Baloglu, S; Kremer, L; Collongues, N; De Seze, J; Kremer, S				Bigaut, Kevin; Achard, Sophie; Hemmert, Celine; Baloglu, Seyyid; Kremer, Laurent; Collongues, Nicolas; De Seze, Jerome; Kremer, Stephane			Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WHITE	Background The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains unclear. Objective Compare brain functional connectivity of patients with NMOSD to healthy subjects in resting-state functional MRI (rs-fMRI). Methods We compared the rs-fMRI connectivity in 12 NMOSD patients with 20 healthy subjects matched for age and sex. Graph theory analysis was used to quantify the role of each node using a set of metrics: degree, global efficiency, clustering and modularity. To summarize the abnormal connectivity profile of brain regions in patients compared to healthy subjects, we defined a hub disruption index k. Results Concerning the global organization of networks in NMOSD, a small-world topology was preserved without significant modification concerning all average metrics. However, visual networks and the sensorimotor network showed decreased connectivity with high interindividual variability. The hub disruption index. was correlated to the Expanded Disability Status Scale (EDSS). Conclusion These results demonstrate a correlation between disability according to the EDSS and neuronal reorganization using the rs-fMRI graph methodology. The conservation of a normal global topological structure despite local modifications in functional connectivity seems to show brain plasticity in response to the disability.	[Bigaut, Kevin; Kremer, Laurent; Collongues, Nicolas; De Seze, Jerome] Hop Univ Strasbourg, Dept Neurol, Strasbourg, France; [Achard, Sophie] CNRS, Grenoble Image Parole Signal Automat, Grenoble, France; [Hemmert, Celine] Grp Hosp Reg Mulhouse Sud Alsace, Dept Radiol, Mulhouse, France; [Baloglu, Seyyid; Kremer, Stephane] Hop Univ Strasbourg, Dept Radiol, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kremer, S (corresponding author), Hop Univ Strasbourg, Dept Radiol, Strasbourg, France.	stephane.kremer@chru-strasbourg.fr	Bigaut, Kévin/ABE-2734-2021; Kremer, Laurent/M-7449-2016	Bigaut, Kevin/0000-0002-5176-580X; Kremer, Laurent/0000-0002-7246-2533				Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; Dogonowski AM, 2013, ACTA NEUROL SCAND, V128, P328, DOI 10.1111/ane.12121; Fleischer V, 2019, NEUROSCIENCE, V403, P35, DOI 10.1016/j.neuroscience.2017.10.033; Fleischer V, 2017, MULT SCLER J, V23, P432, DOI 10.1177/1352458516651503; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Koubiyr I, 2020, MULT SCLER J, V26, P188, DOI 10.1177/1352458518813108; Kremer S, 2015, JAMA NEUROL, V72, P815, DOI 10.1001/jamaneurol.2015.0248; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liu H, 2016, NEUROPSYCH DIS TREAT, V12, P3031, DOI 10.2147/NDT.S120909; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Muthuraman M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/fnins.7016.00014, 10.3389/fnins.2016.00014]; Ridley BGY, 2015, NEUROIMAGE, V118, P39, DOI 10.1016/j.neuroimage.2015.05.096; Termenon M, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00084; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075	22	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211465	10.1371/journal.pone.0211465	http://dx.doi.org/10.1371/journal.pone.0211465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695058	Green Published, gold			2022-12-27	WOS:000457046400035
J	Jha, P; Larsson, M; Christensson, K; Svanberg, AS				Jha, Paridhi; Larsson, Margareta; Christensson, Kyllike; Svanberg, Agneta Skoog			Evaluation of the psychometric properties of Hindi-translated Scale for Measuring Maternal Satisfaction among postnatal women in Chhattisgarh, India	PLOS ONE			English	Article							QUALITY-OF-CARE; GROUNDED THEORY; CHILDBIRTH; BIRTH; PERCEPTIONS; EXPERIENCES; VALIDATION; TRANSITION; FACILITIES; SUPPORT	Satisfaction with childbirth services is a multi-dimensional phenomenon, providing relevant insights into women's opinion on quality of services received. Research studies report a dearth of standardised scales that quantify this phenomenon; and none have been tested in India to the best of authors' knowledge. The current study was undertaken to evaluate psychometric properties of Hindi version of the Turkish Scale for Measuring Maternal Satisfaction: Normal and Caesarean Births versions in order to fill this gap. A cross-sectional survey was conducted in selected public health facilities in Chhattisgarh, India. Healthy women (n = 1004) who gave birth to a single, live neonate, vaginally or via Caesarean section participated. Psychometric assessment was carried out in four steps: 1) scales translated from Turkish to Hindi; 2) Content Validity Index scores calculated for Hindi scales; 3) data collection; 4) statistical analyses for Hindi scales (Normal and Caesarean Birth). A 10-factor model with 36 items emerged for both scales. The Hindi-translated Normal Birth and Caesarean Birth scales had good internal reliability (Cronbach's a coefficients of 0.85 and 0.80, respectively). The Hindi Scales for Measuring Maternal Satisfaction (Normal and Caesarean Birth) are valid and reliable tools for utilization in Indian health facilities. Their multi-dimensional nature presents an opportunity for the care providers and health administrators to incorporate women's opinions in intervention to improve quality of childbirth services. Having an international tool validated within India also provides a platform for comparing cross-country findings.	[Jha, Paridhi; Larsson, Margareta; Svanberg, Agneta Skoog] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Christensson, Kyllike] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Jha, Paridhi] Fdn Res Hlth Syst, Bengaluru, Karnataka, India	Uppsala University; Karolinska Institutet	Jha, P (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Jha, P (corresponding author), Fdn Res Hlth Syst, Bengaluru, Karnataka, India.	paridhi.jha@kbh.uu.se	Jha, Paridhi/K-3352-2017	Jha, Paridhi/0000-0002-1285-7138	Sida	Sida	This study was undertaken as part of a research collaboration between Indian and Swedish institutions for improving maternal and newborn health through strengthening midwifery in India. The project was funded by Sida (http://www.sida.se/contentasset/f3f86755894e44b5a5256e87df3377e9/improving-maternal-and-new-born-health-by-strengthening-midwifery_3695.pdf).	Bell AF, 2016, MIDWIFERY, V39, P112, DOI 10.1016/j.midw.2016.04.014; Bhattacharyya S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1077-8; Bhutta ZA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S5; Bitew K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/460767; Camacho FT, 2012, MATERN CHILD HLTH J, V16, P997, DOI 10.1007/s10995-011-0823-8; Chaturvedi S, 2016, INT J GYNECOL OBSTET, V132, P179, DOI 10.1016/j.ijgo.2015.07.016; Chaturvedi S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-174; Christiaens W, 2007, BMC PREGNANCY CHILDB, V7, P26, DOI [DOI 10.1186/1471-2393-7-26, 10.1186/1471-2393-7-26]; Conesa Ferrer B, 2016, BMJ-BRIT MED J, V6, P1; Cook K, 2012, J PERINAT EDUC, V21, P158, DOI 10.1891/1058-1243.21.3.158; Crowther S, 2016, MIDWIFERY, V40, P40, DOI 10.1016/j.midw.2016.06.005; Das JK, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S4; Devasenapathy N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004401; Diamond-Smith N, 2016, MIDWIFERY, V40, P114, DOI 10.1016/j.midw.2016.06.014; Diaz-Tello F, 2016, REPROD HEALTH MATTER, V24, P56, DOI 10.1016/j.rhm.2016.04.004; Directorate General of Health Services, 2012, IND PUBL HLTH STAND; Everett-Murphy K, 2011, MIDWIFERY, V27, P517, DOI 10.1016/j.midw.2010.04.003; Exavery A, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-48; Fenwick J, 2013, MIDWIFERY, V29, P217, DOI 10.1016/j.midw.2011.12.008; Firth-Cozens J, 2003, CLIN GOVERNANCE INT, V8, P331, DOI DOI 10.1108/14777270310499423; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Goodman P, 2004, J ADV NURS, V46, P212, DOI 10.1111/j.1365-2648.2003.02981.x; Government of India, 2017, LAQSHYA LABOUR ROOM; Gungor I, 2012, MIDWIFERY, V28, P348, DOI 10.1016/j.midw.2011.03.009; Hegde S, 2012, J WOMENS HLTH ISSUES, V1, P1, DOI DOI 10.4172/2325-9795.1000101; Jha P, 2017, WOMEN BIRTH; Jha P, 2016, MIDWIFERY, V39, P78, DOI 10.1016/j.midw.2016.04.012; Johansson H, 2010, J MULTIDISCIP HEALTH, V3, P1; Karkee R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-45; KATZ R, 1988, J COMP FAM STUD, V19, P371; Kirkman Bradley L., 2016, SOURCE ACAD MANAGEME, P557; Larsson BW, 2002, J CLIN NURS, V11, P681, DOI 10.1046/j.1365-2702.2002.00640.x; Larsson G, 1998, SCAND J CARING SCI, V12, P111, DOI 10.1080/02839319850163048; Leap N, 2010, J MIDWIFERY WOM HEAL, V55, P234, DOI 10.1016/j.jmwh.2010.02.001; Martin CH, 2011, INT J HEALTH CARE Q, V24, P124, DOI 10.1108/09526861111105086; Mas-Pons R, 2012, GAC SANIT, V26, P236, DOI 10.1016/j.gaceta.2011.09.019; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; McColl E, 1996, Nurs Stand, V10, P34; Meleis A.I., 2010, TRANSITIONS THEORY M; Ministry of Health and Family Welfare G of I, 2015, NAT FAM HLTH SURV 4; Ministry of Home Affairs G of I, 2013, SAMPL REG SYST STAT; Morestin F, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-20; Moudi Z, 2016, NURS MIDWIFERY STUD, V5, DOI 10.17795/nmsjournal29952; Netemeyer R.G., 2003, SCALING PROCEDURES I; Okello DRO, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0007-5; Pallant J., 2011, SURVIVAL MANUAL STEP; Polit DF., 2008, NURSING RES GENERATI; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Rn KIM, 2014, MATERN CHILD HLTH J, P278; Roy S, 2013, J GLOBAL HLTH CARE S, V3, P1; Saisto T, 2001, BRIT J OBSTET GYNAEC, V108, P492, DOI 10.1016/S0306-5456(00)00122-4; Sando D, 2014, JAIDS-J ACQ IMM DEF, V67, pS228, DOI 10.1097/QAI.0000000000000378; Sawyer A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-108; Sharma B, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-41; Siassakos D, 2009, BJOG-INT J OBSTET GY, V116, P1755, DOI 10.1111/j.1471-0528.2009.02363.x; Slootjes H, 2016, AUST OCCUP THER J, V63, P130, DOI 10.1111/1440-1630.12225; Srivastava A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0525-0; Titaley CR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-485; Tuncalp O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044536; Van Hollen C, 2003, MED ANTHROPOL Q, V17, P49; Welfare F, 2015, REV KAYAK GUID IMPR; WHO, 2018, INTR CAR POS CHILDB; WHO, 2008, WORLD HLTH REPORT 20; WILDE B, 1994, SCAND J CARING SCI, V8, P39, DOI 10.1111/j.1471-6712.1994.tb00223.x; Wilde-Larsson B, 2010, J CLIN NURS, V19, P1748, DOI 10.1111/j.1365-2702.2009.03055.x; Wittkowski A, 2016, CLIN PSYCHOL PSYCHOT; World Health Organization, 2016, STAND IMPR QUAL MAT; World Health Organization,, 2011, MAT NEWB CHILD AD HL	68	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211364	10.1371/journal.pone.0211364	http://dx.doi.org/10.1371/journal.pone.0211364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ3CE	30695046	gold, Green Submitted, Green Published			2022-12-27	WOS:000457046400030
J	Backhaus, SJ; Metschies, G; Billing, M; Kowallick, JT; Gertz, RJ; Lapinskas, T; Pieske, B; Lotz, J; Bigalke, B; Kutty, S; Hasenfuss, G; Beerbaum, P; Kelle, S; Schuster, A				Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Kowallick, Johannes T.; Gertz, Roman J.; Lapinskas, Tomas; Pieske, Burkert; Lotz, Joachim; Bigalke, Boris; Kutty, Shelby; Hasenfuss, Gerd; Beerbaum, Philipp; Kelle, Sebastian; Schuster, Andreas			Cardiovascular magnetic resonance imaging feature tracking: Impact of training on observer performance and reproducibility	PLOS ONE			English	Article							SPECKLE-TRACKING; MYOCARDIAL-INFARCTION; LONGITUDINAL STRAIN; HEART-FAILURE; DEFORMATION; STRATIFICATION; VARIABILITY; SURVIVAL	Background Cardiovascular magnetic resonance feature tracking (CMR-FT) is increasingly used for myocardial deformation assessment including ventricular strain, showing prognostic value beyond established risk markers if used in experienced centres. Little is known about the impact of appropriate training on CMR-FT performance. Consequently, this study aimed to evaluate the impact of training on observer variance using different commercially available CMR-FT software. Methods Intra- and inter-observer reproducibility was assessed prior to and after dedicated one-hour observer training. Employed FT software included 3 different commercially available platforms (TomTec, Medis, Circle). Left (LV) and right (RV) ventricular global longitudinal as well as LV circumferential and radial strains (GLS, GCS and GRS) were studied in 12 heart failure patients and 12 healthy volunteers. Results Training improved intra- and inter-observer reproducibility. GCS and LV GLS showed the highest reproducibility before (ICC>0.86 and >0.81) and after training (ICC>0.91 and >0.92). RV GLS and GRS were more susceptible to tracking inaccuracies and reproducibility was lower. Inter-observer reproducibility was lower than intra-observer reproducibility prior to training with more pronounced improvements after training. Before training, LV strain reproducibility was lower in healthy volunteers as compared to patients with no differences after training. Whilst LV strain reproducibility was sufficient within individual software solutions inter-software comparisons revealed considerable software related variance. Conclusion Observer experience is an important source of variance in CMR-FT derived strain assessment. Dedicated observer training significantly improves reproducibility with most profound benefits in states of high myocardial contractility and potential to facilitate widespread clinical implementation due to optimized robustness and diagnostic performance.	[Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Gertz, Roman J.; Hasenfuss, Gerd; Schuster, Andreas] Georg August Univ, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Backhaus, Soeren J.; Metschies, Georg; Billing, Marcus; Kowallick, Johannes T.; Gertz, Roman J.; Lotz, Joachim; Hasenfuss, Gerd; Schuster, Andreas] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany; [Kowallick, Johannes T.; Lotz, Joachim] Georg August Univ, Univ Med Ctr Gottingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Lapinskas, Tomas; Pieske, Burkert; Kelle, Sebastian] Univ Berlin, German Heart Ctr Berlin DHZB, Dept Internal Med Cardiol, Charite Campus Virchow Clin, Berlin, Germany; [Lapinskas, Tomas] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Bigalke, Boris] Univ Med Ctr Berlin, Dept Cardiol & Pneumol, Charite Campus Benjamin Franklin, Berlin, Germany; [Kutty, Shelby] Univ Nebraska, Coll Med, Childrens Hosp & Med Ctr, Omaha, NE 68198 USA; [Beerbaum, Philipp] Hannover Med Sch, Dept Pediat Cardiol & Intens Care, Hannover, Germany; [Schuster, Andreas] Univ Sydney, Dept Cardiol, Royal North Shore Hosp, Kolling Inst,Nothern Clin Sch, Sydney, NSW, Australia	University of Gottingen; German Centre for Cardiovascular Research; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Nebraska System; Hannover Medical School; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Schuster, A (corresponding author), Georg August Univ, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.; Schuster, A (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany.; Schuster, A (corresponding author), Univ Sydney, Dept Cardiol, Royal North Shore Hosp, Kolling Inst,Nothern Clin Sch, Sydney, NSW, Australia.	andreas_schuster@gmx.net	Kelle, Sebastian/ABH-7348-2020; Lotz, Joachim/G-3376-2015; Lapinskas, Tomas/V-5482-2019; Pieske, Burkert/M-8089-2016	Lotz, Joachim/0000-0002-1412-2741; Lapinskas, Tomas/0000-0001-7726-6948; Pieske, Burkert/0000-0002-6466-5306; Kelle, Sebastian/0000-0001-8105-6599; Backhaus, Soren/0000-0002-2683-6418	German Center for Cardiovascular Research (DZHK)	German Center for Cardiovascular Research (DZHK)	This study was supported by a German Center for Cardiovascular Research (DZHK) research grant awarded to Sebastian Kelle and Andreas Schuster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Beerbaum P, 2009, J MAGN RESON IMAGING, V30, P956, DOI 10.1002/jmri.21948; Biering-Sorensen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158280; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buss SJ, 2015, EUR HEART J-CARD IMG, V16, P307, DOI 10.1093/ehjci/jeu181; Cao JJ, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0448-9; Cheng S, 2013, J AM SOC ECHOCARDIOG, V26, P1258, DOI 10.1016/j.echo.2013.07.002; Donekal S, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-37; Eitel I, 2018, JACC-CARDIOVASC IMAG, V11, P1433, DOI 10.1016/j.jcmg.2017.11.034; Eitel I, 2014, J AM COLL CARDIOL, V64, P1217, DOI 10.1016/j.jacc.2014.06.1194; Ersboll M, 2013, J AM COLL CARDIOL, V61, P2365, DOI 10.1016/j.jacc.2013.02.061; Feisst A, 2018, IJC HEART VASC, V18, P46, DOI 10.1016/j.ijcha.2018.02.007; Gavara J, 2018, JACC-CARDIOVASC IMAG, V11, P1448, DOI 10.1016/j.jcmg.2017.09.017; Gertz RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193746; Heermann P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0075-z; Karamiltsos TD, 2007, J CARDIOVASC MAGN R, V9, P777, DOI 10.1080/10976640701545073; Kowallick JT, 2016, J MAGN RESON IMAGING, V43, P128, DOI 10.1002/jmri.24979; Kowallick JT, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0060-6; Maceira AM, 2018, J MAGN RESON IMAGING, V47, P1415, DOI 10.1002/jmri.25894; de Siqueira MEM, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0258-x; Morton G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-43; Orwat S, 2014, KARDIOL POL, V72, P363, DOI 10.5603/KP.a2013.0319; Paetsch I, 2006, EUR HEART J, V27, P1459, DOI 10.1093/eurheartj/ehi883; Pedrizzetti G, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0269-7; Pennell DJ, 2010, CIRCULATION, V121, P692, DOI 10.1161/CIRCULATIONAHA.108.811547; Romano S, 2018, JACC-CARDIOVASC IMAG, V11, P1419, DOI 10.1016/j.jcmg.2017.10.024; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Russo C, 2014, EUR J HEART FAIL, V16, P1301, DOI 10.1002/ejhf.154; Sakata K, 2016, J ECHOCARDIOGR, V14, P30, DOI 10.1007/s12574-015-0270-4; Schuster A, 2015, CLIN RADIOL, V70, P989, DOI 10.1016/j.crad.2015.05.006; Schuster A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004077; Schuster A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122858; Schuster A, 2013, EUR J RADIOL, V82, P296, DOI 10.1016/j.ejrad.2012.11.012; Schuster A, 2013, INT J CARDIOL, V166, P413, DOI 10.1016/j.ijcard.2011.10.137; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Steinmetz M, 2018, INT J CARDIOL, V257, P54, DOI 10.1016/j.ijcard.2017.11.097; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44	38	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210127	10.1371/journal.pone.0210127	http://dx.doi.org/10.1371/journal.pone.0210127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682045	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500024
J	Bernhard, A; Rasinger, JD; Betancor, MB; Caballero, MJ; Berntssen, MHG; Lundebye, AK; Ornsrud, R				Bernhard, Annette; Rasinger, Josef D.; Betancor, Monica B.; Jose Caballero, Maria; Berntssen, Marc H. G.; Lundebye, Anne-Katrine; Ornsrud, Robin			Tolerance and dose-response assessment of subchronic dietary ethoxyquin exposure in Atlantic salmon (Salmo salar L.)	PLOS ONE			English	Article							SYNTHETIC ANTIOXIDANT ETHOXYQUIN; FED GRADED-LEVELS; DNA-DAMAGE; BUTYLATED HYDROXYANISOLE; OXIDATIVE STRESS; GLUTATHIONE; METABOLISM; EXPRESSION; GROWTH; BIOTRANSFORMATION	Ethoxyquin (EQ; 6-Ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline) has been used as an antioxidant in feed components for pets, livestock and aquaculture. However, possible risks of EQ used in aquafeed for fish health have not yet been characterized. The present study investigated the toxicity and dose-response of subchronic dietary EQ exposure at doses ranging from 41 to 9666 mg EQ/kg feed in Atlantic salmon (Salmo salar L.). Feed at concentrations higher than 1173 mg EQ/kg were rejected by the fish, resulting in reduced feed intake and growth performance. No mortality was observed in fish exposed to any of the doses. A multi-omic screening of metabolome and proteome in salmon liver indicated an effect of dietary EQ on bioenergetics pathways and hepatic redox homeostasis in fish fed concentrations above 119 mg EQ/kg feed. Increased energy expenditure associated with an upregulation of hepatic fatty acid beta-oxidation and induction and carbohydrate catabolic pathways resulted in a dose- dependent depletion of intracytoplasmic lipid vacuoles in liver histological sections, decreasing whole body lipid levels and altered purine/pyrimidine metabolism. Increased GSH and TBARS in the liver indicated a state of oxidative stress, which was associated with activation of the NRF2-mediated oxidative stress response and glutathione-mediated detoxification processes. However, no oxidative DNA damage was observed. As manifestation of altered energy metabolism, the depletion of liver intracytoplasmic lipid vacuoles was considered the critical endpoint for benchmark dose assessment, and a BMDL10 of 243 mg EQ/kg feed was derived as a safe upper limit of EQ exposure in Atlantic salmon.	[Bernhard, Annette; Rasinger, Josef D.; Berntssen, Marc H. G.; Lundebye, Anne-Katrine; Ornsrud, Robin] Inst Marine Res, Bergen, Norway; [Betancor, Monica B.] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Jose Caballero, Maria] Univ Las Palmas Gran Canaria, Sch Vet, Dept Morphol, Las Palmas Gran Canaria, Spain	Institute of Marine Research - Norway; University of Stirling; Universidad de Las Palmas de Gran Canaria	Ornsrud, R (corresponding author), Inst Marine Res, Bergen, Norway.	robin.ornsrud@hi.no	Caballero, Maria Jose/J-6599-2017; Berntssen, Marc/O-9406-2018; Caballero, Maria Jose/U-7580-2019; Rasinger, Josef Daniel/AAO-3687-2020	Caballero, Maria Jose/0000-0002-2575-0997; Caballero, Maria Jose/0000-0002-2575-0997; Rasinger, Josef Daniel/0000-0002-9424-4414; Bernhard, Annette/0000-0003-2542-8583; Betancor, Monica/0000-0003-1626-7458	Norwegian Seafood Research Fund (FHF); Marine Ingredients Organisation (IFFO) Marine Harvest ASA; EWOS AS/Cargill Aqua Nutrition; Biomar AS; Skretting AS; Europharma (FHF project) [901327]	Norwegian Seafood Research Fund (FHF); Marine Ingredients Organisation (IFFO) Marine Harvest ASA; EWOS AS/Cargill Aqua Nutrition; Biomar AS; Skretting AS; Europharma (FHF project)	This study was financed by the Norwegian Seafood Research Fund (FHF; https://www.fhf.no/), the Marine Ingredients Organisation (IFFO) Marine Harvest ASA, EWOS AS/Cargill Aqua Nutrition, Biomar AS, Skretting AS and Europharma (FHF project no. 901327). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; AOAC, 1995, 99215 AOAC; Blaszczyk A, 2006, TOXICOL LETT, V163, P77, DOI 10.1016/j.toxlet.2005.09.040; Blaszczyk A, 2005, CELL MOL BIOL LETT, V10, P15; Blaszczyk Alina, 2005, Acta Pol Pharm, V62, P111; Blaszczyk Alina, 2013, Int J Food Sci, V2013, P585931, DOI 10.1155/2013/585931; Bohne VJB, 2008, FOOD CHEM TOXICOL, V46, P1834, DOI 10.1016/j.fct.2008.01.028; Bohne VJB, 2007, FOOD CHEM TOXICOL, V45, P733, DOI 10.1016/j.fct.2006.10.020; Bohne VJB, 2006, TOXICOL SCI, V93, P11, DOI 10.1093/toxsci/kfl044; de Koning AJ, 2002, INT J FOOD PROP, V5, P451, DOI 10.1081/JFP-120005797; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dibner JJ, 1996, ANIM FEED SCI TECH, V62, P1, DOI 10.1016/S0377-8401(96)01000-0; EFSA, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.229r; European Food Safety Authority (EFSA), 2015, EFSA J, V13, P58; Hamre K, 2001, AQUACULT NUTR, V7, P123, DOI 10.1046/j.1365-2095.2001.00162.x; Han H, 2002, J ANIM SCI, V80, P1117; Hardy A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4970; Hayes JD, 2000, BIOCHEM SOC T, V28, P33, DOI 10.1042/bst0280033; He P, 2000, J FOOD SCI, V65, P1312, DOI 10.1111/j.1365-2621.2000.tb10603.x; Kestemont P, 2001, AQUACULTURE, V203, P85, DOI 10.1016/S0044-8486(01)00615-9; Krumsiek C. L., 1998, Animal Science Research Report - Agricultural Experiment Station, Oklahoma State University, P64; Laohabanjong R, 2009, AQUACULTURE, V286, P283, DOI 10.1016/j.aquaculture.2008.09.038; LIE O, 1994, FISH PHYSIOL BIOCHEM, V13, P241, DOI 10.1007/BF00004362; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lundebye AK, 2010, FOOD ADDIT CONTAM A, V27, P1652, DOI 10.1080/19440049.2010.508195; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Ornsrud R, 2011, J FOOD PROTECT, V74, P1574, DOI 10.4315/0362-028X.JFP-10-547; Penninks A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4920; Rasinger JD, 2014, TOXICOLOGY, V321, P1, DOI 10.1016/j.tox.2014.03.006; Rychen G, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5023; SANDNES K, 1988, J FISH BIOL, V32, P129, DOI 10.1111/j.1095-8649.1988.tb05341.x; Saxena TB, 2000, COMP BIOCHEM PHYS C, V127, P1, DOI 10.1016/S0742-8413(00)00131-6; Schlenk Daniel, 2008, P683, DOI 10.1201/9780203647295.ch16; SHI MM, 1994, J BIOL CHEM, V269, P26512; Skolimowski JJ, 2010, TOXICOL LETT, V193, P194, DOI 10.1016/j.toxlet.2010.01.006; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wang J, 2010, AQUACULTURE, V306, P80, DOI 10.1016/j.aquaculture.2010.06.024; WHO, 2009, PRINC METH RISK ASS, P240; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187; Yamane Y, 1998, J BIOL CHEM, V273, P31075, DOI 10.1074/jbc.273.47.31075; Yamashita Y, 2009, AQUACULT NUTR, V15, P144, DOI 10.1111/j.1365-2095.2008.00577.x	45	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211128	10.1371/journal.pone.0211128	http://dx.doi.org/10.1371/journal.pone.0211128			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682099	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500104
J	Brink, A; Alsma, J; Verdonschot, RJCG; Rood, PPM; Zietse, R; Lingsma, HF; Schuit, SCE				Brink, Anniek; Alsma, Jelmer; Verdonschot, Rob Johannes Carel Gerardus; Rood, Pleunie Petronella Marie; Zietse, Robert; Lingsma, Hester Floor; Schuit, Stephanie Catherine Elisabeth			Predicting mortality in patients with suspected sepsis at the Emergency Department; A retrospective cohort study comparing qSOFA, SIRS and National Early Warning Score	PLOS ONE			English	Article							INFLAMMATORY RESPONSE SYNDROME; INTERNATIONAL CONSENSUS DEFINITIONS; ORGAN FAILURE ASSESSMENT; CRITICAL-CARE; CRITERIA; ADMISSION; ACCURACY; RISK	Objective In hospitalized patients, the risk of sepsis-related mortality can be assessed using the quick Sepsis-related Organ Failure Assessment (qSOFA). Currently, different tools that predict deterioration such as the National Early Warning Score (NEWS) have been introduced in clinical practice in Emergency Departments (ED) worldwide. It remains ambiguous which screening tool for mortality at the ED is best. The objective of this study was to evaluate the predictive performance for mortality of two sepsis-based scores (i.e. qSOFA and Systemic Inflammatory Response Syndrome (SIRS)-criteria) compared to the more general NEWS score, in patients with suspected infection directly at presentation to the ED. Methods We performed a retrospective cohort study. Patients who presented to the ED between June 2012 and May 2016 with suspected sepsis in a large tertiary care center were included. Suspected sepsis was defined as initiation of intravenous antibiotics and/or collection of any culture in the ED. Outcome was defined as 10-day and 30-day mortality after ED presentation. Predictive performance was expressed as discrimination (AUC) and calibration using Hosmer-Lemeshow goodness-of-fit test. Subsequently, sensitivity, and specificity were calculated. Results In total 8,204 patients were included of whom 286 (3.5%) died within ten days and 490 (6.0%) within 30 days after presentation. NEWS had the best performance, followed by qSOFA and SIRS (10-day AUC: 0.837, 0.744, 0.646, 30-day AUC: 0.779, 0.697, 0.631). qSOFA (>= 2) lacked a high sensitivity versus SIRS (>= 2) and NEWS (. 7) (28.5%, 77.2%, 68.0%), whilst entailing highest specificity versus NEWS and SIRS (93.7%, 66.5%, 37.6%). Conclusions NEWS is more accurate in predicting 10- and 30-day mortality than qSOFA and SIRS in patients presenting to the ED with suspected sepsis.	[Brink, Anniek; Alsma, Jelmer; Zietse, Robert; Schuit, Stephanie Catherine Elisabeth] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Verdonschot, Rob Johannes Carel Gerardus; Rood, Pleunie Petronella Marie; Schuit, Stephanie Catherine Elisabeth] Erasmus Univ, Med Ctr, Dept Emergency Med, Rotterdam, Netherlands; [Lingsma, Hester Floor] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Brink, A (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.	a.brink@erasmusmc.nl	Alsma, Jelmer/O-7165-2019	Alsma, Jelmer/0000-0002-2808-1514				Asayama Keisei, 1998, Keio Journal of Medicine, V47, P19; Askim A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0399-4; Bilben B, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0273-9; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Canet E, 2018, J CRIT CARE, V48, P118, DOI 10.1016/j.jcrc.2018.08.022; Carneiro António Henriques, 2017, Rev. bras. ter. intensiva, V29, P4, DOI [10.5935/0103-507x.20170002, 10.5935/0103-507X.20170002]; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Corfield AR, 2014, EMERG MED J, V31, P482, DOI 10.1136/emermed-2012-202186; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Hoikka M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0514-1; Hwang SY, 2018, ANN EMERG MED, V71, P1, DOI 10.1016/j.annemergmed.2017.05.022; Jo S, 2016, J CRIT CARE, V36, P60, DOI 10.1016/j.jcrc.2016.06.016; Jones GR, 1996, QJM-MON J ASSOC PHYS, V89, P515; Kivipuro M, 2018, RESUSCITATION, V128, P164, DOI 10.1016/j.resuscitation.2018.05.020; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Park HK, 2017, J CRIT CARE, V42, P12, DOI 10.1016/j.jcrc.2017.06.020; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Proctor HJ., 1993, ADV TRAUMA LIFE SUPP; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Royal College of Physicians, 2017, NATL EARL WARN SCOR; Sbiti-Rohr D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-011021; Semler MW, 2013, CHEST, V143, P1740, DOI 10.1378/chest.12-1837; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shaw J, 2017, EMERG MED J, V34, P533, DOI 10.1136/emermed-2016-206115; Simpson SQ, 2016, CHEST, V149, P1117, DOI 10.1016/j.chest.2016.02.653; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sjoding MW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0923-8; Sprung CL, 2016, INTENS CARE MED, V42, P2024, DOI 10.1007/s00134-016-4604-0	30	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211133	10.1371/journal.pone.0211133	http://dx.doi.org/10.1371/journal.pone.0211133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682104	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500107
J	Casal, J; Saegerman, C; Bertagnoli, S; Meyer, G; Ganiere, JP; Caufour, P; De Clercq, K; Jacquiet, P; Hautefeuille, C; Etore, F; Napp, S				Casal, Jordi; Saegerman, Claude; Bertagnoli, Stephane; Meyer, Gilles; Ganiere, Jean Pierre; Caufour, Philippe; De Clercq, Kris; Jacquiet, Philippe; Hautefeuille, Claire; Etore, Florence; Napp, Sebastian			A simple method to estimate the number of doses to include in a bank of vaccines. The case of Lumpy Skin Disease in France	PLOS ONE			English	Article								A simple method to estimate the size of the vaccine bank needed to control an epidemic of an exotic infectious disease in case of introduction into a country is presented. The method was applied to the case of a Lumpy Skin disease (LSD) epidemic in France. The size of the stock of vaccines needed was calculated based on a series of simple equations that use some trigonometric functions and take into account the spread of the disease, the time required to obtain good vaccination coverage and the cattle density in the affected region. Assuming a 7-weeks period to vaccinate all the animals and a spread of the disease of 7.3 km/week, the vaccination of 740 716 cattle would be enough to control an epidemic of LSD in France in 90% of the simulations (608 196 cattle would cover 75% of the simulations). The results of this simple method were then validated using a dynamic simulation model, which served as reference for the calculation of the vaccine stock required. The differences between both models in different scenarios, related with the time needed to vaccinate the animals, ranged from 7% to 10.5% more vaccines using the simple method to cover 90% of the simulations, and from 9.0% to 13.8% for 75% of the simulations. The model is easy to use and may be adapted for the control of different diseases in different countries, just by using some simple formulas and few input data.	[Casal, Jordi] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Casal, Jordi; Napp, Sebastian] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Barcelona, Spain; [Casal, Jordi; Saegerman, Claude; Meyer, Gilles; Ganiere, Jean Pierre] Expert Comm Anim Hlth & Welf ANSES, Maisons Alfort, France; [Saegerman, Claude] Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium; [Bertagnoli, Stephane; Meyer, Gilles; Jacquiet, Philippe] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Ganiere, Jean Pierre] ONIRIS, Nantes, France; [Caufour, Philippe] CIRAD, Dept BIOS, UMR, INRA,ASTRE, Montpellier, France; [De Clercq, Kris] CERVA, CODA, Unit Vesicular & Exot Dis, Uccle, Belgium; [Hautefeuille, Claire; Etore, Florence] Agence Natl Securite Sanit Alimentat Environm & T, Maisons Alfort, France	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Liege; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; CIRAD; INRAE; Ecole Nationale Veterinaire d'Alfort (ENVA)	Casal, J (corresponding author), Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain.; Casal, J (corresponding author), UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Barcelona, Spain.; Casal, J; Saegerman, C (corresponding author), Expert Comm Anim Hlth & Welf ANSES, Maisons Alfort, France.; Saegerman, C (corresponding author), Univ Liege, Fundamental & Appl Res Anim & Hlth FARAH Ctr, Liege, Belgium.	Jordi.casal@uab.cat; claude.saegerman@ulg.ac.be	Casal, Jordi/F-3020-2016; Napp, Sebastian/F-3331-2016	Casal, Jordi/0000-0002-6909-9366; Napp, Sebastian/0000-0001-5813-7286; , Etore/0000-0001-7225-4323; Saegerman, Claude/0000-0001-9087-7436				Al-Salihi KA, 2015, TRANSBOUND EMERG DIS, V62, P457, DOI 10.1111/tbed.12386; [Anonymous], 2014, R LANG ENV STAT COMP; Beltran-Beck B, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5051; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P46, DOI 10.1111/j.1865-1682.2007.01012.x; Forman AJ, 2002, REV SCI TECH OIE, V21, P601, DOI 10.20506/rst.21.3.1359; Mercier A, 2018, TRANSBOUND EMERG DIS, V65, P240, DOI 10.1111/tbed.12624; Muleme M, 2012, TROP ANIM HEALTH PRO, V45, P35, DOI 10.1007/s11250-012-0254-6; OIE, VACC BANKS; Pebesma E.J., 2005, R NEWS, V5, P9; Perkins NR, 2011, AUST VET J, V89, P126, DOI 10.1111/j.1751-0813.2011.00766.x; PROZESKY L, 1982, ONDERSTEPOORT J VET, V49, P167; Rivas AL, 2012, TRANSBOUND EMERG DIS, V59, P464, DOI 10.1111/j.1865-1682.2011.01301.x; Tasioudi KE, 2016, TRANSBOUND EMERG DIS, V63, P260, DOI 10.1111/tbed.12497; Tuppurainen ESM, 2012, TRANSBOUND EMERG DIS, V59, P40, DOI 10.1111/j.1865-1682.2011.01242.x	14	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210317	10.1371/journal.pone.0210317	http://dx.doi.org/10.1371/journal.pone.0210317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682041	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500033
J	Castiglione, S; Serio, C; Mondanaro, A; Di Febbraro, M; Profico, A; Girardi, G; Raia, P				Castiglione, S.; Serio, C.; Mondanaro, A.; Di Febbraro, M.; Profico, A.; Girardi, G.; Raia, P.			Simultaneous detection of macroevolutionary patterns in phenotypic means and rate of change with and within phylogenetic trees including extinct species	PLOS ONE			English	Article							BODY-SIZE EVOLUTION; MORPHOLOGICAL DIVERSIFICATION; ECOLOGICAL OPPORTUNITY; ADAPTIVE RADIATIONS; TRAIT EVOLUTION; INNOVATION; MAMMALS; TEMPO; RULE	Recognizing evolutionary trends in phenotypic means and rates requires the application of phylogenetic comparative methods (PCMs). Most PCMs are unsuited to make full use of fossil information, which is a drawback, given the inclusion of such data improves, and in some cases even corrects, the proper understanding of trait evolution. Here we present a new computer application, written in R, that allows the simultaneous computation of temporal trends in phenotypic mean and evolutionary rate along a phylogeny, and to contrast such patterns among different clades within the tree. By using simulation experiments, we show the new implementation, names search. trend is as powerful as existing PCM tools in discerning macroevolutionary patterns in phenotypic means and rates, but differently from any other PCM allows comparing individual clades to each other, and provides rich information about trait evolution for all lineages in the tree.	[Castiglione, S.; Serio, C.; Mondanaro, A.; Girardi, G.; Raia, P.] Univ Naples Federico II, Dept Earth Sci Environm & Resources, Naples, Italy; [Mondanaro, A.] Univ Florence, Dept Earth Sci, Florence, Italy; [Di Febbraro, M.] Univ Molise, Environmetr Lab, Dept Biosci & Terr DiBT, Pesche, Italy; [Profico, A.] Univ Roma Sapienza, Dipartimento Biol Ambientale, Rome, Italy	University of Naples Federico II; University of Florence; University of Molise; Sapienza University Rome	Raia, P (corresponding author), Univ Naples Federico II, Dept Earth Sci Environm & Resources, Naples, Italy.	pasquale.raia@unina.it	Mondanaro, Alessandro/F-6893-2017; Di Febbraro, Mirko/GQA-4462-2022; Castiglione, Silvia/F-6840-2017; Profico, Antonio/Q-3208-2018; Raia, Pasquale/I-8600-2012; Serio, Carmela/F-6854-2017; Di Febbraro, Mirko/I-3167-2019	Mondanaro, Alessandro/0000-0003-0325-7066; Castiglione, Silvia/0000-0002-6140-1495; Profico, Antonio/0000-0003-2884-7118; Raia, Pasquale/0000-0002-4593-8006; Serio, Carmela/0000-0001-5256-5511; Di Febbraro, Mirko/0000-0001-8898-7046				Arbour JH, 2017, EVOLUTION, V71, P1600, DOI 10.1111/evo.13237; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Butler RJ, 2008, J EVOLUTION BIOL, V21, P1673, DOI 10.1111/j.1420-9101.2008.01594.x; Cantalapiedra JL, 2017, SCIENCE, V355, P627, DOI 10.1126/science.aag1772; Castiglione S, 2018, METHODS ECOL EVOL, V9, P974, DOI 10.1111/2041-210X.12954; Clavel J, 2017, P NATL ACAD SCI USA, V114, P4183, DOI 10.1073/pnas.1606868114; Finarelli JA, 2006, SYST BIOL, V55, P301, DOI 10.1080/10635150500541698; Foote M., 1997, ANNU REV ECOL SYST, DOI [10.1146/annurev.ecolsys.28.1.85, DOI 10.1146/ANNUREV.ECOLSYS.28.1.85]; Grant PR, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0146; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Hunt G, 2015, P NATL ACAD SCI USA, V112, P4885, DOI 10.1073/pnas.1403662111; Hunt G, 2012, PALEOBIOLOGY, V38, P351, DOI 10.1666/11047.1; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jablonski D., 1986, Life Sciences Research Report, P313; Kratsch C, 2014, BIOINFORMATICS, V30, pI527, DOI 10.1093/bioinformatics/btu477; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep18627; Liow LH, 2007, EVOLUTION, V61, P885, DOI 10.1111/j.1558-5646.2007.00077.x; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Meloro C, 2010, EVOL BIOL, V37, P177, DOI 10.1007/s11692-010-9094-3; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Montgomery SH, 2013, EVOLUTION, V67, P3339, DOI 10.1111/evo.12197; Pagel M., 2009, MORPHOLOGY SHAPE PHY, P269, DOI [10.1201/9780203165171.ch13, DOI 10.1201/9780203165171.CH13]; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Rabosky DL, 2014, SYST BIOL, V63, P610, DOI 10.1093/sysbio/syu025; Raia P, 2012, AM NAT, V179, P328, DOI 10.1086/664081; Raia P, 2006, EVOLUTION, V60, P1731; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roopnarine PD, 2003, ANNU REV ECOL EVOL S, V34, P605, DOI 10.1146/annurev.ecolsys.34.011802.132407; Schnitzler J, 2017, EVOL ECOL RES, V18, P187; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Slater GJ, 2015, P NATL ACAD SCI USA, V112, P4897, DOI 10.1073/pnas.1403666111; Slater GJ, 2012, EVOLUTION, V66, P3931, DOI 10.1111/j.1558-5646.2012.01723.x; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417	39	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210101	10.1371/journal.pone.0210101	http://dx.doi.org/10.1371/journal.pone.0210101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682060	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500023
J	Marsh, C; Hammond, MD; Crawford, MT				Marsh, Claire; Hammond, Matthew D.; Crawford, Matthew T.			Thinking about negative life events as a mediator between depression and fading affect bias	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY SPECIFICITY; SOCIAL ANXIETY; MENTAL-HEALTH; RUMINATION; DISORDERS; COMORBIDITY; SYMPTOMS; WORRY	The current research examined the links between depressive symptomology and anxiety on the fading of affect associated with positive and negative autobiographical memories. Participants (N = 296) recalled and rated positive and negative events in terms of how pleasant or unpleasant they were at the time they occurred and at the time of event recollection. Multi-level mediation analyses identified evidence that higher levels of depressive symptoms were directly associated with lower affect fade for both negative and positive memories. Tests of indirect effects indicated that depressive symptoms were indirectly related to lower affect fade for negative (but not positive) autobiographical memories via the heightened tendency to think about negative (but not positive) memories. Anxiety was unrelated to affect fade both directly and indirectly. These results suggest that people higher in depressive symptoms retain more negative affect due to an increased likelihood of thinking about negative autobiographical events.	[Marsh, Claire; Hammond, Matthew D.; Crawford, Matthew T.] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	Victoria University Wellington	Crawford, MT (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	Matt.Crawford@vuw.ac.nz	Hammond, Matt/HGC-6370-2022					Adams GC, 2016, J AFFECT DISORDERS, V206, P48, DOI 10.1016/j.jad.2016.07.031; Baikie KA, 2012, J AFFECT DISORDERS, V136, P310, DOI 10.1016/j.jad.2011.11.032; Beck A., 1993, BECK ANXIETY INVENTO; Beck A.T., 1987, BECK DEPRESSION INVE; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; Gibbons JA, 2011, APPL COGNITIVE PSYCH, V25, P663, DOI 10.1002/acp.1738; Glazier BL, 2017, BEHAV THER, V48, P533, DOI 10.1016/j.beth.2016.08.001; Hallford DJ, 2017, INT J MENT HEALTH, V46, P74, DOI 10.1080/00207411.2017.1294968; Hayes A. F., 2018, INTRO MEDIATION MODE; Hirschfeld Robert M. A., 2001, Prim Care Companion J Clin Psychiatry, V3, P244; Hyde LW, 2011, NEUROPSYCHOLOGIA, V49, P651, DOI 10.1016/j.neuropsychologia.2010.08.025; Ricarte JJ, 2016, SCAND J PSYCHOL, V57, P495, DOI 10.1111/sjop.12323; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kizilbash AH, 2002, ARCH CLIN NEUROPSYCH, V17, P57, DOI 10.1016/S0887-6177(00)00101-3; Krans J, 2014, MEMORY, V22, P890, DOI 10.1080/09658211.2013.844261; Krpan KM, 2013, J AFFECT DISORDERS, V150, P1148, DOI 10.1016/j.jad.2013.05.065; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Landau JD, 2009, AM J PSYCHOL, V122, P209; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Muir K, 2017, COGNITION EMOTION, V31, P1392, DOI 10.1080/02699931.2016.1225005; Muthen L.K., 2017, MPLUS USERS GUIDE, V8th ed.; Nezlek JB, 2008, SOC PERSONAL PSYCHOL, V2, P842, DOI 10.1111/j.1751-9004.2007.00059.x; Niles A. N., 2016, COGNITION EMOTION, V30, P1; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Overall NC, 2013, PERS SOC PSYCHOL B, V39, P636, DOI 10.1177/0146167213480188; Qualtrics, 2005, QUALTR SURV SOFTW CO; Ritchie TD, 2006, SELF IDENTITY, V5, P172, DOI 10.1080/15298860600591222; Romero N, 2014, MEMORY, V22, P646, DOI 10.1080/09658211.2013.811254; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Skowronski JJ, 2004, SELF IDENTITY, V3, P285, DOI 10.1080/13576500444000065; Skowronski JJ, 2014, ADV EXP SOC PSYCHOL, V49, P163, DOI 10.1016/B978-0-12-800052-6.00003-2; Starcevic V, 2007, J ANXIETY DISORD, V21, P1016, DOI 10.1016/j.janxdis.2006.10.015; Streiner DL, 2002, CAN J PSYCHIAT, V47, P262, DOI 10.1177/070674370204700307; Suhr M, 2017, J CLIN PSYCHOL, V73, P1586, DOI 10.1002/jclp.22463; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; van Walraven C, 2008, NEUROEPIDEMIOLOGY, V30, P138, DOI 10.1159/000126908; Walker WR, 2014, ADV COGN PSYCHOL, V10, P81, DOI 10.5709/acp-0159-0; Walker WR, 2009, APPL COGNITIVE PSYCH, V23, P1122, DOI 10.1002/acp.1614; Walker WR, 2003, COGNITION EMOTION, V17, P703, DOI 10.1080/02699930302287; Walker WR, 2003, REV GEN PSYCHOL, V7, P203, DOI 10.1037/1089-2680.7.2.203; Walker WR, 1997, APPL COGNITIVE PSYCH, V11, P399, DOI 10.1002/(SICI)1099-0720(199710)11:5<399::AID-ACP462>3.3.CO;2-5; Werner-Seidler A, 2017, SOC PSYCH PSYCH EPID, V52, P1463, DOI 10.1007/s00127-017-1440-7; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	46	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211147	10.1371/journal.pone.0211147	http://dx.doi.org/10.1371/journal.pone.0211147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682113	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500112
J	ul Haq, I; Abd-Alla, A; Tomas, US; Meza, JS; Bourtzis, K; Caceres, C				ul Haq, Ihsan; Abd-Alla, Adly; Tomas, Ulysses Sto; Salvador Meza, Jose; Bourtzis, Kostas; Caceres, Carlos			Cryopreservation of the Mediterranean fruit fly (Diptera: Tephritidae) VIENNA 8 genetic sexing strain: No effect on large scale production of high quality sterile males for SIT applications	PLOS ONE			English	Article							CERATITIS-CAPITATA; INSECT TECHNIQUE; FLIES; ERADICATION; DOMESTICATION; ATTRACTANTS; SUPPRESSION	The sterile insect technique (SIT) integrated in area-wide integrated pest management (AW-IPM) programmes is being used for the successful management of the Mediterranean fruit fly Ceratitis capitata (Wiedemann) (Diptera: Tephritidae) which is a horticultural pest of economic importance in tropical and subtropical countries. All programmes with an SIT component are using the VIENNA genetic sexing strains (GSS), mainly the VIENNA 8 GSS, which have been developed by applying classical genetic approaches. The VIENNA 8 GSS carries two selectable markers, the white pupae and the temperature sensitive lethal genes, which allows the production and release of only males thus increasing the biological efficiency and cost effectiveness of SIT applications. However, mass rearing may affect quality traits of the GSS, in which case replenishment of the colony with wild flies is recommended, a process which is tedious and time consuming. We previously reported the development of a cryopreservation protocol for the VIENNA 8(D53+) strain. In the present study, we report on the evaluation of the cryopreserved strain VIENNA 8(D53+)/Cryo-228L, reared under semi mass rearing conditions, for production parameters, quality control indices and mating competitiveness of males, in a comparative way with the non-cryopreserved VIENNA 8(D53+) strain, against wild type males. The VIENNA 8(D53+) and VIENNA 8(D53+)/Cryo-228L strains were similar for production parameters viz. egg production, pupal production, pupal recovery, and quality control indices like fly emergence, sex ratio and flight ability. Males from both strains were equally competitive with males of the wild type strain in achieving mating with wild type females under field cage conditions. Results are discussed in the context of cryopreservation as a potential backup strategy for refreshing the mass rearing colony with biological material from a cryopreserved stock.	[ul Haq, Ihsan; Abd-Alla, Adly; Tomas, Ulysses Sto; Salvador Meza, Jose; Bourtzis, Kostas; Caceres, Carlos] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria; [ul Haq, Ihsan] Natl Agr Res Ctr, Pk Rd, Islamabad, Pakistan; [Salvador Meza, Jose] SAGARPA IICA, Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; National Agricultural Research Council - Pakistan	ul Haq, I (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria.; ul Haq, I (corresponding author), Natl Agr Res Ctr, Pk Rd, Islamabad, Pakistan.	imihsan@yahoo.com	Meza Hernández, José Salvador/B-6203-2015; Hernández, José Salvador Meza/AAS-2085-2021	Meza Hernández, José Salvador/0000-0001-5178-419X; Hernández, José Salvador Meza/0000-0001-5178-419X; ABD-ALLA, Adly/0000-0001-7540-4462				Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Augustinos AA, 2017, ENTOMOL EXP APPL, V164, P305, DOI 10.1111/eea.12612; Augustinos AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160232; BUSCHPETERSEN E, 1989, ENTOMOL EXP APPL, V51, P241, DOI 10.1007/BF00347887; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Fischer K., 2000, J ECON ENTOMOL, V91, P1406; Fischer K., 1998, J ECON ENTOMOL, V93, P394; Fisher K., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P543; Franz G, 1996, FRUIT FLY PESTS, P185; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gilchrist AS, 2012, J ECON ENTOMOL, V105, P1051, DOI 10.1603/EC11421; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Hendrichs J., 2009, ENCY INSECTS, V2nd ed., P953, DOI DOI 10.1016/B978-0-12-374144-8.00252-6; HOOPER GHS, 1987, ENTOMOL EXP APPL, V44, P161, DOI 10.1007/BF00367625; Ito Y., 2003, Journal of Asia-Pacific Entomology, V6, P119, DOI 10.1016/S1226-8615(08)60177-6; Katsoyannos BI, 1999, J ECON ENTOMOL, V92, P583, DOI 10.1093/jee/92.3.583; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Leopold R.A., 1991, P379; Leopold RA, 2001, ANN ENTOMOL SOC AM, V94, P695, DOI 10.1603/0013-8746(2001)094[0695:COEOTN]2.0.CO;2; Leopold RA, 2010, ANN ENTOMOL SOC AM, V103, P264, DOI 10.1603/AN09094; Liquido N. J., 1991, MISCELLANEOUS PUBLIC, V77; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; Ott RL, 2001, INTRO STAT METHODS D; Rajamohan A, 2007, CRYOBIOLOGY, V54, P44, DOI 10.1016/j.cryobiol.2006.10.192; Rajamohan A, 2003, CRYOLETTERS, V24, P125; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; ROBINSON AS, 1982, GENETICA, V58, P229, DOI 10.1007/BF00128017; ROBINSON AS, 1999, TRENDS ENTOMOL, V2, P81; Roessler Y., 1989, WORLD CROP PESTS FRU, V3, P329; STEINER LF, 1961, J ECON ENTOMOL, V54, P30, DOI 10.1093/jee/54.1.30; VARGAS RI, 1986, J ECON ENTOMOL, V79, P864, DOI 10.1093/jee/79.3.864; Yuval B, 2010, J APPL ENTOMOL, V135, P1; Zygouridis NE, 2014, J APPL ENTOMOL, V138, P423, DOI 10.1111/jen.12042	37	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211259	10.1371/journal.pone.0211259	http://dx.doi.org/10.1371/journal.pone.0211259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682129	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500136
J	Wei, LP; Chang, JR; Han, Z; Wang, RH; Song, LH				Wei, Lianping; Chang, Jianrong; Han, Zhen; Wang, Ronghai; Song, Lihua			Recombinant human growth hormone (rhGH) treatment of MKN-45 xenograft mice improves nutrition status and strengthens immune function without promoting tumor growth	PLOS ONE			English	Article							CACHEXIA; CANCER; THERAPY; GH	The aim of this study was to clarify the combined effects and dose-effect relationships of rhGH on tumor growth, nutrition status, and immune function in MKN-45 xenograft mice. In this study, animal models were induced in nude mice using the subcutaneous transplantation of MKN-45 cells, and rhGH was injected daily for 14 days. Three rhGH treatment dosages were set with reference to the equivalent dosage converted from human clinical dosage, including 2 IU (0.67 mg), 10 IU (3.35 mg) and 50 IU (16.75 mg) per kg body weight. The tumor volume, body weight and food intake were measured every two or three days. After 14 days of rhGH treatment, the tumors were isolated and weighed. The expression levels of Ki-67, vascular endothelial growth factor (VEGF) and CD31in tumor tissues were detected by immunohistochemistry (IHC). The protein expression levels of pJAK2, JAK2, pSTAT3, STAT3, pAKT, AKT, pERK and ERK were measured by western blotting. The percentage of active NK cells in peripheral blood mononuclear cells (PBMCs) was detected by fluorescence-activated cell sorting (FACS). The results showed that rhGH had improved the food intake, increased the body weight and strengthened the immune function of MKN-45 xenograft mice but had not promote tumor growth. MKN-45 xenograft mice treated with rhGH at a higher dosage gained more weight, while those treated with rhGH at a lower dosage showed stronger immune function and smaller tumor volume.	[Wei, Lianping; Han, Zhen; Song, Lihua] Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China; [Chang, Jianrong] Benbu Med Coll, Sci Res Ctr, Benbu, Anhui, Peoples R China; [Wang, Ronghai; Song, Lihua] AnHui Anke Biotechnol Grp Co Ltd, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Song, LH (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei, Anhui, Peoples R China.; Song, LH (corresponding author), AnHui Anke Biotechnol Grp Co Ltd, Hefei, Anhui, Peoples R China.	Songlh@ankebio.com			Natural Science Research Project of Universities in Anhui [KJ2017A148]; Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University [2014KQJ007]	Natural Science Research Project of Universities in Anhui; Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University	This work was supported by the Natural Science Research Project of Universities in Anhui (http://202.38.95.119/srmis), Award Number KJ2017A148 to L.W.; and the Project of the State Key Laboratory of Crop Biology in Anhui Agricultural University (https://kjc.ahau.edu.cn), Award Number 2014KQJ007 to L.W. Authors Ronghai Wang and Lihua Song are employed by An Hui Anke Biotechnology (Group) Co., Ltd. An Hui Anke Biotechnology (Group) Co., Ltd provided support in the form of salaries for authors R.W. and L.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauhofer A, 2001, LANGENBECK ARCH SURG, V386, P132, DOI 10.1007/s004230100206; Beentjes JAM, 2000, CLIN ENDOCRINOL, V52, P457, DOI 10.1046/j.1365-2265.2000.00993.x; Colao A, 2004, ENDOCR REV, V25, P102, DOI 10.1210/er.2002-0022; Dehkhoda F, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00035; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fiebig HH, 2000, ANTI-CANCER DRUG, V11, P659, DOI 10.1097/00001813-200009000-00011; Grofte T, 1997, HEPATOLOGY, V25, P964, DOI 10.1002/hep.510250429; Guevara-Aguirre J, 2018, GROWTH HORM IGF RES, V38, P34, DOI 10.1016/j.ghir.2017.12.006; Gullett N. P., 2010, CURR OPIN CLIN NUTR, V91, P1143, DOI DOI 10.3945/AJCN.2010; Jiang XY, 2017, INT IMMUNOPHARMACOL, V48, P135, DOI 10.1016/j.intimp.2017.05.004; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Lenk K, 2010, J CACHEXIA SARCOPENI, V1, P9, DOI 10.1007/s13539-010-0007-1; Li SY, 2010, TUMORI J, V96, P282, DOI 10.1177/030089161009600216; Lin Y, 2011, J ENDOCRINOL, V211, P249, DOI 10.1530/JOE-11-0100; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Pazaitou-Panayiotou K, 2007, EUR J ENDOCRINOL, V156, P187, DOI 10.1530/EJE-06-0611; Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Schmidt K, 2011, J CACHEXIA SARCOPENI, V2, P105, DOI 10.1007/s13539-011-0029-3; Shen Q, 2007, ENDOCRINOLOGY, V148, P4536, DOI 10.1210/en.2007-0513; Sun L, 2015, NUTR CANCER, V67, P1056, DOI 10.1080/01635581.2015.1073753; Terawaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173113; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; von Haehling S, 2009, PHARMACOL THERAPEUT, V121, P227, DOI 10.1016/j.pharmthera.2008.09.009; Wiren S, 2014, CANCER CAUSE CONTROL, V25, P151, DOI 10.1007/s10552-013-0317-7	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210613	10.1371/journal.pone.0210613	http://dx.doi.org/10.1371/journal.pone.0210613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673747	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800049
J	Yumoto, T; Naito, H; Ihoriya, H; Yorifuji, T; Nakao, A				Yumoto, Tetsuya; Naito, Hiromichi; Ihoriya, Hiromi; Yorifuji, Takashi; Nakao, Atsunori			Mortality in trauma patients admitted during, before, and after national academic emergency medicine and trauma surgery meeting dates in Japan	PLOS ONE			English	Article							WEEKEND; TIMES; CARE; ICU	Annually, many physicians attend national academic meetings. While participating in these meetings can have a positive impact on daily medical practice, attendance may result in reduced medical staffing during the meeting dates. We sought to examine whether there were differences in mortality after trauma among patients admitted to the hospital during, before, and after meeting dates. Using the Japan Trauma Data Bank, we analyzed in-hospital mortality in patients with traumatic injury admitted to the hospital from 2004 to 2015 during the dates of two national academic meetings-the Japanese Association for Acute Medicine (JAAM) and the Japanese Association for the Surgery of Trauma (JAST). We compared the data with that of patients admitted with trauma during identical weekdays in the weeks before and after the meetings, respectively. We used multiple logistic regression analysis to compare outcomes among the three groups. A total of 7,491 patients were included in our analyses, with 2,481, 2,492, and 2,518 patients in the during, before, and after meeting dates groups, respectively; their mortality rates were 7.3%, 8.0%, and 8.5%, respectively. After adjusting for covariates, no significant differences in in-hospital mortality were found among the three groups (adjusted odds ratio [95% CI] of the before meeting dates and after meeting dates groups; 1.18 [0.89-1.56] and 1.23 [0.93-1.63], respectively, with the during meeting dates group as the reference category). No significant differences in in-hospital mortality were found among trauma patients admitted during, before, and after the JAAM and JAST meeting dates.	[Yumoto, Tetsuya; Naito, Hiromichi; Ihoriya, Hiromi; Nakao, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Okayama, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama, Japan	Okayama University; Okayama University	Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Okayama, Japan.	tyumoto@cc.okayama-u.ac.jp	Naito, Hiromichi/AHD-6916-2022	Naito, Hiromichi/0000-0002-7308-1716				Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Carr BG, 2011, ARCH SURG-CHICAGO, V146, P810, DOI 10.1001/archsurg.2011.60; Carr BG, 2010, J TRAUMA, V69, P1042, DOI 10.1097/TA.0b013e3181f6f958; Ford K, 2016, WEST J EMERG MED, V17, P549, DOI 10.5811/westjem.2016.7.29812; Giannoudis V, 2016, INJURY, V47, P2385, DOI 10.1016/j.injury.2016.10.007; Guly HR, 2006, EMERG MED J, V23, P276, DOI 10.1136/emj.2005.028746; Hemmila MR, 2018, JAMA SURG, V153, P747, DOI 10.1001/jamasurg.2018.0985; Hjortdahl M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-48; Japan Trauma Care and Research, 2012, JAP TRAUM DAT BANK A; Jena AB, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008230; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Khoshchehreh M, 2016, INT J CARDIOL, V210, P164, DOI 10.1016/j.ijcard.2016.02.087; Kitamura T, 2016, J EPIDEMIOL, V26, P155, DOI 10.2188/jea.JE20150100; Laupland Kevin B, 2009, J Trauma Manag Outcomes, V3, P8, DOI 10.1186/1752-2897-3-8; Mains C, 2009, J TRAUMA, V66, P1315, DOI 10.1097/TA.0b013e31819d96d8; Mazahir S, 2015, INJURY, V46, P610, DOI 10.1016/j.injury.2015.01.016; Metcalfe D, 2018, J SURG RES, V222, P219, DOI 10.1016/j.jss.2017.10.019; Metcalfe D, 2016, EMERG MED J, V33, P836, DOI 10.1136/emermed-2016-206049; Mizuno S, 2016, INT J CARDIOL, V220, P929, DOI 10.1016/j.ijcard.2016.06.168; Nanchal R, 2012, CHEST, V142, P690, DOI 10.1378/chest.11-2663; Neuraz A, 2015, CRIT CARE MED, V43, P1587, DOI 10.1097/CCM.0000000000001015; Ono Y, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0095-1; Roberts SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131836; Schwartz DA, 2014, J TRAUMA ACUTE CARE, V76, P134, DOI 10.1097/TA.0b013e3182ab0cfc; Sewalt CA, 2018, J TRAUMA ACUTE CARE, V85, P810, DOI 10.1097/TA.0000000000002043; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; Uusaro A, 2003, INTENS CARE MED, V29, P2144, DOI 10.1007/s00134-003-2035-1	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0207049	10.1371/journal.pone.0207049	http://dx.doi.org/10.1371/journal.pone.0207049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695039	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400004
J	De-Arteaga, M; Chen, JS; Huggins, P; Elmer, J; Clermont, G; Dubrawski, A				De-Arteaga, Maria; Chen, Jieshi; Huggins, Peter; Elmer, Jonathan; Clermont, Gilles; Dubrawski, Artur			Predicting neurological recovery with Canonical Autocorrelation Embeddings	PLOS ONE			English	Article							CARDIAC-ARREST; INTENSIVE-CARE; COMATOSE SURVIVORS; RESUSCITATION; ASSOCIATION; SUPPRESSION; VALIDATION; WITHDRAWAL; PROGNOSIS; UPDATE	Early prediction of the potential for neurological recovery after resuscitation from cardiac arrest is difficult but important. Currently, no clinical finding or combination of findings are sufficient to accurately predict or preclude favorable recovery of comatose patients in the first 24 to 48 hours after resuscitation. Thus, life-sustaining therapy is often continued for several days in patients whose irrecoverable injury is not yet recognized. Conversely, early withdrawal of life-sustaining therapy increases mortality among patients who otherwise might have gone on to recover. In this work, we present Canonical Autocorrelation Analysis (CAA) and Canonical Autocorrelation Embeddings (CAE), novel methods suitable for identifying complex patterns in high-resolution multivariate data often collected in highly monitored clinical environments such as intensive care units. CAE embeds sets of datapoints onto a space that characterizes their latent correlation structures and allows direct comparison of these structures through the use of a distance metric. The methodology may be particularly suitable when the unit of analysis is not just an individual datapoint but a dataset, as for instance in patients for whom physiological measures are recorded over time, and where changes of correlation patterns in these datasets are informative for the task at hand. We present a proof of concept to illustrate the potential utility of CAE by applying it to characterize electroencephalographic recordings from 80 comatose survivors of cardiac arrest, aiming to identify patients who will survive to hospital discharge with favorable functional recovery. Our results show that with very low probability of making a Type 1 error, we are able to identify 32.5% of patients who are likely to have a good neurological outcome, some of whom have otherwise unfavorable clinical characteristics. Importantly, some of these had 5% predicted chance of favorable recovery based on initial illness severity measures alone. Providing this information to support clinical decision-making could motivate the continuation of life-sustaining therapies for these patients.	[De-Arteaga, Maria] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [De-Arteaga, Maria] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [De-Arteaga, Maria; Chen, Jieshi; Huggins, Peter; Dubrawski, Artur] Carnegie Mellon Univ, Sch Comp Sci, Auton Lab, Pittsburgh, PA 15213 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Sch Med, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.; De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA.; De-Arteaga, M (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Auton Lab, Pittsburgh, PA 15213 USA.	mdeartea@andrew.cmu.edu		Chen, Jieshi/0000-0003-2660-4913; De-Arteaga, Maria/0000-0003-2297-3308	Defense Advanced Research Projects Agency (DARPA) [FA8750-12-2-0324, FA8750-17-2-0130]; National Institutes of Health (NIH) [5K12HL109068, 1K23NS097629]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS097629] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been partially supported by Defense Advanced Research Projects Agency (DARPA) under awards FA8750-12-2-0324 and FA8750-17-2-0130. Dr. Elmer is supported by National Institutes of Health (NIH) through grants 5K12HL109068 and 1K23NS097629.	Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; Branges L. D., 1959, P AM MATH SOC, V10, P822, DOI [10.1090/s0002-9939-1959-0113131-7, 10.2307/2033481, DOI 10.2307/2033481]; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chen Lujie, 2015, AMIA Annu Symp Proc, V2015, P1841; Cloostermans MC, 2012, CRIT CARE MED, V40, P2867, DOI 10.1097/CCM.0b013e31825b94f0; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; Cortes C, 2016, LECT NOTES ARTIF INT, V9925, P67, DOI 10.1007/978-3-319-46379-7_5; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; El-Arini K, 2006, LECT NOTES ARTIF INT, V4213, P495; Elmer J, 2017, SEMIN NEUROL, V37, P19, DOI 10.1055/s-0036-1597833; Elmer J, 2016, NEUROCRIT CARE, V25, P415, DOI 10.1007/s12028-016-0263-9; Elmer J, 2016, RESUSCITATION, V108, P48, DOI 10.1016/j.resuscitation.2016.09.008; Elmer J, 2016, ANN NEUROL, V80, P175, DOI 10.1002/ana.24697; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Fiterau M., 2012, ADV NEURAL INFORM PR, P3023; Forstner W., 2003, GEODESY THE CHALLENG, P299, DOI [DOI 10.1007/978-3-662-05296-9_31, 10.1007/978-3-662-05296-9_31]; Friman O, 2002, NEUROIMAGE, V16, P454, DOI 10.1006/nimg.2002.1067; Gold B, 2014, RESUSCITATION, V85, P211, DOI 10.1016/j.resuscitation.2013.10.030; Gorski J, 2007, MATH METHOD OPER RES, V66, P373, DOI 10.1007/s00186-007-0161-1; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Hofmeijer J, 2014, CLIN NEUROPHYSIOL, V125, P947, DOI 10.1016/j.clinph.2013.10.017; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Ignaccolo M, 2010, J BIOL PHYS, V36, P185, DOI 10.1007/s10867-009-9171-y; KORTH B, 1976, PSYCHOMETRIKA, V41, P531, DOI 10.1007/BF02296973; KRZANOWSKI WJ, 1979, J AM STAT ASSOC, V74, P703, DOI 10.2307/2286995; Lakkaraju H, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P275, DOI 10.1145/3097983.3098066; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madras D., 2017, ARXIV171106664; Menegazzi JJ, 2004, CIRCULATION, V109, P926, DOI 10.1161/01.CIR.0000112606.41127.D2; Mulder M, 2014, CRIT CARE MED, V42, P2493, DOI 10.1097/CCM.0000000000000540; Sandroni C, 2014, INTENS CARE MED, V40, P1816, DOI 10.1007/s00134-014-3470-x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Todros K, 2012, PR IEEE SEN ARRAY, P361, DOI 10.1109/SAM.2012.6250511; Wiens J., 2012, ICML WORKSH MACH LEA; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210966	10.1371/journal.pone.0210966	http://dx.doi.org/10.1371/journal.pone.0210966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689648	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800016
J	Araujo, ACM; Almeida, EB; Rocha, CQ; Lima, AS; Silva, CR; Tangerina, MMP; Neto, JSL; Costa, LM				Araujo, Ana Cassia M.; Almeida, Eduardo B., Jr.; Rocha, Claudia Q.; Lima, Aldilene S.; Silva, Carolina R.; Tangerina, Marcelo M. P.; Lima Neto, Jose S.; Costa-Junior, Livio M.			Antiparasitic activities of hydroethanolic extracts of Ipomoea imperati (Vahl) Griseb. (Convolvulaceae)	PLOS ONE			English	Article							TANNIFEROUS PLANT-EXTRACTS; VITRO LARVAL MIGRATION; HAEMONCHUS-CONTORTUS; ANTHELMINTIC ACTIVITY; INFECTIVE LARVAE; EXSHEATHMENT; 3RD-STAGE; TANNINS	Ipomoea imperati is widely used in tropical areas to treat several pathological conditions. The effect of this plant against parasitic species has not been investigated even being used for this purpose in the Brazilian northeastern. This study aimed to evaluate the anthelmintic and acaricide potential of a hydroethanolic extract of I. imperati leaves and stolons. I. imperati leaves and stolons were crushed and subjected to maceration in ethanol 70% (v/v), after which the solvent was removed using a rotary evaporator. The chromatographic profile of the extract was obtained by UV Spectrum high-performance liquid chromatography and compounds were identified by liquid chromatography/electrospray ionization tandem mass spectrometry. Identification of the compounds present in the extract was achieved by comparing their retention times and UV spectra with data in the literature. Anthelmintic activity was evaluated by larval exsheathment inhibition assays using Haemonchus contortus larvae and five concentrations of each extract ranging from 0.07 to 1.2 mg/mL. Acaricide activity was evaluated via larval immersion of Rhipicephalus microplus in eight concentrations of each extract ranging from 5.0 to 25.0 mg/mL. Live and dead larvae were counted after 24 hours. The median inhibitory concentration (IC50) for H. contortus larvae and the median lethal concentration (LC50) for R. microplus larvae were calculated. Twelve compounds were observed in the hydroethanolic extract of leaves, with a predominance of the aglycone form of flavonoids and tannins. This extract was effective against H. contortus larvae, presenting an average inhibitory concentration of 0.22 mg/mL, but showed no activity toward R. microplus larvae. The stolon hydroethanolic extract presented 11 compounds, with phenolic acids and glycosylated flavonoids prevailing. This extract showed low activity on R. microplus and no effect on inhibiting H. contortus larval exsheathment at the concentrations tested. This study is the first to assess the anthelmintic and acaricidal activities of I. imperati. Data reported confirm promising potential of I. imperati leaves hydroethanolic extract against H. contortus. This effect could be due to its secondary compounds presents in this extract, such as procyanidin, kaempferol, isoquercitrin and rutin.	[Araujo, Ana Cassia M.] Univ Fed Maranhao, Ctr Ciencias Biol & Saude, Programa Posgrad Biodivers & Conservac, Sao Luis, Maranhao, Brazil; [Almeida, Eduardo B., Jr.] Univ Fed Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil; [Rocha, Claudia Q.; Lima, Aldilene S.] Univ Fed Maranhao, Dept Quim, Sao Luis, Maranhao, Brazil; [Rocha, Claudia Q.; Silva, Carolina R.; Costa-Junior, Livio M.] Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil; [Tangerina, Marcelo M. P.] Univ Estadual Paulista, Inst Biociencias, Lab Bioprospeccao Prod Nat, Sao Vicente, SP, Brazil; [Lima Neto, Jose S.] Univ Fed Piaui, Dept Farm, Lab Geoquim Organ, Teresina, Piaui, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal do Piaui	Almeida, EB (corresponding author), Univ Fed Maranhao, Dept Biol, Sao Luis, Maranhao, Brazil.; Costa, LM (corresponding author), Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil.	ebaj25@yahoo.com.br; livio.martins@ufma.br	Araujo, Ana Cássia Medeiros/AAD-7659-2019; Rocha e Silva, Carolina/HHN-8484-2022; Tangerina, Marcelo M P Marucci Pereira/L-3580-2016; Rocha, Cláudia Quintino da/C-2320-2013; da Rocha, Claudia Quintino/U-8013-2019; de Sousa Lima Neto, José/E-6937-2015; Tangerina, Marcelo/AEF-1225-2022; Lima-Neto, José/T-3483-2019; Costa-Junior, Livio M/H-7530-2012	Tangerina, Marcelo M P Marucci Pereira/0000-0002-4236-094X; Rocha, Cláudia Quintino da/0000-0002-3578-1869; da Rocha, Claudia Quintino/0000-0002-3578-1869; de Sousa Lima Neto, José/0000-0002-3933-6391; Costa-Junior, Livio M/0000-0002-1475-049X; Rocha e Silva, Carolina/0000-0001-8667-1064	Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional" [03/2016]; Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia"; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil); FAPEMA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development)	Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional"; Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia"; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil); FAPEMA(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study had financial support by Financiadora de estudos e projetos by "FINEP Chamada Apoio Institucional 03/2016" to LMCJ and Fundacao de Amparo a Pesquisa e ao Desenvolvimento cientifico e tecnologico do Maranhao (FAPEMA) by "IECT Biotecnologia" to LMCJ. The author CRS received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (Coordination for the Improvement of High Higher Education Personnel, Brazil). The authors ACMA and ASL received scholarship from FAPEMA. The author LMCJ received a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkari H, 2016, VET MED-CZECH, V61, P308, DOI 10.17221/169/2015-VETMED; Ali A, 2016, CIENC RURAL, V46, P1240, DOI 10.1590/0103-8478cr20151416; Alonso-Diaz MA, 2008, VET PARASITOL, V153, P313, DOI 10.1016/j.vetpar.2008.01.042; Alonso-Diaz MA, 2011, VET PARASITOL, V181, P360, DOI 10.1016/j.vetpar.2011.03.052; Athanasiadou S, 2007, ANIMAL, V1, P1392, DOI 10.1017/S1751731107000730; Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Azando EVB, 2011, VET PARASITOL, V180, P292, DOI 10.1016/j.vetpar.2011.03.010; Bahuaud D, 2006, PARASITOLOGY, V132, P545, DOI 10.1017/S0031182005009509; Barrau E, 2005, PARASITOLOGY, V131, P531, DOI 10.1017/S0031182005008024; Brito DRB, 2017, SEMIN-CIENC AGRAR, V38, P1963, DOI 10.5433/1679-0359.2017v38n4p1963; de Oliveira LMB, 2011, REV BRAS PARASITOL V, V20, P155, DOI 10.1590/S1984-29612011000200011; Brunet S, 2011, PARASITOL INT, V60, P419, DOI 10.1016/j.parint.2010.09.011; Cai CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095931; Chougule MB, 2016, PROG DRUG RES, V71, P11, DOI 10.1007/978-3-319-26811-8_3; Costa Neto SV, 2000, B MUS PARA EMILIO GO, V16, P163; De Paula-Zurron ACB, 2010, REV BRAS FARMACOGN, V20, P180, DOI 10.1590/S0102-695X2010000200008; Dhembare A. J., 2015, Der Pharmacia Lettre, V7, P262; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Soares AMD, 2015, REV BRAS PARASITOL V, V24, P396, DOI 10.1590/S1984-29612015072; Estrada-Pena A, 2013, AGRICULTURE-BASEL, V3, P221, DOI 10.3390/agriculture3020221; Felger Richard S., 2012, Journal of the Botanical Research Institute of Texas, V6, P459; Ferreira P. P. A., 2009, Revista Brasileira de Biociencias, V7, P440; Ghosh S, 2014, ASIAN J PHARM CLIN R, V7, P162; Grisi L, 2014, REV BRAS PARASITOL V, V23, P150, DOI 10.1590/S1984-29612014042; Hoste H, 2012, VET PARASITOL, V186, P18, DOI 10.1016/j.vetpar.2011.11.042; Jardim MAG., 2005, REV BRASILEIRA FARMA, V86, P117; Kamaraj C, 2010, PARASITOL RES, V106, P1071, DOI 10.1007/s00436-010-1750-0; Klafke GM, 2006, VET PARASITOL, V142, P386, DOI 10.1016/j.vetpar.2006.07.001; Klongsiriwet C, 2015, INT J PARASITOL-DRUG, V5, P127, DOI 10.1016/j.ijpddr.2015.06.001; Lasisi A. A., 2011, African Journal of Plant Science, V5, P469; Lonard RI, 1999, J COASTAL RES, V15, P645; Malakar C., 2015, ASIAN J PHARM CLIN R, V8, P60; Meira M, 2012, REV BRAS FARMACOGN, V22, P682, DOI 10.1590/S0102-695X2012005000025; Mengistu G, 2017, VET PARASITOL, V237, P110, DOI 10.1016/j.vetpar.2016.12.020; Minho Alessandro P, 2008, Rev Bras Parasitol Vet, V17 Suppl 1, P144; Miyahara MRM, 2011, REV BRAS FARMACOGN, V21, P978, DOI 10.1590/S0102-695X2011005000143; Moreno-Gonzalo J, 2013, VET PARASITOL, V197, P235, DOI 10.1016/j.vetpar.2013.05.010; O'Connor LJ, 2006, VET PARASITOL, V142, P1, DOI 10.1016/j.vetpar.2006.08.035; Oliveira AF, 2017, VET PARASITOL, V236, P121, DOI 10.1016/j.vetpar.2017.02.005; Paula ACB, 2003, BRAZ J MED BIOL RES, V36, P105, DOI 10.1590/S0100-879X2003000100014; Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001; Qadir S, 2010, VET WORLD, V3, P515; Qamar M. F., 2011, Science International (Lahore), V23, P295; Quijada J, 2015, J AGR FOOD CHEM, V63, P6346, DOI 10.1021/acs.jafc.5b00831; Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153; SON-DE FERNEX E.V, 2012, EXPT PARASITOLOGY NE, V131, P413, DOI DOI 10.1016/J.EXPPARA.2012.05.010; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; Zaman MA, 2017, INT J AGRIC BIOL, V19, P957, DOI 10.17957/IJAB/15.0289; Zhang BY, 2015, CHEM PHARM BULL, V63, P255, DOI 10.1248/cpb.c14-00765; Zhou X, 2014, J PARASITOL, V100, P848, DOI 10.1645/14-556.1; Zia-Ul-Haq M, 2012, MOLECULES, V17, P13132, DOI 10.3390/molecules171113132	51	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211372	10.1371/journal.pone.0211372	http://dx.doi.org/10.1371/journal.pone.0211372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682142	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500157
J	Cho, YY; Kwon, OH; Park, MK; Kim, TW; Chung, S				Cho, Yoon Young; Kwon, Oh-Hoon; Park, Myoung Kyu; Kim, Tae-Wan; Chung, Sungkwon			Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of beta-amyloid precursor protein	PLOS ONE			English	Article							ACTIVE GAMMA-SECRETASE; MEMBRANE CHOLESTEROL; IN-VITRO; A-BETA; DISEASE; DETERGENT; DOMAIN; BRAIN; METABOLISM; PEPTIDES	Familial Alzheimer's disease (FAD)-associated presenilin 1 (PS1) serves as a catalytic subunit of.-secretase complex, which mediates the proteolytic liberation of beta-amyloid (A beta) from ss-amyloid precursor protein (APP). In addition to its proteolytic role, PS1 is involved in non-proteolytic functions such as protein trafficking and ion channel regulation. Furthermore, postmortem AD brains as well as AD patients showed dysregulation of cholesterol metabolism. Since cholesterol has been implicated in regulating A beta production, we investigated whether the FAD PS1-associated cholesterol elevation could influence APP processing. We found that in CHO cells stably expressing FAD-associated PS1.E9, total cholesterol levels are elevated compared to cells expressing wild-type PS1. We also found that localization of APP in cholesterol-enriched lipid rafts is substantially increased in the mutant cells. Reducing the cholesterol levels by either methyl-beta-cyclodextrin or an inhibitor of CYP51, an enzyme mediating the elevated cholesterol in PS1.E9-expressing cells, significantly reduced lipid raft-associated APP. In contrast, exogenous cholesterol increased lipid raftassociated APP. These data suggest that in the FAD PS1.E9 cells, the elevated cellular cholesterol level contributes to the altered APP processing by increasing APP localized in lipid rafts.	[Cho, Yoon Young; Kwon, Oh-Hoon; Park, Myoung Kyu; Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kim, Tae-Wan] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Kim, Tae-Wan] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10027 USA	Sungkyunkwan University (SKKU); Columbia University; Columbia University	Chung, S (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Kim, TW (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.; Kim, TW (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY 10027 USA.	twk16@cumc.columbia.edu; schung@skku.edu	CHUNG, SUNGKWON/ABF-8293-2021	Chung, Sungkwon/0000-0003-0505-8773	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2016R1D1A1A099]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2016R1D1A1A099) to SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5; Askarova S., 2011, INT J ALZHEIMERS DIS; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabelo N, 2014, NEUROBIOL AGING, V35, P1801, DOI 10.1016/j.neurobiolaging.2014.02.005; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Grimm MOW, 2006, ACTA NEUROL SCAND, V114, P27, DOI 10.1111/j.1600-0404.2006.00682.x; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Kang MS, 2013, J BIOL CHEM, V288, P20868, DOI 10.1074/jbc.M112.445734; Kosicek M, 2010, BIOCHEM BIOPH RES CO, V393, P404, DOI 10.1016/j.bbrc.2010.02.007; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Ludtmann MHR, 2014, J CELL SCI, V127, P1576, DOI 10.1242/jcs.140939; Marquer C, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-60; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; Maulik M, 2013, MOL NEUROBIOL, V47, P37, DOI 10.1007/s12035-012-8337-y; Nierzwicki L, 2015, J PHYS CHEM LETT, V6, P784, DOI 10.1021/acs.jpclett.5b00197; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Ostrom Rennolds S., 2007, V400, P459; Otto GP, 2016, J ALZHEIMERS DIS, V52, P1177, DOI 10.3233/JAD-150940; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Quintero-Monzon O, 2011, BIOCHEMISTRY-US, V50, P9023, DOI 10.1021/bi2007146; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Sot J, 2002, LANGMUIR, V18, P2828, DOI 10.1021/la011381c; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005	64	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210535	10.1371/journal.pone.0210535	http://dx.doi.org/10.1371/journal.pone.0210535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682043	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500044
J	Choi, JW; Budzevich, M; Wang, SW; Gage, K; Estrella, V; Gillies, RJ				Choi, Jung W.; Budzevich, Mikalai; Wang, Shaowei; Gage, Kenneth; Estrella, Veronica; Gillies, Robert J.			In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes	PLOS ONE			English	Article							PET; FLOW; PERFUSION; SPECT; CU-62-PTSM; GENERATOR; QUANTIFICATION; PERFORMANCE; CU-62-ATSM; HYPOXIA	99m-Technetium-labeled (Tc-99m) erythrocyte imaging with planar scintigraphy is widely used for evaluating both patients with occult gastrointestinal bleeding and patients at risk for chemotherapy-induced cardiotoxicity. While a number of alternative radionuclide-based blood pool imaging agents have been proposed, none have yet to achieve widespread clinical use. Here, we present both in vitro and small animal in vivo imaging evidence that the high physiological expression of the glucose transporter GLUT1 on human erythrocytes allows uptake of the widely available radiotracer 2-deoxy-2-(F-18) fluoro-D-glucose (FDG), at a rate and magnitude sufficient for clinical blood pool positron emission tomographic (PET) imaging. This imaging technique is likely to be amenable to rapid clinical translation, as it can be achieved using a simple FDG labeling protocol, requires a relatively small volume of phlebotomized blood, and can be completed within a relatively short time period. As modern PET scanners typically have much greater count detection sensitivities than that of commonly used clinical gamma scintigraphic cameras, FDG-labeled human erythrocyte PET imaging may not only have significant advantages over Tc-99m-labeled erythrocyte imaging, but may have other novel blood pool imaging applications.	[Choi, Jung W.; Gage, Kenneth; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Diagnost Imaging, Tampa, FL 33612 USA; [Choi, Jung W.; Budzevich, Mikalai; Estrella, Veronica; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Physiol, Tampa, FL 33612 USA; [Wang, Shaowei] Univ S Florida, Dept Med Engn, Tampa, FL USA; [Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Program Canc Biol & Evolut, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Choi, JW (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Diagnost Imaging, Tampa, FL 33612 USA.; Choi, JW (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Physiol, Tampa, FL 33612 USA.	Jung.Choi@Moffitt.org	Gage, Kenneth/AAH-8391-2021; Choi, Jung/G-8127-2016	wang, shaowei/0000-0002-8860-4436; Gillies, Robert/0000-0002-8888-7747; Choi, Jung/0000-0001-8206-4259	NCI NIH HHS [P30 CA076292] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1991, Ann ICRP, V21, P1; Bailey DL, 2016, SEMIN NUCL MED, V46, P428, DOI 10.1053/j.semnuclmed.2016.04.007; Basuli F, 2015, NUCL MED BIOL, V42, P219, DOI 10.1016/j.nucmedbio.2014.11.011; Bonte Frederick J, 2011, Int J Mol Imaging, V2011, P409101, DOI 10.1155/2011/409101; Bratosin D, 2005, CYTOM PART A, V66A, P78, DOI 10.1002/cyto.a.20152; BUROW RD, 1977, CIRCULATION, V56, P1024, DOI 10.1161/01.CIR.56.6.1024; Christy M, 1987, SPECIFIC ABSORBED FR; De Langen AJ, 2008, ONCOLOGIST, V13, P631, DOI 10.1634/theoncologist.2007-0235; Fan AP, 2016, J CEREBR BLOOD F MET, V36, P842, DOI 10.1177/0271678X16636393; Flower MA, 2001, EUR J NUCL MED, V28, P99, DOI 10.1007/s002590000410; Goffin K, 2008, SEMIN NUCL MED, V38, P227, DOI 10.1053/j.semnuclmed.2008.02.004; GREEN MA, 1988, J NUCL MED, V29, P1549; GREEN MA, 1990, J NUCL MED, V31, P1989; Groch MW, 2001, J NUCL MED, V42, P1773; Haynes NG, 2000, J NUCL MED, V41, P309; Herrero P, 1996, J NUCL MED, V37, P1294; Ibaraki M, 2008, J NUCL MED, V49, P50, DOI 10.2967/jnumed.107.044008; ICRP, 2002, ANN ICRP, V32, P5; James ML, 2012, PHYSIOL REV, V92, P897, DOI 10.1152/physrev.00049.2010; Kim SJ, 2005, INT J CARDIOVAS IMAG, V21, P261, DOI 10.1007/s10554-004-6133-0; Lamas GA, 2014, AM HEART J, V168, P37, DOI 10.1016/j.ahj.2014.02.012; Lewis M, 2012, J MED IMAG RADIAT ON, V56, P187, DOI 10.1111/j.1754-9485.2012.02347.x; Lodge MA, 2008, J NUCL MED, V49, P1620, DOI 10.2967/jnumed.108.052076; MacDonald A, 2008, J NUCL MED TECHNOL, V36, P132, DOI 10.2967/jnmt.108.051383; Matsusaka Y, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0266-3; Montel-Hagen A, 2008, BLOOD, V112, P4729, DOI 10.1182/blood-2008-05-159269; Niu G, 2014, J NUCL MED, V55, P1150, DOI 10.2967/jnumed.114.139642; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pelletier-Galarneau M, 2019, J NUCL CARDIOL, V26, P1857, DOI 10.1007/s12350-018-1251-6; Pretorius E, 2016, CELL PHYSIOL BIOCHEM, V39, P1977, DOI 10.1159/000447895; Rahmim A, 2008, NUCL MED COMMUN, V29, P193, DOI 10.1097/MNM.0b013e3282f3a515; Raja S, 2014, NUCL MED COMMUN, V35, P1156, DOI 10.1097/MNM.0000000000000182; Saatchi K, 2012, INT J PHARMACEUT, V422, P418, DOI 10.1016/j.ijpharm.2011.10.036; SHELTON ME, 1990, CIRCULATION, V82, P990, DOI 10.1161/01.CIR.82.3.990; Stabin MG, 2005, J NUCL MED, V46, P1023; Stabin MG, 2003, HEALTH PHYS, V85, P294, DOI 10.1097/00004032-200309000-00006; Stabin MG, 2008, FUNDAMENTALS NUCL ME; THORNE DA, 1987, J NUCL MED, V28, P514; Viskupicova J, 2015, REDOX BIOL, V5, P381, DOI 10.1016/j.redox.2015.06.011; Wallhaus TR, 2001, J NUCL CARDIOL, V8, P67, DOI 10.1067/mnc.2001.109929; Wang ZG, 2015, GENET MOL RES, V14, P14947, DOI 10.4238/2015.November.24.2; Welch MJ, 2000, J NUCL MED, V41, P315; Wong TZ, 2008, AM J ROENTGENOL, V190, P427, DOI 10.2214/AJR.07.2876; Zhang T, 2013, AM J ROENTGENOL, V201, pW698, DOI 10.2214/AJR.12.9698	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211012	10.1371/journal.pone.0211012	http://dx.doi.org/10.1371/journal.pone.0211012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682160	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500089
J	Duffy, KA; Luber, B; Adcock, RA; Chartrand, TL				Duffy, Korrina A.; Luber, Bruce; Adcock, R. Alison; Chartrand, Tanya L.			Enhancing activation in the right temporoparietal junction using theta-burst stimulation: Disambiguating between two hypotheses of top-down control of behavioral mimicry	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; SHARED REPRESENTATIONS; SELF; RECOGNITION; SCHIZOPHRENIA; AFFILIATION; INHIBITION; MECHANISMS; IMITATION; RELEVANCE	Whereas previous research has focused on the role of the rTPJ when consciously inhibiting mimicry, we test the role of the rTPJ on mimicry within a social interaction, during which mimicking occurs nonconsciously. We wanted to determine whether higher rTPJ activation always inhibits the tendency to imitate (regardless of the context) or whether it facilitates mimicry during social interactions (when mimicking is an adaptive response). Participants received either active or sham intermittent theta-burst stimulation (iTBS: a type of stimulation that increases cortical activation) to the rTPJ. Next, we measured how much participants mimicked the hair and face touching of another person. Participants in the active stimulation condition engaged in significantly less mimicry than those in the sham stimulation condition. This finding suggests that even in a context in which mimicking is adaptive, rTPJ inhibits mimicry rather than facilitating it, supporting the hypothesis that rTPJ enhances representations of self over other regardless of the goals within a given context.	[Duffy, Korrina A.; Adcock, R. Alison; Chartrand, Tanya L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Luber, Bruce; Adcock, R. Alison] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Adcock, R. Alison] Duke Univ, Dept Neurobiol, Durham, NC USA; [Chartrand, Tanya L.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Duffy, Korrina A.] Natl Canc Inst, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Rockville, MD 20892 USA; [Luber, Bruce] NIMH, Expt Therapeut & Pathophysiol Branch, Bethesda, MD 20892 USA	Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Duffy, KA (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.; Duffy, KA (corresponding author), Natl Canc Inst, Basic Biobehav & Psychol Sci Branch, Behav Res Program, Rockville, MD 20892 USA.	korrina.duffy@nih.gov	Adcock, R Alison/AAX-6649-2020	Adcock, R Alison/0000-0002-7859-5484				Balconi M, 2014, SOC NEUROSCI-UK, V9, P82, DOI 10.1080/17470919.2013.861361; Banissy MJ, 2011, J NEUROSCI, V31, P1820, DOI 10.1523/JNEUROSCI.5759-09.2011; Barth KS, 2011, FRONT PSYCHIATRY, V2, P1; Beeney JE, 2016, PERSONAL DISORD, V7, P28, DOI 10.1037/per0000127; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chartrand TL., 2009, OXFORD HDB HUMAN ACT, P458; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Christopeit M, 2014, BRAIN STIMUL, V7, P141, DOI 10.1016/j.brs.2013.07.006; Cook JL, 2014, NEUROSCI BIOBEHAV R, V42, P298, DOI 10.1016/j.neubiorev.2014.02.007; Cross KA, 2013, NEUROIMAGE, V83, P493, DOI 10.1016/j.neuroimage.2013.06.060; Cross KA, 2013, HUM BRAIN MAPP, V34, P213, DOI 10.1002/hbm.21428; Davis MH, 1980, JSAS CAT SEL DOC PSY, V10, DOI [10.1080/00223891, DOI 10.1080/00223891]; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Duffy KA, 2017, PSYCHONEUROENDOCRINO, V76, P174, DOI 10.1016/j.psyneuen.2016.11.017; Duffy KA, 2015, PSYCHOL SCI, V26, P1795, DOI 10.1177/0956797615600890; Eddy CM, 2016, J PSYCHIATR RES, V81, P102, DOI 10.1016/j.jpsychires.2016.07.002; Farley SD, 2014, J NONVERBAL BEHAV, V38, P195, DOI 10.1007/s10919-014-0174-4; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Ganos C, 2012, MOVEMENT DISORD, V27, P1222, DOI 10.1002/mds.25103; Hogeveen J, 2015, SOC COGN AFFECT NEUR, V10, P1003, DOI 10.1093/scan/nsu148; Holle H, 2013, NEUROIMAGE, V83, P1041, DOI 10.1016/j.neuroimage.2013.07.073; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Karremans JC, 2008, PERS SOC PSYCHOL B, V34, P939, DOI 10.1177/0146167208316693; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Leary MR, 2013, J PERS ASSESS, V95, P610, DOI 10.1080/00223891.2013.819511; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Maddux WW, 2008, J EXP SOC PSYCHOL, V44, P461, DOI 10.1016/j.jesp.2007.02.003; Matzke B, 2014, PSYCHOPATHOLOGY, V47, P101, DOI 10.1159/000351122; McAdams CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P54, DOI 10.1016/j.pscychresns.2011.06.016; McAdams CJ, 2013, FRONT PSYCHIATRY, V4, P1, DOI [10.3389/fpsyt.2013.00001, DOI 10.3389/FPSYT.2013.00001]; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Nihonsugi T, 2015, J NEUROSCI, V35, P3412, DOI 10.1523/JNEUROSCI.3885-14.2015; Oberman LM, 2009, DEVELOPMENTAL SCI, V12, P510, DOI 10.1111/j.1467-7687.2008.00796.x; Plaze M, 2011, SCHIZOPHRENIA BULL, V37, P212, DOI 10.1093/schbul/sbp081; Riva P, 2015, SOC NEUROSCI-UK, V10, P46, DOI 10.1080/17470919.2014.946621; Riva P, 2012, PSYCHOL SCI, V23, P1473, DOI 10.1177/0956797612450894; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Santiesteban I, 2015, CORTEX, V71, P116, DOI 10.1016/j.cortex.2015.06.019; Santiesteban I, 2012, CURR BIOL, V22, P2274, DOI 10.1016/j.cub.2012.10.018; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; SNYDER M, 1986, J PERS SOC PSYCHOL, V51, P125, DOI 10.1037/0022-3514.51.1.125; Sowden S, 2015, CEREB CORTEX, V25, P1107, DOI 10.1093/cercor/bht306; Spengler S, 2010, SOC NEUROSCI-UK, V5, P401, DOI 10.1080/17470911003687905; Spengler S, 2009, HUM BRAIN MAPP, V30, P3704, DOI 10.1002/hbm.20800; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van den Bos W, 2014, SOC COGN AFFECT NEUR, V9, P2059, DOI 10.1093/scan/nsu003; Varcin KJ, 2010, J INT NEUROPSYCH SOC, V16, P621, DOI 10.1017/S1355617710000329; Wang GR, 2016, BEHAV BRAIN RES, V303, P71, DOI 10.1016/j.bbr.2016.01.047; Ward J, 2015, COGN NEUROSCI-UK, V6, P118, DOI 10.1080/17588928.2015.1042444	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211279	10.1371/journal.pone.0211279	http://dx.doi.org/10.1371/journal.pone.0211279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682141	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500140
J	Krishna, VV; Aravalath, LM; Vikraman, S				Krishna, Vijesh V.; Aravalath, Lagesh M.; Vikraman, Surjit			Does caste determine farmer access to quality information?	PLOS ONE			English	Article							AGRICULTURAL EXTENSION; PUBLIC-GOODS; SOCIAL DIVISIONS; TECHNOLOGY; INEQUALITY; POVERTY; IMPACT; SERVICES; ADOPTION; INNOVATIONS	This paper explores the social inclusiveness of agricultural extension services in India. We estimate the probability and frequency of farmers' access to extension services and resulting changes in crop income across different caste groups. The literature suggests that caste-based social segregation manifests in various spheres of life, and perpetuates economic inequality and oppression. An econometric analysis of nationally-representative data from rural India verifies this with respect to the agricultural sector. Farmers belonging to the socially-marginalized castes are found to have a lower chance of accessing the public extension services, primarily due to their inferior resource-endowment status. Contacting extension agents at least once increased the average annual crop income by about 12 thousand Indian rupees per household, which is equivalent to 36% of the annual crop income of those without access to extension services. There exists significant impact heterogeneity. Farmers from the socially-marginalized castes hardly benefited from accessing the extension services. Based on these observations, we have developed a number of policy recommendations that could improve the social inclusiveness of agricultural development strategies in rural India.	[Krishna, Vijesh V.] Int Maize & Wheat Improvement Ctr CIMMYT, Socioecon Program, Mexico City, DF, Mexico; [Aravalath, Lagesh M.] ICFAI Business Sch IBS Hyderabad, Dept Econ, Hyderabad, Telangana, India; [Vikraman, Surjit] Natl Inst Rural Dev & Panchayati Raj, Ctr Corp Social Responsibil Publ Private Partners, Hyderabad, Telangana, India	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); The ICFAI Foundation for Higher Education (IFHE); ICFAI Business School (IBS)	Krishna, VV (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Socioecon Program, Mexico City, DF, Mexico.	v.krishna@cgiar.org	Aravalath, Lagesh Meethale/E-1206-2019; Krishna, Vijesh/AAD-3431-2022	Aravalath, Lagesh Meethale/0000-0002-8970-5642; Krishna, Vijesh/0000-0003-2191-4736				Abadie A, 2006, ECONOMETRICA, V74, P235, DOI 10.1111/j.1468-0262.2006.00655.x; Aker JC, 2011, AGR ECON-BLACKWELL, V42, P631, DOI 10.1111/j.1574-0862.2011.00545.x; Alesina A, 1999, Q J ECON, V114, P1243, DOI 10.1162/003355399556269; Anderson J. R., 2007, HDB AGR EC, V3, P2343, DOI [10.1016/S1574-0072(06)03044-1, DOI 10.1016/S1574-0072(06)03044-1]; Anderson JR, 2004, WORLD BANK RES OBSER, V19, P41, DOI 10.1093/wbro/lkh013; Anderson S, 2011, AM ECON J-APPL ECON, V3, P239, DOI 10.1257/app.3.1.239; Andersson N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S1; [Anonymous], 2012, AGR CENSUS 2010 11 P; [Anonymous], 2006, SOCIAL EC ED STATUS; [Anonymous], 2014, INDIA EXCLUSION REPO; [Anonymous], 2012, REPORT WORKING GROUP; [Anonymous], 2014, KEY INDICATORS SITUA; Aryal JP, 2010, CASTE DISCRIMINATION; Ayenew HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158454; Babu S. C., 2013, Agricultural Economics Research Review, V26, P159; Balasubramaniam D, 2014, ECONOMICA, V81, P140, DOI 10.1111/ecca.12056; Banerjee A, 2005, J EUR ECON ASSOC, V3, P639, DOI 10.1162/jeea.2005.3.2-3.639; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Benin S, 2011, AGR ECON-BLACKWELL, V42, P249, DOI 10.1111/j.1574-0862.2010.00512.x; Birthal PS, 2015, AGR ECON-BLACKWELL, V46, P549, DOI 10.1111/agec.12181; Borooah VK, 2005, REV DEV ECON, V9, P399, DOI 10.1111/j.1467-9361.2005.00284.x; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Cameron C., 2005, MICROECONOMETRICS US, P1056; Davis K. E., 2008, Journal of International Agricultural and Extension Education, V15, P15; Dercon S, 2011, J DEV ECON, V96, P159, DOI 10.1016/j.jdeveco.2010.08.003; Dercon S, 2009, AM J AGR ECON, V91, P1007, DOI 10.1111/j.1467-8276.2009.01325.x; Desai Sonalde, 2012, Econ Polit Wkly, V46, P40; Deshpande A, 2000, AM ECON REV, V90, P322, DOI 10.1257/aer.90.2.322; Deshpande Ashwini, 2011, GRAMMAR CASTE EC DIS; Dethier JJ, 2012, ECON SYST, V36, P175, DOI 10.1016/j.ecosys.2011.09.003; Di Falco S, 2011, AM J AGR ECON, V93, P825, DOI 10.1093/ajae/aar006; Doss CR, 2001, AGR ECON-BLACKWELL, V25, P27, DOI 10.1016/S0169-5150(00)00096-7; Evenson RE, 2001, HANDB ECON, V18, P573; FAO, 2011, SOC AN AGR RUR INV P; Feder G., 1986, World Bank Research Observer, V1, P139, DOI 10.1093/wbro/1.2.139; Feder G, 2007, HDB AGR EC, P2370; Fontaine X, 2014, WORLD DEV, V64, P407, DOI 10.1016/j.worlddev.2014.06.025; Fu XL, 2016, J DEV STUD, V52, P1561, DOI 10.1080/00220388.2016.1146700; Gido EO, 2015, J AGRIC EDUC EXT, V21, P177, DOI 10.1080/1389224X.2013.872045; Glendenning C.J., 2010, IFPRI DISCUSSION PAP; Greene W.H., 2012, ECONOMETRIC ANAL; Gulati A., 2018, AGR EXTENSION SYSTEM; Guo S.Y., 2014, PROPENSITY SCORE ANA; Heyer Judith, 2010, COMP POLITICAL EC DE, P225; Ickowitz A, 2014, GLOBAL ENVIRON CHANG, V24, P287, DOI 10.1016/j.gloenvcha.2013.12.001; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Ito T, 2009, J DEV ECON, V88, P292, DOI 10.1016/j.jdeveco.2008.06.002; Iversen V, 2010, DISCUSSION PAPERS EC; Jaffrelot C, 2000, J ASIAN STUD, V59, P86, DOI 10.2307/2658585; Joshi D., 2011, Economic and Political Weekly, V46, P56; Joshi PK, 2015, EUR J DEV RES, V27, P438, DOI 10.1057/ejdr.2015.36; Jurajda S, 2005, J EUR ECON ASSOC, V3, P598, DOI 10.1162/1542476054473206; Kabunga NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187816; Kondylis F, 2017, J DEV ECON, V125, P1, DOI 10.1016/j.jdeveco.2016.10.004; Kumar A., 2014, EC POLITICAL WKLY, V49, P74; Kumar SM, 2013, WORLD DEV, V43, P315, DOI 10.1016/j.worlddev.2012.11.001; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Manda J, 2016, J AGR ECON, V67, P130, DOI 10.1111/1477-9552.12127; Mason NM, 2017, J AGR ECON, V68, P45, DOI 10.1111/1477-9552.12159; Mekonnen DA, 2018, WORLD DEV, V105, P321, DOI 10.1016/j.worlddev.2017.04.020; Ministry of Home Affairs, 2011, PRIM CENS ABSTR 2011; Mishra AK, 2016, FOOD POLICY, V62, P110, DOI 10.1016/j.foodpol.2016.05.005; Munshi K, 2004, J DEV ECON, V73, P185, DOI 10.1016/j.jdeveco.2003.03.003; Nakano Y, 2018, WORLD DEV; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Raabe K., 2008, IFPRI DISCUSSION PAP; Ragasa C., 2014, GENDER AGR CLOSING K, P411, DOI [10.1007/978-94-017-8616-4_17, DOI 10.1007/978-94-017-8616-4_17]; Ragasa C, 2013, J AGRIC EDUC EXT, V19, P437, DOI 10.1080/1389224X.2013.817343; Rao S, 2017, ECON POLIT WEEKLY, V52, P32; Rawal V., 2011, REV AGRAR STUD, V1, P108; Sajesh VK, 2016, REV AGRAR STUD, V6, P116; Sarkar S., 2010, ECON POLIT WEEKLY, V45, P45; Singh A, 2011, ECON BULL, V31, P2847; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; Smale M, 2014, J DEV STUD, V50, P680, DOI 10.1080/00220388.2014.887690; Sulaiman VR, 2002, OUTLOOK AGR, V31, P225, DOI 10.5367/000000002101294119; Symes WS, 2016, GLOBAL CHANGE BIOL, V22, P656, DOI 10.1111/gcb.13089; Thorat S., 2009, DALITS INDIA SEARCH; Tsiboe F, 2016, J RURAL STUD, V47, P97, DOI 10.1016/j.jrurstud.2016.07.027; UN UN, 2017, SUSTAINABLE DEV GOAL; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Ying RY, 2017, AGRIBUSINESS, V33, P522, DOI 10.1002/agr.21508; Zacharias A, 2011, WORLD DEV, V39, P1820, DOI 10.1016/j.worlddev.2011.04.026	84	18	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210721	10.1371/journal.pone.0210721	http://dx.doi.org/10.1371/journal.pone.0210721			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682087	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500055
J	Durteste, M; Kyselyova, G; Volokha, A; Judd, A; Thorne, C; Cortina-Borja, M; Malyuta, R; Martsynovska, V; Nizova, N; Bailey, H; Baryshnikova, J; Kaleeva, T; Raus, I; Vihtyuk, N; Mostovenko, O; Kyselyova, G				Durteste, Marion; Kyselyova, Galyna; Volokha, Alla; Judd, Ali; Thorne, Claire; Cortina-Borja, Mario; Malyuta, Ruslan; Martsynovska, Violeta; Nizova, Nataliya; Bailey, Heather; Baryshnikova, Julia; Kaleeva, Tatyana; Raus, Irina; Vihtyuk, Natalia; Mostovenko, Olga; Kyselyova, Galyna		Study Young People Living HIV Ukra	Anxiety symptoms and felt stigma among young people living with perinatally or behaviourally-acquired HIV in Ukraine: A cross-sectional survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEDICATION ADHERENCE; HOSPITAL ANXIETY; DRUG-USE; AUDIT-C; DEPRESSION; YOUTH; WOMEN; DISORDERS; CARE	Background Ukraine has the second largest European HIV epidemic. This study aimed to describe stigma, demographic and social factors and their association with anxiety among perinatally and behaviourally-HIV-infected (PHIV; BHIV) young people in Kiev and Odessa. Methods 104 PHIV and 100 BHIV young people aged 13-25 years completed a confidential tablet-based survey. Survey tools included the Hospital Anxiety and Depression Scale (HADS) (anxiety sub-scale scores of 8-10 indicating mild and >= 11 moderate/severe symptoms in last 7 days), Rosenberg Self-Esteem Scale (RSES) and HIV Stigma Scale (HSS) (short version, composite of disclosure, negative self-image and public attitudes sub-scales). Unadjusted Poisson regression models were fitted to explore factors associated with moderate/severe anxiety symptoms. Results PHIV and BHIV young people were of median age 15.5 [IQR 13.9-17.1] and 23.0 [21.0-24.3] years, having registered for HIV care a median 12.3 [10.3-14.4] and 0.9 [0.2-2.4] years previously; 97% (97/100) and 66% (65/99) respectively were on ART. Overall 43% (95% CI 36-50%) reported any and 13% (95% CI 9-19%) moderate/severe anxiety symptoms, with no difference by HIV acquisition mode (p = 0.405) or gender (p = 0.700). 42% (75/180) reported history of an emotional health problem for which they had not been referred/attended for care. Moderate/severe anxiety symptoms were associated with HIV-related stigma (prevalence ratio (PR) 1.24 95% CI 1.14-1.34 per HSS unit increase), lower self-esteem (PR 0.83 95% CI 0.78-0.90 per RSES point increase), CD4 <= 350 cells/mm(3) (PR 2.29 95% CI 1.06-4.97), having no-one at home who knew the respondent's HIV status (PR 9.15 95% CI 3.40-24.66 vs all know) and, among BHIV, less stable living situation (PR 6.83 95% CI 1.99-23.48 for >= 2 vs no home moves in last 3 years) and history of drug use (PR 4.65 95% CI 1.83-11.85). Conclusions Results indicated unmet need for psychosocial support. Further work is needed to explore strategies for mental health support, particularly around disclosure, self-esteem and stigma.	[Durteste, Marion; Thorne, Claire; Cortina-Borja, Mario; Bailey, Heather] UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Kyselyova, Galyna; Volokha, Alla] Shupyk Natl Med Acad Postgrad Educ, Kiev, Ukraine; [Judd, Ali] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England; [Malyuta, Ruslan] Perinatal Prevent AIDS Initiat, Odessa, Ukraine; [Martsynovska, Violeta; Nizova, Nataliya] Minist Hlth Ukraine, Publ Hlth Ctr, Kiev, Ukraine; [Martsynovska, Violeta] Inst Epidemiol & Infect Dis NAMS, Kiev, Ukraine; [Baryshnikova, Julia; Kaleeva, Tatyana] Odessa Reg Ctr HIV AIDS, Odessa, Ukraine; [Vihtyuk, Natalia; Mostovenko, Olga] Kiev City Ctr HIV AIDS, Kiev, Ukraine; [Kyselyova, Galyna] Shupyk Natl Med Acad Postgrad Educ, Kiev, Ukraine	University of London; University College London; Shupyk National Healthcare University of Ukraine; Medical Research Council Clinical Trials Unit; University of London; University College London; Ministry of Health of Ukraine; National Academy of Medical Sciences of Ukraine; L. V. Gromashevsky Institute of Epidemiology & Infectious Diseases of the National Academy of Medical Sciences of Ukraine; Shupyk National Healthcare University of Ukraine	Bailey, H (corresponding author), UCL, UCL Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England.	heather.bailey@ucl.ac.uk; monovetgalyna@gmail.com	Volokha, Alla/F-8020-2019; Thorne, Claire/C-5943-2008; Borja, Mario Cortina/A-3847-2009	Volokha, Alla/0000-0003-3092-2228; Thorne, Claire/0000-0003-0389-1956; Borja, Mario Cortina/0000-0003-0627-2624; Bailey, Heather/0000-0003-3266-1041	CIPHER grant from the International AIDS Society; NIHR Great Ormond Street Hospital Biomedical Research Centre; Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health; PENTA Foundation; MRC [MC_UU_12023/17] Funding Source: UKRI	CIPHER grant from the International AIDS Society; NIHR Great Ormond Street Hospital Biomedical Research Centre; Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health; PENTA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this project was made possible by a CIPHER grant from the International AIDS Society (https://www.iasociety.org/cipher) held by HB. This research was also supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. MD was supported by a Child Health Research Charitable Incorporated Organisation Vacation Studentship at the UCL Great Ormond Street Institute of Child Health. The Ukraine Paediatric HIV Cohort is funded by the PENTA Foundation (https://penta-id.org/).The views expressed in written materials or publications do not necessarily reflect the official policies of the International AIDS Society or the views of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JV, 2016, AIDS BEHAV, V20, P174, DOI 10.1007/s10461-015-1089-8; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; [Anonymous], 2017, HIV INFECTION IN UKR; Bailey H, 2016, INT AIDS C DURB; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bhana A, 2016, AIDS CARE, V28, P49, DOI 10.1080/09540121.2016.1176676; Bhatia S, 2002, J CLIN ONCOL, V20, P4692, DOI 10.1200/JCO.2002.05.103; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brown LK, 2015, AIDS PATIENT CARE ST, V29, P212, DOI 10.1089/apc.2014.0113; Cosco TD, 2012, J PSYCHOSOM RES, V72, P180, DOI 10.1016/j.jpsychores.2011.06.008; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Delany-Moretlwe S, 2015, J INT AIDS SOC, V18, P29, DOI 10.7448/IAS.18.2.19833; Demchenko I, 2014, PEOPLE LIVING HIV ST; Dumchev K, 2018, INT J STD AIDS, V29, P1337, DOI 10.1177/0956462418784096; Gadow KD, 2012, J DEV BEHAV PEDIATR, V33, P456, DOI 10.1097/DBP.0b013e31825b8482; Gnambs T, 2015, BEHAV RES METHODS, V47, P1237, DOI 10.3758/s13428-014-0533-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Ivanova EL, 2012, AIDS BEHAV, V16, P2181, DOI 10.1007/s10461-011-0133-6; Kapetanovic S, 2011, AIDS PATIENT CARE ST, V25, P493, DOI 10.1089/apc.2011.0107; Kiriazova TK, 2013, HIV MED, V14, P38, DOI 10.1111/hiv.12059; Kiseleva G, 2016, FEATURES PROBLEMS HL; Kuhns LM, 2016, AIDS PATIENT CARE ST, V30, P185, DOI 10.1089/apc.2015.0328; Le Prevost M, 2018, AIDS CARE, V30, P1040, DOI 10.1080/09540121.2018.1441972; Lekhan V. N., 2015, HLTH SYSTEMS TRANSIT; Lewis JV, 2015, AIDS CARE, V27, P1265, DOI 10.1080/09540121.2015.1050984; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Malee KM, 2011, AIDS CARE, V23, P1533, DOI 10.1080/09540121.2011.575120; Malyuta R, 2012, 19 INT AIDS C WASH D; Mellins CA, 2012, AIDS CARE, V24, P953, DOI 10.1080/09540121.2012.668174; Michaud P-A., 2007, ADOLESCENT CHRONIC C; Mutumba M, 2016, J ADOLESCENT HEALTH, V58, P460, DOI 10.1016/j.jadohealth.2015.12.014; Myers B, 2014, PSYCHOL ADDICT BEHAV, V28, P1117, DOI 10.1037/a0037459; Roberts B, 2019, EPIDEMIOL PSYCH SCI, V28, P100, DOI 10.1017/S2045796017000385; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rydstrom LL, 2016, AIDS CARE, V28, P665, DOI 10.1080/09540121.2015.1120267; Sareen J, 2006, PSYCHIAT RES, V142, P11, DOI 10.1016/j.psychres.2006.01.009; Simmons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137062; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; State Institution Public Health Center of the Ministry of Health of Ukraine, HIV INF UKR INF B, V47; Tanney MR, 2012, J PEDIATR HEALTH CAR, V26, P300, DOI 10.1016/j.pedhc.2011.02.014; Thorne C, 2012, ADDICTION, V107, P118, DOI 10.1111/j.1360-0443.2011.03609.x; UNAIDS, 2017, END AIDS PROGR 90 90; VREEMAN RC, 2017, J INT AIDS SOC S3, V20; Walsh AS, 2017, AIDS CARE, V29, P851, DOI 10.1080/09540121.2017.1281878; Wei W, 2016, AIDS CARE, V28, P161, DOI 10.1080/09540121.2016.1178974; Winkler P, 2017, LANCET PSYCHIAT, V4, P634, DOI 10.1016/S2215-0366(17)30135-9; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001; Yankovskyy S, 2016, TRANSCULT PSYCHIATRY, V53, P612, DOI 10.1177/1363461516660900; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210412	10.1371/journal.pone.0210412	http://dx.doi.org/10.1371/journal.pone.0210412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677778	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400013
J	Matas, J; Llorenc, V; Fonollosa, A; Esquinas, C; Diaz-Valle, D; Berasategui, B; Mesquida, M; Artaraz, J; Rios, J; Adan, A				Matas, Jessica; Llorenc, Victor; Fonollosa, Alex; Esquinas, Cristina; Diaz-Valle, David; Berasategui, Barbara; Mesquida, Marina; Artaraz, Joseba; Rios, Jose; Adan, Alfredo			Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis	PLOS ONE			English	Article							VISUAL-ACUITY; PATTERNS	Aims We aimed to investigate predictive factors for visual and anatomic outcomes in patients with macular edema secondary to non-infectious uveitis. Material and methods We conducted a multicenter, prospective, observational, 12-month follow-up study. Participants included in the study were adults with non-infectious uveitic macular edema (UME), defined as central subfoveal thickness (CST) of > 300 mu m as measured by spectral domain optical coherence tomography (SD-OCT) and fluid in the macula. Demographic, clinical and tomographic data was recorded at baseline, 1, 3, 6 and 12 months. Foveal-centered SD-OCT exploration was set as the gold-standard determination of UME using a standard Macular Cube 512x128 A-scan, within a 6 x 6 mm(2) area, and the Enhanced High Definition Single-Line Raster. To assess favorable prognosis, the main outcomes analyzed were the best-corrected visual acuity (BCVA) and the CST. Favorable prognosis was defined as sustained improvement of BCVA (2 lines of gain of the Snellen scale) and CST (decrease of 20% of the initial value or < 300 mu m) within a 12 month period. Results Fifty-six eyes were analyzed. The number of eyes with sustained improvement in the CST was 48 (86.2%), against 23 (41.1%) eyes with sustained improvement in BCVA. Favorable prognosis, as defined above, was observed in 18 (32.1%) eyes. UME prognosis was negatively correlated with baseline foveal thickening, alteration in the vitreo-macular interface and cystoid macular edema. In contrast, bilaterally, systemic disease and the presence of anterior chamber cells were predictive of favorable prognosis. Conclusion Available treatment modalities in UME may avoid chronic UME and improve anatomic outcome. However, the proportion of functional amelioration observed during 12 months of follow-up is lower. Thicker CST, alteration in the vitreo-macular interface and cystoid macular edema may denote less favorable prognosis. Conversely, bilaterally, systemic disease and anterior chamber cells may be associated with favorable prognosis in UME.	[Matas, Jessica; Llorenc, Victor; Adan, Alfredo] Hosp Clin Barcelona, Clin Inst Ophthalmol ICOF, Barcelona, Spain; [Matas, Jessica; Llorenc, Victor; Mesquida, Marina; Adan, Alfredo] August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Fonollosa, Alex; Berasategui, Barbara; Artaraz, Joseba] Univ Basque Country, Hosp Cruces, BioCruces Hlth Res Inst, Dept Ophthalmol, Baracaldo, Spain; [Esquinas, Cristina] Autonomous Univ Barcelona, Valle Hebron Res Inst, Barcelona, Spain; [Diaz-Valle, David] Hosp Clin San Carlos, Ophthalmol Dept, Madrid, Spain; [Diaz-Valle, David] Hosp Clin San Carlos, Hlth Res Inst IdISSC, Madrid, Spain; [Rios, Jose] IDIBAPS, Med Stat Core Facil, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitario Cruces; University of Basque Country; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Clinico San Carlos; Hospital Clinico San Carlos; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Matas, J (corresponding author), Hosp Clin Barcelona, Clin Inst Ophthalmol ICOF, Barcelona, Spain.; Matas, J (corresponding author), August Pi i Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.	matas.jessica@gmail.com	Llorens Bellés, Víctor/V-3892-2019; Fonollosa, Alex/Q-9545-2019; Ríos, José/AAZ-2341-2020	Llorens Bellés, Víctor/0000-0002-7375-1564; Ríos, José/0000-0002-0716-8784; Matas Fassi, Jessica/0000-0003-4448-5575	Spanish Ministry of Economy, Industry and Competitivity, Carlos III Health Institute; European Regional Development Fund [PI13/02148]	Spanish Ministry of Economy, Industry and Competitivity, Carlos III Health Institute; European Regional Development Fund(European Commission)	This work was supported by grants from: Spanish Ministry of Economy, Industry and Competitivity, Carlos III Health Institute, cofinanced by the European Regional Development Fund, identification number: PI13/02148, Principal Investigator: AA; http://www.eng.isciii.es/ISCIII/es/contenidos/fd-investigacion/financiacion.shtml.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Fardeau C, 2015, J FR OPHTALMOL, V38, P74, DOI 10.1016/j.jfo.2014.09.001; Fardeau Christine, 2007, International Ophthalmology, V27, P163, DOI 10.1007/s10792-006-9024-7; Fine HF, 2001, AM J OPHTHALMOL, V132, P794, DOI 10.1016/S0002-9394(01)01103-5; GORTMAKER SL, 1994, CONTEMP SOCIOL, V23, P159, DOI 10.2307/2074954; Iannetti L, 2012, OPHTHALMOLOGICA, V228, P13, DOI 10.1159/000337234; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Lardenoye CWTA, 2006, OPHTHALMOLOGY, V113, P1446, DOI 10.1016/j.ophtha.2006.03.027; Lehpamer B, 2013, AM J OPHTHALMOL, V155, P143, DOI 10.1016/j.ajo.2012.06.028; Levin MH, 2014, OPHTHALMOLOGY, V121, P588, DOI 10.1016/j.ophtha.2013.09.023; Maheshwary AS, 2010, AM J OPHTHALMOL, V150, P63, DOI 10.1016/j.ajo.2010.01.039; MALINOWSKI SM, 1993, OPHTHALMOLOGY, V100, P818; Markomichelakis NN, 2007, OCUL IMMUNOL INFLAMM, V15, P71, DOI 10.1080/09273940701244509; Markomichelakis NN, 2004, OPHTHALMOLOGY, V111, P946, DOI 10.1016/j.ophtha.2003.08.037; Munk MR, 2015, ACTA OPHTHALMOL, V93, pE561, DOI 10.1111/aos.12699; Munk MR, 2013, RETINA-J RET VIT DIS, V33, P1673, DOI 10.1097/IAE.0b013e318285cc52; NUSSENBLATT RB, 1987, OPHTHALMOLOGY, V94, P1134; Ossewaarde-van Norel A, 2011, OCUL IMMUNOL INFLAMM, V19, P75, DOI 10.3109/09273948.2010.509530; Ossewaarde-van Norel J, 2011, ARCH OPHTHALMOL-CHIC, V129, P158, DOI 10.1001/archophthalmol.2010.337; Prieto-del-Cura M., 2009, Arch Soc Esp Oftalmol, V84, P523; Rothova A, 2002, OCUL IMMUNOL INFLAMM, V10, P239, DOI 10.1076/ocii.10.4.239.15589; Rothova A, 2007, CURR OPIN OPHTHALMOL, V18, P487, DOI 10.1097/ICU.0b013e3282f03d2e; Sugar EA, 2011, AM J OPHTHALMOL, V152, P1044, DOI 10.1016/j.ajo.2011.05.028; Tomkins-Netzer O, 2015, OPHTHALMOLOGY, V122, P2351, DOI 10.1016/j.ophtha.2015.07.036; Tranos PG, 2012, RETINA-J RET VIT DIS, V32, P1624, DOI 10.1097/IAE.0b013e3182483348; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902; Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606	27	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210799	10.1371/journal.pone.0210799	http://dx.doi.org/10.1371/journal.pone.0210799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677041	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400026
J	Provost, KA; Smith, M; Miller-Larsson, A; Gudleski, GD; Sethi, S				Provost, Karin A.; Smith, Miyuki; Miller-Larsson, Anna; Gudleski, Gregory D.; Sethi, Sanjay			Bacterial regulation of macrophage bacterial recognition receptors in COPD are differentially modified by budesonide and fluticasone propionate	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NONTYPABLE HAEMOPHILUS-INFLUENZAE; COMMUNITY-ACQUIRED PNEUMONIA; INHALED CORTICOSTEROID USE; HUMAN ALVEOLAR MACROPHAGES; RISK; EXACERBATIONS; SALMETEROL/FLUTICASONE; PHAGOCYTOSIS; EXPRESSION	Rationale Patients with COPD have an increased risk for community-acquired pneumonia, which is further increased by inhaled corticosteroids. Objective To assess effects of the corticosteroids, budesonide and fluticasone propionate, on macrophage bacterial responses in COPD. Methods Monocyte-derived macrophages (MDMs) generated from blood monocytes from 10 nonsmoker controls (NoS), 20 smokers without COPD (Sm), and 40 subjects with moderate to severe COPD (21 ex-smokers (COPD-ES) and 19 current smokers (COPD-S)) were pre-treated with budesonide or fluticasone (10 nM-1 mu M) and challenged with live non-typeable Haemophilus influenzae (NTHI) or Streptococcus pneumoniae (SP). Cell surface bacterial recognition receptor expression (flow cytometry) and cytokine release (bead array) were analyzed. Results NTHI and SP reduced bacterial recognition receptor expression on MDMs from COPD and Sm, but not NoS (except TLR4). SR-AI and MARCO were reduced by both NTHI and SP, whereas other receptors by either NTHI or SP. Among COPD subjects, COPD-ES demonstrated a greater number of reductions as compared to COPD-S. NTHI reduced SR-AI, MARCO, CD11b, CD35 and CD206 in COPD-ES while only SR-AI and CD11b in COPD-S. SP reduced SRA-1, CD1d, TLR2 and TLR4 in both COPD-ES and COPD-S, and reduced MARCO and CD93 only in COPD-ES. All receptors reduced in COPD by NTHI and most by SP, were also reduced in Sm. Budesonide counteracted the receptor reductions induced by both NTHI (CD206 p = 0.03, MARCO p = 0.08) and SP (SR-AI p = 0.02) in COPD-ES. Fluticasone counteracted only SP-induced reductions in TLR2 (p = 0.008 COPD-ES and p = 0.04 COPD-S) and TLR4 (p = 0.02 COPD-ES). Cytokine release was equivalently reduced by both corticosteroids. Conclusions Reduction in macrophage bacterial recognition receptors during bacterial exposure could provide a mechanism for the increased pneumonia risk in COPD. Differential effects of budesonide and fluticasone propionate on macrophage bacterial recognition receptor expression may contribute to the higher pneumonia incidence reported with fluticasone propionate.	[Provost, Karin A.; Smith, Miyuki; Sethi, Sanjay] Vet Affairs Western New York Healthcare Syst Buff, Div Pulm Crit Care & Sleep Med, Vet Hlth Adm, Buffalo, NY 14215 USA; [Provost, Karin A.; Sethi, Sanjay] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14260 USA; [Miller-Larsson, Anna] AstraZeneca Gothenburg, Resp GMed, Molndal, Sweden; [Gudleski, Gregory D.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; AstraZeneca; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Provost, KA (corresponding author), Vet Affairs Western New York Healthcare Syst Buff, Div Pulm Crit Care & Sleep Med, Vet Hlth Adm, Buffalo, NY 14215 USA.; Provost, KA (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Pulm Crit Care & Sleep Med, Buffalo, NY 14260 USA.	kprovost@buffalo.edu			AstraZeneca [D589BN00039]; VA Western New York Healthcare System	AstraZeneca(AstraZeneca); VA Western New York Healthcare System	The funding from AstraZeneca was provided under the Investigator Initiated Grant mechanism (D589BN00039), which was administered by the Buffalo Institute of Medical Research, the non-profit organization associated with the VA Western New York Healthcare System to administer non-VA grant funding. Sponsor had no role in the data collection, analysis, or the decision to publish. Author Miyuki Smith, the lab technician, received support in the form of a salary from the grant funding. Author Anna Miller-Larsson was a full-time employee of AstraZeneca, and participated in the initial study design, particularly with focus on drug solubility and ensuring equal and appropriate drug concentrations for the experimental design. She did not have any additional role in the study design, data collection and analysis or decision to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirall J, 1999, EUR RESPIR J, V13, P349, DOI 10.1183/09031936.99.13234999; Almirall J, 1999, CHEST, V116, P375, DOI 10.1378/chest.116.2.375; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2014, THORAX, V69, P811, DOI 10.1136/thoraxjnl-2013-203669; Berenson CS, 2013, J INFECT DIS, V208, P2036, DOI 10.1093/infdis/jit400; Bhatt SP, 2018, THORAX, V73, P414, DOI 10.1136/thoraxjnl-2017-210722; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Dorrington MG, 2013, J IMMUNOL, V190, P250, DOI 10.4049/jimmunol.1202113; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Ganesan S, 2012, AM J PATHOL, V180, P61, DOI 10.1016/j.ajpath.2011.09.029; Halpin DMG, 2011, INT J CLIN PRACT, V65, P764, DOI 10.1111/j.1742-1241.2011.02685.x; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; JANSON C, 2013, BMJ BRIT MED J, V346, P46319; Ji J, 2016, INT J CHRONIC OBSTR, V11, P1035, DOI 10.2147/COPD.S102668; Li ZG, 2017, J IMMUNOL, V199, P3176, DOI 10.4049/jimmunol.1700140; Liu Y, 2015, INT J CHRONIC OBSTR, V10, P1409, DOI 10.2147/COPD.S82259; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Magnussen H, 2014, NEW ENGL J MED, V371, P1285, DOI 10.1056/NEJMoa1407154; Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6; Morjaria JB, 2017, LUNG, V195, P281, DOI 10.1007/s00408-017-9990-8; Pons AR, 2005, EUR RESPIR J, V25, P647, DOI 10.1183/09031936.05.00062304; Provost KA, 2015, AM J RESP CELL MOL, V52, P728, DOI 10.1165/rcmb.2014-0172OC; Skold CM, 1996, CLIN EXP IMMUNOL, V106, P108, DOI 10.1046/j.1365-2249.1996.d01-805.x; Suissa S, 2015, CHEST, V148, P1177, DOI 10.1378/chest.15-0627; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; ten Oever J, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0055-y; van den Brink KIM, 2008, BRIT J CLIN PHARMACO, V66, P27, DOI 10.1111/j.1365-2125.2008.03164.x; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; von Scheele I, 2010, INHAL TOXICOL, V22, P493, DOI 10.3109/08958370903521216; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2016, NEW ENGL J MED, V374, P2222, DOI 10.1056/NEJMoa1516385; Winkler AR, 2008, EXP LUNG RES, V34, P599, DOI 10.1080/01902140802366261; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0207675	10.1371/journal.pone.0207675	http://dx.doi.org/10.1371/journal.pone.0207675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677037	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400004
J	Fallon, SJ; Mcdougall, AJ; Espinoza, T; Roberts, DT; Brooks, S; Kind, PK; Kennard, MJ; Bond, N; Marshall, SM; Schmidt, D; Hughes, J				Fallon, Stewart J.; Mcdougall, Andrew J.; Espinoza, Tom; Roberts, David T.; Brooks, Steven; Kind, Peter K.; Kennard, Mark J.; Bond, Nick; Marshall, Sharon M.; Schmidt, Dan; Hughes, Jane			Age structure of the Australian lungfish (Neoceratodus forsteri)	PLOS ONE			English	Article							BOMB RADIOCARBON; GROWTH; VALIDATION; OTOLITHS; LENGTH; C-14; RECRUITMENT; REEF; DRUM	The Australian lungfish has been studied for more than a century without any knowledge of the longevity of the species. Traditional methods for ageing fish, such as analysis of otolith (ear stone) rings is complicated in that lungfish otoliths differ from teleost fish in composition. As otolith sampling is also lethal, this is not appropriate for a protected species listed under Australian legislation. Lungfish scales were removed from 500 fish from the Brisbane, Burnett and Mary rivers. A sub-sample of scales (85) were aged using bomb radiocarbon techniques and validated using scales marked previously with oxytetracycline. Lungfish ages ranged from 2.5-77 years of age. Estimated population age structures derived using an Age Length Key revealed different recruitment patterns between river systems. There were statistically significant von Bertalanffy growth model parameters estimated for each of the three rivers based on limited sample sizes. In addition, length frequency distributions between river systems were also significantly different. Further studies will be conducted to review drivers that may explain these inter-river differences.	[Fallon, Stewart J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Mcdougall, Andrew J.; Espinoza, Tom; Marshall, Sharon M.] Queensland Dept Nat Resources Mines & Energy, Bundaberg, Qld, Australia; [Roberts, David T.] Seqwater, Brisbane, Qld, Australia; [Brooks, Steven; Kind, Peter K.] Queensland Dept Agr & Fisheries, Brisbane, Qld, Australia; [Kennard, Mark J.; Bond, Nick; Schmidt, Dan; Hughes, Jane] Griffith Univ, Brisbane, Qld, Australia; [Bond, Nick] La Trobe Univ, Murray Darling Basin Freshwater Res Ctr, Albury Wodonga, Vic, Australia	Australian National University; Griffith University; La Trobe University	Fallon, SJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	stewart.fallon@anu.edu.au	Fallon, Stewart J/G-6645-2011; Bond, Nick R./A-1129-2016; McDougall, Andrew/AAA-8657-2019; Kennard, Mark James/C-3425-2008; Roberts, David/AGK-0029-2022; Roberts, David/W-3004-2019; Schmidt, Daniel/I-9289-2014	Fallon, Stewart J/0000-0002-8064-5903; Bond, Nick R./0000-0003-4294-6008; McDougall, Andrew/0000-0003-3304-984X; Kennard, Mark James/0000-0003-4383-4999; Roberts, David/0000-0002-9768-6314; Schmidt, Daniel/0000-0001-5638-497X	Australian Research Council Linkage Projects grant scheme [LP130100118]; SEQWater	Australian Research Council Linkage Projects grant scheme(Australian Research Council); SEQWater	We received funding from the Australian Research Council Linkage Projects grant scheme, LP130100118 to JH. The purpose of "The Linkage Projects scheme promotes national, and international, collaboration and research partnerships between key stakeholders in research and innovation including higher education institutions, government, business, industry and end-users. Research and development is undertaken to apply advanced knowledge to problems, acquire new knowledge and as a basis for securing commercial and other benefits of research"(https://www.arc.gov.au/grants/linkage-program/linkage-projects).Our commercial partner SEQWater provided funds to the Australian Research Council which were then distributed to the Australian National University and Griffith University. Their funds covered salaries for DS and technician support at ANU. The funds also covered the radiocarbon sample analysis. DTR (SEQWater) is their scientific research officer and his specific role is articulated in the 'author contributions' section. SEQWater did not play a role in any decision to publish.	Andrews AH, 2016, J GEOPHYS RES-OCEANS, V121, P6351, DOI 10.1002/2016JC012043; Andrews AH, 2016, CAN J FISH AQUAT SCI, V73, P1575, DOI 10.1139/cjfas-2016-0019; Arthington AH, 2009, ENVIRON BIOL FISH, V84, P211, DOI 10.1007/s10641-008-9414-y; Baker MS, 2001, LIMNOL OCEANOGR, V46, P1819; Bishop CR, 2017, CONSERVATION GENETIC; Braaten PJ, 2015, J APPL ICHTHYOL, V31, P821, DOI 10.1111/jai.12873; Brooks S, 1995, SHORT TERM STUDY BRE; Brooks SG, 2002, QUEENSLAND REFERENCE; Bruch RM, 2009, T AM FISH SOC, V138, P361, DOI 10.1577/T08-098.1; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/cjfas-58-1-30; Campana SE, 1998, FISH B-NOAA, V96, P185; Campana SE, 2008, CAN J FISH AQUAT SCI, V65, P733, DOI 10.1139/F08-012; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Davis-Foust SL, 2009, T AM FISH SOC, V138, P385, DOI 10.1577/T08-097.1; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Espinoza T, 2013, RIVER RES APPL, V29, P1215, DOI 10.1002/rra.2607; Fallon SJ, 2015, RADIOCARBON, V57, P195, DOI 10.2458/azu_rc.57.18199; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Francis R.I.C.C., 1988, New Zealand Journal of Marine and Freshwater Research, V22, P42; Francis RICC, 2016, FISH RES, V180, P77, DOI 10.1016/j.fishres.2015.02.018; Francis RICC, 2005, MAR FRESHWATER RES, V56, P735, DOI 10.1071/MF04127; Fridriksson A., 1934, RAPPORTS PROCES VERB, V86, P1; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P81, DOI 10.1080/00288330.1986.9516132; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hamel OS, 2008, T AM FISH SOC, V137, P852, DOI 10.1577/T07-144.1; Hernaman V, 2005, MAR ECOL PROG SER, V290, P207, DOI 10.3354/meps290207; Hua Q., 2013, RADIOCARBON, V55, P1; Hughes JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121858; Hydrobiology Pty Ltd, 2007, 11 DAM EIS HYDR PTY; Illidge T, 1893, P ROYAL SOC QUEENSLA, V10, P40; James KM, 2010, RADIOCARBON, V52, P1084, DOI 10.1017/S0033822200046166; Kastelle CR, 2016, ECOL MODEL, V320, P79, DOI 10.1016/j.ecolmodel.2015.09.013; Kemp A, 2015, J MORPHOL; Kemp A, 2014, AUST J ZOOL, V62, P63, DOI 10.1071/ZO13038; Ketchen K. S., 1950, Transactions of the American Fisheries Society, V79, P205, DOI 10.1577/1548-8659(1949)79[205:SSFDAD]2.0.CO;2; KIMURA DK, 1977, J FISH RES BOARD CAN, V34, P317, DOI 10.1139/f77-052; Kind P.K, 2002, MOVEMENT PATTERNS HA; Kind Peter K., 2011, P61; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; LAINE A O, 1991, North American Journal of Fisheries Management, V11, P220, DOI 10.1577/1548-8675(1991)011<0220:AOUSAC>2.3.CO;2; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Marshall SM, 2015, RIVER RES APPL, V31, P552, DOI 10.1002/rra.2754; MARTIN I, 1990, J CONSEIL, V46, P178; Newman SJ, 1996, MAR FRESHWATER RES, V47, P575, DOI 10.1071/MF9960575; Pardo SA, 2013, METHODS ECOL EVOL, V4, P353, DOI 10.1111/2041-210x.12020; Philippsen B, 2013, HERIT SCI, V1, DOI 10.1186/2050-7445-1-24; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Roberts DT, 2014, J FISH BIOL, V84, P163, DOI 10.1111/jfb.12264; Schmidt DJ, 2018, MOL ECOL, V27, P3231, DOI 10.1111/mec.14791; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Threatened Species Scientific Committee, 2003, COMM LIST ADV NEOC F; Turnbull JC, 2017, ATMOS CHEM PHYS, V17, P14771, DOI 10.5194/acp-17-14771-2017; Villamor B, 2011, FISH OCEANOGR, V20, P397, DOI 10.1111/j.1365-2419.2011.00592.x; Wischniowski SG, 2015, CAN J FISH AQUAT SCI, V72, P879, DOI 10.1139/cjfas-2014-0225; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210168	10.1371/journal.pone.0210168	http://dx.doi.org/10.1371/journal.pone.0210168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673738	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800033
J	Bhavsar, V; Schofield, P; Das-Munshi, J; Henderson, C				Bhavsar, Vishal; Schofield, Peter; Das-Munshi, Jayati; Henderson, Claire			Regional differences in mental health stigma-Analysis of nationally representative data from the Health Survey for England, 2014	PLOS ONE			English	Article							SOCIAL DISTANCE; INTERGROUP CONTACT; PUBLIC-ATTITUDES; HELP-SEEKING; ILLNESS; PEOPLE; ASSOCIATION; KNOWLEDGE	Background Mental health stigma persists despite coordinated and widely-evaluated interventions. Socioeconomic, structural, and regional context may be important in shaping attitudes to mental illness, and response to stigma interventions. Regional differences in attitudes towards mental illness could be relevant for intervention, but have not been systematically explored. We evaluated regional variation in mental health stigma using nationally representative data from England, the Health Survey for England (HSE), from 2014. Methods A previously derived scale for mental health-related attitudes with 2 factors (i. tolerance and support, ii. prejudice and exclusion), and overall attitudes, were outcomes. Weighted linear regressions estimated contribution of individual characteristics and region of residence to inter-individual variability in mental health-related attitudes. Results London and southern regions tended to have more negative mental health-related attitudes. These differences were not fully or consistently explained by individual sociodemographic characteristics, or personal familiarity with mental illness. Conclusions Stigma policies could require refinements based on geographic setting. Regions may be in particular need of stigma interventions, or be more resistant to them. Regional differences might be related to media coverage of mental illness, funding differences, service availability, or accessibility of educational opportunities. Greater geographic detail is necessary to examine reasons for regional variation in stigmatizing attitudes towards people with mental illness, for example through multilevel analysis.	[Bhavsar, Vishal] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London, England; [Schofield, Peter] Kings Coll London, Sch Populat Hlth & Environm Sci, Dept Populat Hlth Sci, London, England; [Das-Munshi, Jayati; Henderson, Claire] Kings Coll London, Heath Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England; [Das-Munshi, Jayati; Henderson, Claire] South London Maudsley NHS Fdn Trust, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; South London & Maudsley NHS Trust	Bhavsar, V (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, Sect Womens Mental Hlth, London, England.	vishal.2.bhavsar@kcl.ac.uk	Das-Munshi, Jayati/F-1910-2010	Das-Munshi, Jayati/0000-0002-3913-6859; Schofield, Peter/0000-0003-1201-527X; Bhavsar, Vishal/0000-0001-7519-0599	Health Foundation/Academy of Medical Sciences; Department of Health; South London CLAHRC; Public Health England; Comic Relief; Big Lottery Fund; North East London Commissioning Unit; MRC [MR/K021494/1] Funding Source: UKRI	Health Foundation/Academy of Medical Sciences; Department of Health; South London CLAHRC; Public Health England; Comic Relief; Big Lottery Fund; North East London Commissioning Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was partly carried out while VB was a Wellcome Clinical Research Training Fellow(101681/Z/13/Z). JDM is funded by the Health Foundation/Academy of Medical Sciences. CH is funded by a grant to Mind and Rethink Mental Illness from the Department of Health, Comic Relief and Big Lottery Fund for the evaluation of Time to Change; by the South London CLAHRC; and by Public Health England and the North East London Commissioning Unit for the evaluation of Good Thinking. Funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2008, AUST NZ J PSYCHIAT, V42, P389, DOI 10.1080/00048670801961115; Al Ramiah A, 2013, AM PSYCHOL, V68, P527, DOI 10.1037/a0032603; Allardyce J, 2005, BRIT J PSYCHIAT, V187, P401, DOI 10.1192/bjp.187.5.401; Angermeyer MC, 2003, CAN J PSYCHIAT, V48, P663, DOI 10.1177/070674370304801004; Badger D, 1999, PSYCHIAT SERV, V50, P1624, DOI 10.1176/ps.50.12.1624; Bibby P, 2013, URBAN RURAL AREA DEF; Boyd JE, 2010, SOC PSYCH PSYCH EPID, V45, P1063, DOI 10.1007/s00127-009-0147-9; Brugha T, 2009, ADULT PSYCHIAT MORBI; Chandra A., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.08.011; Cook JE, 2014, SOC SCI MED, V103, P101, DOI 10.1016/j.socscimed.2013.09.023; Corrigan PW, 2005, PSYCHIAT SERV, V56, P551, DOI 10.1176/appi.ps.56.5.551; Corrigan PW, 2005, PSYCHIAT SERV, V56, P557, DOI 10.1176/appi.ps.56.5.557; Corrigan PW, 2004, SCHIZOPHRENIA BULL, V30, P481, DOI 10.1093/oxfordjournals.schbul.a007096; Evans-Lacko S, 2012, PSYCHOL MED, V42, P1741, DOI 10.1017/S0033291711002558; Evans-Lacko S, 2013, BRIT J PSYCHIAT, V202, pS77, DOI 10.1192/bjp.bp.113.126672; Gaddis SM, 2018, SOC SCI MED, V197, P183, DOI 10.1016/j.socscimed.2017.11.029; Gonzales L, 2018, PSYCHIAT SERV, V69, P76, DOI 10.1176/appi.ps.201700165; Hansson L, 2016, ACTA PSYCHIAT SCAND, V134, P71, DOI 10.1111/acps.12609; Henderson C, 2016, ACTA PSYCHIAT SCAND, V134, P3, DOI 10.1111/acps.12605; Henderson C, 2016, ACTA PSYCHIAT SCAND, V134, P23, DOI 10.1111/acps.12607; Henderson C, 2012, CAN J PSYCHIAT, V57, P152, DOI 10.1177/070674371205700304; Hoyt DR, 1997, AM J COMMUN PSYCHOL, V25, P449, DOI 10.1023/A:1024655521619; Ilic N, 2014, HLTH SURVEY ENGLAND, P1; Koschorke M, 2014, SOC SCI MED, V123, P149, DOI 10.1016/j.socscimed.2014.10.035; Liu J, 2016, SOC PSYCH PSYCH EPID, V51, P443, DOI 10.1007/s00127-015-1125-z; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Min SY, 2017, PSYCHIAT QUART, V88, P853, DOI 10.1007/s11126-017-9503-1; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Pescosolido BA, 2015, ANNU REV SOCIOL, V41, P87, DOI 10.1146/annurev-soc-071312-145702; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI [10.1176/appi.ps.62.6.675, 10.1176/ps.62.6.pss6206_0675]; Scholes S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019615; Stafford M, 2007, AM J PUBLIC HEALTH, V97, P2076, DOI 10.2105/AJPH.2006.097154; StataCorp, 2014, STAT STAT SOFTW REL; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6; Wagner U, 2006, SOC PSYCHOL QUART, V69, P380, DOI 10.1177/019027250606900406; Wrigley S, 2005, AUST NZ J PSYCHIAT, V39, P514, DOI 10.1080/j.1440-1614.2005.01612.x	39	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210834	10.1371/journal.pone.0210834	http://dx.doi.org/10.1371/journal.pone.0210834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668597	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400017
J	Shamu, S; Slabbert, J; Guloba, G; Blom, D; Khupakonke, S; Masihleho, N; Kamera, J; Johnson, S; Farirai, T; Nkhwashu, N				Shamu, Simukai; Slabbert, Jean; Guloba, Geoffrey; Blom, Dalene; Khupakonke, Sikhulile; Masihleho, Nomea; Kamera, Julius; Johnson, Suzanne; Farirai, Thato; Nkhwashu, Nkhensani			Linkage to care of HIV positive clients in a community based HIV counselling and testing programme: A success story of non-governmental organisations in a South African district	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RETENTION; OUTREACH; HEALTH	Introduction Although current data projects South Africa potentially meeting the UN target to test 90% of all people living with HIV by 2020, linking them to HIV care remains a big challenge. In an effort to increase linkage to care (LTC) of HIV positive clients an innovative collaborative intervention between two non-governmental organisations was developed and implemented between 2016 and 2017. This paper investigated the outcome of this collaborative intervention. Methods We used a mixed methods approach to assess the outcome of the innovative relationship. This was done by analysing routine programmatic quantitative data on LTC between 2015 and 2017 and qualitatively interviewing five programme managers, four programme implementers and five HIV positive clients on their perceived success/failure factors. Qualitative data were analysed using thematic content analysis while LTC rates were descriptively analysed. Two consultative meetings presented draft findings to programme managers (n = 7) and implementers (n = 10) for feedback, results verification and confirmation. Results In 2015 cumulative LTC rate was 27% and it rose to 85% two years post-intervention in 2017. Six themes emerged as success factors at the health system and structural levels and these include: provision of client escort services, health facility human resource capacity strengthening, inter and intra-organisational teamwork, onsite LTC, facilitated and expedited jumping of queues and shifting administrative tasks to non-clinical staff to protect nurses' time on ART initiation. These measures in turn ensured increased, affordable and swift ART initiation of clients while strengthening client support. Conclusions We concluded that multi-faceted interventions that target both health system challenges including staff shortages, efficiencies, and extended facility opening times, and structural inadequacies, including client time and resource limitations due to poverty or nature of jobs, can help to increase LTC.	[Shamu, Simukai; Slabbert, Jean; Guloba, Geoffrey; Blom, Dalene; Khupakonke, Sikhulile; Johnson, Suzanne; Farirai, Thato; Nkhwashu, Nkhensani] Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa; [Shamu, Simukai] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Masihleho, Nomea; Kamera, Julius] USAID, Pretoria, South Africa	University of Witwatersrand; United States Agency for International Development (USAID)	Shamu, S (corresponding author), Fdn Profess Dev, Hlth Syst Strengthening Div, Pretoria, South Africa.; Shamu, S (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	shamuts@yahoo.com		Shamu, Simukai/0000-0002-2290-0515	United States President's Emergency Plan for AIDS Relief (PEPFAR); Foundation for Professional Development (FPD)	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Foundation for Professional Development (FPD)	The work on this paper was funded by The United States President's Emergency Plan for AIDS Relief (PEPFAR) and Foundation for Professional Development (FPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Coleman SM, 2009, AIDS PATIENT CARE ST, V23, P639, DOI 10.1089/apc.2008.0092; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; FPD, 2017, IMPR LINK CAR COMM B; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hoffman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162085; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kranzer K, 2010, PLOS ONE, V5, P1; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Leon N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-350; Liau A, 2013, AIDS BEHAV, V17, P1941, DOI 10.1007/s10461-013-0435-y; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; Mazars C, 2014, STOP VIOLENCE WOMEN; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Muir-Cochrane E., 2006, INT J QUAL METH, V5, P15, DOI DOI 10.1177/160940690600500107; Naik R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19843; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; Pfeiffer J, 2008, AM J PUBLIC HEALTH, V98, P2134, DOI 10.2105/AJPH.2007.125989; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Sharma M, 2016, NATURE, V528, P1; Siedner MJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0397-1; Stats SA; South African Medical Research Council (SAMRC); ICF, 2017, S AFR DEM HLTH SURV; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; UNAIDS, UN ACC HIV PREV TREA; UNAIDS, 2014, 90 90 90 AMB TREATM; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; van Zyl MA, 2015, AIDS CARE, V27, P921, DOI 10.1080/09540121.2015.1015483; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2015, GUID START ANT THER, P1; World Health Organization (WHO), 2011, COUNTR REG HIGH LEV; Wynberg E, 2014, JIAS, V17, P1, DOI DOI 10.7448/IAS.17.1.18809	45	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210826	10.1371/journal.pone.0210826	http://dx.doi.org/10.1371/journal.pone.0210826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668598	Green Submitted, Green Published, gold			2022-12-27	WOS:000456306400016
J	Ramirez-Cruz, GA; Solano-Zavaleta, I; Mendoza-Hernandez, PE; Mendez-Janovitz, M; Suarez-Rodriguez, M; Zuniga-Vega, JJ				Ramirez-Cruz, Gonzalo A.; Solano-Zavaleta, Israel; Mendoza-Hernandez, Pedro E.; Mendez-Janovitz, Marcela; Suarez-Rodriguez, Monserrat; Zuniga-Vega, J. Jaime			This town ain't big enough for both of us. . .or is it? Spatial co-occurrence between exotic and native species in an urban reserve	PLOS ONE			English	Article							RED-BELLIED SQUIRREL; ECOLOGICAL RESERVE; INVASIVE ALIEN; SAN ANGEL; BIOLOGICAL INVASIONS; POPULATION-DYNAMICS; ECOSYSTEM SERVICES; RESOURCE USE; DRY FOREST; COMPETITION	Exotic species pose a threat to most ecosystems because of their potential to establish negative interactions with native biota. However, exotic species can also offer resources to native species, especially within highly modified environments such as urban ecosystems. We studied 17 exotic-native pairs of species with the potential to compete with one another, or in which one of the species could offer resources to the other, in an urban ecological reserve located within Mexico City. We used two-species occupancy models to analyze the potential association between the presence of the exotic species and the spatial distribution of the native species, as well as to assess if these species tend to avoid each other (negative spatial interaction) or to co-occur more often than expected under the hypothesis of independent occurrences (positive spatial interaction). Our results revealed few cases in which the exotic species influenced occupancy of the native species, and these spatial interactions were mainly positive, indicated by the fact that the occupancy of the native species was usually higher when the exotic species was also present. Seven of the eight observed non-independent patterns of co-occurrence were evident during the dry months of the year, when resources become scarce for most species. Our results also demonstrate that the observed patterns of species co-occurrence depend on the distance to the nearest urban structure and the amount of herb, shrub, and tree cover, indicating that these habitat features influence whether native species avoid or co-occur with exotic species. Our study represents an important contribution to the understanding of temporal dynamics in the co-occurrence between exotic and native species within urban ecological reserves.	[Ramirez-Cruz, Gonzalo A.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico; [Solano-Zavaleta, Israel; Mendoza-Hernandez, Pedro E.; Suarez-Rodriguez, Monserrat; Zuniga-Vega, J. Jaime] Univ Nacl Autonoma Mexico, Dept Ecol & Recursos Nat, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico; [Mendez-Janovitz, Marcela] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Inst Ecol, Ciudad Univ, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zuniga-Vega, JJ (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol & Recursos Nat, Fac Ciencias, Ciudad Univ, Mexico City, DF, Mexico.	jzuniga@ciencias.unam.mx		Ramirez-Cruz, Gonzalo A./0000-0002-6587-7554; Zuniga-Vega, Jose Jaime/0000-0002-9661-1521	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico [PAPIIT IV200117, IV210117]; Consejo Nacional de Ciencia y Tecnologia [440952/270133]	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico through the projects PAPIIT IV200117 and IV210117 awarded to the corresponding author, as well as through Consejo Nacional de Ciencia y Tecnologia through a scholarship awarded to the first author (scholarship no. 440952/270133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Rodriguez S, 2006, TREES-STRUCT FUNCT, V20, P253, DOI 10.1007/s00468-005-0007-5; Aguirre-Acosta N, 2014, BIOL INVASIONS, V16, P1397, DOI 10.1007/s10530-013-0577-x; Aizen MA, 2011, BIOL INVASIONS, V13, P2901, DOI 10.1007/s10530-011-9972-3; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Alvey Alexis A., 2006, Urban Forestry & Urban Greening, V5, P195, DOI 10.1016/j.ufug.2006.09.003; Anderies JM, 2007, J THEOR BIOL, V247, P36, DOI 10.1016/j.jtbi.2007.01.030; Anderson T.R, 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2009, BIODIVERSIDAD ECOSIS; [Anonymous], ESC NAC CIENCIAS BIO; Ares A, 2001, CAN J FOREST RES, V31, P132, DOI 10.1139/cjfr-31-1-132; Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Badyaev A.V., 2012, BIRDS N AM, DOI [10.2173/bna.46, DOI 10.2173/BNA.46]; Balachowski JA, 2016, ANN BOT-LONDON, V118, P357, DOI 10.1093/aob/mcw109; Balicevic R., 2015, Herbologia, V15, P19; Bartowitz KJ, 2016, J VEG SCI, V27, P789, DOI 10.1111/jvs.12397; BEGON M, 2006, ECOLOGY FROM INDIVID; Bertness MD, 2013, ECOLOGY, V94, P1937, DOI 10.1890/12-2150.1; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Botello F, 2007, SOUTHWEST NAT, V52, P326, DOI 10.1894/0038-4909(2007)52[326:NROTRS]2.0.CO;2; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; BROWN LN, 1975, J MAMMAL, V56, P405, DOI 10.2307/1379370; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Burnham K. P., 2002, MODEL SELECTION AND; Castillo-Arguero S., 2009, BIODIVERSIDAD ECOSIS, P107; Cavin JS, 2017, BIOL INVASIONS, V19, P3471, DOI 10.1007/s10530-017-1588-9; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cooper CB, 2007, ECOLOGY, V88, P864, DOI 10.1890/06-0855; Cove MV, 2018, ECOL EVOL, V8, P4042, DOI 10.1002/ece3.3954; Del Fabbro C, 2015, PERSPECT PLANT ECOL, V17, P87, DOI 10.1016/j.ppees.2015.02.002; Dickie IA, 2014, BIOL INVASIONS, V16, P705, DOI 10.1007/s10530-013-0609-6; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Elton C., 1958; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; Estay SA, 2012, BIODIVERS CONSERV, V21, P3699, DOI 10.1007/s10531-012-0391-2; Estevo CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179489; Farris ZJ, 2016, ANIM CONSERV, V19, P189, DOI 10.1111/acv.12233; Farris ZJ, 2017, BIOL CONSERV, V210, P116, DOI 10.1016/j.biocon.2017.04.010; Folberth GA, 2015, ENVIRON POLLUT, V203, P235, DOI 10.1016/j.envpol.2014.09.004; Francis RA, 2015, GEOGRAPHY, V100, P144; Francis RA, 2012, APPL GEOGR, V32, P514, DOI 10.1016/j.apgeog.2011.06.013; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Gaertner M, 2017, BIOL INVASIONS, V19, P3461, DOI 10.1007/s10530-017-1598-7; Garcia E., 1988, MODIFICACIONES SISTE; Garcia S, 1998, FOREST ECOL MANAG, V110, P151, DOI 10.1016/S0378-1127(98)00287-4; Google, 2017, GOOGLE EARTH MOUNTAI; Griffis-Kyle KL, 2005, AM MIDL NAT, V153, P436, DOI 10.1674/0003-0031(2005)153[0436:MSASPO]2.0.CO;2; Harvey JA, 2012, ENTOMOL EXP APPL, V144, P14, DOI 10.1111/j.1570-7458.2012.01252.x; Hasegawa M, 2014, BEHAV ECOL, V25, DOI 10.1093/beheco/aru034; Haynes TB, 2014, J AVIAN BIOL, V45, P296, DOI 10.1111/jav.00394; Hejda M, 2017, DIVERS DISTRIB, V23, P997, DOI 10.1111/ddi.12596; Hinchliffe S., 2006, SCI CULT-UK, V15, P123, DOI DOI 10.1080/09505430600707988; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hortelano-Moncada Y, 2009, REV MEX BIODIVERS, V80, P507; Hossack BR, 2017, BIOL CONSERV, V209, P377, DOI 10.1016/j.biocon.2017.03.004; Howell SN, 1995, A GUIDE TO THE BIRDS; Hulme PE, 2003, ORYX, V37, P178, DOI 10.1017/S003060530300036X; Iles DT, 2013, J ANIM ECOL, V82, P683, DOI 10.1111/1365-2656.12038; Iponga DM, 2008, J ARID ENVIRON, V72, P612, DOI 10.1016/j.jaridenv.2007.10.001; Jarrad FC, 2011, BIOL INVASIONS, V13, P803, DOI 10.1007/s10530-010-9870-0; Jordan NR, 2008, BIOL INVASIONS, V10, P177, DOI 10.1007/s10530-007-9121-1; Kaiser BA, 2010, RESOUR ENERGY ECON, V32, P566, DOI 10.1016/j.reseneeco.2010.04.007; KARR JR, 1983, ECOLOGY, V64, P1481, DOI 10.2307/1937503; Kennedy ED, 2013, BIRDS N AM, DOI [10.2173/bna.315, DOI 10.2173/BNA.315]; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Lincango P, 2015, J WILDLIFE DIS, V51, P907, DOI 10.7589/2015-01-025; Lopez-Gomez V, 2010, ENTOMOL SCI, V13, P174, DOI 10.1111/j.1479-8298.2010.00381.x; MacGregor-Fors I, 2010, BIOL INVASIONS, V12, P87, DOI 10.1007/s10530-009-9432-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKenzie D.I., 2018, OCCUPANCY ESTIMATION, V2nd, DOI DOI 10.1016/B978-0-12-407197-1.00015-6; MacKenzie DI, 2006, J WILDLIFE MANAGE, V70, P367, DOI 10.2193/0022-541X(2006)70[367:MTPORU]2.0.CO;2; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Malo AF, 2013, BEHAV ECOL, V24, P759, DOI 10.1093/beheco/ars202; Martin-Albarracin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143070; Mayle BA, 2013, PEST MANAG SCI, V69, P323, DOI 10.1002/ps.3458; Mazzamuto MV, 2017, BIOL INVASIONS, V19, P1863, DOI 10.1007/s10530-017-1396-2; McClure CJW, 2011, CONDOR, V113, P462, DOI 10.1525/cond.2011.100061; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Montesinos D, 2016, ACTA OECOL, V74, P46, DOI 10.1016/j.actao.2016.06.002; Montgomery WI, 2012, BIOL INVASIONS, V14, P1111, DOI 10.1007/s10530-011-0142-4; Mosher ES, 2009, BIOL INVASIONS, V11, P2317, DOI 10.1007/s10530-008-9418-8; Mueller AJ, 2004, THE BIRDS OF NORTH A, DOI [10.2173/bna.28, DOI 10.2173/BNA.28]; Oguchi Y, 2018, CONDOR, V120, P81, DOI [10.1650/CONDOR-17-27.1, 10.1650/condor-17-27.1]; Orozco Silvia, 2009, Actu Biol, V31, P31; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Palacio Prieto José Luis, 2015, Bol. Soc. Geol. Mex, V67, P227; Pangle KL, 2006, FRESHWATER BIOL, V51, P1070, DOI 10.1111/j.1365-2427.2006.01555.x; Peck HL, 2014, BEHAV ECOL, V25, P582, DOI 10.1093/beheco/aru025; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Peralta-Higuera A, 2009, BIODIVERSIDAD ECOSIS, P27; Possley J, 2006, NAT AREA J, V26, P391, DOI 10.3375/0885-8608(2006)26[391:CEOTIG]2.0.CO;2; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; Ramirez-Albores JE, 2013, B RED LATINOAMERICAN, V3, P4; Ramirez-Cruz GA, 2018, NAT AREA J, V38, P68, DOI 10.3375/043.038.0108; Ramos-Lara N, 2011, SOUTHWEST NAT, V56, P400, DOI 10.1894/N02-RTS-11.1; Razo-Gonzalez M, 2014, APPL SOIL ECOL, V83, P88, DOI 10.1016/j.apsoil.2014.02.007; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Rotherham ID, 2005, J PRACT ECOL CONSERV, V52-62, P3469, DOI [10.1007/s10530-017-1598-7, DOI 10.1007/S10530-017-1598-7]; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; RUOA, 2018, PROGRAMA DE ESTACION; Rzedowski J., 1978, VEGETACION MEXICO; Schlaepfer MA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005568; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schlossberg S, 2010, J WILDLIFE MANAGE, V74, P1513, DOI 10.2193/2008-601; Schooler SS, 2010, BIOL INVASIONS, V12, P3289, DOI 10.1007/s10530-010-9722-y; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; SIBLEY CG, 1973, AUK, V90, P394; Sibley DA, 2000, THE SIBLEY GUIDE TO; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sloane SA, 2001, THE BIRDS OF NORTH A, DOI [10.2173/bna.598, DOI 10.2173/BNA.598]; Smith HM, 2017, BIOL INVASIONS, V19, P1315, DOI 10.1007/s10530-016-1340-x; Sousa R, 2011, BIOL INVASIONS, V13, P1055, DOI 10.1007/s10530-011-9947-4; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; Srinivas M, 2014, J ADV RES DYN CONTRO, V6, P62; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Sthultz CM, 2007, NEW PHYTOL, V173, P135, DOI 10.1111/j.1469-8137.2006.01915.x; Thomas CD, 2015, P NATL ACAD SCI USA, V112, P4387, DOI 10.1073/pnas.1423995112; Thomsen MS, 2011, ENVIRON RES, V111, P899, DOI 10.1016/j.envres.2011.05.024; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Vitousek PM, 1996, AM SCI, V84, P468; Wang F, 2015, BIOL CONSERV, V186, P319, DOI 10.1016/j.biocon.2015.03.032; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Zambrano L, 2016, LA RESERVA ECOLOGICA; Zambrano L, 2006, CAN J FISH AQUAT SCI, V63, P1903, DOI 10.1139/F06-088; Zarzoso-Lacoste D, 2016, BIOL CONSERV, V193, P134, DOI 10.1016/j.biocon.2015.11.018; Zhou AM, 2015, AGR FOREST ENTOMOL, V17, P389, DOI 10.1111/afe.12119	127	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0211050	10.1371/journal.pone.0211050	http://dx.doi.org/10.1371/journal.pone.0211050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657793	Green Submitted, gold, Green Published			2022-12-27	WOS:000456017000028
J	Su, LQ; Fu, JM; Sun, SL; Zhao, GG; Cheng, W; Dou, CC; Quan, MH				Su, LiQiang; Fu, JinMei; Sun, ShunLi; Zhao, GuangGao; Cheng, Wei; Dou, ChuanChuan; Quan, MingHui			Effects of HIIT and MICT on cardiovascular risk factors in adults with overweight and/or obesity: A meta-analysis	PLOS ONE			English	Article							HIGH-INTENSITY INTERVAL; METABOLIC SYNDROME; AEROBIC CAPACITY; BODY-COMPOSITION; LOW-VOLUME; PHYSIOLOGICAL ADAPTATIONS; CARDIORESPIRATORY FITNESS; CARDIOMETABOLIC DISEASE; MODERATE EXERCISE; GLYCEMIC CONTROL	Objective The purpose of this study was to evaluate the effects of high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on cardiovascular disease (CVD) risk factors in adults with overweight and obesity. Methods Twenty-two articles were included by searching six databases, the total number of subjects was 620 in these articles. Outcomes were synthesised using a random-effects meta-analysis of the Standardized mean difference (SMD) in CVD risk factors. Results HIIT and MICT resulted in statistically significant reductions in Weight, BMI, fat%, total cholesterol( TC), and improvement in VO2max. Compared with MICT, subgroup of durations of HIIT training interval >= 2 min can significantly increaseVO(2max) (SMD = 0.444, 95% CI: 0.037 similar to 0.851, P = 0.032), subgroup of energy expenditure of HIIT equal to MICT can significantly increase VO2max (SMD = 0.399, 95% CI: 0.106 similar to 0.692, P = 0.008). Conclusions HIIT appears to provide similar benefits to MICT for improving body composition, VO2maxand TC, but HIIT spent less time than MICT by 9.7 min on one session. HIIT is superior to MICT in improving cardiopulmonary fitness when durations of HIIT training interval >= 2 min or energy expenditure of HIIT same as MICT. PROSPERO ID: CRD42016045835.	[Su, LiQiang] Fujian Normal Univ, Sch Phys Educ & Sport Sci, Fuzhou, Fujian, Peoples R China; [Fu, JinMei; Sun, ShunLi] Jiangxi Res Inst Sports Sci, Nanchang, Jiangxi, Peoples R China; [Zhao, GuangGao] Nanchang Univ, Dept Phys Educ, Nanchang, Jiangxi, Peoples R China; [Cheng, Wei] Tongji Univ, Dept Endocrinol, Yangpu Hosp, Shanghai, Peoples R China; [Dou, ChuanChuan] Jiang Xi Univ Tradit Chinese Med, Coll Humanities, Nanchang, Jiangxi, Peoples R China; [Quan, MingHui] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China	Fujian Normal University; Nanchang University; Tongji University; Jiangxi University of Traditional Chinese Medicine; Shanghai University of Sport	Quan, MH (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	quanminghui@163.com		Quan, Minghui/0000-0002-4016-1322; sun, shun li/0000-0001-8769-1761; Su, Liqiang/0000-0002-3460-780X; Fu, Jinmei/0000-0003-4992-9657	National Natural Science Foundation of China [81703252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81703252, to MingHui Quan).	Adedeji O O, 2000, West Afr J Med, V19, P283; Eguia RA, 2015, NUTR HOSP, V32, P2460, DOI 10.3305/nh.2015.32.6.9776; Ahluwalia A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003402; Ahmadizad S, 2015, HORM MOL BIOL CLIN I, V21, P165, DOI 10.1515/hmbci-2014-0038; ARNER P, 1990, J CLIN INVEST, V85, P893, DOI 10.1172/JCI114516; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Batacan RB, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2015-095841; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Boutcher SH, 2011, J OBES, V2011, DOI 10.1155/2011/868305; Bracken RM, 2009, AMINO ACIDS, V36, P209, DOI 10.1007/s00726-008-0049-2; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Cassidy S, 2017, DIABETOLOGIA, V60, P7, DOI 10.1007/s00125-016-4106-1; Chang KT, 2018, ARCH GERONTOL GERIAT, V78, P165, DOI 10.1016/j.archger.2018.06.002; Cheema BS, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/2052-1847-7-3; Chung J, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0421-z; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Ciolac EG, 2012, AM J CARDIOVASC DIS, V2, P102; Cocks M, 2016, J PHYSIOL-LONDON, V594, P2307, DOI 10.1113/jphysiol.2014.285254; Cornish AK, 2011, EUR J APPL PHYSIOL, V111, P579, DOI 10.1007/s00421-010-1682-5; Costigan SA, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094490; De Nardi AT, 2018, DIABETES RES CLIN PR, V137, P149, DOI 10.1016/j.diabres.2017.12.017; Durstine JL, 2001, SPORTS MED, V31, P1033, DOI 10.2165/00007256-200131150-00002; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Eimarieskandari R., 2012, OVIDIUS U ANN SER PH, V12, P473; Fisher G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138853; Freda PU, 2008, J CLIN ENDOCR METAB, V93, P2334, DOI 10.1210/jc.2007-2780; Garcia-Hermoso A, 2016, OBES REV, V17, P531, DOI 10.1111/obr.12395; Gayda M, 2013, CAN J CARDIOL, V29, P990, DOI 10.1016/j.cjca.2012.11.005; Gerosa-Neto J, 2016, J EXERC REHABIL, V12, P575, DOI 10.12965/jer.1632770.385; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GREDIAGIN MA, 1995, J AM DIET ASSOC, V95, P661, DOI 10.1016/S0002-8223(95)00181-6; Haff GG, 2016, ESSENTIALS STRENGTH, P53; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Higgins S, 2016, APPL PHYSIOL NUTR ME, V41, P1177, DOI 10.1139/apnm-2016-0240; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Hussain SR, 2016, CARDIOL REV, V24, P273, DOI 10.1097/CRD.0000000000000124; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Jelleyman C, 2015, OBES REV, V16, P942, DOI 10.1111/obr.12317; Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092; Keating SE, 2017, OBES REV, V18, P943, DOI 10.1111/obr.12536; Keating SE, 2014, J OBES, V2014, DOI 10.1155/2014/834865; Kessler HS, 2012, SPORTS MED, V42, P489, DOI 10.2165/11630910-000000000-00000; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kong ZW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158589; LeBlanc ES, 2018, JAMA-J AM MED ASSOC, V320, P1172, DOI 10.1001/jama.2018.7777; Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005; Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P835, DOI 10.1139/apnm-2013-0512; Liu HF, 2016, J SHANDONG SPORT U, V32, P95; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; MacInnis MJ, 2017, J PHYSIOL-LONDON, V595, P2915, DOI 10.1113/JP273196; Maillard F, 2018, SPORTS MED, V48, P269, DOI 10.1007/s40279-017-0807-y; Martins C, 2016, INT J SPORT NUTR EXE, V26, P197, DOI 10.1123/ijsnem.2015-0078; Metcalf BS, 2015, DIABETOLOGIA, V58, P2900, DOI 10.1007/s00125-015-3753-y; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Mitranun W, 2014, SCAND J MED SCI SPOR, V24, pE69, DOI 10.1111/sms.12112; Moholdt T, 2012, CLIN REHABIL, V26, P33, DOI 10.1177/0269215511405229; Moreira MM, 2008, ARQ BRAS CARDIOL, V91, P200; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Niiranen TJ, 2016, EXPERT REV CARDIOVAS, V14, P855, DOI 10.1080/14779072.2016.1176528; Nilsson BB, 2008, AM J CARDIOL, V102, P1361, DOI 10.1016/j.amjcard.2008.07.016; Peake JM, 2014, AM J PHYSIOL-ENDOC M, V307, pE539, DOI 10.1152/ajpendo.00276.2014; Pritzlaff CJ, 2000, J APPL PHYSIOL, V89, P937, DOI 10.1152/jappl.2000.89.3.937; Ramos JS, 2015, SPORTS MED, V45, P679, DOI 10.1007/s40279-015-0321-z; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; Sawyer BJ, 2016, J APPL PHYSIOL, V121, P279, DOI 10.1152/japplphysiol.00024.2016; Schjerve IE, 2008, CLIN SCI, V115, P283, DOI 10.1042/CS20070332; Sijie T, 2012, J SPORT MED PHYS FIT, V52, P255; Smith-Ryan AE, 2015, PHYSICIAN SPORTSMED, V43, P107, DOI 10.1080/00913847.2015.1037231; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Suh S, 2011, DIABETES METAB J, V35, P418, DOI 10.4093/dmj.2011.35.4.418; Terada T, 2013, DIABETES RES CLIN PR, V99, P120, DOI 10.1016/j.diabres.2012.10.019; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Trejo-Gutierrez JF, 2007, J CLIN LIPIDOL, V1, P175, DOI 10.1016/j.jacl.2007.05.006; Vella CA, 2017, EUR J SPORT SCI, V17, P1203, DOI 10.1080/17461391.2017.1359679; Wallman K, 2009, RES SPORTS MED, V17, P156, DOI 10.1080/15438620903120215; [王京京 Wang Jingjing], 2015, [中国运动医学杂志, Chinese Journal of Sports Medicine], V34, P15; Wang XM, 2017, J GUANGZHOU SPORT U, V37, P100, DOI [10.3969/j.issn.1007-323X.2017.01.024, DOI 10.3969/J.ISSN.1007-323X.2017.01.024]; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Wewege M, 2017, OBES REV, V18, P635, DOI 10.1111/obr.12532; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Williams CB, 2013, APPL PHYSIOL NUTR ME, V38, P1236, DOI 10.1139/apnm-2013-0101; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Zhang HF, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5071740; Zhang HF, 2015, KINESIOLOGY, V47, P57; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004; 高艳敏, 2017, [中国运动医学杂志, Chinese Journal of Sports Medicine], V36, P628	92	56	64	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0210644	10.1371/journal.pone.0210644	http://dx.doi.org/10.1371/journal.pone.0210644			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689632	gold, Green Submitted, Green Published			2022-12-27	WOS:000457041800010
J	Armstrong, AW; Huang, A; Wang, L; Miao, R; Patel, MY; Gadkari, A; Mallya, UG; Chao, JD				Armstrong, April W.; Huang, Ahong; Wang, Li; Miao, Raymond; Patel, Miraj Y.; Gadkari, Abhijit; Mallya, Usha G.; Chao, Jingdong			Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis	PLOS ONE			English	Article							NATIONAL-HEALTH; COMORBIDITY; GUIDELINES; MANAGEMENT; CARE; BURDEN	At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis included off-label immunosuppressants and corticosteroids. Immunosuppressant therapy is associated with a substantial risk of side-effects, therefore needing clinical monitoring, and is likely to incur a significant healthcare burden for patients and payers. This retrospective cohort study based on claims data measured immunosuppressant use and its associated burden among US adult patients with atopic dermatitis covered under commercial or Medicare Supplemental insurance from January 01, 2010, to September 30, 2015. Overall, based on age, gender, region, and index year, 4201 control patients with atopic dermatitis without immunosuppressant use were matched with 4204 patients treated with immunosuppressants. The majority (68.5%) of patients using immunosuppressants were non-persistent with immunosuppressant treatment during the 12-month follow-up period after a mean (standard deviation) of 88.1 (70.7) days of immunosuppressant use; 72.3% required systemic steroid rescue treatment. Immunosuppressant users had higher incidence of immunosuppressant-related clinical events than controls; in addition, a larger proportion of immunosuppressant users versus controls developed cancer (0.28% vs 0.14%, respectively; P < 0.0001). Healthcare utilization and costs associated with clinical events and monitoring were also higher for immunosuppressant users compared with controls (total costs, $9516 vs $1630, respectively; P < 0.0001; monitoring costs, $363 vs $54, respectively; P < 0.0001). This study revealed that patients treated with systemic immunosuppressants often require systemic steroids or changes to treatment. The increase in immunosuppressant-related clinical events, including the need for increased monitoring with immunosuppressant treatment, compared with controls demonstrates a substantial treatment burden and highlights the unmet need for more effective long-term therapies for atopic dermatitis with improved safety profiles and reduced monitoring requirements.	[Armstrong, April W.] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA; [Huang, Ahong; Wang, Li] STATinMED Res SIMR Inc, Plano, TX USA; [Miao, Raymond; Patel, Miraj Y.; Mallya, Usha G.] Sanofi, Bridgewater, NJ USA; [Gadkari, Abhijit; Chao, Jingdong] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	University of Southern California; Sanofi-Aventis; Regeneron	Armstrong, AW (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA.	aprilarmstrong@post.harvard.edu		Patel, Miraj/0000-0002-3543-1420	Sanofi; Regeneron Pharmaceuticals, Inc.	Sanofi(Sanofi-Aventis); Regeneron Pharmaceuticals, Inc.(Regeneron)	Study funded by Sanofi and Regeneron Pharmaceuticals, Inc. No specific grants were issued to individual authors. Medical writing support was provided by Elien Moes, PhD, ISMPP CMPP (TM) and Sam Lewtas, MRPharmS, of Prime, Knutsford, UK, and funded by Sanofi and Regeneron Pharmaceuticals, Inc. The authors were responsible for all content and editorial decisions, and received no honoraria related to the development of this publication. All authors had full access to all the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis. All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this manuscript, take responsibility for the integrity of the work and have given final approval for the version to be published. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaplin S, 2016, PRESCRIBER, V27, P30, DOI DOI 10.1002/PSB.1505; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cookson H, 2012, CLIN MED, V12, P172, DOI 10.7861/clinmedicine.12-2-172; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eckert L, 2018, J AM ACAD DERMATOL, V78, P54, DOI 10.1016/j.jaad.2017.08.002; Eckert L, 2017, J AM ACAD DERMATOL, V77, P274, DOI 10.1016/j.jaad.2017.04.019; Eichenfield LF, 2017, J ALLERGY CLIN IMMUN, V139, pS49, DOI 10.1016/j.jaci.2017.01.009; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Food and Drugs Administration, 2018, LAB CELLCEPT MYCOPH; Food and Drugs Administration, 2018, LAB ENBREL ET INJ 20; Food and Drugs Administration, 2018, LAB METHOTREXATE TAB; Food and Drugs Administration, 2018, LAB NEORAL SOFT GEL; Food and Drugs Administration, 2018, LAB IMURAN AZ 50 MG; Garritsen FM, 2015, J EUR ACAD DERMATOL, V29, P1905, DOI 10.1111/jdv.13064; Gelbard Christina M, 2008, Patient Prefer Adherence, V2, P387; Lipozencic J, 2007, DERMATOL CLIN, V25, P605, DOI 10.1016/j.det.2007.06.009; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P327, DOI 10.1016/j.jaad.2014.03.030; Simpson EL, 2017, J AM ACAD DERMATOL, V77, P623, DOI 10.1016/j.jaad.2017.06.042; Simpson EL, 2016, J AM ACAD DERMATOL, V74, P491, DOI 10.1016/j.jaad.2015.10.043; Truven Health Analytics, 2018, RES DAT AN TOOLS 201	21	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210517	10.1371/journal.pone.0210517	http://dx.doi.org/10.1371/journal.pone.0210517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682042	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500043
J	Chen, W; He, Y; Chen, CS; Zhu, M; Bi, SY; Liu, J; Xia, MR; Lin, QX; Wang, YW; Wang, WJ				Chen, Wen; He, Yong; Chen, Chuansheng; Zhu, Ming; Bi, Suyu; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Yiwen; Wang, Wenjing			Long-term Chinese calligraphic handwriting training has a positive effect on brain network efficiency	PLOS ONE			English	Article							MEMORY-SYSTEMS; FUNCTIONAL CONNECTIVITY; CORTICAL NETWORKS; CAUDATE-NUCLEUS; HIPPOCAMPUS; PATTERNS; EMOTION; MOTION	As a visual art form, Chinese calligraphic handwriting (CCH) has been found to correlate with certain brain activity and to induce functional connectivity reorganization of the brain. This study investigated the effect of long-term CCH training on brain functional plasticity as assessed with network measures. With the resting-state fMRI data from 31 participants with at least five years of CCH training and 40 controls, we constructed brain functional networks, examined group differences at both the whole brain and modular levels, and correlated the topological characteristics with calligraphy skills. We found that, compared to the control group, the CCH group showed shorter characteristic path lengths and higher local efficiency in certain brain areas in the frontal and parietal cortices, limbic system, basal ganglia, and thalamus. Moreover, these network measures in the cingulate cortex, caudate nucleus, and thalamus were associated with CCH performance (i.e., copying and creating skills). These results suggest that long-term CCH training has a positive effect on the topological characteristics of brain networks.	[Chen, Wen] Beijing Normal Univ, Adv Innovat Ctr Future Educ, Beijing, Peoples R China; [Chen, Wen; He, Yong; Zhu, Ming; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Wenjing] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Chen, Wen; He, Yong; Zhu, Ming; Liu, Jin; Xia, Mingrui; Lin, Qixiang; Wang, Wenjing] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Chen, Wen] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA USA; [Bi, Suyu] Beijing Foreign Studies Univ, Sch Int Journalism & Commun, Beijing, Peoples R China; [Bi, Suyu; Wang, Yiwen] Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of California System; University of California Irvine; Beijing Foreign Studies University; Beijing Normal University	Wang, WJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Wang, WJ (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Wang, YW (corresponding author), Beijing Normal Univ, Sch Arts & Media, Beijing, Peoples R China.	wyiw@sina.com; wangwenjing@bnu.edu.cn	Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; Xia, Mingrui/J-3267-2019; Lin, Qixiang/GXG-3598-2022; wang, yixuan/GXW-2866-2022; He, Yong/Q-5756-2018; Wang, Yixuan/GZK-6559-2022	Xia, Mingrui/0000-0003-4615-9132; Lin, Qixiang/0000-0002-1718-6855; He, Yong/0000-0002-7039-2850; Chen, Chuansheng/0000-0002-8224-1005; Chen, Wen/0000-0001-7563-4495	Project of the Ministry of Education of the People's Republic of China [14YJAZH081]; National Natural Science Foundation of the People's Republic of China [31221003]	Project of the Ministry of Education of the People's Republic of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by the 14YJAZH081 (received by WW) Project of the Ministry of Education of the People's Republic of China (http://en.moe.gov.cn/) and the No. 31221003 (received by YH) Project of the National Natural Science Foundation of the People's Republic of China (http://www.nsfc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the 14YJAZH081 Project of the Ministry of Education of China and the No. 31221003 Project of the National Natural Science Foundation of China. We thank all graduate research assistants who helped with data collection.	Akbar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145906; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Beaty RE, 2018, P NATL ACAD SCI USA, V115, P1087, DOI 10.1073/pnas.1713532115; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Bender AD, 2017, NEUROIMAGE, V158, P455, DOI 10.1016/j.neuroimage.2016.10.035; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Burkhouse KL, 2018, PROG NEURO-PSYCHOPH, V84, P250, DOI 10.1016/j.pnpbp.2018.03.013; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chang WH, 2012, RESTOR NEUROL NEUROS, V30, P179, DOI 10.3233/RNN-2012-110162; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Chen W, 2016, 22 ANN M ORG HUM BRA, DOI [10.1371/journal.pone.0145906, DOI 10.1371/JOURNAL.PONE.0145906]; Chen W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170660; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Ellamil M, 2012, NEUROIMAGE, V59, P1783, DOI 10.1016/j.neuroimage.2011.08.008; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Iaria G, 2003, J NEUROSCI, V23, P5945; Kruschwitz JD, 2015, J NEUROSCI METH, V245, P107, DOI 10.1016/j.jneumeth.2015.02.021; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Lin CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066761; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12277; Maguire EA, 2006, HIPPOCAMPUS, V16, P1091, DOI 10.1002/hipo.20233; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; Min BK, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-10; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Petrella JR, 2011, RADIOLOGY, V259, P317, DOI 10.1148/radiol.11110380; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pinho AL, 2014, J NEUROSCI, V34, P6156, DOI 10.1523/JNEUROSCI.4769-13.2014; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Sarkamo T, 2018, DEMENTIA-LONDON, V17, P670, DOI 10.1177/1471301217729237; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schwabe L, 2013, BIOL PSYCHIAT, V74, P801, DOI 10.1016/j.biopsych.2013.06.001; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tian F, 2018, NEUROSCI LETT, V683, P104, DOI 10.1016/j.neulet.2018.06.036; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yoshino A, 2018, PSYCHOL MED, V48, P1148, DOI 10.1017/S0033291717002598	53	2	2	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210962	10.1371/journal.pone.0210962	http://dx.doi.org/10.1371/journal.pone.0210962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682084	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500080
J	Cimler, R; Maresova, P; Kuhnova, J; Kuca, K				Cimler, Richard; Maresova, Petra; Kuhnova, Jitka; Kuca, Kamil			Predictions of Alzheimer's disease treatment and care costs in European countries	PLOS ONE			English	Article							GLOBAL PREVALENCE; SOCIETAL COSTS; DEMENTIA; IMPACT; MILD; BURDEN	Background Given the increasing lifespan of the elderly and the higher proportion of older people in the global population, the incidence rate of neurodegenerative diseases is increasing. The aim of this study is to evaluate, by means of computer simulations, developments in the costs of treating and caring for people suffering from Alzheimer's disease (AD) in the EU 28 by 2080, while assuming the introduction of drug administrations at various disease stages. Methods Impact analysis leverages a mathematical model that compares five different population development scenarios when introducing different types of drugs to the scenarios but without changing the treatment. Changes in the economic burden are considered as of 2023, when new drugs are expected to enter the market. Findings The results of the simulations show that by prolonging the length of a person's 'stay' in the Mild, Moderate, or Severe stage, the total cost of care for all persons with AD will increase by 2080. For individual scenarios, the percentage of patients and costs increased as follows: Mild by one year, by 10.61%; Mild by two years, by 17.73%; Moderate by one year, by 16.79%; Moderate by two years, by 34.88%; and Severe by one year, by 23.79%. The change in cost development when prolonging the stay in the Mild cognitive impairment stage (by lowering the incidence by 10%, 30%, or 50%) reduced the cost (by 4.88%, 16.78% and 32.48%, respectively). Interpretation The results unambiguously show that any intervention prolonging a patient's stay in any stage will incur additional care costs and an increase in the number of persons with AD. Therefore, extending lifespan is important in terms of improving the quality of life of patients, and the introduction of new drugs must consider the additional costs imposed upon society.	[Cimler, Richard; Kuhnova, Jitka] Univ Hradec Kralove, Fac Sci, Hradec Kralove, Czech Republic; [Maresova, Petra; Kuca, Kamil] Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic	University of Hradec Kralove; University of Hradec Kralove	Kuca, K (corresponding author), Univ Hradec Kralove, Fac Informat & Management, Hradec Kralove, Czech Republic.	kamil.kuca@uhk.cz	Kuhnova, Jitka/C-7564-2016; Kuca, Kamil/D-1396-2011	Kuhnova, Jitka/0000-0001-9223-5672; Kuca, Kamil/0000-0001-9664-1109	Grant Agency of Excellence UHK FIM; project TACR [TL01000300]	Grant Agency of Excellence UHK FIM; project TACR	The support of the Grant Agency of Excellence UHK FIM is gratefully acknowledged. Financial support of the project TACR TL01000300 is also gratefully acknowledged.	Anderson R., 2018, THESIS; [Anonymous], 2015, INNOVATION ACTIVE HL; Arizaga RL, 2005, DEMENTIA MULTIDISCIP, V2, P7; Boada M, 1999, MED CLIN-BARCELONA, V113, P690; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cimler R, 2018, CURR ALZHEIMER RES, V15, P789, DOI 10.2174/1567205015666180202094551; Cummings J., 2017, ALZHEIMERS DEMENTIA; Dodel R, 2015, ALZHEIMERS DEMENT, V11, P933, DOI 10.1016/j.jalz.2015.02.005; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Ernst RL, 1997, ARCH NEUROL-CHICAGO, V54, P687, DOI 10.1001/archneur.1997.00550180013006; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gustavsson A, 2017, ALZHEIMERS DEMENT, V13, P312, DOI 10.1016/j.jalz.2016.12.005; Ikeda S, 2002, DEMENT GERIATR COGN, V13, P33, DOI 10.1159/000048631; Keogh-Brown MR, 2016, EBIOMEDICINE, V4, P184, DOI 10.1016/j.ebiom.2015.12.019; Maresova P, 2018, J ALZHEIMERS DIS, V63, P227, DOI 10.3233/JAD-171028; Maresova P, 2016, NEUROL SCI, V37, P1917, DOI 10.1007/s10072-016-2679-6; Maresova P, 2016, APPL ECON, V48, P1936, DOI 10.1080/00036846.2015.1111986; Maresova P, 2015, CURR ALZHEIMER RES, V12, P903, DOI 10.2174/156720501209151019111448; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Mesterton J, 2010, CURR ALZHEIMER RES, V7, P358, DOI 10.2174/156720510791162430; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Prince M, 2015, WORLD ALZHEIMERS REP; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Schwarzkopf L, 2011, VALUE HEALTH, V14, P827, DOI 10.1016/j.jval.2011.04.005; Skoldunger A, 2013, CURR ALZHEIMER RES, V10, P207, DOI 10.2174/1567205011310020011; Smith DH, 2001, INT J TECHNOL ASSESS, V17, P236, DOI 10.1017/S0266462300105094; Spackman DE, 2012, CURR ALZHEIMER RES, V9, P1050; Suh GH, 2009, VALUE HEALTH, V12, pS49, DOI 10.1111/j.1524-4733.2009.00627.x; Tomaskova H, 2016, NEUROPSYCH DIS TREAT, V12, P1589, DOI 10.2147/NDT.S107969; Wimo A, 2009, COST ILLNESS BURDEN; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006	34	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210958	10.1371/journal.pone.0210958	http://dx.doi.org/10.1371/journal.pone.0210958			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682120	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500079
J	dos Santos, GL; da Silva, ESM; Desloovere, K; Russo, TL				dos Santos, Gabriela Lopes; Moreira da Silva, Erika Shirley; Desloovere, Kaat; Russo, Thiago Luiz			Effects of elastic tape on kinematic parameters during a functional task in chronic hemiparetic subjects: A randomized sham-controlled crossover trial	PLOS ONE			English	Article							HEMIPLEGIC SHOULDER PAIN; MINI-MENTAL-STATE; STROKE PATIENTS; UPPER-LIMB; KINESIO TAPE; EFFECT SIZE; MOVEMENT; DRINKING; MOTION; ELBOW	Background Approximately 50 to 70% of post-stroke subjects present a reduction in the upper limb (UL) function even during the chronic phase. An adjuvant technique widely used in neurorehabilitation is elastic taping applications. However, its efficacy in UL treatment for post-stroke subjects still requires further investigation. Objective To verify the effects of elastic tape (ET) used on the paretic shoulder in upper limb (UL) performance during a drinking task. Method A single-center randomized sham-controlled crossover trial randomized thirteen post-stroke subjects with mild to moderate UL impairment for group allocation to receive first Sham Tape (ST) or first Elastic Tape (ET), with one month of washout. Kinematic measures of a drinking task were taken before and after each intervention (elastic and sham tape), using Three-Dimensional Motion Analysis, and studied using feature analysis and Statistical Parametric Mapping. Outcome measures included spatiotemporal variables, scalar kinematic parameters (starting angles, range of motion-ROM, and endpoint angles) and time-normalized kinematic waveforms of trunk and UL joint angles (scapulothoracic, humerothoracic and elbow). Results Elastic tape provided common modifications throughout the task (shoulder more towards midline, reduced scapula protraction and trunk flexion) and important alterations at specific time-instants. At the end of the reaching phase, for both groups (ET and ST), the elastic tape increased elbow extension [ET: CI = 12.57 (6.90 to 18.17), p<0.001; ST: CI: 12.89 (6.79 to 18.98), p<0.001). At the end of transporting the glass to the mouth, patients who underwent the elastic tape intervention presented more shoulder elevation [ET: CI = 16.40 (4.28 to 28.52), p = 0.007; ST: CI: 15.13 (5.79 to 24.48), p = 0.002)]. Moreover, an increase of elbow extension at the end of transporting the glass to the table was observed for both groups [ET: CI = 8.13 (1.48 to 14.79), p = 0.014; ST: CI: 8.20 (4.03 to 12.38), p<0.001)]. However, no changes in the spatiotemporal parameters were observed for both groups during all the phases of the task (p>0.05). Conclusion The ET changed UL joint motions and posture during a drinking task in chronic hemiparetic subjects, which defines its role as an adjuvant therapy.	[dos Santos, Gabriela Lopes; Moreira da Silva, Erika Shirley; Russo, Thiago Luiz] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Lab Neurol Physiotherapy Res, Sao Carlos, SP, Brazil; [dos Santos, Gabriela Lopes] Fac Alfredo Nasser UNIFAN, ICS, Aparecida De Goiania, Go, Brazil; [Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Leuven, Belgium; [Desloovere, Kaat] Univ Hosp Pellenberg, Clin Mot Anal Lab, CERM, Pellenberg, Belgium	Universidade Federal de Sao Carlos; KU Leuven; KU Leuven; University Hospital Leuven	dos Santos, GL; Russo, TL (corresponding author), Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Lab Neurol Physiotherapy Res, Sao Carlos, SP, Brazil.; dos Santos, GL (corresponding author), Fac Alfredo Nasser UNIFAN, ICS, Aparecida De Goiania, Go, Brazil.	gabrielalsantos@hotmail.com; thiagoluizrusso@gmail.com	Russo, Thiago/B-7555-2012; Santos, Gabriela L Lopes dos/K-6023-2013; da Silva, Erika Shirley Moreira/T-2561-2019	Russo, Thiago/0000-0002-5483-3097; Lopes dos Santos, Gabriela/0000-0002-6230-999X; Silva, Erika Shirley/0000-0003-1485-275X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/CAPES) [2014/25845-6, 2015/21695-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142923/2014-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study (author: GLS) was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/CAPES; grant numbers: 2014/25845-6 and 2015/21695-2), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number: 142923/2014-1).	Adler RJ., 2009, RANDOM FIELDS GEOMET; Alt Murphy M, 2011, NEUROREHAB NEURAL RE, V25, P71, DOI 10.1177/1545968310370748; Aprile I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/636123; Bell A, 2013, TOP STROKE REHABIL, V20, P283, DOI 10.1310/tsr2003-283; Bravi R, 2016, INT J SPORTS MED, V37, P909, DOI 10.1055/s-0042-109777; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Camerota F, 2014, DEV NEUROREHABIL, V17, P384, DOI 10.3109/17518423.2013.830152; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; dos Santos GL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170368; Faraone Stephen V, 2008, P T, V33, P700; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gamage SSHU, 2002, J BIOMECH, V35, P87, DOI 10.1016/S0021-9290(01)00160-9; Hatem SM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00442; Huang YC, 2016, EUR J PHYS REHAB MED, V52, P774; Kalichman L, 2016, INT J REHABIL RES, V39, P272, DOI 10.1097/MRR.0000000000000167; Kandel E.R., 2000, PRINCIPLES NEURAL SC, V4th; Kim EB, 2015, J PHYS THER SCI, V27, P1455, DOI 10.1589/jpts.27.1455; Kim K, 2014, CLIN BIOMECH, V29, P248, DOI 10.1016/j.clinbiomech.2013.12.013; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lee DH, 2015, J PHYS THER SCI, V27, P2101, DOI 10.1589/jpts.27.2101; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Pamuk U, 2015, J BIOMECH, V48, P4262, DOI 10.1016/j.jbiomech.2015.10.036; Pandian JD, 2013, NEUROLOGY, V80, P528, DOI 10.1212/WNL.0b013e318281550e; Parker V M, 1986, Int Rehabil Med, V8, P69; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pillastrini P, 2016, DISABIL REHABIL, V38, P1603, DOI 10.3109/09638288.2015.1107631; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Robertson JVG, 2012, EXP BRAIN RES, V218, P141, DOI 10.1007/s00221-012-3014-y; Roijezon U, 2015, MANUAL THER, V20, P368, DOI 10.1016/j.math.2015.01.008; Russo L, 2018, ASIAN J SPORTS MED; Santos GL, 2018, ARCH PHYS MED REHAB, V99, P501, DOI 10.1016/j.apmr.2017.08.479; Stoykov ME, 2015, J NEUROL PHYS THER, V39, P33, DOI 10.1097/NPT.0000000000000065; Van Herzeele M, 2013, INT J SPORTS MED, V34, P950, DOI 10.1055/s-0033-1334911; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	39	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211332	10.1371/journal.pone.0211332	http://dx.doi.org/10.1371/journal.pone.0211332			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682144	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500150
J	Nakayama, T; Nagata, E; Masuda, H; Asahara, T; Takizawa, S				Nakayama, Taira; Nagata, Eiichiro; Masuda, Haruchika; Asahara, Takayuki; Takizawa, Shunya			Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; FOCAL CEREBRAL-ISCHEMIA; INDUCED ANGIOGENESIS; INTERLEUKIN-10; GROWTH; INJURY; NEOVASCULARIZATION; INHIBITION; MODEL; TUMOR	Various cell-based therapeutic strategies have been investigated for vascular and tissue regeneration after ischemic stroke. We have developed a novel cell population, called regeneration-associated cells (RACs), by quality- and quantity-controlled culture of unfractionated mononuclear cells. RACs were trans-arterially injected into 10-week-old syngeneic male mice at 1, 3, 5 or 7 days after permanent middle cerebral artery occlusion (MCAO) to determine the optimal timing for administration in terms of outcome at day 21. Next, we examined the effects of RACs injection at day 1 after MCAO on neurological deficits, infarct volume, and mediators of vascular regeneration and anti-inflammation at days 7 and 21. Infarct volume at day 21 was significantly reduced by transplantation of RACs at day 1 or 3. RACs injected at day 1 reduced the infarct volume at day 7 and 21. Angiogenesis and anti-inflammatory mediators, VEGF and IL-10, were increased at day 7, and VEGF was still upregulated at day 21. We also observed significantly enhanced ink perfusion in vivo, tube formation in vitro, and definitive endothelial progenitor cell colonies in colony assay. These results suggest that RAC transplantation in MCAO models promoted significant recovery of neural tissues through intensified anti-inflammatory and angiogenic effects.	[Nakayama, Taira; Nagata, Eiichiro; Takizawa, Shunya] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa, Japan; [Masuda, Haruchika] Tokai Univ, Sch Med, Dept Physiol, Isehara, Kanagawa, Japan; [Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University	Takizawa, S (corresponding author), Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa, Japan.	shun@is.icc.u-tokai.ac.jp		Nagata, Eiichiro/0000-0001-6902-8309; Takizawa, Shunya/0000-0002-4567-6384	Japan Society for the Promotion of Science; SENSHIN Medical Research Foundation [26461320]; Japan Agency for Medical Research and Development [15bk0104012h003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Society for the Promotion of Science and SENSHIN Medical Research Foundation, http://www.jsps.go.jp/english/index.html, Scientific Research (C) 26461320, S.T. received the funding; Japan Agency for Medical Research and Development, https://www.amed.go.jp/en/index.html, Grant 15bk0104012h003, T.A. received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bai YY, 2015, STROKE, V46, P1938, DOI 10.1161/STROKEAHA.114.008495; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chen C, 2014, STEM CELLS, V32, P2679, DOI 10.1002/stem.1754; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen JB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041125, 10.1371/journal.pone.0046878]; Cole N, 2003, INFECT IMMUN, V71, P1328, DOI 10.1128/IAI.71.3.1328-1336.2003; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dirnagl U, 2014, STROKE, V45, P1510, DOI 10.1161/STROKEAHA.113.004075; Garcia-Hernandez ML, 2002, IMMUNOLOGY, V105, P231, DOI 10.1046/j.1365-2567.2002.01363.x; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Hatanaka H, 2001, CLIN CANCER RES, V7, P1287; Hecht N, 2014, J CEREBR BLOOD F MET, V34, P1297, DOI 10.1038/jcbfm.2014.78; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Huang SY, 1999, J INTERF CYTOK RES, V19, P697, DOI 10.1089/107999099313532; Iskander A, 2013, STEM CELL TRANSL MED, V2, P703, DOI 10.5966/sctm.2013-0066; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2012, STEM CELL TRANSL MED, V1, P160, DOI 10.5966/sctm.2011-0023; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moubarik C, 2011, STEM CELL REV REP, V7, P208, DOI 10.1007/s12015-010-9157-y; Noisa P, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/647437; Ohta T, 2006, NEUROSURGERY, V59, P679, DOI 10.1227/01.NEU.0000229058.08706.88; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Shen WC, 2013, STEM CELLS DEV, V22, P1408, DOI 10.1089/scd.2012.0445; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Silvestre JS, 2000, CIRC RES, V87, P448; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Stearns ME, 1999, CLIN CANCER RES, V5, P189; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Torrent R, 2015, J CLIN MED, V4, P548, DOI 10.3390/jcm4040548; Vaughan EE, 2012, CELL TRANSPLANT, V21, P1095, DOI 10.3727/096368911X623880; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wang HB, 2014, J NEUROPATH EXP NEUR, V73, P548, DOI 10.1097/NEN.0000000000000077; Yukami T, 2015, STROKE, V46, P1657, DOI 10.1161/STROKEAHA.114.008062; ZHANG FG, 1992, J CEREBR BLOOD F MET, V12, P962, DOI 10.1038/jcbfm.1992.133; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	45	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210198	10.1371/journal.pone.0210198	http://dx.doi.org/10.1371/journal.pone.0210198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682162	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500027
J	Potts, AH; Guo, YP; Ahmer, BMM; Romeo, T				Potts, Anastasia H.; Guo, Yinping; Ahmer, Brian M. M.; Romeo, Tony			Role of CsrA in stress responses and metabolism important for Salmonella virulence revealed by integrated transcriptomics	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; ESCHERICHIA-COLI; MESSENGER-RNA; GENE-EXPRESSION; OXIDATIVE STRESS; H-NS; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR CHARACTERIZATION; INTRACELLULAR ENVIRONMENT	To cause infection, Salmonella must survive and replicate in host niches that present dramatically different environmental conditions. This requires a flexible metabolism and physiology, responsive to conditions of the local milieu. The sequence specific RNA binding protein CsrA serves as a global regulator that governs gene expression required for pathogenicity, metabolism, biofilm formation, and motility in response to nutritional conditions. Its activity is determined by two noncoding small RNAs (sRNA), CsrB and CsrC, which sequester and antagonize this protein. Here, we used ribosome profiling and RNA-seq analysis to comprehensively examine the effects of CsrA on mRNA occupancy with ribosomes, a measure of translation, transcript stability, and the steady state levels of transcripts under in vitro SPI-1 inducing conditions, to simulate growth in the intestinal lumen, and under in vitro SPI-2-inducing conditions, to simulate growth in the Salmonella containing vacuole (SCV) of the macrophage. Our findings uncovered new roles for CsrA in controlling the expression of structural and regulatory genes involved in stress responses, metabolism, and virulence systems required for infection. We observed substantial variation in the CsrA regulon under the two growth conditions. In addition, CsrB/C sRNA levels were greatly reduced under the simulated intracellular conditions and were responsive to nutritional factors that distinguish the intracellular and luminal environments. Altogether, our results reveal CsrA to be a flexible regulator, which is inferred to be intimately involved in maintaining the distinct gene expression patterns associated with growth in the intestine and the macrophage.	[Potts, Anastasia H.; Guo, Yinping; Romeo, Tony] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Ahmer, Brian M. M.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Potts, Anastasia H.] Takara Bio USA Inc, Mountain View, CA USA; [Guo, Yinping] Univ Georgia, Natl Environm Sound Prod Agr Lab, Tifton Campus, Tifton, GA USA	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; Takara Bio Inc.; University System of Georgia; University of Georgia	Romeo, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	tromeo@ufl.edu	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322; Guo, Yinping/0000-0003-1796-6584	National Institutes of Health [R01AI097116, R01GM059969]; National Science Foundation Graduate Research Fellowship Program [DGE-1315138]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R01AI097116 to T.R. and B.M. M.A., R01GM059969 to T.R.]; and the National Science Foundation Graduate Research Fellowship Program [DGE-1315138 to A.H.P.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Akbar S, 2003, MOL MICROBIOL, V47, P715, DOI 10.1046/j.1365-2958.2003.03322.x; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ali MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004209; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Altendorf Karlheinz, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.5.4.5; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Alvarez-Ordonez A, 2011, MICROBIOL-SGM, V157, P3268, DOI 10.1099/mic.0.050351-0; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arenas FA, 2010, BIOCHEM BIOPH RES CO, V398, P690, DOI 10.1016/j.bbrc.2010.07.002; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Balaji B, 2005, APPL ENVIRON MICROB, V71, P8273, DOI 10.1128/AEM.71.12.8273-8283.2005; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Borisov Vitaliy B, 2015, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0012-2015; Brenneman KE, 2013, J BACTERIOL, V195, P3062, DOI 10.1128/JB.00104-13; Brown NF, 2014, MBIO, V5, DOI 10.1128/mBio.01727-14; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Chen CY, 1996, INFECT IMMUN, V64, P4739, DOI 10.1128/IAI.64.11.4739-4743.1996; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; D'Costa VM, 2015, CELL REP, V12, P1508, DOI 10.1016/j.celrep.2015.07.063; Dandekar T, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00191; Daniels JJD, 1996, INFECT IMMUN, V64, P5075, DOI 10.1128/IAI.64.12.5075-5084.1996; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Desai SK, 2016, ELIFE, V5, DOI 10.7554/eLife.10747; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Erhardt M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00949; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Esquerre T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25057; Esquerre T, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1482-8; Faber F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006129; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Fang FC, 2016, CELL HOST MICROBE, V20, P133, DOI 10.1016/j.chom.2016.07.009; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Finn S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00331; Finn S, 2013, APPL ENVIRON MICROB, V79, P4376, DOI 10.1128/AEM.00515-13; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gillis CC, 2018, CELL HOST MICROBE, V23, P54, DOI 10.1016/j.chom.2017.11.006; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Holmqvist E, 2016, EMBO J, V35, P991, DOI 10.15252/embj.201593360; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; IUCHI S, 1994, J BACTERIOL, V176, P1695, DOI 10.1128/jb.176.6.1695-1701.1994; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Jones-Carson J, 2016, MBIO, V7, DOI 10.1128/mBio.02052-16; Jorgensen MG, 2013, GENE DEV, V27, P1132, DOI 10.1101/gad.214734.113; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Katsowich N, 2017, SCIENCE, V355, P735, DOI 10.1126/science.aah4886; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; KINGSLEY R, 1995, FEMS IMMUNOL MED MIC, V11, P257, DOI 10.1016/0928-8244(95)00031-2; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Knuff K, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00335; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kristoffersen SM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r30; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kulkarni PR, 2014, NUCLEIC ACIDS RES, V42, P6811, DOI 10.1093/nar/gku309; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; Leng YY, 2016, MOL MICROBIOL, V99, P627, DOI 10.1111/mmi.13259; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412; Lopez CA, 2015, INFECT IMMUN, V83, P3470, DOI 10.1128/IAI.00351-15; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Martinez LC, 2014, J BACTERIOL, V196, P3746, DOI 10.1128/JB.01799-14; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; McKee AE, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-79; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Nickerson CA, 1997, INFECT IMMUN, V65, P1814, DOI 10.1128/IAI.65.5.1814-1823.1997; Niemann GS, 2011, INFECT IMMUN, V79, P33, DOI 10.1128/IAI.00771-10; Park H, 2015, J BACTERIOL, V197, P3751, DOI 10.1128/JB.00721-15; Parker A, 2017, MOL MICROBIOL, V105, P309, DOI 10.1111/mmi.13702; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez-Morales D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006497; Pires SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142927; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Revelles O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066386; Rivera-Chavez F, 2016, MBIO, V7, DOI 10.1128/mBio.00960-16; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Rivera-Chavez F, 2015, ANNU REV MICROBIOL, V69, P31, DOI 10.1146/annurev-micro-091014-104108; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Rowbury RJ, 1997, LETT APPL MICROBIOL, V24, P319, DOI 10.1046/j.1472-765X.1997.00065.x; Ryan D, 2015, APPL ENVIRON MICROB, V81, P8054, DOI 10.1128/AEM.02172-15; Scallan E, 2013, PEDIATR INFECT DIS J, V32, P217, DOI 10.1097/INF.0b013e31827ca763; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; SHI XL, 1994, J BACTERIOL, V176, P7017, DOI 10.1128/JB.176.22.7017-7023.1994; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Sterzenbach T, 2013, EMBO J, V32, P2872, DOI 10.1038/emboj.2013.206; Subramaniam AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01501; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Unden Gottfried, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.2.2; Vakulskas CA, 2016, NUCLEIC ACIDS RES, V44, P7896, DOI 10.1093/nar/gkw484; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Velayudhan J, 2007, MOL MICROBIOL, V63, P1495, DOI 10.1111/j.1365-2958.2007.05600.x; Viala JP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006556; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Wilson JA, 1998, MICROBIOL-UK, V144, P1823, DOI 10.1099/00221287-144-7-1823; Wu JK, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00945-17, 10.1128/iai.00945-17]; Wu JK, 2018, J AGR FOOD CHEM, V66, P212, DOI 10.1021/acs.jafc.7b04237; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; YIM HH, 1992, J BACTERIOL, V174, P3637, DOI 10.1128/JB.174.11.3637-3644.1992; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zere TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145035; Zhao G, 2008, P NATL ACAD SCI USA, V105, P20924, DOI 10.1073/pnas.0807071106; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	153	25	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211430	10.1371/journal.pone.0211430	http://dx.doi.org/10.1371/journal.pone.0211430			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682134	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500169
J	Sheehan, T; Bachelet, D; Ferschweiler, K				Sheehan, Tim; Bachelet, Dominique; Ferschweiler, Ken			Fire, CO2, and climate effects on modeled vegetation and carbon dynamics in western Oregon and Washington	PLOS ONE			English	Article							CONTERMINOUS UNITED-STATES; MOUNTAIN PINE-BEETLE; LAND-USE; TEMPORAL PATTERNS; ENRICHMENT FACE; FOREST; DISTURBANCE; RESPONSES; WATER; VULNERABILITY	To develop effective long-term strategies, natural resource managers need to account for the projected effects of climate change as well as the uncertainty inherent in those projections. Vegetation models are one important source of projected climate effects. We explore results and associated uncertainties from the MC2 Dynamic Global Vegetation Model for the Pacific Northwest west of the Cascade crest. We compare model results for vegetation cover and carbon dynamics over the period 1895-2100 assuming: 1) unlimited wildfire ignitions versus stochastic ignitions, 2) no fire, and 3) a moderate CO2 fertilization effect versus no CO2 fertilization effect. Carbon stocks decline in all scenarios, except without fire and with a moderate CO2 fertilization effect. The greatest carbon stock loss, approximately 23% of historical levels, occurs with unlimited ignitions and no CO2 fertilization effect. With stochastic ignitions and a CO2 fertilization effect, carbon stocks are more stable than with unlimited ignitions. For all scenarios, the dominant vegetation type shifts from pure conifer to mixed forest, indicating that vegetation cover change is driven solely by climate and that significant mortality and vegetation shifts are likely through the 21st century regardless of fire regime changes.	[Sheehan, Tim; Ferschweiler, Ken] Conservat Biol Inst, Corvallis, OR 97333 USA; [Sheehan, Tim] Oregon State Univ, Grad Sch, Corvallis, OR 97331 USA; [Bachelet, Dominique] Oregon State Univ, Dept Biol & Ecol Engn, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sheehan, T (corresponding author), Conservat Biol Inst, Corvallis, OR 97333 USA.; Sheehan, T (corresponding author), Oregon State Univ, Grad Sch, Corvallis, OR 97331 USA.	tim@consbio.org			U.S. Department of the Interior via the Northwest Climate Science Center [G12AC20495]	U.S. Department of the Interior via the Northwest Climate Science Center	This work was supported by (DB) U.S. Department of the Interior via the Northwest Climate Science Center through agreement #G12AC20495 within the framework of the research project entitled "Integrated Scenarios of climate, hydrology and vegetation for the Northwest", P. Mote (Oregon State University) principal investigator. This organization is now called the Northwest Climate Adaptation Science Center, https://nwcasc.uw.edu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Funding for this research was provided by the U.S. Department of the Interior via the Northwest Climate Science Center through agreement #G12AC20495 within the framework of the research project entitled "Integrated Scenarios of climate, hydrology and vegetation for the Northwest", P. Mote (Oregon State University) principal investigator.	Abatzoglou JT, 2012, INT J CLIMATOL, V32, P772, DOI 10.1002/joc.2312; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Bachelet D, 2015, GLOBAL CHANGE BIOL, V21, P4548, DOI 10.1111/gcb.13048; Barbero R, 2015, INT J WILDLAND FIRE, V24, P892, DOI 10.1071/WF15083; Batllori E, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034018; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Brodribb TJ, 2009, NEW PHYTOL, V183, P839, DOI 10.1111/j.1469-8137.2009.02844.x; Canadian Forestry Service, 1984, TABL CAN FOR FIR WEA; Castedo-Dorado F, 2011, FOREST SYST, V20, P95; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dale VH, 1997, ECOL APPL, V7, P753, DOI 10.1890/1051-0761(1997)007[0753:TRBLUC]2.0.CO;2; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [10.4996/fireecology.0301003, DOI 10.4996/FIREECOLOGY.0301003]; Enright NJ, 2015, FRONT ECOL ENVIRON, V13, P265, DOI 10.1890/140231; Fowler D., 2015, ATMOS CHEM PHYS, V15, P13849, DOI [10.5194/acp-15-13849-2015, DOI 10.5194/acp-15-13849-2015]; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Hantson S, 2016, BIOGEOSCIENCES, V13, P3359, DOI 10.5194/bg-13-3359-2016; Harris RMB, 2016, WIRES CLIM CHANGE, V7, P910, DOI 10.1002/wcc.428; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Keane RE, 2015, ECOL MODEL, V309, P33, DOI 10.1016/j.ecolmodel.2015.04.009; Kitzberger T, 2016, NEW ZEAL J BOT, V54, P247, DOI 10.1080/0028825X.2016.1151903; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Law BE, 2004, GLOBAL CHANGE BIOL, V10, P1429, DOI 10.1111/j.1365-2486.2004.00822.x; Law BE, 2018, P NATL ACAD SCI USA; Littell JS, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00114.1; Lurgi M, 2012, PHILOS T R SOC B, V367, P2913, DOI 10.1098/rstb.2012.0238; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Neary DG, 2009, FOREST ECOL MANAG, V258, P2269, DOI 10.1016/j.foreco.2009.05.027; Norby RJ, 2011, ANNU REV ECOL EVOL S, V42, P181, DOI 10.1146/annurev-ecolsys-102209-144647; Omernik JM, 2014, ENVIRON MANAGE, V54, P1249, DOI 10.1007/s00267-014-0364-1; Parente J, 2018, SCI TOTAL ENVIRON, V631-632, P534, DOI 10.1016/j.scitotenv.2018.03.044; Peterman W, 2014, ECOL MODEL, V294, P84, DOI 10.1016/j.ecolmodel.2014.09.025; Pew KL, 2001, FOREST ECOL MANAG, V140, P1, DOI 10.1016/S0378-1127(00)00271-1; Preisler HK, 2012, ECOLOGY, V93, P2421, DOI 10.1890/11-1412.1; Rabin SS, 2017, GEOSCIENTIFIC MODEL, V20, P1175; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Rienstra JT, 1991, OR9 TN US DEP INT BU; Rogers BM, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001695; Rorig ML, 1999, J APPL METEOROL, V38, P1565, DOI 10.1175/1520-0450(1999)038&lt;1565:COLAWF&gt;2.0.CO;2; Senf C, 2018, GLOBAL CHANGE BIOL, V24, P1201, DOI 10.1111/gcb.13897; Sheehan T, 2015, ECOL MODEL, V317, P16, DOI 10.1016/j.ecolmodel.2015.08.023; Sommerfeld A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06788-9; Spies TA, 2017, ECOLOGY SOC, V22; Sullivan AL, 2009, INT J WILDLAND FIRE, V18, P387, DOI 10.1071/WF06144; Sullivan AL, 2009, INT J WILDLAND FIRE, V18, P369, DOI 10.1071/WF06142; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Tedim F, 2018, FIRE-BASEL, V1, DOI 10.3390/fire1010009; Thomas D., 2017, COSTS LOSSES WILDFIR; Turner DP, 2016, REG ENVIRON CHANGE, V16, P2345, DOI 10.1007/s10113-016-0956-9; Turner David P, 2015, Carbon Balance Manag, V10, P12; Turner DP, 2015, CLIMATIC CHANGE, V133, P335, DOI 10.1007/s10584-015-1465-4; van der Sleen P, 2015, NAT GEOSCI, V8, P24, DOI [10.1038/NGEO2313, 10.1038/ngeo2313]; Van Wagner C.E., 1987, DEV STRUCTURE CANADI; Way DA, 2015, PLANT CELL ENVIRON, V38, P991, DOI 10.1111/pce.12527; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0178; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037	64	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210989	10.1371/journal.pone.0210989	http://dx.doi.org/10.1371/journal.pone.0210989			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682107	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500085
J	Takayama, T; Yamamoto, K; Saito, H; Tatebayashi, K				Takayama, Tomomi; Yamamoto, Katsuyoshi; Saito, Haruo; Tatebayashi, Kazuo			Interaction between the transmembrane domains of Sho1 and Opy2 enhances the signaling efficiency of the Hog1 MAP kinase cascade in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; OSMOTIC-STRESS; PBS2 MAPKK; YEAST; GLYCEROL; PATHWAY; OSMOSTRESS; EXPRESSION; GROWTH	To cope with increased extracellular osmolarity, the budding yeast Saccharomyces cerevisiae activates the Hog1 mitogen-activated protein kinase (MAPK), which controls a variety of adaptive responses. Hog1 is activated through the high-osmolarity glycerol (HOG) pathway, which consists of a core MAPK cascade and two independent upstream branches (SHO1 and SLN1 branches) containing distinct osmosensing machineries. In the SHO1 branch, a homo-oligomer of Sho1, the four-transmembrane (TM) osmosensor, interacts with the transmembrane co-osmosensors, Hkr1 and Msb2, and the membrane anchor protein Opy2, through their TM domains, and activates the Ste20-Ste11-Pbs2-Hog1 kinase cascade. In this study, we isolated and analyzed hyperactive mutants of Sho1 and Opy2 that harbor mutations within their TM domains. Several hyperactive mutations enhanced the interaction between Sho1 and Opy2, indicating the importance of the TM-mediated interaction between Sho1 and Opy2 for facilitating effective signaling. The interaction between the TM domains of Sho1 and Opy2 will place their respective cytoplasmic binding partners Pbs2 and Ste11 in close proximity. Indeed, genetic analyses of the mutants showed that the Sho1-Opy2 interaction enhances the activation of Pbs2 by Ste11, but not Hog1 by Pbs2. Some of the hyperactive mutants had mutations at the extracellular ends of either Sho1 TM4 or Opy2 TM, and defined the Sho1-Opy2 binding site 1 (BS1). Chemical crosslinking and mutational analyses revealed that the cytoplasmic ends of Sho1 TM1 and Opy2 TM also interact with each other, defining the Sho1-Opy2 binding site 2 (BS2). A geometric consideration constrains that one Opy2 molecule must interact with two adjacent Sho1 molecules in Sho1 oligomer. These results raise a possibility that an alteration of the conformation of the Sho1-Opy2 complex might contributes to the osmotic activation of the Hog1 MAPK cascade.	[Takayama, Tomomi; Yamamoto, Katsuyoshi; Saito, Haruo; Tatebayashi, Kazuo] Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Tokyo, Japan; [Tatebayashi, Kazuo] Univ Tokyo, Inst Med Sci, Frontier Res Unit, Lab Mol Genet, Tokyo, Japan; [Takayama, Tomomi; Tatebayashi, Kazuo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Tatebayashi, K (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Cell Signaling, Tokyo, Japan.; Tatebayashi, K (corresponding author), Univ Tokyo, Inst Med Sci, Frontier Res Unit, Lab Mol Genet, Tokyo, Japan.; Tatebayashi, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.	tategone@ims.u-tokyo.ac.jp	Tatebayashi, Kazuo/L-8595-2017; Saito, Haruo/AAF-6113-2019	Tatebayashi, Kazuo/0000-0002-3131-7030; Saito, Haruo/0000-0001-7891-1689	JSPS KAKENHI [JP25440042, JP24247034, JP16H04761]; Sumitomo Foundation [150075]; Salt Science Research Foundation [1732]; Japan Foundation for Applied Enzymology	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; Salt Science Research Foundation; Japan Foundation for Applied Enzymology	This work was supported by JSPS KAKENHI Grant Number JP25440042 to KY, JSPS KAKENHI Grant Number JP24247034 to HS; JSPS KAKENHI Grant Number JP16H04761 to KT (https://www.jsps.go.jp/english/index.html); The Sumitomo Foundation (number 150075)(http://www.sumitomo.or.jp/e/index.html); The Salt Science Research Foundation (number 1732) (http://www.saltscience.or.jp/english.html) and the Japan Foundation for Applied Enzymology (https://www.jfae.or.jp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Yoshikazu Nakamura and Sumiko Watanabe for their generous supports, and Ms. M. Umeda for her assistance. This work was supported in part by JSPS KAKENHI Grant Number JP25440042 to K.Y, JP24247034 to H.S, and JP16H04761 to K.T, and by grants to K.T. from The Sumitomo Foundation (number 150075), The Salt Science Research Foundation (number 1732), and the Japan Foundation for Applied Enzymology.	Adrover MA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002204; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; de Nadal Eulalia, 2008, V20, P81, DOI 10.1007/4735_2007_0244; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; FOREMAN PK, 1994, GENE, V144, P63, DOI 10.1016/0378-1119(94)90204-6; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Horie T, 2008, MOL CELL BIOL, V28, P5172, DOI 10.1128/MCB.00589-08; Lee J, 2013, GENE DEV, V27, P2590, DOI 10.1101/gad.229310.113; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nishimura A, 2016, MOL CELL BIOL, V36, P1109, DOI 10.1128/MCB.01017-15; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Peter M, 1996, EMBO J, V15, P7046, DOI 10.1002/j.1460-2075.1996.tb01096.x; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; ROSE MD, 1991, METHOD ENZYMOL, V194, P195; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004780; Tatebayashi K, 2003, EMBO J, V22, P3624, DOI 10.1093/emboj/cdg353; Tatebayashi K, 2007, EMBO J, V26, P3521, DOI 10.1038/sj.emboj.7601796; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Tatebayashi K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7975; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yamamoto K, 2010, MOL CELL, V40, P87, DOI 10.1016/j.molcel.2010.09.011; Yang HY, 2009, EMBO J, V28, P1380, DOI 10.1038/emboj.2009.104	39	11	14	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211380	10.1371/journal.pone.0211380	http://dx.doi.org/10.1371/journal.pone.0211380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682143	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500161
J	Triguero-Ocana, R; Barasona, JA; Carro, F; Soriguer, RC; Vicente, J; Acevedo, P				Triguero-Ocana, Roxana; Barasona, Jose A.; Carro, Francisco; Soriguer, Ramon C.; Vicente, Joaquin; Acevedo, Pelayo			Spatio-temporal trends in the frequency of interspecific interactions between domestic and wild ungulates from Mediterranean Spain	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS COMPLEX; AFRICAN-SWINE-FEVER; RISK-FACTORS; CATTLE IMPLICATIONS; CONTACT RATES; BOAR; LIVESTOCK; BOVIS; DISEASES; TRANSMISSION	Controlling infections shared by wildlife and livestock requires the understanding and quantification of interspecific interactions between the species involved. This is particularly important in extensive multi-host systems, in which controlled domestic animals interact with uncontrolled, abundant and expanding wild species, such as wild ungulates. We have, therefore, quantified the interspecific interactions between wild boar (Sus scrofa) and free-ranging cattle in Mediterranean Spain, along with their spatio-temporal variability. GPS-GSM-collars were used to monitor 12 cows and 14 wild boar in the Donana National Park between 2011 and 2013. Interactions were defined as encounters between cattle and wild boar within a spatio-temporal window of 52 m and 1 hour. On average, each wild boar interacted with one cow 1.5 +/- (SE) 0.5 times per day, while each cow interacted with one wild boar 1.3 +/- 0.4 times per day. The frequency of interaction was significantly higher during crepuscular hours owing to the overlap of both species' activity, and also during spring and autumn, probably owing to a higher individual aggregation around shared resources. Finally, the frequency of interaction was higher near the most significant shared resources (e.g. water points) but was lower in areas with dense vegetation. The results presented here show the usefulness of GPS monitoring as regards quantifying interactions and helping to clarify the process of pathogen transmission at the wildlife-livestock interface in Mediterranean Spain, along with the main spatio-temporal risk factors. In a changing scenario in which European populations of wild ungulates are increasing, more efficient measures with which to control interactions are required to meet the demands of farmers and managers. Our results, therefore, provide directional hypotheses that could be used to design disease control programmes.	[Triguero-Ocana, Roxana; Vicente, Joaquin; Acevedo, Pelayo] UCLM, CSIC, JCCM, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain; [Barasona, Jose A.] Univ Complutense Madrid, Anim Hlth Dept, VISAVET Ctr, Madrid, Spain; [Carro, Francisco; Soriguer, Ramon C.] CSIC, Estn Biol Donana, Seville, Spain; [Vicente, Joaquin; Acevedo, Pelayo] UCLM, Escuela Tecn Super Ingn Agron, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad de Castilla-La Mancha	Triguero-Ocana, R (corresponding author), UCLM, CSIC, JCCM, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain.	roxana.triguerocana@gmail.com	Carro, Francisco/ABH-4548-2020; Barasona, Jose/ABH-7368-2020; Acevedo, Pelayo/L-6737-2013; Casimiro-Soriguer, Ramon/J-1494-2014	Barasona, Jose/0000-0003-4066-8454; Acevedo, Pelayo/0000-0002-3509-7696; Casimiro-Soriguer, Ramon/0000-0002-9165-7766; Triguero Ocana, Roxana/0000-0003-4875-4306	MINECO [AGL2013-48523-C3-1-R]; UCLM; "Juan de la Cierva" contract from MINECO-UCM [FJCI-201523643]; MINECO-UCLM through a "Ramon y Cajal" contract [RYC-2012-11970]	MINECO(Spanish Government); UCLM; "Juan de la Cierva" contract from MINECO-UCM; MINECO-UCLM through a "Ramon y Cajal" contract	The present work has benefited from the financial aid of a research grant funded by MINECO (AGL2013-48523-C3-1-R). RTO holds a pre-doctoral scholarship from UCLM. JAB is supported by a "Juan de la Cierva" contract (FJCI-201523643) from MINECO-UCM. PA is supported by MINECO-UCLM through a "Ramon y Cajal" contract (RYC-2012-11970).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barasona JA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-107; [Anonymous], 2011, COEFPLOT2 COEFFICIEN; Apollonio M., 2010, EUROPEAN UNGULATES T; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Artois M, 2002, REV SCI TECH OIE, V21, P287, DOI 10.20506/rst.21.2.1332; Barasona JA, 2017, TRANSBOUND EMERG DIS, V64, P1148, DOI 10.1111/tbed.12480; Barasona JA, 2013, PREV VET MED, V111, P42, DOI 10.1016/j.prevetmed.2013.03.009; Barasona JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115608; Barasona JA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0122-7; Bates D, 2015, J STAT SOFT; Bayan B, 1995, AGUAS SUPERFICIALES, V3340, P17; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Brivio F, 2017, MAMM BIOL, V84, P73, DOI 10.1016/j.mambio.2017.01.007; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Carrasco-Garcia R, 2016, EUR J WILDLIFE RES, V62, P65, DOI 10.1007/s10344-015-0974-9; Carro F, 2017, INTEGR ZOOL, V12, P49, DOI 10.1111/1749-4877.12212; Clemente L., 2004, INVESTIG CIENC, P72; Cooper SM, 2010, J WILDLIFE DIS, V46, P152, DOI 10.7589/0090-3558-46.1.152; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Cowie CE, 2014, EUR J WILDLIFE RES, V60, P113, DOI 10.1007/s10344-013-0757-0; Dohna HZ, 2014, PREV VET MED, V113, P447, DOI 10.1016/j.prevetmed.2013.12.004; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Garcia-Saenz A, 2014, SPAT SPATIO-TEMPORAL, V10, P1, DOI 10.1016/j.sste.2014.06.002; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2016, EUR J WILDLIFE RES, V62, P511, DOI 10.1007/s10344-016-1033-x; Gortazar C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004129; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2010, WILDLIFE RES, V37, P668, DOI 10.1071/WR10031; Gortazar C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002776; Guta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104383; Hardstaff JL, 2014, RES VET SCI, V97, pS86, DOI 10.1016/j.rvsc.2013.12.002; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Judge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028941; Keuling O, 2008, EUR J WILDLIFE RES, V54, P729, DOI 10.1007/s10344-008-0204-9; Kukielka E, 2013, PREV VET MED, V112, P213, DOI 10.1016/j.prevetmed.2013.08.008; Kukielka EA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00031; LaHue NP, 2016, PREV VET MED, V128, P101, DOI 10.1016/j.prevetmed.2016.04.011; Latham ADM, 2015, NEW ZEAL J ECOL, V39, P143; Lavelle MJ, 2016, PREV VET MED, V135, P28, DOI 10.1016/j.prevetmed.2016.10.009; Martinez-Lopez B, 2014, PREV VET MED, V116, P268, DOI 10.1016/j.prevetmed.2013.11.002; Miguel E, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00239.1; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Oganesyan AS, 2013, VIRUS RES, V173, P204, DOI 10.1016/j.virusres.2012.12.009; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Putman R, 2011, MAMMAL REV, V41, P175, DOI 10.1111/j.1365-2907.2010.00173.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Russo L, 1997, ETHOL ECOL EVOL, V9, P287, DOI 10.1080/08927014.1997.9522888; Schijven J, 2005, RISK ANAL, V25, P13, DOI 10.1111/j.0272-4332.2005.00563.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-25; Thurfjell H, 2014, ACTA THERIOL, V59, P467, DOI 10.1007/s13364-014-0185-x; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Vicente J, 2014, UNPUB; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Williams DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084368; Woodroffe R, 2016, ECOL LETT, V19, P1201, DOI 10.1111/ele.12654; Wozniakowski G, 2016, ARCH VIROL, V161, P189, DOI 10.1007/s00705-015-2650-5; Zvidzai M., 2013, INT J DEV SUSTAINABI, V2, P455	65	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211216	10.1371/journal.pone.0211216	http://dx.doi.org/10.1371/journal.pone.0211216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682123	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500127
J	Ogbuanu, IU; Li, AJ; Anya, BPM; Tamadji, M; Chirwa, G; Chiwaya, KW; Djalal, ME; Cheikh, D; Machekanyanga, Z; Okeibunor, J; Sanderson, C; Mihigo, R				Ogbuanu, Ikechukwu Udo; Li, Anyie J.; Anya, Blanche-philomene Melanga; Tamadji, Mbaihol; Chirwa, Geoffrey; Chiwaya, Kwame W.; Djalal, Mohamed El-Hafiz; Cheikh, Dah; Machekanyanga, Zorodzai; Okeibunor, Joseph; Sanderson, Colin; Mihigo, Richard			Can vaccination coverage be improved by reducing missed opportunities for vaccination? Findings from assessments in Chad and Malawi using the new WHO methodology	PLOS ONE			English	Article							IMMUNIZATION	Background In 2015, the World Health Organization (WHO) updated the global methodology for assessing and reducing missed opportunities for vaccination (MOV), when eligible children have contact with the health system but are not vaccinated. This paper presents the results of two pilot assessments conducted in Chad and Malawi. Methods Using the ten-step global WHO MOV strategy, we purposively selected districts and health facilities, with non-probabilistic sampling of <24 month old children for exit interviews of caregivers and self-administered knowledge, attitudes, and practices (KAP) surveys of health workers. MOV were calculated based on a child's documented vaccination history (i.e., from a home-based record (HBR) or a health facility vaccination register), including selected vaccines in the national schedule. Results Respondents included caregivers of 353 children in Chad and of 580 children in Malawi. Among those with documented vaccination history, 82% (195/238) were eligible for vaccination in Chad and 47% (225/483) in Malawi. Among eligible children, 51% (99/195) in Chad, and 66% (149/225) in Malawi had one or more MOV on the survey date. During non-vaccination visits, 77% (24/31) of children eligible for vaccination in Chad and 92% (119/129) in Malawi had a MOV compared to 46% (75/164) and 31% (30/96) during vaccination visits, respectively. Among health workers, 92% in Chad and 88% in Malawi were unable to correctly identify valid contraindications for vaccination. Conclusion The new MOV tool was able to characterize the type and potential causes of MOV. In both countries, the findings of the assessments point to two major barriers to full vaccination of eligible children-a lack of coordination between vaccination and curative health services and incomplete vaccination during vaccination visits. National immunization programs should explore tailored efforts to improve health worker practices and to increase vaccine delivery by making better use of existing health service contacts.	[Ogbuanu, Ikechukwu Udo] WHO, Geneva, Switzerland; [Li, Anyie J.] ASPPH CDC Allan Rosenfield Global Hlth Fellowship, Atlanta, GA USA; [Li, Anyie J.] PHI CDC Global Hlth Fellowship, Atlanta, GA USA; [Anya, Blanche-philomene Melanga; Okeibunor, Joseph; Mihigo, Richard] WHO, African Reg Off, Brazzaville, Rep Congo; [Tamadji, Mbaihol] Le Minist Sante Publ Republ Tchad, Ndjamena, Chad; [Chirwa, Geoffrey] Minist Hlth, Lilongwe, Malawi; [Chiwaya, Kwame W.] WHO, Country Off, Lilongwe, Malawi; [Djalal, Mohamed El-Hafiz] WHO, Country Off, Ndjamena, Chad; [Cheikh, Dah] WHO, Cent Africa Intercountry Support Team IST, Libreville, Gabon; [Machekanyanga, Zorodzai] WHO, East & Southern Africa Intercountry Support Team, Harare, Zimbabwe; [Sanderson, Colin] London Sch Hyg & Trop Med, London, England	World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Ogbuanu, IU (corresponding author), WHO, Geneva, Switzerland.	ogbuanui@who.int		Sanderson, Colin/0000-0002-4838-6112	Centers for Disease Control and Prevention (CDC) [U36OE000002]; Association of Schools and Programs of Public Health (ASPPH) [U36OE000002]; CDC [NU2GGH002093-01-00]; Public Health Institute (PHI) [NU2GGH002093-01-00]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Association of Schools and Programs of Public Health (ASPPH); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Public Health Institute (PHI)	AJL is supported by Cooperative Agreement Number U36OE000002 from the Centers for Disease Control and Prevention (CDC) and the Association of Schools and Programs of Public Health (ASPPH) (https://www.aspph.org/study/fellowships-and-internships/) and NU2GGH002093-01-00 from the CDC and the Public Health Institute (PHI) (https://phi-cdcfellows.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, Wkly Epidemiol Rec, V91, P266; Borus P K, 2004, East Afr Med J, V81, P124; Brown DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201538; Brown DW, 2017, WORLD J VACCINE, V7, P1, DOI DOI 10.4236/WJV.2017.71001; Chan M, 2014, LANCET, V383, P1697, DOI 10.1016/S0140-6736(14)60751-0; Clements CJ, 2008, VACCINE, V26, P1926, DOI 10.1016/j.vaccine.2008.02.032; Daly AD, 2003, SAMJ S AFR MED J, V93, P606; Deivanayagam N, 1995, Indian Pediatr, V32, P51; Duclos P, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S2; Garib Z, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4721836; HUTCHINS SS, 1993, B WORLD HEALTH ORGAN, V71, P549; KAHN JG, 1995, B WORLD HEALTH ORGAN, V73, P47; KEJA K, 1988, World Health Statistics Quarterly, V41, P59; Laryea DO, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-90; LOEVINSOHN BP, 1992, B WORLD HEALTH ORGAN, V70, P335; METCALF CA, 1994, S AFR MED J, V84, P149; Mihigo R, AFRICAN HLTH MONITOR; Okwo-Bele J- M, 2018, CLOSING IMMUNIATION; Pan American Health Organization (PAHO), 2013, METH EV MISS OPP VAC; Restrepo-Mendez MC, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30963; Sadoh AE, 2009, J HEALTH POPUL NUTR, V27, P391; Szilagyi P G, 1996, J Public Health Manag Pract, V2, P18; Tugumisirize F, 2002, East Afr Med J, V79, P347; UNICEF and World Health Organization, 2016, PROGR CHALL ACH UN I; Velandia-Gonzalez M, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0043-1; World Health Organization, 2017, GLOB REG IMM PROF 20; World Health Organization, 2017, MISS OPP VACC MOV ST; World Health Organization, 2018, PLANN GUID RED MISS; World Health Organization, 2018, METH ASS MISS OPP VA; Zewdie A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3904-1	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210648	10.1371/journal.pone.0210648	http://dx.doi.org/10.1371/journal.pone.0210648			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677072	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000456700400021
J	Baasland, I; Romundstad, PR; Eide, ML; Jonassen, CM				Baasland, Ingrid; Romundstad, Pal R.; Eide, Maj Liv; Jonassen, Christine M.			Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population	PLOS ONE			English	Article							HYBRID CAPTURE 2; CERVICAL INTRAEPITHELIAL NEOPLASIA; TEST REQUIREMENTS; HR DETECTION; WOMEN; VALIDATION; ASSAY; RISK; PREVALENCE; PREDICTORS	Anyplex II HPV28 ('Anyplex') is a semi-quantitative DNA PCR assay divided into set A, comprising 14 high risk (hr)HPV types; and set B, comprising 5 possibly hrHPV types and 9 low risk (I)HPV types. We compared the ability of Anyplex to that of Hybrid Capture 2 (HC2) and PreTect HPV-Proofer ('Proofer') to detect cervical intraepithelial neoplasia grade two or worse (CIN2+) by HPV types and viral load. This cross-sectional study included 296 women referred to colposcopy with abnormal cervical cytology and/or persistent HPV infection. CIN2+ was identified in 175/296 women. Liquid based cytology samples were used to perform HPV testing. The sensitivity of Anyplex to detect CIN2+ was 98.9% (95% CI 95.9-99.9) and specificity 43.0% (95% CI 34.0-52.3). Restricting to medium and high viral loads in Anyplex set A, sensitivity and specificity were 97.1% (95% CI 93.5-99.1) and 59.5% (95% CI 50.2-68.3) with positive (PPV) and negative predictive value (NPV) 77.6% and 93.5%, respectively, comparable to HC2. Restricting Anyplex to the hrHPV types in Proofer, HPV16, 18, 31, 33 and 45, sensitivity and specificity for CIN2+ were 85.1% (95% CI 79.090.1) and 71.1% (95% CI 62.1-79.0), comparable to Proofer's. When adding HPV52 and 58, the sensitivity for CIN2+ was 92.6% (95% CI 87.6-96.0) and CIN3+ 96.5% (95% CI 92.0-98.8). No value of Anyplex set B was found in detecting CIN2+. In conclusion, the clinical performance of medium and high viral loads in Anyplex set A was comparable to HC2. Restricting the test to the 7 hrHPV types included in the 9-valent HPV-vaccine, HPV16, 18, 31, 33, 45, 52 and 58, satisfies the international criteria for cervical cancer screening with relative sensitivity compared to HC2 for CIN2+ and CIN3+ of 0.98 and 1.01, respectively. Detecting all 28 Anyplex HPV types adds no benefit in a referral population.	[Baasland, Ingrid; Romundstad, Pal R.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Eide, Maj Liv] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Pathol, Trondheim, Norway; [Jonassen, Christine M.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Jonassen, Christine M.] Ostfold Hosp Trust, Ctr Lab Med, Gralum, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Life Sciences	Baasland, I (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.	Ingrid.baasland@ntnu.no		Baasland, Ingrid/0000-0003-0688-8031	Liaison Committee	Liaison Committee	The study was supported by the Liaison Committee between the Central Norway Regional health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Baasland I, 2016, ACTA OBSTET GYN SCAN, V95, P1258, DOI 10.1111/aogs.13009; Cameron RL, 2016, EMERG INFECT DIS, V22, P56, DOI 10.3201/eid2201.150736; Cuzick J, 2016, PAPILLOMAVIRUS RES, V2, P112, DOI 10.1016/j.pvr.2016.05.004; Depuydt CE, 2012, J CLIN MICROBIOL, V50, P4073, DOI 10.1128/JCM.01231-12; Depuydt CE, 2015, CANCER MED-US, V4, P1294, DOI 10.1002/cam4.473; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Engesaether B NM, 2017, IMPLEMENTERING HPV T; Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13; Hesselink AT, 2016, J CLIN VIROL, V76, P36, DOI 10.1016/j.jcv.2016.01.009; Holland NT, 2003, MUTAT RES-REV MUTAT, V543, P217, DOI 10.1016/S1383-5742(02)00090-X; IARC, 2012, MON EV CARC RISKS HU, V100B, P255; Jung S, 2016, ARCH PATHOL LAB MED, V140, P276, DOI 10.5858/arpa.2015-0117-OA; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; Kwon MJ, 2014, J CLIN VIROL, V59, P246, DOI 10.1016/j.jcv.2014.01.015; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Lee DH, 2015, ANN CLIN BIOCH; Lie AK, 2018, GYNECOL ONCOL, V148, P111, DOI 10.1016/j.ygyno.2017.10.031; Lim YK, 2016, J CLIN LAB ANAL; Marcuccilli F, 2015, J VIROL METHODS, V217, P8, DOI 10.1016/j.jviromet.2015.02.018; Meijer CJLM, 2009, J CLIN VIROL, V46, pS1, DOI 10.1016/S1386-6532(09)00540-X; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Ostrbenk A, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01176-18; Pasquier C, 2017, DIAGN MICR INFEC DIS, V87, P25, DOI 10.1016/j.diagmicrobio.2016.08.022; Psifidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115960; Ratnam S, 2010, J CLIN MICROBIOL, V48, P2779, DOI 10.1128/JCM.00382-10; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12; Tavassoli F A, 2003, WHO CLASSIFICATION T, V5; Tota JE, 2015, CANCER EPIDEM BIOMAR, V24, P286, DOI 10.1158/1055-9965.EPI-14-0566; Trope A, 2009, J CLIN MICROBIOL, V47, P2458, DOI 10.1128/JCM.01863-08; Veileder i gynekologisk onkologi (2021), 2021, NASJ HANDL SPROGR GY; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	34	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210997	10.1371/journal.pone.0210997	http://dx.doi.org/10.1371/journal.pone.0210997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673759	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800062
J	Basoli, V; Santaniello, S; Rinaldi, S; Fontani, V; Pigliaru, G; Wieser, M; Strajeriu, A; Castagna, A; Redl, H; Ventura, C; Grillari, R; Maioli, M				Basoli, Valentina; Santaniello, Sara; Rinaldi, Salvatore; Fontani, Vania; Pigliaru, Gianfranco; Wieser, Matthias; Strajeriu, Agata; Castagna, Alessandro; Redl, Heinz; Ventura, Carlo; Grillari, Regina; Maioli, Margherita			Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CARDIAC DIFFERENTIATION; TECHNOLOGY; CARDIOMYOCYTES; FIBROBLASTS; MODEL	It is currently known that pluripotent stem cells can be committed in vitro to the cardiac lineage by the modulation of specific signaling pathways, but it is also well known that, despite the significant increase in cardiomyocyte yield provided by the currently available conditioned media, the resulting cardiogenic commitment remains a highly variable process. Previous studies provided evidence that radio electric fields asymmetrically conveyed through the Radio Electric Asymmetric Conveyer (REAC) technology are able to commit R1 embryonic stem cells and human adipose derived stem cells toward a cardiac phenotype. The present study aimed at investigating whether the effect of physical stimulation by REAC in combination with specific chemical inductors enhance the cardiogenic potential in human induced pluripotent stem cells (iPSCs). The appearance of a cardiac-like phenotype in iPSCs cultured in the presence of a cardiogenic medium, based upon BMP4 and a WNT-inhibitor, was consistently increased by REAC treatment used only during the early fate differentiation for the first 72 hours. REAC-exposed iPSCs exhibited an upregulation in the expression of specific cardiogenic transcripts and morphologically in the number of beating clusters, as compared to cells cultured in the cardiogenic medium alone. Our results indicate that physical modulation of cellular dynamics provided by the REAC offers an affordable strategy to mimic iPSC cardiac-like fates in the presence of a cardiogenic milieu.	[Basoli, Valentina; Santaniello, Sara; Pigliaru, Gianfranco; Maioli, Margherita] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Basoli, Valentina; Rinaldi, Salvatore; Fontani, Vania] Rinaldi Fontani Fdn, Res Dept, Florence, Italy; [Basoli, Valentina; Grillari, Regina] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Santaniello, Sara; Pigliaru, Gianfranco; Ventura, Carlo] CNR, Natl Lab Mol Biol & Stem Cell Engn, Natl Inst Biostruct & Biosyst, Eldor Lab,Innovat Accelerators, Bologna, Italy; [Rinaldi, Salvatore; Fontani, Vania; Castagna, Alessandro; Ventura, Carlo] Rinaldi Fontani Inst, Dept Regenerat Med, Florence, Italy; [Rinaldi, Salvatore; Fontani, Vania; Maioli, Margherita] IRF Shanghai Med Sci, Shanghai, Peoples R China; [Wieser, Matthias; Strajeriu, Agata; Grillari, Regina] Evercyte GmbH, Vienna, Austria; [Wieser, Matthias; Strajeriu, Agata; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Wieser, Matthias; Strajeriu, Agata; Redl, Heinz; Grillari, Regina] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Maioli, Margherita] Univ Sassari, Ctr Dev Biol & Reprogramming CEDEBIOR, Dept Biomed Sci, Sassari, Italy; [Maioli, Margherita] Natl Inst Biostruct & Biosyst, Sassari, Italy	University of Sassari; University of Natural Resources & Life Sciences, Vienna; Consiglio Nazionale delle Ricerche (CNR); Ludwig Boltzmann Institute; University of Sassari	Rinaldi, S (corresponding author), Rinaldi Fontani Fdn, Res Dept, Florence, Italy.; Rinaldi, S (corresponding author), Rinaldi Fontani Inst, Dept Regenerat Med, Florence, Italy.; Rinaldi, S (corresponding author), IRF Shanghai Med Sci, Shanghai, Peoples R China.	srinaldi@irf.it	Ventura, Carlo/AAV-3658-2020; Basoli, Valentina/AEX-6502-2022; Redl, Heinz/AAD-8157-2019	Rinaldi, Salvatore/0000-0002-8961-6316; Basoli, Valentina/0000-0002-4703-7308; Fontani, Vania/0000-0003-0141-6270	Regione Autonoma della Sardegna; Fundamental Research Program [CRP - 60208, CRP - 59886 AMBROSIA, 7/2007]; Banco di Sardegna Foundation [U858.2014/AI.741.MGB Prat.2014.0178]; Evercyte GmbH, Vienna; IRF Shanghai Medical Sciences	Regione Autonoma della Sardegna(Regione Sardegna); Fundamental Research Program; Banco di Sardegna Foundation(Fondazione Banco di Sardegna); Evercyte GmbH, Vienna; IRF Shanghai Medical Sciences	M.M. received specific funding from Regione Autonoma della Sardegna (www.regione.sardegna.it), Fundamental Research Program, L.R. 7/2007 "Promotion of the scientific research and technological innovation in Sardinia" under grant agreement CRP - 60208 and CRP - 59886 AMBROSIA Project, by Banco di Sardegna Foundation (Prot. U858.2014/AI.741.MGB Prat.2014.0178). M.W. and A.S. are employed by Evercyte GmbH, Vienna, but this commercial company only provided financial support in the form of research materials. S.R. and V.F. are partners in IRF Shanghai Medical Sciences, but this company only provided funds for research. All 3 of these funders did not play a role in the study design, data collection and analysis, preparation of the manuscript and decision to publish. The specific roles of M.W, A.S., S.R. and V.F. are articulated in the author contributions' section.	Basoli V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050981; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berlinguer F, 2017, REPROD BIOL ENDOCRIN, V15, P1, DOI 10.1186/s12958-017-0229-6; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Cibrian-Uhalte E, 2006, ENCY REFERENCE GENOM, P237; Collodel G, 2013, CLIN INTERV AGING, V8, P309, DOI 10.2147/CIA.S42229; Hernandez D, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1718041; Kempf H, 2015, NAT PROTOC, V10, P1345, DOI 10.1038/nprot.2015.089; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Luca L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35719; Maioli M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192178; Maioli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28682; Maioli M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10439; Maioli M, 2014, CELL TRANSPLANT, V23, P1489, DOI 10.3727/096368913X672037; Maioli M, 2014, AGE, V36, P9, DOI 10.1007/s11357-013-9537-8; Maioli M, 2013, CELL TRANSPLANT, V22, P1227, DOI 10.3727/096368912X657297; Maioli M, 2012, CELL TRANSPLANT, V21, P1225, DOI 10.3727/096368911X600966; Maioli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015151; Martins AM, 2014, STEM CELL REV REP, V10, P177, DOI 10.1007/s12015-013-9487-7; Merks AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04566-1; Nsair A, 2011, ADV DRUG DELIVER REV, V63, P324, DOI 10.1016/j.addr.2011.01.013; Panaro MA, 2018, NEUROSCI BULL, V34, P270, DOI 10.1007/s12264-017-0188-0; Passino ES, 2017, CLIN INTERV AGING, V12, P1471, DOI 10.2147/CIA.S140976; RINALDI S, 2014, SCI REP UK, V4; Rinaldi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200128; Rinaldi S, 2012, CLIN INTERV AGING, V7, P191, DOI 10.2147/CIA.S33312; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tohyama S, 2016, ETIOLOGY AND MORPHOG, P25; Trollinger DR, 2002, J CELL PHYSIOL, V193, P1, DOI 10.1002/jcp.10144; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10; Ventura C, 2004, FASEB J, V18, P155, DOI 10.1096/fj.04-2695fje; Weng ZH, 2014, STEM CELLS DEV, V23, P1704, DOI 10.1089/scd.2013.0509; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Yassa ME, 2018, LIFE SCI, V196, P38, DOI 10.1016/j.lfs.2018.01.009; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211188	10.1371/journal.pone.0211188	http://dx.doi.org/10.1371/journal.pone.0211188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673752	gold, Green Published			2022-12-27	WOS:000456442800079
J	Cozzi, L; Comito, T; Fogliata, A; Franzese, C; Franceschini, D; Bonifacio, C; Tozzi, A; Di Brina, L; Clerici, E; Tomatis, S; Reggiori, G; Lobefalo, F; Stravato, A; Mancosu, P; Zerbi, A; Sollini, M; Kirienko, M; Chiti, A; Scorsetti, M				Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Franceschini, Davide; Bonifacio, Cristiana; Tozzi, Angelo; Di Brina, Lucia; Clerici, Elena; Tomatis, Stefano; Reggiori, Giacomo; Lobefalo, Francesca; Stravato, Antonella; Mancosu, Pietro; Zerbi, Alessandro; Sollini, Martina; Kirienko, Margarita; Chiti, Arturo; Scorsetti, Marta			Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma	PLOS ONE			English	Article							PET RADIOMICS; RADIOTHERAPY; CANCER; GEMCITABINE; RADIOCHEMOTHERAPY; ADENOCARCINOMA; IMAGES; TRIAL; HEAD	Purpose To appraise the ability of a radiomics signature to predict clinical outcome after stereotactic body radiation therapy (SBRT) for pancreas carcinoma. Methods A cohort of 100 patients was included in this retrospective, single institution analysis. Radiomics texture features were extracted from computed tomography (CT) images obtained for the clinical target volume. The cohort of patients was randomly divided into two separate groups for the training (60 patients) and validation (40 patients). Cox regression models were built to predict overall survival and local control. The significant predictors at univariate analysis were included in a multivariate model. The quality of the models was appraised by means of area under the curve and concordance index. Results A clinical-radiomic signature associated with Overall Survival (OS) was found significant in both training and validation sets (p = 0.01 and 0.05 and concordance index 0.73 and 0.75 respectively). Similarly, a signature was found for Local Control (LC) with p = 0.007 and 0.004 and concordance index 0.69 and 0.75. In the low risk group, the median OS and LC in the validation group were 14.4 and 28.6 months while in the high-risk group were 9.0 and 17.5 months respectively. Conclusion A CT based radiomic signature was identified which correlate with OS and LC after SBRT and allowed to identify low and high-risk groups of patients.	[Cozzi, Luca; Chiti, Arturo; Scorsetti, Marta] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Cozzi, Luca; Comito, Tiziana; Fogliata, Antonella; Franzese, Ciro; Franceschini, Davide; Tozzi, Angelo; Di Brina, Lucia; Clerici, Elena; Tomatis, Stefano; Reggiori, Giacomo; Lobefalo, Francesca; Stravato, Antonella; Mancosu, Pietro; Scorsetti, Marta] Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg, Milan, Italy; [Bonifacio, Cristiana] Humanitas Clin & Res Ctr, Diagnost Radiol, Milan, Italy; [Zerbi, Alessandro] Humanitas Clin & Res Ctr, Pancreat Surg, Milan, Italy; [Sollini, Martina; Kirienko, Margarita; Chiti, Arturo] Humanitas Clin & Res Ctr, Nucl Med, Milan, Italy	Humanitas University	Cozzi, L (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Cozzi, L (corresponding author), Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg, Milan, Italy.	luca.cozzi@humanitas.it	Mancosu, Pietro/AAB-9807-2019; franzese, ciro/P-5195-2019; Sollini, Martina/K-6527-2016; Clerici, Elena/GZG-1993-2022; Franzese, Ciro/AAJ-7311-2020; cozzi, luca/GZL-4895-2022; Chiti, Arturo/K-6524-2016; Franceschini, Davide/AAB-3871-2019; Tomatis, Stefano/AAA-6002-2021; TOZZi, ANGELO/AAP-9979-2020; Mancosu, Pietro/HBQ-0722-2022; Reggiori, Giacomo/HDM-8974-2022; Kirienko, Margarita/K-6552-2016	Mancosu, Pietro/0000-0002-0165-7931; Sollini, Martina/0000-0003-2214-6492; Clerici, Elena/0000-0002-1765-863X; Franzese, Ciro/0000-0001-6893-6284; cozzi, luca/0000-0001-7862-898X; Chiti, Arturo/0000-0002-5806-1856; Franceschini, Davide/0000-0003-1142-2439; TOZZi, ANGELO/0000-0001-7815-4788; Mancosu, Pietro/0000-0002-0165-7931; Tomatis, Stefano/0000-0002-4791-0373; Kirienko, Margarita/0000-0002-3923-1151; reggiori, giacomo/0000-0003-3336-5690; BONIFACIO, CRISTIANA/0000-0002-8551-6801; comito, tiziana/0000-0002-5667-0535; LOBEFALO, FRANCESCA/0000-0003-3634-2582; Scorsetti, Marta/0000-0003-0320-559X; zerbi, alessandro/0000-0002-9176-0448				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Ben-Josef E, 2012, INT J RADIAT ONCOL, V84, P1166, DOI 10.1016/j.ijrobp.2012.02.051; Bogowicz M, 2017, RADIOTHER ONCOL, V125, P385, DOI 10.1016/j.radonc.2017.10.023; Bogowicz M, 2017, INT J RADIAT ONCOL, V99, P921, DOI 10.1016/j.ijrobp.2017.06.002; Brunner TB, 2015, RADIOTHER ONCOL, V114, P109, DOI 10.1016/j.radonc.2014.10.015; Chang DT, 2009, CANCER-AM CANCER SOC, V115, P665, DOI 10.1002/cncr.24059; Chen XJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178961; Chuong MD, 2013, INT J RADIAT ONCOL, V86, P516, DOI 10.1016/j.ijrobp.2013.02.022; Comito T, 2017, TECHNOL CANCER RES T, V16, P295, DOI 10.1177/1533034616650778; Cozzi L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3847-7; Eilaghi A, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0209-5; Hanania AN, 2016, ONCOTARGET, V7, P85776, DOI 10.18632/oncotarget.11769; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herman JM, 2015, CANCER-AM CANCER SOC, V121, P1128, DOI 10.1002/cncr.29161; Kirienko M, 2018, EUR J NUCL MED MOL I, V45, P207, DOI 10.1007/s00259-017-3837-7; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Mahadevan A, 2011, INT J RADIAT ONCOL, V81, pE615, DOI 10.1016/j.ijrobp.2011.04.045; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Permuth JB, 2016, ONCOTARGET, V7, P85785, DOI 10.18632/oncotarget.11768; Polistina F, 2010, ANN SURG ONCOL, V17, P2092, DOI 10.1245/s10434-010-1019-y; R Core Team, R LANG ENV STAT COMP; Rwigema JCM, 2011, AM J CLIN ONCOL-CANC, V34, P63, DOI 10.1097/COC.0b013e3181d270b4; Schellenberg D, 2011, INT J RADIAT ONCOL, V81, P181, DOI 10.1016/j.ijrobp.2010.05.006; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sollini M, 2017, EUR J HYBRID IMAG, V1, DOI 10.1186/s41824-017-0009-8; Sollini M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00426-y; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yue Y, 2017, J GASTROINTEST ONCOL, V8, P127, DOI 10.21037/jgo.2016.12.04	28	38	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210758	10.1371/journal.pone.0210758	http://dx.doi.org/10.1371/journal.pone.0210758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657785	Green Submitted, Green Published, gold			2022-12-27	WOS:000456017000018
J	Zaccaria, A; Del Vicario, M; Quattrociocchi, W; Scala, A; Pietronero, L				Zaccaria, Andrea; Del Vicario, Michela; Quattrociocchi, Walter; Scala, Antonio; Pietronero, Luciano			PopRank: Ranking pages' impact and users' engagement on Facebook	PLOS ONE			English	Article								The advent of social networks revolutionized the way people access to information sources. Understanding the complex relationship between these sources and users is crucial. We introduce an algorithm, that we call PopRank, to assess both the Impact of Facebook pages as well as users' Engagement on the basis of their mutual interactions. The ideas behind the PopRank are that i) high impact pages attract many users with a low engagement, which means that they receive comments from users that rarely comment, and ii) high engagement users interact with high impact pages, that is they mostly comment pages with a high popularity. The resulting ranking of pages can predict the number of comments a page will receive and the number of its future posts. Pages' impact turns out to be slightly dependent on the quality of pages' informative content (e.g., science vs conspiracy) but independent of users' polarization.	[Zaccaria, Andrea; Quattrociocchi, Walter; Scala, Antonio; Pietronero, Luciano] UOS Sapienza, CNR, ISC, Rome, Italy; [Del Vicario, Michela] IMT Sch Adv Studies, Lucca, Italy; [Quattrociocchi, Walter] Ca Foscari Univ Venice, Venice, Italy; [Scala, Antonio] LIMS, London, England; [Pietronero, Luciano] Sapienza Univ Roma, Dipartimento Fis, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); IMT School for Advanced Studies Lucca; Universita Ca Foscari Venezia; Sapienza University Rome	Zaccaria, A (corresponding author), UOS Sapienza, CNR, ISC, Rome, Italy.	and.zaccaria@gmail.com	Scala, Antonio/H-9153-2019; Scala, Antonio/GRS-5823-2022; Quattrociocchi, Walter/L-4550-2016	Scala, Antonio/0000-0002-3414-2686; Quattrociocchi, Walter/0000-0002-4374-9324				Allen Robert, 2017, WHAT HAPPENS ONLINE; Angelini O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177360; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Battiston C., 2014, COMPLEXECONOMIC TIME, V41, P1; Bessi A, 2015, P 24 INT C WORLD WID; Bessi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159641; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134641; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Chavez J. C., 2017, REV REGIONAL STUDIES, V47; Cristelli M., 2015, GROWTH SCENARIOS SUB; Cristelli Matthieu, 2017, POLICY RES WORKING P; Del Vicario M, 2017, SOC NETWORKS, V50, P6, DOI 10.1016/j.socnet.2017.02.002; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Kalogeropoulos A., 2017, REUTERS DIGITAL NEWS; Liao H, 2018, COMPLEXITY, DOI 10.1155/2018/2825948; Page L, 1998, TECHNICAL REPORT; Pugliese E., 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0168540; Pugliese E., 2017, SUSTAINING HIGH GROW; Pugliese E, 2016, EUR PHYS J-SPEC TOP, V225, P1893, DOI 10.1140/epjst/e2015-50118-1; Quattrociocchi W., 2018, ECHO CHAMBERS FACEBO, P1, DOI [10.2139/ssrn.2795110, DOI 10.2139/SSRN.2795110]; Schmidt AL, 2017, P NATL ACAD SCI USA, V114, P3035, DOI 10.1073/pnas.1617052114; Straka M. J., 2018, J STAT PHYS, P1; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Zaccaria A, 2016, J ECON INTERACT COOR, V11, P151, DOI 10.1007/s11403-015-0145-9; Zollo F, 2018, COMPUT SOC SCI, P177, DOI 10.1007/978-3-319-77332-2_10; Zollo F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181821	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211038	10.1371/journal.pone.0211038	http://dx.doi.org/10.1371/journal.pone.0211038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689652	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800018
J	Alvarez, LH; Gomes, DEB; Gonzalez, JEH; Pascutti, PG				Alvarez, Lilian Hernandez; Barreto Gomes, Diego Enry; Hernandez Gonzalez, Jorge Enrique; Pascutti, Pedro Geraldo			Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; MOLECULAR-DYNAMICS; TRYPANOSOMA-CRUZI; FOLDING FUNNELS; HEPARAN-SULFATE; ATOMIC CHARGES; PROTEIN; INHIBITORS; BINDING; INSIGHTS	Trypanosoma cruzi is the causative agent of Chagas disease, a neglected infection affecting millions of people in tropical regions. There are several chemotherapeutic agents for the treatment of this disease, but most of them are highly toxic and generate resistance. Currently, the development of allosteric inhibitors constitutes a promising research field, since it can improve the accessibility to more selective and less toxic medicines. To date, the allosteric drugs prediction is a state-of-the-art topic in rational structure-based computational design. In this work, a simulation strategy was developed for computational discovery of allosteric inhibitors, and it was applied to cruzain, a promising target and the major cysteine protease of T. cruzi. Molecular dynamics simulations, binding free energy calculations and network-based modelling of residue interactions were combined to characterize and compare molecular distinctive features of the apo form and the cruzain-allosteric inhibitor complexes. By using geometry-based criteria on trajectory snapshots, we predicted two main allosteric sites suitable for drug targeting. The results suggest dissimilar mechanisms exerted by the same allosteric site when binding different potential allosteric inhibitors. Finally, we identified the residues involved in suboptimal paths linking the identified site and the orthosteric site. The present study constitutes the first approximation to the design of cruzain allosteric inhibitors and may serve for future pharmacological intervention. Here, no major effects on active site structure were observed due to compound binding (modification of distance and angles between catalytic residues), which indicates that allosteric regulation in cruzain might be mediated via alterations of its dynamical properties similarly to allosteric inhibition of human cathepsin K (HCatK). The current findings are particularly relevant for the design of allosteric modulators of papain-like cysteine proteases.	[Alvarez, Lilian Hernandez; Hernandez Gonzalez, Jorge Enrique] Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil; [Barreto Gomes, Diego Enry] Inst Nacl Metrol Qual & Tecnol INMETRO, Diretoria Metrol Aplicada Ciencias Vida DIMAV, Rio De Janeiro, Brazil; [Barreto Gomes, Diego Enry] Univ Strasbourg, Inst Chim, Strasbourg, France; [Pascutti, Pedro Geraldo] Univ Fed Rio De Janeiro UFRJ, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Estadual Paulista; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade Federal do Rio de Janeiro	Alvarez, LH (corresponding author), Univ Estadual Paulista, Dept Fis, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil.	lilianhern@gmail.com	González, Jorge Enrique Hernández/AAB-2705-2019; Pascutti, Pedro/AAP-7752-2020	Pascutti, Pedro/0000-0002-5454-560X; Barreto Gomes, Diego Enry/0000-0003-4855-040X; Hernandez Gonzalez, Jorge Enrique/0000-0002-4770-8677	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/03911-8, 2016/24587-9]; Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [031/2013 PRO-DEFESA 3, 613]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant number No. 2018/03911-8 to LHA and 2016/24587-9 to JEHG), and by Ministerio da Educacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (grant number 031/2013 PRO-DEFESA 3 to LHA and PGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Bruno Fernandes for technical support and to Prof. Jorge Chahine for his helpful discussions. We thank to Prof. Leandro Cristante de Oliveira for kindly provide computer time at Centro Nacional de Processamento de Alto Desempenho em Sao Paulo (CENAPAD) (grant 613). Also, we thank to mesocenter of Strasbourg for running time allocation. Finally, we thank to LMDM at UFRJ, and to the research group of Prof. Vitor Leite for their support with computational resources.	ALBER T, 1983, CIBA F SYMP, V93, P4; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Arafet K, 2017, ACS CATAL, V7, P1207, DOI 10.1021/acscatal.6b03096; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertoldo JB, 2015, J ENZYM INHIB MED CH, V30, P299, DOI 10.3109/14756366.2014.920839; BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boulton S, 2016, CHEM REV, V116, P6267, DOI 10.1021/acs.chemrev.5b00718; Case DA, AMBER 142014; Chopra N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004826; Costa MGS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S5; Costa TFR, 2012, BBA-PROTEINS PROTEOM, V1824, P493, DOI 10.1016/j.bbapap.2011.12.006; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dalafave DS, 2015, BIOPHYS J, V108, p320A, DOI 10.1016/j.bpj.2014.11.1741; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; DELANO WL, 2004, ABSTR PAP AM CHEM 1, V228; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Durrant JD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000676; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Greener JG, 2018, CURR OPIN STRUC BIOL, V50, P1, DOI 10.1016/j.sbi.2017.10.002; Grutsch S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004620; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Guo JJ, 2016, CHEM REV, V116, P6503, DOI 10.1021/acs.chemrev.5b00590; Hernandez-Rodriguez M, 2016, CURR MED CHEM; Hertig S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004746; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hotez P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005479; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huey R., 2008, USING AUTODOCK 4 AUT, VVolume 8, P54; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Jilkova A, 2014, STRUCTURE, V22, P1786, DOI 10.1016/j.str.2014.09.015; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; Judice WAS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080153; Judice WAS, 2001, EUR J BIOCHEM, V268, P6578, DOI 10.1046/j.0014-2956.2001.02612.x; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar S, 1999, CELL BIOCHEM BIOPHYS, V31, P141, DOI 10.1007/BF02738169; Kumawat A, 2017, P NATL ACAD SCI USA, V114, pE5825, DOI 10.1073/pnas.1705311114; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Lima APCA, 2002, J BIOL CHEM, V277, P5875, DOI 10.1074/jbc.M108518200; Liu J, 2017, P NATL ACAD SCI USA, V114, P7480, DOI 10.1073/pnas.1709071114; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mark W, 2011, CYSTEINE PROTEASES P; Marques AF, 2015, ARCH BIOCHEM BIOPHYS, V573, P92, DOI 10.1016/j.abb.2015.03.007; Marques AF, 2013, BIOORGAN MED CHEM, V21, P3667, DOI 10.1016/j.bmc.2013.04.047; Martinez-Mayorga K, 2015, DRUG DISCOV TODAY, V20, P890, DOI 10.1016/j.drudis.2015.02.004; MCGRATH ME, 1995, J MOL BIOL, V247, P251, DOI 10.1006/jmbi.1994.0137; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morra G, 2014, J CHEM THEORY COMPUT, V10, P5677, DOI 10.1021/ct500326g; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Mott BT, 2010, J MED CHEM, V53, P52, DOI 10.1021/jm901069a; Muchmore SW, 2003, CURR OPIN DRUG DISC, V6, P544; Naganathan AN, 2019, CURR OPIN STRUC BIOL, V54, P1, DOI 10.1016/j.sbi.2018.09.004; Novinec M, 2016, FEBS LETT, V590, P4507, DOI 10.1002/1873-3468.12495; Novinec M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/309718; Novinec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106642; Novinec M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4287; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; Nussinov R, 2015, CURR OPIN STRUC BIOL, V30, P17, DOI 10.1016/j.sbi.2014.11.005; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Rastelli G, 2014, CELL CYCLE, V13, P2296, DOI 10.4161/cc.29295; Ribeiro AAST, 2016, CHEM REV, V116, P6488, DOI 10.1021/acs.chemrev.5b00543; Ribeiro AAST, 2015, J PHYS CHEM B, V119, P1835, DOI 10.1021/jp509906m; Ribeiro I, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000484; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rogers KE, 2012, CHEM BIOL DRUG DES, V80, P398, DOI 10.1111/j.1747-0285.2012.01416.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sajid M, 2011, ADV EXP MED BIOL, V712, P100, DOI 10.1007/978-1-4419-8414-2_7; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sercinoglu O, 2018, NUCL ACIDS RES; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Stank A, 2016, ACCOUNTS CHEM RES, V49, P809, DOI 10.1021/acs.accounts.5b00516; Stanley Nathaniel, 2015, In Silico Pharmacology, V3, P3, DOI 10.1186/s40203-015-0007-0; Swami A, 1997, SIGN PROC ADV WIR CO; Tan C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003751; Tang QL, 2017, HUM MUTAT, V38, P1132, DOI 10.1002/humu.23231; Trossini GHG, 2009, J MOL GRAPH MODEL, V28, P3, DOI 10.1016/j.jmgm.2009.03.001; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603; Verkhivker GM, 2009, CURR TOP MED CHEM, V9, P1369, DOI 10.2174/156802609789895700; Vettoretti G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23830; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wagner JR, 2016, CHEM REV, V116, P6370, DOI 10.1021/acs.chemrev.5b00631; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinkam P, 2013, J MOL BIOL, V425, P647, DOI 10.1016/j.jmb.2012.11.041; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Xiao JJ, 2017, PHYS CHEM CHEM PHYS, V19, P24522, DOI 10.1039/c7cp03671j; Zhao HT, 2015, EUR J MED CHEM, V91, P4, DOI 10.1016/j.ejmech.2014.08.004; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	116	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211227	10.1371/journal.pone.0211227	http://dx.doi.org/10.1371/journal.pone.0211227			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682119	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500129
J	Carubbi, F; Alunno, A; Cipriani, P; Coletti, G; Bigerna, B; Manetti, M; Di Benedetto, P; Bistoni, O; Cipolloni, G; Liakouli, V; Ruscitti, P; Bartoloni, E; Giacomelli, R; Gerli, R				Carubbi, Francesco; Alunno, Alessia; Cipriani, Paola; Coletti, Gino; Bigerna, Barbara; Manetti, Mirko; Di Benedetto, Paola; Bistoni, Onelia; Cipolloni, Gianluca; Liakouli, Vasiliki; Ruscitti, Piero; Bartoloni, Elena; Giacomelli, Roberto; Gerli, Roberto			Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjogren's syndrome minor salivary glands	PLOS ONE			English	Article							ECTOPIC LYMPHOID NEOGENESIS; CLASSIFICATION CRITERIA; CONSENSUS; ORGANIZATION; BIOPSY	Objective A standardization of minor salivary gland (MSG) histopathology in primary Sjogren's syndrome (pSS) has been recently proposed. Although there is strong agreement that germinal center (GC)-like structures should be routinely identified, due to their prognostic value, a consensus regarding the best protocol is still lacking. Aim of this study was to compare the performance of different histological techniques and operators to identify GC-like structures in pSS MSGs. MSG biopsies from 50 pSS patients were studied. Methods Three blinded operators (one pathologist and two rheumatologists with different years of experience in pSS MSG assessment) assessed 50 MSGs of which one slide was stained with haematoxylin and eosin (H&E) and consecutive slides were processed to investigate CD3/CD20, CD21 and Bcl-6 expression. Results By assessing 225 foci, the best agreement was between H&E-stained sections evaluated by the rheumatologist with more years of experience in pSS MSG assessment and CD3/CD20 segregation. In the foci with CD21 positivity, the agreement further increased. Bcl-6 foci could display a GC, detected with other staining, but not vice versa. Conclusion GC assessment on H&E-stained sections should be performed with caution, being operator-dependent. The combination of H&E with CD3/CD20 and CD21 staining should be recommended as it is reliable, feasible, able to overcome the bias of operator experience and easily transferrable into routine practice.	[Carubbi, Francesco; Cipriani, Paola; Di Benedetto, Paola; Liakouli, Vasiliki; Ruscitti, Piero; Giacomelli, Roberto] Univ Aquila, Sch Med, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy; [Carubbi, Francesco] ASL1 Avezzano Sulmona Aquila, Dept Med, Laquila, Italy; [Alunno, Alessia; Bistoni, Onelia; Bartoloni, Elena; Gerli, Roberto] Univ Perugia, Dept Med, Rheumatol Unit, Perugia, Italy; [Coletti, Gino; Cipolloni, Gianluca] ASL1 Avezzano Sulmona Aquila, Biomed Dept, Pathol Unit, Laquila, Italy; [Bigerna, Barbara] Univ Perugia, Dept Med, Inst Haematol, Perugia, Italy; [Manetti, Mirko] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy	University of L'Aquila; University of Perugia; University of Perugia; University of Florence	Giacomelli, R (corresponding author), Univ Aquila, Sch Med, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy.	roberto.giacomelli@cc.univaq.it	Cipriani, Paola/AAC-7382-2022; Ruscitti, Piero/K-4184-2018; Bartoloni, Elena/R-5842-2019; Di Benedetto, Paola PDB/Y-9760-2018; Alunno, Alessia/AAC-8842-2022; Giacomelli, Roberto/AAB-9962-2022; Manetti, Mirko/AEH-9944-2022	Ruscitti, Piero/0000-0003-3487-8551; Di Benedetto, Paola PDB/0000-0003-2927-8703; Manetti, Mirko/0000-0003-3956-8480	European Commission [HarmonicSS GA 731944]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the European Commission: HarmonicSS GA 731944. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunno A, 2018, ANN RHEUM DIS, V77, DOI 10.1136/annrheumdis-2017-212108; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Bombardieri M, 2017, NAT REV RHEUMATOL, V13, P141, DOI 10.1038/nrrheum.2016.217; Brito-Zeron P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.47; Carubbi F, 2014, SEMIN ARTHRITIS RHEU, V44, P314, DOI 10.1016/j.semarthrit.2014.05.015; Delli K, 2016, ANN RHEUM DIS, V75, P1933, DOI 10.1136/annrheumdis-2015-208304; Delli K, 2016, ANN RHEUM DIS, V75, DOI 10.1136/annrheumdis-2016-209480; Fisher BA, 2017, ANN RHEUM DIS, V76, P1161, DOI 10.1136/annrheumdis-2016-210448; Flenghi L, 1996, AM J PATHOL, V148, P1543; Guellec D, 2013, AUTOIMMUN REV, V12, P416, DOI 10.1016/j.autrev.2012.08.001; Haacke EA, 2018, ANN RHEUM DIS, V77, pE32, DOI 10.1136/annrheumdis-2017-212164; Haacke EA, 2017, ANN RHEUM DIS, V76, P1783, DOI 10.1136/annrheumdis-2017-211290; Jonsson MV, 2008, J ORAL PATHOL MED, V37, P515, DOI 10.1111/j.1600-0714.2008.00674.x; Risselada AP, 2014, ANN RHEUM DIS, V73, P1537, DOI 10.1136/annrheumdis-2013-204634; Risselada AP, 2013, SEMIN ARTHRITIS RHEU, V42, P368, DOI 10.1016/j.semarthrit.2012.07.003; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1002/art.39859, 10.1136/annrheumdis-2016-210571]; Theander E, 2011, ANN RHEUM DIS, V70, P1363, DOI 10.1136/ard.2010.144782; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	18	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211142	10.1371/journal.pone.0211142	http://dx.doi.org/10.1371/journal.pone.0211142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682150	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500111
J	Sanchez-Munoz, G; Lopez-de-Andres, A; Hernandez-Barrera, V; Jimenez-Garcia, R; Pedraza-Serrano, F; Puente-Maestu, L; de Miguel-Diez, J				Sanchez-Munoz, Gema; Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier			Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; PREVALENCE; GUIDELINES; DIAGNOSIS; ETIOLOGY; TRENDS	Purpose The objectives of this study were to analyze the characteristics of male and female patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) during 2006-2014 according to the presence or absence of bronchiectasis and to study the factors associated with in-hospital mortality (IHM) in patients hospitalized with AE-COPD and concomitant bronchiectasis. Methods We used the Spanish National Hospital Database to analyze patients admitted with AE-COPD as their primary diagnosis. Patients included in the study were stratified according to the presence or absence of bronchiectasis as their secondary diagnosis. Results We identified 386,646 admissions for AE-COPD, of which 19,679 (5.09%) involved patients with concomitant bronchiectasis. When patients with and without bronchiectasis were compared, we observed that the incidence of infection by Pseudomonas aeruginosa was substantially higher in the former, as were the mean stay, cost, and percentage of readmissions, although IHM and comorbidity were lower. The course of patients with AE-COPD and bronchiectasis was characterized by a gradual increase in prevalence and mean age among men and no differences in prevalence or lower mean age in women. Mortality was 4.24% and 5.02% in patients with and without bronchiectasis, respectively, although significance was lost after a multivariate adjustment (OR 0.94; 95% CI, 0.88-1.01). The factors associated with IHM were older age, higher comorbidity, isolation of P. aeruginosa, mechanical ventilation and readmission. Conclusions The prevalence of admission with AE-COPD and bronchiectasis increased in men but not in women during the study period. In patients hospitalized with AE-COPD, we did not find differences in mortality when comparing the presence and absence of bronchiectasis. The analysis of temporal trends revealed a significant reduction in mortality from 2006 to 2014 in male patients with COPD and concomitant bronchiectasis, but not among women. It is important to consider the factors associated with IHM such as age, comorbidity, isolation of P. aeruginosa, mechanical ventilation and readmission to better identify those patients who are at greater risk of dying during hospitalization.	[Sanchez-Munoz, Gema; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier] Univ Complutense Madrid, Fac Med, Inst Invest Sanitaria Gregorio Maranon liSGM, Hosp Gen Univ Gregorio Maranon,Resp Dept, Madrid, Spain; [Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo] Rey Juan Carlos Univ, Hlth Sci Fac, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos	Lopez-de-Andres, A (corresponding author), Rey Juan Carlos Univ, Hlth Sci Fac, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain.	ana.lopez@urjc.es	Lopez-de-Andres, Ana/AAD-8703-2019; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; de Miguel-Diez, Javier/0000-0003-4543-573X; Puente-Maestu, Luis/0000-0001-8501-0117; Hernandez-Barrera, Valentin/0000-0001-5790-1959	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) - European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") [PI16/00564]; NEUMOMADRID	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) - European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); NEUMOMADRID	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"): grant no. PI16/00564. The authors would like to thank NEUMOMADRID (XVIII Awards Edition, 2018) for grant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Garcia MA, 2018, ARCH BRONCONEUMOL, V54, P79, DOI 10.1016/j.arbres.2017.07.015; Martinez-Garcia MA, 2017, INT J CHRONIC OBSTR, V12, P1401, DOI 10.2147/COPD.S132961; [Anonymous], 2014, GLOBAL STRATEGY DIAG; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; de la Rosa D, 2016, CHRON RESP DIS; De la Rosa D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177931; De Miguel-Diez J, 2016, RESPIROLOGY, V21, P489, DOI 10.1111/resp.12705; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dou S, 2018, INT J CHRONIC OBSTR, V13, P2041, DOI 10.2147/COPD.S163243; Du QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150532; El Gobierno de Espana Ministerio de Empleo y Seguridad Social, 2011, EXPL EST CONJ MIN BA; Finklea JD, 2010, RESP MED, V104, P816, DOI 10.1016/j.rmed.2009.11.021; Gallego M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-103; Gao YH, 2016, RESPIROLOGY, V21, P1376, DOI 10.1111/resp.12832; Gatheral T, 2014, COPD, V11, P605, DOI 10.3109/15412555.2014.922174; Ginde AA, 2008, JT COMM J QUAL PATIE, V34, P678, DOI 10.1016/S1553-7250(08)34086-0; Goeminne PC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-21; [Instituto Nacional de la Salud Instituto Nacional de la Salud.], 2000, CMBD INS AN GRDS; Instituto Nacional de la Salud, 2001, CONJ MIN BAS DAT; Jairam PM, 2015, THORAX, V70, P725, DOI 10.1136/thoraxjnl-2014-206160; Jin Jianmin, 2016, Medicine (Baltimore), V95, pe4219, DOI 10.1097/MD.0000000000004219; Joish VN, 2013, APPL HEALTH ECON HEA, V11, P299, DOI 10.1007/s40258-013-0027-z; Kawamatawong T, 2018, INT J CHRONIC OBSTR, V13, P761, DOI 10.2147/COPD.S139776; Kokturk N, 2016, COPD, V13, P799, DOI 10.1080/15412555.2016.1199666; Lara B, 2011, ARCH BRONCONEUMOL, V47, P389, DOI 10.1016/j.arbres.2011.04.002; Lonni S, 2015, ANN AM THORAC SOC, V12, P1764, DOI 10.1513/AnnalsATS.201507-472OC; Mao B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10961; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Miravitlles M, 2017, ARCH BRONCONEUMOL, V53, P89, DOI 10.1016/j.arbres.2017.01.001; Navaratnam V, 2016, QJM-INT J MED, V109, P523, DOI 10.1093/qjmed/hcv206; Ni YM, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S83910; Olveira C, 2017, ARCH BRONCONEUMOL, V53, P366, DOI 10.1016/j.arbres.2016.12.003; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Sanchez-Munoz G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162282; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31678-6, 10.1016/S0140-6736(16)31012-1]; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211222	10.1371/journal.pone.0211222	http://dx.doi.org/10.1371/journal.pone.0211222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682190	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500128
J	Sato, J; Inagaki, H; Kusui, M; Yokosuka, M; Ushida, T				Sato, Jun; Inagaki, Hideaki; Kusui, Mayu; Yokosuka, Makoto; Ushida, Takahiro			Lowering barometric pressure induces neuronal activation in the superior vestibular nucleus in mice	PLOS ONE			English	Article							MIDDLE-EAR; ALTERNOBARIC VERTIGO; PARATYMPANIC ORGAN; METEOROLOGICAL CHANGES; ATMOSPHERIC-PRESSURE; WEATHER CONDITIONS; NERVE INJURY; RAT MODEL; PAIN; MORPHOLOGY	Weather changes accompanied by decreases in barometric pressure are suggested to trigger meteoropathy, i.e., weather-related pain. We previously reported that neuropathic pain-related behavior in rats is aggravated by lowering barometric pressure, and that this effect is abolished by inner ear lesions. These results suggest that mechanisms that increase vestibular neuronal activity may parallel those that contribute to meteoropathy generation. However, it remains unknown whether changes in barometric pressure activate vestibular neuronal activity. To address this issue, we used expression of c-Fos protein as a marker for neural activation. Male and female mice were placed in a climatic chamber, and the barometric pressure was lowered by 40 hPa, from 1013 hPa, for 50 min (LP stimulation). The total number of c-Fos-positive cells in the vestibular nuclei was counted bilaterally after LP stimulation. We also video-recorded mouse behaviors and calculated the total activity score during the LP stimulation. LP stimulation resulted in significant c-Fos expression in the superior vestibular nucleus (SuVe) of male and female mice. There was no effect of LP stimulation on the total activity score. These data show that distinct neurons in the SuVe respond to LP stimulation. Similar mechanisms may contribute to the generation of meteoropathy in humans.	[Sato, Jun] Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan; [Sato, Jun; Inagaki, Hideaki; Kusui, Mayu; Ushida, Takahiro] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan; [Yokosuka, Makoto] Nippon Vet & Life Sci Univ, Sch Vet Med, Fac Vet Sci, Musashino, Tokyo, Japan	Chubu University; Aichi Medical University; Nippon Veterinary & Life Science University	Sato, J (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Phys Therapy, Kasugai, Aichi, Japan.; Sato, J (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan.	jsato@isc.chubu.ac.jp			Chubu University Grant [30AM17]; Japan Society for the Promotion of Science (JSPS) KAKENHI [23590710, 15K08206]	Chubu University Grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Chubu University Grant (30AM17) (https://www3.chubu.ac.jp/main/english/), and by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 23590710 and 15K08206) (http://www.jsps.go.jp/english/) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 2011, PSYCHONEUROENDOCRINO, V36, P1032, DOI 10.1016/j.psyneuen.2010.12.017; Bluestone CD, 2012, LARYNGOSCOPE, V122, P868, DOI 10.1002/lary.22182; BOSSUT DF, 1995, J NEUROPHYSIOL, V73, P1721, DOI 10.1152/jn.1995.73.4.1721; Breuner CW, 2013, J EXP BIOL, V216, P1982, DOI 10.1242/jeb.081067; DEVOR M, 1994, J NEUROPHYSIOL, V71, P38, DOI 10.1152/jn.1994.71.1.38; Eller-Smith OC, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00035; Endara-Bravo A, 2013, J CLIN SLEEP MED, V9, P1347, DOI 10.5664/jcsm.3288; Funakubo M, 2011, INT J BIOMETEOROL, V55, P319, DOI 10.1007/s00484-010-0339-8; Funakubo M, 2010, EUR J PAIN, V14, P32, DOI 10.1016/j.ejpain.2009.02.004; Funakubo M, 2009, J PHYSIOL SCI, V59, P162; Generaal E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-227; GUEDJ D, 1990, ANN RHEUM DIS, V49, P158, DOI 10.1136/ard.49.3.158; HENDLER NH, 1995, JNMS-J NEUROMUSC SYS, V3, P10; HOLLANDER JL, 1963, B AM METEOROL SOC, V44, P389; Imagawa M, 1998, NEUROSCI LETT, V240, P127, DOI 10.1016/S0304-3940(97)00944-0; IMAGAWA M, 1995, NEUROSCI LETT, V186, P87, DOI 10.1016/0304-3940(95)11288-8; JAMISON RN, 1995, PAIN, V61, P309, DOI 10.1016/0304-3959(94)00215-Z; Jang SH, 2018, NEURAL REGEN RES, V13, P727, DOI 10.4103/1673-5374.230304; KREITHEN ML, 1974, J COMP PHYSIOL, V89, P73, DOI 10.1007/BF00696164; LUNDGREN CE, 1966, AEROSPACE MED, V37, P178; LUNDGREN CE, 1965, BRIT MED J, V2, P511, DOI 10.1136/bmj.2.5460.511; Markia B, 2008, BRAIN STRUCT FUNCT, V213, P239, DOI 10.1007/s00429-008-0172-6; Mitchell SW, 1877, AM J MED SCI, V73, P305; NISHIHARA S, 1992, AM J OTOL, V13, P364; OHalloran KD, 1997, BRAIN RES, V759, P233, DOI 10.1016/S0006-8993(97)00261-8; Okuma H, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1592-4; Paxinos G, 2013, MOUSE BRAIN STEREOTA; Porter JD, 1997, J VESTIBUL RES-EQUIL, V7, P63; SATO F, 1989, J COMP NEUROL, V290, P423, DOI 10.1002/cne.902900310; Sato J, 2004, NEUROSCI LETT, V354, P46, DOI 10.1016/j.neulet.2003.09.057; Sato J, 2003, INT J BIOMETEOROL, V47, P55, DOI 10.1007/s00484-002-0156-9; Sato J, 2001, NEUROSCI LETT, V299, P17, DOI 10.1016/S0304-3940(00)01769-9; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Sato J, 1999, NEUROSCI LETT, V266, P21, DOI 10.1016/S0304-3940(99)00260-8; Sato J, 16 WORLD C PAIN 2016; Scheidt J, 2013, INT J BIOMETEOROL, V57, P649, DOI 10.1007/s00484-012-0582-2; SPROTT RL, 1967, SCIENCE, V157, P1206, DOI 10.1126/science.157.3793.1206; SUZUKI M, 1994, ACTA OTO-LARYNGOL, P9; Suzuki M, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P820; Suzuki M, 1998, ACTA OTO-LARYNGOL, V118, P712; Verges J, 2004, P W PHARMACOL SOC, P134; von Bartheld CS, 2011, J EXP ZOOL PART B, V316B, P402, DOI 10.1002/jez.b.21422; VONBARTHELD CS, 1994, BRAIN BEHAV EVOLUT, V44, P61, DOI 10.1159/000113570; VONBARTHELD CS, 1990, BRAIN BEHAV EVOLUT, V35, P1, DOI 10.1159/000115851; YATES BJ, 1995, BRAIN RES, V689, P197, DOI 10.1016/0006-8993(95)00569-C	45	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211297	10.1371/journal.pone.0211297	http://dx.doi.org/10.1371/journal.pone.0211297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682203	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500146
J	Waller, R; Baxter, L; Fillingham, DJ; Coelho, S; Pozo, JM; Mozumder, M; Frangi, AF; Ince, PG; Simpson, JE; Highley, JR				Waller, Rachel; Baxter, Lynne; Fillingham, Daniel J.; Coelho, Santiago; Pozo, Jose M.; Mozumder, Meghdoot; Frangi, Alejandro F.; Ince, Paul G.; Simpson, Julie E.; Highley, J. Robin			Iba-1(-)/CD68(+) microglia are a prominent feature of age-associated deep subcortical white matter lesions	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBRAL WHITE; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; UNSELECTED COHORT; PATHOLOGY; HYPERINTENSITIES; DYSFUNCTION; ACTIVATION; MYELIN	Deep subcortical lesions (DSCL) of the brain, are present in similar to 60% of the ageing population, and are linked to cognitive decline and depression. DSCL are associated with demyelination, blood brain barrier (BBB) dysfunction, and microgliosis. Microglia are the main immune cell of the brain. Under physiological conditions microglia have a ramified morphology, and react to pathology with a change to a more rounded morphology as well as showing protein expression alterations. This study builds on previous characterisations of DSCL and radiologically 'normal-appearing' white matter (NAWM) by performing a detailed characterisation of a range of microglial markers in addition to markers of vascular integrity. The Cognitive Function and Ageing Study (CFAS) provided control white matter (WM), NAWM and DSCL human post mortem tissue for immunohistochemistry using microglial markers (Iba-1, CD68 and MHCII), a vascular basement membrane marker (collagen IV) and markers of BBB integrity (fibrinogen and aquaporin 4). The immunoreactive profile of CD68 increased in a stepwise manner from controlWM to NAWM to DSCL. This correlated with a shift from small, ramified cells, to larger, more rounded microglia. While there was greater Iba-1 immunoreactivity in NAWM compared to controls, in DSCL, Iba-1 levels were reduced to control levels. A prominent feature of these DSCL was a population of Iba-1(-)/CD68(+) microglia. There were increases in collagen IV, but no change in BBB integrity. Overall the study shows significant differences in the immunoreactive profile of microglial markers. Whether this is a cause or effect of lesion development remains to be elucidated. Identifying microglia subpopulations based on their morphology and molecular markers may ultimately help decipher their function and role in neurodegeneration. Furthermore, this study demonstrates that Iba-1 is not a pan-microglial marker, and that a combination of several microglial markers is required to fully characterise the microglial phenotype.	[Waller, Rachel; Baxter, Lynne; Fillingham, Daniel J.; Ince, Paul G.; Simpson, Julie E.; Highley, J. Robin] Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England; [Coelho, Santiago; Pozo, Jose M.; Frangi, Alejandro F.] Univ Leeds, Sch Comp, Ctr Computat Imaging & Simulat Technol Biomed, Leeds, W Yorkshire, England; [Mozumder, Meghdoot] Univ Sheffield, Dept Engn, Ctr Computat Imaging & Simulat Technol Biomed, Sheffield, S Yorkshire, England	University of Sheffield; University of Leeds; University of Sheffield	Waller, R (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci, Dept Neurosci, Sheffield, S Yorkshire, England.	R.Waller@Sheffield.ac.uk	Pozo, Jose M/M-7604-2016; Waller, Rachel/I-7008-2019; Mozumder, Meghdoot/J-9393-2019; Frangi, Alejandro F/C-6500-2008	Pozo, Jose M/0000-0002-0759-3510; Waller, Rachel/0000-0001-5815-8829; Mozumder, Meghdoot/0000-0002-0656-4291; Frangi, Alejandro F/0000-0002-2675-528X; Coelho, Santiago/0000-0002-1039-4803	OCEAN project - Engineering and Physical Sciences Research Council (EPSRC) [EP/M006328/1]; MedIAN Network - Engineering and Physical Sciences Research Council (EPSRC) [EP/N026993/1]; European Commission FP7 Project VPH-DARE@IT [FP7-ICT-2011-9-601055]; Department of Health; Medical Research Council [MRC/G9901400, MRC U.1052.00.0013]; UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; NIHR Cambridge Biomedical Research Centre; Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield; Sheffield Teaching Hospitals NHS Foundation Trust; Oxford Biomedical Research Centre; Walton Centre NHS Foundation Trust, Liverpool; bet365/Denise Coates Foundation; EPSRC [EP/M000133/1, EP/M006328/1, EP/M006328/2, EP/N026993/1] Funding Source: UKRI; MRC [G1100540, G9901400] Funding Source: UKRI	OCEAN project - Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MedIAN Network - Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission FP7 Project VPH-DARE@IT; Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield; Sheffield Teaching Hospitals NHS Foundation Trust; Oxford Biomedical Research Centre; Walton Centre NHS Foundation Trust, Liverpool; bet365/Denise Coates Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the OCEAN project (EP/M006328/1) and MedIAN Network (EP/N026993/1) both funded by the Engineering and Physical Sciences Research Council (EPSRC) and the European Commission FP7 Project VPH-DARE@IT(FP7-ICT-2011-9-601055).The CFAS study is supported by the Department of Health and the Medical Research Council (grants MRC/G9901400 and MRC U.1052.00.0013); the UKNIHR Biomedical Research Centre for Ageing and Age-related Disease Award to the Newcastle upon Tyne Hospitals Foundation Trust; the Cambridge Brain Bank is supported by the NIHR Cambridge Biomedical Research Centre; The Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield and the Sheffield Teaching Hospitals NHS Foundation Trust; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. The Nanozoomer XR scanner was funded by the bet365/Denise Coates Foundation.	Al-Mashhadi S, 2015, BRAIN PATHOL, V25, P565, DOI 10.1111/bpa.12216; Amici SA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01520; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; Bridges LR, 2014, J NEUROPATH EXP NEUR, V73, P1026, DOI 10.1097/NEN.0000000000000124; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Chen AQ, 2016, BRAIN, V139, P242, DOI 10.1093/brain/awv328; Coelho S, 2018, NEUROIMAGE, V179, P275, DOI 10.1016/j.neuroimage.2018.06.040; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Fernando MS, 2004, NEUROPATH APPL NEURO, V30, P385, DOI 10.1111/j.1365-2990.2004.00550.x; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Hainsworth AH, 2017, STROKE, V48, P2799, DOI 10.1161/STROKEAHA.117.018101; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Huang YH, 2010, NEUROPATH APPL NEURO, V36, P237, DOI 10.1111/j.1365-2990.2009.01049.x; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Minett T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0601-z; MOODY DM, 1991, CLIN NEUR, V37, P372; Ohsawa K, 2000, J CELL SCI, V113, P3073; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryu JK, 2009, J CELL MOL MED, V13, P2911, DOI 10.1111/j.1582-4934.2008.00434.x; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P670, DOI 10.1111/j.1365-2990.2007.00890.x; Simpson JE, 2007, NEUROPATH APPL NEURO, V33, P410, DOI 10.1111/j.1365-2990.2007.00828.x; Simpson JE, 2010, NEUROSCI LETT, V486, P246, DOI 10.1016/j.neulet.2010.09.063; Simpson JE, 2009, STROKE, V40, P369, DOI 10.1161/STROKEAHA.108.529214; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wharton SB, 2015, BRAIN PATHOL, V25, P35, DOI 10.1111/bpa.12219; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	33	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210888	10.1371/journal.pone.0210888	http://dx.doi.org/10.1371/journal.pone.0210888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682074	Green Published, gold, Green Accepted			2022-12-27	WOS:000457037500072
J	Hong, H; Song, JM; Yeom, E				Hong, Hyeonji; Song, Jae Min; Yeom, Eunseop			Variations in pulsatile flow around stenosed microchannel depending on viscosity	PLOS ONE			English	Article							NON-NEWTONIAN MODELS; BLOOD ANALOG FLUID; SHEAR-STRESS; WHOLE-BLOOD; ARTERY; VISUALIZATION; ENLARGEMENT; DEPENDENCE; VOLUME; CELLS	In studying blood flow in the vessels, the characteristics of non-Newtonian fluid are important, considering the role of viscosity in rheology. Stenosis, which is an abnormal narrowing of the vessel, has an influence on flow behavior. Therefore, analysis of blood flow in stenosed vessels is essential. However, most of them exist as simulation outcomes. In this study, non-Newtonian fluid was observed in stenosed microchannels under the pulsatile flow condition. A polydimethylsiloxane channel with 60% stenosis was fabricated by combining an optic fiber and a petri dish, resembling a mold. Three types of samples were prepared by changing the concentrations of xanthan gum, which induces a shear thinning effect (phosphate buffered saline (PBS) solution as the Newtonian fluid and two non-Newtonian fluids mimicking normal blood and highly viscous blood analog). The viscosity of the samples was measured using a Y-shaped microfluidic viscometer. Thereafter, velocity profiles were analyzed under the pulsatile flow condition using the micro-particle image velocimetry (PIV) method. For the Newtonian fluid, the streamline was skewed more to the wall of the channel. The velocity profile of the non-Newtonian fluid was generally blunter than that of the Newtonian fluid. A highly oscillating wall shear stress (WSS) during the pulsatile phase may be attributed to such a bluntness of flow under the same wall shear rate condition with the Newtonian fluid. In addition, a highly viscous flow contributes to the variation in the WSS after passing through the stenosed structures. A similar tendency was observed in simulation results. Such a variation in the WSS was associated with plaque instability or rupture and damage of the tissue layer. These results, related to the influence on the damage to the endothelium or stenotic lesion, may help clinicians understand relevant mechanisms.	[Hong, Hyeonji; Yeom, Eunseop] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea; [Song, Jae Min] Pusan Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Busan, South Korea	Pusan National University; Pusan National University	Yeom, E (corresponding author), Pusan Natl Univ, Sch Mech Engn, Busan, South Korea.	esyeom@pusan.ac.kr	Yeom, Eunseop/AAR-8322-2020	Yeom, Eunseop/0000-0002-9717-030X	National Research Foundation (NRF) of Korea - Korea government (MSIP) [NRF-2016R1C1B2014255, 2017R1C1B5018423]	National Research Foundation (NRF) of Korea - Korea government (MSIP)	This work was supported by a National Research Foundation (NRF) of Korea grant funded by the Korea government (MSIP) (NRF-2016R1C1B2014255 and 2017R1C1B5018423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornsamankul S., 2006, INT J BIOL MED SCI, V1, P42; Anastasiou AD, 2012, MED ENG PHYS, V34, P211, DOI 10.1016/j.medengphy.2011.07.012; Ashrafizaadeh M, 2009, COMPUT MATH APPL, V58, P1045, DOI 10.1016/j.camwa.2009.02.021; Bishop JJ, 2002, AM J PHYSIOL-HEART C, V283, pH1985, DOI 10.1152/ajpheart.00888.2001; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V281, pH951, DOI 10.1152/ajpheart.2001.281.2.H951; Bourdon CJ, 2006, J FLUID ENG-T ASME, V128, P883, DOI 10.1115/1.2201649; Brunette J, 2008, MED ENG PHYS, V30, P1193, DOI 10.1016/j.medengphy.2008.02.012; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; CHIEN S, 1970, SCIENCE, V168, P977, DOI 10.1126/science.168.3934.977; Cowan AQ, 2012, CARDIOVASC DRUG THER, V26, P339, DOI 10.1007/s10557-012-6402-4; Deplano V, 2014, J BIOMECH, V47, P1262, DOI 10.1016/j.jbiomech.2014.02.026; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Dolan JM, 2011, ANN BIOMED ENG, V39, P1620, DOI 10.1007/s10439-011-0267-8; FRY DL, 1968, CIRC RES, V22, P165, DOI 10.1161/01.RES.22.2.165; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Ha H, 2016, KOREAN J RADIOL, V17, P445, DOI 10.3348/kjr.2016.17.4.445; Hong H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186300; Jahangiri M, 2018, INT J ADV DESIGN MAN, V11; Karri S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000934; KUMAR N, 2013, INT J MICRONANOSCALE, V4, P33; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; LOWE GDO, 1992, CIRCULATION, V85, P2329, DOI 10.1161/01.CIR.85.6.2329; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mannino RG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12401; Mejia J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004408; Molla MM, 2012, MED ENG PHYS, V34, P1079, DOI 10.1016/j.medengphy.2011.11.013; Nandakumar N, 2015, EUR J MECH B-FLUID, V49, P29, DOI 10.1016/j.euromechflu.2014.07.005; Nejad AA, 2018, COMPUT METH PROG BIO, V154, P109, DOI 10.1016/j.cmpb.2017.11.016; Nguyen TT, 2004, J BIOMECH ENG-T ASME, V126, P529, DOI 10.1115/1.1785812; Olsen MG, 2003, J FLUID ENG-T ASME, V125, P895, DOI 10.1115/1.1598989; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Pratumwal Y., 2017, SONGKLA J SCI TECHNO, V39, P625, DOI 10.14456/sjst-psu.2017.77; Rabby M.G., 2014, J FLUIDS, V2014; Rabby MG, 2013, PROCEDIA ENGINEER, V56, P225, DOI 10.1016/j.proeng.2013.03.111; Samady H., 2011, CIRCULATION, pCIRCULATIONAHA; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; Siauw WL, 2000, MED ENG PHYS, V22, P265, DOI 10.1016/S1350-4533(00)00036-9; Steinman DA, 2000, J BIOMECH, V33, P623, DOI 10.1016/S0021-9290(99)00205-5; SUTERA SP, 1975, BIOPHYS J, V15, P1, DOI 10.1016/S0006-3495(75)85787-0; Tian FB, 2013, COMPUT BIOL MED, V43, P1098, DOI 10.1016/j.compbiomed.2013.05.023; Toraldo DM, 2013, LUNG, V191, P1, DOI 10.1007/s00408-012-9427-3; Tronc F, 2000, ARTERIOSCL THROM VAS, V20, pE120, DOI 10.1161/01.ATV.20.12.e120; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Usmani AY, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2274-x; Vahidkhah K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28194; van Wyk S, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4923311; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Walker AM, 2014, ANN BIOMED ENG, V42, P97, DOI 10.1007/s10439-013-0893-4; Walker AM, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007746; WELLS RE, 1961, SCIENCE, V133, P763, DOI 10.1126/science.133.3455.763; Yeom E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01985-w; Yeom E, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4883275	54	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210993	10.1371/journal.pone.0210993	http://dx.doi.org/10.1371/journal.pone.0210993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677055	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400040
J	Lewis, KE; Rota, CT; Lituma, CM; Anderson, JT				Lewis, Katharine E.; Rota, Christopher T.; Lituma, Christopher M.; Anderson, James T.			Influence of the Agricultural Conservation Easement Program wetland practices on winter occupancy of Passerellidae sparrows and avian species richness	PLOS ONE			English	Article							ECOSYSTEM SERVICES; HABITAT RELATIONSHIPS; BIRDS; COMMUNITIES; SELECTION; SWAMP; AREA; ASSOCIATIONS; MITIGATION; PREDATION	Wetlands enrolled in the Agricultural Conservation Easement Program (ACEP) are established as a means of restoring wetland ecosystems and wildlife habitat on private, agricultural land. In West Virginia, USA, ACEP wetlands have never been evaluated to determine how they function as wildlife habitat in comparison to other available wetland habitat in the state. We measured the wintering occupancy of Passerellidae species and apparent avian species richness on ACEP wetlands and a set of reference wetlands located on public land in West Virginia to evaluate if ACEP wetlands are being used similarly by avian species to other available wetland habitat in the state. Apparent avian species richness and the occupancy probability of four Passerellidae species-song sparrows (Melospiza melodia), darkeyed juncos (Junco hyemalis), swamp sparrows (Melospiza georgiana), and white-throated sparrows (Zonotrichia albicollis)-did not differ between ACEP and reference sites. In addition to other vegetative and habitat associations for each species, dark-eyed junco occupancy was negatively correlated with wetland size while swamp sparrow occupancy and apparent avian species richness were positively associated with wetland size. These results indicate that ACEP wetlands are providing winter avian habitat as well as another source of wetland habitat in the state. Maintaining and expanding ACEP wetlands in West Virginia would continue to provide wetland systems in areas that are otherwise lacking these habitats.	[Lewis, Katharine E.; Rota, Christopher T.; Lituma, Christopher M.; Anderson, James T.] West Virginia Univ, Davis Coll Agr Nat Resources & Design, Morgantown, WV 26506 USA	West Virginia University	Rota, CT (corresponding author), West Virginia Univ, Davis Coll Agr Nat Resources & Design, Morgantown, WV 26506 USA.	christopher.rota@mail.wvu.edu		Lewis, Katharine/0000-0003-0442-6773; Rota, Christopher/0000-0001-9272-4687	WVU Davis College of Agriculture, Natural Resources, and Design [68-3D47-15-10]; USDA Natural Resources Conservation Service [68-3D47-15-10]; USDA National Institute of Food and Agriculture, McIntire Stennis projects [WVA00124, WVA00128, WVA00117]; West Virginia Agricultural and Forestry Experiment Station; National Science Foundation [OIA-1458952]	WVU Davis College of Agriculture, Natural Resources, and Design; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture, McIntire Stennis projects; West Virginia Agricultural and Forestry Experiment Station; National Science Foundation(National Science Foundation (NSF))	This project was funded through a cooperative agreement between the WVU Davis College of Agriculture, Natural Resources, and Design (https://www.davis.wvu.edu/), and the USDA Natural Resources Conservation Service (https://www.nrcs.usda.gov), grant number 68-3D47-15-10. This work also was supported by the USDA National Institute of Food and Agriculture, McIntire Stennis projects (https://nifa.usda.gov/) WVA00124 (C.T. Rota), WVA00128 (C.M. Lituma), and WVA00117 (J.T. Anderson); and the West Virginia Agricultural and Forestry Experiment Station. J.T. Anderson was supported by the National Science Foundation (https://www.nsf.gov/) under Cooperative Agreement no. OIA-1458952 during manuscript preparation. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2015, APPL HIERARCHICAL MO, DOI DOI 10.1016/C2013-0-19160-X; Balcombe CK, 2005, HYDROBIOLOGIA, V541, P175, DOI 10.1007/s10750-004-5706-1; Balcombe CK, 2005, ECOL ENG, V25, P85, DOI 10.1016/j.ecoleng.2005.03.003; Balcombe CK, 2005, WETLANDS, V25, P130, DOI 10.1672/0277-5212(2005)025[0130:ACOPCI]2.0.CO;2; Baldwin HQ, 2007, WILSON J ORNITHOL, V119, P189, DOI 10.1676/05-129.1; Beadell J, 2003, WILSON BULL, V115, P38, DOI 10.1676/02-041; Beck CW, 1997, CAN J ZOOL, V75, P1636, DOI 10.1139/z97-790; Blank PJ, 2011, WILSON J ORNITHOL, V123, P59, DOI 10.1676/09-202.1; BROWN M, 1986, J WILDLIFE MANAGE, V50, P392, DOI 10.2307/3801093; Brown SC, 1998, J WILDLIFE MANAGE, V62, P1480, DOI 10.2307/3802014; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carr JM, 2014, OECOLOGIA, V174, P713, DOI 10.1007/s00442-013-2804-7; Chandler RB, 2009, AUK, V126, P186, DOI 10.1525/auk.2009.08083; Clipp H.L., 2017, WINTER WATERBIRD COM, DOI [10.1155/2017/1730130, DOI 10.1155/2017/1730130]; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dahl TE, 2011, STATUS TRENDS WETLAN; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dymond Jr, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P1; ESRI, 2016, ARCGIS DESKT VERS 10; Falls J.B., 2010, BIRDS N AM; Fennessy S, 2011, ECOL APPL, V21, pS49, DOI 10.1890/09-0269.1; Frayer W.E., 1983, STATUS TRENDS WETLAN; Fretwell J. D., 1996, NATL WATER SUMMARY W; GOTTFRIED BM, 1975, WILSON BULL, V87, P374; GREENBERG R, 1988, CONDOR, V90, P420, DOI 10.2307/1368570; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Harms TM, 2015, WILSON J ORNITHOL, V127, P670, DOI 10.1676/15-001.1; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Kaminski MR, 2006, WILDLIFE SOC B, V34, P921, DOI 10.2193/0091-7648(2006)34[921:WRTHMO]2.0.CO;2; Kellner K., 2017, PACKAGE JAGSUI WRAPP; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Lewis K. R., 2018, THESIS; MAC ARTHUR ROBERT H., 1967; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION, DOI DOI 10.1016/C2012-0-01164-7; Marcus JF, 2000, WILSON BULL, V112, P517, DOI 10.1676/0043-5643(2000)112[0517:TEOFFB]2.0.CO;2; Mastrangelo ME, 2014, BIOL CONSERV, V179, P63, DOI 10.1016/j.biocon.2014.08.020; Miller AE, 2017, WILSON J ORNITHOL, V129, P85, DOI 10.1676/1559-4491-129.1.85; Mitsch WJ, 2013, AQUAT SCI, V75, P133, DOI 10.1007/s00027-012-0262-7; Moreno-Mateos D, 2009, BIODIVERS CONSERV, V18, P811, DOI 10.1007/s10531-008-9472-7; Morin R. S. G. M., 2017, RESOURCE UPDATE FS 1; MOWBRAY TB, 1997, BIRDS N AM; Mueller-Dombois D, 1974, AIMS METHODS VEGETAT, P48; Murkin HR, 1997, ECOL APPL, V7, P1144; Plummer M., 2003, P 3 INT WORKSH DISTR, V124, P1; PULLIAM HR, 1977, ECOLOGY, V58, P1393, DOI 10.2307/1935091; Ralph CJ, 1993, HDB FIELD METHODS MO; Riffell SK, 2001, WETLANDS, V21, P492, DOI 10.1672/0277-5212(2001)021[0492:AAHROB]2.0.CO;2; Rising JD, 1997, GUIDE IDENTIFICATION; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Rousseau P, 2012, CAN J ZOOL, V90, P595, DOI 10.1139/Z2012-025; Schlossberg S, 2008, ECOL APPL, V18, P1325, DOI 10.1890/08-0020.1; Schlossberg S, 2011, LANDSCAPE URBAN PLAN, V103, P64, DOI 10.1016/j.landurbplan.2011.06.001; SCHNEIDER KJ, 1984, ECOLOGY, V65, P1820, DOI 10.2307/1937778; Smith LA, 2010, WETLANDS, V30, P553, DOI 10.1007/s13157-010-0048-4; TINER RW, 1994, RECENT WETLAND STATU; Weisberg PJ, 2014, ACTA OECOL, V59, P72, DOI 10.1016/j.actao.2014.06.002; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	59	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210878	10.1371/journal.pone.0210878	http://dx.doi.org/10.1371/journal.pone.0210878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677050	Green Submitted, gold, Green Published			2022-12-27	WOS:000456700400030
J	Merklinger-Gruchala, A; Jasienska, G; Kapiszewska, M				Merklinger-Gruchala, Anna; Jasienska, Grazyna; Kapiszewska, Maria			Paternal investment and low birth weight - The mediating role of parity	PLOS ONE			English	Article							FATHER INVOLVEMENT; INFANT-MORTALITY; PARTNER SUPPORT; SOCIAL SUPPORT; LIFE-HISTORY; PREGNANCY; STRESS; EVOLUTION; HEALTH; CONSEQUENCES	According to life-history theory, paternal investment affects the well-being of offspring. We hypothesized that environmental stress caused by a lack of paternal investment may diminish maternal resource allocation during pregnancy, especially for women who already have dependent children. Our study was conducted on a representative group of more than 80,500 singleton, live-born, full-term infants born in Krakow, Poland in the period 1995-2009. Birth data were obtained from the birth registry. We found that missing data about fathers (a proxy measure of low paternal investment) was associated with higher probability of multiparous mothers giving birth to low-birth-weight infants (1.48; 95% CI 1.05-2.08), but this was not the case with primiparous mothers (1.19; 95% CI 0.89-1.59). The statistically significant synergistic effect between parity and paternal investment was found (Synergy Factor = 2.12; 95% CI 1.47-3.05, p<0.001). These findings suggest that in situations of low paternal investment, multiparous mothers face trade-offs between investing in existing versus unborn children, therefore investment in the latter is lower. Such a strategy may benefit maternal fitness due to investment in older children, who have higher reproductive value.	[Merklinger-Gruchala, Anna; Kapiszewska, Maria] Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Krakow, Poland; [Jasienska, Grazyna] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland	Andrzej Frycz Modrzewski Krakow University; Jagiellonian University; Collegium Medicum Jagiellonian University	Merklinger-Gruchala, A (corresponding author), Andrzej Frycz Modrzewski Krakow Univ, Fac Med & Hlth Sci, Krakow, Poland.	amerklinger@afm.edu.pl	Merklinger-Gruchala, Anna/AAD-7255-2022; Kapiszewska, Maria/S-1860-2018	Merklinger-Gruchala, Anna/0000-0002-7822-6945; Jasienska, Grazyna/0000-0001-8716-6342; Kapiszewska, Maria/0000-0002-8864-6636	Ministry of Science and Higher Education [WZiNM/DS/6/2017]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was carried out within the Framework of a Project No. N N404 055 136, financed by the Ministry of Science and Higher Education (to Maria Kapiszewska), and Project No WZiNM/DS/6/2017 financed by the Ministry of Science and Higher Education (to Anna Merklinger-Gruchala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alio AP, 2011, J COMMUN HEALTH, V36, P63, DOI 10.1007/s10900-010-9280-3; Aliyu MH, 2005, BIRTH-ISS PERINAT C, V32, P1, DOI [10.1111/j.0730-7659.2005.00339.x, DOI 10.1111/J.0730-7659.2005.00339.X]; Anderson KG, 2017, HUM NATURE-INT BIOS, V28, P168, DOI 10.1007/s12110-017-9284-0; Anderson KG, 2003, BIODEMOGRAPHY OF HUMAN REPRODUCTION AND FERTILITY, P57; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bentley GR, 2009, STUDIES BIOSOCIAL SO, V3; Bracero L, 2009, J MATERN-FETAL NEO M, V22, P342, DOI 10.1080/14767050802663178; Bribiescas RG, 2010, EVOLUTIONARY ENDOCRI, P127; Bribiescas RG, 2012, CURR ANTHROPOL, V53, pS424, DOI 10.1086/667538; Buss D. M., 2015, EVOLUTIONARY PSYCHOL; Bussieres EL, 2015, DEV REV, V36, P179, DOI 10.1016/j.dr.2015.04.001; Campbell B., 1972, SEXUAL SELECTION DES, DOI DOI 10.1002/AJPA.1330400226; Chamie J., 2017, OUT OF WEDLOCK BIRTH; Cheng ER, 2016, J WOMENS HEALTH, V25, P672, DOI 10.1089/jwh.2015.5462; Coall DA, 2003, SOC SCI MED, V57, P1771, DOI 10.1016/S0277-9536(03)00022-4; Cohen K, 2016, MATERN CHILD HLTH J, V20, P2291, DOI 10.1007/s10995-016-2048-3; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; Coussons-Read ME, 2007, BRAIN BEHAV IMMUN, V21, P343, DOI 10.1016/j.bbi.2006.08.006; Dunkel Schetter C, 2010, HDB HLTH PSYCHOL; Dunkel-Schetter C, 1996, HDB SOCIAL SUPPORT F, P375, DOI 10.1007/s10995-016-2048-3; Elsenbruch S, 2007, HUM REPROD, V22, P869, DOI 10.1093/humrep/del432; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Gaudino JA, 1999, SOC SCI MED, V48, P253, DOI 10.1016/S0277-9536(98)00342-6; Geary DC, 2000, PSYCHOL BULL, V126, P55, DOI 10.1037/0033-2909.126.1.55; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Hinkle SN, 2014, PAEDIATR PERINAT EP, V28, P106, DOI 10.1111/ppe.12099; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hornstra G, 2000, AM J CLIN NUTR, V71, p1262S, DOI 10.1093/ajcn/71.5.1262s; Hrdy S. B., 2007, FAM RELAT, P39, DOI DOI 10.1093/ACPROF:OSO/9780195320510.003.0003; Jasienska G., 2017, ARC LIFE EVOLUTION H, P159; Jasienska G., 2013, FRAGILE WISDOM EVOLU; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Lewandowski P, 2012, ADMITTING PATERNAL A, P7; Mann J., 1992, ADAPTED MIND EVOLUTI, P367; Martin LT, 2007, MATERN CHILD HLTH J, V11, P595, DOI 10.1007/s10995-007-0209-0; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; O'Donnell MH, 2017, THESIS; Padilla YC, 2001, CHILD YOUTH SERV REV, V23, P427, DOI 10.1016/S0190-7409(01)00136-0; Parker VJ, 2010, J REPROD IMMUNOL, V85, P86, DOI 10.1016/j.jri.2009.10.011; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; REDONDO T, 1989, BEHAV ECOL SOCIOBIOL, V25, P369, DOI 10.1007/BF00302995; Rini C, 2006, PERS RELATIONSHIP, V13, P207, DOI 10.1111/j.1475-6811.2006.00114.x; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Sear R., 2011, EVOLUTIONARY PSYCHOL, P215; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shenk MK, 2011, FRONT COLLECT, P17, DOI 10.1007/978-3-642-13968-0_2; Stearns S.C., 1992, pi; Su Q, 2015, PEDIATR NEONATOL, V56, P376, DOI 10.1016/j.pedneo.2015.02.002; Szukalski P., 2017, B INFORM, V6; Tan Hongzhuan, 2004, BMC Pregnancy Childbirth, V4, P21, DOI 10.1186/1471-2393-4-21; Teitler JO, 2001, CHILD YOUTH SERV REV, V23, P403, DOI 10.1016/S0190-7409(01)00137-2; Trevathan W., 2017, HUMAN BIRTH EVOLUTIO, V3rd; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wells JCK, 2003, J THEOR BIOL, V221, P143, DOI 10.1006/jtbi.2003.3183	59	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210715	10.1371/journal.pone.0210715	http://dx.doi.org/10.1371/journal.pone.0210715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI8IY	30677049	Green Published, Green Submitted, gold			2022-12-27	WOS:000456700400025
J	Ballo, O; Tarazzit, I; Stratmann, J; Reinheimer, C; Hogardt, M; Wichelhaus, TA; Kempf, V; Serve, H; Finkelmeier, F; Brandts, C				Ballo, Olivier; Tarazzit, Ikram; Stratmann, Jan; Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard; Serve, Hubert; Finkelmeier, Fabian; Brandts, Christian			Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HIGH-RISK PATIENTS; HEMATOLOGICAL MALIGNANCIES; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; IMPACT; RECOMMENDATIONS; NEUTROPENIA; THERAPY; SOCIETY	Introduction The global spread of multidrug-resistant organisms (MDRO) complicates treatment and isolation measures in hospitals and has shown to increase mortality. Patients with disease- or therapy-related immunodeficiency are especially at risk for fatal infections caused by MDRO. The impact of MDRO colonization on the clinical course of AML patients undergoing intensive induction chemotherapy a potentially curative but highly toxic treatment option- has not been systematically studied. Materials & methods 312 AML patients undergoing intensive induction chemotherapy between 2007 and 2015 were examined for MDRO colonization. Patients with evidence for MDRO before or during the hospital stay of induction chemotherapy were defined as colonized, patients who never had a positive swab for MDRO were defined as noncolonized. Results Of 312 AML patients 90 were colonized and 130 were noncolonized. Colonized patients suffered from significantly more days with fever, spent more days on the intensive care unit and had a higher median C-reactive protein value during the hospital stay. These findings did not result in a prolonged length of hospital stay or an increased mortality rate for colonized patients. However, in a subgroup analysis, patients colonized with carbapenem-resistant enterobacteriaceae (CRE) had a significantly reduced 60- and 90-day, as well as 1- and 2-year survival rates when compared to noncolonized patients. Conclusion Our analysis highlights the importance of intensive MDRO screening especially in patients with febrile neutropenia since persisting fever can be a sign of MDRO-colonization. CRE-colonized patients require special surveillance, since they seem to be at risk for death.	[Ballo, Olivier; Tarazzit, Ikram; Stratmann, Jan; Serve, Hubert; Brandts, Christian] Goethe Univ Hosp, Dept Med, Hematol Oncol, Frankfurt, Germany; [Ballo, Olivier; Serve, Hubert; Finkelmeier, Fabian; Brandts, Christian] Goethe Univ Hosp, Univ Canc Ctr Frankfurt UCT, Frankfurt, Germany; [Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard] Goethe Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Reinheimer, Claudia; Hogardt, Michael; Wichelhaus, Thomas A.; Kempf, Volkhard; Serve, Hubert] Goethe Univ Hosp, Univ Ctr Infect Dis, Frankfurt, Germany; [Finkelmeier, Fabian] Goethe Univ Frankfurt, Dept Med Gastroenterol Hepatol & Endocrinol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Ballo, O; Brandts, C (corresponding author), Goethe Univ Hosp, Dept Med, Hematol Oncol, Frankfurt, Germany.; Ballo, O; Brandts, C (corresponding author), Goethe Univ Hosp, Univ Canc Ctr Frankfurt UCT, Frankfurt, Germany.	olivier.ballo@kgu.de; brandts@em.uni-frankfurt.de						Ahn S, 2011, SUPPORT CARE CANCER, V19, P1151, DOI 10.1007/s00520-010-0928-4; Atallah E, 2007, BLOOD, V110, P3547, DOI 10.1182/blood-2007-06-095844; Chen CY, 2017, INT J ANTIMICROB AG, V49, P272, DOI 10.1016/j.ijantimicag.2016.11.009; Combariza JF, 2015, SUPPORT CARE CANCER, V23, P1009, DOI 10.1007/s00520-014-2454-2; Cornejo-Juarez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035780; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ford CD, 2015, INFECT CONT HOSP EP, V36, P47, DOI 10.1017/ice.2014.3; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gudiol C, 2013, CLIN MICROBIOL INFEC, V19, P474, DOI 10.1111/j.1469-0691.2012.03879.x; Gudiol C, 2011, J ANTIMICROB CHEMOTH, V66, P657, DOI 10.1093/jac/dkq494; HIDDEMANN W, 1987, BLOOD, V69, P744; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Jaiswal SR, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.025; Krug U, 2011, DTSCH ARZTEBL INT, V108, P863, DOI 10.3238/arztebl.2011.0863; Lehouritis P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14554; Liss BJ, 2012, INFECTION, V40, P613, DOI 10.1007/s15010-012-0269-y; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lye DC, 2012, CLIN MICROBIOL INFEC, V18, P502, DOI 10.1111/j.1469-0691.2011.03606.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mandelli F, 2009, J CLIN ONCOL, V27, P5397, DOI 10.1200/JCO.2008.20.6490; Marini BL, 2015, SUPPORT CARE CANCER, V23, P2287, DOI 10.1007/s00520-014-2582-8; Mellinghoff SC, 2018, ANN HEMATOL, V97, P197, DOI 10.1007/s00277-017-3196-2; Micozzi A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2297-9; Neumann S, 2013, ANN HEMATOL, V92, P433, DOI 10.1007/s00277-013-1698-0; Satlin MJ, 2014, CLIN INFECT DIS, V58, P1274, DOI 10.1093/cid/ciu052; Scheich S, 2017, BIOL BLOOD MARROW TR, V23, P1455, DOI 10.1016/j.bbmt.2017.05.016; Sostarich AM, 2008, INFECTION, V36, P31, DOI 10.1007/s15010-007-6316-4; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Trecarichi EM, 2016, AM J HEMATOL, V91, P1076, DOI 10.1002/ajh.24489; Vehreschild MJGT, 2014, J ANTIMICROB CHEMOTH, V69, P3387, DOI 10.1093/jac/dku305; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; WIERNIK PH, 1989, SEMIN ONCOL, V16, P25	34	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210991	10.1371/journal.pone.0210991	http://dx.doi.org/10.1371/journal.pone.0210991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673776	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800061
J	Darwish, HYA; Dalirsefat, SB; Dong, XG; Hua, GY; Chen, JF; Zhang, YY; Li, JX; Xu, JS; Li, JY; Deng, XM; Wu, CX				Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Jianxiong; Xu, Jiansheng; Li, Junying; Deng, Xuemei; Wu, Changxin			Genome-wide association study and a post replication analysis revealed a promising genomic region and candidate genes for chicken eggshell blueness	PLOS ONE			English	Article							PRINCIPAL-COMPONENTS; PIGMENTS; STRATIFICATION; PROLIFERATION; BILIVERDIN; AJAP1; 1P36	The eggshell blueness is an interesting object for chicken genetic studies and blue-shelled chicken industry, especially after the discovery of the causative mutation of chicken blue eggshell. In the present study, genome wide association study (GWAS) was conducted in Chinese Dongxiang blue-shelled chicken underlying four traits of blue eggshell pigments: quantity of biliverdin (QB), quantity of protoporphyrin (QP), quantity of total pigment (QT), and color density trait (CD). A total of 139 individuals were randomly collected for GWAS. We detected two SNPs in genome-wise significance and 35 in suggestive significance, 24 out of the 37 SNP were located either within intron/exon or near 15 genes in a range of -1.17 Mb on GGA21. For further confirmation of the identified SNP loci by GWAS, the follow-up replication studies were performed in two populations. A total of 146 individuals of the second generation derived from the former GWAS population, as well as 280 individuals from an alternative independent population were employed for genotyping by MALDI-TOF MS in a genotype-phenotype association study. Eighteen SNPs evenly distributed on the GGA21 significant region were successfully genotyped in the two populations, of which 4 and 6 SNP loci were shown significantly associated with QB, QT and QP in the two repeat populations, respectively. Further, the SNPs were narrowed down to a region of similar to 653.819 Kb on GGA21 that harbors five candidate genes: AJAP1, TNFRSF9, C1ORF174, CAMTA1, and CEP104. Shell gland of chickens laying dark and light blue eggshell was chosen for detection of mRNA expression of the five candidate genes. The results showed differential expression levels of these genes in the two groups. The specific function of these genes has not yet been defined clearly in chickens and further in-depth studies are needed to explore the new functional role in chicken eggshell blueness.	[Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Junying; Deng, Xuemei; Wu, Changxin] China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Darwish, Hesham Y. A.; Dalirsefat, Seyed Benyamin; Dong, Xianggui; Hua, Guoying; Chen, Jianfei; Zhang, Yuanyuan; Li, Junying; Deng, Xuemei; Wu, Changxin] China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China; [Darwish, Hesham Y. A.] Minist Agr & Land Reclamat, Agr Res Ctr, Res Inst Anim Prod, Giza, Egypt; [Dalirsefat, Seyed Benyamin] Univ Guilan, Fac Agr Sci, Dept Anim Sci, Rasht, Guilan, Iran; [Li, Jianxiong; Xu, Jiansheng] Jiangxi Donghua Livestock & Poultry Breeding Co L, Fuzhou, Jiangxi, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Ministry of Agriculture & Land Reclamation - Egypt; University of Guilan	Deng, XM (corresponding author), China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.; Deng, XM (corresponding author), China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing, Peoples R China.	deng@cau.edu.cn		Zhang, Yuanyuan/0000-0001-7442-6846; Chen, Jianfei/0000-0001-6575-4493; Darwish, Hesham Y. A./0000-0002-4965-3630	National 863 Project of China [2013AA102501]; National Natural Science Foundation [31072024]; China Agriculture Research System [CARS-41]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_15R62]	National 863 Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by grants from the National 863 Project of China (2013AA102501) to XMD, the National Natural Science Foundation (31072024) to XMD, the China Agriculture Research System (CARS-41) to CXW and the Program for Changjiang Scholars and Innovative Research Team in University (IRT_15R62). The funder National 863 Project of China provided support in the form of salaries for authors XGD, GYH, JFC, YYZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors JXL, JSX related to Jiangxi Donghua Livestock & Poultry Breeding Co. Ltd., Jiangxi, China did only play a role in blood and tissue sample collection, and had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Adkerson T, REV EGG COLOR CHICKE; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Butcher GD, 1995, FACTORS CAUSING POOR; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Falconer D. S., 1996, Introduction to quantitative genetics.; Gross JC, 2009, MOL BIOL CELL, V20, P3598, DOI 10.1091/mbc.E08-12-1240; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; HIMES JA, 1975, CORNELL VET, V65, P374; Hotte K, 2017, BIOL OPEN, V6, P723, DOI 10.1242/bio.022335; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; KENNEDY GY, 1973, COMP BIOCHEM PHYSIOL, V44, P11; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LANG MR, 1987, WORLD POULTRY SCI J, V43, P238, DOI 10.1079/WPS19870016; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lin NJ, 2012, MOL CANCER RES, V10, P208, DOI 10.1158/1541-7786.MCR-10-0109; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Nicodemus KK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S78; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punnett RC, 1933, J GENET, V27, P465, DOI 10.1007/BF02981757; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; Scott TA, 2000, POULTRY SCI, V79, P1725, DOI 10.1093/ps/79.12.1725; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Sun CJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1795-7; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Wang D, 2009, BMC P; Wang XT, 2007, POULTRY SCI, V86, P2236, DOI 10.1093/ps/86.10.2236; Wang XT, 2009, POULTRY SCI, V88, P1735, DOI 10.3382/ps.2008-00434; Wang ZP, 2011, J ANIM VET ADV, V10, P92; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Wragg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071393; Zeng L, 2014, INT J ONCOL, V45, P13, DOI 10.3892/ijo.2014.2425; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619; Zhao R, 2006, POULTRY SCI, V85, P546, DOI 10.1093/ps/85.3.546	41	3	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209181	10.1371/journal.pone.0209181	http://dx.doi.org/10.1371/journal.pone.0209181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673708	gold, Green Published, Green Submitted			2022-12-27	WOS:000456442800014
J	Magnusdottir, EE; Lim, R				Magnusdottir, Edda E.; Lim, Rangyn			Subarctic singers: Humpback whale (Megaptera novaeangliae) song structure and progression from an Icelandic feeding ground during winter	PLOS ONE			English	Article							NORTH PACIFIC; ACOUSTIC DETECTIONS; MIGRATION; HAWAIIAN; OCEAN; VOCALIZATIONS; EXCHANGE; DISTANCE; WESTERN; SEX	Humpback whale songs associated with breeding behaviors are increasingly reported outside of traditional low latitude breeding grounds. Songs from a subarctic feeding ground during the winter were quantitatively characterized to investigate the structure and temporal changes of the songs at such an atypical location. Recordings were collected from 26. January to 12. March, 2011, using bottom mounted recorders. Humpback songs were detected on 91% of the recording days with peak singing activities during 9.-26. February. The majority of the recordings included multiple chorusing singers. The songs were characterized by a) common static themes which transitioned consistently to predictable themes, b) shifting themes which occurred less predictably and c) rare themes. A set median sequence was found for four different periods (sets) of recordings (approximately 1 week each). The set medians were highly similar and formed a single cluster indicating that the sequences of themes sung in this area belonged to a single cluster of songs despite of the variation caused by the shifting themes. These subarctic winter songs could, thus, represent a characteristic song type for this area which is comparable to extensively studied songs from traditional low latitude breeding grounds. An increase in the number of themes per sequence was observed throughout the recording period including minor changes in the application of themes in the songs; indicating a gradual song progression. The results confirm that continual singing of sophisticated songs occur during the breeding season in the subarctic. In addition to being a well-established summer feeding ground the study area appears to be an important overwintering site for humpback whales delaying or canceling their migration where males engage in active sexual displays, i.e. singing. Importantly, such singing activity on a shared feeding ground likely aids the cultural transmission of songs in the North Atlantic.	[Magnusdottir, Edda E.; Lim, Rangyn] Univ Iceland, Res Ctr Husavik, Husavik, Iceland; [Magnusdottir, Edda E.; Lim, Rangyn] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Magnusdottir, EE (corresponding author), Univ Iceland, Res Ctr Husavik, Husavik, Iceland.; Magnusdottir, EE (corresponding author), Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland.	eddaem@hi.is		Magnusdottir, Edda/0000-0001-8281-4232	Doctoral Grants of The University of Iceland Research Fund (in Icelandic); Conservation Fund of Palmi Jonasson	Doctoral Grants of The University of Iceland Research Fund (in Icelandic); Conservation Fund of Palmi Jonasson	This research was funded by the Doctoral Grants of The University of Iceland Research Fund (in Icelandic), 200913-Doktorsstyrkir Rannsoknasjoos Haskola Islands to EEM; http://sjodir.hi.is/sites/sjodir.hi.is/files/rsj_pdf_uthl2009.pdf. Further information about the grant can be found at the funder's website: http://sjodir.hi.is/research_funds_0. The second funder is The Conservation Fund of Palmi Jonasson, and a list of grant receivers can be found at the following webpage: http://www.natturuverndarsjodur.is/subpage2_2.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; Barlow J, 1997, ECOLOGY, V78, P535; BROWN MR, 1995, P ROY SOC B-BIOL SCI, V259, P229, DOI 10.1098/rspb.1995.0034; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; CHITTLEBOROUGH R. G., 1958, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V9, P1; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; CLAPHAM PJ, 1987, CAN J ZOOL, V65, P2853, DOI 10.1139/z87-434; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; CLAPHAM PJ, 1993, CAN J ZOOL, V71, P440, DOI 10.1139/z93-063; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Craig AS, 1997, CAN J ZOOL, V75, P1923, DOI 10.1139/z97-822; Darling JD, 2014, AQUAT BIOL, V21, P93, DOI 10.3354/ab00570; Darling JD, 2012, J ACOUST SOC AM, V132, P2955, DOI 10.1121/1.4757739; Darling JD, 2001, MAR MAMMAL SCI, V17, P570, DOI 10.1111/j.1748-7692.2001.tb01005.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; de Heus L, 2014, THESIS; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; DOBSON CW, 1979, BEHAVIOUR, V68, P86, DOI 10.1163/156853979X00250; Eriksen N, 2005, BEHAVIOUR, V142, P305, DOI 10.1163/1568539053778283; Garland EC, 2015, CONSERV BIOL, V29, P1198, DOI 10.1111/cobi.12492; Garland EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079422; Garland EC, 2012, BEHAVIOUR, V149, P1413, DOI 10.1163/1568539X-00003032; Garland EC, 2013, J ACOUST SOC AM, V133, P560, DOI 10.1121/1.4770232; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gunnlaugsson T., 1988, REPORT INT WHALING C, V38, P489; Helweg DA, 1998, BEHAVIOUR, V135, P1; Herman LM, 2013, BEHAV ECOL SOCIOBIOL, V67, P1653, DOI 10.1007/s00265-013-1576-8; Katahira K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024516; Kennedy AS, 2014, CAN J ZOOL, V92, P9, DOI 10.1139/cjz-2013-0161; KOHONEN T, 1985, PATTERN RECOGN LETT, V3, P309, DOI 10.1016/0167-8655(85)90061-3; Lagerquist BA, 2008, MAR MAMMAL SCI, V24, P815, DOI 10.1111/j.1748-7692.2008.00217.x; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; LEMON RE, 1973, ANIM BEHAV, V21, P28, DOI 10.1016/S0003-3472(73)80037-5; LEMON RE, 1971, ANIM BEHAV, V19, P1, DOI 10.1016/S0003-3472(71)80129-X; Lim R. H., 2014, THESIS; Magnusdottir EE, 2015, J ACOUST SOC AM, V138, P3362, DOI 10.1121/1.4935517; Magnusdottir EE, 2014, POLAR BIOL, V37, P427, DOI 10.1007/s00300-014-1448-3; Marcoux M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1093, DOI 10.1007/s00265-006-0342-6; Mate BR, 1998, CAN J ZOOL, V76, P863, DOI 10.1139/cjz-76-5-863; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Mellinger DK., 2002, ISHMAEL 1 0 USERS GU; Mercado E, 2005, ANIM COGN, V8, P93, DOI 10.1007/s10071-004-0238-7; Mercado E, 2010, J ACOUST SOC AM, V127, P2678, DOI 10.1121/1.3309453; MOBLEY JR, 1988, BEHAV ECOL SOCIOBIOL, V23, P211, DOI 10.1007/BF00302944; Murray A, 2012, MAR MAMMAL SCI, V28, pE41, DOI 10.1111/j.1748-7692.2011.00484.x; Nishiwaki M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P49; Nishiwaki M., 1962, Scientific Reports of the Whales Research Institute Tokyo, VNo. 16, P19; Nishiwaki M., 1960, Sci Sep Whales Res Inst, V15, P1; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; Payne K., 1983, COMMUNICATION BEHAV, P9; Payne K, 2000, PROGR CHANGING SONGS, P135; Payne R., 1983, COMMUN BEHAV WHALES, V20, P333; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Petroni F, 2010, PHYSICA A, V389, P2280, DOI 10.1016/j.physa.2010.02.004; Reilly SB, 2008, MEGAPTERA NOVAEANGLI; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; SILBER GK, 1986, CAN J ZOOL, V64, P2075, DOI 10.1139/z86-316; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Smith Tim D., 2009, NAMMCO Scientific Publications, V7, P161; Stevick PT, 2006, J ZOOL, V270, P244, DOI 10.1111/j.1469-7998.2006.00128.x; Stevick PT, 2016, J MAR BIOL ASSOC UK, V96, P885, DOI 10.1017/S0025315416000321; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Stimpert AK, 2011, J ACOUST SOC AM, V129, P476, DOI 10.1121/1.3504708; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Tougaard J, 2006, BEHAVIOUR, V143, P239, DOI 10.1163/156853906775900685; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Van Opzeeland I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073007; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; WINN HE, 1981, BEHAV ECOL SOCIOBIOL, V8, P41, DOI 10.1007/BF00302842; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	82	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210057	10.1371/journal.pone.0210057	http://dx.doi.org/10.1371/journal.pone.0210057			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673737	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800028
J	Newey, R; Koldewyn, K; Ramsey, R				Newey, Rachel; Koldewyn, Kami; Ramsey, Richard			The influence of prosocial priming on visual perspective taking and automatic imitation	PLOS ONE			English	Article							MIND USE; COMPATIBILITY; MIMICRY; CONSEQUENCES; PERCEPTION; KNOWLEDGE; BEHAVIOR	Imitation and perspective taking are core features of non-verbal social interactions. We imitate one another to signal a desire to affiliate and consider others' points of view to better understand their perspective. Prior research suggests that a relationship exists between prosocial behaviour and imitation. For example, priming prosocial behaviours has been shown to increase imitative tendencies in automatic imitation tasks. Despite its importance during social interactions, far less is known about how perspective taking might relate to either prosociality or imitation. The current study investigates the relationship between automatic imitation and perspective taking by testing the extent to which these skills are similarly modulated by prosocial priming. Across all experimental groups, a surprising ceiling effect emerged in the perspective taking task (the Director's Task), which prevented the investigation of prosocial priming on perspective taking. A comparison of other studies using the Director's Task shows wide variability in accuracy scores across studies and is suggestive of low task reliability. In addition, despite using a high-power design, and contrary to three previous studies, no effect of prosocial prime on imitation was observed. Meta-analysing all studies to date suggests that the effects of prosocial primes on imitation are variable and could be small. The current study, therefore, offers caution when using the computerised Director's Task as a measure of perspective taking with adult populations, as it shows high variability across studies and may suffer from a ceiling effect. In addition, the results question the size and robustness of prosocial priming effects on automatic imitation. More generally, by reporting null results we hope to minimise publication bias and by meta-analysing results as studies emerge and making data freely available, we hope to move towards a more cumulative science of social cognition.	[Newey, Rachel; Koldewyn, Kami; Ramsey, Richard] Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales	Bangor University	Koldewyn, K; Ramsey, R (corresponding author), Bangor Univ, Sch Psychol, Wales Inst Cognit Neurosci, Bangor, Gwynedd, Wales.	r.ramsey@bangor.ac.uk; k.koldewyn@bangor.ac.uk	Koldewyn, Kami/Q-6108-2019; Newey, Rachel/U-8147-2019	Koldewyn, Kami/0000-0003-3588-6449; Ramsey, Richard/0000-0002-0329-2112; Newey, Rachel/0000-0001-7242-7167				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Albers C, 2018, J EXP SOC PSYCHOL, V74, P187, DOI 10.1016/j.jesp.2017.09.004; Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; Apperly IA, 2010, Q J EXP PSYCHOL, V63, P1201, DOI 10.1080/17470210903281582; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Boyer TW, 2012, ACTA PSYCHOL, V139, P440, DOI 10.1016/j.actpsy.2012.01.003; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Carpenter M, 2013, CHILD DEV, V84, P1511, DOI 10.1111/cdev.12083; Catmur C, 2011, J EXP PSYCHOL HUMAN, V37, P409, DOI 10.1037/a0019325; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cumming G., 2013, UNDERSTANDING NEW ST; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Dienes Z, 2016, J MATH PSYCHOL, V72, P78, DOI 10.1016/j.jmp.2015.10.003; Dumontheil I, 2012, J COGNITIVE NEUROSCI, V24, P2080, DOI 10.1162/jocn_a_00268; Dumontheil I, 2010, NEUROIMAGE, V52, P1574, DOI 10.1016/j.neuroimage.2010.05.056; Dumontheil I, 2010, DEVELOPMENTAL SCI, V13, P331, DOI 10.1111/j.1467-7687.2009.00888.x; Epley N, 2008, HDB IMAGINATION MENT, P295; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; FLAVELL JH, 1978, DEV PSYCHOL, V14, P462, DOI 10.1037/0012-1649.14.5.462; Fu┬rster J., 2009, OXFORD HDB HUMAN ACT, P173; Gillespie A, 2011, EUR J SOC PSYCHOL, V41, P608, DOI 10.1002/ejsp.788; Gowen E, 2016, COGNITION, V146, P431, DOI 10.1016/j.cognition.2015.10.010; Hale J, 2016, NEUROSCI BIOBEHAV R, V63, P106, DOI 10.1016/j.neubiorev.2016.02.006; Heyes C, 2014, PERSPECT PSYCHOL SCI, V9, P131, DOI 10.1177/1745691613518076; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jeffreys H., 1961, THEORY PROBABILITY; Jimenez L, 2012, ACTA PSYCHOL, V141, P96, DOI 10.1016/j.actpsy.2012.07.007; Keysar B, 2003, COGNITION, V89, P25, DOI 10.1016/S0010-0277(03)00064-7; Keysar B, 2000, PSYCHOL SCI, V11, P32, DOI 10.1111/1467-9280.00211; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Leslie A.M., 1994, MAPPING MIND DOMAIN, P119, DOI [10.1017/cbo9780511752902.006, DOI 10.1017/CBO9780511752902.006]; Macrae CN, 1998, SOC COGNITION, V16, P400, DOI 10.1521/soco.1998.16.4.400; Muller BCN, 2012, PSYCHOL REP, V110, P891, DOI 10.2466/07.09.21.PR0.110.3.891-898; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Ramsey R, 2018, CONSCIOUS COGN, V65, P240, DOI 10.1016/j.concog.2018.08.006; Rosenberg M., 1965, ACCEPTANCE COMMITMEN, P61, DOI [DOI 10.1037/T01038-000, 10.1002/jcop.20412]; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rubio-Fernandez P, 2017, PSYCHON B REV, V24, P1121, DOI 10.3758/s13423-016-1190-7; Santiesteban I, 2015, PSYCHONOMIC B REV, V22; Santiesteban I, 2012, COGNITION, V122, P228, DOI 10.1016/j.cognition.2011.11.004; Shaw DJ, 2017, PSYCHOL RES-PSYCH FO, V81, P1152, DOI 10.1007/s00426-016-0814-x; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; Steinbeis N, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0074; Surtees ADR, 2012, CHILD DEV, V83, P452, DOI 10.1111/j.1467-8624.2011.01730.x; Symeonidou I, 2016, J EXP CHILD PSYCHOL, V149, P81, DOI 10.1016/j.jecp.2015.11.007; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060249; Zwaan RA, 2018, BEHAV BRAIN SCI, V41, DOI 10.1017/S0140525X17001972	61	9	9	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0198867	10.1371/journal.pone.0198867	http://dx.doi.org/10.1371/journal.pone.0198867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673693	Green Published, Green Submitted, gold			2022-12-27	WOS:000456442800002
J	Krzyzanowska, DM; Maciag, T; Ossowicki, A; Rajewska, M; Kaczynski, Z; Czerwicka, M; Rabalski, L; Czaplewska, P; Jafra, S				Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Kaczynski, Zbigniew; Czerwicka, Malgorzata; Rabalski, Lukasz; Czaplewska, Paulina; Jafra, Sylwia			Ochrobactrum quorumnocens sp. nov., a quorum quenching bacterium from the potato rhizosphere, and comparative genome analysis with related type strains	PLOS ONE			English	Article							UREASE GENE-CLUSTER; IDENTIFICATION; VIRULENCE; SUBSTITUTIONS; INACTIVATION; GENERATION; PATHOGEN; STANDARD; SIGNAL; ROOTS	Ochrobactrum spp. are ubiquitous bacteria attracting growing attention as important members of microbiomes of plants and nematodes and as a source of enzymes for biotechnology. Strain Ochrobactrum sp. A44(T) was isolated from the rhizosphere of a field-grown potato in Gelderland, the Netherlands. The strain can interfere with quorum sensing (QS) of Gram-negative bacteria through inactivation of N-acyl homoserine lactones (AHLs) and protect plant tissue against soft rot pathogens, the virulence of which is governed by QS. Phylo-genetic analysis based on 16S rRNA gene alone and concatenation of 16S rRNA gene and MLSA genes (groEL and gyrB) revealed that the closest relatives of A44(T) are O. grignonense OgA9a(T), O. thiophenivorans DSM 7216(T), O. pseudogrignonense CCUG 30717(T), O. pituitosum CCUG 50899(T), and O. rhizosphaerae PR17(T). Genomes of all six type strains were sequenced, significantly expanding the possibility of genome-based analyses in Ochrobactrum spp. Average nucleotide identity (ANIb) and genome-to-genome distance (GGDC) values for A44(T) and the related strains were below the single species thresholds (95% and 70%, respectively), with the highest scores obtained for O. pituitosum CCUG 50899(T) (87.31%; 35.6%), O. rhizosphaerae PR17(T) (86.80%; 34.3%), and O. grignonense OgA9a(T) (86.30%; 33.6%). Distinction of A44(T) from the related type strains was supported by chemotaxonomic and biochemical analyses. Comparative genomics revealed that the core genome for the newly sequenced strains comprises 2731 genes, constituting 50-66% of each individual genome. Through phenotype-to-genotype study, we found that the non-motile strain O. thiophenivorans DSM 7216(T) lacks a cluster of genes related to flagella formation. Moreover, we explored the genetic background of distinct urease activity among the strains. Here, we propose to establish a novel species Ochrobactrum quorumnocens, with A44(T) as the type strain (= LMG 30544(T) = PCM 2957(T)).	[Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Jafra, Sylwia] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Biol Plant Protect, Gdansk, Poland; [Krzyzanowska, Dorota M.; Maciag, Tomasz; Ossowicki, Adam; Rajewska, Magdalena; Rabalski, Lukasz; Czaplewska, Paulina; Jafra, Sylwia] Univ Gdansk, Med Univ Gdansk, Gdansk, Poland; [Kaczynski, Zbigniew; Czerwicka, Malgorzata] Univ Gdansk, Lab Struct Biochem, Fac Chem, Gdansk, Poland; [Rabalski, Lukasz] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Recombinant Vaccines, Gdansk, Poland; [Czaplewska, Paulina] Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Mass Spectrometry, Gdansk, Poland; [Ossowicki, Adam] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Jafra, S (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Lab Biol Plant Protect, Gdansk, Poland.; Jafra, S (corresponding author), Univ Gdansk, Med Univ Gdansk, Gdansk, Poland.	sylwia.jafra@biotech.ug.edu.pl	Ossowicki, Adam/B-6787-2018; Krzyzanowska, Dorota Magdalena/ABA-7067-2021; Rabalski, Lukasz/GON-8553-2022; KNAW, NIOO-KNAW/A-4320-2012	Ossowicki, Adam/0000-0003-1903-9688; Krzyzanowska, Dorota Magdalena/0000-0003-0177-377X; Rabalski, Lukasz/0000-0002-5292-9263; Maciag, Tomasz/0000-0002-4019-5944; Jafra, Sylwia/0000-0002-4194-6180; Kaczynski, Zbigniew/0000-0002-4590-4690; KNAW, NIOO-KNAW/0000-0002-3835-159X; Czaplewska, Paulina/0000-0002-6469-6014; Rajewska, Magdalena/0000-0001-7322-2374	National Science Centre, Poland (Narodowe Centrum Nauki, Polska) [2014/13/B/NZ9/02136]; personal scholarship START 2017 - Foundation for Polish Science (FNP) [START 40.2017]	National Science Centre, Poland (Narodowe Centrum Nauki, Polska); personal scholarship START 2017 - Foundation for Polish Science (FNP)	This study was funded by the National Science Centre, Poland (Narodowe Centrum Nauki, Polska) research grant 2014/13/B/NZ9/02136 to SJ. DK was supported by a personal scholarship START 2017 (START 40.2017) granted by the Foundation for Polish Science (FNP).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aujoulat F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083376; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bohlin J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-249; Cegelski L, 2009, NAT REV MICROBIOL, V7, P836, DOI 10.1038/nrmicro2244; Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11; CHATTERJEE A, 1995, APPL ENVIRON MICROB, V61, P1959, DOI 10.1128/AEM.61.5.1959-1967.1995; Czajkowski R, 2011, ENV MICROBIOL REP, V3, P59, DOI 10.1111/j.1758-2229.2010.00188.x; De Reuse H, 2001, NITROGEN METABOLISM; deKoningWard TF, 1997, FEMS MICROBIOL LETT, V147, P221, DOI 10.1016/S0378-1097(96)00528-9; Dirksen P, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0258-1; Dziewit L, 2015, METHODS MOL BIOL, V1231, P15, DOI 10.1007/978-1-4939-1720-4_2; Fujii T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14276; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Gohil KN, 2016, GENOM DATA, V8, P72, DOI 10.1016/j.gdata.2016.04.003; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Guimaraes LC, 2015, CURR GENOMICS, V16, P245, DOI 10.2174/1389202916666150423002311; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; HOLMES B, 1988, INT J SYST BACTERIOL, V38, P406, DOI 10.1099/00207713-38-4-406; Huang SW, 2012, INT J MOL SCI, V13, P2563, DOI 10.3390/ijms13032563; Huber B, 2010, INT J SYST EVOL MICR, V60, P321, DOI 10.1099/ijs.0.011668-0; Jafra S, 2006, CAN J MICROBIOL, V52, P1006, DOI 10.1139/W06-062; Jafra S, 2004, J MICROBIOL METH, V57, P415, DOI 10.1016/j.mimet.2004.01.015; Kampfer P, 2008, INT J SYST EVOL MICR, V58, P1426, DOI 10.1099/ijs.0.65407-0; Kampfer P, 2007, INT J SYST EVOL MICR, V57, P2513, DOI 10.1099/ijs.0.65066-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kulkarni G, 2017, J INFECT PUBLIC HEAL, V10, P201, DOI 10.1016/j.jiph.2016.04.013; Kulkarni G, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-7; Kulkarni GJ, 2014, FEMS MICROBIOL LETT, V359, P12, DOI 10.1111/1574-6968.12549; Kumar SS, 2012, J HAZARD MATER, V199, P58, DOI 10.1016/j.jhazmat.2011.10.053; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Li L, 2016, ARCH MICROBIOL, V198, P171, DOI 10.1007/s00203-015-1170-8; McMillan DJ, 1998, GENE, V208, P243, DOI 10.1016/S0378-1119(97)00651-3; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Paulucci NS, 2015, MICROBIOL RES, V173, P1, DOI 10.1016/j.micres.2014.12.012; PIRHONEN M, 1993, EMBO J, V12, P2467, DOI 10.1002/j.1460-2075.1993.tb05901.x; Pohlner M, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00541-17; Pozo C, 2002, J APPL MICROBIOL, V92, P1028, DOI 10.1046/j.1365-2672.2002.01613.x; Qiu XH, 2006, J APPL MICROBIOL, V101, P986, DOI 10.1111/j.1365-2672.2006.03016.x; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2017, ANTON LEEUW INT J G, V110, P455, DOI 10.1007/s10482-017-0841-7; Sambrook J, 2001, MOL CLONING LAB MANU; Sangari FJ, 2007, INFECT IMMUN, V75, P774, DOI 10.1128/IAI.01244-06; Scholz HC, 2008, SYST APPL MICROBIOL, V31, P1, DOI 10.1016/j.syapm.2007.10.004; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sipahutar MK, 2017, J HAZARD MATER, V329, P38, DOI 10.1016/j.jhazmat.2017.01.020; Sonke T, 2005, APPL ENVIRON MICROB, V71, P7961, DOI 10.1128/AEM.71.12.7961-7973.2005; Sumayo M, 2013, PLANT PATHOLOGY J, V29, P174, DOI 10.5423/PPJ.SI.09.2012.0143; Swift Simon, 2008, P179, DOI 10.1007/978-3-540-74921-9_7; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Teyssier C, 2005, J MED MICROBIOL, V54, P945, DOI 10.1099/jmm.0.46116-0; Toffanin A, 2002, ARCH MICROBIOL, V177, P290, DOI 10.1007/s00203-001-0392-0; Trujillo ME, 2005, APPL ENVIRON MICROB, V71, P1318, DOI 10.1128/AEM.71.3.1318-1327.2005; Velasco J, 1998, INT J SYST EVOL MICR, V48; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Wozniak-Karczewska M, 2018, NEW BIOTECHNOL, V43, P37, DOI 10.1016/j.nbt.2017.07.006; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0	65	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210874	10.1371/journal.pone.0210874	http://dx.doi.org/10.1371/journal.pone.0210874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668584	Green Published, Green Submitted, gold			2022-12-27	WOS:000456306400022
J	Li, ZH; Hsiao, Y; Godwin, J; Martin, BD; Wakefield, J; Clark, SJ; Hug, L; Sharrow, D; Zhong, K; You, DZ; Ho, J; Mahanani, WR; Fat, DM; Grove, J; Strong, KL; Suzuki, E; Gaigbe-Togbe, V; Gerland, P; Andreev, K; Gu, DA; Spoorenberg, T; Bay, G; Black, R; Alkema, L; Cousens, S; Croft, T; Guillot, M; Masquelier, B; Hill, K; Pedersen, J; Walker, N				Li, Zehang; Hsiao, Yuan; Godwin, Jessica; Martin, Bryan D.; Wakefield, Jon; Clark, Samuel J.; Hug, Lucia; Sharrow, David; Zhong, Kai; You, Danzhen; Ho, Jessica; Mahanani, Wahyu Retno; Fat, Doris Ma; Grove, John; Strong, Kathleen Louise; Suzuki, Emi; Gaigbe-Togbe, Victor; Gerland, Patrick; Andreev, Kirill; Gu, Danan; Spoorenberg, Thomas; Bay, Guiomar; Black, Robert; Alkema, Leontine; Cousens, Simon; Croft, Trevor; Guillot, Michel; Masquelier, Bruno; Hill, Kenneth; Pedersen, Jon; Walker, Neff		United Nations Inter-Agcy Grp Chil; Tech Advisory Grp	Changes in the spatial distribution of the under-five mortality rate: Small-area analysis of 122 DHS surveys in 262 subregions of 35 countries in Africa	PLOS ONE			English	Article							CHILD-MORTALITY; INEQUALITIES; MODELS	The under-five mortality rate (U5MR) is a critical and widely available population health indicator. Both the MDGs and SDGs define targets for improvement in the U5MR, and the SDGs require spatial disaggregation of indicators. We estimate trends in the U5MR for Admin-1 subnational areas using 122 DHS surveys in 35 countries in Africa and assess progress toward the MDG target reductions for each subnational region and each country as a whole. In each country, direct weighted estimates of the U5MR from each survey are calculated and combined into a single estimate for each Admin-1 region across five-year periods. Our method fully accounts for the sample design of each survey. The region-timespecific estimates are smoothed using a Bayesian, space-time model that produces more precise estimates (when compared to the direct estimates) at a one-year scale that are consistent with each other in both space and time. The resulting estimated distributions of the U5MR are summarized and used to assess subnational progress toward the MDG 4 target of two-thirds reduction in the U5MR during 1990-2015. Our space-time modeling approach is tractable and can be readily applied to a large collection of sample survey data. Subnational, regional spatial heterogeneity in the levels and trends in the U5MR vary considerably across Africa. There is no generalizable pattern between spatial heterogeneity and levels or trends in the U5MR. Subnational, small-area estimates of the U5MR: (i) identify subnational regions where interventions are still necessary and those where improvement is well under way; and (ii) countries where there is very little spatial variation and others where there are important differences between subregions in both levels and trends. More work is necessary to improve both the data sources and methods necessary to adequately measure subnational progress toward the SDG child survival targets.	[Li, Zehang] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Hsiao, Yuan; Godwin, Jessica; Martin, Bryan D.; Wakefield, Jon] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Wakefield, Jon] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hsiao, Yuan] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA; [Clark, Samuel J.] Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Hug, Lucia; Sharrow, David; Zhong, Kai; You, Danzhen] United Nations Childrens Fund, New York, NY USA; [Ho, Jessica; Mahanani, Wahyu Retno; Fat, Doris Ma; Grove, John; Strong, Kathleen Louise] WHO, Geneva, Switzerland; [Suzuki, Emi] World Bank Grp, Washington, DC USA; [Gaigbe-Togbe, Victor; Gerland, Patrick; Andreev, Kirill; Gu, Danan; Spoorenberg, Thomas] UN, Dept Econ & Social Affairs, Populat Div, New York, NY USA; [Bay, Guiomar] United Nations Econ Commiss Latin Amer & Caribbea, Populat Div, Santiago, Chile; [Black, Robert; Pedersen, Jon; Walker, Neff] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Alkema, Leontine] Univ Massachusetts, Amherst, MA 01003 USA; [Cousens, Simon] London Sch Hyg & Trop Med, London, England; [Croft, Trevor] ICF, DHS Program, Fairfax, VA USA; [Guillot, Michel] Univ Penn, Philadelphia, PA 19104 USA; [Guillot, Michel] INED, French Inst Demog Studies, Paris, France; [Masquelier, Bruno] Univ Louvain, Louvain La Neuve, Belgium; [Hill, Kenneth] Stanton Hill Res, Nottingham, England	Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of Witwatersrand; UNICEF; World Health Organization; The World Bank; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Amherst; University of London; London School of Hygiene & Tropical Medicine; University of Pennsylvania; Universite Catholique Louvain	Clark, SJ (corresponding author), Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA.; Clark, SJ (corresponding author), Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	work@samclark.net	Clark, Samuel J/A-8419-2009; Hsiao, Yuan/V-4587-2019; Spoorenberg, Thomas/H-4167-2019	Clark, Samuel J/0000-0002-4929-6231; Spoorenberg, Thomas/0000-0001-8608-1398; Li, Zehang/0000-0001-9551-9638	National Institutes of Health (NIH) [NIH R01AI029168, NIH R01CA095994, NIH R01HD086227]; National Science Foundation (NSF) [NSF DGE-1256082]; NIH [P2CHD042828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD042828, R01HD086227] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029168] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH): https://www.nih.gov (JG, NIH R01AI029168; JW, NIH R01CA095994; and SC, NIH R01HD086227) and National Science Foundation (NSF): https://nsf.gov (BM, NSF DGE-1256082). This work was also supported by computing support from NIH P2CHD042828 to the Center for Studies in Demography and Ecology at the University of Washington. The funders had no role in the study design or any other aspect of the work.	Alkema L, 2014, ANN APPL STAT, V8, P2122, DOI 10.1214/14-AOAS768; Allison P.D., 2014, EVENT HIST SURVIVAL, V46; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Amouzou A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-216; [Anonymous], R LANG ENV STAT COMP; [Anonymous], 2017, MILL DEV GOALS; [Anonymous], 2000, STAT MODELS EPIDEMIO, DOI 10.1007/978-1-4612-1284-3_4; [Anonymous], 2017, SUST DEV KNOWL PLATF; Arku RE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002038; Balk D., 2004, Population, Space and Place, V10, P175, DOI 10.1002/psp.328; Bauze AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037861; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bhutta ZA, 2016, LANCET GLOB HEALTH, V4, pE877, DOI 10.1016/S2214-109X(16)30264-9; Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI [10.1016/s2214-109x(16)30212-1, 10.1016/S2214-109X(16)30212-1]; Chen CC, 2014, SPAT SPATIO-TEMPORAL, V11, P33, DOI 10.1016/j.sste.2014.07.002; Chin B, 2011, HEALTH PLACE, V17, P929, DOI 10.1016/j.healthplace.2011.04.006; De P, 2013, J CHILD HEALTH CARE, V17, P397, DOI 10.1177/1367493512468359; Dwyer-Lindgren L, 2014, SPAT SPATIO-TEMPORAL, V11, P89, DOI 10.1016/j.sste.2014.09.002; Elliott P, 2000, SPATIAL EPIDEMIOLOGY; Golding N, 2017, LANCET, V390, P2171, DOI 10.1016/S0140-6736(17)31758-0; Hodge A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103597; Hosseinpoor AR, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0307-y; Hug L, 2017, LEVELS TRENDS CHILD; Jimenez-Soto E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109044; Kazembe L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001421; Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#; Li N., 2015, ESTIMATING LIFE TABL; Lumley T., 2018, SURVEY ANAL COMPLEX; Mercer LD, 2015, ANN APPL STAT, V9, P1889, DOI 10.1214/15-AOAS872; Microsoft R Open, 2021, R OP ENH DISTR MRAN; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Pezzulo C, 2016, GEOSPATIAL MODELING, P13; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Rao JN, 2015, SMALL AREA ESTIMATIO; RUE H., 2005, GAUSSIAN MARKOV RAND; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sachs J., 2021, CRISIS SUSTAINABLE D, DOI [DOI 10.1017/9781009106559, 10.1017/9781009106559, DOI 10.1017/9781009210058]; Sousa A, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-21; Wakefield J, 2019, STAT METHODS MED RES, V28, P2614, DOI 10.1177/0962280218767988; Walker N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001298; Waller L.A., 2004, APPL SPATIAL STAT PU; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	43	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210645	10.1371/journal.pone.0210645	http://dx.doi.org/10.1371/journal.pone.0210645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668609	gold, Green Published			2022-12-27	WOS:000456306400009
J	Yuan, ZY; Yan, JM; Wen, HY; Deng, XY; Li, XB; Su, ST				Yuan, Zhenya; Yan, Junmei; Wen, Hongyu; Deng, Xiaoyi; Li, Xianbin; Su, Siting			Feeding intolerance alters the gut microbiota of preterm infants	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; HEALTH; PROBIOTICS; HOST; CATALOG	Feeding intolerance (FI) is a common disease in preterm infants, often causing a delay in individual development. Gut microbiota play an important role in nutrient absorption and metabolism of preterm infants. To date, few studies have focused on the community composition of gut microbiota of preterm infants with feeding intolerance. In this study, we collected fecal samples from 41 preterm infants diagnosed with feeding intolerance and 29 preterm infants without feeding intolerance, at three specific times during the development and prevalence of feeding intolerance (after birth, when feeding intolerance was diagnosed, after feeding intolerance was gone), from different hospitals for 16S rRNA gene sequencing. The gut microbiota community composition of preterm infants diagnosed with feeding intolerance was significantly different from that of preterm infants without feeding intolerance. At the time when feeding intolerance was diagnosed, the relative abundance of Klebsiella in preterm infants with feeding intolerance increased significantly, and was significantly higher than that of the preterm infants without feeding intolerance. After feeding intolerance was cured, the relative abundance of Klebsiella significantly decreased in the infants diagnosed with feeding intolerance, while the relative abundance of Klebsiella in preterm infants without feeding intolerance was not significantly altered during the development and prevalence of feeding intolerance. Furthermore, we verified that Klebsiella was effective in the diagnosis of feeding intolerance (AUC = 1) in preterm infants, suggesting that Klebsiella is a potential diagnostic biomarker for feeding intolerance.	[Yuan, Zhenya; Wen, Hongyu; Li, Xianbin; Su, Siting] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China; [Yuan, Zhenya; Yan, Junmei; Deng, Xiaoyi] Xuzhou Matern & Child Hlth Care Hosp, Xuzhou, Jiangsu, Peoples R China	Jiangsu Normal University	Wen, HY (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Jiangsu, Peoples R China.	wenhy@jsnu.edu.cn		Yuan, Zhenya/0000-0003-2724-6003				Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Amarachintha S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19868-z; Biedermann L, 2015, EUR J PEDIATR, V174, P151, DOI 10.1007/s00431-014-2476-2; Brooks DH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00328-7; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Chen CM, 2012, PEDIATR NEONATOL, V53, P2, DOI 10.1016/j.pedneo.2011.11.002; Cong Xiaomei, 2016, Yale Journal of Biology and Medicine, V89, P299; Dang S, 2015, J PERINATOL, V35, P447, DOI 10.1038/jp.2014.234; Dessi A, 2016, EXPERT REV MOL DIAGN, V16, P1053, DOI 10.1080/14737159.2016.1211933; Dobbler PT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02243; Fanaro S, 2013, EARLY HUM DEV, V2, P13; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Grishin A, 2016, J PEDIATR SURG, V51, P13, DOI 10.1016/j.jpedsurg.2015.10.006; Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P2264, DOI 10.1001/jama.2016.4341; Kuhre RE, 2018, MOL METAB, V11, P84, DOI 10.1016/j.molmet.2018.03.007; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Martin R, 2014, VIRULENCE, V5, P413, DOI 10.4161/viru.27864; Moore Tiffany A, 2011, Adv Neonatal Care, V11, P149, DOI 10.1097/ANC.0b013e31821ba28e; Nagpal R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01997; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; Oncel MY, 2015, J MATERN-FETAL NEO M, V28, P1790, DOI 10.3109/14767058.2014.968842; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Patel RM, 2013, CLIN PERINATOL, V40, P11, DOI 10.1016/j.clp.2012.12.002; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusconi B, 2017, J PEDIATR-US, V189, P40, DOI 10.1016/j.jpeds.2017.05.075; Sancak S, 2016, J MATERN-FETAL NEO M, V29, P1853, DOI 10.3109/14767058.2015.1066327; Sanchez B, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600240; Sanders ME, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0629-z; Simioni J, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0724-5; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Trampert DC, 2018, BBA MOL CELL RES; von Mutius E, 2017, NAT MED, V23, P274, DOI 10.1038/nm.4299; Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988; Wen HY, 2018, J MICROBIOL BIOTECHN, V28, P652, DOI 10.4014/jmb.1711.11065	37	12	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210609	10.1371/journal.pone.0210609	http://dx.doi.org/10.1371/journal.pone.0210609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI2WF	30668607	gold, Green Published, Green Submitted			2022-12-27	WOS:000456306400008
J	Loibner, M; Hagauer, S; Schwantzer, G; Berghold, A; Zatloukal, K				Loibner, Martina; Hagauer, Sandra; Schwantzer, Gerold; Berghold, Andrea; Zatloukal, Kurt			Limiting factors for wearing personal protective equipment (PPE) in a health care environment evaluated in a randomised study	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; RESPIRATOR WEAR; WORKERS; VIRUS	Pandemics and re-emerging diseases put pressure on the health care system to prepare for patient care and sample logistics requiring enhanced personnel protective equipment (PPE) for health care workers. We generated quantifiable data on ergonomics of PPE applicable in a health care setting by defining error rates and physically limiting factors due to PPE-induced restrictions. Nineteen study volunteers tested randomly allocated head-or full body-ventilated PPE suits equipped with powered-air-purifying-respirators and performed four different tasks (two laboratory tutorials, a timed test of selective attention and a test investigating reaction time, mobility, speed and physical exercise) during 6 working hours at 22 degrees C on one day and 4 working hours at 28 degrees C on another day. Error rates and physical parameters (fluid loss, body temperature, heart rate) were determined and ergonomic-related parameters were assessed hourly using assessment sheets. Depending on the PPE system the most restrictive factors, which however had no negative impact on performance (speed and error rate), were: reduced dexterity due to multiple glove layers, impaired visibility by flexible face shields and back pain related to the respirator of the fully ventilated suit. Heat stress and liquid loss were perceived as restrictive at a working temperature of 28 degrees C but not 22 degrees C.	[Loibner, Martina; Hagauer, Sandra; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria; [Schwantzer, Gerold; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Christian Doppler Lab Biospecimen Res & Biobankin, Graz, Austria.	kurt.zatloukal@medunigraz.at	Schwantzer, Gerold/A-3209-2012	Schwantzer, Gerold/0000-0003-3349-1101; Zatloukal, Kurt/0000-0001-5299-7218	Christian Doppler Research Fund (Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development); ERINHA (European Research Infrastructure on Highly Pathogenic Agents, FP7-INFRA-2010-2-2.8)	Christian Doppler Research Fund (Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development); ERINHA (European Research Infrastructure on Highly Pathogenic Agents, FP7-INFRA-2010-2-2.8)	We would like to acknowledge the Christian Doppler Research Fund (Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development) and ERINHA (European Research Infrastructure on Highly Pathogenic Agents, FP7-INFRA-2010-2-2.8) for financial support of our research project to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGhamri AA, 2013, ERGONOMICS, V56, P791, DOI 10.1080/00140139.2013.767383; Brickenkamp R., 1998, D2 TEST OF ATTENTION; Caretti DM, 1999, AM IND HYG ASSOC J, V60, P213, DOI 10.1202/0002-8894(1999)060<0213:CPAMDR>2.0.CO;2; Caretti DM, 1997, AM IND HYG ASSOC J, V58, P105, DOI 10.1202/0002-8894(1997)058<0105:CPDLRW>2.0.CO;2; Castle N, 2009, RESUSCITATION, V80, P1290, DOI 10.1016/j.resuscitation.2009.08.001; CDC, 2015, INT GUID HEALTHC WOR; Centers for Disease Control and Prevention, 2015, GUID PERS PROT EQ PP; Garner Alan, 2004, Emerg Med Australas, V16, P108, DOI 10.1111/j.1742-6723.2004.00560.x; Hersi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140290; Honda H, 2016, CURR OPIN INFECT DIS, V29, P400, DOI 10.1097/QCO.0000000000000280; Kumin D, 2011, APPL BIOSAF, V16, P94; Li L, 2005, CLIN INFECT DIS, V41, P815, DOI 10.1086/432720; Liverman CT, 2015, FRONT MATTER USE EFF; MacDonald RD, 2006, PREHOSP EMERG CARE, V10, P254, DOI 10.1080/10903120500541076; MacIntyre CR, 2014, INT J NURS STUD, V51, P1421, DOI 10.1016/j.ijnurstu.2014.09.002; Merens A, 2012, EUROSURVEILLANCE, V17, P19; Mertens M, 2013, ANTIVIR RES, V98, P248, DOI 10.1016/j.antiviral.2013.02.007; O'Brien C, 2011, J OCCUP ENVIRON HYG, V8, P588, DOI 10.1080/15459624.2011.613291; Sprecher AG, 2015, J INFECT DIS S2, V212; Steward JA, 2012, VIRUSES-BASEL, V4, P1202, DOI 10.3390/v4081202; Wolfel R, 2015, EURO SURVEILL, V20; Zamora JE, 2006, CAN MED ASSOC J, V175, P249, DOI 10.1503/cmaj.060094; Zillmer EA, 1999, ARCH CLIN NEUROPSYCH, V14, P728; ZIMMERMAN NJ, 1991, ERGONOMICS, V34, P321, DOI 10.1080/00140139108967316	24	70	72	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2019	14	1							e0210775	10.1371/journal.pone.0210775	http://dx.doi.org/10.1371/journal.pone.0210775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI2WF	30668567	Green Published, gold, Green Submitted			2022-12-27	WOS:000456306400013
J	Feyissa, GT; Lockwood, C; Woldie, M; Munn, Z				Feyissa, Garumma Tolu; Lockwood, Craig; Woldie, Mirkuzie; Munn, Zachary			Reducing HIV-related stigma and discrimination in healthcare settings: A systematic review of quantitative evidence	PLOS ONE			English	Review							PEER-GROUP INTERVENTION; REDUCTION INTERVENTION; HOSPITAL WORKERS; NURSING-STUDENTS; HIV/AIDS STIGMA; KNOWLEDGE; ATTITUDES; EDUCATION; PEOPLE; IMPACT	Introduction Stigma and discrimination (SAD) related to HIV compromise access and adherence to treatment and support programs among people living with HIV (PLHIV). The ambitious goal of ending the epidemic of HIV by 2030 set by the United Nations Joint Program of HIV/AIDS (UNAIDS) will thus only be achieved if HIV-related stigma and discrimination are reduced. The objective of this review was to locate, appraise and describe international literature reporting on interventions that addressed HIV-related SAD in healthcare settings. Methods The databases searched were: Cumulative Index to Nursing and Allied Health (CINAHL), Excerpta Medica Database from Elsevier (EMBASE), PubMed and Psychological Information (PsycINFO) database. Two individuals independently appraised the quality of the papers using appraisal instruments from the Joanna Briggs Institute (JBI). Data were extracted from papers included in the review using the standardized data extraction tool from JBI. Quality of evidence for major outcomes was assessed using Grading of Recommendations, Assessment, Development and Evaluation (GRADE). Results We retained 14 records reporting on eight studies. Five categories of SAD reduction (information-based, skills building, structural, contact-based and biomedical interventions) were identified. Training popular opinion leaders (POLs) resulted in significantly lower mean avoidance intent scores (MD = -1.87 [95% CI -2.05 to -1.69]), mean prejudicial attitude scores (MD = -3.77 [95% CI -5.4 to -2.09]) and significantly higher scores in mean compliance to universal precaution (MD = 1.65 [95% CI 1.41 to 1.89]) when compared to usual care (moderate quality evidence). The Summary of Findings table (SOF) is shown in Table 1. Conclusions Evidence of moderate quality indicates that training popular opinion leaders is effective in reducing avoidance intent and prejudicial attitude and improving compliance to universal precaution. Very low quality evidence indicates that professionally-assisted peer group interventions, modular interactive training, participatory self-guided assessment and intervention, contact strategy combined with information giving and empowerment are effective in reducing HIV-related stigma. Further Randomized Controlled Trials (RCTs) are needed. Future trials need to use up-to-date and validated instruments to measure stigma and discrimination.	[Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Woldie, Mirkuzie] Jimma Univ, Ethiopian Evidence Based Hlth Care Ctr JBI Ctr Ex, Jimma, Ethiopia; [Feyissa, Garumma Tolu; Lockwood, Craig; Munn, Zachary] Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia; [Woldie, Mirkuzie] Jimma Univ, Dept Hlth Policy & Management, Jimma, Ethiopia; [Woldie, Mirkuzie] TH Chan Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Addis Ababa, Ethiopia	Jimma University; Jimma University; University of Adelaide; Jimma University; Harvard University; Harvard T.H. Chan School of Public Health	Feyissa, GT (corresponding author), Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Jimma Univ, Ethiopian Evidence Based Hlth Care Ctr JBI Ctr Ex, Jimma, Ethiopia.; Feyissa, GT (corresponding author), Univ Adelaide, Joanna Briggs Inst, Adelaide, SA, Australia.	garummatolu@yahoo.com	Woldie, Mirkuzie/S-4086-2017; Feyissa, Garumma/AAP-9097-2020; Munn, Zachary/AAV-9760-2021	Woldie, Mirkuzie/0000-0002-1777-0816; Feyissa, Garumma/0000-0001-6179-0024; Munn, Zachary/0000-0002-7091-5842	Adelaide scholarship International (ASI); University of Adelaide	Adelaide scholarship International (ASI); University of Adelaide	This study is supported by the Adelaide scholarship International (ASI) granted by the University of Adelaide to GTF.	Al-Mazrou YY, 2005, SAUDI MED J, V26, P1788; Armstrong R., 2007, SYSTEMATIC REV HLTH; Baskaran C, 2014, PRACTICAL STRATEGIES, DOI 10.1016/j.jana.2008.12.005; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS368, DOI 10.1097/QAI.0000000000000519; Bennett C, 1997, J ADV NURS, V26, P273, DOI 10.1046/j.1365-2648.1997.1997026273.x; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Carr D, 2015, ACHIEVING STIGMA FRE; Chambers LA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2197-0; Church K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17981; Churcher S, 2013, STIGMA RELATED HIV A; Endeshaw M, 2014, AIDS CARE, V26, P935, DOI 10.1080/09540121.2013.869537; Ezedinachi ENU, 2002, PUBLIC HEALTH, V116, P106, DOI 10.1038/sj.ph.1900834; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Geibel S, 2017, J ADOLESCENT HEALTH, V60, pS35, DOI 10.1016/j.jadohealth.2016.09.026; GRADEpro G., 2015, GRADEPRO GUID DEV TO; Grossman CI, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18881; Jackson N, 2004, J PUBLIC HEALTH, V26, P303, DOI 10.1093/pubmed/fdh164; Jessica Ogden LN, 2005, COMMON ITS CORE HIV; Joint United Nations Programme on HIV/AIDS (UNAIDS) (WHO) WHO, 2016, GLOB AIDS UPD 2016; Kaponda CPN, 2009, J ASSOC NURSE AIDS C, V20, P230, DOI 10.1016/j.jana.2008.12.005; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Li L, 2015, AIDS CARE, V27, P1439, DOI 10.1080/09540121.2015.1114990; Li L, 2014, INT J EPIDEMIOL, V43, P897, DOI 10.1093/ije/dyt249; Li L, 2014, SOC PSYCH PSYCH EPID, V49, P991, DOI 10.1007/s00127-013-0808-6; Li L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18710; Li L, 2013, AIDS EDUC PREV, V25, P327, DOI 10.1521/aeap.2013.25.4.327; Li L, 2013, AM J PUBLIC HEALTH, V103, P286, DOI 10.2105/AJPH.2012.300854; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Lohiniva AL, 2016, AIDS CARE, V28, P644, DOI 10.1080/09540121.2015.1124974; Loutfy M, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19835; Mahendra V, 2006, HORIZONS RES SUMMARY, DOI [10.31899/HIV2.1027, DOI 10.31899/HIV2.1027]; Mak WWS, 2017, SOC SCI MED, V188, P30, DOI 10.1016/j.socscimed.2017.06.045; Martin J., 2017, CRITICAL APPRAISAL C, P6; McKenzie AG, 2017, HIV ED TOOL INCREASE; Millard T, 2013, AIDS PATIENT CARE ST, V27, P103, DOI 10.1089/apc.2012.0294; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Montgomery P, 2013, J CLIN EPIDEMIOL, V66, P874, DOI 10.1016/j.jclinepi.2013.03.006; Munn Z, 2014, AM J NURS, V114, P49, DOI 10.1097/01.NAJ.0000451683.66447.89; Neema S, 2012, AFR HEALTH SCI, V12, P231, DOI 10.4314/ahs.v12i2.24; Norr KF, 2007, AJAR-AFR J AIDS RES, V6, P239, DOI 10.2989/16085900709490420; Norr KF, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.02.001; Nyblade L, 2006, CAN WE MEASURE HIV S; Nyblade L., 2008, COMMUNITIES CONFRONT; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Oanh KTH, 2008, IMPROVING HOSP BASED; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Paudel V, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0032-9; Ha PN, 2013, GLOB PUBLIC HEALTH, V8, pS61, DOI 10.1080/17441692.2013.799217; Pisal H, 2007, J ASSOC NURSE AIDS C, V18, P32, DOI 10.1016/j.jana.2007.06.002; Porritt K, 2014, AM J NURS, V114, P47, DOI 10.1097/01.NAJ.0000450430.97383.64; Pratt R J, 2001, Int Nurs Rev, V48, P164, DOI 10.1046/j.1466-7657.2001.00081.x; Pulerwitz J, 2015, AIDS BEHAV, V19, P246, DOI 10.1007/s10461-014-0935-4; Pulerwitz J, 2014, LANCET GLOB HEALTH, V2, pE311, DOI 10.1016/S2214-109X(14)70219-0; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; ROBINER WN, 1993, PROF PSYCHOL-RES PR, V24, P35; SANTANA RT, 1992, AIDS, V6, P1359, DOI 10.1097/00002030-199211000-00020; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Shah SM, 2014, WESTERN J NURS RES, V36, P1323, DOI 10.1177/0193945914523685; Sikkema KJ, 2015, GLOB MENT HEALTH, V2, DOI 10.1017/gmh.2015.17; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stewart KE, 1999, J ADV NURS, V30, P687, DOI 10.1046/j.1365-2648.1999.01118.x; Stutterheim SE, 2014, AIDS PATIENT CARE ST, V28; Tufanaru C, 2017, JOANNA BRIGGS I REV; Uebel KE, 2007, J INFECT DIS, V196, pS500, DOI 10.1086/521113; UNAIDS, 2016, HIV REL STIGM HUM RI; UNAIDS, 2016, UNAIDS STRAT 2016 20; USAID. Health Policy Initiative, 2012, PROGR GUID RED HIV K; Uys L, 2009, AIDS PATIENT CARE ST, V23, P1059, DOI 10.1089/apc.2009.0085; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Varas-Diaz N, 2016, AIDS CARE, V28, P376, DOI 10.1080/09540121.2015.1090537; Wang DB, 2009, AIDS CARE, V21, P468, DOI 10.1080/09540120802290357; Williams AB, 2006, J ADV NURS, V53, P710, DOI 10.1111/j.1365-2648.2006.03777.x; Wu S, 2008, AIDS PATIENT CARE ST, V22, P513, DOI 10.1089/apc.2007.0198; Wu ZY, 2002, AIDS EDUC PREV, V14, P379, DOI 10.1521/aeap.14.6.379.24074; Yiu JW, 2010, SOC SCI MED, V71, P38, DOI 10.1016/j.socscimed.2010.02.045; Zachariah GS, AIDS FEAR HLTH CARE	77	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211298	10.1371/journal.pone.0211298	http://dx.doi.org/10.1371/journal.pone.0211298			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682131	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500147
J	Chatsiproios, D; Schmidts-Winkler, IM; Konig, L; Masur, C; Abels, C				Chatsiproios, Dimitrios; Schmidts-Winkler, Iris M.; Koenig, Lisa; Masur, Clarissa; Abels, Christoph			Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment - An open prospective multicenter study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENOPAUSAL SYMPTOMS; SEXUAL DYSFUNCTION; ATROPHY; SURVIVORS; THERAPY; HEALTH; PREVALENCE; MANAGEMENT; MOISTURIZER	This open, prospective, multicenter, observational study was performed to investigate the efficacy and safety of a non-hormonal cream in women undergoing breast cancer treatment and experiencing vulvovaginal dryness symptoms. Overall, 128 patients from 22 study centers participated. The cream was applied to the vagina and vulva for 28 days. For the efficacy analysis, changes in subjective symptoms (feeling of dryness, itching, burning, pain independent of sexual intercourse, dyspareunia, urinary incontinence) were evaluated. Additionally, the following objective diagnostic findings were assessed by a physician: thinning of vaginal epithelium, redness, petechiae, and discharge. Safety and tolerability were assessed by evaluating type and frequency of adverse events, including adverse medical device-related effects. The frequency and intensity of all subjective symptoms significantly improved from baseline at 28 days (p<0.0001). Additionally, 21.4% of patients were completely free of symptoms (p<0.0001) and urinary incontinence was improved or eliminated in 30.8% of women. The overall sum score for all four objective findings was significantly improved from baseline at 28 days (p<0.0001). The frequency of petechial bleedings was significantly reduced (p<0.0001). Further, significant decreases in the severity of vaginal epithelium thinning, redness and petechiae were observed (p<0.0001). More than 88% of patients and investigators assessed the efficacy and tolerability as being good or very good. No serious adverse events were documented. This study demonstrates that the investigated cream is an effective and safe non-hormonal, topical option in the treatment of vulvovaginal dryness symptoms in patients undergoing breast cancer treatment for. However, the study duration and follow-up time of 4 weeks as well as the non-randomized trial design are limitations of the study.	[Chatsiproios, Dimitrios] Gynaecologicum, Kreuzlingen, Switzerland; [Schmidts-Winkler, Iris M.; Koenig, Lisa; Masur, Clarissa; Abels, Christoph] DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTEL, Bielefeld, Germany		Konig, L (corresponding author), DR AUGUST WOLFF GmbH & CO KG ARZNEIMITTEL, Bielefeld, Germany.	lisa.koenig@drwolffgroup.com	Abels, Christoph/GYU-0286-2022		Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany); Dr. August Wolff GmbH & Co. KG Arzneimittel	Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany); Dr. August Wolff GmbH & Co. KG Arzneimittel	The funder Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) provided support in the form of salaries for authors [CA, CM, IMSW and LK] and played an additional role in the study design, decision to publish, and preparation of the manuscript. However, the funder had no role in data collection and analysis. The scientific supervisor of the study [DC] was also sponsored by Dr. August Wolff GmbH & Co. KG Arzneimittel. The specific roles of these authors are articulated in the 'author contributions' section.	Alder Judith, 2010, Ther Umsch, V67, P129, DOI 10.1024/0040-5930/a000024; Baumgart J, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.035; Biglia N, 2010, GYNECOL ENDOCRINOL, V26, P404, DOI 10.3109/09513591003632258; Bygdeman M, 1996, MATURITAS, V23, P259, DOI 10.1016/0378-5122(95)00955-8; Carter J, 2011, J SEX MED, V8, P549, DOI 10.1111/j.1743-6109.2010.01988.x; Cella D, 2008, BREAST CANCER RES TR, V107, P167, DOI 10.1007/s10549-007-9548-1; Chin SN, 2009, CLIN BREAST CANCER, V9, P108, DOI 10.3816/CBC.2009.n.020; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Derzko C, 2007, Curr Oncol, V14 Suppl 1, pS20; Donovan KA, 2012, CANCER-AM CANCER SOC, V118, P582, DOI 10.1002/cncr.26324; Edwards D, 2016, CLIMACTERIC, V19, P151, DOI 10.3109/13697137.2015.1124259; Ganz PA, 1998, J CLIN ONCOL, V16, P501, DOI 10.1200/JCO.1998.16.2.501; Gupta P, 2006, CLIMACTERIC, V9, P49, DOI 10.1080/13697130500487224; Hershman DL, 2011, BREAST CANCER RES TR, V126, P529, DOI 10.1007/s10549-010-1132-4; Holmberg L, 2004, LANCET, V363, P453, DOI 10.1016/S0140-6736(04)15493-7; Jokar Azam, 2016, Int J Community Based Nurs Midwifery, V4, P69; Knobf MT, 2006, ONCOLOGIST, V11, P96, DOI 10.1634/theoncologist.11-2-96; Kwan KW, 2009, CLIN BREAST CANCER, V9, P219, DOI 10.3816/CBC.2009.n.037; Lee YK, 2011, OBSTET GYNECOL, V117, P922, DOI 10.1097/AOG.0b013e3182118790; Levine KB, 2008, MENOPAUSE, V15, P661, DOI 10.1097/gme.0b013e31815a5168; Loprinzi CL, 2008, LANCET ONCOL, V9, P993, DOI 10.1016/S1470-2045(08)70256-0; Loprinzi CL, 1997, J CLIN ONCOL, V15, P969, DOI 10.1200/JCO.1997.15.3.969; Mac Bride MB, 2010, MAYO CLIN PROC, V85, P87, DOI 10.4065/mcp.2009.0413; Mitchell CM, 2018, JAMA INTERN MED, V178, P681, DOI 10.1001/jamainternmed.2018.0116; Morales L, 2004, ANTI-CANCER DRUG, V15, P753, DOI 10.1097/00001813-200409000-00003; Murphy CC, 2012, BREAST CANCER RES TR, V134, P459, DOI 10.1007/s10549-012-2114-5; North Amer Menopause Soc, 2013, MENOPAUSE, V20, P888, DOI [10.1097/gme.0b013e3182a122c2, 10.1097/GME.0b013e3182a122c2]; Partridge AH, 2015, BREAST CARE, V10, P307, DOI 10.1159/000441371; Portman DJ, 2014, MENOPAUSE, V21, P1063, DOI [10.1097/gme.0000000000000329, 10.1097/GME.0000000000000329]; Santoro N, 2009, J SEX MED, V6, P2133, DOI 10.1111/j.1743-6109.2009.01335.x; Sinha A, 2013, CLIMACTERIC, V16, P305, DOI 10.3109/13697137.2012.756466; Sturdee DW, 2010, CLIMACTERIC, V13, P509, DOI 10.3109/13697137.2010.522875; Stute P, 2015, CLIMACTERIC, V18, P582, DOI 10.3109/13697137.2015.1036854; Tersigni C, 2015, J OBSTET GYNAECOL, V35, P835, DOI 10.3109/01443615.2015.1014326; Trinkaus M, 2008, ONCOLOGIST, V13, P222, DOI 10.1634/theoncologist.2007-0234; World Health Organization, 2012, WHOUNFPAFHI360	36	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210967	10.1371/journal.pone.0210967	http://dx.doi.org/10.1371/journal.pone.0210967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677065	Green Published, gold			2022-12-27	WOS:000456700400038
J	Peng, QH; Mechanic, J; Shoieb, A; Pardo, ID; Schaevitz, L; Fenyk-Melody, J; Vitsky, A; Boucher, M; Somps, C; Cook, JC; Liu, CN				Peng, Qinghai; Mechanic, Jordan; Shoieb, Ahmed; Pardo, Ingrid D.; Schaevitz, Laura; Fenyk-Melody, Judith; Vitsky, Allison; Boucher, Magalie; Somps, Chris; Cook, Jon C.; Liu, Chang-Ning			g Circulating microRNA and automated motion analysis as novel methods of assessing chemotherapy-induced peripheral neuropathy in mice	PLOS ONE			English	Article							MECHANICAL ALLODYNIA; RAT MODEL; VINCRISTINE; PACLITAXEL; PAIN; EXPRESSION; NEURONS; INJURY	Chemotherapy-induced peripheral neuropathy (CiPN) is a serious adverse effect in the clinic, but nonclinical assessment methods in animal studies are limited to labor intensive behavioral tests or semi-quantitative microscopic evaluation. Hence, microRNA (miRNA) biomarkers and automated in-life behavioral tracking were assessed for their utility as non-invasive methods. To address the lack of diagnostic biomarkers, we explored miR-124, miR-183 and miR-338 in a CiPN model induced by paclitaxel, a well-known neurotoxic agent. In addition, conventional and Vium's innovative Digital Vivarium technology-based in-life behavioral tests and postmortem microscopic examination of the dorsal root ganglion (DRG) and the sciatic nerve were performed. Terminal blood was collected on days 8 or 16, after 20 mg/kg paclitaxel was administered every other day for total of 4 or 7 doses, respectively, for plasma miRNA quantification by RT-qPCR. DRG and sciatic nerve samples were collected from mice sacrificed on day 16 for miRNA quantification. Among the three miRNAs analyzed, only miR-124 was statistically significantly increased (5 fold and 10 fold on day 8 and day 16, respectively). The increase in circulating miR-124 correlated with cold allodynia and axonal degeneration in both DRG and sciatic nerve. Automated home cage motion analysis revealed for the first time that nighttime motion was significantly decreased (P < 0.05) in paclitaxel-dosed animals. Although both increase in circulating miR-124 and decrease in nighttime motion are compelling, our results provide positive evidence warranting further testing using additional peripheral nerve toxicants and diverse experimental CiPN models.	[Peng, Qinghai; Vitsky, Allison] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, La Jolla, CA USA; [Mechanic, Jordan; Schaevitz, Laura] Vium Inc, Milpitas, CA USA; [Shoieb, Ahmed; Pardo, Ingrid D.; Somps, Chris; Cook, Jon C.; Liu, Chang-Ning] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA; [Fenyk-Melody, Judith] Pfizer Worldwide Res & Dev, Comparat Med, Cambridge, MA USA; [Boucher, Magalie] Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Liu, CN (corresponding author), Pfizer Worldwide Res & Dev, Drug Safety Res & Dev, Groton, CT 06340 USA.	chang-ning.liu@pfizer.com		Liu, Chang-Ning/0000-0002-2094-1401	Pfizer; Vium Inc.	Pfizer(Pfizer); Vium Inc.	The author(s) received no specific funding for this work. QP, AS, IP, JF-M, AV, MB, CS, JCC and C-NL are employed by Pfizer. Pfizer provided support in the form of salaries for authors QP, AS, IP, JF-M, AV, MB, CS, JCC and C-NL and scientific service fee to Vium Inc., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JM and LS are employed by Vium Inc. Vium Inc. provided support in the form of salaries for authors JM and LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aley KO, 1996, NEUROSCIENCE, V73, P259, DOI 10.1016/0306-4522(96)00020-6; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; ARMSTRONG JG, 1967, CANCER RES, V27, P221; Armstrong T, 2005, ONCOL NURS FORUM, V32, P305, DOI 10.1188/05.ONF.305-311; Aschrafi A, 2012, CELL MOL LIFE SCI, V69, P4017, DOI 10.1007/s00018-012-1064-8; Authier N, 1999, NEUROREPORT, V10, P965, DOI 10.1097/00001756-199904060-00013; Authier N, 2003, NEUROTOXICOLOGY, V24, P797, DOI 10.1016/S0161-813X(03)00043-3; Bali KK, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-22; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Beyreuther B, 2006, EUR J PHARMACOL, V539, P64, DOI 10.1016/j.ejphar.2006.04.009; Bhagra Anjali, 2007, Curr Oncol Rep, V9, P290; Callizot N, 2008, CANCER CHEMOTH PHARM, V62, P995, DOI 10.1007/s00280-008-0689-7; Cavaletti G, 2008, FRONT BIOSCI-LANDMRK, V13, P3506, DOI 10.2741/2945; Cavaletti Guido, 2004, Expert Opin Drug Saf, V3, P535, DOI 10.1517/14740338.3.6.535; Costa R, 2011, BRIT J PHARMACOL, V164, P681, DOI 10.1111/j.1476-5381.2011.01408.x; DYER RS, 1985, FUND APPL TOXICOL, V5, P24, DOI 10.1016/0272-0590(85)90048-X; GLANTZ MJ, 1995, J NATL CANCER I, V87, P1077, DOI 10.1093/jnci/87.14.1077; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Hausheer FH, 2006, SEMIN ONCOL, V33, P15, DOI 10.1053/j.seminoncol.2005.12.010; Higuera ES, 2004, METH MOLEC MED, P91; Huehnchen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076772; Lim MA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00818; Lin CR, 2014, EUR J NEUROSCI, V39, P1682, DOI 10.1111/ejn.12522; Liu CN, 2018, J APPL TOXICOL, V38, P193, DOI 10.1002/jat.3513; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; MASON KA, 1995, INT J RADIAT ONCOL, V32, P1381, DOI 10.1016/0360-3016(95)00037-Y; MASUROVSKY EB, 1983, NEUROSCIENCE, V10, P491, DOI 10.1016/0306-4522(83)90148-3; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Muthuraman A, 2011, FOOD CHEM TOXICOL, V49, P2557, DOI 10.1016/j.fct.2011.06.069; Nakamura Y, 2001, NEUROSCI LETT, V304, P5, DOI 10.1016/S0304-3940(01)01720-7; Peng QH, 2014, J APPL TOXICOL, V34, P695, DOI 10.1002/jat.2930; Pike Crystal T, 2012, Chemother Res Pract, V2012, P913848, DOI 10.1155/2012/913848; Polomano RC, 2001, PAIN MED, V2, P8, DOI 10.1046/j.1526-4637.2001.002001008.x; Nieto FR, 2008, PAIN, V137, P520, DOI 10.1016/j.pain.2007.10.012; Rupp A, 2007, J NEUROSCI METH, V166, P266, DOI 10.1016/j.jneumeth.2007.07.015; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Seretny M, 2013, JAMA-J AM MED ASSOC, V310, P537, DOI 10.1001/jama.2013.7902; Smith SB, 2004, LIFE SCI, V74, P2593, DOI 10.1016/j.lfs.2004.01.002; Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009; Stagg NJ, 2016, REGUL TOXICOL PHARM, V82, P1, DOI 10.1016/j.yrtph.2016.10.012; Starobova H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00174; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sudoh Y, 2004, REGION ANESTH PAIN M, V29, P434, DOI 10.1016/j.rapm.2004.06.008; Tasnim A, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0285-4; von Schack D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017670; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang ZF, 2018, MOL NEUROBIOL, V55, P5879, DOI 10.1007/s12035-017-0808-8; Wilkes Gail, 2007, Semin Oncol Nurs, V23, P162, DOI 10.1016/j.soncn.2007.05.001; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	56	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210995	10.1371/journal.pone.0210995	http://dx.doi.org/10.1371/journal.pone.0210995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677061	gold, Green Submitted, Green Published			2022-12-27	WOS:000456700400041
J	Ceulemans, A; Bouzahzah, C; Prat, I; Urassa, W; Kestens, L				Ceulemans, Ann; Bouzahzah, Chaymae; Prat, Irena; Urassa, Willy; Kestens, Luc			CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics	PLOS ONE			English	Article							COUNT; AGREEMENT	Background CD4 T-cell counts are still widely used to assess treatment eligibility and follow-up of HIV-infected patients. The World Health Organization (WHO) prequalification of in vitro diagnostics requested a manufacturer independent laboratory evaluation of the analytical performance at the Institute of Tropical Medicine (ITM) Antwerp, Belgium, of the Muse Auto CD4/CD4% system (Millipore), a new small capillary-flow cytometer dedicated to count absolute CD4-T cells and percentages in venous blood samples from HIV-infected patients. Methods Two hundred and fifty (250) patients were recruited from the HIV outpatient clinic at ITM. Accuracy and precision of CD4 T cell counting on fresh EDTA anticoagulated venous blood samples were assessed in the laboratory on a Muse Auto CD4/CD4% system. Extensive precision analyses were performed both on fresh blood and on normal and low stabilized whole blood controls. Accuracy ((bias) was assessed by comparing results from Muse CD4/CD4% to the reference (single-platform FACSCalibur). Clinical misclassification was measured at 500, 350, 200 and 100 cells/mu L thresholds. Results Intra-assay precision was <5%, and inter-assay was <9%. CD4 T cell counts measured on Muse Auto CD4/CD4% System and on the reference instrument resulted in regression slopes of 0.97 for absolute counts and 1.03 for CD4 T cell percentages and a correlation coefficient of 0.99 for both. The average absolute bias as compared to the reference was negligible (4 cells/mu L or 0.5%). The absolute average bias on CD4 T cell percentages was <1%. Clinical misclassification at different CD4 T cell thresholds was small resulting in sensitivities and specificities equal or >90% at all thresholds except at 100 cells/mu L (sensitivity = 87%). All samples could be analyzed as there was no repetitive rejection errors recorded. Conclusions The Muse Auto CD4/CD4% System performed very well on fresh venous blood samples and met all WHO acceptance criteria for analytical performance of CD4 technologies.	[Ceulemans, Ann; Bouzahzah, Chaymae; Kestens, Luc] Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium; [Prat, Irena; Urassa, Willy] WHO, Geneva, Switzerland; [Kestens, Luc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); World Health Organization; University of Antwerp	Kestens, L (corresponding author), Inst Trop Med, Dept Biomed Sci, Immunol Lab, Antwerp, Belgium.; Kestens, L (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	lkestens@itg.be		Kestens, Luc/0000-0001-9374-1921; Ceulemans, Ann/0000-0002-1615-6785	World Health Organization Prequalification of Diagnostics Programme; World Health Organization	World Health Organization Prequalification of Diagnostics Programme; World Health Organization(World Health Organization)	This study was partially funded by the World Health Organization Prequalification of Diagnostics Programme (http://www.who.int/diagnostics_laboratory/evaluations/alternative/en/). There was no additional external funding received for this study. The funder designed the generic protocol for the evaluation. Data collection and analysis, preparation of the manuscript and decision to publish was the decision of LK.; We are grateful to all patients who provided blood specimens and to all staff members involved in collecting and measuring samples. Funding of this work was partially provided by World Health Organization.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Budd J, 2014, EP09A3 CLSI, V33, P1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneau G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170248; Efron Bradley., 1993, INTRO BOOTSTRAP, DOI 10.1007/978-1-4899-4541-9; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Isaksson A., 2018, INDEPENDENT THESIS A; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kestens L, 2017, CYTOM PART B-CLIN CY, V92, P437, DOI 10.1002/cyto.b.21400; Kouabosso A, 2018, J IMMUNOL METHODS, V455, P95, DOI 10.1016/j.jim.2018.01.008; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mossoro-Kpinde CD, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1082-7; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Strauss K, 1996, COMMUNICATIONS CLIN, V26, DOI [10.1002/(SICI)1097-0320(19960315)26:1%3C52::AID-CYTO8%3E3.0.CO;2-I, DOI 10.1002/(SICI)1097-0320(19960315)26:1%3C52::AID-CYTO8%3E3.0.CO;2-I]; Tukey J. W., 1977, EXPLORATORY DATA ANA; UNAIDS, 2017, FACT SHEET LAT GLOB; UNITAID, 2015, HIV AIDS DIAGN TECHN; Wade D, 2014, J ACQUIR IMMUNE DEFI, V66; WHO, 2014, SUMM STUD PROT MULT; World Health Organization, 2013, CONS GUID US ANT DRU, P148; World Health Organization, 2018, PQD032410600 WHO; World Health Organization, 2016, CONSOLIDATED GUIDELI, P480; World Health Organization, 2017, WHO PROT PERF EV LYM; World Health Organization, 2014, PREQ IN VITR DIAGN P; World Health Organssatioas, 2018, WHO MOD LIST ESS IN	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0209677	10.1371/journal.pone.0209677	http://dx.doi.org/10.1371/journal.pone.0209677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673713	gold, Green Submitted, Green Published			2022-12-27	WOS:000456442800021
J	Figueiro, TH; Arins, GCB; dos Santos, CES; Cembranel, F; de Medeiros, PA; d'Orsi, E; Rech, CR				Figueiro, Thamara Hubler; Budal Arins, Gabriel Claudino; Silva dos Santos, Carla Elane; Cembranel, Francieli; de Medeiros, Paulo Adao; d'Orsi, Eleonora; Rech, Cassiano Ricardo			Association of objectively measured sedentary behavior and physical activity with cardiometabolic risk markers in older adults	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIO-METABOLIC RISK; CARDIOVASCULAR-DISEASE; AEROBIC EXERCISE; LIGHT ACTIVITY; ALL-CAUSE; TIME; MORTALITY; HEALTH; FITNESS	Objective The aim of this study was to examine the associations between sedentary behavior and different intensities of physical activity with cardiometabolic risk, and to analyze the simultaneous effect of excess sedentary behavior and recommended levels of physical activity on cardiometabolic risk markers in older adults. Methods We conducted a population-based cross-sectional study on a sample of older adults (60+) living in Florianopolis, Brazil. The objectively measured predictors were sedentary time, light physical activity and moderate to vigorous physical activity, and the outcomes were markers of cardiometabolic risk. Data were considered valid when the participant had used the accelerometer for at least four days per week. Results The sample included 425 older adults (59.8% women), with a mean age of 73.9 years (95% CI: 73.5-74.4). Sedentary behavior was associated with lower systolic blood pressure levels (beta = -0.03; 95% CI: -0.05; -0.01) and lower HDL cholesterol (beta = -0.02; 95% CI: -0.02; -0.01). Light physical activity was not associated with any cardiovascular risk markers after adjustment. Each minute spent in moderate to vigorous physical activity was associated with lower waist circumference (beta = -0.15; 95% CI: -0.24; -0.05), systolic blood pressure (beta = -0.18; 95% CI: -0.32; -0.04) and plasma glucose (beta = -0.18; 95% CI: -0.33;-0.02), and with higher HDL cholesterol (beta = 0.10; 95% CI: 0.01;0.18). Moreover, physically inactive and sedentary individuals had a greater mean waist circumference and lower HDL cholesterol than physically active and non-sedentary subjects. Conclusion The results suggest that moderate to vigorous physical activity have a positive impact on cardiometabolic risk markers in older adults. Light physical activity does not appear to have a beneficial effect on the cardiometabolic markers, and despite the benefits provided by the different intensities of physical activity, the simultaneous presence of sedentary behavior and low physical activity level was associated with poor cardiometabolic risk markers.	[Figueiro, Thamara Hubler; de Medeiros, Paulo Adao] Univ Fed Santa Catarina, Postgrad Program Collect Hlth, Florianopolis, SC, Brazil; [Budal Arins, Gabriel Claudino; Silva dos Santos, Carla Elane] Univ Fed Santa Catarina, Postgrad Program Phys Educ, Florianopolis, SC, Brazil; [Cembranel, Francieli; d'Orsi, Eleonora] Univ Fed Santa Catarina, Dept Publ Hlth, Florianopolis, SC, Brazil; [d'Orsi, Eleonora] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Cardiovasc Hlth Program, Boston, MA USA; [Rech, Cassiano Ricardo] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal de Santa Catarina (UFSC)	Figueiro, TH (corresponding author), Univ Fed Santa Catarina, Postgrad Program Collect Hlth, Florianopolis, SC, Brazil.	thamara.hf@gmail.com	Figueiró, Thamara Hubler/AAE-8515-2019; Cembranel, Francieli/F-5788-2017; d'Orsi, Eleonora/D-1905-2015; Rech, Cassiano Ricardo/AAU-4340-2020	Figueiró, Thamara Hubler/0000-0001-6502-1396; Cembranel, Francieli/0000-0002-1205-0449; Rech, Cassiano Ricardo/0000-0002-9647-3448; d'Orsi, Eleonora/0000-0003-2027-1089; Arins, Gabriel/0000-0003-1057-2961	Brazilian National Council for Scientific and Technological Development (CNPq) [475904/2013-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This article originates from the EpiFloripa Project 2013/2014 "Lipid profile, inflammatory markers, body composition, health conditions and habits of life in the elderly: a population-based longitudinal study in Florianopolis, SC, EpiFloripa 2013", Santa Catarina. This study was financed by the Brazilian National Council for Scientific and Technological Development (CNPq), grant number 475904/2013-3. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and developed under the Postgraduate Program in Collective Health of the Federal University of Santa Catarina. The Bernard Lown Scholars in Cardiovascular Health Program from Harvard T.H. Chan School of Public Health payed the fees for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2016, AM J EPIDEMIOL, V183, P875, DOI 10.1093/aje/kwv305; Altenburg TM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0090-3; [Anonymous], 2016, DEATHS CAUS AG SEX C; Bakrania K, 2015, BMC PUBLIC HEALTH, P16, DOI [10.1186/s12889-015-2621-5, DOI 10.1186/S12889-015-2621-5]; Barengo NC, 2017, J AM GERIATR SOC, V65, P504, DOI 10.1111/jgs.14694; Barreira TV, 2014, MAYO CLIN PROC, V89, P81, DOI 10.1016/j.mayocp.2013.10.001; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buonani C, 2013, MEDICINA, V46, P273; Carson V, 2014, PREV MED, V65, P23, DOI 10.1016/j.ypmed.2014.04.005; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Schneider IJC, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051006776, 10.11606/s1518-8787.2017051006776]; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; deRezende LFM, 2014, COMPORTAMENTO SEDENT, DOI [10.11606/D.5.2014.tde-15082014, DOI 10.11606/D.5.2014.TDE-15082014]; Edwards MK, 2017, J CLIN LIPIDOL, V11, P119, DOI 10.1016/j.jacl.2016.10.014; Ferguson MA, 1998, J APPL PHYSIOL, V85, P1169, DOI 10.1152/jappl.1998.85.3.1169; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Gerage AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146078; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; Howard B, 2015, MED SCI SPORT EXER, V47, P2093, DOI 10.1249/MSS.0000000000000631; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0361-2; Jimenez-Pavon D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-172; Judice PB, 2015, AGE, V37, DOI 10.1007/s11357-015-9760-6; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Knaeps S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160166; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lamb MJE, 2016, DIABETOLOGIA, V59, P110, DOI 10.1007/s00125-015-3756-8; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; McPhee JS, 2016, BIOGERONTOLOGY, V17, P567, DOI 10.1007/s10522-016-9641-0; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Myint PK, 2014, HEART, V100, P1613, DOI 10.1136/heartjnl-2014-305816; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; O'Donovan C, 2014, J PHYS ACT HEALTH, V11, P272, DOI 10.1123/jpah.2012-0075; PNUD IPEA FJP, 2013, ATL DES HUM; Qi QB, 2015, CIRCULATION, V132, P1560, DOI 10.1161/CIRCULATIONAHA.115.016938; Ramires VV, 2017, INT J BEHAV NUTR PHY, V14, P1, DOI [10.1186/s12966-016-0456-9, DOI 10.1186/S12966-016-0456-9]; Souza DD., 2010, REV BRAS HIPERTENS, V17, P103; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Ueshima K, 2010, AM J PREV MED, V38, P410, DOI 10.1016/j.amepre.2009.12.033; van der Velde JHPM, 2015, INT J ENV RES PUB HE, V12, P2330, DOI 10.3390/ijerph120302330; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2014, DIABETOLOGIA, V57, P305, DOI 10.1007/s00125-013-3102-y; Yano Y, 2015, J AM COLL CARDIOL, V65, P327, DOI 10.1016/j.jacc.2014.10.060	62	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2019	14	1							e0210861	10.1371/journal.pone.0210861	http://dx.doi.org/10.1371/journal.pone.0210861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH8XI	30657795	Green Submitted, Green Published, gold			2022-12-27	WOS:000456017000020
J	Mohammed, E; Browne, LD; Kumar, AUA; Adeeb, F; Fraser, AD; Stack, AG				Mohammed, Elshaeima; Browne, Leonard D.; Kumar, Arun A. U.; Adeeb, Fahd; Fraser, Alexander D.; Stack, Austin G.			Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study	PLOS ONE			English	Article							SERUM URIC-ACID; PARATHYROID-HORMONE; HYPERURICEMIA; RISK; ALLOPURINOL; ASSOCIATION; MANAGEMENT; URATE; EPIDEMIOLOGY; ALBUMINURIA	Background Gout is a common inflammatory arthritis associated with adverse clinical outcomes. Under treatment is common in the general population. The aim of this study was to determine the prevalence of gout and its treatment among patients with chronic kidney disease (CKD). Methods We conducted a multi-centre cross sectional study of patients (n = 522) who attended specialist nephrology clinics in Ireland. Standardized data collection tool recorded clinical characteristics and medication use at clinic visits and kidney function was assessed with standardised creatinine measurements and Estimated Glomerular Filtration Rate (eGFR). The prevalence of gout and the corresponding use of urate lowering therapies (ULT) were determined. Multivariate logistic regression explored correlates of gout expressed as Odds Ratios (OR) and 95% Confidence Intervals (CI) adjusting for demographic and clinical characteristics. Results Overall prevalence of gout was 16.6% and increased significantly from 7.5% in Stage 1-2 CKD to 22.8% in stage 4-5 CKD, P<0.005. Prevalence increased with age (P<0.005) and was higher in men than women (19.1% versus 10.3% P<0.005). Overall, 67.9% of gout patients with CKD were treated with ULT, and the percentage increased with advancing stage of CKD from 55.6% in Stage 1-2 to 77.4% in Stage 4-5, P<0.005. Multivariable modelling identified men (vs women), OR, 1.95 (0.95-4.03), serum albumin, OR 1.09 (1.02-1.16) per 1 g/L lower, poorer kidney function, OR 1.11 (1.01-1.22) per 5 ml/min/1.73m(2) lower, and rising parathyroid hormone levels, OR 1.38 (1.08-1.77) per 50 pg/ml higher as disease correlates. Conclusions Gout is common in CKD and increases with worsening kidney function in the Irish health system. Over two thirds of patients with gout were receiving ULT, increasing to 77% of patients with advanced CKD. Greater awareness of gout in CKD, its treatment and the effectiveness of treatment strategies should be vigorously monitored to improve patient outcomes.	[Mohammed, Elshaeima; Kumar, Arun A. U.; Stack, Austin G.] Univ Hosp Limerick, Dept Med, Div Nephrol, Limerick, Ireland; [Mohammed, Elshaeima; Browne, Leonard D.; Kumar, Arun A. U.; Stack, Austin G.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Adeeb, Fahd; Fraser, Alexander D.] Univ Hosp Limerick, Dept Rheumatol, Limerick, Ireland; [Adeeb, Fahd; Fraser, Alexander D.; Stack, Austin G.] Univ Limerick, Hlth Res Inst, Limerick, Ireland	University of Limerick; University of Limerick; University of Limerick; University of Limerick	Stack, AG (corresponding author), Univ Hosp Limerick, Dept Med, Div Nephrol, Limerick, Ireland.; Stack, AG (corresponding author), Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.; Stack, AG (corresponding author), Univ Limerick, Hlth Res Inst, Limerick, Ireland.	austin.stack@ul.ie	Adeeb, Fahd/I-4454-2019	Adeeb, Fahd/0000-0002-9444-0810; Browne, Leonard/0000-0002-9203-1212	Irish Heart Foundation; Midwest Kidney Disease Research and Education Foundation (MKid), Limerick; Health Research Institute, University of Limerick; Health Research Board of Ireland [HRA-2013-PHR-685, HRA-2013-PHR-437]	Irish Heart Foundation; Midwest Kidney Disease Research and Education Foundation (MKid), Limerick; Health Research Institute, University of Limerick; Health Research Board of Ireland	A.G.S. was supported by grants from the Irish Heart Foundation, Midwest Kidney Disease Research and Education Foundation (MKid), Limerick and the Health Research Institute, University of Limerick. A.G.S and L.D.B. were supported by grants from the Health Research Board of Ireland (HRA-2013-PHR-685 and HRA-2013-PHR-437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek A, 2018, RHEUMATOLOGY, V57, pi51, DOI 10.1093/rheumatology/kex421; [Anonymous], 2021, LANG ENV STAT COMP; Chin KY, 2015, CLIN INTERV AGING, V10, P1377, DOI 10.2147/CIA.S90233; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dalbeth N, 2007, SEMIN DIALYSIS, V20, P391, DOI 10.1111/j.1525-139X.2007.00270.x; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Dehlin M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1062-6; Edwards N L, 2011, J Med Econ, V14, P10, DOI 10.3111/13696998.2010.540874; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hayashino Y, 2016, ACTA DIABETOL, V53, P599, DOI 10.1007/s00592-015-0825-x; HISATOME I, 1992, INTERNAL MED, V31, P807, DOI 10.2169/internalmedicine.31.807; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Hui JY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3769; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Jing JJ, 2015, NEPHROL DIAL TRANSPL, V30, P613, DOI 10.1093/ndt/gfu352; Kim JW, 2018, KOREAN J INTERN MED, V33, P228, DOI 10.3904/kjim.2016.429; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Krishnan E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050046; Kuo CF, 2017, NAT REV RHEUMATOL, V13, P201, DOI 10.1038/nrrheum.2017.27; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Kuo CF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0522-8; Kuo CF, 2015, ANN RHEUM DIS, V74, P661, DOI 10.1136/annrheumdis-2013-204463; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MINTZ DH, 1961, NEW ENGL J MED, V265, P112, DOI 10.1056/NEJM196107202650302; Paik JM, 2012, OSTEOPOROSIS INT, V23, P1727, DOI 10.1007/s00198-011-1776-x; Sedaghat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076827; Singh JA, 2008, ANN RHEUM DIS, V67, P1310, DOI 10.1136/ard.2007.081604; Sircar D, 2015, AM J KIDNEY DIS, V66, P945, DOI 10.1053/j.ajkd.2015.05.017; Stack AG, 2014, QJM-INT J MED, V107, P701, DOI 10.1093/qjmed/hcu057; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Su XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187550; Tseng CH, 2005, KIDNEY INT, V68, P796, DOI 10.1111/j.1523-1755.2005.00459.x; Yu KH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3806	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210487	10.1371/journal.pone.0210487	http://dx.doi.org/10.1371/journal.pone.0210487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682034	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500039
J	Bernardino, JI; Mocroft, A; Wallet, C; de Wit, S; Katlama, C; Reiss, P; Mallon, PW; Richert, L; Molina, JM; Knobel, H; Morlat, P; Babiker, A; Pozniac, A; Raffi, F; Arribas, JR				Bernardino, Jose I.; Mocroft, Amanda; Wallet, Cedrick; de Wit, Stephane; Katlama, Christine; Reiss, Peter; Mallon, Patrick W.; Richert, Laura; Molina, Jean-Michel; Knobel, Hernando; Morlat, Philippe; Babiker, Abdel; Pozniac, Anton; Raffi, Francois; Arribas, Jose R.		NEAT001 ANRS143 Trial Study Grp	Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ANTIRETROVIRAL-NAIVE ADULTS; PROTEASE INHIBITORS; IMMUNE ACTIVATION; HIV; THERAPY; LIPODYSTROPHY; NUCLEOSIDE; RISK	Background Comparison of changes in body composition, adipokines and inflammatory markers after initial therapy with a nucleos(t) ide reverse transcriptase inhibitor (N(t) RTI)-sparing or containing regimen are scarce. Design Randomised Clinical Trial. Methods This is the body composition substudy of NEAT 001/ANRS 143, a randomised trial comparing darunavir/ritonavir (DRV/r) plus either raltegravir (RAL) or tenofovir disoproxil fumarate/ emtricitabine (TDF/FTC) in 805 ART naive HIV-infected adults. The primary endpoint was percentage change in limb fat at week 96. Secondary endpoints were associations among these changes and metabolic markers (IL-6, insulin, leptin, adiponectin, FGF-23). Results 126 subjects (61 DRV/r + RAL and 65 DRV/r + TDF/FTC) were included. The rate of change in BMI between groups for RAL versus TDF/FTC at week 96 was 1.5% per 48-week period (p = 0.015). The rate of change in limb fat mass, trunk fat mass, total body fat and total lean mass was for RAL versus TDF/FTC at week 96 was 2.5% (p = 0.38), 7.3% ((p = 0.021), 4.9% (p = 0.061) and 1.3% (p = 0.12) respectively. Baseline insulin and leptin levels were correlated with baseline limb fat and trunk fat mass [r = 0.31 (p = 0.0043)/r = 0.28 (p = 0.0011) for limb fat, and r = 0.63 (p< 0.0001)/r = 0.50(p< 0.0001) for trunk fat]. After adjustment, a 10% faster increase in leptin between baseline and week 48 was associated with a more rapid increase in limb fat at week 48 (0.5% per 48 weeks, p< 0.001), total body fat mass (0.6% per 48 weeks, p< 0.001), and trunk fat mass (0.3% per 48 weeks, p = 0.0026). Conclusions After week 96 a N(t) RTI sparing regimen of DRV/r + RAL produced a numerically greater percentage increase in body composition variables with only change in trunk fat mass and BMI being significant.	[Bernardino, Jose I.; Arribas, Jose R.] Hosp Univ La Paz, Dept Internal Med, IdiPAZ, Madrid, Spain; [Mocroft, Amanda] UCL, London, England; [Wallet, Cedrick; Richert, Laura] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [de Wit, Stephane] Univ Libre Bruxeles, CHU St Pierre, Brussels, Belgium; [Katlama, Christine] UPMC Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, UMR S 1136,Inst Pierre Louis Epidemiol & Sante Pu, Paris, France; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Amsterdam, Netherlands; [Mallon, Patrick W.] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Molina, Jean-Michel] Univ Paris Diderot, Hop St Louis, INSERM U941, Paris, France; [Knobel, Hernando] Univ Autonoma Barcelona, Hosp del Mar, Dept Infect Dis, Barcelona, Spain; [Morlat, Philippe] Univ Bordeaux, CHU Bordeaux, Inserm U1219, Serv Med Interne & Malad Infect, Bordeaux, France; [Babiker, Abdel] UCL, MRC Clin Trials Unit, London, England; [Pozniac, Anton] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Raffi, Francois] CHU Nantes, Dept Infect Dis, Nantes, France; [Raffi, Francois] INSERM, CIC 1413, Nantes, France	Hospital Universitario La Paz; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Medical Research Council Clinical Trials Unit; University of London; University College London; Imperial College London; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bernardino, JI (corresponding author), Hosp Univ La Paz, Dept Internal Med, IdiPAZ, Madrid, Spain.	jose.bernardino@salud.madrid.org	Bernardino, José Ignacio/AAD-1637-2019; Richert, Laura/T-5801-2019; Knobel, Hernando/AAD-3582-2020; Knobel, Hernando/B-5223-2016; Arribas, Jose/A-1595-2015	Bernardino, José Ignacio/0000-0003-3501-8529; Knobel, Hernando/0000-0003-3186-6416; Knobel, Hernando/0000-0003-3186-6416; Richert, Laura/0000-0002-7682-2225; Arribas, Jose/0000-0002-7410-9450	European Union under the Sixth Framework Programme [LSHP-CT-2006-037570]; Ministerio de Sanidad y Asuntos Sociales de Espana [2009/TRA-054]; Gilead Sciences; Janssen Pharmaceuticals; Merck Laboratories; French National Institute for Health and Medical Research-France Recherche Nord&Sud SIDA-HIV Hepatites (Inserm-ANRS)	European Union under the Sixth Framework Programme; Ministerio de Sanidad y Asuntos Sociales de Espana; Gilead Sciences(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Laboratories(Merck & Company); French National Institute for Health and Medical Research-France Recherche Nord&Sud SIDA-HIV Hepatites (Inserm-ANRS)	NEAT is a project funded to the Instituto Superiori di Sanita-Rome, by the European Union under the Sixth Framework Programme, project number LSHP-CT-2006-037570. This analysis was also partially funded by a grant from the Ministerio de Sanidad y Asuntos Sociales de Espana (2009/TRA-054). The trial was also supported by Gilead Sciences, Janssen Pharmaceuticals, and Merck Laboratories, and the French National Institute for Health and Medical Research-France Recherche Nord&Sud SIDA-HIV Hepatites (Inserm-ANRS) is the sponsor and a funder of the trial.; NEAT is a project funded to the Instituto Superiori di Sanita-Rome, by the European Union under the Sixth Framework Programme, project number LSHP-CT-2006-037570. This analysis was also partially funded by a grant from the Ministerio de Sanidad y Asuntos Sociales de Espana (2009/TRA-054). The trial was also supported by Gilead Sciences, Janssen Pharmaceuticals, and Merck Laboratories, and the French National Institute for Health and Medical Research-France Recherche Nord&Sud SIDA-HIV Hepatites (Inserm-ANRS) is the sponsor and a funder of the trial.	Bedimo RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106221; Beltran LM, 2015, VASC HEALTH RISK MAN, V11, P35, DOI 10.2147/VHRM.S65885; Bernardino JI, 2015, LANCET HIV, V2, pE464, DOI 10.1016/S2352-3018(15)00181-2; Bluher M, 2015, METABOLISM, V64, P131, DOI 10.1016/j.metabol.2014.10.016; Boyd MA, 2017, LANCET HIV, V4, pE13, DOI 10.1016/S2352-3018(16)30189-8; Brown TT, 2013, JAIDS-J ACQ IMM DEF, V63, P323, DOI 10.1097/QAI.0b013e318295eb1d; Freitas P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-347; Grant PM, 2016, AIDS, V30, P2805, DOI 10.1097/QAD.0000000000001248; Guaraldi G, 2014, HIV MED, V15, P587, DOI 10.1111/hiv.12159; Johnson JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE261, DOI 10.1152/ajpendo.00056.2003; Koethe JR, 2016, J INFECT DIS, V214, pS75, DOI 10.1093/infdis/jiw286; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; McComsey GA, 2016, CLIN INFECT DIS, V62, P853, DOI 10.1093/cid/ciw017; McComsey GA, 2013, J INFECT DIS, V207, P604, DOI 10.1093/infdis/jis720; PrayGod G, 2016, EUR J CLIN NUTR, V70, P499, DOI 10.1038/ejcn.2015.221; Raffi F, 2014, LANCET, V384, P1942, DOI 10.1016/S0140-6736(14)61170-3; Reingold JS, 2008, JAIDS-J ACQ IMM DEF, V48, P142, DOI 10.1097/QAI.0b013e3181685727; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]	21	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0209911	10.1371/journal.pone.0209911	http://dx.doi.org/10.1371/journal.pone.0209911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689664	Green Published, Green Submitted, gold			2022-12-27	WOS:000457041800003
J	Qi, RH; Otting, G				Qi, Ruhu; Otting, Gottfried			Mutant T4 DNA polymerase for easy cloning and mutagenesis	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ESCHERICHIA-COLI; RECOMBINANT-DNA; PROTEIN	The advent of high-fidelity DNA polymerases that can be used to linearize and amplify whole plasmids by PCR opened the door to greatly simplified cloning and mutagenesis protocols. Commercially available kits work well, but often have been optimized using undisclosed or proprietory components. Here we show that a mutant T4 DNA polymerase (Y320A) with attenuated 3'-exonuclease activity is uniquely suited to generate single stranded DNA overhangs of uniform length in a more easily controllable manner than the wild-type enzyme, and this can be used to increase the yields of colonies containing correctly modified plasmids in cloning and mutagenesis experiments, which is particularly useful when E. co/icells are of relatively low competency. Standard protocols using the mutant T4 DNA polymerase are provided for the sequence and ligation independent cloning (SLIC) method and a modified QuikChange method, where the mutant enzyme enhances the yield of correctly mutated plasmid and further suppresses parental plasmid during digestion with Dpnl. Single-stranded DNA overhangs generated by the mutant T4 DNA polymerase facilitate subsequent plasmid circularization, annealing and ligation in E. coli.	[Qi, Ruhu; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Australian National University	Otting, G (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia.	gottfried.otting@anu.edu.au	Otting, Gottfried/H-8413-2014	Otting, Gottfried/0000-0002-0563-0146	Australian Research Council [DP170100162, FL170100019]	Australian Research Council(Australian Research Council)	Financial support was obtained from the Australian Research Council (https://www.arc.gov.au), grants DP170100162 and FL170100019 to G. O. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Aslanidis C, 2009, GENOME RES, V4, P172; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; da Silva EF, 2007, NUCLEIC ACIDS RES, V35, P5452, DOI 10.1093/nar/gkm591; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green MR, 2012, MOL CLONING LAB MANU, V1; Huang FQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183974; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Islam MN, 2017, BIOTECHNIQUES, V63, P125, DOI 10.2144/000114588; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LIN TC, 1994, J BIOL CHEM, V269, P19286; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; Sattar AKMA, 1996, BIOCHEMISTRY-US, V35, P16621, DOI 10.1021/bi961552q; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Tan A, 2018, PEERJ, V6, DOI 10.7717/peerj.5383; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; YANG YS, 1993, NUCLEIC ACIDS RES, V21, P1889, DOI 10.1093/nar/21.8.1889; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	30	3	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211065	10.1371/journal.pone.0211065	http://dx.doi.org/10.1371/journal.pone.0211065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673756	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800072
J	Fries, CA; Lawson, SD; Wang, LC; Slaughter, KV; Vemula, PK; Dhayani, A; Joshi, N; Karp, JM; Rickard, RF; Gorantla, VS; Davis, MR				Fries, C. Anton; Lawson, Shari D.; Wang, Lin C.; Slaughter, Kai V.; Vemula, Praveen K.; Dhayani, Ashish; Joshi, Nitin; Karp, Jeffrey M.; Rickard, Rory F.; Gorantla, Vijay S.; Davis, Michael R.			Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study	PLOS ONE			English	Article							UPPER EXTREMITY TRANSPLANTATION; ALLOTRANSPLANTATION; IMMUNOSUPPRESSION; ALEMTUZUMAB; REJECTION; DELIVERY; SKIN; MAINTENANCE; PRODRUGS; MODEL	Background Currently, patients receiving vascularized composite allotransplantation (VCA) grafts must take long-term systemic immunosuppressive therapy to prevent immunologic rejection. The morbidity and mortality associated with these medications is the single greatest barrier to more patients being able to receive these life-enhancing transplants. In contrast to solid organs, VCA, exemplified by hand or face transplants, allow visual diagnosis of clinical acute rejection (AR), directed biopsy and targeted graft therapies. Local immunosuppression in VCA could reduce systemic drug exposure and limit adverse effects. This proof of concept study evaluated, in a large animal forelimb VCA model, the efficacy and tolerability of a novel graft-implanted enzyme-responsive, tacrolimus (TAC)-eluting hydrogel platform, in achieving long-term graft survival. Methods Orthotopic forelimb VCA were performed in single haplotype mismatched mini-swine. Controls (n = 2) received no treatment. Two groups received TAC hydrogel: high dose (n = 4, 91 mg TAC) and low dose (n = 4, 49 mg TAC). The goal was to find a dose that was tolerable and resulted in long-term graft survival. Limbs were evaluated for clinical and histopathological signs of AR. TAC levels were measured in serial blood and skin tissue samples. Tolerability of the dose was evaluated by monitoring animal feeding behavior and weight. Results Control limbs underwent Banff Grade IV AR by post-operative day six. Low dose TAC hydrogel treatment resulted in long-term graft survival time to onset of Grade IV AR ranging from 56 days to 93 days. High dose TAC hydrogel also resulted in long-term graft survival (24 to 42 days), but was not well tolerated. Conclusion Graft-implanted TAC-loaded hydrogel delays the onset of Grade IV AR of mismatched porcine forelimb VCA grafts, resulting in long term graft survival and demonstrates dose-dependent tolerability.	[Fries, C. Anton; Lawson, Shari D.; Wang, Lin C.; Davis, Michael R.] US Army Inst Surg Res, San Antonio, TX 78234 USA; [Fries, C. Anton; Rickard, Rory F.] Royal Ctr Def Med, ICT Ctr, Birmingham, W Midlands, England; [Slaughter, Kai V.; Joshi, Nitin; Karp, Jeffrey M.] Brigham & Womens Hosp, Ctr Nanomed, 75 Francis St, Boston, MA 02115 USA; [Slaughter, Kai V.; Joshi, Nitin; Karp, Jeffrey M.] Brigham & Womens Hosp, Dept Med, Div Engn Med, 75 Francis St, Boston, MA 02115 USA; [Vemula, Praveen K.; Dhayani, Ashish] Inst Stem Cell Biol & Regenerat Med InStem, UAS GKVK Campus, Bangalore, Karnataka, India; [Dhayani, Ashish] SASTRA Univ, Sch Chem & Biotechnol, Thanjavur, India; [Joshi, Nitin; Karp, Jeffrey M.] Harvard Med Sch, Boston, MA USA; [Gorantla, Vijay S.] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA; [Gorantla, Vijay S.; Davis, Michael R.] 59th MDW Sci & Technol, RESTOR Program, Joint Base San Antonio, TX USA	United States Department of Defense; United States Army; Royal Centre for Defence Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; University of Agricultural Sciences Bangalore; Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Harvard University; Harvard Medical School; Wake Forest University; Wake Forest Baptist Medical Center	Fries, CA (corresponding author), US Army Inst Surg Res, San Antonio, TX 78234 USA.; Fries, CA (corresponding author), Royal Ctr Def Med, ICT Ctr, Birmingham, W Midlands, England.	antonfries@gmail.com	Joshi, Nitin/AAE-1435-2020	Karp, Jeffrey/0000-0002-4752-7374; Joshi, Nitin/0000-0001-8138-7611; Dhayani, Ashish/0000-0002-5488-8952; Fries, Charles Anton/0000-0003-0128-5688	US Air Force Medical Service Agency (59MDW Office of Science and Technology); Department of Defense [W81XWH-15-2-0047 Log MR141085]; United Kingdom Ministry of Defence; Department of Defense (DOD) [W81XWH-14-1-0229]; Rheumatology Research Foundation; King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM); Football Players Health Study at Harvard; National Football League Players Association	US Air Force Medical Service Agency (59MDW Office of Science and Technology); Department of Defense(United States Department of Defense); United Kingdom Ministry of Defence; Department of Defense (DOD)(United States Department of Defense); Rheumatology Research Foundation; King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM); Football Players Health Study at Harvard; National Football League Players Association	The studies were supported by intramural grant funding from the US Air Force Medical Service Agency (59MDW Office of Science and Technology) and in part by extramural funding from Department of Defense Grant W81XWH-15-2-0047 Log MR141085 (Reconstructive Transplant Research Program). CAF was funded by a fellowship from the United Kingdom Ministry of Defence. J.M.K. and N.J. were financially supported by Department of Defense (DOD) award W81XWH-14-1-0229, a Disease Targeted Innovative Research Grant from Rheumatology Research Foundation, a grant from King Abdulaziz City for Science and Technology through the Center of Excellence for Biomedicine (CEBM) and with the support of the Football Players Health Study at Harvard. The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliated academic health care centers, the National Football League Players Association, or the Brigham and Women's Hospital.	Ana Luisa R P, 2011, UNDERSTANDING COMPLE, DOI [10.5772/17632, DOI 10.5772/17632]; [Anonymous], 2016, ANESTHESIA PERIOPERA, DOI DOI 10.1007/978-1-4939-6377-5_44; Barbero AM, 2009, TOXICOL IN VITRO, V23, P1, DOI 10.1016/j.tiv.2008.10.008; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Fine RN, 2009, AM J TRANSPLANT, V9, P35, DOI 10.1111/j.1600-6143.2008.02495.x; Fries CA, 2016, PLAST RECONSTR SURG, V138, p461E, DOI 10.1097/PRS.0000000000002451; Fries CA, 2015, CURR TRANSPLANT REP, V2, P284, DOI [10.1007/s40472- 015- 0071- 8, DOI 10.1007/S40472-015-0071-8]; Gajanayake T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008778; Gorantla V, 2001, EUR J TRAUMA, V27, P267, DOI DOI 10.1007/S00068-001-1152-1; Gorantla VS, 2011, HAND CLIN, V27, P511, DOI 10.1016/j.hcl.2011.08.008; Gorantla VS, 2011, HAND CLIN, V27, P481, DOI 10.1016/j.hcl.2011.08.006; Gorantla Vijay S., 2008, P215, DOI 10.1007/978-0-387-74682-1_16; Gorantla VS, 2000, MICROSURG, V20, P420, DOI 10.1002/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O; Ho CS, 2010, DEV COMP IMMUNOL, V34, P250, DOI 10.1016/j.dci.2009.09.006; Ho CS, 2009, HUM IMMUNOL, V70, pS3, DOI 10.1016/j.humimm.2009.09.015; Howsare M, 2017, CURR OPIN ORGAN TRAN, V22, P463, DOI 10.1097/MOT.0000000000000456; Joshi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03691-1; Khalil AA, 2006, PLAST RECONSTR SURG, V117, P1024, DOI 10.1097/01.prs.0000204766.17127.54; Kirresh T, 2017, J PHARMACEUT BIOMED, V136, P32, DOI 10.1016/j.jpba.2016.12.034; LaMattina JC, 2012, TRANSPL INT, V25, P518, DOI 10.1111/j.1432-2277.2012.01448.x; Messner F, 2016, CURR OPIN ORGAN TRAN, V21, P503, DOI 10.1097/MOT.0000000000000343; Monziois M, 2007, MEAT SCI, V76, P54, DOI 10.1016/j.meatsci.2006.10.013; Pruett T L, 2009, YB OF SURG, V2009, P109; Rosenblum D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03705-y; Schneeberger S, 2009, TRANSPL P, V41, P472, DOI 10.1016/j.transproceed.2009.01.019; Schneeberger S, 2009, TRANSPL P, V41, P499, DOI 10.1016/j.transproceed.2009.01.018; Schnider JT, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/495212; Spiller KL, 2017, ADV DRUG DELIVER REV, V122, P74, DOI 10.1016/j.addr.2017.05.010; Surnmerfield A, 2015, MOL IMMUNOL, V66, P14, DOI 10.1016/j.molimm.2014.10.023; Urello MA, 2019, ENCYCLOPEDIA OF BIOMEDICAL ENGINEERING, VOL 1, P565, DOI 10.1016/B978-0-12-801238-3.99892-1; Valeur E, 2017, DRUG DISCOV TODAY, V22, P841, DOI 10.1016/j.drudis.2016.12.004; Vemula PK, 2009, BIOMATERIALS, V30, P383, DOI 10.1016/j.biomaterials.2008.09.045; Vemula PK, 2013, CURR OPIN BIOTECH, V24, P1174, DOI 10.1016/j.copbio.2013.02.006; Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003; Weissenbasher A, 2010, IMMUNOTHERAPY-UK, V2, P783, DOI 10.2217/IMT.10.68; Zhang SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5657	36	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0210914	10.1371/journal.pone.0210914	http://dx.doi.org/10.1371/journal.pone.0210914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677062	Green Published, gold, Green Submitted			2022-12-27	WOS:000456700400033
J	Hui, WJ; Li, T; Liu, WD; Zhou, CY; Gao, F				Hui, Wenjia; Li, Ting; Liu, Weidong; Zhou, Chunyan; Gao, Feng			Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis	PLOS ONE			English	Article							OPEN-LABEL; EPIDEMIOLOGY; VANCOMYCIN; COLITIS; PATIENT; DONORS; FROZEN	Objectives Although systematic evaluation has confirmed the efficacy of fresh fecal microbiota transplantation (FMT) for treatment of recurrent and/or refractory and/or relapse C. difficile infection (RCDI), it lacks the support of well-designed randomized controlled trials (RCTs), and the latest guidelines do not optimize the management of FMT. In this paper, we focus on an in-depth study of fresh FMT and fecal infusion times to guide clinical practice. Methods We reviewed studies in PubMed, Medline, Embase, the Cochrane library and Cochrane Central written in English. The retrieval period was from the establishment of the databases to September 20th, 2018. The retrieval objects were published RCTs of RCDI treated by fresh FMT. The intervention group was fresh FMT group, while the control group included antibiotic therapy or placebo or frozen FMT or capsule. The primary and secondary outcomes were the clinical remission of diarrhea without relapse after 8-17 weeks and the occurrence of severe adverse events, respectively. Subgroup analysis analyzed the effect of single and multiple fecal infusions. Two authors independently completed the information extraction and assessed risk of bias and overall quality of the evidence. Results 8 randomized controlled trials met the inclusion criteria, involving 537 patients (273 in the fresh FMT group and 264 in the control group). The recurrence rate of clinical diarrhea in the fresh FMT group was 11.0% (30/273), which was significantly lower than the control group (24.6%, 65/264; P<0.05); the pooled relative risk (RR) was 0.38 (95%CI:0.16-0.87; I-2=67%; P=0.02) in the fresh FMT group, and the clinical heterogeneity was significant and random effects model was used; However, there was no significant difference neither for the effect of antibiotic treatment/frozen feces transplanted by enema (RR=1.07; 95%CI:0.64-1.80; I-2=0%; P=0.79) or capsule/frozen feces transplanted by colonoscopy (RR=0.42; 95%CI: 0.05-3.94; I-2=43%; P=0.45) compared with fresh FMT. The subgroup analysis showed that FMT by multiple infusions could effectively and significantly (RR=0.24; 95%CI:0.10-0.58; I-2=0%; P=0.001) improve the clinical diarrhea remission rate. Most mild to moderate adverse events caused by FMT were self-limited and could be quickly alleviated; no severe adverse events happened because of FMT. Conclusions Overall, the use of fresh feces for bacterial transplantation was the best efficiency for RCDI compared to antibiotic therapy or placebo. The fecal transmission method by enema was not ideal, but capsules or frozen feces transported by colonoscopy could be an alternative treatment compared to fresh FMT. For patients with severe RCDI, multiple fecal transplants can effectively improve their diarrhea remission rate. The focus of future research should be on how to standardize the production of capsules or frozen feces to better guide the clinical management of RCDI patients by FMT.	[Hui, Wenjia; Li, Ting; Liu, Weidong; Gao, Feng] Peoples Hosp Xin Jiang Uygur Autonomous Reg, Dept Gastroenterol, Urumqi, Xinjiang, Peoples R China; [Zhou, Chunyan] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Gao, F (corresponding author), Peoples Hosp Xin Jiang Uygur Autonomous Reg, Dept Gastroenterol, Urumqi, Xinjiang, Peoples R China.	xjgf@sina.com		Liu, Weidong/0000-0003-3320-3958; Hui, Wenjia/0000-0001-6055-1339				Bang B, 2017, KOREAN J GASTROENTER, V69; Barbut F., 2015, ANNALES PHARMACEUTIQUES FRANCAISES, V73, P13, DOI 10.1016/j.pharma.2014.05.004; Brittnacher MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158897; Broecker F, 2013, DIGESTION, V88, P243, DOI 10.1159/000355955; Camacho-Ortiz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189768; Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Chen B, 2017, J INFECTION, V74, pS120, DOI 10.1016/S0163-4453(17)30202-5; Cohen N, 2016, ISR MED ASS J, V18; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Furuya-Kanamori L, 2017, J CLIN GASTROENTEROL, V51, P145, DOI 10.1097/MCG.0000000000000511; Garcia-Fernandez S, 2016, DIAGN MICR INFEC DIS, V86, P470, DOI 10.1016/j.diagmicrobio.2016.09.004; Garcia-Garcia-de-Paredes A, 2015, GASTROENT HEPAT-BARC, V38, P123, DOI 10.1016/j.gastrohep.2014.07.010; Gupta SB, 2016, CLIN INFECT DIS, V63, P730, DOI 10.1093/cid/ciw364; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hota SS, 2017, CLIN INFECT DIS, V64, P265, DOI 10.1093/cid/ciw731; Ianiro G, 2018, ALIMENT PHARM THER, V48, P152, DOI 10.1111/apt.14816; Jiang ZD, 2017, ALIMENT PHARM THER, V45, P899, DOI 10.1111/apt.13969; JPT H, 2011, COCHRANE HDB SYSTEMA, V2011; Juszczuk K, 2017, POSTEPY HIG MED DOSW, V71; Kao D, 2017, JAMA, V318; Kassam Z, 2014, CLIN LAB MED, V34, P787, DOI 10.1016/j.cll.2014.08.007; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kelly CP, 2008, NEW ENGL J MED, V359; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Konturek PC, 2017, MED PRIN PRACT, V26, P182, DOI 10.1159/000455126; Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098; Li YT, 2016, ALIMENT PHARM THER, V43, P445, DOI 10.1111/apt.13492; Loke P, 2016, PEDIAT ALLERG IMM-UK, V27, P872, DOI 10.1111/pai.12619; McFarland LV, 2016, WORLD J GASTROENTERO, V22, P3078, DOI 10.3748/wjg.v22.i11.3078; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Mendolia G, 2016, GASTROENTEROLOGY, V150, DOI [10.1016/S0016-5085(16)31855-8, DOI 10.1016/S0016-5085(16)31855-8]; Merlo G, 2016, J GASTROEN HEPATOL, V31, P1927, DOI 10.1111/jgh.13402; Moayyedi P, 2017, MED J AUST, V207; Nayak SU, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02760-16; Ontario H Q, 2016, ONT HLTH TECHNOL ASS, V16; Pai N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016698; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Quraishi MN, 2017, ALIMENT PHARM THER, V46, P479, DOI 10.1111/apt.14201; Reijnders D, 2016, CELL METAB, V24, P63, DOI [10.1016/j.cmet.2016.06.016, 10.1016/j.cmet.2016.07.008]; Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saeedi BJ, 2017, OBSTET GYNECOL, V129, P507, DOI 10.1097/AOG.0000000000001911; Seekatz AM, 2014, MBIO, V5, DOI 10.1128/mBio.00893-14; Seufferlein T, 2014, INTERNIST, V55, P455, DOI 10.1007/s00108-014-3483-0; Staley C, 2016, MBIO, V7, DOI 10.1128/mBio.01965-16; Tang GH, 2017, DIAGN MICR INFEC DIS, V88, P322, DOI 10.1016/j.diagmicrobio.2017.05.007; Tian HL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171308; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Wang SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161174; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wilson K, 1993, CLIN INFECT DIS S4, V16; Yamazaki Y, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1070-z; Youngster I, 2014, CLIN INFECT DIS, V58, P1515, DOI 10.1093/cid/ciu135; Zhang FM, 2018, PROTEIN CELL, V9, P462, DOI 10.1007/s13238-018-0541-8; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	59	68	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210016	10.1371/journal.pone.0210016	http://dx.doi.org/10.1371/journal.pone.0210016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673716	Green Published, gold, Green Submitted			2022-12-27	WOS:000456442800027
J	Rioux, CR; Clapper, ML; Cooper, HS; Michaud, J; St Amant, N; Koohsari, H; Workman, L; Kaunga, E; Hensley, H; Pilorget, A; Gerard, C				Rioux, Clement R.; Clapper, Margie L.; Cooper, Harry S.; Michaud, Jean; St Amant, Natalie; Koohsari, Hossein; Workman, Laura; Kaunga, Esther; Hensley, Harvey; Pilorget, Anthony; Gerard, Catherine			Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models	PLOS ONE			English	Article							IMMUNE CELLS; T-CELLS; TARGETED THERAPIES; PRIMARY PREVENTION; ASPIRIN; ASCL2; IMMUNOTHERAPY; NEOPLASIA; CHECKPOINTS; METASTASES	Human achaete scute homolog 2 (HASH2) and its murine ortholog MASH2 are potential targets for colorectal cancer immunotherapy. We assessed immunogenicity and antitumor potential of recombinant MASH2 protein combined with AS15 immunostimulant (recMASH2+AS15) in CB6F1 and Apc(+/Min-FCCC) mice. CB6F1 mice received 4 injections of recMASH2+AS15 or AS15 alone before challenge with TC1-MASH2 tumor cells (Tumor Challenge). Apc(+/Min-FCCC) mice received 9 injections of recMASH2+AS15 or vehicle (phosphate buffer saline [PBS] or AS15 alone), before (two independent Prophylactic Studies) or after (Immunotherapy) colon adenomas were detectable by colonoscopy. CB6F1 mice immunized with recMASH2+AS15 had a significantly smaller mean tumor size and improved survival rate compared to controls (104 mm(2) vs. 197 mm(2) [p = 0.009] and 67% vs. 7% [p = 0.001], respectively). In Prophylactic Study 1, the mean number of colon adenomas was significantly lower in Apc(+/Min-FCCC) mice receiving recMASH2+AS15 compared to PBS (1.8 [95% confidence interval 1.0-3.3] vs. 5.2 [3.7-7.4], p = 0.003). Fewer microadenomas were observed in recMASH2+AS15 groups compared to PBS in both Prophylactic Studies (Study 1: mean 0.4 [0.2-1.0] vs. 1.5 [0.9-2.4], p = 0.009; Study 2: 0.4 [0.2-0.6] vs. 1.1 [0.8-1.5], p = 0.001). In the Immunotherapy Study, fewer colon adenomas tended to be observed in recMASH2+AS15-treated mice (4.1 [2.9-6.0]) compared to controls (AS15 4.7 [3.3-6.6]; PBS 4.9 [3.5-6.9]; no significant difference). recMASH2+AS15 induced MASH2-specific antibody and CD4+ responses in both mouse models. recMASH2+AS15 partially protected mice against MASH2-expressing tumors and reduced spontaneous colorectal adenomas in Apc(+/Min-FCCC) mice, indicating that MASH2/HASH2 antigens are targets for colorectal cancer immunotherapy.	[Rioux, Clement R.; Michaud, Jean; St Amant, Natalie; Koohsari, Hossein; Pilorget, Anthony] GSK, Laval, PQ, Canada; [Clapper, Margie L.; Cooper, Harry S.; Workman, Laura; Kaunga, Esther; Hensley, Harvey] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Gerard, Catherine] GSK, Rixensart, Belgium; [Koohsari, Hossein] Neomed Labs, Laval, PQ, Canada	GlaxoSmithKline; Fox Chase Cancer Center; GlaxoSmithKline	Clapper, ML (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	margie.clapper@fccc.edu		Pilorget, Anthony/0000-0003-3142-2698	GlaxoSmithKline Biologicals SA;  [CA-006927]	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); 	GlaxoSmithKline Biologicals SA funded this study and the development of the manuscript. Experimentation at Fox Chase Cancer Center was supported partially by CA-006927 grant and an appropriation from the Commonwealth of Pennsylvania. The sponsor provided support in the form of salaries for authors [CR, JM, NSA, HK, AP and CG], set the study design, data collection and analysis, and decision to publish. Writing assistance provided by Urszula Miecielica (XPE Pharma & Science) was funded by GlaxoSmithKline Biologicals SA.	Aran V, 2016, CLIN COLORECTAL CANC, V15, P195, DOI 10.1016/j.clcc.2016.02.008; Arber N, 2008, CANCER EPIDEM BIOMAR, V17, P1852, DOI 10.1158/1055-9965.EPI-08-0167; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Baxevanis CN, 2000, J IMMUNOL, V164, P3902, DOI 10.4049/jimmunol.164.7.3902; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bultman SJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500902; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Church SE, 2014, EUR J IMMUNOL, V44, P69, DOI 10.1002/eji.201343718; Cooper HS, 2005, MOL CARCINOGEN, V44, P31, DOI 10.1002/mc.20114; Coyle C, 2016, CURR COLORECT CANC R, V12, P27, DOI 10.1007/s11888-016-0306-9; Curtis NJ, 2012, EJSO-EUR J SURG ONC, V38, P889, DOI 10.1016/j.ejso.2012.05.011; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Deschoolmeester V, 2013, CURR COLORECT CANC R, V9, P380, DOI 10.1007/s11888-013-0182-5; Dhodapkar KM, 2002, J EXP MED, V195, P125, DOI 10.1084/jem.20011097; Drew DA, 2016, NAT REV CANCER, V16, P173, DOI 10.1038/nrc.2016.4; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gerard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094883; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hardingham JE, 2015, MOL MED, V21, pS25, DOI 10.2119/molmed.2015.00149; Hensley HH, 2009, GASTROINTEST ENDOSC, V69, P742, DOI 10.1016/j.gie.2008.09.054; Jochems C, 2011, EXP BIOL MED, V236, P567, DOI 10.1258/ebm.2011.011007; Jubb AM, 2006, ONCOGENE, V25, P3445, DOI 10.1038/sj.onc.1209382; Kan S, 2012, ANTICANCER RES, V32, P5363; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Moriarity A, 2016, THER ADV MED ONCOL, V8, P276, DOI 10.1177/1758834016646734; Oberg A, 2002, INT J COLORECTAL DIS, V17, P25; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pernot S, 2014, WORLD J GASTROENTERO, V20, P3738, DOI 10.3748/wjg.v20.i14.3738; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roncucci L, 2015, EUR J INTERN MED, V26, P752, DOI 10.1016/j.ejim.2015.08.019; Rothwell Peter M, 2013, Recent Results Cancer Res, V191, P121, DOI 10.1007/978-3-642-30331-9_7; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Saebo M, 2008, ANTICANCER RES, V28, P2289; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Singh PP, 2015, GASTROENTEROL REP, V3, P289, DOI 10.1093/gastro/gov053; Speetjens FM, 2011, EXPERT REV VACCINES, V10, P899, DOI [10.1586/ERV.11.63, 10.1586/erv.11.63]; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Stepan H, 2003, BIOL REPROD, V68, P40, DOI 10.1095/biolreprod.102.004945; Tariq K, 2016, CANCER BIOL MED, V13, P120, DOI 10.28092/j.issn.2095-3941.2015.0103; Teixeira MC, 2014, WORLD J GASTROENTERO, V20, P15060, DOI 10.3748/wjg.v20.i41.15060; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; World Cancer Research Fund/American Institute for Cancer Research, 2011, CONT UPD PROJ COL CA; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31	57	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210261	10.1371/journal.pone.0210261	http://dx.doi.org/10.1371/journal.pone.0210261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682058	Green Published, gold, Green Submitted			2022-12-27	WOS:000457037500031
J	Yamada, S; Shimada, M; Morine, Y; Imura, S; Ikemoto, T; Saito, Y; Takasu, C; Yoshikawa, M; Teraoku, H; Yoshimoto, T				Yamada, Shinichiro; Shimada, Mitsuo; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Saito, Yu; Takasu, Chie; Yoshikawa, Masato; Teraoku, Hiroki; Yoshimoto, Toshiaki			A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging	PLOS ONE			English	Article							LIVER-FUNCTION; HEPATOBILIARY PHASE; HEPATIC RESECTION; MRI; FAILURE; REMNANT; SCINTIGRAPHY; DYSFUNCTION; PREDICTION; MORTALITY	Background and aim Dynamic magnetic resonance imaging with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (EOB-MRI) can be used not only to detect liver tumors but also to estimate liver function. The aim of this study was to establish a new EOB-MRI-based formula to determine the resection limit in patients undergoing hepatectomy. Methods Twenty-eight patients with a normal liver (NL group) and five with an unresectable cirrhotic liver (UL group) who underwent EOB-MRI were included. Standardized liver function (SLF) was calculated based on the signal intensity (SI), the volume of each subsegment (S1-S8), and body surface area. A formula defining the resection limit was devised based on the difference in the SLF values of patients in the NL and UL groups. The formula was validated in 50 patients who underwent EOB-MRI and hepatectomy. Results The average SLF value in the NL and UL groups was 2038 and 962 FV/m(2), respectively. The difference (1076 FV/m(2)) was consistent with a 70% in resection volume. Thus, the resection limit for hepatectomy was calculated as a proportion of 70%: 70x(SLF-962)/1076 (%). The one patient who underwent hepatectomy over the resection limit died due to liver failure. In other 49 patients, in whom the resection volume was less than the resection limit, procedures were safely performed. Conclusions Our formula for resection limit based on EOB-MRI can improve the safety of hepatectomy.	[Yamada, Shinichiro; Shimada, Mitsuo; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Saito, Yu; Takasu, Chie; Yoshikawa, Masato; Teraoku, Hiroki; Yoshimoto, Toshiaki] Tokushima Univ, Dept Surg, Tokushima, Japan	Tokushima University	Yamada, S (corresponding author), Tokushima Univ, Dept Surg, Tokushima, Japan.	yamada.shinichirou@tokushima-u.ac.jp		Ikemoto, Tetsuya/0000-0001-9800-1359; Yamada, Shinichiro/0000-0003-3847-751X				Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bae KE, 2012, DIGEST DIS, V30, P617, DOI 10.1159/000343092; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Capussotti L, 2009, BRIT J SURG, V96, P88, DOI 10.1002/bjs.6429; CLAVIEN PA, 1992, SURGERY, V111, P518; Dinant S, 2007, J NUCL MED, V48, P685, DOI 10.2967/jnumed.106.038430; Forsgren MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095700; Guglielmi A, 2012, DIGEST SURG, V29, P6, DOI 10.1159/000335713; Kim T, 1997, JMRI-J MAGN RESON IM, V7, P683, DOI 10.1002/jmri.1880070413; Kokudo N, 2002, WORLD J SURG, V26, P1342, DOI 10.1007/s00268-002-6262-3; Kudo M, 2010, ONCOLOGY-BASEL, V78, P87, DOI 10.1159/000315235; Kwon A, 1997, HEPATOLOGY, V25, P426; MIYAGAWA S, 1995, AM J SURG, V169, P589, DOI 10.1016/S0002-9610(99)80227-X; Motosugi U, 2009, J MAGN RESON IMAGING, V30, P1042, DOI 10.1002/jmri.21956; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Nanashima A, 2004, HEPATOL RES, V28, P184, DOI 10.1016/j.hepres.2003.11.010; Nilsson H, 2015, HPB, V17, P272, DOI 10.1111/hpb.12348; Ninomiya M, 2015, BRIT J SURG, V102, P944, DOI 10.1002/bjs.9820; Ryeom HK, 2004, KOREAN J RADIOL, V5, P231, DOI 10.3348/kjr.2004.5.4.231; SCHUHMANNGIAMPIERI G, 1992, RADIOLOGY, V183, P59, DOI 10.1148/radiology.183.1.1549695; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Shimizu J, 1999, DIGEST DIS SCI, V44, P1330, DOI 10.1023/A:1026679113772; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Sourbron S, 2012, RADIOLOGY, V263, P874, DOI 10.1148/radiol.12110337; Sumiyoshi T, 2013, WORLD J GASTROENTERO, V19, P3217, DOI 10.3748/wjg.v19.i21.3217; Tajima T, 2010, J COMPUT ASSIST TOMO, V34, P362, DOI 10.1097/RCT.0b013e3181cd3304; Utsunomiya T, 2012, J GASTROENTEROL, V47, P470, DOI 10.1007/s00535-011-0513-8; VERA DR, 1991, J NUCL MED, V32, P1169; Verloh N, 2014, EUR RADIOL, V24, P1013, DOI 10.1007/s00330-014-3108-y; Xiao YD, 2015, ONCOL LETT, V9, P1191, DOI 10.3892/ol.2014.2826; YAMANAKA N, 1994, ANN SURG, V219, P342, DOI 10.1097/00000658-199404000-00003	32	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210579	10.1371/journal.pone.0210579	http://dx.doi.org/10.1371/journal.pone.0210579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682046	Green Published, gold			2022-12-27	WOS:000457037500048
J	Yeow, TP; Aun, ESY; Hor, CP; Lim, SL; Khaw, CH; Aziz, NA				Yeow, Toh Peng; Aun, Evelyn Su-Yin; Hor, Chee Peng; Lim, Shueh Lin; Khaw, Chong Hui; Aziz, Nor Azizah			Challenges in the classification and management of Asian youth-onset diabetes mellitus-lessons learned from a single centre study	PLOS ONE			English	Article							C-PEPTIDE; TYPE-2; PREVALENCE; COMPLICATIONS; CHOLESTEROL; DEFINITION; ADULTS	It remains widely perceived that early-onset Type 2 Diabetes (T2D) in children and adolescents is rare and clinically distinct from Type 1 Diabetes (T1D). We studied the challenges of classifying subtypes of early-onset diabetes using clinical features and biomarkers, and management of these patients. We reviewed retrospectively the record of patients < 25 years old who attended the diabetes clinic in Penang General Hospital, Malaysia between 1st December 2012 and 30th June 2015. We examined their clinical features, C-peptide and pancreatic autoantibodies. Comparisons were made between T1D and T2D for magnitude, demographics, metabolic status and complications. We studied 176 patients with a mean age of 20 +/- 3.7 years, 43.2% had T1D, 13.6% had T2D, and 13.6% had mixed features of both. When tested, pancreatic autoantibodies were positive in 59.4% of the T1D. T2D presented two years later than T1D at 14.3 years, 20% were asymptomatic at presentation, and 50% required insulin supplementation despite fasting c-peptide of > 250 pmol/L. HbA(1C) of <= 8.0% (64 mmol/mol) was achieved in 30.3% of T1D, 58.3% of T2D on OAD and 16.7% of T2D on insulin. The T2D had greater cardiovascular risk with higher body mass index, more dyslipidaemia, higher blood pressure and earlier onset of nephropathy. The overlapping clinical features, variable autoimmunity, and beta-cell loss complicate classification of young diabetes. Pancreatic autoantibodies and C-peptide did not always predict diabetes subtypes nor respond to insulin. The poor metabolic control and high cardiovascular risk burden among the T2D highlight the need for population-based study and focused intervention.	[Yeow, Toh Peng; Aun, Evelyn Su-Yin] Penang Med Coll, Dept Med, George Town, Malaysia; [Yeow, Toh Peng; Lim, Shueh Lin; Khaw, Chong Hui; Aziz, Nor Azizah] Penang Gen Hosp, Div Endocrinol, Dept Med, George Town, Malaysia; [Hor, Chee Peng] Seberang Jaya Hosp, Clin Res Ctr, George Town, Malaysia; [Hor, Chee Peng] Kepala Batas Hosp, Dept Med, George Town, Malaysia; [Aun, Evelyn Su-Yin] Sungai Buloh Hosp, Dept Med, Selangor, Malaysia		Yeow, TP (corresponding author), Penang Med Coll, Dept Med, George Town, Malaysia.; Yeow, TP (corresponding author), Penang Gen Hosp, Div Endocrinol, Dept Med, George Town, Malaysia.	tohpeng@rcsiucd.edu.my	Hor, Chee Peng/J-4957-2016	Hor, Chee Peng/0000-0003-0119-6634				Allen DB, 2012, NEW ENGL J MED, V366, P2315, DOI 10.1056/NEJMe1204710; Amed S, 2016, LANCET DIABETES ENDO, V4, P385, DOI 10.1016/S2213-8587(16)00080-2; American Diabetes Association, 2017, Diabetes Care, V40, pS120; American Diabetes Association, 2015, DIABETES CARE, V38; CDC, CHILD TEEN BMI ATL U; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho Min Jung, 2014, Ann Pediatr Endocrinol Metab, V19, P80, DOI 10.6065/apem.2014.19.2.80; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; D'Adamo E, 2011, DIABETES CARE, V34, pS161, DOI 10.2337/dc11-s212; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Dart AB, 2012, DIABETES CARE, V35, P1265, DOI 10.2337/dc11-2312; Fuziah M Z, 2008, Med J Malaysia, V63 Suppl C, P37; Gungor N, 2005, DIABETES CARE, V28, P638, DOI 10.2337/diacare.28.3.638; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Jones AG, 2013, DIABETIC MED, V30, P803, DOI 10.1111/dme.12159; Katz LEL, 2007, PEDIATR DIABETES, V8, P53; Maahs DM, 2007, DIABETES CARE, V30, P2593, DOI 10.2337/dc07-0450; Mauvais-Jarvis F, 2018, PHYSIOL BEHAV, V187, P20, DOI 10.1016/j.physbeh.2017.08.016; McQuaid S, 2005, DIABETES CARE, V28, P1216, DOI 10.2337/diacare.28.5.1216; Ministry of Health Malaysia, 2015, NAT HLTH MORB SURV 2; Mustapha FI, 2012, 15 NAT I HLTH SCI M; Nadeau KJ, 2016, DIABETES CARE, V39, P1635, DOI 10.2337/dc16-1066; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nazaimoon W M, 2000, Med J Malaysia, V55, P318; Nazaimoon WMW, 1999, DIABETES RES CLIN PR, V43, P59, DOI 10.1016/S0168-8227(98)00108-9; Nordestgaard BG, 2016, EUR HEART J, V37, P1944, DOI 10.1093/eurheartj/ehw152; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Song SH, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000044; Stenstrom G, 2005, DIABETES, V54, pS68, DOI 10.2337/diabetes.54.suppl_2.S68; Varbo A, 2015, CIRC RES, V116, P665, DOI 10.1161/CIRCRESAHA.116.304846; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yeow TP, 2017, BMJ OPEN DIAB RES CA, V5, DOI [10.1136/bmjdrc-2016-000317, DOI 10.1136/BMJDRC-2016-000317]; Yoo EG, 2004, J PEDIATR ENDOCR MET, V17, P1423; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211210	10.1371/journal.pone.0211210	http://dx.doi.org/10.1371/journal.pone.0211210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682116	Green Submitted, gold, Green Published			2022-12-27	WOS:000457037500125
J	Helliwell, JF; Shiplett, H; Barrington-Leigh, CP				Helliwell, John F.; Shiplett, Hugh; Barrington-Leigh, Christopher P.			How happy are your neighbours? Variation in life satisfaction among 1200 Canadian neighbourhoods and communities	PLOS ONE			English	Article							HAPPINESS; CONTEXT	This paper presents a new public-use dataset for community-level life satisfaction in Canada, based on more than 500,000 observations from the Canadian Community Health Surveys and the General Social Surveys. The country is divided into 1216 similarly sampled geographic regions, using natural, built, and administrative boundaries. A cross-validation exercise suggests that our choice of minimum sampling thresholds approximately maximizes the predictive power of our estimates. The resulting dataset reveals robust differences in life satisfaction between and across urban and rural communities. We compare aggregated life satisfaction data with a range of key census variables to illustrate some of the ways in which lives differ in the most and least happy communities.	[Helliwell, John F.; Shiplett, Hugh] Univ British Columbia, Vancouver Sch Econ, Vancouver, BC, Canada; [Helliwell, John F.] Canadian Inst Adv Res, Toronto, ON, Canada; [Barrington-Leigh, Christopher P.] McGill Univ, Montreal, PQ, Canada	University of British Columbia; Canadian Institute for Advanced Research (CIFAR); McGill University	Helliwell, JF (corresponding author), Univ British Columbia, Vancouver Sch Econ, Vancouver, BC, Canada.; Helliwell, JF (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	john.helliwell@ubc.ca		Barrington-Leigh, Christopher/0000-0002-3929-5390	Canadian Institute for Advanced Research	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	Research support for this research has come from the Canadian Institute for Advanced Research through its program in social interactions, identity and well-being co-directed by John Helliwell.	ABRAMOWITZ AI, 1983, J POLIT, V45, P767, DOI 10.2307/2130716; Aslam A, 2012, J ECON GEOGR, V12, P627, DOI 10.1093/jeg/lbr041; Barrington-Leigh CP, 2013, CAN PUBLIC POL, V39, P193, DOI 10.3138/CPP.39.2.193; Barrington-Leigh CP, 2008, 14593 WP NAT BUR EC; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Chen JW, 2016, ELECT STUD, V44, P329, DOI 10.1016/j.electstud.2016.06.014; Chen W-H, APPL RES QUAL LIFE, P1, DOI [10.1007/s11482-016-9447-x, DOI 10.1007/S11482-016-9447-X]; Chetty R, 2018, Q J ECON, V133, P1107, DOI 10.1093/qje/qjy007; Flowerdew R., 2001, MODELLING SCALE GEOG; Flowerdew Robin, 2011, Popul Trends, P102, DOI 10.1057/pt.2011.20; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Glaeser EL, 2003, J EUR ECON ASSOC, V1, P345, DOI 10.1162/154247603322390982; Glaeser EL, 2016, J LABOR ECON, V34, pS129, DOI 10.1086/684044; Goff L, 2018, ECON INQ, V56, P2177, DOI 10.1111/ecin.12582; Grannis R, 1998, AM J SOCIOL, V103, P1530, DOI 10.1086/231400; Helliwell J. F., 2018, 25121 NBER; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Helliwell JF, 2018, WORLD HAPPINESS REPO, P12; Helliwell JF, 2011, INT J WELLBEING, V1; Helliwell JF, 2018, SOC INDIC RES, V135, P965, DOI 10.1007/s11205-017-1549-9; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kingdon GG, 2007, J ECON BEHAV ORGAN, V64, P69, DOI 10.1016/j.jebo.2007.03.004; Kytta M, 2016, ENVIRON PLANN B, V43, P34, DOI 10.1177/0265813515600121; Lawless NM, 2011, SOC INDIC RES, V101, P341, DOI 10.1007/s11205-010-9667-7; Lu C., 2015, EC INSIGHTS; Lucas RE, 2014, INVESTIGATING SUBJEC, P161; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Manley D., 2014, HDB REGIONAL SCI, P1157, DOI [DOI 10.1007/978-3-642-23430-9_69, 10.1007/978-3-642-23430-9_69.]; Morrison PS, 2011, REG STUD, V45, P1039, DOI 10.1080/00343401003792476; OECD, 2015, MEAS WELL BEING MEX; Okulicz-Kozaryn A, 2011, SOC INDIC RES, V101, P435, DOI 10.1007/s11205-010-9671-y; Openshaw S., 1984, MODIFIABLE AREAL UNI; Organization for Economic Cooperation and Development, 2013, OECD GUID MEAS SUBJ; Oswald AJ, 2011, REV ECON STAT, V93, P1118, DOI 10.1162/REST_a_00133; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Ploug N., 2017, OKONOMISK ULIGHED DA; Rentfrow PJ, 2009, J RES PERS, V43, P1073, DOI 10.1016/j.jrp.2009.08.005; ROBACK J, 1982, J POLIT ECON, V90, P1257, DOI 10.1086/261120; Rosen S., 1979, CURRENT ISSUES URBAN, P74; Sampson R. J., 2012, GREAT AMERICAN CITY; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Subramanian SV, 2003, HEALTH PLACE, V9, P33, DOI 10.1016/S1353-8292(02)00028-X; Tranmer M, 2001, MODELLING SCALE GEOG, P105; Wilkinson R., 2011, SPIRIT LEVEL WHY GRE	45	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0210091	10.1371/journal.pone.0210091	http://dx.doi.org/10.1371/journal.pone.0210091			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HI4TC	30673727	gold, Green Published			2022-12-27	WOS:000456442800031
J	Li, J; Hughes, AC; Dudgeon, D				Li, Jia; Hughes, Alice C.; Dudgeon, David			Mapping wader biodiversity along the East Asian-Australasian flyway	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LONG-TERM TRENDS; SHOREBIRD POPULATIONS; MIGRATORY SHOREBIRDS; PROTECTED AREAS; GLOBAL PATTERNS; ANNUAL CYCLE; HABITAT LOSS; TIDAL FLATS; YELLOW SEA	Background and goal The study is conducted to facilitate conservation of migratory wader species along the East Asian-Australasian Flyway, particularly to 1) Identify hotspots of wader species richness along the flyway and effectively map how these might change between breeding, non-breeding and migratory phases; 2) Determine if the existing network of protected areas (PA) is sufficient to effectively conserve wader biodiversity hotspots along the EAAF; 3) Assess how species distribution models can provide complementary distribution estimates to existing BirdLife range maps. Methods We use a species distribution modelling (SDM) approach (MaxEnt) to develop temporally explicit individual range maps of 57 migratory wader species across their annual cycle, including breeding, non-breeding and migratory phases, which in turn provide the first biodiversity hotspot map of migratory waders along the EAAF for each of these phases. We assess the protected area coverage during each migration period, and analyse the dominant environmental drivers of distributions for each period. Additionally, we compare model hotspots to those existing range maps of the same species obtained from the BirdLife Internationals' database. Results Our model results indicate an overall higher and a spatially different species richness pattern compared to that derived from a wader biodiversity hotspot map based on BirdLife range maps. Field observation records from the eBird database for our 57 study species confirm many of the hotspots revealed by model outputs (especially within the Yellow Sea coastal region), suggesting that current richness of the EAAF may have been underestimated and certain hotspots overlooked. Less than 10% of the terrestrial zones area (inland and coastal) which support waders are protected and, only 5% of areas with the highest 10% species richness is protected. Main conclusions The study results suggest the need for new areas for migratory wader research and conservation priorities including Yellow Sea region and Russian far-East. It also suggests a need to increase the coverage and percentage of current PA network to achieve Aichi Target 11 for Flyway countries, including giving stronger consideration to the temporal dynamics of wader migration.	[Li, Jia; Dudgeon, David] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China; [Hughes, Alice C.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Beijing, Yunnan, Peoples R China	University of Hong Kong; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Hughes, AC (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Ctr Integrat Conservat, Beijing, Yunnan, Peoples R China.	achughes@xtbg.ac.cn	hughes, Alice/HCH-3838-2022	hughes, Alice/0000-0002-4899-3158	Hong Kong PhD Fellowship Scheme (HKPFS) from the Research Grants Council (RGC) of Hong Kong	Hong Kong PhD Fellowship Scheme (HKPFS) from the Research Grants Council (RGC) of Hong Kong	The first author received scholarship under the Hong Kong PhD Fellowship Scheme (HKPFS) from the Research Grants Council (RGC) of Hong Kong.	Aharon-Rotman Y, 2016, EMU, V116, P199, DOI 10.1071/MU15029; Allen AM, 2016, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00155; [Anonymous], 2012, IUCN SITUATION ANAL; [Anonymous], 2012, RESOLUTION 11, V11; Ausden M, 2001, J APPL ECOL, V38, P320, DOI 10.1046/j.1365-2664.2001.00600.x; Bai QQ, 2015, AVIAN RES, V6, DOI 10.1186/s40657-015-0021-2; Bamford M., 2008, MIGRATORY SHOREBIRDS; Barter M, 2002, SHOREBIRDS YELLOW SE; Bennun L, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12353; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; BirdLife International  & NatureServe, 2015, BIRD SPEC DISTR MAPS; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Boere GC, 2006, FLYWAY CONCEPT WHAT, P40; Brito JC, 2009, BIOL CONSERV, V142, P3020, DOI 10.1016/j.biocon.2009.08.001; Brooks Thomas M., 2015, BIODIVERSITY-OTTAWA, V16, P157, DOI 10.1080/14888386.2015.1075903; Burton NHK, 2006, J APPL ECOL, V43, P464, DOI 10.1111/j.1365-2664.2006.01156.x; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Cao Y, 2013, ECOL MODEL, V259, P30, DOI 10.1016/j.ecolmodel.2013.03.012; Chen TS, 2015, OCEAN COAST MANAGE, V116, P78, DOI 10.1016/j.ocecoaman.2015.07.002; Clemens RS, 2016, EMU, V116, P119, DOI 10.1071/MU15056; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Conklin J.R., 2014, PRIORITIZING MIGRATO; Dhanjal-Adams KL, 2017, CONSERV BIOL, V31, P646, DOI 10.1111/cobi.12842; Dias MP, 2014, ENVIRON MANAGE, V53, P163, DOI 10.1007/s00267-013-0195-5; Drever MC, 2016, WATERBIRDS, V39, P125, DOI 10.1675/063.039.0203; East Asian-Australasian Flyway Partnership, 2015, EAAFP INF BROCH JAN; Erwin RM, 2002, WATERBIRDS, V25, P5; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; Ferro ML, 2015, COLEOPTS BULL, V69, P415, DOI 10.1649/0010-065X-69.3.415; Gaiji S., 2013, BIODIVERS INFORM, V8, P94; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gautreaux J, 2013, STOPOVER ECOLOGY NEA; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Green JMH, 2015, J APPL ECOL, V52, P1483, DOI 10.1111/1365-2664.12508; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Gutierrez JS, 2012, FUNCT ECOL, V26, P236, DOI 10.1111/j.1365-2435.2011.01929.x; Hansen BD., 2016, REVISION E ASIAN AUS; Hansen BD, 2015, AUSTRAL ECOL, V40, P515, DOI 10.1111/aec.12219; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Herring G, 2013, J WILDLIFE MANAGE, V77, P58, DOI 10.1002/jwmg.445; Hua N, 2015, BIRD CONSERV INT, V25, P38, DOI 10.1017/S0959270914000380; Hume ID, 1996, J COMP PHYSIOL B, V166, P388, DOI 10.1007/s003600050024; Iwamura T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0325; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jetz W, 2008, CONSERV BIOL, V22, P110, DOI 10.1111/j.1523-1739.2007.00847.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiang X, 2014, MAR POLLUT BULL, V83, P366, DOI 10.1016/j.marpolbul.2014.03.020; Keola S, 2015, WORLD DEV, V66, P322, DOI 10.1016/j.worlddev.2014.08.017; Kyba CCM, 2015, REMOTE SENS-BASEL, V7, P1, DOI 10.3390/rs70100001; Lei FM, 2003, BIODIVERS CONSERV, V12, P2487, DOI 10.1023/A:1025886718222; Lei W, 2018, BIRD CONSERV INT, V28, P549, DOI 10.1017/S0959270917000508; Leitao PJ, 2011, INT J GEOGR INF SCI, V25, P439, DOI 10.1080/13658816.2010.531020; Li BBV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160566; Li SZ, 2016, WETLANDS, V36, pS57, DOI 10.1007/s13157-015-0641-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; [罗康 Luo Kang], 2013, [四川动物, Sichuan Journal of Zoology], V32, P926; Ma M, 2001, MAR POLLUT BULL, V42, P132, DOI 10.1016/S0025-326X(00)00118-1; Ma ZJ, 2014, SCIENCE, V346, P912, DOI 10.1126/science.1257258; Martin B, 2015, ANIM CONSERV, V18, P73, DOI 10.1111/acv.12139; McFarland KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053986; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moore FR, 2000, STOPOVER ECOLOGY NEA; Moores N, 2016, EMU, V116, P136, DOI 10.1071/MU16006; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; Murray NJ, 2015, J ORNITHOL, V156, pS217, DOI 10.1007/s10336-015-1225-2; Murray NJ, 2015, AUSTRAL ECOL, V40, P472, DOI 10.1111/aec.12211; Murray NJ, 2017, ECOGRAPHY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navedo JG, 2017, J APPL ECOL, V54, P567, DOI 10.1111/1365-2664.12735; Nebel S, 2008, BIOL CONSERV, V141, P971, DOI 10.1016/j.biocon.2008.01.017; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; Oppel S, 2012, BIOL CONSERV, V156, P94, DOI 10.1016/j.biocon.2011.11.013; Palm EC, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0029-6; Pelling HE, 2013, J GEOPHYS RES-OCEANS, V118, P3462, DOI 10.1002/jgrc.20258; Peterson AT, 2018, CONSERV BIOL, V32, P568, DOI 10.1111/cobi.12801; PFISTER C, 1992, BIOL CONSERV, V60, P115, DOI 10.1016/0006-3207(92)91162-L; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pickett EJ, 2018, ENVIRON CONSERV, V45, P147, DOI 10.1017/S0376892917000340; Piersma T, 2016, J APPL ECOL, V53, P479, DOI 10.1111/1365-2664.12582; Piersma Theunis, 2003, Wader Study Group Bulletin, V100, P5; Polce C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076308; Ramazi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122205; Ramesh V, 2017, BIOL CONSERV, V210, P205, DOI 10.1016/j.biocon.2017.03.019; Ramsar Convention on Wetlands, 1996, RAMS SIT CRIT 9 CRIT; Reside AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013569; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Runge CA, 2015, SCIENCE, V350, P1255, DOI 10.1126/science.aac9180; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Skagen SK, 2012, ECOL APPL, V22, P1131, DOI 10.1890/11-0291.1; Smart J, 2006, J APPL ECOL, V43, P454, DOI 10.1111/j.1365-2664.2006.01166.x; Somveille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070907; Studds CE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14895; Sullivan BL, 2017, BIOL CONSERV, V208, P5, DOI 10.1016/j.biocon.2016.04.031; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Szabo JK, 2016, EMU, V116, P215, DOI 10.1071/MU15133; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; Tong Menxiu, 2012, Wader Study Group Bulletin, V119, P208; VELASQUEZ CR, 1992, COLON WATERBIRD, V15, P43, DOI 10.2307/1521353; Wang HJ, 2010, J HYDROL, V391, P302, DOI 10.1016/j.jhydrol.2010.07.030; WATKINS D, 1993, NATL PLAN SHOREBIRD; Wauchope HS, 2017, GLOBAL CHANGE BIOL, V23, P1085, DOI 10.1111/gcb.13404; WIERSMA P, 1994, CONDOR, V96, P257, DOI 10.2307/1369313; Williamson L, 2013, BIODIVERS CONSERV, V22, P1501, DOI 10.1007/s10531-013-0488-2; Wu JS, 2013, REMOTE SENS ENVIRON, V134, P111, DOI 10.1016/j.rse.2013.03.001; Wu YJ, 2017, J BIOGEOGR, V44, P615, DOI 10.1111/jbi.12862; Xia SX, 2017, BIOL CONSERV, V210, P72, DOI 10.1016/j.biocon.2016.07.025; Zhang SD, 2018, BIRD CONSERV INT, V28, P534, DOI 10.1017/S0959270917000430; Zhu Jing, 2007, Acta Ecologica Sinica, V27, P2149; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2	111	16	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210552	10.1371/journal.pone.0210552	http://dx.doi.org/10.1371/journal.pone.0210552			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682055	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500045
J	Theuerkauf, SJ; Eggleston, DB; Puckett, BJ				Theuerkauf, Seth J.; Eggleston, David B.; Puckett, Brandon J.			Integrating ecosystem services considerations within a GIS-based habitat suitability index for oyster restoration	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA; NORTH-CAROLINA; CHLOROPHYLL-A; NEUSE RIVER; ESTUARY; MODEL; HYPOXIA; GROWTH; CONSEQUENCES; BIODIVERSITY	Geospatial habitat suitability index (HSI) models have emerged as powerful tools that integrate pertinent spatial information to guide habitat restoration efforts, but have rarely accounted for spatial variation in ecosystem service provision. In this study, we utilized satellite-derived chlorophyll a concentrations for Pamlico Sound, North Carolina, USA in conjunction with data on water flow velocities and dissolved oxygen concentrations to identify potential restoration locations that would maximize the oyster reef-associated ecosystem service of water filtration. We integrated these novel factors associated with oyster water filtration ecosystem services within an existing, 'Metapopulation Persistence' focused GIS-based, HSI model containing biophysical (e.g., salinity, oyster larval connectivity) and logistical(e.g., distance to nearest restoration material stockpile site) factors to identify suitable locations for oyster restoration that maximize long-term persistence of restored oyster populations and water filtration ecosystem service provision. Furthermore, we compared the 'Water Filtration' optimized HSI with the HSI optimized for 'Metapopulation Persistence,' as well as a hybrid model that optimized for both water filtration and metapopulation persistence. Optimal restoration locations (i.e., locations corresponding to the top 1% of suitability scores) were identified that were consistent among the three HSI scenarios (i.e., "win-win" locations), as well as optimal locations unique to a given HSI scenario (i.e., "tradeoff" locations). The modeling framework utilized in this study can provide guidance to restoration practitioners to maximize the cost-efficiency and ecosystem services value of habitat restoration efforts. Furthermore, the functional relationships between oyster water filtration and chlorophyll a concentrations, water flow velocities, and dissolved oxygen applied in this study can guide field- and lab-testing of hypotheses related to optimal conditions for oyster reef restoration to maximize water quality enhancement benefits.	[Theuerkauf, Seth J.; Eggleston, David B.; Puckett, Brandon J.] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA; [Puckett, Brandon J.] North Carolina Coastal Reserve & Natl Estuarine R, Beaufort, NC USA	University of North Carolina; North Carolina State University	Theuerkauf, SJ (corresponding author), North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Ctr Marine Sci & Technol, Morehead City, NC 28557 USA.	sjtheuer@ncsu.edu	Theuerkauf, Seth/AAB-3290-2020	Puckett, Brandon/0000-0001-9615-6242; Theuerkauf, Seth/0000-0003-2556-5174; Eggleston, David/0000-0001-7840-2665	North Carolina Sea Grant [R12-HCE-2]; North Carolina Space Grant Fellowship; National Defense Science and Engineering Graduate Fellowship - Department of Defense, Air Force Office of Scientific Research [FA9550-11-C-0028]; National Defense Science and Engineering Graduate Fellowship - American Society for Engineering Education [32 CFR 168a]; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; National Science Foundation, Division of Ocean Sciences [OCE-1155609]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES027302] Funding Source: NIH RePORTER	North Carolina Sea Grant; North Carolina Space Grant Fellowship; National Defense Science and Engineering Graduate Fellowship - Department of Defense, Air Force Office of Scientific Research; National Defense Science and Engineering Graduate Fellowship - American Society for Engineering Education; North Carolina Coastal Conservation Association Scholarship; Beneath the Sea Foundation Scholarship; National Science Foundation, Division of Ocean Sciences(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for the project and completion of the manuscript was provided by a North Carolina Sea Grant and North Carolina Space Grant Fellowship, a National Defense Science and Engineering Graduate Fellowship (contract FA9550-11-C-0028 awarded by the Department of Defense, Air Force Office of Scientific Research, 32 CFR 168a, American Society for Engineering Education), a North Carolina Coastal Conservation Association Scholarship, and a Beneath the Sea Foundation Scholarship to S. Theuerkauf, as well as North Carolina Sea Grant (R12-HCE-2) and the National Science Foundation, Division of Ocean Sciences (OCE-1155609) to D. Eggleston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TK, 2007, J SHELLFISH RES, V26, P949, DOI 10.2983/0730-8000(2007)26[949:AHSIMF]2.0.CO;2; Battista T, 1999, THESIS; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bernard FR, 1983, PHYSL MARICULTURE SO, V63; Brooks RP, 1997, WILDLIFE SOC B, V25, P163; BROWN J R, 1988, Aquaculture and Fisheries Management, V19, P109, DOI 10.1111/j.1365-2109.1988.tb00414.x; Bullock JM, 2011, TRENDS ECOL EVOL, V26, P541, DOI 10.1016/j.tree.2011.06.011; Burkholder J, 2004, P NATL ACAD SCI USA, V101, P9291, DOI 10.1073/pnas.0306842101; Cake E.W, 1983, HABITAT SUITABILITY; CERCO CF, 1995, J ENVIRON ENG-ASCE, V121, P549, DOI 10.1061/(ASCE)0733-9372(1995)121:8(549); Cerco CF, 2005, ASSESSING 10 FOLD IN; Cho Y, 2012, OCEAN COAST MANAGE, V56, P10, DOI 10.1016/j.ocecoaman.2011.10.009; Cloern JE, 1982, MARINE ECOLOGY PROGR, V9, P192; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Conomos T. J., 1979, SAN FRANCISCO BAY UR, P47; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; DAME RF, 1989, MAR ECOL PROG SER, V54, P249, DOI 10.3354/meps054249; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Epperly S. P, 1986, NMFSSEFC175 NAT OC A; FALKOWSKI P, 1985, J PLANKTON RES, V7, P715, DOI 10.1093/plankt/7.5.715; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Grizzle RE, 2001, DEV AQUAC FISH SCI, V31, P305; Haase AT, 2012, ESTUAR COAST SHELF S, V101, P33, DOI 10.1016/j.ecss.2012.02.011; Harsh Deborah A., 1999, P251; Housego RM, 2016, ESTUAR COAST, V39, P495, DOI 10.1007/s12237-015-9998-3; Keith DJ, 2014, REMOTE SENS ENVIRON, V153, P61, DOI 10.1016/j.rse.2014.05.019; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kellogg ML, 2013, MAR ECOL PROG SER, V480, P1, DOI 10.3354/meps10331; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; KORRINGA P., 1952, QUART REV BIOL, V27, P266, DOI 10.1086/399023; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Lenihan HS, 1996, LIMNOL OCEANOGR, V41, P1359, DOI 10.4319/lo.1996.41.6.1359; Luettich R., 1992, CERCTRDRP926; Luettich RA, 2002, CONT SHELF RES, V22, P1669, DOI 10.1016/S0278-4343(02)00031-6; Paerl HW, 1999, MAR ECOL PROG SER, V186, P307, DOI 10.3354/meps186307; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Peters JW, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00326; Pietrafesa Leonard J, 1986, UNC SEA GRANT PUBLIC; Puckett BJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00076; Puckett BJ, 2014, FISH OCEANOGR, V23, P342, DOI 10.1111/fog.12067; Puckett BJ, 2012, MAR COAST FISH, V4, P605, DOI 10.1080/19425120.2012.713892; R Core Team, 2021, R LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyns NB, 2006, LIMNOL OCEANOGR, V51, P1982, DOI 10.4319/lo.2006.51.5.1982; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; Roloff GJ, 1999, WILDLIFE SOC B, V27, P973; Sokoletsky LG, 2011, REMOTE SENS-BASEL, V3, P684, DOI 10.3390/rs3040684; SONIAT TM, 1988, ESTUARIES, V11, P87, DOI 10.2307/1351995; Swannack TM, 2014, J SHELLFISH RES, V33, P395, DOI 10.2983/035.033.0208; Theuerkauf SJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00064; Theuerkauf SJ, 2015, J SHELLFISH RES, V34, P241, DOI 10.2983/035.034.0205; Wildish D., 1997, BENTHIC SUSPENSION F; WilsonOrmond EA, 1997, MAR ECOL-P S Z N I, V18, P1, DOI 10.1111/j.1439-0485.1997.tb00424.x	55	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0210936	10.1371/journal.pone.0210936	http://dx.doi.org/10.1371/journal.pone.0210936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682064	Green Submitted, Green Published, gold			2022-12-27	WOS:000457037500075
J	Mori, N; Mochizuki, T; Yamazaki, F; Takei, S; Mano, H; Matsugi, T; Setou, M				Mori, Naoto; Mochizuki, Takaharu; Yamazaki, Fumiyoshi; Takei, Shiro; Mano, Hidetoshi; Matsugi, Takeshi; Setou, Mitsutoshi			MALDI imaging mass spectrometry revealed atropine distribution in the ocular tissues and its transit from anterior to posterior regions in the whole-eye of rabbit after topical administration	PLOS ONE			English	Article							DRUG-DELIVERY; CHEMISTRY; DIAGNOSIS; BRAIN	It is essential to elucidate drug distribution in the ocular tissues and drug transit in the eye for ophthalmic pharmaceutical manufacturers. Atropine is a reversible muscarinic receptor used to treat various diseases. However, its distribution in ocular tissues is still incompletely understood. Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) evaluates drug distribution in biological samples. However, there have been few investigations of drug distribution in ocular tissues, including whole-eye segments. In the present study, we explored the spatial distribution of atropine in the whole-eye segment by MALDI-IMS, and then evaluated the changes in atropine level along the anterior-posterior and superior-inferior axes. A 1% atropine solution was administered to a rabbit and after 30 min, its eye was enucleated, sectioned, and analyzed by MALDI-IMS. Atropine accumulated primarily in the tear menisci but was found at substantially lower concentrations in the tissue surrounding the conjunctival sacs. Relative differences in atropine levels between the anterior and posterior regions provided insights into the post-instillation behavior of atropine. Atropine signal intensities differed among corneal layers and between the superior and inferior eyeball regions. Differences in signal intensity among tissues indicated that the drug migrated to the posterior regions via a periocular-scleral route. Line scan analysis elucidated atropine transit from the anterior to the posterior region. This information is useful for atropine delivery in the ocular tissues and indicates that MALDI-IMS is effective for revealing drug distribution in whole-eye sections.	[Mori, Naoto; Mochizuki, Takaharu; Mano, Hidetoshi; Matsugi, Takeshi] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma, Nara, Japan; [Yamazaki, Fumiyoshi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cellular & Mol Anat, Hamamatsu, Shizuoka, Japan; [Yamazaki, Fumiyoshi; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Hamamatsu, Shizuoka, Japan; [Takei, Shiro] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Lab Fish Biol, Kasugai, Aichi, Japan; [Setou, Mitsutoshi] Preeminent Med Photon Educ & Res Ctr, Inst Med Photon Res, Dept Syst Mol Anat, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China	Santen Pharmaceutical Co Ltd; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chubu University; University of Hong Kong	Mori, N (corresponding author), Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma, Nara, Japan.	naoto.mori@santen.com		Mori, Naoto/0000-0001-6454-0418	MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; AMED [JP18gm0910004]; Santen Pharmaceutical Co. Ltd.	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform - Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; AMED(Japan Agency for Medical Research and Development (AMED)); Santen Pharmaceutical Co. Ltd.	This study was supported by MEXT/JSPS KAKENHI Grant Number JP15H05898B1; Imaging Platform supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; and AMED under Grant Number JP18gm0910004. Santen Pharmaceutical Co. Ltd. provided support in the form of salaries for NM, T. Mochizuki, HM, and T. Matsugi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal RV, 2010, INDIAN J OPHTHALMOL, V58, P11, DOI 10.4103/0301-4738.58468; Asano N, 2017, BIOL PHARM BULL, V40, P1586, DOI 10.1248/bpb.b17-00288; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Brignole-Baudouin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050180; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Chia A, 2016, OPHTHALMOLOGY, V123, P391, DOI 10.1016/j.ophtha.2015.07.004; Chumbley CW, 2016, ANAL CHEM, V88, P2392, DOI 10.1021/acs.analchem.5b04409; Clark TY, 2015, J OCUL PHARMACOL TH, V31, P541, DOI 10.1089/jop.2015.0043; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Crouch RK, 2015, PROG MOL BIOL TRANSL, V134, P449, DOI 10.1016/bs.pmbts.2015.06.005; Fraunfelder F T, 1976, Trans Am Ophthalmol Soc, V74, P457; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goodwin RJA, 2016, J BIOMOL SCREEN, V21, P187, DOI 10.1177/1087057115623740; GREENSTEIN SH, 1984, B NEW YORK ACAD MED, V60, P961; Greer T, 2011, J PROTEOMICS, V74, P2617, DOI 10.1016/j.jprot.2011.03.032; Grove KJ, 2017, SLAS DISCOV, V22, P1239, DOI 10.1177/2472555217724780; Harrison PK, 2006, N-S ARCH PHARMACOL, V373, P230, DOI 10.1007/s00210-006-0054-5; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; HOLLY FJ, 1985, T OPHTHAL SOC UK, V104, P374; Kallback P, 2012, J PROTEOMICS, V75, P4941, DOI 10.1016/j.jprot.2012.07.034; LIEBL H, 1967, J APPL PHYS, V38, P5277, DOI 10.1063/1.1709314; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; MEISNER D, 1989, INT J PHARM, V55, P105, DOI 10.1016/0378-5173(89)90030-6; Mitchelson Frederick, 2012, Handb Exp Pharmacol, P263, DOI 10.1007/978-3-642-23274-9_12; Mizuno K, 2009, INVEST OPHTH VIS SCI, V50, P2839, DOI 10.1167/iovs.08-2922; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; Shen MX, 2009, INVEST OPHTH VIS SCI, V50, P2722, DOI 10.1167/iovs.08-2704; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiura Y, 2010, J NEUROIMMUNE PHARM, V5, P31, DOI 10.1007/s11481-009-9162-6; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Tahara K, 2017, ASIAN J PHARM SCI, V12, P394, DOI 10.1016/j.ajps.2017.03.002; Takai N, 2012, RAPID COMMUN MASS SP, V26, P1549, DOI 10.1002/rcm.6256; Tigges M, 1999, OPTOMETRY VISION SCI, V76, P397, DOI 10.1097/00006324-199906000-00020; Uchida A, 2007, AM J OPHTHALMOL, V144, P232, DOI 10.1016/j.ajo.2007.04.006; Zaima N, 2011, ATHEROSCLEROSIS, V217, P427, DOI 10.1016/j.atherosclerosis.2011.03.044	37	8	8	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211376	10.1371/journal.pone.0211376	http://dx.doi.org/10.1371/journal.pone.0211376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682156	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500159
J	Quesada, JIP; Kerr, ZY; Bertucci, WM; Carpes, FP				Priego Quesada, Jose Ignacio; Kerr, Zachary Y.; Bertucci, William M.; Carpes, Felipe P.			A retrospective international study on factors associated with injury, discomfort and pain perception among cyclists	PLOS ONE			English	Article							OVERUSE INJURIES; SPORTS INJURIES; COMFORT; RELIABILITY; EXERCISE; LEVEL; RISK; EPIDEMIOLOGY; TOLERANCE; STATEMENT	Although cycling has been associated with overuse/fatigue and acute injuries, there is lack of information regarding associated risk factors and prevention factors. The objective of the study was to determine the factors associated with injury, and perceptions of discomfort and pain in cyclists. A total of 739 cyclists completed an online questionnaire between February and October 2016. The questionnaire acquired information on participant demographics, characteristics related to cycling profile and fitness training, bike components and cycling posture, self-reported perceptions of comfort and pain, and injuries sustained in the last 12 months. Logistic regression models estimated odds ratios (OR) and 95% confidence intervals (95% CI) that examined factors associated with reporting overuse/fatigue injury, acute injury, body discomfort, saddle discomfort, and pain while cycling. Odds of reporting an overuse/fatigue injury increased when the cyclists complemented training with running (OR = 1.74; 95% CI = 1.03-2.91) or swimming (OR = 2.17; 95% CI = 1.19-3.88), and with reported pain while cycling (OR = 1.17; 95% CI = 1.05-3.69) and not cycling (OR = 1.76; 95% CI = 1.07-2.90). Odds of reporting an acute injury increased when biking to work (OR = 1.79; 95% CI = 1.07-2.86), and decreased with increased average cycling speed (1-km/h decrease OR = 0.93; 95% CI = 0.88-0.97), and compared to low-end bike, with the use of mid-range (OR = 0.25; 95% CI = 0.09-0.72) and high-end bike (OR = 0.34; 95% CI = 0.13-0.96). Although body discomfort was only associated with saddle discomfort and the presence of pain during cycling, saddle discomfort was also associated with biking to work (OR = 0.46; 95% CI = 0.22-0.88). Finally, pain perception was associated with a number of factors such as ride to work, core training, cycling experience, saddle discomfort, pain while not cycling. Numerous factors are associated with injury, and perceptions of discomfort and pain in cyclists. Such factors should be considered when developing training routines, bicycle maintenance best practices, and injury prevention programs.	[Priego Quesada, Jose Ignacio] Univ Valencia, Dept Phys Educ & Sports, Res Grp Sports Biomech GIBD, Valencia, Spain; [Priego Quesada, Jose Ignacio] Univ Valencia, Dept Physiol, Biophys & Med Phys Grp, Valencia, Spain; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Bertucci, William M.] Univ Reims, UFR STAPS, Lab Performance Hlth Metrol & Soc, PSMS,EA 7507, Reims, France; [Carpes, Felipe P.] Fed Univ Pampa, Lab Neuromech, Appl Neuromech Res Grp, Uruguaiana, Brazil	University of Valencia; University of Valencia; University of North Carolina; University of North Carolina Chapel Hill; Universite de Reims Champagne-Ardenne; Universidade Federal do Pampa	Quesada, JIP (corresponding author), Univ Valencia, Dept Phys Educ & Sports, Res Grp Sports Biomech GIBD, Valencia, Spain.; Quesada, JIP (corresponding author), Univ Valencia, Dept Physiol, Biophys & Med Phys Grp, Valencia, Spain.	j.priego.gibd@gmail.com	Carpes, Felipe P/A-1069-2010; Priego-Quesada, Jose Ignacio/D-3424-2013	Carpes, Felipe P/0000-0001-8923-4855; Priego-Quesada, Jose Ignacio/0000-0002-0375-1454				Abt JP, 2007, J STRENGTH COND RES, V21, P1300; Aldred R, 2018, ACCIDENT ANAL PREV, V117, P75, DOI 10.1016/j.aap.2018.03.003; Assa T, 2019, EUR J PAIN, V23, P686, DOI 10.1002/ejp.1335; Astokorki AHY, 2017, SCAND J MED SCI SPOR, V27, P309, DOI 10.1111/sms.12659; Ayachi FS, 2015, APPL ERGON, V46, P124, DOI 10.1016/j.apergo.2014.07.010; Barrios C, 2015, INT J SPORTS MED, V36, P241, DOI 10.1055/s-0034-1389983; Bini R. R., 2012, J SCI CYCLING, V1, P9; Bini RR, 2014, BIOMECHANICS CYCLING, P55, DOI [10.1007/978-3-319-05539-8_6, DOI 10.1007/978-3-319-05539-8_6]; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Calleja-Gonzalez J, 2018, J EXERC REHABIL, V14, P545, DOI 10.12965/jer.1836244.122; Candotti CT, 2007, SPORT BIOMECH, V6, P31, DOI 10.1080/14763140601058490; Chapman AR, 2007, EXP BRAIN RES, V181, P503, DOI 10.1007/s00221-007-0949-5; Chen C, 2017, ACCIDENT ANAL PREV, V108, P234, DOI 10.1016/j.aap.2017.09.001; Chen YL, 2014, APPL ERGON, V45, P1181, DOI 10.1016/j.apergo.2014.02.006; Choi S, 2011, TEXT RES J, V81, P81, DOI 10.1177/0040517510377822; Chu CH, 2010, COMPUT IND, V61, P541, DOI 10.1016/j.compind.2010.03.004; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Clarsen B, 2010, AM J SPORT MED, V38, P2494, DOI 10.1177/0363546510376816; Dahlquist M, 2015, CLIN J SPORT MED, V25, P88, DOI 10.1097/JSM.0000000000000111; De Bernardo N, 2012, J SPORT SCI, V30, P1047, DOI 10.1080/02640414.2012.687112; De Vera MA, 2010, AM J EPIDEMIOL, V172, P1190, DOI 10.1093/aje/kwq273; Decock M, 2016, BRIT J SPORT MED, V50, P669, DOI 10.1136/bjsports-2015-095612; Dettori NJ, 2006, SPORTS MED, V36, P7, DOI 10.2165/00007256-200636010-00002; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hakansson S, 2018, EUR J PAIN, V22, P1813, DOI 10.1002/ejp.1277; Hermans TJN, 2016, J SEX MED, V13, P40, DOI 10.1016/j.jsxm.2015.11.004; Jones MD, 2014, MED SCI SPORT EXER, V46, P1640, DOI 10.1249/MSS.0000000000000273; Kinchington M, 2010, J SPORT SCI MED, V9, P652; Lam WK, 2011, FOOTWEAR SCI, V3, P151, DOI 10.1080/19424280.2011.630680; Liu Z, 2014, INT J CLOTH SCI TECH, V26, P118, DOI 10.1108/IJCST-02-2013-0009; Min-Chi Chiu, 2013, Human Interface and the Management of Information. Information and Interaction Design. 15th International Conference, HCI International 2013. Proceedings: LNCS 8016, P12, DOI 10.1007/978-3-642-39209-2_2; Munera M, 2015, P I MECH ENG P-J SPO, V229, P231, DOI 10.1177/1754337115579606; Munera M, 2015, MECH IND, V16, DOI 10.1051/meca/2015028; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Oser SM, 2013, PRIMARY CARE, V40, P969, DOI 10.1016/j.pop.2013.08.011; Paungmali A, 2017, PAIN PRACT, V17, P1008, DOI 10.1111/papr.12552; Pavelka E, 1998, BICYCLING MAGAZINES; Quesada JIP, 2017, J SPORT SCI, V35, P1459, DOI 10.1080/02640414.2016.1215496; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramos-Ortega J, 2014, CLIN J SPORT MED, V24, P251, DOI 10.1097/JSM.0000000000000027; Rankin KM, 2008, CANCER EPIDEM BIOMAR, V17, P2639, DOI 10.1158/1055-9965.EPI-08-0304; Roi GS, 2014, ACCIDENT ANAL PREV, V73, P170, DOI 10.1016/j.aap.2014.08.010; Rose C, 2017, INT J SPORTS MED, V38, P1049, DOI 10.1055/s-0043-114861; Scheepers S, 2016, IMAGING TRIATHLON IN, P557, DOI [10.1007/978-3-319-14307-1_21, DOI 10.1007/978-3-319-14307-1_21]; Silberman MR, 2013, CURR SPORT MED REP, V12, P337, DOI 10.1249/JSR.0b013e3182a4bab7; Sondergaard KHE, 2010, J BIOMECH, V43, P1997, DOI 10.1016/j.jbiomech.2010.03.009; Springer BA, 2013, PHYS THER SPORT, V14, P77, DOI 10.1016/j.ptsp.2012.11.001; Stanley J, 2015, INT J SPORT PHYSIOL, V10, P528, DOI 10.1123/ijspp.2014-0196; Taylor N, 2013, AUSTR J PARAMED, V10; Townes DA, 2005, WILD ENVIRON MED, V16, P125, DOI 10.1580/1080-6032(2005)16[125:IAIDAM]2.0.CO;2; Trofaier ML, 2016, INT UROGYNECOL J, V27, P513, DOI 10.1007/s00192-015-2803-9; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Verma R, 2016, J ELECTROMYOGR KINES, V27, P78, DOI 10.1016/j.jelekin.2016.02.003; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zwingenberger S, 2014, J SPORT SCI, V32, P583, DOI 10.1080/02640414.2013.843018	57	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211197	10.1371/journal.pone.0211197	http://dx.doi.org/10.1371/journal.pone.0211197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682136	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500122
J	Limony, Y; Koziel, S; Friger, M				Limony, Yehuda; Koziel, Slawomir; Friger, Michael			Association between the onset age of puberty and parental height	PLOS ONE			English	Article							SECONDARY SEXUAL CHARACTERISTICS; PRECOCIOUS PUBERTY; PEDIATRIC RESEARCH; FINAL HEIGHT; OF-ONSET; GROWTH; MENARCHE; RISK; CHILDHOOD; CHILDREN	Background The onset age of physiological puberty is greatly variable. This variability has been attributed to environmental factors and to genetic factors although a very little is explained by genome-wide associations studies. Previously, we reported the existence of an association between the onset age of puberty and final height. It is known that final height is associated with parental height (specifically, with the "target height"). We hypothesized that the variability of the onset age of puberty contributes to the attainment of a final height which is similar to the target height. We hypothesized that whenever a child's height-percentile differs from the target height percentile (we called this difference the "height gap"), the onset of puberty is advanced or delayed so that they are closer or even equal at the end of pubertal growth. The association between height gap and onset age of puberty was investigated in the reported study. Methods The study is an observational retrospective study on growth during puberty in 170 Israeli (60 girls) and 335 Polish children (162 girls). Anthropometric measurements were analyzed by multivariable linear regression with the onset age of the pubertal growth spurt (PGS) as the dependent variable, and two independent variables "height gap" and body mass index (BMI)-both standardized. Results The adjusted coefficient of determination (adj R-2) between the onset age of the PGS and the two independent variables was 0.69 (Israeli girls), 0.50 (Israeli boys, BMI excluded), 0.25 (Polish girls) and 0.13 (Polish boys). A prediction model for the onset age of puberty is presented. Conclusions The association between the "height gap" and the onset age of puberty suggests that the variability of this age is part of the targeted process of statural growth. The proposed model may explain idiopathic cases of precocious and delayed puberty.	[Limony, Yehuda] Ben Gurion Univ Negev, Clalit Hlth Serv, Fac Hlth Sci, Pediat Endocrinol Unit, Beer Sheva, Israel; [Koziel, Slawomir] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Anthropol, Wroclaw, Poland; [Friger, Michael] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University; Clalit Health Services; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Ben Gurion University	Limony, Y (corresponding author), Ben Gurion Univ Negev, Clalit Hlth Serv, Fac Hlth Sci, Pediat Endocrinol Unit, Beer Sheva, Israel.	limony@zahav.net.il	Kozieł, Sławomir/AAE-1003-2022; Limony, Yehuda/AAY-4880-2021	Kozieł, Sławomir/0000-0002-0584-4427; Limony, Yehuda/0000-0003-2686-0095				Addo OY, 2014, PEDIATR RES, V76, P564, DOI 10.1038/pr.2014.131; Aksglaede L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008450; BIELICKI T, 1975, STUD PHYS ANTHR, V2, P53; Bodicoat DH, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3613; Bonjour JP, 2014, ENDOCR REV, V35, P820, DOI 10.1210/er.2014-1007; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Cousminer DL, 2013, HUM MOL GENET, V22, P2735, DOI 10.1093/hmg/ddt104; CROWNE EC, 1990, ARCH DIS CHILD, V65, P1109, DOI 10.1136/adc.65.10.1109; De Leonibus C, 2014, PEDIATR OBES, V9, P292, DOI 10.1111/j.2047-6310.2013.00176.x; Dreyfus J, 2015, J PEDIATR-US, V167, P344, DOI 10.1016/j.jpeds.2015.04.032; Euling SY, 2008, PEDIATRICS, V121, pS167, DOI 10.1542/peds.2007-1813C; FALKNER F, 1986, HUMAN GROWTH COMPREH, V2; Falkner F, 1986, HUMAN GROWTH COMPREH, V3; Fujita M, 2008, TOHOKU J EXP MED, V216, P297, DOI 10.1620/tjem.216.297; He F, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4681-1; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Holmgren A, 2017, PEDIATR RES, V81, P448, DOI 10.1038/pr.2016.253; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Karlberg J, 2003, HORM RES, V60, P27, DOI 10.1159/000071223; Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70; Lee JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0164; Lee JM, 2010, ARCH PEDIAT ADOL MED, V164, P139, DOI 10.1001/archpediatrics.2009.258; Limony Y, 2015, PEDIATR RES, V78, P351, DOI 10.1038/pr.2015.104; Lundeen EA, 2016, J NUTR, V146, P622, DOI 10.3945/jn.115.222000; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; Marceau K, 2011, DEV PSYCHOL, V47, P1389, DOI 10.1037/a0023838; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Papadimitriou A, 2010, J CLIN ENDOCR METAB, V95, P4535, DOI 10.1210/jc.2010-0895; Plant TM, 2015, FRONT NEUROENDOCRIN, V38, P73, DOI 10.1016/j.yfrne.2015.04.002; Qiu CS, 2013, J CLIN ENDOCR METAB, V98, P1612, DOI 10.1210/jc.2012-2919; Reinehr T, 2017, J PEDIATR-US, V184, P143, DOI 10.1016/j.jpeds.2017.01.066; Rosenfield RL, 2000, PEDIATRICS, V106, P622, DOI 10.1542/peds.106.3.622; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Roth CL, 2012, REV ENDOCR METAB DIS, V13, P129, DOI 10.1007/s11154-012-9212-x; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Song Y, 2016, PEDIATR OBES, V11, P369, DOI 10.1111/ijpo.12073; Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939; Toppari J, 2010, MOL CELL ENDOCRINOL, V324, P39, DOI 10.1016/j.mce.2010.03.011; Verkauskiene R, 2013, HORM RES PAEDIAT, V80, P69, DOI 10.1159/000353759; Virdis R, 1998, ARCH DIS CHILD, V78, P152, DOI 10.1136/adc.78.2.152; WALISZKO A, 1976, Studies in Physical Anthropology, P27	45	4	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211334	10.1371/journal.pone.0211334	http://dx.doi.org/10.1371/journal.pone.0211334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682183	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500151
J	Porcacchia, P; de Toledo, PA; Rodriguez-Baena, A; Martin-Rodriguez, JF; Palomar, FJ; Vargas-Gonzalez, L; Jesus, S; Koch, G; Mir, P				Porcacchia, Paolo; Alvarez de Toledo, Paloma; Rodriguez-Baena, Antonio; Francisco Martin-Rodriguez, Juan; Palomar, Francisco J.; Vargas-Gonzalez, Laura; Jesus, Silvia; Koch, Giacomo; Mir, Pablo			Abnormal cerebellar connectivity and plasticity in isolated cervical dystonia	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA BURST STIMULATION; MOTOR CORTEX; SECONDARY; CIRCUIT; BRAIN; TASK	There is increasing evidence that supports the role of the cerebellum in the pathophysiology of dystonia. We used transcranial magnetic stimulation to test the hypothesis that patients with cervical dystonia may have a disrupted cerebellar cortical connectivity at rest, and that cerebellar plasticity is altered too. We enrolled 12 patients with isolated cervical dystonia and 13 controls. A paired-pulse transcranial magnetic stimulation protocol was applied over the right cerebellum and the left primary motor area. Changes in the amplitude of motor evoked potentials were analysed. Continuous and intermittent Theta Burst Stimulation over the cerebellum was also applied. The effects of these repetitive protocols on cortical excitability, on intra-cortical circuits and on cerebellar cortical inhibition were analysed. In healthy subjects, but not in dystonic patients, a conditioning stimulus over the cerebellum was able to inhibit the amplitude of the motor evoked potentials from primary motor cortex. In healthy subjects continuous and intermittent cerebellar Theta Burst Stimulation were able to decrease and increase respectively motor cortex excitability. Continuous Theta Burst Stimulation was able to abolish the cerebellar cortical inhibition observed in basal condition. These effects were not observed in patients with cervical dystonia. Cerebellar cortical connectivity and cerebellar plasticity is altered at rest in patients with cervical dystonia.	[Porcacchia, Paolo; Alvarez de Toledo, Paloma; Rodriguez-Baena, Antonio; Francisco Martin-Rodriguez, Juan; Palomar, Francisco J.; Vargas-Gonzalez, Laura; Jesus, Silvia; Mir, Pablo] Univ Seville, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Inst Biomed Sevilla,Hosp Univ Virgen Rocio,CSIC, Seville, Spain; [Porcacchia, Paolo; Palomar, Francisco J.] Hosp Univ Virgen Rocio, Serv Neurol & Neurofisiol Clin, Unidad Neurofisiol Clin, Seville, Spain; [Koch, Giacomo] Univ Roma Tor Vergata, Dipartimento Neurosci, Clin Neurol, Rome, Italy; [Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; University of Rome Tor Vergata; CIBERNED	Mir, P (corresponding author), Univ Seville, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Inst Biomed Sevilla,Hosp Univ Virgen Rocio,CSIC, Seville, Spain.; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain.	pmir@us.es	Mir, Pablo/C-8662-2013; Termine, Cristinano/AAB-8366-2022; Palomar, Francisco J/N-3089-2018	Mir, Pablo/0000-0003-1656-302X; Porcacchia, Paolo/0000-0003-3879-286X; KOch, Giacomo/0000-0001-6155-9439; Palomar, Francisco J/0000-0002-6541-8243; Martin Rodriguez, Juan Francisco/0000-0003-1392-8775	Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; Instituto de Salud Carlos III [CP08/00174, PI10/01674, PI13/01461]; Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471/2013]; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; Jaques and Gloria Gossweiler Foundation	Ministerio de Economia y Competitividad de Espana(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia; Consejeria de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Jaques and Gloria Gossweiler Foundation	This research was supported by grants from the Ministerio de Economia y Competitividad de Espana (SAF2007-60700), the Instituto de Salud Carlos III (CP08/00174, PI10/01674, PI13/01461), the Consejeria de Economia, Innovacion, Ciencia y Empresa de la Junta de Andalucia (CVI-02526, CTS-7685), the Consejeria de Salud y Bienestar Social de la Junta de Andalucia (PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471/2013), the Sociedad Andaluza de Neurologia, the Fundacion Alicia Koplowitz, the Fundacion Mutua Madrilena and the Jaques and Gloria Gossweiler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio S, 2014, MOVEMENT DISORD, V29, P1185, DOI 10.1002/mds.25888; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Brighina F, 2009, EXP BRAIN RES, V192, P651, DOI 10.1007/s00221-008-1572-9; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Carrillo F, 2013, BRAIN STIMUL, V6, P582, DOI 10.1016/j.brs.2012.12.004; Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Delmaire C, 2007, NEUROLOGY, V69, P376, DOI 10.1212/01.wnl.0000266591.49624.1a; Di Lorenzo F, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00002; Draganski B, 2003, NEUROLOGY, V61, P1228, DOI 10.1212/01.WNL.0000094240.93745.83; Filip P, 2017, MOVEMENT DISORD, V32, P757, DOI 10.1002/mds.26930; Hoffland BS, 2013, EUR J NEUROSCI, V38, P2166, DOI 10.1111/ejn.12186; Hubsch C, 2013, BRAIN, V136, P2050, DOI 10.1093/brain/awt147; Koch G, 2014, BRAIN STIMUL, V7, P564, DOI 10.1016/j.brs.2014.05.002; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Kojovic M, 2013, BRAIN, V136, P2038, DOI 10.1093/brain/awt150; LeDoux MS, 2003, MOVEMENT DISORD, V18, P60, DOI 10.1002/mds.10301; Munchau A, 1999, J NEUROL, V246, P840, DOI 10.1007/s004150050465; Pizoli CE, 2002, J NEUROSCI, V22, P7825; Popa T, 2010, BRAIN STIMUL, V3, P161, DOI 10.1016/j.brs.2009.10.001; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Sadnicka A, 2015, EUR J NEUROL, V22, P762, DOI 10.1111/ene.12521; Sadnicka A, 2014, MOVEMENT DISORD, V29, P1304, DOI 10.1002/mds.25881; Siebner HR, 1999, NEUROLOGY, V52, P529, DOI 10.1212/WNL.52.3.529; Song CH, 2014, NEUROBIOL DIS, V62, P372, DOI 10.1016/j.nbd.2013.10.003; Teo JTH, 2009, J NEUROL NEUROSUR PS, V80, P80, DOI 10.1136/jnnp.2008.144626; Torriero S, 2011, J COGNITIVE NEUROSCI, V23, P338, DOI 10.1162/jocn.2010.21471; UGAWA Y, 1995, ANN NEUROL, V37, P703, DOI 10.1002/ana.410370603	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211367	10.1371/journal.pone.0211367	http://dx.doi.org/10.1371/journal.pone.0211367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682155	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500155
J	Skagerlund, K; Ostergren, R; Vastfjall, D; Traff, U				Skagerlund, Kenny; Ostergren, Rickard; Vastfjall, Daniel; Traff, Ulf			How does mathematics anxiety impair mathematical abilities? Investigating the link between math anxiety, working memory, and number processing	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; LONGITUDINAL PREDICTORS; NUMERACY; CHILDREN; SKILLS; DISABILITIES; ACHIEVEMENT; PERFORMANCE; RISK; COMPREHENSION	In contemporary society, it is essential to have adequate mathematical skills. Being numerate has been linked to positive life outcomes and well-being in adults. It is also acknowledged that math anxiety (MA) hampers mathematical skills increasingly with age. Still, the mechanisms by which MA affect performance remain debated. Using structural equation modeling (SEM), we contrast the different ways in which MA has been suggested to interfere with math abilities. Our models indicate that MA may affect math performance through three pathways: (1) indirectly through working memory ability, giving support for the 'affective drop' hypothesis of MA's role in mathematical performance, (2) indirectly through symbolic number processing, corroborating the notion of domain-specific mechanisms pertaining to number, and (3) a direct effect of MA on math performance. Importantly, the pathways vary in terms of their relative strength depending on what type of mathematical problems are being solved. These findings shed light on the mechanisms by which MA may interfere with mathematical performance.	[Skagerlund, Kenny; Ostergren, Rickard; Vastfjall, Daniel; Traff, Ulf] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Vastfjall, Daniel] Linkoping Univ, JEDILab, Div Econ, Dept Management & Engn, Linkoping, Sweden	Linkoping University; Linkoping University	Skagerlund, K (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	kenny.skagerlund@liu.se	Västfjäll, Daniel/F-9629-2014	Skagerlund, Kenny/0000-0003-1894-3595; Vastfjall, Daniel/0000-0003-2873-4500	Marianne and Marcus Wallenberg Foundation [2014-0173]	Marianne and Marcus Wallenberg Foundation	This research was supported by a grant from the Marianne and Marcus Wallenberg Foundation (Dnr: 2014-0173; https://www.wallenberg.com/mmw/en) awarded to D. V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderisson U, 2007, APPL COGNITIVE PSYCH, V21, P1201, DOI 10.1002/acp.1317; Andersson U, 2008, J EDUC PSYCHOL, V100, P48, DOI 10.1037/0022-0663.100.1.48; Ashcraft MH, 2009, J PSYCHOEDUC ASSESS, V27, P197, DOI 10.1177/0734282908330580; ASHCRAFT MH, 1994, COGNITION EMOTION, V8, P97, DOI 10.1080/02699939408408931; Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196; Beilock SL, 2010, P NATL ACAD SCI USA, V107, P1860, DOI 10.1073/pnas.0910967107; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Butterworth B., 2005, HDB MATH COGNITION, V1st, P455; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Cirino PT, 2016, J EXP CHILD PSYCHOL, V145, P95, DOI 10.1016/j.jecp.2015.12.010; Cokely ET, 2012, JUDGM DECIS MAK, V7, P25; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2010, DEVELOPMENTAL SCI, V13, P508, DOI 10.1111/j.1467-7687.2009.00897.x; Dehaene S., 1997, NUMBER SENSE; Douglas H.P., 2017, J NUMERICAL COGNITIO, V3, P642, DOI [10.5964/jnc.v3i3.113, DOI 10.5964/JNC.V3I3.113]; Dowker A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00508; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuchs LS, 2005, J EDUC PSYCHOL, V97, P493, DOI 10.1037/0022-0663.97.3.493; Fuchs LS, 2010, CHILD DEV, V81, P1520, DOI 10.1111/j.1467-8624.2010.01489.x; Geary DC, 2010, LEARN INDIVID DIFFER, V20, P130, DOI 10.1016/j.lindif.2009.10.008; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Gebuis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025405; Georges C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01401; HEMBREE R, 1990, J RES MATH EDUC, V21, P33, DOI 10.2307/749455; Hunt TE, 2011, J PSYCHOEDUC ASSESS, V29, P455, DOI 10.1177/0734282910392892; Jordan NC, 2010, LEARN INDIVID DIFFER, V20, P82, DOI 10.1016/j.lindif.2009.07.004; Justicia-Galiano MJ, 2017, BRIT J EDUC PSYCHOL, V87, P573, DOI 10.1111/bjep.12165; Kline R., 2016, PRINCIPLES PRACTICE; Kucian K, 2015, EUR J PEDIATR, V174, P1, DOI 10.1007/s00431-014-2455-7; Kyttala M, 2008, EUR J PSYCHOL EDUC, V23, P77, DOI 10.1007/BF03173141; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lindskog M, 2017, COGNITION, V159, P156, DOI 10.1016/j.cognition.2016.11.014; Lindskog M, 2015, SCAND J PSYCHOL, V56, P132, DOI 10.1111/sjop.12189; Lyons IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048076; Maloney EA, 2011, Q J EXP PSYCHOL, V64, P10, DOI 10.1080/17470218.2010.533278; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer ML, 2010, LEARN INDIVID DIFFER, V20, P101, DOI 10.1016/j.lindif.2009.08.004; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Park D, 2014, J EXP PSYCHOL-APPL, V20, P103, DOI 10.1037/xap0000013; Parsons S., 2005, DOES NUMERACY MATTER; Paulos J., 1988, INNUMERACY MATH ILLI; Peters E, 2012, CURR DIR PSYCHOL SCI, V21, P31, DOI 10.1177/0963721411429960; Pletzer B, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00202; Ramirez G, 2011, SCIENCE, V331, P211, DOI 10.1126/science.1199427; RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Sasanguie D, 2017, COGNITION, V165, P26, DOI 10.1016/j.cognition.2017.04.007; Schneider M, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12372; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Skagerlund K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00675; Sowinski C, 2015, J EXP CHILD PSYCHOL, V131, P73, DOI 10.1016/j.jecp.2014.11.004; Suarez-Pellicioni M, 2016, COGN AFFECT BEHAV NE, V16, P3, DOI 10.3758/s13415-015-0370-7; Supekar K, 2015, J NEUROSCI, V35, P12574, DOI 10.1523/JNEUROSCI.0786-15.2015; Swanson HL, 2006, J EDUC PSYCHOL, V98, P265, DOI 10.1037/0022-0663.98.2.265; Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471; Szucs D, 2014, DEVELOPMENTAL SCI, V17, P506, DOI 10.1111/desc.12144; Traff U, 2018, J EXP CHILD PSYCHOL, V167, P369, DOI 10.1016/j.jecp.2017.11.010; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weller JA, 2013, J BEHAV DECIS MAKING, V26, P198, DOI 10.1002/bdm.1751; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T; Young CB, 2012, PSYCHOL SCI, V23, P492, DOI 10.1177/0956797611429134	67	21	22	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211283	10.1371/journal.pone.0211283	http://dx.doi.org/10.1371/journal.pone.0211283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HJ2YV	30682125	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500141
J	Wu, D; Zou, CX; Cao, W; Xiao, T; Gong, GL				Wu, Dan; Zou, Changxin; Cao, Wei; Xiao, Tong; Gong, Guoli			Ecosystem services changes between 2000 and 2015 in the Loess Plateau, China: A response to ecological restoration	PLOS ONE			English	Article							SOIL-EROSION; WIND EROSION; PATTERNS; CROPLAND; PROGRAM; FOREST; AREAS	The Loess Plateau of China is one of the most severe soil and water loss areas in the world. Since 1999, the Grain to Green Program (GTGP) has been implemented in the region. This study aimed to analyze spatial and temporal variations of ecosystem services from 2000 to 2015 to assess the effects of the GTGP, including carbon sequestration, water regulation, soil conservation and sand fixation. During the study period, the area of forest land and grassland significantly expanded, while the area of farmland decreased sharply. Ecosystem services showed an overall improvement with localized deterioration. Carbon sequestration, water regulation and soil conservation increased substantially. Sand fixation showed a decreasing trend mainly because of decreased wind speeds. There were synergies between carbon sequestration and water regulation, and tradeoffs between soil conservation and sand fixation. It was concluded that ecological projects have contributed significantly to the rehabilitation of the fragile ecosystems of this region. To make these projects more successful and sustainable, long-term management procedures are necessary to maintain and consolidate the improvements.	[Wu, Dan; Zou, Changxin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Cao, Wei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China; [Xiao, Tong] Minist Environm Protect, Satellite Environm Ctr, Beijing, Peoples R China; [Gong, Guoli] Shanxi Acad Environm Planning, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Cao, W (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Land Surface Pattern & Simulat, Beijing, Peoples R China.	caowei@igsnrr.ac.cn			National Key R&D Program of China [2017YFC0506404, 2017YFC0506606]; National Natural Science Foundation of China [41501117]; basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China [GYZX170306]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China	This research was funded by National Key R&D Program of China (2017YFC0506404, 2017YFC0506606), National Natural Science Foundation of China (41501117) and basic research funding for the central level scientific research institutes, Nanjing Institute of Environmental Sciences, Ministry of Environmental Protection, China (GYZX170306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHYS TEACH, DOI DOI 10.1119/1.2344558; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Chen YP, 2015, NAT GEOSCI, V8, P739, DOI 10.1038/ngeo2544; Costanza R., 1997, WORLD ENV, V387, P3, DOI [10.1038/387253a0, DOI 10.1038/387253A0]; Costanza R, 2017, ECOSYST SERV, V28, P1, DOI 10.1016/j.ecoser.2017.09.008; Fang HY, 2011, AFR J MICROBIOL RES, V5, P1414; Feng XM, 2012, HYDROL EARTH SYST SC, V16, P4161; Fryrear DW, 2000, J SOIL WATER CONSERV, V55, P183; Fu B.J., 2012, CHIN J NAT MED-CHINA, V34, P261; [巩国丽 Gong Guoli], 2014, [地理科学进展, Progress in Geography], V33, P825; Gong ZN, 2017, J GEOGR SCI, V27, P143, DOI 10.1007/s11442-017-1369-5; Halle S, 2007, RESTOR ECOL, V15, P358, DOI 10.1111/j.1526-100X.2007.00226.x; Heinsch F. A, 2003, USERS GUIDE VERSION; Hu YunFeng, 2017, Journal of Resources and Ecology, V8, P352, DOI 10.5814/j.issn.1674-764x.2017.04.006; Huang L, 2012, RENEW SUST ENERG REV, V16, P1291, DOI 10.1016/j.rser.2011.10.004; Jiang C, 2016, ECOL ENG, V93, P24, DOI 10.1016/j.ecoleng.2016.05.011; Joshi A.K., 2018, PROC NATL ACAD SCI I, P1, DOI [10.1007/s40011-018-0969-x, DOI 10.1007/S40011-018-0969-X]; Kim JK, 2014, QUATERN INT, V344, P75, DOI 10.1016/j.quaint.2014.07.036; Kinnell PI, 2010, EARTH SURF PROCESSES, V33, P1627; Li BY, 2018, ECOL INDIC, V84, P837, DOI 10.1016/j.ecolind.2017.10.001; Li YR, 2014, LAND USE POLICY, V39, P188, DOI 10.1016/j.landusepol.2014.02.016; Li Z, 2015, GEOMORPHOLOGY, V228, P462, DOI 10.1016/j.geomorph.2014.10.005; Liu J.H., 2013, J MT SCI-ENGL, V27, P113; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6; Liu Y, 2012, GEOMORPHOLOGY, V138, P404, DOI 10.1016/j.geomorph.2011.10.009; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Qiu GY, 2011, J ENVIRON QUAL, V40, P1745, DOI 10.2134/jeq2010.0263; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Renard K. G., 1997, AGR HDB; Rustomji P., 2008, WATER RESOUR RES, V44, P148; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Sun WY, 2013, J GEOGR SCI, V23, P1091, DOI 10.1007/s11442-013-1065-z; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang S, 2004, FOREST POLICY ECON, V6, P71, DOI 10.1016/S1389-9341(02)00078-3; Wei LN, 2013, CHINA SCIENCEPAPER, V8, P377; Xu J., 2002, INT ECON REV, V3, P56; Xu JT, 2006, ECOL ECON, V57, P595, DOI 10.1016/j.ecolecon.2005.05.008; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Yin RS, 2010, ENVIRON MANAGE, V45, P429, DOI 10.1007/s00267-009-9373-x; Zhang BQ, 2016, SCI TOTAL ENVIRON, V539, P436, DOI 10.1016/j.scitotenv.2015.08.132; Zhang HY, 2018, ECOL ENG, V116, P67, DOI 10.1016/j.ecoleng.2018.02.028; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; [赵安周 Zhao Anzhou], 2017, [自然资源学报, Journal of Natural Resources], V32, P449; [赵同谦 Zhao Tongqian], 2004, [自然资源学报, Journal of Natural Resources], V19, P480; Zhou Y., 1999, J MT SCI-ENGL, V17, P324	49	23	23	15	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0209483	10.1371/journal.pone.0209483	http://dx.doi.org/10.1371/journal.pone.0209483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689646	Green Submitted, gold, Green Published			2022-12-27	WOS:000457041800002
J	Lee, YJ; Shu, MS; Kim, JY; Kim, YH; Sim, KH; Sung, WJ; Eun, JR				Lee, Youn Ju; Shu, Mi-Sun; Kim, Jong-Yeon; Kim, Yun-Hye; Sim, Kyeong Hwa; Sung, Woo Jung; Eun, Jong Ryeol			Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway	PLOS ONE			English	Article							PHOSPHODIESTERASE-3 INHIBITOR CILOSTAZOL; ETHANOL-INDUCED DAMAGE; INDUCED LIVER-INJURY; OXIDATIVE STRESS; RAT-LIVER; KINASE; EXPRESSION; METFORMIN; AUTOPHAGY; DYSFUNCTION	Alcoholic liver disease (ALD) is a worldwide health problem and hepatocyte apoptosis has been associated with the development/progression of ALD. However, no definite effective pharmacotherapy for ALD is currently available. Cilostazol, a selective type III phosphodiesterase inhibitor has been shown to protect hepatocytes from ethanol-induced apoptosis. In the present study, the underlying mechanisms for the protective effects of cilostazol were examined. Primary rat hepatocytes were treated with ethanol in the presence or absence of cilostazol. Cell viability and intracellular cAMP were measured. Apoptosis was detected by Hoechst staining, TUNEL assay, and caspase-3 activity assay. The roles of cAMP and AMP-activated protein kinase (AMPK) pathways in the action of CTZ were explored using pharmacological inhibitors and siRNAs. Liver from mice received ethanol (5g/kg body weight) by oral gavage following cilostazol treatment intraperitoneally was obtained for measurement of apoptosis and activation of AMPK pathway. Cilostazol inhibited ethanolinduced hepatocyte apoptosis and potentiated the increases in cAMP level induced by forskolin. However, the anti-apoptotic effect of cilostazol was not reversed by an inhibitor of adenylyl cyclase. Interestingly, cilostazol activated AMPK and increased the level of LC3-II, a marker of autophagy. The inhibition of AMPK abolished the effects of cilostazol on LC3-II expression and apoptosis. Moreover, the inhibition of LKB1 and CaMKK2, upstream kinases of AMPK, dampened cilostazol-inhibited apoptosis as well as AMPK activation. In conclusion, cilostazol protected hepatocytes from apoptosis induced by ethanol mainly via AMPK pathway which is regulated by both LKB1 and CaMKK2. Our results suggest that cilostazol may have potential as a promising therapeutic drug for treatment of ALD.	[Lee, Youn Ju; Shu, Mi-Sun; Sim, Kyeong Hwa] Catholic Univ Daegu, Sch Med, Dept Pharmacol, Daegu, South Korea; [Kim, Jong-Yeon; Kim, Yun-Hye] Yeungnam Univ, Sch Med, Dept Physiol, Daegu, South Korea; [Sung, Woo Jung] Catholic Univ Daegu, Sch Med, Dept Pathol, Daegu, South Korea; [Eun, Jong Ryeol] Hanyang Univ, Myongj Hosp, Dept Internal Med, Coll Med, Goyang, South Korea	Catholic University of Daegu; Yeungnam University; Catholic University of Daegu; Hanyang University	Eun, JR (corresponding author), Hanyang Univ, Myongj Hosp, Dept Internal Med, Coll Med, Goyang, South Korea.	dreundavis@gmail.com		Eun, Jong Ryeol/0000-0002-8583-0737	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0069506]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (no. 2009-0069506).	Arsene D, 2016, HEPATOL INT, V10, P538, DOI 10.1007/s12072-015-9701-6; Avila DV, 2016, J PATHOL, V240, P96, DOI 10.1002/path.4760; Bai T, 2016, PHARMACOL RES, V105, P1, DOI 10.1016/j.phrs.2015.12.022; Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570; Bhattacharjee R, 2012, BIOCHEM BIOPH RES CO, V423, P85, DOI 10.1016/j.bbrc.2012.05.087; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Cai L, 2015, BIOCHEM BIOPH RES CO, V465, P381, DOI 10.1016/j.bbrc.2015.08.009; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chattipakorn SC, 2014, J GERIATR CARDIOL, V11, P151, DOI 10.3969/j.issn.1671-5411.2014.02.014; Choi BK, 2015, PHYTOTHER RES, V29, P1577, DOI 10.1002/ptr.5415; Fuest M, 2012, HEPATOLOGY, V55, P408, DOI 10.1002/hep.24699; Fujii T, 2017, J SURG RES, V213, P207, DOI 10.1016/j.jss.2017.02.020; Gobejishvili L, 2006, AM J PHYSIOL-GASTR L, V291, pG681, DOI 10.1152/ajpgi.00098.2006; Guo XL, 2016, EUR J PHARMACOL, V791, P578, DOI 10.1016/j.ejphar.2016.09.031; Hashimoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132835; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Ishii H, 2015, J CARDIOL, V66, P97, DOI 10.1016/j.jjcc.2015.03.011; Jang JY, 2018, CLIN MOL HEPATOL, V24, P93, DOI 10.3350/cmh.2017.0079; Jeon BH, 2015, METABOLISM, V64, P1444, DOI 10.1016/j.metabol.2015.07.014; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kim HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep31169; Kim J, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.16; Lee HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134486; Mandal S, 2014, ALCOHOL, V48, P123, DOI 10.1016/j.alcohol.2013.11.005; Mandal S, 2013, FOOD CHEM TOXICOL, V59, P236, DOI 10.1016/j.fct.2013.05.056; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506; Noh BK, 2011, BIOCHEM BIOPH RES CO, V414, P361, DOI 10.1016/j.bbrc.2011.09.077; Park SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160620; Park WS, 2010, INT IMMUNOPHARMACOL, V10, P1077, DOI 10.1016/j.intimp.2010.06.008; Ratchford EV, 2017, J VASC SURG, V66, P275, DOI 10.1016/j.jvs.2017.02.040; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Singal AK, 2014, CLIN GASTROENTEROL H, V12, P555, DOI 10.1016/j.cgh.2013.06.013; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tanano I, 2013, INVEST OPHTH VIS SCI, V54, P1443, DOI 10.1167/iovs.12-10115; Tseng SY, 2016, J VASC SURG, V63, P1051, DOI 10.1016/j.jvs.2014.10.103; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P3380, DOI 10.2741/3460; von Heesen M, 2015, LIVER TRANSPLANT, V21, P792, DOI 10.1002/lt.24114; Weng YI, 2000, EUR J PHARMACOL, V398, P323, DOI 10.1016/S0014-2999(00)00313-7; Wu DF, 2013, REDOX BIOL, V1, P552, DOI 10.1016/j.redox.2013.10.008; Xie XH, 2018, CELL STRESS CHAPERON, V23, P203, DOI 10.1007/s12192-017-0828-3; Yang LL, 2012, FREE RADICAL BIO MED, V53, P1170, DOI 10.1016/j.freeradbiomed.2012.06.029; Zhang M, 2017, AM J TRANSL RES, V9, P823	48	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2019	14	1							e0211415	10.1371/journal.pone.0211415	http://dx.doi.org/10.1371/journal.pone.0211415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3CE	30695051	Green Published, Green Submitted, gold			2022-12-27	WOS:000457046400033
J	Kim, Y; Lee, D; Lee, J; Lee, S; Lawler, S				Kim, Yangjin; Lee, Donggu; Lee, Junho; Lee, Seongwon; Lawler, Sean			Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model	PLOS ONE			English	Article							ANTITUMOR IMMUNE-RESPONSES; COLONY-STIMULATING FACTOR; NATURAL-KILLER-CELLS; TGF-BETA; LYMPHOCYTE RATIO; INTERFERON-BETA; T-CELLS; BREAST-CANCER; IN-VITRO; BONE-MARROW	Neutrophils display rapid and potent innate immune responses in various diseases. Tumor-associated neutrophils (TANs) however either induce or overcome immunosuppressive functions of the tumor microenvironment through complex tumor-stroma crosstalk. We developed a mathematical model to address the question of how phenotypic alterations between tumor suppressive N1 TANS, and tumor promoting N2 TANs affect nonlinear tumor growth in a complex tumor microenvironment. The model provides a visual display of the complex behavior of populations of TANs and tumors in response to various TGF-beta and IFN-beta stimuli. In addition, the effect of anti-tumor drug administration is incorporated in the model in an effort to achieve optimal anti-tumor efficacy. The simulation results from the mathematical model were in good agreement with experimental data. We found that the N2-to-N1 ratio (N21R) index is positively correlated with aggressive tumor growth, suggesting that this may be a good prognostic factor. We also found that the antitumor efficacy increases when the relative ratio (Dap) of delayed apoptotic cell death of N1 and N2 TANs is either very small or relatively large, providing a basis for therapeutically targeting prometastatic N2 TANs.	[Kim, Yangjin; Lee, Donggu; Lee, Junho] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Yangjin] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Lee, Seongwon] Natl Inst Math Sci, Div Math Models, Daejeon, South Korea; [Lawler, Sean] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Lawler, Sean] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Konkuk University; University System of Ohio; Ohio State University; National Institute for Mathematical Sciences (NIMS), Republic of Korea; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.; Kim, Y (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014	Kim, Yangjin/0000-0002-8905-8481	Konkuk University	Konkuk University	This work was supported by Konkuk University 2015 Research fund (www.konkuk.ac.kr, Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was supported by Konkuk University in 2015 (Yangjin Kim).	Abulaiti A, 2013, LUNG CANCER, V82, P204, DOI 10.1016/j.lungcan.2013.08.008; Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Aktas ON, 2018, J CANCER RES CLIN, V144, P997, DOI 10.1007/s00432-018-2635-3; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Andzinski L, 2016, INT J CANCER, V138, P1982, DOI 10.1002/ijc.29945; Andzinski L, 2015, INT J CANCER, V136, P572, DOI 10.1002/ijc.28957; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Arelaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154484; Atzpodien J, 2008, CANCER BIOTHER RADIO, V23, P129, DOI 10.1089/cbr.2007.0429; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; Bajetta E, 2008, NAT CLIN PRACT ONCOL, V5, P4, DOI 10.1038/ncponc1007; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bellocq A, 1998, AM J PATHOL, V152, P83; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Brockwell NK, 2017, CANCER IMMUNOL RES, V5, P871, DOI 10.1158/2326-6066.CIR-17-0150; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Calone I., 2012, Experimental Oncology, V34, P9; CARTWRIGHT GE, 1964, BLOOD, V24, P780, DOI 10.1182/blood.V24.6.780.780; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02537-y; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chiantore MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036909; Choe C, 2015, ONCOTARGETS THER, V8, P3665, DOI 10.2147/OTT.S89659; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cools-Lartigue J, 2014, CELL MOL LIFE SCI, V71, P4179, DOI 10.1007/s00018-014-1683-3; Corwin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079115; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; CRESTANI B, 1994, J CLIN INVEST, V94, P731, DOI 10.1172/JCI117392; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dale DC, 1998, TRANSFUSION, V38, P713, DOI 10.1046/j.1537-2995.1998.38898375509.x; de Kleijn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072249; Demers M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22946; Demidenko E., 2013, WILEY SERIES; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Doherty MR, 2018, DNA CELL BIOL, V37, P513, DOI 10.1089/dna.2018.4247; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2006, J THEOR BIOL, V241, P158, DOI 10.1016/j.jtbi.2005.11.015; Engblom C, 2017, SCIENCE, V358, DOI 10.1126/science.aal5081; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Ghosh D, 2016, CURR CANCER THER REV, V12, P237, DOI 10.2174/1573394713666170316124158; Gong L, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-154; Gordon-Weeks AN, 2017, HEPATOLOGY, V65, P1920, DOI 10.1002/hep.29088; Granot Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/701067; Granot Z, 2015, CANCER RES, V75, P4441, DOI 10.1158/0008-5472.CAN-15-1502; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Grimes M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aaq1087; Hagerling C, 2016, SEMIN IMMUNOL, V28, P197, DOI 10.1016/j.smim.2016.02.003; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hattar K, 2014, CANCER IMMUNOL IMMUN, V63, P1297, DOI 10.1007/s00262-014-1606-z; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Horie M, 2012, BIOCHEM BIOPH RES CO, V423, P158, DOI 10.1016/j.bbrc.2012.05.104; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Huang HL, 2012, ACTA BIOCH BIOPH SIN, V44, P737, DOI 10.1093/abbs/gms060; Huang QT, 2017, ONCOTARGET, V8, P16755, DOI 10.18632/oncotarget.15157; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Ibrahim SA, 2017, J IMMUNOL S, V198; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kasahara Y, 1997, BLOOD, V89, P1748, DOI 10.1182/blood.V89.5.1748.1748_1748_1753; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2018, P NATL ACAD SCI USA, V115, P4927, DOI 10.1073/pnas.1715295115; Kim Y, 2017, IEEE T BIO-MED ENG, V64, P519, DOI 10.1109/TBME.2016.2637828; Kim Y, 2015, MATH BIOSCI ENG, V12, P1141, DOI 10.3934/mbe.2015.12.1141; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114370; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00053; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kingwell E, 2014, J NEUROL NEUROSUR PS, V85, P1096, DOI 10.1136/jnnp-2013-307238; Kinoshita T, 2013, CANCER SCI, V104, P409, DOI 10.1111/cas.12099; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 2008, NAT CLIN PRACT ONCOL, V5, P2, DOI 10.1038/ncponc1004; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; Gabelloni ML, 2013, SEMIN IMMUNOPATHOL, V35, P423, DOI 10.1007/s00281-013-0364-x; Lee B, 2017, SCI REP-UK, V7, DOI 10.1038/srep39498; Lens MB, 2002, J CLIN ONCOL, V20, P1818, DOI 10.1200/JCO.2002.07.070; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Liang W, 2016, CANCER IMMUNOL RES, V4, P83, DOI 10.1158/2326-6066.CIR-15-0313; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7; Liu XM, 2017, ONCOTARGET, V8, P50209, DOI 10.18632/oncotarget.16854; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Madar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061353; Maeda S, 2014, J BIOL CHEM, V289, P23786, DOI 10.1074/jbc.M114.551879; Maini P, 2010, P INT C MATH IND; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masson V, 2004, FASEB J, V18, P234, DOI 10.1096/fj.04-2140fje; McKenna SD, 2004, J INTERF CYTOK RES, V24, P119, DOI 10.1089/107999004322813363; Mitselou A, 2010, HISTOL HISTOPATHOL, V25, P1257, DOI 10.14670/HH-25.1257; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Moroy G, 2012, ANTI-CANCER AGENT ME, V12, P565, DOI 10.2174/187152012800617696; Ni XY, 2012, ONCOL REP, V28, P615, DOI 10.3892/or.2012.1822; Oh SS, 2012, INT J MOL MED, V29, P1153, DOI 10.3892/ijmm.2012.936; Ohshio Y, 2013, ONCOL REP, V30, P1000, DOI 10.3892/or.2013.2505; Okada Y, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0040-y; Park MY, 2010, CANCER GENE THER, V17, P356, DOI 10.1038/cgt.2009.78; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Patel MR, 2015, ONCOTARGET, V6, P33165, DOI 10.18632/oncotarget.5320; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peng B, 2015, INT J CLIN EXP MED, V8, P3098; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pistelli M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1204-2; Catani JPP, 2016, TRANSL ONCOL, V9, P565, DOI 10.1016/j.tranon.2016.09.011; Powell DR, 2016, TRENDS IMMUNOL, V37, P41, DOI 10.1016/j.it.2015.11.008; Price TH, 1996, BLOOD, V88, P335; PRICE TH, 1977, J CLIN INVEST, V59, P475, DOI 10.1172/JCI108662; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qu J, 2017, ONCOTARGET, V9, P10147, DOI [10.18632/oncotarget, DOI 10.18632/ONCOTARGET]; Revels SL, 2018, J THORAC DIS, V10, P617, DOI 10.21037/jtd.2018.01.105; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rogge L, 1998, J IMMUNOL, V161, P6567; Romani L, 1997, J IMMUNOL, V158, P5349; ROSENSHEIN MS, 1979, J CLIN INVEST, V64, P580, DOI 10.1172/JCI109496; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Saha S, 2016, CANCER CELL, V30, P11, DOI 10.1016/j.ccell.2016.06.016; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Salmon P, 1996, J INTERF CYTOK RES, V16, P759, DOI 10.1089/jir.1996.16.759; Sangaletti S, 2014, CANCER DISCOV, V4, P110, DOI 10.1158/2159-8290.CD-13-0276; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Schaaf MB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0061-0; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Serizawa M, 2013, J THORAC ONCOL, V8, P259, DOI 10.1097/JTO.0b013e318279e942; Shaul ME, 2018, FEBS J, V285, P4316, DOI 10.1111/febs.14524; Shaul ME, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232221; Shen L, 2007, CLIN EXP IMMUNOL, V149, P155, DOI 10.1111/j.1365-2249.2007.03376.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shih CS, 2009, NEUROMOL MED, V11, P43, DOI 10.1007/s12017-009-8059-0; Shimizu K, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0710-7; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; STEINBACH KH, 1979, BLUT, V39, P27, DOI 10.1007/BF01008072; Stratigos M, 2016, TRANSL LUNG CANCER R, V5, P389, DOI 10.21037/tlcr.2016.08.04; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swierczak A, 2015, CANCER METAST REV, V34, P735, DOI 10.1007/s10555-015-9594-9; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takeshima T, 2016, P NATL ACAD SCI USA, V113, P11300, DOI 10.1073/pnas.1613187113; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Tavakoli Maryam, 2012, Mater Sociomed, V24, P203, DOI 10.5455/msm.2012.24.203-205; Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tuting T, 2016, SCIENCE, V352, P145, DOI 10.1126/science.aaf7300; Uribe-Querol E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/983698; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Wakabayashi T, 2008, J GENE MED, V10, P329, DOI 10.1002/jgm.1160; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Wang RF, 2006, SEMIN IMMUNOL, V18, P136, DOI 10.1016/j.smim.2006.01.008; Wang RF, 2006, SEMIN CANCER BIOL, V16, P73, DOI 10.1016/j.semcancer.2005.07.009; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weis JA, 2017, COMPUT METHOD APPL M, V314, P494, DOI 10.1016/j.cma.2016.08.024; WELCH DR, 1989, P NATL ACAD SCI USA, V86, P5859, DOI 10.1073/pnas.86.15.5859; Wheatley K, 2003, CANCER TREAT REV, V29, P241, DOI 10.1016/S0305-7372(03)00074-4; Xu YF, 2013, P NATL ACAD SCI USA, V110, P7726, DOI 10.1073/pnas.1302906110; Yan B, 2013, J IMMUNOL, V190, P5882, DOI 10.4049/jimmunol.1201881; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yuan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14273; Zeren S, 2015, INT SURG, V100, P1185, DOI 10.9738/INTSURG-D-15-00044.1; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	191	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2019	14	1							e0211041	10.1371/journal.pone.0211041	http://dx.doi.org/10.1371/journal.pone.0211041			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ3AL	30689655	Green Published, gold, Green Submitted			2022-12-27	WOS:000457041800019
J	Guo, Z; Han, JC; Li, J; Xu, Y; Wang, XL				Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan; Wang, Xiaoli			Effects of long-term fertilization on soil organic carbon mineralization and microbial community structure	PLOS ONE			English	Article							LAND-USE; BIOMASS; SEQUESTRATION; ECOSYSTEMS; GRASSLANDS; DYNAMICS; NITROGEN; MATTER; SIZE	Soil microorganisms play a pivotal role in carbon mineralization and their diversity is crucial to the function of soil ecosystems. However, the effects of long-term fertilization on microbial-mediated carbon mineralization are poorly understood. To identify the relative roles of microbes in carbon mineralization of yellow paddies, we investigated the long-term fertilization effects on soil properties and microbial communities and their relationships with carbon mineralization. The treatments included: no fertilization (CK), chemical fertilizer (NPK), organic fertilizer (M), and constant organic-inorganic fertilizer (MNPK). NPK treatment significantly increased soil water content (WC), while M and MNPK treatments significantly increased the content of soil organic carbon (SOC), total nitrogen (TN), soil microbial bio-mass carbon (SMBC), soil microbial biomass nitrogen (SMBN), and WC. Strong increases in CO2 emissions, potential mineralized carbon, and turnover rate constant were observed in both organic-fertilizer treatments (M and MNPK), relative to the CK treatment. These changes in soil properties can be attributed to the variation in microbial communities. NPK treatment had no significant effect. Different fertilization treatments changed soil microbial community; SOC and SMBN were the most important contributors to the variance in microbial community composition. The variations in community composition did not significant influence carbon mineralization; however, carbon mineralization was significantly influenced by the abundance of several non-dominant bacteria. The results suggest that SOC, SMBN, and non-dominant bacteria (Gemmatimonadetes and Latescibacteria), have a close relationship to carbon mineralization, and should be preferentially considered in predicting carbon mineralization under long-term fertilization.	[Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Minist Land & Resources China, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Shaanxi, Peoples R China; [Guo, Zhen; Han, Jichang; Li, Juan; Xu, Yan] Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Xiaoli] Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China	Ministry of Natural Resources of the People's Republic of China; Guizhou University	Wang, XL (corresponding author), Guizhou Univ, Coll Agr, Guiyang, Guizhou, Peoples R China.	15202974884@163.com	Guo, Zhen/P-4584-2018	Guo, Zhen/0000-0003-3383-6341	Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial [2018-JC18]; National Natural Science Foundation of China [31860160]; Shaanxi Provincial Land Engineering Construction Group Co., Ltd.	Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Land Engineering Construction Group Co., Ltd.	This research was supported by The Open Fundation of Chang'an University Key Laboratory of Land Rehabilitation of Shaanxi Provincial (2018-JC18) and The National Natural Science Foundation of China (31860160). The funding organizations had no role in the design, management, analysis, or interpretation of the data, nor in the preparation, review or approval of the manuscript. The funder, Juan Li, provided support in the funding acquisition and project administration of this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The company, Shaanxi Provincial Land Engineering Construction Group Co., Ltd. (Chairman of the board, Jichang Han), provided support in the form of salaries for authors [Zhen Guo, Juan Li], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beauregard MS, 2010, MICROB ECOL, V59, P379, DOI 10.1007/s00248-009-9583-z; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Creamer CA, 2015, SOIL BIOL BIOCHEM, V80, P175, DOI 10.1016/j.soilbio.2014.10.008; Dai XQ, 2017, SCI TOTAL ENVIRON, V580, P556, DOI 10.1016/j.scitotenv.2016.11.212; Dai XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082147; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eo J, 2016, AGR ECOSYST ENVIRON, V231, P176, DOI 10.1016/j.agee.2016.06.039; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fangueiro D, 2007, SOIL BIOL BIOCHEM, V39, P2608, DOI 10.1016/j.soilbio.2007.05.012; Garcia-Pausas J, 2011, SOIL BIOL BIOCHEM, V43, P1705, DOI 10.1016/j.soilbio.2011.04.016; Grunwald D, 2016, SOIL TILL RES, V164, P11, DOI 10.1016/j.still.2016.01.002; IPCC, 2001, CLIMATE CHANGE 2001; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Kemmitt SJ, 2008, SOIL BIOL BIOCHEM, V40, P61, DOI 10.1016/j.soilbio.2007.06.021; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Li J, 2018, PLOS ONE, V13; Liu ZJ, 2014, BIOL FERT SOILS, V50, P537, DOI 10.1007/s00374-013-0864-9; LONG SP, 1991, ECOL APPL, V1, P139, DOI 10.2307/1941807; Mi J, 2015, LANDSCAPE ECOL, V30, P1683, DOI 10.1007/s10980-014-0040-0; Minasny B, 2011, EUR J SOIL SCI, V62, P728, DOI 10.1111/j.1365-2389.2011.01386.x; Nelson D.W., 1996, METHODS SOIL ANAL PA, V5, P961, DOI [10.2136/sssabookser5.3.c34, DOI 10.2136/SSSABOOKSER5.3.C34]; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Ribeiro HM, 2010, J PLANT NUTR SOIL SC, V173, P39, DOI 10.1002/jpln.200900015; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Wagai R, 1998, SOIL BIOL BIOCHEM, V30, P1501, DOI 10.1016/S0038-0717(98)00041-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang HJ, 2015, BIOL FERT SOILS, V51, P137, DOI 10.1007/s00374-014-0957-0; Zhou P, 2016, AGR ECOSYST ENVIRON, V219, P93, DOI 10.1016/j.agee.2015.12.012	33	57	61	39	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211163	10.1371/journal.pone.0211163	http://dx.doi.org/10.1371/journal.pone.0211163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682124	gold, Green Published, Green Submitted			2022-12-27	WOS:000457037500116
J	Lee, DH; Yu, EJ; Aldahl, J; Yang, JL; He, YF; Hooker, E; Le, V; Mi, JQ; Olson, A; Wu, HQ; Geradts, J; Xiao, GQ; Gonzalgo, ML; Cardiff, RD; Sun, ZJ				Lee, Dong-Hong; Yu, Eun-Jeong; Aldahl, Joseph; Yang, Julie; He, Yongfeng; Hooker, Erika; Le, Vien; Mi, Jiaqi; Olson, Adam; Wu, Huiqing; Geradts, Joseph; Xiao, Guang Q.; Gonzalgo, Mark L.; Cardiff, Robert D.; Sun, Zijie			Deletion of the p16(INK4a) tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; ACTIVATION; P16; METHYLATION; CASTRATION; INHIBITOR; FREQUENCY; CLONING; PROTEIN	The tumor suppressor p16(Ink4a), encoded by the INK4a gene, is an inhibitor of cyclin D-dependent kinases 4 and 6, CDK4 and CDK6. This inhibition prevents the phosphorylation of the retinoblastoma protein (pRb), resulting in cellular senescence through inhibition of E2F-mediated transcription of S phase genes required for cell proliferation. The p16(Ink4a) plays an important role in tumor suppression, whereby its deletion, mutation, or epigenetic silencing is a frequently observed genetic alteration in prostate cancer. To assess its roles and related molecular mechanisms in prostate cancer initiation and progression, we generated a mouse model with conditional deletion of p16(Ink4a) in prostatic luminal epithelium. The mice underwent oncogenic transformation and developed prostatic intraepithelial neoplasia (PIN) from eight months of age, but failed to develop prostatic tumors. Given the prevalence of aberrant androgen signaling pathways in prostate cancer initiation and progression, we then generated R26hAR(L/wt):p16(L/L): PB-Cre4 compound mice, in which conditional expression of the human AR transgene and deletion of p16(Ink4a) co-occur in prostatic luminal epithelial cells. While R26hAR(L/wt):PB-Cre4 mice showed no visible pathological changes, R26hAR(L/wt):p16(L/L): PB-Cre4 compound mice displayed an early onset of high-grade PIN (HGPIN), prostatic carcinoma, and metastatic lesions. Strikingly, we observed tumors resembling human sarcomatoid carcinoma with intermixed focal regions of signet ring cell carcinoma (SRCC) in the prostates of the compound mice. Further characterization of these tumors showed they were of luminal epithelial cell origin, and featured characteristics of epithelial to mesenchymal transition (EMT) with enhanced proliferative and invasive capabilities. Our results not only implicate a biological role for AR expression and p16(Ink4a) deletion in the pathogenesis of prostatic SRCC, but also provide a new and unique genetically engineered mouse (GEM) model for investigating the molecular mechanisms for SRCC development.	[Lee, Dong-Hong; Yu, Eun-Jeong; Aldahl, Joseph; Yang, Julie; He, Yongfeng; Hooker, Erika; Le, Vien; Mi, Jiaqi; Olson, Adam; Sun, Zijie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Wu, Huiqing] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA USA; [Geradts, Joseph] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [Xiao, Guang Q.] Univ South Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Urol, Miami, FL 33136 USA; [Cardiff, Robert D.] Univ Calif Davis, Comparat Med, Davis, CA 95616 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Southern California; University of Miami; University of California System; University of California Davis	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	zjsun@coh.org	Mi, Jiaqi/GVU-4732-2022; le, vien/GWV-7308-2022; He, Yongfeng/AAR-8257-2020	Mi, Jiaqi/0000-0002-6537-7795; Olson, Adam W./0000-0003-3118-0393; Aldahl, Joseph/0000-0001-9664-5644; Hooker, Erika/0000-0002-4515-4041	 [NIHR01CA070297];  [NIHR01CA151623];  [NIHR01CA166894];  [NIHR21CA190021];  [NIHR01DK104941];  [NIHP30CA033572]; NATIONAL CANCER INSTITUTE [R01CA166894, P30CA093373, R01CA070297, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIHR01CA070297 for ZJS, NIHR01CA151623 for ZJS, NIHR01CA166894 for ZJS, NIHR21CA190021 for ZJS, NIHR01DK104941 for ZJS, and NIHP30CA033572 for JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agus DB, 1999, J NATL CANCER I, V91, P1869, DOI 10.1093/jnci/91.21.1869; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Chakravarti A, 2003, J CLIN ONCOL, V21, P3328, DOI 10.1200/JCO.2003.12.151; Chakravarti A, 2007, J CLIN ONCOL, V25, P3082, DOI 10.1200/JCO.2006.08.4152; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chi SG, 1997, CLIN CANCER RES, V3, P1889; Chrysanthos NV, 2018, AM J GASTROENTEROL, V113, P1427, DOI 10.1038/s41395-018-0099-3; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; D'Abronzo LS, 2017, ONCOGENE, V36, P6359, DOI 10.1038/onc.2017.233; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; DUNDORE PA, 1995, CANCER, V76, P1035, DOI 10.1002/1097-0142(19950915)76:6<1035::AID-CNCR2820760618>3.0.CO;2-8; Feng W, 2015, J BUON, V20, P1074; Fujita K, 2004, INT J UROL, V11, P178, DOI 10.1111/j.1442-2042.2003.00763.x; Gadhikar MA, 2018, CANCER RES, V78, P781, DOI 10.1158/0008-5472.CAN-17-2802; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; GUERIN D, 1993, HISTOPATHOLOGY, V22, P367, DOI 10.1111/j.1365-2559.1993.tb00137.x; Hansel DE, 2006, AM J SURG PATHOL, V30, P1316, DOI 10.1097/01.pas.0000209838.92842.bf; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jarrard DF, 1997, GENE CHROMOSOME CANC, V19, P90, DOI 10.1002/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Kubota Y, 1995, PROSTATE, V27, P314, DOI 10.1002/pros.2990270604; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Nichetti F, 2017, TUMORI; Ortiz B, 2014, P NATL ACAD SCI USA, V111, P8149, DOI 10.1073/pnas.1401952111; Pang A, 2018, J CLIN ONCOL, V36, P210, DOI 10.1200/JCO.2017.74.9523; Paplomata E, 2011, J CLIN ONCOL, V29, pE627, DOI 10.1200/JCO.2011.35.2385; PATEL D, 1991, BIOCHEM PHARMACOL, V42, P1577, DOI 10.1016/0006-2952(91)90427-7; Perinchery G, 1999, INT J CANCER, V83, P610, DOI 10.1002/(SICI)1097-0215(19991126)83:5<610::AID-IJC7>3.0.CO;2-2; Qian JQ, 1997, HUM PATHOL, V28, P143, DOI 10.1016/S0046-8177(97)90097-6; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodrigues DN, 2015, HISTOPATHOLOGY, V66, P898, DOI 10.1111/his.12493; Saito S, 1999, UROLOGY, V54, P141, DOI 10.1016/S0090-4295(98)00595-0; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; SANCHEZ ER, 1990, BIOCHEMISTRY-US, V29, P5145, DOI 10.1021/bi00473a021; SHANNON RL, 1992, CANCER, V69, P2676, DOI 10.1002/1097-0142(19920601)69:11<2676::AID-CNCR2820691109>3.0.CO;2-P; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Sullivan W. P., 1992, J STEROID BIOCHEM, V43, P37; Wang Y, 2017, PHARMACOGENOMICS, V18, P77, DOI 10.2217/pgs-2016-0075; Warner JN, 2010, MAYO CLIN PROC, V85, P1130, DOI 10.4065/mcp.2010.0463; Wei LY, 2017, J ZHEJIANG UNIV-SC B, V18, P1026, DOI 10.1631/jzus.B1700159; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	57	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2019	14	1							e0211153	10.1371/journal.pone.0211153	http://dx.doi.org/10.1371/journal.pone.0211153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI8IY	30677079	gold, Green Published, Green Submitted			2022-12-27	WOS:000456700400054
J	Cerritelli, F; van Dun, PLS; Esteves, JE; Consorti, G; Sciomachen, P; Lacorte, E; Vanacore, N; Marasco, ML; Maggiani, A; Cavallaro, A; Silvestri, D; Zurlo, J; Petracca, M; Fornari, M; Bersan, V; Lo Voi, G; Papa, L; Tamagnini, S; Filipazzi, R; Stirpe, T; Colonna, S; Gavazzi, A; Manzotti, A; Bergna, A; Marco, S; Franscini, F; Donnaquio, G; Parisi, A; Valente, M; Botti, E				Cerritelli, Francesco; van Dun, Patrick L. S.; Esteves, Jorge E.; Consorti, Giacomo; Sciomachen, Paola; Lacorte, Eleonora; Vanacore, Nicola; Marasco, Marcello Luca; Maggiani, Alberto; Cavallaro, Antonio; Silvestri, Dario; Zurlo, Joseph; Petracca, Marco; Fornari, Mauro; Bersan, Veronica; Lo Voi, Giacomo; Papa, Liria; Tamagnini, Sandro; Filipazzi, Roberta; Stirpe, Tatiana; Colonna, Saverio; Gavazzi, Alessandro; Manzotti, Andrea; Bergna, Andrea; Marco, Sbarbaro; Franscini, Federico; Donnaquio, Guglielmo; Parisi, Alessandro; Valente, Massimo; Botti, Emanuele		OPERA-IT Grp	The Italian Osteopathic Practitioners Estimates and RAtes (OPERA) study: A cross sectional survey	PLOS ONE			English	Article								The prevalence of osteopathic practitioners, their professional profile and features of their clinical practice, particularly where statutory regulation does not yet exist, are still significantly underreported. The Osteopathic Practitioners Estimates and RAtes (OPERA) project was developed as an European-based census dedicated to profiling the osteopathic profession across Europe. The present study aimed to describe the osteopathic practitioners and the profession in Italy. A voluntary, online based, closed-ended survey was distributed across Italy in the period between February and June 2017. An e-based campaign was set up to reach the Italian osteopathic professionals. Participants were asked to complete the forms by filling in the information regarding the demographics, working status and professional activities, education, consultation fees, patient complaints, treatment and management. The survey was completed by 4816 individuals. 196 people started the survey but did not finish, which corresponds to a 4% attrition rate. The majority of respondents were males (66.7%). The modal age group was 30-39 (40.0%). 73.8% of respondents had a previous academic degree, mainly in the fields of sports science (36.4%) and physiotherapy (25.3%). 25.6% declared not to have a previous academic degree. The majority of respondents declared to work alone (58.4%), while the remaining declared to work in association with other professionals. The osteopaths/citizens ratio was 8.0 osteopaths/100,000 citizens. The profile of osteopaths in Italy seems to be characterised by a self-employed young adult male working mostly as a sole practitioner, who has been trained as osteopath through a part-time curriculum and had a previous degree mostly in the fields of sports science or physiotherapy. These results provide important insights into the osteopathic profession in Italy. The varied professional educational backgrounds need to be considered with regard to the implementation of a professional licensing process and future pre-registration education in the country. The number of respondents is an estimate of the actual number of Italian osteopaths. Only the completion of the regulatory process and the creation of the mandatory official register will allow to know the number of Italy based osteopaths.	[Cerritelli, Francesco; Consorti, Giacomo] Fdn COME Collaborat, Clin Human Based Res Dept, Pescara, Italy; [van Dun, Patrick L. S.] Fdn COME Collaborat, Belgium Natl Ctr, Mechelen, Belgium; [Esteves, Jorge E.] Fdn COME Collaborat, Gulf Natl Ctr, Riyadh, Saudi Arabia; [Esteves, Jorge E.] Inst Piaget, Lisbon, Portugal; [Sciomachen, Paola] Registro Osteopati Italia, Milan, Italy; [Lacorte, Eleonora; Vanacore, Nicola] Natl Inst Hlth, Rome, Italy; [Marasco, Marcello Luca] ABEos, Laquila, Italy; [Maggiani, Alberto] AIMO, Saronno, Italy; [Cavallaro, Antonio] AISERCO, Palermo, Italy; [Silvestri, Dario] ASOMI, Turin, Italy; [Zurlo, Joseph; Petracca, Marco] CERDO, Rome, Italy; [Fornari, Mauro] CIO, Parma, Italy; [Bersan, Veronica] CSDOI, Verona, Italy; [Lo Voi, Giacomo] CSOT, Rome, Italy; [Papa, Liria] ICOM, Milan, Italy; [Tamagnini, Sandro] ICOMM, Rome, Italy; [Filipazzi, Roberta] IEMO, Genoa, Italy; [Stirpe, Tatiana] Meta Osteopatia, Rome, Italy; [Colonna, Saverio] OSCE, Bologna, Italy; [Gavazzi, Alessandro] SOFI, Rome, Italy; [Manzotti, Andrea; Bergna, Andrea] SOMA, Milan, Italy; [Marco, Sbarbaro] SSOI, Turin, Italy; [Franscini, Federico] APO, Turin, Italy; [Donnaquio, Guglielmo] Osteopatia Bambini, Imperia, Italy; [Parisi, Alessandro] SIOS, Imperia, Italy; [Valente, Massimo] Tuttosteopatia, Bisceglie, Italy; [Botti, Emanuele] Adv Osteopathy, Milan, Italy	Istituto Superiore di Sanita (ISS)	Cerritelli, F (corresponding author), Fdn COME Collaborat, Clin Human Based Res Dept, Pescara, Italy.	fcerritelli@comecollaboration.org	Vanacore, Nicola/ABC-7196-2021; Cerritelli, Francesco/AAJ-5003-2020; Cerritelli, Francesco/O-8416-2015	Lacorte, Eleonora/0000-0001-8530-9207; Consorti, Giacomo/0000-0003-3085-283X; Cerritelli, Francesco/0000-0002-2963-9620; Esteves, Jorge/0000-0001-9637-678X	Registro Osteopati d'Italia, ROI-2016	Registro Osteopati d'Italia, ROI-2016	This work was supported by the Registro Osteopati d'Italia, ROI-2016 (www.roi.it) to FC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, OST OST MED GLOB VIE; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bleakley A, 2013, MED EDUC, V47, P59, DOI 10.1111/j.1365-2923.2012.04351.x; Burke SR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-227; CEN// TC. Project Committee, 2015, OST HEALTHC PROV MAI; Drumare J.-E., 2012, RAP OSEOSTEO OST EXC; Dubois TCJ, 2012, OSTEOPATHIC TEACHING; Dyson B, 2014, IMPROVING GEN PRACTI; Eumetra Monterosa, 2017, OP IT SULL; European Parliament, NUTS CLASS NOM TERR; Fawkes C, 2010, STANDARDISED DATA CO; Forum for Osteopathic Regulation in Europe, 2018, REGULATION; General Osteopathic Council, 2012, OST OP SURV; Guo YM, 2016, AM J PUBLIC HEALTH, V106, P1422, DOI 10.2105/AJPH.2016.303198; ISTAT, 2018, POP RES GENN 2018; Jamison JR, 1991, AUST J OSTEOPATHY, V3, P24; KPMG, 2011, OST PRACT; Landurier G, 2018, OBSERVATOIRE SOCIOEC; Licciardone JC, 2011, J AM OSTEOPATH ASSOC, V111, P670; McDonnell A, 2006, BRIT MED J, V332, P109, DOI 10.1136/bmj.332.7533.109; McGrath MC, 2015, INT J OSTEOPATH MED, V18, P130, DOI 10.1016/j.ijosm.2015.01.004; Orrock P, 2009, INT J OSTEOPATH MED, V12, P14, DOI 10.1016/j.ijosm.2008.04.002; Orrock PJ, 2009, INT J OSTEOPATH MED, V12, P128, DOI 10.1016/j.ijosm.2009.06.001; Osteopathic International Alliance, 2014, SCOP PRACT; van Dun PLS, 2016, INT J OSTEOPATH MED, V20, P3, DOI 10.1016/j.ijosm.2016.01.003; Vaucher P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023770; Vogel S, 2008, INT J OSTEOPATH MED, P153, DOI 10.1016/j.ijosm.2008.08.007; World Health Organization, 2010, BENCHM TRAIN TRAD CO	28	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2019	14	1							e0211353	10.1371/journal.pone.0211353	http://dx.doi.org/10.1371/journal.pone.0211353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HJ2YV	30682169	Green Published, Green Submitted, gold			2022-12-27	WOS:000457037500154
J	Brusa, P; Allais, G; Scarinzi, C; Baratta, F; Parente, M; Rolando, S; Gnavi, R; Spadea, T; Costa, G; Benedetto, C; Mana, M; Giaccone, M; Mandelli, A; Manzoni, GC; Bussone, G				Brusa, Paola; Allais, Gianni; Scarinzi, Cecilia; Baratta, Francesca; Parente, Marco; Rolando, Sara; Gnavi, Roberto; Spadea, Teresa; Costa, Giuseppe; Benedetto, Chiara; Mana, Massimo; Giaccone, Mario; Mandelli, Andrea; Manzoni, Gian Camillo; Bussone, Gennaro			Self-medication for migraine: A nationwide cross-sectional study in Italy	PLOS ONE			English	Article							HEADACHE; CARE; DISORDERS; EUROPE; COST	Headache disorders are considered the second leading cause of years lived with disability worldwide, and 90% of people have a headache episode at least once a year, thus representing a relevant public health priority. As the pharmacist is often the first and only point of reference for people complaining of headache, we carried out a survey in a nationwide sample of Italian pharmacies, in order to describe the distribution of migraine or non-migraine type headaches and medicines overuse among people entering pharmacies seeking for self-medication; and to evaluate the association, in particular of migraine, with socio-demographic and clinical characteristics, and with the pathway of care followed by the patients. A 14-item questionnaire, including socio-demographic and clinical factors, was administered by trained pharmacists to subjects who entered a pharmacy requesting self-medication for a headache attack. The ID Migraine TM Screener was used to classify headache sufferers in four classes. From June 2016 to January 2017, 4424 people have been interviewed. The prevalence of definite migraines was 40%, significantly higher among women and less educated people. About half of all headache sufferers and a third of migraineurs do not consider their condition as a disease and are not cared by any doctor. Among people seeking self medication in pharmacies for acute headache attacks, the rate of definite or probable migraine is high, and a large percentage of them is not correctly diagnosed and treated. The pharmacy can be a valuable observatory for the study of headaches, and the first important step to improve the quality of care delivered to these patients.	[Brusa, Paola; Baratta, Francesca; Parente, Marco] Univ Turin, Dept Sci & Technol Drugs, Turin, Italy; [Brusa, Paola; Giaccone, Mario] Order Pharmacists Turin, Turin, Italy; [Allais, Gianni; Rolando, Sara; Benedetto, Chiara] Univ Turin, Dept Surg Sci, Womens Headache Ctr, Turin, Italy; [Allais, Gianni; Manzoni, Gian Camillo; Bussone, Gennaro] Italian Headache Fdn, FI CEF Onlus, Milan, Italy; [Scarinzi, Cecilia; Gnavi, Roberto; Spadea, Teresa; Costa, Giuseppe] ASL TO3, Epidemiol Unit, Turin, Italy; [Mana, Massimo] ATF Informat, Cuneo, Italy; [Giaccone, Mario; Mandelli, Andrea] Federat Orders Italian Pharmacists, FOFI, Rome, Italy	University of Turin; University of Turin	Brusa, P (corresponding author), Univ Turin, Dept Sci & Technol Drugs, Turin, Italy.; Brusa, P (corresponding author), Order Pharmacists Turin, Turin, Italy.	paola.brusa@unito.it	costa, giuseppe/K-2526-2016; Gnavi, Roberto/J-9263-2016; Allais, Gianni/AAE-6244-2019; Baratta, Francesca/AAL-8754-2021; Spadea, Teresa/K-4991-2016	Gnavi, Roberto/0000-0003-1919-2199; Allais, Gianni/0000-0002-1946-0109; Baratta, Francesca/0000-0001-5483-8501; Spadea, Teresa/0000-0002-0771-0545; BRUSA, Paola/0000-0001-6266-4492; COSTA, Giuseppe/0000-0003-3187-4889	FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy; Federation of the Orders of Italian Pharmacists (FOFI)	FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy; Federation of the Orders of Italian Pharmacists (FOFI)	The authors declare that this study was funded by FOFI, Federation of the Orders of Italian Pharmacists, Rome, Italy. The source of the funding had no role in the design of the study or the analysis and interpretation of the data. The role of the Federation was solely to verify that the study had been conducted in accordance with the agreed methodology.; The authors would like to thank the Federation of the Orders of Italian Pharmacists (FOFI) for its contribution both to the extension of the project to the national level and financial support and the Italian Headache Foundation (FICEF Onlus) for its contribution in drawing up the project and the organisation of the online training course for pharmacists that participated in the study.	Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Brusa P, 2015, NEUROL SCI, V36, pS93, DOI 10.1007/s10072-015-2156-7; Brusa P, 2014, NEUROL SCI, V35, pA5, DOI 10.1007/s10072-014-1733-5; Brusa P, 2017, NEUROL SCI, V38, pS15, DOI 10.1007/s10072-017-2908-7; Cevoli S, 2009, CEPHALALGIA, V29, P1285, DOI 10.1111/j.1468-2982.2009.01874.x; D'Amico D, 2017, NEUROL SCI, V38, pS3, DOI 10.1007/s10072-017-2891-z; Dodick DW, 2018, HEADACHE, V58, P1358, DOI 10.1111/head.13426; Fischer M, 2016, HEADACHE, V56, P952, DOI 10.1111/head.12820; Giaccone M, 2014, NEUROL SCI, V35, pA1, DOI 10.1007/s10072-014-1732-6; Horvat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052510; Katsarava Z, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0839-1; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Lipton RB, 1998, HEADACHE, V38, P87, DOI 10.1046/j.1526-4610.1998.3802087.x; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Manzoni GC, 2011, J HEADACHE PAIN, V12, P585, DOI 10.1007/s10194-011-0393-6; Manzoni Gian Camillo, 2010, Handb Clin Neurol, V97, P3, DOI 10.1016/S0072-9752(10)97001-2; Martelletti P, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-017-0830-2; MATHEW NT, 1982, HEADACHE, V22, P66, DOI 10.1111/j.1526-4610.1982.hed2202066.x; Miller Sarah, 2014, Practitioner, V258, P19; Pugliatti M, 2008, NEUROL SCI, V29, P99, DOI 10.1007/s10072-008-0868-7; Rapoport AM, 2004, NEUROL SCI, V25, pS258, DOI 10.1007/s10072-004-0301-9; Saylor D, 2018, SEMIN NEUROL, V38, P182, DOI 10.1055/s-0038-1646946; UNESCO Institute for Statistics, 2012, INT STAND CLASS ED I; Vandenbussche N, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0875-x; Viana M, 2018, CEPHALALGIA, V38, P383, DOI 10.1177/0333102416683917; World Health Organization, 2011, LIFT BURD 2011 ATL H	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2019	14	1							e0211191	10.1371/journal.pone.0211191	http://dx.doi.org/10.1371/journal.pone.0211191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HI4TC	30673780	Green Published, gold			2022-12-27	WOS:000456442800080
